FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Al Nazawi, AM
   Aqili, J
   Alzahrani, M
   McCall, PJ
   Weetman, D
AF Al Nazawi, Ashwaq M.
   Aqili, Jabir
   Alzahrani, Mohammed
   McCall, Philip J.
   Weetman, David
TI Combined target site (kdr) mutations play a primary role in highly
   pyrethroid resistant phenotypes of Aedes aegypti from Saudi Arabia
SO PARASITES & VECTORS
LA English
DT Article
DE Dengue; Saudi Arabia; Aedes aegypti; Insecticide resistance; Piperonyl
   butoxide (PBO); Knockdown resistance
ID GATED SODIUM-CHANNEL; INSECTICIDE RESISTANCE; KNOCKDOWN RESISTANCE;
   DENGUE VECTOR; PIPERONYL BUTOXIDE; POINT MUTATIONS; GENE; VACCINE;
   V1016G; F1534C
AB Background: Pyrethroid resistance is a threat to effective vector control of Aedes aegypti, the vector of dengue, Zika and other arboviruses, but there are many major knowledge gaps on the mechanisms of resistance. In Jeddah and Makkah, the principal dengue-endemic areas of Saudi Arabia, pyrethroids are used widely for Ae. aegypti control but information about resistance remains sparse, and the underlying genetic basis is unknown. Findings from an ongoing study in this internationally significant area are reported here.
   Methods: Aedes aegypti collected from each city were raised to adults and assayed for resistance to permethrin, deltamethrin (with and without the synergist piperonyl butoxide, PBO), fenitrothion, and bendiocarb. Two fragments of the voltage-gated sodium channel (Vgsc), encompassing four previously identified mutation sites, were sequenced and subsequently genotyped to determine associations with resistance. Expression of five candidate genes (CYP9J10, CYP9J28, CYP9J32, CYP9M6, ABCB4) previously associated with pyrethroid resistance was compared between assay survivors and controls.
   Results: Jeddah and Makkah populations exhibited resistance to multiple insecticides and a similarly high prevalence of resistance to deltamethrin compared to a resistant Cayman strain, with a significant influence of age and exposure duration on survival. PBO pre-exposure increased pyrethroid mortality significantly in the Jeddah, but not the Makkah strain. Three potentially interacting Vgsc mutations were detected: V1016G and S989P were in perfect linkage disequilibrium in each strain and strongly predicted survival, especially in the Makkah strain, but were in negative linkage disequilibrium with 1534C, though some females with the Vgsc triple mutation were detected. The candidate gene CYP9J28 was significantly over-expressed in Jeddah compared to two susceptible reference strains, but none of the candidate genes was consistently up- regulated to a significant level in the Makkah strain.
   Conclusions: Despite their proximity, Makkah and Jeddah exhibit significant differences in pyrethroid resistance phenotypes, with some evidence to suggest a different balance of mechanisms, for example with more impact associated with CYP450s in the Jeddah strain, and the dual kdr mutations 989P and 1016G in the more resistant Makkah strain. The results overall demonstrate a major role for paired target site mutations in pyrethroid resistance and highlight their utility for diagnostic monitoring.
C1 [Al Nazawi, Ashwaq M.; McCall, Philip J.; Weetman, David] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Al Nazawi, Ashwaq M.; Aqili, Jabir; Alzahrani, Mohammed] Saudi Minist Hlth, Riyadh, Saudi Arabia.
RP Al Nazawi, AM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.; Al Nazawi, AM (corresponding author), Saudi Minist Hlth, Riyadh, Saudi Arabia.
EM A.Alnazawi@liverpool.ac.uk
RI Weetman, David/M-1261-2014
OI Weetman, David/0000-0002-5820-1388; McCall, Philip/0000-0002-0007-3985
FU Saudi Cultural Bureau; EUEuropean Union (EU) [FP7-281803]
FX This work was supported by a PhD Studentship from the Saudi Cultural
   Bureau to Ashwaq M AI Nazawi. PJM was supported in part by EU grant
   FP7-281803 IDAMS (www.idams.eu). The contents of this publication are
   the sole responsibility of the authors and do not necessarily reflect
   the views of the European Commission. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alsheikh A. A., 2016, Biosciences, Biotechnology Research Asia, V13, P155, DOI 10.13005/bbra/2018
   Aziz AT, 2011, ASIAN PAC J TROP DIS, V1, P94, DOI DOI 10.1016/S2222-1808(11)60044-3
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Betancourt-Cravioto M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003009
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x
   Biosystems A., 2008, GUID PERF REL QUANT, P1
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Fakeeh M, 2001, AM J TROP MED HYG, V65, P764, DOI 10.4269/ajtmh.2001.65.764
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haq Z, 2013, E MEDITERR HEALTH J, V19, P888
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916
   Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Sanchez-Arroyo H, 2001, J ECON ENTOMOL, V94, P1209, DOI 10.1603/0022-0493-94.5.1209
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, 2006, GUID TEST MOSQ AD IN
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
NR 51
TC 14
Z9 14
U1 1
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 27
PY 2017
VL 10
AR 161
DI 10.1186/s13071-017-2096-6
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EQ0OF
UT WOS:000397769800002
PM 28347352
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Fitzgibbon, WE
   Morgan, JJ
   Webb, GF
AF Fitzgibbon, W. E.
   Morgan, J. J.
   Webb, G. F.
TI An outbreak vector-host epidemic model with spatial structure: the
   2015-2016 Zika outbreak in Rio De Janeiro
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Criss-cross dynamics; Local reproduction number; Zika epidemic
ID REACTION-DIFFUSION SYSTEM; ASYMPTOTIC PROFILES; AEDES-ALBOPICTUS;
   STEADY-STATES; DISEASE; CIRCULATION; AEGYPTI; BORNE
AB Background: A deterministic model is developed for the spatial spread of an epidemic disease in a geographical setting. The disease is borne by vectors to susceptible hosts through criss-cross dynamics. The model is focused on an outbreak that arises from a small number of infected hosts imported into a subregion of the geographical setting. The goal is to understand how spatial heterogeneity of the vector and host populations influences the dynamics of the outbreak, in both the geographical spread and the final size of the epidemic.
   Methods: Partial differential equations are formulated to describe the spatial interaction of the hosts and vectors. The partial differential equations have reaction-diffusion terms to describe the criss-cross interactions of hosts and vectors. The partial differential equations of the model are analyzed and proven to be well-posed. A local basic reproduction number for the epidemic is analyzed.
   Results: The epidemic outcomes of the model are correlated to the spatially dependent parameters and initial conditions of the model. The partial differential equations of the model are adapted to seasonality of the vector population, and applied to the 2015-2016 Zika seasonal outbreak in Rio de Janeiro Municipality in Brazil.
   Conclusions: The results for the model simulations of the 2015-2016 Zika seasonal outbreak in Rio de Janeiro Municipality indicate that the spatial distribution and final size of the epidemic at the end of the season are strongly dependent on the location and magnitude of local outbreaks at the beginning of the season. The application of the model to the Rio de Janeiro Municipality Zika 2015-2016 outbreak is limited by incompleteness of the epidemic data and by uncertainties in the parametric assumptions of the model.
C1 [Fitzgibbon, W. E.; Morgan, J. J.] Univ Houston, Dept Math, Houston, TX 77204 USA.
   [Webb, G. F.] Vanderbilt Univ, Dept Math, Nashville, TN 37240 USA.
RP Webb, GF (corresponding author), Vanderbilt Univ, Dept Math, Nashville, TN 37240 USA.
EM glenn.f.webb@vanderbilt.edu
CR Allen LJS, 2008, DISCRETE CONT DYN-A, V21, P1
   Anita S, 2009, DISCRETE CONT DYN-B, V11, P805, DOI 10.3934/dcdsb.2009.11.805
   BAILEY NTJ, 1957, MATH THEORY EPIDEMIC
   Bastos L, 2016, BIORXIV055475
   Bogoch II, 2017, LANCET INFECT DIS
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CAPASSO V, 1978, SIAM J APPL MATH, V35, P274, DOI 10.1137/0135022
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   CDC, 2016, ZIK VIR
   Chowell G, 2016, PLOS CURR, V31
   da Saude M, 2016, MONITORAMENTO CASES, V47
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fitzgibbon WE, 2004, DIFFER INTEGRAL EQU, V17, P781
   Fitzgibbon WE, 2005, BIOL INVASIONS, V7, P863, DOI 10.1007/s10530-005-5210-1
   FITZGIBBON WE, 1995, MATH BIOSCI, V128, P131, DOI 10.1016/0025-5564(94)00070-G
   FITZGIBBON WE, 1994, J MATH ANAL APPL, V184, P399, DOI 10.1006/jmaa.1994.1209
   Fitzgibbon WE, 2008, LECT NOTES MATH, P115
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Ho SM, 2016, EPIDEMIOL INFECT, V145, P1
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Huff A, 2016, PLOS CURR, V10, P8
   Kucharsky A, 2016, PLOS NEGLECTED TROPI, V10
   Majumder MS, 2016, JMIR PUBLIC HLTH SUR, V1
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Martin R. H., 1976, NONLINEAR OPERATORS
   Massad E, 2016, GLOB HLTH ACTION, V17
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Pazy A., 1983, SEMIGROUPS OPERATORS
   Peng R, 2009, J DIFFER EQUATIONS, V247, P1096, DOI 10.1016/j.jde.2009.05.002
   Robert CJ, 2016, PLOS ONE, V11
   Smoller J., 1994, SHOCK WAVES REACTION
   THRALL PH, 1993, AM NAT, V142, P543, DOI 10.1086/285554
   WEBB GF, 1981, J MATH ANAL APPL, V84, P150, DOI 10.1016/0022-247X(81)90156-6
   World Health Organization, 2016, ZIK VIR
   Wu YX, 2016, J DIFFER EQUATIONS, V261, P4424, DOI 10.1016/j.jde.2016.06.028
   Zinszer K, 2017, EMERG INFECT DIS
NR 40
TC 13
Z9 13
U1 2
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD MAR 27
PY 2017
VL 14
AR 7
DI 10.1186/s12976-017-0051-z
PG 17
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA EP6XP
UT WOS:000397522500001
PM 28347332
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Godoy, AS
   Lima, GMA
   Oliveira, KIZ
   Torres, NU
   Maluf, FV
   Guido, RVC
   Oliva, G
AF Godoy, Andre S.
   Lima, Gustavo M. A.
   Oliveira, Ketllyn I. Z.
   Torres, Naiara U.
   Maluf, Fernando V.
   Guido, Rafael V. C.
   Oliva, Glaucius
TI Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase
SO NATURE COMMUNICATIONS
LA English
DT Article
ID STRUCTURE REFINEMENT; DOMAIN; PHENIX
AB The current Zika virus (ZIKV) outbreak became a global health threat of complex epidemiology and devastating neurological impacts, therefore requiring urgent efforts towards the development of novel efficacious and safe antiviral drugs. Due to its central role in RNA viral replication, the non-structural protein 5 (NS5) RNA-dependent RNA-polymerase (RdRp) is a prime target for drug discovery. Here we describe the crystal structure of the recombinant ZIKV NS5 RdRp domain at 1.9 angstrom resolution as a platform for structure-based drug design strategy. The overall structure is similar to other flaviviral homologues. However, the priming loop target site, which is suitable for non-nucleoside polymerase inhibitor design, shows significant differences in comparison with the dengue virus structures, including a tighter pocket and a modified local charge distribution.
C1 [Godoy, Andre S.; Lima, Gustavo M. A.; Oliveira, Ketllyn I. Z.; Torres, Naiara U.; Maluf, Fernando V.; Guido, Rafael V. C.; Oliva, Glaucius] Univ Sao Paulo, Inst Phys Sao Carlos, Ave Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.
   [Torres, Naiara U.; Maluf, Fernando V.] Cellco Biotec, R Alberto Lanzoni,993 Parque Santa Felicia, BR-13562390 Sao Carlos, SP, Brazil.
RP Oliva, G (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Ave Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.
EM oliva@ifsc.usp.br
RI Lima, Gustavo/D-6453-2017; Guido, Rafael Victorio Carvalho/A-7450-2009;
   Oliva, Glaucius/B-9059-2012; Godoy, Andre/AAF-2432-2020; Godoy, Andre
   S/I-1302-2017
OI Lima, Gustavo/0000-0002-0011-5559; Guido, Rafael Victorio
   Carvalho/0000-0002-7187-0818; Godoy, Andre/0000-0002-0613-9164; Godoy,
   Andre S/0000-0002-0613-9164
FU EMU/FAPESP [2015/16811-3]; Sao Paulo Research Foundation-FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07600-3,
   2014/50381-3, 2016/19712-9, 2016/17153-2]
FX We thank H.M. Pereira for technical assistance with the crystallization
   robot facility (EMU/FAPESP grant 2015/16811-3) and J.R.C. Muniz for data
   collection support at the synchrotron beamline MX2 (LNLS, Campinas).
   Funding from the Sao Paulo Research Foundation-FAPESP (CEPID grant
   2013/07600-3, PIPE grant 2014/50381-3, and fellowships 2016/19712-9,
   2016/17153-2) is gratefully acknowledged.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Anusuya S, 2016, J BIOMOL STRUCT DYN, V34, P1512, DOI 10.1080/07391102.2015.1081620
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X
   Wilkins MR, 1999, METH MOL B, V112, P531
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172
NR 24
TC 46
Z9 50
U1 1
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 27
PY 2017
VL 8
AR 14764
DI 10.1038/ncomms14764
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EP5EL
UT WOS:000397401700003
PM 28345596
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, BX
   Tan, XF
   Thurmond, S
   Zhang, ZM
   Lin, A
   Hai, R
   Song, JK
AF Wang, Boxiao
   Tan, Xiao-Feng
   Thurmond, Stephanie
   Zhang, Zhi-Min
   Lin, Asher
   Hai, Rong
   Song, Jikui
TI The structure of Zika virus NS5 reveals a conserved domain conformation
SO NATURE COMMUNICATIONS
LA English
DT Article
ID I INTERFERON; RNA-SYNTHESIS; PROTEIN; ANTAGONIST; METHYLTRANSFERASE;
   FLAVIVIRUS; SOFTWARE
AB The recent outbreak of Zika virus (ZIKV) has imposed a serious threat to public health. Here we report the crystal structure of the ZIKV NS5 protein in complex with S-adenosyl-L-homocysteine, in which the tandem methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp) domains stack into one of the two alternative conformations of flavivirus NS5 proteins. The activity of this NS5 protein is verified through a de novo RdRp assay on a subgenomic ZIKV RNA template. Importantly, our structural analysis leads to the identification of a potential drug-binding site of ZIKV NS5, which might facilitate the development of novel antivirals for ZIKV.
C1 [Wang, Boxiao; Tan, Xiao-Feng; Zhang, Zhi-Min; Lin, Asher; Song, Jikui] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   [Thurmond, Stephanie; Hai, Rong] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.
RP Song, JK (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Hai, R (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.
EM ronghai@ucr.edu; jikui.song@ucr.edu
FU March of Dimes FoundationMarch of Dimes [1-FY15-345]; Sidney Kimmel
   Foundation for Cancer Research; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1R35GM119721];
   National Institutes of Health, National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS); Howard Hughes Medical InstituteHoward Hughes
   Medical Institute; Office of Science, Office of Basic Energy Sciences
   and of the US Department of Energy [DE-AC02-05CH11231]
FX This work was supported by March of Dimes Foundation (1-FY15-345),
   Kimmel Scholar Award from Sidney Kimmel Foundation for Cancer Research
   and NIH (1R35GM119721) (to J.S.). The Berkeley Center for Structural
   Biology is supported, in part, by the National Institutes of Health,
   National Institute of General Medical Sciences and the Howard Hughes
   Medical Institute. The Advanced Light Source is supported by the
   Director, Office of Science, Office of Basic Energy Sciences and of the
   US Department of Energy under Contract No DE-AC02-05CH11231.
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 29
TC 43
Z9 44
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 27
PY 2017
VL 8
AR 14763
DI 10.1038/ncomms14763
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EP5EL
UT WOS:000397401700002
PM 28345600
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, BY
   Yi, GH
   Du, FL
   Chuang, YC
   Vaughan, RC
   Sankaran, B
   Kao, CC
   Li, PW
AF Zhao, Baoyu
   Yi, Guanghui
   Du, Fenglei
   Chuang, Yin-Chih
   Vaughan, Robert C.
   Sankaran, Banumathi
   Kao, C. Cheng
   Li, Pingwei
TI Structure and function of the Zika virus full-length NS5 protein
SO NATURE COMMUNICATIONS
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; 2'-C-METHYLCYTIDINE;
   INITIATION; EFFICACY
AB The recent outbreak of Zika virus (ZIKV) has infected over 1 million people in over 30 countries. ZIKV replicates its RNA genome using virally encoded replication proteins. Nonstructural protein 5 (NS5) contains a methyltransferase for RNA capping and a polymerase for viral RNA synthesis. Here we report the crystal structures of full-length NS5 and its polymerase domain at 3.0 angstrom resolution. The NS5 structure has striking similarities to the NS5 protein of the related Japanese encephalitis virus. The methyltransferase contains in-line pockets for substrate binding and the active site. Key residues in the polymerase are located in similar positions to those of the initiation complex for the hepatitis C virus polymerase. The polymerase conformation is affected by the methyltransferase, which enables a more efficiently elongation of RNA synthesis in vitro. Overall, our results will contribute to future studies on ZIKV infection and the development of inhibitors of ZIKV replication.
C1 [Zhao, Baoyu; Du, Fenglei; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.
   [Yi, Guanghui; Chuang, Yin-Chih; Vaughan, Robert C.; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.
   [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Mol Biophys & Integrated Bioimaging, 1 Cyclotron Rd, Berkeley, CA 94720 USA.
RP Li, PW (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.
EM ckao@indiana.edu; pingwei@tamu.edu
OI Vaughan, Robert/0000-0002-7028-9976
FU Johnson Center for Innovation and Translational Research; National
   Institutes of Health, National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS); Howard Hughes Medical InstituteHoward Hughes
   Medical Institute; Office of Science, Office of Basic Energy Sciences,
   of the U.S. Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC02-05CH11231]
FX C.C.K. acknowledges seed funding from the Johnson Center for Innovation
   and Translational Research. We thank Laura Kao for editing the
   manuscript. The Berkeley Center for Structural Biology is supported in
   part by the National Institutes of Health, National Institute of General
   Medical Sciences and the Howard Hughes Medical Institute. The advanced
   light source is supported by the Director, Office of Science, Office of
   Basic Energy Sciences, of the U.S. Department of Energy under Contract
   No. DE-AC02-05CH11231.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653
   Byszewska M, 2014, RNA BIOL, V11, P1597, DOI 10.1080/15476286.2015.1004955
   Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Julander JG, 2010, ANTIVIR RES, V86, P261, DOI 10.1016/j.antiviral.2010.03.004
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee JC, 2015, ANTIVIR RES, V116, P1, DOI 10.1016/j.antiviral.2015.01.002
   Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rice C. M., 2006, FIELDS VIROLOGY
   van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0
   Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109
   Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595
   Vaughan Robert C, 2015, Methods Mol Biol, V1297, P225, DOI 10.1007/978-1-4939-2562-9_16
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 33
TC 61
Z9 63
U1 2
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 27
PY 2017
VL 8
AR 14762
DI 10.1038/ncomms14762
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EP5EL
UT WOS:000397401700001
PM 28345656
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hancock, WT
   Soeters, HM
   Hills, SL
   Link-Gelles, R
   Evans, ME
   Daley, WR
   Piercefield, E
   Anesi, MS
   Mataia, MA
   Uso, AM
   Sili, B
   Tufa, AJ
   Solaita, J
   Irvin-Barnwell, E
   Meaney-Delman, D
   Wilken, J
   Weidle, P
   Toews, KAE
   Walker, W
   Talboy, PM
   Gallo, WK
   Krishna, N
   Laws, RL
   Reynolds, MR
   Koneru, A
   Gould, CV
AF Hancock, W. Thane
   Soeters, Heidi M.
   Hills, Susan L.
   Link-Gelles, Ruth
   Evans, Mary E.
   Daley, W. Randolph
   Piercefield, Emily
   Anesi, Magele Scott
   Mataia, Mary Aseta
   Uso, Anaise M.
   Sili, Benjamin
   Tufa, Aifili John
   Solaita, Jacqueline
   Irvin-Barnwell, Elizabeth
   Meaney-Delman, Dana
   Wilken, Jason
   Weidle, Paul
   Toews, Karrie-Ann E.
   Walker, William
   Talboy, Phillip M.
   Gallo, William K.
   Krishna, Nevin
   Laws, Rebecca L.
   Reynolds, Megan R.
   Koneru, Alaya
   Gould, Carolyn V.
TI Establishing a Timeline to Discontinue Routine Testing of Asymptomatic
   Pregnant Women for Zika Virus Infection - American Samoa, 2016-2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; OUTBREAK
C1 [Hancock, W. Thane; Daley, W. Randolph; Wilken, Jason; Toews, Karrie-Ann E.; Krishna, Nevin] CDC, Off Publ Hlth Preparedness & Response, Div State & Local Readiness, Atlanta, GA 30333 USA.
   [Soeters, Heidi M.] CDC, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Atlanta, GA 30333 USA.
   [Hills, Susan L.; Walker, William; Gould, Carolyn V.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Link-Gelles, Ruth; Walker, William; Laws, Rebecca L.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Link-Gelles, Ruth; Koneru, Alaya] CDC, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Evans, Mary E.; Weidle, Paul] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Piercefield, Emily] CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Anesi, Magele Scott; Mataia, Mary Aseta; Uso, Anaise M.; Sili, Benjamin; Solaita, Jacqueline] Amer Samoa Govt, Dept Hlth, Pago Pago, AS USA.
   [Tufa, Aifili John] Pacific Isl Hlth Officers Assoc, Honolulu, HI USA.
   [Irvin-Barnwell, Elizabeth] Agcy Tox Subst & Dis Registry, Div Toxicol & Human Hlth Sci, Atlanta, GA USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Talboy, Phillip M.] CDC, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Gallo, William K.] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Laws, Rebecca L.] Calif Dept Hlth, Div Environm & Occupat Dis Control, Sacramento, CA USA.
   [Reynolds, Megan R.] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
RP Hancock, WT (corresponding author), CDC, Off Publ Hlth Preparedness & Response, Div State & Local Readiness, Atlanta, GA 30333 USA.
EM vie1@cdc.gov
RI Soeters, Heidi/H-3271-2019
OI Soeters, Heidi/0000-0002-9415-9340
CR CDC, 2016, GUID US LAB TEST ZIK
   CDC, 2016, INT CDC ZIK RESP PLA
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Healy JM, 2016, MMWR-MORBID MORTAL W, V65, P1146, DOI 10.15585/mmwr.mm6541a4
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133
NR 7
TC 6
Z9 6
U1 1
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 24
PY 2017
VL 66
IS 11
BP 299
EP 301
DI 10.15585/mmwr.mm6611a5
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EP3VV
UT WOS:000397310700004
PM 28333910
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Maxwell, MJ
   de Carvalho, MHF
   Hoet, AE
   Vigilato, MAN
   Pompei, JC
   Cosivi, O
   Vilas, VJD
AF Maxwell, Melody J.
   Freire de Carvalho, Mary H.
   Hoet, Armando E.
   Vigilato, Marco A. N.
   Pompei, Julio C.
   Cosivi, Ottorino
   del Rio Vilas, Victor J.
TI Building the road to a regional zoonoses strategy: A survey of zoonoses
   programmes in the Americas
SO PLOS ONE
LA English
DT Article
AB Background
   In recent years, global public health security has been threatened by zoonotic disease emergence as exemplified by outbreaks of H5N1 and H1N1 influenza, SARS, and most recently Ebola and Zika. Additionally, endemic zoonoses, such as rabies, burden countries year after year, placing demands on limited finances and personnel. To survey the baseline status of the emerging and endemic zoonoses programmes of the Latin American and the Caribbean (LAC) countries, the Pan American Health Organization (PAHO) conducted a survey of priority emerging and endemic zoonoses, countries A prioritization criteria and methodologies, and suggestions to strengthen countries capacities and regional approaches to zoonoses control.
   Methods
   A fillable online questionnaire was sent to the zoonoses programme managers of the Ministries of Health (MOH) and Ministries of Agriculture (MAg) of 33 LAC countries from January to April of 2015. The questionnaire comprised 36 single, multiple choice and open-ended questions to inform the objectives of the survey. A descriptive exploratory analysis was completed.
   Results
   Fifty-four ministries (26 MOH, 25 MAg, and 3 combined responses) in 31 LAC countries responded to the survey. Within the ministries, 22 (85%) MOH, 5 (20%) MAg, and 2 (67%) combined entities indicated they had specialized zoonoses units. For endemic zoonoses, 32 of 54 ministries responded that they conduct formal prioritization exercises, most of them annually (69%). The three priority endemic zoonoses for the MOHs were leptospirosis, rabies, and brucellosis while the three priorities for the MAgs were brucellosis, rabies, and tuberculosis. Diagnosis for rabies and leptospirosis were cited as the capacities most in need of development. The most needed cross-cutting capacity was coordination between stakeholders. For emerging zoonoses, 28 ministries performed formal prioritization exercises. The top prioritization criteria were probability of introduction into the country and impact. The three priority emerging zoonoses for the MOHs were Ebola viral disease, avian influenza, and Chikungunya while for the MAgs were avian influenza, bovine spongiform encephalopathy and West Nile virus disease. Surveillance for avian influenza and Ebola, and diagnosis for BSE were quoted as the capacities most needed. For all zoonoses, the majority of respondents (69%) ranked their relationship with the other Ministry as productive or very productive, and 31% minimally productive. Many countries requested a formal regional network, better regional communication and collaboration, and integrated surveillance.
   Conclusions
   The survey is the first comprehensive effort to date to inform the status of zoonoses programmes in LAC. The information collected here will be used to develop a regional strategy for zoonoses (both endemic and emerging), increase efforts, advocacy, and promote prompt identification and management of EIDs and improvement of endemic programmes.
C1 [Maxwell, Melody J.; Freire de Carvalho, Mary H.; Vigilato, Marco A. N.; Pompei, Julio C.; Cosivi, Ottorino; del Rio Vilas, Victor J.] PANAFTOSA PAHO WHO, Rio De Janeiro, Brazil.
   [Hoet, Armando E.] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Vet Publ Hlth Program, Columbus, OH 43210 USA.
   [Hoet, Armando E.] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA.
   [Maxwell, Melody J.] APHIS, Int Serv, USDA, Riverdale, MD USA.
   [del Rio Vilas, Victor J.] Univ Surrey, Sch Vet Med, Guildford, Surrey, England.
RP Vilas, VJD (corresponding author), PANAFTOSA PAHO WHO, Rio De Janeiro, Brazil.; Vilas, VJD (corresponding author), Univ Surrey, Sch Vet Med, Guildford, Surrey, England.
EM vdelriovilas@yahoo.co.uk
RI Vigilato, Marco Antonio Natal/G-3848-2012
OI Vigilato, Marco Antonio Natal/0000-0003-3920-0766; Maxwell,
   Melody/0000-0003-2475-781X; del rio vilas, victor/0000-0002-1674-9951
FU National Security Education Program
FX We would like to acknowledge the David L. Boren Fellowship, sponsored by
   the National Security Education Program, for their support of the lead
   author (MJM) during her research.
CR [Anonymous], 2014, IHR CORE CAPACITY MO
   Clavijo A, 2013, AM J TROP MED HYG, V89, P1040, DOI 10.4269/ajtmh.13-0229
   Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467
   FAO\WHO [Food and Agriculture Organization of the United Nations/World Health Organization], 2014, MICR RISK ASS SER, V23, P302
   Gibbs E., 2014, EVOLUTION ONE HLTH D, P85
   Grace D., 2012, ZOONOSES PROJECT, V4, P1
   Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Msellati L, 2012, REV SCI TECH OIE, V31, P413
   Pan American Health Organization (PAHO), 2015, INF EP REG AM 2009 2
   Pan American Health Organization (PAHO), 2016, 17 INT MIN M HLTH AG
   R Core Team, 2014, R LANG ENV STAT COMP
   SAS Institute, 2013, US JMP 11
   Schneider MC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000964
   Steele K, 2009, RISK ANAL, V29, P26, DOI 10.1111/j.1539-6924.2008.01130.x
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   UN General Assembly, 2015, ARES701 UN GEN ASS
   Vilas VJD, 2011, EUROSURVEILLANCE, V16, P24
   Vilas VJD, 2013, PREV VET MED, V108, P94, DOI 10.1016/j.prevetmed.2012.08.007
   Vrbova L, 2010, TRANSBOUND EMERG DIS, V57, P154, DOI 10.1111/j.1865-1682.2010.01100.x
   Wang LF, 2014, REV SCI TECH OIE, V33, P569, DOI 10.20506/rst.33.2.2311
   WHO, 2008, INT HLTH REG 2005
   World Bank, 2015, WORK END POV LAT AM
   World Health Organization, NEGL ZOON DIS
   World Health Organization, 2010, FAO OIE WHO COLL SHA
   World Health Organization, 2014, INT HLTH REG 2005 SU, P64
NR 27
TC 7
Z9 7
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2017
VL 12
IS 3
AR e0174175
DI 10.1371/journal.pone.0174175
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER8VS
UT WOS:000399102200058
PM 28333986
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Richner, JM
   Himansu, S
   Dowd, KA
   Butler, SL
   Salazar, V
   Fox, JM
   Julander, JG
   Tang, WW
   Shresta, S
   Pierson, TC
   Ciaramella, G
   Diamond, MS
AF Richner, Justin M.
   Himansu, Sunny
   Dowd, Kimberly A.
   Butler, Scott L.
   Salazar, Vanessa
   Fox, Julie M.
   Julander, Justin G.
   Tang, William W.
   Shresta, Sujan
   Pierson, Theodore C.
   Ciaramella, Giuseppe
   Diamond, Michael S.
TI Modified mRNA Vaccines Protect against Zika Virus Infection (vol 168, pg
   1114, 2017)
SO CELL
LA English
DT Correction
EM Giuseppe.Ciaramella@Valeratx.com; diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Richner,
   Justin/0000-0002-5344-118X; Fox, Julie/0000-0003-0567-738X; Salazar,
   Vanessa/0000-0002-1947-6039
CR Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
NR 1
TC 63
Z9 65
U1 3
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 23
PY 2017
VL 169
IS 1
BP 176
EP 176
DI 10.1016/j.cell.2017.03.016
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EP0PU
UT WOS:000397090000019
PM 28340344
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Wang, AY
   Thurmond, S
   Islas, L
   Hui, KY
   Hai, R
AF Wang, Anyou
   Thurmond, Stephanie
   Islas, Leonel
   Hui, Kingyung
   Hai, Rong
TI Zika virus genome biology and molecular pathogenesis
SO EMERGING MICROBES & INFECTIONS
LA English
DT Review
ID DENGUE VIRUS; VERTICAL TRANSMISSION; CROSS-REACTIVITY; SOUTH-PACIFIC;
   INFECTION; CELLS; MICE; SPECIFICITY; MICRONESIA; EMERGENCE
AB Zika virus (ZIKV) is an emerging RNA virus in the widespread Flavivirus genus. Recently, ZIKV has rapidly spread around the world and has been implicated in human disease, including neurological disorders, triggering public and scientific attention. Understanding how ZIKV causes disease is the highest priority, yet little is known about this virus. Here we examine the currently published data from ZIKV studies to provide the latest understanding of ZIKV genome biology and molecular pathogenesis. The ZIKV genome evolved rapidly from the Flavivirus genus and diverged from the members of this genus, even within the dengue virus cluster to which ZIKV belongs. Genome variations and divergences also exist among ZIKV strains/isolates. These genome divergences might account for the uniqueness of Zika disease. ZIKV infection activates not only the antiviral immune response but also the pro-inflammatory responses associated with disease symptoms. Strikingly, ZIKV activates protein complexes that are functionally associated with disease process, such as glial cell activation and proliferation ( for example, Toll-like receptors), apoptosis and cell death, and inflammation. The activation of these complexes may critically contribute to Zika disease. The novel insights into ZIKV genome divergence and disease mechanisms summarized in this review will help accelerate the development of anti-ZIKV strategies.
C1 [Wang, Anyou; Islas, Leonel; Hai, Rong] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
   [Thurmond, Stephanie; Islas, Leonel; Hui, Kingyung; Hai, Rong] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
RP Wang, AY; Hai, R (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.; Hai, R (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
EM anyou.wang@alumni.ucr.edu; rong.hai@ucr.edu
OI Wang, Anyou/0000-0002-4981-3606
CR Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Wang AY, 2010, J BACTERIOL, V192, P2809, DOI 10.1128/JB.01462-09
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 57
TC 49
Z9 53
U1 2
U2 33
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 22
PY 2017
VL 6
AR e13
DI 10.1038/emi.2016.141
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EQ1JF
UT WOS:000397825300002
PM 28325921
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carta, KAG
   Mendoza, I
   Morr, I
   Mendoza, I
   Misticchio, F
   Meza, Y
   Finizola, V
   Chazzin, G
   Marques, J
AF Gonzalez Carta, Karina Auristela
   Mendoza, Ivan
   Morr, Igoor
   Mendoza, Ivan
   Misticchio, Francesca
   Meza, Yolimar
   Finizola, Vicente
   Chazzin, Gerardo
   Marques, Juan
TI MYOCARDITIS, HEART FAILURE AND ARRHYTHMIAS IN PATIENTS WITH ZIKA
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Meeting Abstract
CT 66th Annual Scientific Session and Expo of the
   American-College-of-Cardiology (ACC)
CY MAR 17-19, 2017
CL Washington, DC
SP Amer Coll Cardiol
C1 [Gonzalez Carta, Karina Auristela; Mendoza, Ivan; Morr, Igoor; Mendoza, Ivan; Misticchio, Francesca; Meza, Yolimar; Finizola, Vicente; Chazzin, Gerardo; Marques, Juan] Inst Trop Med, Caracas, Venezuela.
RI Mendoza, Ines/T-4733-2017
OI Mendoza, Ines/0000-0002-8266-2598
NR 0
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 21
PY 2017
VL 69
IS 11
SU S
MA 1250-293
BP 906
EP 906
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EP4HT
UT WOS:000397342301428
DA 2020-07-08
ER

PT J
AU Hsieh, YH
AF Hsieh, Ying-Hen
TI Temporal patterns and geographic heterogeneity of Zika virus (ZIKV)
   outbreaks in French Polynesia and Central America
SO PEERJ
LA English
DT Article
DE ZIKV; Oceania; Central Aermica; Geography; Temporal; Heterogeneity;
   Phenomenological model; Basic reproduction number; Turning point
ID REPRODUCTION NUMBER; EPIDEMIOLOGY; COLOMBIA; TRANSMISSIBILITY;
   INFECTION; ISLAND; SARS
AB Background. Zika virus (ZIKV) transmission has been reported in 67 countries/territories in the Oceania region and the Americas since 2015, prompting the World Health Organization (WHO) to declare ZIKV as a Public Health Emergency of International Concern in February 2016, due to its strong association with medical complications such as microcephaly and Guillain-Barre Syndrome (GBS). However, a substantial gap in knowledge still exists regarding differing temporal pattern and potential of transmission of ZIKV in different regions of the world.
   Methods. We use a phenomenological model to ascertain the temporal patterns and transmission potential of ZIKV in various countries/territories, by fitting the model to Zika case data from Yap Island and French Polynesia in the Oceania region and 11 countries/territories with confirmed case data, namely, Colombia, Ecuador, French Guiana, Guadeloupe, Guatemala, Mexico, Nicaragua, Panama, Puerto Rico, Saint Martin, and Suriname, to pinpoint the waves of infections in each country/territory and to estimate the respective basic reproduction number R-0.
   Results. Six of these time series datasets resulted in statistically significant model fit of at least one wave of reported cases, namely that of French Polynesia, Colombia, Puerto Rico, Guatemala, Suriname and Saint Martin. However, only Colombia and Guatemala exhibited two waves of cases while the others had only one wave. Temporal patterns of the second wave in Colombia and the single wave in Suriname are very similar, with the respective turning points separated by merely a week. Moreover, the mean estimates of R-0 for Colombia, Guatemala and Suriname, all land-based populations, range between 1.05 and 1.75, while the corresponding mean estimates for R-0 of island populations in French Polynesia, Puerto Rico and Saint Martin are significantly lower with a range of 5.70-6.89. Wealso fit the Richards model to Zika case data from six main archipelagos in French Polynesia, suggesting the outbreak in all six island populations occurred during the same time, albeit with different peak time, with mean R-0 range of 3.09-5.05.
   Discussion. Using the same modeling methodology, in this study we found a significant difference between transmissibility (as quantified by R-0) in island populations as opposed to land-based countries/territories, possibly suggesting an important role of geographic heterogeneity in the spread of vector-borne diseases and its future course, which requires further monitoring. Our result has potential implications for planning respective intervention and control policies targeted for island and land-based populations.
C1 [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan.
   [Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan.
RP Hsieh, YH (corresponding author), China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan.; Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.
EM hsieh@mail.cmu.edu.tw
RI Hsieh, Ying-Hen/E-9685-2010
FU Taiwan Ministry of Science and Technology (MOST) grants
   [103-2314-B-039-010-MY3, 103-2115-M-039-002-MY2]
FX YHH is funded by Taiwan Ministry of Science and Technology (MOST) grants
   (103-2314-B-039-010-MY3 and 103-2115-M-039-002-MY2). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centre d'hygi e ne et de Salubrit e publique, 2014, SURV DENG ZIK POL FR
   Chowell G, 2016, PLOS CURRENTS
   Cohen J., 2016, SCI MAR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca RF, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004760, DOI 10.1371/JOURNAL.PNTD.0005173.]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396
   Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023
   Hsieh YH, 2015, PEERJ, V3, DOI 10.7717/peerj.1505
   Hsieh YH, 2013, TROP MED INT HEALTH, V18, P830, DOI 10.1111/tmi.12105
   Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Majumder MS, 2016, B WHO, DOI 10.2471/BLT.16.171009
   Monaghan AJ, 2016, PLOS CURRENTS
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Pan American Health Organization, 2016, CUM CAS REP COUNTR T
   Pan American Health Organization, 2016, SUSP CONF ZIK CAS RE
   Pan American Health Organization (PAHO), 2016, COUNTR TERR AUT TRAN
   Pierson TC, 2013, FIELDS VIROLOGY
   Razum O, 2003, LANCET, V361, P1739, DOI 10.1016/S0140-6736(03)13335-1
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Theil H., 1961, EC FORECASTING POLIC
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   WHO, 2015, DIS OUTBREAK NE 0208
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 38
TC 6
Z9 6
U1 0
U2 8
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAR 21
PY 2017
VL 5
AR e3015
DI 10.7717/peerj.3015
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO7ZH
UT WOS:000396908100004
PM 28344900
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chahal, JS
   Fang, T
   Woodham, AW
   Khan, OF
   Ling, JJ
   Anderson, DG
   Ploegh, HL
AF Chahal, Jasdave S.
   Fang, Tao
   Woodham, Andrew W.
   Khan, Omar F.
   Ling, Jingjing
   Anderson, Daniel G.
   Ploegh, Hidde L.
TI An RNA nanoparticle vaccine against Zika virus elicits antibody and
   CD8+T cell responses in a mouse model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CD8(+) T-CELLS; DENGUE VIRUS; PEPTIDE; INFECTION; PROTECTION;
   GLYCOPROTEIN; PATHOGENESIS; REACTIVITY; BINDING; BRAZIL
AB The Zika virus (ZIKV) outbreak in the Americas and South Pacific poses a significant burden on human health because of ZIKV's neurotropic effects in the course of fetal development. Vaccine candidates against ZIKV are coming online, but immunological tools to study anti-ZIKV responses in preclinical models, particularly T cell responses, remain sparse. We deployed RNA nanoparticle technology to create a vaccine candidate that elicited ZIKV E protein-specific IgG responses in C57BL/ 6 mice as assayed by ELISA. Using this tool, we identified a unique H-2Db-restricted epitope to which there was a CD8+ T cell response in mice immunized with our modified dendrimer-based RNA nanoparticle vaccine. These results demonstrate that this approach can be used to evaluate new candidate antigens and identify immune correlates without the use of live virus.
C1 [Chahal, Jasdave S.; Fang, Tao; Woodham, Andrew W.; Ling, Jingjing; Ploegh, Hidde L.] Cambridge Ctr 9, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
   [Chahal, Jasdave S.; Khan, Omar F.; Anderson, Daniel G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.
   [Ploegh, Hidde L.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.
RP Ploegh, HL (corresponding author), Cambridge Ctr 9, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.; Ploegh, HL (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.
EM hidde.ploegh@childrens.harvard.edu
RI Fang, Tao/F-8594-2011; Khan, Omar/G-6952-2014
OI Fang, Tao/0000-0001-8129-8635; Khan, Omar/0000-0003-3811-2369
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI087879];
   Fujifilm/MediVector, Inc.; Lustgarten Foundation; Koch Institute for
   Integrative Cancer Research at MIT; Dana-Farber/Harvard Cancer Center
   (DF/HCC); Department of Defense Office of Congressionally Directed
   Medical Research's Joint Warfighter Medical Research Program; Cancer
   Center Support (core) from National Cancer Institute [P30-CA14051]; NIH
   F32 grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GRANT11974346]; ASTAR NSS (PhD)
   scholarship
FX Funding was provided by the National Institutes of Health (grant R01
   AI087879), a Fujifilm/MediVector, Inc. grant, and a grant from the
   Lustgarten Foundation to H.L.P.,and in part by an award from the Bridge
   Project, a partnership between the Koch Institute for Integrative Cancer
   Research at MIT and the Dana-Farber/Harvard Cancer Center (DF/HCC) to
   D.G.A., as well as the Department of Defense Office of Congressionally
   Directed Medical Research's Joint Warfighter Medical Research Program to
   D.G.A. This work was supported in part by Cancer Center Support (core)
   Grant P30-CA14051 from the National Cancer Institute. A.W.W. is an
   Arnold O. Beckman Postdoctoral Fellow and received additional support
   from an NIH F32 grant (GRANT11974346). J.L. was supported by an ASTAR
   NSS (PhD) scholarship. We thank the Whitehead Institute flow cytometry
   facility for instrument usage.
CR ALAHDAL MN, 1985, J VIROL, V54, P53, DOI 10.1128/JVI.54.1.53-57.1985
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR DIS US 2015
   CDC, 2016, ADV PEOPL LIV TRAV W
   Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DERES K, 1992, EUR J IMMUNOL, V22, P1603, DOI 10.1002/eji.1830220638
   DEWAAL LP, 1983, J IMMUNOL, V130, P1090
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929
   FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kwilas S, 2014, CURR GENE THER, V14, P200, DOI 10.2174/1566523214666140522122633
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56
   Li ML, 2004, INT REV IMMUNOL, V23, P7, DOI 10.1080/08830180490265529
   LIPFORD GB, 1993, J IMMUNOL, V150, P1212
   Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   METTLER NE, 1971, APPL MICROBIOL, V22, P377, DOI 10.1128/AEM.22.3.377-379.1971
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   National Institute of Allergy and Infectious Diseases, 2016, SAF IMM ZIK VIR DNA
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E., 2014, Eurosurveillance, V19, P20720
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rudolph MG, 2001, IMMUNITY, V14, P231, DOI 10.1016/S1074-7613(01)00105-4
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Simon MD, 2014, CHEMBIOCHEM, V15, P713, DOI 10.1002/cbic.201300796
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 42
Z9 42
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2017
VL 7
AR 252
DI 10.1038/s41598-017-00193-w
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO7CD
UT WOS:000396847900013
PM 28325910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU He, DH
   Gao, DZ
   Lou, YJ
   Zhao, S
   Ruan, SG
AF He, Daihai
   Gao, Daozhou
   Lou, Yijun
   Zhao, Shi
   Ruan, Shigui
TI A comparison study of Zika virus outbreaks in French Polynesia, Colombia
   and the State of Bahia in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; DROUGHT-INDUCED AMPLIFICATION; TRANSMISSION; DISEASE
AB Zika virus (ZIKV) disease outbreaks occurred in French Polynesia in 2013-2014 and in Brazil and Colombia in 2015-2016, respectively. Using our recently developed ZIKV disease model, we simulated the reported ZIKV infection cases from French Polynesia, Colombia and the State of Bahia of Brazil. Moreover, we estimated that the infection attack rates were 78.0% (95% confidence interval (CI): 63.5-86.3%) in French Polynesia which closely matches a previous serological study; 20.8% ( 95% CI: 1.1-50.0%) in Colombia which suggests that the attack rate was most likely less than 50%; and 32.4% (95% CI: 2.5-94.2%) in the State of Bahia in Brazil which suggests that the attack rate is unidentifiable with monthly data in Bahia. Furthermore, we found that the association of precipitation and ZIKV outbreak was more evident in Colombia than the other two places. These results are helpful for us to understand the possible evolution, to control the on-going outbreaks, to prevent the potential geographic spread, and to study the ecological and epidemiological characteristics of ZIKV.
C1 [He, Daihai; Lou, Yijun; Zhao, Shi] Hong Kong Polytech Univ, Dept Appl Math, Hung Hom, Kowloon, Hong Kong, Peoples R China.
   [Gao, Daozhou] Shanghai Normal Univ, Math & Sci Coll, Shanghai 200234, Peoples R China.
   [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
RP Ruan, SG (corresponding author), Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
EM ruan@math.miami.edu
RI He, Daihai/A-9347-2008; Ruan, Shigui/AAF-9165-2020; Lou,
   Yijun/V-1624-2017; Gao, Daozhou/J-3157-2014
OI Ruan, Shigui/0000-0002-6348-8205; Gao, Daozhou/0000-0003-3991-569X; He,
   Daihai/0000-0003-3253-654X
FU Early Career Scheme from Hong Kong Research Grants Council [PolyU
   251001/14M, PolyU 253004/14P]; Program for Professors of Special
   Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   Learning [TP2015050]; Shanghai Gaofeng Project for University Academic
   Development Program; NNSF of ChinaNational Natural Science Foundation of
   China [11601336]; National Science FoundationNational Science Foundation
   (NSF) [DMS-1412454]
FX This work was partially supported by the Early Career Scheme from Hong
   Kong Research Grants Council (PolyU 251001/14M, PolyU 253004/14P),
   Program for Professors of Special Appointment (Eastern Scholar) at
   Shanghai Institutions of Higher Learning (TP2015050), Shanghai Gaofeng
   Project for University Academic Development Program, NNSF of China (No.
   11601336), and National Science Foundation (DMS-1412454).
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   EPSTEIN PR, 2001, GLOBAL CHANGE HUM HL, V2, P105, DOI DOI 10.1023/A:1015089901425
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson BJ, 2013, J MED ENTOMOL, V50, P195, DOI 10.1603/ME12035
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization, 2016, ZIK EP REP COL 9 SEP
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD 30 JUN 20
   Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 23
TC 17
Z9 17
U1 1
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2017
VL 7
AR 273
DI 10.1038/s41598-017-00253-1
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO7CD
UT WOS:000396847900034
PM 28325935
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, YX
   Liu, QX
   Zhou, J
   Xie, WH
   Chen, C
   Wang, ZF
   Yang, HT
   Cui, J
AF Wu, Yaoxing
   Liu, Qingxiang
   Zhou, Jie
   Xie, Weihong
   Chen, Cheng
   Wang, Zefang
   Yang, Haitao
   Cui, Jun
TI Zika virus evades interferon-mediated antiviral response through the
   co-operation of multiple nonstructural proteins in vitro
SO CELL DISCOVERY
LA English
DT Article
DE antiviral immunity; nonstructural proteins; type I interferon signaling;
   Zika virus
ID RECOGNITION; INFECTION; IDENTIFICATION; RECEPTORS; UBIQUITIN; DENGUE;
   BRAZIL; MAVS
AB Type I interferon (IFN) serves as the first line of defense against invading pathogens. Inhibition of IFN-triggered signaling cascade by Zika virus (ZIKV) plays a critical role for ZIKV to evade antiviral responses from host cells. Here we demonstrate that ZIKV nonstructural proteins NS1, NS4B and NS2B3 inhibit the induction of IFN and downstream IFN-stimulated genes through diverse strategies. NS1 and NS4B of ZIKV inhibit IFN beta signaling at TANK-binding kinase 1 level, whereas NS2B-NS3 of ZIKV impairs JAK-STAT signaling pathway by degrading Jak1 and reduces virus-induced apoptotic cell death. Furthermore, co-operation of NS1, NS4B and NS2B3 further enhances viral infection by blocking IFN-induced autophagic degradation of NS2B3. Hence, our study reveals a novel antagonistic system employing multiple ZIKV nonstructural proteins in restricting the innate antiviral responses.
C1 [Wu, Yaoxing; Liu, Qingxiang; Zhou, Jie; Xie, Weihong; Cui, Jun] Minist Educ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China.
   [Chen, Cheng; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.
   [Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China.
   [Cui, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.
RP Cui, J (corresponding author), Minist Educ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China.; Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China.; Cui, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.
EM yanght@tju.edu.cn; cuij5@mail.sysu.edu.cn
FU National Key Basic Research Program of ChinaNational Basic Research
   Program of China [2015CB859800]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31522018, 31170832];
   Guangdong Natural Science Funds for Distinguished Young Scholar
   [S2013050014772]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [15lgjc02]; Training Program for Outstanding Young Teachers in Higher
   Education institutions of Guangdong Province [YQ2015001]; Guangzhou
   Science and Technology Project [201605030012]; National Key Research
   Program of China [2016YFD0500300]
FX We thank Dr Gucheng Zeng for the assistance of ZIKV infection
   experiments. This work was supported by National Key Basic Research
   Program of China (2015CB859800), National Natural Science Foundation of
   China (31522018 and 31170832), Guangdong Natural Science Funds for
   Distinguished Young Scholar (S2013050014772), the Fundamental Research
   Funds for the Central Universities (15lgjc02), the Training Program for
   Outstanding Young Teachers in Higher Education institutions of Guangdong
   Province (YQ2015001), Guangzhou Science and Technology Project
   (201605030012) and National Key Research Program of China
   (2016YFD0500300).
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Boyle KB, 2013, CURR OPIN MICROBIOL, V16, P339, DOI 10.1016/j.mib.2013.03.010
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chattopadhyay S, 2016, IMMUNITY, V44, P1151, DOI 10.1016/j.immuni.2016.04.009
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liu BY, 2017, NAT IMMUNOL, V18, P214, DOI 10.1038/ni.3641
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027
   Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013
   Xing JJ, 2016, NAT IMMUNOL, V17, P1373, DOI 10.1038/ni.3580
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 42
TC 61
Z9 62
U1 2
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD MAR 21
PY 2017
VL 3
AR UNSP 17006
DI 10.1038/celldisc.2017.6
PG 14
WC Cell Biology
SC Cell Biology
GA FM3KM
UT WOS:000414904000001
PM 28373913
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, CF
   Deng, YQ
   Wang, S
   Ma, F
   Aliyari, R
   Huang, XY
   Zhang, NN
   Watanabe, M
   Dong, HL
   Liu, P
   Li, XF
   Ye, Q
   Tian, M
   Hong, S
   Fan, JW
   Zhao, H
   Li, LL
   Vishlaghi, N
   Buth, JE
   Au, C
   Liu, Y
   Lu, N
   Du, PS
   Qin, FXF
   Zhang, B
   Gong, DY
   Dai, XH
   Sun, R
   Novitch, BG
   Xu, ZH
   Qin, CF
   Cheng, GH
AF Li, Chunfeng
   Deng, Yong-Qiang
   Wang, Shuo
   Ma, Feng
   Aliyari, Roghiyh
   Huang, Xing-Yao
   Zhang, Na-Na
   Watanabe, Momoko
   Dong, Hao-Long
   Liu, Ping
   Li, Xiao-Feng
   Ye, Qing
   Tian, Min
   Hong, Shuai
   Fan, Junwan
   Zhao, Hui
   Li, Lili
   Vishlaghi, Neda
   Buth, Jessie E.
   Au, Connie
   Liu, Ying
   Lu, Ning
   Du, Peishuang
   Qin, F. Xiao-Feng
   Zhang, Bo
   Gong, Danyang
   Dai, Xinghong
   Sun, Ren
   Novitch, Bennett G.
   Xu, Zhiheng
   Qin, Cheng-Feng
   Cheng, Genhong
TI 25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its
   Associated Microcephaly in a Mouse Model
SO IMMUNITY
LA English
DT Article
ID PLACENTAL TROPHOBLASTS; CHOLESTEROL; OXYSTEROLS; IDENTIFICATION;
   TRANSCRIPTION; REPLICATION; MACROPHAGES; ACTIVATION; INHIBITORS; RHESUS
AB Zika virus (ZIKV) has become a public health threat due to its global transmission and link to severe congenital disorders. The host immune responses to ZIKV infection have not been fully elucidated, and effective therapeutics are not currently available. Herein, we demonstrated that cholesterol-25-hydroxylase (CH25H) was induced in response to ZIKV infection and that its enzymatic product, 25-hydroxycholesterol (25HC), was a critical mediator of host protection against ZIKV. Synthetic 25HC addition inhibited ZIKV infection in vitro by blocking viral entry, and treatment with 25HC reduced viremia and conferred protection against ZIKV in mice and rhesus macaques. 25HC suppressed ZIKV infection and reduced tissue damage in human cortical organoids and the embryonic brain of the ZIKV-induced mouse microcephaly model. Our findings highlight the protective role of CH25H during ZIKV infection and the potential use of 25HC as a natural antiviral agent to combat ZIKV infection and prevent ZIKV-associated outcomes, such as microcephaly.
C1 [Li, Chunfeng; Ma, Feng; Qin, F. Xiao-Feng; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Ma, Feng; Qin, F. Xiao-Feng; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Ma, Feng; Qin, F. Xiao-Feng; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Li, Chunfeng; Deng, Yong-Qiang; Huang, Xing-Yao; Zhang, Na-Na; Dong, Hao-Long; Li, Xiao-Feng; Ye, Qing; Tian, Min; Zhao, Hui; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Wang, Shuo; Hong, Shuai; Fan, Junwan; Xu, Zhiheng] Chinese Acad Sci, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Wang, Shuo; Hong, Shuai; Fan, Junwan; Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
   [Ma, Feng; Aliyari, Roghiyh; Au, Connie; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Zhang, Na-Na; Qin, Cheng-Feng] Guangxi Med Univ, Nanning 530021, Peoples R China.
   [Watanabe, Momoko; Vishlaghi, Neda; Buth, Jessie E.; Novitch, Bennett G.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Watanabe, Momoko; Vishlaghi, Neda; Buth, Jessie E.; Novitch, Bennett G.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.
   [Liu, Ping; Li, Lili; Liu, Ying; Lu, Ning; Du, Peishuang] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China.
   [Tian, Min] Capital Med Univ, Beijing Tradit Med Chinese Hosp, Beijing 100069, Peoples R China.
   [Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Gong, Danyang; Dai, Xinghong; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Gong, Danyang; Dai, Xinghong; Sun, Ren] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.
RP Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Chinese Acad Sci, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Qin, CF (corresponding author), Guangxi Med Univ, Nanning 530021, Peoples R China.; Novitch, BG (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.; Novitch, BG (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.
EM bnovitch@ucla.edu; zhxu@genetics.ac.cn; qincf@bmi.ac.cn;
   gcheng@mednet.ucla.edu
RI Li, Chunfeng/S-3185-2019; Qin, Cheng-Feng/I-6839-2019
OI Li, Chunfeng/0000-0001-8883-9078; Qin, Cheng-Feng/0000-0002-0632-2807;
   huang, xingyao/0000-0002-3917-8100; Dai, Xinghong/0000-0002-4102-3175;
   Novitch, Bennett/0000-0002-2696-3708; Xu, Zhiheng/0000-0002-4809-2851
FU CAMS Initiative for Innovative Medicine [2016-I2M-1-005]; National
   Science and Technology Major Project for "Significant New Drugs
   Innovation and Development" [2015ZX09102023]; NSFC (China)National
   Natural Science Foundation of China [91542201, 81590765]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01AI069120, AI056154, AI078389, R01 NS089817]; PUMC
   Youth Fund [3332016125]; NSFCNational Natural Science Foundation of
   China [31500145, 31670883, 31430037]; MOST (China)Ministry of Science
   and Technology, China [2016YFD0500304]; State Key Laboratory of Pathogen
   and Biosecurity [SKLPBS1601]; NSFC Excellent Young Scientist [81522025];
   Innovative Research Group [81621005]; Newton Advanced Fellowship from
   the UK Academy of Medical Sciences [NAF003/1003]; NSFC of ChinaNational
   Natural Science Foundation of China [81661130162]; Shanghai
   brain-intelligence project from STCSM [16JC1420500]; Beijing brain
   project [Z161100002616004]; MOST [2014CB942801, 2012YQ03026006];
   CIRMCalifornia Institute for Regenerative Medicine [DISC1-08819]; UCLA
   Broad Stem Cell Research Center (BSCRC); UCLA BSCRC
FX This work was supported by the CAMS Initiative for Innovative Medicine
   (No. 2016-I2M-1-005), National Science and Technology Major Project for
   "Significant New Drugs Innovation and Development" (2015ZX09102023),
   NSFC (China, 91542201, 81590765), NIH R01AI069120, AI056154, and
   AI078389 grants to G.C., PUMC Youth Fund (3332016125) and NSFC
   (31500145) to C.L., NSFC (31670883) to F.M., MOST (China,
   2016YFD0500304) and the State Key Laboratory of Pathogen and Biosecurity
   (SKLPBS1601), the NSFC Excellent Young Scientist (81522025), the
   Innovative Research Group (81621005), and the Newton Advanced Fellowship
   from the UK Academy of Medical Sciences (NAF003/1003) and the NSFC of
   China (81661130162) to C.-F.Q., NSFC (31430037), Shanghai
   brain-intelligence project from STCSM (16JC1420500), Beijing brain
   project (Z161100002616004) and MOST (2014CB942801 and 2012YQ03026006) to
   Z.X., NIH R01 NS089817, CIRM DISC1-08819, and a research award from the
   UCLA Broad Stem Cell Research Center (BSCRC) to B.G.N. M.W. was
   supported by a training fellowship from the UCLA BSCRC. We thank Natalie
   Quanquin (UCLA) and Lina Yuan (Suzhou Institute of Systems Medicine) for
   their help in editing the manuscript and RNA sequencing, respectively.
   We wish to thank Pei-Gang Wang (Capital Medical University, Beijing),
   Qi-Bin Leng (Institute Pasteur of Shanghai, CAS), Pei-Yong Shi (Novartis
   Institute for Infectious Diseases), and Guanghou Shui (Institute of
   Genetics and Developmental Biology, CAS), for providing us with critical
   reagents and helpful discussions.
CR Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07242
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Holmes RS, 2011, 3 BIOTECH, V1, P99, DOI 10.1007/s13205-011-0013-9
   Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665
   Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266
   Larkin JC, 2014, PLACENTA, V35, P919, DOI 10.1016/j.placenta.2014.09.002
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moog C, 1998, ANTIVIR CHEM CHEMOTH, V9, P491, DOI 10.1177/095632029800900605
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260
   Woollett LA, 2001, FRONT BIOSCI, V6, pD536, DOI 10.2741/Woollett
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 48
TC 107
Z9 113
U1 2
U2 67
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD MAR 21
PY 2017
VL 46
IS 3
BP 446
EP 456
DI 10.1016/j.immuni.2017.02.012
PG 11
WC Immunology
SC Immunology
GA EO6QR
UT WOS:000396818100016
PM 28314593
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Lau, SM
   Chua, TH
   Sulaiman, WY
   Joanne, S
   Lim, YAL
   Sekaran, SD
   Chinna, K
   Venugopalan, B
   Vythilingam, I
AF Lau, Sai Ming
   Chua, Tock H.
   Sulaiman, Wan-Yussof
   Joanne, Sylvia
   Lim, Yvonne Ai-Lian
   Sekaran, Shamala Devi
   Chinna, Karuthan
   Venugopalan, Balan
   Vythilingam, Indra
TI A new paradigm for Aedes spp. surveillance using gravid ovipositing
   sticky trap and NS1 antigen test kit
SO PARASITES & VECTORS
LA English
DT Article
DE GOS traps; Dengue NS1 kit; Aedes mosquito; Surveillance
ID AEGYPTI DIPTERA-CULICIDAE; DENGUE HEMORRHAGIC-FEVER; ZIKA VIRUS;
   POPULATION-DYNAMICS; VECTOR CONTROL; PUERTO-RICO; MALAYSIA; MOSQUITOS;
   TRANSMISSION; BRAZIL
AB Background: Dengue remains a serious public health problem in Southeast Asia and has increased 37-fold in Malaysia compared to decades ago. New strategies are urgently needed for early detection and control of dengue epidemics.
   Methods: We conducted a two year study in a high human density dengue-endemic urban area in Selangor, where Gravid Ovipositing Sticky (GOS) traps were set up to capture adult Aedes spp. mosquitoes. All Aedes mosquitoes were tested using the NS1 dengue antigen test kit. All dengue cases from the study site notified to the State Health Department were recorded. Weekly microclimatic temperature, relative humidity (RH) and rainfall were monitored.
   Results: Aedes aegypti was the predominant mosquito (95.6%) caught in GOS traps and 23% (43/187 pools of 5 mosquitoes each) were found to be positive for dengue using the NS1 antigen kit. Confirmed cases of dengue were observed with a lag of one week after positive Ae. aegypti were detected. Aedes aegypti density as analysed by distributed lag non-linear models, will increase lag of 2-3 weeks for temperature increase from 28 to 30 degrees C; and lag of three weeks for increased rainfall.
   Conclusion: Proactive strategy is needed for dengue vector surveillance programme. One method would be to use the GOS trap which is simple to setup, cost effective (below USD 1 per trap) and environmental friendly (i. e. use recyclable plastic materials) to capture Ae. aegypti followed by a rapid method of detecting of dengue virus using the NS1 dengue antigen kit. Control measures should be initiated when positive mosquitoes are detected.
C1 Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.
   [Lau, Sai Ming; Venugopalan, Balan] State Vector Borne Dis Control Unit, Selangor State Hlth Dept, 29 Jalan Bayu Tinggi, Klang 11200, Selangor, Malaysia.
   [Lau, Sai Ming; Sulaiman, Wan-Yussof; Joanne, Sylvia; Lim, Yvonne Ai-Lian; Vythilingam, Indra] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.
   [Chua, Tock H.] Univ Malaysia, Fac Med & Hlth Sci, Dept Pathobiol & Med Diagnost, Kota Kinabalu 88400, Sabah, Malaysia.
   [Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Microbiol, Kuala Lumpur 506030, Malaysia.
   [Chinna, Karuthan] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia.
   [Venugopalan, Balan] Jalan Panglima Bukit Gantung Wahab, Perak State Hlth Dept, Ipoh 30590, Perak, Malaysia.
RP Vythilingam, I (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.
EM indra.vythilingam@gmail.com
RI Lahuddin, Haslinda/S-1588-2017; Wan Sulaiman, Wan Yusoff/L-5295-2016;
   VYTHILINGAM, INDRA/Q-5019-2016; Chua, Tock H/E-4157-2012; Devi, Shamala
   Devi/B-9735-2010; Vythilingam, Indra/E-8334-2010; sulaiman, wan yusoff
   wan/C-1030-2010; LIM, YVONNE AL/B-5276-2010; Sekaran, Shamala
   Devi/B-8482-2008
OI Chua, Tock H/0000-0002-8984-8723; Devi, Shamala
   Devi/0000-0002-0478-0425; LIM, YVONNE AL/0000-0003-4050-6332; Sekaran,
   Shamala Devi/0000-0002-0478-0425
FU University of MalayaUniversiti Malaya [PG192-2015A]
FX This study was funded by University of Malaya student grant PG192-2015A
   provided to the first author.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   [Anonymous], 2016, DISTRIBUTED LAG NONL
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x
   Chang MS, 2011, WEST PAC SURVEILL RE, V2, P9, DOI [10.5365/WPSAR.2010.1.1.012, 10.5365/wpsar.2010.1.1.012]
   Chen Chee Dhang, 2005, Trop Biomed, V22, P39
   CHEONG WH, 1967, B WORLD HEALTH ORGAN, V36, P586
   Cheong WH, 1986, BULLETIN, V23, P155
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Facchinelli L, 2008, AM J TROP MED HYG, V78, P904, DOI 10.4269/ajtmh.2008.78.904
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Focks DA, 2003, REV ENTOMOLOGICAL SA, P1
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Harburguer L, 2016, J MED ENTOMOL, V53, P647, DOI 10.1093/jme/tjw022
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Ho T., 1980, MED J MALAYSIA, V24, P409
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Kwa B. H., 2008, Environment Development and Sustainability, V10, P209, DOI 10.1007/s10668-006-9060-5
   Lau SM, 2015, TROP MED INT HEALTH, V20, P1271, DOI 10.1111/tmi.12555
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, P65
   MACDONALD W W, 1956, Ann Trop Med Parasitol, V50, P399
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Mia MS, 2013, ASIAN PAC J TROP MED, V6, P462, DOI 10.1016/S1995-7645(13)60075-9
   Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mudin RN, 2015, INT MED J MALAYS, V14, P5
   Muller DA, 2012, J VIROL METHODS, V183, P90, DOI 10.1016/j.jviromet.2012.03.033
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   R Development Core Team, 2011, LANG ENV STAT COMP
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Ritchie S, 2016, ARBOVIRUSES MOL BIOL
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Shekhar K C, 1992, Asia Pac J Public Health, V6, P126
   Shekhar K C, 1992, Asia Pac J Public Health, V6, P15
   Skae FMT, 1902, BRIT MED J, V1902, P1581, DOI 10.1136/bmj.2.2185.1581-a
   Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494
   Sylvestre G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-155
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   WALLACE H G, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P1
   Wan-Norafikah O, 2010, J ASIA-PAC ENTOMOL, V13, P175, DOI 10.1016/j.aspen.2010.03.003
   Xu HY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002805
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 69
TC 13
Z9 15
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 21
PY 2017
VL 10
AR 151
DI 10.1186/s13071-017-2091-y
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO7WF
UT WOS:000396900100002
PM 28327173
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Priye, A
   Bird, SW
   Light, YK
   Ball, CS
   Negrete, OA
   Meagher, RJ
AF Priye, Aashish
   Bird, Sara W.
   Light, Yooli K.
   Ball, Cameron S.
   Negrete, Oscar A.
   Meagher, Robert J.
TI A smartphone-based diagnostic platform for rapid detection of Zika,
   chikungunya, and dengue viruses
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; HUMAN COLOR-VISION; COLORIMETRIC
   DETECTION; MOBILE PHONE; ASSAY; DNA; LIMITATIONS; SAMPLES; PCR
AB Current multiplexed diagnostics for Zika, dengue, and chikungunya viruses are situated outside the intersection of affordability, high performance, and suitability for use at the point-of-care in resourcelimited settings. Consequently, insufficient diagnostic capabilities are a key limitation facing current Zika outbreak management strategies. Here we demonstrate highly sensitive and specific detection of Zika, chikungunya, and dengue viruses by coupling reverse-transcription loop-mediated isothermal amplification (RT-LAMP) with our recently developed quenching of unincorporated amplification signal reporters (QUASR) technique. We conduct reactions in a simple, inexpensive and portable "LAMP box" supplemented with a consumer class smartphone. The entire assembly can be powered by a 5 V USB source such as a USB power bank or solar panel. Our smartphone employs a novel algorithm utilizing chromaticity to analyze fluorescence signals, which improves the discrimination of positive/ negative signals by 5-fold when compared to detection with traditional RGB intensity sensors or the naked eye. The ability to detect ZIKV directly from crude human sample matrices (blood, urine, and saliva) demonstrates our device's utility for widespread clinical deployment. Together, these advances enable our system to host the key components necessary to expand the use of nucleic acid amplification-based detection assays towards point-of-care settings where they are needed most.
C1 [Priye, Aashish; Bird, Sara W.; Ball, Cameron S.; Negrete, Oscar A.; Meagher, Robert J.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94550 USA.
   [Light, Yooli K.] Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94550 USA.
RP Priye, A; Meagher, RJ (corresponding author), Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94550 USA.
EM apriye@sandia.gov; rmeaghe@sandia.gov
RI , 星翼/AAP-2910-2020
OI Meagher, Robert/0000-0002-6262-2126
FU Sandia National Laboratories' Laboratory Directed Research and
   Development (LDRD) [173111, 190245]; National Institute of Allergy and
   Infectious Disease (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [1R21AI120973]; U.S. Department
   of Energy's National Nuclear Security AdministrationNational Nuclear
   Security Administration [DE-AC04-94AL85000]
FX Viruses: We acknowledge Dr. Brandy Russell (Centers for Disease Control
   and Prevention, Fort Collins, CO) for the ZIKV strains PRVABC59 (Puerto
   Rico) and R103451 (Honduras). We acknowledge Dr. Michael Busch (Blood
   Systems Research Institute, San Francisco, CA) for the Brazilian ZIKV
   isolate. The following reagent was obtained through BEI Resources,
   NIAID, NIH: Genomic RNA from Dengue Virus Type 1, Hawaii, NR-4287. We
   acknowledge the group of Dr. Lark Coffey (University of
   California-Davis) for providing RNA from the other viruses in Table 1.
   This work was funded by a grant from Sandia National Laboratories'
   Laboratory Directed Research and Development (LDRD) program (Project#
   173111, PI: Meagher and Project# 190245)), and by a grant from the
   National Institute of Allergy and Infectious Disease (NIAID grant
   1R21AI120973, PI: Meagher). Sandia National Laboratories is a
   multi-program laboratory managed and operated by Sandia Corporation, a
   wholly owned subsidiary of Lockheed Martin Corporation, for the U.S.
   Department of Energy's National Nuclear Security Administration under
   Contract DE-AC04-94AL85000.
CR Anez G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004445
   Ball CS, 2016, ANAL CHEM, V88, P3562, DOI 10.1021/acs.analchem.5b04054
   Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h
   Coyne C. B., 2016, NATURE REV MICROBIOL
   Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432
   Dauner AL, 2015, DIAGN MICR INFEC DIS, V83, P30, DOI 10.1016/j.diagmicrobio.2015.05.004
   Deeb SS, 2005, CLIN GENET, V67, P369, DOI 10.1111/j.1399-0004.2004.00343.x
   Fiorentino DG, 2016, CURR OBSTET GYNECOL, V5, P234, DOI 10.1007/s13669-016-0171-1
   Fronczek CF, 2014, RSC ADV, V4, P11103, DOI 10.1039/c3ra47688j
   Gallegos D, 2013, LAB CHIP, V13, P2124, DOI 10.1039/c3lc40991k
   Guo WH, 2011, PROTEIN EXPRES PURIF, V77, P185, DOI 10.1016/j.pep.2011.01.015
   Hayashida K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003578
   Huang YW, 2013, ANALYST, V138, P2522, DOI 10.1039/c3an36875k
   Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003
   Jiang L., 2014, SCI REPORTS, V4
   Kemleu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165506
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lau YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138694
   Lee S, 2014, LAB CHIP, V14, P1437, DOI 10.1039/c3lc51375k
   Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Oncescu V, 2014, LAB CHIP, V14, P759, DOI 10.1039/c3lc51194d
   Oncescu V, 2013, LAB CHIP, V13, P3232, DOI 10.1039/c3lc50431j
   Organization W. H., 2016, ZIK VIR MICR GUILL B
   Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Park TS, 2013, LAB CHIP, V13, P4832, DOI 10.1039/c3lc50976a
   Priye A., 2016, ANAL CHEM
   Priye A., 2016, MICROFLUIDIC METHODS, P55
   Shen L, 2012, LAB CHIP, V12, P4240, DOI [10.1039/c2lc40741, 10.1039/c2lc40741h]
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Skandarajah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096906
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k
   Wei QS, 2014, ACS NANO, V8, P12725, DOI 10.1021/nn505821y
   Wheeler SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147962
   Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8
   Yu HJ, 2014, ANAL CHEM, V86, P8805, DOI 10.1021/ac502080t
NR 46
TC 90
Z9 92
U1 14
U2 87
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 20
PY 2017
VL 7
AR 44778
DI 10.1038/srep44778
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO7SN
UT WOS:000396890500001
PM 28317856
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ribeiro, EM
   Lopes, TF
   Kerbage, SC
   Pessoa, ALS
   Cavalcanti, LPD
AF Ribeiro, Erlane Marques
   Lopes, Thayse Figueiredo
   Kerbage, Saile Cavalcante
   Santos Pessoa, Andre Luis
   de Goes Cavalcanti, Luciano Pamplona
TI From the perception of a cluster of cases of children with microcephaly
   to congenital Zika syndrome in Brazil: the lessons we have learned and
   the challenges that lie ahead of us
SO JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
LA English
DT Letter
ID VIRUS-INFECTION; TRANSMISSION
C1 [Ribeiro, Erlane Marques; Kerbage, Saile Cavalcante; Santos Pessoa, Andre Luis] Albert Sabin Childrens Hosp, Fortaleza, CE, Brazil.
   [Ribeiro, Erlane Marques; Lopes, Thayse Figueiredo] Christus Univ Ctr, Fortaleza, CE, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, CE, Brazil.
RP Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, CE, Brazil.
EM pamplona.luciano@gmail.com
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Ministerio da Saude, 2016, PROT AT SAUD RESP OC, P42
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 15
TC 3
Z9 3
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1678-9199
J9 J VENOM ANIM TOXINS
JI J. Venom. Anim. Toxins Trop. Dis.
PD MAR 20
PY 2017
VL 23
IS 1
AR 15
DI 10.1186/s40409-017-0107-x
PG 3
WC Toxicology; Tropical Medicine; Zoology
SC Toxicology; Tropical Medicine; Zoology
GA EP8ZS
UT WOS:000397664000001
PM 28331488
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dzaki, N
   Ramli, KN
   Azlan, A
   Ishak, IH
   Azzam, G
AF Dzaki, Najat
   Ramli, Karima N.
   Azlan, Azali
   Ishak, Intan H.
   Azzam, Ghows
TI Evaluation of reference genes at different developmental stages for
   quantitative real-time PCR in Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; MAJOR ARBOVIRUS VECTOR; RT-PCR;
   MESSENGER-RNA; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; TRANSCRIPTIONAL
   PROFILES; DROSOPHILA-MELANOGASTER; ABIOTIC STRESS; DENGUE VIRUS
AB The mosquito Aedes aegypti (Ae. aegypti) is the most notorious vector of illness-causing viruses such as Dengue, Chikugunya, and Zika. Although numerous genetic expression studies utilizing quantitative real-time PCR (qPCR) have been conducted with regards to Ae. aegypti, a panel of genes to be used suitably as references for the purpose of expression-level normalization within this epidemiologically important insect is presently lacking. Here, the usability of seven widely-utilized reference genes i.e. actin (ACT), eukaryotic elongation factor 1 alpha (eEF1 alpha), alpha tubulin (alpha-tubulin), ribosomal proteins L8, L32 and S17 (RPL8, RPL32 and RPS17), and glyceraldeyde 3-phosphate dehydrogenase (GAPDH) were investigated. Expression patterns of the reference genes were observed in sixteen pre-determined developmental stages and in cell culture. Gene stability was inferred from qPCR data through three freely available algorithms i.e. BestKeeper, geNorm, and NormFinder. The consensus rankings generated from stability values provided by these programs suggest a combination of at least two genes for normalization. ACT and RPS17 are the most dependably expressed reference genes and therefore, we propose an ACT/RPS17 combination for normalization in all Ae. aegypti derived samples. GAPDH performed least desirably, and is thus not a recommended reference gene. This study emphasizes the importance of validating reference genes in Ae. aegypti for qPCR based research.
C1 [Dzaki, Najat; Ramli, Karima N.; Azlan, Azali; Ishak, Intan H.; Azzam, Ghows] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
   [Ishak, Intan H.; Azzam, Ghows] Univ Sains Malaysia, Vector Control & Res Unit, Sch Biol Sci, George Town 11800, Malaysia.
RP Azzam, G (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.; Azzam, G (corresponding author), Univ Sains Malaysia, Vector Control & Res Unit, Sch Biol Sci, George Town 11800, Malaysia.
EM ghows@usm.my
RI Abd-Alhameed, Raed/AAG-5608-2020; Ishak, Intan/C-8723-2016; Azzam,
   Ghows/C-5592-2013; Azlan, Azali/X-2354-2019
OI Abd-Alhameed, Raed/0000-0003-2972-9965; Ishak,
   Intan/0000-0002-8916-0451; Azzam, Ghows/0000-0001-5352-8675; Dzaki,
   Najat/0000-0001-9661-6827
FU Fundamental Research Grant Scheme [203/PBIOLOGI/6711457]; Universiti
   Sains Malaysia Research University GrantUniversiti Sains Malaysia
   [1001/PBIOLOGI/811320]; Short Term Grant [304/PBIOLOGI/6313195]; Science
   Fund grant [305/PBIOLOGI/613238]; Yayasan Khazanah
FX We would like to thank all our collaborators and colleagues for the
   discussion and the work conducted in this lab. We would especially like
   to thank the Vector Control Research Unit, Universiti Sains Malaysia for
   providing the mosquito samples. This study was funded by the Fundamental
   Research Grant Scheme (203/PBIOLOGI/6711457), Universiti Sains Malaysia
   Research University Grant (1001/PBIOLOGI/811320), Short Term Grant
   (304/PBIOLOGI/6313195) and Science Fund grant (305/PBIOLOGI/613238).
   N.D. is funded by Yayasan Khazanah.
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886
   Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Bustin Stephen A, 2004, J Biomol Tech, V15, P155
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cardoso GA, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.2
   Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049
   Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005
   Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010
   Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10
   Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208
   Fischer M, 2005, J MOL DIAGN, V7, P89, DOI 10.1016/S1525-1578(10)60013-X
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062
   Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171
   Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6
   Guo JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07042
   Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93
   Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0
   Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946
   Kafatos F. C., 2009, RNA ISOLATION MOSQUI
   Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2
   Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Leming MT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1128
   Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762
   Liu MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087417
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LONG CW, 1970, J BIOL CHEM, V245, P80
   Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mazzacano CA, 1996, INSECT BIOCHEM MOLEC, V26, P563, DOI 10.1016/S0965-1748(96)00011-2
   Meng YL, 2013, SCI HORTIC-AMSTERDAM, V158, P16, DOI 10.1016/j.scienta.2013.04.019
   Morlais I, 2003, MOL GENET GENOMICS, V269, P753, DOI 10.1007/s00438-003-0882-7
   Morlais I, 2001, GENETICS, V158, P1125
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285
   Padmanabha H, 2011, MED VET ENTOMOL, V25, P445, DOI 10.1111/j.1365-2915.2011.00950.x
   Pattern R, RNA ISOLATION REVERS
   Perez MH, 2012, J INSECT PHYSIOL, V58, P824, DOI 10.1016/j.jinsphys.2012.03.005
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014
   Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177
   Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304
   Rey JR, 2009, AQUAT ECOL, V43, P987, DOI 10.1007/s10452-009-9232-0
   Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-648
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301
   Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9
   Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376
   Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979
   Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776
   Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007
   Weinberg-Shukron A, 2015, J CLIN INVEST, V125, P4295, DOI 10.1172/JCI83553
   Yeung AT, 2004, BIOTECHNIQUES, V36, P266, DOI 10.2144/04362RR01
   Zhai YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106800
   Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730
NR 71
TC 21
Z9 23
U1 3
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 16
PY 2017
VL 7
AR 43618
DI 10.1038/srep43618
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO3AV
UT WOS:000396568200001
PM 28300076
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Manica, M
   Rosa, R
   della Torre, A
   Caputo, B
AF Manica, Mattia
   Rosa, Roberto
   della Torre, Alessandra
   Caputo, Beniamino
TI From eggs to bites: do ovitrap data provide reliable estimates of Aedes
   albopictus biting females?
SO PEERJ
LA English
DT Article
DE Invasive mosquitoes; Epidemiological modelling; Chikungunya; Biting
   rate; R-0; Zika; Dengue; Europe; Ovitrap; Arboviruses
ID DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; EPIDEMIC; OUTBREAK; MOSQUITOS;
   AEGYPTI; DISEASE; VECTOR; DENGUE; ROME
AB Background. Aedes albopictus is an aggressive invasive mosquito species that represents a serious health concern not only in tropical areas, but also in temperate regions due to its role as vector of arboviruses. Estimates of mosquito biting rates are essential to account for vector- human contact in models aimed to predict the risk of arbovirus autochthonous transmission and outbreaks, as well as nuisance thresholds useful for correct planning of mosquito control interventions. Methods targeting daytime and outdoor biting Ae. albopictus females (e.g.,Human Landing Collection, HLC) are expensive and difficult to implement in large scale schemes. Instead, egg- collections by ovitraps are the most widely used routine approach for large- scale monitoring of the species. The aim of this work was to assess whether ovitrap data can be exploited to estimate numbers of adult biting Ae. albopictus females and whether the resulting relationship could be used to build risk models helpful for decision- makers in charge of planning of mosquito- control activities in infested areas.
   Method. Ovitrap collections and HLCs were carried out in hot-spots of A e. albopictus abundance in Rome (Italy) along a whole reproductive season. The relationship between the two sets of data was assessed by generalized least square analysis, taking into account meteorological parameters.
   Result. The mean number of mosquito females/person collected by HLC in 15 0 (i. e., females/HLC) and the mean number of eggs/day were 18.9 +/- 0.7 and 39.0 +/- 2.0, respectively. The regression models found a significant positive relationship between the two sets of data and estimated an increase of one biting female/person every five additional eggs found in ovitraps. Both observed and fitted values indicated presence of adults in the absence of eggs in ovitraps. Notably, wide confidence intervals of estimates of biting females based on eggs were observed. The patterns of exotic arbovirus outbreak probability obtained by introducing these estimates in risk models were similar to those based on females/HLC (R0 > 1 in 86% and 40% of sampling dates for Chikungunya and Zika, respectively; R0 < 1 along the entire season for Dengue). Moreover, the model predicted that in this case-study scenario an R0 > 1 for Chikungunya is also to be expected when few/no eggs/day are collected by ovitraps.
   Discussion. This work provides the first evidence of the possibility to predict mean number of adult biting Ae. albopictus females based on mean number of eggs and to compute the threshold of eggs/ovitrap associated to epidemiological risk of arbovirus transmission in the study area. Overall, however, the large confidence intervals in the model predictions represent a caveat regarding the reliability of monitoring schemes based exclusively on ovitrap collections to estimate numbers of biting females and plan control interventions.
C1 [Manica, Mattia; della Torre, Alessandra; Caputo, Beniamino] Univ Rome, Fondazione Cenci Bolognetti, Dipartimento Sanita Pubblica & Malattie Infett, Lab affiliated Ist Pasteur Italia, Rome, Italy.
   [Manica, Mattia; Rosa, Roberto] Ctr Ric Innovazione, Fondazione Edmund Mach, Dipartimento Biodiversita Ecol Mol, San Michele All Adige, Italy.
RP Caputo, B (corresponding author), Univ Rome, Fondazione Cenci Bolognetti, Dipartimento Sanita Pubblica & Malattie Infett, Lab affiliated Ist Pasteur Italia, Rome, Italy.
EM beniamino.caputo@uniroma1.it
RI Rosa, Roberto/B-8562-2011
OI Rosa, Roberto/0000-0002-8655-2230; MANICA, MATTIA/0000-0003-3709-1199
FU EUEuropean Union (EU) [FP7-261504]; Autonomous Province of Trento
   (Italy)Autonomous Province of Trento
FX This work has been funded by EU grant FP7-261504 EDENext, and is
   catalogued by the EDENext Steering Committee as EDENext475. RR was
   partially funded by the Autonomous Province of Trento (Italy), Research
   funds for Grandi Progetti, Project LExEM (Laboratory of Excellence for
   Epidemiology and Modelling, http://www.lexem.eu). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Barton K., 2016, MUMIN MULTIMODEL INF
   Burnham K. P., 2002, MODEL SELECTION MULT
   Caputo B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0734-4
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Davis TJ, 2016, J VECTOR ECOL, V41, P11, DOI 10.1111/jvec.12188
   Davis TJ, 2015, J AM MOSQUITO CONTR, V31, P321, DOI 10.2987/moco-31-04-321-328.1
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Di Luca Marco, 2001, Annali dell'Istituto Superiore di Sanita, V37, P249
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   ECDC, 2012, GUID SURV INV EUR
   Enserink M, 2006, SCIENCE, V311, P1085, DOI 10.1126/science.311.5764.1085a
   Faraway J. J., 2006, C&H TEXT STAT SCI
   Flacio E, 2006, PARASITE VECTOR, V8, DOI [10.1186/s13071-015-0793-6, DOI 10.1186/S13071-015-0793-6.]
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Guzzetta G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004762
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115
   ISS, 2016, PIAN NAZ SORV RISP A
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Marini L, 2015, PLOS ONE, V10, P1
   Mazerolle M, 2016, AICCMODAVG MODEL SEL
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   MOGI M, 1981, RES POPUL ECOL, V23, P328, DOI 10.1007/BF02515635
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Pinheiro J., 2011, NLME LINEAR NONLINEA, DOI DOI 10.1371/J0URNAL.P0NE.0018860
   Qiu YT, 2007, ECOL CONT VECTOR-BOR, V1, P329
   R Core Team, 2016, R LANG ENV STAT COMP
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x
   Severini F., 2008, Parassitologia (Rome), V50, P121
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Straetemans M., 2008, Eurosurveillance, V13, P8040
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Tantowijoyo W, 2016, J MED ENTOMOL, V53, P188, DOI 10.1093/jme/tjv180
   Vallorani R, 2015, ENVIRON ENTOMOL, V44, P1182, DOI 10.1093/ee/nvv067
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Velo E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1501-x
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zuur Alain F., 2009, P1
NR 59
TC 7
Z9 7
U1 0
U2 17
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAR 16
PY 2017
VL 5
AR e2998
DI 10.7717/peerj.2998
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO7YW
UT WOS:000396907000001
PM 28321362
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fortuna, C
   Remoli, ME
   Rizzo, C
   Benedetti, E
   Fiorentini, C
   Bella, A
   Argentini, C
   Farchi, F
   Castilletti, C
   Capobianchi, MR
   Zammarchi, L
   Bartoloni, A
   Zanchetta, N
   Gismondo, MR
   Nelli, LC
   Vitale, G
   Baldelli, F
   D'Agaro, P
   Sodano, G
   Rezza, G
AF Fortuna, Claudia
   Remoli, Maria Elena
   Rizzo, Caterina
   Benedetti, Eleonora
   Fiorentini, Cristiano
   Bella, Antonino
   Argentini, Claudio
   Farchi, Francesca
   Castilletti, Concetta
   Capobianchi, Maria Rosaria
   Zammarchi, Lorenzo
   Bartoloni, Alessandro
   Zanchetta, Nadia
   Gismondo, Maria Rita
   Nelli, Luca Ceccherini
   Vitale, Giustina
   Baldelli, Franco
   D'Agaro, Pierlanfranco
   Sodano, Giuseppe
   Rezza, Giovanni
CA Arbovirus Working Grp
TI Imported arboviral infections in Italy, July 2014-October 2015: a
   National Reference Laboratory report
SO BMC INFECTIOUS DISEASES
LA English
DT Article
ID ZIKA VIRUS-INFECTION; CHIKUNGUNYA VIRUS; 1ST REPORT; OUTBREAK; DENGUE;
   KOREICUS; AMERICA; VECTOR; NUMBER; STATES
AB Background: Imported cases of infections due to Dengue (DENV) and Chikungunya (CHIKV) viruses and, more recently, Zika virus (ZIKV) are commonly reported among travelers returning from endemic regions. In areas where potentially competent vectors are present, the risk of autochthonous transmission of these vector-borne pathogens is relatively high. Laboratory surveillance is crucial to rapidly detect imported cases in order to reduce the risk of transmission. This study describes the laboratory activity performed by the National Reference Laboratory for Arboviruses (NRLA) at the Italian National Institute of Health in the period from July 2014 to October 2015.
   Methods: Samples from 180 patients visited/hospitalized with a suspected DENV/CHIKV/ZIKV infection were sent to the NRLA from several Italian Hospitals and from Regional Reference Laboratories for Arboviruses, in agreement with the National Plan on human surveillance of vector-borne diseases. Both serological (ELISA IgM test and Plaque Reduction Neutralization Test-PRNT) and molecular assays (Real Time PCR tests, RT-PCR plus nested PCR and sequencing of positive samples) were performed.
   Results: DENV infection was the most frequently diagnosed (80 confirmed/probable cases), and all four genotypes were detected. However, an increase in imported CHIKV cases (41 confirmed/probable cases) was observed, along with the detection of the first ZIKV cases (4 confirmed cases), as a consequence of the recent spread of both CHIKV and ZIKV in the Americas.
   Conclusions: Main diagnostic issues highlighted in our study are sensitivity limitations of molecular tests, and the importance of PRNT to confirm serological results for differential diagnosis of Arboviruses. The continuous evaluation of diagnostic strategy, and the implementation of laboratories networks involved in surveillance activities is essential to ensure correct diagnosis, and to improve the preparedness for a rapid and proper identification of viral threats.
C1 [Fortuna, Claudia; Remoli, Maria Elena; Benedetti, Eleonora; Fiorentini, Cristiano; Argentini, Claudio; Farchi, Francesca; Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Rome, Italy.
   [Rizzo, Caterina; Bella, Antonino] Ist Super Sanita, Natl Ctr Epidemiol & Hlth Promot, Rome, Italy.
   [Castilletti, Concetta; Capobianchi, Maria Rosaria] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy.
   [Zammarchi, Lorenzo] Careggi Univ Hosp, Infect & Trop Dis Unit, Florence, Italy.
   [Bartoloni, Alessandro] Univ Florence, Dept Expt & Clin Med, Florence, Italy.
   [Zanchetta, Nadia; Gismondo, Maria Rita] Luigi Sacco Hosp, Clin Microbiol Virol & Bioemergency, Milan, Italy.
   [Nelli, Luca Ceccherini] Univ Pisa, Pisa Univ Hosp, Azienda Osped Univ Pisana, Virol Sect, Pisa, Italy.
   [Nelli, Luca Ceccherini] Univ Pisa, Pisa Univ Hosp, Azienda Osped Univ Pisana, Retrovirus Ctr,Dept Translat Res NSMT, Pisa, Italy.
   [Vitale, Giustina] Palermo Univ Hosp, Azienda Osped Univ Policlin Palermo, Dept Lab Diag, Palermo, Italy.
   [Baldelli, Franco] Univ Perugia, Dept Med, Clin Infect Dis, Perugia, Italy.
   [D'Agaro, Pierlanfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [D'Agaro, Pierlanfranco] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Sodano, Giuseppe] AO Colli, UOC Microbiol & Virol, Hosp Infect Dis D Cotugno, Monaldi,Cotugno,CTO, Naples, Italy.
RP Fortuna, C (corresponding author), Ist Super Sanita, Dept Infect Dis, Rome, Italy.
EM giulietta.venturi@iss.it
RI FORTUNA, CLAUDIA/O-9446-2015; BARTOLONI, ALESSANDRO/K-3403-2018; Bella,
   Antonino/AAB-9943-2019; Castilletti, Concetta/B-6545-2016; VENTURI,
   GIULIETTA/O-8123-2015; Rizzo, Caterina/H-4092-2012; Castilletti,
   Concetta/AAA-8408-2019; Colavita, Francesca/I-8848-2018; CAPORALI, MARIA
   GRAZIA/N-7960-2017; Gismondo, Maria Rita/I-3965-2017
OI FORTUNA, CLAUDIA/0000-0001-8878-4505; BARTOLONI,
   ALESSANDRO/0000-0001-9758-1523; Castilletti,
   Concetta/0000-0001-9819-236X; VENTURI, GIULIETTA/0000-0002-9078-8350;
   Rizzo, Caterina/0000-0002-5583-7508; Castilletti,
   Concetta/0000-0001-9819-236X; Quartu, Serena/0000-0003-3866-3021;
   Colavita, Francesca/0000-0003-0640-8667; CAPORALI, MARIA
   GRAZIA/0000-0002-8806-0416; Remoli, Maria Elena/0000-0003-3565-383X;
   Gismondo, Maria Rita/0000-0001-6926-8660; ZAMMARCHI,
   Lorenzo/0000-0003-0892-8404; lalle, eleonora/0000-0002-7063-9905
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Avsic-Zupanc T, 2013, CLIN MICROBIOL INFEC, V19, P683, DOI 10.1111/1469-0691.12215
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feldstein LR, 2016, AM J TROP MED HYG, V95, P885, DOI 10.4269/ajtmh.16-0288
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lagi F, 2014, J TRAVEL MED, V21, P340, DOI 10.1111/jtm.12144
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Ministero della Salute Direzione Generale della Prevenzione Sanitaria Ufficio V, 2014, MAL INF PROF INT EX
   Ministero della Salute Direzione Generale della Prevenzione Sanitaria Ufficio V, 2015, MAL INF PROF INT EX
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montarsi F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1208-4
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Requena-Mendez A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.28.20853
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rossini G, 2016, EPIDEMIOL INFECT, V144, P1912, DOI 10.1017/S0950268815002940
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Suk JE, 2014, EUR J PUBLIC HEALTH, V24, P531, DOI 10.1093/eurpub/cku041
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 50
TC 13
Z9 13
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 16
PY 2017
VL 17
AR 216
DI 10.1186/s12879-017-2320-1
PG 15
WC Infectious Diseases
SC Infectious Diseases
GA EP5BI
UT WOS:000397393600003
PM 28302072
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hasan, SS
   Miller, A
   Sapparapu, G
   Fernandez, E
   Klose, T
   Long, F
   Fokine, A
   Porta, JC
   Jiang, W
   Diamond, MS
   Crowe, JE
   Kuhn, RJ
   Rossmann, MG
AF Hasan, S. Saif
   Miller, Andrew
   Sapparapu, Gopal
   Fernandez, Estefania
   Klose, Thomas
   Long, Feng
   Fokine, Andrei
   Porta, Jason C.
   Jiang, Wen
   Diamond, Michael S.
   Crowe, James E., Jr.
   Kuhn, Richard J.
   Rossmann, Michael G.
TI A human antibody against Zika virus crosslinks the E protein to prevent
   infection
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NEUTRALIZING HUMAN-ANTIBODIES; DENGUE VIRUS; HIGHLY POTENT; ENVELOPE
   GLYCOPROTEIN; ANGSTROM RESOLUTION; SURFACE-PROTEINS; STRUCTURAL BASIS;
   MEMBRANE-FUSION; FLAVIVIRUS; TRANSMISSION
AB The recent Zika virus (ZIKV) epidemic has been linked to unusual and severe clinical manifestations including microcephaly in fetuses of infected pregnant women and Guillian-Barre syndrome in adults. Neutralizing antibodies present a possible therapeutic approach to prevent and control ZIKV infection. Here we present a 6.2 angstrom resolution three-dimensional cryo-electron microscopy (cryoEM) structure of an infectious ZIKV (strain H/PF/2013, French Polynesia) in complex with the Fab fragment of a highly therapeutic and neutralizing human monoclonal antibody, ZIKV-117. The antibody had been shown to prevent fetal infection and demise in mice. The structure shows that ZIKV-117 Fabs cross-link the monomers within the surface E glycoprotein dimers as well as between neighbouring dimers, thus preventing the reorganization of E protein monomers into fusogenic trimers in the acidic environment of endosomes.
C1 [Hasan, S. Saif; Miller, Andrew; Klose, Thomas; Long, Feng; Fokine, Andrei; Porta, Jason C.; Jiang, Wen; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.
   [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Jiang, Wen; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.
   [Jiang, Wen; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
RP Kuhn, RJ; Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.; Kuhn, RJ; Rossmann, MG (corresponding author), Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.; Kuhn, RJ; Rossmann, MG (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
EM kuhnr@purdue.edu; mr@purdue.edu
RI amsalu, ribka/G-8780-2019; Diamond, Michael/AAH-1733-2019; Crowe, James
   E./B-5549-2009
OI Diamond, Michael/0000-0002-8791-3165; Crowe, James
   E./0000-0002-0049-1079; Jiang, Wen/0000-0002-1292-2411
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI076331,
   R01 AI073755, R01 AI104972]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [HHSN272201400024C]
FX We thank Yinguan Sun and Valorie D. Bowman (Purdue University) for
   technical help in cryoEM data collection, Yue Liu and Vidya Mangala
   Prasad (Purdue University) for advice in fitting of coordinates, and
   Chuan Xiao (University of Texas at El Paso) for assistance in drawing
   roadmaps. CryoEM data were collected at the Purdue University CryoEM
   facility. This work was supported by U.S. National Institutes of Health
   grant awards R01 AI076331 (to M.G.R.), R01 AI073755 (to M.S.D.,
   sub-awards to R.J.K., M.G.R. and J.E.C.) and R01 AI104972 (to M.S.D.) as
   well as National Institutes of Health contract HHSN272201400024C (to
   J.E.C.).
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   CDC, 2016, ALL COUNTR TERR ACT
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19
   Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu Z, 2016, STRUCTURE, V24, P319, DOI 10.1016/j.str.2015.12.006
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NYC Health, 2016, HLTH DEP REP 4 MOR B
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sapparapu G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005719
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thornburg NJ, 2016, J CLIN INVEST, V126, P1482, DOI 10.1172/JCI85317
   Wang, 2016, SCI TRANSL MED, V369
   Yu GM, 2016, J STRUCT BIOL, V195, P207, DOI 10.1016/j.jsb.2016.06.003
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 55
TC 62
Z9 65
U1 0
U2 53
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 16
PY 2017
VL 8
AR 14722
DI 10.1038/ncomms14722
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO0OV
UT WOS:000396398600001
PM 28300075
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Siddharta, A
   Pfaender, S
   Vielle, NJ
   Dijkman, R
   Friesland, M
   Becker, B
   Yang, J
   Engelmann, M
   Todt, D
   Windisch, MP
   Brill, FH
   Steinmann, J
   Steinmann, J
   Becker, S
   Alves, MP
   Pietschmann, T
   Eickmann, M
   Thiel, V
   Steinmann, E
AF Siddharta, Anindya
   Pfaender, Stephanie
   Vielle, Nathalie Jane
   Dijkman, Ronald
   Friesland, Martina
   Becker, Britta
   Yang, Jaewon
   Engelmann, Michael
   Todt, Daniel
   Windisch, Marc P.
   Brill, Florian H.
   Steinmann, Joerg
   Steinmann, Jochen
   Becker, Stephan
   Alves, Marco P.
   Pietschmann, Thomas
   Eickmann, Markus
   Thiel, Volker
   Steinmann, Eike
TI Virucidal Activity of World Health Organization-Recommended Formulations
   Against Enveloped Viruses, Including Zika, Ebola, and Emerging
   Coronaviruses
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Ebola virus; WHO; SARS; MERS
ID ENVIRONMENTAL STABILITY; VACCINIA VIRUS; EFFICACY
AB The World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-) emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-) emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations.
C1 [Siddharta, Anindya; Friesland, Martina; Engelmann, Michael; Todt, Daniel; Pietschmann, Thomas; Steinmann, Eike] Twincore, Ctr Expt & Clin Infect Res, Inst Expt Virol, Feodor Lynen Str 7-9, D-30625 Hannover, Germany.
   [Becker, Britta; Brill, Florian H.; Steinmann, Jochen] Dr Brill Partner GmbH, Inst Hyg & Microbiol, Bremen, Germany.
   [Steinmann, Joerg] Univ Duisburg Essen, Inst Med Microbiol, Univ Hosp Essen, Duisburg, Germany.
   [Becker, Stephan; Eickmann, Markus] Philipps Univ Marburg, Inst Virol, Marburg, Germany.
   [Vielle, Nathalie Jane; Dijkman, Ronald; Alves, Marco P.; Thiel, Volker] Univ Bern, Dept Infect Dis & Pathobiol, Vetsuisse Fac, Bern, Switzerland.
   [Vielle, Nathalie Jane; Thiel, Volker] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
   [Pfaender, Stephanie; Vielle, Nathalie Jane; Dijkman, Ronald; Alves, Marco P.; Thiel, Volker] Inst Virol & Immunol, Fed Dept Home Affairs, Bern, Switzerland.
   [Pfaender, Stephanie; Vielle, Nathalie Jane; Dijkman, Ronald; Alves, Marco P.; Thiel, Volker] Inst Virol & Immunol, Fed Dept Home Affairs, Mittelhausern, Switzerland.
   [Yang, Jaewon; Alves, Marco P.] Inst Pasteur Korea, App Mol Virol, Seongnam, Gyeonggi Do, South Korea.
RP Steinmann, E (corresponding author), Twincore, Ctr Expt & Clin Infect Res, Inst Expt Virol, Feodor Lynen Str 7-9, D-30625 Hannover, Germany.
EM eike.steinmann@twincore.de
RI Thiel, Volker/AAI-2391-2019; Todt, Daniel/W-9362-2019
OI Todt, Daniel/0000-0002-3564-1014; Steinmann, Eike/0000-0002-3654-9965;
   Pfaender, Stephanie/0000-0002-3957-5448; Dijkman,
   Ronald/0000-0003-0320-2743; Thiel, Volker/0000-0002-5783-0887
FU Helmholtz Centre for Infection Research; National Research Foundation of
   Korea grant - Korean government [2014K1A4A7A01074644]; Institute Pasteur
   Ebola Task Force; Gyeonggi-do, KISTI
FX E. S. was supported by the Helmholtz Centre for Infection Research. M.
   P. W. and J. Y. were supported by a National Research Foundation of
   Korea grant funded by the Korean government (2014K1A4A7A01074644),
   Gyeonggi-do, KISTI, and the Institute Pasteur Ebola Task Force.
CR Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1
   Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803
   Eggers M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1111-9
   Klein M, 1963, SOAP CHEM SPEC, V39, P70
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15
   Pfaender S, 2016, REV MED VIROL, V26, P330, DOI 10.1002/rmv.1890
   Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103
   Rabenau HF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-185
   Steinmann J, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-34
   Steinmann J, 2010, AM J INFECT CONTROL, V38, P66, DOI 10.1016/j.ajic.2009.07.009
   Suchomel M, 2011, J HOSP INFECT, V77, P263, DOI 10.1016/j.jhin.2010.10.014
   Suchomel M, 2013, INFECT CONT HOSP EP, V34, P245, DOI 10.1086/669528
   Watt A, 2014, J VIROL, V88, P10511, DOI 10.1128/JVI.01272-14
   World Health Organization, 2009, WHO GUID HAND HYG HE
NR 15
TC 12
Z9 13
U1 3
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 15
PY 2017
VL 215
IS 6
BP 902
EP 906
DI 10.1093/infdis/jix046
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EV7UE
UT WOS:000401986300010
PM 28453839
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Meaney-Delman, DM
   Jamieson, DJ
   Rasmussen, SA
AF Meaney-Delman, Dana M.
   Jamieson, Denise J.
   Rasmussen, Sonja A.
TI Addressing the Effects of Established and Emerging Infections During
   Pregnancy
SO BIRTH DEFECTS RESEARCH
LA English
DT Editorial Material
ID WEST-NILE-VIRUS; ZIKA VIRUS; WOMEN; BIOTERRORISM; MONKEYPOX; BRAZIL
C1 [Meaney-Delman, Dana M.; Jamieson, Denise J.; Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Meaney-Delman, DM (corresponding author), Ctr Dis Control & Prevent, CDC, 1600 Clifton Rd,MS C12, Atlanta, GA 30333 USA.
EM vmo0@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cono J, 2006, EMERG INFECT DIS, V12, P1631, DOI 10.3201/eid1211.060618
   COSSART YE, 1975, LANCET, V1, P72
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   Faherty LJ, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.08.031
   *I MED, 1992, EM INF MICR THREATS
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jamieson DJ, 2005, CLIN PERINATOL, V32, P765, DOI 10.1016/j.clp.2005.04.008
   Jamieson DJ, 2004, OBSTET GYNECOL, V103, P754, DOI 10.1097/01.AOG.0000114987.76424.6d
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Obican S, 2011, AM J MED GENET C, V157C, P150, DOI 10.1002/ajmg.c.30310
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004
   Rasmussen SA, 2005, AM J PUBLIC HEALTH, V95, P1942, DOI 10.2105/AJPH.2004.054957
   Rasmussen SA, 2007, AM J MED GENET A, V143A, P2896, DOI 10.1002/ajmg.a.32077
   Rasmussen SA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0020-2016
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068
   VANELSACKERNIELE AMW, 1989, BRIT J OBSTET GYNAEC, V96, P768
   Webster WS, 1998, TERATOLOGY, V58, P13
   WESSELHOEFT C, 1947, NEW ENGL J MED, V236, P943, DOI 10.1056/NEJM194706192362506
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 0
Z9 0
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR 15
PY 2017
VL 109
IS 5
SI SI
BP 307
EP 310
DI 10.1002/bdr2.1018
PG 4
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA ER4WT
UT WOS:000398803400001
PM 28398682
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rasmussen, SA
   Meaney-Delman, DM
   Petersen, LR
   Jamieson, DJ
AF Rasmussen, Sonja A.
   Meaney-Delman, Dana M.
   Petersen, Lyle R.
   Jamieson, Denise J.
TI Studying the Effects of Emerging Infections on the Fetus: Experience
   with West Nile and Zika Viruses
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE teratogens; infections; emerging infections; West Nile virus; Zika
   virus; teratogenicity
ID UNITED-STATES; PREGNANT-WOMEN; BIRTH-DEFECTS; BRAZIL; TRANSMISSION;
   OUTCOMES; SURVEILLANCE; ASSOCIATION; INFANTS; BRAIN
AB Emerging infections have the potential to produce adverse effects on the pregnant woman or her fetus; however, studying these effects is often challenging. We review our experiences with investigating the prenatal effects of two mosquito-borne infections that emerged in the past 2 decades, West Nile virus (WNV) and Zika virus. Concerns regarding teratogenicity were raised about both viruses; Zika virus has been confirmed to be teratogenic, while WNV appears not to increase the risk for adverse outcomes, although teratogenicity has not been excluded. Study designs used to examine the effects of both viruses include case reports and series, pregnancy registries, and cohort studies. Case-control studies and birth defects surveillance systems are being used to study the effects during pregnancy of Zika virus, but not the effects of WNV, because a specific phenotype was observed among infants with congenital Zika infection, but not among infants with congenital WNV infection. Experimental data that demonstrated that Zika virus was neurotropic have also been useful because they provided biologic plausibility for Zika virus's teratogenic effects: these findings were consistent with observations in congenitally infected infants. Challenges encountered with studies to evaluate the effects of these infections include the broad range of possible adverse outcomes, the inability to include all infected pregnant women in studies because many infections are asymptomatic, and the difficulty with interpretation of diagnostic testing of infants (WNV and Zika) and pregnant women (Zika). This review might be helpful to guide future studies of the effects of emerging infections during pregnancy. (C) 2017 Wiley Periodicals, Inc.
C1 [Rasmussen, Sonja A.; Meaney-Delman, Dana M.; Petersen, Lyle R.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Rasmussen, SA (corresponding author), CDC, 1600 Clifton Rd,MS E-33, Atlanta, GA 30333 USA.
EM skr9@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   [Anonymous], 1998, MMWR Recomm Rep, V47, P1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, N ENGL J MED EPUB
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P154
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1133
   Chapa JB, 2003, OBSTET GYNECOL, V102, P229, DOI 10.1016/S0029-7844(03)00614-8
   CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   FRIEDMAN JM, 1992, TERATOLOGY, V45, P187, DOI 10.1002/tera.1420450212
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Hayes EB, 2004, PEDIATRICS, V113, P1375, DOI 10.1542/peds.113.5.1375
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lessa FC, 2015, NEW ENGL J MED, V372, P2369, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2016, JAMA PEDIAT
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Pan American Health Organization, 2015, INCR MICR NE BRAZ EP
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2001, EMERG INFECT DIS, V7, P611
   Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2005, AM J PUBLIC HEALTH, V95, P1942, DOI 10.2105/AJPH.2004.054957
   Rasmussen SA, 2007, AM J MED GENET A, V143A, P2896, DOI 10.1002/ajmg.a.32077
   Rasmussen SA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0020-2016
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scialli AR, 2005, BIRTH DEFECTS RES A, V73, P421, DOI 10.1002/bdra.21039
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Skoff TH, 2015, EMERG INFECT DIS, V21, P1568, DOI 10.3201/eid2109.150023
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trevathan E, 2016, BIRTH DEFECTS RES A, V106, P869, DOI 10.1002/bdra.23582
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
   Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Webster WS, 1998, TERATOLOGY, V58, P13
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 72
TC 2
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR 15
PY 2017
VL 109
IS 5
SI SI
BP 363
EP 371
DI 10.1002/bdr2.1006
PG 9
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA ER4WT
UT WOS:000398803400007
PM 28398684
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gilboa, SM
   Mai, CT
   Shapiro-Mendoza, CK
   Cragan, JD
   Moore, CA
   Meaney-Delman, DM
   Jamieson, DJ
   Honein, MA
   Boyle, CA
AF Gilboa, Suzanne M.
   Mai, Cara T.
   Shapiro-Mendoza, Carrie K.
   Cragan, Janet D.
   Moore, Cynthia A.
   Meaney-Delman, Dana M.
   Jamieson, Denise J.
   Honein, Margaret A.
   Boyle, Coleen A.
TI Population-Based Pregnancy and Birth Defects Surveillance in the Era of
   Zika Virus
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE pregnancy; birth defects; surveillance; Zika virus; monitoring
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; REPRODUCTIVE AGE; WOMEN;
   INFECTION; INFANTS; GUIDELINES; OUTBREAK; EXPOSURE; REGISTRY
AB Background: Zika virus is a newly recognized human teratogen; monitoring its impact on the birth prevalence of microcephaly and other adverse pregnancy outcomes will continue to be an urgent need in the United States and worldwide. Methods: When the Centers for Disease Control and Prevention (CDC) activated the Emergency Operations Center for the Zika virus outbreak response in January of 2016, public health leadership recognized that a joint, coordinated effort was required between activities focused on the effects of the infection among pregnant women and those focused on birth defects in fetuses and infants. Before the introduction of Zika virus in the Americas, population- based birth defects surveillance occurred independently of pregnancy surveillance activities. Results: The coordination of pregnancy surveillance and birth defects surveillance implemented through the CDC Zika virus response represents a paradigm shift. Conclusion: Coordination of these surveillance systems provides an opportunity to capture information from both a prospective and retrospective approach. This relatively modest investment in the public health infrastructure can continue to protect pregnant women and their infants during the ongoing response to Zika virus and in the next emergent threat to maternal and child health. (C) 2017 Wiley Periodicals, Inc.
C1 [Gilboa, Suzanne M.; Mai, Cara T.; Shapiro-Mendoza, Carrie K.; Cragan, Janet D.; Moore, Cynthia A.; Meaney-Delman, Dana M.; Jamieson, Denise J.; Honein, Margaret A.; Boyle, Coleen A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Mail Stop E-86,4770 Buford Highway, Atlanta, GA 30341 USA.
RP Gilboa, SM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Mail Stop E-86,4770 Buford Highway, Atlanta, GA 30341 USA.
EM sgilboa@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Jamieson,
   Denise/0000-0003-2597-1201
CR Ailes EC, 2014, MATERN CHILD HLTH J, V18, P1578, DOI 10.1007/s10995-013-1415-6
   Anderka M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2223-2
   [Anonymous], 1992, MMWR Recomm Rep, V41, P1
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294
   Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V54, P279
   Correa Adolfo, 2007, Birth Defects Res A Clin Mol Teratol, V79, P65
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Druschel C, 2001, TERATOLOGY, V64, pS30, DOI 10.1002/tera.1082
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497
   Goderis J, 2016, J PEDIATR-US, V172, P110, DOI 10.1016/j.jpeds.2016.01.024
   Honein MA, 1999, AM J PUBLIC HEALTH, V89, P1238, DOI 10.2105/AJPH.89.8.1238
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lynberg MC, 1994, DATA ACTION CDCS PUB, P217
   Mai CT, 2016, J PUBLIC HEALTH MAN, V22, pE1, DOI 10.1097/PHH.0000000000000221
   Mai CT, 2015, BIRTH DEFECTS RES A, V103, P972, DOI 10.1002/bdra.23461
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miller E, 2006, BIRTH DEFECTS RES A, V76, P787, DOI 10.1002/bdra.20331
   Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735
   Person A, 2013, MMWR-MORBID MORTAL W, V62, P728
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA JD, 2017, BRITH DEFECTS RES A
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   US Food and Drug Administration, 1996, FED REGISTER, V61, P8781
NR 34
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR 15
PY 2017
VL 109
IS 5
SI SI
BP 372
EP 378
DI 10.1002/bdr2.1007
PG 7
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA ER4WT
UT WOS:000398803400008
PM 28398681
OA Bronze
DA 2020-07-08
ER

PT J
AU Noguchi, LM
   Beigi, RH
AF Noguchi, Lisa M.
   Beigi, Richard H.
TI Treatment of Infections during Pregnancy: Progress and Challenges
SO BIRTH DEFECTS RESEARCH
LA English
DT Review
DE infection; pregnancy; pharmacokinetics; registries
ID INFLUENZA; EPIDEMIOLOGY; PREVENTION; MALARIA; BURDEN; WOMEN
AB Background: Emergence of Zika virus as a pathogen with important implications for perinatal outcomes highlights the need to identify safe and effective strategies for prevention and treatment of maternal infections. Methods: While substantial progress has been made in this area in recent years, significant regulatory and health systems barriers must still be overcome to identify and deliver evidence-based drug therapies for pregnant women. Results: We review progress and outstanding challenges associated with the identification and implementation of new treatment options for maternal infections. Conclusion: We describe several strategies in use to optimize the application of existing evidence. (C) 2017 Wiley Periodicals, Inc.
C1 [Noguchi, Lisa M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA.
   [Beigi, Richard H.] UPMC, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA.
RP Beigi, RH (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA.
EM rbeigi@mail.magee.edu
CR Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4
   Anderson GD, 2005, CLIN PHARMACOKINET, V44, P989, DOI 10.2165/00003088-200544100-00001
   [Anonymous], 2015, GUID START ANT THER
   [Anonymous], 2016, TER
   Beigi RH, 2015, CLIN PHARMACOL THER, V98, P403, DOI 10.1002/cpt.179
   Beigi RH, 2015, SEMIN PERINATOL, V39, P556, DOI 10.1053/j.semperi.2015.08.012
   Beigi RH, 2014, OBSTET GYN CLIN N AM, V41, P535, DOI 10.1016/j.ogc.2014.08.002
   Briggs GG, 2009, BIRTH DEFECTS RES A, V85, P109, DOI 10.1002/bdra.20551
   CDC, 2015, REC OBST HLTH CAR PR
   Committee APRS, 2016, ANT PREGN REG
   Coscia Lisa A, 2010, Clin Transpl, P65
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Food and Drug Administration Health and Human Services, 2014, FED REGISTER, V79, P72063
   Gilbert S, 2016, CHALLENGES ADV HIV R
   Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752
   Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36
   Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5
   Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455
   McCormack SA, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00009
   Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438
   Nahum GG, 2006, OBSTET GYNECOL, V107, P1120, DOI 10.1097/01.AOG.0000216197.26783.b5
   Rasmussen SA, 2012, CLIN OBSTET GYNECOL, V55, P487, DOI 10.1097/GRF.0b013e31824df23e
   Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900
   Riley C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145616
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   WHO, 2015, GUID TREATM MAL
   World Health Organization, 2015, WORLD MAL REP 2015
   World Health Organization, 2015, WHO REC PREV TREATM
NR 29
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR 15
PY 2017
VL 109
IS 5
SI SI
BP 387
EP 390
DI 10.1002/bdr2.1005
PG 4
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA ER4WT
UT WOS:000398803400010
PM 28398676
OA Bronze
DA 2020-07-08
ER

PT J
AU Vermund, SH
AF Vermund, Sten H.
TI The Vital Case for Global Health Investments by the US Government
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE health policy; global health; research investments; travel medicine;
   tropical medicine
ID ZIKA VIRUS; PUERTO-RICO; DISEASE; PROGRAMS; IMPACT; TRANSMISSION;
   METAANALYSIS; PARTNERSHIP; NUTRITION; LESSONS
C1 [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.
   [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.
RP Vermund, SH (corresponding author), Yale Sch Publ Hlth, POB 208034, New Haven, CT 06520 USA.
EM sten.vermund@yale.edu
RI Vermund, Sten/AAD-3592-2020
OI Vermund, Sten/0000-0001-7289-8698
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P30 AI110527]
FX This work was supported by the National Institutes of Health [grant
   number P30 AI110527].
CR [Anonymous], 2016, EB EP W AFR P WORKSH
   Bartsch SM, 2015, PATHOG GLOB HEALTH, V109, P4, DOI 10.1179/2047773214Y.0000000169
   Bearnot B, 2014, AM J TROP MED HYG, V91, P863, DOI 10.4269/ajtmh.13-0481
   Cancedda C, 2014, ACAD MED, V89, P1117, DOI 10.1097/ACM.0000000000000376
   Castilhos RM, 2016, CLIN GENET, V89, P295, DOI 10.1111/cge.12641
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Gordon CA, 2016, ADV PARASIT, V91, P311, DOI 10.1016/bs.apar.2015.12.002
   Halim N, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0189-y
   Heimburger DC, 2015, AM J TROP MED HYG, V93, P1201, DOI 10.4269/ajtmh.15-0432
   Herstein JJ, 2016, EMERG INFECT DIS, V22, P350, DOI 10.3201/eid2202.151431
   Kampe EOI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010399
   Kastner RJ, 2016, ADV PARASIT, V94, P393, DOI 10.1016/bs.apar.2016.08.004
   Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Munzel T, 2017, EUR HEART J, V38, P550, DOI 10.1093/eurheartj/ehw269
   Nakanjako D, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0087-2
   Ndebele P, 2014, J EMPIR RES HUM RES, V9, P24, DOI 10.1525/jer.2014.9.2.24
   Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120
   Phung D, 2016, SCI TOTAL ENVIRON, V550, P1084, DOI 10.1016/j.scitotenv.2016.01.154
   Salthammer T, 2016, ENVIRON INT, V94, P196, DOI 10.1016/j.envint.2016.05.009
   Sepulveda-Falla D, 2012, J ALZHEIMERS DIS, V32, P1, DOI 10.3233/JAD-2012-120907
   Shekar M, 2016, MATERN CHILD NUTR, V12, P186, DOI 10.1111/mcn.12281
   Shretta R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1635-5
   Sicuri E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130603
   Sturke R, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32407
   Tollefson J, 2016, NATURE, V535, P15
   Ton TGN, 2015, AM J TROP MED HYG, V92, P163, DOI 10.4269/ajtmh.14-0398
   Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185
   Wenzel RP, 2005, ARCH MED RES, V36, P610, DOI 10.1016/j.arcmed.2005.03.040
   Xu ZW, 2016, ENVIRON INT, V89-90, P193, DOI 10.1016/j.envint.2016.02.007
   Yassi A, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0145-0
   Zunt JR, 2016, AM J TROP MED HYG, V95, P728, DOI 10.4269/ajtmh.16-0190
NR 34
TC 4
Z9 4
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 15
PY 2017
VL 64
IS 6
BP 707
EP 710
DI 10.1093/cid/cix048
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3TI
UT WOS:000397304200003
PM 28158519
OA Bronze
DA 2020-07-08
ER

PT J
AU Huch, M
   Knoblich, JA
   Lutolf, MP
   Martinez-Arias, A
AF Huch, Meritxell
   Knoblich, Juergen A.
   Lutolf, Matthias P.
   Martinez-Arias, Alfonso
TI The hope and the hype of organoid research
SO DEVELOPMENT
LA English
DT Editorial Material
DE Disease modelling; Organoids; Stem cells; Therapies
ID CELL-DERIVED ORGANOIDS; EMBRYONIC STEM-CELLS; IN-VITRO EXPANSION;
   CEREBRAL ORGANOIDS; HUMAN LIVER; ZIKA VIRUS; CULTURES; TISSUES; CANCER;
   MOUSE
AB The recent increase in organoid research has been met with great enthusiasm, as well as expectation, from the scientific community and the public alike. There is no doubt that this technology opens up a world of possibilities for scientific discovery in developmental biology as well as in translational research, but whether organoids can truly live up to this challenge is, for some, still an open question. In this Spotlight article, Meritxell Huch and Juergen Knoblich begin by discussing the exciting promise of organoid technology and give concrete examples of how this promise is starting to be realised. In the second part, Matthias Lutolf and Alfonso Martinez-Arias offer a careful and considered view of the state of the organoid field and its current limitations, and lay out the approach they feel is necessary to maximise the potential of organoid technology.
C1 [Huch, Meritxell] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.
   [Huch, Meritxell] Univ Cambridge, Wellcome Trust, Med Res Council Stem Cell Inst, Gleeson Bldg,Tennis Court Rd, Cambridge CB2 1QR, England.
   [Huch, Meritxell] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.
   [Knoblich, Juergen A.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.
   [Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Sch Engn, CH-1015 Lausanne, Switzerland.
   [Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland.
   [Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.
   [Martinez-Arias, Alfonso] Univ Cambridge, Dept Genet, Downing Site, Cambridge CB2 3EH, England.
RP Huch, M (corresponding author), Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.; Huch, M (corresponding author), Univ Cambridge, Wellcome Trust, Med Res Council Stem Cell Inst, Gleeson Bldg,Tennis Court Rd, Cambridge CB2 1QR, England.; Huch, M (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.; Knoblich, JA (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.; Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, CH-1015 Lausanne, Switzerland.; Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland.; Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.; Martinez-Arias, A (corresponding author), Univ Cambridge, Dept Genet, Downing Site, Cambridge CB2 3EH, England.
EM m.huch@gurdon.cam.ac.uk; juergen.knoblich@imba.oeaw.ac.at;
   matthias.lutolf@epfl.ch; ama11@hermes.cam.ac.uk
RI Knoblich, Juergen A/C-2974-2015
OI Knoblich, Juergen A/0000-0002-6751-3404; Martinez Arias,
   Alfonso/0000-0002-1781-564X
FU Wellcome TrustWellcome Trust; Royal SocietyRoyal Society of London
   [104151/Z/14/Z]; Horizon 2020 grant (LSFM4LIFE); Austrian Academy of
   Sciences; Austrian Science FundAustrian Science Fund (FWF) [I_1281-B19,
   Z_153_B09]; European Research Council (ERC)European Research Council
   (ERC); Ecole Polytechnique Federale de Lausanne (EPFL); EU Seventh
   Framework Programme HEALTH research programme PluriMes; Horizon 2020
   project 'INTENS'; Novartis Foundation for Medical-Biological Research;
   Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC); Isaac Newton Trust;
   ERCEuropean Research Council (ERC)
FX M.H. is a Wellcome Trust Sir Henry Dale Fellow and is jointly funded by
   the Wellcome Trust and the Royal Society (104151/Z/14/Z); M.H. is also
   partially funded by a Horizon 2020 grant (LSFM4LIFE). J.A.K. is funded
   by the Austrian Academy of Sciences, the Austrian Science Fund (grants
   I_1281-B19 and Z_153_B09), and an Advanced Grant from the European
   Research Council (ERC). M.P.L. is supported by funding from Ecole
   Polytechnique Federale de Lausanne (EPFL), the ERC, the EU Seventh
   Framework Programme HEALTH research programme PluriMes, the Horizon 2020
   project 'INTENS', and the Novartis Foundation for Medical-Biological
   Research. A.M.-A. is supported by the Biotechnology and Biological
   Sciences Research Council and the Isaac Newton Trust.
CR Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768
   Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021
   Daley GQ, 2016, STEM CELL REP, V6, P787, DOI 10.1016/j.stemcr.2016.05.001
   De Robertis EM, 2014, DEV CELL, V30, P510, DOI 10.1016/j.devcel.2014.08.022
   Dekkers JF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8278
   Drost J, 2017, DEVELOPMENT, V144, P968, DOI 10.1242/dev.140566
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016
   Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168
   Horder T, 2010, ELS, DOI [10.1002/9780470015902.a0003080.pub2, DOI 10.1002/9780470015902.A0003080.PUB2]
   Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Hyun I, 2016, NATURE, V533, P169, DOI 10.1038/533169a
   Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470
   Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   McCauley HA, 2017, DEVELOPMENT, V144, P958, DOI 10.1242/dev.140731
   McCracken KW, 2017, NATURE, V541, P182, DOI 10.1038/nature21021
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Noguchi TK, 2015, NAT CELL BIOL, V17, P984, DOI 10.1038/ncb3200
   Pampaloni F, 2015, CELL TISSUE RES, V360, P129, DOI 10.1007/s00441-015-2144-5
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Sasai Y, 2012, DEVELOPMENT, V139, P4111, DOI 10.1242/dev.079590
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
NR 39
TC 78
Z9 79
U1 4
U2 36
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD MAR 15
PY 2017
VL 144
IS 6
SI SI
BP 938
EP 941
DI 10.1242/dev.150201
PG 4
WC Developmental Biology
SC Developmental Biology
GA EN8BC
UT WOS:000396224900002
PM 28292837
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Qian, XY
   Nguyen, HN
   Jacob, F
   Song, HJ
   Ming, GL
AF Qian, Xuyu
   Nguyen, Ha Nam
   Jacob, Fadi
   Song, Hongjun
   Ming, Guo-li
TI Using brain organoids to understand Zika virus-induced microcephaly
SO DEVELOPMENT
LA English
DT Editorial Material
DE Zika; Cortex; iPSC; Microcephaly; Organoids
ID PLURIPOTENT STEM-CELLS; NEURAL PROGENITORS; CEREBRAL ORGANOIDS; RADIAL
   GLIA; NEURONS; INFECTION; AMERICA; MODELS; BRAZIL; DIFFERENTIATION
AB Technologies to differentiate human pluripotent stem cells into three-dimensional organized structures that resemble in vivo organs are pushing the frontiers of human disease modeling and drug development. In response to the global health emergency posed by the Zika virus (ZIKV) outbreak, brain organoids engineered to mimic the developing human fetal brain have been employed to model ZIKV-induced microcephaly. Here, we discuss the advantages of brain organoids over other model systems to study development and highlight recent advances in understanding ZIKV pathophysiology and its underlying pathogenesis mechanisms. We further discuss perspectives on overcoming limitations of current organoid systems for their future use in ZIKV research.
C1 [Qian, Xuyu; Nguyen, Ha Nam; Jacob, Fadi; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Qian, Xuyu; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Nguyen, Ha Nam; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Jacob, Fadi; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
RP Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
EM gming1@jhmi.edu
RI Qian, Xuyu/C-1240-2017
OI Qian, Xuyu/0000-0001-5944-3816; Jacob, Fadi/0000-0002-0094-8454; Ming,
   Guo-li/0000-0002-2517-6075
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01MH105128,
   R35NS097370, R37NS047344, U19MH106434, P01NS097206, T32MH015330];
   Maryland Stem Cell Research Fund; Simons Foundation Autism Research
   Initiative (SFARI); Foundation for Prader-Willi Research; Dr.Miriam and
   Sheldon G.Adelson Medical Research Foundation
FX Work in the authors' laboratories was supported by the National
   Institutes of Health (R01MH105128 and R35NS097370 to G.-l.M.;
   R37NS047344, U19MH106434 and P01NS097206 to H.S.; T32MH015330 to
   H.N.N.), Maryland Stem Cell Research Fund (to G.-l.M.and H.S.), Simons
   Foundation Autism Research Initiative (SFARI) (to G.-l.M.and H.S.),
   Foundation for Prader-Willi Research (to G.-l.M.) and Dr.Miriam and
   Sheldon G.Adelson Medical Research Foundation (to G.-l.M.). Deposited in
   PMC for release after 12 months.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CDC, 2016, ZIK VIR
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Merkle FT, 2015, DEVELOPMENT, V142, P633, DOI 10.1242/dev.117978
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 42
TC 64
Z9 64
U1 1
U2 30
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD MAR 15
PY 2017
VL 144
IS 6
SI SI
BP 952
EP 957
DI 10.1242/dev.140707
PG 6
WC Developmental Biology
SC Developmental Biology
GA EN8BC
UT WOS:000396224900005
PM 28292840
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Pagliusi, S
   Ting, CC
   Lobos, F
AF Pagliusi, Sonia
   Ting, Ching-Chia
   Lobos, Fernando
CA DCVMN Executive Comm Grp
TI Vaccines: Shaping global health
SO VACCINE
LA English
DT Article; Proceedings Paper
CT Annual General Meeting of the
   Developing-Countries-Vaccine-Manufacturers-Network
CY OCT 24-26, 2016
CL Buenos Aires, ARGENTINA
SP Developing Countries Vaccine Manufacturers Network
DE Vaccine access; Immunization; Developing countries; Quality; Regulatory
   convergence
ID CHALLENGES
AB The Developing Countries Vaccine Manufacturers' Network (DCVMN) gathered leaders in immunization programs, vaccine manufacturing, representatives of the Argentinean Health Authorities and Pan American Health Organization, among other global health stakeholders, for its 17th Annual General Meeting in Buenos Aires, to reflect on how vaccines are shaping global health. Polio eradication and elimination of measles and rubella from the Americas is a result of successful collaboration, made possible by timely supply of affordable vaccines. After decades of intense competition for high-value markets, collaboration with developing countries has become critical, and involvement of multiple manufacturers as well as public- and private-sector investments are essential, for developing new vaccines against emerging infectious diseases. The recent Zika virus outbreak and the accelerated Ebola vaccine development exemplify the need for international partnerships to combat infectious diseases. A new player, Coalition for Epidemic Preparedness Innovations (CEPI) has made its entrance in the global health community, aiming to stimulate research preparedness against emerging infections. Face-to-face panel discussions facilitated the dialogue around challenges, such as risks of viability to vaccine development and regulatory convergence, to improve access to sustainable vaccine supply. It was discussed that joint efforts to optimizing regulatory pathways in developing countries, reducing registration time by up to 50%, are required. Outbreaks of emerging infections and the global Polio eradication and containment challenges are reminders of the importance of vaccines' access, and of the importance of new public private partnerships.
C1 [Pagliusi, Sonia; Ting, Ching-Chia] DCVMN Int, Route Crassier 7, CH-1262 Nyon, Switzerland.
   [Lobos, Fernando] Sinergium Biotech, Ruta Panamer,Km 38-7,P1619IEA, Buenos Aires, DF, Argentina.
RP Pagliusi, S (corresponding author), DCVMN Int, Route Crassier 7, CH-1262 Nyon, Switzerland.
EM s.pagliusi@dcvmn.org; c.ting@dcvmn.net;
   fernando.lobos@sinergiumbiotech.com
FU Merck (MilliporeSigma); Temptime Corporation; GE HealthcareGE
   Healthcare; Bioengineering; GEA; Bosch; OMPI (Stevanato Group); Applikon
   Biotechnology; Alfa Wasserman; Munters; Bill & Melinda Gates
   FoundationGates Foundation [OPP1157021]
FX We are grateful to all speakers and moderators whose contribution made
   the agenda invaluable. We thank corporate partners for supporting DCVMN
   with unrestricted educational grants: Merck (MilliporeSigma), Temptime
   Corporation, GE Healthcare, Bioengineering, GEA, Bosch, OMPI (Stevanato
   Group), Applikon Biotechnology, Alfa Wasserman, Munters. We are indebted
   to the experts who graciously served as rapporteurs of specific
   sessions: D. Kristensen, S. Sobti, and J. Hendriks. We thank S.
   Villasenor for administrative assistance and M. Dennehy for editorial
   support. This conference was partly supported by a grant from the Bill &
   Melinda Gates Foundation, Grant no. OPP1157021.
CR [Anonymous], 2016, WEEKLY EPIDEMIOLOGIC, V91, P421
   [Anonymous], REG PLATF ACC INN HL
   [Anonymous], 2016, GAP 3 CONT CERT SCH
   [Anonymous], 2016, QAS16686 WHO EMPRSS
   [Anonymous], 2015, PREP WITHDR ALL OR P
   Cohen J, 2016, COMMENTARY NEW VACCI
   Gavi The Vaccine Alliance, 2015, VACC ALL RES EV GAV
   GPEI, POL NOW
   Hotez PJ, 2016, VACCINE, V34, P3549, DOI 10.1016/j.vaccine.2016.03.112
   Jacoby E, 2015, VACCINE, V33, P4699, DOI 10.1016/j.vaccine.2015.03.062
   Meeting of the Strategic Advisory Group of Experts on Immunization, 2016, WEEKLY EPIDEMIOLOGIC, V91, P561
   PAHO/WHO Regional office for the Americas, 2016, REG AM DECL LIBR SAR
   Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405
   Precioso AR, 2015, VACCINE, V33, P7121, DOI 10.1016/j.vaccine.2015.09.105
   Regional office for Africa of World Health Organization, 2014, OUTBREAK NEWS   0323
   UNICEF, 2016, IN POL VACC SUPPL UP
   World Health Organization, REPL TRIV OPV BIV OP
NR 17
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAR 14
PY 2017
VL 35
IS 12
BP 1579
EP 1585
DI 10.1016/j.vaccine.2017.02.017
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EO8RU
UT WOS:000396958400001
PM 28237501
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Molko, N
   Simon, O
   Guyon, D
   Biron, A
   Dupont-Rouzeyrol, M
   Gourinat, AC
AF Molko, Nicolas
   Simon, Olivier
   Guyon, David
   Biron, Antoine
   Dupont-Rouzeyrol, Myrielle
   Gourinat, Ann-Claire
TI ZIKA VIRUS INFECTION AND MYASTHENIA GRAVIS: REPORT OF 2 CASES
SO NEUROLOGY
LA English
DT Editorial Material
C1 [Molko, Nicolas; Simon, Olivier; Guyon, David] Terr Hosp, Noumea, New Caledonia.
   [Biron, Antoine; Dupont-Rouzeyrol, Myrielle; Gourinat, Ann-Claire] Inst Pasteur Int Network, Inst Pasteur New Caledonia, Noumea, New Caledonia.
RP Molko, N (corresponding author), Terr Hosp, Noumea, New Caledonia.
EM n.molko@cht.nc
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leis AA, 2014, MUSCLE NERVE, V49, P26, DOI 10.1002/mus.23869
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
NR 6
TC 13
Z9 13
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAR 14
PY 2017
VL 88
IS 11
BP 1097
EP 1098
DI 10.1212/WNL.0000000000003697
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA EP4XL
UT WOS:000397383100017
PM 28188305
OA Bronze
DA 2020-07-08
ER

PT J
AU Dodson, BL
   Rasgon, JL
AF Dodson, Brittany L.
   Rasgon, Jason L.
TI Vector competence of Anopheles and Culex mosquitoes for Zika virus
SO PEERJ
LA English
DT Article
DE Zika virus; Mosquito; Vector competence; Emerging pathogen
ID WEST-NILE-VIRUS; INFECTION; FEVER; SUSCEPTIBILITY; TRANSMISSION;
   PIPIENS; FLAVIVIRUSES; CALIFORNIA; BIRDS
AB Zika virus is a newly emergent mosquito-borne flavivirus that has caused recent large outbreaks in the new world, leading to dramatic increases in serious disease pathology including Guillain-Barre syndrome, newborn rnicrocephaly, and infant brain damage. Although Aedes mosquitoes are thought to be the primary mosquito species driving infection, the virus has been isolated from dozens of mosquito species,.including Culex and Anopheles species, and we lack a thorough species and we lack a understanding of which mosquito species to target for vector control. We exposed Anopheles gambiae,Anopheles stephertsi, and Culex quinquefasciatus mosquitoes to blood meals supplemented with two Zika virus strains. Mosquito bodies, legs, and saliva were collected five, seven, and 14 days post blood meal and tested for infectious virus, by plaque assay.. Regardless of titer, virus strain, or timepoint, Anopheles gambiae, Anopheles stephensi, and Culex quinquefasciatus mosquitoes were refractory to Zika virus infection. We conclude that Anopheles gambiae, Anopheles stephensi, and Culex quinquefasciatus mosquitoes likely do not contribute significantly to Zika virus transmission to humans. However, future studies should continue to explore the potential for other novel potential vectors to transmit the virus.
C1 [Dodson, Brittany L.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
   [Rasgon, Jason L.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
RP Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.; Rasgon, JL (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.; Rasgon, JL (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
EM jlr54@psu.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RO1A1116636,
   R21A1128918]
FX This work was supported by the National Institutes of Health (grants
   RO1A1116636 and R21A1128918 to JLR). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bernard KA, 2001, EMERG INFECT DIS, V7, P679
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   CORBET P. S., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P463, DOI 10.1016/0035-9203(61)90095-5
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-199
   Dodson BL, 2011, VECTOR-BORNE ZOONOT, V11, P1493, DOI 10.1089/vbz.2011.0662
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2016, BIORXIV, DOI [10.1101/073197, DOI 10.1101/073197]
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW A. J., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P517, DOI 10.1016/0035-9203(60)90025-0
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kramer LD, 2001, ANN NY ACAD SCI, V951, P84
   Lutwama JJ, 1999, AM J TROP MED HYG, V61, P158, DOI 10.4269/ajtmh.1999.61.158
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Musso D, 2016, TRANSFUSION, V54, P2924, DOI [10.1111/trf.13271, DOI 10.1111/TRF.13271]
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pujhari S, 2016, PEERJ PREPRINTS, V4, DOI [10.7287/peerj.preprints.1781v1, DOI 10.7287/PEERJ.PREPRINTS.1781V1]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REISEN WK, 1990, AM J TROP MED HYG, V43, P419, DOI 10.4269/ajtmh.1990.43.419
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tabachnick WJ, 1996, AM J TROP MED HYG, V54, P481, DOI 10.4269/ajtmh.1996.54.481
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136
   Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WILLIAMS M. C, 1961, TRANS ROY SOC TROP MED AND HYG, V55, P135, DOI 10.1016/0035-9203(61)90017-7
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 48
TC 24
Z9 26
U1 1
U2 14
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAR 14
PY 2017
VL 5
AR e3096
DI 10.7717/peerj.3096
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO7YN
UT WOS:000396906100012
PM 28316896
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McGrath, EL
   Rossi, SL
   Gao, JL
   Widen, SG
   Grant, AC
   Dunn, TJ
   Azar, SR
   Roundy, CM
   Xiong, Y
   Prusak, DJ
   Loucas, BD
   Wood, TG
   Yu, YJ
   Fernandez-Salas, I
   Weaver, SC
   Vasilakis, N
   Wu, P
AF McGrath, Erica L.
   Rossi, Shannan L.
   Gao, Junling
   Widen, Steven G.
   Grant, Auston C.
   Dunn, Tiffany J.
   Azar, Sasha R.
   Roundy, Christopher M.
   Xiong, Ying
   Prusak, Deborah J.
   Loucas, Bradford D.
   Wood, Thomas G.
   Yu, Yongjia
   Fernandez-Salas, Ildefonso
   Weaver, Scott C.
   Vasilakis, Nikos
   Wu, Ping
TI Differential Responses of Human Fetal Brain Neural Stem Cells to Zika
   Virus Infection
SO STEM CELL REPORTS
LA English
DT Article
ID PROGENITOR CELLS; GROWTH; PROLIFERATION; GENERATION; ORGANOIDS;
   PROFILES; STRAINS; NEURONS; GENE
AB Zika virus (ZIKV) infection causes microcephaly in a subset of infants born to infected pregnant mothers. It is unknown whether human individual differences contribute to differential susceptibility of ZIKV-related neuropathology. Here, we use an Asian-lineage ZIKV strain, isolated from the 2015 Mexican outbreak (Mex1-7), to infect primary human neural stem cells (hNSCs) originally derived from three individual fetal brains. All three strains of hNSCs exhibited similar rates of Mex1-7 infection and reduced proliferation. However, Mex1-7 decreased neuronal differentiation in only two of the three stem cell strains. Correspondingly, ZIKA-mediated transcriptome alterations were similar in these two strains but significantly different from that of the third strain with no ZIKV-induced neuronal reduction. This study thus confirms that an Asian-lineage ZIKV strain infects primary hNSCs and demonstrates a cell-strain-dependent response of hNSCs to ZIKV infection.
C1 [McGrath, Erica L.; Gao, Junling; Grant, Auston C.; Dunn, Tiffany J.; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Azar, Sasha R.; Roundy, Christopher M.; Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Azar, Sasha R.; Roundy, Christopher M.; Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Widen, Steven G.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Roundy, Christopher M.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Xiong, Ying; Loucas, Bradford D.; Yu, Yongjia] Univ Texas Med Branch, Dept Radiol & Oncol, Galveston, TX 77555 USA.
   [Wood, Thomas G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso] Ctr Reg Salud Publ, Inst Nacl Salud Publ, Tapachula 30700, Chiapas, Mexico.
   [Wu, Ping] Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
RP Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Wu, P (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
EM nivasila@utmb.edu; piwu@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU John S. Dunn Foundation (P.W.); Brown Foundation of Houston; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R24AI120942, R21AI12950901, 4T32DA007287]; Chief
   Research Office at the University of Texas Medical Branch
FX This work was supported in part by funds from the John S. Dunn
   Foundation (P.W.), the Brown Foundation of Houston (S.C.W. and N.V.),
   NIH grants R24AI120942 (N.V. and S. C.W.), R21AI12950901 (P.W. and
   N.V.), and 4T32DA007287 (E.L.M.), and the Chief Research Office at the
   University of Texas Medical Branch (P.W.).
CR Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Brasil P, 2016, N ENGL J MED
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guerbois M., 2016, J INFECT DIS
   Haddow A. D., 2012, PLOS NEGLECT TROP D, V6, pe1477
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044
   Walker PJ, 2015, AM J TROP MED HYG, V93, P1041, DOI 10.4269/ajtmh.15-0344
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
   Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110
NR 37
TC 50
Z9 51
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2213-6711
J9 STEM CELL REP
JI Stem Cell Rep.
PD MAR 14
PY 2017
VL 8
IS 3
BP 715
EP 727
DI 10.1016/j.stemcr.2017.01.008
PG 13
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EP0VD
UT WOS:000397103900019
PM 28216147
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Costa-da-Silva, AL
   Ioshino, RS
   de Araujo, HRC
   Kojin, BB
   Zanotto, PMDA
   Oliveira, DBL
   Melo, SR
   Durigon, EL
   Capurro, ML
AF Costa-da-Silva, Andre Luis
   Ioshino, Rafaella Sayuri
   Correa de Araujo, Helena Rocha
   Kojin, Bianca Burini
   de Andrade Zanotto, Paolo Marinho
   Leal Oliveira, Danielle Bruna
   Melo, Stella Rezende
   Durigon, Edison Luiz
   Capurro, Margareth Lara
TI Laboratory strains of Aedes aegypti are competent to Brazilian Zika
   virus (vol 12, e0171951, 2017)
SO PLOS ONE
LA English
DT Correction
RI de A. Zanotto, Paolo M./B-9286-2019; Costa-Da-Silva, Andre
   Luis/J-8913-2019
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Costa-Da-Silva, Andre
   Luis/0000-0002-7615-7376
FU National Institutes of Health/National Institute of Allergy and
   Infectious Diseases (NIH/NIAID)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01 AI115595]
FX This study was supported by the National Institutes of Health/National
   Institute of Allergy and Infectious Diseases (NIH/NIAID) U01
   AI115595(https://www.nih.gov/).
CR Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
NR 1
TC 2
Z9 2
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2017
VL 12
IS 3
AR e0174081
DI 10.1371/journal.pone.0174081
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN6CP
UT WOS:000396092400046
PM 28288192
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hamzelou, J
AF Hamzelou, Jessica
TI Dormant Zika is back for round two
SO NEW SCIENTIST
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU REED BUSINESS INFORMATION LTD
PI SUTTON
PA QUADRANT HOUSE THE QUADRANT, SUTTON SM2 5AS, SURREY, ENGLAND
SN 0262-4079
J9 NEW SCI
JI New Sci.
PD MAR 11
PY 2017
VL 233
IS 3116
BP 8
EP 8
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN4IF
UT WOS:000395970500002
DA 2020-07-08
ER

PT J
AU Pagani, I
   Ghezzi, S
   Ulisse, A
   Rubio, A
   Turrini, F
   Garavaglia, E
   Candiani, M
   Castilletti, C
   Ippolito, G
   Poli, G
   Broccoli, V
   Panina-Bordignon, P
   Vicenzi, E
AF Pagani, Isabel
   Ghezzi, Silvia
   Ulisse, Adele
   Rubio, Alicia
   Turrini, Filippo
   Garavaglia, Elisabetta
   Candiani, Massimo
   Castilletti, Concetta
   Ippolito, Giuseppe
   Poli, Guido
   Broccoli, Vania
   Panina-Bordignon, Paola
   Vicenzi, Elisa
TI Human Endometrial Stromal Cells Are Highly Permissive To Productive
   Infection by Zika Virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; SEXUAL TRANSMISSION; IMMUNE-RESPONSES;
   REPLICATION; PROTECTION; RECEPTORS; ENTRY
AB Zika virus (ZIKV) is a recently re-emerged flavivirus transmitted to humans by mosquito bites but also from mother to fetus and by sexual intercourse. We here show that primary human endometrial stromal cells (HESC) are highly permissive to ZIKV infection and support its in vitro replication. ZIKV envelope expression was detected in the endoplasmic reticulum whereas double-stranded viral RNA colocalized with vimentin filaments to the perinuclear region. ZIKV productive infection also occurred in the human T-HESC cell line together with the induction of interferon-beta (IFN-beta) and of IFN-stimulated genes. Notably, in vitro decidualization of T-HESC with cyclic AMP and progesterone upregulated the cell surface expression of the ZIKV entry co-receptor AXL and boosted ZIKV replication by ca. 100-fold. Thus, endometrial stromal cells, particularly if decidualized, likely represent a crucial cell target of ZIKV reaching them, either via the uterine vasculature in the viremic phase of the infection or by sexual viral transmission, and a potential source of virus spreading to placental trophoblasts during pregnancy.
C1 [Pagani, Isabel; Ghezzi, Silvia; Turrini, Filippo; Vicenzi, Elisa] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Viral Pathogens & Biosafety Unit, Milan, Italy.
   [Ulisse, Adele; Panina-Bordignon, Paola] Ist Sci San Raffaele, Div Genet & Cell Biol, Reprod Sci Lab, Milan, Italy.
   [Rubio, Alicia] Ist Sci San Raffaele, Div Neurosci, Milan, Italy.
   [Garavaglia, Elisabetta; Candiani, Massimo] Ist Sci San Raffaele, Obstet & Gynecol Unit, Milan, Italy.
   [Candiani, Massimo; Poli, Guido] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy.
   [Castilletti, Concetta; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
   [Poli, Guido] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunopathogenesis Unit, Milan, Italy.
   [Broccoli, Vania] Natl Res Council CNR, Inst Neurosci, Milan, Italy.
RP Vicenzi, E (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Viral Pathogens & Biosafety Unit, Milan, Italy.; Panina-Bordignon, P (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, Reprod Sci Lab, Milan, Italy.
EM panina.paola@hsr.it; vicenzi.elisa@hsr.it
RI Ippolito, Giuseppe/J-7207-2017; ghezzi, silvia/AAN-4092-2020; Panina,
   Paola/AAO-4563-2020; Turrini, Filippo/I-3677-2018; Vicenzi,
   Elisa/AAL-3980-2020; Castilletti, Concetta/AAA-8408-2019; Pagani,
   Isabel/AAB-3301-2019; Castilletti, Concetta/B-6545-2016; Poli,
   Guido/AAL-4161-2020
OI Turrini, Filippo/0000-0002-9121-9117; Castilletti,
   Concetta/0000-0001-9819-236X; Pagani, Isabel/0000-0001-5396-0740;
   Castilletti, Concetta/0000-0001-9819-236X; Poli,
   Guido/0000-0001-7241-4526; Ippolito, Giuseppe/0000-0002-1076-2979;
   Broccoli, Vania/0000-0003-4050-0926; PERNO, CARLO
   FEDERICO/0000-0002-0825-5388; Ghezzi, Silvia/0000-0002-7586-663X
FU European Union, Seventh Framework ProgrammeEuropean Union (EU)
   [278433-PREDEMICS]; European Union's Horizon research and innovation
   programme [653316-EVAg]
FX We thank Maria Rosaria Capobianchi, National Institute for Infectious
   Diseases "Lazzaro Spallanzani", Rome, Italy and Edwin Yates, University
   of Liverpool, UK for critical reading of the manuscript and helpful
   suggestions. Giuseppe Ippolito acknowledges the European Union, Seventh
   Framework Programme (Grant No 278433-PREDEMICS) and European Union's
   Horizon 2020 research and innovation programme (grant agreement No
   653316-EVAg).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alexandre KB, 2016, VIROLOGY, V497, P69, DOI 10.1016/j.virol.2016.07.004
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003
   Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Murakami K, 2014, ENDOCRINOLOGY, V155, P4542, DOI 10.1210/en.2014-1370
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Saba E, 2013, MUCOSAL IMMUNOL, V6, P1081, DOI 10.1038/mi.2013.2
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 43
TC 26
Z9 27
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 10
PY 2017
VL 7
AR 44286
DI 10.1038/srep44286
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO2FN
UT WOS:000396512100001
PM 28281680
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Groeneveld, GH
   Dalhuijsen, A
   Kara-Zaitri, C
   Hamilton, B
   de Waal, MW
   van Dissel, JT
   van Steenbergen, JE
AF Groeneveld, Geert H.
   Dalhuijsen, Anton
   Kara-Zaitri, Chakib
   Hamilton, Bob
   de Waal, Margot W.
   van Dissel, Jaap T.
   van Steenbergen, Jim E.
TI ICARES: a real-time automated detection tool for clusters of infectious
   diseases in the Netherlands
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Cluster detection; Respiratory tract infection; Meningoencephalitis;
   Hepatitis; Real-time; Automated
ID SYNDROMIC SURVEILLANCE; INFLUENZA; OUTBREAKS
AB Background: Clusters of infectious diseases are frequently detected late. Real-time, detailed information about an evolving cluster and possible associated conditions is essential for local policy makers, travelers planning to visit the area, and the local population. This is currently illustrated in the Zika virus outbreak.
   Methods: In the Netherlands, ICARES (Integrated Crisis Alert and Response System) has been developed and tested on three syndromes as an automated, real-time tool for early detection of clusters of infectious diseases. From local general practices, General Practice Out-of-Hours services and a hospital, the numbers of routinely used syndrome codes for three piloted tracts i.e., respiratory tract infection, hepatitis and encephalitis/meningitis, are sent on a daily basis to a central unit of infectious disease control. Historic data combined with information about patients' syndromes, age cohort, gender and postal code area have been used to detect clusters of cases.
   Results: During the first 2 years, two out of eight alerts appeared to be a real cluster. The first was part of the seasonal increase in Enterovirus encephalitis and the second was a remarkably long lasting influenza season with high peak incidence.
   Conclusions: This tool is believed to be the first flexible automated, real-time cluster detection system for infectious diseases, based on physician information from both general practitioners and hospitals. ICARES is able to detect and follow small regional clusters in real time and can handle any diseases entity that is regularly registered by first line physicians. Its value will be improved when more health care institutions agree to link up with ICARES thus improving further the signal-to-noise ratio.
C1 [Groeneveld, Geert H.] Leiden Univ, Med Ctr, Dept Internal Med & Infect Dis, POB 96002300 RC, Leiden, Netherlands.
   [Dalhuijsen, Anton] Publ Hlth Serv Hollands Midden, Unit Infect Dis Control, Leiden, Netherlands.
   [Kara-Zaitri, Chakib] Univ Bradford, Fac Engn & Informat, Bradford, W Yorkshire, England.
   [Hamilton, Bob] InFact, Shipley, England.
   [de Waal, Margot W.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.
   [van Dissel, Jaap T.; van Steenbergen, Jim E.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, RIVM, Bilthoven, Netherlands.
   [van Dissel, Jaap T.; van Steenbergen, Jim E.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.
RP Groeneveld, GH (corresponding author), Leiden Univ, Med Ctr, Dept Internal Med & Infect Dis, POB 96002300 RC, Leiden, Netherlands.
EM g.h.groeneveld@lumc.nl
OI Kara-Zaitri, Chakib/0000-0003-4841-7692
FU The Netherlands Organisation for Health Research and Development,
   ZonMWNetherlands Organization for Health Research and Development
   [204000001]; Virgo consortium - Dutch government [FES0908]; Netherlands
   Genomics Initiative (NGI) [050-060-452]
FX This work was supported by The Netherlands Organisation for Health
   Research and Development, ZonMW [grant number 204000001], by the Virgo
   consortium, funded by the Dutch government [grant number FES0908], and
   by the Netherlands Genomics Initiative (NGI) [grant number 050-060-452].
CR Al-Tawfiq JA, 2014, LANCET INFECT DIS, V14, P992, DOI 10.1016/S1473-3099(14)70840-0
   Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027
   Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007
   Buehler JW, 2009, BIOSECUR BIOTERROR, V7, P165, DOI 10.1089/bsp.2009.0013
   Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200
   Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176
   Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483
   Fricker RD, 2008, STAT MED, V27, P3407, DOI 10.1002/sim.3197
   Griffin BA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-483
   Heaton MJ, 2012, STAT MED, V31, P2123, DOI 10.1002/sim.5350
   Lamberts H, 1987, ICPC INT CLASSIFICAT
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Lettinga KD, 2002, EMERG INFECT DIS, V8, P1448, DOI 10.3201/eid0812.020035
   Mukhi SN., 2010, J PUBL HLTH INFORM, V2, pe3
   Njoo KH, 2004, HUISARTS WET, V47, P42
   Pan American Health Organization, 2016, EP AL INCR MICR NE B
   Singh BK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-726
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9
   Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Witkop C., 2011, Morbidity and Mortality Weekly Report, V60, P406
   World Bank, 2012, PEOPL PATH OUR PLAN
NR 23
TC 0
Z9 0
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 9
PY 2017
VL 17
AR 201
DI 10.1186/s12879-017-2300-5
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EP5AZ
UT WOS:000397392700002
PM 28279150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pardi, N
   Hogan, MJ
   Pelc, RS
   Muramatsu, H
   Andersen, H
   DeMaso, CR
   Dowd, KA
   Sutherland, LL
   Scearce, RM
   Parks, R
   Wagner, W
   Granados, A
   Greenhouse, J
   Walker, M
   Willis, E
   Yu, JS
   Mcgee, CE
   Sempowski, GD
   Mui, BL
   Tam, YK
   Huang, YJ
   Vanlandingham, D
   Holmes, VM
   Balachandran, H
   Sahu, S
   Lifton, M
   Higgs, S
   Hensley, SE
   Madden, TD
   Hope, MJ
   Kariko, K
   Santra, S
   Graham, BS
   Lewis, MG
   Pierson, TC
   Haynes, BF
   Weissman, D
AF Pardi, Norbert
   Hogan, Michael J.
   Pelc, Rebecca S.
   Muramatsu, Hiromi
   Andersen, Hanne
   DeMaso, Christina R.
   Dowd, Kimberly A.
   Sutherland, Laura L.
   Scearce, Richard M.
   Parks, Robert
   Wagner, Wendeline
   Granados, Alex
   Greenhouse, Jack
   Walker, Michelle
   Willis, Elinor
   Yu, Jae-Sung
   McGee, Charles E.
   Sempowski, Gregory D.
   Mui, Barbara L.
   Tam, Ying K.
   Huang, Yan-Jang
   Vanlandingham, Dana
   Holmes, Veronica M.
   Balachandran, Harikrishnan
   Sahu, Sujata
   Lifton, Michelle
   Higgs, Stephen
   Hensley, Scott E.
   Madden, Thomas D.
   Hope, Michael J.
   Kariko, Katalin
   Santra, Sampa
   Graham, Barney S.
   Lewis, Mark G.
   Pierson, Theodore C.
   Haynes, Barton F.
   Weissman, Drew
TI Zika virus protection by a single low-dose nucleoside-modified mRNA
   vaccination
SO NATURE
LA English
DT Article
ID LIPID NANOPARTICLES; INFECTION; VACCINES; PSEUDOURIDINE; THERAPEUTICS;
   SPECIFICITY; EXPRESSION; IMMUNITY; VECTORS; THERAPY
AB Zika virus (ZIKV) has recently emerged as a pandemic associated with severe neuropathology in newborns and adults(1). There are no ZIKV-specific treatments or preventatives. Therefore, the development of a safe and effective vaccine is a high priority. Messenger RNA (mRNA) has emerged as a versatile and highly effective platform to deliver vaccine antigens and therapeutic proteins(2,3). Here we demonstrate that a single low-dose intradermal immunization with lipid-nanoparticle-encapsulated nucleoside-modified mRNA (mRNA-LNP) encoding the pre-membrane and envelope glycoproteins of a strain from the ZIKV outbreak in 2013 elicited potent and durable neutralizing antibody responses in mice and non-human primates. Immunization with 30 mu g of nucleoside-modified ZIKV mRNA-LNP protected mice against ZIKV challenges at 2 weeks or 5 months after vaccination, and a single dose of 50 mu g was sufficient to protect non-human primates against a challenge at 5 weeks after vaccination. These data demonstrate that nucleoside-modified mRNA-LNP elicits rapid and durable protective immunity and therefore represents a new and promising vaccine candidate for the global fight against ZIKV.
C1 [Pardi, Norbert; Hogan, Michael J.; Muramatsu, Hiromi; Holmes, Veronica M.; Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Pelc, Rebecca S.; DeMaso, Christina R.; Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Andersen, Hanne; Wagner, Wendeline; Granados, Alex; Greenhouse, Jack; Walker, Michelle; Lewis, Mark G.] Bioqual Inc, Rockville, MD 20850 USA.
   [Sutherland, Laura L.; Scearce, Richard M.; Parks, Robert; Yu, Jae-Sung; McGee, Charles E.; Sempowski, Gregory D.; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.
   [Hensley, Scott E.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Mui, Barbara L.; Tam, Ying K.; Madden, Thomas D.; Hope, Michael J.] Acuitas Therapeut, Vancouver, BC V6T 1Z3, Canada.
   [Huang, Yan-Jang; Vanlandingham, Dana; Higgs, Stephen] Kansas State Univ, Coll Vet Med, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Huang, Yan-Jang; Vanlandingham, Dana; Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Balachandran, Harikrishnan; Sahu, Sujata; Lifton, Michelle; Santra, Sampa] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Kariko, Katalin] BioNTech RNA Pharmaceut, Goldgrube 12, D-55131 Mainz, Germany.
   [Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Weissman, D (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM dreww@upenn.edu
RI Graham, Barney S./AAC-5898-2019
OI Graham, Barney S./0000-0001-8112-0853; Hogan,
   Michael/0000-0002-6244-2993; Pelc, Rebecca/0000-0001-5080-4945; Elyard,
   Hanne/0000-0003-1103-9608; Balachandran,
   Harikrishnan/0000-0001-9336-0555
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [UC6-AI058607, AI100645, U19-AI057229,
   T32 AI007632-14, R01-AI050484, R01-AI124429, R01-AI084860]; Department
   of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine,
   Kansas State University; NIAID Division of Intramural ResearchUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); Vaccine Research CenterUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID); Takeda
   Pharmaceuticals, New Frontier Science
FX We thank R. Tesh at the UTMB World Reference Center for Emerging Viruses
   and Arboviruses for providing ZIKV stocks. We gratefully acknowledge the
   technical or administrative support of M. Bertrand, L. Arwood, C.
   Sample, M. J. Barr, C. Vivian, T. Gurley and M. A. Moody, E. E. Ooi, S.
   Lok, H.-X. Liao, S. Awasthi, L. Hook, F. Shaheen, and the UPenn CFAR.
   The Virology Unit of the Duke Regional Biocontainment Laboratory (Duke
   Human Vaccine Institute) received support from the NIH, UC6-AI058607.
   The Duke Center for HIV/AIDS Vaccine Immunology received support from
   NIH AI100645. D.V. received funding from the Department of Diagnostic
   Medicine and Pathobiology, College of Veterinary Medicine, Kansas State
   University. R.S.P., C.R.D., K.A.D., T.C.P. and B.S.G. were funded by the
   NIAID Division of Intramural Research and the Vaccine Research Center.
   S.E.H. received funding through NIH U19-AI057229. M. J. Hog. received
   funding from NIH T32 AI007632-14. D.W. received funding from NIH
   R01-AI050484, R01-AI124429 and R01-AI084860, and Takeda Pharmaceuticals,
   New Frontier Science.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263
   Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037
   Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007
   Pardi Norbert, 2013, Methods Mol Biol, V969, P29, DOI 10.1007/978-1-62703-260-5_2
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004
   Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103
   Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325
   Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710
   Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859
   Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3
NR 31
TC 229
Z9 237
U1 11
U2 136
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 9
PY 2017
VL 543
IS 7644
BP 248
EP +
DI 10.1038/nature21428
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN0GQ
UT WOS:000395688700040
PM 28151488
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Richner, JM
   Himansu, S
   Dowd, KA
   Butler, SL
   Salazar, V
   Fox, JM
   Julander, JG
   Tang, WW
   Shresta, S
   Pierson, TC
   Ciaramella, G
   Diamond, MS
AF Richner, Justin M.
   Himansu, Sunny
   Dowd, Kimberly A.
   Butler, Scott L.
   Salazar, Vanessa
   Fox, Julie M.
   Julander, Justin G.
   Tang, William W.
   Shresta, Sujan
   Pierson, Theodore C.
   Ciaramella, Giuseppe
   Diamond, Michael S.
TI Modified mRNA Vaccines Protect against Zika Virus Infection
SO CELL
LA English
DT Article
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; CROSS-REACTIVE
   ANTIBODIES; MALE SEXUAL TRANSMISSION; DENGUE VIRUS; ENVELOPE PROTEIN;
   DNA VACCINE; IN-VITRO; IMMUNE-RESPONSES; STRUCTURAL BASIS
AB The emergence of ZIKV infection has prompted a global effort to develop safe and effective vaccines. We engineered a lipid nanoparticle (LNP) encapsulated modified mRNA vaccine encoding wild-type or variant ZIKV structural genes and tested immunogenicity and protection in mice. Two doses of modified mRNA LNPs encoding prM-E genes that produced virus-like particles resulted in high neutralizing antibody titers (similar to 1/100,000) that protected against ZIKV infection and conferred sterilizing immunity. To offset a theoretical concern of ZIKV vaccines inducing antibodies that cross-react with the related dengue virus (DENV), we designed modified prM-E RNA encoding mutations destroying the conserved fusion-loop epitope in the E protein. This variant protected against ZIKV and diminished production of antibodies enhancing DENV infection in cells or mice. A modified mRNA vaccine can prevent ZIKV disease and be adapted to reduce the risk of sensitizing individuals to subsequent exposure to DENV, should this become a clinically relevant concern.
C1 [Richner, Justin M.; Salazar, Vanessa; Fox, Julie M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Himansu, Sunny; Butler, Scott L.; Ciaramella, Giuseppe] Valera LLC, 500 Technol Sq, Cambridge, MA 02139 USA.
   [Dowd, Kimberly A.; Pierson, Theodore C.] NIH, Viral Pathogenesis Sect, Bldg 10, Bethesda, MD 20892 USA.
   [Julander, Justin G.] Utah State Univ, Inst Antiviral Res, Logan, UT 84335 USA.
   [Tang, William W.; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Ciaramella, G (corresponding author), Valera LLC, 500 Technol Sq, Cambridge, MA 02139 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM Giuseppe.Ciaramella@Valeratx.com; diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Fox, Julie/0000-0003-0567-738X;
   Salazar, Vanessa/0000-0002-1947-6039; Richner,
   Justin/0000-0002-5344-118X
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI073755, R01 AI104972, P01 AI106695,
   R01 AI116813]; DARPAUnited States Department of DefenseDefense Advanced
   Research Projects Agency (DARPA) [W911NF-13-1-0417]; Moderna
FX This work was supported by grants from the NIH-NIAID (R01 AI073755, R01
   AI104972, and P01 AI106695 to M.S.D; R01 AI116813 to S.S), the
   intramural program of NIH-NIAID (T.C.P), a research grant from DARPA
   (agreement #W911NF-13-1-0417), and by a research grant from Moderna. We
   thank W. H. Hui (University of California, Los Angeles) for performing
   the negative stain imaging of the SVPs. M.S.D. is a consultant for
   Inbios, Visterra, and Takeda Pharmaceuticals and on the Scientific
   Advisory Boards of Moderna and OvaGene. S.H., S.L.B., and G.C. are
   employees of Valera LLC, a Moderna Venture focusing on the development
   of therapeutic approaches for infectious diseases, including ZIKV mRNA
   vaccines.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogers WM, 2015, J INFECT DIS, V211, P947, DOI 10.1093/infdis/jiu522
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Chen S, 2016, J CONTROL RELEASE, V235, P236, DOI 10.1016/j.jconrel.2016.05.059
   Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80
   Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115
   Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121
   Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Muthumani K., 2016, VACCINES
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pardi N., 2017, NATURE
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 72
TC 192
Z9 195
U1 12
U2 163
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 9
PY 2017
VL 168
IS 6
BP 1114
EP +
DI 10.1016/j.cell.2017.02.017
PG 22
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EN8ZF
UT WOS:000396287900018
PM 28222903
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU LePage, DP
   Metcalf, JA
   Bordenstein, SR
   On, JM
   Perlmutter, JI
   Shropshire, JD
   Layton, EM
   Funkhouser-Jones, LJ
   Beckmann, JF
   Bordenstein, SR
AF LePage, Daniel P.
   Metcalf, Jason A.
   Bordenstein, Sarah R.
   On, Jungmin
   Perlmutter, Jessamyn I.
   Shropshire, J. Dylan
   Layton, Emily M.
   Funkhouser-Jones, Lisa J.
   Beckmann, John F.
   Bordenstein, Seth R.
TI Prophage WO genes recapitulate and enhance Wolbachia-induced cytoplasmic
   incompatibility
SO NATURE
LA English
DT Article
ID DROSOPHILA-MELANOGASTER; PHAGE WO; PROTEIN; EXPRESSION; DATABASE; MODEL
AB The genus Wolbachia is an archetype of maternally inherited intracellular bacteria that infect the germline of numerous invertebrate species worldwide. They can selfishly alter arthropod sex ratios and reproductive strategies to increase the proportion of the infected matriline in the population. The most common reproductive manipulation is cytoplasmic incompatibility, which results in embryonic lethality in crosses between infected males and uninfected females. Females infected with the same Wolbachia strain rescue this lethality. Despite more than 40 years of research(1) and relevance to symbiont-induced speciation(2,3), as well as control of arbovirus vectors(4-6) and agricultural pests(7), the bacterial genes underlying cytoplasmic incompatibility remain unknown. Here we use comparative and transgenic approaches to demonstrate that two differentially transcribed, co-diverging genes in the eukaryotic association module of prophage WO8 from Wolbachia strain wMel recapitulate and enhance cytoplasmic incompatibility. Dual expression in transgenic, uninfected males of Drosophila melanogaster crossed to uninfected females causes embryonic lethality. Each gene additively augments embryonic lethality in crosses between infected males and uninfected females. Lethality associates with embryonic defects that parallel those of wild-type cytoplasmic incompatibility and is notably rescued by wMel-infected embryos in all cases. The discovery of cytoplasmic incompatibility factor genes cifA and cifB pioneers genetic studies of prophage WO-induced reproductive manipulations and informs the continuing use of Wolbachia to control dengue and Zika virus transmission to humans.
C1 [LePage, Daniel P.; Metcalf, Jason A.; Bordenstein, Sarah R.; On, Jungmin; Perlmutter, Jessamyn I.; Shropshire, J. Dylan; Layton, Emily M.; Funkhouser-Jones, Lisa J.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Beckmann, John F.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.
   [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Bordenstein, SR (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM s.bordenstein@vanderbilt.edu
OI Shropshire, Dylan/0000-0003-4221-2178; Layton, Emily/0000-0002-7869-0916
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R21 HD086833];
   National Science FoundationNational Science Foundation (NSF) [IOS
   1456778, DEB-1501398]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5T32GM008554,
   T32GM07347, AI081322, CA68485, DK20593, DK58404, DK59637, EY08126]
FX This work was supported by National Institutes of Health (NIH) R21
   HD086833 and National Science Foundation IOS 1456778 to Seth R.B.,
   National Science Foundation DEB-1501398 and NIH 5T32GM008554 training
   grant support to D.P.L., NIH T32GM07347 training grant support for
   J.A.M. to the Vanderbilt Medical Scientist Training Program, and NIH
   AI081322 to A.M.F. Imaging was performed in part through the use of the
   Vanderbilt University Medical Center Cell Imaging Shared Resource
   (supported by NIH grants CA68485, DK20593, DK58404, DK59637, and
   EY08126). We thank K. Jernigan and P. Snider for help with preliminary
   studies, and A. Brooks for assistance with figure preparation.
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P867, DOI 10.1016/j.ibmb.2013.07.002
   Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P272, DOI 10.1016/j.ibmb.2012.12.007
   Bordenstein SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13155
   Bordenstein SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029106
   Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543
   Bossan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019757
   Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011
   Callaini G, 1996, J INVERTEBR PATHOL, V67, P55, DOI 10.1006/jipa.1996.0009
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149
   Chatzispyrou IA, 2015, CANCER RES, V75, P4446, DOI 10.1158/0008-5472.CAN-15-1626
   Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ferguson SB, 2012, J CELL SCI, V125, P1407, DOI 10.1242/jcs.090381
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Foe V. E., 1993, DEV DROSOPHILA MELAN, pCh 3
   Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121
   Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775
   Gutzwiller F, 2015, G3-GENES GENOM GENET, V5, P2843, DOI 10.1534/g3.115.021931
   Hurvich C. M., 1993, J TIME ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X
   Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0
   Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325
   Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133
   Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343
   Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8
   LePage DP, 2014, PEERJ, V2, DOI 10.7717/peerj.678
   Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931
   Lorenzen MD, 2008, P NATL ACAD SCI USA, V105, P10085, DOI 10.1073/pnas.0800444105
   Metcalf JA, 2014, PEERJ, V2, DOI 10.7717/peerj.529
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Poinsot D, 1998, GENETICS, V150, P227
   Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15
   Southall T. D., 2008, CSH PROTOC, V2008, P49
   Vallenet D., 2009, DATABASE-OXFORD, V2009, DOI DOI 10.1093/DATABASE/BAP021
   Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren J. H., 2009, COLD SPRING HARB PRO, V2009
   White-Cooper H, 2012, SPERMATOGENESIS, V2, P11, DOI DOI 10.4161/SPMG.19088
   WRIGHT JD, 1981, J INVERTEBR PATHOL, V38, P409, DOI 10.1016/0022-2011(81)90109-9
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
   Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101
   Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 55
TC 119
Z9 119
U1 3
U2 108
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 9
PY 2017
VL 543
IS 7644
BP 243
EP +
DI 10.1038/nature21391
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN0GQ
UT WOS:000395688700039
PM 28241146
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lazear, HM
AF Lazear, Helen M.
TI What to Expect When You're Expecting Zika
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS-INFECTION; MICE; PREGNANCY
AB The 2015 emergence of Zika virus (ZIKV) in the Americas brought new attention to this previously obscure virus. Experimental model systems have been instrumental in rapidly advancing our understanding of ZIKV pathogenesis. Here, Lazear looks back on the events leading to the development of the ZIKV mouse model reported in Cell Host & Microbe.
C1 [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
RP Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM helen.lazear@med.unc.edu
OI Lazear, Helen/0000-0002-8649-4579
FU UNC Department of Microbiology and Immunology; Lineberger Comprehensive
   Cancer Center
FX H.M.L. owes many thanks to colleagues at Wash U and UNC who have
   supported this research and apologizes to the many researchers whose
   work was not cited due to reference limitations. H.M.L. is supported by
   start-up funds from the UNC Department of Microbiology and Immunology
   and the Lineberger Comprehensive Cancer Center.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Centers for Disease Control and Prevention National Institutes of Health, 2009, BIOSAFETY MICROBIOLO
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Diamond MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005182
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Racaniello V, 2016, THIS WEEK VIROLOGY
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 15
TC 1
Z9 1
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAR 8
PY 2017
VL 21
IS 3
BP 305
EP 308
DI 10.1016/j.chom.2017.02.015
PG 4
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EO0GF
UT WOS:000396375600011
PM 28279337
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hacker, I
   Harrell, RA
   Eichner, G
   Pilitt, KL
   O'Brochta, DA
   Handler, AM
   Schetelig, MF
AF Haecker, Irina
   Harrell, Robert A., II
   Eichner, Gerrit
   Pilitt, Kristina L.
   O'Brochta, David A.
   Handler, Alfred M.
   Schetelig, Marc F.
TI Cre/lox-Recombinase-Mediated Cassette Exchange for Reversible
   Site-Specific Genomic Targeting of the Disease Vector, Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MUTANT LOX SITES; GERMLINE TRANSFORMATION; INTEGRATION; DNA; DROSOPHILA;
   MOSQUITO; PIGGYBAC; TRANSGENESIS; NUCLEASES; SYSTEM
AB Site-specific genome modification (SSM) is an important tool for mosquito functional genomics and comparative gene expression studies, which contribute to a better understanding of mosquito biology and are thus a key to finding new strategies to eliminate vector-borne diseases. Moreover, it allows for the creation of advanced transgenic strains for vector control programs. SSM circumvents the drawbacks of transposon-mediated transgenesis, where random transgene integration into the host genome results in insertional mutagenesis and variable position effects. We applied the Cre/lox recombinase-mediated cassette exchange (RMCE) system to Aedes aegypti, the vector of dengue, chikungunya, and Zika viruses. In this context we created four target site lines for RMCE and evaluated their fitness costs. Cre-RMCE is functional in a two-step mechanism and with good efficiency in Ae. aegypti. The advantages of Cre-RMCE over existing site-specific modification systems for Ae. aegypti, phiC31-RMCE and CRISPR, originate in the preservation of the recombination sites, which 1) allows successive modifications and rapid expansion or adaptation of existing systems by repeated targeting of the same site; and 2) provides reversibility, thus allowing the excision of undesired sequences. Thereby, Cre-RMCE complements existing genomic modification tools, adding flexibility and versatility to vector genome targeting.
C1 [Haecker, Irina; Schetelig, Marc F.] Justus Liebig Univ Glessen, Inst Insect Biotechnol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.
   [Harrell, Robert A., II; Pilitt, Kristina L.; O'Brochta, David A.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20850 USA.
   [Harrell, Robert A., II] Univ Maryland, Insect Transformat Facil, Rockville, MD 20850 USA.
   [Eichner, Gerrit] Univ Giessen, Math Inst, Arndtstr 2, D-35392 Giessen, Germany.
   [O'Brochta, David A.] Univ Maryland, Dept Entomol, Rockville, MD 20850 USA.
   [Handler, Alfred M.] USDA ARS, Ctr Med Agr & Vet Entomol, 1700 SW 23rd Dr, Gainesville, FL 32608 USA.
RP Hacker, I (corresponding author), Justus Liebig Univ Glessen, Inst Insect Biotechnol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.
EM irina.haecker@agrar.uni-giessen.de; marc.schetelig@agrar.uni-giessen.de
RI Schetelig, Marc F./AAD-2332-2019
OI Schetelig, Marc F./0000-0002-9217-394X
FU Emmy Noether program of the German Research FoundationGerman Research
   Foundation (DFG) [SCHE 1833/1-1]; Biotechnology Risk Assessment Program
   from the USDA - National Institute of Food and Agriculture
   [2015-33522-24094]
FX We thank Tanja Rehling for excellent technical assistance. The Emmy
   Noether program of the German Research Foundation (SCHE 1833/1-1; to
   MFS;
   http://www.dfg.de/foerderung/programme/einzelfoerderung/emmy_noether/)
   and the LOEWE Center for Insect Biotechnology and Bioresources (to MFS;
   https://wissenschaft.hessen.de/loewe), National Institute for Allergy
   and Infectious Diseases R01AI099060 (to DOB; https://www.niaid.nih.gov),
   and Biotechnology Risk Assessment Program competitive grant number
   2015-33522-24094 from the USDA - National Institute of Food and
   Agriculture (to AMH;
   https://nifa.usda.gov/funding-opportunity/biotechnology-risk-assessment-
   research-grants-program-brag). The funders had no role in study design,
   data collection, analysis and interpretation, decision to publish, or
   preparation of the manuscript.
CR ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x
   Andrews B J, 1986, Basic Life Sci, V40, P407
   [Anonymous], 2015, PACKAGE SURVIVAL ANA
   Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868
   Ashburner M., 1989, DROSOPHILA LAB MANUA, V2
   Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2
   Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   FLEISS JL, 2003, STAT METHODS RATES P
   Fox J., 2011, R COMPANION APPL REG
   Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Haghighat-Khah RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121097
   Halekoh U, 2014, J STAT SOFTW, V59, P1
   Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x
   Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102
   Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1
   Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110
   Horn M., 1995, MULTIPLE TESTS AUSWA
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526
   Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788
   Long DP, 2013, INSECT BIOCHEM MOLEC, V43, P997, DOI 10.1016/j.ibmb.2013.08.001
   Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264
   Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587
   Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x
   Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022
   Schetelig MF, 2013, GENETICA, V141, P189, DOI 10.1007/s10709-013-9717-6
   Schetelig MF, 2013, G3-GENES GENOM GENET, V3, P687, DOI 10.1534/g3.112.005488
   Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P790, DOI 10.1016/j.ibmb.2012.07.007
   Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106
   SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003
   Siegal ML, 1996, GENETICS, V144, P715
   Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505
   Wimmer EA, 2005, NAT METHODS, V2, P580, DOI 10.1038/nmeth0805-580
   Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37
NR 44
TC 5
Z9 5
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 7
PY 2017
VL 7
AR 43883
DI 10.1038/srep43883
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM9TS
UT WOS:000395654600001
PM 28266580
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, JM
   Fu, T
   Mao, HY
   Wang, Z
   Pan, JH
   Rutherford, S
   Ren, JP
   Dong, XJ
   Chen, Y
   Zhu, ZH
   Qi, XH
   Gong, ZY
   Liu, QY
   Yu, HJ
   Zhu, LB
   Chen, WX
   Chen, ZP
   Zhang, YJ
   Chen, EF
AF Sun, Jimin
   Fu, Tao
   Mao, Haiyan
   Wang, Zhen
   Pan, Junhang
   Rutherford, Shannon
   Ren, Jiangping
   Dong, Xuanjun
   Chen, Yin
   Zhu, Zhihong
   Qi, Xiaohua
   Gong, Zhenyu
   Liu, Qiyong
   Yu, Hongjie
   Zhu, Liebo
   Chen, Wenxian
   Chen, Zhiping
   Zhang, Yanjun
   Chen, Enfu
TI A cluster of Zika virus infection in a Chinese tour group returning from
   Fiji and Samoa
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AEDES-AEGYPTI; ASIAN LINEAGE; YELLOW-FEVER; DENGUE; TRANSMISSION; URINE;
   MICRONESIA; EPIDEMIC; NIGERIA; STATE
AB Zika virus is currently causing extensive outbreaks in a number of countries in South and Central America and the Caribbean and has been associated with foetal abnormalities. We report an outbreak of Zika virus infection in a Chinese tour-group returning from a nine day holiday in Fiji and Samoa. The index case was a 38-year old male who developed symptoms while travelling back from Fiji to Hong Kong on the 14th February, 2016. A field investigation was initiated to define the epidemiological, clinical and virological characteristics of Zika virus infection in this tour group and revealed two further symptomatic infections and one asymptomatic infection among the 33 travellers; an overall infection attack rate of 12% in these travellers. Active surveillance led to detection of Zika virus RNA in the serum of one case four days prior to onset of symptoms and detection of Zika virus in saliva from one asymptomatic infection.
C1 [Sun, Jimin; Mao, Haiyan; Wang, Zhen; Pan, Junhang; Ren, Jiangping; Chen, Yin; Qi, Xiaohua; Gong, Zhenyu; Chen, Zhiping; Zhang, Yanjun; Chen, Enfu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China.
   [Sun, Jimin; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Fu, Tao; Zhu, Zhihong; Zhu, Liebo; Chen, Wenxian] Yiwu Municipal Ctr Dis Control & Prevent, Yiwu, Peoples R China.
   [Rutherford, Shannon] Griffith Univ, Ctr Environm & Populat Hlth, Sch Environm, Nathan, Qld 4111, Australia.
   [Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early warning Infect Dis, Div Infect Dis, Beijing, Peoples R China.
RP Chen, ZP; Zhang, YJ; Chen, EF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China.
EM zpchen@cdc.zj.cn; yjzhang@cdc.zj.cn; zjcdccef@126.com
CR Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen B, 2015, LANCET, V385, P1621, DOI 10.1016/S0140-6736(15)60793-0
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Liu L, 2017, INFECT GENET EVOL, V48, P40, DOI 10.1016/j.meegid.2016.10.023
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396
   Wang G, 2014, SE ASIAN J TROP MED, V45, P290
   World Health Organization, 2016, ZIK VIR
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
   Wu HaiXia, 2015, Disease Surveillance, V30, P310
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 33
TC 1
Z9 2
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 7
PY 2017
VL 7
AR 43527
DI 10.1038/srep43527
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM9MK
UT WOS:000395635500001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Seib, K
   Pollard, AJ
   de Wals, P
   Andrews, RM
   Zhou, FJ
   Hatchett, RJ
   Pickering, LK
   Orenstein, WA
AF Seib, Katherine
   Pollard, Andrew J.
   de Wals, Philippe
   Andrews, Ross M.
   Zhou, Fangjun
   Hatchett, Richard J.
   Pickering, Larry K.
   Orenstein, Walter A.
TI Policy making for vaccine use as a driver of vaccine innovation and
   development in the developed world
SO VACCINE
LA English
DT Review
DE Vaccine development; Innovation; United States; Canada; United Kingdom;
   Australia
ID COST-EFFECTIVENESS THRESHOLD; CONGENITAL-RUBELLA SYNDROME;
   ADVISORY-COMMITTEE; IMMUNIZATION PRACTICES; UNITED-STATES;
   RECOMMENDATIONS; PREVENTION; DECISIONS; HISTORY; IMPACT
AB In the past 200 years, vaccines have had unmistakable impacts on public health including declines in morbidity and mortality, most markedly in economically-developed countries. Highly engineered vaccines including vaccines for conditions other than infectious diseases are expected to dominate future vaccine development. We examine immunization vaccine policy as a driver of vaccine innovation and development. The pathways to recommendation for use of licensed vaccines in the US, UK, Canada and Australia have been similar, including: expert review of disease epidemiology, disease burden and severity; vaccine immunogenicity, efficacy and safety; programmatic feasibility; public demand; and increasingly cost-effectiveness. Other attributes particularly important in development of future vaccines are likely to include: duration of immunity for improved vaccines such as pertussis; a greater emphasis on optimizing community protection rather than direct protection only; programmatic implementation, feasibility, improvements (as in the case of development of a universal influenza vaccine); public concerns/confidence/fears related to outbreak pathogens like Ebola and Zika virus; and major societal burden for combating hard to treat diseases like HIV and antimicrobial resistant pathogens. Driving innovation and production of future vaccines faces enormous economic hurdles as available approaches, technologies and regulatory pathways become more complex. As such, cost-mitigating strategies and focused, aligned efforts (by governments, private organizations, and private-public partnerships) will likely be needed to continue to spur major advances in vaccine technologies and development. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Seib, Katherine; Orenstein, Walter A.] Emory Univ, Sch Med, Div Infect Dis, 1599 Clifton Rd,Room 6-403, Atlanta, GA 30322 USA.
   [Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford, England.
   [Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England.
   [de Wals, Philippe] Univ Laval, Quebec Univ Hosp, Res Ctr, Quebec City, PQ, Canada.
   [de Wals, Philippe] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada.
   [Andrews, Ross M.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Andrews, Ross M.] Australian Tech Advisory Grp Immunisat, Darwin, NT, Australia.
   [Zhou, Fangjun] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Hatchett, Richard J.] US Dept HHS, Biomed Adv Res & Dev Author, Washington, DC 20201 USA.
   [Pickering, Larry K.] Emory Univ, Sch Med, Pediat Infect Dis, Atlanta, GA USA.
RP Seib, K (corresponding author), Emory Univ, Sch Med, Div Infect Dis, 1599 Clifton Rd,Room 6-403, Atlanta, GA 30322 USA.
EM kseib@emory.edu
FU Glaxo-Smith-KlineGlaxoSmithKline; NovartisNovartis; Sanofi Pasteur;
   PfizerPfizer; Quebec Ministry of Health and Social Services; Health
   Canada; Public Health Agency of Canada
FX PdW: Received research grants, and reimbursements of travel expenses
   from vaccine manufacturers including Glaxo-Smith-Kline, Novartis, Sanofi
   Pasteur, and Pfizer, as well as from governmental agencies including the
   Quebec Ministry of Health and Social Services, Health Canada, and the
   Public Health Agency of Canada.
CR Ahmed F, 2011, VACCINE, V29, P9171, DOI 10.1016/j.vaccine.2011.08.005
   AIDS Info, 1999, IOM REP OFF NEW LOOK
   [Anonymous], 2001, WHO GLOB STRAT CONT
   [Anonymous], 2014, OFF NATL COMMUN DIS
   Australia Government Department of Health, 2015, AUSTR TECHN ADV GROU
   Australian Government Department of Health, 2015, GUID PREP SUBM PHARM
   Australian Government Department of Health, 2014, AUSTR TECHN GROUP IM
   Australian Government Department of Health, 2016, AUSTR TECHN ADV GROU
   Canadian Agency for Drugs and Technologies in Health, 2006, GUID EC EV HLTH TECH
   Centers for Disease Control and Prevention, 2014, ADV COMM IMM PRACT A
   Centers for Disease Control and Prevention, 2015, MMWR-MORBID MORTAL W, V63
   Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V60, P1762
   Centers for Disease Control and Prevention, 2014, VACC CHILDR PROGR QU
   Centers for Disease Control & Prevention (CDC), 2010, ACT BACT SURV PROV R
   Chan J, 2015, COMMUN DIS INTELL, V39, pE19
   Cheffins T, 1998, BRIT J OBSTET GYNAEC, V105, P998, DOI 10.1111/j.1471-0528.1998.tb10264.x
   Coleman MS, 2005, HEALTH AFFAIR, V24, P635, DOI 10.1377/hlthaff.24.3.635
   *COMM STUD PRIOR V, 1999, VACC 21 CENT TOOL DE
   CONDON RJ, 1993, MED J AUSTRALIA, V158, P379, DOI 10.5694/j.1326-5377.1993.tb121830.x
   Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1
   De Wals P, 2011, EXPERT REV VACCINES, V10, P55, DOI [10.1586/ERV.10.151, 10.1586/erv.10.151]
   Dekker CL, 2008, NVAC SUBCOMMITTEE VA
   Department of Health and Human Services, 2015, BARDA UNV PATH FORW
   Dertzbaugh MT, 1998, PLASMID, V39, P100, DOI 10.1006/plas.1997.1329
   Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864
   Dey A, 2016, COMMUN DIS INTELL, V40, pS1
   Haddix AC, 2002, PREVENTION EFFECTIVE
   Hagan JE, 2015, MMWR-MORBID MORTAL W, V64, P527
   Health Resources and Services Administration, NAT VACC INJ COMP PR
   Health Resources and Services Administration, 2015, NAT VACC INJ COMP PR
   Hinman AR, 2015, AM J PREV MED, V49, pS399, DOI 10.1016/j.amepre.2015.04.018
   *I MED, 1999, VACC 21 CENT TOOL DE
   Ismail SJ, 2010, VACCINE, V28, pA58, DOI 10.1016/j.vaccine.2010.02.035
   Khandaker G, 2014, VACCINE, V32, P6746, DOI 10.1016/j.vaccine.2014.10.021
   Klein NP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3326
   Larsen J., 2015, NATL VACCINE ADVIS C, P1
   McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004
   McCullers Jonathan A, 2008, P T, V33, P35
   MENSER MA, 1985, REV INFECT DIS, V7, pS37
   Menzies Robert, 2008, Commun Dis Intell Q Rep, V32 Suppl, pS2
   National Advisory Committee on Immunization (NACI), 2009, Can Commun Dis Rep, V35, P1
   National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR
   National Institute of Allergy and Infectious Diseases, 1999, IOM REP OFF NEW LOOK
   National Research Council, 1985, VACC SUPPL INN
   National Vaccine Advisory Committee, 2014, PUBLIC HLTH REP, V129, P12
   Nolan TM, 2010, VACCINE, V28, pA76, DOI 10.1016/j.vaccine.2010.02.038
   Notifications of Infectious Diseases, 2013, MUMPS NOT ENGL WAL E
   Plotkin SA, 2013, VACCINES DEV NEW VAC, P1008
   Plotkin SA, 2013, SHORT HIST VACCINATI, P6
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   [Public Health Agency of Canada National Advisory Committee on Immunization (NACI)], 2015, NACI
   Public Health Agency of Canada, 2013, CAN IMM GUID
   Public Health Agency of Canada, 2013, CHIEF PUBL HLTH OFF
   Public Health Agency of Canada, 2013, IMM VACC PREV DIS ST
   Public Health England, 2013, JOINT COMM VACC IMM
   Robinson R., 2014, NAT VACC ADV COMM M, P1
   Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155
   Sando L, 2014, 1 HELICOBACTER PYLOR
   Scheerlinck JPY, 2001, VACCINE, V19, P2647, DOI 10.1016/S0264-410X(00)00495-3
   Schnirring L, 2015, EXPERTS PROPOSE 2 BI
   Schuchat A., 2012, CONTROLLING VACCINE
   Smith JC, 2009, ANN INTERN MED, V150, P45, DOI 10.7326/0003-4819-150-1-200901060-00009
   Smith JC, 2014, MMWR-MORBID MORTAL W, V63, P955
   Sullivan E M, 1999, Commun Dis Intell, V23, P209
   The College of Physicians of Philadelphia, 2015, HIST LYME DIS VACC
   The Joint Committee on Vaccination and Immunisation, 2013, GREEN BOOK IMM INF D
   The Royal College of Pathologists of Australasia, 2012, IMM VACC PREV DIS
   The Royal College of Pathologists of Australasia, 2012, FOOD GROW SCH TASKF, P1
   The White House, 2014, NAT STRAT COMB ANT R
   United Kingdom National Department of Health, 2008, IMM INF DIS GREEB B
   United Kingdom National Health Service, 2013, JOINT COMM VACC IMM, P1
   Vogel FR, 2000, CLIN INFECT DIS, V30, pS266, DOI 10.1086/313883
   Walton LR, 2015, VACCINE, V33, P405, DOI 10.1016/j.vaccine.2014.09.043
   Watson J C, 1998, MMWR Recomm Rep, V47, P1
   Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41
   Whitney CG, 2014, MMWR-MORBID MORTAL W, V63, P352
   World Health Organisation, 2010, SMALLP ER PROGR SEP
   World Health Organization, 2014, ANT RES GLOB REP SUR
   Zhou FJ, 2014, PEDIATRICS, V133, P577, DOI 10.1542/peds.2013-0698
NR 79
TC 4
Z9 6
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAR 7
PY 2017
VL 35
IS 10
BP 1380
EP 1389
DI 10.1016/j.vaccine.2016.10.080
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EM9DK
UT WOS:000395611300004
PM 28253995
DA 2020-07-08
ER

PT J
AU Terradas, G
   Joubert, DA
   McGraw, EA
AF Terradas, Gerard
   Joubert, D. Albert
   McGraw, Elizabeth A.
TI The RNAi pathway plays a small part in Wolbachia-mediated blocking of
   dengue virus in mosquito cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DROSOPHILA INNATE IMMUNITY; AEDES-AEGYPTI; ANTIVIRAL PROTECTION;
   INFECTION; STAT; INTERFERENCE; STRAIN; POPULATIONS; CHIKUNGUNYA;
   SYMBIONT
AB Wolbachia pipientis is an insect endosymbiont known to limit the replication of viruses including dengue and Zika in their primary mosquito vector, Aedes aegypti. Wolbachia is being released into mosquito populations globally in a bid to control the diseases caused by these viruses. It is theorized that Wolbachia's priming of the insect immune system may confer protection against subsequent viral infection. Other hypotheses posit a role for competition between Wolbachia and viruses for host cellular resources. Using an A. aegypti cell line infected with Wolbachia, we tested the effects of targeting siRNAs against the major innate immune pathways on dengue virus loads. We show that while Wolbachia infection induces genes in the Toll, JAK/STAT and RNAi pathways, only reduced expression of RNAi leads to a rebound of dengue virus loads in Wolbachia-infected cells. The magnitude of the effect explained less than 10% of the total DENV load, demonstrating that blocking must be dependent on other factors in addition to the expression of RNAi. The findings bode well for the long-term stability of blocking given that immunity gene expression would likely be highly plastic and susceptible to rapid evolution.
C1 [Terradas, Gerard; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.
   [Joubert, D. Albert] Monash Univ, Inst Vector Borne Dis, Clayton, Vic 3800, Australia.
RP McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.
EM beth.mcgraw@monash.edu
OI Terradas, Gerard/0000-0003-4285-4007
FU National Health & Medical Research Council of Australia grantNational
   Health and Medical Research Council of Australia [APP1103804]
FX The authors wish to thank Yi Dong for creating the Wolbachia-infected
   cell line. The research was supported by a National Health & Medical
   Research Council of Australia grant (APP1103804) to EAM.
CR Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Anbutsu H, 2010, INSECT MOL BIOL, V19, P481, DOI 10.1111/j.1365-2583.2010.01008.x
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6
   Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   Cooper DM, 2009, INSECT BIOCHEM MOLEC, V39, P47, DOI 10.1016/j.ibmb.2008.09.011
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Dudzic JP, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0193-6
   Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6
   Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hedges LM, 2012, APPL ENVIRON MICROB, V78, P6773, DOI 10.1128/AEM.01650-12
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kingsolver MB, 2012, P NATL ACAD SCI USA, V109, P18639, DOI 10.1073/pnas.1216736109
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   Miller WJ, 2006, APPL ENVIRON MICROB, V72, P826, DOI 10.1128/AEM.72.1.826-835.2006
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Pacca C, 2009, VIRUS GENES, V38, P224, DOI 10.1007/s11262-009-0328-3
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y
   Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004
   Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   Xi Z., 2008, PLOS PATH, V4, P1, DOI 10.1371/
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Ye YXH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000385
NR 85
TC 24
Z9 24
U1 0
U2 24
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 6
PY 2017
VL 7
AR 43847
DI 10.1038/srep43847
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM9HD
UT WOS:000395621600001
PM 28262718
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Boggild, AK
   Geduld, J
   Libman, M
   Yansouni, CP
   McCarthy, AE
   Hajek, J
   Ghesquiere, W
   Mirzanejad, Y
   Vincelette, J
   Kuhn, S
   Plourde, PJ
   Chakrabarti, S
   Freedman, DO
   Kain, KC
AF Boggild, Andrea K.
   Geduld, Jennifer
   Libman, Michael
   Yansouni, Cedric P.
   McCarthy, Anne E.
   Hajek, Jan
   Ghesquiere, Wayne
   Mirzanejad, Yazdan
   Vincelette, Jean
   Kuhn, Susan
   Plourde, Pierre J.
   Chakrabarti, Sumontra
   Freedman, David O.
   Kain, Kevin C.
TI Surveillance report of Zika virus among Canadian travellers returning
   from the Americas
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Article
ID GEOSENTINEL SURVEILLANCE; SEXUAL TRANSMISSION; INFECTION; ILLNESS;
   DENGUE; FETAL
AB BACKGROUND: Widespread transmission of Zika virus in the Americas has occurred since late 2015. We examined demographic and travel-related characteristics of returned Canadian travellers with Zika infection acquired in the Americas to illuminate risk factors for acquisition and the clinical spectrum.
   METHODS: We analyzed demographic and travel-related data for returned Canadian travellers who presented to a CanTravNet site between October 2015 and September 2016 for care of Zika virus acquired in the Americas. Data were collected with use of the GeoSentinel Surveillance Network data platform.
   RESULTS: During the study period, 1118 travellers presented to a CanTravNet site after returning from the Americas, 41 (3.7%) of whom had Zika infection. Zika infection from the Americas was diagnosed at CanTravNet sites as often as dengue (n = 41) over the study period. In the first half of the study period, Zika virus burden was borne by people visiting friends and relatives in South America. In the latter half, coincident with the increased spread of Zika throughout the Caribbean and Central America, Zika virus occurred more often in tourists in the Caribbean. Forty (98%) of the travellers with Zika infection acquired it through probable mosquito exposure, and 1 had confirmed sexual acquisition. Congenital transmission occurred in 2 of 3 pregnancies. Two (5%) of those with Zika had symptoms resembling those of Guillain-Barre syndrome, 1 of whom also had Zika viral meningitis.
   INTERPRETATION: Even in this small cohort, we observed the full clinical spectrum of acute Zika virus, including adverse fetal and neurologic outcomes. Our observations suggest that complications from Zika infection are underestimated by data arising exclusively from populations where Zika is endemic. Travellers should adhere to mosquito-avoidance measures and barrier protection during sexual activity.
C1 [Boggild, Andrea K.; Chakrabarti, Sumontra; Kain, Kevin C.] Univ Hlth Network, Div Infect Dis, Trop Dis Unit, Dept Med, Toronto, ON, Canada.
   Univ Toronto, Toronto, ON, Canada.
   [Boggild, Andrea K.] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada.
   [Geduld, Jennifer] Publ Hlth Agcy Canada, Off Border & Travel Hlth, Ottawa, ON, Canada.
   [Libman, Michael; Yansouni, Cedric P.] McGill Univ, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada.
   [McCarthy, Anne E.] Ottawa Hosp, Div Infect Dis, Trop Med & Int Hlth Clin, Ottawa, ON, Canada.
   Univ Ottawa, Ottawa, ON, Canada.
   [Hajek, Jan; Mirzanejad, Yazdan] Univ British Columbia, Div Infect Dis, Vancouver, BC, Canada.
   [Ghesquiere, Wayne] Vancouver Isl Hlth Author, Infect Dis, Victoria, BC, Canada.
   [Ghesquiere, Wayne] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Mirzanejad, Yazdan] Fraser Hlth, Surrey, BC, Canada.
   [Vincelette, Jean] Univ Montreal, Hop St Luc, CHUM, Montreal, PQ, Canada.
   [Kuhn, Susan] Alberta Childrens Prov Gen Hosp, Sect Pediat Infect Dis, Dept Pediat, Calgary, AB, Canada.
   [Kuhn, Susan] Alberta Childrens Prov Gen Hosp, Sect Pediat Infect Dis, Dept Med, Calgary, AB, Canada.
   Univ Calgary, Calgary, AB, Canada.
   [Plourde, Pierre J.] Winnipeg Reg Hlth Author, Populat & Publ Hlth Program, Travel Hlth Serv, Winnipeg, MB, Canada.
   [Plourde, Pierre J.] Winnipeg Reg Hlth Author, Populat & Publ Hlth Program, Trop Med Serv, Winnipeg, MB, Canada.
   [Chakrabarti, Sumontra] Trillium Hlth Partners, Mississauga, ON, Canada.
   [Freedman, David O.] Univ Alabama Birmingham, Ctr Geog Med, Dept Med, Birmingham, AL USA.
   [Kain, Kevin C.] Sandra Rotman Ctr, SAR Labs, Toronto, ON, Canada.
RP Boggild, AK (corresponding author), Univ Hlth Network, Div Infect Dis, Trop Dis Unit, Dept Med, Toronto, ON, Canada.; Boggild, AK (corresponding author), Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada.
EM andrea.boggild@utoronto.ca
OI Freedman, David O./0000-0002-5642-5257; /0000-0002-4765-3469; Kain,
   Kevin/0000-0001-6068-1272
FU Public Health Agency of Canada's Office of Border and Travel Health; US
   Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50/CCU412347]; ISTM
FX CanTravNet is funded through the Public Health Agency of Canada's Office
   of Border and Travel Health. It was created by grouping the Canadian
   sites of GeoSentinel, a global surveillance network of the International
   Society of Travel Medicine (ISTM), which is supported by Cooperative
   Agreement U50/CCU412347 from the US Centers for Disease Control and
   Prevention and the ISTM. The funding sources of GeoSentinel had no role
   in the study design, data analysis, data interpretation or drafting of
   the manuscript. The funding source of CanTravNet contributed to the
   study design and critical appraisal of the manuscript, but it did not
   have access to raw data.
CR Alejo-Cancho I, 2016, DIAGN MICR INFEC DIS, V86, P160, DOI 10.1016/j.diagmicrobio.2016.07.016
   [Anonymous], 2016, ZIK VIR INF GLOB UPD
   [Anonymous], ANT VIR ELISA IGM TE
   [Anonymous], 2017, SURV ZIK VIR
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Boggild A, 2011, Can Commun Dis Rep, V37, P1, DOI 10.14745/ccdr.v37i00a03
   Boggild A K, 2014, Can Commun Dis Rep, V40, P313
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Constenla D, POTENTIAL EC IMPACT
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Meltzer E, 2009, TRAVEL MED INFECT DI, V7, P278, DOI 10.1016/j.tmaid.2009.05.002
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Schofield S, 2012, Can Commun Dis Rep, V38, P1, DOI 10.14745/ccdr.v38i00a03
   Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, ZIK VIR FACT SHEET
   Zika Working Group, 2016, Can Commun Dis Rep, V42, P101
NR 32
TC 19
Z9 19
U1 0
U2 5
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD MAR 6
PY 2017
VL 189
IS 9
BP E334
EP E340
DI 10.1503/cmaj.161241
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA EM7ZI
UT WOS:000395530500002
PM 28280063
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yuan, S
   Luo, Q
   Zhang, ZW
   Li, ZL
AF Yuan, Shu
   Luo, Qin
   Zhang, Zhong-Wei
   Li, Zi-Lin
TI Commentary: Teratogenic effects of the Zika virus and the roleof the
   placenta
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Editorial Material
DE Zikavirus; microcephaly; placental barrier; virustransfer; treatment
   time window; infection time
ID INFECTION; PREGNANCY; TRIMESTER; CELLS
C1 [Yuan, Shu; Zhang, Zhong-Wei] Sichuan Agr Univ, Coll Resources, Chengdu, Peoples R China.
   [Luo, Qin] Chengdu Med Coll, Sch Biomed Sci, Chengdu, Peoples R China.
   [Li, Zi-Lin] Gen Hosp Lanzhou Mil Reg, Lanzhou, Peoples R China.
RP Yuan, S (corresponding author), Sichuan Agr Univ, Coll Resources, Chengdu, Peoples R China.
EM roundtree318@hotmail.com
FU Preeminent Youth Fund of Sichuan Province [2015JQO045]
FX This work was funded by the Preeminent Youth Fund of Sichuan Province
   (2015JQO045).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 18
TC 4
Z9 4
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD MAR 3
PY 2017
VL 7
AR 62
DI 10.3389/fcimb.2017.00062
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EM5BR
UT WOS:000395327400001
PM 28316955
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roach, T
   Alcendor, DJ
AF Roach, Tracoyia
   Alcendor, Donald J.
TI Zika virus infection of cellular components of the blood-retinal
   barriers: implications for viral associated congenital ocular disease
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
DE Zika virus; Blood-retinal barrier; Retinal endothelial cells; Retinal
   pigmented epithelial cells; Retinal pericytes; Cytokines; Inflammation
ID PERICYTES
AB Background: Ocular abnormalities present in microcephalic infants with presumed Zika virus (ZIKV) congenital disease includes focal pigment mottling of the retina, chorioretinal atrophy, optic nerve abnormalities, and lens dislocation. Target cells in the ocular compartment for ZIKV infectivity are unknown. The cellular response of ocular cells to ZIKV infection has not been described. Mechanisms for viral dissemination in the ocular compartment of ZIKV-infected infants and adults have not been reported. Here, we identify target cells for ZIKV infectivity in both the inner and outer blood-retinal barriers (IBRB and OBRB), describe the cytokine expression profile in the IBRB after ZIKV exposure, and propose a mechanism for viral dissemination in the retina.
   Methods: We expose primary cellular components of the IBRB including human retinal microvascular endothelial cells, retinal pericytes, and Muller cells as well as retinal pigmented epithelial cells of the OBRB to the PRVABC56 strain of ZIKV. Viral infectivity was analyzed by microscopy, immunofluorescence, and reverse transcription polymerase chain reaction (RT-PCR and qRT-PCR). Angiogenic and proinflammatory cytokines were measured by Luminex assays.
   Results: We find by immunofluorescent staining using the Flavivirus 4G2 monoclonal antibody that retinal endothelial cells and pericytes of the IBRB and retinal pigmented epithelial cells of the OBRB are fully permissive for ZIKV infection but not Muller cells when compared to mock-infected controls. We confirmed ZIKV infectivity in retinal endothelial cells, retinal pericytes, and retinal pigmented epithelial cells by RT-PCR and qRT-PCR using ZIKV-specific oligonucleotide primers. Expression profiles by Luminex assays in retinal endothelial cells infected with ZIKV revealed a marginal increase in levels of beta-2 microglobulin (beta 2-m), granulocyte macrophage colony-stimulating factor (GMCSF), intercellular adhesion molecule 1 (ICAM-1), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP1), and vascular cell adhesion molecule 1 (VCAM-1) and higher levels of regulated upon activation, normal T cell expressed and presumably secreted (RANTES) but lower levels of interleukin-4 (IL-4) compared to controls.
   Conclusions: Retinal endothelial cells, retinal pericytes, and retinal pigmented epithelial cells are fully permissive for ZIKV lytic replication and are primary target cells in the retinal barriers for infection. ZIKV infection of retinal endothelial cells and retinal pericytes induces significantly higher levels of RANTES that likely contributes to ocular inflammation.
C1 [Roach, Tracoyia; Alcendor, Donald J.] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Sch Med, Dept Microbiol & Immunol, 1005 Dr D B Todd Jr Blvd, Nashville, TN 37208 USA.
RP Alcendor, DJ (corresponding author), Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Sch Med, Dept Microbiol & Immunol, 1005 Dr D B Todd Jr Blvd, Nashville, TN 37208 USA.
EM dalcendor@mmc.edu
OI Alcendor, Donald/0000-0002-4568-8158
FU National Center for Advancing Translational Sciences of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [3UH2TR000491-02S1]; National
   Heart Lung and Blood InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R25 HL096223-06]
FX DJA was supported by the Meharry President, Dr. James E. K. Hildreth,
   Zika virus Research Startup Award. The research reported in this
   publication was also supported by the National Center for Advancing
   Translational Sciences of the National Institutes of Health under the
   Award Number 3UH2TR000491-02S1 to DJA. TR was supported by the
   Vanderbilt Summer Science Academy grant from the National Heart Lung and
   Blood Institute under the Award Number R25 HL096223-06.
CR Alcendor DJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-95
   Belfort R, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1305
   Brasil Ministerio da Saude, 2016, INF EP 25 SEM EP SE
   Bryant P, 2002, ARCH DIS CHILD-FETAL, V87, pF75, DOI 10.1136/fn.87.2.F75
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   European Centre for Disease Prevention and Control, NICR BRAZ POT LINK Z
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Heukelbach J, 2016, INFECT DEV CTRIES, V2, P116
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuno N, 2011, POLYMERS-BASEL, V3, P193, DOI 10.3390/polym3010193
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Nawa M, 2001, J VIROL METHODS, V92, P65, DOI 10.1016/S0166-0934(00)00274-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Siawaya JFD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002535
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wilkerson I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0219-y
   World Health Organization (WHO), EP AL NEUR SYNDR CON
NR 32
TC 27
Z9 29
U1 0
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD MAR 3
PY 2017
VL 14
AR 43
DI 10.1186/s12974-017-0824-7
PG 12
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA EP1NE
UT WOS:000397150800001
PM 28253931
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cragan, JD
   Mai, CT
   Petersen, EE
   Liberman, RF
   Forestieri, NE
   Stevens, AC
   Delaney, A
   Dawson, AL
   Ellington, SR
   Shapiro-Mendoza, CK
   Dunn, JE
   Higgins, CA
   Meyer, RE
   Williams, T
   Polen, KND
   Newsome, K
   Reynolds, M
   Isenburg, J
   Gilboa, SM
   Meaney-Delman, DM
   Moore, CA
   Boyle, CA
   Honein, MA
AF Cragan, Janet D.
   Mai, Cara T.
   Petersen, Emily E.
   Liberman, Rebecca F.
   Forestieri, Nina E.
   Stevens, Alissa C.
   Delaney, Augustina
   Dawson, April L.
   Ellington, Sascha R.
   Shapiro-Mendoza, Carrie K.
   Dunn, Julie E.
   Higgins, Cathleen A.
   Meyer, Robert E.
   Williams, Tonya
   Polen, Kara N. D.
   Newsome, Kim
   Reynolds, Megan
   Isenburg, Jennifer
   Gilboa, Suzanne M.
   Meaney-Delman, Dana M.
   Moore, Cynthia A.
   Boyle, Coleen A.
   Honein, Margaret A.
TI Baseline Prevalence of Birth Defects Associated with Congenital Zika
   Virus Infection - Massachusetts, North Carolina, and Atlanta, Georgia,
   2013-2014
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Cragan, Janet D.; Mai, Cara T.; Delaney, Augustina; Dawson, April L.; Polen, Kara N. D.; Newsome, Kim; Reynolds, Megan; Isenburg, Jennifer; Gilboa, Suzanne M.; Moore, Cynthia A.; Honein, Margaret A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
   [Petersen, Emily E.; Ellington, Sascha R.; Shapiro-Mendoza, Carrie K.] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30333 USA.
   [Liberman, Rebecca F.; Dunn, Julie E.; Higgins, Cathleen A.] Ctr Birth Defects Res & Prevent, Massachusetts Dept Publ Hlth, Boston, MA USA.
   [Forestieri, Nina E.] North Carolina Dept Hlth & Human Serv, Birth Defects Monitoring Program, Raleigh, NC USA.
   [Stevens, Alissa C.; Williams, Tonya] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Human Dev & Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana M.] CDC, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.
   [Boyle, Coleen A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
RP Cragan, JD (corresponding author), CDC, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
EM eocbirthdef@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782
CR Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st), 2017, STAND NEWB REF VER P
   Mai CT, 2015, PUBLIC HEALTH REP, V130, P722, DOI 10.1177/003335491513000621
   Mason CA, 2005, BIRTH DEFECTS RES A, V73, P690, DOI 10.1002/bdra.20211
   Moore CA, 2016, JAMA PEDIAT
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 8
TC 25
Z9 25
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 3
PY 2017
VL 66
IS 8
BP 19
EP 22
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN4GL
UT WOS:000395965900004
PM 28253231
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Li, Y
   Muffat, J
   Omer, A
   Bosch, I
   Lancaster, MA
   Sur, M
   Gehrke, L
   Knoblich, JA
   Jaenisch, R
AF Li, Yun
   Muffat, Julien
   Omer, Attya
   Bosch, Irene
   Lancaster, Madeline A.
   Sur, Mriganka
   Gehrke, Lee
   Knoblich, Juergen A.
   Jaenisch, Rudolf
TI Induction of Expansion and Folding in Human Cerebral Organoids
SO CELL STEM CELL
LA English
DT Article
ID STEM-CELLS; RADIAL GLIA; BRAIN; PTEN; CORTEX; AKT3; MUTATIONS;
   EVOLUTION; GROWTH; ACTIVATION
AB An expansion of the cerebral neocortex is thought to be the foundation for the unique intellectual abilities of humans. It has been suggested that an increase in the proliferative potential of neural progenitors (NPs) underlies the expansion of the cortex and its convoluted appearance. Here we show that increasing NP proliferation induces expansion and folding in an in vitro model of human corticogenesis. Deletion of PTEN stimulates proliferation and generates significantly larger and substantially folded cerebral organoids. This genetic modification allows sustained cell cycle re-entry, expansion of the progenitor population, and delayed neuronal differentiation, all key features of the developing human cortex. In contrast, Pten deletion in mouse organoids does not lead to folding. Finally, we utilized the expanded cerebral organoids to show that infection with Zika virus impairs cortical growth and folding. Our study provides new insights into the mechanisms regulating the structure and organization of the human cortex.
C1 [Li, Yun; Muffat, Julien; Omer, Attya; Jaenisch, Rudolf] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
   [Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Lancaster, Madeline A.; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria.
   [Sur, Mriganka] Picower Inst Learning & Memory, Cambridge, MA 02139 USA.
   [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Gehrke, Lee] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Jaenisch, Rudolf] MIT, Dept Biol, 31 Ames St, Cambridge, MA 02139 USA.
RP Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, 31 Ames St, Cambridge, MA 02139 USA.
EM jaenisch@wi.mit.edu
RI Li, Yun/C-3367-2011; Knoblich, Juergen A/C-2974-2015
OI Li, Yun/0000-0002-5849-5910; Knoblich, Juergen A/0000-0002-6751-3404;
   Muffat, Julien/0000-0003-1889-7023; Lancaster,
   Madeline/0000-0003-2324-8853
FU Simons Foundation postdoctoral fellowship; International Rett Syndrome
   Foundation postdoctoral fellowship; NARSAD Young Investigator Grant from
   the Brain and Behavior Research FoundationNARSAD; European
   Leukodystrophy Association; Jerome and Florence Brill Graduate Student
   Fellowship; Simons Foundation [SFARI 204106, SFLIFE 286977]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [HD 045022, R01-MH104610, R01-NS088538, AI100190];
   ELA Foundation; Emerald Foundation; BiogenBiogen; Simons Center for the
   Social Brain at MIT
FX The authors thank Dongdong Fu, Raaji Alagappan, Tenzin Lungjangwa, Sean
   Corcoran, Laure Freland, and Grisilda Bakiasi for technical support and
   Danielle Feldman and members of the Jaenisch lab for helpful
   discussions. We thank Magdalena Renner for advice on cerebral organoid
   cultures; Wendy Salmon, Dr. Christian Cortes Campos, and Dr. Ryann Fame
   for help with light sheet imaging; Dr. Bryan Luikart for the PTEN-GFP
   plasmid; and Dr. Michael Robinson for the AKT plasmids. Y.L. received
   funding from a Simons Foundation postdoctoral fellowship, an
   International Rett Syndrome Foundation postdoctoral fellowship, and a
   NARSAD Young Investigator Grant from the Brain and Behavior Research
   Foundation. J.M. received support from the European Leukodystrophy
   Association and a NARSAD Young Investigator Grant from the Brain and
   Behavior Research Foundation. A.O. was supported by a Jerome and
   Florence Brill Graduate Student Fellowship. Work in the R.J. laboratory
   was supported by grants from the Simons Foundation (SFARI 204106 and
   SFLIFE 286977); NIH Grants HD 045022, R01-MH104610, and R01-NS088538;
   the ELA Foundation; the Emerald Foundation; Biogen; and the Simons
   Center for the Social Brain at MIT. Work in the L.G. laboratory was
   supported by NIH AI100190. R.J. is an advisor to Stemgent and a
   cofounder of Fate Therapeutics and Fulcrum Therapeutics.
CR Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392
   Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999
   Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DiLiberti JH, 1998, AM J MED GENET, V79, P284, DOI 10.1002/(SICI)1096-8628(19981002)79:4<284::AID-AJMG10>3.0.CO;2-N
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Fricano CJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00030
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200
   Juanes M, 2015, CLIN ENDOCRINOL, V82, P704, DOI 10.1111/cen.12555
   Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242
   Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008
   Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2
   Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0
   Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329
   Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023
   Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010
   Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001
   Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Marchese M, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-26
   Mirzaa GM, 2013, AM J MED GENET C, V163C, P122, DOI 10.1002/ajmg.c.31361
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116
   RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425
   Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013
   Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027
   Stelzer Y, 2015, CELL, V163, P218, DOI 10.1016/j.cell.2015.08.046
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Terrone G, 2016, EUR J HUM GENET, V24, P1359, DOI 10.1038/ejhg.2016.7
   Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544
   Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 49
TC 95
Z9 96
U1 3
U2 47
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAR 2
PY 2017
VL 20
IS 3
BP 385
EP +
DI 10.1016/j.stem.2016.11.017
PG 15
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EO0GC
UT WOS:000396375300013
PM 28041895
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Gabriel, E
   Ramani, A
   Karow, U
   Gottardo, M
   Natarajan, K
   Gooi, LM
   Goranci-Buzhala, G
   Krut, O
   Peters, F
   Nikolic, M
   Kuivanen, S
   Korhonen, E
   Smura, T
   Vapalahti, O
   Papantonis, A
   Schmidt-Chanasit, J
   Riparbelli, M
   Callaini, G
   Kronke, M
   Utermohlen, O
   Gopalakrishnan, J
AF Gabriel, Elke
   Ramani, Anand
   Karow, Ulrike
   Gottardo, Marco
   Natarajan, Karthick
   Gooi, Li Ming
   Goranci-Buzhala, Gladiola
   Krut, Oleg
   Peters, Franziska
   Nikolic, Milos
   Kuivanen, Suvi
   Korhonen, Essi
   Smura, Teemu
   Vapalahti, Olli
   Papantonis, Argyris
   Schmidt-Chanasit, Jonas
   Riparbelli, Maria
   Callaini, Giuliano
   Kroenke, Martin
   Utermoehlen, Olaf
   Gopalakrishnan, Jay
TI Recent Zika Virus Isolates Induce Premature Differentiation of Neural
   Progenitors in Human Brain Organoids
SO CELL STEM CELL
LA English
DT Article
ID CELL-CYCLE; CEREBRAL ORGANOIDS; MOUSE-BRAIN; STEM-CELLS; CEP152;
   MUTATIONS; INFECTION; NEURONS; BIOLOGY; MITOSIS
AB The recent Zika virus (ZIKV) epidemic is associated with microcephaly in newborns. Although the connection between ZIKV and neurodevelopmental defects is widely recognized, the underlying mechanisms are poorly understood. Here we show that two recently isolated strains of ZIKV, an American strain from an infected fetal brain (FB-GWUH-2016) and a closely-related Asian strain (H/PF/2013), productively infect human iPSC-derived brain organoids. Both of these strains readily target to and replicate in proliferating ventricular zone (VZ) apical progenitors. The main phenotypic effect was premature differentiation of neural progenitors associated with centrosome perturbation, even during early stages of infection, leading to progenitor depletion, disruption of the VZ, impaired neurogenesis, and cortical thinning. The infection pattern and cellular outcome differ from those seen with the extensively passaged ZIKV strain MR766. The structural changes we see after infection with these more recently isolated viral strains closely resemble those seen in ZIKV-associated microcephaly.
C1 [Gabriel, Elke; Ramani, Anand; Natarajan, Karthick; Gooi, Li Ming; Goranci-Buzhala, Gladiola; Gopalakrishnan, Jay] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany.
   [Gabriel, Elke; Ramani, Anand; Natarajan, Karthick; Gooi, Li Ming; Goranci-Buzhala, Gladiola; Gopalakrishnan, Jay] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany.
   [Karow, Ulrike; Krut, Oleg; Kroenke, Martin; Utermoehlen, Olaf] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany.
   [Gottardo, Marco; Riparbelli, Maria; Callaini, Giuliano] Univ Siena, Dept Life Sci, I-53100 Siena, Italy.
   [Peters, Franziska] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany.
   [Nikolic, Milos; Papantonis, Argyris; Kroenke, Martin; Utermoehlen, Olaf] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany.
   [Kuivanen, Suvi; Korhonen, Essi; Smura, Teemu; Vapalahti, Olli] Helsinki Univ Hosp, Dept Virol, Helsinki 00029, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki 00029, Finland.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, Jonas; Kroenke, Martin] German Ctr Infect Res DZIF, D-50935 Cologne, Germany.
   [Kroenke, Martin] CECAD, Cologne, Germany.
RP Gopalakrishnan, J (corresponding author), Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany.; Gopalakrishnan, J (corresponding author), Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany.
EM jay.gopalakrishnan@uni-koeln.de
RI Callaini, Giuliano/T-6353-2018; Smura, Teemu P/C-4063-2016; Papantonis,
   Argyris/AAF-5164-2020; Gottardo, Marco/G-7801-2018
OI Callaini, Giuliano/0000-0003-2252-0309; Gottardo,
   Marco/0000-0001-8649-7799; Vapalahti, Olli/0000-0003-2270-6824;
   Korhonen, Essi/0000-0003-4730-7715; Papantonis,
   Argyris/0000-0001-7551-1073
FU Fritz Thyssen Foundation [20.16.0.027 MN]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [GO2301/2-1, CRC
   670]; CMMC; Koln Fortune Program/Faculty of Medicine, University of
   Cologne;  [SFB829]
FX We are grateful to members of our labs for technical expertise and
   feedback. We are grateful to Dr. Christian Drosten of Bonn University
   for his kind gift of the anti-flavivirus envelope antibody. We are
   grateful to the light microscopy and tissue embedding facilities of
   CMMC. This work is supported by the Fritz Thyssen Foundation
   (20.16.0.027 MN) and by Deutsche Forschungsgemeinschaft grant GO2301/2-1
   (to J.G.). The work of M.K. and O.U. is supported by the Deutsche
   Forschungsgemeinschaft (CRC 670). M.N. and A.P. are supported by the
   Fritz Thyssen Foundation and by CMMC core funding. F.P. is supported by
   SFB829 and by the Koln Fortune Program/Faculty of Medicine, University
   of Cologne.
CR Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825
   Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831
   Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moya N, 2014, STEM CELL REP, V3, P1015, DOI 10.1016/j.stemcr.2014.10.004
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P
   Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174
   Rubenstein J.L., 2013, PATTERNING CELL TYPE
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tapias A, 2014, CELL STEM CELL, V14, P632, DOI 10.1016/j.stem.2014.04.001
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026
   Zheng XD, 2014, P NATL ACAD SCI USA, V111, pE354, DOI 10.1073/pnas.1317535111
NR 47
TC 96
Z9 97
U1 2
U2 47
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAR 2
PY 2017
VL 20
IS 3
BP 397
EP +
DI 10.1016/j.stem.2016.12.005
PG 15
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EO0GC
UT WOS:000396375300014
PM 28132835
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Bob, NS
   Ba, H
   Fall, G
   Ishagh, E
   Diallo, MY
   Sow, A
   Sembene, PM
   Faye, O
   El Kouri, B
   Sidi, ML
   Sall, AA
AF Bob, Ndeye Sakha
   Ba, Hampate
   Fall, Gamou
   Ishagh, Elkhalil
   Diallo, Mamadou Y.
   Sow, Abdourahmane
   Sembene, Pape Mbacke
   Faye, Ousmane
   El Kouri, Brahim
   Sidi, Mohamed Lemine
   Sall, Amadou Alpha
TI Detection of the Northeastern African Rift Valley Fever Virus Lineage
   During the 2015 Outbreak in Mauritania
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE Mauritania; Northeastern African lineage; phylogeny; Rift Valley fever;
   2015
ID SOUTHERN MAURITANIA; RAPID DETECTION; EPIDEMIC; DISEASE
AB Background. Rift Valley fever (RVF) is an acute viral anthropozoonosis that causes epizootics and epidemics among livestock population and humans. Multiple emergences and reemergences of the virus have occurred in Mauritania over the last decade. This article describes the outbreak that occurred in 2015 in Mauritania and reports the results of serological and molecular investigations of blood samples collected from suspected RVF patients.
   Methods. An RVF outbreak was reported from 14 September to 26 November 2015 in Mauritania. Overall, 184 suspected cases from different localities were identified by 26 health facilities. Blood samples were collected and tested by enzyme-linked immunosorbent assay (ELISA) and real-time reverse-transcription polymerase chain reaction (RT-PCR) at the Institut Pasteur de Dakar (IPD). Sequencing of partial genomes and phylogenetic analyses were performed on RT-PCR-positive samples. As part of routine surveillance at IPD, samples were also screened for dengue, yellow fever, West Nile, Crimean Congo hemorrhagic fever, Zika, and Chikungunya viruses by ELISA and RT-PCR.
   Results. Of the 184 suspected cases, there were 57 confirmed cases and 12 deaths. Phylogenetic analysis of the sequences indicated an emergence of a virus that originated from Northeastern Africa. Our results show co-circulation of other arboviruses in Mauritania-dengue, Crimean Congo hemorrhagic fever, and West Nile viruses.
   Conclusion. The Northeastern Africa lineage of RVF was responsible for the outbreak in Mauritania in 2015. Co-circulation of multiples arboviruses was detected. This calls for systematic differential diagnosis and highlights the need to strengthen arbovirus surveillance in Africa.
C1 [Bob, Ndeye Sakha; Fall, Gamou; Sow, Abdourahmane; Faye, Ousmane; Sall, Amadou Alpha] Pasteur Inst Dakar, Pole Virol, Arbovirus & Viral Hemorrhag Fevers Unit, Dakar, Senegal.
   [Ba, Hampate; El Kouri, Brahim] Natl Inst Publ Hlth Res, Viral Hemorrhag Fevers Diagnost Unit, Nouakchott, Mauritania.
   [Ishagh, Elkhalil] Minist Hlth, Dept Epidemiol Surveillance, Nouakchott, Mauritania.
   [Diallo, Mamadou Y.] WHO, Hlth Secur & Emergency, Nouakchott, Mauritania.
   [Sow, Abdourahmane] West African Hlth Org, Ouagadougou, Burkina Faso.
   [Sembene, Pape Mbacke] Cheikh Anta Diop Univ Dakar, Dakar, Senegal.
   [Sidi, Mohamed Lemine] Minist Hlth, Direct Dis Control, Nouakchott, Mauritania.
RP Faye, O (corresponding author), Pasteur Inst Dakar, Arbovirus & Viral Hemorrhag Fevers Unit, Dakar, Senegal.
EM ofaye@pasteur.sn
OI Ba, Hampate/0000-0002-9299-5775
FU Institut Pasteur de Dakar
FX This work was supported by the Institut Pasteur de Dakar.
CR Baudin M, 2016, LANCET GLOB HEALTH, V4, pE864, DOI [10.1016/S2214-109X(16)30176-0, 10.1016/s2214-109x(16)30176-0]
   Boushab M B, 2015, Bull Soc Pathol Exot, V108, P102, DOI 10.1007/s13149-015-0417-y
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   DIGOUTTE JP, 1989, RES VIROLOGY, V140, P27, DOI 10.1016/S0923-2516(89)80081-0
   El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397
   Fall G, 2016, VECTOR-BORNE ZOONOT, V16, P781, DOI 10.1089/vbz.2016.1967
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2007, EMERG INFECT DIS, V13, P1016, DOI 10.3201/eid1307.061487
   Faye O, 2014, EMERG INFECT DIS, V20, P300, DOI 10.3201/eid2002.130996
   Franceinfo, EB PRINC DAT EP
   GEAR JAMES, 1951, S AFRICAN MED JOUR, V25, P908
   Ikegami T, 2012, ANTIVIR RES, V95, P293, DOI 10.1016/j.antiviral.2012.06.001
   JOUAN A, 1988, ANN INST PASTEUR VIR, V139, P307, DOI 10.1016/S0769-2617(88)80046-7
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   Nabeth P, 2001, EMERG INFECT DIS, V7, P1052, DOI 10.3201/eid0706.010627
   Ndione Jacques-Andre, 2009, Secheresse (Montrouge), V20, P153, DOI 10.1684/sec.2009.0170
   SALUZZO JF, 1987, LANCET, V1, P504
   Soumare POL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035216
   Sow A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw149
   Sow A, 2014, EMERG INFECT DIS, V20, P296, DOI 10.3201/eid2002.131000
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004
   Weidmann M, 2008, J CLIN VIROL, V41, P138, DOI 10.1016/j.jcv.2007.10.001
   Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81
   Weidmann M, 2010, J CLIN VIROL, V48, P187, DOI 10.1016/j.jcv.2010.04.013
   World Health Organization, WHO PUBL LIST TOP EM
NR 29
TC 4
Z9 4
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SPR
PY 2017
VL 4
IS 2
DI 10.1093/ofid/ofx087
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FA8HD
UT WOS:000405685900062
PM 28638845
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waggoner, JJ
   Rouphael, N
   Xu, YX
   Natrajan, M
   Lai, LL
   Patel, SM
   Levit, RD
   Edupuganti, S
   Mulligan, MJ
AF Waggoner, Jesse J.
   Rouphael, Nadine
   Xu, Yongxian
   Natrajan, Muktha
   Lai, Lilin
   Patel, Shital M.
   Levit, Rebeca D.
   Edupuganti, Srilatha
   Mulligan, Mark J.
TI Pericarditis Associated With Acute Zika Virus Infection in a Returning
   Traveler
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE pericarditis; Zika viru
ID DENGUE
AB Despite the widespread outbreak, few cases of Zika virus associated with cardiac manifestations have been described. We present a case of pericarditis in the setting of an acute, symptomatic Zika virus infection in a traveler returning from St. Thomas. Clinicians should be alert for this potential complication of Zika virus infection.
C1 [Waggoner, Jesse J.; Rouphael, Nadine; Xu, Yongxian; Natrajan, Muktha; Lai, Lilin; Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Levit, Rebeca D.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA.
   [Rouphael, Nadine; Xu, Yongxian; Natrajan, Muktha; Lai, Lilin; Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Emory Vaccine Ctr, Hope Clin, Decatur, GA USA.
   [Patel, Shital M.] Baylor Coll Med, Houston, TX 77030 USA.
RP Waggoner, JJ (corresponding author), 550 Peachtree St,MOT 7th Floor, Atlanta, GA 30308 USA.
EM jesse.j.waggoner@emory.edu
RI Mulligan, Mark/V-9275-2019
OI Levit, Rebecca/0000-0001-5405-8716; Natrajan,
   Muktha/0000-0003-1854-0382; Lai, Lilin/0000-0002-9528-6990
FU National Institutes of Health/National Institute of Allergy and
   Infectious Diseases/Division of Microbiology and Infectious Diseases
   (DMID) Vaccine and Treatment Evaluation Unit (VTEU) [HHSN272201300018I,
   DMID 16-0017]; VTEU award [HHSN27220130015I]; Georgia Research Alliance
FX This case report details a research study participant in a Zika virus
   natural history study funded by a National Institutes of Health/National
   Institute of Allergy and Infectious Diseases/Division of Microbiology
   and Infectious Diseases (DMID) Vaccine and Treatment Evaluation Unit
   (VTEU) award to Emory University (Contract No. HHSN272201300018I funding
   the DMID 16-0017 study). Baylor College of Medicine support was provided
   by a VTEU award (Contract No. HHSN27220130015I). Additional support was
   provided by the Georgia Research Alliance.
CR Aletti M, 2016, CLIN INFECT DIS
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Carta KAG, 2017, J AM COLL CARDIOL, V69, P906
   Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levy PY, 2003, MEDICINE, V82, P385, DOI 10.1097/01.md.0000101574.54295.73
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 16
TC 3
Z9 3
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SPR
PY 2017
VL 4
IS 2
DI 10.1093/ofid/ofx103
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FA8HD
UT WOS:000405685900075
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mccaskey, D
AF Mccaskey, Daniel
TI ULTRA VIRES? THE THREAT OF ZIKA
SO ADMINISTRATIVE LAW REVIEW
LA English
DT Article
ID WEST-NILE-VIRUS; UNITED-STATES; OUTBREAK
C1 [Mccaskey, Daniel] Amer Univ, Washington Coll Law, Washington, DC 20016 USA.
RP Mccaskey, D (corresponding author), Amer Univ, Washington Coll Law, Washington, DC 20016 USA.
CR Abbott Ernest B., 2008, ASIAN PACIFIC LAW PO, V9, P193
   Ackerman Sloane, 2016, NY LJ           0829
   Adamski Tanya, 2006, PERSPECTIVES PUBLIC, V3
   Almeida Tatiana, 2016, POVERTY INEQUALITY H
   American Health Line, 2016, CDC UNV EM ZIK RESP
   American Public Health Association, 2012, NAT PREP REP ASS STA, V1, P44
   [Anonymous], 2014, ASS CAP 2012 SURV PR, V9
   [Anonymous], 2016, CLICK 2 HOUSTON 0818
   Association of State and Territorial Health Officials, 2015, SWARM GUID EM MAN VE
   Association of State & Territorial Health Officials, 2004, PUBL HLTH CONFR MOSQ, V1, P7
   ASTHO, 2008, ASS STATE TERRITORIA, V1, P1
   ASTHO, 2008, ASS STATE TERRITORIA, V1, P26
   AUSTIN D. ANDREW, 2016, R44095 C RES SERV
   Barrett ADT, 2014, AM J TROP MED HYG, V90, P389, DOI 10.4269/ajtmh.14-0009
   Barros A. F., 2015, 2015 IEEE International Magnetics Conference (INTERMAG), DOI 10.1109/INTMAG.2015.7157783
   Beaubien Jason, 2016, ZIKA CASES SURGE PUE
   Beck J., 2016, ATLANTIC
   Beil Laura, 2016, SCI NEWS, P22
   Binker Mark, 2016, ZIKA VIRUS ARRIVES U
   Bridgforth L R, 1984, Public Hist, V6, P5
   Bridgforth Lucie Robertson, 1984, PUB HIST SUMMER, V6, P22
   Bunge J., 2017, WALL ST J
   Byrne S., 2016, CONSUMER REPORTS
   Calif Robert M., 2016, FDA TAKES ACTION ZIK
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caputo Mark, 2016, POLITICO
   CDC, 2013, LOC PUBL HLTH SYST P, V1, P57
   CDC, 2016, AV MOSQ BIT
   CDC, 2016, EX ORD EM DECL W NIL, V1, P6
   Centers for Disease Control Centers Dis. Control Prev., 2016, ZIK VIR HOM, P1
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Cordero Jose F., 2016, PUERTO RICO TRUST SC, V1, P2
   Cragen Janet D., 2017, MMWR-MORBID MORTAL W, V66
   Currier M., 2005, Morbidity and Mortality Weekly Report, V54, P529
   Dana David, 2016, BC ENV AFF L REV, V43, P281
   Dana David, 2016, BC ENV AFF L REV, V43, P282
   Daub Travis, 2009, PBS NEWSHOUR    1008
   DEP'T OF HEALTH AND HUMAN SERVS, 2016, US ANT RES MAN, P8
   Dolgin Janet L., 2016, ABA HLTH LAW SEC, V29, P1
   Dolgin Janet L., 2016, ABA HLTH LAW SEC, P6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eisenstein Michael, 2016, NATURE
   EPSTEIN SUSAN, 2016, R44460 C RES SERV
   Ernest B, 2008, ASIAN PACIFIC LAW PO, V9, P186
   Eyerman Joe, 2005, CROSS NATL COMP INTE
   Fee E, 2004, AM J PUBLIC HEALTH, V94, P1694, DOI 10.2105/AJPH.94.10.1694
   Food and Drug Administration (FDA), 2016, FDA REL FIN ENV ASS
   Fox M, 2016, NBC NEWS
   Frieden Tom, 2016, CDC TRANSCRIPT CDC T
   Friedman U., 2016, ATLANTIC
   Froio Nicole, 2016, GUARDIAN
   Gebbie K., 2002, WHO WILL KEEP PUBLIC
   Glenza J., 2016, GUARDIAN
   GOODMAN RICHARD E., 2007, LAW PUBLIC HLTH PRAC, V1, P55
   GOSTIN LAWRENCE O., 2016, PUBLIC HLTH LAW POWE, P153
   Granados JAT, 2009, P NATL ACAD SCI USA, V106, P17290, DOI 10.1073/pnas.0904491106
   GRIFFITHS JEFFREY, 2010, PUBLIC HLTH INFECT D, V1, P365
   Guptill SC, 2003, EMERG INFECT DIS, V9, P483, DOI 10.3201/eid0904.020421
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hayden E, 2016, NATURE
   INSTITUTE OF MEDICINE OF THE NAT'L ACADEMIES, 2003, FUT PUBL HLTH 21 CEN
   Kapucu N, 2009, PUBLIC ADMIN REV, V69, P297, DOI 10.1111/j.1540-6210.2008.01975.x
   Kimball Thomas D., 2016, LOY L REV, V62, P115
   Kimball Thomas D., 2016, LOY L REV, V62, P113
   Kindhauser MK, ZIKA ORIGIN SPREAD M
   Klain Ronald A., 2016, WASH POST
   Klain Ronald A., 2016, DEMOCRACY J IDEAS
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   Kline Beth, 2006, PERSPECTIVES PUBLIC, V3, P3
   Kreps Gary A., 1990, INT J MASS EMERGENCI, V8, P275
   Kreps Gary A., 1990, INT J MASS EMERGENCI, V8, P280
   Lander Mark, 2016, NY TIMES
   Laupland KB, 2014, CAN J INFECT DIS MED, V25, P128, DOI 10.1155/2014/527378
   Lemout Craig, 2011, MOSQUITO RES FEELS B
   LINDSAY BRUCE R., 2014, R43537 C RES SERV
   Lister SA., 2005, OVERVIEW US PUBLIC H
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   McKenna Maryn, 2016, NATL GEOGRAPHIC PHEN
   McNeil Jr Donald G., 2016, NY TIMES
   Meit Michael, 2012, PROMISING PRACTICES, V1, P2
   Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507
   Monaghan Andrew J., 2016, PUB LIB SCI CURRENT
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Najafipour Farshad, 2015, J ARCH MIL MED, V1, P2
   O'Donnell J., 2016, US TODAY
   Osterholm Michael C., 2017, NY TIMES
   Parmet Wendy E., 2010, ST LOUIS U J HLTH L, V4, P113
   Porta Miguel, 2014, DICT EPIDEMIOLOGY, V9
   Price Polly J., 2011, EMORY LJ, V60, P327
   Price Polly J., 2011, EMORY LJ, V60, P325
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REDHEAD C. STEPHEN, 2016, R44505 C RES SERV, V1, P2
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Reiter Paul, 2001, ENVIRON HEALTH PERSP, V109, P142
   Richards Edward, 2007, J HLTH CARE L POLY, V10, P61
   Richards Edward P., 2007, J HEALTH CARE L POLY, V10, P64
   Rutkow L, 2014, J LAW MED ETHICS, V42, P64, DOI 10.1111/jlme.12119
   Salinsky Eileen, 2010, GOVT PUBLIC HLTH OVE, V1, P5
   Savitt Todd L., 1988, DIS DISTINCTIVENESS, P8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEELKE CLARE RIBANDO, 2016, R44545 C RES SERV
   Sejvar James J, 2003, Ochsner J, V5, P6
   Shamel Kelly E., 2002, MO ENV L POLY REV, V10, P56
   Singleton CM, 2006, ADMIN LAW REV, V58, P645
   Singleton Christa-Marie, 2006, ADM L REV, V58, P646
   Staples JE, 2014, AM J TROP MED HYG, V90, P402, DOI 10.4269/ajtmh.13-0206
   Steenhuyse Julie, 2016, REUTERS
   Sun Lena H., 2017, WASH POST
   Sun Lena H., 2016, WASH POST
   Tapia Granados Jose A., 2009, P NATL ACAD SCI USA, V106
   TURNOCK BERNARD J., 2004, PUBLIC HLTH WHAT IT, V1, P138
   United Nations Zika, 2016, ZIK UN HLTH AG LAUNC
   VANEMDEN HF, 2004, PEST VECTOR CONTROL, P1
   Whitaker Alan G., 2011, NATL SECURITY PROCES, V19
   WHO, 2016, ZIK VIR OUTBR GLOB R
   WHO, 2016, 2 WHO
   World Health Organization, 2015, GLOB ACT PLAN CONTR, P1, DOI DOI 10.1016/S0968-8080(12)40660-7
   Yuhas Alan, 2016, GUARDIAN
NR 119
TC 0
Z9 0
U1 0
U2 3
PU AMER BAR ASSOC, ADMINISTRATIVE LAW & REGULATORY PRACTICE SECTION
PI CHICAGO
PA 321 N CLARK ST, CHICAGO, IL 60610 USA
SN 0001-8368
EI 2326-9154
J9 ADMIN LAW REV
JI Adm. Law Rev.
PD SPR
PY 2017
VL 69
IS 2
BP 495
EP 527
PG 33
WC Law
SC Government & Law
GA FA7SO
UT WOS:000405647400009
DA 2020-07-08
ER

PT J
AU Adhikari, EH
   Nelson, DB
   Johnson, KA
   Jacobs, S
   Rogers, VL
   Roberts, SW
   Sexton, T
   McIntire, DD
   Casey, BM
AF Adhikari, Emily H.
   Nelson, David B.
   Johnson, Kathryn A.
   Jacobs, Sara
   Rogers, Vanessa L.
   Roberts, Scott W.
   Sexton, Taylor
   McIntire, Donald D.
   Casey, Brian M.
TI Infant outcomes among women with Zika virus infection during pregnancy:
   results of a large prenatal Zika screening program
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE neonatal head circumference; population-based screening; pregnancy;
   travel history; Zika virus infection
ID UNITED-STATES; INTERIM GUIDELINES; AUGUST 2016; TRANSMISSION; GUIDANCE;
   OUTBREAK; DISEASE; FLORIDA
AB BACKGROUND: Zika virus infection during pregnancy is a known cause of congenital microcephaly and other neurologic morbidities. OBJECTIVE: We present the results of a large-scale prenatal screening program in place at a single-center health care system since March 14, 2016. Our aims were to report the baseline prevalence of travelassociated Zika infection in our pregnant population, determine travel characteristics of women with evidence of Zika infection, and evaluate maternal and neonatal outcomes compared to women without evidence of Zika infection.
   STUDY DESIGN: This is a prospective, observational study of prenatal Zika virus screening in our health care system. We screened all pregnant women for recent travel to a Zika-affected area, and the serum was tested for those considered at risk for infection. We compared maternal demographic and travel characteristics and perinatal outcomes among women with positive and negative Zika virus tests during pregnancy. Comprehensive neurologic evaluation was performed on all infants delivered of women with evidence of possible Zika virus infection during pregnancy. Head circumference percentiles by gestational age were compared for infants delivered of women with positive and negative Zika virus test results.
   RESULTS: From March 14 through Oct. 1, 2016, a total of 14,161 pregnant women were screened for travel to a Zika-affected country. A total of 610 (4.3%) women reported travel, and test results were available in 547. Of these, evidence of possible Zika virus infection was found in 29 (5.3%). In our population, the prevalence of asymptomatic or symptomatic Zika virus infection among pregnant women was 2/1000. Women with evidence of Zika virus infection were more likely to have traveled from Central or South America (97% vs 12%, P <.001). There were 391 deliveries available for analysis. There was no significant difference in obstetric or neonatal morbidities among women with or without evidence of possible Zika virus infection. Additionally, there was no difference in mean head circumference of infants born to women with positive vs negative Zika virus testing. No microcephalic infants born to women with Zika infection were identified, although 1 infant with hydranencephaly was born to a woman with unconfirmed possible Zika disease. Long-term outcomes for infants exposed to maternal Zika infection during pregnancy are yet unknown.
   CONCLUSION: Based on a large-scale prenatal Zika screening program in an area with a predominantly Hispanic population, we identified that 4% were at risk from reported travel with only 2/1000 infected. Women traveling from heavily affected areas were most at risk for infection. Neonatal head circumference percentiles among infants born to women with evidence of possible Zika virus infection during pregnancy were not reduced when compared to infants born to women without infection.
C1 [Adhikari, Emily H.; Nelson, David B.; Jacobs, Sara; Rogers, Vanessa L.; Roberts, Scott W.; McIntire, Donald D.; Casey, Brian M.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.
   [Johnson, Kathryn A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA.
   [Sexton, Taylor] Dallas Cty Hlth & Human Serv, Dallas, TX USA.
RP Adhikari, EH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.
EM emily.adhikari@utsouthwestern.edu
OI Adhikari, Emily/0000-0002-4060-2685; mcintire,
   donald/0000-0002-9799-7905
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P474
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos Rde M, 2016, J CLIN VIROL, V77, P69
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   FRIEDRICH MJ, 2016, JAMA, V316, P1537
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Nelson B, 2016, PLOS CURR, V31, P8
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913
   Pacheco O, 2016, N ENGL J MED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
NR 24
TC 14
Z9 14
U1 0
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD MAR
PY 2017
VL 216
IS 3
AR 292.e1-8
DI 10.1016/j.ajog.2017.01.018
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP0PR
UT WOS:000397089700030
PM 28153665
OA Bronze
DA 2020-07-08
ER

PT J
AU Gostin, LO
AF Gostin, Lawrence O.
TI OUR SHARED VULNERABILITY TO DANGEROUS PATHOGENS
SO MEDICAL LAW REVIEW
LA English
DT Article
DE Global Health Crisis; Global Health Governance; Global Health Security;
   International Health Regulations; Security Dividend; World Health
   Organization
ID HEALTH; EBOLA; INFLUENZA; EPIDEMIC
AB The international community vastly underestimates the risk and scale of our shared vulnerability to fast moving pathogens. Ranging from SARS and novel influenzas to Ebola and Zika, the world seems to be caught off guard, despite the regularity of global health threats historically. More importantly, when governments and international institutions underestimate the threat, they also underinvest in preparedness. Failure to prepare has deep costs in human lives and economic productivity. Here, I offer a pathway to preparedness for, and rapid response to, infectious disease threats: robust and resilient national health systems; strong institutions capable of leading, particularly the World Health Organization; and investments in research and development. Overall, the world needs a strong system of laws and governance, ranging from the International Health Regulations through to norms of transparency and accountability. To secure our common future, the world needs sustained investment and leadership. I propose a 'security dividend', both financial and institutional, to remake the global health security system.
C1 [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.
RP Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.
EM gostin@law.georgetown.edu
OI Gostin, Lawrence/0000-0001-5286-4044
CR AGINAM O, 2005, GLOBAL HLTH GOVERNAN
   [Anonymous], 2016, PROTECTING HUMANITY
   [Anonymous], 2015, REP REV COMM 2 EXT E
   Buse K, 2001, B WORLD HEALTH ORGAN, V79, P748
   Commission on a Global Health Risk Framework for the Future, 2016, NEGLECTED DIMENSIONS
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Drazen JM, 2014, NEW ENGL J MED, V371, P2029, DOI 10.1056/NEJMe1413139
   Elbe S., 2010, SECURITY GLOBAL HLTH
   Fan V, 2016, NATL BUREAU EC RES, P14
   Fidler David P., 1999, INT LAW INFECT DISEA
   Fidler DP, 2005, CHIN J INT LAW, V4, P325, DOI DOI 10.1093/CHINESEJIL/JMI029
   Freeman M, 2014, LAW GLOBAL HLTH CURR, V16
   Gagnon ML, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-24
   Gale A., 2015, WALL STREET J
   general L.O. GOSTIN, 2014, GLOBAL HLTH LAW
   Gostin LO, 2015, PUBLIC HEALTH, V129, P854, DOI 10.1016/j.puhe.2015.05.002
   Gostin LO, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002042
   Gostin LO, 2016, MILBANK Q, V94, P264, DOI 10.1111/1468-0009.12186
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P2376, DOI 10.1001/jama.2009.849
   Gostin LO, 2017, LANCET
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Holbrooke R, 2005, FRONTLINE
   Jonas OB, 2013, PANDEMIC RISK, P2
   Keefe TJ, 2008, POLITICS OF GLOBAL HEALTH GOVERNANCE: UNITED BY CONTAGION, P1, DOI 10.1057/9780230611955
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   McInnes Colin, 2012, GLOBAL HLTH INT RELA
   McNeill William H., 1976, PLAGUES PEOPLES
   Medicine Sans Frontieres [MSF], 2015, PUSH LIM YEAR LARG E, P8
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   ONISHI NORIMITSU, 2014, NY TIMES
   Peiris JSM, 2016, LANCET INFECT DIS, V16, P252, DOI 10.1016/S1473-3099(15)00502-2
   Price-Smith AT, 2001, HLTH NATIONS INFECT
   Puska P, 2000, ACTA CARDIOL, V55, P213, DOI 10.2143/AC.55.4.2005743
   Sands P, 2016, LANCET
   The United Nations, 2015, SUST DEV KNOWL PLATF
   The White House Office of the Press Secretary, 2014, US RESP EB EP W AFR
   The World Bank Group, 2014, EC IMP 2014 EB EP SH, P2
   The World Bank Group, 2016, PAND EM FAC
   Thompson N, 2014, EBOLA VIRUS COUNTRIE
   *WHO, 2003, SUMM TABL SARS CAS B
   WHO, 2001, INV HLTH SUMM FIND C
   WHO, 2005, WHO IMPL INT HLTH RE
   WHO (Resolution of the Forty-Sixth World Health Assembly), 1993, HLTH DEV CHANG WORLD
   World Bank Group, 2016, SHORT TERM EC COSTS
   World Health Organization,, 2016, WORLD HLTH ASS AGR N
   World Health Organization, 2016, ADV GROUP REF WHOS W, P10
   World Health Organization, 2008, CLOS GAP GEN HLTH EQ, P23
   World Health Organization, 2015, REP EB INT ASS P JUL, P21
   Zinsser Hans, 1935, RATS LICE HIST
NR 51
TC 1
Z9 1
U1 2
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0967-0742
EI 1464-3790
J9 MED LAW REV
JI Med. Law. Rev.
PD SPR
PY 2017
VL 25
IS 2
BP 185
EP 199
DI 10.1093/medlaw/fwx016
PG 15
WC Law; Medicine, Legal
SC Government & Law; Legal Medicine
GA EZ1MH
UT WOS:000404474600002
PM 28419346
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Zika virus infection: Factor contributing to emergence and pathogenesis
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
ID DENGUE
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dyer O, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4740
   Joob B, 2016, ASIAN PAC J TROP MED, V9, P700, DOI 10.1016/j.apjtm.2016.05.016
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Sriwijitalai W, 2016, REV BRAS GINECOL OBS, V38, P314, DOI 10.1055/s-0036-1584947
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   Wiwanitkit V, 2016, ARQ NEURO-PSIQUIAT, V74, P692, DOI 10.1590/0004-282X20160089
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 11
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 458
EP +
DI 10.4103/1755-6783.208734
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600039
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Afebrile Zika virus infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Haikou, Peoples R China.
RP Joob, B (corresponding author), Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 473
EP +
DI 10.4103/1755-6783.208699
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600056
DA 2020-07-08
ER

PT J
AU Sriwijitralai, W
   Wiwanitkit, V
AF Sriwijitralai, Won
   Wiwanitkit, Viroj
TI Not all cases with Zika virus infection have thrombocytopenia
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sriwijitralai, Won] RV Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Sriwijitralai, W (corresponding author), RV Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 474
EP 474
DI 10.4103/1755-6783.208700
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600057
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Gastric symptom in Zika virus infection: Do we forget it?
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Trop Med, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Barrera-Cruz Antonio, 2016, Rev Med Inst Mex Seguro Soc, V54, P211
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Wiwanitkit S, 2016, ASIAN PAC J IN PRESS
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 7
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 478
EP +
DI 10.4103/1755-6783.196837
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600062
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Temperature that can promote Zika virus infection: A summary from Thai
   cases
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Dept Med Sci, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, ikeji Ara Keji, Osun State, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Coll Med, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Attaway DF, 2016, ACTA TROP, V158, P248, DOI 10.1016/j.actatropica.2016.02.018
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2016, ASIAN PAC J IN PRESS
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 479
EP 479
DI 10.4103/1755-6783.196839
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600063
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI What can we interpret from the distance between sites with emerging Zika
   virus infection? A case of Thailand
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 480
EP +
DI 10.4103/1755-6783.196841
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600065
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanikit, V
AF Wiwanitkit, Somsri
   Wiwanikit, Viroj
TI Zika virus infection, blood glucose, and diabetes mellitus
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanikit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanikit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Lee IK, 2007, PANCREAS, V35, P381, DOI 10.1097/01.mpa.0000297828.05678.7a
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 8
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 484
EP +
DI 10.4103/1755-6783.196857
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600069
DA 2020-07-08
ER

PT J
AU Tin, SS
   Wiwanitkit, V
   Wiwanitkit, S
AF Tin, Sim Sai
   Wiwanitkit, Viroj
   Wiwanitkit, Somsri
TI Electrocardiography and echocardiography finding in Zika virus
   infection: Limited available data
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Tin, Sim Sai] Shantou Med Ctr, Shantou, Peoples R China.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Deng Y, 2016, ZHONGHUA WEI ZHONG B, V28, P2106
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 485
EP 485
DI 10.4103/1755-6783.188494
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600070
DA 2020-07-08
ER

PT J
AU Sriwijitalai, W
   Wiwanitkit, V
AF Sriwijitalai, Won
   Wiwanitkit, Viroj
TI Peptide similarity, but no structure similarity: Can it explain the
   autoimmunity theory for pathology in Zika virus infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sriwijitalai, Won] RVT Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Sriwijitalai, W (corresponding author), RVT Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Lucchese G, 2016, AUTOIMMUN REV
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
DI 10.4103/1755-6783.196858
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600068
DA 2020-07-08
ER

PT J
AU Sriwijitralai, W
   Wiwanitkit, V
AF Sriwijitralai, Won
   Wiwanitkit, Viroj
TI Zika virus infection: Serious but low fatality
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sriwijitralai, Won] RV Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Sriwijitralai, W (corresponding author), RV Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Brasil P, 2016, N ENGL J MED
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
DI 10.4103/1755-6783.208701
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600058
DA 2020-07-08
ER

PT J
AU Sriwijitralai, W
   Wiwanitkit, V
AF Sriwijitralai, Won
   Wiwanitkit, Viroj
TI Lymphadenopathy is not common among Thai patients with Zika virus
   infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sriwijitralai, Won] RV Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Haikou, Peoples R China.
RP Sriwijitralai, W (corresponding author), RV Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Brasil P, 2016, N ENGL J MED
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
DI 10.4103/1755-6783.208697
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600055
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Zika virus infection: Existence of hemoconcentration
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
   Wiwanitkit V, 2010, EXPERT REV ANTI-INFE, V8, P841, DOI [10.1586/eri.10.53, 10.1586/ERI.10.53]
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
DI 10.4103/1755-6783.208706
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600072
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Estimated risk for Zika virus seropositivity among pregnant women in
   area with indexed case in Thailand
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Dept Med Sci, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, Ikeji Ara Keji, Osun State, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Coll Med, Pune, Maharashtra, India.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 6
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
DI 10.4103/1755-6783.196840
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600064
DA 2020-07-08
ER

PT J
AU Iyer, VV
   Tejal, A
   Poddar, A
   Maithili, D
   Rasika, LG
   Bendre, A
   Jaswal, V
AF Iyer, Vidhya V.
   Tejal, A.
   Poddar, A.
   Maithili, D.
   Rasika, L. G.
   Bendre, A.
   Jaswal, Vani
TI An Indian Perspective of Some Recent Developments in Polio, DPT, Zika
   and Rotavirus Vaccines
SO INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE Vaccines; clinical trials; pharmacokinetics; pharmacodynamics; virus;
   attenuated vaccine; Nanopatch (TM)
ID VIRUS-LIKE PARTICLES; LIPID COMPLEXES ISCOMS; WHOLE-CELL PERTUSSIS;
   DELIVERY-SYSTEMS; IMMUNOSTIMULATING COMPLEXES; ANTIBODY-RESPONSES; SKIN;
   VACCINATION; EXPERIENCE; INFECTION
AB This review is aimed at equipping the reader with fundamental knowledge pertaining to vaccines, their pharmacokinetics and pharmacodynamics, along with specific examples with respect to clinical trials and mechanism of action. Poliomyelitis, rotavirus and diphtheria-pertussis-tetanus vaccines have been discussed in this review. Progress made in vaccines has been discussed, from failed clinical trials to recent ground-breaking developments. Efforts made to combat the recent outbreak of Zika virus have also been included. The recent development of the Nanopatch (TM) technology aims at revolutionizing the vaccine industry.
C1 [Iyer, Vidhya V.; Tejal, A.; Poddar, A.; Maithili, D.; Rasika, L. G.; Bendre, A.; Jaswal, Vani] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.
RP Iyer, VV (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.
EM vidhyaiyer.v@vit.ac.in
CR Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077
   Barr IG, 1998, ADV DRUG DELIVER REV, V32, P247, DOI 10.1016/S0169-409X(98)00013-1
   BASS JW, 1985, PEDIATR INFECT DIS J, V4, P614, DOI 10.1097/00006454-198511000-00003
   Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007
   Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259
   CLAASSEN I, 1992, RES IMMUNOL, V143, P531, DOI 10.1016/0923-2494(92)80065-S
   Clem AS, 2011, J GLOB INFECT DIS, V3, P73, DOI 10.4103/0974-777X.77299
   Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843
   Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07
   Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016
   Fitzpatrick M., 2006, J ROY SOC MED, V99, p[156, 156], DOI [10.1258/jrsm.99.3, DOI 10.1258/JRSM.99.3.156]
   Galanis E, 2006, CAN MED ASSOC J, V174, P451, DOI 10.1503/cmaj.050379
   Gregory AE, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00013
   Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018
   Hamborsky J., 2015, EPIDEMIOLOGY PREVENT
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Henriksen-Lacey M, 2011, EXPERT OPIN DRUG DEL, V8, P505, DOI 10.1517/17425247.2011.558081
   Heurtault B, 2010, EXPERT OPIN DRUG DEL, V7, P829, DOI 10.1517/17425247.2010.488687
   Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278
   John TJ, 2013, INDIAN J MED RES, V137, P881
   KERSTEN GFA, 1991, BIOCHIM BIOPHYS ACTA, V1062, P165, DOI 10.1016/0005-2736(91)90388-O
   KERSTEN GFA, 1988, INFECT IMMUN, V56, P432, DOI 10.1128/IAI.56.2.432-438.1988
   Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   KINGSMAN SM, 1988, VACCINE, V6, P304, DOI 10.1016/0264-410X(88)90174-0
   Knobler S, 2002, CONSIDERATIONS VIRAL
   Lahariya C, 2014, INDIAN J MED RES, V139, P491
   LOVGREN K, 1988, BIOTECHNOL APPL BIOC, V10, P161
   Michael D. Decker, 1996, J INFECT DIS, V174, P270
   MOREIN B, 1985, VACCINE, V3, P83, DOI 10.1016/0264-410X(85)90055-6
   MOREIN B, 1995, CLIN IMMUNOTHER, V3, P461, DOI 10.1007/BF03259065
   Mowery DC, 1995, J HEALTH POLIT POLIC, V20, P973, DOI 10.1215/03616878-20-4-973
   Muller DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22094
   Murdin AD, 1996, VACCINE, V14, P735, DOI 10.1016/0264-410X(95)00211-I
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NOBLE GR, 1987, JAMA-J AM MED ASSOC, V257, P1351, DOI 10.1001/jama.257.10.1351
   Pallavi B, 2015, AUSTIN J NANOMED NAN, V3, P1039
   Patel MK, 2012, J PHARMACOL PHARMACO, V3, P71, DOI 10.4103/0976-500X.92514
   Paul Y, 2008, INDIAN PEDIATR, V45, P381
   Pearson FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067888
   Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x
   Plosker GL, 2012, DRUGS R&D, V12, P239, DOI 10.2165/11208130-000000000-00000
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]
   Sala F, 2003, VACCINE, V21, P803, DOI 10.1016/S0264-410X(02)00603-5
   Suh H, 2014, CLIN EXP VACCINE RES, V3, P42, DOI 10.7774/cevr.2014.3.1.42
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928
   Tiwari S, 2009, BIOTECHNOL ADV, V27, P449, DOI 10.1016/j.biotechadv.2009.03.006
   Valtanen S, 2000, J INFECT DIS, V182, P1, DOI 10.1086/315684
   Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16
   Ward Richard L, 2008, Ther Clin Risk Manag, V4, P49
   Westerman LE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-40
   Williams SCP, 2013, P NATL ACAD SCI USA, V110, P10049, DOI 10.1073/pnas.1309653110
   Xiong Zhuo, 2013, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V30, P1283
   Young KR, 2006, METHODS, V40, P98, DOI 10.1016/j.ymeth.2006.05.024
   Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4
   Zurbriggen S, 2008, APPL ENVIRON MICROB, V74, P5608, DOI 10.1128/AEM.02764-07
NR 57
TC 0
Z9 0
U1 0
U2 4
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0250-474X
EI 1998-3743
J9 INDIAN J PHARM SCI
JI Indian J. Pharm. Sci.
PD MAR-APR
PY 2017
VL 79
IS 2
BP 175
EP 185
DI 10.4172/pharmaceutical-sciences.1000215
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EZ3DU
UT WOS:000404591400002
OA Bronze
DA 2020-07-08
ER

PT J
AU Campos, AGD
   Lira, RPC
   Arantes, TEFE
AF de Moura Campos, Adriana Gondim
   Cavalcanti Lira, Rodrigo Pessoa
   Faria e Arantes, Tiago Eugenio
TI Response: macular atrophy and Zika virus infection
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
RI Lira, Rodrigo Pessoa Cavalcanti/G-9211-2012; Arantes, Tiago
   EF/I-3093-2013
OI Lira, Rodrigo Pessoa Cavalcanti/0000-0002-7274-1065; Arantes, Tiago
   EF/0000-0002-8122-3446
NR 0
TC 1
Z9 1
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAR-APR
PY 2017
VL 80
IS 2
BP 137
EP 137
PG 1
WC Ophthalmology
SC Ophthalmology
GA EX5AR
UT WOS:000403248600018
PM 31364831
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Macular atrophy and Zika virus infection
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
ID OPTICAL COHERENCE TOMOGRAPHY
C1 [Joob, Beuy] Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Med Acad Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Rifkin LM, 2016, JAMA OPHTHALMOL, V134, P1427, DOI 10.1001/jamaophthalmol.2016.4299
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
NR 4
TC 0
Z9 0
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAR-APR
PY 2017
VL 80
IS 2
BP 137
EP 137
DI 10.5935/0004-2749.20170033
PG 1
WC Ophthalmology
SC Ophthalmology
GA EX5AR
UT WOS:000403248600017
PM 28591291
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tripathy, K
AF Tripathy, Koushik
TI Optical coherence tomography in congenital Zika syndrome
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
ID MACULAR ATROPHY; VIRUS-INFECTION; INFANTS
C1 [Tripathy, Koushik] ICARE Eye Hosp & Postgrad Inst, E3A,Sect 26, Noida 201301, Uttar Pradesh, India.
RP Tripathy, K (corresponding author), ICARE Eye Hosp & Postgrad Inst, E3A,Sect 26, Noida 201301, Uttar Pradesh, India.
EM drkoushiktripathy@icarehospital.org
RI Tripathy, Koushik/O-1801-2019
OI Tripathy, Koushik/0000-0002-9756-128X
CR Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 0
Z9 0
U1 0
U2 0
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAR-APR
PY 2017
VL 80
IS 2
BP 138
EP 138
DI 10.5935/0004-2749.20170034
PG 1
WC Ophthalmology
SC Ophthalmology
GA EX5AR
UT WOS:000403248600019
PM 28591292
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hupert, N
AF Hupert, Nathaniel
TI Who's Invading Whom? Zika and Intergenerational Public Health
SO SOCIAL RESEARCH
LA English
DT Article
ID POPULATION; WAR
C1 [Hupert, Nathaniel] Cornell Univ, Ithaca, NY 14853 USA.
   [Hupert, Nathaniel] Ctr Dis Control & Prevent CDC, Preparedness Modeling Unit, Atlanta, GA USA.
RP Hupert, N (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.
CR Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103
   Cox LA, 2008, RISK ANAL, V28, P1749, DOI 10.1111/j.1539-6924.2008.01142.x
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Dzau VJ, 2016, NEW ENGL J MED, V375, P203, DOI 10.1056/NEJMp1605847
   Eunomia, 2016, PLASTICS MARINE ENV
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gardiner SM, 2006, ENVIRON VALUE, V15, P397, DOI 10.3197/096327106778226293
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hotez P.J., 2016, PLOS NEGLECTED TROPI, V10
   Julvez J, 2016, AM J EPIDEMIOL, V183, P169, DOI 10.1093/aje/kwv195
   Larson BMH, 2005, SCI COMMUN, V26, P243, DOI 10.1177/1075547004273019
   Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321
   Liboiron M, 2016, J MAT CULT, V21, P87, DOI 10.1177/1359183515622966
   Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004
   Nowak A, 2009, J ROY SOC MED, V102, P98, DOI 10.1258/jrsm.2009.080274
   Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Saldanha C., 2006, ICE AGE THE MELTDOWN
   SATTENSPIEL L, 1987, HUM BIOL, V59, P411
   Specter M, 2012, NEW YORKER
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
   Winn P., 2016, PUBLIC RADIO IN 1213
   World Economic Forum, 2016, NEW PLAST EC RETH FU
NR 23
TC 1
Z9 1
U1 0
U2 1
PU NEW SCHOOL UNIV
PI NEW YORK
PA GRADUATE FACULTY, 65 5TH AVE, RM 354, NEW YORK, NY 10003 USA
SN 0037-783X
J9 SOC RES
JI Soc. Res.
PD SPR
PY 2017
VL 84
IS 1
BP 83
EP 105
PG 23
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA EW9ZI
UT WOS:000402877500008
DA 2020-07-08
ER

PT J
AU Gardner, L
   Chen, N
   Sarkar, S
AF Gardner, Lauren
   Chen, Nan
   Sarkar, Sahotra
TI Vector status of Aedes species determines geographical risk of
   autochthonous Zika virus establishment
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NICHE MODELS; TRANSMISSION; AMERICA; ARBOVIRUSES; INFECTION; AFRICA;
   REGION; DENGUE; FEVER
AB Background
   The 2015-16 Zika virus pandemic originating in Latin America led to predictions of a catastrophic global spread of the disease. Since the current outbreak began in Brazil in May 2015 local transmission of Zika has been reported in over 60 countries and territories, with over 750 thousand confirmed and suspected cases. As a result of its range expansion attention has focused on possible modes of transmission, of which the arthropod vector-based disease spread cycle involving Aedes species is believed to be the most important. Additional causes of concern are the emerging new links between Zika disease and Guillain-Barre Syndrome (GBS), and a once rare congenital disease, microcephaly.
   Methodology/principal findings
   Like dengue and chikungunya, the geographic establishment of Zika is thought to be limited by the occurrence of its principal vector mosquito species, Ae. aegypti and, possibly, Ae. albopictus. While Ae. albopictus populations are more widely established than those of Ae. aegypti, the relative competence of these species as a Zika vector is unknown. The analysis reported here presents a global risk model that considers the role of each vector species independently, and quantifies the potential spreading risk of Zika into new regions. Six scenarios are evaluated which vary in the weight assigned to Ae. albopictus as a possible spreading vector. The scenarios are bounded by the extreme assumptions that spread is driven by air travel and Ae. aegypti presence alone and spread driven equally by both species. For each scenario destination cities at highest risk of Zika outbreaks are prioritized, as are source cities in affected regions. Finally, intercontinental air travel routes that pose the highest risk for Zika spread are also ranked. The results are compared between scenarios.
   Conclusions/significance
   Results from the analysis reveal that if Ae. aegypti is the only competent Zika vector, then risk is geographically limited; in North America mainly to Florida and Texas. However, if Ae. albopictus proves to be a competent vector of Zika, which does not yet appear to be the case, then there is risk of local establishment in all American regions including Canada and Chile, much of Western Europe, Australia, New Zealand, as well as South and East Asia, with a substantial increase in risk to Asia due to the more recent local establishment of Zika in Singapore.
C1 [Gardner, Lauren; Chen, Nan] Univ New South Wales UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW, Australia.
   [Sarkar, Sahotra] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
   [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA.
RP Gardner, L (corresponding author), Univ New South Wales UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW, Australia.
EM l.gardner@unsw.edu.au
CR Aliota M, 2016, EMERG INFECT DIS
   [Anonymous], 2009, JF MAPPING SPECIES D
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2016, EURO SURVEILL, V21
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Centers for Disease Control and Prevention (CDC), 2016, AR ZIK
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, NEW ENGLAND J MED
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gardner LM, 2015, TRANSPORT RES REC, P25, DOI 10.3141/2501-04
   Gardner LM, 2012, J TROPICAL MED, V2012
   Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS ADV ACC
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills S, 2016, MMWR MORB MORTAL WKL
   IATA, 2016, AIR PASS MARK AN DEC
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jupille H, 2016, BIORXIV
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kutsuna S, 2014, EURO SURVEILLANCE, V18
   Lanciotti R, 2015, EMERG INFECT DIS, V22
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Margules CR, 2007, ECOL BIODIVERS CONS, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824
   MoH, 2016, MIN HLTH SING ZIK
   Monaghan A, 2016, PLOS CURRENTS OUTBRE
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, 2015, EP AL INCR MICR NE B
   PAHO, 2016, ZIK CAS CONG SYNDR A
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tappe D, 2014, EURO SURVEILL, V19
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Waehre T, 2013, EMERG INFECT DIS, V20
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), 2016, ZIK VIR TECHN REP
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
   World Health Organization (WHO), 2016, WHO SIT REP ZIK VIR
NR 68
TC 16
Z9 16
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2017
VL 11
IS 3
AR e0005487
DI 10.1371/journal.pntd.0005487
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1LG
UT WOS:000402251300062
PM 28339472
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Montgomery, BL
   Shivas, MA
   Hall-Mendelin, S
   Edwards, J
   Hamilton, NA
   Jansen, CC
   McMahon, JL
   Warrilow, D
   van den Hurk, AF
AF Montgomery, Brian L.
   Shivas, Martin A.
   Hall-Mendelin, Sonja
   Edwards, Jim
   Hamilton, Nicholas A.
   Jansen, Cassie C.
   McMahon, Jamie L.
   Warrilow, David
   van den Hurk, Andrew F.
TI Rapid Surveillance for Vector Presence (RSVP): Development of a novel
   system for detecting Aedes aegypti and Aedes albopictus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MARK-RELEASE-RECAPTURE; BG-SENTINEL TRAPS; DENGUE VECTOR;
   DIPTERA-CULICIDAE; STEGOMYIA-ALBOPICTUS; INVASIVE MOSQUITOS; NORTH
   QUEENSLAND; LETHAL OVITRAP; KEY CONTAINER; WOLBACHIA
AB Background
   The globally important Zika, dengue and chikungunya viruses are primarily transmitted by the invasive mosquitoes, Aedes aegypti and Aedes albopictus. In Australia, there is an increasing risk that these species may invade highly urbanized regions and trigger outbreaks. We describe the development of a Rapid Surveillance for Vector Presence (RSVP) system to expedite presence-absence surveys for both species.
   Methodology/ Principal findings
   We developed a methodology that uses molecular assays to efficiently screen pooled ovitrap (egg trap) samples for traces of target species ribosomal RNA. Firstly, specific real-time reverse transcription-polymerase chain reaction (RT-PCR) assays were developed which detect a single Ae. aegypti or Ae. albopictus first instar larva in samples containing 4,999 and 999 non-target mosquitoes, respectively. ImageJ software was evaluated as an automated egg counting tool using ovitrap collections obtained from Brisbane, Australia. Qualitative assessment of ovistrips was required prior to automation because ImageJ did not differentiate between Aedes eggs and other objects or contaminants on 44.5% of ovistrips assessed, thus compromising the accuracy of egg counts. As a proof of concept, the RSVP was evaluated in Brisbane, Rockhampton and Goomeri, locations where Ae. aegypti is considered absent, present, and at the margin of its range, respectively. In Brisbane, Ae. aegypti was not detected in 25 pools formed from 477 ovitraps, comprising approximate to 54,300 eggs. In Rockhampton, Ae. aegypti was detected in 4/6 pools derived from 45 ovitraps, comprising approximate to 1,700 eggs. In Goomeri, Ae. aegypti was detected in 5/8 pools derived from 62 ovitraps, comprising approximate to 4,200 eggs.
   Conclusions/Significance
   RSVP can rapidly detect nucleic acids from low numbers of target species within large samples of endemic species aggregated from multiple ovitraps. This screening capability facilitates deployment of ovitrap configurations of varying spatial scales, from a single residential block to entire suburbs or towns. RSVP is a powerful tool for surveillance of invasive Aedes spp., validation of species eradication and quality assurance for vector control operations implemented during disease outbreaks.
C1 [Montgomery, Brian L.] Queensland Hlth, Metro South Publ Hlth Unit, Coopers Plains, Qld, Australia.
   [Shivas, Martin A.] Brisbane City Council, Mosquito & Pest Management, Fortitude Valley, Qld, Australia.
   [Hall-Mendelin, Sonja; McMahon, Jamie L.; Warrilow, David; van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol, Forens & Sci Serv, Coopers Plains, Qld, Australia.
   [Edwards, Jim] Queensland Hlth, Rockhampton Publ Hlth Unit, Rockhampton, Qld, Australia.
   [Hamilton, Nicholas A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.
   [Jansen, Cassie C.] Queensland Hlth, Metro North Publ Hlth Unit, Windsor, Qld, Australia.
RP van den Hurk, AF (corresponding author), Queensland Govt, Dept Hlth, Publ Hlth Virol, Forens & Sci Serv, Coopers Plains, Qld, Australia.
EM andrew.vandenhurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019; Jansen, Cassie C/C-1465-2009;
   Hamilton, Nicholas A/A-6033-2010
OI van den Hurk, Andrew/0000-0001-6262-831X; Jansen, Cassie
   C/0000-0002-0655-2725; Hamilton, Nicholas A/0000-0003-0331-3427;
   McMahon, Jamie/0000-0002-9304-1500
FU Communicable Diseases Branch, Department of Health, Queensland
   Government
FX Aspects of this study were funded by Communicable Diseases Branch,
   Department of Health, Queensland Government. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Australian Bureau of Statistics, 2011, DAT REG LOC GOV AR
   Azil AH, 2014, J VECTOR ECOL, V39, P153, DOI 10.1111/j.1948-7134.2014.12082.x
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Brasil LM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0052-2
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Crepeau TN, 2013, J AM MOSQUITO CONTR, V29, P177, DOI 10.2987/12-6277r.1
   Deblauwe I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-201
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Falsone L, 2015, J VECTOR ECOL, V40, P256, DOI 10.1111/jvec.12162
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   Fonseca DM, 2015, J MED ENTOMOL, V52, P705, DOI 10.1093/jme/tjv060
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P32
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105
   Hoffmann AA, 2014, MED VET ENTOMOL, V28, P90, DOI 10.1111/mve.12077
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Johnson BJ, 2016, J MED ENTOM IN PRESS
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   KAY BH, 1990, MED J AUSTRALIA, V153, P31, DOI 10.5694/j.1326-5377.1990.tb125460.x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lamche Gisela D, 2003, Commun Dis Intell Q Rep, V27, P105
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Madon MB, 2003, J AM MOSQUITO CONTR, V19, P297
   Mains JW, 2008, J AM MOSQUITO CONTR, V24, P496, DOI 10.2987/5740.1
   Mariappan T, 2008, J MED ENTOMOL, V45, P148, DOI 10.1603/0022-2585(2008)45[148:DRHSAD]2.0.CO;2
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   McNaughton D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002794
   McNaughton D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001785
   McNaughton D, 2010, ACTA TROP, V116, P74, DOI 10.1016/j.actatropica.2010.05.012
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mello CB, 2009, RECENT ADV BIOMEDICA
   Montgomery BL, 2004, J AM MOSQUITO CONTR, V20, P365
   Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicholson J, 2014, J MED ENTOMOL, V51, P948, DOI 10.1603/ME14079
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Rasic G, 2014, ECOL APPL, V24, P1226, DOI 10.1890/13-1305.1
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Reiskind MH, 2012, J MED ENTOMOL, V49, P71, DOI 10.1603/ME10270
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Ritchie S., 2002, ENV HLTH, V2, P13
   Ritchie SA, 2001, J AM MOSQUITO CONTR, V17, P206
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Russell RC, 2005, COMMUN DIS INTELL, V29, P296
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schneider J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162493
   Tantowijoyo W, 2016, J MED ENTOMOL, V53, P188, DOI 10.1093/jme/tjv180
   Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023
   Unlu I, 2016, PEST MANAG SCI, V72, P1427, DOI 10.1002/ps.4174
   Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139
   Van Den Hurk AF, 2010, ANN TROP MED PARASIT, V104, P623, DOI 10.1179/136485910X12851868779984
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Viennet E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004943
   Wai KT, 2012, PATHOG GLOB HEALTH, V106, P436, DOI 10.1179/2047773212Y.0000000063
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Whelan P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001619
   Williams CR, 2007, J MED ENTOMOL, V44, P256, DOI 10.1603/0022-2585(2007)44[256:IOABLO]2.0.CO;2
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P635, DOI 10.2987/8756-971X(2006)22[635:OOUFAA]2.0.CO;2
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
   Wu HH, 2013, J MED ENTOMOL, V50, P261, DOI 10.1603/ME11263
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
NR 88
TC 8
Z9 8
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2017
VL 11
IS 3
AR e0005505
DI 10.1371/journal.pntd.0005505
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1LG
UT WOS:000402251300066
PM 28339458
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Snyder, RE
   Boone, CE
   Cardoso, CAA
   Aguiar-Alves, F
   Neves, FPG
   Riley, LW
AF Snyder, Robert E.
   Boone, Claire E.
   Araujo Cardoso, Claudete A.
   Aguiar-Alves, Fabio
   Neves, Felipe P. G.
   Riley, Lee W.
TI Zika: A scourge in urban slums
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; AMERICA; DENGUE
C1 [Snyder, Robert E.; Boone, Claire E.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA.
   [Araujo Cardoso, Claudete A.] Univ Fed Fluminense, Sch Med, Maternal & Child Dept, Niteroi, RJ, Brazil.
   [Aguiar-Alves, Fabio] Univ Fed Fluminense, Pathol Program, Lab Univ Rodolpho Albino, Niteroi, RJ, Brazil.
   [Neves, Felipe P. G.] Univ Fed Fluminense, Biomed Inst, Dept Microbiol & Parasitol, Niteroi, RJ, Brazil.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Riley, LW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA.; Riley, LW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM lwriley@berkeley.edu
RI Aguiar-Alves, Fabio/F-7001-2015; Snyder, Robert E./AAD-4433-2020; Neves,
   Felipe Piedade Goncalves/U-3284-2019
OI Snyder, Robert E./0000-0001-9743-0872; Neves, Felipe Piedade
   Goncalves/0000-0002-3606-2540
CR [Anonymous], 2016, B EPIDEMIOL, V47, P1, DOI DOI 10.1080/03740463.2015.1069049
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Payne M., 2016, WASHINGTON POST
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Rosa-Freitas MG, 2010, OECOLOGIA AUSTRALIS, V14, P641, DOI [DOI 10.4257/OECO.2010.1403.04, 10.4257/oeco.2010.1403.04]
   Snyder RE, 2014, LANCET GLOB HEALTH, V2, pE685, DOI 10.1016/S2214-109X(14)70339-0
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
NR 15
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2017
VL 11
IS 3
AR e0005287
DI 10.1371/journal.pntd.0005287
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1LG
UT WOS:000402251300008
PM 28333922
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ritchie, SA
   Johnson, BJ
AF Ritchie, Scott A.
   Johnson, Brian J.
TI Advances in Vector Control Science: Rear-and-Release Strategies Show
   Promise... but Don't Forget the Basics
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE vector control; SIT; Aedes aegypti; Wolbachia; gene drive
ID AUTOCIDAL GRAVID OVITRAP; AEDES-AEGYPTI; GENE DRIVE; DENGUE-FEVER;
   MOSQUITO; WOLBACHIA; INFECTION; DIPTERA; CHIKUNGUNYA; ALBOPICTUS
AB Both chikungunya and Zika viruses have recently swept from Africa across the Pacific to the Americas, causing major outbreaks of disease in humans. In the meantime, dengue epidemics continue throughout the tropics. Traditional vector control programs based on strategies from 1950s and 1960s have been relatively ineffective in combating recent epidemics. In response, new methods involving the rearing and releasing of large numbers of mosquitoes to eliminate or modify local Aedes populations are being developed, with several currently conducting field releases in high-risk countries. These advances, include the release of Wolbachia-infected Aedes aegypti and Aedes albopictus, for either its virus-blocking capabilities, sterilization by cytoplasmic incompatibility, or both; the release of Aedes carrying dominant lethal genes, such as the OX513A strain of A. aegypti; and other emerging techniques, such as advancing gene-drive technologies, are summarized, as well as current stages of development and primary operational and regulatory hurdles. Although these technologies show great promise, none are ready for widespread rollout for cities of millions of people. Thus, efforts should be made to avoid methods such as space sprays that have failed and improve existing technologies to increase their efficacy.
C1 [Ritchie, Scott A.; Johnson, Brian J.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Qld 4878, Australia.
   [Ritchie, Scott A.; Johnson, Brian J.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.
RP Ritchie, SA (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Bldg E4,McGregor Rd, Smithfield, Qld 4878, Australia.
EM scott.ritchie@jcu.edu.au
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia; Queensland State Government
FX This work was in part supported by the National Health and Medical
   Research Council of Australia and the Queensland State Government
   (Accelerate Fellowship to D.A.M.).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alphey L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003909
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Chakradhar S, 2015, NAT MED, V21, P416, DOI 10.1038/nm0515-416
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Delhi ON, 1975, NATURE, V256, P355
   Esteva L, 2005, MATH BIOSCI, V198, P132, DOI 10.1016/j.mbs.2005.06.004
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gubler D, 2005, REV PANAM SALUD PUBL, V17, P221
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Johnson BJ, 2016, J MED ENTOMOL, V53, P245, DOI 10.1093/jme/tjv165
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1
   Knerer G, 2015, HEALTH CARE MANAG SC, V18, P205, DOI 10.1007/s10729-013-9263-x
   Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Li CX, 2010, J AM MOSQUITO CONTR, V26, P346, DOI 10.2987/10-6007.1
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Reiter P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004769
   Resnik DB, 2014, DEV WORLD BIOETH, V14, P37, DOI 10.1111/dewb.12011
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie S, 2014, AUSTRAL ENTOMOL, V53, P363, DOI 10.1111/aen.12127
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Trout RT, 2007, J MED ENTOMOL, V44, P470, DOI 10.1603/0022-2585(2007)44[470:EOTPIA]2.0.CO;2
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
NR 63
TC 17
Z9 17
U1 0
U2 21
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2017
VL 215
SU 2
BP S103
EP S108
DI 10.1093/infdis/jiw575
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EV7TM
UT WOS:000401984500004
PM 28403439
OA Bronze
DA 2020-07-08
ER

PT J
AU AlQahtani, FS
   AiShebly, MM
   Govindarajan, M
   Senthilmurugan, S
   Vijayan, P
   Benelli, G
AF AlQahtani, Fatma Saeed
   AlShebly, Mashael Marzouq
   Govindarajan, Marimuthu
   Senthilmurugan, Sengamalai
   Vijayan, Periasamy
   Benelli, Giovanni
TI Green and facile biosynthesis of silver nanocomposites using the aqueous
   extract of Rubus ellipticus leaves: Toxicity and oviposition deterrent
   activity against Zika virus, malaria and filariasis mosquito vectors
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE St. Louis encephalitis; Green synthesis; Mosquito-bome diseases;
   Nanotechnology; West Nile virus
ID NONTARGET AQUATIC ORGANISMS; CULEX-QUINQUEFASCIATUS DIPTERA; LEAF
   EXTRACT; ANOPHELES-STEPHENSI; AEDES-AEGYPTI; VETERINARY IMPORTANCE;
   PREDATION EFFICIENCY; OVICIDAL ACTIVITY; NANOPARTICLES; CULICIDAE
AB Botanical-based nanosynthesis has been recently reported as a cheap alternative for mosquito management In this study, we investigated the synthesis of silver nanoparticles (AgNPs) using the leaf extract of Rubus ellipticus and AgNPs were characterized using UV-vis spectroscopy, XRD, FTIR, SEM, TEM and EDX analyses. The toxicity of R. ellipticus leaf extract and AgNPs was evaluated against eggs, larvae and adults of Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. Compared to the leaf aqueous extract, biosynthesized AgNPs showed higher toxicity against the mosquito larvae with LC50 values of 12.50, 13.83 and 15.09 mu g/mL, respectively. AgNPs exerted zero hatchability at 60, 75 and 90 mu g/mL on A. stephensi, A. aegypti, and C. quinquefasciatus, respectively. Concentrations of 12-60 mu g/mL reduced egg laying by gravid females from 72.28 to 91.48%. Maximum adulticidal efficacy was observed for AgNPs, with LD50 values were 21.10, 23.04 and 25.06 mu g/mL, respectively. AgNPs were found safer to non-target organisms Anisops bouvieri, Diplonychus indicus and Gambusia affinis, with LC50 values ranging from 896 to 2261 mu g/mL. Overall, R. ellipticus-fabricated AgNPs acted as effective toxic agents and ovideterrents against three important mosquitoes species, with little harmful effects on non-target aquatic species. (C) 2016 Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society. Published by Elsevier B.V. All rights reserved.
C1 [AlQahtani, Fatma Saeed] King Saud Univ, Dept Pathol, Coll Med, Hematol Unit, Riyadh, Saudi Arabia.
   [AlQahtani, Fatma Saeed; AlShebly, Mashael Marzouq] King Saud Univ Med City, Riyadh, Saudi Arabia.
   [AlShebly, Mashael Marzouq] King Saud Univ, Coll Med, Dept Obstet & Gynecol, Riyadh, Saudi Arabia.
   [Govindarajan, Marimuthu; Senthilmurugan, Sengamalai; Vijayan, Periasamy] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI Benelli, Giovanni/0000-0001-8971-6010; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931
CR Benelli G, 2016, J CLUST SCI
   Benelli G., 2016, ENZYME MICROB TECHNO
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, PARASITOL RES MG, V8, P155, DOI 10.1007/978-3-319-25292-6_8
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Campolo O., 2015, J EC ENTOMOL
   DAVIS EE, 1994, J AM MOSQUITO CONTR, V10, P316
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D.T., 1971, PROBIT ANAL
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   Govindarajan M, 2011, EUR REV MED PHARMACO, V15, P787
   Govindarajan M, 2011, PARASITOL RES, V109, P353, DOI 10.1007/s00436-011-2263-1
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, PARASITOL RES MG, V8, P99, DOI 10.1007/978-3-319-25292-6_7
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Khan IA, 2004, ETHANOMEDICINE HUMAN, V3
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Nair PMG, 2011, AQUAT TOXICOL, V101, P31, DOI 10.1016/j.aquatox.2010.08.013
   Nathan S. S., 2006, ECOTOX ENVIRON SAFE, V64, P82
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017
   Rajkumar S, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.15
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Shankar SS, 2004, APPL NANOSCI, V1, P69, DOI DOI 10.1088/0957-4484/18/10/105104
   Siddiqui BS, 2000, PHYTOCHEMISTRY, V53, P371, DOI 10.1016/S0031-9422(99)00548-8
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Subramaniam J, 2017, J CLUST SCI, V28, P413, DOI 10.1007/s10876-016-1113-9
   Vadivelan R., 2009, Journal of Natural Remedies, V9, P74
   Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vijayakumar M, 2013, IND CROP PROD, V41, P235, DOI 10.1016/j.indcrop.2012.04.017
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   World Health Organization, 1981, WHOVBC81807
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
   Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031
NR 53
TC 14
Z9 14
U1 0
U2 9
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
EI 1876-7990
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD MAR
PY 2017
VL 20
IS 1
BP 157
EP 164
DI 10.1016/j.aspen.2016.12.004
PG 8
WC Entomology
SC Entomology
GA EU3UK
UT WOS:000400956300022
DA 2020-07-08
ER

PT J
AU Robinson, JL
AF Robinson, Joan L.
TI Zika virus: What does a physician caring for children in Canada need to
   know?
SO PAEDIATRICS & CHILD HEALTH
LA English
DT Article
DE Congenital infection; Microcephaly; Teratogen; Zika virus
ID INFECTION; BRAZIL
AB Zika virus (ZIKV) was recently recognized to be teratogenic. The diagnosis of congenital ZIKV syndrome should be considered in children with unexplained microcephaly, intracranial calcifications, ventriculomegaly or major structural central nervous system abnormalities. Management is evolving but suggestions are provided for children with findings compatible with congenital infection and for those born to women with potential exposure during pregnancy.
C1 [Robinson, Joan L.] Canadian Paediat Soc, Infect Dis & Immunizat Comm, Ottawa, ON, Canada.
RP Robinson, JL (corresponding author), Canadian Paediat Soc, 100-2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada.
EM info@cps.ca
RI ROBINSON, JOAN/J-3349-2019
OI ROBINSON, JOAN/0000-0001-9831-5681
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barzon L., 2016, EURO SURVEILL, V21
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 29
TC 1
Z9 1
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1205-7088
EI 1918-1485
J9 PAED CHILD HEALT-CAN
JI Paediatr. Child Health
PD MAR 1
PY 2017
VL 22
IS 1
BP 48
EP 51
DI 10.1093/pch/pxx012
PG 4
WC Pediatrics
SC Pediatrics
GA EV0OR
UT WOS:000401441000016
PM 29480900
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Sanchez-Herrera, AR
   Hernandez, H
   Hernandez-Iriarte, J
   Diaz-Ricardo, K
   Castellanos, J
   Villamil-Macareno, WD
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Rosendo Sanchez-Herrera, Alvaro
   Hernandez, Hugo
   Hernandez-Iriarte, Jayder
   Diaz-Ricardo, Kelly
   Castellanos, Jaime
   de Jess Villamil-Macareno, Wilmer
   Rodriguez-Morales, Alfonso J.
TI Guillain-Barre syndrome during the Zika virus outbreak in Sucre,
   Colombia, 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
ID DIAGNOSIS; HEALTH
C1 [Villamil-Gomez, Wilmer E.; Hernandez-Iriarte, Jayder; Diaz-Ricardo, Kelly; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika & Other Arbovir, Pereira, Risaralda, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Panamer Assoc Infect Dis API, Comm Travel Med, Quito, Ecuador.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol ACIN, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Rosendo Sanchez-Herrera, Alvaro] Clin Santa Maria, Intens Care Unit, Sincelejo, Sucre, Colombia.
   [Hernandez, Hugo] Clin Santa Maria, Sci Direct, Sincelejo, Sucre, Colombia.
   [Castellanos, Jaime] Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
   [de Jess Villamil-Macareno, Wilmer] Univ Bosque, Semillero Invest, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Bldg 14,Carrera 27 10-02 Barrio Alamos, Pereira 660003, Risaralda, Colombia.
EM ajrodriguezmmd@gmail.com
RI Castellanos, Jaime/W-2635-2019; AJ, Rodriguez-Morales/R-9765-2016
OI Castellanos, Jaime/0000-0003-1596-8383; AJ,
   Rodriguez-Morales/0000-0001-9773-2192
FU CTO Colombia; Universidad Tecnologica de Pereira (UTP); Latin American
   Society for Travel Medicine (SLAMVI); Pan-American Association of
   Infectious Diseases (API)
FX Presentation of this study at the IV Latin American Congress of Travel
   Medicine (Sociedad Latinoamericana de Medicina del Viajero, SLAMVI),
   Buenos Aires, Argentina, October 6-7, 2016, was funded by CTO Colombia
   (airticket for Dr. Rodriguez-Morales), Universidad Tecnologica de
   Pereira (UTP), the Latin American Society for Travel Medicine (SLAMVI)
   (registration fees and hotel for Drs. Rodriguez-Morales and
   Villamil-Gomez) and the Pan-American Association of Infectious Diseases
   (API) (airticket for Dr. Villamil-Gomez).
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Pinto-Diaz CA, 2017, AUTOIMMUN REV
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodríguez-Morales Alfonso J., 2016, Infect., V20, P59, DOI 10.1016/j.infect.2016.02.001
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
NR 7
TC 11
Z9 11
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAR-APR
PY 2017
VL 16
BP 62
EP 63
DI 10.1016/j.tmaid.2017.03.012
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EU6DW
UT WOS:000401125200014
PM 28347781
DA 2020-07-08
ER

PT J
AU Widman, DG
   Young, E
   Yount, BL
   Plante, KS
   Gallichotte, EN
   Carbaugh, DL
   Peck, KM
   Plante, J
   Swanstrom, J
   Heise, MT
   Lazear, HM
   Baric, RS
AF Widman, Douglas G.
   Young, Ellen
   Yount, Boyd L.
   Plante, Kenneth S.
   Gallichotte, Emily N.
   Carbaugh, Derek L.
   Peck, Kayla M.
   Plante, Jessica
   Swanstrom, Jesica
   Heise, Mark T.
   Lazear, Helen M.
   Baric, Ralph S.
TI A Reverse Genetics Platform That Spans the Zika Virus Family Tree
SO MBIO
LA English
DT Article
ID WEST-NILE-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS; ENVELOPE PROTEIN
   GLYCOSYLATION; LENGTH INFECTIOUS CDNA; FRENCH-POLYNESIA; STRAIN;
   TRANSMISSION; OUTBREAK; BRAZIL; PATHOGENESIS
AB Zika virus (ZIKV), a mosquito-borne flavivirus discovered in 1947, has only recently caused large outbreaks and emerged as a significant human pathogen. In 2015, ZIKV was detected in Brazil, and the resulting epidemic has spread throughout the Western Hemisphere. Severe complications from ZIKV infection include neurological disorders such as Guillain-Barre syndrome in adults and a variety of fetal abnormalities, including microcephaly, blindness, placental insufficiency, and fetal demise. There is an urgent need for tools and reagents to study the pathogenesis of epidemic ZIKV and for testing vaccines and antivirals. Using a reverse genetics platform, we generated six ZIKV infectious clones and derivative viruses representing diverse temporal and geographic origins. These include three versions of MR766, the prototype 1947 strain (with and without a glycosylation site in the envelope protein), and H/PF/2013, a 2013 human isolate from French Polynesia representative of the virus introduced to Brazil. In the course of synthesizing a clone of a circulating Brazilian strain, phylogenetic studies identified two distinct ZIKV clades in Brazil. We reconstructed viable clones of strains SPH2015 and BeH819015, representing ancestral members of each clade. We assessed recombinant virus replication, binding to monoclonal antibodies, and virulence in mice. This panel of molecular clones and recombinant virus isolates will enable targeted studies of viral determinants of pathogenesis, adaptation, and evolution, as well as the rational attenuation of contemporary outbreak strains to facilitate the design of vaccines and therapeutics.
   IMPORTANCE Viral emergence is a poorly understood process as evidenced by the sudden emergence of Zika virus in Latin America and the Caribbean. Malleable reagents that both predate and span an expanding epidemic are key to understanding the virologic determinants that regulate pathogenesis and transmission. We have generated representative cDNA molecular clones and recombinant viruses that span the known ZIKV family tree, including early Brazilian isolates. Recombinant viruses replicated efficiently in cell culture and were pathogenic in immunodeficient mice, providing a genetic platform for rational vaccine and therapeutic design.
C1 [Widman, Douglas G.; Young, Ellen; Yount, Boyd L.; Plante, Jessica; Swanstrom, Jesica; Baric, Ralph S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Gallichotte, Emily N.; Carbaugh, Derek L.; Heise, Mark T.; Lazear, Helen M.; Baric, Ralph S.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Plante, Kenneth S.; Heise, Mark T.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA.
   [Peck, Kayla M.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA.
RP Baric, RS (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.; Baric, RS (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM rbaric@email.unc.edu
OI Peck, Kayla/0000-0001-7745-6995; Plante, Jessica/0000-0002-4768-7458;
   Widman, Douglas/0000-0002-3585-6373
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI 107810, AI 109761, R01 AI 107731,
   U19 AI 100625]; Lineberger Comprehensive Cancer Center;  [AI 100625]; 
   [T32 AI 007151-36A1]
FX This work was funded by NIH grants AI 107810 (R.S.B.), AI 109761
   (R.S.B.), R01 AI 107731 (de Silva), and U19 AI 100625 (R.S.B./M.T.H.),
   as well as startup funds from the Lineberger Comprehensive Cancer Center
   (D.L.C. and H.M.L.). K.S.P. was funded by AI 100625 and T32 AI
   007151-36A1.
CR Baronti C, 2014, GENOME ANNOUNC, V2
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MANDL CW, 1991, BIOTECHNIQUES, V10, P484
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICE C M, 1989, New Biologist, V1, P285
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EURO SURVEILL, P21
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Xue KS, 2016, ELIFE, V5, DOI 10.7554/eLife.13974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100
   Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 56
TC 37
Z9 37
U1 5
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2017
VL 8
IS 2
AR e02014-16
DI 10.1128/mBio.02014-16
PG 15
WC Microbiology
SC Microbiology
GA ET8TW
UT WOS:000400575700064
PM 28270583
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, SR
   Liu, YX
AF Chen, Su-Ren
   Liu, Yi-Xun
TI Focuses on the impact of Zika virus infection on the male reproductive
   tract
SO NATIONAL SCIENCE REVIEW
LA English
DT Editorial Material
ID MICE
C1 [Chen, Su-Ren; Liu, Yi-Xun] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing, Peoples R China.
RP Chen, SR; Liu, YX (corresponding author), Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing, Peoples R China.
EM chensuren@ioz.ac.cn; liuyx@ioz.ac.cn
RI Chen, Su-Ren/S-1025-2017
OI Chen, Su-Ren/0000-0002-9337-5412
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Chen SR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.344
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
NR 4
TC 1
Z9 1
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2095-5138
EI 2053-714X
J9 NATL SCI REV
JI Natl. Sci. Rev.
PD MAR
PY 2017
VL 4
IS 2
BP 157
EP 157
DI 10.1093/nsr/nww096
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU1VX
UT WOS:000400815000003
OA Other Gold
DA 2020-07-08
ER

PT J
AU Nguyen, KK
   O'Brien, BE
   Steele, RW
AF Nguyen, Kerrie K.
   O'Brien, Brigid E.
   Steele, Russell W.
TI Zika Virus: The New Rubella Epidemic
SO CLINICAL PEDIATRICS
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; SEXUAL TRANSMISSION; UNITED-STATES; INFECTION;
   OUTBREAK; INFANTS; BRAZIL
C1 [Nguyen, Kerrie K.; O'Brien, Brigid E.; Steele, Russell W.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Nguyen, Kerrie K.; O'Brien, Brigid E.; Steele, Russell W.] Ochsner Childrens Hlth Ctr, New Orleans, LA USA.
   [Steele, Russell W.] Univ Queensland, Sch Med, New Orleans, LA USA.
RP Nguyen, KK (corresponding author), Tulane Univ, Dept Pediat, Sch Med, 1315 Jefferson Highway, New Orleans, LA 70121 USA.
EM knguye4@tulane.edu
CR [Anonymous], CAS COUNTS US
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, PREGN WOM AN LAB EV
   Centers for Disease Control and Prevention, CDC ISS TRAV GUID RE
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, 2016, CDC REC SUBS ZIK IGM
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Interim guidance for Zika virus testing of urine-United States, 2016, MMWR-MORBID MORTAL W, V2016, P65, DOI 10.15585/mmwr.mm6518e1
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riley L, PRACTICE ADVISORY UP
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   WHO, 2016, PREV SEX TRANSM ZIK
NR 30
TC 2
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0009-9228
EI 1938-2707
J9 CLIN PEDIATR
JI Clin. Pediatr.
PD MAR
PY 2017
VL 56
IS 3
BP 213
EP 216
DI 10.1177/0009922816677039
PG 4
WC Pediatrics
SC Pediatrics
GA ES7ON
UT WOS:000399739800001
PM 27872364
DA 2020-07-08
ER

PT J
AU Su, YF
   Wu, CH
   Lee, TF
AF Su, Yi-Feng
   Wu, Cheng-Hao
   Lee, Tsui-Feng
TI PUBLIC HEALTH EMERGENCY RESPONSE IN TAIWAN
SO HEALTH SECURITY
LA English
DT Article
DE Public health; Emergency Operation Center; International Health
   Regulations; Global Health Security Agenda; Joint External Evaluation
   tool
AB In recent years, growth of international travel and trade, as well as climate change, has resulted in the frequent emergence and reemergence of infectious diseases such as Ebola, Zika, and MERS. In 2016, Taiwan used the Joint External Evaluation (JEE) tool to evaluate its public health emergency response capacities and understand important areas for improvement. This article presents Taiwan's disaster and public health emergency response organizational structure, real-time integrated information, response processes, and command center structure. After reviewing the results of the JEE tool and drawing lessons from emergency response efforts in the United States, we provide 3 recommendations that may enhance Taiwan's public health emergency response capacities: establish common principles for disaster response regardless of which agency is in charge, standardize operation procedures, and perform regular training that includes nongovernmental organizations and a range of government departments.
C1 [Su, Yi-Feng; Wu, Cheng-Hao; Lee, Tsui-Feng] Taiwan Ctr Dis Control, Emergency Operat Ctr, 6 Linsen S Rd, Taipei 10050, Taiwan.
RP Su, YF (corresponding author), Taiwan Ctr Dis Control, Emergency Operat Ctr, 6 Linsen S Rd, Taipei 10050, Taiwan.
EM Evonne-Su@cdc.gov.tw
CR Centers for Disease Control Department of Health R. O. C (Taiwan), 2015, GUID NAT DIS EM RESP
   Dilley M, 2005, DISAST RISK MANAGE, P1
   Hsiao CS, 2016, EPIDEMIOLOGY B, V32, P52
   Hsu YC, 2015, J MED HLTH, V4, P17
   Katz R, 2014, BIOSECUR BIOTERROR, V12, P231, DOI 10.1089/bsp.2014.0038
   Tso YE, 2007, EMERGENCY MANAGEMENT
   UPMC Center for Health Security, 2016, IHR JOINT EXT EV TAI
   US Dep. Homel. Secur, 2013, NAT RESP FRAM
   Walsh DW, 2010, NATL INCIDENT MANAGE
NR 9
TC 1
Z9 1
U1 7
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD MAR-APR
PY 2017
VL 15
IS 2
BP 137
EP 143
DI 10.1089/hs.2016.0108
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES6SI
UT WOS:000399679300003
PM 28418737
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Jian, SW
   Chen, CM
   Lee, CY
   Liu, DP
AF Jian, Shu-Wan
   Chen, Chiu-Mei
   Lee, Cheng-Yi
   Liu, Ding-Ping
TI REAL-TIME SURVEILLANCE OF INFECTIOUS DISEASES: TAIWAN'S EXPERIENCE
SO HEALTH SECURITY
LA English
DT Article
DE Surveillance; Infectious diseases
ID GUILLAIN-BARRE-SYNDROME
AB Integration of multiple surveillance systems advances early warning and supports better decision making during infectious disease events. Taiwan has a comprehensive network of laboratory, epidemiologic, and early warning surveillance systems with nationwide representation. Hospitals and clinical laboratories have deployed automatic reporting mechanisms since 2014 and have effectively improved timeliness of infectious disease and laboratory data reporting. In June 2016, the capacity of real-time surveillance in Taiwan was externally assessed and was found to have a demonstrated and sustainable capability. We describe Taiwan's disease surveillance system and use surveillance efforts for influenza and Zika virus as examples of surveillance capability. Timely and integrated influenza information showed a higher level and extended pattern of influenza activity during the 2015-16 season, which ensured prompt information dissemination and the coordination of response operations. Taiwan also has well-developed disease detection systems and was the first country to report imported cases of Zika virus from Miami Beach and Singapore. This illustrates a high level of awareness and willingness among health workers to report emerging infectious diseases, and highlights the robust and sensitive nature of Taiwan's surveillance system. These 2 examples demonstrate the flexibility of the surveillance systems in Taiwan to adapt to emerging infectious diseases and major communicable diseases. Through participation in the GHSA, Taiwan can more actively collaborate with national counterparts and use its expertise to strengthen global and regional surveillance capacity in the Asia Pacific and in Southeast Asia, in order to advance a world safe and secure from infectious disease.
C1 [Jian, Shu-Wan; Chen, Chiu-Mei; Lee, Cheng-Yi; Liu, Ding-Ping] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.
RP Liu, DP (corresponding author), Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.
EM dpliu@cdc.gov.tw
CR Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4
   Benedetti MD, 2015, NEUROEPIDEMIOLOGY, V45, P90, DOI 10.1159/000438752
   Centers for Disease Control R. O. C. (Taiwan), 2015, APPL US CLOUD COMP C
   Choffnes Eileen, 2010, INFECT DIS MOVEMENT
   Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120
   Hauck LJ, 2008, J NEUROL NEUROSUR PS, V79, P318, DOI 10.1136/jnnp.2007.118810
   Hu YP, 2016, J TAIWAN ASS MED INF, V25, P23
   Jian SW, 2016, TAIWAN EPIDEMIOL B, V32, P225
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lai SK, 2010, TAIWAN EPIDEMIOLOGY, V26, P251
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   MCLEAN M, 1994, EPIDEMIOLOGY, V5, P443, DOI 10.1097/00001648-199407000-00011
   US Centers for Disease Control and Prevention, 2016, ZIK GUILL BARR SYNDR
   WHO, 2016, ZIK VIR OUTBR GLOB R
   World Health Organization, 2016, ZIK SIT REP
   Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18
   Wu WJ, 2009, TAIWAN EPIDEMIOL B, V25, P727
NR 17
TC 7
Z9 7
U1 3
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD MAR-APR
PY 2017
VL 15
IS 2
BP 144
EP 153
DI 10.1089/hs.2016.0107
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES6SI
UT WOS:000399679300004
PM 28418738
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ho, LL
   Tsai, YH
   Lee, WP
   Liao, ST
   Wu, LG
   Wu, YC
AF Ho, Li-Li
   Tsai, Yu-Hui
   Lee, Wang-Ping
   Liao, Szu-Tsai
   Wu, Li-Gin
   Wu, Yi-Chun
TI Taiwan's Travel and Border Health Measures in Response to Zika
SO HEALTH SECURITY
LA English
DT Article
DE Border health; Zika; Entry screening; Travel health; Fever screening;
   Surveillance
AB Zika virus has recently emerged as a worldwide public health concern. Travel and border health measures stand as one of the main strategies and frontline defenses in responding to international epidemics. As of October 31, 2016, Taiwan has reported 13 imported cases, 5 of which were detected through routine entry screening and active monitoring at international airports. This article shares Taiwan's disease surveillance activities at designated points of entry and travel and border health measures in response to Zika. The Taiwan government collaborates with its tourism industry to disseminate information about precautionary measures and encourages tour guides to report suspected individuals or events to activate early response measures. Taiwan also engages in vector control activities at points of entry, including targeting aircraft from countries where vector-borne diseases are endemic, implementing mosquito sweep measures, and collecting vector surveillance data. In future emerging and reemerging disease events, entry surveillance at designated points of entry may enable early detection of diseases of international origin and more rapid activation of public health preparedness activities and international collaboration. Taiwan will continue to maximize border and travel health measures in compliance with IHR (2005) requirements, which rely on continued risk assessment, practical implementation activities, and engagement with all stakeholders.
C1 [Ho, Li-Li; Tsai, Yu-Hui; Lee, Wang-Ping; Liao, Szu-Tsai; Wu, Li-Gin; Wu, Yi-Chun] Minist Hlth & Welf, Ctr Dis Control, Div Quarantine, Taipei, Taiwan.
RP Wu, YC (corresponding author), Taiwan CDC, Div Quarantine, 6 Linsen S Rd, Taipei, Taiwan.
EM wuyj@cdc.gov.tw
CR Chiu HH, 2014, BIOSECUR BIOTERROR, V12, P346, DOI 10.1089/bsp.2014.0016
   Chiu HH, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24516
   Cohen NJ, 2016, MMWR-MORBID MORTAL W, V65, P57, DOI 10.15585/mmwr.su6503a9
   Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82
   Hale MJ, 2012, EMERG INFECT DIS, V18, P866, DOI 10.3201/eid1805.111080
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   International Civil Aviation Organization, 2016, ASS REP AG IT OCT 31
   Jordaan A, 2016, 5 PAN EUR M ICAO COL
   National Business Aviation Association, 2016, SOM COUNTR REQ MOSQ
   Nuzzo JB, 2014, BIOSECUR BIOTERROR, V12, P306, DOI 10.1089/bsp.2014.1030
   Selvey LA, 2015, EMERG INFECT DIS, V21, P197, DOI 10.3201/eid2102.131610
   Shu PY, 2008, EMERG INFECT DIS, V14, P1325, DOI 10.3201/eid1408.071304
   Taiwan Centers for Disease Control, 2016, REP ASS VIS DES POE
   Taiwan Centers for Disease Control, 2016, IHR JEE REP TAIW
   WHO, 2016, AIRCR DIS MOSQ CONTR
   WHO (World Health Organization), 2016, VECT SURV CONTR PORT
   Wiwanitkit S, 2016, J FORMOS MED ASSOC, V115, P822, DOI 10.1016/j.jfma.2016.06.003
   World Health Organization, 2015, HDB MAN PUBL HLTH EV
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2015, IHR COR CAP IMPL STA
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2009, ASS TOOL COR CAP REQ
   Wu HH, 2014, TAIWAN EPI B, V3, P174
NR 23
TC 8
Z9 8
U1 2
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD MAR-APR
PY 2017
VL 15
IS 2
BP 185
EP 191
DI 10.1089/hs.2016.0106
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES6SI
UT WOS:000399679300009
PM 28418744
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Danish, SH
   Reza, Z
   Sohail, AA
AF Danish, Syed Hasan
   Reza, Zawwar
   Sohail, Abdul Ahad
TI Case reports and their importance in Medical Literature
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Review
DE Case reports; medical literature; importance
ID CLINICAL CASE-REPORT; IMPACT; CARE
AB It is important to appreciate how case reports have paved the way for modern research. They are still largely considered the first line of evidence. Indeed global endemics such as HIV and Zika Virus have been traced back to initial case reports. Strictly speaking; case reports are anecdotes - a factual story telling about nature's own experiment. Case reports can be characterized by two huge advantages, their ability to present novel, rare cases in a manner that can lead to the expansion in research of such cases and their use in generating new, innovative hypothesis that can be used to direct further research. The aim of this article is to identify the place and purpose of case reports in the current research setting with a focus on highlighting itsmerits and limitation amongst other things.
C1 [Danish, Syed Hasan] Ziauddin Med Univ, Dept Community Hlth Sci, Karachi, Pakistan.
   [Reza, Zawwar; Sohail, Abdul Ahad] Ziauddin Med Univ, Karachi, Pakistan.
RP Reza, Z (corresponding author), Ziauddin Med Univ, Karachi, Pakistan.
EM scoutzawwar@gmail.com
CR Baric H, 2013, CROAT MED J, V54, P507, DOI 10.3325/cmj.2013.54.507
   Florek Aleksandra G, 2016, J Med Case Rep, V10, P86, DOI 10.1186/s13256-016-0851-5
   Frank M, 2003, J MED LIBR ASSOC, V91, P4
   Gagnier JJ, 2013, HEADACHE, V53, P1541, DOI 10.1111/head.12246
   Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90
   Garg Rakesh, 2016, J Med Case Rep, V10, P88, DOI 10.1186/s13256-016-0853-3
   Gopikrishna Velayutham, 2010, J Conserv Dent, V13, P265, DOI 10.4103/0972-0707.73375
   JOKI T, 1962, Duodecim, V78, P822
   Kellett J, 2014, EUR J INTERN MED, V25, P583, DOI 10.1016/j.ejim.2014.07.006
   Ketterman EB, 2014, J MED LIBR ASSOC, V102, P137, DOI DOI 10.3163/1536-5050.102.2.023]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahajan RP, 2008, BRIT J ANAESTH, V100, P744, DOI 10.1093/bja/aen128
   Masic Izet, 2015, Acta Inform Med, V23, P4, DOI 10.5455/aim.2015.23.4-11
   Nissen T, 2014, JRSM OPEN, V5
   Nissen Trygve, 2014, BMC Res Notes, V7, P264, DOI 10.1186/1756-0500-7-264
   Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362
   Peh WCG, 2010, SINGAP MED J, V51, P10
   Pimlott N, 2014, CAN FAM PHYSICIAN, V60, P966
   Rison Richard A, 2016, J Med Case Rep, V10, P91, DOI 10.1186/s13256-016-0867-x
   Rison Richard A, 2016, J Med Case Rep, V10, P92, DOI 10.1186/s13256-016-0868-9
   Rison Richard A, 2013, J Med Case Rep, V7, P239, DOI 10.1186/1752-1947-7-239
   Rison Richard A, 2013, J Med Case Rep, V7, P261, DOI 10.1186/1752-1947-7-261
   Ruha AM, 2009, J MED TOXICOL, V5, P1, DOI 10.1007/BF03160972
   Ryan Terence J, 2014, Indian Dermatol Online J, V5, P113, DOI 10.4103/2229-5178.131062
   Schriger DL, 2006, ANN EMERG MED, V48, P743, DOI 10.1016/j.annemergmed.2006.03.028
   Sorinola Olanrewaju, 2004, BMC Med Educ, V4, P4, DOI 10.1186/1472-6920-4-4
   Talanow R, 2008, J RADIOL CASE REP, V2, P1, DOI 10.3941/jrcr.v2i2.38
   Tarcoveanu E, 2011, CHIRURGIA-BUCHAREST, V106, P581
   Tomaszewski C, 2006, J MED TOXICOL, V2, P139, DOI 10.1007/BF03161180
   Wyler von Ballmoos Moritz C, 2015, J Clin Med Res, V7, P428, DOI 10.14740/jocmr2115w
NR 30
TC 4
Z9 4
U1 0
U2 0
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD MAR
PY 2017
VL 67
IS 3
BP 451
EP 453
PG 3
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA ES0UI
UT WOS:000399242300024
PM 28303999
DA 2020-07-08
ER

PT J
AU Marques, AM
   Velozo, LS
   Carvalho, MA
   Serdeiro, MT
   Honorio, NA
   Kaplan, MAC
   Maleck, M
AF Marques, Andre M.
   Velozo, Leosvaldo S.
   Carvalho, Michelle A.
   Serdeiro, Michele T.
   Honorio, Nildimar A.
   Kaplan, Maria Auxiliadora C.
   Maleck, Marise
TI Larvicidal activity of Ottonia anisum metabolites against Aedes aegypti:
   A potential natural alternative source for mosquito vector control in
   Brazil
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Article
DE 1-butyl-3,4-methylenedioxybenzene; Aedes aegypti; dengue; larvicidal
   activity; Ottonia anisum; Piper
ID ROOTS; PIPER; TOXICITY; LIGNANS; PHYTOCHEMISTRY; GRANDISIN; EXTRACTS
AB Background & objectives: Aedes aegypti mosquito is the principal vector of the viruses responsible for urban yellow fever, dengue, dengue haemorrhagic fever, as well as Zika and chikungunya in Brazil. The present study was aimed to investigate the insecticidal potential of the extract and fractions of Ottonia anisum, along with special metabolites isolated from it, as natural alternatives against larvae (L3) of Ae. aegypti, vector of potentially deadly tropical infections in Brazil.
   Methods: The plant species O. anisum was collected in March 2015, at Xerem area, in Rio de Janeiro City, Brazil. Crude extracts and the isolated pure compounds were screened for toxicity against Ae. aegypti larvae (L3). Bioassays were performed on 20 larvae (L3) of Ae. aegypti in triplicate. The samples were dissolved in a mixture of acetone and DMSO at final concentrations of 1-200 mu g/ml. The toxicity of the solutions was evaluated towards the growth and development of Ae. aegypti larvae till emergence of adults.
   Results: The crude hexane extract showed 100% larval mortality 24 h after treatment at a concentration of 200 mu g/ml. The bioassays using 1-butyl-3,4-methylenedioxybenzene revealed 100% mortality among L3 larvae, 24 h after the treatment at a concentration of 30 mu g/ml, the LC50 recorded was 1.6 mu g/ml. At concentration of 10 mu g/ml, the L3 larval mortality recorded was 92%.
   Interpretation & conclusion: The metabolite 1-butyl-3,4-methylenedioxybenzene showed potent toxicity against Ae. aegypti larvae. This arylbutanoid agent could be used as a natural alternative adjuvant pesticide, in new compositions that would be environmentally safer.
C1 [Marques, Andre M.; Velozo, Leosvaldo S.; Kaplan, Maria Auxiliadora C.] Univ Fed Rio de Janeiro, Hlth Sci Ctr, Walter Mors Inst Res Nat Prod IPPN, Rio De Janeiro, Brazil.
   [Carvalho, Michelle A.; Serdeiro, Michele T.; Maleck, Marise] Univ Severino Sombra, Vector Insect Lab, Av Expedicionario Oswaldo Almeida Ramos, Rio De Janeiro, Brazil.
   [Serdeiro, Michele T.] Fiocruz MS, Inst Oswaldo Cruz, Interdisciplinary Lab Entomol Surveillance Dipter, Rio De Janeiro, Brazil.
   [Honorio, Nildimar A.] Fiocruz MS, Inst Oswaldo Cruz, Sentinel Operat Ctr Vector Mosquitoes, Rio De Janeiro, Brazil.
   [Honorio, Nildimar A.] Fiocruz MS, Inst Oswaldo Cruz, Hematozoa Transmis Mosquitoes Lab LATHEMA, Rio De Janeiro, Brazil.
   [Maleck, Marise] Univ Severino Sombra, Environm Sci, Av Expedicionario Oswaldo Almeida Ramos, Vassouras, Brazil.
   [Maleck, Marise] Univ Severino Sombra, Hlth Sci, Av Expedicionario Oswaldo Almeida Ramos, Vassouras, Brazil.
   [Maleck, Marise] Fiocruz MS, Inst Oswaldo Cruz, Lab Entomol Med & Forense, Rio De Janeiro, Brazil.
RP Marques, AM (corresponding author), Univ Fed Rio de Janeiro, Hlth Sci Ctr, Walter Mors Inst Res Nat Prod IPPN, Rio De Janeiro, Brazil.; Marques, AM (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Pesquisas Prod Nat Walter Mors IPPN, Bloco H,1 Andar, BR-21941590 Rio De Janeiro, Brazil.
EM andrefarmaciarj@yahoo.com.br
RI Marques, Andre M/I-5898-2018
OI Marques, Andre M/0000-0001-5444-5724
FU CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX The authors wish to thank to CAPES, FAPERJ and CNPq for financially
   supporting the study.
CR Narciso JOA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-172
   [Anonymous], 2017, EM PREP RESP YELL FE
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Cabral MMO, 2009, J AM MOSQUITO CONTR, V25, P103, DOI 10.2987/08-5828.1
   Colvard MD, 2006, J ETHNOPHARMACOL, V107, P134, DOI 10.1016/j.jep.2006.04.005
   de Almeida RRP, 2009, CHEM BIODIVERS, V6, P1427, DOI 10.1002/cbdv.200800212
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   do Nascimento JC, 2013, PEST MANAG SCI, V69, P1267, DOI 10.1002/ps.3495
   Garcez WS, 2013, REV VIRTUAL QUIM, V5, P363, DOI 10.5935/1984-6835.20130034
   Gyawali N, 2016, J VECTOR DIS, V53, P293
   HAMILTON MA, 1978, ENVIRON SCI TECHNOL, V12, P417, DOI 10.1021/es60140a017
   Harmatha J, 2002, ENTOMOL EXP APPL, V104, P51, DOI 10.1023/A:1021286002077
   Hernandez-Lambrano R, 2015, J STORED PROD RES, V62, P81, DOI 10.1016/j.jspr.2015.04.004
   Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x
   Lee Hoi-Seon, 2005, Journal of Applied Biological Chemistry, V48, P65
   Leitao F, 2014, REV BRAS FARMACOGN, V24, P225, DOI 10.1016/j.bjp.2014.04.005
   Leite ACCF, 2012, REV BRAS FARMACOGN, V22, P517, DOI 10.1590/S0102-695X2012005000016
   Lopez KSE, 2016, AN ACAD BRAS CIENC, V88, P2229, DOI 10.1590/0001-3765201620150821
   Maleck M, 2017, J MED ENTOMOL, V54, P159, DOI 10.1093/jme/tjw130
   Maleck M, 2014, J MED ENTOMOL, V51, P458, DOI 10.1603/ME13069
   Herrera JM, 2015, IND CROP PROD, V70, P435, DOI 10.1016/j.indcrop.2015.03.074
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Marques André M, 2015, Univ. Sci., V20, P61, DOI 10.11144/Javeriana.SC20-1.amgp
   Marques AM, 2011, NAT PROD COMMUN, V6, P939
   Marques AM, 2008, REV BRAS FARMACOGN, V18, P709, DOI 10.1590/S0102-695X2008000500013
   Moreira D. L., 1997, Journal of Essential Oil Research, V9, P565
   Motulsky H. J., 2002, ANAL DATA GRAPHPAD P
   Murray M, 2012, J TOXICOL ENV HEAL B, V15, P365, DOI 10.1080/10937404.2012.705105
   Navickiene HMD, 2007, PEST MANAG SCI, V63, P399, DOI 10.1002/ps.1340
   PAHO, 2016, ZIK EP REP BRAZ
   Park IK, 2005, J AGR FOOD CHEM, V53, P969, DOI 10.1021/jf048208h
   Parmar VS, 1997, PHYTOCHEMISTRY, V46, P597, DOI 10.1016/S0031-9422(97)00328-2
   Scott Ian M., 2008, Phytochemistry Reviews, V7, P65, DOI 10.1007/s11101-006-9058-5
   Sokal R.R., 1979, BIOMETRIA PRINCIPIOS, P832
   Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106
NR 35
TC 3
Z9 3
U1 0
U2 19
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD MAR
PY 2017
VL 54
IS 1
BP 61
EP 68
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA ES0IM
UT WOS:000399210000008
PM 28352047
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Halabi, J
   Esakky, P
   Scheaffer, S
   Drury, A
   Diamond, MS
   Moley, KH
AF Halabi, Jacques
   Esakky, Prabagaran
   Scheaffer, Suzanne
   Drury, Andrea
   Diamond, Michael S.
   Moley, Kelle H.
TI Zika Virus Infection Damages the Testes in Mice.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 64th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 15-18, 2017
CL Orlando, FL
SP Soc Reprod Invest
C1 [Halabi, Jacques; Esakky, Prabagaran; Scheaffer, Suzanne; Drury, Andrea; Diamond, Michael S.; Moley, Kelle H.] Washington Univ, Sch Med, St Louis, MO USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2017
VL 24
SU 1
MA O-098
BP 85A
EP 85A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA ER8CL
UT WOS:000399043900099
DA 2020-07-08
ER

PT J
AU Panina-Bordignon, P
   Pagani, I
   Ghezzi, S
   Ulisse, A
   Rubio, A
   Garavaglia, E
   Ippolito, G
   Poli, G
   Vicenzi, E
AF Panina-Bordignon, Paola
   Pagani, Isabel
   Ghezzi, Silvia
   Ulisse, Adele
   Rubio, Alicia
   Garavaglia, Elisabetta
   Ippolito, Giuseppe
   Poli, Guido
   Vicenzi, Elisa
TI Zika Virus Infects Human Endometrial Stromal Cells.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 64th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 15-18, 2017
CL Orlando, FL
SP Soc Reprod Invest
C1 [Panina-Bordignon, Paola; Pagani, Isabel; Ghezzi, Silvia; Ulisse, Adele; Rubio, Alicia; Garavaglia, Elisabetta; Poli, Guido; Vicenzi, Elisa] San Raffaele, Milan, Italy.
   Spallanzani, Rome, Italy.
RI Panina, Paola/AAO-4563-2020; Ippolito, Giuseppe/J-7207-2017; Vicenzi,
   Elisa/AAL-3980-2020; Poli, Guido/AAL-4161-2020; ghezzi,
   silvia/AAN-4092-2020
OI Poli, Guido/0000-0001-7241-4526; 
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2017
VL 24
SU 1
MA O-097
BP 85A
EP 85A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA ER8CL
UT WOS:000399043900098
DA 2020-07-08
ER

PT J
AU Grigsby, PL
   Roberts, VH
   Hirsch, AJ
   Schabel, MC
   Kroenke, CD
   Lo, JO
   Wang, XJ
   Liu, Z
   Smith, J
   Haese, N
   Kelleher, M
   Broeckel, R
   Kreklywich, CN
   Parkins, CJ
   Smith, P
   DeFillppis, V
   Messer, W
   Nelson, JA
   Hennebold, JD
   Grafe, M
   Colgin, L
   Lewis, A
   MacAllister, R
   Morgan, TK
   Frias, AE
   Streblow, DN
AF Grigsby, Peta L.
   Roberts, Victoria H.
   Hirsch, Alec J.
   Schabel, Matthias C.
   Kroenke, Chris D.
   Lo, Jamie O.
   Wang, Xiaojie
   Liu, Zheng
   Smith, Jessica
   Haese, Nicole
   Kelleher, Meredith
   Broeckel, Rebecca
   Kreklywich, Craig N.
   Parkins, Christopher J.
   Smith, Patricia
   DeFillppis, Victor
   Messer, William
   Nelson, Jay A.
   Hennebold, Jon D.
   Grafe, Marjorie
   Colgin, Lois
   Lewis, Anne
   MacAllister, Rhonda
   Morgan, Terry K.
   Frias, Antonio E.
   Streblow, Daniel N.
TI Zika Infection in Pregnant Rhesus Macaques Results in Placental Injury
   and Altered Brain Development Independent of Microcephaly.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 64th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 15-18, 2017
CL Orlando, FL
SP Soc Reprod Invest
C1 [Grigsby, Peta L.; Roberts, Victoria H.; Hirsch, Alec J.; Smith, Jessica; Haese, Nicole; Kelleher, Meredith; Broeckel, Rebecca; Kreklywich, Craig N.; Parkins, Christopher J.; Smith, Patricia; DeFillppis, Victor; Nelson, Jay A.; Hennebold, Jon D.; Colgin, Lois; Lewis, Anne; MacAllister, Rhonda; Streblow, Daniel N.] Oregon Natl Primate Res Ctr, Portland, OR USA.
   [Schabel, Matthias C.; Kroenke, Chris D.; Lo, Jamie O.; Wang, Xiaojie; Liu, Zheng; Messer, William; Grafe, Marjorie; Morgan, Terry K.; Frias, Antonio E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
RI Schabel, Matthias C./H-4647-2019; Haese, Nicole/AAN-4551-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2017
VL 24
SU 1
MA O-100
BP 86A
EP 86A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA ER8CL
UT WOS:000399043900101
DA 2020-07-08
ER

PT J
AU Cadot, L
   Segondy, M
   Foulongne, V
AF Cadot, L.
   Segondy, M.
   Foulongne, V.
TI Laboratory surveillance of arboviral infections in a southern France
   region colonized by Aedes albopictus
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Arboviruses; chikungunya virus; dengue virus; surveillance; Zika virus
ID DENGUE; VIRUS
AB The establishment of Aedes albopictus in southern France, a recognized competent vector for several arboviruses, represents a new threat for the local transmission and spread of what were until recently considered as tropical diseases. A preparedness and response plan, based on vigilance of both clinicians and laboratories, has introduced significant changes in guidelines and behaviour regarding patients' care specifically during the activity period of mosquitoes. In the present study, we report the results of a 1-year activity in arboviral infection diagnosis. A total of 141 patients were included in this retrospective study. The number of suspected imported and autochthonous cases was 69 and 72, respectively. A diagnosis of arboviral infection was confirmed for 15 (21.7%) suspected imported cases, with identification of 13 dengue viruses, one chikungunya virus and one Zika virus. No autochthonous cases were detected. This report illustrates the increase in requests for arboviral infection diagnosis and confirms the challenge with identifying autochthonous arboviral infection cases in many unspecific febrile syndromes.
C1 [Cadot, L.; Segondy, M.; Foulongne, V.] Univ Montpellier, Pathogenesis & Control Chron Infect, Virol Lab, Montpellier Univ Hosp,INSERM U1058, Montpellier, France.
RP Foulongne, V (corresponding author), Montpellier Univ Hosp, Virol Lab, 80 Ave A Fliche, F-34295 Montpellier 5, France.
EM v-foulongne@chu-montpellier.fr
CR de Kleijn EMH, 1997, MEDICINE, V76, P392, DOI 10.1097/00005792-199711000-00002
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Ministry of Social Affairs Health and Women's Rights, 2015, DGSRI12015125 MIN SO
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
NR 13
TC 0
Z9 0
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAR
PY 2017
VL 145
IS 4
BP 710
EP 714
DI 10.1017/S0950268816002818
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA ER7CW
UT WOS:000398968800009
PM 27903317
OA Bronze
DA 2020-07-08
ER

PT J
AU Buechler, CR
   Bailey, AL
   Weiler, AM
   Barry, GL
   Breitbach, ME
   Stewart, LM
   Jasinska, AJ
   Freimer, NB
   Apetrei, C
   Phillips-Conroy, JE
   Jolly, CJ
   Rogers, J
   Friedrich, TC
   O'Connor, DH
AF Buechler, Connor R.
   Bailey, Adam L.
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Breitbach, Meghan E.
   Stewart, Laurel M.
   Jasinska, Anna J.
   Freimer, Nelson B.
   Apetrei, Cristian
   Phillips-Conroy, Jane E.
   Jolly, Clifford J.
   Rogers, Jeffrey
   Friedrich, Thomas C.
   O'Connor, David H.
TI Seroprevalence of Zika Virus in Wild African Green Monkeys and Baboons
SO MSPHERE
LA English
DT Article
DE false-positive reactions; Flavivirus; sensitivity and specificity;
   seroepidemiologic studies; Zika virus; Zika virus infection
ID ARTERIVIRUSES
AB Zika virus (ZIKV) has recently spread through the Americas and has been associated with a range of health effects, including birth defects in children born to women infected during pregnancy. Although the natural reservoir of ZIKV remains poorly defined, the virus was first identified in a captive "sentinel" macaque monkey in Africa in 1947. However, the virus has not been reported in humans or nonhuman primates (NHPs) in Africa outside Gabon in over a decade. Here, we examine ZIKV infection in 239 wild baboons and African green monkeys from South Africa, the Gambia, Tanzania, and Zambia using combinations of unbiased deep sequencing, quantitative reverse transcription-PCR (qRT-PCR), and an antibody capture assay that we optimized using serum collected from captive macaque monkeys exposed to ZIKV, dengue virus, and yellow fever virus. While we did not find evidence of active ZIKV infection in wild NHPs in Africa, we found variable ZIKV seropositivity of up to 16% in some of the NHP populations sampled. We anticipate that these results and the methodology described within will help in continued efforts to determine the prevalence, natural reservoir, and transmission dynamics of ZIKV in Africa and elsewhere.
   IMPORTANCE Zika virus (ZIKV) is a mosquito-borne virus originally discovered in a captive monkey living in the Zika Forest of Uganda, Africa, in 1947. Recently, an outbreak in South America has shown that ZIKV infection can cause myriad health effects, including birth defects in the children of women infected during pregnancy. Here, we sought to investigate ZIKV infection in wild African primates to better understand its emergence and spread, looking for evidence of active or prior infection. Our results suggest that up to 16% of some populations of nonhuman primate were, at some point, exposed to ZIKV. We anticipate that this study will be useful for future studies that examine the spread of infections from wild animals to humans in general and those studying ZIKV in primates in particular.
C1 [Buechler, Connor R.; Bailey, Adam L.; Breitbach, Meghan E.; Stewart, Laurel M.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol, Madison, WI 53706 USA.
   [Buechler, Connor R.; Bailey, Adam L.; Weiler, Andrea M.; Barry, Gabrielle L.; Friedrich, Thomas C.; O'Connor, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
   [Jasinska, Anna J.; Freimer, Nelson B.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA.
   [Apetrei, Cristian] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Apetrei, Cristian] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA.
   [Phillips-Conroy, Jane E.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO USA.
   [Phillips-Conroy, Jane E.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.
   [Jolly, Clifford J.] NYU, Dept Anthropol, New York, NY 10003 USA.
   [Rogers, Jeffrey] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin Madison, Dept Pathol, Madison, WI 53706 USA.; O'Connor, DH (corresponding author), Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
EM dhoconno@wisc.edu
OI apetrei, cristian/0000-0002-0322-7185
FU Department of Health and Human Services/Public Health Service/National
   Institutes of Health [R01Al116382-01A1]; University of Wisconsin-Madison
   [P51OD011106]; Research Facilities Improvement ProgramUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [RR15459-01,
   RR020141-01]; National Science FoundationNational Science Foundation
   (NSF) [BNS83-03506]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01RR016300, R01OD010980]
FX We thank the Department of Health and Human Services/Public Health
   Service/National Institutes of Health (R01Al116382-01A1 to D.H. O'C.)
   for funding. We are also thankful for P51OD011106 awarded to the WNPRC,
   University of Wisconsin-Madison. This research was conducted in part at
   a facility constructed with support from the Research Facilities
   Improvement Program (grant no. RR15459-01 and RR020141-01). The
   collection of blood samples from Mikumi baboons was funded by National
   Science Foundation grant BNS83-03506 to J.E.P.-C. (Washington
   University). Vervet samples were collected through the UCLA Systems
   Biology Sample Repository funded by National Institutes of Health grants
   R01RR016300 and R01OD010980 to N.B.F. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bailey AL, 2016, J VIROL, V90, P6724, DOI 10.1128/JVI.00573-16
   Bailey AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3467
   Bailey AL, 2014, J VIROL, V88, P13231, DOI 10.1128/JVI.02203-14
   Bailey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090714
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauck M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-107
   Lauck M, 2013, J VIROL, V87, P688, DOI 10.1128/JVI.02433-12
   Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056
   Ma DZ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003011
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rogers J., 1989, THESIS
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 19
TC 21
Z9 21
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAR-APR
PY 2017
VL 2
IS 2
AR e00392-16
DI 10.1128/mSphere.00392-16
PG 7
WC Microbiology
SC Microbiology
GA ER9VH
UT WOS:000399174700027
PM 28289727
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Landry, MD
   Raman, SR
   Kennedy, K
   Bettger, JP
   Magnusson, D
AF Landry, Michel D.
   Raman, Sudha R.
   Kennedy, Kai
   Bettger, Janet Prvu
   Magnusson, Dawn
TI Zika Virus (ZIKV), Global Public Health, Disability, and Rehabilitation:
   Connecting the Dots...
SO PHYSICAL THERAPY
LA English
DT Editorial Material
ID CASE SERIES; BRAZIL; EPIDEMIOLOGY
C1 [Landry, Michel D.; Kennedy, Kai] Duke Univ, Phys Therapy Div, Dept Orthopaed Surg, DUMC 104002, Durham, NC 27710 USA.
   [Landry, Michel D.] Duke Univ, DGHI, DUMC 104002, Durham, NC 27710 USA.
   [Raman, Sudha R.] Duke Clin Res Inst, Ctr Pragmat Hlth Serv Res, Durham, NC USA.
   [Bettger, Janet Prvu] Duke Univ, Dept Orthopaed Surg, DGHI, Durham, NC 27706 USA.
   [Magnusson, Dawn] Univ Colorado, Phys Therapy Program, Anschutz Med Campus, Aurora, CO USA.
RP Landry, MD (corresponding author), Duke Univ, Phys Therapy Div, Dept Orthopaed Surg, DUMC 104002, Durham, NC 27710 USA.; Landry, MD (corresponding author), Duke Univ, DGHI, DUMC 104002, Durham, NC 27710 USA.
EM mike.landry@duke.edu
CR [Anonymous], 2016, STRAIGHTS TIMES 0901
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bricaire F, 2016, PRESSE MED, V45, P281, DOI 10.1016/j.lpm.2016.03.001
   Centers for Disease Control and Prevention, 2016, CAS COUNTS US
   Duffy MR, 2009, NEW ENGL J MED, V360, P315
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Landry Michel D, 2015, WHO South East Asia J Public Health, V4, P150, DOI 10.4103/2224-3151.206684
   Landry MD, 2015, AM J PUBLIC HEALTH, V105, P1515, DOI 10.2105/AJPH.2015.302809
   Lyon J, 2016, JAMA-J AM MED ASSOC, V316, P1246, DOI 10.1001/jama.2016.11054
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wilkan N, 2016, LANCET, V16
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, WHO DIR GEN BRIEFS E
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 4
Z9 4
U1 0
U2 3
PU AMER PHYSICAL THERAPY ASSOC
PI ALEXANDRIA
PA 1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA
SN 0031-9023
EI 1538-6724
J9 PHYS THER
JI Phys. Ther.
PD MAR
PY 2017
VL 97
IS 3
BP 275
EP 279
DI 10.2522/ptj.20160476
PG 5
WC Orthopedics; Rehabilitation
SC Orthopedics; Rehabilitation
GA ER5CV
UT WOS:000398819900002
PM 28204734
DA 2020-07-08
ER

PT J
AU Neto, DFD
   Lorenzon-Ojea, A
   Gomes, SZ
   Bandeira, C
   Zanotto, P
   Palmisano, G
   Bevilacqua, E
AF Ferreira de Lima Neto, D.
   Lorenzon-Ojea, A.
   Zago Gomes, S.
   Bandeira, C.
   Zanotto, P.
   Palmisano, G.
   Bevilacqua, E.
TI ZIKA VIRUS INFECTION IN HUMAN PLACENTAL CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the
   Latin-American-Society-for-Maternal-Fetal-Interaction-and-Placenta
   (SLIMP)
CY APR 11-13, 2017
CL Puerto Varas, CHILE
SP Latin Amer Soc Maternal Fetal Interact & Placenta
C1 [Ferreira de Lima Neto, D.; Lorenzon-Ojea, A.; Zago Gomes, S.; Bandeira, C.; Zanotto, P.; Palmisano, G.; Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, Brazil.
RI Lorenzon, Aline R/G-8733-2014; de A. Zanotto, Paolo M./B-9286-2019
OI Lorenzon, Aline R/0000-0002-6052-6296; de A. Zanotto, Paolo
   M./0000-0002-8167-0625
FU FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX Fapesp and CNPq.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAR
PY 2017
VL 51
BP 106
EP 106
DI 10.1016/j.placenta.2017.01.033
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA ER2SZ
UT WOS:000398645400038
DA 2020-07-08
ER

PT J
AU Ribeiro, MR
   Moreli, JB
   Marques, RE
   Papa, MP
   Meuren, LM
   Rahal, P
   Arruda, LB
   Oliani, AH
   Oliani, DCMV
   Oliani, SM
   Narayanan, A
   Nogueira, ML
AF Ribeiro, M. R.
   Moreli, J. B.
   Marques, R. E.
   Papa, M. P.
   Meuren, L. M.
   Rahal, P.
   Arruda, L. B.
   Oliani, A. H.
   Oliani, D. C. M. V.
   Oliani, S. M.
   Narayanan, A.
   Nogueira, M. L.
TI STUDY OF ZIKA VIRUS INFECTION IN HUMAN PLACENTA EXPLANTS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the
   Latin-American-Society-for-Maternal-Fetal-Interaction-and-Placenta
   (SLIMP)
CY APR 11-13, 2017
CL Puerto Varas, CHILE
SP Latin Amer Soc Maternal Fetal Interact & Placenta
C1 [Ribeiro, M. R.; Rahal, P.; Oliani, S. M.] Sao Paulo State Univ UNESP, Inst Biosci Letters & Exact Sci, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil.
   [Moreli, J. B.] Univ Fed Sao Paulo UNIFESP, Sao Paulo, SP, Brazil.
   [Marques, R. E.] Natl Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.
   [Papa, M. P.; Meuren, L. M.; Arruda, L. B.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [Narayanan, A.] George Mason Univ, Fairfax, VA 22030 USA.
   [Ribeiro, M. R.; Oliani, A. H.; Oliani, D. C. M. V.; Nogueira, M. L.] Fac Med Sao Jose do Rio Preto FAMERP, Lab Virol Res, Sao Jose Do Rio Preto, SP, Brazil.
RI OLIANI, ANTONIO/O-1673-2019; Nogueira, Mauricio L/B-7599-2012; Arruda,
   Luciana B/N-9086-2013; Marques, Rafael Elias/R-4890-2016
OI Nogueira, Mauricio L/0000-0003-1102-2419; Marques, Rafael
   Elias/0000-0002-6949-0947
NR 0
TC 0
Z9 0
U1 1
U2 7
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAR
PY 2017
VL 51
BP 119
EP 120
DI 10.1016/j.placenta.2017.01.074
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA ER2SZ
UT WOS:000398645400080
DA 2020-07-08
ER

PT J
AU Bradt, DL
   Bradley, KK
   Hoback, WW
   Noden, BH
AF Bradt, David L.
   Bradley, Kristy K.
   Hoback, W. Wyatt
   Noden, Bruce H.
TI NEW RECORDS OF AEDES AEGYPTI IN SOUTHERN OKLAHOMA, 2016
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; urban surveillance; yellow fever mosquito; Zika virus
ID ZIKA VIRUS; UNITED-STATES; SURVEILLANCE; VECTOR; TRANSMISSION;
   ALBOPICTUS; TRAPS; AREAS; TEXAS
AB Aedes aegypti is an important subtropical vector species and is predicted to have a limited year-round distribution in the southern United States. Collection of the species has not been officially verified in Oklahoma since 1940. Adult mosquitoes were collected in 42 sites across 7 different cities in Oklahoma using 3 different mosquito traps between May and September 2016. Between July and September 2016, 88 Ae. aegypti adults were collected at 18 different sites in 4 different cities across southern Oklahoma. Centers for Disease Control and Prevention mini light traps baited with CO2 attracted the highest numbers of Ae. aegypti individuals compared to Biogents (BG)-Sentinel((R)) traps baited with Biogents (BG)-lure and octenol and Centers for Disease Control and Prevention gravid traps baited with Bermuda grass-infused water. The discovery of Ae. aegypti mosquitoes within urban/exurban areas in Oklahoma is important from an ecological as well as a public health perspective.
C1 [Bradt, David L.; Hoback, W. Wyatt; Noden, Bruce H.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Noble Res Ctr 127, Stillwater, OK 74078 USA.
   [Bradley, Kristy K.] Oklahoma Dept Hlth, Off State Epidemiologist, 1000 NE Tenth St, Oklahoma City, OK 73117 USA.
RP Bradt, DL (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Noble Res Ctr 127, Stillwater, OK 74078 USA.
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; Oklahoma State Department of Health; National
   Institute of Food and Agriculture/United States Department of
   Agriculture Hatch Grant funds through the Oklahoma Agricultural
   Experiment Station [OKL-02909]
FX We thank Lisa Coburn for the assistance in the identification and
   confirmation of the Ae. aegypti species. Additionally, we thank the
   Oklahoma State University County Extension personnel who actively
   assisted in the identification of initial surveillance sites in each
   urban area, as well as Hasan Melouk and Trisha Dubie for constructive
   comments on an earlier version of this manuscript. Funding for this
   project was made possible by a Public Health Emergency Preparedness
   Cooperative Agreement between the CDC and the Oklahoma State Department
   of Health. Partial funding for this project was also provided by
   National Institute of Food and Agriculture/United States Department of
   Agriculture Hatch Grant funds through the Oklahoma Agricultural
   Experiment Station (OKL-02909).
CR Arimoto H, 2015, J AM MOSQUITO CONTR, V31, P384, DOI 10.2987/moco-31-04-384-387.1
   CDC [Centers for Disease Control and Prevention], 2016, CDCS RESP ZIK EST RA
   CDC [Centers for Disease Control and Prevention], 2015, ARBONET NAT ARB SURV
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Hahn MB, 2016, J MED ENTOMOL, V2016, P1
   Harwood JF, 2015, J AM MOSQUITO CONTR, V31, P242, DOI 10.2987/moco-31-03-242-247.1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   MORLAN HB, 1965, AM J TROP MED HYG, V14, P892, DOI 10.4269/ajtmh.1965.14.892
   Noden BH, 2015, J AM MOSQUITO CONTR, V31, P336, DOI 10.2987/moco-31-04-336-345.1
   Paras KL, 2014, MED VET ENTOMOL, V28, P60, DOI 10.1111/mve.12069
   REITER P, 1986, J AM MOSQUITO CONTR, V2, P209
   Rozeboom LE., 1942, TECHN B OKL AGR ME T
   Rozeboom LE, 1938, P OKLA ACAD SCI, P81
   Russell RC, 2004, J AM MOSQUITO CONTR, V20, P370
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   White SL, 2009, J MED ENTOMOL, V46, P1494, DOI 10.1603/033.046.0637
   WOMACK ML, 1993, J AM MOSQUITO CONTR, V9, P367
NR 23
TC 4
Z9 4
U1 0
U2 7
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD MAR
PY 2017
VL 33
IS 1
BP 56
EP 59
DI 10.2987/16-6627.1
PG 4
WC Entomology
SC Entomology
GA ER1CA
UT WOS:000398525500008
PM 28388329
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Neurological problem due to Zika virus infection: What should be
   discussed?
SO NEUROLOGY INDIA
LA English
DT Letter
C1 [Joob, Beuy] Med Ctr, Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 3
Z9 3
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD MAR-APR
PY 2017
VL 65
IS 2
BP 439
EP U341
DI 10.4103/neuroindia.NI_912_16
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA ER2BH
UT WOS:000398598400060
PM 28290434
DA 2020-07-08
ER

PT J
AU Hajra, SK
   Bandyopadhyay, D
   Hajra, SK
AF Hajra, Adrija
   Bandyopadhyay, Dhrubajyoti
   Hajra, Shyamal Kumar
TI Author's Reply: Zika virus: Some interesting points
SO NEUROLOGY INDIA
LA English
DT Letter
C1 [Hajra, Adrija] IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
   [Bandyopadhyay, Dhrubajyoti] Lady Hardinge Med Coll & Hosp, Dept Accid & Emergency, New Delhi, India.
   [Hajra, Shyamal Kumar] NMB Diagnost Ctr, Serampore, W Bengal, India.
RP Hajra, SK (corresponding author), IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
EM adrija847@gmail.com
RI Hajra, Adrija/AAM-5736-2020; Bandyopadhyay, Dhrubajyoti/AAQ-5622-2020
OI Bandyopadhyay, Dhrubajyoti/0000-0002-0709-4324
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD MAR-APR
PY 2017
VL 65
IS 2
BP 440
EP U365
DI 10.4103/0028-3886.201875
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA ER2BH
UT WOS:000398598400061
PM 28290436
DA 2020-07-08
ER

PT J
AU Marks, PW
   Petersen, LR
AF Marks, Peter W.
   Petersen, Lyle R.
TI Decision making in the face of uncertainty: the challenge of emerging
   infectious diseases
SO TRANSFUSION
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; WEST-NILE-VIRUS; UNITED-STATES; BIRTH-DEFECTS;
   PUERTO-RICO; TRANSMISSION; PREGNANCY; RISK; INACTIVATION; OUTBREAK
C1 [Marks, Peter W.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
   [Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
RP Marks, PW (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
EM peter.marks@fda.hhs.gov
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Betsem E, 2017, EMERG INFECT DIS, P23
   Bielaire D, 2017, TRANSFUSION, V57
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Devine DV, 2016, HEMATOL ONCOL CLIN N, V30, P609, DOI 10.1016/j.hoc.2016.01.005
   Dodd RY, 2012, BRIT J HAEMATOL, V159, P135, DOI 10.1111/bjh.12031
   Farcet M, 2017, TRANSFUSION, V57
   Galel S, 2017, TRANSFUSION, V57
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Hahn M. B., 2016, J MED ENTOMOL
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Katz LM, 2014, CURR OPIN HEMATOL, V21, P509, DOI 10.1097/MOH.0000000000000089
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Kuhnel D, 2017, TRANSFUSION, V57, P802, DOI 10.1111/trf.13964
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Laughhunn A, 2017, TRANSFUSION, V57
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murphy M, 2017, TRANSFUSION, V57
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   PAHO, 2016, CHIK STAT DAT
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2014, TRANSFUSION, V54, P1911, DOI 10.1111/trf.12790
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stone M, 2017, TRANSFUSION, V57
   Suffolk County Government, 2013, HLTH COMM REP DENG V
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Williamson P, 2017, TRANSFUSION, V57
NR 47
TC 3
Z9 3
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 723
EP 728
DI 10.1111/trf.14037
PN 2
PG 6
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000001
PM 28345226
OA Bronze
DA 2020-07-08
ER

PT J
AU Bierlaire, D
   Mauguin, S
   Broult, J
   Musso, D
AF Bierlaire, Damien
   Mauguin, Sylvie
   Broult, Julien
   Musso, Didier
TI Zika virus and blood transfusion: the experience of French Polynesia
SO TRANSFUSION
LA English
DT Article
ID TRANSMISSION; INACTIVATION; PLASMA; ILLUMINATION; ULTRAVIOLET;
   MICRONESIA; AMOTOSALEN; PLATELET; OUTBREAK; DONORS
AB BACKGROUND Between October 2013 and March 2014, French Polynesia experienced the largest Zika virus (ZIKV) outbreak ever described before the emergence of ZIKV in the Americas in 2015. As arbovirus transfusion-transmitted (TT) infections have been previously reported, we hypothesized that transfusion of blood products could also transmit ZIKV.
   STUDY DESIGN AND METHODS Mitigation strategies to prevent ZIKV-TT infections included nonspecific measures and the implementation of a laboratory developed ZIKV-specific nucleic acid testing (NAT) assay. Donor sera were tested in pools of 3 and constitutive sera of ZIKV-reactive pools were tested individually. Donor sera were tested prospectively and retrospectively. A posttransfusion follow-up of a patient transfused with ZIKV RNA-reactive blood products was implemented.
   RESULTS NAT detected 42 blood donor sera as ZIKV RNA reactive of 1505 tested (2.8%). Thirty ZIKV RNA-reactive blood products collected before the implementation of NAT were transfused to 26 recipients. Posttransfusion investigations were conducted by the hemovigilance unit and data were available for 12 recipients. Symptomatic ZIKV-TT infections were not reported.
   CONCLUSION Predonation screening of blood donors, postdonation information, products discard, and quarantine of blood products were not effective enough to prevent transfusion of ZIKV RNA-reactive blood products. ZIKV NAT was an effective measure once implemented to prevent transfusion of ZIKV RNA-reactive blood products but it is difficult to evaluate the effectiveness of this measure to prevent ZIKV-TT infection, which is a rare event.
C1 [Bierlaire, Damien; Mauguin, Sylvie] Hop Taaone, Hemovigilance Unit, POB 1640, F-98713 Tahiti, French Polynesi, France.
   [Broult, Julien] Hop Taaone, French Polynesian Blood Bank, Tahiti, French Polynesi, France.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
RP Bierlaire, D (corresponding author), Hop Taaone, Hemovigilance Unit, POB 1640, F-98713 Tahiti, French Polynesi, France.
EM damien.bierlaire@cht.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], 2010, BLOOD PROD ADV COMM
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, BLOOD TRANSFUS, V28, P1
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nkohkwo A, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.363
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   WHO, 2016, MAINT SAF AD BLOOD S
NR 26
TC 19
Z9 19
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 729
EP 733
DI 10.1111/trf.14028
PN 2
PG 5
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000002
PM 28185278
OA Bronze
DA 2020-07-08
ER

PT J
AU Baylis, SA
   Hanschmann, KMO
   Schnierle, BS
   Trosemeier, JH
   Blumel, J
AF Baylis, Sally A.
   Hanschmann, Kay-Martin O.
   Schnierle, Barbara S.
   Troesemeier, Jan-Hendrik
   Bluemel, Johannes
CA Zika Virus Collaborative Study Grp
TI Harmonization of nucleic acid testing for Zika virus: development of the
   1(st) World Health Organization International Standard
SO TRANSFUSION
LA English
DT Article
ID SEXUAL TRANSMISSION; OUTBREAK
AB BACKGROUND With the ongoing public health emergency due to Zika virus (ZIKV), nucleic acid testing (NAT) is essential for clinical diagnosis and screening of blood donors. However, NAT for ZIKV has not been standardized, and this study was performed to establish a World Health Organization (WHO) International Standard (IS) for ZIKV RNA; WHO ISs have been used to improve detection and quantification of blood-borne viruses.
   STUDY DESIGN AND METHODS The candidate IS (cIS), code number 11468/16, was prepared by heat inactivation and lyophilization of a ZIKV strain isolated from a patient in French Polynesia in 2013. The cIS was evaluated together with other reference materials, including both Asian and African ZIKV lineages as well as a panel of clinical samples and in vitro-transcribed RNAs. The samples for evaluation were distributed to 24 laboratories from 11 countries. The assays used consisted of a mixture of in-house developed and commercial assays (available or in development).
   RESULTS The potencies of the standards were determined by quantitative and qualitative assays. In total, 37 sets of data were analyzed: 19 from quantitative assays and 18 from qualitative assays. Data demonstrated wide variations in reported potencies of the cIS and the other study samples.
   CONCLUSIONS Assay variability was substantially reduced when ZIKV RNA concentrations from the biological reference materials and clinical samples were expressed relative to the cIS. Thus, the WHO has established 11468/16 as the 1(st) IS for ZIKV RNA, with a unitage of 50,000,000 IU/mL.
C1 [Baylis, Sally A.; Hanschmann, Kay-Martin O.; Schnierle, Barbara S.; Troesemeier, Jan-Hendrik; Bluemel, Johannes; Zika Virus Collaborative Study Grp] Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
RP Baylis, SA (corresponding author), Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
EM Sally.Baylis@pei.de
RI Schnierle, Barbara/AAG-8108-2019
FU German Ministry of Health
FX This work was supported by grant "Sicherheit von Blut(produkten) und
   Geweben hinsichtlich der Abwesenheit von Zikaviren from the German
   Ministry of Health.
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baylis SA, 2015, TRANSFUS MED HEMOTH, V42, P211, DOI 10.1159/000435872
   Baylis SA, 2013, EMERG INFECT DIS, V19, P729, DOI 10.3201/eid1905.121845
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 19
Z9 19
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 748
EP 761
DI 10.1111/trf.14026
PN 2
PG 14
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000004
PM 28229462
OA Bronze
DA 2020-07-08
ER

PT J
AU Galel, SA
   Williamson, PC
   Busch, MP
   Stanek, D
   Bakkour, S
   Stone, M
   Lu, K
   Jones, S
   Rossmann, SN
   Pate, LL
AF Galel, Susan A.
   Williamson, Phillip C.
   Busch, Michael P.
   Stanek, Danielle
   Bakkour, Sonia
   Stone, Mars
   Lu, Kai
   Jones, Scott
   Rossmann, Susan N.
   Pate, Lisa Lee
CA Cobas Zika IND Study Grp
TI First Zika-positive donations in the continental United States
SO TRANSFUSION
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; VIRUS TRANSMISSION; FRENCH-POLYNESIA;
   PUERTO-RICO; AMERICA
AB BACKGROUND Zika virus (ZIKV) has spread in the Americas, including parts of the southern United States, and infection can be associated with serious complications, including congenital brain abnormalities. Probable transfusion transmission of ZIKV has been documented in Brazil.
   STUDY DESIGN AND METHODS Preemptive testing of blood donations for ZIKV RNA was implemented in southern US states at risk of local transmission using a test approved under a Food and Drug Administration (FDA) investigational new drug application, cobas Zika. Screening was expanded after issuance of an updated FDA guidance. Donations reactive on initial screening were further tested by nucleic acid and antibody tests to determine the donor status.
   RESULTS Of 358,786 donations from US states screened by individual donation testing, 23 were initially reactive on cobas Zika. Fourteen of these represented probable ZIKV infection based on reactivity on additional nucleic acid testing or anti-Zika immunoglobulin M. Ten of the 14 donors reported travel to an identified ZIKV-active area within 90 days before donation (median time from end of travel to donation, 25 days; range, 6-71 days). Three donors with travel history also had a potential sexual exposure. Only seven of the 14 donations with probable ZIKV infection were detectable upon 1:6 dilution to simulate minipool testing. The estimated specificity of the cobas Zika test was 99.997%.
   CONCLUSION Screening of donations for ZIKV RNA can interdict ZIKV-infected donors. Donor risk factors include travel more than 4 weeks before donation and sexual exposure. Minipool screening would have detected only 50% of the RNA-positive donations.
C1 [Galel, Susan A.; Pate, Lisa Lee] Roche Mol Syst Inc, 4300 Hacienda Dr, Pleasanton, CA 94588 USA.
   [Williamson, Phillip C.] Creat Testing Solut, St Petersburg, FL USA.
   [Busch, Michael P.; Bakkour, Sonia; Stone, Mars; Lu, Kai] Blood Syst Res Inst, San Francisco, CA USA.
   [Stanek, Danielle] Florida Dept Hlth, Tallahassee, FL USA.
   [Jones, Scott] QualTex Labs, San Antonio, TX USA.
   [Rossmann, Susan N.] Gulf Coast Reg Blood Ctr, Houston, TX USA.
RP Galel, SA (corresponding author), Roche Mol Syst Inc, 4300 Hacienda Dr, Pleasanton, CA 94588 USA.
EM susan.galel@roche.com
FU Roche Molecular Systems, Inc.
FX This study was sponsored by Roche Molecular Systems, Inc., to evaluate
   the specificity of the cobas Zika test for screening of blood donations
   for the presence of Zika virus RNA. The cobas Zika test is an
   investigational device and limited by US law to investigational use.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   [Anonymous], 2016, ADV PEOPL LIV TRAV S
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   U. S. Food and Drug Administration, 2016, GUID IND REV REC RED
   U. S. Food and Drug Administration, 2016, GUID IND REC DON SCR
NR 21
TC 35
Z9 36
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 762
EP 769
DI 10.1111/trf.14029
PN 2
PG 8
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000005
PM 28164310
OA Other Gold
DA 2020-07-08
ER

PT J
AU Williamson, PC
   Linnen, JM
   Kessler, DA
   Shaz, BH
   Kamel, H
   Vassallo, RR
   Winkelman, V
   Gao, K
   Ziermann, R
   Menezes, J
   Thomas, S
   Holmberg, JA
   Bakkour, S
   Stone, M
   Lu, K
   Simmons, G
   Busch, MP
AF Williamson, Phillip C.
   Linnen, Jeffrey M.
   Kessler, Debra A.
   Shaz, Beth H.
   Kamel, Hany
   Vassallo, Ralph R.
   Winkelman, Valerie
   Gao, Kui
   Ziermann, Rainer
   Menezes, Juscilene
   Thomas, Stephen
   Holmberg, Jerry A.
   Bakkour, Sonia
   Stone, Mars
   Lu, Kai
   Simmons, Graham
   Busch, Michael P.
TI First cases of Zika virus-infected US blood donors outside states with
   areas of active transmission
SO TRANSFUSION
LA English
DT Article
ID FRENCH-POLYNESIA; BORNE TRANSMISSION; EMERGING PATHOGENS; PUERTO-RICO
AB BACKGROUND Zika virus (ZIKV) is transmitted by Aedes mosquitos and can result in severe congenital and adult neurologic abnormalities. ZIKV has rapidly spread northward through Central America and the Caribbean and autochthonous cases have been identified in the continental United States. High rates of ZIKA RNA positivity were detected in blood donors during previous epidemics. ZIKV transmission by transfused blood from healthy donor components has been a growing concern.
   STUDY DESIGN AND METHODS Individual-donation aliquots of plasma from volunteer blood donors were tested individually with an investigational Procleix ZIKV assay. Initially reactive samples were tested for ZIKV RNA in plasma and red blood cells (RBCs) and for ZIKV-specific antibodies in serum. A confirmed positive classification required confirmation of RNA and/or detection of ZIKV antibodies in index and/or follow-up samples.
   RESULTS Between September 19 and November 30, 2016, a total of 466,834 donations were screened for ZIKV RNA. Five donors (one in approx. 93,000) were reactive for ZIKV RNA by both the Procleix ZIKV assay and supplemental testing. The donations were collected outside areas considered as having active transmission, and all five donors had travel exposures. A lookback case demonstrated no infection despite transfusion of a Zika IgG-positive platelet (PLT) component with probable low levels of ZIKV RNA.
   CONCLUSIONS This report describes the first ZIKV-positive donors detected outside areas with active transmission. These donors most likely represent travel-acquired tail-end infections with prolonged RBC-associated ZIKV RNA. The lack of transmission to the recipient of an apheresis PLT may suggest that these units are not infectious.
C1 [Williamson, Phillip C.; Winkelman, Valerie] Creat Testing Solut, 2424 W Erie Dr, Tempe, AZ 85282 USA.
   [Linnen, Jeffrey M.; Gao, Kui; Ziermann, Rainer; Menezes, Juscilene; Thomas, Stephen] Hologic Inc, San Diego, CA USA.
   [Kessler, Debra A.; Shaz, Beth H.] New York Blood Ctr, New York, NY 10021 USA.
   [Kamel, Hany; Vassallo, Ralph R.] Blood Syst Inc, Scottsdale, AZ USA.
   [Holmberg, Jerry A.] Grifols Diagnost Solut Inc, Emeryville, CA USA.
   [Bakkour, Sonia; Stone, Mars; Lu, Kai; Simmons, Graham; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
RP Williamson, PC (corresponding author), Creat Testing Solut, 2424 W Erie Dr, Tempe, AZ 85282 USA.
EM pwilliamson@mycts.org
RI Simmons, Graham/G-3523-2012
OI Simmons, Graham/0000-0002-9615-7023
CR [Anonymous], 2016, UPD REC ZIK DENG CHI
   [Anonymous], 2016, TRIOPL REAL TIM RT P
   [Anonymous], 2016, TEX ANN LOC ZIK VIR
   Bakkour S, 2016, ORL FL AM ASS BLOOD
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bres V, 2016, ORL FL AM ASS BLOOD
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Food and Drug Administration, 2016, REV REC RED RISK ZIK
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lustig Y, 2016, EURO SURVEILL, V21
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stone M, 2017, TRANSFUSION, V57
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 45
TC 27
Z9 27
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 770
EP 778
DI 10.1111/trf.14041
PN 2
PG 9
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000006
PM 28229475
OA Bronze
DA 2020-07-08
ER

PT J
AU Laughhunn, A
   Maria, FS
   Broult, J
   Lanteri, MC
   Stassinopoulos, A
   Musso, D
   Aubry, M
AF Laughhunn, Andrew
   Maria, Felicia Santa
   Broult, Julien
   Lanteri, Marion C.
   Stassinopoulos, Adonis
   Musso, Didier
   Aubry, Maite
TI Amustaline (S-303) treatment inactivates high levels of Zika virus in
   red blood cell components
SO TRANSFUSION
LA English
DT Article
ID PATHOGEN INACTIVATION; PLATELET COMPONENTS; CHIKUNGUNYA VIRUS;
   TRANSFUSION; AMOTOSALEN; ULTRAVIOLET; ILLUMINATION; PLASMA; LIGHT;
   TRANSMISSION
AB BACKGROUND The potential for Zika virus (ZIKV) transfusion-transmission (TT) has been demonstrated in French Polynesia and Brazil. Pathogen inactivation (PI) of blood products is a proactive strategy to inactivate TT pathogens including arboviruses. Inactivation of West Nile, dengue, Zika, and chikungunya viruses was previously demonstrated by photochemical treatment with amotosalen and ultravioletA (UVA) illumination. In this study, we evaluated ZIKV inactivation in red blood cell (RBC) components by a chemical approach that uses amustaline (S-303) and glutathione (GSH).
   STUDY DESIGN AND METHODS RBC components were spiked with a high titer of ZIKV. Viral titers (infectivity) and ZIKV RNA loads (reverse transcription-polymerase chain reaction) were measured in spiked RBCs before and after S-303 and GSH treatment and confirmed using repetitive passages in cell culture. A mock-treated arm validated the approach by demonstrating stability of the virus (infectivity and RNA load) during the process.
   RESULTS The mean ZIKV infectivity titer and RNA load in RBCs were 5.990.2 log 50% tissue culture infectious dose (TCID50)/mL and 7.75 +/- 0.16 log genomic equivalents/mL before inactivation. No infectivity was detected immediately after S-303 and GSH treatment and after five serial passages in cell culture.
   CONCLUSION Complete ZIKV inactivation of more than 5.99 log TCID50/mL in RBCs was achieved using S-303 and GSH at levels higher than those found in asymptomatic ZIKV-infected blood donors. Therefore, the S-303 and GSH PI system is promising for mitigating the risk of ZIKV TT.
C1 [Laughhunn, Andrew; Maria, Felicia Santa; Lanteri, Marion C.; Stassinopoulos, Adonis] Cerus Corp, Concord, CA USA.
   [Broult, Julien] Hop Taaone, Ctr Transfus Sanguine Polynesie Francaise, Pirae, French Polynesi, France.
   [Musso, Didier; Aubry, Maite] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, French Polynesi, France.
RP Aubry, M (corresponding author), Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
EM maubry@ilm.pf
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Aubry, Maite/0000-0002-9913-5794
FU Cerus Corporation
FX This study was partially funded by Cerus Corporation.
CR Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   American Association of Blood Banks, 2016, AABB ASS B
   Aubry M, 2015, AMOTOSALEN ULTRAVIOL, P189
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bakkour S, 2016, TRANSFUSION, V56, P410, DOI 10.1111/trf.13360
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P61
   Bierlaire D, 2014, TRANSFUS CLIN BIOL, V21, P234, DOI DOI 10.1016/J.TRACLI.2014.08.005
   Brixner V., 2015, 25 REG C INT SOC BLO, P28
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Control ECfDPa, 2014, ZIK VIR INF OUTBR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis K, 2012, TRANSFUSION, V52, P2012
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   Gubler D., 2007, FIELDS VIROLOGY
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Henschler R, 2011, TRANSFUS MED HEMOTH, V38, P33, DOI 10.1159/000324458
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Kessler CM, 2016, CLIN ADV HEMATOL ONC, V14, P677
   Kleinman S, 2015, TRANSFUSION, V55, P2983, DOI 10.1111/trf.13259
   Kuehnert MJ, 2016, TRANSFUSION, V56, P1669, DOI 10.1111/trf.13673
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Lin LL, 2005, TRANSFUSION, V45, P580, DOI 10.1111/j.0041-1132.2005.04316.x
   Lustig Y, 2016, EURO SURVEILL, V21
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   Maria FS, 2016, TRANSFUSION, V56, p11A
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mufti NA, 2010, BIOLOGICALS, V38, P14, DOI 10.1016/j.biologicals.2009.10.019
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, ISBT SCI SERIES, DOI [10.1111/voxs.12335, DOI 10.1111/VOXS.12335]
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2016, TRANSFUSION, V56, P3143, DOI 10.1111/trf.13861
   Musso D, 2016, LANCET INFECT DIS, V16, P1108, DOI 10.1016/S1473-3099(16)30337-1
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nkohkwo A, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.363
   North A, 2011, TRANSFUSION, V51, P2208, DOI 10.1111/j.1537-2995.2011.03132.x
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Prevention CfDCa, 2016, MORB MORT WEEKL REP
   ProMED-mail, 2015, ZIK VIR AM
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richard V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138161
   Sawyer L, 2007, TRANSFUSION, V47, P1062, DOI 10.1111/j.1537-2995.2007.01237.x
   Stassinopoulos A, 2004, BLOOD, V104, p738A, DOI 10.1182/blood.V104.11.2703.2703
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   U.S. Department of Health and Human Services, 2016, AUG REV REC RED RISK
   US Department of Health and Human Services, 2016, FEBR REC DON SCREEN
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wiltshire M, 2016, TRANSFUSION MED, V26, P208, DOI 10.1111/tme.12298
   World Health Organization, ZIK VIR MICR GUILL B
   World Health Organization, 2016, MAINT SAF AD BLOOD S
NR 65
TC 18
Z9 18
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 779
EP 789
DI 10.1111/trf.13993
PN 2
PG 11
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000007
PM 28164306
OA Other Gold
DA 2020-07-08
ER

PT J
AU Blumel, J
   Musso, D
   Teitz, S
   Miyabayashi, T
   Boller, K
   Schnierle, BS
   Baylis, SA
AF Bluemel, Johannes
   Musso, Didier
   Teitz, Sebastian
   Miyabayashi, Tomoyuki
   Boller, Klaus
   Schnierle, Barbara S.
   Baylis, Sally A.
TI Inactivation and removal of Zika virus during manufacture of
   plasma-derived medicinal products
SO TRANSFUSION
LA English
DT Article
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; OUTBREAK; SAFETY
AB BACKGROUND Zika virus (ZIKV) is an emerging mosquito-borne Flavivirus of major public health concern. The potential for ZIKV transmission by blood transfusion has been demonstrated; however, inactivation or removal of ZIKV during the manufacture of plasma-derived medicinal products has not been specifically investigated.
   STUDY DESIGN AND METHODS Inactivation of ZIKV by pasteurization and solvent/detergent (S/D) treatment was investigated by spiking high-titer ZIKV stocks into human serum albumin and applying either heat or adding different mixtures of S/D reagents and assaying for infectious virus particles. Removal of ZIKV was evaluated using filters of differing pore sizes (75, 40, 35, and 19 nm), assaying for infectious virus and RNA. Electron microscopy was performed to determine the size of ZIKV particles. Neutralization of virus infectivity by immunoglobulins was investigated.
   RESULTS ZIKV was effectively and rapidly inactivated by liquid heat treatment as well as by various mixtures of S/D reagents with reduction factors more than 4 log, in each case. Effective reduction of ZIKV infectivity was demonstrated for virus filtration for filters with average pore sizes of not more than 40 nm, although a significant proportion of virus RNA was detected in the 40- to 35-nm filtrates likely due to the presence of subviral particles observed by electron microscopy. None of the immunoglobulin preparations investigated neutralized ZIKV infectivity.
   CONCLUSIONS Pasteurization and S/D treatment very rapidly inactivated ZIKV and filters with a pore size of not more than 40 nm removed all infectious ZIKV, demonstrating the effectiveness of these virus reduction strategies used during the manufacture of plasma-derived medicinal products.
C1 [Bluemel, Johannes; Boller, Klaus; Schnierle, Barbara S.; Baylis, Sally A.] Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
   [Musso, Didier] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Teitz, Sebastian; Miyabayashi, Tomoyuki] Asahi Kasei, Cologne, Germany.
RP Blumel, J (corresponding author), Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
EM johannes.bluemel@pei.de
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020; Schnierle,
   Barbara/AAG-8108-2019
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; 
CR [Anonymous], 2016, IPFA POS PAP ZIK VIR
   [Anonymous], 2016, ZIK VIR DIS EP 6 UPD
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baylis SA, 2011, VACCINE, V29, P690, DOI 10.1016/j.vaccine.2010.11.028
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boller K, 1997, J VIROL, V71, P4581, DOI 10.1128/JVI.71.6.4581-4588.1997
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X
   Leydold SM, 2012, TRANSFUSION, V52, P2122, DOI 10.1111/j.1537-2995.2012.03565.x
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Park SL, 2016, J VIROL METHODS, V234, P152, DOI 10.1016/j.jviromet.2016.04.004
   Pfleiderer C, 2008, J MED VIROL, V80, P557, DOI 10.1002/jmv.21110
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Seitz H, 2002, BIOLOGICALS, V30, P197, DOI 10.1006/biol.2002.0328
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   WHO, 2016, MAINT SAF AD BLOOD S
   Xie YW, 2008, TRANSFUSION, V48, P1342, DOI 10.1111/j.1537-2995.2008.01647.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 37
TC 13
Z9 13
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 790
EP 796
DI 10.1111/trf.13873
PN 2
PG 7
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000008
PM 27731495
OA Other Gold
DA 2020-07-08
ER

PT J
AU Kuhnel, D
   Muller, S
   Pichotta, A
   Radomski, KU
   Volk, A
   Schmidt, T
AF Kuehnel, Denis
   Mueller, Sebastian
   Pichotta, Alexander
   Radomski, Kai Uwe
   Volk, Andreas
   Schmidt, Torben
TI Inactivation of Zika virus by solvent/detergent treatment of human
   plasma and other plasma-derived products and pasteurization of human
   serum albumin
SO TRANSFUSION
LA English
DT Article
ID WEST-NILE-VIRUS; BLOOD-TRANSFUSION; PROTEIN FRACTION; TRANSMISSION;
   ASSOCIATION; DERIVATIVES; ISOLATIONS; OUTBREAK; UPDATE; SAFETY
AB BACKGROUND In 2016 the World Health Organization declared the mosquito-borne Zika virus (ZIKV) a public health emergency of international concern. ZIKV is a blood-borne pathogen, which therefore causes concerns regarding the safety of human plasma-derived products due to potential contamination of the blood supply. This study investigated the effectiveness of viral inactivation steps used during the routine manufacturing of various plasma-derived products to reduce ZIKV infectivity.
   STUDY DESIGN AND METHODS Human plasma and intermediates from the production of various plasma-derived products were spiked with ZIKV and subjected to virus inactivation using the identical techniques (either solvent/detergent [S/D] treatment or pasteurization) and conditions used for the actual production of the respective products. Samples were taken and the viral loads measured before and after inactivation.
   RESULTS After S/D treatment of spiked intermediates of the plasma-derived products Octaplas(LG), Octagam, and Octanate, the viral loads were below the limit of detection in all cases. The mean log reduction factor (LRF) was at least 6.78 log for Octaplas(LG), at least 7.00 log for Octagam, and at least 6.18 log for Octanate after 60, 240, and 480 minutes of S/D treatment, respectively. For 25% human serum albumin (HSA), the mean LRF for ZIKV was at least 7.48 log after pasteurization at 60 degrees C for 120 minutes.
   CONCLUSION These results demonstrate that the commonly used virus inactivation processes utilized during the production of human plasma and plasma-derived products, namely, S/D treatment or pasteurization, are effective for inactivation of ZIKV.
C1 [Kuehnel, Denis; Mueller, Sebastian; Pichotta, Alexander; Radomski, Kai Uwe; Volk, Andreas; Schmidt, Torben] Octapharma Biopharmaceut GmbH, Virus & Prion Validat Dept, Altenhoeferallee 3, D-60438 Frankfurt, Germany.
RP Kuhnel, D (corresponding author), Octapharma Biopharmaceut GmbH, Virus & Prion Validat Dept, Altenhoeferallee 3, D-60438 Frankfurt, Germany.
EM denis.kuehnel@octapharma.com
FU Octapharma AG
FX We are grateful to Dr Markus Eickmann (Philipps-Universit_ at Marburg,
   Marburg, Germany), Culture Collections Public Health England (PHE), and
   National Collection of Pathogen Viruses (NCPV) for providing Zika virus.
   We thank the entire personnel of the Octapharma Virus and Prion
   Department who performed the virus safety studies, as well as Mr
   Tor-Einar Svae, Mr Stefan Winge, and Mr Friedrich Schoen for review of
   the manuscript. Medical writing assistance was provided by nspm ltd,
   Meggen, Switzerland, and funded by Octapharma AG. DK wrote the first
   draft of the paper; DK, SM, AP, KUR, and AV designed the studies and
   participated in technical study performance; and DK, SM, AP, KUR, AV,
   and TS contributed to manuscript writing. All authors reviewed and
   critically edited the manuscript; the final version has been approved by
   all authors.
CR [Anonymous], IN ZIKA VIR ZIKV SOL
   [Anonymous], 2012, BLOOD DON SEL GUID A
   [Anonymous], 2016, ZIK VIR SAF BLOOD SU
   [Anonymous], 2016, REV REC RED RISK ZIK
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Blodgett R, 2010, BACTERIAL ANAL MANUA
   Brownie C, 2011, BIOLOGICALS, V39, P224, DOI 10.1016/j.biologicals.2011.06.007
   Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x
   Centers for Disease Control and Prevention, 2016, ZIK BLOOD TRANSF
   COCHRAN WG, 1950, BIOMETRICS, V6, P105, DOI 10.2307/3001491
   Committee for Medicinal Products for Human Use (CHMP), 2004, CPMPBWP26995
   Committee for Proprietary Medicinal Products, 1996, CPMPBWP26895
   *CPMP, 1996, CPMPBWP26895
   Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Erstad BL, 1996, PHARMACOTHERAPY, V16, P996
   Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gemeinsame Bekanntmachung von Paul-Ehrlich-Institut und Bundesgesundheitsamt, 1994, VIR DIAGN VAL ANF VA, P84
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayden E, 2016, NATURE
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Holsinger VH, 1997, REV SCI TECH OIE, V16, P441, DOI 10.20506/rst.16.2.1037
   Horowitz B, 1998, VOX SANG, V74, P203, DOI 10.1111/j.1423-0410.1998.tb05473.x
   Hotta J, 2010, US RESP DIS, V6, P40
   KARBER G, 1931, N-S ARCH PHARMACOL, V152, P380
   KIMURA T, 1988, J GEN VIROL, V69, P1247, DOI 10.1099/0022-1317-69-6-1247
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994
   Ogedegbe HO, 2001, LAB MED, V32, P156, DOI 10.1309/C2VD-X9A5-2W6H-DP48
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Palmer S, 2005, BMJ-BRIT MED J, V331, P1256, DOI 10.1136/bmj.331.7527.1256
   PATTISON CP, 1976, AM J EPIDEMIOL, V103, P399, DOI 10.1093/oxfordjournals.aje.a112239
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Remington KM, 2004, VOX SANG, V87, P10, DOI 10.1111/j.1423-0410.2004.00530.x
   Rezvan H, 2001, ARCH IRAN MED, V4, P10
   Rezvan H, 2006, MED J ISLAM REPUB IR, V20, P86
   Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40
   Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2001, WHO TECH REP SER, V924, P150
   Xie YW, 2008, TRANSFUSION, V48, P1342, DOI 10.1111/j.1537-2995.2008.01647.x
NR 52
TC 5
Z9 7
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 802
EP 810
DI 10.1111/trf.13964
PN 2
PG 9
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000010
PM 28019034
OA Other Gold
DA 2020-07-08
ER

PT J
AU Murphy, MSQ
   Shehata, N
   Colas, JA
   Chasse, M
   Fergusson, DA
   O'Brien, SF
   Goldman, M
   Tinmouth, A
   Forster, AJ
   Wilson, K
AF Murphy, Malia S. Q.
   Shehata, Nadine
   Colas, Jo Ann
   Chasse, Michael
   Fergusson, Dean A.
   O'Brien, Sheila F.
   Goldman, Mindy
   Tinmouth, Alan
   Forster, Alan J.
   Wilson, Kumanan
TI Risk of exposure to blood products during pregnancy: guidance for Zika
   and other donor deferral policies
SO TRANSFUSION
LA English
DT Article
ID TRANSFUSION; VIRUS; WOMEN
AB BACKGROUND: Exposure to blood products during pregnancy carries a potential risk of transfusion transmission of infectious agents. Blood agencies have historically sought optimal deferral and testing strategies to protect blood supplies in part to ensure the protection of pregnant women and their unborn infants. The Zika virus outbreak of 2016 has heightened attention to these concerns. In the current context of the recent Zika outbreak, and also more broadly, data are needed to shed light on the likelihood of exposure to blood products throughout pregnancy to inform policy.
   STUDY DESIGN AND METHODS: Hospital administrative data from a large tertiary care center were examined for outpatient and nondelivery inpatient transfusion events in pregnant women between January 1, 2007, and December 31, 2013. Those pregnancies resulting in miscarriage were excluded from analysis.
   RESULTS: A total of 45,179 pregnancies resulting in delivery of a live or stillborn infant were documented at The Ottawa Hospital during the study period. Our findings indicate that 0.124%, or 1240 in 1,000,000, expectant mothers received transfusion at some point during their pregnancies with 0.04%, or 400 per 1,000,000, expectant mothers receiving a transfusion in the first trimester.
   CONCLUSION: Data from a large tertiary care center suggest that the risk of maternal and fetal exposure to blood products by transfusion during any stage of pregnancy is very low. Such a low likelihood of transfusion should be taken into consideration when developing donor deferral policies designed to protect women against transfusion-associated infection transmission during pregnancy and could inform evaluations of the risk of prenatal transfusion transmission of the Zika virus.
C1 [Murphy, Malia S. Q.; Colas, Jo Ann; Fergusson, Dean A.; Tinmouth, Alan; Forster, Alan J.; Wilson, Kumanan] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   [Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Inst Hlth Policy Management & Evaluat, Dept Med,Div Hematol, Toronto, ON, Canada.
   [Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Inst Hlth Policy Management & Evaluat, Dept Lab Med,Div Hematol, Toronto, ON, Canada.
   [Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Inst Hlth Policy Management & Evaluat, Dept Pathobiol,Div Hematol, Toronto, ON, Canada.
   [Chasse, Michael] Univ Montreal, Dept Med, Montreal, PQ, Canada.
   [Chasse, Michael] Univ Montreal, Ctr Rech Ctr Hosp, Montreal, PQ, Canada.
   [Fergusson, Dean A.; Tinmouth, Alan; Forster, Alan J.; Wilson, Kumanan] Univ Ottawa, Dept Med, Ottawa, ON, Canada.
   [O'Brien, Sheila F.; Goldman, Mindy] Canadian Blood Serv, Ottawa, ON, Canada.
RP Wilson, K (corresponding author), Ottawa Hosp, Civ Campus,1053 Carling Ave,Box 684,Adm Serv Bldg, Ottawa, ON K1Y 4E9, Canada.
EM kwilson@ohri.ca
RI Chasse, Michael/L-7906-2017; Shehata, Nadine/AAG-1124-2019; Chasse,
   Michael/Y-7820-2019
OI Chasse, Michael/0000-0001-7075-1924; Chasse,
   Michael/0000-0001-7075-1924; Shehata, Nadine/0000-0002-9267-6256;
   Fergusson, Dean/0000-0002-3389-2485
FU Canadian Institute of Health Research/Canadian Blood Services New
   Investigator AwardCanadian Institutes of Health Research (CIHR);
   Canadian Blood Services, Small Project Fund
FX Funding was provided by a Canadian Blood Services, Small Project Fund.
   HS was supported by a Canadian Institute of Health Research/Canadian
   Blood Services New Investigator Award. Canadian Blood Services did not
   have a role in the design, analysis, or interpretation of the results.
CR [Anonymous], PREV DENG PREGN
   [Anonymous], 2016, POSS ASS ZIK VIR INF
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bennett JL, 2011, TRANSFUS MED REV, V25, P267, DOI 10.1016/j.tmrv.2011.05.002
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chasse M, 2016, JAMA INTERN MED, V176, P1307, DOI 10.1001/jamainternmed.2016.3324
   Government of Canada, 2016, ZIK VIR INF GLOB UPD
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   O'Brien SF, 2016, TRANSFUSION, V56, p12A
   Pendry K, 2015, TRANSFUSION MED, V25, P129, DOI 10.1111/tme.12223
   Petrakos G, 2016, IN J WOMENS HEALTH, V8, P441, DOI 10.2147/IJWH.S89308
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Shehata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138427
   Shehata N, 2014, TRANSFUSION, V54, P2631, DOI 10.1111/trf.12644
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 18
TC 6
Z9 6
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 811
EP 815
DI 10.1111/trf.14001
PN 2
PG 5
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000011
PM 28164300
OA Bronze
DA 2020-07-08
ER

PT J
AU Upadhyay, AK
   Cyr, M
   Longenecker, K
   Tripathi, R
   Sun, CH
   Kempf, DJ
AF Upadhyay, Anup K.
   Cyr, Matthew
   Longenecker, Kenton
   Tripathi, Rakesh
   Sun, Chaohong
   Kempf, Dale J.
TI Crystal structure of full-length Zika virus NS5 protein reveals a
   conformation similar to Japanese encephalitis virus NS5
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE Zika virus; NS5; nonstructural protein 5
ID DEPENDENT RNA-POLYMERASE; METHYLTRANSFERASE; INHIBITORS; DISCOVERY;
   TARGET; MODEL
AB The rapid spread of the recent Zika virus (ZIKV) epidemic across various countries in the American continent poses a major health hazard for the unborn fetuses of pregnant women. To date, there is no effective medical intervention. The nonstructural protein 5 of Zika virus (ZIKV-NS5) is critical for ZIKV replication through the 50-RNA capping and RNA polymerase activities present in its N-terminal methyltransferase (MTase) and C-terminal RNA-dependent RNA polymerase (RdRp) domains, respectively. The crystal structure of the full-length ZIKV-NS5 protein has been determined at 3.05 angstrom resolution from a crystal belonging to space group P2(1)2(1)2 and containing two protein molecules in the asymmetric unit. The structure is similar to that reported for the NS5 protein from Japanese encephalitis virus and suggests opportunities for structure-based drug design targeting either its MTase or RdRp domain.
C1 [Upadhyay, Anup K.; Cyr, Matthew; Longenecker, Kenton; Tripathi, Rakesh; Sun, Chaohong; Kempf, Dale J.] AbbVie Inc, 1 North Waukegan Rd, N Chicago, IL 60064 USA.
RP Upadhyay, AK; Kempf, DJ (corresponding author), AbbVie Inc, 1 North Waukegan Rd, N Chicago, IL 60064 USA.
EM anup.upadhyay@abbvie.com; dale.j.kempf@abbvie.com
FU AbbVieAbbott Laboratories; FIWH; Industrial Macromolecular
   Crystallography Association; Hauptman-Woodward Medical Research
   Institute; DOE Office of ScienceUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]
FX AKU, KL, RT, CS and DJK are employees of AbbVie. This study was
   partially sponsored by AbbVie. MC performed his portion of this study at
   AbbVie as a Franciscan Institute for World Health (FIWH) Summer Intern
   in partnership with the AbbVie Neglected Diseases Program. AKU, CS and
   DJK designed the study. RT designed the expression constructs. AKU and
   MC performed the protein expression, purification, biophysical
   characterization and crystallization. KL performed the X-ray data
   collection, processing and structure determination. AKU, KL and DJK
   wrote the manuscript. All authors provided edits to the manuscript and
   reviewed the final version. Dr Jeffrey Rohde (Franciscan University,
   Steubenville, Ohio, USA) is acknowledged for his leadership and
   coordination of the FIWH intern program. William and Susan Reighard are
   gratefully acknowledged for financial support of FIWH. Use of the
   IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by
   the companies of the Industrial Macromolecular Crystallography
   Association through a contract with Hauptman-Woodward Medical Research
   Institute. This research used resources of the Advanced Photon Source, a
   US Department of Energy (DOE) Office of Science User Facility operated
   for the DOE Office of Science by Argonne National Laboratory under
   Contract No. DE-AC02-06CH11357.
CR Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giangaspero M, 2008, J VIROL METHODS, V153, P280, DOI 10.1016/j.jviromet.2008.06.024
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sesmero E, 2015, VIRUSES-BASEL, V7, P3974, DOI 10.3390/v7072808
   Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058
   Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhang Johnathan, 2016, N Am J Med Sci (Boston), V9, P47
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 35
TC 44
Z9 45
U1 0
U2 8
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD MAR
PY 2017
VL 73
BP 116
EP 122
DI 10.1107/S2053230X17001601
PN 3
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA EO8CY
UT WOS:000396917800001
PM 28291746
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Hershey, DW
AF Hershey, Douglas W.
TI Testing for Zika in asymptomatic travelers at risk
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Editorial Material
C1 [Hershey, Douglas W.] Prenatal Diag Northern Calif Med Grp, Sacramento, CA 95814 USA.
RP Hershey, DW (corresponding author), Prenatal Diag Northern Calif Med Grp, Sacramento, CA 95814 USA.
EM dhershey@pndx.com
CR Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD MAR
PY 2017
VL 216
IS 3
BP 208
EP 208
DI 10.1016/j.ajog.2016.12.014
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP0PR
UT WOS:000397089700008
PM 28104310
OA Bronze
DA 2020-07-08
ER

PT J
AU Spiliopoulos, D
   Wooton, G
   Economides, DL
   Wright, A
AF Spiliopoulos, D.
   Wooton, G.
   Economides, D. L.
   Wright, A.
TI Surveillance of pregnant women exposed to Zika virus areas
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Meeting Abstract
C1 [Spiliopoulos, D.; Wooton, G.; Economides, D. L.; Wright, A.] Royal Free London NHS Fdn Trust, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAR
PY 2017
VL 124
SU S2
SI SI
MA P.FM.2
BP 17
EP 17
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EQ6MT
UT WOS:000398196800034
DA 2020-07-08
ER

PT J
AU Aiken, ARA
   Aiken, CE
   Trussell, J
AF Aiken, A. R. A.
   Aiken, C. E.
   Trussell, J.
TI In the midst of Zika pregnancy advisories, termination of pregnancy is
   the elephant in the room
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
ID UNITED-STATES; ABORTION
C1 [Aiken, A. R. A.] Univ Texas Austin, LBJ Sch Publ Affairs, Austin, TX 78712 USA.
   [Aiken, A. R. A.; Trussell, J.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
   [Aiken, C. E.] Univ Cambridge, Univ Dept Obstet & Gynaecol, Cambridge, England.
   [Aiken, C. E.] NIHR Cambridge Comprehens Biomed Res Ctr, Cambridge, England.
   [Trussell, J.] Univ Edinburgh, Chalmers Ctr, Edinburgh, Midlothian, Scotland.
RP Aiken, ARA (corresponding author), Univ Texas Austin, Austin, TX 78713 USA.
EM araa2@utexas.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R24HD047879]
FX This work was supported by the Eunice Kennedy Shriver National Institute
   of Child Health and Human Development grant for Infrastructure for
   Population Research at Princeton University, grant R24HD047879. The
   views expressed are solely those of the authors.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Aiken ARA, 2016, CONTRACEPTION, V93, P412, DOI 10.1016/j.contraception.2016.01.007
   Centers for Disease Control and Prevention, 2016, MORBIDITY MORTALITY
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Franca GV, 2016, LANCET S
   Guttmacher Institute, 2016, STAT LAWS POL OV AB
   Guttmacher Institute, 2015, BRIEF FACTS AB LAT A
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, PREGN MAN CONT ZIK V
   World Health Organization Regional Office for Europe, 2016, ZIK VIR TECHN REP
NR 12
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAR
PY 2017
VL 124
IS 4
BP 546
EP 548
DI 10.1111/1471-0528.14296
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP4YQ
UT WOS:000397386400001
PM 27593186
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Moron, AF
AF Fernandes Moron, A.
TI Zika virus outbreak and reproductive rights
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Fernandes Moron, A.] Univ Fed Sao Paulo, Dept Obstet, Escola Paulista Med, UNIFESP, Sao Paulo, Brazil.
RP Moron, AF (corresponding author), Univ Fed Sao Paulo, Dept Obstet, Escola Paulista Med, UNIFESP, Sao Paulo, Brazil.
RI MORON, ANTONIO F./H-4987-2013
OI MORON, ANTONIO F./0000-0002-7963-1758
CR ALIKEN, 2016, NEW ENGL J MED, V375, P396
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
NR 2
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAR
PY 2017
VL 124
IS 4
BP 549
EP 549
DI 10.1111/1471-0528.14387
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP4YQ
UT WOS:000397386400002
PM 28224753
OA Bronze
DA 2020-07-08
ER

PT J
AU Merle, H
   Najioullah, F
   Chassery, M
   Cesaire, R
   Hage, R
AF Merle, Harold
   Najioullah, Fatiha
   Chassery, Maxime
   Cesaire, Raymond
   Hage, Rabih
TI Zika-Related Bilateral Hypertensive Anterior Acute Uveitis
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
ID VIRUS-INFECTION
C1 [Merle, Harold; Chassery, Maxime; Hage, Rabih] Univ Hosp Martinique, Dept Ophthalmol, Fort De France, Martinique, France.
   [Najioullah, Fatiha; Cesaire, Raymond] Univ Hosp Martinique, Dept Virol, Fort De France, Martinique, France.
RP Merle, H (corresponding author), Univ Hosp Martinique, Hop Pierre Zobda Quitman, BP 632, F-97261 Fort De France, France.
EM harold.merle@chu-fortdefrance.fr
CR Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
NR 6
TC 7
Z9 7
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAR 1
PY 2017
VL 135
IS 3
BP 284
EP +
DI 10.1001/jamaophthalmol.2016.5689
PG 3
WC Ophthalmology
SC Ophthalmology
GA EP6MO
UT WOS:000397493800028
PM 28152146
DA 2020-07-08
ER

PT J
AU Xue, L
   Manore, CA
   Thongsripong, P
   Hyman, JM
AF Xue, Ling
   Manore, Carrie A.
   Thongsripong, Panpim
   Hyman, James M.
TI Two-sex mosquito model for the persistence of Wolbachia
SO JOURNAL OF BIOLOGICAL DYNAMICS
LA English
DT Article
DE Dengue fever; chikungunya; Zika; vertical transmission; backward
   bifurcation; cytoplasmic incompatibility; basic reproduction number;
   threshold condition
ID AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; SHORTENING WOLBACHIA; BLOCKS
   DENGUE; TRANSMISSION; INFECTION; ALBOPICTUS; DYNAMICS; VECTOR;
   TEMPERATURE
AB We develop and analyse an ordinary differential equation model to investigate the transmission dynamics of releasing Wolbachia-infected mosquitoes to establish an endemic infection in a population of wild uninfected mosquitoes. Wolbachia is a genus of endosymbiotic bacteria that can infect mosquitoes and reduce their ability to transmit some viral mosquito-transmitted diseases, including dengue fever, chikungunya, and Zika. Although the bacterium is transmitted vertically from infected mothers to their offspring, it can be difficult to establish an endemic infection in a wild mosquito population. Our transmission model for the adult and aquatic-stage mosquitoes takes into account Wolbachia-induced fitness change and cytoplasmic incompatibility. We show that, for a wide range of realistic parameter values, the basic reproduction number, , is less than one. Hence, the epidemic will die out if only a few Wolbachia-infected mosquitoes are introduced into the wild population. Even though the basic reproduction number is less than one, an endemic Wolbachia infection can be established if a sufficient number of infected mosquitoes are released. This threshold effect is created by a backward bifurcation with three coexisting equilibria: a stable zero-infection equilibrium, an intermediate-infection unstable endemic equilibrium, and a high-infection stable endemic equilibrium. We analyse the impact of reducing the wild mosquito population before introducing the infected mosquitoes and observed that the most effective approach to establish the infection in the wild is based on reducing mosquitoes in both the adult and aquatic stages.
C1 [Xue, Ling; Manore, Carrie A.; Hyman, James M.] Tulane Univ, Dept Math, Ctr Computat Sci, New Orleans, LA 70118 USA.
   [Thongsripong, Panpim] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.
RP Xue, L; Manore, CA; Hyman, JM (corresponding author), Tulane Univ, Dept Math, Ctr Computat Sci, New Orleans, LA 70118 USA.; Thongsripong, P (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.
EM lxue2@tulane.edu; cmanore@tulane.edu; tpanpim@gmail.com;
   mhyman@tulane.edu
RI Hyman, James M/AAF-7389-2020
OI Hyman, James M/0000-0001-5247-5794
FU endowment for the Evelyn and John G. Phillips Distinguished Chair in
   Mathematics at Tulane University; National Science Foundation
   (NSF)National Science Foundation (NSF) [MPS-DMS-1122666, MPS-DMS-156353,
   DEB-RAPID 1641130, CHE-1314029]; NIH/NIGMS program for Models of
   Infectious Disease Agent Study (MIDAS) award [U01GM097661]
FX This work was supported by the endowment for the Evelyn and John G.
   Phillips Distinguished Chair in Mathematics at Tulane University, the
   National Science Foundation (NSF) awards MPS-DMS-1122666,
   MPS-DMS-156353, DEB-RAPID 1641130, NSF grant CHE-1314029, and the
   NIH/NIGMS program for Models of Infectious Disease Agent Study (MIDAS)
   award U01GM097661.
CR Bian G., 2010, PLOS NEGLECTED TROP, V6
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 1998, BIOSCIENCE, V48, P287, DOI 10.2307/1313355
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chan M.H., 2016, PREPRINT
   Crain PR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-290
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Dobson SL, 2002, GENETICS, V160, P1087
   Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6
   Dutra H.L.C., 2016, CELL HOST MICROBE
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gunaratne C., 2016, PREPRINT
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Hofbauer J., 1980, P AMS, V107, P1137
   Hoffmann A. A., 1997, INFLUENTIAL PASSENGE
   Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Jacups SP, 2013, J MED ENTOMOL, V50, P344, DOI 10.1603/ME12043
   Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Koiller J., 2014, TECHNICAL REPORT
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lam SK, 2011, VACCINE, V29, P9417, DOI 10.1016/j.vaccine.2011.08.047
   Li MY, 2002, IMA VOL MATH APPL, V126, P295
   Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1
   MalletParet J, 1996, J DIFFER EQUATIONS, V125, P441, DOI 10.1006/jdeq.1996.0037
   Marquardt W., 2005, BIOL DIS VECTORS
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   MULDOWNEY JS, 1990, ROCKY MT J MATH, V20, P857, DOI 10.1216/rmjm/1181073047
   Ndii MZ, 2015, MATH BIOSCI, V262, P157, DOI 10.1016/j.mbs.2014.12.011
   Ndii MZ, 2012, ANZIAM J, V53, P213, DOI 10.1017/S1446181112000132
   Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476
   Schofield P, 2002, J THEOR BIOL, V215, P121, DOI 10.1006/jtbi.2001.2493
   Schraiber JG, 2012, J THEOR BIOL, V297, P26, DOI 10.1016/j.jtbi.2011.12.006
   Seppa N., 2015, SCI NEWS MAGAZINE SO, V187, P16
   Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025
   Souto-Maior C, 2015, THEOR ECOL-NETH, V8, P53, DOI 10.1007/s12080-014-0235-7
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Suh E, 2013, J INVERTEBR PATHOL, V114, P173, DOI 10.1016/j.jip.2013.08.001
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vidyasagar M., 1980, IEEE T AUTOMAT CONTR, V25, P892
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Zhang XH, 2015, NONLINEAR ANAL-REAL, V22, P236, DOI 10.1016/j.nonrwa.2014.09.004
NR 59
TC 7
Z9 7
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1751-3758
EI 1751-3766
J9 J BIOL DYNAM
JI J. Biol. Dyn.
PD MAR
PY 2017
VL 11
IS 1
SU 1
BP 216
EP 237
DI 10.1080/17513758.2016.1229051
PG 22
WC Ecology; Mathematical & Computational Biology
SC Environmental Sciences & Ecology; Mathematical & Computational Biology
GA EN0RS
UT WOS:000395717900011
PM 27628851
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cox, J
AF Cox, Jane
TI A Pregnant Teen Living in an Area With Active Zika Virus Transmission
SO JOURNAL OF PEDIATRIC HEALTH CARE
LA English
DT Editorial Material
DE Case report; epidemiology; Zika
ID UPDATE INTERIM GUIDANCE; UNITED-STATES
C1 [Cox, Jane] NCH Community Home Care, Nursing, Naples, FL USA.
RP Cox, J (corresponding author), 8813 Tamiami Trl E, Naples, FL 34113 USA.
EM Jane.cox@nchmd.org
CR American College of Obstetricians and Gynecologists, 2016, PRACT ADV ZIK VIR
   Centers for Disease Control and Prevention, 2016, UPD WOM TRYING BEC P
   Chang D., 2016, THE MIAMI HERALD
   Dunkelberger L., 2016, ADDITIONAL ZIKA VIRU
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Florida Department of Health, 2016, ZIK UPD
   LeBeaud A., 2016, ZIKA VIRUS INFECT OV
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   U.S. Department of Health and Human Services, 2016, HER WHAT YOU NEED KN
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5245
EI 1532-656X
J9 J PEDIATR HEALTH CAR
JI J. Pediatr. Health Care
PD MAR-APR
PY 2017
VL 31
IS 2
BP 232
EP 234
DI 10.1016/j.pedhc.2016.10.009
PG 3
WC Health Policy & Services; Nursing; Pediatrics
SC Health Care Sciences & Services; Nursing; Pediatrics
GA EQ5KB
UT WOS:000398120500015
PM 27916339
DA 2020-07-08
ER

PT J
AU Nain, M
   Mukherjee, S
   Karmakar, SP
   Paton, AW
   Paton, JC
   Abdin, MZ
   Basu, A
   Kalia, M
   Vrati, S
AF Nain, Minu
   Mukherjee, Sriparna
   Karmakar, Sonali Porey
   Paton, Adrienne W.
   Paton, James C.
   Abdin, M. Z.
   Basu, Anirban
   Kalia, Manjula
   Vrati, Sudhanshu
TI GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry
   and Replication in Mammalian Cells
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Japanese encephalitis virus; flavivirus; host-cell interactions;
   receptors; viral replication; virus entry
ID ENDOPLASMIC-RETICULUM STRESS; WEST-NILE-VIRUS; MOLECULAR CHAPERONE BIP;
   SUBTILASE CYTOTOXIN; DOMAIN-III; ENVELOPE PROTEIN; TRANSIENT
   ASSOCIATION; COXSACKIEVIRUS A9; ACTIVATES PERK; GLYCOPROTEIN
AB Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, is the leading cause of viral encephalitis in Southeast Asia with potential to become a global pathogen. Here, we identify glucose-regulated protein 78 (GRP78) as an important host protein for virus entry and replication. Using the plasma membrane fractions from mouse neuronal (Neuro2a) cells, mass spectroscopy analysis identified GRP78 as a protein interacting with recombinant JEV envelope protein domain III. GRP78 was found to be expressed on the plasma membranes of Neuro2a cells, mouse primary neurons, and human epithelial Huh-7 cells. Antibodies against GRP78 significantly inhibited JEV entry in all three cell types, suggesting an important role of the protein in virus entry. Depletion of GRP78 by small interfering RNA ( siRNA) significantly blocked JEV entry into Neuro2a cells, further supporting its role in virus uptake. Immunofluorescence studies showed extensive colocalization of GRP78 with JEV envelope protein in virus-infected cells. This interaction was also confirmed by immunoprecipitation studies. Additionally, GRP78 was shown to have an important role in JEV replication, as treatment of cells post-virus entry with subtilase cytotoxin that specifically cleaved GRP78 led to a substantial reduction in viral RNA replication and protein synthesis, resulting in significantly reduced extracellular virus titers. Our results indicate that GRP78, an endoplasmic reticulum chaperon of the HSP70 family, is a novel host factor involved at multiple steps of the JEV life cycle and could be a potential therapeutic target.
   IMPORTANCE Recent years have seen a rapid spread of mosquito-borne diseases caused by flaviviruses. The flavivirus family includes West Nile, dengue, Japanese encephalitis, and Zika viruses, which are major threats to public health with potential to become global pathogens. JEV is the major cause of viral encephalitis in several parts of Southeast Asia, affecting a predominantly pediatric population with a high mortality rate. This study is focused on identification of crucial host factors that could be targeted to cripple virus infection and ultimately lead to development of effective antivirals. We have identified a cellular protein, GRP78, that plays a dual role in virus entry and virus replication, two crucial steps of the virus life cycle, and thus is a novel host factor that could be a potential therapeutic target.
C1 [Nain, Minu; Karmakar, Sonali Porey; Kalia, Manjula; Vrati, Sudhanshu] Vaccine & Infect Dis Res Ctr, Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, Faridabad, India.
   [Nain, Minu; Abdin, M. Z.] Fac Sci, Dept Biotechnol, New Delhi, India.
   [Mukherjee, Sriparna; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India.
   [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Dept Mol & Cellular Biol, Adelaide, SA, Australia.
   [Vrati, Sudhanshu] Reg Ctr Biotechnol, NCR Biotech Sci Cluster, Faridabad, India.
RP Nain, M (corresponding author), Vaccine & Infect Dis Res Ctr, Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, Faridabad, India.; Nain, M (corresponding author), Fac Sci, Dept Biotechnol, New Delhi, India.
OI Kalia, Manjula/0000-0002-3376-3659
FU Indo-French CentreFrench National Research Agency (ANR) [5203-3];
   Department of Biotechnology, Ministry of Science and Technology
   [BT/MB/01/VIDRC/08]; Tata Innovation Fellowship [BT/HRD/35/01/02/2014];
   DST Inspire Fellowship [IF/140074]; CSIR fellowshipCouncil of Scientific
   & Industrial Research (CSIR) - India
FX This work was supported by research grant 5203-3 from the Indo-French
   Centre for the Promotion of Advanced Research (IFCPAR) to M. K. and
   grant BT/MB/01/VIDRC/08 from the Department of Biotechnology, Ministry
   of Science and Technology, to S.V.A.B. acknowledges support from a Tata
   Innovation Fellowship (BT/HRD/35/01/02/2014) and S. M. from a DST
   Inspire Fellowship (IF/140074). M. N. was supported by a CSIR
   fellowship.
CR Bellani S, 2014, CELL DEATH DIFFER, V21, P1971, DOI 10.1038/cdd.2014.111
   Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56
   Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0
   Bhullar D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114931
   Buchkovich NJ, 2008, J VIROL, V82, P31, DOI 10.1128/JVI.01881-07
   Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009
   Chiou SS, 2005, J MED VIROL, V76, P583, DOI 10.1002/jmv.20406
   Cho DY, 2003, J VIROL, V77, P2784, DOI 10.1128/JVI.77.4.2784-2788.2003
   Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991
   Fan Jingjing, 2013, Virologica Sinica, V28, P152, DOI 10.1007/s12250-013-3331-8
   Gaudin Y, 1997, J VIROL, V71, P3742, DOI 10.1128/JVI.71.5.3742-3750.1997
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Ghosh S, 2015, J NEUROCHEM, V135, P368, DOI 10.1111/jnc.13208
   Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200
   Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]
   Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2
   Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09
   HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002
   Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574
   Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010
   Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523
   Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   MACHAMER CE, 1990, J BIOL CHEM, V265, P6879
   Maruri-Avidal L, 2008, J VIROL, V82, P5368, DOI 10.1128/JVI.02751-07
   Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003
   Misra UK, 2008, J CELL BIOCHEM, V104, P96, DOI 10.1002/jcb.21607
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MULVEY M, 1995, J VIROL, V69, P1621, DOI 10.1128/JVI.69.3.1621-1627.1995
   Nain M, 2016, REV MED VIROL, V26, P129, DOI 10.1002/rmv.1868
   NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273
   Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124
   Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392
   Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08
   Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409
   Ren JP, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-83
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rosenberg E, 2001, CANCER RES, V61, P764
   ROUX L, 1990, VIROLOGY, V175, P161, DOI 10.1016/0042-6822(90)90196-X
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266
   Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036
   Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002
   Triantafilou M, 2001, HUM IMMUNOL, V62, P764, DOI 10.1016/S0198-8859(01)00269-5
   Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736
   Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09
   Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x
   Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200
   Wu YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-128
   Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017
   Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0
   Zu XY, 2014, ANTIVIR RES, V104, P7, DOI 10.1016/j.antiviral.2014.01.011
NR 75
TC 25
Z9 25
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2017
VL 91
IS 6
DI 10.1128/JVI.02274-16
PG 21
WC Virology
SC Virology
GA EQ5CF
UT WOS:000398098300026
PM 28053106
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Meinhardt, A
AF Meinhardt, Andreas
TI Infection: A new threat on the horizon-Zika virus and male fertility
SO NATURE REVIEWS UROLOGY
LA English
DT Editorial Material
ID SERTOLI-CELLS; EPIDIDYMIS; SEMEN
C1 [Meinhardt, Andreas] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.
RP Meinhardt, A (corresponding author), Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.
EM andreas.meinhardt@anatomie.med.uni-giessen.de
CR Dejucq-Rainsford N, 2004, CURR PHARM DESIGN, V10, P557, DOI 10.2174/1381612043453225
   Govero J, 2016, NATURE
   Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Michel V, 2016, J PATHOL, V240, P15, DOI 10.1002/path.4748
   Pilatz A, 2015, EUR UROL, V68, P428, DOI 10.1016/j.eururo.2014.12.005
   Savasi V, 2013, HUM REPROD UPDATE, V19, P136, DOI 10.1093/humupd/dms046
   Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7
   Suarez-Pinzon W, 2000, DIABETES, V49, P1810, DOI 10.2337/diabetes.49.11.1810
NR 10
TC 4
Z9 4
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4812
EI 1759-4820
J9 NAT REV UROL
JI Nat. Rev. Urol.
PD MAR
PY 2017
VL 14
IS 3
BP 135
EP +
DI 10.1038/nrurol.2016.265
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA EN1UX
UT WOS:000395796800008
PM 28072401
DA 2020-07-08
ER

PT J
AU Bell, SG
AF Bell, Susan Givens
TI Laboratory Evaluation of Infants with Possible Congenital Zika Virus
   Infection
SO NEONATAL NETWORK
LA English
DT Article
DE Zika virus; congenital infection; real-time
   reverseranscription-polymerase chain reaction; enzyme-linked
   inimunosorbent assay; laboratory testing
ID UPDATE INTERIM GUIDANCE; UNITED-STATES
AB Our understanding of the effects of maternal Zika virus infection on the newborn continues to evolve. First discovered in 1947 in the Zika Forest in Uganda, the world became more aware of the virus in 2015, with reports of hundreds of cases of inicrocephaly in Brazilian newborns whose mothers reported symptoms related to Zika viral infection during pregnancy. This article reviews the current guidelines for laboratory evaluation of newborns with possible congenital Zika virus infection.
C1 [Bell, Susan Givens] Childrens Hosp & Clin Minnesota, St Paul, MN 55102 USA.
   [Bell, Susan Givens] Acad Neonatal Nursing, St Paul, MN USA.
   [Bell, Susan Givens] FANNP, St Paul, MN USA.
   [Bell, Susan Givens] NANN, St Paul, MN USA.
   [Bell, Susan Givens] NANNP, St Paul, MN USA.
   [Bell, Susan Givens] AANP, St Paul, MN USA.
   [Bell, Susan Givens] Sigma Theta Tau, St Paul, MN USA.
   [Bell, Susan Givens] Honor Soc Phi Kappa Phi, St Paul, MN USA.
RP Bell, SG (corresponding author), Childrens Hosp & Clin Minnesota, Neonatal Nurse Practitioner Serv, St Paul, MN 55102 USA.
EM sjgbell@gmail.com
CR American College of Obstetricians and Gynecologists, 2016, PRACT ADV ZIK VIR
   Birkebaek NH, 2003, J CLIN ENDOCR METAB, V88, P5281, DOI 10.1210/jc.2003-030527
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, FLAV
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/clinchem.2004.036517
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   World Health Organization, 2016, ZIK VIR COMPL HIST Z
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER PUBLISHING CO
PI NEW YORK
PA 11 WEST 42ND STREET, NEW YORK, NY 10036 USA
SN 0730-0832
EI 1539-2880
J9 NEONATAL NETW
JI Neonatal Netw.
PD MAR-APR
PY 2017
VL 36
IS 2
BP 103
EP 106
DI 10.1891/0730-0832.36.2.103
PG 4
WC Nursing
SC Nursing
GA EN9EG
UT WOS:000396302900006
PM 28320497
DA 2020-07-08
ER

PT J
AU Zerillo, J
   Kim, S
   Hill, B
   DeMaria, S
   Sakai, T
AF Zerillo, Jeron
   Kim, Sang
   Hill, Bryan
   DeMaria, Samuel, Jr.
   Sakai, Tetsuro
TI Noteworthy Literature Published in 2016 for Abdominal Organ Transplant
   Anesthesiologists: Pancreas, Intestine, and Renal Transplantation
SO SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA
LA English
DT Article
DE review; anesthesiology; pancreas transplantation; intestine
   transplantation; kidney transplantation
ID KIDNEY-TRANSPLANTATION; AWAITING TRANSPLANTATION; HEMODIALYSIS-PATIENTS;
   UNITED-STATES; DISEASE; MORTALITY; CANDIDATES; RECIPIENTS; SURVIVAL;
   RISK
AB More than 400 peer-reviewed publications on the topic of pancreas transplantation, more than 400 on intestine transplantation, and more than 3000 on renal transplantation were published in 2016. This review will highlight the most pertinent literature for anesthesiologists caring for patients undergoing non-liver abdominal organ transplantation. This review is the second part in an annual series to review relevant contributions in the field of abdominal organ transplantation focusing on pancreas, intestine, and renal transplantation. We explore a myriad of topics, including outcomes determined by center size, novel assessment of intestine graft function, the effect of Zika virus on the transplant population, appropriate fluid management for renal transplantation, cardiovascular risk assessment in the transplant population, and several topics pertinent to optimizing patient and graft survival.
C1 [Zerillo, Jeron; Kim, Sang; Hill, Bryan; DeMaria, Samuel, Jr.] Icahn Sch Med Mt Sinai, One Gustave Levy Pl, New York, NY 10029 USA.
   [Sakai, Tetsuro] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA.
RP Zerillo, J (corresponding author), Icahn Sch Med Mt Sinai, One Gustave Levy Pl, New York, NY 10029 USA.
EM jeron.zerillo@mountsinai.org
RI ; DeMaria, Samuel/I-8138-2013
OI Zerillo, Jeron/0000-0001-6563-4125; DeMaria, Samuel/0000-0003-2808-5539
CR Axelrod DA, 2010, AM J TRANSPLANT, V10, P837, DOI 10.1111/j.1600-6143.2009.02996.x
   Charytan D, 2007, AM J KIDNEY DIS, V49, P409, DOI 10.1053/j.ajkd.2006.11.042
   Charytan DM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003558
   Gerlach UA, 2016, AM J TRANSPLANT, V16, P1892, DOI 10.1111/ajt.13693
   Gill JS, 2005, J AM SOC NEPHROL, V16, P808, DOI 10.1681/ASN.2004090810
   Hachamovitch R, 1998, CIRCULATION, V97, P535
   Hart A, 2016, AM J TRANSPLANT, V16, P11, DOI 10.1111/ajt.13666
   Himmelfarb J, 2005, AM J KIDNEY DIS, V45, P1122, DOI 10.1053/j.ajkd.2005.02.031
   Kandaswamy R, 2016, AM J TRANSPLANT, V16, P47, DOI 10.1111/ajt.13667
   Kopp W, 2017, TRANSPLANTATION, V101, P1247, DOI 10.1097/TP.0000000000001308
   Kumar N, 2011, CLIN J AM SOC NEPHRO, V6, P1912, DOI 10.2215/CJN.08680910
   Lenihan CR, 2017, TRANSPLANTATION, V101, P851, DOI 10.1097/TP.0000000000001446
   Lentine KL, 2012, CIRCULATION, V126, P617, DOI 10.1161/CIR.0b013e31823eb07a
   Levi DM, 2003, LANCET, V361, P2173, DOI 10.1016/S0140-6736(03)13769-5
   Lindley EM, 2016, AM J CARDIOL, V117, P146, DOI 10.1016/j.amjcard.2015.10.016
   Lonning K, 2016, TRANSPLANTATION, V100, P2705, DOI 10.1097/TP.0000000000001363
   Medin C, 2000, NEPHROL DIAL TRANSPL, V15, P701, DOI 10.1093/ndt/15.5.701
   Molnar MZ, 2017, TRANSPLANTATION, V101, P1353, DOI 10.1097/TP.0000000000001326
   Moody WE, 2016, AM J CARDIOL, V117, P1387, DOI 10.1016/j.amjcard.2016.02.003
   Niemann CU, 2015, NEW ENGL J MED, V373, P405, DOI 10.1056/NEJMoa1501969
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   O'Malley CMN, 2002, TRANSPLANT P, V34, P3142, DOI 10.1016/S0041-1345(02)03593-5
   Perez-Saez MJ, 2016, AM J TRANSPLANT, V16, P2724, DOI 10.1111/ajt.13800
   Rabbat CG, 2000, J AM SOC NEPHROL, V11, P917
   Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8
   Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI [10.1053/j.ajkd.2015.05.001, 10.1053/j.ajkd.2015.12.014]
   Sarno G, 2014, J AM COLL CARDIOL, V64, P16, DOI 10.1016/j.jacc.2014.04.022
   Scalea JR, 2017, AM J TRANSPLANT, V17, P191, DOI 10.1111/ajt.13948
   Scalea JR, 2016, TRANSPL INT, V29, P810, DOI 10.1111/tri.12754
   Smith JM, 2016, AM J TRANSPLANT, V16, P99, DOI 10.1111/ajt.13669
   Stoumpos S, 2015, TRANSPL INT, V28, P10, DOI 10.1111/tri.12413
   Wan S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010741.pub2
   Wang LW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008691.pub2
   WHO, 2016, HIST ZIK VIR
   Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303
   Wong G, 2017, TRANSPLANTATION, V101, P1152, DOI 10.1097/TP.0000000000001351
   World Health Organization, 2016, STRAT RESP PLAN Q UP
NR 37
TC 2
Z9 2
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1089-2532
EI 1940-5596
J9 SEMIN CARDIOTHORAC V
JI Semin. Cardiothorac. Vasc. Anesth.
PD MAR
PY 2017
VL 21
IS 1
BP 70
EP 80
DI 10.1177/1089253216688538
PG 11
WC Anesthesiology
SC Anesthesiology
GA EM6AV
UT WOS:000395396100010
PM 28107792
DA 2020-07-08
ER

PT J
AU Ragan, IK
   Blizzard, EL
   Gordy, P
   Bowen, RA
AF Ragan, Izabela K.
   Blizzard, Emily L.
   Gordy, Paul
   Bowen, Richard A.
TI Investigating the Potential Role of North American Animals as Hosts for
   Zika Virus
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Review
DE animal reservoirs; immunity; North American animals; viremia; Zika virus
ID WEST-NILE-VIRUS; ARBOVIRUSES; SURVEILLANCE
AB The recent emergence of the mosquito-borne Zika virus (ZIKV) in the Americas has become a global public health concern. We describe a series of experimental infections designed to investigate whether animals within certain taxonomic groups in North America have the potential to serve as ZIKV amplifying or maintenance hosts. Species investigated included armadillos, cottontail rabbits, goats, mink, chickens, pigeons, ground hogs, deer mice, cattle, raccoons, ducks, Syrian Golden hamsters, garter snakes, leopard frogs, house sparrows, and pigs. Infectious virus was isolated from blood only in frogs and armadillos; however, the magnitude of viremia was low. In addition, neutralizing antibodies were detected after infection in goats, rabbits, ducks, frogs, and pigs. This study indicates that the animals tested to date are unlikely to act as animal reservoirs for ZIKV, but that rabbits and pigs could potentially serve as sentinel species. Understanding the transmission cycle and maintenance of ZIKV in animals will help in developing effective surveillance programs and preventative measures for future outbreaks.
C1 [Ragan, Izabela K.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Blizzard, Emily L.; Gordy, Paul; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, 3107 Rampart Rd, Ft Collins, CO 80523 USA.
RP Bowen, RA (corresponding author), Colorado State Univ, Dept Biomed Sci, 3107 Rampart Rd, Ft Collins, CO 80523 USA.
EM rbowen@colostate.edu
OI Ragan, Izabela/0000-0002-1379-6015
FU U.S. Department of Homeland SecurityUnited States Department of Homeland
   Security (DHS) [DHS-2010-ST-061-AG0001]
FX The work completed by Izabela Ragan was supported by the U.S. Department
   of Homeland Security under grant award number DHS-2010-ST-061-AG0001.
   The authors thank Dennis Kohler and Patrick Whitley for providing mink
   and Jeff Root for the raccoons. ZIKV stocks were originally provided by
   Robert Tesh and the CDC. The views and conclusions contained in this
   document are those of the authors and should not be interpreted as
   necessarily representing the official policies, either expressed or
   implied, of the U.S. Department of Homeland Security.
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fagbami AH, 2009, J HYG LOND, V83, P213
   Favoretto S, 1 DETECTION ZIKA VIR
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halliday JEB, 2007, J R SOC INTERFACE, V4, P973, DOI 10.1098/rsif.2007.0237
   Inoue S, 2003, J MED PRIMATOL, V32, P89, DOI 10.1034/j.1600-0684.2003.00015.x
   Komar N, 2001, ANN NY ACAD SCI, V951, P58
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Lucia S, 2016, ALL COUNTRIES TERRIT
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Reisen WK, 2013, VIRUSES-BASEL, V5, P2079, DOI 10.3390/v5092079
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   WESTAWAY EG, 1966, AM J EPIDEMIOL, V84, P439, DOI 10.1093/oxfordjournals.aje.a120657
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 20
TC 17
Z9 20
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAR
PY 2017
VL 17
IS 3
BP 161
EP 164
DI 10.1089/vbz.2016.2099
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EM6DO
UT WOS:000395403200001
PM 28145811
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, V.
TI Comment on "Zika virus disease: Should we be worried?"
SO ACTAS DERMO-SIFILIOGRAFICAS
LA English
DT Letter
C1 [Wiwanitkit, V.] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Peoples R China.
EM wviroj@yahoo.com
CR Alonso JP, 2016, ACTAS DERMO-SIFILOGR, V107, P625, DOI 10.1016/j.ad.2016.08.001
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER ESPANA S I
PI MADRID
PA INFANTA MERCEDES 90, MADRID, 28020, SPAIN
SN 0001-7310
EI 1578-2190
J9 ACTAS DERMO-SIFILOGR
JI Actas Dermo-Sifilogr.
PD MAR
PY 2017
VL 108
IS 2
BP 173
EP 173
PG 1
WC Dermatology
SC Dermatology
GA EQ5CQ
UT WOS:000398099500021
PM 27914622
DA 2020-07-08
ER

PT J
AU Alonso, JP
AF Alonso, J. P.
TI Response to Professor Wiwanitkit's Comment on "Zika Virus Disease:
   Should We Be Worried?"
SO ACTAS DERMO-SIFILIOGRAFICAS
LA English
DT Letter
C1 [Alonso, J. P.] Direcc Gen Salud Publ, Dept Sanidad, Zaragoza, Spain.
RP Alonso, JP (corresponding author), Direcc Gen Salud Publ, Dept Sanidad, Zaragoza, Spain.
EM jpalonso@aragon.es
CR Alonso JP, 2016, ACTAS DERMO-SIFILOGR, V107, P625, DOI 10.1016/j.ad.2016.08.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER ESPANA S I
PI MADRID
PA INFANTA MERCEDES 90, MADRID, 28020, SPAIN
SN 0001-7310
EI 1578-2190
J9 ACTAS DERMO-SIFILOGR
JI Actas Dermo-Sifilogr.
PD MAR
PY 2017
VL 108
IS 2
BP 174
EP 174
PG 1
WC Dermatology
SC Dermatology
GA EQ5CQ
UT WOS:000398099500022
PM 27914626
DA 2020-07-08
ER

PT J
AU Howells, ME
   Lynn, C
   Sesepasara, M
AF Howells, M. E.
   Lynn, C.
   Sesepasara, M.
TI The embodiment of inequality: Zika risk in the Pacific Island of
   American Samoa
SO AMERICAN JOURNAL OF HUMAN BIOLOGY
LA English
DT Meeting Abstract
C1 [Howells, M. E.] Univ North Carolina Wilmington, Dept Anthropol, Wilmington, NC USA.
   [Howells, M. E.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.
   [Lynn, C.] Univ Alabama, Dept Anthropol, Tuscaloosa, AL USA.
FU University of North Carolina Wilmington; University of Alabama
FX University of North Carolina Wilmington and the University of Alabama
   and is part of the Pepe, Aiga, and Tina Health Study (PATHs) in American
   Samoa.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-0533
EI 1520-6300
J9 AM J HUM BIOL
JI Am. J. Hum. Biol.
PD MAR-APR
PY 2017
VL 29
IS 2
SI SI
MA P19
PG 2
WC Anthropology; Biology
SC Anthropology; Life Sciences & Biomedicine - Other Topics
GA EP5GM
UT WOS:000397407000060
DA 2020-07-08
ER

PT J
AU Pieters, M
   Howells, ME
AF Pieters, M.
   Howells, M. E.
TI Zika in rural Guatemala: Condom stigmatization and the embodiment of
   risk
SO AMERICAN JOURNAL OF HUMAN BIOLOGY
LA English
DT Meeting Abstract
C1 [Pieters, M.; Howells, M. E.] Univ North Carolina Wilmington, Dept Anthropol, Wilmington, NC USA.
   [Howells, M. E.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.
FU University of North Carolina Wilmington Summer Undergraduate Research
   and Creativity Awards (SURCA)
FX University of North Carolina Wilmington Summer Undergraduate Research
   and Creativity Awards (SURCA).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-0533
EI 1520-6300
J9 AM J HUM BIOL
JI Am. J. Hum. Biol.
PD MAR-APR
PY 2017
VL 29
IS 2
SI SI
MA P17
PG 1
WC Anthropology; Biology
SC Anthropology; Life Sciences & Biomedicine - Other Topics
GA EP5GM
UT WOS:000397407000096
DA 2020-07-08
ER

PT J
AU Blumberg, EA
   Fishman, JA
AF Blumberg, E. A.
   Fishman, J. A.
TI Zika Virus in Transplantation: Emerging Infection and Opportunities
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Editorial Material
ID DENGUE VIRUS
C1 [Blumberg, E. A.] Univ Penn, Sch Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.
   [Fishman, J. A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.
   [Fishman, J. A.] Massachusetts Gen Hosp, Transplant Ctr, Boston, MA 02114 USA.
   [Fishman, J. A.] Harvard Med Sch, Boston, MA 02115 USA.
RP Fishman, JA (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Fishman, JA (corresponding author), Massachusetts Gen Hosp, Transplant Ctr, Boston, MA 02114 USA.; Fishman, JA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM jfishman@partners.org
CR Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wilson MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14058
   World Health Organization, 2016, WHOZIKVMOC161
NR 8
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAR
PY 2017
VL 17
IS 3
DI 10.1111/ajt.14083
PG 2
WC Surgery; Transplantation
SC Surgery; Transplantation
GA EP5PY
UT WOS:000397432100005
PM 27743485
DA 2020-07-08
ER

PT J
AU Nogueira, ML
   Estofolete, CF
   Terzian, ACB
   do Vale, EPBM
   da Silva, RCMA
   da Silva, RF
   Ramalho, HJ
   Charpiot, IMMF
   Vasilakis, N
   Abbud, M
AF Nogueira, M. L.
   Estofolete, C. F.
   Terzian, A. C. B.
   Mascarin do Vale, E. P. B.
   da Silva, R. C. M. A.
   da Silva, R. F.
   Ramalho, H. J.
   Fernandes Charpiot, I. M. M.
   Vasilakis, N.
   Abbud-Filho, M.
TI Zika Virus Infection and Solid Organ Transplantation: A New Challenge
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
ID DENGUE
AB Public health concerns exist surrounding the epidemic of the Zika virus (ZIKV) and the rapid growth of transplantation in developing countries, including endemic zones of active arbovirus transmission, as well as travel to such regions by potential organ donors and recipients. Few data exist regarding the clinical characteristics of ZIKV infection in immunocompromised hosts. Laboratory screening protocols for transplantation to differentiate ZIKV infections from other endemic viral diseases and for the detection of possible donor-derived infection have not been stated. The diagnosis of ZIKV infection remains a challenge, fueled by the lack of standardized commercially available diagnostic tests and validated reference diagnostic laboratories, as well as the limited duration of ZIKV viremia. In this small series, ZIKV infection in renal and liver recipients presented without rash, conjunctivitis, or neurological symptoms, and with abnormal graft function, thrombocytopenia, and bacterial superinfection. We report the first case series of ZIKV infection in solid organ recipients, with a description of clinical and laboratory features and therapeutic management.
C1 [Nogueira, M. L.; Estofolete, C. F.; Terzian, A. C. B.; Mascarin do Vale, E. P. B.] Med Sch Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, R. C. M. A.; da Silva, R. F.; Ramalho, H. J.; Fernandes Charpiot, I. M. M.] Hosp Base, Med Sch Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Vasilakis, N.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, N.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, N.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Abbud-Filho, M.] Sao Jose Rio do Preto Hosp Base, Urol & Nephrol Inst, Med Sch Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Med Sch Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Abbud-Filho, Mario/E-5525-2017; Nogueira, Mauricio L/B-7599-2012; Alves
   da Silva, Rita de Cassia/A-3404-2019; Estofolete, Cassia/N-6673-2019; da
   Silva, Renato Ferreira/A-3016-2019; Abbud-Filho, Mario/H-6801-2019
OI Abbud-Filho, Mario/0000-0002-5079-9813; Nogueira, Mauricio
   L/0000-0003-1102-2419; Estofolete, Cassia/0000-0001-7324-1591; da Silva,
   Renato Ferreira/0000-0002-9548-1892; 
CR Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BRASIL, 2016, DENG DIAGN MAN CLIN, P58
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, 2016, ADV PEOPL LIV TRAV S
   CDC, 2016, ZIK VIR CAP VERD
   CDC, 2016, ALL COUNTR TERR ACT
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Kotton CN, 2016, TRANSPLANTATION, V100, P970, DOI 10.1097/TP.0000000000001179
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasim A, 2013, TRANSPL INFECT DIS, V15, P516, DOI 10.1111/tid.12114
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PHE, 2016, ZIK VIR IMM PAT PUBL
   Renaud CJ, 2007, NEPHROLOGY, V12, P305, DOI 10.1111/j.1440-1797.2007.00785.x
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   WHO, 1998, WEEKL EP REP DENG DE, P182
   WHO, 2016, ZIK VIR INF GLOB UPD, P73
NR 28
TC 36
Z9 38
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAR
PY 2017
VL 17
IS 3
DI 10.1111/ajt.14047
PG 5
WC Surgery; Transplantation
SC Surgery; Transplantation
GA EP5PY
UT WOS:000397432100025
PM 27629942
DA 2020-07-08
ER

PT J
AU Wilson, MR
   Zimmermann, LL
   Crawford, ED
   Sample, HA
   Soni, PR
   Baker, AN
   Khan, LM
   DeRisi, JL
AF Wilson, M. R.
   Zimmermann, L. L.
   Crawford, E. D.
   Sample, H. A.
   Soni, P. R.
   Baker, A. N.
   Khan, L. M.
   DeRisi, J. L.
TI Acute West Nile Virus Meningoencephalitis Diagnosed Via Metagenomic Deep
   Sequencing of Cerebrospinal Fluid in a Renal Transplant Patient
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
ID RECIPIENTS; ENCEPHALITIS; OUTBREAK; DISEASE; TRANSMISSION; INFECTION;
   SEARCH
AB Solid organ transplant patients are vulnerable to suffering neurologic complications from a wide array of viral infections and can be sentinels in the population who are first to get serious complications from emerging infections like the recent waves of arboviruses, including West Nile virus, Chikungunya virus, Zika virus, and Dengue virus. The diverse and rapidly changing landscape of possible causes of viral encephalitis poses great challenges for traditional candidate-based infectious disease diagnostics that already fail to identify a causative pathogen in approximately 50% of encephalitis cases. We present the case of a 14-year-old girl on immunosuppression for a renal transplant who presented with acute meningoencephalitis. Traditional diagnostics failed to identify an etiology. RNA extracted from her cerebrospinal fluid was subjected to unbiased metagenomic deep sequencing, enhanced with the use of a Cas9-based technique for host depletion. This analysis identified West Nile virus (WNV). Convalescent serum serologies subsequently confirmed WNV seroconversion. These results support a clear clinical role for metagenomic deep sequencing in the setting of suspected viral encephalitis, especially in the context of the high-risk transplant patient population.
C1 [Wilson, M. R.; Crawford, E. D.; Sample, H. A.; Khan, L. M.; DeRisi, J. L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.
   [Wilson, M. R.; Sample, H. A.] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Zimmermann, L. L.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA.
   [Crawford, E. D.; DeRisi, J. L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
   [Soni, P. R.; Baker, A. N.] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA.
RP Wilson, MR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Wilson, MR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.
EM michael.wilson@ucsf.edu
RI Crawford, Emily/AAA-9674-2019
OI Crawford, Emily/0000-0003-4182-2337; Wilson, Michael/0000-0002-8705-5084
FU UCSF Center for Next-Gen Precision Medicine - Sandler Foundation; UCSF
   Center for Next-Gen Precision Medicine - William K. Bowes, Jr.
   Foundation; Howard Hughes Medical InstituteHoward Hughes Medical
   Institute; National Center for Advancing Translational Sciences of the
   National Institutes of Health (NIH) [KL2TR000143]
FX Research reported in this publication was supported by the UCSF Center
   for Next-Gen Precision Medicine supported by the Sandler and William K.
   Bowes, Jr. Foundations (J.L.D., H.A.S, L.M.K., and M.R.W.); Howard
   Hughes Medical Institute (J.L.D.); and the National Center for Advancing
   Translational Sciences of the National Institutes of Health (NIH) under
   Award Number KL2TR000143 (M.R.W.). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NIH. We thank Derek Bogdanoff and Eric Chow in the
   UCSF Center for Advanced Technology for their expertise and assistance
   operating the Illumina sequencer. We thank the Sandler and William K.
   Bowes, Jr. Foundations for their generous philanthropic support. Lastly,
   we thank the patient and her family for their participation in this
   research program.
CR Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841
   Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65
   Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82
   Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Kistler AL, 2010, J VIROL, V84, P2176, DOI 10.1128/JVI.02191-09
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Prasad N, 2012, TRANSPL INFECT DIS, V14, P163, DOI 10.1111/j.1399-3062.2011.00699.x
   Pruitt AA, 2013, NEUROHOSPITALIST, V3, P152, DOI 10.1177/1941874412466090
   Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967
   Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12
   Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086
   Wang J, 2007, ADV CRYPTOLOGY CHINA, V2007, P306
   Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wright AJ, 2014, CLIN INFECT DIS, V59, P1001, DOI 10.1093/cid/ciu428
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Xuan L, 2013, TRANSPLANTATION, V96, P560, DOI 10.1097/TP.0b013e31829d38af
   Yango AF, 2014, TRANSPLANTATION, V97, P953, DOI 10.1097/01.TP.0000438621.81686.ab
   Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10
   Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595
   ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714
NR 27
TC 31
Z9 33
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAR
PY 2017
VL 17
IS 3
DI 10.1111/ajt.14058
PG 6
WC Surgery; Transplantation
SC Surgery; Transplantation
GA EP5PY
UT WOS:000397432100027
PM 27647685
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salchuddin, AR
   Haslan, H
   Mamikutty, N
   Zaidun, NH
   Azmi, MF
   Senin, MM
   Fuad, SBSA
   Thent, ZC
AF Salchuddin, Ahmad Ruzian
   Haslan, Haszianaliza
   Mamikutty, Norshalizah
   Zaidun, Nurul Hannim
   Azmi, Mohamad Fairuz
   Senin, Mohamad Mu'izuddin
   Fuad, Syed Baharom Syed Ahmad
   Thent, Zar Chi
TI Zika virus infection and its emerging trends in Southeast Asia
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE Zika virus; Emerging infection; Microcephaly; Neurological complication
ID RIO-DE-JANEIRO; SEXUAL TRANSMISSION; FRENCH-POLYNESIA;
   PHYLOGENETIC-RELATIONSHIPS; DECEMBER 2013; TRAVELERS; OUTBREAK; DISEASE;
   FEBRILE; PATIENT
AB Zika virus is a mosquito-borne flavivirus that represents a public health emergency at the ongoing epidemic. Previously, this rare virus was limited to sporadic cases in Africa and Asia until its emergence in Brazil, South America in 2015, where it rapidly spread throughout the world. Recently, a high number of cases were reported in Singapore and other Southeast Asia countries. A combination of factors explains the current Zika virus outbreak although it is highly likely that the changes in the climate and high frequency of travelling contribute to the spread of Aedes vector carrying the Zika virus mainly to the tropical climate countries such as the Southeast Asia. The Zika virus is known to cause mild clinical symptoms similar to those of dengue and chikungunya and transmitted by different species of Aedes mosquitoes. However, neurological complications such as Guillain-Barre syndrome in adults, and congenital anomalies, including microcephaly in babies born to infected mothers, raised a serious concern. Currently, there is no specific antiviral treatment or vaccine available for Zika virus infection. Therefore, international public health response is primarily focused on preventing infection, particularly in pregnant women, and on providing up-to-date recommendations to reduce the risk of non-vector transmission of Zika virus.
C1 [Salchuddin, Ahmad Ruzian; Haslan, Haszianaliza; Mamikutty, Norshalizah; Zaidun, Nurul Hannim; Azmi, Mohamad Fairuz; Senin, Mohamad Mu'izuddin; Fuad, Syed Baharom Syed Ahmad; Thent, Zar Chi] Univ Teknol Malaysia, Fac Med, Discipline Anatomy, Selangor, Malaysia.
   [Senin, Mohamad Mu'izuddin] Klinik Dr Muiz, Selangor, Malaysia.
RP Salchuddin, AR (corresponding author), Univ Teknol Malaysia, Fac Med, Discipline Anatomy, Selangor, Malaysia.
EM ruz_arbs@yahoo.com
RI theint, zar chi/AAA-5780-2019; amsalu, ribka/G-8780-2019; Das,
   Srijit/E-8457-2017
OI theint, zar chi/0000-0002-7915-0364; Das, Srijit/0000-0001-8302-7257;
   Azmi, Muhammad Fairuz/0000-0003-4526-9057; Salehuddin, Ahmad
   Ruzain/0000-0003-0913-186X
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], THE STRAITS TIMES
   [Anonymous], NEW STRAITS TIMES
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Diseases Control and Prevention (CDC), ZIK VIR SE AS
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Henry R, 2014, EMERG INFECT DIS, V20, P1090, DOI DOI 10.3201/EID2006.131508
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nicastri E, 2009, EUROSURVEILLANCE, V14, P19446
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2013, EUROSURVEILLANCE, V54, P54
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 66
TC 12
Z9 12
U1 0
U2 12
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAR
PY 2017
VL 10
IS 3
BP 201
EP 208
DI 10.1016/j.apjtm.2017.03.002
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EP6IU
UT WOS:000397482700001
PM 28442104
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tosepu, R
AF Tosepu, Ramadhan
TI Temperature and development of Zika virus infection: an Indonesian case
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Zika virus; Temperature; Diseases
AB Distribution of Zika virus has spread throughout the world. WHO has announced that Zika virus disease is a global health problem. As a tropical country, Indonesia has the potential to spread Zika virus. This letter is to report that there was a single case of zika in Jambi province published by the Eijkman Institute for Molecular Biology. This case was analyzed with the temperature in the scene, which is considered as an appropriate factor to development of Zika virus.
C1 [Tosepu, Ramadhan] Univ Halu Oleo, Fac Publ Hlth, Kendari, Indonesia.
RP Tosepu, R (corresponding author), Univ Halu Oleo, Fac Publ Hlth, Kendari, Indonesia.
EM ramadhan.tosepu@uho.ac.id
RI Tosepu, Ramadhan/P-8564-2015
OI Tosepu, Ramadhan/0000-0002-6092-9992
CR Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Nurdiana A, 2015, PROCEDIA ENVIRON SCI, V24, P141, DOI 10.1016/j.proenv.2015.03.019
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P614, DOI 10.1016/j.apjtm.2016.04.017
   Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034
NR 10
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAR
PY 2017
VL 10
IS 3
BP 300
EP 300
DI 10.1016/j.apjtm.2017.03.013
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EP6IU
UT WOS:000397482700015
PM 28442118
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Quintens, R
AF Quintens, Roel
TI Convergence and divergence between the transcriptional responses to Zika
   virus infection and prenatal irradiation
SO CELL DEATH & DISEASE
LA English
DT Editorial Material
ID NEUROGENESIS; BRAIN; MICE; P53
C1 [Quintens, Roel] Belgian Nucl Res Ctr, Inst Environm Hlth & Safety, Radiobiol Unit, Mol, Belgium.
RP Quintens, R (corresponding author), CEN SCK, Belgian Nucl Res Ctr, Inst Environm Hlth & Safety, Radiobiol Unit, Boeretang 200, B-2400 Mol, Belgium.
EM roel.quintens@sckcen.be
RI Quintens, Roel/G-5339-2017
OI Quintens, Roel/0000-0002-4359-3403
FU EU-FP7 project CEREBRAD [295552]; Research Foundation-FlandersFWO
   [CO-90-15-3905-00]
FX This research is supported by the EU-FP7 project CEREBRAD (grant
   agreement 295552) and the Research Foundation-Flanders (grant agreement
   CO-90-15-3905-00).
CR Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035
   Case CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064575
   Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8
   Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007
   Quintens R, 2015, BIOL OPEN, V4, P331, DOI 10.1242/bio.20149969
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Verreet T, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00083
   Verreet T, 2015, J NEURODEV DISORD, V7, DOI 10.1186/1866-1955-7-3
   Zhou WW, 2016, ELIFE, V5, DOI 10.7554/eLife.18108
NR 14
TC 0
Z9 0
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAR
PY 2017
VL 8
AR e2672
DI 10.1038/cddis.2017.109
PG 3
WC Cell Biology
SC Cell Biology
GA EP5VM
UT WOS:000397447100048
PM 28300836
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lin, GG
   Zhang, K
   Zhang, D
   Han, YX
   Xie, JH
   Li, JM
AF Lin, Guigao
   Zhang, Kuo
   Zhang, Dong
   Han, Yanxi
   Xie, Jiehong
   Li, Jinming
TI Fast preparation of a long chimeric armored RNA as controls for external
   quality assessment for molecular detection of Zika virus
SO CLINICA CHIMICA ACTA
LA English
DT Article
DE Zika virus; Armored RNA; External quality assessment; Molecular
   diagnosis
ID REVERSE TRANSCRIPTION-PCR; BRANCHED DNA; TRANSMISSION; AMERICA
AB Background: The emergence of Zika virus demands accurate laboratory diagnostics. Nucleic acid testing is currently the definitive method for diagnosis of Zika infection. In 2016, an external quality assurance (EQA) for assessing the quality of molecular testing of Zika virus was carried out in China.
   Methods: A single armored RNA encapsulating a 4942-nucleotides (nt) long specific RNA sequence of Zika virus was prepared and used as positive samples. A pre-tested EQA panel, consisting of 4 negative and 6 positive samples with different concentrations of armored RNA, was distributed to 38 laboratories that perform molecular detection of Zilca virus.
   Results: A total of 39 data sets (1 laboratory used two test kits in parallel), produced by using commercial (n = 38) or laboratory developed (n = 1) quantitative reverse-transcriptase PCR (qRT-PCR) kits, were received. Of these, 35 (89.7%) had correct results for all 10 samples, and 4 (10.3%) reported at least 1 error (11 in total). The testing errors were all false-negatives, highlighting the need of improvements in detecting sensitivity.
   Conclusions: The EQA reveals that the majority of participating laboratories are proficient in molecular testing of Zika virus. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Li, Jinming] Beijing Hosp, Natl Ctr Gerontol, Natl Ctr Clin Labs, 1 Dahua Rd, Beijing 100730, Peoples R China.
   Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China.
RP Li, JM (corresponding author), Beijing Hosp, Natl Ctr Gerontol, Natl Ctr Clin Labs, 1 Dahua Rd, Beijing 100730, Peoples R China.
EM linguigao1982@163.com; sarahkuo@163.com; danwin_0607@163.com;
   hanyanxicici@163.com; jhxie@nccl.org.cn; jmli@nccl.org.cn
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DuBois DB, 2001, U. S. patent, Patent No. [6,214,982, 6214982]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hong P, 2012, VIRUS RES, V167, P1, DOI 10.1016/j.virusres.2012.04.004
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan Y, 2012, INT J NANOMED, V7, P5957, DOI 10.2147/IJN.S37990
   Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590, DOI 10.1128/JCM.36.12.3590-3594.1998
   Rolfsson O, 2016, J MOL BIOL, V428, P431, DOI 10.1016/j.jmb.2015.11.014
   Sun Y, 2013, J CLIN MICROBIOL, V51, P4055, DOI 10.1128/JCM.02018-13
   WalkerPeach CR, 1999, CLIN CHEM, V45, P2079
   Wang GJ, 2016, ONCOTARGET, V7, P59402, DOI 10.18632/oncotarget.10681
   Wang GJ, 2015, DIAGN MICR INFEC DIS, V83, P355, DOI 10.1016/j.diagmicrobio.2015.07.025
   Wang GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132659
   Wei BJ, 2008, INTERVIROLOGY, V51, P144, DOI 10.1159/000141707
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Yu XF, 2008, J CLIN MICROBIOL, V46, P837, DOI 10.1128/JCM.01904-07
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhan S, 2009, J CLIN MICROBIOL, V47, P2571, DOI 10.1128/JCM.00232-09
   Zhang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134681
   Zhang J., 2016, J TRAVEL MED, V23
   Zhang L, 2016, J CLIN VIROL, V75, P5, DOI 10.1016/j.jcv.2015.12.001
   Zhang LL, 2015, APPL MICROBIOL BIOT, V99, P2815, DOI 10.1007/s00253-014-6113-9
NR 35
TC 1
Z9 4
U1 0
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD MAR
PY 2017
VL 466
BP 138
EP 144
DI 10.1016/j.cca.2017.01.023
PG 7
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA EQ1MQ
UT WOS:000397834600022
PM 28111270
DA 2020-07-08
ER

PT J
AU Gonzalez-Salazar, C
   Stephens, CR
   Sanchez-Cordero, V
AF Gonzalez-Salazar, Constantino
   Stephens, Christopher R.
   Sanchez-Cordero, Victor
TI Predicting the Potential Role of Non-human Hosts in Zika Virus
   Maintenance
SO ECOHEALTH
LA English
DT Article
DE Wildlife host; Dengue; Chikungunya; Zika virus; Arbovirus; Aedes aegypti
ID TRYPANOSOMA-CRUZI; DIDELPHIS-VIRGINIANA; SEROLOGIC EVIDENCE; DENGUE
   VIRUS; INFECTION; BATS; YUCATAN; TRANSMISSION; DISTURBANCE; DIVERSITY
AB Arboviruses are often maintained in complex cycles involving vertebrates such as mammals or birds and blood-feeding mosquitoes. However, the role of wildlife hosts in their emergence or re-emergence in human populations has received little attention. The recent emergence of Zika virus in America, and previous occurrences of chikungunya and dengue, forces us to confront a potential new disease-emergence phenomenon. Using a spatial data mining framework to identify potential biotic interactions, based on the degree of co-occurrence between different species, we identified those mammal species with the highest potential for establishing mammal-vector interactions, considering as principal vector Aedes aegypti. Seven of the top ten identified mammal species with highest potential were bats, with two of them having previously been confirmed as positive hosts for dengue in Mexico. We hope that this will raise interest of Mexican public health authorities and academic institutions to assess the role of wild hosts in the maintenance and spread of arboviruses.
C1 [Gonzalez-Salazar, Constantino; Stephens, Christopher R.] Univ Nacl Autonoma Mexico, C3, Ciudad Univ, Mexico City 04510, DF, Mexico.
   [Stephens, Christopher R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico.
   [Sanchez-Cordero, Victor] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico.
RP Gonzalez-Salazar, C (corresponding author), Univ Nacl Autonoma Mexico, C3, Ciudad Univ, Mexico City 04510, DF, Mexico.
EM cgsalazar7@gmail.com
RI Gonzalez-Salazar, Constantino/M-3913-2015
OI Gonzalez-Salazar, Constantino/0000-0001-7347-714X
FU PAPIIT-UNAMPrograma de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IG200217];
   Centro de Ciencias de la Complejidad; Laboratorio Nacional de Ciencias
   de la Complejidad
FX Mosquito data were kindly provided by the National Commission for the
   Knowledge and Use of Biodiversity (Comision Nacional para el
   Conocimiento y Uso de la Biodiversidad, CONABIO) of Mexico. We deeply
   thank two anonymous referees for their significant comments and
   suggestions to improve this manuscript. We are grateful for financial
   support from PAPIIT-UNAM grant number IG200217. CGS is grateful for
   financial support from the Centro de Ciencias de la Complejidad and the
   Laboratorio Nacional de Ciencias de la Complejidad.
CR Aguilar-Setien A, 2008, EPIDEMIOL INFECT, V136, P1678, DOI 10.1017/S0950268808000460
   Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0
   Lopez-Cancino SA, 2015, ACTA TROP, V151, P58, DOI 10.1016/j.actatropica.2015.07.021
   Berzunza-Cruz M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003438
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cruz-Salazar B, 2016, J TROP ECOL, V32, P146, DOI 10.1017/S0266467416000080
   Curi NHD, 2006, MEM I OSWALDO CRUZ, V101, P99, DOI 10.1590/S0074-02762006000100019
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ECDC, 2015, RAP RISK ASS ZIK VIR
   ESTRADA A, 1994, ECOGRAPHY, V17, P229, DOI 10.1111/j.1600-0587.1994.tb00098.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gonzalez-Salazar C, 2013, ECOL MODEL, V248, P57, DOI 10.1016/j.ecolmodel.2012.10.007
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hennessy C, 2015, J WILDLIFE MANAGE, V79, P112, DOI 10.1002/jwmg.812
   Herrera L, 2010, B MALARIOL SALUD AMB, V50, P3
   Kaddumukasa A. M., 2015, AFR J BIOTECHNOL, V14, P1418, DOI DOI 10.5897/AJB2015.14474
   Klimpel S, 2014, PARASITOLOGY RES MON
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Machain-Williams C, 2013, J WILDLIFE DIS, V49, P684, DOI 10.7589/2012-12-318
   Martinez-Hernandez F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-405
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI 10.1046/j.1523-1739.2000.99068.x
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110
   REAGAN REGINALD L., 1955, TRANS AMER MICROSC SOC, V74, P77, DOI 10.2307/3223847
   Rico Chávez Oscar, 2015, Veterinaria México OA, V2, P01
   Ruiz-Pina HA, 2002, MEM I OSWALDO CRUZ, V97, P613, DOI 10.1590/S0074-02762002000500003
   Sotomayor-Bonilla J, 2014, AM J TROP MED HYG, V91, P129, DOI 10.4269/ajtmh.13-0524
   Stephens CR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005004
   Stephens CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005725
   Turner PE, 2010, EVOLUTION, V64, P3273, DOI 10.1111/j.1558-5646.2010.01051.x
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villegas-Garcia JC, 2001, REV BIOL TROP, V49, P685
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   World Health Organization WHO, 2016, REP ZIK SIT NEUR SYN
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 40
TC 7
Z9 7
U1 2
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD MAR
PY 2017
VL 14
IS 1
BP 171
EP 177
DI 10.1007/s10393-017-1206-4
PG 7
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA EQ3UJ
UT WOS:000397998300018
PM 28180996
OA Green Published
DA 2020-07-08
ER

PT J
AU Bennouna, A
   Balenghien, T
   El Rhaffouli, H
   Schaffner, F
   Garros, C
   Gardes, L
   Lhor, Y
   Hammoumi, S
   Chlyeh, G
   Fihri, OF
AF Bennouna, A.
   Balenghien, T.
   El Rhaffouli, H.
   Schaffner, F.
   Garros, C.
   Gardes, L.
   Lhor, Y.
   Hammoumi, S.
   Chlyeh, G.
   Fihri, O. Fassi
TI First record of Stegomyia albopicta (= Aedes albopictus) in Morocco: a
   major threat to public health in North Africa?
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Stegomyia albopicta; arbovirus; Asian tiger mosquito; vector; Morocco
ID MOSQUITO; SKUSE
AB The Asian tiger mosquito Stegomyia albopicta (= Aedes albopictus) (Diptera: Culicidae), native to Asian forests, is a nuisance mosquito and is responsible for the transmission of arboviruses of public health importance, such as dengue, chikungunya and Zika viruses. It has colonized parts of all continents, except Antarctica, over the past 30-40 years. However, to date, the only records of S. albopicta in North Africa refer to occasional collections in 2010 and 2014 in Algeria. In early September 2015, S. albopicta larvae and adults were collected in a district of Rabat, Morocco. Morphological identification was confirmed by molecular analysis. This is the first record of this invasive mosquito in Morocco. A national surveillance programme will be implemented in 2016 to establish its geographical distribution in Morocco and to instigate control measures to prevent the establishment of new populations and the transmission of arboviruses.
C1 [Bennouna, A.; Balenghien, T.; Fihri, O. Fassi] Inst Agron & Vet Med Hassan II, Dept Anim Pathol & Publ Hlth, Microbiol Immunol & Infect Dis Unit, Rabat, Morocco.
   [Balenghien, T.; Garros, C.; Gardes, L.] CMAEE, Unit Mixte Rech UMR 15, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France.
   [El Rhaffouli, H.] Univ Mohammed V Souissi, Mohammed V Mil Teaching Hosp, Biosafety Level & Res Lab 3, Rabat, Morocco.
   [Schaffner, F.] Francis Schaffner Consultancy, Riehen, Switzerland.
   [Schaffner, F.] Univ Zurich, Natl Ctr Vector Entomol, Inst Parasitol, Zurich, Switzerland.
   [Lhor, Y.] Off Natl Securi Sanit Prod Alimentaires ONSSA, Rabat, Morocco.
   [Hammoumi, S.] IRD, Inst Sci Evolut Montpellier, CNRS, UMR 226,UM2,Inst Sci Evolut Montpellier, Montpellier, France.
   [Chlyeh, G.] Inst Agron & Vet Med Hassan II, Dept Prod Protect & Biotechnol Vegetales, Unite Zool, Rabat, Morocco.
RP Bennouna, A (corresponding author), Rabat Inst, Hassan II Inst Agron & Vet Med, Dept Anim Pathol & Publ Hlth, Microbiol Immunol & Infect Dis Unit, POB 6202, Rabat 10101, Morocco.
EM bennouna1amal@gmail.com
OI Schaffner, Francis/0000-0001-9166-7617
FU EUEuropean Union (EU) [FP7-613996]
FX This study was partially funded by EU grant FP7-613996 Vmerge and is
   catalogued by the VMERGE Steering Committee as Vmerge010
   (http://www.vmerge.eu). The contents of this publication are the
   responsibility of only the authors and do not necessarily reflect the
   views of the European Commission.
CR Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Desvars A, 2015, ACTA TROP, V142, P5, DOI 10.1016/j.actatropica.2014.10.018
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Izri A, 2011, CLIN MICROBIOL INFEC, V17, P1116, DOI 10.1111/j.1469-0691.2010.03443.x
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   Lafri Ismail, 2014, Bulletin de la Societe Zoologique de France, V139, P257
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Ministere de l'Equipement, 2014, METL CHIFFR
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Schaffner F., 2001, IDENTIFICATION TRAIN
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
NR 19
TC 9
Z9 10
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD MAR
PY 2017
VL 31
IS 1
BP 102
EP 106
DI 10.1111/mve.12194
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EP4EX
UT WOS:000397334600014
PM 27775162
DA 2020-07-08
ER

PT J
AU Rahman, NA
   Huhtaniemi, I
AF Rahman, Nafis A.
   Huhtaniemi, Ilpo
TI Zika virus infection-do they also endanger male fertility?
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
C1 [Rahman, Nafis A.; Huhtaniemi, Ilpo] Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland.
   [Rahman, Nafis A.] Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, PL-15276 Bialystok, Poland.
   [Huhtaniemi, Ilpo] Imperial Coll London, Inst Reprod & Dev Biol, London W12 ONN, England.
RP Rahman, NA; Huhtaniemi, I (corresponding author), Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland.; Rahman, NA (corresponding author), Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, PL-15276 Bialystok, Poland.; Huhtaniemi, I (corresponding author), Imperial Coll London, Inst Reprod & Dev Biol, London W12 ONN, England.
EM nafis.rahman@utu.fi; ilpo.huhtaniemi@imperial.ac.uk
CR Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Ma W., 2016, CELL, V167
NR 4
TC 2
Z9 2
U1 0
U2 1
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD MAR
PY 2017
VL 60
IS 3
BP 324
EP 325
DI 10.1007/s11427-016-0414-4
PG 2
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EO7LB
UT WOS:000396871100015
PM 28108947
DA 2020-07-08
ER

PT J
AU Roth, NJ
   Schafer, W
   Popp, B
   Stucki, M
   Fang, R
AF Roth, Nathan J.
   Schaefer, Wolfram
   Popp, Birgit
   Stucki, Martin
   Fang, Randel
TI Verification of effective Zika virus reduction by production steps used
   in the manufacture of plasma-derived medicinal products
SO TRANSFUSION
LA English
DT Letter
ID WEST-NILE-VIRUS; INACTIVATION
C1 [Roth, Nathan J.; Schaefer, Wolfram; Popp, Birgit; Stucki, Martin; Fang, Randel] Global Pathogen Safety, Bern, Switzerland.
   [Roth, Nathan J.; Stucki, Martin] CSL Behring AG, Bern, Switzerland.
   [Schaefer, Wolfram; Popp, Birgit] CSL Behring GmbH, Marburg, Germany.
   [Fang, Randel] CSL Behring Australia Pty Ltd, Broadmeadows, Australia.
RP Roth, NJ (corresponding author), Global Pathogen Safety, Bern, Switzerland.; Roth, NJ (corresponding author), CSL Behring AG, Bern, Switzerland.
EM nathan.roth@cslbehring.com
RI Roth, Nathan J/K-3894-2013
CR Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   NOWAK T, 1992, BIOLOGICALS, V20, P83, DOI 10.1016/S1045-1056(05)80011-9
   Remington KM, 2004, VOX SANG, V87, P10, DOI 10.1111/j.1423-0410.2004.00530.x
NR 4
TC 5
Z9 5
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
BP 720
EP 721
DI 10.1111/trf.14038
PG 2
WC Hematology
SC Hematology
GA EP6NU
UT WOS:000397497000034
PM 28297081
DA 2020-07-08
ER

PT J
AU Pyzocha, NJ
   Chinchen, SE
   Maurer, DM
AF Pyzocha, Natasha J.
   Chinchen, Stephanie E.
   Maurer, Douglas M.
TI Zany Over Zika Virus: An Overview of Diagnosis and Treatment Modalities
SO CURRENT SPORTS MEDICINE REPORTS
LA English
DT Review
ID INFECTION; TRANSMISSION; AMERICA
AB Zika virus has been a recent international public health concern with outbreaks occurring in the Americas, Caribbean, and Pacific. The zoonotic infection is primarily spread to humans by the bite of an infected Aedes mosquito. The virus also can be transmitted via bodily fluids, sexual intercourse, and maternal-fetal vertical transmission. Asymptomatic presentation is common. If symptoms do occur, individuals display a low-grade fever, maculopapular rash, arthralgia, or conjunctivitis 2 to 7 d after infection. Infection is concerning due to its associated fetal effects in pregnant women and relationship with Guillain-Barre syndrome. Diagnosis should be suspected in individuals with the appropriate symptomatology and exposure history. Diagnostic tests for the Zika virus are available and vary based on symptomduration. Treatment is supportive, and surveillance is suggested for all pregnant women. Prior infection is thought to provide immunity toward future exposures. Prevention and education is key in decreasing the spread of disease.
C1 [Pyzocha, Natasha J.] Evans Army Community Hosp, Dept Family Med, Ft Carson, CO USA.
   [Chinchen, Stephanie E.; Maurer, Douglas M.] Madigan Army Med Ctr, Dept Family Med, Ft Lewis, WA USA.
RP Pyzocha, NJ (corresponding author), DiRaimondo Aviat Clin, Dept Family Med, Bldg 1058, Ft Carson, CO 80913 USA.
EM Natasha.j.pyzocha.mil@mail.mil
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], ZIK VIR WHAT CLIN NE
   [Anonymous], ZIK VIR TRANSM RISKS
   [Anonymous], ZIK VIR TEST ZIK VIR
   [Anonymous], ZIK VIR PROT YOURS S
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR PREGN WOM
   Centers for Disease Control and Prevention, ZIK VIR AR ZIK
   Centers for Disease Control and Prevention (CDC), ZIK VIR PREV
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Emergencies preparedness response, EM PREP RESP PSYCH S
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   World health organization, EM HIST ZIK VIR
   World Health Organization, WHO EXP PRIOR VACC D
   World Health Organization (WHO), EM PREP RESP ZIK VIR
NR 25
TC 3
Z9 3
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1537-890X
EI 1537-8918
J9 CURR SPORT MED REP
JI Curr. Sport. Med. Rep.
PD MAR-APR
PY 2017
VL 16
IS 2
BP 109
EP 113
DI 10.1249/JSR.0000000000000346
PG 5
WC Sport Sciences
SC Sport Sciences
GA EN3WG
UT WOS:000395938000013
PM 28282358
DA 2020-07-08
ER

PT J
AU Carrieri, M
   Albieri, A
   Urbanelli, S
   Angelini, P
   Venturelli, C
   Matrangolo, C
   Bellini, R
AF Carrieri, Marco
   Albieri, Alessandro
   Urbanelli, Sandra
   Angelini, Paola
   Venturelli, Claudio
   Matrangolo, Carmela
   Bellini, Romeo
TI Quality control and data validation procedure in large-scale
   quantitative monitoring of mosquito density: the case of Aedes
   albopictus in Emilia-Romagna region, Italy
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Aedes albopictus; chikungunya; dengue; Zika; monitoring network; risk
   assessment; quality control; data validation
ID CHIKUNGUNYA OUTBREAK AREA; POPULATION-SIZE SURVEY; FRANCE; DENGUE;
   VIRUS; SKUSE
AB The risk of local transmission of chikungunya, dengue, and Zika viruses from viremic travelers arriving from affected areas is a real possibility in southern Europe, due to the large presence of the vector Aedes albopictus. The first chikungunya outbreak in Europe occurred in the Emilia-Romagna region, Italy, in 2007, prompting the regional public health department to implement an Ae. albopictus monitoring and control plan. This paper presents the procedure developed for the quality control of the data collected by the regional ovitrap monitoring network. The quality control procedure consists of four successive steps; the first step is data acquisition and the second is an automatic data processing step, while skilled technicians according to specific procedures perform the third and fourth steps by checking the exact position of the ovitraps and by conducting human landing collections, respectively. The paper also presents the results of this quality control procedure applied to the data collected through the large-scale Ae. albopictus monitoring operation performed in Emilia-Romagna in 2015.
C1 [Carrieri, Marco; Albieri, Alessandro; Bellini, Romeo] Ctr Agr Ambiente G Nicoli, Dept Med & Vet Entomol, Sustenia, Crevalcore, Italy.
   [Urbanelli, Sandra] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy.
   [Angelini, Paola] Publ Hlth Serv, Bologna, Italy.
   [Venturelli, Claudio; Matrangolo, Carmela] Romagna Local Publ Hlth Unit, Dept Publ Hlth, Cesena, Italy.
RP Bellini, R (corresponding author), Ctr Agr Ambiente G Nicoli, Dept Med & Vet Entomol, Sustenia, Crevalcore, Italy.
EM rbellini@caa.it
RI URBANELLI, Sandra/N-8821-2016
OI URBANELLI, Sandra/0000-0003-1183-0344; Carrieri,
   Marco/0000-0001-6444-0636
FU EU Environmental Funding Program [LIFE12 ENV/GR/000466]; Regional Health
   Authority of Emilia-Romagna
FX This study has been conducted in the frame of the LIFE CONOPS project
   Development & demonstration of management plans against - the climate
   change enhanced invasive mosquitoes in S. Europe' (LIFE12 ENV/GR/000466)
   co-funded by the EU Environmental Funding Program LIFE+ Environment
   Policy and Governance with the support of the Regional Health Authority
   of Emilia-Romagna.
CR Albieri A, 2010, B INSECTOL, V63, P209
   Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Buntin G. David, 1994, P99
   Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259
   Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Carrieri M, 2009, J AM MOSQUITO CONTR, V25, P149, DOI 10.2987/08-5852.1
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Romi R, 2008, EUR INFECT DIS, V2, P98
   Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
NR 20
TC 2
Z9 2
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD MAR
PY 2017
VL 111
IS 2
BP 83
EP 90
DI 10.1080/20477724.2017.1292992
PG 8
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA EN5EZ
UT WOS:000396029700005
PM 28274195
OA Green Published
DA 2020-07-08
ER

PT J
AU Deichstetter, P
AF Deichstetter, Peggy
TI The Effect of Climate Change on Mosquito-Borne Diseases
SO AMERICAN BIOLOGY TEACHER
LA English
DT Article
DE mosquitoes; vector-borne diseases; climate change; hatch rate
ID TEMPERATURE; MALARIA; DYNAMICS; SPREAD
AB Global climate change will affect all living things on this planet. For many species, the change in their environment may mean extinction. However, there is one organism, the mosquito, that may benefit from changes in the climate. This paper addresses the possible effects of climate change on mosquitoes, including longer breeding seasons and increased hatch rates of populations. The enlarged population will cause mosquitoes to seek more territory, and the warmer climate will in turn make more territory available. If mosquitoes increase in population, there may be an amplification of mosquito-borne diseases such as malaria, yellow fever, Chikungunya virus, St. Louis encephalitis, West Nile virus, and the Zika virus. This trend of increased range because of climate change has already been observed in dengue fever. This information can be used as an engaging segue into teaching students about climate change and vector-borne disease.
C1 [Deichstetter, Peggy] Devry Univ, 4N610 Wescot Lane, West Chicago, IL 60185 USA.
RP Deichstetter, P (corresponding author), Devry Univ, 4N610 Wescot Lane, West Chicago, IL 60185 USA.
EM pdeichstetter@gmail.com
CR Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328
   Bambrick HJ, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2059
   Barchfield J, 2016, HLTH OFFICIALS PROBE
   Bouzid M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-781
   CDC, 2016, ZIK VIR
   Center for Disease Control, 2016, GUIALL BARR SYNDR
   Center for Disease Control, 2016, MOSQ BORN DIS
   Center for Disease Control, 2016, DET PREV VECT BORN D
   Cha A., 2016, WASHINGTON POST
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Cornwall W, 2016, SCIENCE, V351, P1249, DOI 10.1126/science.351.6279.1249
   Daniel Milan, 2009, Central European Journal of Public Health, V17, P139
   Ehiri JE, 2004, J PUBLIC HEALTH POL, V25, P9, DOI 10.1057/palgrave.jphp.3190001
   Ewing C., 2013, HUMANS VS MOSQUITOES
   Ewing DA, 2016, J THEOR BIOL, V400, P65, DOI 10.1016/j.jtbi.2016.04.008
   Fleming JR, 2014, ENVIRON HIST-UK, V20, P577, DOI 10.3197/096734014X14091313617442
   Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737
   Harvey C., 2016, WASH POST, P1, DOI DOI 10.1002/9781118663219
   Kovats RS, 2001, PHILOS T ROY SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584
   McMichael A. J., 2010, BIOMED CENTRAL BIOL, V8, P1
   Meason B, 2014, HEALTH HUM RIGHTS, V16, P105
   Medley KA, 2015, MOL ECOL, V24, P284, DOI 10.1111/mec.12925
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Phillips D., 2016, WASHINGTON POST
   Reiter P., 2001, ENVIRON HEALTH PERSP, V109, P140
   Rogers DJ, 2000, SCIENCE, V289, P1763
   Semenza J. C, 2012, ENVIRON HEALTH PERSP, V120, P285
   Singh S, 2005, J BIOL SYST, V13, P1, DOI 10.1142/S0218339005001367
   Solow AR, 2015, SCIENCE, V349, P1444, DOI 10.1126/science.aad2132
   Sternberg ED, 2014, TRENDS PARASITOL, V30, P115, DOI 10.1016/j.pt.2013.12.010
   Sun L., 2016, WASHINGTON POST
   van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wimberly M. C., 2014, AM J TROPICAL HYGIEN, V91
   World Health Organization, 2015, GLOB ACT PLAN CONTR, P1, DOI DOI 10.1016/S0968-8080(12)40660-7
   Yacoub S, 2011, PHILOS T R SOC A, V369, P1719, DOI 10.1098/rsta.2011.0013
NR 43
TC 1
Z9 1
U1 2
U2 82
PU NATL ASSOC BIOLOGY TEACHERS INC
PI RESTON
PA 12030 SUNRISE VALLEY DR, #110, RESTON, VA 20191 USA
SN 0002-7685
EI 1938-4211
J9 AM BIOL TEACH
JI Am. Biol. Teach.
PD MAR
PY 2017
VL 79
IS 3
BP 169
EP 173
DI 10.1525/abt.2017.79.3.169
PG 5
WC Biology; Education, Scientific Disciplines
SC Life Sciences & Biomedicine - Other Topics; Education & Educational
   Research
GA EM8MA
UT WOS:000395564200002
DA 2020-07-08
ER

PT J
AU Lu, GF
   Bluemling, GR
   Collop, P
   Hager, M
   Kuiper, D
   Gurale, BP
   Painter, GR
   De La Rosa, A
   Kolykhalov, AA
AF Lu, Gaofei
   Bluemling, Gregory R.
   Collop, Paul
   Hager, Michael
   Kuiper, Damien
   Gurale, Bharat P.
   Painter, George R.
   De La Rosa, Abel
   Kolykhalov, Alexander A.
TI Analysis of Ribonucleotide 5 '-Triphosphate Analogs as Potential
   Inhibitors of Zika Virus RNA-Dependent RNA Polymerase by Using
   Nonradioactive Polymerase Assays
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE RdRp; ZIKV; Zika virus; nonradioactive assay; polymerase assay;
   polymerase inhibitor
ID HEPATITIS-C VIRUS; ENZYMATIC METHOD; NUCLEOTIDE; NS5B; DNA;
   IDENTIFICATION; TRANSMISSION; NUCLEOSIDE; SOFOSBUVIR; EFFICIENCY
AB Zika virus (ZIKV) is an emerging human pathogen that is spreading rapidly through the Americas and has been linked to the development of microcephaly and to a dramatically increased number of Guillain-Barre syndrome cases. Currently, no vaccine or therapeutic options for the prevention or treatment of ZIKV infections exist. In the study described in this report, we expressed, purified, and characterized full-length nonstructural protein 5 (NS5) and the NS5 polymerase domain (NS5pol) of ZIKV RNA-dependent RNA polymerase. Using purified NS5, we developed an in vitro nonradioactive primer extension assay employing a fluorescently labeled primertemplate pair. Both purified NS5 and NS5pol can carry out in vitro RNA-dependent RNA synthesis in this assay. Our results show that Mn2+ is required for enzymatic activity, while Mg2+ is not. We found that ZIKV NS5 can utilize single-stranded DNA but not double-stranded DNA as a template or a primer to synthesize RNA. The assay was used to compare the efficiency of incorporation of analog 5'-triphosphates by the ZIKV polymerase and to calculate their discrimination versus that of natural ribonucleotide triphosphates (rNTPs). The 50% inhibitory concentrations for analog rNTPs were determined in an alternative nonradioactive coupled-enzyme assay. We determined that, in general, 2'-C-methyl- and 2'-C-ethynyl-substituted analog 5'-triphosphates were efficiently incorporated by the ZIKV polymerase and were also efficient chain terminators. Derivatives of these molecules may serve as potential antiviral compounds to be developed to combat ZIKV infection. This report provides the first characterization of ZIKV polymerase and demonstrates the utility of in vitro polymerase assays in the identification of potential ZIKV inhibitors.
C1 [Lu, Gaofei; Bluemling, Gregory R.; Collop, Paul; Hager, Michael; Kuiper, Damien; Gurale, Bharat P.; Painter, George R.; De La Rosa, Abel; Kolykhalov, Alexander A.] Emory Univ, EIDD, Atlanta, GA 30322 USA.
   [Bluemling, Gregory R.; Painter, George R.; De La Rosa, Abel; Kolykhalov, Alexander A.] Drug Innovat Ventures Emory DRIVE, Atlanta, GA 30322 USA.
   [Painter, George R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.
RP Kolykhalov, AA (corresponding author), Emory Univ, EIDD, Atlanta, GA 30322 USA.; Kolykhalov, AA (corresponding author), Drug Innovat Ventures Emory DRIVE, Atlanta, GA 30322 USA.
EM a.kolykhalov@emory.edu
FU Georgia Research Alliance (GRA) grant [GRA.VL16.C3]
FX Partial funding for this project was provided by Georgia Research
   Alliance (GRA) grant GRA.VL16.C3.
CR Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3
   Arnold JJ, 1999, J BIOL CHEM, V274, P37060, DOI 10.1074/jbc.274.52.37060
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10
   Cholongitas E, 2014, ANN GASTROENTEROL, V27, P331
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Degasperi E, 2014, HEPATIC MED-EVID RES, V6, P25, DOI 10.2147/HMER.S44375
   Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999
   Fung A, 2014, ANTIMICROB AGENTS CH, V58, P3636, DOI 10.1128/AAC.02666-14
   Gentile I, 2013, CURR MED CHEM, V20, P3733, DOI 10.2174/09298673113209990178
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lahser FC, 2004, ANAL BIOCHEM, V325, P247, DOI 10.1016/j.ab.2003.10.034
   Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morin B, 2014, J BIOL CHEM, V289, P9961, DOI 10.1074/jbc.M113.542761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   NYREN P, 1987, ANAL BIOCHEM, V167, P235, DOI 10.1016/0003-2697(87)90158-8
   NYREN P, 1985, ANAL BIOCHEM, V151, P504, DOI 10.1016/0003-2697(85)90211-8
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169
   Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432
   Sacramento CQ, 2016, BIORXIV
   Siegel RW, 1999, J VIROL, V73, P6424, DOI 10.1128/JVI.73.8.6424-6429.1999
   Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j
   TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361
   Waheed Y, 2013, INFECT GENET EVOL, V14, P247, DOI 10.1016/j.meegid.2012.12.004
   Yu F, 2007, ARCH VIROL, V152, P1859, DOI 10.1007/s00705-007-1007-0
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 41
TC 26
Z9 26
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAR
PY 2017
VL 61
IS 3
AR UNSP e01967-16
DI 10.1128/AAC.01967-16
PG 15
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA EL4QM
UT WOS:000394605900036
PM 27993851
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Medina, SS
   Ozelo, MC
AF Medina, S. S.
   Ozelo, M. C.
TI Zika virus and inherited bleeding disorders
SO HAEMOPHILIA
LA English
DT Editorial Material
ID INACTIVATION; OUTBREAK; ISLAND
C1 [Medina, S. S.; Ozelo, M. C.] Univ Estadual Campinas, INCT Sangue Hemoctr UNICAMP, IHTC Claudio LP Correa, Campinas, SP, Brazil.
   [Ozelo, M. C.] Univ Estadual Campinas, FCM UNICAMP, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil.
RP Ozelo, MC (corresponding author), Univ Estadual Campinas, INCT Sangue Hemoctr Unicamp, IHTC Hemophilia Unit Claudio Luiz Pizzigatti Corr, Rua Carlos Chagas 480,Cidade Univ, BR-13083878 Sao Paulo, Brazil.
EM margaret@unicamp.br
RI Ozelo, Margareth C/K-5819-2012
OI Ozelo, Margareth C/0000-0001-5938-0675
FU PfizerPfizer; Novo NordiskNovo Nordisk; Baxalta-Shire; BiogenBiogen;
   BayerBayer AG; CSL Behring; Novo Nordisk BiogenNovo Nordisk
FX S.S. Medina has received consultancy fee from Pfizer, and speaker fees
   from Novo Nordisk, Baxalta-Shire, Pfizer and Biogen. M C. Ozelo has
   received funding for research from Bayer, CSL Behring, Novo Nordisk
   Biogen and Baxalta-Shire, and consultancy and speaker fees from Novo
   Nordisk, Baxalta-Shire, Pfizer and Biogen.
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Key NS, 2007, LANCET, V370, P439, DOI 10.1016/S0140-6736(07)61199-4
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pecci A, 2016, CLIN GENET, V89, P141, DOI 10.1111/cge.12603
   Peyvandi F, 2016, J THROMB HAEMOST, V14, P2095, DOI 10.1111/jth.13491
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 17
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD MAR
PY 2017
VL 23
IS 2
BP 177
EP 179
DI 10.1111/hae.13177
PG 3
WC Hematology
SC Hematology
GA EP5GC
UT WOS:000397406000001
PM 28300361
OA Bronze
DA 2020-07-08
ER

PT J
AU Liu, L
   Zhang, S
   Wu, D
   Song, JD
   Li, A
   Zhang, H
   Wu, W
   Tan, QQ
   Li, C
   Zhang, QF
   Zhou, HQ
   Liang, MF
   Ke, CW
   Li, DX
AF Liu, Lin
   Zhang, Shuo
   Wu, De
   Song, Jingdong
   Li, Aqian
   Zhang, Huan
   Wu, Wei
   Tan, Qiqi
   Li, Chuan
   Zhang, Quanfu
   Zhou, Huiqiong
   Liang, Mifang
   Ke, Changwen
   Li, Dexin
TI Identification and genetic characterization of Zika virus isolated from
   an imported case in China
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Virus features; Next-generation sequencing; Genomic analysis
ID MOSQUITOS; OUTBREAK; FEVER
AB Zika virus (ZIKV) is a reemerging flavivirus that stroke Brazil in 2015 and appeared in China for the first time in 2016. Sequencing and genomic analysis are essential for Zika virus study. However, the complete genome length of Zika virus is still a disputable issue. In this study, we reported the complete genomic sequence of Zika virus strain ZKC2/2016 from an imported case in China, in February 2016. The virus was isolated and virus characteristics were identified by cytopathic effect, quantitative real time-PCR, immunofluorescence assay and electronic microscopy. Next generation sequencing (NGS) technique and 5' and 3' Rapid Amplification cDNA Ends (RACE) PCR were used to sequence the complete genome. The genome length of this newly obtained Zika virus strain is 10,807 base pairs (bp). Genetic analysis showed that ZKC2/2016, along with other Chinese Zika virus strains in 2016, formed three clusters within Asian linage. Multiple sequence alignment and prediction of RNA secondary structure of untranslated regions (UTRs) of ZKC2/2016 and several other ZIKV strains indicated that the difference of ZIKV genome length mainly laid in UTRs. Besides, those genomes shorter than 10,790 bp were probably incomplete due to lacking conserved secondary RNA structures in untranslated regions which were playing important roles in flavivirus replication. Our findings benefited the disease control of Zika fever in China and the study of Zika virus genome. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Liu, Lin; Zhang, Shuo; Song, Jingdong; Li, Aqian; Wu, Wei; Li, Chuan; Zhang, Quanfu; Liang, Mifang; Li, Dexin] Natl Inst Viral Dis Control & Prevent, NHFPC Key Lab Med Virol, Beijing, Peoples R China.
   [Wu, De; Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Ke, Changwen] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Peoples R China.
RP Ke, CW (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Li, DX (corresponding author), Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM Kecw1965@aliyun.com; lidx@chinacdc.cn
RI Zhou, Huiqiong/S-1276-2016
OI Zhou, Huiqiong/0000-0003-2124-6563
FU Zika Special Project of the MOST Reform and Development Project;
   Foundation of China-Hong Kong Research Grants Council [81261160504]
FX This work was supported by Zika Special Project of the MOST Reform and
   Development Project; Natural Science Foundation of China- Hong Kong
   Research Grants Council Joint Research Scheme (81261160504).
CR BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lin YP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1379-4
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu L., 2016, GENOME ANNOUNC, V4
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EURO SURVEILL, V19
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 20
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2017
VL 48
BP 40
EP 46
DI 10.1016/j.meegid.2016.10.023
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA EM6ZQ
UT WOS:000395461600007
PM 27810502
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus Infection - Proposed Management Strategies
SO MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Nok Mueang, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Wiwanitkit S, 2016, FORMOS MED ASS, V115, P822, DOI [10.1016/j.jfma.2016.06.003, DOI 10.1016/J.JFMA.2016.06.003]
   Wiwanitkit S, 2016, ANN TROP MED PUBLIC, V9, P361, DOI 10.4103/1755-6783.190206
   Zammarchi L, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.056
NR 3
TC 1
Z9 1
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2035-3006
J9 MEDITERR J HEMATOL I
JI Med. J. Hematol. Infect. Dis.
PD MAR 1
PY 2017
VL 9
AR e2017016
DI 10.4084/MJHID.2017.016
PG 1
WC Hematology; Infectious Diseases
SC Hematology; Infectious Diseases
GA EP9QR
UT WOS:000397708600001
PM 28293404
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Heinz, FX
   Stiasny, K
AF Heinz, Franz X.
   Stiasny, Karin
TI The Antigenic Structure of Zika Virus and Its Relation to Other
   Flaviviruses: Implications for Infection and Immunoprophylaxis
SO MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
LA English
DT Review
DE flavivirus antigenic structure; Zika virus
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; BORNE
   ENCEPHALITIS-VIRUS; NEUTRALIZING HUMAN-ANTIBODIES; HUMAN
   MONOCLONAL-ANTIBODIES; CROSS-REACTIVE ANTIBODIES; MEMORY B-CELLS; DENGUE
   VIRUS; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE
AB Zika virus was discovered similar to 70 years ago in Uganda and maintained a low profile as a human disease agent in Africa and Asia. Only recently has it caused explosive outbreaks in previously unaffected regions, first in Oceania and then in the Americas since 2015. Of special concern is the newly identified link between congenital malformations (especially microcephaly) and Zika virus infections during pregnancy. At present, it is unclear whether Zika virus changed its pathogenicity or whether the huge number of infections allowed the recognition of a previously cryptic pathogenic property. The purpose of this review is to discuss recent data on the molecular antigenic structure of Zika virus in the context of antibodymediated neutralization and antibody-dependent enhancement (ADE) of infection, a phenomenon that has been implicated in the development of severe disease caused by the related dengue viruses. Emphasis is given to epitopes of antibodies that potently neutralize Zika virus and also to epitopes that provide antigenic links to other important human-pathogenic flaviviruses such as dengue, yellow fever, West Nile, Japanese encephalitis, and tick-borne encephalitis viruses. The antigenic cross talk between Zika and dengue viruses appears to be of special importance, since they cocirculate in many regions of endemicity and sequential infections are likely to occur frequently. New insights into the molecular antigenic structure of Zika virus and flaviviruses in general have provided the foundation for great progress made in developing Zika virus vaccines and antibodies for passive immunization.
C1 [Heinz, Franz X.; Stiasny, Karin] Med Univ Vienna, Dept Virol, Vienna, Austria.
RP Heinz, FX (corresponding author), Med Univ Vienna, Dept Virol, Vienna, Austria.
EM franz.x.heinz@meduniwien.ac.at
OI Stiasny, Karin/0000-0002-1902-8674
FU Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P25265, I1378,
   P22914, P17035]
FX Research performed by us and cited in this review was supported by the
   Austrian Science Fund (FWF grants P25265, I1378, P22914, and P17035).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett P., 2013, VACCINES, P773, DOI 10.1016/B978-1-4557-0090-5.00011-2
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Butler John E, 2004, Methods Mol Med, V94, P333
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvert AE, 2011, VIROLOGY, V410, P30, DOI 10.1016/j.virol.2010.10.033
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Cherrier MV, 2009, EMBO J
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Durbin AP, 2016, CELL, V166, P1, DOI 10.1016/j.cell.2016.06.036
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Fisher D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0737-9
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead S.B., 2013, VACCINES, P312
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hombach J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5923
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Juckstock J, 2015, PHARMACOLOGY, V95, P209, DOI 10.1159/000381626
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kulp DW, 2013, CURR OPIN VIROL, V3, P322, DOI 10.1016/j.coviro.2013.05.010
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lindenbach B.D., 2013, FIELDS VIROLOGY, P712
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Monath TP, 2013, VACCINES, P870, DOI 10.1016/B978-1-4557-0090-5.00043-4.
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   PAHO/WHO, 2016, REG ZIK EP UPD AM DE
   Pantoja P, 2016, SECONDARY ZIKA VIRUS
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   PORTERFIELD JS, 1975, MED BIOL, V53, P400
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2013, NATURE, V497, P443, DOI 10.1038/497443a
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sanchez MD, 2007, VIROLOGY, V359, P336, DOI 10.1016/j.virol.2006.08.047
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simmonds P., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stauft CB, 2016, COMP AFRICAN ASIAN A
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2016, CURR ZIK PROD PIP
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
   Young MK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010586.pub2
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10
NR 166
TC 61
Z9 62
U1 1
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1092-2172
EI 1098-5557
J9 MICROBIOL MOL BIOL R
JI Microbiol. Mol. Biol. Rev.
PD MAR
PY 2017
VL 81
IS 1
AR e00055
DI 10.1128/MMBR.00055-16
PG 27
WC Microbiology
SC Microbiology
GA EP6KI
UT WOS:000397488000007
PM 28179396
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Huang, HX
   Falgout, B
   Takeda, K
   Yamada, KM
   Dhawan, S
AF Huang, Hanxia
   Falgout, Barry
   Takeda, Kazuyo
   Yamada, Kenneth M.
   Dhawan, Subhash
TI Nrf2-dependent induction of innate host defense via heme oxygenase-1
   inhibits Zika virus replication
SO VIROLOGY
LA English
DT Article
DE Zika; Monocytes; Macrophages; Heme oxygenase-1; Nuclear factor
   erythroid-related factor 2
ID INFECTION; HCV
AB We identified primary human monocyte-derived macrophages (MDM) as vulnerable target cells for Zika virus (ZIKV) infection. We demonstrate dramatic effects of hemin, the natural inducer of the heme catabolic enzyme heme oxygenase-1 (HO-1), in the reduction of ZIKV replication in vitro. Both LLC-MK2 monkey kidney cells and primary MDM exhibited hemin-induced HO-1 expression with major reductions of > 90% in ZIKV replication, with little toxicity to infected cells. Silencing expression of HO-1 or its upstream regulatory gene, nuclear factor erythroid-related factor 2 (Nrf2), attenuated hemin-induced suppression of ZIKV infection, suggesting an important role for induction of these intracellular mediators in retarding ZIKV replication. The inverse correlation between hemin-induced HO-1 levels and ZIKV replication provides a potentially useful therapeutic modality based on stimulation of an innate cellular response against Zika virus infection.
C1 [Huang, Hanxia; Falgout, Barry; Takeda, Kazuyo; Dhawan, Subhash] US FDA, Silver Spring, MD 20993 USA.
   [Yamada, Kenneth M.] NIH, Bldg 10, Bethesda, MD 20892 USA.
RP Dhawan, S (corresponding author), US FDA, Silver Spring, MD 20993 USA.
EM subhash.dhawan@fda.hhs.gov
FU NIDCR Intramural Research ProgramUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Dental & Craniofacial Research (NIDCR); FDA Intramural
   Research Program
FX We thank Dr. Rana Nagarkatti and Dr. Sreenivas Gannavaram for critical
   review of the manuscript. The findings and conclusions in this paper
   have not been formally disseminated by the Food and Drug Administration
   and should not be construed to represent any agency determination or
   policy. This work was supported by FDA and NIDCR Intramural Research
   Programs.
CR Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619
   Chen WC, 2013, ANTIMICROB AGENTS CH, V57, P1180, DOI 10.1128/AAC.02053-12
   Choi RJ, 2014, REDOX BIOL, V2, P504, DOI 10.1016/j.redox.2014.02.001
   Devadas K, 2006, J IMMUNOL, V176, P4252, DOI 10.4049/jimmunol.176.7.4252
   Devadas K, 2010, J LEUKOCYTE BIOL, V87, P915, DOI 10.1189/jlb.0307172
   Dhawan S., 2013, CURR TRENDS IMMUNOL, V14, P65
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hill-Batorski L, 2013, J VIROL, V87, P13795, DOI 10.1128/JVI.02422-13
   Hou WH, 2009, WORLD J GASTROENTERO, V15, P4499, DOI 10.3748/wjg.15.4499
   Kang JS, 2014, NUTRIENTS, V6, P5667, DOI 10.3390/nu6125667
   Lee HJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-143
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Protzer U, 2007, GASTROENTEROLOGY, V133, P1156, DOI 10.1053/j.gastro.2007.07.021
   Rasmussen AL, 2016, CELL HOST MICROBE, V19, P611, DOI 10.1016/j.chom.2016.04.016
   Schmidt WN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00129
   Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106
   Siegert SWK, 2008, ADV THER, V25, P842, DOI 10.1007/s12325-008-0094-y
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X
   Zhou Zhao-Hua, 2013, Curr Trends Immunol, V14, P53
   Zhou ZH, 2013, BIOCHEM BIOPH RES CO, V435, P373, DOI 10.1016/j.bbrc.2013.04.095
NR 25
TC 6
Z9 6
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAR
PY 2017
VL 503
BP 1
EP 5
DI 10.1016/j.virol.2016.12.019
PG 5
WC Virology
SC Virology
GA EM5MR
UT WOS:000395356200001
PM 28068513
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Rut, W
   Zhang, LL
   Kasperkiewicz, P
   Poreba, M
   Hilgenfeld, R
   Drag, M
AF Rut, Wioletta
   Zhang, Linlin
   Kasperkiewicz, Paulina
   Poreba, Marcin
   Hilgenfeld, Rolf
   Drag, Marcin
TI Extended substrate specificity and first potent irreversible
   inhibitor/activity-based probe design for Zika virus NS2B-NS3 protease
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Irreversible inhibitor; Proteolytic enzyme; ZIKA; Substrate specificity
AB Zika virus is spread by Aedes mosquitoes and is linked to acute neurological disorders, especially to microcephaly in newborn children and Guillan-Barre Syndrome. The NS2B-NS3 protease of this virus is responsible for polyprotein processing and therefore considered an attractive drug target. In this study, we have used the Hybrid Combinatorial Substrate Library (HyCoSuL) approach to determine the substrate specificity of ZIKV NS2B-NS3 protease in the P4-P1 positions using natural and a large spectrum of unnatural amino acids. Obtained data demonstrate a high level of specificity of the S3-S1 subsites, especially for basic amino acids. However, the 54 site exhibits a very broad preference toward natural and unnatural amino acids with selected D-amino acids being favored over L enantiomers. This information was used for the design of a very potent phosphonate inhibitor/activity-based probe of ZIKV NS2B-NS3 protease.(C) 2016 Elsevier B.V. All rights reserved.
C1 [Rut, Wioletta; Kasperkiewicz, Paulina; Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland.
   [Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, D-23562 Lubeck, Germany.
   [Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, DZIF, German Ctr Infect Res, Hamburg Lubeck Borstel Riems Site, D-23562 Lubeck, Germany.
   [Kasperkiewicz, Paulina; Poreba, Marcin] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA.
RP Drag, M (corresponding author), Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM marcin.drag@pwr.edu.pl
FU Polish Ministry of Science and Higher Education for the Faculty of
   Chemistry at Wroclaw University of Technology; Foundation for Polish
   ScienceFoundation for Polish Science; German Center for Infection
   Research (DZIF)
FX This work was supported by a statutory activity subsidy from the Polish
   Ministry of Science and Higher Education for the Faculty of Chemistry at
   Wroclaw University of Technology and Foundation for Polish Science. PK
   is a beneficiary of a START scholarship from the Foundation for Polish
   Science. The work of LZ and RH is funded by the German Center for
   Infection Research (DZIF).
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fontanet A, 2016, LANCET, V387, P2600, DOI 10.1016/S0140-6736(16)30773-5
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Kasperkiewicz P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132818
   Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Poreba M, 2016, CELL CHEM BIOL, V23, P1023, DOI 10.1016/j.chembiol.2016.05.020
   Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 13
TC 30
Z9 31
U1 2
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2017
VL 139
BP 88
EP 94
DI 10.1016/j.antiviral.2016.12.018
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EL1QW
UT WOS:000394397100011
PM 28034744
DA 2020-07-08
ER

PT J
AU de Wispelaere, M
   Carocci, M
   Liang, YK
   Liu, QS
   Sun, E
   Vetter, ML
   Wang, JH
   Gray, NS
   Yang, PL
AF de Wispelaere, Melissanne
   Carocci, Margot
   Liang, Yanke
   Liu, Qingsong
   Sun, Eileen
   Vetter, Michael L.
   Wang, Jinhua
   Gray, Nathanael S.
   Yang, Priscilla L.
TI Discovery of host-targeted covalent inhibitors of dengue virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID PROTEIN; REPLICATION; TRANSLATION; INFECTION; REVEALS
AB We report here on an approach targeting the host reactive cysteinome to identify inhibitors of host factors required for the infectious cycle of Flaviviruses and other viruses. We used two parallel cellular phenotypic screens to identify a series of covalent inhibitors, exemplified by QL-XII-47, that are active against dengue virus. We show that the compounds effectively block viral protein expression and that this inhibition is associated with repression of downstream processes of the infectious cycle, and thus significantly contributes to the potent antiviral activity of these compounds. We demonstrate that QL-XII-47's antiviral activity requires selective, covalent modification of a host target by showing that the compound's antiviral activity is recapitulated when cells are preincubated with QL-XII-47 and then washed prior to viral infection and by showing that QL-XII-47R, a non-reactive analog, lacks antiviral activity at concentrations more than 20-fold higher than QL-XII-47's IC90. QL-XII-47's inhibition of Zika virus, West Nile virus, hepatitis C virus, and poliovirus further suggests that it acts via a target mediating inhibition of these other medically relevant viruses. These results demonstrate the utility of screens targeting the host reactive cysteinome for rapid identification of compounds with potent antiviral activity. (C) 2016 Elsevier B.V. All rights reserved.
C1 [de Wispelaere, Melissanne; Carocci, Margot; Vetter, Michael L.; Yang, Priscilla L.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Liang, Yanke; Liu, Qingsong; Wang, Jinhua; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.
   [Liang, Yanke; Liu, Qingsong; Wang, Jinhua; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Sun, Eileen] Harvard Univ, Dept Phys, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.
RP Yang, PL (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
EM priscilla_yang@hms.harvard.edu
RI de Wispelaere, Melissanne/S-3117-2019
OI de Wispelaere, Melissanne/0000-0002-0682-3054; Yang,
   Priscilla/0000-0001-7456-2557
FU National Science Foundation Graduate Research FellowshipNational Science
   Foundation (NSF); F. Hoffmann-La Roche LtdHoffmann-La Roche; NIH
   grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U54A1057159 NERP018, R01A1076442]
FX We gratefully acknowledge Ted Pierson for the plasmids used for DV2 RVP
   production and the DV2 replicon cell line; Eva Harris for the DV2
   replicon plasmid; Takaji Wakita for the HCV and EMCV plasmids; Charles
   Rice for HCV plasmids; John Aaskov for the 6F3.1 hybridoma; Aaron
   Schmidt and Stephen Harrison for the DV2<SUP>419-447</SUP> peptide; and
   Lee Gehrke, Aravinda de Silva, Michael Diamond, Didier Musso and
   Nathalie Pardigon for viruses. We thank the Harvard ICCB-Longwood
   Screening Facility for instrument usage and support. E.S was supported
   by a National Science Foundation Graduate Research Fellowship. This
   research was partially funded by F. Hoffmann-La Roche Ltd and NIH grants
   U54A1057159 NERP018 (NERCE) and R01A1076442 (Yang).
CR Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Carocci M, 2016, ANTIVIR RES, V128, P57, DOI 10.1016/j.antiviral.2016.02.005
   Cheng HM, 2016, BIOORG MED CHEM LETT, V26, P1861, DOI 10.1016/j.bmcl.2016.02.067
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859
   Davids MS, 2014, FUTURE ONCOL, V10, P957, DOI 10.2217/fon.14.51
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Edgil D, 2003, VIROLOGY, V317, P275, DOI 10.1016/j.virol.2003.08.012
   Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034
   Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107
   Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005
   Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393
   Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/nchembio.1582, 10.1038/NCHEMBIO.1582]
   Leardkamolkarn V, 2012, J BIOMOL SCREEN, V17, P283, DOI 10.1177/1087057111426903
   Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24
   Liu FY, 2013, ACS CHEM BIOL, V8, P1423, DOI 10.1021/cb4000629
   Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0
   Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708
   Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q
   Rothman AL, 2016, J INFECT DIS, V214, P825, DOI 10.1093/infdis/jiw068
   Rueckert R R, 1981, Methods Enzymol, V78, P315
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tan L, 2015, J MED CHEM, V58, P6589, DOI 10.1021/acs.jmedchem.5b00710
   van der Linden WA, 2016, ACS INFECT DIS, V2, P173, DOI 10.1021/acsinfecdis.5b00130
   Wang QY, 2011, ANTIMICROB AGENTS CH, V55, P4072, DOI 10.1128/AAC.00620-11
   Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472
   Wu H, 2016, LEUKEMIA, V30, P173, DOI 10.1038/leu.2015.180
   Wu H, 2014, ACS CHEM BIOL, V9, P1086, DOI 10.1021/cb4008524
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 46
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2017
VL 139
BP 171
EP 179
DI 10.1016/j.antiviral.2016.12.017
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EL1QW
UT WOS:000394397100021
PM 28034743
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Safadi, MAP
   Nascimento-Carvalho, CM
AF Palazzi Safadi, Marco Aurelio
   Nascimento-Carvalho, Cristiana M.
TI Update on Zika: What You Need to Know
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Review
ID VIRUS-INFECTION; CASE SERIES; BRAZIL
C1 [Palazzi Safadi, Marco Aurelio] Santa Casa Sao Paulo Sch Med Sci, Dept Pediat, Sao Paulo, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Dept Pediat, Salvador, BA, Brazil.
RP Safadi, MAP (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Alameda Indigenas 228, BR-04059060 Sao Paulo, Brazil.
EM masa-fadi@uol.com.br
RI safadi, marco aurelio palazzi/B-7157-2015
OI safadi, marco aurelio palazzi/0000-0002-4401-9446
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Brasil P, 2016, NEW ENGL J MED, V16, P742
   Brazilian Ministry of Health, 2016, EPIDEMIOLOGICAL B
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIKA VIR
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, ZIK VIR VACC PROD DE
NR 17
TC 4
Z9 4
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD MAR
PY 2017
VL 36
IS 3
BP 333
EP 336
DI 10.1097/INF.0000000000001449
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA EL1CE
UT WOS:000394357300021
PM 27977548
DA 2020-07-08
ER

PT J
AU Iwasaki, A
AF Iwasaki, Akiko
TI Immune Regulation of Antibody Access to Neuronal Tissues
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID BLOOD-BRAIN-BARRIER; TIGHT JUNCTION PROTEINS; CENTRAL-NERVOUS-SYSTEM;
   ZIKA VIRUS; T-CELLS; AMYLOID-BETA; ENDOTHELIAL-CELLS; HERPES-SIMPLEX;
   NEURAL PROGENITORS; ALZHEIMERS-DISEASE
AB This review highlights recent advances in how the innate and adaptive immune systems control the blood-brain barrier (BBB) and the blood-nerve barrier (BNB). Interferons and TAM receptors play key roles in innate immune control of the BBB. Cells of the adaptive immune system, particularly CD4(+) T cells, take distinct routes to enter neural tissues and mediate immune surveillance. Furthermore, T cell-mediated opening of the BBB and the BNB is crucial to allow antibody access and thereby block the replication of neurotropic viruses. Such novel insights gained from basic research provide key foundations for future design of therapeutic strategies-enabling antibody access to the brain may be key to cancer immunotherapy and to the use of vaccines against neurodegenerative conditions such as Alzheimer's disease.
C1 [Iwasaki, Akiko] Yale Univ Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA.
RP Iwasaki, A (corresponding author), Yale Univ Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA.
EM akiko.iwasaki@yalo.odu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01A1054359,
   R21A1131284, R56A1125504, R41A1120269]; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute
FX I wish to thank the members of my laboratory for their work that
   inspired me to think about how adaptive immunity is coordinated against
   viral pathogens. Work in my laboratory is supported by funding from the
   National Institutes of Health (R01A1054359, R21A1131284, R56A1125504,
   R41A1120269) and the Howard Hughes Medical Institute.
CR Agadjanyan MG, 2015, ALZHEIMERS DEMENT, V11, P1246, DOI 10.1016/j.jalz.2015.06.1884
   An J, 2003, VIRCHOWS ARCH, V442, P472, DOI 10.1007/s00428-003-0785-3
   Annie Y., 2015, ELIFE, V4, P03733
   Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022
   Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), NAT GENET, V41, P824
   BARON JL, 1994, J CLIN INVEST, V93, P1700, DOI 10.1172/JCI117153
   BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57
   Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324
   Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847
   Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829
   Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759
   BROSNAN CF, 1990, ANN NEUROL, V27, pS75, DOI 10.1002/ana.410270719
   Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com
   Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092
   Char Q., 2014, J VIROL, V88, P4698
   CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859
   COOK ML, 1973, INFECT IMMUN, V7, P272, DOI 10.1128/IAI.7.2.272-288.1973
   Corfas G, 2004, J NEUROSCI, V24, P9250, DOI 10.1523/JNEUROSCI.3649-04.2004
   Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Dittmar S, 2008, J VIROL, V82, P11273, DOI 10.1128/JVI.00775-08
   Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004
   FADEN H, 1990, J INFECT DIS, V162, P1291, DOI 10.1093/infdis/162.6.1291
   Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11
   Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x
   Fraussen J, 2016, AUTOIMMUN REV, V15, P896, DOI 10.1016/j.autrev.2016.07.008
   Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009
   Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3
   Gunn BM, 2016, TRENDS MOL MED, V22, P969, DOI 10.1016/j.molmed.2016.09.002
   Hooper DC, 1998, J VIROL, V72, P3711, DOI 10.1128/JVI.72.5.3711-3719.1998
   Iijima N, 2016, NATURE, V533, P552, DOI 10.1038/nature17979
   Iwasaki A, 2016, ANNU REV IMMUNOL, V34, P575, DOI 10.1146/annurev-immunol-032414-112315
   Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074
   Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651
   Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100
   Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540
   KOJIMA K, 1994, J EXP MED, V180, P817, DOI 10.1084/jem.180.3.817
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Latov N, 2014, NAT REV NEUROL, V10, P435, DOI 10.1038/nrneurol.2014.117
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   LININGTON C, 1988, AM J PATHOL, V130, P443
   Ma GZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016964
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001
   Muller WA, 2014, AM J PATHOL, V184, P886, DOI 10.1016/j.ajpath.2013.12.033
   Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8
   Parr MB, 2000, IMMUNOLOGY, V99, P540, DOI 10.1046/j.1365-2567.2000.00980.x
   PLAKHOV IV, 1995, VIROLOGY, V209, P257, DOI 10.1006/viro.1995.1252
   Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
   Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015
   Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644
   Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130
   Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716
   Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319
   Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636
   Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839
   Sato A, 2014, J VIROL, V88, P13699, DOI 10.1128/JVI.02279-14
   Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046
   Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251
   Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938
   Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323
   Sherwood JK, 1996, NAT BIOTECHNOL, V14, P468, DOI 10.1038/nbt0496-468
   Slemers E.R., 2018, ALZHEIMERS DEMENT, V12, P110
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   Sterner RM, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.06.009
   STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377
   Tang H., 2010, CELL STEM CELL, V18, P587
   Tsutsui Y, 2008, PATHOL INT, V58, P257, DOI 10.1111/j.1440-1827.2008.02221.x
   Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Vandenberghe R, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0189-7
   Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084
   Weerasuriya A., 2011, METHOD MOL BIOL, V636, P140
   Westland KW, 1999, BRAIN, V122, P1283, DOI 10.1093/brain/122.7.1283
   WHALEY KJ, 1994, J INFECT DIS, V169, P647, DOI 10.1093/infdis/169.3.647
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215
   Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067
   Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386
NR 102
TC 16
Z9 16
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD MAR
PY 2017
VL 23
IS 3
BP 227
EP 245
DI 10.1016/j.molmed.2017.01.004
PG 19
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA EP1KG
UT WOS:000397143200005
PM 28185790
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wiwanitkt, V
AF Wiwanitkt, Viroj
TI Zika virus infection, issue on dermatological problem
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Letter
C1 [Wiwanitkt, Viroj] Hainan Med Univ, Trop Med, Haikou, Hainan, Peoples R China.
RP Wiwanitkt, V (corresponding author), Hainan Med Univ, Trop Med, Haikou, Hainan, Peoples R China.
EM wviroj@yahoo.com
CR Mlacker S, 2016, INT J DERMATOL, V55, P1369, DOI 10.1111/ijd.13399
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 3
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD MAR
PY 2017
VL 56
IS 3
BP E67
EP E68
DI 10.1111/ijd.13511
PG 3
WC Dermatology
SC Dermatology
GA EK5QL
UT WOS:000393980800010
PM 28000206
DA 2020-07-08
ER

PT J
AU Yokoyama, S
   Starmer, WT
AF Yokoyama, Shozo
   Starmer, William T.
TI Possible Roles of New Mutations Shared by Asian and American Zika
   Viruses
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE Zika viruses; evolutionary tree; evolutionary rates; RNA structures
ID PHYLOGENETIC ANALYSIS; NUCLEOTIDE-SEQUENCES; DENGUE VIRUS; FLAVIVIRUS;
   MUTAGENESIS; INFECTION; GENOME; REPLICATION; EVOLUTION; OUTBREAK
AB Originating in Africa, the Zika virus (ZIKV) has spread to Asia, Pacific Islands and now to the Americas and beyond. Since the first isolation in 1947, ZIKV strains have been sampled at various times in the last 69 years, but this history has not been reflected in studying the patterns of mutation accumulation in their genomes. Implementing the viral history, we show that the ZIKV ancestor appeared sometime in 1930-1945 and, at that point, its mutation rate was probably less than 0.2 x 10(-3)/nucleotide site/year and subsequently increased significantly in most of its descendants. Sustaining a high mutation rate of 4 x 10(-3)/site/year throughout its evolution, the Ancestral Asian strain, which was sampled from a mosquito in Malaysia, accumulated 13 mutations in the 3'-untranslated region of RNA stem-loops prior to 1963, seven of which generate more stable stem-loop structures and are likely to inhibit cellular antiviral activities, including immune and RNA interference (RNAi) pathways. The seven mutations have been maintained in all Asian and American strains and may be responsible for serious medical problems we are facing today and offer testable hypotheses to examine their roles in molecular interactions during brain development.
C1 [Yokoyama, Shozo] Emory Univ, Dept Biol, Atlanta, GA 30322 USA.
   [Starmer, William T.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.
RP Yokoyama, S (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.
EM syokoya@emory.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [EY016400]; Emory
   University
FX We thank Ruth Yokoyama and two anonymus reviewers for their helpful
   comments as well as Michael Derry and Darin Melton at Emory University
   for resolving IT issues. This work was supported partially by National
   Institutes of Health (EY016400) and Emory University (S.Y.).
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   GOJOBORI T, 1985, P NATL ACAD SCI USA, V82, P4198, DOI 10.1073/pnas.82.12.4198
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Huang YJS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-60
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   JUKES T H, 1969, P21
   KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LI WH, 1988, MOL BIOL EVOL, V5, P313
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nei M., 2013, MUTATION DRIVEN EVOL
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Tajima S, 2007, J GEN VIROL, V88, P2214, DOI 10.1099/vir.0.82661-0
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tumban E, 2011, J GEN VIROL, V92, P841, DOI 10.1099/vir.0.026997-0
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Winkelmann ER, 2011, VIROLOGY, V421, P96, DOI 10.1016/j.virol.2011.09.007
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Yokoyama S., 1991, EVOLUTION MOL LEVEL
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 58
TC 12
Z9 13
U1 1
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD MAR
PY 2017
VL 34
IS 3
BP 525
EP 534
DI 10.1093/molbev/msw270
PG 10
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA EO2FA
UT WOS:000396510800002
PM 28087772
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tran, A
AF Tran, Anthony
TI Monoclonal Antibodies Show Promise as the Key to Zika Virus Diagnostics
SO CLINICAL CHEMISTRY
LA English
DT Editorial Material
C1 [Tran, Anthony] Dist Columbia Dept Forens Sci, Div Publ Hlth Lab, 401 E St SW, Washington, DC 20024 USA.
RP Tran, A (corresponding author), Dist Columbia Dept Forens Sci, Div Publ Hlth Lab, 401 E St SW, Washington, DC 20024 USA.
EM anthony.tran@dc.gov
CR Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
NR 1
TC 0
Z9 0
U1 0
U2 4
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD MAR
PY 2017
VL 63
IS 3
BP 790
EP 791
DI 10.1373/clinchem.2016.267971
PG 2
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA EL6LU
UT WOS:000394734900026
PM 28242837
OA Bronze
DA 2020-07-08
ER

PT J
AU Uncini, A
   Shahrizaila, N
   Kuwabara, S
AF Uncini, Antonino
   Shahrizaila, Nortina
   Kuwabara, Satoshi
TI Zika virus infection and Guillain-Barre syndrome: a review focused on
   clinical and electrophysiological subtypes
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Review
ID ELECTRODIAGNOSTIC CRITERIA; DENGUE-FEVER
AB In 2016, we have seen a rapid emergence of Zika virus-associated Guillain-Barre syndrome (GBS) since its first description in a French-Polynesian patient in 2014. Current evidence estimates the incidence of GBS at 24 cases per 100 000 persons infected by Zika virus. This will result in a sharp rise in the number of GBS cases worldwide with the anticipated global spread of Zika virus. A better understanding of the pathogenesis of Zika-associated GBS is crucial to prepare us for the current epidemic. In this review, we evaluate the existing literature on GBS in association with Zika and other flavivirus to better define its clinical subtypes and electrophysiological characteristics, demonstrating a demyelinating subtype of GBS in most cases. We also recommend measures that will help reduce the gaps in knowledge that currently exist.
C1 [Uncini, Antonino] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Luigi Polacchi, I-66100 Chieti, Italy.
   [Shahrizaila, Nortina] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia.
   [Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.
RP Uncini, A (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Luigi Polacchi, I-66100 Chieti, Italy.
EM uncini@unich.it
RI Lahuddin, Haslinda/S-1588-2017; SHAHRIZAILA, NORTINA/B-9402-2010
OI Kuwabara, Satoshi/0000-0002-4716-8578
CR Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Boo YL, 2015, TZU CHI MED J
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026
   Chew NKGK, 1998, NEUROL J SE ASIA, V3, P85
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Esack A, 1999, W INDIAN MED J, V48, P36
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hiew FL, 2016, CLIN NEUROPHYSIOL, V127, P1683, DOI 10.1016/j.clinph.2015.09.131
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kumar Sudhir, 2005, Neurol India, V53, P250
   Kuwabara S, 1998, ANN NEUROL, V44, P202, DOI 10.1002/ana.410440210
   Mitsuma S, 2015, CLIN NEUROPHYSIOL, V126, P1805, DOI 10.1016/j.clinph.2014.11.027
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rajabally YA, 2011, MUSCLE NERVE, V43, P751, DOI 10.1002/mus.21974
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129
   Sekiguchi Y, 2012, J NEUROL NEUROSUR PS, V83, P23, DOI 10.1136/jnnp-2011-300309
   Shahrizaila N, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/829129
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Uncini A, 2015, J NEUROL NEUROSUR PS, V86, P1186, DOI 10.1136/jnnp-2014-310097
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538
   Van Den Bergh PYK, 2004, MUSCLE NERVE, V29, P565, DOI 10.1002/mus.20022
   Verma R, 2011, ANN INDIAN ACAD NEUR, V14, P272, DOI 10.4103/0972-2327.91946
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
NR 46
TC 40
Z9 41
U1 0
U2 17
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD MAR
PY 2017
VL 88
IS 3
BP 266
EP 271
DI 10.1136/jnnp-2016-314310
PG 6
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA EL3ED
UT WOS:000394501500014
PM 27799296
OA Bronze
DA 2020-07-08
ER

PT J
AU Musso, D
   Lanteri, MC
AF Musso, Didier
   Lanteri, Marion C.
TI Emergence of Zika virus: where does it come from and where is it going
   to?
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti 98713, France.
   [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.] Cerus Corp, Concord, CA USA.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti 98713, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Leo Y-S, 2016, LANCET INFECT DIS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Sadarangani SP, 2016, ANN ACAD MED SINGAP, V45, P381
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 5
TC 11
Z9 12
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2017
VL 17
IS 3
BP 255
EP 255
DI 10.1016/S1473-3099(17)30070-1
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EL6KX
UT WOS:000394732600012
PM 28244380
OA Bronze
DA 2020-07-08
ER

PT J
AU Mohammadi, D
AF Mohammadi, Dora
TI One-shot Zika vaccine
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2017
VL 17
IS 3
BP 271
EP 271
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EL6KX
UT WOS:000394732600032
DA 2020-07-08
ER

PT J
AU Sharma, M
   Yadav, K
   Yadav, N
   Ferdinand, KC
AF Sharma, Megha
   Yadav, Kapil
   Yadav, Nitika
   Ferdinand, Keith C.
TI Zika virus pandemic-analysis of Facebook as a social media health
   information platform
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Public health; Epidemic; Viral; Conspiracy theory
ID UNITED-STATES
AB The arrival of Zika virus in the United States has generated a lot of activity on social media focusing on the algorithmic increase in the spread of the disease and its concerning complications. Accurate and credible dissemination of correct information about the arbovirus could help in decreasing the pandemic spread and associated apprehension in the population. Our study examined the effective use of the social media site Facebook (Facebook Inc, Menlo Park, CA) as an information source for the Zika virus pandemic. We found that the misleading posts were far more popular than the posts dispersing accurate, relevant public health information about the disease. (C) 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Sharma, Megha] Med Coll Wisconsin, Dept Pediat, Div Neonatal Perinatal Med, 8701 W Watertown Plank Rd, Wauwatosa, WI 53213 USA.
   [Yadav, Kapil] Tulane Univ, Sch Med, Dept Med, Div Cardiovasc Dis, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Yadav, Nitika; Ferdinand, Keith C.] Tulane Univ, Sch Med, Dept Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.
RP Sharma, M (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Neonatal Perinatal Med, 8701 W Watertown Plank Rd, Wauwatosa, WI 53213 USA.
EM msharma@mcw.edu
CR Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Holcomb J., NEWS USE SOCIAL MEDI
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
NR 4
TC 59
Z9 59
U1 9
U2 27
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD MAR 1
PY 2017
VL 45
IS 3
BP 301
EP 302
DI 10.1016/j.ajic.2016.08.022
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EQ4KU
UT WOS:000398046700018
PM 27776823
DA 2020-07-08
ER

PT J
AU Eppes, C
   Rac, M
   Dunn, J
   Versalovic, J
   Murray, KO
   Suter, MA
   Cortes, MS
   Espinoza, J
   Seferovic, MD
   Lee, W
   Hotez, P
   Mastrobattista, J
   Clark, SL
   Belfort, MA
   Aagaard, KM
AF Eppes, Catherine
   Rac, Martha
   Dunn, James
   Versalovic, James
   Murray, Kristy O.
   Suter, Melissa A.
   Cortes, Magda Sanz
   Espinoza, Jimmy
   Seferovic, Maxim D.
   Lee, Wesley
   Hotez, Peter
   Mastrobattista, Joan
   Clark, Steven L.
   Belfort, Michael A.
   Aagaard, Kjersti M.
TI Testing for Zika virus infection in pregnancy: key concepts to deal with
   an emerging epidemic
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Review
DE amniotic fluid analysis; Centers for Disease Control and Prevention
   recommendations; counseling of the patient at risk; Dengue virus; fetal
   magnetic resonance imaging; Food and Drug Administration regulations;
   head circumference; epidemiology; flaviviridae family; immunoglobulin M
   serology; microcephaly; neurosonography; perinatal viral infection;
   plaque reduction neutralization test; reverse transcriptase-polymerase
   chain reaction; transplacental transmission of viruses; viral culture;
   viral detection with polymerase chain reaction; viral detection with
   real-time reverse transcriptase-polymerase chain reaction; Zika virus;
   Zika virus in pregnancy
ID FETAL-BRAIN; PROLONGED DETECTION; INTERIM GUIDANCE; ULTRASOUND;
   PERSISTENCE; INFANTS; BRAZIL; ANTIBODIES; GROWTH; STATES
AB Zika virus is an emerging mosquito-borne (Aedes genus) arbovirus of the Flaviviridae family. Following epidemics in Micronesia and French Polynesia during the past decade, more recent Zika virus infection outbreaks were first reported in South America as early as May 2013 and spread to now 50 countries throughout the Americas. Although no other flavivirus has previously been known to cause major fetal malformations following perinatal infection, reports of a causal link between Zika virus and microcephaly, brain and ocular malformations, and fetal loss emerged from hard-hit regions of Brazil by October 2015. Among the minority of infected women with symptoms, clinical manifestations of Zika virus infection may include fever, headache, arthralgia, myalgia, and maculopapular rash; however, only 1 of every 4-5 people who are infected have any symptoms. Thus, clinical symptom reporting is an ineffective screening tool for the relative risk assessment of Zika virus infection in the majority of patients. As previously occurred with other largely asymptomatic viral infections posing perinatal transmission risk (such as HIV or cytomegalovirus), we must develop and implement rapid, sensitive, and specific screening and diagnostic testing for both viral detection and estimation of timing of exposure. Unfortunately, despite an unprecedented surge in attempts to rapidly advance perinatal clinical testing for a previously obscure arbovirus, there are several ongoing hindrances to molecular-and sonographic-based screening and diagnosis of congenital Zika virus infection. These include the following: (1) difficulty in estimating the timing of exposure for women living in endemic areas and thus limited interpretability of immunoglobulin M serologies; (2) cross-reaction of immunoglobulin serologies with other endemic flaviruses, such as dengue; (3) persistent viremia and viruria in pregnancy weeks to months after primary exposure; and (4) fetal brain malformations and anomalies preceding the sonographic detection of microcephaly. In this commentary, we discuss screening and diagnostic considerations that are grounded not only in the realities of current obstetrical practice in a largely global population but also in basic immunology and virology. We review recent epidemiological data pertaining to the risk of congenital Zika virus malformations based on trimester of exposure and consider side by side with emerging data demonstrating replication of Zika virus in placental and fetal tissue throughout gestation. We discuss limitations to ultrasound based strategies that rely largely or solely on the detection of microcephaly and provide alternative neurosonographic approaches for the detection of malformations that may precede or occur independent of a small head circumference. This expert review provides information that is of value for the following: (1) obstetrician, maternal-fetal medicine specialist, midwife, patient, and family in cases of suspected Zika virus infection; (2) review of the methodology for laboratory testing to explore the presence of the virus and the immune response; (3) ultrasound-based assessment of the fetus suspected to be exposed to Zika virus with particular emphasis on the central nervous system; and (4) identification of areas ready for development.
C1 [Eppes, Catherine; Rac, Martha; Suter, Melissa A.; Cortes, Magda Sanz; Espinoza, Jimmy; Seferovic, Maxim D.; Lee, Wesley; Mastrobattista, Joan; Clark, Steven L.; Belfort, Michael A.; Aagaard, Kjersti M.] Texas Childrens Hosp, Dept Obstet, Houston, TX 77030 USA.
   [Eppes, Catherine; Rac, Martha; Suter, Melissa A.; Cortes, Magda Sanz; Espinoza, Jimmy; Seferovic, Maxim D.; Lee, Wesley; Mastrobattista, Joan; Clark, Steven L.; Belfort, Michael A.; Aagaard, Kjersti M.] Texas Childrens Hosp, Dept Gynecol, Houston, TX 77030 USA.
   [Dunn, James; Versalovic, James] Texas Childrens Hosp, Dept Pathol & Immunol, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Versalovic, James; Murray, Kristy O.; Hotez, Peter; Belfort, Michael A.; Aagaard, Kjersti M.] Texas Childrens Hosp, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Versalovic, James; Aagaard, Kjersti M.] Texas Childrens Hosp, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Eppes, Catherine; Rac, Martha; Suter, Melissa A.; Cortes, Magda Sanz; Espinoza, Jimmy; Seferovic, Maxim D.; Lee, Wesley; Mastrobattista, Joan; Clark, Steven L.; Belfort, Michael A.; Aagaard, Kjersti M.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA.
   [Dunn, James; Versalovic, James] Texas Childrens Hosp, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Dunn, James; Versalovic, James] Texas Childrens Hosp, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Versalovic, James; Murray, Kristy O.; Hotez, Peter] Texas Childrens Hosp, Pediat, Houston, TX 77030 USA.
RP Aagaard, KM (corresponding author), Texas Childrens Hosp, Dept Obstet, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Texas Childrens Hosp, Dept Gynecol, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Texas Childrens Hosp, Natl Sch Trop Med, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Texas Childrens Hosp, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA.
EM aagaardt@bcm.edu
OI Sanz-Cortes, Magda/0000-0002-0265-9859; Espinoza,
   Jimmy/0000-0002-9830-2212
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [K99 HD075858]
CR Aagaard-Tillery KM, 2006, SEMIN FETAL NEONAT M, V11, P279, DOI 10.1016/j.siny.2006.04.003
   Achiron R, 2001, ULTRASOUND OBST GYN, V18, P343, DOI 10.1046/j.0960-7692.2001.00512.x
   Babaliche Prakash, 2015, J Assoc Physicians India, V63, P38
   Besnard M, 2014, EURO SURVEILL, V19
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P178, DOI 10.1002/uog.3906
   Malinger G, 2006, EUR J RADIOL, V57, P226, DOI 10.1016/j.ejrad.2005.11.022
   Malinger G, 2001, PRENATAL DIAG, V21, P687, DOI 10.1002/pd.137
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monteagudo A, 2000, ULTRASOUND OBST GYN, V16, P307, DOI 10.1046/j.1469-0705.2000.00264.x
   Monteagudo A, 2009, PRENATAL DIAG, V29, P326, DOI 10.1002/pd.2146
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Murray KO, 2013, AM J TROP MED HYG, V89, P996, DOI 10.4269/ajtmh.13-0232
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reusken C, 2016, EURO SURVEILL, V21
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Sari A, 2005, ACTA RADIOL, V46, P631, DOI 10.1080/02841850510021715
   Sarno M, ULTRASOUND IN PRESS
   Sherer DM, 2007, ULTRASOUND OBST GYN, V29, P32, DOI 10.1002/uog.3879
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Suter MA, 2016, NAT REV ENDOCRINOL, V12, P437, DOI 10.1038/nrendo.2016.101
   Toi A, 2004, ULTRASOUND OBST GYN, V24, P706, DOI 10.1002/uog.1802
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vannice KS, 2016, VACCINE
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 59
TC 41
Z9 42
U1 1
U2 17
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD MAR
PY 2017
VL 216
IS 3
BP 209
EP 225
DI 10.1016/j.ajog.2017.01.020
PG 17
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP0PR
UT WOS:000397089700009
PM 28126366
OA Other Gold
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI What to be concern from the sites of existed emerging cases of Zika
   virus infection in Thailand?
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM soraysri@outlook.co.th
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 472
EP 472
DI 10.4103/1755-6783.208696
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EZ3EE
UT WOS:000404592600054
DA 2020-07-08
ER

PT J
AU Varghese, FS
   Rausalu, K
   Hakanen, M
   Saul, S
   Kummerer, BM
   Susi, P
   Merits, A
   Ahola, T
AF Varghese, Finny S.
   Rausalu, Kai
   Hakanen, Marika
   Saul, Sirle
   Kuemmerer, Beate M.
   Susi, Petri
   Merits, Andres
   Ahola, Tero
TI Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic
   Environment of Endocytic Compartments
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE Zika virus; chikungunya virus; envelope protein; resistant mutant; virus
   entry; antiviral
ID SEMLIKI-FOREST-VIRUS; FULL-LENGTH CDNA; CHIKUNGUNYA VIRUS; IN-VITRO;
   LYSOSOMAL FUNCTION; CELL ENTRY; CHLOROQUINE; INFECTION; ANTIVIRALS;
   MUTATIONS
AB As new pathogenic viruses continue to emerge, it is paramount to have intervention strategies that target a common denominator in these pathogens. The fusion of viral and cellular membranes during viral entry is one such process that is used by many pathogenic viruses, including chikungunya virus, West Nile virus, and influenza virus. Obatoclax, a small-molecule antagonist of the Bcl-2 family of proteins, was previously determined to have activity against influenza A virus and also Sindbis virus. Here, we report it to be active against alphaviruses, like chikungunya virus (50% effective concentration [EC50] = 0.03 mu M) and Semliki Forest virus (SFV; EC50 = 0.11 mu M). Obatoclax inhibited viral entry processes in an SFV temperaturesensitive mutant entry assay. A neutral red retention assay revealed that obatoclax induces the rapid neutralization of the acidic environment of endolysosomal vesicles and thereby most likely inhibits viral fusion. Characterization of escape mutants revealed that the L369I mutation in the SFV E1 fusion protein was sufficient to confer partial resistance against obatoclax. Other inhibitors that target the Bcl-2 family of antiapoptotic proteins inhibited neither viral entry nor endolysosomal acidification, suggesting that the antiviral mechanism of obatoclax does not depend on its anticancer targets. Obatoclax inhibited the growth of flaviviruses, like Zika virus, West Nile virus, and yellow fever virus, which require low pH for fusion, but not that of pH-independent picornaviruses, like coxsackievirus A9, echovirus 6, and echovirus 7. In conclusion, obatoclax is a novel inhibitor of endosomal acidification that prevents viral fusion and that could be pursued as a potential broad-spectrum antiviral candidate.
C1 [Varghese, Finny S.; Ahola, Tero] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.
   [Rausalu, Kai; Saul, Sirle; Merits, Andres] Univ Tartu, Inst Technol, Tartu, Estonia.
   [Hakanen, Marika; Susi, Petri] Univ Turku, Dept Virol, Turku, Finland.
   [Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.
   [Varghese, Finny S.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Med Microbiol, Med Ctr, Nijmegen, Netherlands.
RP Varghese, FS; Ahola, T (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.; Varghese, FS (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Med Microbiol, Med Ctr, Nijmegen, Netherlands.
EM finny.varghese@radboudumc.nl; tero.ahola@helsinki.fi
RI Merits, Andres/H-3125-2015; Susi, Petri/AAL-8194-2020; Varghese,
   Finny/P-9496-2016; Rausalu, Kai/G-6493-2019
OI Merits, Andres/0000-0001-8193-0071; Susi, Petri/0000-0002-9245-3271;
   Varghese, Finny/0000-0002-7900-5482; Rausalu, Kai/0000-0002-8926-5907;
   Koivu, Marika/0000-0002-4371-2142
FU Academy of FinlandAcademy of Finland [265997]; European Regional
   Development Fund through the Centre of Excellence in Molecular Cell
   Engineering, Estonia [2014-2020.4.01.15-0013]; Estonian Research Council
   [IUT 20-27]; European UnionEuropean Union (EU) [612308]; Biocenter
   Finland
FX This work was funded by the Academy of Finland (grant 265997 to T.A.),
   the European Regional Development Fund through the Centre of Excellence
   in Molecular Cell Engineering, Estonia (grant 2014-2020.4.01.15-0013 to
   A.M.), the Estonian Research Council (grant IUT 20-27 to A.M.), and the
   European Union (AIROPico, FP7-PEOPLE-2013-IAPP grant no. 612308 to
   P.S.). F.S.V. was a fellow of the Integrative Life Sciences doctoral
   program. The Drug Discovery and Chemical Biology Network is funded by
   Biocenter Finland.
CR Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681
   Balistreri G, 2007, J VIROL, V81, P2849, DOI 10.1128/JVI.02078-06
   Besbes S, 2015, ONCOTARGET, V6, P12862, DOI 10.18632/oncotarget.3868
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028
   Champa D, 2016, ONCOTARGET, V7, P34453, DOI 10.18632/oncotarget.9121
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Goard CA, 2013, CORE EVID, V8, P15, DOI 10.2147/CE.S42568
   Gould EA, 2010, ANTIVIR RES, V87, P111, DOI 10.1016/j.antiviral.2009.07.007
   Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15
   Huttunen M, 2014, J VIROL, V88, P5138, DOI 10.1128/JVI.03275-13
   Hwang JJ, 2010, CLIN CANCER RES, V16, P4038, DOI 10.1158/1078-0432.CCR-10-0822
   Joudeh J, 2012, EXPERT OPIN INV DRUG, V21, P363, DOI 10.1517/13543784.2012.652302
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kielian M, 2014, ANNU REV VIROL, V1, P171, DOI 10.1146/annurev-virology-031413-085521
   Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796
   Kim C, 2012, MBIO, V3, DOI 10.1128/mBio.00304-11
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   LILJESTROM P, 1991, J VIROL, V65, P4107
   Lulla V, 2006, J VIROL, V80, P3108, DOI 10.1128/JVI.80.6.3108-3111.2006
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574
   Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737
   Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048
   Stamelos VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150696
   Suomalainen M, 2013, CURR OPIN VIROL, V3, P27, DOI 10.1016/j.coviro.2012.12.004
   Thaa B, 2015, J VIROL, V89, P11420, DOI 10.1128/JVI.01579-15
   Tuthill TJ, 2010, CURR TOP MICROBIOL, V343, P43, DOI 10.1007/82_2010_37
   Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007
   Utt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151616
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   Yu L, 2016, ONCOTARGET, V7, P14693, DOI 10.18632/oncotarget.7492
NR 55
TC 25
Z9 26
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAR
PY 2017
VL 61
IS 3
DI 10.1128/AAC.02227-16
PG 17
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA EL4QM
UT WOS:000394605900065
PM 27993855
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lee, H
   Ren, JH
   Nocadello, S
   Rice, AJ
   Ojeda, I
   Light, S
   Minasov, G
   Vargas, J
   Nagarathnam, D
   Anderson, WF
   Johnson, ME
AF Lee, Hyun
   Ren, Jinhong
   Nocadello, Salvatore
   Rice, Amy J.
   Ojeda, Isabel
   Light, Samuel
   Minasov, George
   Vargas, Jason
   Nagarathnam, Dhanapalan
   Anderson, Wayne F.
   Johnson, Michael E.
TI Identification of novel small molecule inhibitors against NS2B/NS3
   serine protease from Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika flavivirus; NS2B/NS3 serine protease; Small molecule inhibitor; apo
   ZIKV NS2B-NS3(pro) structure
ID WEST-NILE-VIRUS; NS2B-NS3 PROTEASE; DRUG DISCOVERY; STRUCTURAL BASIS;
   DENGUE; FLAVIVIRUS; RESISTANCE; DESIGN; CONFORMATION; DERIVATIVES
AB Zika flavivirus infection during pregnancy appears to produce higher risk of microcephaly, and also causes multiple neurological problems such as Guillain Barre syndrome. The Zika virus is now widespread in Central and South America, and is anticipated to become an increasing risk in the southern United States. With continuing global travel and the spread of the mosquito vector, the exposure is expected to accelerate, but there are no currently approved treatments against the Zika virus. The Zika NS2B/NS3 protease is an attractive drug target due to its essential role in viral replication. Our studies have identified several compounds with inhibitory activity (IC50) and binding affinity (K-D) of similar to 5-10 mu M against the Zika NS2B-NS3 protease from testing 71 HCV NS3/NS4A inhibitors that were initially discovered by high-throughput screening of 40,967 compounds. Competition surface plasmon resonance studies and mechanism of inhibition analyses by enzyme kinetics subsequently determined the best compound to be a competitive inhibitor with a K-i; value of 9.5 mu M. We also determined the X-ray structure of the Zika NS2B-NS3 protease in a "pre-open conformation", a conformation never observed before for any flavivirus proteases. This provides the foundation for new structure-based inhibitor design. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lee, Hyun; Johnson, Michael E.] Novalex Therapeut Inc, 2242 Harrison Suite 201, Chicago, IL 60612 USA.
   [Ren, Jinhong; Rice, Amy J.; Ojeda, Isabel; Vargas, Jason] Univ Illinois, Ctr Biomol Sci, 900 S Ashland, Chicago, IL 60607 USA.
   [Rice, Amy J.; Ojeda, Isabel; Vargas, Jason] Univ Illinois, Dept Med Chem & Pharmacognosy, 833 S Wood St, Chicago, IL 60612 USA.
   [Nocadello, Salvatore; Light, Samuel; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis CSGID, Feinberg Sch Med, Dept Biochem & Mol Genet, 303 E Chicago Ave, Chicago, IL 60611 USA.
   [Nagarathnam, Dhanapalan] DNSK Int LLC, NEBA Bldg,925 Sherman Ave, Hamden, CT 06514 USA.
RP Johnson, ME (corresponding author), Novalex Therapeut Inc, 2242 Harrison Suite 201, Chicago, IL 60612 USA.
EM mssjohnson@novalextherapeutics.com
RI Johnson, Michael E/F-5141-2013
OI Johnson, Michael E/0000-0002-8246-4081; Lee, Hyun/0000-0003-2570-8120;
   Light, Sam/0000-0002-8074-1348; Minasov, George/0000-0001-5460-3462
FU Federal funds from the National Institute of Allergy and Infectious
   Diseases, National Institutes of Health, Department of Health and Human
   Services [HHSN272201200026C];  [AI112114]
FX This project has been funded in part with Federal funds from the
   National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, under
   Contract No. HHSN272201200026C, and by grant AI112114. We thank
   ChemAxon, Ltd. for an academic research license of their cheminformatics
   suite including JChem and JChem for Excel for data analysis.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Anderson W. F., 2009, Infectious Disorders - Drug Targets, V9, P507
   Bhakat S, 2014, EUR J MED CHEM, V87, P677, DOI 10.1016/j.ejmech.2014.10.010
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Chan J. F., 2016, J INFECT, V72
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Cunha M. S., 2016, GENOME ANNOUNCEMENTS, V4
   Deng J, 2012, J MED CHEM, V55, P6278, DOI 10.1021/jm300146f
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i753
   Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Imperato P. J., 2016, J COMMUNITY HLTH, V41
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lai HG, 2013, ANTIVIR RES, V97, P74, DOI 10.1016/j.antiviral.2012.10.009
   Lai HG, 2013, BIOORGAN MED CHEM, V21, P102, DOI 10.1016/j.bmc.2012.10.058
   Lee HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084272
   Lei J, 2016, VIROL SIN, V31, P288, DOI 10.1007/s12250-016-3742-4
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li LF, 2015, CHEM BIOL DRUG DES, V86, P255, DOI 10.1111/cbdd.12500
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1362
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Schrodinger, 2016, EP VERS 3 5
   Schrodinger, 2016, SCHROD SUIT 2016 1 P
   Schrodinger, 2016, LIGPR VERS 3 7
   Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z
   Sirohi D., 2016, SCIENCE, P352
   Smith D. W., 2016, LANCET, P387
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006
   Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465
   Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Weaver S. C., 2016, ANTIVIR RES, P130
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Zhou GC, 2013, BIOORG MED CHEM LETT, V23, P6549, DOI 10.1016/j.bmcl.2013.10.071
NR 64
TC 65
Z9 69
U1 9
U2 83
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2017
VL 139
BP 49
EP 58
DI 10.1016/j.antiviral.2016.12.016
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EL1QW
UT WOS:000394397100007
PM 28034741
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Kuivanen, S
   Bespalov, MM
   Nandania, J
   Ianevski, A
   Velagapudi, V
   De Brabander, JK
   Kainov, DE
   Vapalahti, O
AF Kuivanen, Suvi
   Bespalov, Maxim M.
   Nandania, Jatin
   Ianevski, Aleksandr
   Velagapudi, Vidya
   De Brabander, Jef K.
   Kainov, Denis E.
   Vapalahti, Olli
TI Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus
   infection in vitro and differentially affect cellular signaling,
   transcription and metabolism
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID REPLICATION; CELLS; IDENTIFICATION; EXPRESSION; APOPTOSIS; SCREEN;
   CYCLE; MICE; CREB; P27
AB An epidemic of Zika virus (ZIKV) infection associated with congenital abnormalities such as microcephaly, is ongoing in the Americas and the Pacific. Currently there are no approved therapies to treat this emerging viral disease. Here, we tested three cell-directed broad-spectrum antiviral compounds against ZIKV replication using human retinal pigment epithelial (RPE) cells and a low-passage ZIKV strain isolated from fetal brain. We found that obatoclax, SaliPhe, and gemcitabine inhibited ZIKV infections at noncytotoxic concentrations. Moreover, all three compounds prevented production of viral RNA and proteins as well as activation of cellular caspase 8, 3 and 7. However, these compounds differentially affected ZIKV-mediated transcription, translation and posttranslational modifications of cellular factors as well as metabolic pathways indicating that these agents possess different mechanisms of action. Interestingly, combination of obatoclax and SaliPhe at nanomolar concentrations had a synergistic effect against ZIKV infection. Thus, our results provided the foundation for development of broad-spectrum cell-directed antivirals or their combinations for treatment of ZIKV and other emerging viral diseases. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kuivanen, Suvi; Vapalahti, Olli] Univ Helsinki, Medicum, Dept Virol, FIN-00014 Helsinki, Finland.
   [Bespalov, Maxim M.] Univ Helsinki, Biomedicum Stem Cells Ctr, Dept Mol Neurol, Res Program Unit, FIN-00014 Helsinki, Finland.
   [Nandania, Jatin; Ianevski, Aleksandr; Velagapudi, Vidya; Kainov, Denis E.] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland.
   [De Brabander, Jef K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.
   [Vapalahti, Olli] Univ Helsinki, Dept Virol & Immunol, FIN-00014 Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland.
RP Vapalahti, O (corresponding author), Univ Helsinki, Medicum, Dept Virol, FIN-00014 Helsinki, Finland.; Kainov, DE (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland.
EM denis.kainov@helsinki.fi; olli.vapalahti@helsinki.fi
RI Kainov, Denis/I-5526-2019; Bespalov, Maxim/O-2817-2016; Velagapudi,
   Vidya/L-7278-2015
OI Kainov, Denis/0000-0001-7716-6955; Bespalov, Maxim/0000-0002-8754-5753;
   Velagapudi, Vidya/0000-0002-8261-7164; Vapalahti,
   Olli/0000-0003-2270-6824; Ianevski, Aleksandr/0000-0002-7780-482X
FU Jane and Aatos Erkko Foundation; University of Helsinki [465/51/2014];
   Juselius Foundation, Academy of Finland; Helsinki University Hospital
   Funds; Robert A. Welch FoundationThe Welch Foundation [1-1422]
FX We thank Ms. Irina Suomalainen for help with IFA experiments. This study
   was supported by Jane and Aatos Erkko Foundation (to D.E.K.), three-year
   research grant from University of Helsinki (No. 465/51/2014, to D.E.K.),
   Juselius Foundation, Academy of Finland and Helsinki University Hospital
   Funds (to O.V.), and the Robert A. Welch Foundation (1-1422, to
   J.K.D.B.).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Anastasina M, 2016, BBA-GENE REGUL MECH, V1859, P1440, DOI 10.1016/j.bbagrm.2016.09.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Borgeling Y, 2014, J BIOL CHEM, V289, P13, DOI 10.1074/jbc.M113.469239
   Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272
   Champa D, 2016, ONCOTARGET, V7, P34453, DOI 10.18632/oncotarget.9121
   Chen KF, 2012, CANCER LETT, V321, P27, DOI 10.1016/j.canlet.2012.03.023
   Chia YL, 2014, ANTIVIR RES, V102, P11, DOI 10.1016/j.antiviral.2013.11.012
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Paula Freitas B., 2016, JAMA OPHTHALMOL BRAZ
   De Vita F, 2012, CELL CYCLE, V11, P1583, DOI 10.4161/cc.20003
   Denisova OV, 2014, ANTIMICROB AGENTS CH, V58, P3689, DOI 10.1128/AAC.02798-13
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Francois S, 2016, J VIROL, V90, P8686, DOI 10.1128/JVI.00920-16
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Fu Y, 2016, ANTIVIR RES, V133, P23, DOI 10.1016/j.antiviral.2016.07.008
   Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]
   James SJ, 2015, CELL REP
   Jiang M, 2015, J LEUKOCYTE BIOL, V97, P307, DOI 10.1189/jlb.2A0114-059RR
   Lansakara DSP, 2012, INT J PHARMACEUT, V429, P123, DOI 10.1016/j.ijpharm.2012.03.014
   Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789
   Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moysan E, 2013, MOL PHARMACEUT, V10, P430, DOI 10.1021/mp300370t
   Muller KH, 2014, ANTIMICROB AGENTS CH, V58, P2905, DOI 10.1128/AAC.02284-13
   Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x
   Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104
   Parra B., 2016, N ENGL J MED
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Soderholm S., 2016, MOL CELL PROTEOM
   Soderholm S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100269
   Soderholm S, 2016, ANTIVIR RES, V126, P69, DOI 10.1016/j.antiviral.2015.12.011
   Spugnini EP, 2015, BBA-BIOMEMBRANES, V1848, P2715, DOI 10.1016/j.bbamem.2014.10.015
   Steven A, 2016, ONCOTARGET, V7, P35454, DOI 10.18632/oncotarget.7721
   Su JC, 2012, EUR J MED CHEM, V56, P127, DOI 10.1016/j.ejmech.2012.08.024
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Xiang A, 2015, ANTIVIR RES, V120, P7, DOI 10.1016/j.antiviral.2015.04.013
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 45
TC 38
Z9 40
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2017
VL 139
BP 117
EP 128
DI 10.1016/j.antiviral.2016.12.022
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EL1QW
UT WOS:000394397100015
PM 28049006
DA 2020-07-08
ER

PT J
AU Lim, HJ
   Nguyen, TTH
   Kim, NM
   Park, JS
   Jang, TS
   Kim, D
AF Lim, Hee-jung
   Thi Thanh Hanh Nguyen
   Kim, Nahyun M.
   Park, Jun-Seong
   Jang, Tae-Su
   Kim, Doman
TI Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus
   and their structure activity relationship
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Flavanoids; Myricetin; Polyphenols; Protease; Zika virus
ID FLAVIVIRUS; PROTEINS; OUTBREAK; COMPLEX; BRAZIL
AB To determine the inhibitory activities of flavonoids against NS2B-NS3 protease of ZIKA virus (ZIKV NS2B-NS3(pro)) expressed in Escherichia coli BL21 (DE3) and their structure activity relationship.
   ZIKV NS2B-NS3(pro) was expressed in E. coli BL21(DE3) as a 35 kDa protein. It had a K (m) of 26 A mu M with the fluorogenic peptide Dabcyl-KTSAVLQSGFRKME-Edan. The purified ZIKV NS2B-NS3(pro) was used for inhibition and kinetic assays to determine the activities of 22 polyphenol compounds. These polyphenol compounds at 100 A mu M inhibited the activity of ZIKV NS2B-NS3(pro) by 6.2-88%. Seven polyphenol compounds had IC50 ranging from 22 +/- 0.2 to 112 +/- 5.5 A mu M. Myricetin showed a mixed type inhibitory pattern against ZIKV NS2B-NS3(pro) protease. Its IC50 value was 22 +/- 0.2 A mu M with a K (i) value of 8.9 +/- 1.9 A mu M.
   The chemical structure of a polyphenol compound and its inhibitory activity against ZIKV NS2B-NS3(pro) can be explored to develop highly selective inhibitors against ZIKV NS2B-NS3(pro).
C1 [Lim, Hee-jung; Thi Thanh Hanh Nguyen; Jang, Tae-Su; Kim, Doman] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea.
   [Lim, Hee-jung; Thi Thanh Hanh Nguyen; Jang, Tae-Su; Kim, Doman] Seoul Natl Univ, Inst Food Industrializat, Inst Green Biosci & Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea.
   [Kim, Nahyun M.] Univ Southern Calif, Neurobiol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA.
   [Park, Jun-Seong] Amorepacific Corp R&D Ctr, Skin Res Inst, Yongin 17074, South Korea.
RP Kim, D (corresponding author), Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea.; Kim, D (corresponding author), Seoul Natl Univ, Inst Food Industrializat, Inst Green Biosci & Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea.
EM kimdm@snu.ac.kr
FU Agriculture, Food and Rural Affairs Research Center Support Program;
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01056929,
   2015R1D1A4A01020522]
FX This work was partially supported by Agriculture, Food and Rural Affairs
   Research Center Support Program, Agriculture, Food and Rural Affairs
   Research Center Support Program (D. Kim) and by the Basic Science
   Research Program through the National Research Foundation of Korea (NRF)
   funded by the Ministry of Education (NRF-2015R1D1A1A01056929; D. Kim,
   and 2015R1D1A4A01020522; T. T. Hanh Nguyen).
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, GENOME ANNOUN, V4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR DIS EP POT A
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049
   Moon YH, 2006, J AGR FOOD CHEM, V54, P1230, DOI 10.1021/jf052359i
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Thi THN, 2012, BIOTECHNOL LETT, V34, P831, DOI 10.1007/s10529-011-0845-8
   Vinson JA, 2001, J AGR FOOD CHEM, V49, P5315, DOI 10.1021/jf0009293
   World Health Organization, 2016, SAUDI MED J, V37, P332
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 21
TC 33
Z9 34
U1 5
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAR
PY 2017
VL 39
IS 3
BP 415
EP 421
DI 10.1007/s10529-016-2261-6
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EK9NP
UT WOS:000394251500009
PM 27885509
OA Green Published
DA 2020-07-08
ER

PT J
AU Gelber, SE
   Grunebaum, A
   McCullough, LB
   Chervenak, FA
AF Gelber, S. E.
   Grunebaum, A.
   McCullough, L. B.
   Chervenak, F. A.
TI Fulfilling professional responsibilities when counselling patients about
   Zika infection
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Gelber, S. E.; Grunebaum, A.; Chervenak, F. A.] Cornell Univ, Weill Med Coll, Dept Obstet & Gynecol, New York, NY 10021 USA.
   [McCullough, L. B.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.
RP Gelber, SE (corresponding author), Cornell Univ, Weill Med Coll, Dept Obstet & Gynecol, New York, NY 10021 USA.
RI Chervenak, Frank/P-3555-2017
OI Chervenak, Frank/0000-0002-4600-0853
CR CHERVENAK, 2010, AM J OBSTET GYNECOL, V203
   CHERVENAK, 2009, AM J OBSTET GYNECOL, V201
   Chervenak FA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.006
NR 3
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAR
PY 2017
VL 124
IS 4
BP 550
EP 550
DI 10.1111/1471-0528.14388
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP4YQ
UT WOS:000397386400003
PM 27860092
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Hearing loss in congenital Zika virus
SO BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Inst Nat Med Sci, Dev & Estab Project, Suvannhabhumi Clin Training Res & Dev Ctr, Nok Mueang, Surin Province, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Inst Nat Med Sci, Dev & Estab Project, Suvannhabhumi Clin Training Res & Dev Ctr, Nok Mueang, Surin Province, Thailand.
EM wviroj@yahoo.com
CR Calvani M Jr, 1991, Minerva Pediatr, V43, P595
   Leal MC, 2016, BRAZ J OTORHINOLAR, DOI DOI 10.1016/J.BJ0RL.2016.06.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
NR 4
TC 3
Z9 3
U1 0
U2 3
PU ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
PI SAO PAULO
PA AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL
SN 1808-8694
EI 1808-8686
J9 BRAZ J OTORHINOLAR
JI Braz. J. Otorhinolaryngol.
PD MAR-APR
PY 2017
VL 83
IS 2
BP 239
EP 239
DI 10.1016/j.bjorl.2016.08.007
PG 1
WC Otorhinolaryngology
SC Otorhinolaryngology
GA EQ3PV
UT WOS:000397985900020
PM 27650293
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jaenisch, T
   Rosenberger, KD
   Brito, C
   Brady, O
   Brasil, P
   Marques, ETA
AF Jaenisch, Thomas
   Rosenberger, Kerstin Daniela
   Brito, Carlos
   Brady, Oliver
   Brasil, Patricia
   Marques, Ernesto T. A.
TI Risk of microcephaly after Zika virus infection in Brazil, 2015 to 2016
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
AB Objective To estimate the risk of microcephaly in babies born to women infected by the Zika virus during pregnancy in Brazil in an epidemic between 2015 and 2016.
   Methods We obtained data on the number of notified and confirmed microcephaly cases in each Brazilian state between November 2015 and October 2016 from the health ministry. For Pernambuco State, one of the hardest hit, weekly data were available from August 2015 to October 2016 for different definitions of microcephaly. The absolute risk of microcephaly was calculated using the average number of live births reported in each state in the corresponding time period between 2012 and 2014 and assuming two infection rates: 10% and 50%. The relative risk was estimated using the reported background frequency of microcephaly in Brazil of 1.98 per 10 000 live births.
   Findings The estimated absolute risk of a notified microcephaly case varied from 0.03 to 17.1% according to geographical area, the definition of microcephaly used and the infection rate. Assuming a 50% infection rate, there was an 18-127 fold higher probability of microcephaly in children born to mothers with infection during pregnancy compared with children born to mothers without infection during pregnancy in Pernambuco State. For a 10% infection rate, the probability was.88-635 folds higher.
   Conclusion A large variation in the estimated risk of microcephaly was found in Brazil. Research is needed into possible effect modifiers, reliable measures of Zika virus infection and clear endpoints for congenital malformations.
C1 [Jaenisch, Thomas; Rosenberger, Kerstin Daniela] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
   [Brito, Carlos] Univ Fed Pernambuco, Dept Internal Med, Recife, PE, Brazil.
   [Brady, Oliver] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Ernesto T. A.] Aggeu Magalhaes Res Ctr, Virol & Expt Therapeut Lab, Recife, PE, Brazil.
RP Jaenisch, T (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
EM thomas.jaenisch@urz.uni-heidelberg.de
RI Marques, Ernesto T. A/L-4967-2013; Jaenisch, Thomas/H-3473-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; 
FU European Union's Horizon 2020 research and innovation programme
   (ZIKAlliance grant) [734548]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation programme (ZIKAlliance grant agreement no. 734548) and
   Seventh Framework Programme for Research and Technological Development
   (International Research Consortium on Dengue Risk Assessment, Management
   and Surveillance, IDAMS, grant agreement no. 281803). The manuscript has
   been given the IDAMS publication reference number IDAMS 35.
CR [Anonymous], 2015, MICR BRAZ POT LINK Z
   [Anonymous], 2016, NASC VIV BRAS
   [Anonymous], 2016, HUFFINGTON POST
   [Anonymous], 2015, FREQ MICR NASC BRAS
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65
   Microcefalia e outran alteracOes do sistema nervoso central, 2016, 90 SEVSSESPE MICR OU
   Microcefalia e outras afteracoes do sistema nervoso central, 2016, 70 SEVSSESPE MICR OU
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monitoramento dos casos de microcefalia no Brasil, 2016, 48 MON CAS MICR BRAS
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Partlow J, 2016, WASHINGTON POST
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silviera M., 2015, NAO ENGRAVIDEM AGORA
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 30
TC 35
Z9 36
U1 0
U2 8
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD MAR
PY 2017
VL 95
IS 3
BP 191
EP 198
DI 10.2471/BLT.16.178608
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN4IX
UT WOS:000395972300008
PM 28250532
OA Green Published, Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Cheng, C
   Wu, JN
   Fikrig, E
   Wang, PH
   Chen, JG
   Eda, S
   Terry, P
AF Cheng, Cheng
   Wu, Jayne
   Fikrig, Erol
   Wang, Penghua
   Chen, Jiangang
   Eda, Shigetoshi
   Terry, Paul
TI Unamplified RNA Sensor for On-Site Screening of Zika Virus Disease in a
   Limited Resource Setting
SO CHEMELECTROCHEM
LA English
DT Article
DE AC electrokinetics; capacitive sensing; point-of-care diagnostics; RNA
   sensor; Zika virus
ID SERODIAGNOSIS; IMMUNOSENSOR; RESPONSES; OUTBREAK
AB Recent outbreaks of Zika virus have been declared a public health emergency of international concern. The diagnosis of Zika infection is based on a person's recent travel history, symptoms, and laboratory test results. However, the diagnosis of Zika infection may be delayed because symptoms are often mild and nondescript, and confirmatory laboratory tests are relatively time-consuming and expensive. Given the lack of an effective vaccine against Zika virus, and a relatively short period of viremia, developing a rapid and sensitive means of detecting the Zika virus in serum is a public health priority. This work presents a novel RNA sensor, based on a sequence-specific probe and AC electrokinetics-enhanced capacitive sensing technology to directly capture and detect Zika virus RNA. This method allows detection and quantification of Zika virus RNA in only 30seconds, with a low limit of detection (LOD) reaching 158.1copies/L. The sensor is also tested for its specificity, showing no false-positive signals from other viruses. In addition, the biosensor is portable, inexpensive, and simple to use, without the need of signal amplification, which makes it ideal for field applications.
C1 [Cheng, Cheng; Wu, Jayne] Univ Tennessee, Dept Elect Engn & Comp Sci, 1520 Middle Dr, Knoxville, TN 37996 USA.
   [Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA.
   [Wang, Penghua] New York Med Coll, Sch Med, Dept Microbiol & Imunol, Valhalla, NY 10595 USA.
   [Chen, Jiangang] Univ Tennessee, Dept Publ Hlth, Knoxville, TN 37996 USA.
   [Eda, Shigetoshi] Univ Tennessee, Inst Agr, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA.
   [Terry, Paul] Univ Tennessee, Grad Sch Med, Dept Med, 1924 Alcoa Hwy, Knoxville, TN 37920 USA.
RP Wu, JN (corresponding author), Univ Tennessee, Dept Elect Engn & Comp Sci, 1520 Middle Dr, Knoxville, TN 37996 USA.
EM jaynewu@utk.edu
RI Cheng, Cheng/L-9403-2016; wang, Penghua/AAL-4011-2020; Wu,
   Jayne/A-8871-2009
OI Cheng, Cheng/0000-0002-5401-6185; Wu, Jayne/0000-0001-5143-9425
FU University of Tennessee Initiative for PON/POC Nanobiosensing and Center
   for Wildlife Health
FX Support from the University of Tennessee Initiative for PON/POC
   Nanobiosensing and Center for Wildlife Health are acknowledged.
CR Baden L. R., 2016, NEW ENGL J MED, V374, P1552, DOI [DOI 10.1056/NEJMRA1602113, 10.1056/NEJMra1602113]
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cheng C., 2016, ACS APPL MATER INTER, DOI [10.1021/acsami.6b03743, DOI 10.1021/ACSAMI.6B03743]
   Cui H., 2013, 2013 IEEE SENSORS, P4, DOI DOI 10.1109/ICSENS.2013.6688157
   Cui HC, 2013, ANALYST, V138, P7188, DOI 10.1039/c3an01112g
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li SS, 2015, ELECTROPHORESIS, V36, P471, DOI 10.1002/elps.201400284
   Li SS, 2014, BIOSENS BIOELECTRON, V51, P437, DOI 10.1016/j.bios.2013.08.016
   Li SS, 2013, BIOSENS BIOELECTRON, V41, P649, DOI 10.1016/j.bios.2012.09.036
   Liu XZ, 2011, SENSOR ACTUAT A-PHYS, V171, P406, DOI 10.1016/j.sna.2011.08.007
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mirzajani H, 2017, BIOSENS BIOELECTRON, V89, P1059, DOI 10.1016/j.bios.2016.09.109
   Mirzajani H, 2016, SENSOR ACTUAT B-CHEM, V235, P330, DOI 10.1016/j.snb.2016.05.073
   Moradi N, 2013, ANAL METHODS-UK, V5, P6531, DOI 10.1039/c3ay40871j
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   WHO, 2018, ZIK VIR COMPL QUEST
   World Health Organization, 2016, CURR ZIK PROD PIP
NR 24
TC 9
Z9 9
U1 1
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2196-0216
J9 CHEMELECTROCHEM
JI ChemElectroChem
PD MAR
PY 2017
VL 4
IS 3
BP 485
EP 489
DI 10.1002/celc.201600831
PG 5
WC Electrochemistry
SC Electrochemistry
GA EP6FL
UT WOS:000397473700007
DA 2020-07-08
ER

PT J
AU Song, JZ
   Liu, CC
   Mauk, MG
   Rankin, SC
   Lok, JB
   Greenberg, RM
   Bau, HH
AF Song, Jinzhao
   Liu, Changchun
   Mauk, Michael G.
   Rankin, Shelley C.
   Lok, James B.
   Greenberg, Robert M.
   Bau, Haim H.
TI Two-Stage Isothermal Enzymatic Amplification for Concurrent Multiplex
   Molecular Detection
SO CLINICAL CHEMISTRY
LA English
DT Article
ID RECOMBINASE POLYMERASE AMPLIFICATION; SUB-SAHARAN AFRICA;
   SCHISTOSOMA-MANSONI; PLASMODIUM-FALCIPARUM; RESPIRATORY VIRUSES; ZIKA
   VIRUS; PCR; DNA; DIAGNOSIS; INFLUENZA
AB BACKGROUND: The wide array of pathogens responsible for infectious diseases makes it difficult to identify causative pathogens with single-plex tests. Although multiplex PCR detects multiple targets, it is restricted to centralized laboratories, which delays test results or makes multiplexing unavailable, depriving healthcare providers of critical, real-time information.
   METHODS: To address the need for point-of-care (POC) highly multiplexed tests, we propose the 2-stage, nested like, rapid (<40 min) isothermal amplification assay, dubbed rapid amplification (RAMP). RAMP's first-stage uses outer loop-mediated isothermal amplification (LAMP) primers to amplify all targets with recombinase polymerase amplification (RPA). First-stage amplicons are ali-quoted to second stage reactors, each specialized for a specific target, to undergo LAMP. The assay is implemented in a microfluidic chip. LAMP amplicons are detected in situ with colorimetric dye or with a fluorescent dye and a smartphone.
   RESULTS: In experiments on a benchtop and in a microfluidic format, RAMP demonstrated high level of multiplexing (>= 16); high sensitivity (i.e., 1 plaque-forming unit of Zika virus) and specificity (no false positives or negatives); speed (<40 min); ease of use; and ability to cope with minimally processed samples.
   CONCLUSIONS: RAMP is a hybrid, 2-stage, rapid, and highly sensitive and specific assay with extensive multiplexing capabilities, combining the advantages of RPA and LAMP, while circumventing their respective shortcomings. RAMP can be used in the lab, but one of its distinct advantages is amenability to simple implementation in a microfluidic format for use at the POC, providing healthcare personnel with an inexpensive, highly sensitive tool to detect multiple pathogens in a single sample, on site. (C) 2016 American Association for Clinical Chemistry
C1 [Song, Jinzhao; Liu, Changchun; Mauk, Michael G.; Bau, Haim H.] Univ Penn, Sch Engn & Appl Sci, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
   [Rankin, Shelley C.; Lok, James B.; Greenberg, Robert M.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.
RP Bau, HH (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, 233 Towne Bldg, Philadelphia, PA 19104 USA.
EM bau@seas.upenn.edu
RI Bau, Haim H/D-1161-2009
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R41AI104418-01A1]
FX J. Lok, NIH; R. Greenberg, NIH; H. Bau, NIH grant 1R41AI104418-01A1 (to
   the institution).
CR Coulibaly JT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001384
   Crannell Z, 2016, ANAL CHEM, V88, P1610, DOI 10.1021/acs.analchem.5b03267
   Crannell ZA, 2014, ANAL CHEM, V86, P5615, DOI 10.1021/ac5011298
   Deshpande A, 2012, EXPERT REV MOL DIAGN, V12, P645, DOI [10.1586/ERM.12.60, 10.1586/erm.12.60]
   Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207
   Gordon CA, 2011, MOL CELL PROBE, V25, P143, DOI 10.1016/j.mcp.2011.05.002
   Hatchette TF, 2009, CAN J PUBLIC HEALTH, V100, P204, DOI 10.1007/BF03405541
   Jung JH, 2015, ANAL CHIM ACTA, V853, P541, DOI 10.1016/j.aca.2014.10.020
   Kersting S, 2014, MICROCHIM ACTA, V181, P1715, DOI 10.1007/s00604-014-1198-5
   Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99
   Kim J, 2009, LAB CHIP, V9, P606, DOI 10.1039/b807915c
   Kongs A, 2001, TROP MED INT HEALTH, V6, P163, DOI 10.1046/j.1365-3156.2001.00687.x
   Liang C, 2012, ANAL CHEM, V84, P3758, DOI 10.1021/ac3003825
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06
   Mazigo HD, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0587-2
   Mbah MLN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003234
   Mbah MLN, 2013, TROP MED INT HEALTH, V18, P1174, DOI 10.1111/tmi.12165
   Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Palka-Santini M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-1
   Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Popowitch EB, 2013, J CLIN MICROBIOL, V51, P1528, DOI 10.1128/JCM.03368-12
   Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047
   Reddington Kate, 2014, Biomol Detect Quantif, V1, P3
   Rosser A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1055-3
   Saha K, 2014, INDIAN J MED MICROBI, V32, P130, DOI 10.4103/0255-0857.129782
   Simon GG, 2016, INT J INFECT DIS, V42, P54, DOI 10.1016/j.ijid.2015.11.006
   Soe MJ, 2013, ANALYST, V138, P5871, DOI 10.1039/c3an00803g
   Soe MJ, 2013, CLIN CHEM, V59, P436, DOI 10.1373/clinchem.2012.193664
   Song JZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004318
   Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428
NR 37
TC 27
Z9 27
U1 2
U2 46
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD MAR
PY 2017
VL 63
IS 3
BP 714
EP 722
DI 10.1373/clinchem.2016.263665
PG 9
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA EL6LU
UT WOS:000394734900013
PM 28073898
OA Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Vinhaes, ES
   Santos, LA
   Dias, L
   Andrade, NA
   Bezerra, VH
   de Carvalho, AT
   de Moraes, L
   Henriques, DF
   Azar, SR
   Vasilakis, N
   Ko, AI
   Andrade, BB
   Siqueira, IC
   Khouri, R
   Boaventura, VS
AF Vinhaes, Eriko S.
   Santos, Luciane A.
   Dias, Lislane
   Andrade, Nilvano A.
   Bezerra, Victor H.
   de Carvalho, Anderson T.
   de Moraes, Laise
   Henriques, Daniele F.
   Azar, Sasha R.
   Vasilakis, Nikos
   Ko, Albert I.
   Andrade, Bruno B.
   Siqueira, Isadora C.
   Khouri, Ricardo
   Boaventura, Viviane S.
TI Transient Hearing Loss in Adults Associated With Zika Virus Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; sensorineural hearing loss; tinnitus; dizziness
ID BRAZIL
AB In 2015, during the outbreak of Zika virus (ZIKV) in Brazil, we identified 3 cases of acute hearing loss after exanthematous illness. Serology yielded finding compatible with ZIKV as the cause of a confirmed (n = 1) and a probable (n = 2) flavivirus infection, indicating an association between ZIKV infection and transient hearing loss.
C1 [Vinhaes, Eriko S.; Dias, Lislane; Andrade, Nilvano A.; Bezerra, Victor H.; de Carvalho, Anderson T.; Boaventura, Viviane S.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Santos, Luciane A.; de Moraes, Laise; Ko, Albert I.; Andrade, Bruno B.; Siqueira, Isadora C.; Khouri, Ricardo; Boaventura, Viviane S.] Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz MS, Salvador, BA, Brazil.
   [Henriques, Daniele F.] World Hlth Org, Inst Evandro Chagas, Collaborating Ctr Reference & Res Arbovirus, Fundacao Nacl Sa,Minist Saude, Belem, Para, Brazil.
   [Azar, Sasha R.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX USA.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Andrade, Bruno B.] Jose Silveira Fdn, Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil.
   [Khouri, Ricardo] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Boaventura, Viviane S.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP Boaventura, VS (corresponding author), Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM viviane.boaventura@bahia.fiocruz.br
RI Andrade, Bruno/AAI-2248-2020; de Siqueira, Isadora Cristina/R-9953-2016;
   Khouri, Ricardo/M-3184-2018; Ko, Albert Icksang/P-2343-2015; de Moraes,
   Laise/N-4475-2017
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Khouri,
   Ricardo/0000-0001-5664-4436; Ko, Albert Icksang/0000-0001-9023-2339; de
   Moraes, Laise/0000-0001-9095-5860
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1 R01 AI121207, R24
   AI120942]; "Programa Ciencias sem fronteiras," Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico of Brazil
FX This work was supported by the National Institutes of Health (grant
   numbers 1 R01 AI121207 and R24 AI120942). R. K. and L. A. S. were
   supported by "Programa Ciencias sem fronteiras," Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico of Brazil.
CR Casetta I, 2011, J NEUROL, V258, P1880, DOI 10.1007/s00415-011-6011-3
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Ribeiro BNF, 2015, INT J SURG CASE REP, V8, P38, DOI 10.1016/j.ijscr.2014.10.057
   Greco A, 2011, AUTOIMMUN REV, V10, P756, DOI 10.1016/j.autrev.2011.05.005
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7
   Taki M, 2009, AURIS NASUS LARYNX, V36, P345, DOI 10.1016/j.anl.2008.05.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 14
Z9 14
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2017
VL 64
IS 5
BP 675
EP 677
DI 10.1093/cid/ciw770
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3TA
UT WOS:000397303400020
PM 27927858
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aletti, M
   Lecoules, S
   Kanczuga, V
   Soler, C
   Maquart, M
   Simon, F
   Leparc-Goffart, I
AF Aletti, Marc
   Lecoules, Stephane
   Kanczuga, Vincent
   Soler, Charles
   Maquart, Marianne
   Simon, Fabrice
   Leparc-Goffart, Isabelle
TI Transient Myocarditis Associated With Acute Zika Virus Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; myocarditis; imported viral disease; reemerging disease;
   sentinel surveillance
ID CARDIOMYOPATHY
AB Zika virus outbreak is spreading in the Americas. This emerging infection is associated with neurological complication. We report the first travel-acquired Zika acute infection complicated with myocarditis imported to mainland France. We recommend an electrocardiogram and troponin if any cardiac symptoms are present in a patient with acute Zika infection.
C1 [Aletti, Marc; Lecoules, Stephane] Percy Mil Teaching Hosp, Dept Internal Med, Clamart, France.
   [Kanczuga, Vincent] Percy Mil Teaching Hosp, Dept Cardiol, Clamart, France.
   [Soler, Charles] Percy Mil Teaching Hosp, Dept Microbiol, Clamart, France.
   [Maquart, Marianne; Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Arbovirus Reference Ctr, Paris, France.
   [Simon, Fabrice] Laveran Mil Teaching Hosp, Dept Infect Dis, Marseille, France.
RP Aletti, M (corresponding author), Mil Teaching Hosp PERCY, 101 Bd Henri Barbusse, F-92190 Clamart, France.
EM marc.aletti@free.fr
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mitchell C, PAHO WHO COUNTRIES T
   OBEYESEKERE I, 1973, AM HEART J, V85, P186, DOI 10.1016/0002-8703(73)90459-6
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simon F, 2008, AM J TROP MED HYG, V78, P212, DOI 10.4269/ajtmh.2008.78.212
NR 8
TC 11
Z9 13
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2017
VL 64
IS 5
BP 678
EP 679
DI 10.1093/cid/ciw802
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3TA
UT WOS:000397303400021
PM 27940942
OA Bronze
DA 2020-07-08
ER

PT J
AU Khawar, W
   Bromberg, R
   Moor, M
   Lyubynska, N
   Mahmoudi, H
AF Khawar, Waqaar
   Bromberg, Romina
   Moor, Molly
   Lyubynska, Natalya
   Mahmoudi, Hilda
TI Seven Cases of Zika Virus Infection in South Florida
SO CUREUS
LA English
DT Article
DE zika virus; tropical disease; public health
ID DISEASE; STATES; BRAIN
AB Introduction
   Zika virus, an arbovirus of the Flaviviridae family, is a mosquito-borne virus known to cause microcephaly through vertical transmission. Infection presents with mild, self-limiting symptoms. Currently, a Zika virus outbreak has spread across most of South and Central America. Travel-related and sexually transmitted cases have been reported across the United States. However, the vector-borne transmission has been limited to Florida and Texas. We present seven cases of Zika virus infection that presented at a single institution in South Florida.
   Methods
   Patients were included that had real-time polymerase-chain reaction (RT-PCR) for Zika virus RNA in urine or serum or enzyme-linked immunosorbent assay (ELISA) for Immunoglobulin M (IgM) antibody against Zika virus in serum.
   Results
   All seven patients reported recent travel or employment in areas of active Zika virus transmission and at least two of the four most commonly reported symptoms (fever, arthralgia, rash, and conjunctivitis) with a rash present in all patients. All patients had positive RT-PCR for Zika virus RNA in urine. RT-PCR for Zika virus RNA in serum was negative in four of five patients that were tested, indicating that these patients likely presented one to two weeks after symptom onset.
   Conclusion
   The future of Zika virus outbreaks in other cities in the United States is still uncertain. However, it is clear that prevention and control policies are urgently needed. We have presented seven confirmed cases of Zika virus infection in South Florida. In addition to conducting research concerning both the diagnostic and therapeutic aspects of the virus, there is a need for public awareness of its presentation, methods of transmission, and subsequent clinical outcomes.
C1 [Khawar, Waqaar; Bromberg, Romina; Lyubynska, Natalya] Aventura Hosp & Med Ctr, Dept Internal Med, Aventura, FL 33180 USA.
   [Moor, Molly; Mahmoudi, Hilda] Aventura Hosp & Med Ctr, GME, Aventura, FL USA.
RP Khawar, W (corresponding author), Aventura Hosp & Med Ctr, Dept Internal Med, Aventura, FL 33180 USA.
EM waqaark@gmail.com
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], 2016, COUNTRIES TERRITORIE
   [Anonymous], 2016, TEXAS ANNOUNCES ADDI
   [Anonymous], 2016, ZIKA VIRUS
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   DCHHS, 2016, DCHHS REPORTS 1 ZIKA
   Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
NR 28
TC 4
Z9 4
U1 0
U2 1
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD MAR
PY 2017
VL 9
IS 3
AR UNSP e1099
DI 10.7759/cureus.1099
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA HE7LV
UT WOS:000453620000037
PM 28413745
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Yang, YJ
   Shan, C
   Zou, J
   Muruato, AE
   Bruno, DN
   Daniele, BDM
   Vasconcelos, PFC
   Rossi, SL
   Weaver, SC
   Xie, XP
   Shi, PY
AF Yang, Yujiao
   Shan, Chao
   Zou, Jing
   Muruato, Antonio E.
   Bruno, Diniz Nunes
   Daniele, Barbosa de Almeida Medeiros
   Vasconcelos, Pedro F. C.
   Rossi, Shannan L.
   Weaver, Scott C.
   Xie, Xuping
   Shi, Pei-Yong
TI A cDNA Clone-Launched Platform for High-Yield Production of Inactivated
   Zika Vaccine
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus vaccine; Flavivirus NS1; Flavivirus assembly
ID NONSTRUCTURAL PROTEINS NS1; VIRUS; NS2A; BINDING; MODEL; NS4B
AB A purified inactivated vaccine (PIV) using the Zika virus (ZIKV) Puerto Rico strain PRVABC59 showed efficacy in monkeys, and is currently in a phase I clinical trial. High-yield manufacture of this PIV is essential for its development and vaccine access. Here we report an infectious cDNA clone-launched platform to maximize its yield. A single NS1 protein substitution (K265E) was identified to increase ZIKV replication on Vero cells (a cell line approved for vaccine production) for both Cambodian FSS13025 and Puerto Rico PRVABC59 strains. The NS1 mutation did not affect viral RNA synthesis, but significantly increased virion assembly through an increased interaction between NS1 and NS2A (a known regulator of flavivirus assembly). The NS1 mutant virus retained wild-type virulence in the A129mouse model, but decreased its competence to infect Aedes aegypti mosquitoes. To further increase virus yield, we constructed an infectious cDNA clone of the clinical trial PIV strain PRVABC59 containing three viral replication-enhancing mutations (NS1 K265E, prM H83R, and NS3 S356F). The mutant cDNA clone produced >25-fold more ZIKV than the wild-type parent on Vero cells. This cDNA clone-launched manufacture platform has the advantages of higher virus yield, shortened manufacture time, and minimized chance of contamination. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Yang, Yujiao; Shan, Chao; Zou, Jing; Bruno, Diniz Nunes; Daniele, Barbosa de Almeida Medeiros; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, 5-104A Med Res Bldg, Galveston, TX 77555 USA.
   [Yang, Yujiao] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.
   [Muruato, Antonio E.; Rossi, Shannan L.; Weaver, Scott C.] Inst Human Infect & Immunity, Galveston, TX USA.
   [Muruato, Antonio E.; Weaver, Scott C.; Shi, Pei-Yong] Inst Translat Sci, Galveston, TX USA.
   [Bruno, Diniz Nunes; Daniele, Barbosa de Almeida Medeiros; Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Minist Saude, Secao Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
   [Rossi, Shannan L.] Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX USA.
   [Weaver, Scott C.] Dept Microbiol & Immunol, Galveston, TX USA.
   [Weaver, Scott C.] Sealy Ctr Vaccine Dev, Galveston, TX USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Vasconcelos, Pedro F. C.; Shi, Pei-Yong] Para State Univ, Dept Pathol, Belem, Para, Brazil.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Xie, XP; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 5-104A Med Res Bldg, Galveston, TX 77555 USA.
EM xuxie@utmb.edu; peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019; Vasconcelos, Pedro/AAH-3142-2019; Weaver,
   Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556; Shan, Chao/0000-0002-3953-3782
FU University of Texas Medical Branch (UTMB) startup award; UTMB Innovation
   and Commercialization award; University of Texas STARs Award; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01AI087856, AI120942]; Pan American Health
   Organization [SCON2016-01353]; UTMB CTSAUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR-001439]
FX P.Y.S. was supported by University of Texas Medical Branch (UTMB)
   startup award, UTMB Innovation and Commercialization award, University
   of Texas STARs Award, NIH grant R01AI087856, Pan American Health
   Organization grant SCON2016-01353, and UTMB CTSA UL1TR-001439. This
   research was also supported by NIH grant AI120942 to S.C.W.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Griffiths E., 1987, 747 WHO, V747
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 36
TC 22
Z9 23
U1 1
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD MAR
PY 2017
VL 17
BP 145
EP 156
DI 10.1016/j.ebiom.2017.02.003
PG 12
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EQ4UV
UT WOS:000398075700025
PM 28196656
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shan, C
   Xie, XP
   Ren, P
   Loeffelholz, MJ
   Yang, YJ
   Furuya, A
   Dupuis, AP
   Kramer, LD
   Wong, SJ
   Shi, PY
AF Shan, Chao
   Xie, Xuping
   Ren, Ping
   Loeffelholz, Michael J.
   Yang, Yujiao
   Furuya, Andrea
   Dupuis, Alan P., II
   Kramer, Laura D.
   Wong, Susan J.
   Shi, Pei-Yong
TI A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in
   Patients
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; Dengue virus; Flavivirus diagnosis; Serologic assay;
   Neutralization assay
ID WEST-NILE-VIRUS; LOUIS ENCEPHALITIS-VIRUS; ORIGINAL ANTIGENIC SIN;
   DENGUE VIRUS; INFECTION; LUCIFERASE; PROTEINS; REPLICON; IMMUNOASSAY;
   PARTICLES
AB The potential association of microcephaly and other congenital abnormalities with Zika virus (ZIKV) infection during pregnancy underlines the critical need for a rapid and accurate diagnosis. Due to the short duration of ZIKV viremia in infected patients, a serologic assay that detects antibody responses to viral infection plays an essential role in diagnosing patient specimens. The current serologic diagnosis of ZIKV infection relies heavily on the labor intensive Plaque Reduction Neutralization Test (PRNT) that requires more than one-week turnaround time and represents a major bottleneck for patient diagnosis. To overcome this limitation, we have developed a high-throughput assay for ZIKV and dengue virus (DENV) diagnosis that can attain the "gold standard" of the current PRNT assay. The new assay is homogeneous and utilizes luciferase viruses to quantify the neutralizing antibody titers in a 96-well format. Using 91 human specimens, we showed that the reporter diagnostic assay has a higher dynamic range and maintains the relative specificity of the traditional PRNT assay. Besides the improvement of assay throughput, the reporter virus technology has also shortened the turnaround timeto less than two days. Collectively, our results suggest that, along with the viral RT-PCR assay, the reporter virus-based serologic assay could be potentially used as the first-line test for clinical diagnosis of ZIKV infection as well as for vaccine clinical trials. (C) 2017 The Author(s). Published by Elsevier B.V.
C1 [Shan, Chao; Xie, Xuping; Yang, Yujiao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Ren, Ping; Loeffelholz, Michael J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Furuya, Andrea; Dupuis, Alan P., II; Kramer, Laura D.; Wong, Susan J.] Wadsworth Ctr, New York State Dept Hlth, Albany, NY USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019
OI Shan, Chao/0000-0002-3953-3782; Ren, Ping/0000-0002-4022-6667
FU University of Texas Medical Branch (UTMB) startup award; UTMB Innovation
   and Commercialization award; University of Texas STARs Award; CDC grant
   for the Western Gulf Center of Excellence for Vector-Borne Diseases; Pan
   American Health Organization [SCON2016-01353]; UTMB CTSAUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR-001439]
FX P.Y.S. lab was partially supported by University of Texas Medical Branch
   (UTMB) startup award, UTMB Innovation and Commercialization award,
   University of Texas STARs Award, CDC grant for the Western Gulf Center
   of Excellence for Vector-Borne Diseases, Pan American Health
   Organization grant SCON2016-01353, and UTMB CTSA UL1TR-001439.
CR Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Garcia G, 1997, AM J TROP MED HYG, V56, P466, DOI 10.4269/ajtmh.1997.56.466
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998
   KUNO G, 1993, T ROY SOC TROP MED H, V87, P103, DOI 10.1016/0035-9203(93)90444-U
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LINDENBACH B, 2013, FIELDS VIROLOGY, V1, P712
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Shu PY, 2000, J MED VIROL, V62, P224, DOI 10.1002/1096-9071(200010)62:2&lt;224::AID-JMV14&gt;3.0.CO;2-C
   Shu PY, 2002, J CLIN MICROBIOL, V40, P1840, DOI 10.1128/JCM.40.5.1840-1844.2002
   Shustov AV, 2007, J VIROL, V81, P11737, DOI 10.1128/JVI.01112-07
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Taketa-Graham M, 2010, AM J TROP MED HYG, V82, P501, DOI 10.4269/ajtmh.2010.09-0297
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Zhang PT, 2016, VIRUS RES, V211, P17, DOI 10.1016/j.virusres.2015.09.015
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 27
TC 33
Z9 33
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD MAR
PY 2017
VL 17
BP 157
EP 162
DI 10.1016/j.ebiom.2017.03.006
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EQ4UV
UT WOS:000398075700026
PM 28283425
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Agusto, FB
   Bewick, S
   Fagan, WF
AF Agusto, F. B.
   Bewick, S.
   Fagan, W. F.
TI Mathematical model for Zika virus dynamics with sexual transmission
   route
SO ECOLOGICAL COMPLEXITY
LA English
DT Article
DE Zika virus; Heterosexual and homosexual couples; Sexual transmission;
   Stability; Backward bifurcation
ID AEDES-AEGYPTI; CHIKUNGUNYA; DISEASE; DENGUE; POPULATION; FEVER;
   BIFURCATIONS; ALBOPICTUS; DISPERSAL; EMERGENCE
AB Zika virus is a flavivirus transmitted to humans primarily through the bite of infected Aedes mosquitoes. In addition to vector-borne spread, however, the virus can also be transmitted through sexual contact. In this paper, we formulate and analyze a new system of ordinary differential equations which incorporates both vector and sexual transmission routes. Theoretical analysis of this model when there is no disease induced mortality shows that the disease-free equilibrium is locally and globally asymptotically stable whenever the associated reproduction number is less than unity and unstable otherwise. However, when we extend this same model to include Zika induced mortality, which have been documented in Latin America, we find that the model exhibits a backward bifurcation. Specifically, a stable disease-free equilibrium co-exists with a stable endemic equilibrium when the associated reproduction number is less than unity. To further explore model predictions, we use numerical simulations to assess the importance of sexual transmission to disease dynamics. This analysis shows that risky behavior involving multiple sexual partners, particularly among male populations, substantially increases the number of infected individuals in the population, contributing significantly to the disease burden in the community. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Agusto, F. B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.
   [Bewick, S.; Fagan, W. F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA.
RP Agusto, FB (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.
EM fbagusto@gmail.com
OI Agusto, Folashade/0000-0001-6137-6480
FU Strategic Environmental Research and Development Program [RC-2639];
   University of Kansas [NFGRF-2302100]; US National Science
   FoundationNational Science Foundation (NSF) [DMS-1225917]
FX This research was supported by the Strategic Environmental Research and
   Development Program under grant RC-2639. One of the author, FBA, had
   additional support from University of Kansas under grant NFGRF-2302100
   and WFF, had further support from the US National Science Foundation
   under grant DMS-1225917.
CR Agusto FB, 2013, MATH BIOSCI, V243, P147, DOI 10.1016/j.mbs.2013.02.001
   Agusto FB, 2010, ANZIAM J, V51, P394, DOI 10.1017/S1446181110000891
   Agusto FB, 2011, MATH METHOD APPL SCI, V34, P1873, DOI 10.1002/mma.1486
   ANDERSON R M, 1991
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bewick S., 2016, ZIKA VIRUS ENDEMIC V
   Brauer F, 2004, J MATH ANAL APPL, V298, P418, DOI 10.1016/j.jmaa.2004.05.045
   Brauer F, 2001, MATH BIOSCI, V171, P143, DOI 10.1016/S0025-5564(01)00057-8
   Brent C., 2016, MMWR-MORBID MORTAL W, V65, P1
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carr J, 1981, APPL CTR MANIFOLD TH
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   Castillo-Chavez C., 2002, MATH APPROACHES EMER
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Coelho F.C., 2016, 055459 BIORXIV
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard D.T., 2016, MMWR-MORBID MORTAL W, V372, P14
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Dushoff J, 1998, J MATH BIOL, V36, P227, DOI 10.1007/s002850050099
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hillin T., 2014, THIS IS OFTEN MARRIE
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JEFFRIES C, 1977, CAN J MATH, V29, P315, DOI 10.4153/CJM-1977-035-3
   Karimi F., 2016, CABLE NEWS NETWORK
   Lakshmikantham V., 1989, STABILITY ANAL NONLI
   Lyons A, 2013, AIDS BEHAV, V17, P1370, DOI 10.1007/s10461-012-0332-9
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   PETERSEN LR, 1992, J ACQ IMMUN DEF SYND, V5, P853
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sebastian MR, 2009, INDIAN J PEDIATR, V76, P185, DOI 10.1007/s12098-009-0049-6
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   Smith HL, 1995, THEORY CHEMOSTAT
   Traynor K, 2016, AM J HEALTH-SYST PH, V73, P508, DOI 10.2146/news160023
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wikipedia, 2015, LIST SOV STAT DEP TE
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   World Health Organization, 2016, MICR BRAZ DIS OUTBR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 68
TC 20
Z9 21
U1 1
U2 25
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1476-945X
EI 1476-9840
J9 ECOL COMPLEX
JI Ecol. Complex.
PD MAR
PY 2017
VL 29
BP 61
EP 81
DI 10.1016/j.ecocom.2016.12.007
PG 21
WC Ecology
SC Environmental Sciences & Ecology
GA EQ1MR
UT WOS:000397834700006
OA Bronze
DA 2020-07-08
ER

PT J
AU AlShebly, MM
   AlQahtani, FS
   Govindarajan, M
   Gopinath, K
   Vijayan, P
   Benelli, G
AF AlShebly, Mashael Marzouq
   AlQahtani, Fatma Saeed
   Govindarajan, Marimuthu
   Gopinath, Kasi
   Vijayan, Periasamy
   Benelli, Giovanni
TI Toxicity of ar-curcumene and epi-beta-bisabolol from Hedychium larsenii
   (Zingiberaceae) essential oil on malaria, chikungunya and St. Louis
   encephalitis mosquito vectors
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Biosafety; Dengue; Zika virus; Filariasis; Oviposition deterrent;
   Non-target organism
ID ECO-FRIENDLY LARVICIDES; RHIZOME ESSENTIAL OILS; AEDES-AEGYPTI DIPTERA;
   CHEMICAL-COMPOSITION; ANTIMICROBIAL ACTIVITY; ANOPHELES-STEPHENSI;
   DENGUE; REPELLENTS; CONSTITUENTS; GARDNERIANUM
AB Mosquitoes act as vectors of key pathogens and parasites. Plant essential oils have been recognized as important sources of biopesticides, which do not induce resistance and have limited toxic effects on human health and non target organisms. In this research, we evaluated the larvicidal and oviposition deterrence activity of Hedychium larsenii essential oil (EO) and its major compounds ar-curcumene and epi-beta-bisabolol. Both molecules showed high toxicity against early third instars of Anopheles sWphensi (LC50=10.45 and 14.68 mu g/ml), Aedes aegypti (LC50=11.24 and 15.83 mu g/ml) and Culex quinquefasciatus (LC50= 12.24 and 17.27 mu g/ml). In addition, low doses of ar-curcumene and epi-beta-bisabolol were effective as oviposition deterrents against the three tested mosquito species. Notably, the acute toxicity of H. larsenii oil and its major compounds against the mosquito biocontrol agent Poecilla redculata was low, with LC50 higher than 1500 ppm. Overall, the results from this study revealed that ar-curcumene and epi-beta-bisabolol from the H. larsenii oil can be considered for the development of novel and effective mosquito larvicides.
C1 [AlShebly, Mashael Marzouq] King Saud Univ, Coll Med, Dept Obstet & Gynecol, Riyadh, Saudi Arabia.
   [AlShebly, Mashael Marzouq; AlQahtani, Fatma Saeed] King Saud Univ Med City, Riyadh, Saudi Arabia.
   [AlQahtani, Fatma Saeed] King Saud Univ, Coll Med, Hematol Unit, Dept Pathol, Riyadh, Saudi Arabia.
   [Govindarajan, Marimuthu; Vijayan, Periasamy] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Gopinath, Kasi] Bharathiar Univ, Dept Bot, Coimbatore 641046, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI Benelli, Giovanni/0000-0001-8971-6010; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055
   Baez D, 2011, J ESSENT OIL RES, V23, P64, DOI 10.1080/10412905.2011.9700460
   Benelli G., 2016, IND CROPS PRODUCTS
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   BERNHARD L, 2003, PHYSIOTHERAPY, V89, P743
   bin Ahmad F, 2004, J ESSENT OIL RES, V16, P299
   Bisht GS, 2006, FITOTERAPIA, V77, P240, DOI 10.1016/j.fitote.2006.02.004
   Thanh BV, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0054-3
   Champakaew D, 2007, PARASITOL RES, V100, P729, DOI 10.1007/s00436-006-0350-5
   Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012
   Dan M, 1999, NORD J BOT, V19, P333, DOI 10.1111/j.1756-1051.1999.tb01121.x
   DEO P G, 1988, International Pest Control, V30, P118
   dos Santos BCB, 2010, J ESSENT OIL RES, V22, P305, DOI 10.1080/10412905.2010.9700331
   Elango G, 2009, PARASITOL RES, V105, P1567, DOI 10.1007/s00436-009-1593-8
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gopanraj G, 2005, Acta Pharm, V55, P315
   Govindarajan M., 2016, COMB CHEM HIGH THROU
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Gurib-Fakim A, 2002, J ESSENT OIL RES, V14, P271, DOI 10.1080/10412905.2002.9699850
   Jain S.K., 1995, PHYTOGEOGR ENDEM, V5, P154
   Johnson, 1999, CRC ETHNOBOTANY DESK, P210
   Joshi S, 2008, CHEM BIODIVERS, V5, P299, DOI 10.1002/cbdv.200890027
   KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111
   MALHOTRA C L, 1984, Journal of Economic and Taxonomic Botany, V5, P841
   Medeiros JR, 2003, PHYTOCHEMISTRY, V64, P561, DOI 10.1016/S0031-9422(03)00338-8
   Morikawa T, 2002, CHEM PHARM BULL, V50, P1045, DOI 10.1248/cpb.50.1045
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Pavela R., 2016, J PEST SCI
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pitasawat B, 2007, FITOTERAPIA, V78, P205, DOI 10.1016/j.fitote.2007.01.003
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Sabulal B, 2007, J ESSENT OIL RES, V19, P93, DOI 10.1080/10412905.2007.9699237
   Sakhanokho HF, 2013, MOLECULES, V18, P4308, DOI 10.3390/molecules18044308
   Sharma PK, 1979, J SCI RES PLANT MED, V1, P17
   SIRIRUGSA P, 1995, NORD J BOT, V15, P301, DOI 10.1111/j.1756-1051.1995.tb00156.x
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Sutthanont N, 2010, J VECTOR ECOL, V35, P106, DOI 10.1111/j.1948-7134.2010.00036.x
   Tewtrakul S., 1998, J SCI TECHNOL, V20, P183
   Weyerstahl P, 1998, FLAVOUR FRAG J, V13, P377, DOI 10.1002/(SICI)1099-1026(199811/12)13:6&lt;377::AID-FFJ755&gt;3.0.CO;2-F
   Weyerstahl P, 1995, FLAVOUR FRAG J, V10, P179, DOI [10.1002/ffj.2730100310, 10.1002/ffj.2730100606, 10.1002/ffj.2730100504]
   WHO, 2005, WHOCDSWHOPESGCDPP13
   World Health Organization, 2014, WHODCOWHD1
   WU TL, 2000, FLORA CHINA, V24, P322
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
   Zhou Q, 2008, CHEM PHARM BULL, V56, P210, DOI 10.1248/cpb.56.210
NR 55
TC 19
Z9 19
U1 1
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD MAR
PY 2017
VL 137
BP 149
EP 157
DI 10.1016/j.ecoenv.2016.11.028
PG 9
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA EI8VN
UT WOS:000392786400019
PM 27918946
DA 2020-07-08
ER

PT J
AU Bhatnagar, J
   Rabeneck, DB
   Martines, RB
   Reagan-Steiner, S
   Ermias, Y
   Estetter, LBC
   Suzuki, T
   Ritter, J
   Keating, MK
   Hale, G
   Gary, J
   Muehlenbachs, A
   Lambert, A
   Lanciotti, R
   Oduyebo, T
   Meaney-Delman, D
   Bolanos, F
   Saad, EAP
   Shieh, WJ
   Zaki, SR
AF Bhatnagar, Julu
   Rabeneck, Demi B.
   Martines, Roosecelis B.
   Reagan-Steiner, Sarah
   Ermias, Yokabed
   Estetter, Lindsey B. C.
   Suzuki, Tadaki
   Ritter, Jana
   Keating, M. Kelly
   Hale, Gillian
   Gary, Joy
   Muehlenbachs, Atis
   Lambert, Amy
   Lanciotti, Robert
   Oduyebo, Titilope
   Meaney-Delman, Dana
   Bolanos, Fernando
   Saad, Edgar Alberto Parra
   Shieh, Wun-Ju
   Zaki, Sherif R.
TI Zika Virus RNA Replication and Persistence in Brain and Placental Tissue
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RT-PCR; INFECTION; PREGNANCY; ANTIBODY; DEFECTS; BRAZIL
AB Zika virus is causally linked with congenital microcephaly and may be associated with pregnancy loss. However, the mechanisms of Zika virus intrauterine transmission, replication, and tropism and persistence in tissues are poorly understood. We tested tissues from 52 case-patients: 8 infants with microcephaly who died and 44 women suspected of being infected with Zika virus during pregnancy. By reverse transcription PCR, tissues from 32 (62%) case-patients (brains from 8 infants with microcephaly and placental/fetal tissues from 24 women) were positive for Zika virus. In situ hybridization localized replicative Zika virus RNA in brains of 7 infants and in placentas of 9 women who had pregnancy losses during the first or second trimester. These findings demonstrate that Zika virus replicates and persists in fetal brains and placentas, providing direct evidence of its association with microcephaly. Tissue-based reverse transcription PCR extends the time frame of Zika virus detection in congenital and pregnancy-associated infections.
C1 [Bhatnagar, Julu; Rabeneck, Demi B.; Martines, Roosecelis B.; Reagan-Steiner, Sarah; Ermias, Yokabed; Estetter, Lindsey B. C.; Suzuki, Tadaki; Ritter, Jana; Keating, M. Kelly; Hale, Gillian; Gary, Joy; Muehlenbachs, Atis; Oduyebo, Titilope; Meaney-Delman, Dana; Shieh, Wun-Ju; Zaki, Sherif R.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop G32, Atlanta, GA 30329 USA.
   [Lambert, Amy; Lanciotti, Robert] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Bolanos, Fernando] Patol Hosp Univ Neiva, Neiva, Colombia.
   [Saad, Edgar Alberto Parra] Inst Nacl Salud, Bogota, Colombia.
   [Bhatnagar, Julu] CDC, Mol Pathol, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol,Natl Ctr, Atlanta, GA 30333 USA.
RP Bhatnagar, J (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop G32, Atlanta, GA 30329 USA.; Bhatnagar, J (corresponding author), CDC, Mol Pathol, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol,Natl Ctr, Atlanta, GA 30333 USA.
EM jbhatnagar@cdc.gov
CR Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2007, J CLIN VIROL, V38, P106, DOI 10.1016/j.jcv.2006.11.003
   Bhatnagar J, 2012, AM J TROP MED HYG, V86, P335, DOI 10.4269/ajtmh.2012.11-0346
   Brasil P, 2016, N ENGL J MED
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Christensen BM, 2016, PLOS NEGL TROP DIS, V10
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakajima N, 2010, JPN J INFECT DIS, V63, P67
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Neill J F, 1998, Trans Am Ophthalmol Soc, V96, P813
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritter IM, 2016, ARCH PATHOL LAB MED
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Winchester SA, 2013, J CLIN MICROBIOL, V51, P1622, DOI 10.1128/JCM.03239-12
NR 40
TC 95
Z9 96
U1 2
U2 34
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2017
VL 23
IS 3
BP 405
EP 414
DI 10.3201/eid2303.161499
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EL7WB
UT WOS:000394830900004
PM 27959260
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hart, CE
   Roundy, CM
   Azar, SR
   Huang, JH
   Yun, RM
   Reynolds, E
   Leal, G
   Nava, MR
   Vela, J
   Stark, PM
   Debboun, M
   Rossi, S
   Vasilakis, N
   Thangamani, S
   Weaver, SC
AF Hart, Charles E.
   Roundy, Christopher M.
   Azar, Sasha R.
   Huang, Jing H.
   Yun, Ruimei
   Reynolds, Erin
   Leal, Grace
   Nava, Martin R.
   Vela, Jeremy
   Stark, Pamela M.
   Debboun, Mustapha
   Rossi, Shannan
   Vasilakis, Nikos
   Thangamani, Saravanan
   Weaver, Scott C.
TI Zika Virus Vector Competency of Mosquitoes, Gulf Coast, United States
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB Zika virus has recently spread throughout the Americas. Although Aedes aegypti mosquitoes are considered the primary vector, Culex quinquefasciatus and mosquitoes of other species may also be vectors. We tested Cx. quinquefasciatus and Ae. taeniorhynchus mosquitoes from the US Gulf Coast; both were refractory to infection and incapable of transmission.
C1 [Hart, Charles E.; Roundy, Christopher M.; Azar, Sasha R.; Huang, Jing H.; Yun, Ruimei; Reynolds, Erin; Leal, Grace; Rossi, Shannan; Vasilakis, Nikos; Thangamani, Saravanan; Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Nava, Martin R.; Vela, Jeremy; Stark, Pamela M.; Debboun, Mustapha] Harris Cty Publ Hlth, Houston, TX USA.
RP Thangamani, S; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sathanga@utmb.edu; sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011; Thangamani, Saravanan/E-7371-2010
OI Weaver, Scott C/0000-0001-8016-8556; Thangamani,
   Saravanan/0000-0002-4269-5993
FU Institute for Human Infections and Immunity [R24AI120942, 1U01AI115577]
FX This work was supported by a pilot grant by the Institute for Human
   Infections and Immunity (R24AI120942, 1U01AI115577).
CR Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Guo XX, 2014, J AM MOSQUITO CONTR, V30, P309, DOI 10.2987/14-6439R.1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391
   Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 10
TC 26
Z9 26
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2017
VL 23
IS 3
BP 559
EP 560
DI 10.3201/eid2303.161636
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EL7WB
UT WOS:000394830900040
PM 28005002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rahman, KM
   Harley, D
   Plummer, D
AF Rahman, Kazi Mizanur
   Harley, David
   Plummer, David
TI Zika virus infection and Commonwealth Games 2018 on the Gold Coast,
   Australia
SO INFECTION DISEASE & HEALTH
LA English
DT Letter
DE Zika virus; Commonwealth Games 2018; Australia
ID AEDES-AEGYPTI; CASE SERIES; BRAZIL; DENGUE; TRANSMISSION
C1 [Rahman, Kazi Mizanur; Plummer, David] Griffith Univ, Publ Hlth, Sch Med, Gold Coast, Qld, Australia.
   [Rahman, Kazi Mizanur; Plummer, David] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.
   [Harley, David] Australian Natl Univ, Res Sch Populat Hlth, Coll Med Biol & Environm, Acton, ACT, Australia.
   [Harley, David] Australian Natl Univ, Med Sch, Coll Med Biol & Environm, Acton, ACT, Australia.
RP Rahman, KM (corresponding author), Griffith Univ, Publ Hlth, Sch Med, Gold Coast, Qld, Australia.; Rahman, KM (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.
RI Plummer, David/Q-7461-2019; Plummer, David C/D-7314-2013; HARLEY,
   David/B-4910-2017
OI Plummer, David C/0000-0003-4301-0068; HARLEY, David/0000-0001-6691-5420
FU Griffith University School of Medicine, Gold Coast, Queensland,
   Australia [MED1009]
FX This work received funding from Griffith University School of Medicine,
   Gold Coast, Queensland, Australia through the start-up research funding
   (MED1009) mechanism for Kazi Rahman.
CR [Anonymous], 2015, GAM CHANG COUNC DOC
   [Anonymous], 2013, 21 COMM GAM
   Attaran A, 2016, LANCET INFECT DIS, V16, P1001, DOI 10.1016/S1473-3099(16)30230-4
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, ZIK VIR SYMPT TEST T
   CDC, 2016, ALL COUNTR TERR ACT
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Department of Health D, 2015, APP 7 EX RISK MATR
   DOH, 2016, ZIK VIR NOT ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Focks D. A., 2003, TDRIDEDEN031
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Oehler E, 2014, EURO SERVEILL, V19
   PHE, 2016, HLTH PROT GUID ZIK V
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Venturi G, 2014, EURO SURVEILL, V21
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Webb C, 2016, GUIDE MOSQUITOES AUS
   WHO, 2013, COUNTR TERR AR SHOW
   WHO, 2016, EM ZIK SIT REP
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), 5 M EM COMM INT HLTH
NR 32
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2468-0451
J9 INFECT DIS HEALTH
JI Infect. Dis. Health
PD MAR
PY 2017
VL 22
IS 1
BP 48
EP 50
DI 10.1016/j.idh.2016.12.001
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GI1XK
UT WOS:000434163800008
OA Bronze
DA 2020-07-08
ER

PT J
AU Weaver, S
AF Weaver, Scott
TI Zika Virus: History, Evolution, Transmission, Emergence Mechanisms, and
   Activities of the GVN Task Force
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Meeting Abstract
CT 18th Annual International Meeting of the Institute-of-Human-Virology
   (IHV)
CY SEP 19-22, 2016
CL Univ Maryland, Sch Med, Baltimore, MD
SP Inst Human Virol
HO Univ Maryland, Sch Med
C1 [Weaver, Scott] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
NR 0
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD MAR
PY 2017
VL 74
SU 3
MA C-102
BP 42
EP 42
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GO9YL
UT WOS:000440464100017
DA 2020-07-08
ER

PT J
AU Moore, CA
   Staples, JE
   Dobyns, WB
   Pessoa, A
   Ventura, CV
   Da Fonseca, EB
   Ribeiro, EM
   Ventura, LO
   Neto, NN
   Arena, JF
   Rasmussen, SA
AF Moore, Cynthia A.
   Staples, J. Erin
   Dobyns, William B.
   Pessoa, Andre
   Ventura, Camila V.
   Da Fonseca, Eduardo Borges
   Ribeiro, Erlane Marques
   Ventura, Liana O.
   Nogueira Neto, Norberto
   Arena, J. Fernando
   Rasmussen, Sonja A.
TI Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for
   Pediatric Clinicians
SO JAMA PEDIATRICS
LA English
DT Review
ID BRAIN DISRUPTION SEQUENCE; VIRUS-INFECTION; IMAGING FINDINGS;
   HEARING-LOSS; CASE SERIES; INFANTS; BRAZIL; CALCIFICATION;
   ARTHROGRYPOSIS; DESTRUCTION
AB IMPORTANCE Zika virus infection can be prenatally passed from a pregnant woman to her fetus. There is sufficient evidence to conclude that intrauterine Zika virus infection is a cause of microcephaly and serious brain anomalies, but the full spectrum of anomalies has not been delineated. To inform pediatric clinicians who may be called on to evaluate and treat affected infants and children, we review the most recent evidence to better characterize congenital Zika syndrome.
   OBSERVATIONS We reviewed published reports of congenital anomalies occurring in fetuses or infants with presumed or laboratory-confirmed intrauterine Zika virus infection. We conducted a comprehensive search of the English literature using Medline and EMBASE for Zika from inception through September 30, 2016. Congenital anomalies were considered in the context of the presumed pathogenetic mechanism related to the neurotropic properties of the virus. We conclude that congenital Zika syndrome is a recognizable pattern of structural anomalies and functional disabilities secondary to central and, perhaps, peripheral nervous system damage. Although many of the components of this syndrome, such as cognitive, sensory, and motor disabilities, are shared by other congenital infections, there are 5 features that are rarely seen with other congenital infections or are unique to congenital Zika virus infection: (1) severe microcephaly with partially collapsed skull; (2) thin cerebral cortices with subcortical calcifications; (3) macular scarring and focal pigmentary retinal mottling; (4) congenital contractures; and (5) marked early hypertonia and symptoms of extrapyramidal involvement.
   CONCLUSIONS AND RELEVANCE Although the full spectrum of adverse reproductive outcomes caused by Zika virus infection is not yet determined, a distinctive phenotype-the congenital Zika syndrome- has emerged. Recognition of this phenotype by clinicians for infants and children can help ensure appropriate etiologic evaluation and comprehensive clinical investigation to define the range of anomalies in an affected infant as well as determine essential follow-up and ongoing care.
C1 [Moore, Cynthia A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Mail Stop E-86,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   [Staples, J. Erin] Ctr Dis Control & Prevent, Zoonot Infect Dis, Ft Collins, CO USA.
   [Dobyns, William B.] Univ Washington, Seattle, WA USA.
   [Dobyns, William B.] Seattle Childrens Res Inst, Seattle, WA USA.
   [Pessoa, Andre; Ribeiro, Erlane Marques] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] HOPE Eye Hosp, Recife, PE, Brazil.
   [Ventura, Camila V.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Da Fonseca, Eduardo Borges; Nogueira Neto, Norberto] NOVA Diagnost Imagem, Joao Pessoa, Paraiba, Brazil.
   [Da Fonseca, Eduardo Borges] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Ribeiro, Erlane Marques] Estacio Fac Med Juazeiro Norte, Juazeiro De Norte, Ceara, Brazil.
   [Arena, J. Fernando] Carter Consulting, Atlanta, GA USA.
   [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA USA.
RP Moore, CA (corresponding author), Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Mail Stop E-86,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
EM cam0@cdc.gov
RI Ventura, Camila V/N-2654-2018; Dobyns, William/AAI-2768-2020; Ventura,
   Liana Vieira O/N-6151-2018
OI Ventura, Camila V/0000-0002-2927-4684; Dobyns,
   William/0000-0002-7681-2844; Ventura, Liana Vieira O/0000-0001-6529-6883
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [U54 HD083091];
   NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS058721, R01 NS050375]
CR Abdel-Salam GMH, 2015, AM J MED GENET A, V167, P1089, DOI 10.1002/ajmg.a.37010
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   ALEXANDER IE, 1995, EUR J PEDIATR, V154, P654, DOI 10.1007/BF02079071
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281
   Besnard M, 2016, EURO SURVEILL, V21
   Bilavsky E, 2015, ACTA PAEDIATR, V104, pE388, DOI 10.1111/apa.13053
   Brasil P, 2016, N ENGL J MED
   Briggs TA, 2008, AM J MED GENET A, V146A, P3173, DOI 10.1002/ajmg.a.32614
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   *CDCP, AR WITH ZIK
   *CDCP, POT RANG US
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   COSTELLO A, DEFINING SYNDROME AS
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Degani S, 2006, OBSTET GYNECOL SURV, V61, P329, DOI 10.1097/01.ogx.0000216518.85796.88
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4850
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HALL JG, 1982, TERATOLOGY, V25, P173, DOI 10.1002/tera.1420250207
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Konstantinidou A, 2007, J MED VIROL, V79, P754, DOI 10.1002/jmv.20887
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   La Piana R, 2016, NEUROLOGY, V86, P28, DOI 10.1212/WNL.0000000000002228
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2010, AM J HUM GENET, V87, P882, DOI 10.1016/j.ajhg.2010.10.026
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pacheco O, 2016, N ENGL J MED
   Paciorkowski AR, 2013, AM J MED GENET A, V161A, P1523, DOI 10.1002/ajmg.a.35969
   Pan American Health Organization, 2016, EP AL NEUR SYNDR CON
   Parmar H, 2012, NEUROIMAG CLIN N AM, V22, P707, DOI 10.1016/j.nic.2012.05.016
   Perez S, 2016, EURO SURVEILL, V21
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schram A, 2004, AM J MED GENET A, V127A, P172, DOI 10.1002/ajmg.a.20645
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares de Souza A, 2016, CLIN INFECT DIS
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 75
TC 250
Z9 256
U1 9
U2 53
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD MAR 1
PY 2017
VL 171
IS 3
BP 288
EP 295
DI 10.1001/jamapediatrics.2016.3982
PG 8
WC Pediatrics
SC Pediatrics
GA EN7SL
UT WOS:000396202400020
PM 27812690
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
   Poretti, A
   Huisman, TAGM
   Werner, H
   Keshavarz, E
   Araujo, E
AF Mehrjardi, Mohammad Zare
   Poretti, Andrea
   Huisman, Thierry A. G. M.
   Werner, Heron
   Keshavarz, Elham
   Araujo Junior, Edward
TI Neuroimaging findings of congenital Zika virus infection: a pictorial
   essay
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Article
DE Zika virus (ZIKV); Congenital; Radiology; Neuroimaging; Microcephaly
ID FETUSES
AB Zika virus (ZIKV) is a mosquito-borne arbovirus from the Flaviviridae family. It had caused several epidemics since its discovery in 1947, but there was no significant attention to this virus until the recent outbreak in Brazil in 2015. The main concern is the causal relationship between prenatal ZIKV infection and congenital microcephaly, which has been confirmed recently. Moreover, ZIKV may cause other central nervous system abnormalities such as brain parenchymal atrophy with secondary ventriculomegaly, intracranial calcification, malformations of cortical development (such as polymicrogyria, and lissencephaly-pachygyria), agenesis/hypoplasia of the corpus callosum, cerebellar and brainstem hypoplasia, sensorineural hearing-loss, and ocular abnormalities as well as arthrogryposis in the infected fetuses. Postnatal (acquired) ZIKV infection usually has an asymptomatic or mildly symptomatic course, while prenatal (congenital) ZIKV infection has a more severe course and may cause severe brain anomalies that are described as congenital Zika syndrome. In this pictorial essay, we aim to illustrate the prenatal and postnatal neuroimaging findings that may be seen in fetuses and neonates with congenital Zika syndrome, and will discuss possible radiological differential diagnoses. A detailed knowledge of these findings is paramount for an early correct diagnosis, prognosis determination, and counseling of the affected children and families.
C1 [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
   [Poretti, Andrea; Huisman, Thierry A. G. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Sect Pediat Neuroradiol,Div Pediat Radiol, Baltimore, MD USA.
   [Werner, Heron] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, RJ, Brazil.
   [Keshavarz, Elham] Shahid Beheshti Univ Med Sci, Mahdieh Womens Hosp, Dept Radiol, Tehran, Iran.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
EM zare@sbmu.ac.ir; aporett1@jhmi.edu; thuisma1@jhmi.edu;
   heronwerner@hotmail.com; elhamkeshavarz@yahoo.com;
   araujojred@terra.com.br
RI Junior, Edward Araujo/E-1228-2012; Mehrjardi, Mohammad Zare/G-8980-2017;
   Werner, Heron/W-1578-2019
OI Junior, Edward Araujo/0000-0002-6145-2532; Mehrjardi, Mohammad
   Zare/0000-0001-5793-5323; 
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hennekam RC, 2013, AM J MED GENET A, V161, P2726, DOI 10.1002/ajmg.a.36249
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2016, JAMA PEDIAT, DOI [10.1001/jamapediat-rics.2016.3982, DOI 10.1001/JAMAPEDIAT-RICS.2016.3982]
   Poretti A, 2016, AM J NEURORADIOL, V37, P1764, DOI 10.3174/ajnr.A4924
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
NR 16
TC 17
Z9 19
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD MAR
PY 2017
VL 35
IS 3
BP 89
EP 94
DI 10.1007/s11604-016-0609-4
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EN9GF
UT WOS:000396308000001
PM 28074379
OA Bronze
DA 2020-07-08
ER

PT J
AU Xu, HT
   Hassounah, SA
   Colby-Germinario, SP
   Oliveira, M
   Fogarty, C
   Quan, YD
   Han, YS
   Golubkov, O
   Ibanescu, I
   Brenner, B
   Stranix, BR
   Wainberg, MA
AF Xu, Hong-Tao
   Hassounah, Said A.
   Colby-Germinario, Susan P.
   Oliveira, Maureen
   Fogarty, Clare
   Quan, Yudong
   Han, Yingshan
   Golubkov, Olga
   Ibanescu, Ilinca
   Brenner, Bluma
   Stranix, Brent R.
   Wainberg, Mark A.
TI Purification of Zika virus RNA-dependent RNA polymerase and its use to
   identify small-molecule Zika inhibitors
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID DENGUE VIRUS; REVERSE-TRANSCRIPTASE; CRYSTAL-STRUCTURE; DRUG DISCOVERY;
   RAMACHANDRAN PLOT; I-TASSER; RESISTANCE; PROTEIN; HIV-1; REPLICATION
AB Background: The viral RNA-dependent RNA polymerase (RdRp) enzymes of the Flaviviridae family are essential for viral replication and are logically important targets for development of antiviral therapeutic agents. Zika virus (ZIKV) is a rapidly re-emerging human pathogen for which no vaccine or antiviral agent is currently available.
   Methods: To facilitate development of ZIKV RdRp inhibitors, we have established an RdRp assay using purified recombinant ZIKV NS5 polymerase.
   Results: We have shown that both the hepatitis C virus (HCV) nucleoside inhibitor sofosbuvir triphosphate and a pyridoxine-derived non-nucleoside small-molecule inhibitor, DMB213, can act against ZIKV RdRp activity at IC(50)s of 7.3 and 5.2 mu M, respectively, in RNA synthesis reactions catalysed by recombinant ZIKV NS5 polymerase. Cellbased assays confirmed the anti-ZIKV activity of sofosbuvir and DMB213 with 50% effective concentrations (EC(50)s) of 8.3 and 4.6 mu M, respectively. Control studies showed that DMB213 did not inhibit recombinant HIV-1 reverse transcriptase and showed only very weak inhibition of HIV- 1 integrase strand-transfer activity. The S604T substitution in motif B of the ZIKV RdRp, which corresponds to the S282T substitution in motif B of HCV RdRp, which confers resistance to nucleotide inhibitors, also conferred resistance to sofosbuvir triphosphate, but not to DMB213. Enzyme assays showed that DMB213 appears to be competitive with natural nucleoside triphosphate (NTP) substrates.
   Conclusions: Recombinant ZIKV RdRp assays can be useful tools for the screening of both nucleos(t) ide compounds and non-nucleotide metal ion-chelating agents that interfere with ZIKV replication.
C1 [Xu, Hong-Tao; Hassounah, Said A.; Colby-Germinario, Susan P.; Oliveira, Maureen; Fogarty, Clare; Quan, Yudong; Han, Yingshan; Golubkov, Olga; Ibanescu, Ilinca; Brenner, Bluma; Wainberg, Mark A.] McGill Univ, Lady Davis Inst Med Res, Jewish Gen Hosp, AIDS Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.
   [Stranix, Brent R.] Champlain Explorat Pharma Inc, Montreal, PQ, Canada.
   [Wainberg, Mark A.] McGill Univ, Dept Med, Montreal, PQ, Canada.
   [Wainberg, Mark A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.
RP Wainberg, MA (corresponding author), McGill Univ, Lady Davis Inst Med Res, Jewish Gen Hosp, AIDS Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.
EM mark.wainberg@mcgill.ca
RI Brenner, Bluma/I-8714-2019
OI Hassounah, Said/0000-0002-9712-1313
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR) [CCM104886]
FX This work was partly supported by research grant CCM104886 from the
   Canadian Institutes of Health Research (CIHR).
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Bar-Magen T, 2010, AIDS, V24, P2171, DOI 10.1097/QAD.0b013e32833cf265
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dutartre H, 2006, ANTIMICROB AGENTS CH, V50, P4161, DOI 10.1128/AAC.00433-06
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gong Edwin Yunhao, 2013, Methods Mol Biol, V1030, P237, DOI 10.1007/978-1-62703-484-5_19
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Julander JG, 2010, ANTIVIR RES, V86, P261, DOI 10.1016/j.antiviral.2010.03.004
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kolaskar AS, 1996, INT J PEPT PROT RES, V47, P110
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   McConachie SM, 2016, EXPERT REV CLIN PHAR, V9, P287, DOI 10.1586/17512433.2016.1129272
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169
   Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Sheik SS, 2002, BIOINFORMATICS, V18, P1548, DOI 10.1093/bioinformatics/18.11.1548
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Steffens S, 1999, J GEN VIROL, V80, P2583, DOI 10.1099/0022-1317-80-10-2583
   STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498
   Stranix B, 2009, US patent, Patent No. [US8742123 B2, 8742123]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
   Xu HT, 2015, ANTIMICROB AGENTS CH, V59, P3189, DOI 10.1128/AAC.00315-15
   Xu HT, 2011, J VIROL, V85, P11300, DOI 10.1128/JVI.05584-11
   Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14
   Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zopf S, 2016, WORLD J HEPATOL, V8, P139, DOI 10.4254/wjh.v8.i3.139
NR 62
TC 31
Z9 34
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD MAR
PY 2017
VL 72
IS 3
BP 727
EP 734
DI 10.1093/jac/dkw514
PG 8
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA EQ4IE
UT WOS:000398038800011
PM 28069884
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Valansi, C
   Moi, D
   Leikina, E
   Matveev, E
   Grana, M
   Chernomordik, LV
   Romero, H
   Aguilar, PS
   Podbilewicz, B
AF Valansi, Clari
   Moi, David
   Leikina, Evgenia
   Matveev, Elena
   Grana, Martin
   Chernomordik, Leonid V.
   Romero, Hector
   Aguilar, Pablo S.
   Podbilewicz, Benjamin
TI Arabidopsis HAP2/GCS1 is a gamete fusion protein homologous to somatic
   and viral fusogens
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID CELL-CELL FUSION; MEMBRANE-FUSION; STRUCTURE SIMILARITY; WEB SERVER;
   C-ELEGANS; MECHANISMS; HAP2; FERTILIZATION; CHLAMYDOMONAS; SIMULATIONS
AB Cell-cell fusion is inherent to sexual reproduction. Loss of HAPLESS 2/GENERATIVE CELL SPECIFIC 1 (HAP2/GCS1) proteins results in gamete fusion failure in diverse organisms, but their exact role is unclear. In this study, we show that Arabidopsis thaliana HAP2/GCS1 is sufficient to promote mammalian cell-cell fusion. Hemifusion and complete fusion depend on HAP2/GCS1 presence in both fusing cells. Furthermore, expression of HAP2 on the surface of pseudotyped vesicular stomatitis virus results in homotypic virus-cell fusion. We demonstrate that the Caenorhabditis elegans Epithelial Fusion Failure 1 (EFF-1) somatic cell fusogen can replace HAP2/GCS1 in one of the fusing membranes, indicating that HAP2/GCS1 and EFF-1 share a similar fusion mechanism. Structural modeling of the HAP2/GCS1 protein family predicts that they are homologous to EFF-1 and viral class II fusion proteins (e.g., Zika virus). We name this superfamily Fusexins: fusion proteins essential for sexual reproduction and exoplasmic merger of plasma membranes. We suggest a common origin and evolution of sexual reproduction, enveloped virus entry into cells, and somatic cell fusion.
C1 [Valansi, Clari; Matveev, Elena; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.
   [Moi, David; Aguilar, Pablo S.] Univ Nacl San Martin, Inst Invest Biotecnol Dr Rodolfo A Ugald, Lab Biol Celular Membranas, RA-1650 Buenos Aires, DF, Argentina.
   [Leikina, Evgenia; Chernomordik, Leonid V.] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Membrane Biol, Bethesda, MD 20892 USA.
   [Grana, Martin] Inst Pasteur Montevideo, Unidad Bioinformat, Montevideo 11400, Uruguay.
   [Romero, Hector] Univ Republic, Fac Ciencias, Dept Ecol & Evoluc,Ctr Univ Reg Este, Unidad Genom Evolut,Lab Org & Evolucion Genoma, Montevideo 11400, Uruguay.
RP Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.; Aguilar, PS (corresponding author), Univ Nacl San Martin, Inst Invest Biotecnol Dr Rodolfo A Ugald, Lab Biol Celular Membranas, RA-1650 Buenos Aires, DF, Argentina.
EM paguilar@iib.unsam.edu.ar; podbilew@technion.ac.il
RI Grana, Martin/R-7245-2019
OI Grana, Martin/0000-0003-1182-8236; Podbilewicz,
   Benjamin/0000-0002-0411-4182
FU International Centre for Genetic Engineering and Biotechnology
   [CRP/URU11-01]; Fondo para la Investigacion Cientifica y Tecnologica,
   ArgentinaANPCyT [PICT-2014-3034]; Israel Science FoundationIsrael
   Science Foundation [826/08]; H European Research Council [ELEGANSFUSION
   268843]; United States-Israel Binational Science FoundationUS-Israel
   Binational Science Foundation [2013151]; Intramural Research Program of
   the Eunice Kennedy Shriver National Institute of Child Health and Human
   Development, National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD); Agencia Nacional de Investigacion e Innovacion;
   Programa de Desarrollo de las Ciencias Basicas
FX This work was supported by the International Centre for Genetic
   Engineering and Biotechnology (grant CRP/URU11-01 to P.S. Aguilar), the
   Fondo para la Investigacion Cientifica y Tecnologica, Argentina (grant
   PICT-2014-3034 to P.S. Aguilar), Israel Science Foundation (grant 826/08
   to B. Podbilewicz), the H2020 European Research Council (Advanced grant
   ELEGANSFUSION 268843 to B. Podbilewicz), and the United States-Israel
   Binational Science Foundation (grant 2013151 to L.V. Chernomordik and B.
   Podbilewicz). The research in the laboratory of L.V. Chernomordik was
   also supported by the Intramural Research Program of the Eunice Kennedy
   Shriver National Institute of Child Health and Human Development,
   National Institutes of Health. D. Moi is a fellow from the Consejo
   Nacional de Investigaciones Cientificas y Tecnicas, Argentina. M. Grana
   and H. Romero acknowledge support from Agencia Nacional de Investigacion
   e Innovacion and Programa de Desarrollo de las Ciencias Basicas.
CR Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011
   Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203
   Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015
   Cole ES, 2014, CURR BIOL, V24, P2168, DOI 10.1016/j.cub.2014.07.064
   DIJKWEL PA, 1986, NUCLEIC ACIDS RES, V14, P3241, DOI 10.1093/nar/14.8.3241
   Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276
   Forslund K, 2008, MOL BIOL EVOL, V25, P254, DOI 10.1093/molbev/msm254
   Gattegno T, 2007, MOL BIOL CELL, V18, P1153, DOI 10.1091/mbc.E06-09-0855
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909
   Igonet S, 2012, CELL, V151, P1634, DOI 10.1016/j.cell.2012.11.041
   Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447
   Kalev I, 2012, BIOINFORMATICS, V28, P2996, DOI 10.1093/bioinformatics/bts538
   Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796
   Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150
   Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508
   Liu YJ, 2015, DEVELOPMENT, V142, P962, DOI 10.1242/dev.118844
   Maruyama D, 2016, SEMIN CELL DEV BIOL, V60, P127, DOI 10.1016/j.semcdb.2016.07.024
   Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345
   Okamoto M, 2016, DEV BIOL, V415, P6, DOI 10.1016/j.ydbio.2016.05.018
   Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020
   Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004
   Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/nmeth.1818, 10.1038/NMETH.1818]
   Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764
   Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485
   von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683
   WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]
   Wong JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000882
   Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007
   Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945
   Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17
   Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251
   Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
NR 46
TC 33
Z9 35
U1 1
U2 4
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR
PY 2017
VL 216
IS 3
BP 571
EP 581
DI 10.1083/jcb.201610093
PG 11
WC Cell Biology
SC Cell Biology
GA EN2FV
UT WOS:000395826200012
PM 28137780
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Xiang, B
   Gao, P
   Kang, YF
   Ren, T
AF Xiang, Bin
   Gao, Pei
   Kang, Yinfeng
   Ren, Tao
TI Importation of Zika Virus in China: A significant risk in southern China
SO JOURNAL OF INFECTION
LA English
DT Letter
C1 [Xiang, Bin; Gao, Pei; Kang, Yinfeng; Ren, Tao] South China Agr Univ, Coll Vet Med, 483 Wushan Rd, Guangzhou 510642, Guangdong, Peoples R China.
   [Xiang, Bin; Gao, Pei; Kang, Yinfeng; Ren, Tao] Key Lab Zoonosis Prevent & Control Guangdong Prov, Guangzhou 510642, Guangdong, Peoples R China.
   [Xiang, Bin; Gao, Pei; Kang, Yinfeng; Ren, Tao] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou 510642, Guangdong, Peoples R China.
   [Kang, Yinfeng] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China.
RP Kang, YF; Ren, T (corresponding author), South China Agr Univ, Coll Vet Med, 483 Wushan Rd, Guangzhou 510642, Guangdong, Peoples R China.
EM kangyf@sysucc.org.cn; rentao6868@126.com
OI Ren, Tao/0000-0002-5213-8736
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31072139, 31372412]; Chinese Special Fund for
   Agro-scientific Research in the Public Interest [201303033]; Science and
   Technology Projects of Guangdong Province [2012A020800006]; Doctoral
   Fund of Ministry of Education of ChinaMinistry of Education, China
   [20124404110016]
FX This study was funded in part by grants from the National Natural
   Science Foundation of China (No. 31072139, No. 31372412), the Chinese
   Special Fund for Agro-scientific Research in the Public Interest (No.
   201303033), the Science and Technology Projects of Guangdong Province
   (No.2012A020800006), and Doctoral Fund of Ministry of Education of China
   ( No. 20124404110016).
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Charles AS, 2016, PLOS CURR, V2016, P8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Sang S.W., 2014, PLOS ONE, V9
   Wang P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3604-4
NR 10
TC 7
Z9 10
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAR
PY 2017
VL 74
IS 3
BP 328
EP 330
DI 10.1016/j.jinf.2017.01.004
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EP3DQ
UT WOS:000397263200016
PM 28109676
OA Bronze
DA 2020-07-08
ER

PT J
AU Rabaan, AA
   Bazzi, AM
   Al-Ahmed, SH
   Al-Ghaith, MH
   Al-Tawfiq, JA
AF Rabaan, Ali A.
   Bazzi, Ali M.
   Al-Ahmed, Shamsah H.
   Al-Ghaith, Mohamed H.
   Al-Tawfiq, Jaffar A.
TI Overview of Zika infection, epidemiology, transmission and control
   measures
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE ZIKV; Zika infection; Epidemiology; Transmission; Control measures;
   Diagnostic test
ID PUBLIC-HEALTH PREPAREDNESS; FRENCH-POLYNESIA; VIRUS OUTBREAK;
   UNITED-STATES; VECTOR
AB The current Zika virus outbreak in the Americas and the proposed link to increases in microcephaly and neurological disorders have prompted the World Health Organization to declare a Public Health Emergency of International Concern on February 1, 2016. The virus is transmitted by Aedes mosquitoes and potentially by transfusion, perinatal and sexual transmission. The potential for spread into countries where Aedes mosquitoes are endemic is high. Previously, cases tended to be sporadic and associated with mild, non-specific symptoms. Prior outbreaks occurred in Yap Island in Micronesia in 2007, the first time Zika arose outside of Africa and Asia, and in French Polynesia in 2013. A birth data review has confirmed that the latter outbreak was followed by an increase in microcephaly cases. A coordinated international response is needed to address mosquito control; expedite development of diagnostic tests, vaccines and specific treatments for Zika; and address the proposed link to microcephaly and neurological diseases. (C) 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
C1 [Rabaan, Ali A.] Johns Hopkins Aramco Healthcare, Mol Diagnost Lab, Dhahran, Saudi Arabia.
   [Bazzi, Ali M.] Johns Hopkins Aramco Healthcare, Microbiol Lab, Dhahran, Saudi Arabia.
   [Al-Ahmed, Shamsah H.] Qatif Cent Hosp, Specialty Paediat Med, Qatif, Saudi Arabia.
   [Al-Ghaith, Mohamed H.] Johns Hopkins Aramco Healthcare, Lab Dept, Dhahran, Saudi Arabia.
   [Al-Tawfiq, Jaffar A.] Johns Hopkins Aramco Healthcare, Specialty Internal Med, Dhahran, Saudi Arabia.
   [Al-Tawfiq, Jaffar A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
RP Rabaan, AA (corresponding author), Johns Hopkins Aramco Healthcare, POB 76,Room 281-C,Bldg 62, Dhahran 31311, Saudi Arabia.
EM arabaan@gmail.com
RI Rabaan, Ali/AAI-3928-2020
OI Rabaan, Ali/0000-0002-6774-9847
CR Ageep TB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-484
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Centers for Disease Control and Prevention [CDC], 2016, ZIK VIR
   Centers for Disease Control and Prevention [CDC], JAP ENC
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   EUROIMMUN UK, 1 COMM ANT TESTS ZIK
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Maria AT, 2016, EURO SURVEILL, V21
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Robinson AS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S1
   Rubin E. J., 2016, N ENGL J MED
   Science Alert, 2016, IND CO SAYS THEY HAV
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Venturi G, 2014, EURO SURVEILL, V21
   WHO, 2016, ZIK SIT REP NEUR SYN
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 49
TC 16
Z9 16
U1 0
U2 9
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAR-APR
PY 2017
VL 10
IS 2
BP 141
EP 149
DI 10.1016/j.jiph.2016.05.007
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EW4IG
UT WOS:000402464600001
PM 27283926
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castanha, PMS
   Nascimento, EJM
   Braga, C
   Cordeiro, MT
   de Carvalho, OV
   de Mendonca, LR
   Azevedo, EAN
   Franca, RFO
   Dhalia, R
   Marques, ETA
AF Castanha, Priscila M. S.
   Nascimento, Eduardo J. M.
   Braga, Cynthia
   Cordeiro, Marli T.
   de Carvalho, Otavio V.
   de Mendonca, Leila R.
   Azevedo, Elisa A. N.
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
TI Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; antibody dependent enhancement; dengue antibodies
AB Anti-Flavivirus antibodies are highly cross-reactive and may facilitate Zika virus (ZIKV) infection through the antibody-dependent enhancement (ADE) mechanism. We demonstrate that dengue-specific antibodies enhance the infection of a primary Brazilian ZIKV isolate in a Fc gamma RII-expressing K562 cell line. In addition, we demonstrate that serum samples from dengue-immune pregnant women enhanced ZIKV infection. These findings highlight the need for epidemiological studies and animal models to further confirm the role of ADE in the development of congenital and neurological complications associated with ZIKV infections.
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; de Carvalho, Otavio V.; de Mendonca, Leila R.; Azevedo, Elisa A. N.; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Inst Biol Sci, Fac Med Sci, Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [de Carvalho, Otavio V.] Univ Fed Vicosa, Vicosa, MG, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), Ctr Vaccine Res, 3501 5th Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013; amsalu, ribka/G-8780-2019; Braga,
   Maria Cynthia/A-8204-2013; Dhalia, Rafael/AAD-5432-2020; CASTANHA,
   PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; CASTANHA, PRISCILA/0000-0002-1220-5308;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)CAPES; Center for Vaccine Research, University of
   Pittsburgh; Fogarty Training Program [D43TW006592 Pitt GIDRTP/ 323 NIH];
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [482915/2010-2 MCT/CNPq-321 14/2010]; Strategic Program to
   Support Health Research/PAPES VI [322 407697/2012-8]; National Institute
   of Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19 AI56541]
FX This work was supported by the Brazilian Federal Agency for Support and
   Evaluation of Graduate Education (CAPES); Center for Vaccine Research,
   University of Pittsburgh; Fogarty Training Program (D43TW006592 Pitt
   GIDRTP/ 323 NIH to P. M. S. C.); National Council for Scientific and
   Technological Development (CNPq) (482915/2010-2 MCT/CNPq-321 14/2010);
   Strategic Program to Support Health Research/PAPES VI (322
   407697/2012-8); and the National Institute of Allergy and Infectious
   Diseases (U19 AI56541).
CR Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
NR 15
TC 60
Z9 62
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2017
VL 215
IS 5
BP 781
EP 785
DI 10.1093/infdis/jiw638
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ER2PO
UT WOS:000398636500018
PM 28039355
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Nourollahpour Shiadeh, M
   Rostami, A
   Danesh, M
   Sajedi, AA
AF Nourollahpour Shiadeh, Malihe
   Rostami, Ali
   Danesh, Mahmonir
   Sajedi, Ali Asghar
TI Zika virus as new emerging global health threat for pregnancy and child
   birth
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Letter
C1 [Nourollahpour Shiadeh, Malihe; Danesh, Mahmonir] Mazandaran Univ Med Sci, Nursing & Midwifery Sch, Dept Midwifery & Reprod Hlth, Sari, Iran.
   [Rostami, Ali] Shahid Beheshti Univ Med Sci, Sch Med, Dept Parasitol & Mycol, Tehran, Iran.
   [Sajedi, Ali Asghar] Shahid Beheshti Univ Med Sci, Sch Med, Dept Forens Med & Toxicol, Tehran, Iran.
RP Rostami, A (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Parasitol & Mycol, Tehran, Iran.
EM alirostami1984@gmail.com
RI Rostami, Ali/R-3347-2017
OI Rostami, Ali/0000-0002-1358-1321
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 4
Z9 4
U1 0
U2 48
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD MAR
PY 2017
VL 30
IS 5
BP 562
EP 562
DI 10.1080/14767058.2016.1177820
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EJ4WL
UT WOS:000393217700012
PM 27072040
DA 2020-07-08
ER

PT J
AU Yun, SI
   Lee, YM
AF Yun, Sang-Im
   Lee, Young-Min
TI Zika virus: An emerging flavivirus
SO JOURNAL OF MICROBIOLOGY
LA English
DT Review
DE Zika virus; flavivirus; mosquito-borne virus; arbovirus; microcephaly;
   Guillain-Barre syndrome; replication; pathogenesis
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS;
   NONSTRUCTURAL PROTEIN NS2A; 3'-TERMINAL STEM-LOOP; DENGUE-VIRUS;
   ENVELOPE PROTEIN; CRYSTAL-STRUCTURE; NS2B-NS3 PROTEASE; SUBGENOMIC RNA
AB Zika virus (ZIKV) is a previously little-known flavivirus closely related to Japanese encephalitis, West Nile, dengue, and yellow fever viruses, all of which are primarily transmitted by blood-sucking mosquitoes. Since its discovery in Uganda in 1947, ZIKV has continued to expand its geographic range, from equatorial Africa and Asia to the Pacific Islands, then further afield to South and Central America and the Caribbean. Currently, ZIKV is actively circulating not only in much of Latin America and its neighbors but also in parts of the Pacific Islands and Southeast Asia. Although ZIKV infection generally causes only mild symptoms in some infected individuals, it is associated with a range of neuroimmunological disorders, including Guillain-Barr, syndrome, meningoencephalitis, and myelitis. Recently, maternal ZIKV infection during pregnancy has been linked to neonatal malformations, resulting in various degrees of congenital abnormalities, microcephaly, and even abortion. Despite its emergence as an important public health problem, however, little is known about ZIKV biology, and neither vaccine nor drug is available to control ZIKV infection. This article provides a brief introduction to ZIKV with a major emphasis on its molecular virology, in order to help facilitate the development of diagnostics, therapeutics, and vaccines.
C1 [Yun, Sang-Im; Lee, Young-Min] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.
   [Lee, Young-Min] Utah State Univ, Coll Agr & Appl Sci, Utah Sci Technol & Res, Logan, UT 84322 USA.
RP Lee, YM (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.; Lee, YM (corresponding author), Utah State Univ, Coll Agr & Appl Sci, Utah Sci Technol & Res, Logan, UT 84322 USA.
EM youngmin.lee@usu.edu
FU Utah Science Technology and Research [A34637, A36815]; American Board of
   Obstetrics and Gynecology [200784-00001]; American College of
   Obstetricians and Gynecologists; American Society for Reproductive
   Medicine; Society for Reproductive Endocrinology and Infertility
FX This work was supported by grants from the Utah Science Technology and
   Research (A34637 and A36815) and by a grant (200784-00001) from the
   American Board of Obstetrics and Gynecology, the American College of
   Obstetricians and Gynecologists, the American Society for Reproductive
   Medicine, and the Society for Reproductive Endocrinology and
   Infertility. We thank Dr. Deborah McClellan for her careful and critical
   reading of the manuscript.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CASTLE E, 1986, VIROLOGY, V149, P10, DOI 10.1016/0042-6822(86)90082-6
   CASTLE E, 1985, VIROLOGY, V145, P227, DOI 10.1016/0042-6822(85)90156-4
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2017, CAS COUNTS US
   CDC, 2017, OUTC PREGN LAB EV PO
   CDC, 2017, ZIK CAS REP US
   CDC, 2016, ALL COUNTR TERR ACT
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Charley PA, 2016, VIRUS RES, V212, P70, DOI 10.1016/j.virusres.2015.09.009
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2017, CURR ZIK TRANSM
   Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Iglesias NG, 2011, RNA BIOL, V8, P249, DOI 10.4161/rna.8.2.14992
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kim JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124318
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liao MF, 2010, J VIROL, V84, P5730, DOI 10.1128/JVI.00170-10
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MASON PW, 1987, VIROLOGY, V158, P361, DOI 10.1016/0042-6822(87)90208-X
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Olsthoorn RCL, 2001, RNA, V7, P1370
   PAHO/ WHO, 2017, ZIK EP UPD
   PAHO/WHO, 2016, ZIK SUSP CONF CAS RE
   Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pijlman GP, 2006, J VIROL, V80, P11255, DOI 10.1128/JVI.01559-06
   Pijlman GP, 2014, CURR OPIN VIROL, V7, P55, DOI 10.1016/j.coviro.2014.04.002
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   PREUGSCHAT F, 1991, VIROLOGY, V185, P689, DOI 10.1016/0042-6822(91)90540-R
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Simmonds P., 2017, J GEN VIROL IN PRESS
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Song BH, 2008, RNA, V14, P1791, DOI 10.1261/rna.993608
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   SPEIGHT G, 1988, J GEN VIROL, V69, P23, DOI 10.1099/0022-1317-69-1-23
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2004, J VIROL, V78, P3178, DOI 10.1128/JVI.78.6.3178-3183.2004
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002
   Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1985, VIROLOGY, V147, P264, DOI 10.1016/0042-6822(85)90129-1
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   WHO, 2016, WHO STAT 5 M EM COMM
   Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200
   Wu R, 2015, PROC NAECON IEEE NAT, P89, DOI 10.1109/NAECON.2015.7443044
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994
   Yang F, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-17, 10.1186/1743-422X-8-492]
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Yun SI, 2016, J GEN VIROL, V97, P2575, DOI 10.1099/jgv.0.000574
   Yun SI, 2009, J VIROL, V83, P7909, DOI 10.1128/JVI.02541-08
   Yun SI, 2006, MOL BIOL FLAVIVIRUS, P225
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhang C, 2016, DEV MKT SCI, P6
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 277
TC 39
Z9 40
U1 0
U2 53
PU MICROBIOLOGICAL  SOCIETY KOREA
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER 803, 635-4 YEOGSAM-DONG, KANGNAM-KU,
   SEOUL 135-703, SOUTH KOREA
SN 1225-8873
EI 1976-3794
J9 J MICROBIOL
JI J. Microbiol.
PD MAR
PY 2017
VL 55
IS 3
BP 204
EP 219
DI 10.1007/s12275-017-7063-6
PG 16
WC Microbiology
SC Microbiology
GA EM0EJ
UT WOS:000394991300005
PM 28243937
DA 2020-07-08
ER

PT J
AU Moore, KJ
   Qualls, W
   Brennan, V
   Yang, X
   Caban-Martinez, AJ
AF Moore, Kevin J.
   Qualls, Whitney
   Brennan, Victoria
   Yang, Xuan
   Caban-Martinez, Alberto J.
TI Mosquito Control Practices and Zika Knowledge Among Outdoor Construction
   Workers in Miami-Dade County, Florida
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Letter
C1 [Moore, Kevin J.; Brennan, Victoria; Yang, Xuan; Caban-Martinez, Alberto J.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Qualls, Whitney] Dept State Hlth Serv, Zoonosis Control, Austin, TX USA.
RP Caban-Martinez, AJ (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Publ Hlth Sci, Don Soffer Clin Res Ctr, 1120 NW 14th St,10th Floor,Rm 1025, Miami, FL 33136 USA.
EM acaban@med.miami.edu
RI , J/AAG-1499-2019
OI , J/0000-0002-5960-1308
FU National institute for Occupational Safety and HealthUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USANational Institute for Occupational Safety & Health
   (NIOSH) [K01OH010485]
FX This work was supported by the National institute for Occupational
   Safety and Health grant K01OH010485.
CR Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Bhargava Anurag, 2007, Indian J Med Ethics, V4, P18
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buchanan SN, 2005, ARCH ENVIRON OCCUP H, V60, P276, DOI 10.3200/AEOH.60.5.276-280
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Dong XWS, 2011, AM J IND MED, V54, P339, DOI 10.1002/ajim.20928
   Eliades M. James, 2005, Morbidity and Mortality Weekly Report, V54, P25
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Rasania S. K., 2002, Journal of Communicable Diseases, V34, P78
   Seet RCS, 2005, J CLIN VIROL, V33, P336, DOI 10.1016/j.jcv.2005.03.002
   Strafela P, 2016, ARCH PATHOL LAB MED
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   U. S. Department of Labor, 2016, INT GUID PROT WORK O
NR 15
TC 8
Z9 8
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-2752
EI 1536-5948
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD MAR
PY 2017
VL 59
IS 3
BP E17
EP E19
DI 10.1097/JOM.0000000000000960
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN3JM
UT WOS:000395904800002
PM 28267109
DA 2020-07-08
ER

PT J
AU Coutard, B
   Barral, K
   Lichiere, J
   Selisko, B
   Martin, B
   Aouadi, W
   Lombardia, MO
   Debart, F
   Vasseur, JJ
   Guillemot, JC
   Canard, B
   Decroly, E
AF Coutard, Bruno
   Barral, Karine
   Lichiere, Julie
   Selisko, Barbara
   Martin, Baptiste
   Aouadi, Wahiba
   Lombardia, Miguel Ortiz
   Debart, Francoise
   Vasseur, Jean-Jacques
   Guillemot, Jean Claude
   Canard, Bruno
   Decroly, Etienne
TI Zika Virus Methyltransferase: Structure and Functions for Drug Design
   Perspectives
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE methyltransferase; RNA processing; Zika virus; flavivirus; protein
   structure-function
ID IFIT FAMILY-MEMBERS; NS5 METHYLTRANSFERASE; MESSENGER-RNA; 2'-O
   METHYLATION; CAPPED RNAS; RIG-I; FLAVIVIRUS; DISCOVERY; PROTEIN; DOMAIN
AB The Flavivirus Zika virus (ZIKV) is the causal agent of neurological disorders like microcephaly in newborns or Guillain-Barre syndrome. Its NS5 protein embeds a methyltransferase (MTase) domain involved in the formation of the viral mRNA cap. We investigated the structural and functional properties of the ZIKV MTase. We show that the ZIKV MTase can methylate RNA cap structures at the N-7 position of the cap, and at the 2'-O position on the ribose of the first nucleotide, yielding a cap-1 structure. In addition, the ZIKV MTase methylates the ribose 2'-O position of internal adenosines of RNA substrates. The crystal structure of the ZIKV MTase determined at a 2.01-angstrom resolution reveals a crystallographic homodimer. One chain is bound to the methyl donor (S-adenosyl-L-methionine [SAM]) and shows a high structural similarity to the dengue virus (DENV) MTase. The second chain lacks SAM and displays conformational changes in the alpha X alpha-helix contributing to the SAM and RNA binding. These conformational modifications reveal a possible molecular mechanism of the enzymatic turnover involving a conserved Ser/Arg motif. In the second chain, the SAM binding site accommodates a sulfate close to a glycerol that could serve as a basis for structure-based drug design. In addition, compounds known to inhibit the DENV MTase show similar inhibition potency on the ZIKV MTase. Altogether these results contribute to a better understanding of the ZIKV MTase, a central player in viral replication and host innate immune response, and lay the basis for the development of potential antiviral drugs.
   IMPORTANCE The Zika virus (ZIKV) is associated with microcephaly in newborns, and other neurological disorders such as Guillain-Barre syndrome. It is urgent to develop antiviral strategies inhibiting the viral replication. The ZIKV NS5 embeds a methyltransferase involved in the viral mRNA capping process, which is essential for viral replication and control of virus detection by innate immune mechanisms. We demonstrate that the ZIKV methyltransferase methylates the mRNA cap and adenosines located in RNA sequences. The structure of ZIKV methyltransferase shows high structural similarities to the dengue virus methyltransferase, but conformational specificities highlight the role of a conserved Ser/Arg motif, which participates in RNA and SAM recognition during the reaction turnover. In addition, the SAM binding site accommodates a sulfate and a glycerol, offering structural information to initiate structure-based drug design. Altogether, these results contribute to a better understanding of the Flavivirus methyltransferases, which are central players in the virus replication.
C1 [Coutard, Bruno; Lichiere, Julie; Selisko, Barbara; Martin, Baptiste; Aouadi, Wahiba; Guillemot, Jean Claude; Canard, Bruno; Decroly, Etienne] Aix Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France.
   [Barral, Karine] Aix Marseille Univ, CNRS, INSERM, Inst Paoli Calmettes,CRCM, Marseille, France.
   [Lombardia, Miguel Ortiz] Aix Marseille Univ, CNRS, Struct & Genom Informat Lab, UMR 7256,IMM FR 3479, Luminy Campus, Marseille, France.
   [Debart, Francoise; Vasseur, Jean-Jacques] Univ Montpellier, IBMM, Dept Nucle Acids, UMR 5247,CNRS,ENSCM, Montpellier, France.
RP Decroly, E (corresponding author), Aix Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France.
EM Etienne.Decroly@afmb.univ-mrs.fr
RI Debart, Francoise/D-4320-2019
OI Debart, Francoise/0000-0003-3422-3926; DECROLY,
   Etienne/0000-0002-6046-024X; Canard, Bruno/0000-0003-4924-1991; Vasseur,
   Jean-Jacques/0000-0002-4379-6139
FU European program H under the ZIKAlliance project [734548]; EVAg Research
   Infrastructure [653316]; French research agency ANR (VMTaseIn)French
   National Research Agency (ANR) [ANR-ST14-ASTR-0026]; French research
   agency ANR (FragVir)French National Research Agency (ANR)
   [ANR-13-JS07-0006-01]; DGA-MRIS scholarship; "Mediterranee Infection"
   Foundation
FX This work was supported by the European program H2020 under the
   ZIKAlliance project (grant agreement 734548) and the EVAg Research
   Infrastructure (grant agreement 653316) and by the French research
   agency ANR (VMTaseIn, grant ANR-ST14-ASTR-0026, and FragVir, grant
   ANR-13-JS07-0006-01). B.M. is the recipient of a DGA-MRIS scholarship
   and W.A. the recipient of a scholarship from the "Mediterranee
   Infection" Foundation.
CR Barral K, 2013, ANTIVIR RES, V99, P292, DOI 10.1016/j.antiviral.2013.06.001
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Bricogne G, 2011, BUSTER VERSION 2 11
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007
   Idrus S, 2012, BIOINFORMATION, V8, P348, DOI 10.6026/97320630008348
   Jansson AM, 2009, ACTA CRYSTALLOGR D, V65, P796, DOI 10.1107/S0907444909017260
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Krissinel Evgeny, 2012, J Mol Biochem, V1, P76
   Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Lavergne T, 2008, CHEM-EUR J, V14, P9135, DOI 10.1002/chem.200801392
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015
   Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0
   Thillier Y, 2012, RNA, V18, P856, DOI 10.1261/rna.030932.111
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zlatev I, 2010, ORG LETT, V12, P2190, DOI 10.1021/ol1004214
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 53
TC 66
Z9 68
U1 1
U2 30
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2017
VL 91
IS 5
AR UNSP e02202-16
DI 10.1128/JVI.02202-16
PG 15
WC Virology
SC Virology
GA EL1BV
UT WOS:000394356400028
PM 28031359
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Schwartzmann, PV
   Ramalho, LNZ
   Neder, L
   Vilar, FC
   Ayub-Ferreira, SM
   Romeiro, MF
   Takayanagui, OM
   dos Santos, AC
   Schmidt, A
   Figueiredo, LTM
   Arena, R
   Simoes, MV
AF Schwartzmann, Pedro V.
   Ramalho, Leandra N. Z.
   Neder, Luciano
   Vilar, Fernando C.
   Ayub-Ferreira, Silvia M.
   Romeiro, Marilia F.
   Takayanagui, Osvaldo M.
   dos Santos, Antonio C.
   Schmidt, Andre
   Figueiredo, Luiz T. M.
   Arena, Ross
   Simoes, Marcus V.
TI Zika Virus Meningoencephalitis in an Immunocompromised Patient
SO MAYO CLINIC PROCEEDINGS
LA English
DT Article
ID INFECTION; DISEASE; DENGUE; BRAZIL; FEVER; CHILD
AB The World Health Organization considers the Zika virus (ZIKV) outbreak in the Americas a global public health emergency. The neurologic complications due to ZIKV infection comprise microcephaly, meningoencephalitis, and Guillain- Barre syndrome. We describe a fatal case of an adult patient receiving an immunosuppressive regimen following heart transplant. The patient was admitted with acute neurologic impairment and experienced progressive hemodynamic instability and mental deterioration that finally culminated in death. At autopsy, a pseudotumoral form of ZIKV meningoencephalitis was confirmed. Zika virus infection was documented by reverse trancriptase-polymerase chain reaction, immunohistochemistry, and immunofluorescence and electron microscopy of the brain parenchyma and cerebral spinal fluid. The sequencing of the viral genome in this patient confirmed a Brazilian ZIKV strain. In this case, central nervous system involvement and ZIKV propagation to other organs in a disseminated pattern is quite similar to that observed in other fatal Flaviviridae viral infections. (C) 2017 Mayo Foundation for Medical Education and Research.
C1 [Schwartzmann, Pedro V.; Ramalho, Leandra N. Z.; Neder, Luciano; Vilar, Fernando C.; Ayub-Ferreira, Silvia M.; Romeiro, Marilia F.; Takayanagui, Osvaldo M.; dos Santos, Antonio C.; Schmidt, Andre; Figueiredo, Luiz T. M.; Simoes, Marcus V.] Univ Sao Paulo, Cardiol Ctr, Internal Med Dept, Med Sch Ribeirao Preto, Sao Paulo, Brazil.
   [Arena, Ross] Univ Illinois, Coll Appl Hlth Sci, Dept Phys Therapy, Chicago, IL USA.
RP Schwartzmann, PV (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Hosp Clin Ribeirao Preto, Cardiol Ctr,Internal Med Dept,Clin Hosp, Ave Bandeirantes,3900 Monte Alegre, BR-14048900 Sao Paulo, Brazil.
EM pedrovs@usp.br
RI Ayub-Ferreira, Silvia/AAK-4196-2020; Vilar, Fernando
   Crivelenti/AAK-4233-2020; Arena, Ross/A-3141-2008; Ramalho,
   Leandra/A-3983-2010; Schmidt, Andre/G-1569-2011
OI Arena, Ross/0000-0002-6675-1996; Ramalho, Leandra/0000-0002-3486-5294;
   Schmidt, Andre/0000-0002-1090-8165; vilar, fernando
   crivelenti/0000-0001-8232-5375
CR Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Carvalho MA, 2016, J PEDIATR GASTR NUTR, V62, pE7, DOI 10.1097/MPG.0000000000000377
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chmelik V, 2016, J CLIN VIROL, V74, P73, DOI 10.1016/j.jcv.2015.11.029
   Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   SHOPE RE, 1979, DIAGNOSTIC PROCEDURE, P767
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 19
TC 31
Z9 33
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD MAR
PY 2017
VL 92
IS 3
BP 460
EP 466
DI 10.1016/j.mayocp.2016.12.019
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER6VZ
UT WOS:000398948600021
PM 28259231
OA Bronze
DA 2020-07-08
ER

PT J
AU Wijdicks, EFM
   Klein, CJ
AF Wijdicks, Eelco F. M.
   Klein, Christopher J.
TI Guillain-Barre Syndrome
SO MAYO CLINIC PROCEEDINGS
LA English
DT Article
ID MILLER-FISHER-SYNDROME; CAMPYLOBACTER-JEJUNI INFECTION; MECHANICAL
   VENTILATION; INFLUENZA VACCINE; RESPIRATORY MUSCLES; RANDOMIZED-TRIAL;
   PLASMA-EXCHANGE; NORTHERN CHINA; POWER SPECTRUM; POLYNEUROPATHY
AB Guillain-Barre syndrome is an acute inflammatory immune-mediated polyradiculoneuropathy presenting typically with tingling, progressive weakness, and pain. Variants and formes frustes may complicate recognition. The best known variant is the sensory ataxic form of Miller Fisher syndrome, which also affects the oculomotor nerves and the brain stem. Divergent pathologic mechanisms lead to demyelinating, axonal, or mixed demyelinating-axonal damage. In the demyelinating form, yet to be identified antigens are inferred by complement activation, myelin destruction, and macrophage-activated cleanup. In the axonal and Miller Fisher variants, gangliosides (GM1, GD1a, GQ1b) are targeted by immunoglobulins and share antigenic epitopes with some bacterial and viral antigens. Campylobacter jejuni infection is associated with an axonal-onset variant; affected patients commonly experience more rapid deterioration. Many other antecedent infectious agents have been recognized including the most recently identified, Zika virus. Supportive care remains the mainstay of therapy. Plasma exchange or intravenous immunoglobin hastens recovery. Combination immunotherapy is not more effective, and the efficacy of prolonged immunotherapy is unproven. One in 3 patients will have deterioration severe enough to require prolonged intensive care monitoring or mechanical ventilation. Full recovery is often seen; most patients regain ambulation, even in severe cases, but disability remains in up to 10% and perhaps more. Numerous challenges remain including early identification and control of infectious triggers, improved access of modern neurointensive care worldwide, and translating our understanding of pathogenesis into meaningful preventive or assistive therapies. This review provides a historical perspective at the centenary of the first description of the syndrome, insights into its pathogenesis, triage, initial immunotherapy, and management in the intensive care unit. (C) 2016 Mayo Foundation for Medical Education and Research.
C1 [Wijdicks, Eelco F. M.] Mayo Clin, Div Crit Care Neurol, Dept Neurol, Rochester, MN USA.
   [Klein, Christopher J.] Mayo Clin, Div Peripheral Nerve Dis, Dept Neurol, Rochester, MN USA.
RP Wijdicks, EFM (corresponding author), Mayo Clin, Div Crit Care Neurol, 200 First St SW, Rochester, MN 55905 USA.
EM wijde@mayo.edu
OI Klein, Christopher/0000-0002-4012-8856
CR Ali MI, 2006, RESP CARE, V51, P1403
   Baxter R, 2012, CLIN INFECT DIS, V54, P800, DOI 10.1093/cid/cir960
   Bernsen RAJAM, 1999, NEUROLOGY, V53, P409, DOI 10.1212/WNL.53.2.409
   Bolton CF, 2004, NEUROLOGY BREATHING
   BRETTLE RP, 1978, LANCET, V2, P1100
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   BROWN WF, 1984, BRAIN, V107, P219, DOI 10.1093/brain/107.1.219
   Burns TM, 2001, MUSCLE NERVE, V24, P963, DOI 10.1002/mus.1095
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHIBA A, 1992, ANN NEUROL, V31, P677, DOI 10.1002/ana.410310619
   CORNBLATH DR, 1990, ANN NEUROL, V27, pS17, DOI 10.1002/ana.410270706
   Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1
   Davidson AI, 2016, J PERIPHER NERV SYST
   DERENNE JP, 1978, AM REV RESPIR DIS, V118, P119
   EMMONS PR, 1975, ARCH NEUROL-CHICAGO, V32, P59, DOI 10.1001/archneur.1975.00490430081017
   FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Flachenecker P, 1997, BRAIN, V120, P1885, DOI 10.1093/brain/120.10.1885
   Flachenecker P, 2000, CLIN AUTON RES, V10, P185, DOI 10.1007/BF02291354
   Fletcher DD, 2000, NEUROLOGY, V54, P2311, DOI 10.1212/WNL.54.12.2311
   Fugate JE, 2009, NEUROCRIT CARE, V11, P395, DOI 10.1007/s12028-009-9279-8
   Galtrey Clare M, 2012, Pract Neurol, V12, P49, DOI 10.1136/practneurol-2011-000116
   Gordon PH, 2001, ARCH NEUROL-CHICAGO, V58, P913, DOI 10.1001/archneur.58.6.913
   GRIFFIN JW, 1995, BRAIN, V118, P577, DOI 10.1093/brain/118.3.577
   Griffin JW, 1996, ANN NEUROL, V39, P17, DOI 10.1002/ana.410390105
   GRIGGS RC, 1981, ARCH NEUROL-CHICAGO, V38, P9, DOI 10.1001/archneur.1981.00510010035004
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   HAYMAKER W, 1949, MEDICINE, V28, P59, DOI 10.1097/00005792-194902000-00003
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Hughes RAC, 1997, LANCET, V349, P225
   Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6
   Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kramer CL, 2015, NEUROLOGY, V84, pe57, DOI 10.1212/WNL.0000000000001296
   KURLAND LT, 1985, ARCH NEUROL-CHICAGO, V42, P1089, DOI 10.1001/archneur.1985.04060100075026
   Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020
   Landry O, 1859, GAZETTE HEBDOMADAIRE, V6, P472
   Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501
   Lawn ND, 2001, ARCH NEUROL-CHICAGO, V58, P893, DOI 10.1001/archneur.58.6.893
   Lawn ND, 1999, MUSCLE NERVE, V22, P1058
   LICHTENFELD P, 1971, AM J MED, V50, P772, DOI 10.1016/0002-9343(71)90185-9
   Mahecha M. P., 2016, IMMUNOL RES
   McCarthy N, 1999, EPIDEMIOL INFECT, V122, P15, DOI 10.1017/S0950268898001861
   MCKHANN, 1985, NEUROLOGY, V35, P1096
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   MCLEOD JG, 1981, ANN NEUROL, V9, P20, DOI 10.1002/ana.410090705
   MITCHELL PL, 1967, AM J MED, V42, P986, DOI 10.1016/0002-9343(67)90079-4
   Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171
   Nagarajan E, NEUROL CLIN IN PRESS
   Nowe T, 2008, J NEUROL, V255, P756, DOI 10.1007/s00415-008-0783-0
   Ogawara K, 2000, ANN NEUROL, V48, P624, DOI 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.3.CO;2-F
   PHILLIPS MS, 1984, J NEUROL NEUROSUR PS, V47, P492, DOI 10.1136/jnnp.47.5.492
   Poland GA, 2012, VACCINE, V30, P5801, DOI 10.1016/j.vaccine.2012.06.093
   Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   ROGOFF JB, 1977, JAMA-J AM MED ASSOC, V237, P2470, DOI 10.1001/jama.1977.03270500022009
   ROPPER AH, 1990, ARCH NEUROL-CHICAGO, V47, P706, DOI 10.1001/archneur.1990.00530060120029
   ROPPER AH, 1986, ARCH NEUROL-CHICAGO, V43, P1150, DOI 10.1001/archneur.1986.00520110044012
   ROPPER AH, 1994, BAILLIERE CLIN NEUR, V3, P95
   ROPPER AH, 1990, ARCH NEUROL-CHICAGO, V47, P881, DOI 10.1001/archneur.1990.00530080065012
   ROPPER AH, 1991, GUILLAIN BARRE SYNDR
   Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8
   TRUAX BT, 1984, SEMIN NEUROL, V4, P462, DOI 10.1055/s-2008-1041579
   van den Berg B, 2014, NEUROLOGY, V82, P1984, DOI 10.1212/WNL.0000000000000481
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Walgaard C, 2017, NEUROCRIT CARE, V26, P6, DOI 10.1007/s12028-016-0311-5
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   WIEDERHOLT WC, 1964, MAYO CLIN PROC, V39, P427
   Wijdicks EFM, 2016, NEUROCRIT CARE, V25, P288, DOI 10.1007/s12028-016-0323-1
   Wijdicks EFM, 2000, NEUROLOGY, V55, P452, DOI 10.1212/WNL.55.3.452
   Wijdicks EFM, 2002, PRACT NEUROL, V2, P208
   Wijdicks EFM, 2000, NEUROLOGICAL EPONYMS, P219
   Willison HJ, 2016, GBS100 CELEBRATING C
   Winters JL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-101
   Yamaguchi N, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.6610
   Yuan CL, 2000, EUR NEUROL, V44, P79, DOI 10.1159/000008201
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
   YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900
   Yuki Nobuhiro, 2015, Brain Nerve, V67, P1341, DOI 10.11477/mf.1416200304
   ZOCHODNE DW, 1994, MUSCLE NERVE, V17, P1145, DOI 10.1002/mus.880171004
NR 87
TC 41
Z9 43
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD MAR
PY 2017
VL 92
IS 3
BP 467
EP 479
DI 10.1016/j.mayocp.2016.12.002
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER6VZ
UT WOS:000398948600022
PM 28259232
OA Bronze
DA 2020-07-08
ER

PT J
AU Costa, VV
   Del Sarto, JL
   Rocha, RF
   Silva, FR
   Doria, JG
   Olmo, IG
   Marques, RE
   Queiroz, CM
   Foureaux, G
   Araujo, JMS
   Cramer, A
   Real, ALCV
   Ribeiro, LS
   Sardi, SI
   Ferreira, AJ
   Machado, FS
   de Oliveira, AC
   Teixeira, AL
   Nakaya, HI
   Souza, DG
   Ribeiro, FM
   Teixeira, MM
AF Costa, Vivian V.
   Del Sarto, Juliana L.
   Rocha, Rebeca F.
   Silva, Flavia R.
   Doria, Juliana G.
   Olmo, Isabella G.
   Marques, Rafael E.
   Queiroz-Junior, Celso M.
   Foureaux, Giselle
   Araujo, Julia Maria S.
   Cramer, Allysson
   Real, Ana Luiza C. V.
   Ribeiro, Lucas S.
   Sardi, Silvia I.
   Ferreira, Anderson J.
   Machado, Fabiana S.
   de Oliveira, Antonio C.
   Teixeira, Antonio L.
   Nakaya, Helder I.
   Souza, Danielle G.
   Ribeiro, Fabiola M.
   Teixeira, Mauro M.
TI N-Methyl-D-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death
   Induced by Zika Virus Infection
SO MBIO
LA English
DT Article
DE NMDA receptor; Zika virus; intraocular pressure; memantine;
   microgliosis; mouse model; neuronal death
ID METABOTROPIC GLUTAMATE RECEPTORS; ALZHEIMERS-DISEASE;
   HUNTINGTONS-DISEASE; HOST-RESISTANCE; MOUSE MODEL; IFN-GAMMA; IN-VITRO;
   MEMANTINE; MICE; TRANSMISSION
AB Zika virus (ZIKV) infection is a global health emergency that causes significant neurodegeneration. Neurodegenerative processes may be exacerbated by N-methyl-D-aspartate receptor (NMDAR)-dependent neuronal excitoxicity. Here, we have exploited the hypothesis that ZIKV-induced neurodegeneration can be rescued by blocking NMDA overstimulation with memantine. Our results show that ZIKV actively replicates in primary neurons and that virus replication is directly associated with massive neuronal cell death. Interestingly, treatment with memantine or other NMDAR blockers, including dizocilpine (MK-801), agmatine sulfate, or ifenprodil, prevents neuronal death without interfering with the ability of ZIKV to replicate in these cells. Moreover, in vivo experiments demonstrate that therapeutic memantine treatment prevents the increase of intraocular pressure (IOP) induced by infection and massively reduces neurodegeneration and microgliosis in the brain of infected mice. Our results indicate that the blockade of NMDARs by memantine provides potent neuroprotective effects against ZIKV-induced neuronal damage, suggesting it could be a viable treatment for patients at risk for ZIKV infection-induced neurodegeneration.
   IMPORTANCE Zika virus (ZIKV) infection is a global health emergency associated with serious neurological complications, including microcephaly and Guillain-Barre syndrome. Infection of experimental animals with ZIKV causes significant neuronal damage and microgliosis. Treatment with drugs that block NMDARs prevented neuronal damage both in vitro and in vivo. These results suggest that overactivation of NMDARs contributes significantly to the neuronal damage induced by ZIKV infection, and this is amenable to inhibition by drug treatment.
C1 [Costa, Vivian V.; Del Sarto, Juliana L.; Rocha, Rebeca F.; Marques, Rafael E.; Cramer, Allysson; Ribeiro, Lucas S.; Machado, Fabiana S.; Souza, Danielle G.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Immunopharmacol Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Costa, Vivian V.; Araujo, Julia Maria S.; Ribeiro, Lucas S.; Souza, Danielle G.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Host Interact Microorganism Lab, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Silva, Flavia R.; Doria, Juliana G.; Olmo, Isabella G.; Real, Ana Luiza C. V.; Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, Neurobiochem Lab, Belo Horizonte, MG, Brazil.
   [Queiroz-Junior, Celso M.; Foureaux, Giselle; Ferreira, Anderson J.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Morphol, Cardiac Biol Lab, Belo Horizonte, MG, Brazil.
   [Cramer, Allysson; Machado, Fabiana S.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Immunoregulat Infect Dis Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Sardi, Silvia I.] Univ Fed Bahia UFBA, Dept Virol, Virol Lab, Salvador, BA, Brazil.
   [de Oliveira, Antonio C.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Neuropharmacol Lab, Dept Pharmacol, Belo Horizonte, MG, Brazil.
   [Teixeira, Antonio L.] Univ Texas Houston, Hlth Sci Ctr Houston, McGovern Med Houston, Dept Psychiat & Behav Sci, Houston, TX USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Dept Clin Anal & Toxicol, Sch Pharmaceut Sci, Metabol Appl Hlth Lab, Sao Paulo, Brazil.
RP Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci ICB, Immunopharmacol Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.; Ribeiro, FM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, Neurobiochem Lab, Belo Horizonte, MG, Brazil.
EM fmribeiro@icb.ufmg.br; mmtex.ufmg@gmail.com
RI Rodrigues, Dra. Flavia/A-9986-2018; Teixeira, Antonio L/N-3315-2014;
   Nakaya, Helder/AAF-1738-2020; Nakaya, Helder/A-1397-2010; Marques,
   Rafael Elias/R-4890-2016; Costa, Vivian VVC/I-2499-2018; Queiroz-Junior,
   Celso/L-5438-2013; Ribeiro, Fabiola/E-8831-2013; Olmo, Isabella
   Guimaraes/W-5050-2019; sardi, silvia ines/P-9349-2016; de Paiva Froes
   Rocha, Rebeca/B-2477-2018
OI Rodrigues, Dra. Flavia/0000-0003-3007-9795; Teixeira, Antonio
   L/0000-0002-9621-5422; Nakaya, Helder/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Marques, Rafael Elias/0000-0002-6949-0947;
   Costa, Vivian VVC/0000-0002-0175-642X; Queiroz-Junior,
   Celso/0000-0002-7884-7709; Ribeiro, Fabiola/0000-0001-7042-9433; Olmo,
   Isabella Guimaraes/0000-0002-0007-3280; sardi, silvia
   ines/0000-0002-2002-8436; Secchim Ribeiro, Lucas/0000-0001-8876-3827; de
   Paiva Froes Rocha, Rebeca/0000-0002-5678-4006; Simao Machado,
   Fabiana/0000-0001-9272-5209
FU National Institute of Science and Technology in Dengue (INCT dengue);
   Brazilian National Science Council (CNPq, Brazil); Minas Gerais
   Foundation for Science (FAPEMIG, Brazil); Financiadora de Estudos e
   Pesquisa (FINEP, Brazil); Comissao de Apoio a Pessoal de Ensino Superior
   (CAPES, Brazil)
FX This work has received financial support from the National Institute of
   Science and Technology in Dengue (INCT dengue), a program funded by The
   Brazilian National Science Council (CNPq, Brazil) and Minas Gerais
   Foundation for Science (FAPEMIG, Brazil). This work also received
   financial support from Financiadora de Estudos e Pesquisa (FINEP,
   Brazil) and Comissao de Apoio a Pessoal de Ensino Superior (CAPES,
   Brazil).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Anderson ER, 2004, J NEUROSCI, V24, P7194, DOI 10.1523/JNEUROSCI.1933-04.2004
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8
   CHEN HSV, 1992, J NEUROSCI, V12, P4427
   Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909
   Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Costa VV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001663
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L
   Esposito Z, 2013, CNS NEUROSCI THER, V19, P549, DOI 10.1111/cns.12095
   Fagundes CT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001449
   FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z
   Foureaux G, 2013, INVEST OPHTH VIS SCI, V54, P4296, DOI 10.1167/iovs.12-11427
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268
   Li C, 2016, ACTA ASTRONAUT, V129, P74, DOI 10.1016/j.actaastro.2016.08.032
   Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008
   Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958
   LIPTON SA, 1992, NEUROLOGY, V42, P1403, DOI 10.1212/WNL.42.7.1403
   Lopez-Valdes HE, 2014, STROKE, V45, P2093, DOI 10.1161/STROKEAHA.113.004476
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Minkeviciene R, 2004, J PHARMACOL EXP THER, V311, P677, DOI 10.1124/jpet.104.071027
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7
   Moretti Morgana, 2014, Front Biosci (Elite Ed), V6, P341
   MULLER WEG, 1992, EUR J PHARM-MOLEC PH, V226, P209, DOI 10.1016/0922-4106(92)90063-2
   Murugan M, 2013, CNS NEUROL DISORD-DR, V12, P773, DOI 10.2174/18715273113126660174
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0
   Ott BR, 2007, J NEUROL, V254, P351, DOI 10.1007/s00415-006-0374-x
   Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   RYTIK PG, 1991, AIDS RES HUM RETROV, V7, P89, DOI 10.1089/aid.1991.7.89
   Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054
   Silva ACSE, 2016, NEUROPSYCH DIS TREAT, V12, P1747, DOI 10.2147/NDT.S113037
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wang YC, 2017, J CEREBR BLOOD F MET, V37, P980, DOI 10.1177/0271678X16648971
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010
   Young AB, 2003, J CLIN INVEST, V111, P299, DOI 10.1172/JCI200317742
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 69
TC 37
Z9 38
U1 1
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2017
VL 8
IS 2
AR e00350-17
DI 10.1128/mBio.00350-17
PG 16
WC Microbiology
SC Microbiology
GA ET8TW
UT WOS:000400575700017
PM 28442607
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tsetsarkin, KA
   Liu, GP
   Volkova, E
   Pletnev, AG
AF Tsetsarkin, Konstantin A.
   Liu, Guangping
   Volkova, Evgeniya
   Pletnev, Alexander G.
TI Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for
   Flavivirus Attenuation and Live Vaccine Development
SO MBIO
LA English
DT Article
DE attenuation; vaccine; flavivirus; internal ribosome entry site; microRNA
ID TICK-BORNE ENCEPHALITIS; INTERFERON PROTECTS; LANGAT VIRUS; DNA VACCINE;
   ZIKA VIRUS; REPLICATION; GENOME; REGION; SITE; NEUROVIRULENCE
AB The recent emergence of Zika virus underscores the need for new strategies for a rapid development of safe flavivirus vaccines. Using another flavivirus (Langat virus [LGTV]) that belongs to the group of tick-borne flaviviruses as a model, we describe a dual strategy for virus attenuation which synergistically accesses the specificity of microRNA (miRNA) genome targeting and the effectiveness of internal ribosome entry site (IRES) insertion. To increase the stability and immunogenicity of bicistronic LGTVs, we developed a novel approach in which the capsid (C) protein gene was relocated into the 3' noncoding region (NCR) and expressed under translational control from an IRES. Engineered bicistronic LGTVs carrying multiple target sequences for brain-specific miRNAs were stable in Vero cells and induced adaptive immunity in mice. Importantly, miRNA-targeted bicistronic LGTVs were not pathogenic for either newborn mice after intracranial inoculation or adult immunocompromised mice (SCID or type I interferon receptor knockout) after intraperitoneal injection. Moreover, bicistronic LGTVs were restricted for replication in tick-derived cells, suggesting an interruption of viral transmission in nature by arthropod vectors. This approach is suitable for reliable attenuation of many flaviviruses and may enable development of live attenuated flavivirus vaccines.
   IMPORTANCE The recent emergence of Zika virus underscores the need for new strategies for a rapid development of safe flavivirus vaccines. Allied separately attenuating approaches based on (i) microRNA genome targeting and (ii) internal ribosome entry site insertion are not sufficient for relievable attenuation of neurotropic flavivirus pathogenesis. Here, we describe a novel dual strategy that combines the specificity of miRNA-based and the effectiveness of IRES-based attenuating approaches, allowing us to overcome these critical limitations. This developed approach provides a robust platform for reliable attenuation of many flaviviruses and may enable development of live flavivirus vaccines.
C1 [Tsetsarkin, Konstantin A.; Liu, Guangping; Pletnev, Alexander G.] NIAID, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Volkova, Evgeniya] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Pletnev, AG (corresponding author), NIAID, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM apletnev@niaid.nih.gov
FU Division of Intramural Research Program of the National Institute of
   Allergy and Infectious Diseases, National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID)
FX This work was supported by the Division of Intramural Research Program
   of the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health.
CR Campbell MS, 2000, VIROLOGY, V269, P225, DOI 10.1006/viro.2000.0220
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frese M, 2014, J VIROL, V88, P2056, DOI 10.1128/JVI.03051-13
   Halstead S. B., 2008, VACCINES, P311
   Ishikawa T, 2008, VACCINE, V26, P2772, DOI 10.1016/j.vaccine.2008.03.010
   Kofler RM, 2004, P NATL ACAD SCI USA, V101, P1951, DOI 10.1073/pnas.0307145101
   Kunze U, 2016, TICKS TICK-BORNE DIS, V7, P399, DOI 10.1016/j.ttbdis.2015.12.018
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Mason PW, 2006, VIROLOGY, V351, P432, DOI 10.1016/j.virol.2006.04.003
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061
   MUNDERLOH UG, 1994, J PARASITOL, V80, P533, DOI 10.2307/3283188
   Orlinger KK, 2007, J VIROL, V81, P12619, DOI 10.1128/JVI.01017-07
   Orlinger KK, 2006, J VIROL, V80, P12197, DOI 10.1128/JVI.01540-06
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Pletnev AG, 2001, J VIROL, V75, P8259, DOI 10.1128/JVI.75.17.8259-8267.2001
   Rumyantsev AA, 2013, P NATL ACAD SCI USA, V110, P13103, DOI 10.1073/pnas.1306245110
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3
   Teterina NL, 2016, ANTIVIR RES, V127, P57, DOI 10.1016/j.antiviral.2016.01.003
   Tsetsarkin KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33088
   Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061
   Tsetsarkin KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004852
   Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Woolaway KE, 2001, J VIROL, V75, P10244, DOI 10.1128/JVI.75.21.10244-10249.2001
NR 29
TC 5
Z9 8
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2017
VL 8
IS 2
AR e02326-16
DI 10.1128/mBio.02326-16
PG 11
WC Microbiology
SC Microbiology
GA ET8TW
UT WOS:000400575700062
PM 28420742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bennett, B
   Carney, T
AF Bennett, Belinda
   Carney, Terry
TI PUBLIC HEALTH EMERGENCIES OF INTERNATIONAL CONCERN: GLOBAL, REGIONAL,
   AND LOCAL RESPONSES TO RISK
SO MEDICAL LAW REVIEW
LA English
DT Article
DE Global health; International Health Regulations; Pandemics; Risk;
   Governance; Health emergencies
ID DISEASE SURVEILLANCE; HUMAN-RIGHTS; ZIKA VIRUS; EBOLA; REGULATIONS;
   GOVERNANCE; MANAGEMENT; EPIDEMIC; SYSTEMS
AB The declaration in 2009 that the H1N1 pandemic constituted a public health emergency of international concern (PHEIC) was the first such declaration under the revised International Health Regulations that were adopted in 2005. In the period since then PHEIC have been declared in relation to polio, Ebola, and Zika. This article evaluates initiatives that have been introduced globally, within the Asia-Pacific region, and within Australia, to strengthen preparedness for public health emergencies. Through analysis of evolving conceptualisations of risk, surveillance of zoonotic diseases, and development of public health capacities, the article argues that to date the global community has failed to make the necessary investments in health system strengthening, and that without these investments, global public health emergencies will continue to be an ongoing challenge.
C1 [Bennett, Belinda] Queensland Univ Technol, Sch Law, Australian Ctr Hlth Law Res, Hlth Law & New Technol, 2 George St, Brisbane, Qld 4000, Australia.
   [Carney, Terry] Univ Sydney, Fac Law, Law, Eastern Ave, Sydney, NSW 2006, Australia.
RP Bennett, B (corresponding author), Queensland Univ Technol, Sch Law, Australian Ctr Hlth Law Res, Hlth Law & New Technol, 2 George St, Brisbane, Qld 4000, Australia.
EM belinda.bennett@qut.edu.au
OI Carney, Terry/0000-0002-3612-5986; Bennett, Belinda/0000-0003-0912-5662
FU Australian Research CouncilAustralian Research Council [DP0987239]
FX Research for this article was supported by Discovery Grant (DP0987239)
   from the Australian Research Council. The authors wish to thank the
   anonymous reviewers for their helpful comments and suggestions.
CR [Anonymous], 2016, LANCET, V388, P1026
   [Anonymous], 2016, PROT HUM FUT HLTH CR, P21
   Bashford A, 1998, HEALTH, V2, P387
   Bennett B., 2014, LAW GLOBAL HLTH CURR, V16, P121
   Bennett B, 2016, J LAW MED, V24, P7
   Bennett B, 2015, J BIOETHIC INQ, V12, P419, DOI 10.1007/s11673-014-9555-y
   Bennett B, 2015, J LAW MED, V22, P506
   Bol GF, 2016, EMBO REP, V17, P1, DOI 10.15252/embr.201541678
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bond K. C., 2013, Emerging Health Threats Journal, V6, P19913, DOI 10.3402/ehtj.v6i0.19913
   Capps B, 2015, BIOETHICS, V29, P588, DOI 10.1111/bioe.12145
   Carney T, 2012, J LAW MED, V19, P550
   Carney Terry, 2011, AUSTR MENTAL HLTH TR
   Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1
   Davies S. E., 2015, DIS DIPLOMACY INT NO
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Davies SE, 2013, INT J HUM RIGHTS, V17, P133, DOI 10.1080/13642987.2012.710840
   Davies SE, 2012, GLOB CHANG PEACE SEC, V24, P95, DOI 10.1080/14781158.2012.641272
   Davies SE, 2012, GLOB PUBLIC HEALTH, V7, P695, DOI 10.1080/17441692.2012.699538
   Edge JS, 2015, GLOB HEALT, P157
   Fidler DP, 2005, CHIN J INT LAW, V4, P325, DOI DOI 10.1093/CHINESEJIL/JMI029
   Frau Robert, 2016, GOTT JIL, V7, P271
   Frau Robert, 2016, GOTT JIL, V7, P225
   Gostin LO, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002042
   Gostin LO, 2016, MILBANK Q, V94, P264, DOI 10.1111/1468-0009.12186
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Harman S, 2016, THIRD WORLD Q, V37, P524, DOI 10.1080/01436597.2015.1108827
   Hayden EC, 2016, NATURE, V531, P19, DOI 10.1038/531019a
   Heath JB, 2016, HARVARD INT LAW J, V57, P1
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hodge James G, 2015, NOTRE DAME JL ETHICS, V29, P358
   Hodge JG, 2015, NOTRE DAME J LAW ETH, V29, P355
   Hodge Jr James G., 2008, N Y U ANN SURV AM L, V64, P249
   Kamradt-Scott A, 2016, THIRD WORLD Q, V37, P401, DOI 10.1080/01436597.2015.1112232
   Katz R, 2015, LANCET GLOB HEALTH, V3, pE352, DOI 10.1016/S2214-109X(15)00025-X
   Katz Rebecca, 2010, GLOBAL HLTH GOVERNAN, P1
   Koch T, 2015, DISASTER MED PUBLIC, V9, P51, DOI 10.1017/dmp.2014.107
   Kwok-ming P, 2015, WEST PAC SURVEILL RE, V6, DOI 10.2471/WPSAR.2015.6.1.002
   Lakoff A, 2015, ECON SOC, V44, P40, DOI 10.1080/03085147.2014.983833
   LAREAL P. VIL-, 2016, GO JIL
   Largent Emily A, 2016, J MED ETHICS, P1
   Lee K, 2013, HEALTH POLICY PLANN, V28, P778, DOI 10.1093/heapol/czs127
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Mackey TK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2016-y
   McInnes C, 2015, INT AFF, V91, P1299, DOI 10.1111/1468-2346.12454
   Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5
   Moore Melinda, 2015, BMC Res Notes, V8, P90, DOI 10.1186/s13104-015-1047-6
   Mythen G, 2015, RISK GOVERNANCE: THE ARTICULATION OF HAZARD, POLITICS AND ECOLOGY, P43, DOI 10.1007/978-94-017-9328-5_3
   November Valerie, 2015, RISK DISASTER CRISIS, P37
   Ottersen T, 2016, AM J LAW MED, V42, P356, DOI 10.1177/0098858816658273
   Pagliari C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004795
   Pandemic Influenza Risk Management WHO Interim Guidance, 2013, PAND INFL RISK MAN W
   Saxena A, 2016, CLIN TRIALS, V13, P96, DOI 10.1177/1740774515621870
   Seetoh T, 2012, GLOB PUBLIC HEALTH, V7, P717, DOI 10.1080/17441692.2012.699541
   Sell TK, 2017, EMERG INFECT DIS, V23, P108, DOI 10.3201/eid2301.160589
   Selvey LA, 2015, EMERG INFECT DIS, V21, P197, DOI 10.3201/eid2102.131610
   Sinha MS, 2016, AM J LAW MED, V42, P223, DOI 10.1177/0098858816658269
   Stephenson N, 2009, SOCIOL HEALTH ILL, V31, P525, DOI 10.1111/j.1467-9566.2009.01162.x
   Triggs Gillian, 2015, COMMUNICATION
   Verweij M, 2016, PUBLIC HEALTH ETH-UK, V9, P1, DOI 10.1093/phe/phw003
   Villarreal Pedro A, 2016, GO JIL, V7, P108
   Wenham C, 2016, THIRD WORLD Q, V37, P436, DOI 10.1080/01436597.2015.1116366
   WHO, 2016, REP COMM END CHILDH, P30
   World Health Organization, 2015, MIDDL E RESP SYNDR C
   World Health Organization, 2010, ATLAS SUBST US 2010, P7
   World Health Organization, 2016, R D BLUEPR ACT PREV, P6
   World Health Organization, 2015, REP EB INT ASS PAN, P13
   World Health Organization, 2016, GUID MAN ETH ISS INF
   World Health Organization, 2011, COMP AN NAT PAND INF
   World Health Organization, 2013, EV PAND A HINI 2009
   Zidar A, 2015, INT J HUM RIGHTS, V19, P505, DOI 10.1080/13642987.2015.1045340
NR 72
TC 3
Z9 3
U1 19
U2 29
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0967-0742
EI 1464-3790
J9 MED LAW REV
JI Med. Law. Rev.
PD SPR
PY 2017
VL 25
IS 2
BP 223
EP 239
DI 10.1093/medlaw/fwx004
PG 17
WC Law; Medicine, Legal
SC Government & Law; Legal Medicine
GA EZ1MH
UT WOS:000404474600004
PM 28379440
OA Green Published
DA 2020-07-08
ER

PT J
AU Boukadida, C
   Torres-Flores, JM
   Yocupicio-Monroy, M
   Piten-Isidro, E
   Rivero-Arrieta, AY
   Luna-Villalobos, YA
   Martinez-Vargas, L
   Alcaraz-Estrada, SL
   Torres, KJ
   Lira, R
   Reyes-Teran, G
   Sevilla-Reyes, EE
AF Boukadida, Celia
   Torres-Flores, Jesus M.
   Yocupicio-Monroy, Martha
   Piten-Isidro, Elvira
   Rivero-Arrieta, Amaranta Y.
   Luna-Villalobos, Yara A.
   Martinez-Vargas, Liliane
   Alcaraz-Estrada, Sofia L.
   Torres, Klintsy J.
   Lira, Rosalia
   Reyes-Teran, Gustavo
   Sevilla-Reyes, Edgar E.
TI Complete Genome Sequences, before and after Mammalian Cell Culture, of
   Zika Virus Isolated from the Serum of a Symptomatic Male Patient from
   Oaxaca, Mexico
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Zika virus (ZIKV) is an emerging arthropod-borne flavivirus associated with severe congenital malformations and neurological complications. Although the ZIKV genome is well characterized, there is limited information regarding changes after cell isolation and culture adaptation. We isolated, and passaged in Vero cells, ZIKV from the serum of a symptomatic male patient and compared the viral genomes before and after culture. Single nucleotide polymorphisms were characteristic among serum-circulating genomes, while such diversity decreased after cell culture.
C1 [Boukadida, Celia; Piten-Isidro, Elvira; Rivero-Arrieta, Amaranta Y.; Luna-Villalobos, Yara A.; Martinez-Vargas, Liliane; Torres, Klintsy J.; Reyes-Teran, Gustavo; Sevilla-Reyes, Edgar E.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.
   [Torres-Flores, Jesus M.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Virol, Mexico City, DF, Mexico.
   [Yocupicio-Monroy, Martha] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico.
   [Alcaraz-Estrada, Sofia L.] Inst Seguridad & Serv Sociales Trabajadores Esta, Ctr Med Nacl 20 Noviembre, Mexico City, DF, Mexico.
   [Lira, Rosalia] IMSS, UMAE Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City, DF, Mexico.
RP Sevilla-Reyes, EE (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.
EM edgar.sevilla@cieni.org.mx
RI Flores, Jesus Miguel Torres/AAE-2860-2020
OI Boukadida, Celia/0000-0002-1744-0083; Torres Flores,
   Jesus/0000-0002-2194-521X; Torres, Klintsy J./0000-0003-4231-4123;
   Yocupicio-Monroy, Martha/0000-0001-7885-5656; Lira,
   Rosalia/0000-0002-6812-9471
FU Red Mexicana de Virologia-CONACyT [Red INMUNOCANEI-CONACYT 269316]; 
   [269826]
FX This work was partially supported by Red INMUNOCANEI-CONACYT 269316 and
   Red Mexicana de Virologia-CONACyT 269826. The funders had no role in
   study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343
   Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163
NR 5
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAR
PY 2017
VL 5
IS 12
AR e00072-17
DI 10.1128/genomeA.00072-17
PG 2
WC Microbiology
SC Microbiology
GA VI1EG
UT WOS:000460689100017
PM 28336600
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Houldcroft, CJ
   Beale, MA
   Breuer, J
AF Houldcroft, Charlotte J.
   Beale, Mathew A.
   Breuer, Judith
TI Clinical and biological insights from viral genome sequencing
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID EPSTEIN-BARR-VIRUS; VARICELLA-ZOSTER-VIRUS; DRUG-RESISTANCE; ZIKA VIRUS;
   REAL-TIME; ANTIRETROVIRAL TREATMENT; EVOLUTIONARY PATTERNS; TARGET
   ENRICHMENT; ANTIVIRAL DRUGS; HIV
AB Whole-genome sequencing (WGS) of pathogens is becoming increasingly important not only for basic research but also for clinical science and practice. In virology, WGS is important for the development of novel treatments and vaccines, and for increasing the power of molecular epidemiology and evolutionary genomics. In this Opinion article, we suggest that WGS of viruses in a clinical setting will become increasingly important for patient care. We give an overview of different WGS methods that are used in virology and summarize their advantages and disadvantages. Although there are only partially addressed technical, financial and ethical issues in regard to the clinical application of viral WGS, this technique provides important insights into virus transmission, evolution and pathogenesis.
C1 [Houldcroft, Charlotte J.] UCL, Great Ormond St Inst Child Hlth, Dept Infect Immun & Inflammat, London WC1N 1EH, England.
   [Beale, Mathew A.; Breuer, Judith] UCL, Div Infect & Immun, London WC1E 6BT, England.
   [Beale, Mathew A.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.
   [Breuer, Judith] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 3JH, England.
RP Breuer, J (corresponding author), UCL, Div Infect & Immun, London WC1E 6BT, England.; Breuer, J (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 3JH, England.
EM j.breuer@ucl.ac.uk
RI Houldcroft, Charlotte/L-2497-2019; Toniolo, Antonio Q./B-4103-2015
OI Houldcroft, Charlotte/0000-0002-1833-5285; Toniolo, Antonio
   Q./0000-0003-3008-2126; Breuer, Judith/0000-0001-8246-0534; Beale,
   Mathew/0000-0002-4740-3187
FU Action Medical Research [GN2424]; European Union's Seventh Programme for
   research, technological development and demonstrationEuropean Union (EU)
   [304875]; UK National Institute for Health Research Biomedical Research
   Centre at GOSH National Health Service (NHS) Foundation Trust; UCL;
   University College London Hospitals (UCLH)/UCL National Institute for
   Health Research Biomedical Research Centre; Action Medical Research
   [2424]
FX The authors thank J. Brown and K. Gilmour (Great Ormond Street Hospital
   (GOSH), London, UK) and R. Doyle (University College London (UCL), UK)
   for their helpful discussions, and J. Quick (University of Birmingham,
   UK) for sharing unpublished MinION statistics. C.J.H. was funded by
   Action Medical Research (grant GN2424). M.A.B. was funded through the
   European Union's Seventh Programme for research, technological
   development and demonstration under grant agreement number 304875 held
   by J.B. This work was supported by the UK National Institute for Health
   Research Biomedical Research Centre at GOSH National Health Service
   (NHS) Foundation Trust and UCL. J.B. receives funding from the
   University College London Hospitals (UCLH)/UCL National Institute for
   Health Research Biomedical Research Centre. The authors acknowledge
   infrastructure support for the UCL Pathogen Genomics Unit, from the UCL
   UK Medical Research Council (MRC) Centre for Molecular Medical Virology
   and the UCLH/UCL National Institute for Health Research Biomedical
   Research Centre. The funders had no role in study design, data
   collection and interpretation, or the decision to submit work for
   publication.
CR Aanensen DM, 2016, MBIO, V7, DOI 10.1128/mBio.00444-16
   Agoti CN, 2015, J VIROL, V89, P3444, DOI 10.1128/JVI.03391-14
   Allen UD, 2016, PEDIATR TRANSPLANT, V20, P124, DOI 10.1111/petr.12610
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123
   Bialasiewicz S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-275
   Blomquist Thomas, 2015, Biomol Detect Quantif, V5, P30
   Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1
   Breitwieser Florian P, 2015, F1000Res, V4, P180, DOI 10.12688/f1000research.6743.2
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16
   Brown JR, 2015, CLIN INFECT DIS, V60, P881, DOI 10.1093/cid/ciu940
   Brunnemann AK, 2015, ANTIMICROB AGENTS CH, V59, P2726, DOI 10.1128/AAC.05115-14
   Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7
   Bull RA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2575-8
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cartwright EJP, 2011, NATURE, V471, P578, DOI 10.1038/471578d
   Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966
   Chou SW, 2014, ANTIMICROB AGENTS CH, V58, P4697, DOI 10.1128/AAC.03214-14
   Clevenbergh P, 2000, ANTIVIR THER, V5, P65
   Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496
   Cotten M, 2014, J VIROL, V88, P11056, DOI 10.1128/JVI.01333-14
   Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251
   Denesvre C, 2015, VIRUS GENES, V51, P209, DOI 10.1007/s11262-015-1231-8
   Depledge DP, 2014, MOL BIOL EVOL, V31, P397, DOI 10.1093/molbev/mst210
   Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805
   Donaldson CD, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00830-13
   Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227
   Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2
   Ebert K, 2013, J VIROL, V87, P10389, DOI 10.1128/JVI.01654-13
   Eckert S. E., 2016, ENRICHMENT LONG DNA
   Ellison D. W., 2016, GENOME ANNOUNC, V4
   Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096
   FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800
   Fonager J, 2015, J CLIN VIROL, V73, P95, DOI 10.1016/j.jcv.2015.11.009
   Franco S, 2014, GASTROENTEROLOGY, V147, P599, DOI 10.1053/j.gastro.2014.05.010
   FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397
   Fremond ML, 2015, J PEDIAT INF DIS SOC, V4, pE53, DOI 10.1093/jpids/piv040
   Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10
   GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871
   Gardy JL, 2015, J INFECT DIS, V212, P1574, DOI 10.1093/infdis/jiv271
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gnaneshan S, 2007, NUCLEIC ACIDS RES, V35, pD367, DOI 10.1093/nar/gkl874
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183
   Guan HZ, 2016, J NEUROVIROL, V22, P240, DOI 10.1007/s13365-015-0390-7
   Hall RJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00224
   Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a
   Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627
   Hofmann B, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0096-2
   Hong LZ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0517-9
   Houldcroft CJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01317
   Houldcroft CJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00188
   Huang WH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15223
   Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111
   Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905
   Itakura J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138060
   Jensen RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122636
   Johnson TA, 2016, MBIO, V7, DOI 10.1128/mBio.02214-15
   Kamperschroer C, 2016, VIROLOGY, V488, P28, DOI 10.1016/j.virol.2015.10.025
   Karamitros T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157600
   Karamitros T, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv773
   Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07
   Khudyakov Y, 2012, ANTIVIR THER, V17, P1465, DOI 10.3851/IMP2476
   Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z
   Kim JH, 2014, WORLD J GASTROENTERO, V20, P5708, DOI 10.3748/wjg.v20.i19.5708
   Kimberlin DW, 1996, J ANTIMICROB CHEMOTH, V37, P403, DOI 10.1093/jac/37.3.403
   Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824
   Kohl C, 2015, EMERG INFECT DIS, V21, P48, DOI 10.3201/eid2101.140766
   Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805
   Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485
   Kundu S, 2013, CLIN INFECT DIS, V57, P407, DOI 10.1093/cid/cit287
   Kyeyune F, 2016, ANTIMICROB AGENTS CH, V60, P3380, DOI 10.1128/AAC.00038-16
   Lamelas A, 2014, MBIO, V5, DOI 10.1128/mBio.01974-14
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lanier ER, 2016, J INFECT DIS, V214, P32, DOI 10.1093/infdis/jiw073
   Lassalle F, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew017
   Lecuit M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00025
   Lei HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16706
   Li CH, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0140-7
   Lipkin WI, 2015, J INFECT DIS, V212, pS26, DOI 10.1093/infdis/jiu649
   Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11
   Loman NJ, 2015, NAT REV MICROBIOL, V13, P787, DOI 10.1038/nrmicro3565
   Mathijs E, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00440-16
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Mbisa JL, 2015, CLIN INFECT DIS, V61, P829, DOI 10.1093/cid/civ393
   McGinnis J, 2016, J CLIN VIROL, V79, P44, DOI 10.1016/j.jcv.2016.03.005
   Melendez DP, 2015, INFECT DRUG RESIST, V8, P269, DOI 10.2147/IDR.S79131
   Miia JV, 2015, ARCH VIROL, V160, P1489, DOI 10.1007/s00705-015-2424-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morfopoulou S., 2016, ACTA NEUROPATHOL
   Morfopoulou S, 2016, NEW ENGL J MED, V375, P497, DOI 10.1056/NEJMc1509458
   Mulcahy-O'Grady H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00029
   Munnink BBO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078454
   Munro AC, 2016, FUTURE VIROL, V11, P163, DOI 10.2217/fvl.16.5
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912
   Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13
   Newman RM, 2013, J INFECT DIS, V208, P17, DOI 10.1093/infdis/jis679
   Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753
   Palser AL, 2015, J VIROL, V89, P5222, DOI 10.1128/JVI.03614-14
   Parameswaran P, 2012, J VIROL, V86, P8546, DOI 10.1128/JVI.00736-12
   Paredes R, 2010, ANTIVIR RES, V85, P245, DOI 10.1016/j.antiviral.2009.09.015
   Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003
   Perlejewski K, 2015, J VIROL METHODS, V226, P1, DOI 10.1016/j.jviromet.2015.09.010
   Pierucci P, 2016, J HEART LUNG TRANSPL, V35, P685, DOI 10.1016/j.healun.2015.12.031
   Piret J, 2014, REV MED VIROL, V24, P186, DOI 10.1002/rmv.1787
   Power RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163746
   Public Health England, 2013, GOOD LAB PRACT PERF
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Renzette N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001344
   Rhee SY, 2010, ANTIVIR RES, V88, P269, DOI 10.1016/j.antiviral.2010.09.012
   Rogers MB, 2015, MBIO, V6, DOI 10.1128/mBio.02464-14
   Rosseel T, 2014, TRANSBOUND EMERG DIS, V61, P293, DOI 10.1111/tbed.12251
   Sabina J, 2015, METHODS MOL BIOL, V1347, P15, DOI 10.1007/978-1-4939-2990-0_2
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Sauvage V, 2016, TRANSFUS CLIN BIOL, V23, P28, DOI 10.1016/j.tracli.2015.12.002
   Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397
   Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356
   Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08
   Swenson LC, 2012, CURR OPIN HIV AIDS, V7, P478, DOI 10.1097/COH.0b013e328356e9da
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543
   Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109101
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Tweedy J, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01498-14
   Van Laethem K, 2015, CURR OPIN VIROL, V14, P16, DOI 10.1016/j.coviro.2015.06.001
   Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771
   Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857
   Viana R. V., 2011, WIDE SPECTRA QUALITY
   Watson SJ, 2015, J VIROL, V89, P9920, DOI 10.1128/JVI.00840-15
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14
   Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Zaraket H, 2010, J CLIN MICROBIOL, V48, P1085, DOI 10.1128/JCM.01532-09
   Zhou B, 2015, SCI REP-UK, V5, DOI 10.1038/srep17123
NR 145
TC 74
Z9 76
U1 8
U2 60
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD MAR
PY 2017
VL 15
IS 3
BP 183
EP 192
DI 10.1038/nrmicro.2016.182
PG 10
WC Microbiology
SC Microbiology
GA EK9ZD
UT WOS:000394281600012
PM 28090077
OA Green Published
DA 2020-07-08
ER

PT J
AU Freitas, BDP
   Ko, AI
   Khouri, R
   Mayoral, M
   Henriques, DF
   Maia, M
   Belfort, R
AF Freitas, Bruno De Paula
   Ko, Albert I.
   Khouri, Ricardo
   Mayoral, Monica
   Henriques, Daniele Freitas
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Glaucoma and Congenital Zika Syndrome
SO OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS-INFECTION
C1 [Freitas, Bruno De Paula; Mayoral, Monica] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Freitas, Bruno De Paula; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Med Sch, Vis Inst, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Ko, Albert I.; Khouri, Ricardo] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Henriques, Daniele Freitas] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Paulista Med Sch, Dept Ophthalmol, Rua Botucatu,821, BR-04023062 Sao Paulo, SP, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Ko, Albert Icksang/P-2343-2015; Khouri, Ricardo/M-3184-2018; Maia,
   Mauricio/I-5892-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Khouri,
   Ricardo/0000-0001-5664-4436; Maia, Mauricio/0000-0002-7034-8091
CR Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD MAR
PY 2017
VL 124
IS 3
BP 407
EP 408
PG 2
WC Ophthalmology
SC Ophthalmology
GA EQ1SB
UT WOS:000397848800040
PM 27914834
DA 2020-07-08
ER

PT J
AU Filomatori, CV
   Carballeda, JM
   Villordo, SM
   Aguirre, S
   Pallares, HM
   Maestre, AM
   Sanchez-Vargas, I
   Blair, CD
   Fabri, C
   Morales, MA
   Fernandez-Sesma, A
   Gamarnik, AV
AF Filomatori, Claudia V.
   Carballeda, Juan M.
   Villordo, Sergio M.
   Aguirre, Sebastian
   Pallares, Horacio M.
   Maestre, Ana M.
   Sanchez-Vargas, Irma
   Blair, Carol D.
   Fabri, Cintia
   Morales, Maria A.
   Fernandez-Sesma, Ana
   Gamarnik, Andrea V.
TI Dengue virus genomic variation associated with mosquito adaptation
   defines the pattern of viral non-coding RNAs and fitness in human cells
SO PLOS PATHOGENS
LA English
DT Article
ID SUBGENOMIC FLAVIVIRUS RNA; ENCEPHALITIS-VIRUS; HEMORRHAGIC-FEVER;
   SRI-LANKA; EMERGENCE; INTERFERON; PATHOGENICITY; REPLACEMENT;
   PSEUDOKNOT; RESISTANT
AB The Flavivirus genus includes a large number of medically relevant pathogens that cycle between humans and arthropods. This host alternation imposes a selective pressure on the viral population. Here, we found that dengue virus, the most important viral human pathogen transmitted by insects, evolved a mechanism to differentially regulate the production of viral non-coding RNAs in mosquitos and humans, with a significant impact on viral fitness in each host. Flavivirus infections accumulate non-coding RNAs derived from the viral 3'UTRs (known as sfRNAs), relevant in viral pathogenesis and immune evasion. We found that dengue virus host adaptation leads to the accumulation of different species of sfRNAs in vertebrate and invertebrate cells. This process does not depend on differences in the host machinery; but it was found to be dependent on the selection of specific mutations in the viral 3'UTR. Dissecting the viral population and studying phenotypes of cloned variants, the molecular determinants for the switch in the sfRNA pattern during host change were mapped to a single RNA structure. Point mutations selected in mosquito cells were sufficient to change the pattern of sfRNAs, induce higher type I interferon responses and reduce viral fitness in human cells, explaining the rapid clearance of certain viral variants after host change. In addition, using epidemic and pre-epidemic Zika viruses, similar patterns of sfRNAs were observed in mosquito and human infected cells, but they were different from those observed during dengue virus infections, indicating that distinct selective pressures act on the 3'UTR of these closely related viruses. In summary, we present a novel mechanism by which dengue virus evolved an RNA structure that is under strong selective pressure in the two hosts, as regulator of non-coding RNA accumulation and viral fitness. This work provides new ideas about the impact of host adaptation on the variability and evolution of flavivirus 3'UTRs with possible implications in virulence and viral transmission.
C1 [Filomatori, Claudia V.; Carballeda, Juan M.; Villordo, Sergio M.; Pallares, Horacio M.; Gamarnik, Andrea V.] Fdn Inst Leloir CONICET, Ave Patricias Argentinas 435, Buenos Aires, DF, Argentina.
   [Aguirre, Sebastian; Maestre, Ana M.; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Sanchez-Vargas, Irma; Blair, Carol D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO USA.
   [Fabri, Cintia; Morales, Maria A.] ANLIS, Inst Nacl Enfermedades Virales Humanas Dr Julio I, Dept Invest, Pergamino, Argentina.
RP Gamarnik, AV (corresponding author), Fdn Inst Leloir CONICET, Ave Patricias Argentinas 435, Buenos Aires, DF, Argentina.
EM agamarnik@leloir.org.ar
RI Merens, Ana Maestre/I-2445-2019; Blair, Carol/D-1357-2019; FILOMATORI,
   Claudia/W-9924-2019
OI Merens, Ana Maestre/0000-0002-2494-0879; Blair,
   Carol/0000-0002-2803-0354; Aguirre, Sebastian/0000-0001-6079-5544
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01A1095175,
   R01A1073450, 1R21A1116022, 1U19A1118610]; Agencia Nacional de Promocion
   Cientifica PICT [2014-2111, 2015-2555]; Defense Advanced Research
   Projects AgencyUnited States Department of DefenseDefense Advanced
   Research Projects Agency (DARPA) [HR0011-11-C-0094]
FX This work was supported by: National Institute of Health R01A1095175 to
   AVG, R01A1073450, 1R21A1116022, and 1U19A1118610 to AFS; Agencia
   Nacional de Promocion Cientifica PICT 2014-2111 and 2015-2555 to AVG;
   Defense Advanced Research Projects Agency HR0011-11-C-0094 to AVG and
   AFS. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Andrade CC, 2016, J EVOL BIOL
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Santiago GA, 2012, J INFECT DIS, V206, P893, DOI 10.1093/infdis/jis426
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Sessions OM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004044
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sirisena PDNN, 2014, INT J INFECT DIS, V19, P6, DOI 10.1016/j.ijid.2013.10.012
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111
   Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 46
TC 42
Z9 41
U1 2
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2017
VL 13
IS 3
AR e1006265
DI 10.1371/journal.ppat.1006265
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EQ5JZ
UT WOS:000398120300037
PM 28264033
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hirsch, AJ
   Smith, JL
   Haese, NN
   Broeckel, RM
   Parkins, CJ
   Kreklywich, C
   DeFilippis, VR
   Denton, M
   Smith, PP
   Messer, WB
   Colgin, LMA
   Ducore, RM
   Grigsby, PL
   Hennebold, JD
   Swanson, T
   Legasse, AW
   Axthelm, MK
   MacAllister, R
   Wiley, CA
   Nelson, JA
   Streblow, DN
AF Hirsch, Alec J.
   Smith, Jessica L.
   Haese, Nicole N.
   Broeckel, Rebecca M.
   Parkins, Christopher J.
   Kreklywich, Craig
   DeFilippis, Victor R.
   Denton, Michael
   Smith, Patricia P.
   Messer, William B.
   Colgin, Lois M. A.
   Ducore, Rebecca M.
   Grigsby, Peta L.
   Hennebold, Jon D.
   Swanson, Tonya
   Legasse, Alfred W.
   Axthelm, Michael K.
   MacAllister, Rhonda
   Wiley, Clayton A.
   Nelson, Jay A.
   Streblow, Daniel N.
TI Zika Virus infection of rhesus macaques leads to viral persistence in
   multiple tissues
SO PLOS PATHOGENS
LA English
DT Article
ID WEST-NILE-VIRUS; NF-KAPPA-B; YELLOW-FEVER; CHIKUNGUNYA; MODEL;
   INFLAMMATION; SPECIFICITY; ANTIBODIES; MOSQUITOS; OUTBREAK
AB Zika virus (ZIKV), an emerging flavivirus, has recently spread explosively through the Western hemisphere. In addition to symptoms including fever, rash, arthralgia, and conjunctivitis, ZIKV infection of pregnant women can cause microcephaly and other developmental abnormalities in the fetus. We report herein the results of ZIKV infection of adult rhesus macaques. Following subcutaneous infection, animals developed transient plasma viremia and viruria from 1-7 days post infection (dpi) that was accompanied by the development of a rash, fever and conjunctivitis. Animals produced a robust adaptive immune response to ZIKV, although systemic cytokine response was minimal. At 7 dpi, virus was detected in peripheral nervous tissue, multiple lymphoid tissues, joints, and the uterus of the necropsied animals. Notably, viral RNA persisted in neuronal, lymphoid and joint/muscle tissues and the male and female reproductive tissues through 28 to 35 dpi. The tropism and persistence of ZIKV in the peripheral nerves and reproductive tract may provide a mechanism of subsequent neuropathogenesis and sexual transmission.
C1 [Hirsch, Alec J.; Smith, Jessica L.; Haese, Nicole N.; Broeckel, Rebecca M.; Parkins, Christopher J.; Kreklywich, Craig; DeFilippis, Victor R.; Denton, Michael; Smith, Patricia P.; Nelson, Jay A.; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.
   [Messer, William B.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.
   [Colgin, Lois M. A.; Ducore, Rebecca M.] Oregon Natl Primate Res Ctr, Div Comparat Med, Pathol Serv Unit, Beaverton, OR USA.
   [Grigsby, Peta L.; Hennebold, Jon D.] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA.
   [Hennebold, Jon D.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Streblow, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA.
   [MacAllister, Rhonda] Oregon Natl Primate Res Ctr, Div Comparat Med, Clin Med Unit, Beaverton, OR USA.
   [Wiley, Clayton A.] Univ Pittsburgh, Div Neuropathol, UPMC Presbyterian Hosp, Pittsburgh, PA USA.
RP Streblow, DN (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Streblow, DN (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA.
EM streblow@ohsu.edu
RI Haese, Nicole/AAN-4551-2020; amsalu, ribka/G-8780-2019
OI Hennebold, Jon/0000-0002-6760-3733; Broeckel,
   Rebecca/0000-0003-3740-5442
FU Oregon National Primate Research Center Pilot Project awarded through
   the Division of Pathobiology and Immunology the Division of Reproductive
   and Developmental Sciences; Division of Reproductive and Developmental
   Sciences as well as the National Institutes of Health [U42OD010426]
FX This work was supported by Oregon National Primate Research Center Pilot
   Project awarded through the Division of Pathobiology and Immunology the
   Division of Reproductive and Developmental Sciences as well as the
   National Institutes of Health (Grant U42OD010426).The funders had no
   role in study design, datacollection and analysis,decision to publish,
   or preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Bernhard CA, 2015, P NATL ACAD SCI USA, V112, P5461, DOI 10.1073/pnas.1423356112
   Brasil P., 2016, NEW ENGLAND J MED
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Calvet G., 2016, LANCET INFECT DIS
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davidson A, 2016, 65 MMWR, V65
   De Kock M, 2013, CNS NEUROSCI THER, V19, P403, DOI 10.1111/cns.12104
   DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, ZIK VIR INF OUTBR, P1
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Lanciotti RS, 2016, EMERGING INFECT DIS, V22
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGLAND J MED
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Pal P, 2014, J VIROL, V88, P8213, DOI 10.1128/JVI.01032-14
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09
   Soncin F, 2015, CELL MOL LIFE SCI, V72, P1291, DOI 10.1007/s00018-014-1794-x
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Wertheimer AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015514
   Whitmer T, 2015, J VIROL, V89, P8687, DOI 10.1128/JVI.01149-15
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 45
TC 113
Z9 115
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2017
VL 13
IS 3
AR e1006219
DI 10.1371/journal.ppat.1006219
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EQ5JZ
UT WOS:000398120300031
PM 28278237
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tripathi, S
   Balasubramaniam, VRMT
   Brown, JA
   Mena, I
   Grant, A
   Bardina, SV
   Maringer, K
   Schwarz, MC
   Maestre, AM
   Sourisseau, M
   Albrecht, RA
   Krammer, F
   Evans, MJ
   Fernandez-Sesma, A
   Lim, JK
   Garcia-Sastre, A
AF Tripathi, Shashank
   Balasubramaniam, Vinod R. M. T.
   Brown, Julia A.
   Mena, Ignacio
   Grant, Alesha
   Bardina, Susana V.
   Maringer, Kevin
   Schwarz, Megan C.
   Maestre, Ana M.
   Sourisseau, Marion
   Albrecht, Randy A.
   Krammer, Florian
   Evans, Matthew J.
   Fernandez-Sesma, Ana
   Lim, Jean K.
   Garcia-Sastre, Adolfo
TI A novel Zika virus mouse model reveals strain specific differences in
   virus pathogenesis and host inflammatory immune responses
SO PLOS PATHOGENS
LA English
DT Article
ID NEURAL PROGENITORS; ASIAN-LINEAGE; INFECTION; MICE; EMERGENCE; EXPOSURE;
   BRAIN; LEADS; PREGNANCY; DAMAGE
AB Zika virus (ZIKV) is a mosquito borne flavivirus, which was a neglected tropical pathogen until it emerged and spread across the Pacific Area and the Americas, causing large human outbreaks associated with fetal abnormalities and neurological disease in adults. The factors that contributed to the emergence, spread and change in pathogenesis of ZIKV are not understood. We previously reported that ZIKV evades cellular antiviral responses by targeting STAT2 for degradation in human cells. In this study, we demonstrate that Stat2 (-/-)mice are highly susceptible to ZIKV infection, recapitulate virus spread to the central nervous system (CNS), gonads and other visceral organs, and display neurological symptoms. Further, we exploit this model to compare ZIKV pathogenesis caused by a panel of ZIKV strains of a range of spatiotemporal history of isolation and representing African and Asian lineages. We observed that African ZIKV strains induce short episodes of severe neurological symptoms followed by lethality. In comparison, Asian strains manifest prolonged signs of neuronal malfunctions, occasionally causing death of the Stat2 -/-mice. African ZIKV strains induced higher levels of inflammatory cytokines and markers associated with cellular infiltration in the infected brain in mice, which may explain exacerbated pathogenesis in comparison to those of the Asian lineage. Interestingly, viral RNA levels in different organs did not correlate with the pathogenicity of the different strains. Taken together, we have established a new murine model that supports ZIKV infection and demonstrate its utility in highlighting intrinsic differences in the inflammatory response induced by different ZIKV strains leading to severity of disease. This study paves the way for the future interrogation of strain-specific changes in the ZIKV genome and their contribution to viral pathogenesis.
C1 [Tripathi, Shashank; Balasubramaniam, Vinod R. M. T.; Brown, Julia A.; Mena, Ignacio; Grant, Alesha; Bardina, Susana V.; Maringer, Kevin; Schwarz, Megan C.; Maestre, Ana M.; Sourisseau, Marion; Albrecht, Randy A.; Krammer, Florian; Evans, Matthew J.; Fernandez-Sesma, Ana; Lim, Jean K.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Tripathi, Shashank; Balasubramaniam, Vinod R. M. T.; Grant, Alesha; Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Brown, Julia A.; Grant, Alesha; Bardina, Susana V.] Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, Microbiol Training Area, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
   [Maringer, Kevin] Univ Surrey, Guildford, Surrey, England.
RP Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
EM adolfo.garcia-sastre@mssm.edu
RI Krammer, Florian/H-3237-2019; Mena, Ignacio/I-1222-2019; Merens, Ana
   Maestre/I-2445-2019; RMT Balasubramaniam, Vinod/B-6957-2017
OI Krammer, Florian/0000-0003-4121-776X; Mena, Ignacio/0000-0001-5464-7086;
   Merens, Ana Maestre/0000-0002-2494-0879; RMT Balasubramaniam,
   Vinod/0000-0001-9583-307X; Maringer, Kevin/0000-0003-0977-8807
FU NIAID,HIPC (AGS) [U19AI118610, R01AI073450]; Sir Henry Wellcome Trust
   Fellowship [096062]
FX This work was partially funded by a supplement to NIAID grant
   U19AI118610 as part of the HIPC (AGS) and by R01AI073450 (AFS). KM was
   funded by a Sir Henry Wellcome Trust Fellowship (096062). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Biancotto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076091
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Verbist KC, 2012, CYTOKINE, V59, P467, DOI 10.1016/j.cyto.2012.05.020
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 44
TC 107
Z9 109
U1 0
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2017
VL 13
IS 3
AR e1006258
DI 10.1371/journal.ppat.1006258
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EQ5JZ
UT WOS:000398120300029
PM 28278235
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Wong, G
   Li, SH
   Liu, L
   Liu, YX
   Bi, YH
AF Wong, Gary
   Li, Shihua
   Liu, Lei
   Liu, Yingxia
   Bi, Yuhai
TI Zika virus in the testes: should we be worried?
SO PROTEIN & CELL
LA English
DT Editorial Material
ID MALE SEXUAL TRANSMISSION; OUTBREAK; SEMEN
C1 [Wong, Gary; Liu, Lei; Liu, Yingxia; Bi, Yuhai] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, State Key Discipline Infect Dis, Shenzhen 518112, Peoples R China.
   [Wong, Gary; Li, Shihua; Bi, Yuhai] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
RP Bi, YH (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, State Key Discipline Infect Dis, Shenzhen 518112, Peoples R China.
EM beeyh@im.ac.cn
RI Liu, lei/V-9405-2018
OI Liu, lei/0000-0001-9612-6844
FU Chinese Academy of SciencesChinese Academy of Sciences [KJZD-EW-L09,
   KJZD-EW-L15]; Sanming Project of Medicine in Shenzhen
   [ZDSYS201504301534057]; Shenzhen Science and Technology Research and
   Development Project [JCYJ2016 0427151920801, JCYJ20160427153238750];
   Youth Innovation Promotion Association of Chinese Academy of Sciences
   (CAS); Banting Postdoctoral Fellowship from the Canadian Institutes of
   Health Research (CIHR)Canadian Institutes of Health Research (CIHR);
   CASDefence Research & Development Organisation (DRDO)Chinese Academy of
   Sciences
FX This work was supported by the intramural special grant for influenza
   virus research from the Chinese Academy of Sciences (KJZD-EW-L09 and
   KJZD-EW-L15), the Sanming Project of Medicine in Shenzhen
   (ZDSYS201504301534057), and the Shenzhen Science and Technology Research
   and Development Project (JCYJ2016 0427151920801 and
   JCYJ20160427153238750). Y.B. is supported by the Youth Innovation
   Promotion Association of Chinese Academy of Sciences (CAS). G.W. is the
   recipient of a Banting Postdoctoral Fellowship from the Canadian
   Institutes of Health Research (CIHR), and a President's International
   Fellowship Initiative from the CAS. Gary Wong and Shihua Li are
   co-authors on the Cell study described in this manuscript. All authors
   declare no other competing interests.
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Govero J, 2016, NATURE
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma W, 2016, CELL
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Osuna CE, 2016, NAT MED
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   World Health Organization, 2016, ZIK SIT REP 24 NOV 2
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 18
TC 10
Z9 10
U1 0
U2 4
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD MAR
PY 2017
VL 8
IS 3
BP 162
EP 164
DI 10.1007/s13238-016-0357-3
PG 3
WC Cell Biology
SC Cell Biology
GA EM0EI
UT WOS:000394991200002
PM 28110372
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stone, M
   Lanteri, MC
   Bakkour, S
   Deng, XT
   Galel, SA
   Linnen, JM
   Munoz-Jordan, JL
   Lanciotti, RS
   Rios, M
   Gallian, P
   Musso, D
   Levi, JE
   Sabino, EC
   Coffey, LL
   Busch, MP
AF Stone, Mars
   Lanteri, Marion C.
   Bakkour, Sonia
   Deng, Xutao
   Galel, Susan A.
   Linnen, Jeffrey M.
   Munoz-Jordan, Jorge L.
   Lanciotti, Robert S.
   Rios, Maria
   Gallian, Pierre
   Musso, Didier
   Levi, Jose E.
   Sabino, Ester C.
   Coffey, Lark L.
   Busch, Michael P.
TI Relative analytical sensitivity of donor nucleic acid amplification
   technology screening and diagnostic real-time polymerase chain reaction
   assays for detection of Zika virus RNA
SO TRANSFUSION
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; MALE SEXUAL TRANSMISSION; UNITED-STATES;
   BLOOD-TRANSFUSION; FRENCH-POLYNESIA; PREGNANT-WOMEN; BRAZIL; URINE;
   INFECTION; OUTBREAK
AB BACKGROUND Zika virus (ZIKV) has spread rapidly in the Pacific and throughout the Americas and is associated with severe congenital and adult neurologic outcomes. Nucleic acid amplification technology (NAT) assays were developed for diagnostic applications and for blood donor screening on high-throughput NAT systems. We distributed blinded panels to compare the analytical performance of blood screening relative to diagnostic NAT assays.
   STUDY DESIGN AND METHODS A 25-member, coded panel (11 half-log dilutions of a 2013 French Polynesia ZIKV isolate and 2015 Brazilian donor plasma implicated in transfusion transmission, and 3 negative controls) was sent to 11 laboratories that performed 17 assays with 2 to 12 replicates per panel member. Results were analyzed for the percentage reactivity at each dilution and by probit analysis to estimate the 50% and 95% limits of detection (LOD50 and LOD95, respectively).
   RESULTS Donor-screening NAT assays that process approximately 500 mu L of plasma into amplification reactions were comparable in sensitivity (LOD50 and LOD95, 2.5 and 15-18 copies/mL) and were approximately 10-fold to 100-fold more sensitive than research laboratory-developed and diagnostic reverse transcriptase-polymerase chain reaction tests that process from 10 to 30 mu L of plasma per amplification. Increasing sample input volume assayed with the Centers for Disease Control and Prevention reverse transcriptase-polymerase chain reaction assays increased the LODs by 10-fold to 30-fold.
   CONCLUSIONS Blood donor-screening ZIKV NAT assays demonstrate similar excellent sensitivities to assays currently used for screening for transfusion-transmitted viruses and are substantially more sensitive than most other laboratory-developed and diagnostic ZIKV reverse transcriptase-polymerase chain reaction assays. Enhancing sensitivities of laboratory-developed and diagnostic assays may be achievable by increasing sample input.
C1 [Stone, Mars; Lanteri, Marion C.; Bakkour, Sonia; Deng, Xutao; Busch, Michael P.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Linnen, Jeffrey M.] Hologic Inc, San Diego, CA USA.
   [Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, CDC, San Juan, PR USA.
   [Lanciotti, Robert S.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Rios, Maria] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Gallian, Pierre] Etab Francais Sang, St Denis, Reunion, France.
   [Gallian, Pierre] Aix Marseille Univ, Marseille, France.
   [Gallian, Pierre] Inst Hosp Univ Mediterranee Infect, INSERM, French Inst Res Dev, Unite Mixte Rech,Emergence Pathol Virales D190, Marseille, France.
   [Musso, Didier] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Levi, Jose E.] Univ Sao Paulo, Dept Biol Mol, Fundacao Prosangue, Hemoctr Sao Paulo, Sao Paulo, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
   [Coffey, Lark L.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
RP Busch, MP (corresponding author), Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM mbusch@bloodsystems.org
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020; Sabino, Ester
   Cerdeira/F-7750-2010
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Sabino, Ester Cerdeira/0000-0003-2623-5126
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EURO SURVEILL, V19
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Centers for Disease Control and Prevention, 2016, AR WITH ZIK
   Centers for Disease Control and Prevention, 2016, CAS COUNTS US
   Centers for Disease Control and Prevention (CDC), 2016, PREGN OUTC US DISTR
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   ECDC, 2016, ZIK VIR SAF SUBST HU
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galel S, 2016, TRANSFUSION, V57
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Jayakumar P, 2016, SOUTH MED J, V109, P697, DOI 10.14423/SMJ.0000000000000550
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   US Food and Drug Administration, EM US AUTH
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Weiner E, 2016, 2016 AABB ANN M OCT
   WHO, 2016, MAINT SAF AD BLOOD S
   Williamson P, 2016, TRANSFUSION, V57
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 51
TC 20
Z9 20
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 734
EP 747
DI 10.1111/trf.14031
PN 2
PG 14
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000003
PM 28194799
OA Bronze
DA 2020-07-08
ER

PT J
AU Farcet, MR
   Kreil, TR
AF Farcet, Maria R.
   Kreil, Thomas R.
TI Zika virus is not thermostable: very effective virus inactivation during
   heat treatment (pasteurization) of human serum albumin
SO TRANSFUSION
LA English
DT Article
ID WEST-NILE-VIRUS; BLOOD-TRANSFUSION; PLASMA PRODUCTS; SAFETY;
   TRANSMISSION; HEMISPHERE; OUTBREAK; STATES
AB BACKGROUND The ongoing Zika virus (ZIKV) outbreak in the Americas has also raised concerns around the potential for ZIKV transmission via blood products. Plasma-derived products are considered safe, because effective viral-inactivation and removal methods are implemented in their manufacturing processes. However, a recent study has indicated that ZIKV is thermally stable compared with the closely related Dengue virus, thus raising the question of whether heat treatments, as embedded in the manufacturing of plasma-derived products, are as effective against ZIKV as was previously shown for other Flaviviruses. Therefore, the sensitivity of ZIKV to heat inactivation was investigated using the pasteurization of human serum albumin (HSA) as an example.
   STUDY DESIGN AND METHODS Heat treatment (58.01.0 degrees C for 59010 minutes) of HSA was investigated for the capacity to reduce ZIKV in two different protein concentrations (5% and 25% HSA). The results were compared with data obtained in identical set-ups for the closely related West Nile virus, tick-borne encephalitis virus, and bovine viral diarrhea virus.
   RESULTS Heat treatment of HSA inactivated ZIKV to below the limit of detection already during the heating phase to 57.0 degrees C, that is, even before the 10-hour incubation at 58.0 +/- 1.0 degrees C commenced. For West Nile virus, bovine viral diarrhea virus, and tick-borne encephalitis virus, incubations up to 180 minutes were required to achieve inactivation to below the limit of detection.
   CONCLUSION ZIKV was more sensitive to heat treatment than other members of the Flaviviridae and thus does not pose a concern for plasma products that include a heat treatment in their manufacturing process.
C1 [Farcet, Maria R.; Kreil, Thomas R.] Global Pathogen Safety, Benatzkygasse 2-6, A-1221 Vienna, Austria.
RP Kreil, TR (corresponding author), Global Pathogen Safety, Benatzkygasse 2-6, A-1221 Vienna, Austria.
EM thomas.kreil@shire.com
CR AABB SmartBrief, 2016, ZIK VIR STRUCT REM S
   [Anonymous], 2015, TRANSF ASS ZIK VIR R
   [Anonymous], RAP RISK ASS ZIK VIR
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Medicines Agency Committee for Proprietary Medicinal Products (CPMP), 1996, CPMPBWP26895REV EUR
   Farcet MR, 2012, TRANSFUSION, V52, P181, DOI 10.1111/j.1537-2995.2011.03251.x
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kreil TR, 2007, TRANSFUSION, V47, P452, DOI 10.1111/j.1537-2995.2007.01135.x
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leydold SM, 2012, TRANSFUSION, V52, P2122, DOI 10.1111/j.1537-2995.2012.03565.x
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Remington KM, 2004, VOX SANG, V87, P10, DOI 10.1111/j.1423-0410.2004.00530.x
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Xie YW, 2008, TRANSFUSION, V48, P1342, DOI 10.1111/j.1537-2995.2008.01647.x
NR 24
TC 4
Z9 5
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2017
VL 57
IS 3
SI SI
BP 797
EP 801
DI 10.1111/trf.13953
PN 2
PG 5
WC Hematology
SC Hematology
GA ER1ZZ
UT WOS:000398595000009
PM 27987206
DA 2020-07-08
ER

PT J
AU de Magalhaes-Barbosa, MC
   Prata-Barbosa, A
   Robaina, JR
   Raymundo, CE
   Lima-Setta, F
AF de Magalhaes-Barbosa, Maria Clara
   Prata-Barbosa, Arnaldo
   Robaina, Jaqueline Rodrigues
   Raymundo, Carlos Eduardo
   Lima-Setta, Fernanda
TI New trends of the microcephaly and Zika virus outbreak in Brazil, July
   2016-December 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
C1 [de Magalhaes-Barbosa, Maria Clara; Prata-Barbosa, Arnaldo; Robaina, Jaqueline Rodrigues; Raymundo, Carlos Eduardo; Lima-Setta, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Dept Pediat, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo; Lima-Setta, Fernanda] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Cidade Univ,Rua Bruno Lobo,50, BR-21941612 Rio De Janeiro, Brazil.
RP de Magalhaes-Barbosa, MC (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM mariaclaramb@globo.com; arnaldoprata@globo.com; jaque.robaina@gmail.com;
   caducer@gmail.com; felimasetta@gmail.com
RI Prata-Barbosa, Arnaldo/B-2212-2009
OI Prata-Barbosa, Arnaldo/0000-0002-4726-9782; de Magalhaes-Barbosa, Maria
   Clara/0000-0003-0959-0775
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Brasil Ministerio da Saude, 2016, MON CAS MICR BRAS IN
   Brasil Ministerio da Saude, BRAS MIN SAUD B EP
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 7
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAR-APR
PY 2017
VL 16
BP 52
EP 57
DI 10.1016/j.tmaid.2017.03.009
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EU6DW
UT WOS:000401125200011
PM 28342826
DA 2020-07-08
ER

PT J
AU Fong, CY
   Biswas, A
   Stunkel, W
   Chong, YS
   Bongso, A
AF Fong, Chui-Yee
   Biswas, Arijit
   Stunkel, Walter
   Chong, Yap-Seng
   Bongso, Ariff
TI Tissues Derived From Reprogrammed Wharton's Jelly Stem Cells of the
   Umbilical Cord Provide an Ideal Platform to Study the Effects of
   Glucose, Zika Virus, and Other Agents on the Fetus
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE FETAL TISSUES; GESTATIONAL DIABETES MELLITUS; REPROGRAMMING; UMBILICAL
   CORD; WHARTON'S JELLY STEM CELLS; ZIKA VIRUS
ID GESTATIONAL DIABETES-MELLITUS; FREE CULTURE-CONDITIONS; MESENCHYMAL
   STEM; IN-VITRO; STROMAL CELLS; BIRTH-WEIGHT; DIFFERENTIATION; BLOOD;
   MATRIX; PROLIFERATION
AB The infants of mothers with gestational diabetes mellitus (GDM) have an increased risk of metabolic and cardiovascular disease. It has been difficult to study the direct effects of maternal hyperglycemia on the fetus because of inaccessibility of fetal tissues. The development of tissues that simulate the function of fetal organs using stem cell technology provides an unprecedented opportunity to study this disorder. Stem cells in the Wharton's jelly of the umbilical cord (hWJSCs), possess unique properties that are different from other stem cells. They are primitive, present in large numbers, non-tumorigenic, hypoimmunogenic, tumoricidal, and carry a genetic signature that represents the fetus. They are multipotent but their differentiation into functional pancreatic and cardiovascular tissues has been challenging. We have been able to reprogram hWJSCs from normal and GDM cords into induced pluripotent stem cells (iPSCs) from which a variety of functional fetal tissues including insulin-producing and cardiovascular tissues could be derived. Such tissues from reprogrammed hWJSCs of normal and GDM cords that physiologically and genetically mimic the fetus of the diabetic or non-diabetic mother are an ideal platform to study the effects of glucose, the Zika virus, and other harmful agents on the fetus. The immature stemness phenotype of hWJSCs, easy accessibility, availability in large numbers without the need for propagation, and lower risk of accumulation of epigenetic mutations make them the most attractive candidate over other umbilical cord cell types for reprogramming. Additionally, some of their beneficial genes may be retained in memory in the iPSCs derived from them. J. Cell. Biochem. 118: 437-441, 2017. (c) 2016 Wiley Periodicals, Inc.
C1 [Fong, Chui-Yee; Biswas, Arijit; Chong, Yap-Seng; Bongso, Ariff] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Obstet & Gynaecol, Singapore, Singapore.
   [Stunkel, Walter; Chong, Yap-Seng] Singapore Inst Clin Sci, Singapore, Singapore.
RP Bongso, A (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, 1E Kent Ridge Rd,NUHS Tower Block,Level 12, Singapore 119228, Singapore.
EM obgbongs@nus.edu.sg
OI BISWAS, ARIJIT/0000-0002-3311-2135; Chong, Yap Seng/0000-0002-7232-8473
FU National University Health System (NUHS); Aspiration Fund
   [R-174-000-156-720, R-174-000-155-720]
FX Grant sponsor: National University Health System (NUHS); Grant sponsor:
   Aspiration Fund (Partner and New Idea categories); Grant numbers:
   R-174-000-156-720, R-174-000-155-720.
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Ayuzawa R, 2009, CANCER LETT, V280, P31, DOI 10.1016/j.canlet.2009.02.011
   Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709
   Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034
   Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808
   Bongso A, 2011, STEM CELLS BENCH BED
   Bongso A, 2013, STEM CELL REV REP, V9, P226, DOI 10.1007/s12015-012-9418-z
   Bradley RJ., 1989, CURRENT REV OBSTETRI
   BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248
   Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451
   Chao KC, 2012, J CELL MOL MED, V16, P1803, DOI 10.1111/j.1582-4934.2011.01459.x
   Conconi M. T., 2011, OPEN TISSUE ENG REGE, V4, P6, DOI DOI 10.2174/1875043501104010006
   Conconi MT, 2006, INT J MOL MED, V18, P1089
   Corotchi MC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt232
   Fan CG, 2011, STEM CELL REV REP, V7, P195, DOI 10.1007/s12015-010-9168-8
   Fong CY, 2007, REPROD BIOMED ONLINE, V15, P708, DOI 10.1016/S1472-6483(10)60539-1
   Fong CY, 2012, STEM CELL REV REP, V8, P195, DOI 10.1007/s12015-011-9289-8
   Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x
   Fong CY, 2010, REPROD BIOMED ONLINE, V21, P391, DOI 10.1016/j.rbmo.2010.04.010
   Fonseka M, 2012, CELL BIOL INT, V36, P793, DOI 10.1042/CBI20110595
   Gauthaman K, 2011, TISSUE ENG PT A, V17, P71, DOI [10.1089/ten.tea.2010.0224, 10.1089/ten.TEA.2010.0224]
   Gauthaman K, 2012, REPROD BIOMED ONLINE, V24, P235, DOI 10.1016/j.rbmo.2011.10.007
   Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221
   Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471
   Hatlapatka T, 2011, TISSUE ENG PART C-ME, V17, P485, DOI [10.1089/ten.tec.2010.0406, 10.1089/ten.TEC.2010.0406]
   Holemans K, 2003, J PHYSIOL-LONDON, V547, P11, DOI 10.1113/jphysiol.2002.036582
   Hollweck T, 2011, OPEN TISSUE ENG REGE, V4, P95
   Joseph R, 2015, MOL ENDOCRINOL, V29, P909, DOI 10.1210/me.2015-1020
   Kim J, 2015, STEM CELLS DEV, V24, P575, DOI 10.1089/scd.2014.0349
   Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342
   La Rocca G, 2009, HISTOCHEM CELL BIOL, V131, P267, DOI 10.1007/s00418-008-0519-3
   Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001
   Liang XJ, 2012, CELL BIOL INT, V36, P215, DOI 10.1042/CBI20110350
   Lin HD, 2016, J CELL BIOCHEM, V117, P2045, DOI 10.1002/jcb.25501
   Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062844
   Lv YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-196
   Ma Y, 2012, BREAST CANCER RES TR, V133, P473, DOI 10.1007/s10549-011-1774-x
   Messerli M, 2013, REPROD SCI, V20, P1455, DOI 10.1177/1933719113488443
   Nold JL, 2004, PEDIATR CLIN N AM, V51, P619, DOI 10.1016/j.pcl.2004.01.003
   Obershain SS, 1970, NEW ENGL J MED, V283, P566
   PEDERSEN J, 1977, PREGNANT DIABETIC HE
   Pera MF, 2009, NATURE, V458, P715, DOI 10.1038/458715a
   Schoenwolf GC, 2015, LARSENS HUMAN EMBRYO
   SCHWARTZ R, 1994, DIABETES CARE, V17, P640, DOI 10.2337/diacare.17.7.640
   Shi M, 2012, STEM CELL TRANSL MED, V1, P725, DOI 10.5966/sctm.2012-0034
   Subramanian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127992
   Sukarieh R, 2014, HUM REPROD, V29, P2287, DOI 10.1093/humrep/deu209
   Sun B, 2010, CANCER LETT, V296, P178, DOI 10.1016/j.canlet.2010.04.007
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439
   Wajid N, 2015, CELL TISSUE BANK, V16, P389, DOI 10.1007/s10561-014-9483-4
   Wang XY, 2008, BLOOD, V111, P2436, DOI 10.1182/blood-2007-07-099333
   Wang YW, 2012, STEM CELLS DEV, V21, P1401, DOI 10.1089/scd.2011.0441
   Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028
   Wu KH, 2013, CELL TRANSPLANT, V22, P2041, DOI 10.3727/096368912X663533
   Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366
   Yang HT, 2013, J CELL MOL MED, V17, P1096, DOI 10.1111/jcmm.12095
   Zeddou M, 2010, CELL BIOL INT, V34, P693, DOI 10.1042/CBI20090414
NR 59
TC 0
Z9 0
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD MAR
PY 2017
VL 118
IS 3
BP 437
EP 441
DI 10.1002/jcb.25733
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EI4VR
UT WOS:000392492200001
PM 27617437
DA 2020-07-08
ER

PT J
AU Kim, SY
   Zhao, J
   Liu, XY
   Fraser, K
   Lin, L
   Zhang, X
   Zhang, FM
   Dordick, JS
   Linhardt, RJ
AF Kim, So Young
   Zhao, Jing
   Liu, Xinyue
   Fraser, Keith
   Lin, Lei
   Zhang, Xing
   Zhang, Fuming
   Dordick, Jonathan S.
   Linhardt, Robert J.
TI Interaction of Zika Virus Envelope Protein with Glycosaminoglycans
SO BIOCHEMISTRY
LA English
DT Article
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; DENGUE-VIRUS;
   HEPARAN-SULFATE; DC-SIGN; INFECTION; BINDING; RECEPTOR; FEVER; ENTRY
AB In February 2016, the World Health Organization declared a Public Health Emergency of International Concern on Zika Virus (ZIKV), because of its association with severe fetal anomalies of congenitally infected humans. This has led to urgent efforts by academic, federal, and industry research groups to improve our understanding of the pathogenesis of ZIKV and to develop detection methods, therapeutic strategies, and vaccines. Although we still do not have the entire picture of the pathogenesis of ZIKV, extensive research has been conducted on related pathogenic flaviviruses (i.e., dengue virus, West Nile virus, and yellow fever virus). Binding to glycosaminoglycans (GAGs) through its envelope protein is the first step in successful host cell invasion of dengue virus. In this study, we examined ZIKV envelope protein (ZIKV E) binding to GAGs in a real time interaction study using surface plasmon resonance (SPR) to explore the role of GAGs in host cell entry of ZIKV into placenta and brain. ZIKV E strongly binds (KD = 443 nM) pharmaceutical heparin (HP), a highly sulfated GAG, and binds with lower avidity to less sulfated GAGs, suggesting that the ZIKV E-GAG interaction may be electrostatically driven. Using SPR competition assays with various chain length HP oligosaccharides (from 4 to 18 saccharide units in length), we observed that ZIKV E preferentially binds to longer HP oligosaccharides (with 8-18 saccharides). Next, we examined GAGs prepared from human placentas to determine if they bound ZIKV E, possibly mediating placental cell invasion of ZIKV. Compositional analysis of these GAGs as well as SPR binding studies showed that both chondroitin sulfate and heparan sulfate GAGs, present on the placenta, showed low-micromolar interactions with ZIKV E. Both porcine brain CS and HS also showed micromolar binding with ZIKV E. Moreover, heparan sulfate with a higher TriS content, the dominant repeating unit of HP, shows a high affinity for ZIKV E. These results suggest that GAGs may be utilized as attachment factors for host cell entry of Zika virus as they do in other pathogenic flaviviruses. They may also assist us in advancing our understanding of the pathogenesis of ZIKV and guide us in designing therapeutics to combat ZIKV with more insight.
C1 [Kim, So Young; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Biochem & Biophys Grad Program, Troy, NY 12180 USA.
   [Zhao, Jing; Liu, Xinyue; Lin, Lei; Zhang, Xing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA.
   [Fraser, Keith; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Zhang, Fuming; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA.
   [Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Zhang, FM; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
EM zhangf2@rpi.edu; linhar@rpi.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HL094463, HL62244,
   N5088496]
FX This research was funded through National Institutes of Health Grants
   HL094463, HL62244, and N5088496.
CR [Anonymous], 2016, PREGN WOM AN LAB EV
   [Anonymous], 2016, WORLD HLTH REP INS B
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   ASCENCIO F, 1993, J MED MICROBIOL, V38, P240, DOI 10.1099/00222615-38-4-240
   Beaudet JM, 2014, GLYCOCONJUGATE J, V31, P109, DOI 10.1007/s10719-013-9506-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen HL, 2010, BIOPOLYMERS, V94, P331, DOI 10.1002/bip.21371
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Day YSN, 2002, PROTEIN SCI, V11, P1017, DOI 10.1110/ps.4330102
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   HOLZMANN H, 1990, J VIROL, V64, P5156, DOI 10.1128/JVI.64.10.5156-5159.1990
   ISHAK R, 1988, J GEN VIROL, V69, P325, DOI 10.1099/0022-1317-69-2-325
   JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512
   Jenssen H, 2008, ANTIVIR RES, V79, P192, DOI 10.1016/j.antiviral.2008.03.004
   JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Kamhi E, 2013, BIOL REV, V88, P928, DOI 10.1111/brv.12034
   Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026
   Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5
   Liu ZL, 2010, BIOCHEMISTRY-US, V49, P9839, DOI 10.1021/bi101305b
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Mendoza MY, 2002, AM J TROP MED HYG, V67, P76, DOI 10.4269/ajtmh.2002.67.76
   Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0
   PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167
   PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Roze B, 2016, EUROSURVEILLANCE, V21, P1
   Sanchez IJ, 1996, J GEN VIROL, V77, P2541, DOI 10.1099/0022-1317-77-10-2541
   Sarkar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141127
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Weyers A., 2013, FEBS J, V280
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Yachdav G, 2016, BIOINFORMATICS, V32, P3501, DOI 10.1093/bioinformatics/btw474
   Zhang FM, 2009, BIOCHEMISTRY-US, V48, P8379, DOI 10.1021/bi9006379
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 88
TC 40
Z9 40
U1 7
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 28
PY 2017
VL 56
IS 8
BP 1151
EP 1162
DI 10.1021/acs.biochem.6b01056
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EM5OK
UT WOS:000395361000014
PM 28151637
DA 2020-07-08
ER

PT J
AU Crawford, JE
   Alves, JM
   Palmer, WJ
   Day, JP
   Sylla, M
   Ramasamy, R
   Surendran, SN
   Black, WC
   Pain, A
   Jiggins, FM
AF Crawford, Jacob E.
   Alves, Joel M.
   Palmer, William J.
   Day, Jonathan P.
   Sylla, Massamba
   Ramasamy, Ranjan
   Surendran, Sinnathamby N.
   Black, William C.
   Pain, Arnab
   Jiggins, Francis M.
TI Population genomics reveals that an anthropophilic population of Aedes
   aegypti mosquitoes in West Africa recently gave rise to American and
   Asian populations of this major disease vector
SO BMC BIOLOGY
LA English
DT Article
DE Aedes aegypti; Anthropophilic; Dengue virus; Zika virus; Arboviral
   diseases; Mosquito evolution; Vector-borne diseases
ID YELLOW-FEVER; DENGUE; EVOLUTION; GENETICS; SEQUENCE; BEHAVIOR; SPREAD;
   DNA; MITOCHONDRIAL; PATTERNS
AB Background: The mosquito Aedes aegypti is the main vector of dengue, Zika, chikungunya and yellow fever viruses. This major disease vector is thought to have arisen when the African subspecies Ae. aegypti formosus evolved from being zoophilic and living in forest habitats into a form that specialises on humans and resides near human population centres. The resulting domestic subspecies, Ae. aegypti aegypti, is found throughout the tropics and largely blood-feeds on humans.
   Results: To understand this transition, we have sequenced the exomes of mosquitoes collected from five populations from around the world. We found that Ae. aegypti specimens from an urban population in Senegal in West Africa were more closely related to populations in Mexico and Sri Lanka than they were to a nearby forest population. We estimate that the populations in Senegal and Mexico split just a few hundred years ago, and we found no evidence of Ae. aegypti aegypti mosquitoes migrating back to Africa from elsewhere in the tropics. The out-of-Africa migration was accompanied by a dramatic reduction in effective population size, resulting in a loss of genetic diversity and rare genetic variants.
   Conclusions: We conclude that a domestic population of Ae. aegypti in Senegal and domestic populations on other continents are more closely related to each other than to other African populations. This suggests that an ancestral population of Ae. aegypti evolved to become a human specialist in Africa, giving rise to the subspecies Ae. aegypti aegypti. The descendants of this population are still found in West Africa today, and the rest of the world was colonised when mosquitoes from this population migrated out of Africa. This is the first report of an African population of Ae. aegypti aegypti mosquitoes that is closely related to Asian and American populations. As the two subspecies differ in their ability to vector disease, their existence side by side in West Africa may have important implications for disease transmission.
C1 [Crawford, Jacob E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
   [Crawford, Jacob E.] Verily Life Sci, San Francisco, CA 94080 USA.
   [Alves, Joel M.; Palmer, William J.; Day, Jonathan P.; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.
   [Alves, Joel M.] Univ Porto, Ctr Invest & Biodiversidade & Recursos Genet, InBIO, CIBIO, Campus Agr Vairao, P-4485661 Vairao, Portugal.
   [Black, William C.] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA.
   [Ramasamy, Ranjan; Surendran, Sinnathamby N.] ID FISH Technol, Palo Alto, CA 94303 USA.
   [Surendran, Sinnathamby N.] Univ Jaffna, Dept Zool, Jaffna, Sri Lanka.
   [Surendran, Sinnathamby N.] KAUST, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia.
RP Jiggins, FM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.
EM fmj1001@cam.ac.uk
RI Ramasamy, Ranjan/AAF-3921-2020; Alves, Joel/L-8007-2013; Pain,
   Arnab/L-5766-2015
OI Ramasamy, Ranjan/0000-0003-0246-7053; Crawford,
   Jacob/0000-0002-6745-9145; Alves, Joel/0000-0001-6138-9134; Jiggins,
   Francis Michael/0000-0001-7470-8157; Pain, Arnab/0000-0002-1755-2819
FU European Research Council grant Drosophila Infection [281668]; KAUST AEA
   award; Medical Research Council Centenary Award; National Institutes of
   Health Ruth L. Kirschstein National Research Service AwardUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA
FX This work was funded by European Research Council grant Drosophila
   Infection 281668 to FMJ, a KAUST AEA award to FMJ and AP, a Medical
   Research Council Centenary Award to WJP and a National Institutes of
   Health Ruth L. Kirschstein National Research Service Award to JC.
CR Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Arya GH, 2015, CHEM SENSES, V40, P233, DOI 10.1093/chemse/bjv001
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330
   Dickson LB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004626
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Droop AP, 2016, BIOINFORMATICS, V32, P1883, DOI 10.1093/bioinformatics/btw088
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905
   Falush D, 2016, BIORXIV
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a
   Fumagalli M, 2014, BIOINFORMATICS, V30, P1486, DOI 10.1093/bioinformatics/btu041
   Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056
   Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109
   Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014
   Li H., 2013, ALIGNING SEQUENCE RE, P3
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299
   Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131
   MARUYAMA T, 1985, GENETICS, V111, P675
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686
   MOORE DF, 1979, J MED ENTOMOL, V16, P223, DOI 10.1093/jmedent/16.3.223
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   R Core Team, 2015, R LANG ENV STAT COMP
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365
   Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Sylla M, 2013, J VECTOR ECOL, V38, P237, DOI 10.1111/j.1948-7134.2013.12036.x
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   TAJIMA F, 1989, GENETICS, V123, P585
   Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x
   TRPIS M, 1978, B ENTOMOL RES, V68, P521, DOI 10.1017/S0007485300009494
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371
NR 67
TC 25
Z9 27
U1 2
U2 29
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD FEB 28
PY 2017
VL 15
AR 16
DI 10.1186/s12915-017-0351-0
PG 16
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EM7HO
UT WOS:000395482300001
PM 28241828
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cortese, M
   Goellner, S
   Acosta, EG
   Neufeldt, CJ
   Oleksiuk, O
   Lampe, M
   Haselmann, U
   Funaya, C
   Schieber, N
   Ronchi, P
   Schorb, M
   Pruunsild, P
   Schwab, Y
   Chatel-Chaix, L
   Ruggieri, A
   Bartenschlager, R
AF Cortese, Mirko
   Goellner, Sarah
   Acosta, Eliana Gisela
   Neufeldt, Christopher John
   Oleksiuk, Olga
   Lampe, Marko
   Haselmann, Uta
   Funaya, Charlotta
   Schieber, Nicole
   Ronchi, Paolo
   Schorb, Martin
   Pruunsild, Priit
   Schwab, Yannick
   Chatel-Chaix, Laurent
   Ruggieri, Alessia
   Bartenschlager, Ralf
TI Ultrastructural Characterization of Zika Virus Replication Factories
SO CELL REPORTS
LA English
DT Article
ID DENGUE VIRUS; 3-DIMENSIONAL ARCHITECTURE; FLAVIVIRUS INFECTION; NEURAL
   PROGENITORS; NS3 PROTEIN; CELLS; MICROTUBULES; VIMENTIN; SITES; MICE
AB A global concern has emerged with the pandemic spread of Zika virus (ZIKV) infections that can cause severe neurological symptoms in adults and new-borns. ZIKV is a positive-strand RNA virus replicating in virus-induced membranous replication factories (RFs). Here we used various imaging techniques to investigate the ultrastructural details of ZIKV RFs and their relationship with host cell organelles. Analyses of human hepatic cells and neural progenitor cells infected with ZIKV revealed endoplasmic reticulum (ER) membrane invaginations containing pore-like openings toward the cytosol, reminiscent to RFs in Dengue virus-infected cells. Both the MR766 African strain and the H/PF/2013 Asian strain, the latter linked to neurological diseases, induce RFs of similar architecture. Importantly, ZIKV infection causes a drastic reorganization of microtubules and intermediate filaments forming cage-like structures surrounding the viral RF. Consistently, ZIKV replication is suppressed by cytoskeleton-targeting drugs. Thus, ZIKV RFs are tightly linked to rearrangements of the host cell cytoskeleton.
C1 [Cortese, Mirko; Goellner, Sarah; Acosta, Eliana Gisela; Neufeldt, Christopher John; Oleksiuk, Olga; Haselmann, Uta; Chatel-Chaix, Laurent; Ruggieri, Alessia; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany.
   [Lampe, Marko] European Mol Biol Lab, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany.
   [Funaya, Charlotta] Heidelberg Univ, Electron Microscopy Core Facil, D-69120 Heidelberg, Germany.
   [Schieber, Nicole; Schwab, Yannick] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.
   [Ronchi, Paolo; Schorb, Martin; Schwab, Yannick] European Mol Biol Lab, Electron Microscopy Core Facil, D-69117 Heidelberg, Germany.
   [Pruunsild, Priit] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, D-69120 Heidelberg, Germany.
   [Chatel-Chaix, Laurent] Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ H7V 1B7, Canada.
   [Bartenschlager, Ralf] Heidelberg Univ, German Ctr Infect Res DZIF, D-69120 Heidelberg, Germany.
RP Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany.; Bartenschlager, R (corresponding author), Heidelberg Univ, German Ctr Infect Res DZIF, D-69120 Heidelberg, Germany.
EM ralf.bartenschlager@med.uni-heidelberg.de
RI Ronchi, Paolo/AAC-5008-2019; Bartenschlager, Ralf/L-2582-2015; Ronchi,
   Paolo/A-6689-2013; Neufeldt, Christopher/AAD-1702-2019
OI Bartenschlager, Ralf/0000-0001-5601-9307; Neufeldt,
   Christopher/0000-0002-4551-1811; Ronchi, Paolo/0000-0001-9010-533X;
   Schorb, Martin/0000-0003-4910-1868; Oleksiuk, Olga/0000-0002-6100-107X;
   Lampe, Marko/0000-0002-4510-9048; Goellner, Sarah/0000-0002-3300-4273;
   Ruggieri, Alessia/0000-0001-9981-3308; Cortese,
   Mirko/0000-0003-1786-4211
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [RGPIN-201605584];
   European Molecular Biology Organization (EMBO)European Molecular Biology
   Organization (EMBO) [ALTF 466-2016]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 1129];
   Excellence Cluster Cell Networks at Heidelberg University
FX We gratefully acknowledge the expert support provided by the Electron
   Microscopy Core Facility at Heidelberg University, the Flow Cytometry
   and FACS Core Facility of the Center for Molecular Biology of Heidelberg
   University (ZMBH), and the Electron Microscopy Core Facility at the
   European Molecular Biology Laboratory (EMBL) Heidelberg. We thank the
   Advanced Light Micro-scopy Facility (ALMF) at the European Molecular
   Biology Laboratory (EMBL) and Leica Microsystems for support. We are
   grateful to Dr. Vibor Laketa and the Infectious Diseases Imaging
   Platform (IDIP) at the Department of Infectious Diseases, University
   Hospital Heidelberg, for the excellent microscopy support. We are
   grateful to Hilmar Bading, in whose laboratory the hNPCs were generated,
   to Dr. Gualtiero Alvisi for constructing the YFP-Sec61b-encoding
   plasmid, and to the European Virus Archive (EVAg) for provision of ZIKV
   strains. We are very grateful to Philipp Klein for support in cell
   sorting and live-cell imaging. We thank Thais Moraes for virus stock
   production. This work was supported by grants from the Deutsche
   Forschungsgemeinschaft (SFB 1129 to R.B and A. R). L.C.-C. holds a
   Discovery Grant from the Natural Sciences and Engineering Research
   Council of Canada (RGPIN-201605584). P.P. holds a fellowship by the
   Excellence Cluster Cell Networks at Heidelberg University. C.J.N is
   funded by a European Molecular Biology Organization (EMBO) Long-Term
   Fellowship (ALTF 466-2016).
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen W, 2008, ARCH VIROL, V153, P1777, DOI 10.1007/s00705-008-0183-x
   Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0
   Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elder GA, 1999, J CELL BIOL, V146, P181
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Maier HJ, 2013, MBIO, V4, DOI 10.1128/mBio.00801-13
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877
   Neufeldt CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005428
   NG ML, 1989, ARCH VIROL, V106, P103, DOI 10.1007/BF01311042
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011
   Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
NR 42
TC 91
Z9 92
U1 2
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 28
PY 2017
VL 18
IS 9
BP 2113
EP 2123
DI 10.1016/j.celrep.2017.02.014
PG 11
WC Cell Biology
SC Cell Biology
GA EP4CO
UT WOS:000397328400006
PM 28249158
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Evans, MV
   Dallas, TA
   Han, BA
   Murdock, CC
   Drake, JM
AF Evans, Michelle V.
   Dallas, Tad A.
   Han, Barbara A.
   Murdock, Courtney C.
   Drake, John M.
TI Data-driven identification of potential Zika virus vectors
SO ELIFE
LA English
DT Article
ID WEST-NILE-VIRUS; MOSQUITOS DIPTERA-CULICIDAE; HOST-FEEDING PATTERNS;
   EQUINE-ENCEPHALITIS-VIRUS; RIFT-VALLEY FEVER; CULEX-TRITAENIORHYNCHUS
   DIPTERA; AEDES SOLLICITANS WALKER; ANOPHELES HYRCANUS GROUP; SHERTALLAI
   KERALA STATE; PRESENCE-ONLY DATA
AB Zika is an emerging virus whose rapid spread is of great public health concern. Knowledge about transmission remains incomplete, especially concerning potential transmission in geographic areas in which it has not yet been introduced. To identify unknown vectors of Zika, we developed a data-driven model linking vector species and the Zika virus via vector-virus trait combinations that confer a propensity toward associations in an ecological network connecting flaviviruses and their mosquito vectors. Our model predicts that thirty-five species may be able to transmit the virus, seven of which are found in the continental United States, including Culex quinquefasciatus and Cx. pipiens. We suggest that empirical studies prioritize these species to confirm predictions of vector competence, enabling the correct identification of populations at risk for transmission within the United States.
C1 [Evans, Michelle V.; Dallas, Tad A.; Murdock, Courtney C.; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Evans, Michelle V.; Murdock, Courtney C.; Drake, John M.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Dallas, Tad A.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA USA.
   [Han, Barbara A.] Cary Inst Ecosyst Studies, Millbrook, NY USA.
   [Murdock, Courtney C.] Univ Georgia, Ctr Trop Emerging Global Dis, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
   [Murdock, Courtney C.; Drake, John M.] Univ Georgia, River Basin Ctr, Athens, GA 30602 USA.
RP Evans, MV (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.; Evans, MV (corresponding author), Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
EM mvevans@uga.edu
RI Dallas, Tad/H-5577-2019; Evans, Michelle V./S-1027-2019; Han,
   Barbara/H-9363-2015
OI Dallas, Tad/0000-0003-3328-9958; Evans, Michelle V./0000-0002-5628-0502;
   Han, Barbara/0000-0002-9948-3078
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1640780]; University of Georgia Presidential Fellowship; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01GM110744]
FX National Science Foundation DEB-1640780 Courtney C Murdock; University
   of Georgia Presidential Fellowship Michelle V Evans; National Institutes
   of Health U01GM110744 John M Drake; The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Adebote A. David, 2006, Journal of Entomology, V3, P180
   AITKEN THG, 1959, AM J TROP MED HYG, V8, P41, DOI 10.4269/ajtmh.1959.8.41
   Al-Sheik Adel A., 2011, Journal of the Egyptian Society of Parasitology, V41, P615
   Aldemir A, 2010, J MED ENTOMOL, V47, P22, DOI 10.1603/033.047.0103
   Alencar J, 2005, J MED ENTOMOL, V42, P981, DOI 10.1603/0022-2585(2005)042[0981:FPOHJD]2.0.CO;2
   Alencar J, 2008, J MED ENTOMOL, V45, P873, DOI 10.1603/0022-2585(2008)45[873:FPOHCA]2.0.CO;2
   Alfonzo D, 2005, J MED ENTOMOL, V42, P278, DOI 10.1603/0022-2585(2005)042[0278:ECOTAH]2.0.CO;2
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Amerasinghe F. P., 1994, Journal of the National Science Council of Sri Lanka, V22, P279
   AMERASINGHE FP, 1995, TROP ZOOL, V8, P43, DOI 10.1080/03946975.1995.10539271
   Ammar Sherif E, 2012, J Egypt Soc Parasitol, V42, P191
   Anderson JF, 2007, J MED ENTOMOL, V44, P1102, DOI 10.1603/0022-2585(2007)44[1102:NAOMDC]2.0.CO;2
   Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360
   Anonymous, 2005, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P4
   Apperson CS, 2002, J MED ENTOMOL, V39, P777, DOI 10.1603/0022-2585-39.5.777
   ARNELL J H, 1973, Contributions of the American Entomological Institute, V10, P1
   Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2
   Bagirov G A, 1994, Med Parazitol (Mosk), P39
   Barker CM, 2009, J VECTOR ECOL, V34, P276, DOI [10.3376/038.034.0214, 10.1111/j.1948-7134.2009.00036.x]
   Barnett HC, 1962, P 11 INT C ENT, P341
   Bashar K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-39
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   BECKER G, 1983, Zeitschrift fuer Angewandte Zoologie, V70, P73
   BEGUM A, 1986, Bangladesh Journal of Zoology, V14, P41
   Belton P, 1979, J ENTOMOLOGICAL SOC, V75
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bennett KL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004250
   Beran GW, 1994, HDB ZOONOSES
   Bhattacharyya D. R., 1994, Journal of Communicable Diseases, V26, P133
   Bohart R. M., 1946, MOSQUITOES OKINAWA I
   BOORMAN J. P. T., 1961, BULL ENTOMOL RES, V52, P709, DOI 10.1017/S0007485300055723
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOREHAM PFL, 1975, B ENTOMOL RES, V65, P69, DOI 10.1017/S0007485300005770
   Bosak PJ, 2001, J VECTOR ECOL, V26, P103
   Bousses P., 2013, Bulletin de la Societe de Pathologie Exotique, V106, P113, DOI 10.1007/s13149-013-0288-7
   Boxmeyer CE, 1999, J AM MOSQUITO CONTR, V15, P128
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brugman VA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1034-8
   Bueno-MariA R, 2015, EMERGING ZOONOSES EC
   Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P62
   Burkett-Cadena N. D, 2013, MOSQUITOES SE US
   Bustamante DM, 2010, AM J TROP MED HYG, V82, P1172, DOI 10.4269/ajtmh.2010.09-0323
   CALLAHAN JL, 1987, J AM MOSQUITO CONTR, V3, P176
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CAA, 2015, ANN ENTOMOL SOC AM, V108, P449, DOI 10.1093/aesa/sav040
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Carpenter S. J, 1974, MOSQUITOES N AM N ME
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   CHADEE D D, 1985, Mosquito Systematics, V17, P147
   CHADEE DD, 1992, MED VET ENTOMOL, V6, P143, DOI 10.1111/j.1365-2915.1992.tb00592.x
   CHADEE DD, 1989, MED VET ENTOMOL, V3, P231, DOI 10.1111/j.1365-2915.1989.tb00221.x
   CHADEE DD, 1993, MED VET ENTOMOL, V7, P141, DOI 10.1111/j.1365-2915.1993.tb00667.x
   Chalvet-Monfray K, 2007, ECOL MODEL, V204, P540, DOI 10.1016/j.ecolmodel.2007.01.024
   Chambers T. J., 2003, FLAVIVIRUSES DETECTI
   CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X
   CHAPMAN H. C., 1960, ANN ENT SOC AMER, V53, P706, DOI 10.1093/aesa/53.6.706
   Chapman HF, 1999, MED VET ENTOMOL, V13, P423, DOI 10.1046/j.1365-2915.1999.00195.x
   Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3
   Chen CD, 2014, ASIAN BIOMED, V8, P315, DOI 10.5372/1905-7415.0803.295
   Chevalier V, 2004, MED VET ENTOMOL, V18, P247, DOI 10.1111/j.0269-283X.2004.00511.x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coggeshall LT, 1944, AM J PUBLIC HEALTH N, V34, P75, DOI 10.2105/AJPH.34.1.75
   COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144, DOI 10.1159/000150333
   Cook GC, 2009, MANSONS TROPICAL DIS
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Cooper RD, 2006, J AM MOSQUITO CONTR, V22, P213, DOI 10.2987/8756-971X(2006)22[213:TAFOPN]2.0.CO;2
   CORBET P S, 1962, East Afr Med J, V39, P511
   Crans WJ, 1996, J VECTOR ECOL, V21, P6
   Crans WJ, 1996, J VECTOR ECOL, V21, P1
   Crans WJ., 2016, NEW JERSEY MOSQUITO
   Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   DAVIES JB, 1978, B ENTOMOL RES, V68, P707, DOI 10.1017/S0007485300009664
   DAVIES JB, 1975, B ENTOMOL RES, V65, P81, DOI 10.1017/S0007485300005794
   Davis GE, 1931, AM J HYG, V14, P130, DOI 10.1093/oxfordjournals.aje.a117751
   Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111
   DEGALLIER N, 1978, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V16, P73
   DeGroote JP, 2012, VECTOR-BORNE ZOONOT, V12, P657, DOI 10.1089/vbz.2011.0786
   Derraik Jose G B, 2007, N Z Med J, V120, pU2830
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DIAGNE N, 1994, B SOC PATHOL EXOT, V87, P267
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Digoutte JP, 1999, B SOC PATHOL EXOT, V92, P343
   DOHERTY RL, 1964, AUST J EXP BIOL MED, V42, P149, DOI 10.1038/icb.1964.16
   DOUCET J., 1961, BULL SOC PATHOL EXOT, V54, P1253
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eastwood G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01519
   Ebel GD, 2005, J MED ENTOMOL, V42, P838, DOI 10.1603/0022-2585(2005)042[0838:CRDCRA]2.0.CO;2
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Ellis BR, 2007, VECTOR-BORNE ZOONOT, V7, P129, DOI 10.1089/vbz.2006.0561
   EVANS A. M., 1926, ANN TROP MED AND PARASITOL, V20, P97
   Fakoorziba MR, 2008, J ENTOMOL RES SOC, V10, P1
   Fall AG, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-99
   Fall AG, 2013, INT J ENV RES PUB HE, V10, P4718, DOI 10.3390/ijerph10104718
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feng LC., 1983, CHINESE MED J, V2, P503
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferro C, 2003, EMERG INFECT DIS, V9, P49
   FLEMINGS MILTON B., 1959, JOUR ECON ENT, V52, P490, DOI 10.1093/jee/52.3.490
   Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   FORATTINI OP, 1988, REV SAUDE PUBL, V22, P84, DOI 10.1590/S0034-89101988000200003
   Fornadel CM, 2011, VECTOR-BORNE ZOONOT, V11, P1173, DOI 10.1089/vbz.2010.0082
   Frances SP, 2002, J MED ENTOMOL, V39, P541, DOI 10.1603/0022-2585-39.3.541
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   FROHNE W. C., 1953, TRANS AMER MICROSC SOC, V72, P103, DOI 10.2307/3223507
   Fyodorova MV, 2006, J MED ENTOMOL, V43, P552, DOI 10.1603/0022-2585(2006)43[552:EOPWNV]2.0.CO;2
   GAD AM, 1995, J MED ENTOMOL, V32, P573, DOI 10.1093/jmedent/32.5.573
   GALINDO P, 1958, AM J TROP MED HYG, V7, P429, DOI 10.4269/ajtmh.1958.7.429
   GALINDO P, 1950, AM J TROP MED, V30, P533
   GALINDO P, 1951, AM J TROP MED, V31, P98
   Gamino V, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-65
   GEOFFROY B, 1987, Mosquito Systematics, V19, P100
   GERMAIN M, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P125
   Giberson Donna J., 2007, Journal of the Acadian Entomological Society, V3, P7
   Gillies M. T., 1968, S A Inst med Res Johannesburg Publ, VNo. 54, P1
   Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038
   Gomes AD, 2010, EPIDEMIOL SERV SAUDE, V19, P101
   Gomes B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-93
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   GRESSER I, 1958, AM J TROP MED HYG, V7, P365, DOI 10.4269/ajtmh.1958.7.365
   Grieco JP, 2006, J MED ENTOMOL, V43, P614, DOI 10.1603/0022-2585(2006)43[614:DOAAAV]2.0.CO;2
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Guimares AE, 2000, MEM I OSWALDO CRUZ, V95, P753, DOI 10.1590/S0074-02762000000600002
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow A. J., 1942, BULL ENT RES, V33, P91, DOI 10.1017/S0007485300026389
   HADDOW A. J., 1961, BULL ENTOMOL RES, V52, P317, DOI 10.1017/S0007485300055449
   HADDOW A. J., 1964, BULL ENTOMOL RES, V55, P589, DOI 10.1017/S0007485300049695
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HADDOW AJ, 1946, B ENTOMOL RES, V37, P57, DOI 10.1017/S0007485300021994
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2012, J MED ENTOMOL, V49, P371, DOI 10.1603/ME11148
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Han BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004815
   Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112
   HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P375
   Harbach R. E., 2015, MOSQUITO TAXONOMIC I
   Harbach RE, 2007, J AM MOSQUITO CONTR, V23, P224, DOI 10.2987/8756-971X(2007)23[224:UPMAAS]2.0.CO;2
   Harbach RE, 1988, RESEARCHGATE, V24, P1
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   HEARNDEN MN, 1995, J AM MOSQUITO CONTR, V11, P211
   HEINEMANN S J, 1980, Mosquito Systematics, V12, P179
   Herve JP, 1975, CAH ORSTOM EMP, V14, P235
   HERVY J-P, 1986, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V24, P59
   Hickman R, 2013, CULISETA MELANURA BI
   HOOGSTRAAL H, 1951, AM J TROP MED, V31, P659
   HOPKINS GHE, 1952, MOSQUITOES ETHIOPIAN
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214
   IWUALA MOE, 1981, ENVIRON ENTOMOL, V10, P592, DOI 10.1093/ee/10.5.592
   Jansen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134975
   Jansen CC, 2009, AUST J ENTOMOL, V48, P53, DOI 10.1111/j.1440-6055.2008.00671.x
   Johansen CA, 2009, J MED ENTOMOL, V46, P1167, DOI 10.1603/033.046.0527
   JUPP P G, 1967, Journal of the Entomological Society of Southern Africa, V30, P34
   JUPP P. G., 1967, J ENTOMOL SOC S AFR, V30, P243
   JUPP PG, 1987, J AM MOSQUITO CONTR, V3, P131
   Jupp PG, 1998, J AM MOSQUITO CONTR, V14, P40
   Jupp PG, 2002, T ROY SOC TROP MED H, V96, P493, DOI 10.1016/S0035-9203(02)90417-7
   JUPP PG, 1976, J MED ENTOMOL, V12, P647, DOI 10.1093/jmedent/12.6.647
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Kanojia PC, 2004, J MED ENTOMOL, V41, P994, DOI 10.1603/0022-2585-41.5.994
   Kanojia PC, 2003, J AM MOSQUITO CONTR, V19, P151
   Karabatsos N., 1985, AM J TROP MED HYG, V27, P372
   KARCH S, 1993, B SOC PATHOL EXOT, V86, P68
   KARCH S, 1992, B SOC PATHOL EXOT, V85, P388
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   Kay BH, 2000, J MED ENTOMOL, V37, P846, DOI 10.1603/0022-2585-37.6.846
   KENAWY MA, 1987, J MED ENTOMOL, V24, P35, DOI 10.1093/jmedent/24.1.35
   Kenawy Mohamed A., 1998, Journal of the Egyptian Society of Parasitology, V28, P449
   KERR J. A., 1932, ANN TROP MED AND PARASITOL [LIVERPOOL], V26, P119
   Khoshdel-Nezamiha F, 2014, J ARTHROPOD-BORNE DI, V8, P163
   Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364
   King Willard V., 1946, PROC ENT SOC WASHINGTON, V48, P186
   Kirby MJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-41
   Knight J, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.0601
   KNIGHT KENNETH L., 1953, PACIFIC SCI, V7, P453
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   KULKARNI S M, 1988, Journal of Communicable Diseases, V20, P280
   KUMAR NP, 1989, INDIAN J MED RES-A, V89, P52
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LAEMMERT HW, 1947, J IMMUNOL, V55, P61
   Lane RP, 2012, MED INSECTS ARACHNID
   Laporta GZ, 2008, REV BRAS ENTOMOL, V52, P663, DOI 10.1590/S0085-56262008000400019
   LE BERRE R., 1961, BULL SOC PATHOL EXOT, V53, P1054
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee Jong-Soo, 1995, Korean Journal of Parasitology, V33, P19, DOI 10.3347/kjp.1995.33.1.19
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   LINTHICUM KJ, 1985, B ENTOMOL RES, V75, P661, DOI 10.1017/S0007485300015923
   Liu CR, 2016, ECOL EVOL, V6, P337, DOI 10.1002/ece3.1878
   Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058
   LIU L. B., 1960, ACTA ENT SINICA, V10, P86
   Llorente F, 2015, VET RES, V46, DOI 10.1186/s13567-015-0233-9
   Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x
   LOGAN TM, 1991, J AM MOSQUITO CONTR, V7, P395
   Lopes J, 1996, ARQ BIOL TECNOL, V39, P671
   Lopes Jose, 1997, Revista Brasileira de Zoologia, V14, P571, DOI 10.1590/S0101-81751997000300007
   LOUNIBOS LP, 1980, B ENTOMOL RES, V70, P309, DOI 10.1017/S0007485300007598
   Lourenco-de-Oliveira R., 1985, Memorias do Instituto Oswaldo Cruz, V80, P123
   Lutomiah J, 2014, VECTOR-BORNE ZOONOT, V14, P656, DOI 10.1089/vbz.2013.1564
   MacDONALD W. W., 1965, J MED ENTOMOL, V1, P335, DOI 10.1093/jmedent/1.4.335
   Mackay AJ, 2010, J MED ENTOMOL, V47, P238, DOI 10.1603/ME09168
   Mackenzie J., 2012, JAPANESE ENCEPHALITI
   Maestre-Serrano R, 2013, BIOMEDICA, V33, P185, DOI 10.7705/biomedica.v33i0.706
   Mahmood F, 1998, J MED ENTOMOL, V35, P1007, DOI 10.1093/jmedent/35.6.1007
   Mahy B.W., 2009, DICT VIROLOGY
   MARTIN DH, 1973, J MED ENTOMOL, V10, P206, DOI 10.1093/jmedent/10.2.206
   McCLELLAND G.A.H., 1960, ANN TROP MED AND PARASITOL, V54, P300
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   MIYAGI I, 1983, Mosquito Systematics, V15, P18
   Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2
   Molaei G, 2006, AM J TROP MED HYG, V75, P1140, DOI 10.4269/ajtmh.2006.75.1140
   Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL, V54, P251, DOI 10.1093/jme/tjw212
   Mores CN, 2007, VECTOR-BORNE ZOONOT, V7, P279, DOI 10.1089/vbz.2006.0557
   MORRISON A, 1992, J AM MOSQUITO CONTR, V8, P52
   MORSY T A, 1990, Journal of the Egyptian Society of Parasitology, V20, P265
   MOUCHET J., 1957, BULL SOC PATHOL EXOT, V50, P378
   Multini LC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1256-9
   Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549
   Murdock CC, 2010, J MED ENTOMOL, V47, P226, DOI 10.1603/ME09137
   Muriu SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-43
   Muturi EJ, 2008, PARASITOL RES, V102, P1329, DOI 10.1007/s00436-008-0914-7
   Muturi EJ, 2011, VECTOR-BORNE ZOONOT, V11, P1157, DOI 10.1089/vbz.2010.0209
   Mwandawiro Charles, 1999, Medical Entomology and Zoology, V50, P267
   Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44
   Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114
   Mwangangi JM, 2009, J VECTOR DIS, V46, P65
   Natal Delsio, 1998, Revista Brasileira de Entomologia, V41, P213
   Navarro J.C., 2015, Journal of Entomology and Zoology Studies, V3, P169
   Nicholson J, 2015, J MED ENTOMOL, V52, P375, DOI 10.1093/jme/tjv004
   Nikolay B, 2012, AM J TROP MED HYG, V86, P993, DOI 10.4269/ajtmh.2012.11-0509
   NIR Y, 1972, ARCH GES VIRUSFORSCH, V36, P105, DOI 10.1007/BF01250300
   Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0
   Njabo KY, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-193
   NJOGU AR, 1971, B ENTOMOL RES, V60, P473, DOI 10.1017/S0007485300040426
   NSW Health, 2016, NSW ARB SURV VECT MO
   Ohba S, 2015, ACTA TROP, V142, P89, DOI 10.1016/j.actatropica.2014.11.002
   OKORIE T G, 1978, Nigerian Journal of Entomology, V3, P81
   Omondi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134375
   PANDIAN RS, 1992, COMP PHYSIOL ECOL, V17, P66
   Paramasivan R., 2015, International Journal of Mosquito Research, V2, P106
   Parascandola M, 2004, PERSPECT BIOL MED, V47, P244, DOI 10.1353/pbm.2004.0032
   PATERSON H. E., 1964, Medical Proceedings, V10, P188
   Pedro PM, 2008, HEREDITY, V101, P186, DOI 10.1038/hdy.2008.45
   PEIRIS JSM, 1992, T ROY SOC TROP MED H, V86, P307, DOI 10.1016/0035-9203(92)90325-7
   PENN GH, 1947, J PARASITOL, V33, P43, DOI 10.2307/3273619
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   PEYTON E. L., 1964, MOSQUITO NEWS, V24, P449
   Pinto CS, 2009, MEM I OSWALDO CRUZ, V104, P592, DOI 10.1590/S0074-02762009000400010
   Poncon N, 2007, EMERG INFECT DIS, V13, P1810, DOI 10.3201/eid1312.070730
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prummongkol S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.1101
   Qualls WA, 2012, J AM MOSQUITO CONTR, V28, P219, DOI 10.2987/12-6255R.1
   Radrova J, 2013, J MED ENTOMOL, V50, P1097, DOI 10.1603/ME13029
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   RAMOS H D C, 1990, Garcia De Orta Serie de Zoologia, V17, P31
   Ramsdale Clement D., 2001, European Mosquito Bulletin, V10, P25
   REINERT J. F., 1970, Contributions of the American Entomological Institute, V5, P1
   Reinert JF, 1986, MOSQ SYST, V3, P307
   Reinert JF, 2008, ZOOL J LINN SOC-LOND, V153, P29, DOI 10.1111/j.1096-3642.2008.00382.x
   REISEN W, 1993, WING BEATS, V4, P16
   REISEN W K, 1976, Biologia (Lahore), V22, P67
   RENSHAW M, 1995, B ENTOMOL RES, V85, P125, DOI 10.1017/S0007485300052081
   RENSHAW M, 1994, MED VET ENTOMOL, V8, P187, DOI 10.1111/j.1365-2915.1994.tb00162.x
   REUBEN R, 1971, J MED ENTOMOL, V8, P363, DOI 10.1093/jmedent/8.4.363
   REUBEN R, 1992, AM J TROP MED HYG, V46, P654, DOI 10.4269/ajtmh.1992.46.654
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   Ridgeway G, 2015, GBM GEN BOOSTED REGR
   Robert V, 1998, J MED ENTOMOL, V35, P948, DOI 10.1093/jmedent/35.6.948
   Robinson W. H., 2005, URBAN INSECTS ARACHN
   Rochlin I, 2008, J AM MOSQUITO CONTR, V24, P359, DOI 10.2987/5748.1
   Rueda LM, 2006, J VECTOR ECOL, V31, P198, DOI 10.3376/1081-1710(2006)31[198:DALHCO]2.0.CO;2
   Rueda LM, 2005, J AM MOSQUITO CONTR, V21, P458, DOI 10.2987/8756-971X(2006)21[458:HADOAS]2.0.CO;2
   RUEGER MYRTLE E., 1964, MOSQUITO NEWS, V24, P39
   Russel R., 2013, ENCY MED VET ENTOMOL
   Russell RC, 1986, AUSTR J ENTOMOLOGY, V25, P235, DOI [10.1111/j.1440-6055.1986.tb01109.x, DOI 10.1111/J.1440-6055.1986.TB01109.X]
   Russell RC, 2012, J AM MOSQUITO CONTR, V28, P24, DOI 10.2987/8756-971X-28.4s.24
   Ryan PA, 2000, AUST J ENTOMOL, V39, P212, DOI 10.1046/j.1440-6055.2000.00169.x
   SABESAN S, 1991, INDIAN J MED RES-A, V93, P253
   Sallum MAM, 1996, J AM MOSQUITO CONTR, V12, P517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwetz J., 1930, REV ZOOLOGIE BOT AFR, V4, P311
   Sebesta O, 2010, J VECTOR ECOL, V35, P156, DOI 10.1111/j.1948-7134.2010.00042.x
   Serandour J, 2006, ENTOMOL EXP APPL, V120, P195, DOI 10.1111/j.1570-7458.2006.00444.x
   SERVICE M. W., 1965, BULL ENTOMOL RES, V55, P637, DOI 10.1017/S0007485300049749
   Service M. W., 1993, MOSQUITO ECOLOGY FIE, DOI [10.1007/978-94-015-8113-4, DOI 10.1007/978-94-015-8113-4]
   Service MW, 1965, J APPL ECOL, V2, P1, DOI DOI 10.2307/2401689
   Shililu J, 2003, J MED ENTOMOL, V40, P921, DOI 10.1603/0022-2585-40.6.921
   Silva JD, 2012, J VECTOR ECOL, V37, P342, DOI 10.1111/j.1948-7134.2012.00237.x
   Silver JB., 2007, MOSQUITO ECOLOGY FIE
   Simsek Fatih Mehmet, 2004, Turkish Journal of Zoology, V28, P337
   Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89
   SIRIVANAKARN S, 1980, Mosquito Systematics, V12, P25
   Smith GCS, 2014, AM J EPIDEMIOL, V180, P318, DOI 10.1093/aje/kwu140
   SMITH ME, 1966, AM MIDL NAT, V76, P125, DOI 10.2307/2423238
   SNOW WF, 1973, B ENTOMOL RES, V62, P517, DOI 10.1017/S0007485300004041
   SNOW WF, 1978, B ENTOMOL RES, V68, P695, DOI 10.1017/S0007485300009652
   Someren ECC, 1967, P ROYAL ENTOMOLOGI B, V36, P11, DOI [10.1111/j.1365-3113.1967.tb00528.x, DOI 10.1111/J.1365-3113.1967.TB00528.X]
   SOMMERMAN KATHRYN M., 1964, MOSQUITO NEWS, V24, P60
   Sriwichai P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1295-x
   Stein M, 2013, MEM I OSWALDO CRUZ, V108, P563, DOI 10.1590/S0074-02762013000500005
   STEYN J. J., 1955, S AFRICAN MED JOUR, V29, P1114
   Suarez-Mutis MC, 2009, MEM I OSWALDO CRUZ, V104, P11, DOI 10.1590/S0074-02762009000100002
   Sudeep AB, 2014, J VECTOR DIS, V51, P251
   Sylla M, 2013, J VECTOR ECOL, V38, P237, DOI 10.1111/j.1948-7134.2013.12036.x
   TAKAHASHI M, 1968, J MED ENTOMOL, V5, P329, DOI 10.1093/jmedent/5.3.329
   Tang Y, 2015, TRANSBOUND EMERG DIS, V62, P209, DOI 10.1111/tbed.12111
   Taye A, 2006, ACTA TROP, V97, P50, DOI 10.1016/j.actatropica.2005.08.002
   Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503
   Toma Takako, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P532
   Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480
   Tsunoda T, 2012, SE ASIAN J TROP MED, V43, P1375
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Van Der KUYP E., 1949, DOCUMENTA NEERLAND ET INDONES MORBIS TROP, V1, P142
   VANREGENMORTEL MHV, 2000, VIRUS TAXONOMY CLASS
   Ventim R, 2012, PARASITOL RES, V111, P637, DOI 10.1007/s00436-012-2880-3
   Veronesi R, 2012, J VECTOR ECOL, V37, P49, DOI 10.1111/j.1948-7134.2012.00199.x
   Versteirt V, 2013, B ENTOMOL RES, V103, P193, DOI 10.1017/S0007485312000521
   Viana LA, 2010, J MED ENTOMOL, V47, P670, DOI 10.1603/ME09260
   WADDELL MB, 1945, AM J TROP MED, V25, P225
   Walter Reed Biosystematics Unit W.D., 2016, WALT REED BIOS UN SY
   Wang L Y, 1975, Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi, V8, P274
   Wang ZM, 2012, J MED ENTOMOL, V49, P1283, DOI 10.1603/ME11131
   Wanson M., 1946, ARCH INST PASTEUR ALGERIE, V24, P153
   Weaver SC, 2005, ARCH VIROL, P33
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Webb C, 2016, GUIDE MOSQUITOES AUS
   WHARTON R. H., 1962, BULL INST MED RES FED MALAYA, V11, P1
   Williams CR, 2005, PHYSIOL ENTOMOL, V30, P309, DOI 10.1111/j.1365-3032.2005.00462.x
   Williams CR, 2005, AUST J ENTOMOL, V44, P110, DOI 10.1111/j.1440-6055.2005.00463.x
   WRIGHT AE, 1981, AUST J EXP BIOL MED, V59, P357, DOI 10.1038/icb.1981.30
   Yee DA, 2014, J MED ENTOMOL, V51, P89, DOI 10.1603/ME13182
   Young EC, 2007, NEW ZEAL J ZOOL, V34, P57, DOI 10.1080/03014220709510064
NR 343
TC 21
Z9 21
U1 2
U2 21
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD FEB 28
PY 2017
VL 6
AR e22053
DI 10.7554/eLife.22053
PG 38
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EN7IF
UT WOS:000396174600001
PM 28244371
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rather, IA
   Kumar, S
   Bajpai, VK
   Lim, J
   Park, YH
AF Rather, Irfan A.
   Kumar, Sanjay
   Bajpai, Vivek K.
   Lim, Jeongheui
   Park, Yong-Ha
TI Prevention and Control Strategies to Counter ZIKA Epidemic
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE ZIKA; diagnoses; prevention; treatment; awareness
ID FRENCH-POLYNESIA; VIRUS-INFECTION; DISEASE; TRANSMISSION; OUTBREAK;
   DENGUE; SYSTEMS; STATES
AB ZIKA virus (ZIKA) has now become a global phenomenon. Since 2007, evidence of ZIKA transmission has been reported over 72 countries and territories. The transmission of ZIKA has made World Health Organization to categorize the situation under the ambit of a health emergency. This situation is serious because there appears to be a highly tangible link between infection during pregnancy and the occurrence of microcephaly and Guillain-Barre syndrome. In the context of this emergency situation, this review article intends to discuss the prevention and control strategies such as avoiding travel to infected area, being careful from mosquito bites, take precautions to reduce the risk of sexual transmission, and seek medical care for any acute illness with rash or fever. This review is an attempt to analyze the results of those campaigns, keeping in view the variables and constants that affect any such measures. Furthermore, this article will suggest proactive measures that can be employed to effectively combat the epidemic transmission of the ZIKA.
C1 [Rather, Irfan A.; Bajpai, Vivek K.; Park, Yong-Ha] Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, South Korea.
   [Kumar, Sanjay] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.
   [Lim, Jeongheui] Natl Sci Museum, ICT & Future Planning, Daejeon, South Korea.
RP Bajpai, VK; Park, YH (corresponding author), Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, South Korea.; Lim, J (corresponding author), Natl Sci Museum, ICT & Future Planning, Daejeon, South Korea.
EM vbajpai04@ynu.ac.kr; jeongheuilim@gmail.com; peter@ynu.ac.kr
RI Rather, Irfan A./AAH-1425-2019
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Alphey L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003909
   [Anonymous], 2016, EUR CTR DIS PREV CON
   [Anonymous], 2016, DAILY MAIL
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Baeumner AJ, 2002, ANAL CHEM, V74, P1442, DOI 10.1021/ac015675e
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, COUNTR TERR ACT LOC
   CDC, 2016, ZIKA US
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Hafiz MY, 2016, INFECT DRUG RESIST, V9, DOI 10.2147/IDR.S108057
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   LaMotte S., 2016, ZIKA WAS SEXUALLY TR
   Lee MS, 2011, CAN J VET RES, V75, P122
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reuters, 2016, ZIKA PITS OLD ANT TA
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Statista, 2016, RISK ZIK VIR INF TRA
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, SIT REP 16 JUN 2016
   Wojda TR, 2015, J GLOB INFECT DIS, V7, P127, DOI 10.4103/0974-777X.170495
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 47
TC 23
Z9 25
U1 0
U2 23
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 28
PY 2017
VL 8
AR 305
DI 10.3389/fmicb.2017.00305
PG 8
WC Microbiology
SC Microbiology
GA EL9HI
UT WOS:000394930900001
PM 28293228
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhou, H
   Wang, FH
   Wang, HF
   Chen, C
   Zhang, TQ
   Han, X
   Wang, DP
   Chen, C
   Wu, C
   Xie, W
   Wang, ZF
   Zhang, L
   Wang, LF
   Yang, HT
AF Zhou, Han
   Wang, Fenghua
   Wang, Haofeng
   Chen, Cheng
   Zhang, Tianqing
   Han, Xu
   Wang, Deping
   Chen, Chen
   Wu, Chen
   Xie, Wei
   Wang, Zefang
   Zhang, Lei
   Wang, Lanfeng
   Yang, Haitao
TI The conformational changes of Zika virus methyltransferase upon
   converting SAM to SAH
SO ONCOTARGET
LA English
DT Article
DE Zika virus; methyltransferase; crystal structure; SAH; antiviral drug
   development
ID NS5 METHYLTRANSFERASE; AMERICA
AB An outbreak of Zika virus (ZIKV) infection has been reported in South and Central America and the Caribbean. Neonatal microcephaly potentially associated with ZIKV infection has already caused a public health emergency of international concern. Currently, there are no clinically effective vaccines or antiviral drugs available to treat ZIKV infection. The methyltransferase domain (MTase) of ZIKV nonstructural protein 5 (NS5) can sequentially methylate guanine N-7 and ribose 2'-O to form (m7N)GpppA(2'Om) cap structure in the new RNA transcripts. This methylation step is crucial for ZIKV replication cycle and evading the host immune system, making it a target for drug design. Here, we present the 1.76 angstrom crystal structure of ZIKV MTase in complex with the byproduct SAH, providing insight into the elegant methylation process, which will benefit the following antiviral drug development.
C1 [Zhou, Han; Wang, Fenghua; Wang, Haofeng; Chen, Cheng; Zhang, Tianqing; Han, Xu; Wang, Deping; Chen, Chen; Wu, Chen; Xie, Wei; Wang, Zefang; Zhang, Lei; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Wang, Lanfeng] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
RP Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.; Wang, LF (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
EM lanfwang@ips.ac.cn; yanght@tju.edu.cn
FU National Key Basic Research Program of China (973 program)National Basic
   Research Program of China [2015CB859800]; National Key Research Program
   of China [2016YFD0500300]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31528006]; Institute
   Pasteur of Shanghai, Chinese Academy of Sciences
FX This work was supported by National Key Basic Research Program of China
   (973 program) (No. 2015CB859800), National Key Research Program of China
   (No. 2016YFD0500300), National Natural Science Foundation of China (No.
   31528006) and the start-up funds from Institute Pasteur of Shanghai,
   Chinese Academy of Sciences.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Petersen LR, 2016, NEW ENGLAND J MED, V374
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 19
TC 11
Z9 13
U1 0
U2 13
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 28
PY 2017
VL 8
IS 9
BP 14830
EP 14834
DI 10.18632/oncotarget.14780
PG 5
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EN4YV
UT WOS:000396013700050
PM 28122329
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Sheridan, MA
   Yunusov, D
   Balaraman, V
   Alexenko, AP
   Yabe, S
   Verjovski-Almeida, S
   Schust, DJ
   Franz, AW
   Sadovsky, Y
   Toshihiko, E
   Roberts, RM
AF Sheridan, Megan A.
   Yunusov, Dinar
   Balaraman, Velmurugan
   Alexenko, Andrei P.
   Yabe, Shinichiro
   Verjovski-Almeida, Sergio
   Schust, Danny J.
   Franz, Alexander W.
   Sadovsky, Yoel
   Toshihiko, Ezashi
   Roberts, R. Michael
TI Vulnerability of primitive human placental trophoblast to Zika virus
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE embryonic stem cell; placenta; pregnancy; trophoblast; Zika virus
ID EMBRYONIC STEM-CELLS; INNATE IMMUNE-RESPONSES; DENGUE VIRUS;
   HEPARAN-SULFATE; 1ST-TRIMESTER TROPHOBLAST; SELF-ORGANIZATION;
   VIRAL-INFECTIONS; BIRTH-DEFECTS; 1ST TRIMESTER; TAM RECEPTORS
AB Infection of pregnant women by Asian lineage strains of Zika virus (ZIKV) has been linked to brain abnormalities in their infants, yet it is uncertain when during pregnancy the human conceptus is most vulnerable to the virus. We have examined two models to study susceptibility of human placental trophoblast to ZIKV: cytotrophoblast and syncytiotrophoblast derived from placental villi at term and colonies of trophoblast differentiated from embryonic stem cells (ESC). The latter appear to be analogous to the primitive placenta formed during implantation. The cells from term placentas, which resist infection, do not express genes encoding most attachment factors implicated in ZIKV entry but do express many genes associated with antiviral defense. By contrast, the ESC-derived trophoblasts possess a wide range of attachment factors for ZIKV entry and lack components of a robust antiviral response system. These cells, particularly areas of syncytiotrophoblast within the colonies, quickly become infected, produce infectious virus and undergo lysis within 48 h after exposure to lowtiters (multiplicity of infection > 0.07) of an African lineage strain (MR766 Uganda: ZIKV(U)) considered to be benignwith regards to effects on fetal development. Unexpectedly, lytic effects required significantly higher titers of the presumed more virulent FSS13025 Cambodia (ZIKV(C)). Our data suggest that the developing fetus might be most vulnerable to ZIKV early in the first trimester before a protective zone of mature villous trophoblast has been established. Additionally, MR766 is highly trophic toward primitive trophoblast, which may put the early conceptus of an infected mother at high risk for destruction.
C1 [Sheridan, Megan A.; Yunusov, Dinar; Alexenko, Andrei P.; Toshihiko, Ezashi; Roberts, R. Michael] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.
   [Sheridan, Megan A.; Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
   [Yunusov, Dinar; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, SP, Brazil.
   [Yunusov, Dinar; Verjovski-Almeida, Sergio] Inst Butantan, Lab Gene Express, BR-05503900 Sao Paulo, SP, Brazil.
   [Balaraman, Velmurugan; Franz, Alexander W.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Alexenko, Andrei P.; Toshihiko, Ezashi; Roberts, R. Michael] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
   [Yabe, Shinichiro; Schust, Danny J.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA.
   [Sadovsky, Yoel] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.
RP Roberts, RM (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.; Roberts, RM (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Roberts, RM (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
EM robertsrm@missouri.edu
RI Verjovski-Almeida, Sergio/AAI-2728-2020; amsalu, ribka/G-8780-2019;
   Verjovski-Almeida, Sergio/E-4082-2012
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Yunusov, Dinar/0000-0003-3478-7203;
   Sadovsky, Yoel/0000-0003-2969-6737; Sheridan, Megan/0000-0002-6878-7976
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01HD077108];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01HD067759]; Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/03620-2]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2010/51152-7]
FX We thank D. F. Reith for administrative assistance and Dr. Alexander
   Jurkevich and the University of Missouri Molecular Cytology Core for
   assistance with the confocal imaging. Zika virus stocks were prepared
   and maintained in the virology laboratory of the Laboratory for
   Infectious Disease Research at the University of Missouri. This study
   was supported by by National Institutes of Health (NIH) Grant
   R01HD077108 (to T.E. and D.J.S.) and NIH Grant R01HD067759 (to R.M.R.);
   by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant
   2014/03620-2 (to S.V.-A.); and by Fellowship 2010/51152-7 from FAPESP
   (to D.Y.).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110
   Amoroso E, 1952, PHYSIOLOGY REPRODUCT, V2, P127
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Boyd JD, 1970, HUMAN PLACENTA
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1
   Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Colpitts CC, 2014, J VIROL, V88, P7806, DOI 10.1128/JVI.00896-14
   Connell BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00385
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013
   Doran KS, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010090
   ENDERS AC, 1989, AM J ANAT, V186, P85, DOI 10.1002/aja.1001860107
   Enders AC, 1997, HUM REPROD UPDATE, V3, P561, DOI 10.1093/humupd/3.6.561
   ENDERS AC, 1991, AM J ANAT, V192, P329, DOI 10.1002/aja.1001920403
   FOIDART JM, 1992, INT J DEV BIOL, V36, P451
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9
   HERTIG AT, 1956, AM J ANAT, V98, P435, DOI 10.1002/aja.1000980306
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Horii M, 2016, P NATL ACAD SCI USA, V113, pE3882, DOI 10.1073/pnas.1604747113
   HOSHINA M, 1982, J CELL BIOL, V93, P190, DOI 10.1083/jcb.93.1.190
   HUSTIN J, 1987, AM J OBSTET GYNECOL, V157, P162, DOI 10.1016/S0002-9378(87)80371-X
   James JL, 2012, PLACENTA, V33, P327, DOI 10.1016/j.placenta.2012.01.020
   Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-115
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Klimyte EM, 2016, J VIROL, V90, P9237, DOI 10.1128/JVI.01362-16
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee CQE, 2016, STEM CELL REP, V6, P257, DOI 10.1016/j.stemcr.2016.01.006
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nelson DM, 1999, AM J OBSTET GYNECOL, V180, P896, DOI 10.1016/S0002-9378(99)70661-7
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265
   Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465
   Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009
   Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438
   Yabe S, 2016, P NATL ACAD SCI USA, V113, pE2598, DOI 10.1073/pnas.1601630113
   Yang Y, 2015, P NATL ACAD SCI USA, V112, pE2337, DOI 10.1073/pnas.1504778112
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yunusov D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32753
NR 88
TC 48
Z9 49
U1 1
U2 24
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 28
PY 2017
VL 114
IS 9
BP E1587
EP E1596
DI 10.1073/pnas.1616097114
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM1TZ
UT WOS:000395101200004
PM 28193876
OA Bronze, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Chibueze, EC
   Tirado, V
   Lopes, KD
   Balogun, OO
   Takemoto, Y
   Swa, T
   Dagvadorj, A
   Nagata, C
   Morisaki, N
   Menendez, C
   Ota, E
   Mori, R
   Oladapo, OT
AF Chibueze, Ezinne C.
   Tirado, Veronika
   Lopes, Katharina da Silva
   Balogun, Olukunmi O.
   Takemoto, Yo
   Swa, Toshiyuki
   Dagvadorj, Amarjargal
   Nagata, Chie
   Morisaki, Naho
   Menendez, Clara
   Ota, Erika
   Mori, Rintaro
   Oladapo, Olufemi T.
TI Zika virus infection in pregnancy: a systematic review of disease course
   and complications
SO REPRODUCTIVE HEALTH
LA English
DT Review
ID BRAZIL; EPIDEMIOLOGY; TRAVELERS; OUTBREAK; TRANSMISSION; AMERICA; STATES
AB Objectives: To characterize maternal Zika virus (ZIKV) infection and complement the evidence base for the WHO interim guidance on pregnancy management in the context of ZIKV infection.
   Methods: We searched the relevant database from inception until March 2016. Two review authors independently screened and assessed full texts of eligible reports and extracted data from relevant studies. The quality of studies was assessed using the Newcastle-Ottawa Scale (NOS) and the National Institute of Health (NIH) tool for observational studies and case series/reports, respectively.
   Results: Among 142 eligible full-text articles, 18 met the inclusion criteria (13 case series/reports and five cohort studies). Common symptoms among pregnant women with suspected/confirmed ZIKV infection were fever, rash, and arthralgia. One case of Guillain-Barre syndrome was reported among ZIKV-infected mothers, no other case of severe maternal morbidity or mortality reported. Complications reported in association with maternal ZIKV infection included a broad range of fetal and newborn neurological and ocular abnormalities; fetal growth restriction, stillbirth, and perinatal death. Microcephaly was the primary neurological complication reported in eight studies, with an incidence of about 1% among newborns of ZIKV infected women in one study.
   Conclusion: Given the extensive and variable fetal and newborn presentations/complications associated with prenatal ZIKV infection, and the dearth of information provided, knowledge gaps are evident. Further research and comprehensive reporting may provide a better understanding of ZIKV infection in pregnancy and attendant maternal/fetal complications. This knowledge could inform the creation of effective and evidence-based strategies, guidelines and recommendations aimed at the management of maternal ZIKV infection. Adherence to current best practice guidelines for prenatal care among health providers is encouraged, in the context of maternal ZIKV infection.
C1 [Chibueze, Ezinne C.; Lopes, Katharina da Silva; Balogun, Olukunmi O.; Takemoto, Yo; Swa, Toshiyuki; Dagvadorj, Amarjargal; Ota, Erika; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.
   [Tirado, Veronika] Karolinska Inst, Dept Publ Hlth Sci Global Hlth IHCAR, Stockholm, Sweden.
   [Swa, Toshiyuki] Osaka Univ, Grad Sch Human Sci, Osaka, Japan.
   [Dagvadorj, Amarjargal] Kyoto Univ, Dept Hlth Informat, Syako Ku, Yoshida Konoe Cho, Kyoto, Japan.
   [Nagata, Chie] Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan.
   [Morisaki, Naho] Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan.
   [Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.
   [Menendez, Clara; Oladapo, Olufemi T.] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Ota, Erika] St Lukes Int Univ, Grad Sch Nursing Global Hlth Nursing, Tokyo, Japan.
RP Chibueze, EC (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.
EM ezinne.chibueze@gmail.com
RI Menendez, Clara/Q-3446-2016
OI Menendez, Clara/0000-0002-2641-6907; Mori, Rintaro/0000-0001-7656-6156;
   Velasco Tirado, Virginia/0000-0001-7175-1758; Ota,
   Erika/0000-0002-3945-7441; Morisaki, Naho/0000-0001-6151-4513
FU UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP),
   Department of Reproductive Health and Research, World Health
   Organization; Research on Global Health Issues; Japan Agency for Medical
   Research and Development (AMED)Japan Agency for Medical Research and
   Development (AMED); Clinical Research Program for Child Health and
   Development from Japan Agency for Medical Research and Development
   (AMED)Japan Agency for Medical Research and Development (AMED); National
   Center for Child Health and Development (NCCHD)
FX The preparation of this review was financially supported by the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP),
   Department of Reproductive Health and Research, World Health
   Organization; Research on Global Health Issues, Japan Agency for Medical
   Research and Development (AMED), Clinical Research Program for Child
   Health and Development from Japan Agency for Medical Research and
   Development (AMED) and the National Center for Child Health and
   Development (NCCHD).
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Besnard M, 2014, EURO SURVEILL, V19
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chibueze EC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0752-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eurosurveillance Editorial Team, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.5.30128
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wells GA, 2012, SCALE
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 40
TC 33
Z9 33
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD FEB 28
PY 2017
VL 14
AR 28
DI 10.1186/s12978-017-0285-6
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN0PS
UT WOS:000395712500001
PM 28241773
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, PK
   Guest, JM
   Kanwar, M
   Boss, J
   Gao, N
   Juzych, MS
   Abrams, GW
   Yu, FS
   Kumar, A
AF Singh, Pawan Kumar
   Guest, John-Michael
   Kanwar, Mamta
   Boss, Joseph
   Gao, Nan
   Juzych, Mark S.
   Abrams, Gary W.
   Yu, Fu-Shin
   Kumar, Ashok
TI Zika virus infects cells lining the blood-retinal barrier and causes
   chorioretinal atrophy in mouse eyes
SO JCI INSIGHT
LA English
DT Article
ID MULLER GLIA; DENGUE-FEVER; CHIKUNGUNYA; RESPONSES; TUMORS; BRAZIL; RISK;
   TLR2
AB Zika virus (ZIKV) is an important pathogen that causes not only neurologic, but also ocular, abnormalities. Thus, it is imperative that models to study ZIKV pathogenesis in the eye are developed to identify potential targets for interventions. Here, we studied ZIKV interactions with human retinal cells and evaluated ZIKV's pathobiology in mouse eyes. We showed that cells lining the blood-retinal barrier (BRB), the retinal endothelium, and retinal pigment epithelium (RPE) were highly permissive and susceptible to ZIKV-induced cell death. Direct inoculation of ZIKV in eyes of adult C57BL/6 and IFN-stimulated gene 15 (ISG15) KO mice caused chorioretinal atrophy with RPE mottling, a common ocular manifestation of congenital ZIKV infection in humans. This response was associated with induced expression of multiple inflammatory and antiviral (IFNs) response genes in the infected mouse retina. Interestingly, ISG15 KO eyes exhibited severe chorioretinitis, which coincided with increased retinal cell death and higher ZIKV replication. Collectively, our study provides the first evidence to our knowledge that ZIKV causes retinal lesions and infects the cells lining the BRB and that ISG15 plays a role in retinal innate defense against ZIKV infection. Our mouse model can be used to study mechanisms underlying ZIKV-induced chorioretinitis and to gauge ocular antiviral therapies.
C1 [Singh, Pawan Kumar; Guest, John-Michael; Kanwar, Mamta; Boss, Joseph; Gao, Nan; Juzych, Mark S.; Abrams, Gary W.; Yu, Fu-Shin; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Ophthalmol, Kresge Eye Inst, 4717 St Antoine, Detroit, MI 48201 USA.
   [Singh, Pawan Kumar; Yu, Fu-Shin; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI USA.
   [Kumar, Ashok] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI USA.
RP Kumar, A (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Kresge Eye Inst, 4717 St Antoine, Detroit, MI 48201 USA.
EM akuma@med.wayne.edu
OI Singh, Pawan Kumar/0000-0001-5517-1120
FU Research to Prevent Blindness (RPB)Research to Prevent Blindness (RPB);
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P30EY004068]
FX This study was supported by an unrestricted grant from Research to
   Prevent Blindness (RPB) to Kresge Eye Institute. The microscopy,
   imaging, and cytometry resource core is supported, in part, by an NIH
   center grant P30EY004068 (PI: Linda D. Hazlett, Department of Anatomy
   and Cell Biology, Wayne State University). We sincerely thank Rajiv Shah
   (Department of Ophthalmology, Wake Forest University) and Mircea Coca
   and Wendewessen Amde (Chicagoland Eye and Retina Foundation) for
   unbiased grading of fundus images. The authors are grateful to Kathy
   Spindler (University of Michigan, Ann Arbor, Michigan, USA) for helping
   us with plaque assays and Bruce G. Rottmann for critical editing of the
   manuscript.
CR Abbasi Aziz-un-Nisa, 2016, J Ayub Med Coll Abbottabad, V28, P1
   ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681
   Anninger W, 2004, CLIN INFECT DIS, V38, pE55, DOI 10.1086/382884
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Atchaneeyasakul LO, 1998, OPHTHALMIC GENET, V19, P39, DOI 10.1076/opge.19.1.39.2178
   Bains HS, 2003, ARCH OPHTHALMOL-CHIC, V121, P205, DOI 10.1001/archopht.121.2.205
   Coburn PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154560
   Constable PA, 2009, OPHTHAL PHYSL OPT, V29, P557, DOI 10.1111/j.1475-1313.2009.00671.x
   Dahlmann F, 2015, J INFECT DIS, V212, pS247, DOI 10.1093/infdis/jiv140
   Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayek S, 2015, JAMA OPHTHALMOL, V133, P849, DOI 10.1001/jamaophthalmol.2015.0698
   Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson BW, 2004, AM J TROP MED HYG, V70, P89, DOI 10.4269/ajtmh.2004.70.89
   Kochan T, 2012, INFECT IMMUN, V80, P2076, DOI 10.1128/IAI.00149-12
   Kumar A., 2012, ISRN REHABIL, V2012, P1, DOI DOI 10.1088/1757-899X/27/1
   Kumar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128423
   Kumar A, 2013, CRIT REV IMMUNOL, V33, P119, DOI 10.1615/CritRevImmunol.2013006618
   Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589
   Li ML, 2015, JAMA OPHTHALMOL, V133, P1329, DOI 10.1001/jamaophthalmol.2015.2687
   Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346
   Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Morales DJ, 2015, J VIROL, V89, P337, DOI 10.1128/JVI.02110-14
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pandey RK, 2013, INDIAN J MED RES, V138, P609
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Ram J, 2013, JAMA OPHTHALMOL, V131, DOI 10.1001/jamaophthalmol.2013.4566
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Shamsuddin N, 2011, J IMMUNOL, V186, P7089, DOI 10.4049/jimmunol.1100565
   Singh PK, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.34
   Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33
   Singh P, 2015, J NANOMATER, V2015, DOI 10.1155/2015/234741
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Talreja D, 2015, INVEST OPHTH VIS SCI, V56, P1719, DOI 10.1167/iovs.14-16087
   Talreja D, 2014, INVEST OPHTH VIS SCI, V55, P2392, DOI 10.1167/iovs.13-13401
   Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114
   Trzupek KM, 2007, AM J MED GENET A, V143A, P1218, DOI 10.1002/ajmg.a.31717
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021
   Yip VCH, 2012, OPHTHALMOL THER, V1, DOI 10.1007/s40123-012-0002-z
NR 63
TC 39
Z9 39
U1 0
U2 8
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD FEB 23
PY 2017
VL 2
IS 4
AR e92340
DI 10.1172/jci.insight.92340
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EN5ET
UT WOS:000396029100018
PM 28239662
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Barletta, ABF
   Nascimento-Silva, MCL
   Talyuli, OAC
   Oliveira, JHM
   Pereira, LOR
   Oliveira, PL
   Sorgine, MHF
AF Barletta, Ana Beatriz Ferreira
   Nascimento-Silva, Maria Clara L.
   Talyuli, Octavio A. C.
   Oliveira, Jose Henrique M.
   Ramos Pereira, Luiza Oliveira
   Oliveira, Pedro L.
   Sorgine, Marcos Henrique F.
TI Microbiota activates IMD pathway and limits Sindbis infection in Aedes
   aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Sindbis virus; Immune response; IMD; Microbiota
ID JAK-STAT PATHWAY; TOLL; VECTOR; VIRUS; EXPRESSION; INSECTS; MIDGUT;
   SYSTEM; GENES; MODEL
AB Background: Aedes aegypti is the main vector of important arboviruses such as dengue, Zika and chikungunya. During infections mosquitoes can activate the immune pathways Toll, IMD and JAK/ STAT to limit pathogen replication.
   Results: Here, we evaluate the immune response profile of Ae. aegypti against Sindbis virus (SINV). We analyzed gene expression of components of Toll, IMD and JAK/STAT pathways and showed that a blood meal and virus infection upregulated aaREL2 in a microbiota-dependent fashion, since this induction was prevented by antibiotic. The presence of the microbiota activates IMD and impaired the replication of SINV in the midgut. Constitutive activation of the IMD pathway, by Caspar depletion, leads to a decrease in microbiota levels and an increase in SINV loads.
   Conclusion: Together, these results suggest that a blood meal is able to activate innate immune pathways, through a nutrient induced growth of microbiota, leading to upregulation of aaREL2 and IMD activation. Microbiota levels seemed to have a reciprocal interaction, where the proliferation of the microbiota activates IMD pathway that in turn controls bacterial levels, allowing SINV replication in Ae. aegypti mosquitoes. The activation of the IMD pathway seems to have an indirect effect in SINV levels that is induced by the microbiota. Keywords: Aedes aegypti, Sindbis virus, Immune response, IMD, Microbiota
C1 [Barletta, Ana Beatriz Ferreira; Nascimento-Silva, Maria Clara L.; Talyuli, Octavio A. C.; Oliveira, Pedro L.; Sorgine, Marcos Henrique F.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, RJ, Brazil.
   [Oliveira, Jose Henrique M.] Univ Fed Santa Catarina, Depat Microbiol Imunol Parasitol, Florianopolis, SC, Brazil.
   [Ramos Pereira, Luiza Oliveira] Fiocruz MS, Lab Pesquisas Leishmaniose, IOC, Rio De Janeiro, RJ, Brazil.
RP Barletta, ABF (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, RJ, Brazil.
EM barletta@bioqmed.ufrj.br
RI Pereira, Luiza O R/P-7606-2018; Oliveira, Pedro/A-9438-2010
OI Pereira, Luiza O R/0000-0002-8132-1724; Barletta Ferreira, Ana
   Beatriz/0000-0001-9913-3775; Oliveira, Pedro/0000-0003-0307-354X;
   /0000-0003-3814-5312
FU HHMIHoward Hughes Medical Institute; PRONEX; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX This work was supported by HHMI,PRONEX and CNPq.
CR Adouchief S, 2016, REV MED VIROL, V26, P221, DOI 10.1002/rmv.1876
   Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2
   Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025
   Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148
   Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737
   Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921
   Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Magalhaes T, 2010, ACTA TROP, V113, P167, DOI 10.1016/j.actatropica.2009.10.013
   MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8
   Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357
   Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006
   Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Shin SW, 2003, P NATL ACAD SCI USA, V100, P2616, DOI 10.1073/pnas.0537347100
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Upton LM, 2015, J INNATE IMMUN, V7, P74, DOI 10.1159/000365331
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 33
TC 24
Z9 24
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 23
PY 2017
VL 10
AR 103
DI 10.1186/s13071-017-2040-9
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO7UQ
UT WOS:000396896000002
PM 28231846
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khrustalev, VV
   Khrustaleva, TA
   Sharma, N
   Giri, R
AF Khrustalev, Vladislav V.
   Khrustaleva, Tatyana A.
   Sharma, Nitin
   Giri, Rajanish
TI Mutational Pressure in Zika Virus: Local ADAR-Editing Areas Associated
   with Pauses in Translation and Replication
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Zika virus; mutational pressure; pauses in replication; ADAR-editing;
   ribosome stalling
ID DOUBLE-STRANDED-RNA; CODON USAGE BIAS; G-QUADRUPLEXES; DNA; INITIATION;
   GENES
AB Zika virus (ZIKV) spread led to the recent medical health emergency of international concern. Understanding the variations in virus system is of utmost need. Using available complete sequences of ZIKV we estimated directions of mutational pressure along the length of consensus sequences of three lineages of the virus. Results showed that guanine usage is growing in ZIKV RNA plus strand due to adenine to guanine transitions, while adenine usage is growing due to cytosine to adenine transversions. Especially high levels of guanine have been found in two-fold degenerated sites of certain areas of RNA plus strand with high amount of secondary structure. The usage of cytosine in two-fold degenerated sites shows direct dependence on the amount of secondary structure in 52% (consensus sequence of East African ZIKV lineage)-32% (consensus sequence of epidemic strains) of the length of RNA minus strand. These facts are the evidences of ADAR-editing of both strands of ZIKV genome during pauses in replication. RNA plus strand can also be edited by ADAR during pauses in translation caused by the appearance of groups of rare codons. According to our results, RNA minus strand of epidemic ZIKV strain has lower number of points in which polymerase can be stalled (allowing ADAR-editing) compared to other strains. The data on preferable directions of mutational pressure in epidemic ZIKV strain is useful for future vaccine development and understanding the evolution of new strains.
C1 [Khrustalev, Vladislav V.] Belarusian State Med Univ, Dept Gen Chem, Minsk, BELARUS.
   [Khrustaleva, Tatyana A.] Natl Acad Sci Belarus, Inst Physiol, Lab Cellular Technol, Minsk, BELARUS.
   [Sharma, Nitin; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, India.
RP Khrustalev, VV (corresponding author), Belarusian State Med Univ, Dept Gen Chem, Minsk, BELARUS.; Giri, R (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, India.
EM vvkhrustalev@mail.ru; rajanishgiri@iitmandi.ac.in
RI Khrustalev, Vladislav/O-3833-2017; Giri, Rajanish/Q-6530-2018
OI Khrustalev, Vladislav/0000-0003-1373-3329; Sharma,
   Nitin/0000-0002-8176-7056; Giri, Rajanish/0000-0002-2046-836X
FU DST grant, India [YSS/2015/000613]; Indian Institute of Technology Mandi
FX This work has been funded by DST grant, India (YSS/2015/000613) that
   belongs to RG and Indian Institute of Technology Mandi.
CR Angeletti S, 2016, PATHOG GLOB HEALTH, V110, P269, DOI 10.1080/20477724.2016.1235337
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Canugovi C, 2009, FASEB J, V23, P34, DOI 10.1096/fj.08-115352
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cea V, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00209
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cristillo AD, 2001, J THEOR BIOL, V208, P475, DOI 10.1006/jtbi.2000.2233
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Cuevas JM, 2016, INFECT GENET EVOL, V41, P233, DOI 10.1016/j.meegid.2016.04.017
   Dana A, 2014, NUCLEIC ACIDS RES, V42, P9171, DOI 10.1093/nar/gku646
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005
   Guo FB, 2012, DNA RES, V19, P477, DOI 10.1093/dnares/dss027
   Guo FB, 2009, DNA RES, V16, P91, DOI 10.1093/dnares/dsp001
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023
   JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992
   Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168
   Khrustalev Vladislav Victorovich, 2015, Advances in Bioinformatics, V2015, P678587, DOI 10.1155/2015/678587
   Khrustalev Vladislav Victorovich, 2015, Int J Bioinform Res Appl, V11, P347
   Khrustalev VV, 2014, GENE, V546, P16, DOI 10.1016/j.gene.2014.05.045
   Khrustalev Vladislav Victorovich, 2011, Int J Bioinform Res Appl, V7, P82, DOI 10.1504/IJBRA.2011.039171
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g
   Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710
   Marintchev A, 2013, BBA-GENE REGUL MECH, V1829, P799, DOI 10.1016/j.bbagrm.2013.01.005
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   Rosenblum G, 2013, J AM CHEM SOC, V135, P11322, DOI 10.1021/ja405205c
   Stanton A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3183-3
   SUEOKA N, 1993, J MOL EVOL, V37, P137, DOI 10.1007/BF02407349
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Tomaselli S, 2015, CURR ISSUES MOL BIOL, V17, P37
   Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531
   Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Vilfan ID, 2008, NUCLEIC ACIDS RES, V36, P7059, DOI 10.1093/nar/gkn836
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zhao HL, 2015, INT J MOL SCI, V16, P23111, DOI 10.3390/ijms160923111
NR 46
TC 16
Z9 16
U1 2
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD FEB 22
PY 2017
VL 7
AR 44
DI 10.3389/fcimb.2017.00044
PG 17
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EL2OP
UT WOS:000394459500002
PM 28275585
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU van den Pol, AN
   Mao, GC
   Yang, Y
   Ornaghi, S
   Davis, JN
AF N., Anthony
   Mao, Guochao
   Yang, Yang
   Ornaghi, Sara
   Davis, John N.
TI Zika Virus Targeting in the Developing Brain
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE astrocyte; behavior dysfunction; development; infection; neurotropic;
   virus
ID CENTRAL-NERVOUS-SYSTEM; CYTOMEGALOVIRUS-INFECTION; PSEUDORABIES VIRUS;
   CASE SERIES; PREGNANCY; EPIDEMIOLOGY; REPLICATION; INTERFERON;
   EXPRESSION; TRANSPORT
AB Zika virus (ZIKV), a positive-sense RNA flavivirus, has attracted considerable attention recently for its potential to cause serious neurological problems, including microcephaly, cortical thinning, and blindness during early development. Recent findings suggest that ZIKV infection of the brain can occur not only during very early stages of development, but also in later fetal/early neonatal stages of maturation. Surprisingly, after peripheral inoculation of immunocompetent mice on the day of birth, the first cells targeted throughout the brain were isolated astrocytes. At later stages, more neurons showed ZIKV immunoreactivity, in part potentially due to ZIKV release from infected astrocytes. In all developing mice studied, we detected infection of retinal neurons; in many mice, this was also associated with infection of the lateral geniculate, suprachiasmatic nuclei, and superior colliculus, suggesting a commonality for the virus to infect cells of the visual system. Interestingly, in mature mice lacking a Type 1 interferon response (IFNR-/-), after inoculation of the eye, the initial majority of infected cells in the visual system were glial cells along the optic tract. ZIKV microinjection into the somatosensory cortex on one side of the normal mouse brain resulted in mirror infection restricted to the contralateral somatosensory cortex without any infection of midline brain regions, indicating the virus can move by axonal transport to synaptically coupled brain loci. These data support the view that ZIKV shows considerable complexity in targeting the CNS and may target different cells at different stages of brain development.
C1 [N., Anthony; Mao, Guochao; Yang, Yang; Ornaghi, Sara; Davis, John N.] Yale Univ Sch Med, Dept Neurosurgery, 333 Cedar St,New Haven, New Haven, CT 06520 USA.
RP van den Pol, AN (corresponding author), Yale Univ Sch Med, Dept Neurosurgery, 333 Cedar St,New Haven, New Haven, CT 06520 USA.
EM anthony.vandenpol@yale.edu
RI Ornaghi, Sara/K-4261-2018
OI Ornaghi, Sara/0000-0001-6898-7217
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 CA175577,
   CA188359]
FX This work was supported by National Institutes of Health R01 CA175577
   and CA188359. We thank Dr. Brett Lindenbach for the initial supply of
   ZIKV.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   BRAY PF, 1981, ANN NEUROL, V9, P499, DOI 10.1002/ana.410090513
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Card JP, 1995, J NEUROVIROL, V1, P349, DOI 10.3109/13550289509111024
   CARD JP, 1993, J NEUROSCI, V13, P2515
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014
   Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Carvalho Leal M, 2016, BRAZ J OTORHINOLAR, V30, P30127
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gallagher SK, 2010, J COMP NEUROL, V518, P3130, DOI 10.1002/cne.22387
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LINDENBACH BD, 2001, FIELDS VIROLOGY, P991
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4298
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MOCARSKI ES, 2007, FIELDS VIROLOGY, P2701
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Perez-Jimenez A, 1998, REV NEUROLOGIA, V26, P42
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Trevathan E, 2016, BIRTH DEFECTS RES A, V106, P869, DOI 10.1002/bdra.23582
   Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x
   van den Pol AN, 2002, J VIROL, V76, P1309, DOI 10.1128/JVI.76.3.1309-1327.2002
   van den Pol AN, 2007, J VIROL, V81, P332, DOI 10.1128/JVI.01592-06
   van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002
   van den Pol AN, 2014, J VIROL, V88, P3695, DOI 10.1128/JVI.03509-13
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302
   Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 66
TC 77
Z9 77
U1 1
U2 23
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 22
PY 2017
VL 37
IS 8
BP 2161
EP 2175
DI 10.1523/JNEUROSCI.3124-16.2017
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA EP2BV
UT WOS:000397188900018
PM 28123079
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Baxter, RHG
   Contet, A
   Krueger, K
AF Baxter, Richard H. G.
   Contet, Alicia
   Krueger, Kathryn
TI Arthropod Innate Immune Systems and Vector-Borne Diseases
SO BIOCHEMISTRY
LA English
DT Article
ID COMPLEMENT-LIKE PROTEIN; DOMAIN SERINE PROTEASES; MANDUCA-SEXTA
   HEMOLYMPH; ANOPHELES-GAMBIAE; DROSOPHILA-MELANOGASTER;
   CRYSTAL-STRUCTURE; PROPHENOLOXIDASE ACTIVATION; CROSS-LINKING;
   ANTIMICROBIAL PEPTIDES; PROCLOTTING ENZYME
AB Arthropods, especially ticks and mosquitoes, are the vectors for a number of parasitic and viral human diseases, including malaria, sleeping sickness, Dengue, and Zika, yet arthropods show tremendous individual variation in their capacity to transmit disease. A key factor in this capacity is the group of genetically encoded immune factors that counteract infection by the pathogen. Arthropod-specific pattern recognition receptors and protease cascades detect and respond to infection. Proteins such as antimicrobial peptides, thioester-containing proteins, and transglutaminases effect responses such as lysis, phagocytosis, melanization, and agglutination. Effector responses are initiated by damage signals such as reactive oxygen species signaling from epithelial cells and recognized by cell surface receptors on hemocytes. Antiviral immunity is primarily mediated by siRNA pathways but coupled with interferon-like signaling, antimicrobial peptides, and thioester-containing proteins. Molecular mechanisms of immunity are closely linked to related traits of longevity and fertility, and arthropods have the capacity for innate immunological memory. Advances in understanding vector immunity can be leveraged to develop novel control strategies for reducing the rate of transmission of both ancient and emerging threats to global health.
C1 [Baxter, Richard H. G.; Contet, Alicia; Krueger, Kathryn] Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT 06511 USA.
RP Baxter, RHG (corresponding author), 225 Prospect St, New Haven, CT 06520 USA.
EM richard.baxter@yale.edu
RI Baxter, Richard/F-3027-2013
OI Baxter, Richard/0000-0001-5140-1726
FU National Institute of General Medical Sciences of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [IR01GM114358]
FX This work was supported in part by the National Institute of General
   Medical Sciences (IR01GM114358) of the National Institutes of Health.
CR Abbas AK, 2005, CELLULAR MOL IMMUNOL
   Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   An CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079533
   An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z
   An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112
   Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554
   Arefin B, 2014, J INNATE IMMUN, V6, P192, DOI 10.1159/000353734
   Batz T, 2014, DEVELOPMENT, V141, P899, DOI 10.1242/dev.102160
   Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001
   Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104
   Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107
   Bernhardt SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044198
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4
   Blandin SA, 2007, IMMUNOL REV, V219, P8, DOI 10.1111/j.1600-065X.2007.00553.x
   Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241
   Bryant CE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120015
   Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009
   Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106
   Bukhari T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-23
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Castillejo-Lopez C, 2005, BIOCHEM BIOPH RES CO, V338, P1075, DOI 10.1016/j.bbrc.2005.10.042
   Charroux B, 2009, MICROBES INFECT, V11, P631, DOI 10.1016/j.micinf.2009.03.004
   Cheng G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022786
   Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136
   Contreras-Garduno J, 2014, MICROBES INFECT, V16, P261, DOI 10.1016/j.micinf.2013.11.010
   Dambach P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1438-8
   DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104
   Dias RD, 2015, PEPTIDES, V72, P64, DOI 10.1016/j.peptides.2015.04.017
   Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Dostalova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-276
   Doucet D, 2012, ADV INSECT PHYSIOL, V43, P437, DOI 10.1016/B978-0-12-391500-9.00006-1
   Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132
   El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643
   Estevez-Lao TY, 2014, INSECT BIOCHEM MOLEC, V44, P12, DOI 10.1016/j.ibmb.2013.10.008
   Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115
   Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640
   Fernandes EKK, 2012, EXP PARASITOL, V130, P300, DOI 10.1016/j.exppara.2011.11.004
   Forlani L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003778
   Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gerdemann C, 2002, ACCOUNTS CHEM RES, V35, P183, DOI 10.1021/ar990019a
   Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046
   Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003
   Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311
   Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765
   Hall S, 2014, DEVELOPMENT, V141, P889, DOI 10.1242/dev.102152
   Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030
   Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006
   Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001
   Iatsenko I, 2016, IMMUNITY, V45, P1013, DOI 10.1016/j.immuni.2016.10.029
   Ibrahim MA, 2013, EXP BIOL MED, V238, P350, DOI 10.1177/1535370213477973
   Igboin CO, 2011, INFECT IMMUN, V79, P449, DOI 10.1128/IAI.00785-10
   Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013
   Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1
   Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200
   Jones J. C., 1977, CIRCULATORY SYSTEM I
   Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200
   Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003
   Keebaugh ES, 2014, DEV COMP IMMUNOL, V42, P111, DOI 10.1016/j.dci.2013.06.001
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kellenberger C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182741
   Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200
   Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200
   Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200
   Kumar S, 2005, INSECT BIOCHEM MOLEC, V35, P721, DOI 10.1016/j.ibmb.2005.02.014
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006
   Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427
   Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958
   Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7
   Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106
   Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200
   Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3
   Matthews KR, 2011, SCIENCE, V331, P1149, DOI 10.1126/science.1198077
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028
   McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127
   Midega J, 2013, PATHOG GLOB HEALTH, V107, P463, DOI 10.1179/204777213X13867543472674
   Milutinovic B, 2016, ZOOLOGY, V119, P254, DOI 10.1016/j.zool.2016.03.006
   Milutinovic B, 2016, SEMIN IMMUNOL, V28, P328, DOI 10.1016/j.smim.2016.05.004
   Ming M, 2014, J BIOL CHEM, V289, P7558, DOI 10.1074/jbc.M113.543884
   Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006
   Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moreira S, 2010, CURR BIOL, V20, P464, DOI 10.1016/j.cub.2010.01.047
   MUTA T, 1990, J BIOL CHEM, V265, P22426
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nam HJ, 2012, EMBO J, V31, P1253, DOI 10.1038/emboj.2011.476
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nsango SE, 2013, J BIOL CHEM, V288, P16145, DOI 10.1074/jbc.M112.443267
   O'Neill SL, 2016, SCIENCE, V352, P526, DOI 10.1126/science.352.6285.526-a
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Oppedijk SF, 2016, BBA-BIOMEMBRANES, V1858, P947, DOI 10.1016/j.bbamem.2015.10.024
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541
   Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026
   Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006
   Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891
   Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200
   Pompon J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002255
   Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623
   Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023
   Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Ramirez JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8403
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Ramphul UN, 2015, P NATL ACAD SCI USA, V112, P1273, DOI 10.1073/pnas.1423586112
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rangarajan N, 2013, BIOCHEMISTRY-US, V52, P6584, DOI 10.1021/bi400785j
   Rehman AA, 2013, J CELL PHYSIOL, V228, P1665, DOI 10.1002/jcp.24266
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006
   Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019
   Schwenke RA, 2016, ANNU REV ENTOMOL, V61, P239, DOI 10.1146/annurev-ento-010715-023924
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133
   Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970
   Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477
   SMITH CL, 1992, PROTEIN SCI, V1, P1225, DOI 10.1002/pro.5560010915
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004
   Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240
   Sugumaran M, 2010, ADV INSECT PHYSIOL, V39, P151, DOI 10.1016/S0065-2806(10)39005-9
   Suzuki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12701
   Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200
   Unckless RL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0291
   Veillard F, 2016, BIOCHIMIE, V122, P255, DOI 10.1016/j.biochi.2015.10.007
   Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001
   Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009
   Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013
   Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763
   Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531
   Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887
   Weavers H, 2016, CELL, V165, P1658, DOI 10.1016/j.cell.2016.04.049
   Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691
   Weiss BL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000619
   Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111
   Williams Marni, 2014, Biophysical Reviews, V6, P261, DOI 10.1007/s12551-014-0142-6
   World Health Organization, 2006, WHO TECHNICAL REPORT, P62
   Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027
   Xu J, 2012, CELL HOST MICROBE, V12, P531, DOI 10.1016/j.chom.2012.08.011
   Yassine H, 2014, J INNATE IMMUN, V6, P806, DOI 10.1159/000363296
   Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6
   Zhang X, 2016, INSECT BIOCHEM MOLEC, V71, P106, DOI 10.1016/j.ibmb.2016.02.008
   Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011
NR 169
TC 19
Z9 19
U1 3
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 21
PY 2017
VL 56
IS 7
BP 907
EP 918
DI 10.1021/acs.biochem.6b00870
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EL6IL
UT WOS:000394725300002
PM 28072517
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Barouch, DH
   Thomas, SJ
   Michael, NL
AF Barouch, Dan H.
   Thomas, Stephen J.
   Michael, Nelson L.
TI Prospects for a Zika Virus Vaccine
SO IMMUNITY
LA English
DT Review
ID ANTIBODY-DEPENDENT ENHANCEMENT; BORNE ENCEPHALITIS-VIRUS;
   GUILLAIN-BARRE-SYNDROME; TETRAVALENT DENGUE VACCINE; JAPANESE
   ENCEPHALITIS; PROTECTIVE EFFICACY; CROSS-REACTIVITY; STRUCTURAL BASIS;
   BIRTH-DEFECTS; INFECTION
AB A recent unprecedented outbreak of Zika virus (ZIKV) in the Americas has been associated with microcephaly and other congenital malformations in infants as well as Guillain-Barre syndrome in adults. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Promising data from preclinical vaccine studies in mice and monkeys suggest that an effective vaccine will likely be possible, but important scientific challenges remain. Here we review the current state of ZIKV vaccine development. We discuss different vaccination strategies and we highlight challenges facing clinical evaluation of ZIKV vaccine candidates.
C1 [Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Harvard Med Sch, Boston, MA 02215 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT Harvard, Cambridge, MA 02139 USA.
   [Thomas, Stephen J.] State Univ New York, Upstate Med Univ, Syracuse, NY 13210 USA.
   [Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA.
RP Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Harvard Med Sch, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Barouch, Dan/Y-3918-2019
FU U.S. Military Research and Materiel Command; U.S. Military HIV Research
   Program [W81XWH-11-2-0174]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI095985,
   AI096040, AI100663, AI124377]; Ragon Institute of MGH, MIT, and Harvard
FX We acknowledge support from the U.S. Military Research and Materiel
   Command and the U.S. Military HIV Research Program (W81XWH-11-2-0174),
   the NIH (AI095985, AI096040, AI100663, AI124377), and the Ragon
   Institute of MGH, MIT, and Harvard. The views expressed in this
   manuscript are those of the authors and do not represent the official
   views of the Department of the Army or the Department of Defense.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Charles AS, 2016, PLOS CURR, V2016, P8
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N., 2017, NATURE
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   SPECTOR S, 1968, APPL MICROBIOL, V16, P1770, DOI 10.1128/AEM.16.11.1770-1775.1968
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Venturi G, 2006, J VIROL METHODS, V134, P136, DOI 10.1016/j.jviromet.2005.12.010
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   WHO, 2016, VACCINE, V34, P302, DOI 10.1016/j.vaccine.2015.07.057
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 78
TC 50
Z9 52
U1 1
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD FEB 21
PY 2017
VL 46
IS 2
BP 176
EP 182
DI 10.1016/j.immuni.2017.02.005
PG 7
WC Immunology
SC Immunology
GA EO0TM
UT WOS:000396410900007
PM 28228277
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Paules, CI
   Fauci, AS
AF Paules, Catharine I.
   Fauci, Anthony S.
TI Emerging and Reemerging Infectious Diseases The Dichotomy Between Acute
   Outbreaks and Chronic Endemicity
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; WEST NILE VIRUS
C1 [Paules, Catharine I.; Fauci, Anthony S.] NIAID, Off Director, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Fauci, AS (corresponding author), NIAID, 31 Ctr Dr,MSC 2520,Bldg 31,Room 7A-03, Bethesda, MD 20892 USA.
EM afauci@niaid.nih.gov
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Collucci C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6360
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
NR 7
TC 11
Z9 11
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD FEB 21
PY 2017
VL 317
IS 7
BP 691
EP 692
DI 10.1001/jama.2016.21079
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL8WR
UT WOS:000394901600011
PM 28097318
DA 2020-07-08
ER

PT J
AU Vermillion, MS
   Lei, J
   Shabi, Y
   Baxter, VK
   Crilly, NP
   McLane, M
   Griffin, DE
   Pekosz, A
   Klein, SL
   Burd, I
AF Vermillion, Meghan S.
   Lei, Jun
   Shabi, Yahya
   Baxter, Victoria K.
   Crilly, Nathan P.
   McLane, Michael
   Griffin, Diane E.
   Pekosz, Andrew
   Klein, Sabra L.
   Burd, Irina
TI Intrauterine Zika virus infection of pregnant immunocompetent mice
   models transplacental transmission and adverse perinatal outcomes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NEURAL PROGENITORS; 1ST TRIMESTER; BRAIN; CELLS; ORGANOIDS; SYSTEM;
   STRAIN; GROWTH; BIRTH; RISK
AB Zika virus (ZIKV) crosses the placenta and causes congenital disease. Here we develop an animal model utilizing direct ZIKV inoculation into the uterine wall of pregnant, immunocompetent mice to evaluate transplacental transmission. Intrauterine inoculation at embryonic day (E) 10, but not E14, with African, Asian or American strains of ZIKV reduces fetal viability and increases infection of placental and fetal tissues. ZIKV inoculation at E10 causes placental inflammation, placental dysfunction and reduces neonatal brain cortical thickness, which is associated with increased activation of microglia. Viral antigen localizes in trophoblast and endothelial cells in the placenta, and endothelial, microglial and neural progenitor cells in the fetal brain. ZIKV infection of the placenta increases production of IFN beta and expression of IFN-stimulated genes 48 h after infection. This mouse model provides a platform for identifying factors at the maternal-fetal interface that contribute to adverse perinatal outcomes in a host with an intact immune system.
C1 [Vermillion, Meghan S.; Baxter, Victoria K.; Crilly, Nathan P.; Griffin, Diane E.; Pekosz, Andrew; Klein, Sabra L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
   [Vermillion, Meghan S.; Baxter, Victoria K.] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA.
   [Lei, Jun; Shabi, Yahya; McLane, Michael; Burd, Irina] Johns Hopkins Univ, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Sch Med, Baltimore, MD 21287 USA.
   [Crilly, Nathan P.] Univ Tennessee, Sch Vet Med, Knoxville, TN 37996 USA.
RP Klein, SL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.; Burd, I (corresponding author), Johns Hopkins Univ, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Sch Med, Baltimore, MD 21287 USA.
EM Sklein2@jhu.edu; Iburd@jhmi.edu
OI Pekosz, Andrew/0000-0003-3248-1761
FU Center for Emerging and Infectious Diseases (CEVID) at Johns Hopkins
   University; Medtronics award from the Society for Women's Health
   Research; Integrated Research Center for Fetal Medicine; Sheikh Abdullah
   Bugshan Fund; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 OD011089]; Merial
   Veterinary Scholars Program
FX We thank members of the Klein and Pekosz labs for detailed discussions
   about these data, Anne Jedlicka for assistance with qRT-PCR and Jennifer
   Fairman and Alan Burd for graphic assistance. The work was supported by
   the Center for Emerging and Infectious Diseases (CEVID) at Johns Hopkins
   University, Medtronics award from the Society for Women's Health
   Research (S.L.K.), Integrated Research Center for Fetal Medicine (I.B.)
   and Sheikh Abdullah Bugshan Fund (I.B.), the NIH T32 OD011089 Training
   Veterinarians for Careers in Biomedical Research (M.S.V. and V.K.B.) and
   the Merial Veterinary Scholars Program (N.P.C.).
CR Barton MA, 2016, CAN MED ASSOC J, V188, pE118, DOI 10.1503/cmaj.160179
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009
   Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen JJ, 2011, J HUAZHONG U SCI-MED, V31, P371, DOI 10.1007/s11596-011-0383-6
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Ishikawa H, 2006, REPROD TOXICOL, V21, P267, DOI 10.1016/j.reprotox.2005.08.002
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jozuka K. O., 2016, THAILAND CONFIRMS AS
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lisman BAM, 2007, HUM REPROD, V22, P2254, DOI 10.1093/humrep/dem143
   Liu S., 2016, CIRC RES
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mayhew TM, 2009, J ANAT, V215, P77, DOI 10.1111/j.1469-7580.2008.00994.x
   McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3048
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molnar Z, 2016, NAT REV NEUROL, V12, P315, DOI 10.1038/nrneurol.2016.71
   Moore CA, 2016, JAMA PEDIAT
   Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pacheco O, 2016, N ENGL J MED
   Patten AR, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00093
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang Y., 2010, VASCULAR BIOL PLACEN
   Wu D, 2015, J MAGN RESON IMAGING, V42, P717, DOI 10.1002/jmri.24828
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 66
TC 65
Z9 66
U1 0
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 21
PY 2017
VL 8
AR 14575
DI 10.1038/ncomms14575
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL3DZ
UT WOS:000394501100001
PM 28220786
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Richard, AS
   Shim, BS
   Kwon, YC
   Zhang, R
   Otsuka, Y
   Schmitt, K
   Berri, F
   Diamond, MS
   Choe, H
AF Richard, Audrey Stephanie
   Shim, Byoung-Shik
   Kwon, Young-Chan
   Zhang, Rong
   Otsuka, Yuka
   Schmitt, Kimberly
   Berri, Fatma
   Diamond, Michael S.
   Choe, Hyeryun
TI AXL-dependent infection of human fetal endothelial cells distinguishes
   Zika virus from other pathogenic flaviviruses
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; Flaviviruses; AXL; placental barrier; fetal endothelial cell
ID DENGUE VIRUS; DC-SIGN; HUMAN BRAIN; GAS6; RECEPTORS; PHOSPHATIDYLSERINE;
   IDENTIFICATION; TRANSMISSION; ACTIVATION; MATURATION
AB Although a causal relationship between Zika virus (ZIKV) and microcephaly has been established, it remains unclear why ZIKV, but not other pathogenic flaviviruses, causes congenital defects. Here we show that when viruses are produced in mammalian cells, ZIKV, but not the closely related dengue virus (DENV) or West Nile virus (WNV), can efficiently infect key placental barrier cells that directly contact the fetal bloodstream. We show that AXL, a receptor tyrosine kinase, is the primary ZIKV entry cofactor on human umbilical vein endothelial cells (HUVECs), and that ZIKV uses AXL with much greater efficiency than does DENV or WNV. Consistent with this observation, only ZIKV, but not WNV or DENV, bound the AXL ligand Gas6. In comparison, when DENV and WNV were produced in insect cells, they also infected HUVECs in an AXL-dependent manner. Our data suggest that ZIKV, when produced from mammalian cells, infects fetal endothelial cells much more efficiently than other pathogenic flaviviruses because it binds Gas6 more avidly, which in turn facilitates its interaction with AXL.
C1 [Richard, Audrey Stephanie; Shim, Byoung-Shik; Kwon, Young-Chan; Otsuka, Yuka; Schmitt, Kimberly; Berri, Fatma; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA.
   [Zhang, Rong; Diamond, Michael S.] Washington Univ Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Zhang, Rong; Diamond, Michael S.] Washington Univ Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Zhang, Rong; Diamond, Michael S.] Washington Univ Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Zhang, Rong; Diamond, Michael S.] Washington Univ Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Choe, H (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA.
EM hchoe@scripps.edu
RI Diamond, Michael/AAH-1733-2019; Zhang, Rong/J-5434-2018
OI Diamond, Michael/0000-0002-8791-3165; Zhang, Rong/0000-0003-2941-4808
FU Scripps Research Institute; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI110692,
   R01 AI073755, R01 AI101400]
FX We thank Dr. Robert Tesh at the University of Texas Medical Branch at
   Galveston, and the World Reference Center for Emerging Viruses and
   Arboviruses, for providing us with WNV, ZIKV, and hyperimmune ascites
   against ZIKV. This work was supported by startup funds from The Scripps
   Research Institute and NIH Grants R01 AI110692 to H.C.) and R01 AI073755
   and R01 AI101400 to M.S.D.).
CR Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48
   Bauer T, 2012, J EXP MED, V209, P2033, DOI 10.1084/jem.20120493
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Blostein MD, 2011, J THROMB THROMBOLYS, V32, P272, DOI 10.1007/s11239-011-0597-2
   Borgel D, 2006, CRIT CARE MED, V34, P219, DOI 10.1097/01.CCM.0000195014.56254.8A
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li N, 2015, IMMUNOL CELL BIOL, V93, P311, DOI 10.1038/icb.2014.97
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Mukhtar M, 2002, VIROLOGY, V297, P78, DOI 10.1006/viro.2002.1376
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Winkelmann ER, 2016, F1000RESEARCH, DOI 10.12688/f1000research.7404.1
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662
NR 52
TC 81
Z9 82
U1 1
U2 29
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 21
PY 2017
VL 114
IS 8
BP 2024
EP 2029
DI 10.1073/pnas.1620558114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM1TI
UT WOS:000395099500085
PM 28167751
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Bukrinsky, M
AF Bukrinsky, Michael
TI Yeast help identify cytopathic factors of Zika virus
SO CELL AND BIOSCIENCE
LA English
DT Editorial Material
DE Zika virus; ZIKV proteins; TOR pathway; Microcephaly; Yeast
ID PROTEINS
AB Accumulating evidence implicates Zika virus (ZIKV) in pathogenesis of microcephaly in newborns and Guillain-Barre syndrome in adults. However, it remains unclear which viral proteins are responsible for these effects and what are the underlying mechanisms of their pathogenic activity. A recent paper by Drs. Zhao and Gallo, and their colleagues at University of Maryland in Baltimore used fission yeast for genome-wide analysis of ZIKV proteins. They demonstrated cytopathogenic activity for seven ZIKV proteins, anaC, C, prM, M, E, NS2B and NS4A. This activity was shown to be dependent on oxidative stress, and for NS4A they demonstrated involvement of the TOR stress-response pathway. Taken together, the findings presented in this paper provide the basis for further mechanistic studies that potentially can identify therapeutic means to treat neuro and immune complications of ZIKV infection.
C1 [Bukrinsky, Michael] George Washington Univ, Sch Med & Hlth Sci, 2300 Eye St NW, Washington, DC 20037 USA.
RP Bukrinsky, M (corresponding author), George Washington Univ, Sch Med & Hlth Sci, 2300 Eye St NW, Washington, DC 20037 USA.
EM mbukrins@gwu.edu
FU MITM internal funding
FX This work was supported by MITM internal funding.
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
NR 11
TC 2
Z9 2
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD FEB 20
PY 2017
VL 7
AR 12
DI 10.1186/s13578-017-0139-5
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EM7AA
UT WOS:000395462600001
PM 28239447
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Journel, I
   Andrecy, LL
   Metellus, D
   Pierre, JS
   Faublas, RM
   Jain, S
   Dismer, AM
   Fitter, DL
   Neptune, D
   Laraque, MJ
   Corvil, S
   Pierre, M
   Buteau, J
   Lafontant, D
   Patel, R
   Lemoine, JF
   Lowrance, DW
   Charles, M
   Boncy, J
   Adrien, P
AF Journel, Ito
   Andrecy, Lesly L.
   Metellus, Dudley
   Pierre, Jean S.
   Faublas, Rose Murka
   Jain, Stanley
   Dismer, Amber M.
   Fitter, David L.
   Neptune, Daniel
   Laraque, Marie Jose
   Corvil, Salomon
   Pierre, Manise
   Buteau, Josiane
   Lafontant, Donald
   Patel, Roopal
   Lemoine, Jean Frantz
   Lowrance, David W.
   Charles, Macarthur
   Boncy, Jacques
   Adrien, Paul
TI Transmission of Zika Virus - Haiti, October 12, 2015-September 10, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Journel, Ito; Laraque, Marie Jose; Buteau, Josiane; Lafontant, Donald; Boncy, Jacques] Natl Lab Publ Hlth, Port Au Prince, Haiti.
   [Andrecy, Lesly L.; Metellus, Dudley; Pierre, Jean S.; Faublas, Rose Murka; Neptune, Daniel; Laraque, Marie Jose; Corvil, Salomon; Adrien, Paul] Directorate Epidemiol Lab & Res, Port Au Prince, Haiti.
   [Jain, Stanley; Fitter, David L.; Pierre, Manise; Patel, Roopal; Charles, Macarthur] CDC, Port Au Prince, Haiti.
   [Dismer, Amber M.] CDC, Div Global Hlth Protect, Atlanta, GA 30333 USA.
   [Lemoine, Jean Frantz] Natl Malaria Control Program, Port Au Prince, Haiti.
   [Lowrance, David W.] CDC, Dar Es Salaam, Tanzania.
RP Adrien, P (corresponding author), Directorate Epidemiol Lab & Res, Port Au Prince, Haiti.
EM padrien2004@yahoo.fr
CR Direction de Promotion de la Sante et de Protection de l'Environement; Ministere de la Sante Publique et de la Population; Pan American Health Organization; World Health Organization, 2016, ZIK FANM ANS AK ZIK
   Ministere de la Sante Publique et de la Population, 2016, GUID NAT SURV EP ZIK
   Pan American Health Organization, 2015, ALG DET ZIK VIR ZIKV
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Singer R, 2016, PANDEMIES CHOLERA ZI
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 8
TC 6
Z9 6
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD FEB 17
PY 2017
VL 66
IS 6
BP 172
EP 176
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EL3ZZ
UT WOS:000394561000004
PM 28207688
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez, SD
   Chung, HN
   Gonzales, KK
   Vulcan, J
   Li, YY
   Ahumada, JA
   Romero, HM
   De La Torre, M
   Shu, FJ
   Hansen, IA
AF Rodriguez, Stacy D.
   Chung, Hae-Na
   Gonzales, Kristina K.
   Vulcan, Julia
   Li, Yiyi
   Ahumada, Jorge A.
   Romero, Hector M.
   De La Torre, Mario
   Shu, Fangjun
   Hansen, Immo A.
TI Efficacy of Some Wearable Devices Compared with Spray-On Insect
   Repellents for the Yellow Fever Mosquito, Aedes aegypti (L.) (Diptera:
   Culicidae)
SO JOURNAL OF INSECT SCIENCE
LA English
DT Article
DE repellent; Aedes; yellow fever mosquito; DEET; taxis cage
ID PERSONAL PROTECTION; WIND-TUNNEL; ZIKA VIRUS; MALARIA; EPIDEMIOLOGY;
   RESPONSES; AMERICA; DENGUE
AB The current Zika health crisis in the Americas has created an intense interest in mosquito control methods and products. Mosquito vectors of Zika are of the genus Aedes, mainly the yellow fever mosquito, Aedes aegypti. L. The use of repellents to alter mosquito host seeking behavior is an effective method for the prevention of mosquito-borne diseases. A large number of different spray-on repellents and wearable repellent devices are commercially available. The efficacies of many repellents are unknown. This study focuses on the efficacy of eleven different repellents in reducing the number of Ae. aegypti female mosquitoes attracted to human bait. We performed attraction-inhibition assays using a taxis cage in a wind tunnel setting. One person was placed upwind of the taxis cage and the mosquito movement towards or away from the person was recorded. The person was treated with various spray-on repellents or equipped with different mosquito repellent devices. We found that the spray-on repellents containing N,N-Diethyl-meta-toluamide and p-menthane-3,8-diol had the highest efficacy in repelling mosquitoes compared to repellents with other ingredients. From the five wearable devices that we tested, only the one that releases Metofluthrin significantly reduced the numbers of attracted mosquitoes. The citronella candle had no effect. We conclude that many of the products that we tested that were marketed as repellents do not reduce mosquito attraction to humans.
C1 [Rodriguez, Stacy D.; Chung, Hae-Na; Gonzales, Kristina K.; Vulcan, Julia; Hansen, Immo A.] New Mexico State Univ, Dept Biol, 1200 S Horseshoe Dr, Las Cruces, NM 88003 USA.
   [Ahumada, Jorge A.; Romero, Hector M.; De La Torre, Mario; Shu, Fangjun] New Mexico State Univ, Mech & Aerosp Engn, 1040 S Horseshoe Dr, Las Cruces, NM 88003 USA.
   [Li, Yiyi] New Mexico State Univ, Dept Comp Sci, 1290 Frenger Mall, Las Cruces, NM 88003 USA.
   [Hansen, Immo A.] New Mexico State Univ, Inst Appl Biosci, 1200 S Horseshoe Dr, Las Cruces, NM 88003 USA.
RP Rodriguez, SD (corresponding author), New Mexico State Univ, Dept Biol, 1200 S Horseshoe Dr, Las Cruces, NM 88003 USA.
EM stacyr@nmsu.edu
CR Andrade CFS, 2010, J VECTOR ECOL, V35, P75, DOI 10.1111/j.1948-7134.2010.00031.x
   Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2
   Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x
   Durrheim DN, 2002, MED VET ENTOMOL, V16, P112, DOI 10.1046/j.0269-283x.2002.00349.x
   EIRAS AE, 1991, B ENTOMOL RES, V81, P151, DOI 10.1017/S0007485300051221
   ELZEN GW, 1986, ENTOMOL EXP APPL, V42, P285, DOI 10.1007/BF00629316
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FOSTER WA, 1985, J AM MOSQUITO CONTR, V1, P199
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023
   Fuss SH, 2013, MOL CELL NEUROSCI, V56, P212, DOI 10.1016/j.mcn.2013.05.002
   Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014
   Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442
   GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kroeger A, 1997, AM J TROP MED HYG, V56, P580, DOI 10.4269/ajtmh.1997.56.580
   Kroeger A, 1999, T ROY SOC TROP MED H, V93, P565, DOI 10.1016/S0035-9203(99)90048-2
   Lorenz LM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-131
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Marquardt W. C, 2004, BIOL DIS VECTORS
   MILLER JR, 1978, J CHEM ECOL, V4, P187, DOI 10.1007/BF00988054
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mount G., 1976, MOSQ NEWS, V36
   Patel EK, 2012, INT J PHARM CHEM BIO, V2, P310
   Revay EE, 2013, ACTA TROP, V125, P226, DOI 10.1016/j.actatropica.2012.10.009
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P77
   TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816
   TUMLINSON JH, 1989, ARCH INSECT BIOCHEM, V10, P255, DOI 10.1002/arch.940100402
   VISSER JH, 1976, ENTOMOL EXP APPL, V20, P275, DOI 10.1007/BF00573833
   WHO, 2013, GUID EFF TEST SPAT R
   Xue RD, 2012, J MED ENTOMOL, V49, P652, DOI 10.1603/ME10227
   Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017
NR 41
TC 13
Z9 13
U1 1
U2 14
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
EI 1536-2442
J9 J INSECT SCI
JI J Insect Sci.
PD FEB 16
PY 2017
VL 17
AR 24
DI 10.1093/jisesa/iew117
PG 6
WC Entomology
SC Entomology
GA EO4WM
UT WOS:000396695000001
PM 28423421
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leal, WS
   Barbosa, RMR
   Zeng, FF
   Faierstein, GB
   Tan, KM
   Paiva, MHS
   Guedes, DRD
   Crespo, MM
   Ayres, CFJ
AF Leal, Walter S.
   Barbosa, Rosangela M. R.
   Zeng, Fangfang
   Faierstein, Gabriel B.
   Tan, Kaiming
   Paiva, Marcelo H. S.
   Guedes, Duschinka R. D.
   Crespo, Monica M.
   Ayres, Constancia F. J.
TI Does Zika virus infection affect mosquito response to repellents?
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AEGYPTI DIPTERA-CULICIDAE; AEDES-AEGYPTI; SINDBIS VIRUS; INSECT
   REPELLENTS; DENGUE VIRUS; DEET; ANOPHELES; BRAZIL; OUTBREAK; EFFICACY
AB The World Health Organization (WHO) recommends that people travelling to or living in areas with Zika virus (ZIKV) outbreaks or epidemics adopt prophylactic measures to reduce or eliminate mosquito bites, including the use of insect repellents. It is, however, unknown whether repellents are effective against ZIKV-infected mosquitoes, in part because of the ethical concerns related to exposing a human subject's arm to infected mosquitoes in the standard arm-in-cage assay. We used a previously developed, human subject-free behavioural assay, which mimics a human subject to evaluate the top two recommended insect repellents. Our measurements showed that DEET provided significantly higher protection than picaridin provided against noninfected, host-seeking females of the southern house mosquito, Culex quinquefasciatus, and the yellow fever mosquito, Aedes aegypti. When tested at lower doses, we observed a significant reduction in DEET-elicited protection against ZIKV-infected yellow fever mosquitoes from old and recent laboratory colonies. The reduction in protection is more likely associated with aging than the virus infection and could be compensated by applying a 5x higher dose of DEET. A substantial protection against ZIKV-infected and old noninfected mosquitoes was achieved with 5% DEET, which corresponds approximately to a 30% dose in the conventional arm-in-cage assays.
C1 [Leal, Walter S.; Zeng, Fangfang; Tan, Kaiming] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
   [Barbosa, Rosangela M. R.; Faierstein, Gabriel B.; Paiva, Marcelo H. S.; Guedes, Duschinka R. D.; Crespo, Monica M.; Ayres, Constancia F. J.] Fundacao Oswaldo Cruz, Dept Entomol, Ctr Pesquisas Aggeu Magalhaes, Campus Univ Fed Pernambuco, BR-50740465 Recife, PE, Brazil.
   [Paiva, Marcelo H. S.] Univ Fed Pernambuco, Ctr Acad Agreste, Rodovia BR-104,Km 59 Nova Caruaru, BR-55002970 Caruaru, PE, Brazil.
RP Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
EM wsleal@ucdavis.edu
RI Ayres, Constancia/AAQ-3448-2020
FU National Institute of Allergy and Infectious Diseases (NIAID) of the
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI128931]; National
   Institute of Allergy and Infectious Diseases (NIAID) of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI128931]
FX The authors thank Dr. Anthon Cornel (University of California,
   Department of Entomology & Nematology) for providing mosquitoes that
   allowed us to duplicate his colony at the Davis campus, Dr. Kamal
   Chauhan (United States Department of Agriculture, Agricultural Research
   Service, Invasive Insect Biocontrol and Behavior Laboratory) for
   providing a sample of picaridin, and Dr. Bogdan Barnych (University of
   California, Department of Entomology & Nematology) for NMR measurements.
   Research reported in this publication was supported by the National
   Institute of Allergy and Infectious Diseases (NIAID) of the National
   Institutes of Health under award number R21AI128931. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH.
CR [Anonymous], 2009, GUID EFF TEST MOSQ R
   Badolo A, 2004, TROP MED INT HEALTH, V9, P330, DOI 10.1111/j.1365-3156.2004.01206.x
   Barbosa PP, 2016, J MED ENTOMOL, V53, P613, DOI 10.1093/jme/tjw034
   Bowers DF, 2003, J MED ENTOMOL, V40, P698, DOI 10.1603/0022-2585-40.5.698
   Brown M, 1997, J AM ACAD DERMATOL, V36, P243, DOI 10.1016/S0190-9622(97)70289-5
   BUESCHER MD, 1983, MOSQ NEWS, V43, P364
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, 2016, ZIK VIR CAS COUNTS U
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EPA, 2010, PROD PERF TEST GUID
   EPA, 2016, DEET
   Frances SP, 2011, J MED ENTOMOL, V48, P334, DOI 10.1603/ME10120
   Guedes DRD, 2016, BIORXIV, DOI [10.1101/073197, DOI 10.1101/073197]
   Klun JA, 2003, J MED ENTOMOL, V40, P293, DOI 10.1603/0022-2585-40.3.293
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal W., 2016, F1000 RES, V5, DOI 10.12688/f1000research.9839.2
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Miller JR, 2009, J ECON ENTOMOL, V102, P2056, DOI 10.1603/029.102.0606
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Obermayr U, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P91
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Patel RV, 2016, PHARMACOTHERAPY, V36, P1272, DOI 10.1002/phar.1854
   Qualls WA, 2012, ACTA TROP, V122, P284, DOI 10.1016/j.actatropica.2012.01.012
   Qualls WA, 2012, J MED ENTOMOL, V49, P418, DOI 10.1603/ME11102
   Qualls WA, 2011, J MED ENTOMOL, V48, P1226, DOI 10.1603/ME10163
   SELIM S, 1995, FUND APPL TOXICOL, V25, P95, DOI 10.1006/faat.1995.1043
   Sugiharto VA, 2016, J MED ENTOMOL, V53, P687, DOI 10.1093/jme/tjw030
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tisgratog R, 2016, J AM MOSQUITO CONTR, V32, P177, DOI 10.2987/16-6567.1
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149
   World Health Organization, 2016, ZIK VIR
   Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 9
Z9 9
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 16
PY 2017
VL 7
AR 42826
DI 10.1038/srep42826
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK9FB
UT WOS:000394228300001
PM 28205633
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hulo, C
   Masson, P
   de Castro, E
   Auchincloss, AH
   Foulger, R
   Poux, S
   Lomax, J
   Bougueleret, L
   Xenarios, I
   Le Mercier, P
AF Hulo, Chantal
   Masson, Patrick
   de Castro, Edouard
   Auchincloss, Andrea H.
   Foulger, Rebecca
   Poux, Sylvain
   Lomax, Jane
   Bougueleret, Lydie
   Xenarios, Ioannis
   Le Mercier, Philippe
TI The ins and outs of eukaryotic viruses: Knowledge base and ontology of a
   viral infection
SO PLOS ONE
LA English
DT Article
ID STRANDED-RNA VIRUSES; DNA-REPLICATION; TRANSLATIONAL TERMINATION; GENE
   ONTOLOGY; ENTRY; INFLUENZA; CELLS; TRANSCRIPTION; MICROTUBULES;
   TRAFFICKING
AB Viruses are genetically diverse, infect a wide range of tissues and host cells and follow unique processes for replicating themselves. All these processes were investigated and indexed in ViralZone knowledge base. To facilitate standardizing data, a simple ontology of viral life cycle terms was developed to provide a common vocabulary for annotating data sets. New terminology was developed to address unique viral replication cycle processes, and existing terminology was modified and adapted. The virus life-cycle is classically described by schematic pictures. Using this ontology, it can be represented by a combination of successive terms: "entry", "latency", "transcription", "replication" and "exit". Each of these parts is broken down into discrete steps. For example Zika virus "entry" is broken down in successive steps: "Attachment", "Apoptotic mimicry", "Viral endocytosis/macropinocytosis", "Fusion with host endosomal membrane", "Viral factory". To demonstrate the utility of a standard ontology for virus biology, this work was completed by annotating virus data in the ViralZone, UniProtKB and Gene Ontology databases.
C1 [Hulo, Chantal; Masson, Patrick; de Castro, Edouard; Auchincloss, Andrea H.; Poux, Sylvain; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe] Univ Geneva, Sch Med, CMU, SIB Swiss Inst Bioinformat, Geneva, Switzerland.
   [Foulger, Rebecca; Lomax, Jane] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England.
RP Le Mercier, P (corresponding author), Univ Geneva, Sch Med, CMU, SIB Swiss Inst Bioinformat, Geneva, Switzerland.
EM philippe.lemercier@isb-sib.ch
RI Lomax, Jane/H-2788-2019
OI Lomax, Jane/0000-0001-8865-4321; de Castro, Edouard/0000-0001-5436-7383;
   Le Mercier, Philippe/0000-0001-8528-090X; Foulger,
   Rebecca/0000-0001-8682-8754; Poux, Sylvain/0000-0001-7299-6685
FU Swiss Federal Government through the State Secretariat for Education,
   Research and Innovation SERI; National Institute of General Medical
   Sciences (NIGMS)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U41HG007822]; Swiss National
   Science Foundation (SNSF)Swiss National Science Foundation (SNSF)
   [IZLSZ3_148802]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; National Human Genome Research Institute (NHGRI)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI)
FX The Swiss-Prot group is part of the SIB Swiss Institute of
   Bioinformatics and of the UniProt Consortium. Swiss-Prot group
   activities are supported by the Swiss Federal Government through the
   State Secretariat for Education, Research and Innovation SERI, the
   National Institutes of Health (NIH), National Human Genome Research
   Institute (NHGRI) and National Institute of General Medical Sciences
   (NIGMS) grant U41HG007822 and the Swiss National Science Foundation
   (SNSF) grant IZLSZ3_148802.
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347
   Brandes N, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0128-3
   CALLAHAN L, 1994, AIDS RES HUM RETROV, V10, P231, DOI 10.1089/aid.1994.10.231
   Cheung AK, 2012, VIRUS RES, V164, P46, DOI 10.1016/j.virusres.2011.10.012
   Coenen A, 1997, GENET RES, V69, P1, DOI 10.1017/S001667239600256X
   Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X
   de Felipe P., 2004, GENET VACCINES THER, V2, P13, DOI DOI 10.1186/1479-0556-2-13
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996
   Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113
   Foulger RE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0481-x
   Ghazal P, 2000, IMMUNOL RES, V21, P219, DOI 10.1385/IR:21:2-3:219
   Goff SP, 2004, CELL CYCLE, V3, P123
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999
   Helenius A, 2013, CURR OPIN VIROL, V3, P1, DOI 10.1016/j.coviro.2013.01.003
   Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757
   Howard AR, 2012, J VIROL, V86, P5905, DOI 10.1128/JVI.06997-11
   Hu WS, 2012, COLD SPRING HARB PER, V2
   Huang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164787
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559
   Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032
   Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979
   Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0
   Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29
   Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3
   Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x
   Liu H, 2003, CURR TOP MICROBIOL, V272, P131
   Masson P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108075
   Mattei S, 2016, CURR OPIN VIROL, V18, P27, DOI 10.1016/j.coviro.2016.02.008
   McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308
   Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013
   Mhamdi M, 2007, HEPATOLOGY, V46, P95, DOI 10.1002/hep.21666
   Moss B, 2013, COLD SPRING HARB PER, V5, P5
   Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008
   Niehl A, 2011, PROTOPLASMA, V248, P75, DOI 10.1007/s00709-010-0246-1
   Onfelt Bjorn, 2005, Sci STKE, V2005, ppe55, DOI 10.1126/stke.3132005pe55
   Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018
   Powell ML, 2008, BIOCHEM SOC T, V36, P717, DOI 10.1042/BST0360717
   Raghava S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002116
   Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029
   Schudt G., 2015, J INFECT DIS
   Schudt G, 2013, P NATL ACAD SCI USA, V110, P14402, DOI 10.1073/pnas.1307681110
   Shulla A, 2016, CURR OPIN MICROBIOL, V32, P82, DOI 10.1016/j.mib.2016.05.003
   Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11
   Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013
   The Gene Ontology: enhancements for, 2011, NUCLEIC ACIDS RES, V40, pD559, DOI [10.1093/nar/gkr1028, DOI 10.1093/NAR/GKR1028]
   Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673
   Ward BM, 2011, VIROLOGY, V411, P244, DOI 10.1016/j.virol.2010.12.024
   Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093
   White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389
NR 58
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 16
PY 2017
VL 12
IS 2
AR e0171746
DI 10.1371/journal.pone.0171746
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL2BG
UT WOS:000394424500050
PM 28207819
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Zika Striking Women at Higher Rates Than Men: US Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD FEB 15
PY 2017
VL 64
IS 4
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3SB
UT WOS:000397300900001
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Arboviral infection and Gulllain-Barre syndrome in Fiji
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
ID ZIKA VIRUS-INFECTION
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Hainan, Peoples R China.; Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Pastula DM, 2017, J NEUROL SCI, V372, P350, DOI 10.1016/j.jns.2016.08.064
   Ralapanawa D. M., 2015, BMC RES NOTES, V8
   Wiwanitkit V, 2016, ARQ NEURO-PSIQUIAT, V74, P692, DOI 10.1590/0004-282X20160089
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2017
VL 373
BP 17
EP 17
DI 10.1016/j.jns.2016.12.017
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EK8US
UT WOS:000394200700005
PM 28131181
DA 2020-07-08
ER

PT J
AU Barbosa-Lima, G
   Pinto, LSD
   Kaiser, CR
   Wardell, JL
   De Freitas, CS
   Vieira, YR
   Marttorelli, A
   Neto, JC
   Bozza, PT
   Wardell, SMSV
   de Souza, MVN
   Souza, TML
AF Barbosa-Lima, Giselle
   da Silveira Pinto, Ligia S.
   Kaiser, Carlos R.
   Wardell, James L.
   De Freitas, Caroline S.
   Vieira, Yasmine R.
   Marttorelli, Andressa
   Neto, Jose Cerbino
   Bozza, Patricia T.
   Wardell, Solange M. S. V.
   de Souza, Marcus V. N.
   Souza, Thiago M. L.
TI N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives,
   synthesized by thermal and ultrasonic means, are endowed with anti-Zika
   virus activity
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Zika virus; Quinoline derivatives; Sonochemical method
ID SEXUAL TRANSMISSION; ANTICANCER AGENTS; ANTIMALARIAL ACTIVITY;
   MEFLOQUINE; INHIBITORS; INFECTION; POTENT; SCREEN
AB Zika virus (ZIKV), an emerging Flavivirus, was recently associated with severe neurological complications and congenital diseases. Therefore, development of antiviral agents capable of inhibiting ZIKV replication is urgent. Chloroquine is a molecule with a confirmed safety history for use with pregnant women, and has been found to exhibit anti-ZIKV activity at concentrations around 10 mu M. This suggests that modifications to the chloroquine structure could be promising for obtaining more effective anti-ZIKV agents. Here, we report the ability of a series of N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives to inhibit ZIKV replication in vitro. We have found that the quinoline derivative, N-(2-((5-nitrofuran-2-yl)methylimino)ethyl)-7-chloroquinolin-4-amine, 40, was the most potent compound within this series, reducing ZIKV replication by 72% at 10 M. Compound 40 exhibits an EC50 value of 0.8 0.07 M, compared to that of chloroquine of 12 +/- 3.2 mu M. Good activities were also obtained for other compounds, including those with aryl groups = phenyl, 4-fluorophenyl, 4-nitrophenyl, 2,6dimethoxyphenyl, 3-pyridinyl and 5-nitrothien-2-yl. Syntheses of these quinoline derivatives have been obtained both by thermal and ultrasonic means. The ultrasonic method produced comparable yields to the thermal (reflux) method in very much shorter times 30-180 s compared to 30-180 min reactions times. These results indicate that this group of compounds is a good follow-up point for the potential discovery of new drugs against the Zika disease. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Barbosa-Lima, Giselle; De Freitas, Caroline S.; Vieira, Yasmine R.; Marttorelli, Andressa; Bozza, Patricia T.; Souza, Thiago M. L.] Fiocruz Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Barbosa-Lima, Giselle; De Freitas, Caroline S.; Vieira, Yasmine R.; Marttorelli, Andressa; Souza, Thiago M. L.] Fiocruz Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine R.; Neto, Jose Cerbino; Souza, Thiago M. L.] Fiocruz Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [da Silveira Pinto, Ligia S.; Kaiser, Carlos R.; de Souza, Marcus V. N.] Univ Fed Rio de Janeiro, Dept Quim Organ, Rio De Janeiro, Brazil.
   [Wardell, James L.; de Souza, Marcus V. N.] Fiocruz Fundacao Oswaldo Cruz, Inst Tecnol Farmacos Far Manguinhos, POB 21041-250, Rio De Janeiro, Brazil.
   [Wardell, James L.] Univ Aberdeen, Dept Chem, Old Aberdeen, Scotland.
   [Wardell, Solange M. S. V.] CHEMSOL, 1 Harcourt Rd, Aberdeen AB15 5NY, Scotland.
RP de Souza, MVN (corresponding author), Fiocruz Fundacao Oswaldo Cruz, Inst Tecnol Farmacos Far Manguinhos, POB 21041-250, Rio De Janeiro, Brazil.
EM marcos_souza@far.fiocruz.br
RI Kaiser, Carlos R/D-1049-2015; Souza, Thiago Moreno L./G-2900-2012; Neto,
   Jose Cerbino/P-3713-2018; de Souza, Marcus/W-5002-2019
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Neto, Jose
   Cerbino/0000-0001-9254-917X; Bozza, Patricia/0000-0001-8349-9529
FU PAPES/Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES; FaperjCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from PAPES/Fiocruz
   (www.ioc.fiocruz.br), CNPq (www.cnpq.br), CAPES (www.capes.gov.br) and
   Faperj (www.faperj.br). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acosta EP, 2011, GOODMAN GILMANS PHAR, P1593
   Andrade AA, 2007, EUR J PHARMACOL, V558, P194, DOI 10.1016/j.ejphar.2006.11.061
   [Anonymous], 2012, CRYSTALCLEAR SM EXP
   [Anonymous], MERC 3 3 1
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bispo MDF, 2015, MONATSH CHEM, V146, P2041, DOI 10.1007/s00706-015-1570-0
   Cunico W, 2006, BIOORG MED CHEM LETT, V16, P649, DOI 10.1016/j.bmcl.2005.10.033
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Souza MVN, 2009, BIOORGAN MED CHEM, V17, P1474, DOI 10.1016/j.bmc.2009.01.013
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delvecchio R., 2016, COLD SPRING IN PRESS
   Facchinetti V, 2015, J HETEROCYCLIC CHEM, V52, P1245, DOI 10.1002/jhet.2212
   Flexner Charles, 2011, GOODMAN GILMANS PHAR, V1623, P1626
   Goncalves RSB, 2010, EUR J MED CHEM, V45, P6095, DOI 10.1016/j.ejmech.2010.09.024
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Montenegro RC, 2012, LETT DRUG DES DISCOV, V9, P251
   Montenegro RC, 2011, MED CHEM, V7, P599
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodrigues FAR, 2014, BIOORG MED CHEM LETT, V24, P934, DOI 10.1016/j.bmcl.2013.12.074
   Rodrigues FAR, 2014, CHEM BIOL DRUG DES, V83, P126, DOI 10.1111/cbdd.12210
   Sacramento C. Q, 2016, COLD SPRING IN PRESS
   SCUDIERO DA, 1988, CANCER RES, V48, P4827
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112
   Varotti FD, 2008, ANTIMICROB AGENTS CH, V52, P3868, DOI 10.1128/AAC.00510-08
   WHO, WHO REP ZIK SIT REP
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 30
TC 9
Z9 10
U1 2
U2 8
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 15
PY 2017
VL 127
BP 434
EP 441
DI 10.1016/j.ejmech.2017.01.007
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EP1VQ
UT WOS:000397172800036
PM 28092859
DA 2020-07-08
ER

PT J
AU Pruszynski, CA
   Hribar, LJ
   Mickle, R
   Leal, AL
AF Pruszynski, Catherine A.
   Hribar, Lawrence J.
   Mickle, Robert
   Leal, Andrea L.
TI A Large Scale Biorational Approach Using Bacillus thuringiensis
   israeliensis (Strain AM65-52) for Managing Aedes aegypti Populations to
   Prevent Dengue, Chikungunya and Zika Transmission
SO PLOS ONE
LA English
DT Article
ID VAR. ISRAELENSIS; KEY-WEST; DIPTERA-CULICIDAE; ALBOPICTUS; MOSQUITO;
   SUSCEPTIBILITY; INVERTEBRATES; FORMULATIONS; RESIDENTS; FLORIDA
AB Background
   Aedes aegypti is a container-inhabiting mosquito and a vector of dengue, chikungunya, and Zika viruses. In 2009 several cases of autochthonous dengue transmission were reported in Key West, Florida, USA prompting a comprehensive response to control A. aegypti. In Key West, larvae of this mosquito develop in containers around human habitations which can be numerous and labor intensive to find and treat. Aerial applications of larvicide covering large areas in a short time can be an efficient and economical method to control A. aegypti. Bacillus thuringiensis israelensis (Bti) is a bacterial larvicide which is highly target specific and appropriate for wide area spraying over urban areas, but to date, there are no studies that evaluate aerial spraying of Bti to control container mosquitoes like A. aegypti.
   Methodology
   This paper examines the effectiveness of aerial larvicide applications using VectoBac (R) WG, a commercially available Bti formulation, for A. aegypti control in an urban setting in the USA. Droplet characteristics and spray drop deposition were evaluated in Key West, Florida, USA. The mortality of A. aegypti in containers placed under canopy in an urban environment was also evaluated. Efficacy of multiple larvicide applications on adult female A. aegypti population reduction was compared between an untreated control and treatment site.
   Conclusions
   Droplet characteristics showed that small droplets can penetrate through dense canopy to reach small containers. VectoBac WG droplets reached small containers under heavy canopy in sufficient amounts to cause >55% mortality on all application days and >90% mortality on 3 of 5 application days while controls had <5% mortality. Aerial applications of dVectoBac WG caused significant decrease in adult female populations throughout the summer and during the 38 th week (last application) the difference in adult female numbers between untreated and treated sites was >50%. Aerial larvicide applications using VectoBac WG can cover wide areas in a short period of time and can be effective in controlling A. aegypti and reducing A. aegypti-borne transmission in urban areas similar to Key West, Florida, USA.
C1 [Pruszynski, Catherine A.; Hribar, Lawrence J.; Leal, Andrea L.] Florida Keys Mosquito Control Dist, Coll Rd, Key West, FL 33040 USA.
   [Mickle, Robert] REMSpC Spray Consulting, Welsh Dr, Ayr, ON, Canada.
RP Pruszynski, CA (corresponding author), Florida Keys Mosquito Control Dist, Coll Rd, Key West, FL 33040 USA.
EM cpruz@keysmosquito.org
FU Florida Keys Mosquito Control District; Monroe County property taxes
FX The authors received no specific funding for this work. Author Robert
   Mickle is the owner of the commercial company "REMSpC Spray Consulting"
   and was paid a consulting fee by the government agency, Florida Keys
   Mosquito Control District, for his evaluation of the droplet analysis
   evaluated for this experiment. The Florida Keys Mosquito Control
   District is an independent taxing district in Monroe County, Florida.
   The FKMCD budget is funded by a percentage of Monroe County property
   taxes. The funders (tax-payers of Monroe Co.) did not play a role in the
   study design, collection and analysis, decision to publish, or
   preparation of the manuscript and only provided financial support in the
   form of authors' salaries and research materials.
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Aldemir A, 2009, J AM MOSQUITO CONTR, V25, P113, DOI 10.2987/08-5836.1
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Attar N., 2016, NAT REV MICROBIOL, V2016, P14
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Becker N, 2003, J AM MOSQUITO CONTR, V19, P63
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Boisvert M, 2005, UTILIZATION BACILLUS, P87
   Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2
   Caquet T, 2011, ECOTOX ENVIRON SAFE, V74, P1122, DOI 10.1016/j.ecoenv.2011.04.028
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dunford JC, 2014, J AM MOSQUITO CONTR, V30, P191, DOI 10.2987/14-6400R.1
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Glare TR, 1998, ENV HLTH IMPACTS BAC, P81
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   Guide Who, 1994, WHO GUIDEL DRINK QUA, P1
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1
   Hribar Lawrence J., 2011, Studia Dipterologica, V17, P237
   Huber Karine, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P81
   IPCS Enviornmental Health Criteria 217, 1999, IPCS ENV HLTH CRIT 2
   Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844
   Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Key West Chamber of Commerce, 2015, KEY W MONR COUNT DEM
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lagadic L, 2014, J APPL ECOL, V51, P102, DOI 10.1111/1365-2664.12165
   Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071
   Lee H. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P601
   Lee YW, 2006, J AM MOSQUITO CONTR, V22, P97, DOI 10.2987/8756-971X(2006)22[97:SOLAFA]2.0.CO;2
   Mao T, 1997, AICHE J, V43, P2169, DOI 10.1002/aic.690430903
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Reece AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004521
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y
   Rodriguez MM, 2004, J MEDIAL ENTOMOL, V38, P623
   Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1
   Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296
   To Setha, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P261
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Vilarinhos PTR, 2004, J AM MOSQUITO CONTR, V20, P311
   Wickham H., 2009, GGPLOT2
   Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035
   World Health Organization, 2016, ZIK FACT SHEET
   World Health Organization, 2015, CHIK FACT SHEET
   World Health Organization, 2016, WHOPES REC COMP FORM
NR 53
TC 12
Z9 12
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 15
PY 2017
VL 12
IS 2
AR e0170079
DI 10.1371/journal.pone.0170079
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL2BF
UT WOS:000394424400013
PM 28199323
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sari, O
   Bassit, L
   Gavegnano, C
   McBrayer, TR
   McCormick, L
   Cox, B
   Coats, SJ
   Amblard, F
   Schinazi, RF
AF Sari, Ozkan
   Bassit, Leda
   Gavegnano, Christina
   McBrayer, Tamara R.
   McCormick, Louise
   Cox, Bryan
   Coats, Steven J.
   Amblard, Franck
   Schinazi, Raymond F.
TI Synthesis and antiviral evaluation of 2 ',2 ',3 ',3 '-tetrafluoro
   nucleoside analogs
SO TETRAHEDRON LETTERS
LA English
DT Article
DE Nucleoside; Prodrug; Antiviral; Fluorine; Mitsunobu
AB Herein, we report the synthesis of novel 2',2',3',3'-tetrafluorinated nucleoside analogs along with their phosphoramidate prodrugs. A tetrafluoro ribose moiety was coupled with different Boc/benzoyl-protected nucleobases under Mitsunobu conditions. After deprotection, tetrafluorinated nucleosides 13b, 14b, 20b-22b were reacted with phenyl-(isopropoxy-t-alaninyl)-phosphorochloridate to afford corresponding monophosphate prodrugs 24b-28b. All synthesized compounds were evaluated against several DNA and RNA viruses including HIV, HBV, HCV, Ebola and Zika viruses. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Sari, Ozkan; Bassit, Leda; Gavegnano, Christina; McCormick, Louise; Cox, Bryan; Amblard, Franck; Schinazi, Raymond F.] Emory Univ, Ctr AIDS Res, Sch Med, Dept Pediat,Lab Biochem Pharmacol, Atlanta, GA 30322 USA.
   [McBrayer, Tamara R.; Coats, Steven J.] Cocrystal Pharma Inc, 1860 Montreal Rd, Tucker, GA 30084 USA.
RP Schinazi, RF (corresponding author), Emory Univ, Ctr AIDS Res, Sch Med, Dept Pediat,Lab Biochem Pharmacol, Atlanta, GA 30322 USA.
EM rschina@emory.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5P30-AI-50409]
FX This work was supported in part by NIH Grant 5P30-AI-50409 (CFAR). Dr.
   Schinazi is the Chairman and a major shareholder of Cocrystal Pharma,
   Inc. Emory received no funding from Cocrystal Pharma, Inc. to perform
   this work and vice versa.
CR Bovdell AJ, 2004, ANGEW CHEM INT EDIT, V43, P5677
   Dey S, 2000, J ORG CHEM, V65, P7697, DOI 10.1021/jo000983i
   Dimagno SG, 2000, US Patent, Patent No. [6,013,790, 6013790]
   Huang M, 2014, J CHEM THEORY COMPUT, V10, P1538, DOI 10.1021/ct401013s
   Kramer RA, 2012, HELV CHIM ACTA, V95, P2621, DOI 10.1002/hlca.201200557
   Linclau B, 2009, ORG BIOMOL CHEM, V7, P803, DOI 10.1039/b817260a
   Liu P, 2008, J FLUORINE CHEM, V129, P743, DOI 10.1016/j.jfluchem.2008.06.007
   McGuigan C, 2005, J MED CHEM, V48, P3504, DOI 10.1021/jm0491400
   PERLMAN ME, 1985, J MED CHEM, V28, P741, DOI 10.1021/jm00383a009
   Porcheddu A, 2008, EUR J ORG CHEM, V2008, P5786, DOI 10.1002/ejoc.200800891
   Pradere U, 2014, CHEM REV, V114, P9154, DOI 10.1021/cr5002035
   Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c
   REICHMAN U, 1975, CARBOHYD RES, V42, P233, DOI 10.1016/S0008-6215(00)84265-2
   SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061
   Stuyver LJ, 2003, ANTIMICROB AGENTS CH, V47, P244, DOI 10.1128/AAC.47.1.244-254.2003
   Stuyver LJ, 2002, ANTIMICROB AGENTS CH, V46, P3854, DOI 10.1128/AAC.46.12.3854-3860.2002
   SU TL, 1986, J MED CHEM, V29, P151, DOI 10.1021/jm00151a025
   Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018
   WATANABE KA, 1984, J MED CHEM, V27, P91, DOI 10.1021/jm00367a020
   WATANABE KA, 1983, J MED CHEM, V26, P152, DOI 10.1021/jm00356a007
   Wojtowicz-Rajchel H, 2012, J FLUORINE CHEM, V143, P11, DOI 10.1016/j.jfluchem.2012.06.026
   WRIGHT JA, 1969, J ORG CHEM, V34, P2632, DOI 10.1021/jo01261a031
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 23
TC 3
Z9 3
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4039
J9 TETRAHEDRON LETT
JI Tetrahedron Lett.
PD FEB 15
PY 2017
VL 58
IS 7
BP 642
EP 644
DI 10.1016/j.tetlet.2017.01.006
PG 3
WC Chemistry, Organic
SC Chemistry
GA EK4ZN
UT WOS:000393936800011
PM 28163339
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wang, DP
   Chen, C
   Liu, SN
   Zhou, H
   Yang, KL
   Zhao, Q
   Ji, XY
   Chen, C
   Xie, W
   Wang, ZF
   Mi, LZ
   Yang, HT
AF Wang, Deping
   Chen, Cheng
   Liu, Shengnan
   Zhou, Han
   Yang, Kailin
   Zhao, Qi
   Ji, Xiaoyun
   Chen, Chen
   Xie, Wei
   Wang, Zefang
   Mi, Li-Zhi
   Yang, Haitao
TI A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus
   NS1 Assembly in Vitro
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; MEMBRANE ASSOCIATION; GLYCOPROTEIN NS1;
   ANTIBODY; FORM; DETERMINANT; AMERICA; SURFACE
AB An unprecedented epidemic of Zika virus (ZIKV) infection had spread to South and Central America. ZIKV infection was recently confirmed by CDC (the Centers for Disease Control and Prevention) to cause neonatal microcephaly, which posed a significant public health emergency of international concern. No specific vaccines or drugs are currently available to fight ZIKV infection. ZIKV nonstructural protein 1 (NS1) plays an essential role in viral replication and immune evasion. We determined the crystal structure of ZIKV NS1(172-352),which forms a head-to-head, symmetric dimer with a unique 14-stranded beta-ladder conserved among flaviviruses. The assembly of the beta-ladder dimer is concentration dependent. Strikingly, one pathogenic mutation T233A (NCBI accession no. KU527068), found in the brain tissue of infected fetus with neonatal microcephaly, is located at the dimer interface. Thr233, a unique residue found in ZIKV but not in other flaviviruses, organizes a central hydrogen bonding network at NS1 dimer interface. Mutation of Thr233 to Ala disrupts this elaborated interaction network, and destabilizes the NS1 dimeric assembly in vitro. In addition, our structural comparison of epitopes for protective antibody 22NS1, targeting West Nile Virus NS1, could potentially be valuable in understanding its anti-virus specificities and in the development of antibodies against ZIKV.
C1 [Wang, Deping; Chen, Cheng; Liu, Shengnan; Zhou, Han; Chen, Chen; Xie, Wei; Wang, Zefang; Mi, Li-Zhi; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Chen, Cheng; Wang, Zefang; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA.
   [Zhao, Qi; Ji, Xiaoyun] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
RP Mi, LZ; Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
EM lizhi.mi@tju.edu.cn; yanght@tju.edu.cn
RI Mi, Li-Zhi/B-1371-2016
OI Mi, Li-Zhi/0000-0001-9907-5245
FU National Key Basic Research Program of China (973 program)National Basic
   Research Program of China [2015CB859800, 2014CB542800]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [31528006, 31470730]
FX We would like to thank Zuokun Lu for data collection at beamline BL18U1
   and BL19U1 of the Shanghai Synchrotron Radiation Facility (SSRF);
   Lanfeng Wang for discussion and advice. This work was supported by
   National Key Basic Research Program of China (973 program) (No.
   2015CB859800 and 2014CB542800 to H.Y.) and National Natural Science
   Foundation of China (No. 31528006 to H.Y. and No. 31470730 to LZ.M.).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Brown WC, 2011, PROTEIN EXPRES PURIF, V77, P34, DOI 10.1016/j.pep.2011.01.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Cruz-Rivera M, 2013, J CLIN MICROBIOL, V51, P629, DOI 10.1128/JCM.03042-12
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 48
TC 12
Z9 13
U1 0
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 15
PY 2017
VL 7
AR 42580
DI 10.1038/srep42580
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK9LY
UT WOS:000394247200001
PM 28198446
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Darbellay, J
   Lai, K
   Babiuk, S
   Berhane, Y
   Ambagala, A
   Wheler, C
   Wilson, D
   Walker, S
   Potter, A
   Gilmour, M
   Safronetz, D
   Gerdts, V
   Karniychuk, U
AF Darbellay, Joseph
   Lai, Kenneth
   Babiuk, Shawn
   Berhane, Yohannes
   Ambagala, Aruna
   Wheler, Colette
   Wilson, Donald
   Walker, Stewart
   Potter, Andrew
   Gilmour, Matthew
   Safronetz, David
   Gerdts, Volker
   Karniychuk, Uladzimir
TI Neonatal pigs are susceptible to experimental Zika virus infection
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID JAPANESE ENCEPHALITIS-VIRUS; WEST-NILE VIRUS; ANTIBODIES
C1 [Darbellay, Joseph; Lai, Kenneth; Wheler, Colette; Wilson, Donald; Walker, Stewart; Potter, Andrew; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Int Vaccine Ctr VIDO InterVac, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada.
   [Darbellay, Joseph; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 5B4, Canada.
   [Babiuk, Shawn; Berhane, Yohannes; Ambagala, Aruna] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, 1015 Arlington St, Winnipeg, MB R3E 3M4, Canada.
   [Gilmour, Matthew; Safronetz, David] Publ Hlth Agcy Canada, Canada Natl Microbiol Lab, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, Int Vaccine Ctr VIDO InterVac, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 5B4, Canada.
EM u.karniychuk@usask.ca
OI Karniychuk, Uladzimir/0000-0001-7802-9223
FU Genome Canada Emerging Issue Program
FX This work was approved by the University of Saskatchewan's Animal
   Research Ethics Board and adhered to the Canadian Council on Animal Care
   guidelines for humane animal use. We would like to acknowledge the
   VIDO-InterVac animal care personnel for the excellent assistance with in
   vivo experiments. The study was funded by Genome Canada Emerging Issue
   Program. This paper was published with the permission of the Director of
   VIDO-InterVac, journal series number 787.
CR Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   ILKAL MA, 1994, ACTA VIROL, V38, P157
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SCHERER WF, 1959, J IMMUNOL, V83, P620
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
NR 15
TC 17
Z9 17
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD FEB 15
PY 2017
VL 6
AR e6
DI 10.1038/emi.2016.133
PG 4
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EM6XE
UT WOS:000395455100001
PM 28196970
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barbosa-Limaa, G
   Moraes, AM
   Araujo, ADS
   da Silva, ET
   de Freitas, CS
   Vieira, YR
   Marttorelli, A
   Neto, JC
   Bozza, PT
   de Souza, MVN
   Souza, TML
AF Barbosa-Limaa, Giselle
   Moraes, Adriana M.
   Araujo, Adriele da S.
   da Silva, Emerson T.
   de Freitas, Caroline S.
   Vieira, Yasmine R.
   Marttorelli, Andressa
   Neto, Jose Cerbino
   Bozza, Patricia T.
   de Souza, Marcus V. N.
   Souza, Thiago Moreno. L.
TI 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus
   activity, compared to mefloquine
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Zika virus; Quinoline derivatives; Mefloquine; Antiviral
ID PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SEXUAL TRANSMISSION;
   OXAZOLIDINE DERIVATIVES; CELL-DEATH; INFECTION; IDENTIFICATION;
   CYTOTOXICITY; INHIBITORS; BRAZIL; DRUGS
AB Zika virus (ZIKV), an arthropod-born Flavivirus, has been associated with a wide range of neurological diseases in adults, foetuses and neonates. Since no vaccine is available, repurposing of antiviral drugs currently in medical use is necessary. Mefloquine has confirmed anti-ZIKV activity. We used medicinal chemistry-driven approaches to synthesize and evaluate the ability of a series of new 2,8bis(trifluoromethyl)quinoline derivatives to inhibit ZIKV replication in vitro, in order to improve the potency of mefloquine. We found that quinoline derivatives 3a and 4 were the most potent compounds within this series, both with mean EC50 values of 0.8 mu M which represents a potency 5 times that of mefloquine. These results indicate that new 2,8-bis(trifluoromethyl)quinoline chemical structures may be promising for the development of novel anti-ZIKV drugs. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Barbosa-Limaa, Giselle; de Freitas, Caroline S.; Vieira, Yasmine R.; Marttorelli, Andressa; Bozza, Patricia T.; Souza, Thiago Moreno. L.] Inst Oswaldo Cruz, Fiocruz Fundagao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Barbosa-Limaa, Giselle; de Freitas, Caroline S.; Vieira, Yasmine R.; Marttorelli, Andressa; Souza, Thiago Moreno. L.] Ctr Desenvolvimento Tecnol Saude, Fiocruz Fundagao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Barbosa-Limaa, Giselle; Vieira, Yasmine R.; Neto, Jose Cerbino; Souza, Thiago Moreno. L.] Inst Nacl Infectologia Evandro Chagas, Fiocruz Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Moraes, Adriana M.; Araujo, Adriele da S.; da Silva, Emerson T.; de Souza, Marcus V. N.] Inst Tecnologia Farmacos Far Manguinhos, Fiocruz Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Moraes, Adriana M.; de Souza, Marcus V. N.] Univ Fed Rio Janeiro, Dept Qufm Organ, Rio De Janeiro, Brazil.
RP de Souza, MVN (corresponding author), Inst Tecnologia Farmacos Far Manguinhos, Fiocruz Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.; de Souza, MVN (corresponding author), Univ Fed Rio Janeiro, Dept Qufm Organ, Rio De Janeiro, Brazil.
EM marcos_souza@far.fiocruz.br
RI de Souza, Marcus/W-5002-2019; Souza, Thiago Moreno L./G-2900-2012; Neto,
   Jose Cerbino/P-3713-2018
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Neto, Jose
   Cerbino/0000-0001-9254-917X; Bozza, Patricia/0000-0001-8349-9529
FU PAPES/Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq); FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This study was supported by grants from PAPES/Fiocruz (www.
   ioc.fiocruz.br), CNPq (www.cnpq.br) and Faperj (www.faperj.br). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bermudez LE., 2014, TUBERC RES TREAT, V2014
   Brasil P, 2016, N ENGL J MED
   Brickelmaier M, 2009, ANTIMICROB AGENTS CH, V53, P1840, DOI 10.1128/AAC.01614-08
   Briguglio I, 2015, EUR J MED CHEM, V105, P63, DOI 10.1016/j.ejmech.2015.10.002
   CDC, 2011, CDC MAL TRAV REC IMM
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delvecchio R., 2016, COLD SPRING HARB LAB
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Eswaran S, 2010, EUR J MED CHEM, V45, P3374, DOI 10.1016/j.ejmech.2010.04.022
   Goncalves RSB, 2012, BIOORGAN MED CHEM, V20, P243, DOI 10.1016/j.bmc.2011.11.006
   Gourineni VC, 2014, CASE REP NEUROL MED, DOI 10.1155/2014/549271
   Hamann AR, 2014, BIOORG MED CHEM LETT, V24, P5466, DOI 10.1016/j.bmcl.2014.10.015
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Jayaprakash S, 2006, CHEMMEDCHEM, V1, P593, DOI 10.1002/cmdc.200600010
   Jimenez A., 2016, TRANSFUS MED REV
   Kgokong JL, 2001, EUR J PHARM SCI, V12, P369, DOI 10.1016/S0928-0987(00)00137-8
   Krieger D, 2015, EUR RESPIR J, V46, P1503, DOI 10.1183/13993003.00321-2015
   Kurmann R, 2015, J NEUROVIROL, V21, P694, DOI 10.1007/s13365-015-0340-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu Y, 2016, INTERNATIONAL CONFERENCE ON CONTROL AND AUTOMATION (ICCA 2016), P350
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Matheron S., 2016, CLIN INFECT DIS
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naito K, 2012, INTERNAL MED, V51, P205, DOI 10.2169/internalmedicine.51.6253
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pukrittayakamee S, 2004, ACTA TROP, V89, P351, DOI 10.1016/j.actatropica.2003.10.012
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodrigues FAR, 2014, CHEM BIOL DRUG DES, V83, P126, DOI 10.1111/cbdd.12210
   Rodrigues L.C., 2016, LANCET INFECT DIS
   Sacramento C. Q, 2016, COLD SPRING HARB LAB
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SCUDIERO DA, 1988, CANCER RES, V48, P4827
   Shin JW, 2014, J CLIN NEUROSCI, V21, P1661, DOI 10.1016/j.jocn.2013.12.031
   Sumangala V, 2010, ARCH PHARM RES, V33, P1911, DOI 10.1007/s12272-010-1204-3
   WHO, 1995, WHO MOD PRESCR INF D
   WHO, 2016, WHO ANN PUBL HLT EM
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yan KH, 2013, ONCOL LETT, V5, P1567, DOI 10.3892/ol.2013.1259
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 49
TC 18
Z9 18
U1 1
U2 15
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 15
PY 2017
VL 127
BP 334
EP 340
DI 10.1016/j.ejmech.2016.12.058
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EP1VQ
UT WOS:000397172800028
PM 28068604
DA 2020-07-08
ER

PT J
AU Caminade, C
   Turner, J
   Metelmann, S
   Hesson, JC
   Blagrove, MSC
   Solomon, T
   Morse, AP
   Baylis, M
AF Caminade, Cyril
   Turner, Joanne
   Metelmann, Soeren
   Hesson, Jenny C.
   Blagrove, Marcus S. C.
   Solomon, Tom
   Morse, Andrew P.
   Baylis, Matthew
TI Global risk model for vector-borne transmission of Zika virus reveals
   the role of El Nino 2015 (vol 114, pg 119, 2016)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Correction
CR Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
NR 1
TC 0
Z9 0
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 14
PY 2017
VL 114
IS 7
BP E1301
EP E1302
DI 10.1073/pnas.1700746114
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK5TR
UT WOS:000393989300031
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Raoult, D
AF Raoult, Didier
TI Double paradigm shift for the antibiotics' activity on viruses: Zika's
   lesson
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Letter
C1 [Raoult, Didier] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERM 1095, CNRS07278,IRD198, F-13005 Marseille, France.
RP Raoult, D (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERM 1095, CNRS07278,IRD198, F-13005 Marseille, France.
EM didier.raoult@gmail.com
CR Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Caetano RA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23452
   Colson P, 2016, INT J ANTIMICROB AG, V48, P349, DOI 10.1016/j.ijantimicag.2016.07.004
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
NR 5
TC 1
Z9 1
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 14
PY 2017
VL 114
IS 7
BP E1045
EP E1045
DI 10.1073/pnas.1620247114
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK5TR
UT WOS:000393989300003
PM 28143935
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Conde, JN
   Silva, EM
   Barbosa, AS
   Mohana-Borges, R
AF Conde, Jonas N.
   Silva, Emiliana M.
   Barbosa, Angela S.
   Mohana-Borges, Ronaldo
TI The Complement System in Flavivirus Infections
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE complement system; flavivirus; dengue; NS1 protein; immune evasion
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN NS1; ANTIBODY-MEDIATED
   NEUTRALIZATION; BORNE ENCEPHALITIS-VIRUS; DENGUE HEMORRHAGIC-FEVER;
   MANNOSE-BINDING LECTIN; YELLOW-FEVER; GLYCOPROTEIN NS1; RNA REPLICATION;
   FACTOR-H
AB The incidence of flavivirus infections has increased dramatically in recent decades in tropical and sub-tropical climates worldwide, affecting hundreds of millions of people each year. The Flaviviridae family includes dengue, West Nile, Zika, Japanese encephalitis, and yellow fever viruses that are typically transmitted by mosquitoes or ticks, and cause a wide range of symptoms, such as fever, shock, meningitis, paralysis, birth defects, and death. The flavivirus genome is composed of a single positive-sense RNA molecule encoding a single viral polyprotein. This polyprotein is further processed by viral and host proteases into three structural proteins (C, prM/M, E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) that are involved in viral replication and pathogenicity. The complement system has been described to play an important role in flavivirus infection either by protecting the host and/or by influencing disease pathogenesis. In this mini-review, we will explore the role of complement system inhibition and/or activation against infection by the Flavivirus genus, with an emphasis on dengue and West Nile viruses.
C1 [Conde, Jonas N.; Silva, Emiliana M.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [Barbosa, Angela S.] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil.
RP Conde, JN; Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
EM jonasconde@biof.ufrj.br; mohana@biof.ufrj.br
RI Nascimento conde, Jonas/D-4481-2019; Barbosa, Angela S/I-3518-2013;
   Borges, Ronaldo S Mohana/C-5575-2013
OI Barbosa, Angela S/0000-0002-6458-9489; 
FU ICGEB [CRP/BRA15-02]
FX We want to thank the ICGEB grant (project CRP/BRA15-02).
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040
   BOKISCH VA, 1973, NEW ENGL J MED, V289, P996, DOI 10.1056/NEJM197311082891902
   BRANDT WE, 1970, J IMMUNOL, V105, P1565
   CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986
   CARDOSA MJ, 1983, J EXP MED, V158, P258, DOI 10.1084/jem.158.1.258
   Chan M, 2016, LANCET, V387, P2165, DOI 10.1016/S0140-6736(16)30620-1
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   CROOKS AJ, 1990, J CHROMATOGR, V502, P59, DOI 10.1016/S0021-9673(01)89563-7
   CROOKS AJ, 1994, J GEN VIROL, V75, P3453, DOI 10.1099/0022-1317-75-12-3453
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Douradinha B, 2014, VIRUS RES, V179, P231, DOI 10.1016/j.virusres.2013.11.007
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fragnoud R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1271-7
   Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069
   Huerta V, 2016, J PROTEOMICS, V131, P205, DOI 10.1016/j.jprot.2015.11.003
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MCCLOUD T G, 1970, Virology, V41, P569
   Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Mehlhop E, 2009, VIROLOGY, V393, P11, DOI 10.1016/j.virol.2009.08.019
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nishioka K., 1974, ALLERG IMMUNOL, V2, P385
   Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   RUSSELL PK, 1970, J IMMUNOL, V105, P838
   SCHLESINGER JJ, 1990, J GEN VIROL, V71, P593, DOI 10.1099/0022-1317-71-3-593
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   Shresta S, 2012, MBIO, V3, DOI 10.1128/mBio.00003-12
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045
   Thielens NM, 2002, IMMUNOBIOLOGY, V205, P563, DOI 10.1078/0171-2985-00155
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 85
TC 12
Z9 12
U1 0
U2 32
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 14
PY 2017
VL 8
AR 213
DI 10.3389/fmicb.2017.00213
PG 7
WC Microbiology
SC Microbiology
GA EK3PI
UT WOS:000393837900001
PM 28261172
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duggal, NK
   Ritter, JM
   Pestorius, SE
   Zaki, SR
   Davis, BS
   Chang, GJJ
   Bowen, RA
   Brault, AC
AF Duggal, Nisha K.
   Ritter, Jana M.
   Pestorius, Samuel E.
   Zaki, Sherif R.
   Davis, Brent S.
   Chang, Gwong-Jen J.
   Bowen, Richard A.
   Brault, Aaron C.
TI Frequent Zika Virus Sexual Transmission and Prolonged Viral RNA Shedding
   in an Immunodeficient Mouse Model
SO CELL REPORTS
LA English
DT Article
ID INFECTION; SEMEN; MICE
AB Circulation of Zika virus (ZIKV) was first identified in the Western hemisphere in late 2014. Primarily transmitted through mosquito bite, ZIKV can also be transmitted through sex and from mother to fetus, and maternal ZIKVinfection has been associated with fetal malformations. We assessed immunodeficient AG129 mice for their capacity to shed ZIKV in semen and to infect female mice via sexual transmission. Infectious virus was detected in semen between 7 and 21 days post-inoculation, and ZIKV RNA was detected in semen through 58 days post-inoculation. During mating, 73% of infected males transmitted ZIKV to uninfected females, and 50% of females became infected, with evidence of fetal infection in resulting pregnancies. Semen from vasectomized mice contained significantly lower levels of infectious virus, though sexual transmission still occurred. This model provides a platform for studying the kinetics of ZIKV sexual transmission and prolonged RNA shedding also observed in human semen.
C1 [Duggal, Nisha K.; Davis, Brent S.; Chang, Gwong-Jen J.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Ritter, Jana M.; Pestorius, Samuel E.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.
   [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HELLER CG, 1964, RECENT PROG HORM RES, V20, P545
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   OAKBERG EF, 1957, NATURE, V180, P1137, DOI 10.1038/1801137a0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pan American Health Organisation, 2016, REG ZIK EP UPD AM
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheth PM, 2012, MUCOSAL IMMUNOL, V5, P248, DOI 10.1038/mi.2012.1
   Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 30
TC 84
Z9 86
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 14
PY 2017
VL 18
IS 7
BP 1751
EP 1760
DI 10.1016/j.celrep.2017.01.056
PG 10
WC Cell Biology
SC Cell Biology
GA EP4BG
UT WOS:000397324900016
PM 28199846
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI WHO Calls Off Global Zika Emergency
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 3
Z9 3
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD FEB 14
PY 2017
VL 317
IS 3
BP 246
EP 246
DI 10.1001/jama.2016.20447
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FY4NL
UT WOS:000426801400001
PM 28114564
DA 2020-07-08
ER

PT J
AU Ferreira, DAD
   Degener, CM
   Marques-Toledo, CD
   Bendati, MM
   Fetzer, LO
   Teixeira, CP
   Eiras, AE
AF da Cruz Ferreira, Danielle Andreza
   Degener, Carolin Marlen
   Marques-Toledo, Cecilia de Almeida
   Bendati, Maria Mercedes
   Fetzer, Liane Oliveira
   Teixeira, Camila P.
   Eiras, Alvaro Eduardo
TI Meteorological variables and mosquito monitoring are good predictors for
   infestation trends of Aedes aegypti, the vector of dengue, chikungunya
   and Zika
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Dengue; Surveillance; MosquiTRAP
ID RIO-DE-JANEIRO; CLIMATE-CHANGE; GLOBAL DISTRIBUTION; DIPTERA-CULICIDAE;
   NORTH QUEENSLAND; SEASONAL PATTERN; VIRUS-INFECTIONS; BRAZIL; ABUNDANCE;
   TRANSMISSION
AB Background: Aedes aegypti is an important vector for arboviroses and widely distributed throughout the world. Climatic factors can influence vector population dynamics and, consequently, disease transmission. The aim of this study was to characterize the temporal dynamics of an Ae. aegypti population and dengue cases and to investigate the relationship between meteorological variables and mosquito infestation.
   Methods: We monitored and analyzed the adult female Ae. aegypti population, the dengue-fever vector, in Porto Alegre, a subtropical city in Brazil using the MI-Dengue system (intelligent dengue monitoring). This system uses sticky traps to monitor weekly infestation indices. We fitted generalized additive models (GAM) with climate variables including precipitation, temperature and humidity, and a GAM that additionally included mosquito abundance in the previous week as an explanatory variable. Logistic regression was used to evaluate the effect of adult mosquito infestation on the probability of dengue occurrence.
   Results: Adult mosquito abundance was strongly seasonal, with low infestation indices during the winters and high infestation during the summers. Weekly minimum temperatures above 18 C-degrees were strongly associated with increased mosquito abundance, whereas humidity above 75% had a negative effect on abundance. The GAM model that included adult mosquito infestation in the previous week adjusted and predicted the observed data much better than the model which included only meteorological predictor variables. Dengue was also seasonal and 98% of all cases occurred at times of high adult Ae. aegypti infestation. The probability of dengue occurrence increased by 25%, when the mean number of adult mosquitos caught by monitoring traps increased by 0.1 mosquitoes per week.
   Conclusions: The results suggest that continuous monitoring of dengue vector population allows for more reliable predictions of infestation indices. The adult mosquito infestation index was a good predictor of dengue occurrence. Weekly adult dengue vector monitoring is a helpful dengue control strategy in subtropical Brazilian cities.
C1 [da Cruz Ferreira, Danielle Andreza; Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Degener, Carolin Marlen] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Marques-Toledo, Cecilia de Almeida] Ecovec Ltda, Parque Tecnol Belo Horizonte BHTec Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Marques-Toledo, Cecilia de Almeida] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Bendati, Maria Mercedes; Fetzer, Liane Oliveira] CGVS SMS, Vigilancia Roedores & Vetores, Porto Alegre, RS, Brazil.
   [Teixeira, Camila P.] UNIFEMM, Sete Lagoas, Brazil.
RP Ferreira, DAD (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM danielleandreza3@gmail.com
RI Eiras, Alvaro/Z-6023-2019; Teixeira, Camila/H-9589-2014
OI Eiras, Alvaro/0000-0002-3045-0673; 
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais)Minas Gerais State Research Foundation (FAPEMIG);
   CNPq/DECIT-MSNational Council for Scientific and Technological
   Development (CNPq) [404211/2012-7]; CAPESCAPES [3048-2011]
FX DACF, CMD, and AEE received fellowships from CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico) and FAPEMIG (Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais). This project was funded by
   CNPq/DECIT-MS (Grant # 404211/2012-7), and CAPES (Grant # 3048-2011).
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arboleda S, 2012, J VECTOR ECOL, V37, P37, DOI 10.1111/j.1948-7134.2012.00198.x
   Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x
   Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouzid M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-781
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Center for Disease Control and Prevention (CDC), 2014, DENG EP
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3
   Degener CM, 2014, MEM I OSWALDO CRUZ, V109, P1030, DOI 10.1590/0074-0276140234
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   European Centre for Disease Prevention and Control, 2014, ANN EPID REP 2014 EM, P30
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, P2004, DOI DOI 10.HTTPS://D0I.0RG/10.1371/J0URNAL.PNTD
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hii Yien Ling, 2016, Curr Environ Health Rep, V3, P81, DOI 10.1007/s40572-016-0078-z
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   IBGE - Instituto Brasileiro de Geografia e Estatastica, CENS 2010
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Micieli MV, 2003, MEM I OSWALDO CRUZ, V98, P659, DOI 10.1590/S0074-02762003000500013
   Ministerio da Saude (MS), 2013, LEV RAP IND AED AEG
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Rubio-Palis Y, 2011, B MALARIOL SALUD AMB, V51, P145
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Secretaria Municipal do meio ambiente, 2008, DIAGN AMB PORT AL GE
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Venables W. N., 2002, MODERN APPL STAT S
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   Wood S. N., 2006, GEN ADDITIVE MODELS
   Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034
   Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357
NR 54
TC 17
Z9 17
U1 2
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 13
PY 2017
VL 10
AR 78
DI 10.1186/s13071-017-2025-8
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EN9PM
UT WOS:000396332100001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Another kind of Zika public health emergency
SO LANCET
LA English
DT Editorial Material
NR 0
TC 7
Z9 7
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 11
PY 2017
VL 389
IS 10069
BP 573
EP 573
DI 10.1016/S0140-6736(17)30325-2
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL9AF
UT WOS:000394910800001
PM 28195040
OA Bronze
DA 2020-07-08
ER

PT J
AU Costa-da-Silva, AL
   Ioshino, RS
   de Araujo, HRC
   Kojin, BB
   Zanotto, PMD
   Oliveira, DBL
   Melo, SR
   Durigon, EL
   Capurro, ML
AF Costa-da-Silva, Andre Luis
   Ioshino, Rafaella Sayuri
   Correa de Araujo, Helena Rocha
   Kojin, Bianca Burini
   de Andrade Zanotto, Paolo Marinho
   Leal Oliveira, Danielle Bruna
   Melo, Stella Rezende
   Durigon, Edison Luiz
   Capurro, Margareth Lara
TI Laboratory strains of Aedes aegypti are competent to Brazilian Zika
   virus
SO PLOS ONE
LA English
DT Article
ID DIPTERA-CULICIDAE; MOSQUITOS; SUSCEPTIBILITY; VECTOR; TRANSMISSION;
   REPLICATION; POPULATIONS; RESISTANCE; SINGAPORE; GENETICS
AB The Zika virus outbreaks are unprecedented human threat in relation to congenital malformations and neurological/autoimmune complications. Since this virus has high potential to spread in regions presenting the vectors, improvement in mosquito control is a top priority. Thus, Aedes aegypti laboratory strains will be fundamental to support studies in different research fields implicated on Zika-mosquito interactions which are the basis for the development of innovative control methods. In this sense, our aim was to determine the main infection aspects of a Brazilian Zika strain in reference Aedes aegypti laboratory mosquitoes. We orally exposed Rockefeller, Higgs and Rexville mosquitoes to the Brazilian ZIKV (ZIKV(BR)) and qRT-PCR was applied to determine the infection, dissemination and detection rates of ZIKV in the collected saliva as well as viral levels in mosquito tissues. The three strains sustain the virus development but Higgs showed significantly lower viral loads in bodies at 14 days post-infection (dpi) and the lowest prevalences in bodies and heads. The Rockefeller strain was the most susceptible at 7 dpi but similar dissemination rates were observed at 14 dpi. Although variations exist, the ZIKVBR RNA shows detectable levels in saliva of the three strains at 14 dpi but is only detected in Rockefeller at 7 dpi. Moreover, saliva samples from the three strains were confirmed to be infectious when intrathoracically injected into mosquitoes. The ZIKVBR kinetics was monitored in Rockefeller mosquitoes and virus could be identified in the heads at 4 dpi but was more consistently detected late in infection. Our study presents the first evaluation on how Brazilian Zika virus behaves in reference Aedes aegypti strains and shed light on how the infection evolves over time. Vector competence and hallmarks of the ZIKVBR development were revealed in laboratory mosquitoes, providing additional information to accelerate studies focused on ZIKV-mosquito interactions.
C1 [Costa-da-Silva, Andre Luis; Ioshino, Rafaella Sayuri; Correa de Araujo, Helena Rocha; Kojin, Bianca Burini; Capurro, Margareth Lara] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, SP, Brazil.
   [Costa-da-Silva, Andre Luis; Ioshino, Rafaella Sayuri; Correa de Araujo, Helena Rocha; Kojin, Bianca Burini; Capurro, Margareth Lara] INCT EM, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Rio De Janeiro, Brazil.
   [de Andrade Zanotto, Paolo Marinho; Leal Oliveira, Danielle Bruna; Melo, Stella Rezende; Durigon, Edison Luiz] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil.
RP Costa-da-Silva, AL; Capurro, ML (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, SP, Brazil.; Costa-da-Silva, AL; Capurro, ML (corresponding author), INCT EM, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Rio De Janeiro, Brazil.
EM alcosta@icb.usp.br; mcapurro@icb.usp.br
RI Oliveira, Danielle BL/H-8030-2015; Costa-Da-Silva, Andre
   Luis/J-8913-2019; Capurro, Margareth/M-5286-2019; Capurro,
   Margareth/F-8679-2012; de A. Zanotto, Paolo M./B-9286-2019
OI Oliveira, Danielle BL/0000-0002-3452-1336; Costa-Da-Silva, Andre
   Luis/0000-0002-7615-7376; Capurro, Margareth/0000-0002-7480-2116; de A.
   Zanotto, Paolo M./0000-0002-8167-0625; Oliveira,
   Danielle/0000-0002-0534-0886
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/19921-9, 2014/17766-9, 2013/16609-4];
   Coordination for the Improvement of Higher Education PersonnelCAPES
   [003/16]; National Institute of Science and Technology, Molecular
   Entomology; Postdoctoral National Program of the Coordination for the
   Improvement of Higher Education Personnel - PNPD/CAPES [1252482,
   1497027]; CAPESCAPES [5126/2015-00]; Brazilian National Research
   Council, cnpq.br [303341/2012-2]
FX This work was funded by grants #2013/19921-9 and #2014/17766-9 from Sao
   Paulo Research Foundation, www.fapesp.br, grant 003/16 from Coordination
   for the Improvement of Higher Education Personnel, www.capes.gov.br, and
   National Institute of Science and Technology, Molecular Entomology,
   www.inctem.bioqmed.ufrj.br. ALCS and BBK were supported by fellowships
   #1252482 and #1497027 from Postdoctoral National Program of the
   Coordination for the Improvement of Higher Education Personnel -
   PNPD/CAPES. HRCA was supported by fellowship #2013/16609-4 from Sao
   Paulo Research Foundation. DBLO was supported by fellowship
   #5126/2015-00 from CAPES. RSI and SRM were supported by fellowships from
   CAPES. MLC was supported by fellowship #303341/2012-2, productivity in
   research, from Brazilian National Research Council, cnpq.br. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064
   Bonizzoni M., 2012, PLOS ONE, V7
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Costa-da-Silva AL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-364
   Costa-da-Silva AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053816
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Kojin BB, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1207-8
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249
   WHO, 2016, WHO ZIK STRAT RESP F
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 34
TC 21
Z9 21
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 10
PY 2017
VL 12
IS 2
AR e0171951
DI 10.1371/journal.pone.0171951
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK9KV
UT WOS:000394244300064
PM 28187183
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goindin, D
   Delannay, C
   Gelasse, A
   Ramdini, C
   Gaude, T
   Faucon, F
   David, JP
   Gustave, J
   Vega-Rua, A
   Fouque, F
AF Goindin, Daniella
   Delannay, Christelle
   Gelasse, Andric
   Ramdini, Cedric
   Gaude, Thierry
   Faucon, Frederic
   David, Jean-Philippe
   Gustave, Joel
   Vega-Rua, Anubis
   Fouque, Florence
TI Levels of insecticide resistance to deltamethrin, malathion, and
   temephos, and associated mechanisms in Aedes aegypti mosquitoes from the
   Guadeloupe and Saint Martin islands (French West Indies)
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Article
DE Aedes aegypti; Mosquitoes; Insecticide resistance; Deltamethrin;
   Malathion; Temephos; Guadeloupe; Saint Martin
ID SODIUM-CHANNEL GENE; DENGUE VECTOR; DIPTERA-CULICIDAE; PYRETHROID
   RESISTANCE; ANOPHELES-GAMBIAE; MOLECULAR-BASIS; ZIKA VIRUS;
   CROSS-RESISTANCE; 1ST REPORT; SELECTION
AB Background: In the Guadeloupe and Saint Martin islands, Aedes aegypti mosquitoes are the only recognized vectors of dengue, chikungunya, and Zika viruses. For around 40 years, malathion was used as a mosquito adulticide and temephos as a larvicide. Since the European Union banned the use of these two insecticide molecules in the first decade of the 21st century, deltamethrin and Bacillus thuringiensis var. israelensis are the remaining adulticide and larvicide, respectively, used in Guadeloupe. In order to improve the management of vector control activities in Guadeloupe and Saint Martin, we investigated Ae. aegypti resistance to and mechanisms associated with deltamethrin, malathion, and temephos.
   Methods: Ae. aegypti mosquitoes were collected from six different localities of Guadeloupe and Saint Martin. Larvae were used for malathion and temephos bioassays, and adult mosquitoes for deltamethrin bioassays, following World Health Organization recommendations. Knockdown resistance (Kdr) genotyping for V1016I and F1534C mutations, and expression levels of eight enzymes involved in detoxification mechanisms were examined in comparison with the susceptible reference Bora Bora strain.
   Results: Resistance ratios (RR50) calculated for Ae. aegypti larvae showed high resistance levels to temephos (from 8.9 to 33.1-fold) and low resistance levels to malathion (from 1.7 to 4.4-fold). Adult females displayed moderate resistance levels to deltamethrin regarding the time necessary to affect 50% of individuals, varying from 8.0 to 28.1-fold. Molecular investigations on adult mosquitoes showed high resistant allele frequencies for V1016I and F1534C (from 85 to 96% and from 90 to 98%, respectively), as well as an overexpression of the glutathione S-transferase gene, GSTe2, the carboxylesterase CCEae3a, and the cytochrome genes 014614, CYP6BB2, CYP6M11, and CYP9J23.
   Conclusions: Ae. aegypti populations from Guadeloupe and Saint Martin exhibit multiple resistance to organophosphates(temephos and malathion), and pyrethroids(deltamethrin). The mechanisms associated with these resistance patterns show strong frequencies of F1534C and V1016I Kdr mutations, and an over-expression of CCEae3a, GSTe2, and four cytochrome P450 genes(014614, CYP9J23, CYP6M11, CYP6BB2). These results will form the baseline for a deeper understanding of the insecticide resistance levels and associated mechanisms of Ae. aegypti populations and will be used to improve vector control strategies in Guadeloupe and Saint Martin.
C1 [Goindin, Daniella; Delannay, Christelle; Gelasse, Andric; Vega-Rua, Anubis] Pasteur Inst Guadeloupe, Unit Environm & Hlth, Lab Med Entomol, Les Abymes 97183, Guadeloupe, France.
   [Ramdini, Cedric; Gustave, Joel] Reg Hlth Agcy, Vector Control Serv, Les Abymes, Guadeloupe, France.
   [Gaude, Thierry; Faucon, Frederic; David, Jean-Philippe] CNRS, Alpine Ecol Lab LECA, UMR 5553, 2233 Rue Piscine BP53, F-38041 Grenoble 9, France.
   [Gaude, Thierry; Faucon, Frederic; David, Jean-Philippe] Univ Grenoble Alpes, Grenoble, France.
   [Gaude, Thierry; Faucon, Frederic; David, Jean-Philippe] Univ Grenoble Alpes, Environm & Syst Biol BEeSy, Grenoble, France.
   [Fouque, Florence] WHO, Vector Environm & Soc Unit, Special Programme Res & Training Trop Dis TDR, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
RP Goindin, D (corresponding author), Pasteur Inst Guadeloupe, Unit Environm & Hlth, Lab Med Entomol, Les Abymes 97183, Guadeloupe, France.
EM daniella.goindin@gmail.com
FU Fonds Europeen de Developpement Economique et Regional project
   [FED-1-1.4 32932]; ARSUnited States Department of Agriculture (USDA)USDA
   Agricultural Research Service [2014-140116]; La Region Guadeloupe; Le
   Fond Social Europeen; University of Antilles
FX This study was financially supported by the Fonds Europeen de
   Developpement Economique et Regional project FED-1-1.4 32932 and by the
   ARS through the collaboration convention no 2014-140116. DG was
   supported by La Region Guadeloupe, Le Fond Social Europeen, and the
   University of Antilles.
CR Alvarez LC, 2013, J MED ENTOMOL, V50, P1031, DOI 10.1603/ME12254
   [Anonymous], 2016, EM VIR ZIK A GUYANE
   ANSES, 2011, AV ANS RAPP EXP COLL
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064
   Bisset JA, 2011, MED VET ENTOMOL, V25, P233, DOI 10.1111/j.1365-2915.2011.00959.x
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Cabidoche Y.-M., 2011, INNOV AGRON, V16, P117
   Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x
   Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617
   Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, P1
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Etienne M., 2006, ETUDE BIOECOLOGIE AE
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Gottschamel J, 2016, PLANT MOL BIOL, V91, P497, DOI 10.1007/s11103-016-0484-5
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146
   Larrieu S, 2014, ACTA TROP, V131, P37, DOI 10.1016/j.actatropica.2013.11.023
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008
   Maia RT, 2014, BRAZ ARCH BIOL TECHN, V57, P689, DOI 10.1590/S1516-8913201402234
   Marcombe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077857
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z
   Paiva MHS, 2015, GENOMICS ELSEVIER BV, V107, P40
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Philbert A., 2014, ADV ENTOMOL, V2, P120, DOI DOI 10.4236/ae.2014.23019
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Rosine J., 1999, THESIS
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924
   Settimi L, 2016, ENVIRON INT, V91, P332, DOI 10.1016/j.envint.2016.02.034
   Somwang P, 2011, PARASITOL RES, V109, P531, DOI 10.1007/s00436-011-2280-0
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   WHO, 2010, GLOB MAL PR IN PRESS
   WHO, 2013, TEST PROC INREMO
   WORLD HEALTH ORGANIZATION, 2006, WHOCDSNTDWHOPESGCDPP
   Yanola J, 2008, 2 INT C DENG DENG HA, P15
   Yanola J, 2010, PESTIC BIOCH PHYSL
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 37
Z9 38
U1 1
U2 22
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2095-5162
EI 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD FEB 10
PY 2017
VL 6
AR UNSP 38
DI 10.1186/s40249-017-0254-x
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EL0IB
UT WOS:000394305000001
PM 28187780
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Yellow fever stalks Brazil in Zika's wake
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4756
NR 1
TC 2
Z9 2
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 8
PY 2017
VL 356
AR j707
DI 10.1136/bmj.j707
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL4FX
UT WOS:000394578200018
PM 28179231
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Miner, JJ
   Diamond, MS
AF Miner, Jonathan J.
   Diamond, Michael S.
TI Zika Virus Pathogenesis and Tissue Tropism
SO CELL HOST & MICROBE
LA English
DT Review
ID NEUTRALIZING HUMAN-ANTIBODIES; GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS;
   SEXUAL TRANSMISSION; NEURAL PROGENITORS; CEREBRAL ORGANOIDS;
   CROSS-REACTIVITY; STRUCTURAL BASIS; RHESUS-MONKEYS; HIGHLY POTENT
AB Although Zika virus (ZIKV) was isolated approximately 70 years ago, few experimental studies had been published prior to 2016. The recent spread of ZIKV to countries in the Western Hemisphere is associated with reports of microcephaly, congenital malformations, and Guillain-Barre ' syndrome. This has resulted in ZIKV being declared a public health emergency and has greatly accelerated the pace of ZIKV research and discovery. Within a short time period, useful mouse and non-human primate disease models have been established, and pre-clinical evaluation of therapeutics and vaccines has begun. Unexpectedly, ZIKV exhibits a broad tropism and persistence in body tissues and fluids, which contributes to the clinical manifestations and epidemiology that have been observed during the current epidemic. In this Review, we highlight recent advances in our understanding of ZIKV pathogenesis, tissue tropism, and the resulting pathology and discuss areas for future investigation.
C1 [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972];
   Rheumatology Research Foundation; Moderna; Visterra
FX NIH grants (R01 AI073755 and R01 AI104972) to M.S.D supported this work.
   J.J.M. was supported by a scientist development award from the
   Rheumatology Research Foundation. M.S.D is a consultant for InBios,
   Aviana, and Visterra, a member of the Scientific Advisory Board of
   OraGene Moderna, and a recipient of research grants from Moderna and
   Visterra.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bhatnagar J., 2017, EMERG INFECT DIS
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, N ENGL J MED
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Charles A., 2016, PLOS CURRENTS OUTBRE
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal M.C., 2016, REV BRAS OTORRINOLAR
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED
   Pierson T., 2013, FLAVIVIRUSES
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weger-Lucarelli J., 2016, J VIROL, V91
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zea-Vera AF, 2016, LUPUS
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 98
TC 147
Z9 148
U1 3
U2 54
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD FEB 8
PY 2017
VL 21
IS 2
BP 134
EP 142
DI 10.1016/j.chom.2017.01.004
PG 9
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EO0FJ
UT WOS:000396373400006
PM 28182948
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Painter, JE
   Plaster, AN
   Tjersland, DH
   Jacobsen, KH
AF Painter, Julia E.
   Plaster, Ashley N.
   Tjersland, Dylan H.
   Jacobsen, Kathryn H.
TI Zika virus knowledge, attitudes, and vaccine interest among university
   students
SO VACCINE
LA English
DT Article
ID HUMAN-PAPILLOMAVIRUS VACCINATION; FEMALE COLLEGE-STUDENTS; HPV VACCINE;
   INFLUENZA VACCINATION; UNITED-STATES; H1N1 VACCINE; YOUNG-ADULTS; WOMEN;
   INTENTIONS; COVERAGE
AB Background: Zika virus vaccine development is underway. We examined interest in receiving a Zika virus vaccine (after one becomes commercially available) among students at a large public university in Northern Virginia.
   Methods: An online survey of Zika virus-related knowledge, attitudes, and interest in receiving a Zika vaccine was completed by 619 undergraduate students in April, 2016. Stepwise logistic regression with backward elimination was used to identify the variables most strongly associated with interest in being vaccinated against Zika virus.
   Results: More than half of participants (52.8%) reported that they would be likely or very likely to be vaccinated against Zika virus. Vaccination interest was significantly higher among participants who received an influenza vaccine in the past year (p = 0.002), had higher levels of knowledge about Zika virus (p = 0.046), reported knowing where to access information about Zika virus (p = 0.041), had higher perceived susceptibility to Zika virus (p < 0.001), and believed that the U.S. Government should prioritize actions to control Zika virus (p = 0.001).
   Conclusions: Communication and intervention strategies encouraging vaccine uptake may benefit from increasing knowledge of Zika virus, addressing perceived susceptibility, and reaching students, travelers, and others who may be seeking information about prevention of Zika virus and other emerging infectious diseases. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Painter, Julia E.; Plaster, Ashley N.; Tjersland, Dylan H.; Jacobsen, Kathryn H.] George Mason Univ, Coll Hlth & Human Serv, Dept Global & Community Hlth, Fairfax, VA 22030 USA.
RP Painter, JE (corresponding author), George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr,Robinson Hall B432, Fairfax, VA 22030 USA.
EM jpainte6@gmu.edu; aplaster@masonlive.gmu.edu;
   dtjersla@masonlive.gmu.edu; kjacobse@gmu.edu
RI Jacobsen, Kathryn H./B-5857-2008
OI Jacobsen, Kathryn H./0000-0002-4198-6246
FU Department of Global and Community Health at George Mason University
FX Funding for this study was provided by the Department of Global and
   Community Health at George Mason University.
CR American College Health Association, 2016, AM COLL HLTH ASS NAT
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bednarczyk RA, 2015, VACCINE, V33, P1659, DOI 10.1016/j.vaccine.2015.02.033
   Benjamin SM, 2016, INFLUENZA RES TREAT, V2016, DOI [10.1155/201614248071, DOI 10.1155/201614248071]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Daley EM, 2010, J WOMENS HEALTH, V19, P1885, DOI 10.1089/jwh.2009.1861
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3
   George Mason University, 2016, OFF ENR
   Grace-Leitch L, 2016, BEHAV MED, V42, P205, DOI 10.1080/08964289.2015.1121131
   Hahn M. B., 2016, J MED ENTOMOL
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jaffe S, 2016, LANCET, V387, P1801, DOI 10.1016/S0140-6736(16)30360-9
   Jones G, 2016, J AM COLL HEALTH, V64, P545, DOI 10.1080/07448481.2016.1192542
   Jones M, 2008, J AM COLL HEALTH, V57, P23, DOI 10.3200/JACH.57.1.23-32
   Lefkowitz ES, 2014, WOMEN HEALTH, V54, P487, DOI 10.1080/03630242.2014.903552
   Lenselink CH, 2008, PUBLIC HEALTH, V122, P1295, DOI 10.1016/j.puhe.2008.02.010
   Licht AS, 2010, SEX TRANSM INFECT, V86, P74, DOI 10.1136/sti.2009.037705
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Montaiio D.E., 2008, HLTH BEHAV HLTH ED T, P67, DOI DOI 10.1016/S0033-3506(49)81524-1
   National Center for Education Statistics, 2016, DIG ED STAT TABL 303
   Nichol KL, 2008, ARCH PEDIAT ADOL MED, V162, P1113, DOI 10.1001/archpedi.162.12.1113
   Nyhan B, 2012, J ADOLESCENT HEALTH, V51, P302, DOI 10.1016/j.jadohealth.2012.02.014
   Poehling KA, 2012, J AM COLL HEALTH, V60, P541, DOI 10.1080/07448481.2012.700973
   Ramsey MA, 2011, VACCINE, V29, P7599, DOI 10.1016/j.vaccine.2011.07.130
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratanasiripong NT, 2013, VACCINE, V31, P1370, DOI 10.1016/j.vaccine.2013.01.001
   Ravert RD, 2012, ADV PREV MED, V2012
   Schlenker EH, 2013, S D MED, V66, P457
   Schlenker EH, 2013, S D MED, V66, P453
   Schlenker EH, 2013, S D MED, V66, P451
   Schlenker Evelyn H, 2013, S D Med, V66, P453
   Seale H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-307
   Shropshire AM, 2013, J AM COLL HEALTH, V61, P435, DOI 10.1080/07448481.2013.830619
   Sonmez S, 2006, ANN TOURISM RES, V33, P895, DOI 10.1016/j.annals.2006.06.005
   Thompson EL, 2016, VACCINE, V34, P3119, DOI 10.1016/j.vaccine.2016.04.063
   Uddin M, 2010, J EPIDEMIOL COMMUN H, V64, P808, DOI 10.1136/jech.2009.090852
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1
   Yang ZJ, 2015, J HEALTH COMMUN, V20, P69, DOI 10.1080/10810730.2014.904023
   Yang ZJ, 2012, RISK ANAL, V32, P1703, DOI 10.1111/j.1539-6924.2012.01799.x
NR 45
TC 14
Z9 14
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 7
PY 2017
VL 35
IS 6
BP 960
EP 965
DI 10.1016/j.vaccine.2016.12.050
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EK8SX
UT WOS:000394196000017
PM 28069360
DA 2020-07-08
ER

PT J
AU Rawle, RJ
   Webster, E
   Goronzy, I
   Boxer, S
   Kasson, P
AF Rawle, Robert J.
   Webster, Elizabeth
   Goronzy, Isabel
   Boxer, Steven
   Kasson, Peter
TI Single-Virus Observation of pH-Triggered Zika Fusion in the Absence of a
   Cellular Receptor
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 61st Annual Meeting of the Biophysical-Society
CY FEB 11-15, 2017
CL New Orleans, LA
SP Biophys Soc
C1 [Rawle, Robert J.; Kasson, Peter] Univ Virginia, Mol Physiol & Biol Phys, Charlottesville, VA USA.
   [Webster, Elizabeth; Goronzy, Isabel; Boxer, Steven] Stanford Univ, Chem, Stanford, CA 94305 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 3
PY 2017
VL 112
IS 3
SU 1
MA 413-Pos
BP 80A
EP 80A
DI 10.1016/j.bpj.2016.11.479
PG 1
WC Biophysics
SC Biophysics
GA EW2LL
UT WOS:000402328000413
OA Bronze
DA 2020-07-08
ER

PT J
AU Sharma, A
   Lal, SK
AF Sharma, Anshika
   Lal, Sunil K.
TI Zika Virus: Transmission, Detection, Control, and Prevention
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Flavivirus infection; arbovirus; sylvatic cycle; microcephaly;
   Guillain-Barre syndrome; Zika diagnosis
ID WEST NILE VIRUS; SEXUAL TRANSMISSION; UNITED-STATES; INTERIM GUIDELINES;
   FRENCH-POLYNESIA; PREGNANT-WOMEN; INFECTION; EMERGENCE; OUTBREAK;
   MOSQUITOS
AB Zika virus (ZIKV) is a mosquito-borne Flavivirus discovered in Uganda in the 1940s. To date, three major ZIKV outbreaks have been reported. ZIKV infections have known to be primarily asymptomatic while causing mild illness in a few cases. However, the recent emergence and spread of ZIKV in the Americas has resulted in the declaration of Public Health Emergency of International Concern due to the potential association between the infection and prenatal microcephaly or other brain anomalies. In Brazil, a 20-fold increase in prenatal microcephaly cases and 19% increase in Guillain-Barre Syndrome (GBS) cases were reported in 2015, as compared to the preceding year. The probable deleterious effects of ZIKV infection prompt the urgent development of diagnostics and therapeutics. To this end, the existing evidences supporting the increasingly common prenatal microcephaly and GBS association and the current known ZIKV transmission dynamics, modes of detection (molecular and serology-based), and current control strategies are summarized in this review. This review also emphasizes the importance of understanding ZIKV transmission in order to design a sensitive yet cost and time-efficient detection technique. Development of an efficient detection technique would subsequently allow for better surveillance and control of ZIKV infection. Currently, limited literature is available on the pathogenesis of ZIKV, hence, focusing on the modes of ZIKV transmission could potentially contribute to the understanding of the disease spectrum and formulation of targeted treatment and control.
C1 [Sharma, Anshika; Lal, Sunil K.] Monash Univ, Sch Sci, Subang Jaya, Selangor, Malaysia.
RP Lal, SK (corresponding author), Monash Univ, Sch Sci, Subang Jaya, Selangor, Malaysia.
EM sunil.lal@monash.edu
RI amsalu, ribka/G-8780-2019
FU Monash University, MalaysiaMonash University
FX This work was supported by internal funds from Monash University,
   Malaysia.
CR Agencia Fiocruz de Noticias, 2016, FIOCR PERN ANSW QUES
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, OBSTET GYNECOL SURV, V71, P331, DOI 10.1097/01.ogx.0000483239.08585.8d
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, ZINK DIS US 2015 201
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P877
   Centers for Disease Control and Prevention Newsroom, 2016, 1 FEM MAL SEX TRANSM
   Centers for Infectious Disease Research and Policy, 2016, BRAZ CONF BOOLD TRAN
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Dockrill P., 2016, THIS NEW LOW COST TE
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Kelly S, 2013, MMWR-MORBID MORTAL W, V62, P622
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Macdonald F., 2016, INDIAN CO SAYS THEY
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   O'Brien SF, 2010, TRANSFUSION, V50, P1118, DOI 10.1111/j.1537-2995.2009.02550.x
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, ZIK VIR ZIKV INC TRE
   Pan American Health Organization, 2016, ZIK ACT EP REG OPS A
   Pan American Health Organization, 2016, EP AL NEUR SYNDR CON
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pupella S, 2013, BLOOD TRANSFUS-ITALY, V11, P563, DOI 10.2450/2013.0077-13
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Santora M., 2016, TWIST ZIKA OUTBREAK
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, 2016, ZIK VIR EP UPD
   World Health Organization, 2016, GUILL BARR SYNDR FRA
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 104
TC 45
Z9 45
U1 1
U2 122
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 3
PY 2017
VL 8
AR 110
DI 10.3389/fmicb.2017.00110
PG 14
WC Microbiology
SC Microbiology
GA EJ4XG
UT WOS:000393220000001
PM 28217114
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tsujimoto, H
   Hanley, KA
   Sundararajan, A
   Devitt, NP
   Schilkey, FD
   Hansen, IA
AF Tsujimoto, Hitoshi
   Hanley, Kathryn A.
   Sundararajan, Anitha
   Devitt, Nicholas P.
   Schilkey, Faye D.
   Hansen, Immo A.
TI Dengue virus serotype 2 infection alters midgut and carcass gene
   expression in the Asian tiger mosquito, Aedes albopictus
SO PLOS ONE
LA English
DT Article
ID ANOPHELES-GAMBIAE; GLOBAL DISTRIBUTION; AEGYPTI MOSQUITOS;
   IMMUNE-RESPONSE; WOLBACHIA; TRANSMISSION; STRAINS; PROTEIN; HOST;
   ACTIVATION
AB Background
   The Asian tiger mosquito, Aedes albopictus is currently an important vector for dengue, chikungunya and Zika virus, and its role in transmission of arthropod-borne viruses (arboviruses) may increase in the future due to its ability to colonize temperate regions. In contrast to Aedes aegypti, the dominant vector of dengue, chikungunya and Zika virus, genetic responses of Ae. albopictus upon infection with an arbovirus are not well characterized. Here we present a study of the changes in transcript expression in Ae. albopictus exposed to dengue virus serotype 2 via feeding on an artificial bloodmeal.
   Methodology/Principal findings
   We isolated midguts and midgut-free carcasses of Ae. albopictus fed on bloodmeals containing dengue virus as well as controls fed on virus-free control meals at day 1 and day 5 post-feeding. We confirmed infection of midguts from mosquitoes sampled on day 5 post-feeding via RT-PCR. RNAseq analysis revealed dynamic modulation of the expression of several putative immunity and dengue virus-responsive genes, some of whose expression was verified by qRT-PCR. For example, a serine protease gene was up-regulated in the midgut at 1 day post infection, which may potentially enhance mosquito susceptibility to dengue infection, while 14 leucine-rich repeat genes, previously shown to be involved in mosquito antiviral defenses, were down-regulated in the carcass at 5 days post infection. The number of significantly modulated genes decreased over time in midguts and increased in carcasses.
   Conclusion/Significance
   Dengue virus exposure results in the modulation of genes in a time-and site-specific manner. Previous literature on the interaction between mosquitoes and mosquito-borne pathogens suggests that most of the changes that occurred in Ae. albopictus exposed to DENV would favor virus infection. Many genes identified in this study warrant further characterization to understand their role in viral manipulation of and antiviral response of Ae. albopictus.
C1 [Tsujimoto, Hitoshi; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Sundararajan, Anitha; Devitt, Nicholas P.; Schilkey, Faye D.] Natl Ctr Genome Resources, NM INBRE Sequencing & Bioinformat Core, Santa Fe, NM USA.
   [Tsujimoto, Hitoshi] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
RP Tsujimoto, H (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.; Tsujimoto, H (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
EM HitTsujimoto@gmail.com
FU National Center for Genome Resources (NCGR); NM-INBRE pilot grant;
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [4SC1AI109055-04]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1R15AI113628-01]
FX This work was supported by funding by National Center for Genome
   Resources (NCGR), NM-INBRE pilot grant to HT, National Institutes of
   Health (NIH) 4SC1AI109055-04 to IAH, and NIH 1R15AI113628-01 to KAH. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356
   Armbruster PA., 2016, J MED ENTOMOL
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252
   Chisenhall DM, 2014, AM J TROP MED HYG, V90, P431, DOI 10.4269/ajtmh.13-0412
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Faraji A., 2016, J MED ENTOMOL
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   Guo XX, 2013, ACTA TROP, V128, P566, DOI 10.1016/j.actatropica.2013.08.006
   Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Levy F, 2004, MOL CELL PROTEOMICS, V3, P156, DOI 10.1074/mcp.M300114-MCP200
   Liu YX, 2016, INSECT SCI, V23, P377, DOI 10.1111/1744-7917.12339
   Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Macours N, 2004, INSECT BIOCHEM MOLEC, V34, P501, DOI 10.1016/j.ibmb.2004.03.007
   McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019
   METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937
   MILLER NA, 2008, ALPHEUS J COMPUT SCI, V1, P132, DOI DOI 10.4172/JCSB.1000013
   Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Shin SW, 2011, EMBO REP, V12, P938, DOI 10.1038/embor.2011.130
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Tsetsarkin KA, 2014, NAT COMMUN, P5
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vanlandingham DL, 2016, J MED ENTOMOL
   Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531
   WHITEHEAD RH, 1971, T ROY SOC TROP MED H, V65, P661, DOI 10.1016/0035-9203(71)90051-4
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yan H, 2014, J MED VIROL, V86, P1428, DOI 10.1002/jmv.23815
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
   Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4
NR 69
TC 11
Z9 11
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 2
PY 2017
VL 12
IS 2
AR e0171345
DI 10.1371/journal.pone.0171345
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DB
UT WOS:000396161200130
PM 28152011
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ali, M
   Folz, R
   Miller, K
   Johnson, BR
   Kiarie, J
AF Ali, Moazzam
   Folz, Rachel
   Miller, Kelsey
   Johnson, Brooke Ronald, Jr.
   Kiarie, James
TI A study protocol for facility assessment and follow-up evaluations of
   the barriers to access, availability, utilization and readiness of
   contraception, abortion and postabortion services in Zika affected areas
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Zika virus; Health facilities; Rapid assessment; Contraception; Abortion
   care; Post-abortion care; Latin America
ID REPRODUCTIVE HEALTH; CRISIS; BRAZIL; WOMEN; EBOLA
AB Background: The Zika virus epidemic in Latin America has elicited official recommendations for women to delay or avoid pregnancy in affected countries, which has increased demand for family planning services. It is likely, however, that health facilities in areas where the population is most vulnerable to the disease lack the capacity to respond to the increased demand for family planning services. Our objectives are to perform facilities assessment and understand client perceptions in areas affected by Zika virus, and to track changes in these parameters over time.
   Methods/design: We will collaborate with local health authorities to map facilities that have the capacity to provide services in contraception and safe abortion, including induced abortion to the full extent of the law and post-abortion care for treatment of complications from unsafe abortion and post-abortion contraception. We then will carry out a survey of facilities to assess the availability of services and their readiness to provide contraception and safe abortion care. All facilities will be assessed for baseline readiness and availability of services, and a random subsample of surveyed facilities will be reassessed in second and third rounds of surveys. Focus group interviews with clients will be conducted as part of the facilities surveys in order to gain an understanding of the community's knowledge, needs and perceived barriers to healthcare in the context of the Zika virus epidemic.
   Discussion: The findings of this study will aid the response to Zika virus ranging from the identification of healthcare facilities that can be potentially strengthened, to the formulation of interventions to reduce barriers and improve readiness of facilities to provide contraception and safe abortion services. Lessons learned from this study will help to build and strengthen health systems that are more prepared to consistently providing reproductive healthcare services in the context of health emergencies.
C1 [Ali, Moazzam; Folz, Rachel; Miller, Kelsey; Johnson, Brooke Ronald, Jr.; Kiarie, James] World Hlth Org, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Ali, M (corresponding author), World Hlth Org, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM alimoa@who.int
OI kiarie, james/0000-0003-4180-7858
FU  [5149]
FX The study is funded by Large Anonymous Donor under the Grant ID 5149 for
   Women, Communities, and Health Systems in the Context of Zika. The
   funding sources did not play a role in the study design, in the writing
   of the report, or in the decision to submit the article for publication.
CR Aiken AR, 2016, N ENGL J MED
   Ali MM, 2005, SOC SCI MED, V60, P1175, DOI 10.1016/j.socscimed.2004.07.002
   Barden-O'Fallon Janine, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.0b0ba06009dd091bc39ddb3c6d7b0826
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Columbine M, 2012, SOCIAL SCI METHODS R
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Delamou A, 2014, LANCET, V384, P2105, DOI 10.1016/S0140-6736(14)62364-3
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   Garcia-Subirats I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-10
   Guttmacher Institute, 2016, SEX REPR HLTH RES AN
   Menendez C, 2015, LANCET GLOB HEALTH, V3, pE130, DOI 10.1016/S2214-109X(15)70009-4
   Mutter J, 2010, NATURE, V466, P1042, DOI 10.1038/4661042a
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Singh S, 2014, ADDING IT COSTS BENE
   Ugaz Jorge I, 2015, Int J Gynaecol Obstet, V130 Suppl 3, pE3, DOI 10.1016/j.ijgo.2015.03.021
   United Nations, 2011, POP DIV WORLD AB POL
   WHO, 2016, PREV SEX TRANSM ZIK
   World Health Organization, 2012, SAF AB TECHN POL GUI
   World Health Organization, 2015, SERV AV READ ASS SAR
NR 23
TC 3
Z9 3
U1 1
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD FEB 2
PY 2017
VL 14
AR 18
DI 10.1186/s12978-017-0283-8
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EJ3DJ
UT WOS:000393092500002
PM 28153043
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ali, M
   Miller, K
   Folz, R
   Johnson, BR
   Kiarie, J
AF Ali, Moazzam
   Miller, Kelsey
   Folz, Rachel
   Johnson, Brooke Ronald, Jr.
   Kiarie, James
TI Study protocol on establishment of sentinel sites network for
   contraceptive and abortion trends, needs and utilization of services in
   Zika virus affected countries
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Contraception demand; Sentinel Sites; Zika virus; Family planning; Safe
   abortion
ID LATIN-AMERICA; HEALTH; SURVEILLANCE; SYSTEMS
AB Background: ZIKV(Zika Virus) during pregnancy can result in many adverse events such as fetal deaths or newborns with congenital abnormalities including microcephaly and other neural irregularities. Due to these harmful outcomes of pregnancy associated with the Zika virus, we can expect to see a change in the type and scale of demand for family planning and safe abortion services in areas affected by the Zika virus. The monitoring and reporting capacities of the local health clinics in these areas could benefit from the introduction of infrastructural improvements necessary to establish a sentinel site network. Through these sites, the WHO will collect data on the situation from local health professionals to get real time information from the population group and act accordingly to mitigate the consequences of the Zika virus outbreak in a localized and culturally appropriate way. The objectives are to establish a sentinel sites surveillance network for reporting on uptake and utilization of contraception and safe abortion care services; to strengthen monitoring, and data quality assurance in the selected sentinel surveillance sites; and finally to assess the contraception and safe abortion care service utilization trends in the affected sites on a regular basis.
   Methods: The proposal includes a set of objectives and actions that enable the creation of a set of criteria for the selection of the sentinel sites, as well the implementation of monitoring and reporting systems that will be used in data collection.
   Discussion: The data collected will be used to better understand the changing demand for family planning and safe abortion needs. This will ultimately be used to inform local health workers and policy makers as to how best to track the continued Zika virus outbreak and mitigate the consequences. The learning from establishment of surveillance sentinel sites will help to strengthen health systems at regional and subregional levels that are more adaptable and capable of providing reproductive healthcare services and of responding to future emergencies.
C1 [Ali, Moazzam; Miller, Kelsey; Folz, Rachel; Johnson, Brooke Ronald, Jr.; Kiarie, James] World Hlth Org, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Ali, M (corresponding author), World Hlth Org, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM alimoa@who.int
OI kiarie, james/0000-0003-4180-7858
FU  [5149]
FX The study is funded by Large Anonymous Donor under the Grant ID 5149 for
   Women, Communities, and Health Systems in the Context of Zika. The
   funding sources did not play a role in the study design, in the writing
   of the report, or in the decision to submit the article for publication.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, LANCET GLOBAL HLTH, V4, pe427
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   British Broadcasting Corporation, 2016, ZIK VIR TRIGG PREGN
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Garcia-Subirats I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-10
   Kandel N, 2016, B WORLD HEALTH ORGAN, V94, P705, DOI 10.2471/BLT.16.171504
   McNeil Jr Donald G., 2016, NY TIMES
   Menendez C, 2015, LANCET GLOB HEALTH, V3, pE130, DOI 10.1016/S2214-109X(15)70009-4
   Mishra N, 2012, B WORLD HEALTH ORGAN, V90, P895, DOI 10.2471/BLT.12.109124
   Polio Global Eradication Initiative, 2001, TECHN SHEETS POL ER
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Van Man N, 2005, J INFECT DIS, V192, pS127
   WHO, 2016, ON YEAR ZIK OUTBR OB
   WHO, 2016, PREV SEX TRANSM ZIK
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2007, GLOB FRAM IMM MON SU
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 18
TC 4
Z9 4
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD FEB 2
PY 2017
VL 14
AR 19
DI 10.1186/s12978-017-0282-9
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EJ3DJ
UT WOS:000393092500003
PM 28153056
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lo, NC
   Addiss, DG
   Hotez, PJ
   King, CH
   Stothard, JR
   Evans, DS
   Colley, DG
   Lin, W
   Coulibaly, JT
   Bustinduy, AL
   Raso, G
   Bendavid, E
   Bogoch, II
   Fenwick, A
   Savioli, L
   Molyneux, D
   Utzinger, J
   Andrews, JR
AF Lo, Nathan C.
   Addiss, David G.
   Hotez, Peter J.
   King, Charles H.
   Stothard, J. Russell
   Evans, Darin S.
   Colley, Daniel G.
   Lin, William
   Coulibaly, Jean T.
   Bustinduy, Amaya L.
   Raso, Giovanna
   Bendavid, Eran
   Bogoch, Isaac I.
   Fenwick, Alan
   Savioli, Lorenzo
   Molyneux, David
   Utzinger, Jurg
   Andrews, Jason R.
TI A call to strengthen the global strategy against schistosomiasis and
   soil-transmitted helminthiasis: the time is now
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID NEGLECTED TROPICAL DISEASES; COST-EFFECTIVENESS; 188 COUNTRIES;
   PREVALENCE; DISABILITY; INFECTION; INJURIES; AFRICA; IMPACT
AB In 2001, the World Health Assembly (WHA) passed the landmark WHA 54.19 resolution for global scale-up of mass administration of anthelmintic drugs for morbidity control of schistosomiasis and soil-transmitted helminthiasis, which affect more than 1.5 billion of the world's poorest people. Since then, more than a decade of research and experience has yielded crucial knowledge on the control and elimination of these helminthiases. However, the global strategy has remained largely unchanged since the original 2001 WHA resolution and associated WHO guidelines on preventive chemotherapy. In this Personal View, we highlight recent advances that, taken together, support a call to revise the global strategy and guidelines for preventive chemotherapy and complementary interventions against schistosomiasis and soil-transmitted helminthiasis. These advances include the development of guidance that is specific to goals of morbidity control and elimination of transmission. We quantify the result of forgoing this opportunity by computing the yearly disease burden, mortality, and lost economic productivity associated with maintaining the status quo. Without change, we estimate that the population of sub-Saharan Africa will probably lose 2.3 million disability-adjusted life-years and US$3.5 billion of economic productivity every year, which is comparable to recent acute epidemics, including the 2014 Ebola and 2015 Zika epidemics. We propose that the time is now to strengthen the global strategy to address the substantial disease burden of schistosomiasis and soil-transmitted helminthiasis.
C1 [Lo, Nathan C.; Andrews, Jason R.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, 300 Pasteur Dr,Lane L-134, Stanford, CA 94305 USA.
   [Lo, Nathan C.] Stanford Univ, Sch Med, Div Epidemiol, Stanford, CA 94305 USA.
   [Addiss, David G.] Task Force Global Hlth, Children Worms, Decatur, GA USA.
   [Hotez, Peter J.] Baylor Coll Med, Sabin Vaccine Inst, Houston, TX 77030 USA.
   Texas Childrens Hosp, Baylor Coll Med, Natl Sch Trop Med, Ctr Vaccine Dev, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Hotez, Peter J.] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX USA.
   [King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.
   [Stothard, J. Russell; Molyneux, David] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool, Merseyside, England.
   [Evans, Darin S.] US Agcy Int Dev, Global Hlth, Washington, DC 20523 USA.
   [Colley, Daniel G.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.
   [Colley, Daniel G.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.
   [Lin, William] Johnson & Johnson, Global Publ Hlth, New Brunswick, NJ USA.
   [Coulibaly, Jean T.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire.
   [Coulibaly, Jean T.] Ctr Suisse Rech Sci Cote dIvoire, Abidjan, Cote Ivoire.
   [Coulibaly, Jean T.; Raso, Giovanna; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Coulibaly, Jean T.; Raso, Giovanna; Utzinger, Jurg] Univ Basel, Basel, Switzerland.
   [Bustinduy, Amaya L.] London Sch Hyg & Trop Med, Clin Res Dept, London, England.
   [Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA.
   [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA.
   [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA.
   [Bogoch, Isaac I.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Toronto Gen Hosp, Univ Hlth Network, Div Internal Med & Infect Dis, Toronto, ON, Canada.
   [Fenwick, Alan] Imperial Coll London, Schistosomiasis Control Initiat, London, England.
   [Savioli, Lorenzo] Global Schistosomiasis Alliance, Chavannes De Bogis, Switzerland.
RP Lo, NC (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, 300 Pasteur Dr,Lane L-134, Stanford, CA 94305 USA.
EM nathan.lo@stanford.edu
RI ; Stothard, Russell/I-9717-2016
OI Colley, Daniel/0000-0002-9381-8420; Evans, Darin/0000-0003-1180-8980;
   King, Charles/0000-0001-8349-9270; Stothard,
   Russell/0000-0002-9370-3420; Bustinduy, Amaya/0000-0001-6131-4159
FU National Institutes of Health Medical Scientist Training Program (MSTP);
   Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF);
   University of Georgia Research Foundation; Bill & Melinda Gates
   FoundationGates Foundation; Schistosomiasis Consortium for Operational
   Research and Evaluation (SCORE); UK Department for International
   Development as part of COUNTDOWN Implementation research award
FX NCL dedicates this article to the inspirational memory of Vicki Mosley.
   We received financial support from the National Institutes of Health
   Medical Scientist Training Program (MSTP), Doris Duke Charitable
   Foundation, University of Georgia Research Foundation, Bill & Melinda
   Gates Foundation, and Schistosomiasis Consortium for Operational
   Research and Evaluation (SCORE). DM and JRS receive support from the UK
   Department for International Development as part of the COUNTDOWN
   Implementation research award.
CR Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435
   Anderson RM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003897
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P456
   Bieri FA, 2013, NEW ENGL J MED, V368, P1603, DOI 10.1056/NEJMoa1204885
   Bustinduy AL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004946
   Clarke NE, 2016, LANCET IN PRESS
   Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9
   Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639
   de Silva N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004203
   Deol A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1824-7
   Evans D, 2011, ANN TROP MED PARASIT, V105, P537, DOI 10.1179/2047773211Y.0000000010
   Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439
   Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000
   Grimes JET, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0005236, 10.1371/journal.pntd.0004515]
   Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296
   Gurarie D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1144-3
   Gyorkos Theresa W, 2013, PLoS Negl Trop Dis, V7, pe2397, DOI 10.1371/journal.pntd.0002397
   Hicks JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004214
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0003895
   Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003672
   Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621
   Karagiannis-Voules DA, 2015, LANCET INFECT DIS, V15, P74, DOI 10.1016/S1473-3099(14)71004-7
   Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6
   King CH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004290
   Lai YS, 2015, LANCET INFECT DIS, V15, P927, DOI 10.1016/S1473-3099(15)00066-3
   Lelo AE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003221
   Lo NC, 2016, LANCET INFECT DIS, V16, P1065, DOI 10.1016/S1473-3099(16)30073-1
   Lo NC, 2016, LANCET INFECT DIS, V16, P762, DOI 10.1016/S1473-3099(16)30049-4
   Lo NC, 2015, LANCET GLOB HEALTH, V3, pE629, DOI 10.1016/S2214-109X(15)00047-9
   Means AR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004737
   Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336
   Molyneux DH, 2016, LANCET
   Montresor A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004165
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Ndayishimiye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002684
   Rollinson D, 2013, ACTA TROP, V128, P423, DOI 10.1016/j.actatropica.2012.04.013
   Sokolow SH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004794
   Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620
   Taylor D, 2015, FROM THE CAM TO THE ZAMBEZI: COLONIAL SERVICE AND THE PATH TO THE NEW ZAMBIA, P1, DOI 10.1002/14651858.CD000371.pub6
   Truscott JE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-266
   Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   WALKER M, 2016, PARASITE VECTOR, V9
   Welch VA, 2016, LANCET GLOB IN PRESS
   WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1
   WHO, 2015, WAT SAN HYG ACC SUST
   WHO, 2006, PREV CHEM HUM HELM C
   World Health Organization, 2012, ACC WORK OV GLOB IMP
   Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162
NR 49
TC 48
Z9 49
U1 5
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2017
VL 17
IS 2
BP E64
EP E69
DI 10.1016/S1473-3099(16)30535-7
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FI9YO
UT WOS:000412365900005
PM 27914852
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Sheppard, TL
AF Sheppard, Terry L.
TI RNA STRUCTURE Untying Zika's knots
SO NATURE CHEMICAL BIOLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1552-4450
EI 1552-4469
J9 NAT CHEM BIOL
JI Nat. Chem. Biol.
PD FEB
PY 2017
VL 13
IS 2
BP 129
EP 129
DI 10.1038/nchembio.2294
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FD2SA
UT WOS:000407383900003
PM 28103218
DA 2020-07-08
ER

PT J
AU Mahecha, MP
   Ojeda, E
   Vega, DA
   Sarmiento-Monroy, JC
   Anaya, JM
AF Mahecha, Maria P.
   Ojeda, Ernesto
   Vega, Daniel A.
   Sarmiento-Monroy, Juan C.
   Anaya, Juan-Manuel
TI Guillain-Barr, syndrome in Colombia: where do we stand now?
SO IMMUNOLOGIC RESEARCH
LA English
DT Article
DE Guillain-Barre syndrome; Zika virus; Anti-gangliosides antibodies; Latin
   America
ID VIRUS; POLYRADICULONEUROPATHY; NEUROPATHIES; VACCINATION; MORTALITY;
   INFECTION; DIAGNOSIS; OUTBREAK; CHILD
AB Guillain-Barr, syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed.
C1 [Mahecha, Maria P.; Sarmiento-Monroy, Juan C.; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-C-69, Bogota, Colombia.
   [Ojeda, Ernesto] Mederi Hosp Univ Mayor, Dept Neurol, Calle 24 29-45, Bogota, Colombia.
   [Vega, Daniel A.] Mederi Hosp Univ Mayor, Intens Care Unit, Calle 24 29-45, Bogota, Colombia.
RP Anaya, JM (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-C-69, Bogota, Colombia.
EM anayajm@gmail.com
RI ; Anaya, Juan-Manuel/J-1960-2016
OI Sarmiento-Monroy, Juan Camilo/0000-0002-8426-7268; Anaya,
   Juan-Manuel/0000-0002-6444-1249
FU Universidad del Rosario, Bogota, Colombia
FX The authors are grateful to all the members of the Center for Autoimmune
   Diseases Research (CREA) for their fruitful discussions and comments to
   this work. The Universidad del Rosario, Bogota, Colombia, supported this
   work.
CR An JY, 2008, INTERNAL MED, V47, P1539, DOI 10.2169/internalmedicine.47.1224
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   ASBURY AK, 1990, ANN NEUROL, V27, pS2, DOI 10.1002/ana.410270703
   Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x
   Blum S, 2014, J PERIPHER NERV SYST, V19, P88, DOI 10.1111/jns5.12074
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrillo AG, 1980, REV COLOMB PEDIAT PU, V32, P125
   Cea G, 2015, REV MED CHILE, V143, P183, DOI 10.4067/S0034-98872015000200005
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Córdoba Juan Pablo, 2014, Acta Neurol Colomb., V30, P89
   daSilveira CM, 1997, LANCET, V349, P14, DOI 10.1016/S0140-6736(96)07408-9
   Dias-Tosta E, 2002, ARQ NEURO-PSIQUIAT, V60, P367, DOI 10.1590/S0004-282X2002000300005
   Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4, DOI 10.33588/rn.5801.2013370
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Dourado ME, 2003, ACTA NEUROL SCAND, V108, P102, DOI 10.1034/j.1600-0404.2003.00103.x
   Eldar AH, 2014, AUTOIMMUN REV, V13, P525, DOI 10.1016/j.autrev.2014.01.033
   Escobar V, 1986, B EPIDEMIOL ANTIOQ, V11, P98
   Gonzalez M Guillermo, 2015, Acta Neurol Colomb., V31, P54
   Gonzalez P, 2016, NEUROLOGIA, V31, P389, DOI 10.1016/j.nrl.2014.09.004
   Guerra C, 2013, BIOMEDICA, V33, P513, DOI 10.7705/biomedica.v33i4.1438
   Guzmán G Guillermo E, 2015, Rev.Colomb.Reumatol., V22, P71, DOI 10.1016/j.rcreu.2015.02.004
   Hernández-Beltrán Natalia, 2015, Infect., V19, P172, DOI 10.1016/j.infect.2015.01.001
   Hicks DJ, 2012, CLIN EXP IMMUNOL, V169, P199, DOI 10.1111/j.1365-2249.2012.04592.x
   Isaza-Jaramillo SP, 2009, ACTA NEUROL COLOMB, V25, P123
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Jasti AK, 2016, EXPERT REV CLIN IMMU, V12, P1175, DOI 10.1080/1744666X.2016.1193006
   Kokubun N, 2012, J NEUROL SCI, V319, P164, DOI 10.1016/j.jns.2012.05.001
   Lim JP, 2014, AUTOIMMUN REV, V13, P1070, DOI 10.1016/j.autrev.2014.08.005
   LOPEZ F, 1973, AM J EPIDEMIOL, V98, P226, DOI 10.1093/oxfordjournals.aje.a121551
   Lopez FD, 2003, MED CLIN-BARCELONA, V121, P518
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Montalvo Raúl, 2010, Rev. perú. med. exp. salud publica, V27, P292, DOI 10.1590/S1726-46342010000200020
   Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171
   Netto AB, 2011, ANN INDIAN ACAD NEUR, V14, P262, DOI 10.4103/0972-2327.91942
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Ortiz-Corredor F, 2007, REV NEUROLOGIA, V44, P636, DOI 10.33588/rn.4410.2005313
   Ortiz-Corredor F, 2007, ACTA NEUROL SCAND, V115, P289, DOI 10.1111/j.1600-0404.2006.00766.x
   Ortiz-Corredor F, 2004, REV NEUROLOGIA, V38, P518, DOI 10.33588/rn.3806.2003375
   Ortiz-Corredor F, 2003, REV NEUROLOGIA, V36, P1113, DOI 10.33588/rn.3612.2003056
   Ortiz-Corredor F, 2007, DISABIL REHABIL, V29, P883, DOI 10.1080/09638280701240326
   Ortiz-Corredor F, 2006, CHILD NERV SYST, V22, P1328, DOI 10.1007/s00381-006-0092-9
   Palacios E., 1982, ACTA MED COLOMB, V7, P69
   Paradiso G, 1999, ANN NEUROL, V46, P701, DOI 10.1002/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7
   Pelaez Carvajal D., 1998, CARACTERIZACION MOL
   Sharma Chandra Mohan, 2011, J Indian Med Assoc, V109, P682
   Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124
   Spagnoli C, 2016, EUR J PAEDIATR NEURO, V20, P168, DOI 10.1016/j.ejpn.2015.11.004
   TORO G, 1977, ARCH NEUROL-CHICAGO, V34, P694, DOI 10.1001/archneur.1977.00500230064011
   Toro G, 2009, GUIA PRACTICA ATENCI, P24
   Toro J, 2013, MULT SCLER RELAT DIS, V2, P395, DOI 10.1016/j.msard.2013.03.003
   Tse ACT, 2012, J CLIN NEUROSCI, V19, P607, DOI 10.1016/j.jocn.2011.06.024
   van Sorge NM, 2004, AUTOIMMUN REV, V3, P151, DOI 10.1016/S1568-9972(03)00089-2
   Vega D, 2008, ACTA COLOMB CUID INT, V8, P219
   VERGARA I, 1979, ARCH NEUROL-CHICAGO, V36, P254, DOI 10.1001/archneur.1979.00500400108026
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Vinzio S, 2000, ANN MED INTERNE, V151, P309
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Winters JL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-101
   Zuniga-Gonzalez Edgar Alfredo, 2007, Rev Med Inst Mex Seguro Soc, V45, P463
NR 62
TC 10
Z9 11
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0257-277X
EI 1559-0755
J9 IMMUNOL RES
JI Immunol. Res.
PD FEB
PY 2017
VL 65
IS 1
SI SI
BP 72
EP 81
DI 10.1007/s12026-016-8816-8
PG 10
WC Immunology
SC Immunology
GA ET3JX
UT WOS:000400175600010
PM 27421717
OA Bronze
DA 2020-07-08
ER

PT J
AU Graul, AI
   Dulsat, C
   Tracy, M
   Cruces, E
AF Graul, A. I.
   Dulsat, C.
   Tracy, M.
   Cruces, E.
TI The year's new drugs & biologics 2016: Part II - Trends and highlights
   of an unforgettable year
SO DRUGS OF TODAY
LA English
DT Review
DE Drug approvals; Ebola; Zika; Orphan drugs; Drug pricing; Pipeline
   attrition; Mergers and acquisitions
ID RECOMMENDATIONS; INHIBITOR; EFFICACY; COST
AB This eagle's-eye overview of the drug industry in 2016 provides insight into some of last year's top stories, including disease outbreaks that drove R&D, orphan drug development, pipeline attrition, drug pricing, and the ongoing movement in M&A. We also consider recent political events in the U.S. and U.K. and their potential impact on the industry in the years to come, and take a glimpse into the crystal ball to anticipate the new drugs that may be approved in 2017.
C1 [Graul, A. I.; Dulsat, C.; Tracy, M.; Cruces, E.] Clarivate Analyt, 398 Provenca, Barcelona 08025, Spain.
RP Graul, AI (corresponding author), Clarivate Analyt, 398 Provenca, Barcelona 08025, Spain.
EM ann.graul@clarivate.com
CR Abbott A, 2016, NATURE, V540, P15, DOI 10.1038/nature.2016.21045
   [Anonymous], 2016, REUTERS BUSINES 1207
   [Anonymous], 2012, WHIT PAP EC POW ORPH
   [Anonymous], 2016, PROPL AR FUR PRIC EP
   Behre HM, 2016, J CLIN ENDOCR METAB, V101, P4779, DOI 10.1210/jc.2016-2141
   Chan M., 2017, GRAND CHALLENGES NEX
   Cheng A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0568-6
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   Davies E. H., 2017, BR J CLIN PHARM
   Fidler B., 2016, XCONOMY         1229
   Gupta R, 2016, NEW ENGL J MED, V375, P2213, DOI 10.1056/NEJMp1609578
   Haucap J., 2016, 218 DICE IDEAS
   Haucap J., 2016, HARVARD BUSINESS REV
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hudson KL, 2017, NEW ENGL J MED, V376, P111, DOI 10.1056/NEJMp1615745
   Janoudi G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0539-3
   Jarvis LM, 2016, CHEM ENG NEWS, V94, P36
   Kaur R, 2016, J PHARMACOL PHARMACO, V7, P120, DOI 10.4103/0976-500X.189661
   Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004
   Kerbrat A, 2016, NEW ENGL J MED, V375, P1717, DOI 10.1056/NEJMoa1604221
   Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237
   Kibble A., 2016, CLARIVATE ANAL  1223
   Kondo H, 2017, THER INNOV REGUL SCI, V51, P51, DOI 10.1177/2168479016662682
   Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a
   McMahon MA, 2017, NAT REV NEUROL, V13, P7, DOI 10.1038/nrneurol.2016.190
   Mullard A, 2016, NAT REV DRUG DISCOV, V15, P669, DOI 10.1038/nrd.2016.207
   Regalado A., 2015, MIT TECHNOLOGY REV
   Rodriguez-Monguio R, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-016-0551-7
   Sanders Bernie, 2016, COMMUNICATION
   US Food and Drug Administration, 2017, 22 CAS STUD PHAS 2 P
   Vivot A., 2017, ANN ONCOL
NR 31
TC 0
Z9 0
U1 0
U2 12
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 1699-3993
EI 1699-4019
J9 DRUG TODAY
JI Drugs Today
PD FEB
PY 2017
VL 53
IS 2
BP 117
EP 158
DI 10.1358/dot.2017.53.2.2618153
PG 42
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ER6TC
UT WOS:000398940000003
PM 28387389
DA 2020-07-08
ER

PT J
AU Passi, D
   Sharma, S
   Dutta, SR
   Ahmed, M
AF Passi, Deepak
   Sharma, Sarang
   Dutta, Shubha Ranjan
   Ahmed, Musharib
TI Zika Virus Diseases - The New Face of an Ancient Enemy as Global Public
   Health Emergency (2016): Brief Review and Recent Updates
SO INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Review
DE Aedes; arbovirus; congenital microcephaly; Guillain-Barre syndrome; Zika
   virus
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; OUTBREAK; STATES
AB Zika virus (ZIKV) disease is caused by a virus transmitted by Aedes mosquito. It presents as flu-like symptoms lasting for 5-7 days and shows potential association with neurological and autoimmune complications such as congenital microcephaly and adult paralysis disorder, Guillain-Barre syndrome. Treatment measures are conservative as the disease is self-limiting. ZIKV earlier affected several tropical regions of Africa and Asia from 1951 to 2006. Subsequently, it moved out from these regions to land as outbreaks in Yap Island, French Polynesia, South America, and most recently in Brazil. The WHO declared it as an international public health emergency in 2016 and an extraordinary event with recommendations for improving communications, tightening vigil on ZIKV infections, and improving mosquito control measures. The authors in this article aim to briefly discuss ZIKV infection, its epidemiology, clinical manifestations, management, and prevention.
C1 [Passi, Deepak] ESIC Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, New Delhi, India.
   [Sharma, Sarang] ESIC Dent Coll & Hosp, Dept Conservat Dent & Endodont, Rohini-85, New Delhi, India.
   [Dutta, Shubha Ranjan] MB Kedia Dent Coll, Dept Oral & Maxillofacial Surg, Birgunj, Nepal.
   [Ahmed, Musharib] Inderprastha Dent Coll & Hosp, Dept Pedodont, Ghaziabad, Uttar Pradesh, India.
RP Sharma, S (corresponding author), ESIC Dent Coll & Hosp, Dept Conservat Dent & Endodont, Rohini-85, New Delhi, India.
EM sarang74in@gmail.com
RI DUTTA, SHUBHA RANJAN/E-2528-2018
OI DUTTA, SHUBHA RANJAN/0000-0003-3643-1200
CR [Anonymous], GOAL 3 ENS HLTH LIV
   [Anonymous], 2015, SERGIPE REGISTERS 28
   [Anonymous], 2016, EMERGENCIES ZIKA SIT
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brazil Confirms Blood-transfusion Zika, 2016, CIDRAP NEWS     0214
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centres for Disease Control and Prevention, 2015, ZIK VIR DIS US
   Craig AT, 2016, B WHO
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frontline, SPREAD ZIK
   Giri D., 2016, ZIKA VIRUS STRUCTURE
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health (Brazil), 2015, PUBL HLTH EV REL CAS
   Ministry of Health (Brazil), 2015, MICR
   Ministry of Health of the Republic of Panama, 2015, MIN HLTH INF PAN POP
   Ministry of Public Health and Social Welfare Paraguay, 2015, INTR ZIK VIR ZIKAV P
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Pan American Health Organization-World Health Organization-Regional Office for the Americas, 2015, EP AL ZIK VIR INF 20
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2015, DIS OUTBR NEWS ZIK V
NR 43
TC 8
Z9 8
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2008-7802
EI 2008-8213
J9 INT J PREVENTIVE MED
JI Int. J. Preventive Med.
PD FEB
PY 2017
VL 8
AR 6
DI 10.4103/2008-7802.199641
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER7PN
UT WOS:000399005900002
PM 28250906
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Seizure and Zika virus infection
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Osun State, Nigeria.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pimpri Chinchwad, India.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 5
TC 2
Z9 2
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD FEB
PY 2017
VL 45
BP 1
EP 1
DI 10.1016/j.seizure.2016.11.004
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EQ3YF
UT WOS:000398009200001
PM 27894003
OA Bronze
DA 2020-07-08
ER

PT J
AU Moreno-Madrinan, MJ
   Turell, M
AF Moreno-Madrinan, Max J.
   Turell, Michael
TI Factors of Concern Regarding Zika and Other Aedes aegypti-Transmitted
   Viruses in the United States
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Vectors; El Nino; socioeconomic; urbanization; globalization
ID PUBLIC-HEALTH IMPLICATIONS; HOST-FEEDING PATTERNS; TEXAS-MEXICO BORDER;
   EL-NINO; ALBOPICTUS DIPTERA; DENGUE VIRUS; JAPONICUS-JAPONICUS;
   STEGOMYIA AEGYPTI; GEOGRAPHIC RANGE; CLIMATE-CHANGE
AB The recent explosive outbreaks of Zika and chikungunya throughout the Americas has raised concerns about the threats that these and similar diseases may pose to the United States (U.S.). The commonly accepted association between tropical climates and the endemicity of these diseases has led to concerns about the possibility of their redistribution due to climate change and transmission arising from cases imported from endemic regions initiating outbreaks in the United States. While such possibilities are indeed well founded, the analysis of historical records not only confirms the potential critical role of traveling and globalization but also reveals that the climate in the United States currently is suitable for local transmission of these viruses. Thus, the main factors preventing these diseases from occurring in the United States today are more likely socioeconomic such as lifestyle, housing infrastructure, and good sanitation. As long as such conditions are maintained, it seems unlikely that local transmission will occur to any great degree, particularly in the northern states. Indeed, a contributing factor to explain the current endemicity of these diseases in less-developed American countries may be well explained by socioeconomic and some lifestyle characteristics in such countries.
C1 [Moreno-Madrinan, Max J.] Indiana Univ, IUPUI, Fairbanks Sch Publ Hlth, Dept Environm Hlth Sci, Indianapolis, IN 46204 USA.
   [Turell, Michael] 7217 Ridge Rd, Frederick, MD USA.
RP Moreno-Madrinan, MJ (corresponding author), Indiana Univ, IUPUI, Fairbanks Sch Publ Hlth, Dept Environm Hlth Sci, Indianapolis, IN 46204 USA.
EM mmorenom@iu.edu; mturell@erols.com
FU IUPUI Chancellor for Research Support Funds
FX We thank Mary Lefevers and Jeffrey Ashby (Indiana University) for
   assistance with literature searches. This study was funded by a grant
   from the IUPUI Chancellor for Research Support Funds to the Fairbanks
   School of Public Health, Department of Environmental Health Sciences.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   [Anonymous], 2014, TIEMPO
   Arnebeck B., 2008, SHORT HIST YELLOW FE
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]
   (CDC) Centers for Disease Control and Prevention, 2016, ZIK VIR US 2015 2016
   Centers for Disease Control and Prevention, 2016, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention (CDC), 2016, W NIL VIR
   Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2
   Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   (CPC) Climate Prediction Center, 2015, COLD WARM EP SEAS
   Crosby M. C., 2006, AM PLAGUE UNTOLD STO
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gagnon AS, 2001, CLIM RES, V19, P35, DOI 10.3354/cr019035
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x
   Kovats RS, 2000, B WORLD HEALTH ORGAN, V78, P1127
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1
   Monaghan A. J., 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.OUTBREAKS.50DFC7F46798675FC63E7D7DA563DA76.]
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6
   Patterson Gordon M, 2009, MOSQUITO CRUSADES HI
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Poveda G, 2000, NINO SO OSCILLATION, P183, DOI DOI 10.1017/CBO9780511573125.007
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Richardson K., 2011, ENTOMOL SOC AM, p[914, 914]
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Ruiz-Lopez F, 2016, BIOMEDICA, V36, P303, DOI 10.7705/biomedica.v36i2.3301
   Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141
   Stanforth A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090770
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 65
TC 9
Z9 10
U1 2
U2 32
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD FEB
PY 2017
VL 54
IS 2
BP 251
EP 257
DI 10.1093/jme/tjw212
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EQ5ED
UT WOS:000398103900001
PM 28399294
DA 2020-07-08
ER

PT J
AU Barrera, R
   Acevedo, V
   Felix, GE
   Hemme, RR
   Vazquez, J
   Munoz, JL
   Amador, M
AF Barrera, Roberto
   Acevedo, Veronica
   Felix, Gilberto E.
   Hemme, Ryan R.
   Vazquez, Jesus
   Munoz, Jorge L.
   Amador, Manuel
TI Impact of Autocidal Gravid Ovitraps on Chikungunya Virus Incidence in
   Aedes aegypti (Diptera: Culicidae) in Areas With and Without Traps
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito control; Aedes aegypti; arboviral transmission; invasive
   species; vector-borne pathogen
ID DENGUE TRANSMISSION; LETHAL OVITRAP; VECTOR CONTROL; PUERTO-RICO; ZIKA
   VIRUS; 1ST REPORT; SURVEILLANCE; POPULATIONS; WOLBACHIA; COMMUNITIES
AB Puerto Rico detected the first confirmed case of chikungunya virus (CHIKV) in May 2014 and the virus rapidly spread throughout the island. The invasion of CHIKV allowed us to observe Aedes aegypti (L.) densities, infection rates, and impact of vector control in urban areas using CDC autocidal gravid ovitraps (AGO traps) for mosquito control over several years. Because local mosquitoes can only get the virus from infectious residents, detecting the presence of virus in mosquitoes functions as a proxy for the presence of virus in people. We monitored the incidence of CHIKV in gravid females of Ae. aegypti in four neighborhoods- two with three AGO traps per home in most homes and two nearby neighborhoods without AGO mosquito control traps. Monitoring of mosquito density took place weekly using sentinel AGO traps from June to December 2014. In all, 1,334 pools of female Ae. aegypti (23,329 individuals) were processed by real- time reverse transcription PCR to identify CHIKV and DENV RNA. Density of Ae. aegypti females was 10.5 times lower (91%) in the two areas with AGO control traps during the study. Ten times (90.9%) more CHIKV- positive pools were identified in the nonintervention areas (50/55 pools) than in intervention areas (5/55). We found a significant linear relationship between the number of positive pools and both density of Ae. aegypti and vector index (average number of expected infected mosquitoes per trap per week). Temporal and spatial patterns of positive CHIKV pools suggested limited virus circulation in areas with AGO traps.
C1 [Barrera, Roberto; Acevedo, Veronica; Felix, Gilberto E.; Hemme, Ryan R.; Amador, Manuel] Ctr Dis Control & Prevent, Entomol & Ecol Act, Dengue Branch, San Juan, PR 00920 USA.
   [Vazquez, Jesus; Munoz, Jorge L.] Ctr Dis Control & Prevent, Mol Diagnost Lab, Dengue Branch, San Juan, PR USA.
RP Barrera, R (corresponding author), Ctr Dis Control & Prevent, Entomol & Ecol Act, Dengue Branch, San Juan, PR 00920 USA.
EM rbarrera@cdc.gov; gra3@cdc.gov; ckn5@cdc.gov; wma0@cdc.gov;
   jvazquez@cdc.gov; ckq2@cdc.gov; maa4@cdc.gov
OI Norris, Douglas/0000-0002-4631-2777
FU Division of Vector Borne Infectious Diseases, Centers for Disease
   Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX We thank the residents and Municipalities of Salinas and Guayama and our
   technical personnel Orlando Gonzalez, Juan Medina, Jose Gonzalez, and
   Luis Rivera. Funding was provided by the Division of Vector Borne
   Infectious Diseases, Centers for Disease Control and Prevention. This
   investigation would not have been possible without the support of Dr.
   Harold Margolis, Chief of the CDC Dengue Branch.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Barrera R, 2010, REV BIOMEDICA, V21, P179
   Barrera R, 2016, BIOMEDICA, V36, P454, DOI 10.7705/biomedica.v36i3.2892
   Barrera R, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P103
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggerstaff B, 2016, POOLEDINRATE VERSION
   Brown A.W.A., 1974, P PAP 42 C CAL MOSQ
   CONNOR M. E., 1923, American Journal of Tropical Medicine, V3, P9
   DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Degener CM, 2015, MEM I OSWALDO CRUZ, V110, P517, DOI 10.1590/0074-02760140374
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Dzul-Manzanilla F, 2015, J AM MOSQUITO CONTR, V31, P275, DOI 10.2987/moco-31-03-275-277.1
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Jones RC, 2011, J AM MOSQUITO CONTR, V27, P315, DOI 10.2987/10-6098.1
   Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lindh JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000474
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406
   MOGI M, 1990, J MED ENTOMOL, V27, P509, DOI 10.1093/jmedent/27.4.509
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Ritchie SA, 2008, J AM MOSQUITO CONTR, V24, P47, DOI 10.2987/5658.1
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Sithiprasasna R, 2003, J MED ENTOMOL, V40, P455, DOI 10.1603/0022-2585-40.4.455
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wolbers M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001937
NR 52
TC 22
Z9 22
U1 1
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD FEB
PY 2017
VL 54
IS 2
BP 387
EP 395
DI 10.1093/jme/tjw187
PG 9
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EQ5ED
UT WOS:000398103900017
PM 28031347
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Dzul-Manzanilla, F
   Ibarra-Lopez, J
   Marin, WB
   Martini-Jaimes, A
   Leyva, JT
   Correa-Morales, F
   Huerta, H
   Manrique-Saide, P
   Vazquez-Prokopec, GM
AF Dzul-Manzanilla, Felipe
   Ibarra-Lopez, Jesus
   Bibiano Marin, Wilbert
   Martini-Jaimes, Andres
   Torres Leyva, Joel
   Correa-Morales, Fabian
   Huerta, Heron
   Manrique-Saide, Pablo
   Vazquez-Prokopec, Gonzalo M.
TI Indoor Resting Behavior of Aedes aegypti (Diptera: Culicidae) in
   Acapulco, Mexico
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito abundance; dengue; indoor residual spraying; vector behavior
ID DENGUE VIRUS TRANSMISSION; TREATED HOUSE SCREENS; IQUITOS; VECTOR; PERU;
   DISPERSAL; PATTERNS
AB The markedly anthropophilic and endophilic behaviors of Aedes aegypti (L.) make it a very efficient vector of dengue, chikungunya, and Zika viruses. Although a large body of research has investigated the immature habitats and conditions for adult emergence, relatively few studies have focused on the indoor resting behavior and distribution of vectors within houses. We investigated the resting behavior of Ae. aegypti indoors in 979 houses of the city of Acapulco, Mexico, by performing exhaustive indoor mosquito collections to describe the rooms and height at which mosquitoes were found resting. In total, 1,403 adult and 747 female Ae. aegypti were collected, primarily indoors (98% adults and 99% females). Primary resting locations included bedrooms (44%), living rooms (25%), and bathrooms (20%), followed by kitchens (9%). Aedes aegypti significantly rested below 1.5 m of height (82% adults, 83% females, and 87% bloodfed females); the odds of finding adult Ae. aegypti mosquitoes below 1.5 m was 17 times higher than above 1.5 m. Our findings provide relevant information for the design of insecticide- based interventions selectively targeting the adult resting population, such as indoor residual spraying.
C1 [Dzul-Manzanilla, Felipe; Ibarra-Lopez, Jesus; Correa-Morales, Fabian] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Eje 4 Sur Benjamin Franklin, Mexico City, DF, Mexico.
   [Bibiano Marin, Wilbert; Manrique-Saide, Pablo] Univ Autonoma Yucatan, Dept Zool, Unidad Colaborat Bioensayos Entomol, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico.
   [Martini-Jaimes, Andres] Serv Estat Salud Guerrero, Ruffo Figueroa SN, Burocratas 39090, Chilpancingo De, Mexico.
   [Torres Leyva, Joel] Univ Autonoma Guerrero, Unidad Acad Matemat, Ave Javier Mundez Aponte 1, Fraccionamiento Servidor, Guerrero, Mexico.
   [Huerta, Heron] Secretaria Salud, Inst Diagnost & Referencia Epidemiol InDRE, Francisco de P Miranda 177, Lomas De Plateros, Mexico.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, 400 Dowman Dr, Atlanta, GA 30322 USA.
RP Vazquez-Prokopec, GM (corresponding author), Emory Univ, Dept Environm Sci, 400 Dowman Dr, Atlanta, GA 30322 USA.
EM fdzul@me.com; ibarrajosejesus@gmail.com; wbm.biol@gmail.com;
   entomo_martini@hotmail.com; joel.torres.leyva@gmail.com;
   fabiancorrea@msn.com; cerato_2000@yahoo.com;
   pablo_manrique2000@hotmail.com; gmvazqu@emory.edu
OI Huerta, Heron/0000-0002-7935-9758; Correa Morales,
   Fabian/0000-0002-6193-1242
FU Consejo de Ciencia y Tecnologia; Government of Guerrero State
   [GUE-2008-01-91330]; National Science FoundationNational Science
   Foundation (NSF) [NSF/EEID/RAPID: 1640698]
FX We thank the Secretaria de Salud from Guerrero State for the operational
   support provided to conduct this research and the residents of Acapulco
   for kindly allowing us to enter their homes. This research was supported
   by Consejo de Ciencia y Tecnologia and the Government of Guerrero State
   (GUE-2008-01-91330, Dzul-Manzanilla, PI) and the National Science
   Foundation (NSF/EEID/RAPID: 1640698, Vazquez-Prokopec, PI).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Pant C. P., 1971, WHOVBC70235, V2
   Paz-Soldan V. A., 2016, GLOB PUBLIC HLT 0517, V17, P1
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   SOPER FL, 1965, AM J TROP MED HYG, V14, P887, DOI 10.4269/ajtmh.1965.14.887
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tainchum K, 2013, J MED ENTOMOL, V50, P59, DOI 10.1603/ME11027
   Therneau TM, 2013, MODELING SURVIVAL DA
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   *WHO, 2006, WHOHTMMAL20061112
NR 27
TC 21
Z9 22
U1 2
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD FEB
PY 2017
VL 54
IS 2
BP 501
EP 504
DI 10.1093/jme/tjw203
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EQ5ED
UT WOS:000398103900035
PM 28011725
DA 2020-07-08
ER

PT J
AU Heydari, N
   Larsen, DA
   Neira, M
   Ayala, EB
   Fernandez, P
   Adrian, J
   Rochford, R
   Stewart-Ibarra, AM
AF Heydari, Naveed
   Larsen, David A.
   Neira, Marco
   Beltran Ayala, Efrain
   Fernandez, Prissila
   Adrian, Jefferson
   Rochford, Rosemary
   Stewart-Ibarra, Anna M.
TI Household Dengue Prevention Interventions, Expenditures, and Barriers to
   Aedes aegypti Control in Machala, Ecuador
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Aedes aegypti; mosquito control; economic cost; dengue fever; KAP;
   Ecuador
ID GENETICALLY-MODIFIED MOSQUITOS; MALARIA PREVENTION; HEMORRHAGIC-FEVER;
   ECONOMIC-IMPACT; PERSONAL PROTECTION; COMMUNITIES; URBAN; COST;
   DETERMINANTS; PERCEPTIONS
AB The Aedes aegypti mosquito is an efficient vector for the transmission of Zika, chikungunya, and dengue viruses, causing major epidemics and a significant social and economic burden throughout the tropics and subtropics. The primary means of preventing these diseases is household-level mosquito control. However, relatively little is known about the economic burden of Ae. aegypti control in resource-limited communities. We surveyed residents from 40 households in a high-risk community at the urban periphery in the city of Machala, Ecuador, on dengue perceptions, vector control interventions, household expenditures, and factors influencing purchasing decisions. The results of this study show that households spend a monthly median of US$2.00, or 1.90% (range: 0.00%, 9.21%) of their family income on Ae. aegypti control interventions. Households reported employing, on average, five different mosquito control and dengue prevention interventions, including aerosols, liquid sprays, repellents, mosquito coils, and unimpregnated bed nets. We found that effectiveness and cost were the most important factors that influence people's decisions to purchase a mosquito control product. Our findings will inform the development and deployment of new Ae. aegypti control interventions by the public health and private sectors, and add to prior studies that have focused on the economic burden of dengue-like illness.
C1 [Heydari, Naveed; Rochford, Rosemary] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO 80045 USA.
   [Heydari, Naveed; Fernandez, Prissila; Adrian, Jefferson; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Larsen, David A.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.
   [Neira, Marco] Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer CISeAL, Quito 170170, Ecuador.
   [Beltran Ayala, Efrain] Univ Tecn Machala, Machala 070102, Ecuador.
RP Heydari, N (corresponding author), Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO 80045 USA.; Heydari, N (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
EM naveedheydari@ucdenver.edu; dalarsen@syr.edu; MVNEIRA@puce.edu.ec;
   felixbeltran57@hotmail.com; pipita_fernandez@hotmail.com;
   jeff.adn@gmail.com; rosemary.rochford@ucdenver.edu; amstew01@gmail.com
RI Larsen, David/D-4027-2016
OI Larsen, David/0000-0002-1876-6536; Stewart-Ibarra,
   Anna/0000-0002-3383-4672
FU Deployed Warfighters Protection Program Grant [W911QY-15-1-0005]; Rotary
   Club International
FX We would like to thank the community members of Luz de America for their
   participation in this study. We would also like to thank colleagues at
   the Ministry of Health in Machala for facilitating and supporting this
   research. This study was supported in part by the Deployed Warfighters
   Protection Program Grant (W911QY-15-1-0005) and a fellowship from the
   Rotary Club International to Naveed Heydari.
CR Al-Dubai SAR, 2013, SE ASIAN J TROP MED, V44, P37
   Alfonso-Sierra E., 2016, PATHOG GLOB HEALTH, V7724, P1
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Amin L, 2015, SCI ENG ETHICS, V21, P655, DOI 10.1007/s11948-014-9557-5
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogdan R. C., 2006, QUALITATIVE RES ED I
   Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786
   Constenla Dagna, 2015, Value Health Reg Issues, V8, P80, DOI 10.1016/j.vhri.2015.06.001
   Constenla D, 2015, PHARMACOECONOMICS, V33, P1107, DOI 10.1007/s40273-015-0294-7
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   Deaton Angus, 2000, ANAL HOUSEHOLD SURVE
   Direccion Nacional de Vigilancia Epidemiologica, AN EP 1994 2014
   Drummond Michael F, 2015, METHODS EC EVALUATIO
   FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   GUIGUEMDE TR, 1994, T ROY SOC TROP MED H, V88, P285, DOI 10.1016/0035-9203(94)90079-5
   Hanh TTT, 2009, AM J TROP MED HYG, V80, P312, DOI 10.4269/ajtmh.2009.80.312
   Harving ML, 2007, DAN MED BULL, V54, P170
   Huy R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-155
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Johnson BJ, 2017, INSECTS, V8, DOI 10.3390/insects8010005
   Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262
   Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692
   LIU WK, 1989, TOXICOL LETT, V45, P121, DOI 10.1016/0378-4274(89)90001-5
   Marshall JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-128
   MATSUMOTO K, 1989, EISEI KAGAKU, V35, P237, DOI 10.1248/jhs1956.35.237
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Mitchell-Foster K., 2013, THESIS
   Mitchell-Fostera K, 2015, T ROY SOC TROP MED H, V109, P126, DOI 10.1093/trstmh/tru209
   Mulla MS, 2001, J AM MOSQUITO CONTR, V17, P153
   Nuwaha F, 2002, TROP MED INT HEALTH, V7, P462, DOI 10.1046/j.1365-3156.2002.00877.x
   Okorie PN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-154
   Okrah J, 2002, TROP MED INT HEALTH, V7, P240, DOI 10.1046/j.1365-3156.2002.00856.x
   Parks W., 2004, PLANNING SOCIAL MOBI
   PARKS W, 2004, DENGUE B, V28, pS1
   Paz-Soldan VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160386
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   R Core Team, 2013, R LANG ENV STAT COMP
   Rashed S, 2000, AM J TROP MED HYG, V62, P181, DOI 10.4269/ajtmh.2000.62.181
   Scott-Fiorenzano JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1937-z
   Snehalatha KS, 2003, ACTA TROP, V88, P3, DOI 10.1016/S0001-706X(03)00155-4
   Steketee RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008409
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x
   Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x
   World Bank, SHORT TERM EC COSTS
NR 52
TC 14
Z9 14
U1 0
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2017
VL 14
IS 2
AR 196
DI 10.3390/ijerph14020196
PG 15
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EM7CA
UT WOS:000395467900088
PM 28212349
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Piermarini, PM
   Esquivel, CJ
   Denton, JS
AF Piermarini, Peter M.
   Esquivel, Carlos J.
   Denton, Jerod S.
TI Malpighian Tubules as Novel Targets for Mosquito Control
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Malpighian tubules; mosquito; Kir channels; insecticides; small
   molecule; homeostasis; detoxification
ID POTASSIUM KIR CHANNELS; YELLOW-FEVER MOSQUITO; LARGE GENE LISTS;
   AEDES-AEGYPTI; INSECTICIDE RESISTANCE; ANOPHELES-GAMBIAE; PRINCIPAL
   CELLS; ZIKA VIRUS; VECTOR; DIURESIS
AB The Malpighian tubules and hindgut are the renal excretory tissues of mosquitoes; they are essential to maintaining hemolymph water and solute homeostasis. Moreover, they make important contributions to detoxifying metabolic wastes and xenobiotics in the hemolymph. We have focused on elucidating the molecular mechanisms of Malpighian tubule function in adult female mosquitoes and developing chemical tools as prototypes for next-generation mosquitocides that would act via a novel mechanism of action (i.e., renal failure). To date, we have targeted inward rectifier potassium (Kir) channels expressed in the Malpighian tubules of the yellow fever mosquito Aedes aegypti and malaria mosquito Anopheles gambiae. Inhibition of these channels with small molecules inhibits transepithelial K+ and fluid secretion in Malpighian tubules, leading to a disruption of hemolymph K+ and fluid homeostasis in adult female mosquitoes. In addition, we have used next-generation sequencing to characterize the transcriptome of Malpighian tubules in the Asian tiger mosquito Aedes albopictus, before and after blood meals, to reveal new molecular targets for potentially disrupting Malpighian tubule function. Within 24 h after a blood meal, the Malpighian tubules enhance the mRNA expression of genes encoding mechanisms involved with the detoxification of metabolic wastes produced during blood digestion (e.g., heme, NH3, reactive oxygen species). The development of chemical tools targeting these molecular mechanisms in Malpighian tubules may offer a promising avenue for the development of mosquitocides that are highly-selective against hematophagous females, which are the only life stage that transmits pathogens.
C1 [Piermarini, Peter M.; Esquivel, Carlos J.] Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA.
   [Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA.
   [Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.
RP Piermarini, PM (corresponding author), Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA.
EM piermarini.1@osu.edu; esquivelpalma.1@buckeyemail.osu.edu;
   jerod.s.denton@Vanderbilt.Edu
FU Foundation for the National Institutes of Health through the
   Vector-Based Transmission of Control: Discovery Research (VCTR) program
   of the Grand Challenges in Global Health initiative [PIER11VCTR]; OARDC
   SEEDS grant [OHOA1471]
FX We dedicate this article to Klaus W. Beyenbach (Cornell University) in
   recognition of his retirement and more than 30 years of research into
   the physiology of mosquito Malpighian tubules. We also thank Klaus W.
   Beyenbach for the specific research contributions he has made in our
   collaborative effort to characterize the physiological roles of Kir
   channels in Malpighian tubules. The work highlighted in this article was
   supported by a grant from the Foundation for the National Institutes of
   Health through the Vector-Based Transmission of Control: Discovery
   Research (VCTR) program of the Grand Challenges in Global Health
   initiative (PIER11VCTR), an OARDC SEEDS grant (OHOA1471;
   oardc.osu.edu/seeds/), and State and Federal funds appropriated to the
   Ohio Agricultural Research and Development Center, The Ohio State
   University.
CR Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x
   Beyenbach KW, 2002, J INSECT PHYSIOL, V48, P375, DOI 10.1016/S0022-1910(02)00057-4
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRADLEY TJ, 1982, TISSUE CELL, V14, P759, DOI 10.1016/0040-8166(82)90064-7
   BRIEGEL H, 1975, J INSECT PHYSIOL, V21, P1597, DOI 10.1016/0022-1910(75)90197-3
   Esquivel CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1784
   Esquivel CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002929
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Kupferschmidt K, 2016, SCIENCE, V354, P171, DOI 10.1126/science.354.6309.171
   Lima VLA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038349
   Lowe DM, 2014, J BIOMOL SCREEN, V19, P508, DOI 10.1177/1087057113518069
   Oliveira VS, 2013, BIOORGAN MED CHEM, V21, P6996, DOI 10.1016/j.bmc.2013.09.020
   Overend G, 2015, INSECT BIOCHEM MOLEC, V67, P47, DOI 10.1016/j.ibmb.2015.05.007
   Paglino A, 2008, INSECT BIOCHEM MOLEC, V38, P871, DOI 10.1016/j.ibmb.2008.05.011
   Piermarini P., 2015, NONTRADITIONAL MODEL, P255
   Piermarini P. M., 2016, RENAL EXCRETORY PROC, P393
   Piermarini PM, 2015, INSECT BIOCHEM MOLEC, V67, P59, DOI 10.1016/j.ibmb.2015.06.006
   Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009
   Prast-Nielsen S, 2011, FREE RADICAL BIO MED, V50, P1114, DOI 10.1016/j.freeradbiomed.2011.01.020
   Raphemot R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110772
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Rouhier MF, 2014, AM J PHYSIOL-REG I, V307, pR850, DOI 10.1152/ajpregu.00106.2014
   Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700
   Scott BN, 2004, J EXP BIOL, V207, P1655, DOI 10.1242/jeb.00932
   Seegers N, 2014, J BIOMOL SCREEN, V19, P1266, DOI 10.1177/1087057114536616
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WILLIAMS JC, 1983, J COMP PHYSIOL, V153, P257, DOI 10.1007/BF00689629
   Yang ZX, 2017, COMP BIOCHEM PHYS B, V204, P35, DOI 10.1016/j.cbpb.2016.11.003
NR 34
TC 7
Z9 10
U1 2
U2 15
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2017
VL 14
IS 2
AR 111
DI 10.3390/ijerph14020111
PG 15
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EM7CA
UT WOS:000395467900003
PM 28125032
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kelley, SO
AF Kelley, Shana O.
TI What Are Clinically Relevant Levels of Cellular and Biomolecular
   Analytes?
SO ACS SENSORS
LA English
DT Article
DE bioanalysis; DNA detection; protein detection; clinical samples;
   infectious disease; cancer
ID VIRAL LOAD; REAL-TIME; ADULT PATIENTS; NUCLEIC-ACIDS; PANDEMIC H1N1;
   TUMOR-CELLS; ZIKA VIRUS; ASSAY; CANCER; DIAGNOSIS
AB The ultimate goal of developing sensors for biomolecular analytes is to offer new tools for the analysis of clinical specimens for biomarkers of disease. It is thus important to understand the types of samples that are routinely used in the clinic for specific indications, and what the typical levels of relevant analytes are in these specimens. This Sensor Issues article summarizes information concerning levels of target molecules and cells that are of interest for the development of new diagnostics for infectious disease and cancer. Having this information in hand helps better define the "needle-in-a-haystack" challenge associated with developing robust sensors with the needed levels of sensitivity and specificity.
C1 [Kelley, Shana O.] Univ Toronto, Fac Arts & Sci, Dept Chem, Toronto, ON M5S 3M2, Canada.
   [Kelley, Shana O.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada.
   [Kelley, Shana O.] Univ Toronto, Fac Med, Inst Biomat & Biomed Engn, Toronto, ON M5S 3M2, Canada.
   [Kelley, Shana O.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 3M2, Canada.
RP Kelley, SO (corresponding author), Univ Toronto, Fac Arts & Sci, Dept Chem, Toronto, ON M5S 3M2, Canada.; Kelley, SO (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada.; Kelley, SO (corresponding author), Univ Toronto, Fac Med, Inst Biomat & Biomed Engn, Toronto, ON M5S 3M2, Canada.; Kelley, SO (corresponding author), Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 3M2, Canada.
EM shana.kelley@utoronto.ca
RI Kelley, Shana/H-5856-2015
OI Kelley, Shana/0000-0003-3360-5359
CR Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820
   Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361
   Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2
   Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC
   Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   Bruinsma SM, 2016, NAT REV UROL, V13, P151, DOI 10.1038/nrurol.2015.313
   Capaldo P, 2016, ACS SENSORS, V1, P1003, DOI 10.1021/acssensors.6b00262
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Chang HJ, 2016, ACS SENSORS, V1, P645, DOI 10.1021/acssensors.6b00053
   Chaturvedi P, 2016, ACS SENSORS, V1, P488, DOI 10.1021/acssensors.6b00003
   Chu C, 2010, AM FAM PHYSICIAN, V81, P1239
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Dey S, 2016, ACS SENSORS, V1, P399, DOI 10.1021/acssensors.5b00157
   Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759
   Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605
   Green BJ, 2016, ANGEW CHEM INT EDIT, V55, P1252, DOI 10.1002/anie.201505100
   Honeyborne I, 2014, J CLIN MICROBIOL, V52, P3064, DOI 10.1128/JCM.01128-14
   Huertas CS, 2016, ACS SENSORS, V1, P748, DOI 10.1021/acssensors.6b00162
   Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   Labib M, 2016, CHEM REV, V116, P9001, DOI 10.1021/acs.chemrev.6b00220
   Lang JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004261
   Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383
   Leung F, 2016, CLIN CHEM, V62, P1054, DOI 10.1373/clinchem.2016.260331
   Lifson MA, 2016, ADV DRUG DELIVER REV, V103, P90, DOI 10.1016/j.addr.2016.05.018
   Lim SH, 2016, ACS SENSORS, V1, P852, DOI 10.1021/acssensors.6b00309
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Naze F, 2009, J VIROL METHODS, V162, P1, DOI 10.1016/j.jviromet.2009.03.006
   Ng BYC, 2016, ACS SENSORS, V1, P173, DOI 10.1021/acssensors.5b00171
   Ngaosuwankul N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-75
   PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641
   Rusling JF, 2010, ANALYST, V135, P2496, DOI 10.1039/c0an00204f
   Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066
   Strassl R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135963
   Tamkovich SN, 2005, CLIN CHEM, V51, P1317, DOI 10.1373/clinchem.2004.045062
   Tang CK, 2016, ACS SENSORS, V1, P1036, DOI 10.1021/acssensors.6b00256
   Thaxton CS, 2009, P NATL ACAD SCI USA, V106, P18437, DOI 10.1073/pnas.0904719106
   To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664
   Torrente-Rodriguez RM, 2016, ACS SENSORS, V1, P896, DOI 10.1021/acssensors.6b00266
   Verhoeven PO, 2012, J CLIN MICROBIOL, V50, P2063, DOI 10.1128/JCM.00157-12
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Wee EJH, 2016, ACS SENSORS, V1, P670, DOI 10.1021/acssensors.6b00105
   Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029
   YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990
   Zhou CX, 2016, ACS SENSORS, V1, P965, DOI 10.1021/acssensors.6b00333
NR 46
TC 40
Z9 40
U1 4
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD FEB
PY 2017
VL 2
IS 2
BP 193
EP 197
DI 10.1021/acssensors.6b00691
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA EM0ZM
UT WOS:000395047000002
PM 28723142
DA 2020-07-08
ER

PT J
AU Baud, D
   Musso, D
   Vouga, M
   Alves, MP
   Vulliemoz, N
AF Baud, David
   Musso, Didier
   Vouga, Manon
   Alves, Marco P.
   Vulliemoz, Nicolas
TI Zika virus: A new threat to human reproduction
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
DE congenital infection; microcephaly; semen; sexual transmission; Zika
ID VECTOR-BORNE TRANSMISSION; MALE SEXUAL TRANSMISSION;
   GUILLAIN-BARRE-SYNDROME; CLINICAL MANAGEMENT; INFECTION; SEMEN;
   ARBOVIRUSES; PERSISTENCE; DISEASE; DONORS
AB Zika virus (ZIKV) was first isolated in 1947 in a rhesus monkey from the Zika forest of Uganda. Until 2007, only 14 human cases were reported. The first large human outbreak occurred in 2007 (Yap Island, Federated States of Micronesia, Pacific) followed by French Polynesia in 2013 and Brazil in 2015. The virus is mainly transmitted through Aedes mosquito bites, but sexual and post-transfusion transmissions have been reported. Symptoms include low-grade fever, maculopapular rash, conjunctivitis, myalgia, arthralgia, and asthenia. During the recent outbreaks in French Polynesia and Brazil, ZIKV infection has been associated with two major complications: microcephaly and Guillain-Barre syndrome. Since fetal infection includes other birth defects, congenital Zika syndrome has been used to define in utero infection. The majority of sexual transmission occurred from a symptomatic male to a female, but female-to-male and male-to-male transmission have been reported. Asymptomatic male-to-female transmission has also been described. Importantly, ZIKV RNA can persist at least 6 months in semen. The male urogenital tract may therefore act as a reservoir for the virus. ZIKV RNA was detected in a cervical swab of a patient 3 days after presenting the classic symptoms suggesting a potential tropism for the female genital tract. Long--lasting presence of ZIKV RNA might not indicate that the individual is infectious but makes recommendation for couples potentially exposed to the virus and willing to conceive difficult. It will also be important to determine whether genital ZIKV infection might have a deleterious effect on male and female fertility.
C1 [Baud, David; Vouga, Manon] Univ Lausanne Hosp, Dept Femme Mere Enfant, Materno Fetal & Obstet Res Unit, Lausanne, Switzerland.
   [Musso, Didier] Inst Louis Malard, Unit Emerging Infect Dis, French Polynesia, France.
   [Alves, Marco P.] Inst Immunol & Virol, Mittelh usern, Switzerland.
   [Alves, Marco P.] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [Vulliemoz, Nicolas] Univ Lausanne Hosp, Dept Femme Mere Enfant, Reprod Med Unit, Lausanne, Switzerland.
   [Baud, David] Dept Femme Mere Enfant, Materno Fetal & Obstet Res Unit, David Baud, Lausanne, Switzerland.
RP Baud, D (corresponding author), Dept Femme Mere Enfant, Materno Fetal & Obstet Res Unit, David Baud, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5319
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, P21
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaskell KM, 2017, EMERG INFECT DIS, P23
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Melo AS, 2016, JAMA NEUROL
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, LANCET INFECT DIS, V16, P1108, DOI 10.1016/S1473-3099(16)30337-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EUROSURVEILLANCE, P21
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   WHO/CDC/ICBDSR, 2014, BIRTH DEF SURV MAN P
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 66
TC 24
Z9 24
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12614
DI 10.1111/aji.12614
PG 13
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200007
PM 27966802
OA Bronze
DA 2020-07-08
ER

PT J
AU de Carvalho, NS
   de Carvalho, BF
   Doris, B
   Biscaia, ES
   Fugaca, CA
   de Noronha, L
AF de Carvalho, Newton Sergio
   de Carvalho, Beatriz Freitas
   Doris, Bruna
   Biscaia, Evellyn Silverio
   Fugaca, Cyllian Arias
   de Noronha, Lucia
TI Zika virus and pregnancy: An overview
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
DE congenital malformations; microcephaly; obstetrician; pregnancy; Zika
   virus
ID SEXUAL TRANSMISSION; INFECTION; BRAZIL; NEWBORNS; BARRIER; CONDOMS
AB In May 2015, the first episodes of Zika virus infection of the Latin America were confirmed in Brazil, where currently 196 976 cases were reported. The main route of transmission occurs by Aedes mosquitoes, and the most common symptoms are maculopapular rash, fever, conjunctivitis, polyarthralgia, and periarticular edema. However, the infection is asymptomatic in 80% of the cases. The congenital infection is characterized when the transmission to the fetus occurs during pregnancy, but the mechanisms of how the virus infects the placenta remain unclear. Anatomopathological findings were described in first-and third-trimester human placentas; however, the major affected tissue of the baby is the neural. Several clinical situations were listed in these fetuses, such as neurological, ophthalmological, auditory, and articular alterations. The World Health Organization proposed a new congenital syndrome caused by Zika virus. The virus has an important neurotropism and the main manifestation observed in the syndrome is microcephaly, which is usually severe and associated with other neurological injuries. The appearance of sudden rash in pregnant women determines immediate investigation through RT-PCR and serological analysis. Moreover, the prevention consists in using repellents and avoiding endemic areas, considering that the vaccine is still under development.
C1 [de Carvalho, Newton Sergio] Univ Fed Parana, Infect Dis Gynecol & Obstet Sector, Dept Gynecol & Obstet, Clin Hosp, Curitiba, PR, Brazil.
   [de Carvalho, Beatriz Freitas; Doris, Bruna; Biscaia, Evellyn Silverio; Fugaca, Cyllian Arias; de Noronha, Lucia] Pontif Cathol Univ Parana, Curitiba, PR, Brazil.
RP de Carvalho, NS (corresponding author), Univ Fed Parana, Infect Dis Gynecol & Obstet Sector, Dept Gynecol & Obstet, Clin Hosp, Curitiba, PR, Brazil.
EM newtosdc@gmail.com
RI de carvalho, newton/B-8175-2015; noronha, lucia/F-6339-2015
OI de carvalho, newton/0000-0001-7561-4566; noronha,
   lucia/0000-0003-0310-7164
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   [Anonymous], 2005, WHO STAT 1 M INT HLT
   [Anonymous], 2016, POSSIBLE ASS ZIKA VI
   [Anonymous], 2016, ZIKA VIRUS VACCINE P
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benirschke K, 2006, PATHOLOGY HUMAN PLAC, P700
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   CAREY RF, 1992, SEX TRANSM DIS, V19, P230, DOI 10.1097/00007435-199207000-00009
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcante AL, 2016, B EPIDEMIOLOGICO, V47, P47
   Chibueze EC, 2016, B WORLD HEALTH ORGAN, V6, P1
   COES - Microcefalias, 2016, MON CAS MICR BRAS, V2016
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V59, P23
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   GREENOUGH A, 1994, ARCH DIS CHILD-FETAL, V70, pF163, DOI 10.1136/fn.70.3.F163
   Hayden EC, 2016, NATURE, V532, P16
   He Q, 2013, AM J OBSTET GYNECOL, V33, P395, DOI DOI 10.1186/S12348-014-0026-8
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Manhart LE, 2002, SEX TRANSM DIS, V29, P725, DOI 10.1097/00007435-200211000-00018
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Ommeren MV, 2016, GUIA PRELIMINAR PROV, P18
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, P1
   Rosenberg AZ, 2016, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2016-0401-OA, DOI 10.5858/ARPA.2016--0401-OA]
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2016, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2016-0343-OA, DOI 10.5858/ARPA.2016--0343--OA]
   Secretaria da Saude do Estado da Bahia, 2016, PROT AT GEST SUSP ZI
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 69
TC 9
Z9 9
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12616
DI 10.1111/aji.12616
PG 8
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200009
PM 28045216
OA Bronze
DA 2020-07-08
ER

PT J
AU Fuwa, K
   Hayakawa, S
AF Fuwa, Kazumasa
   Hayakawa, Satoshi
TI Mechanisms and possible controls of the in utero Zika virus infection:
   Where is the Holy Grail?
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE microcephaly; TORCH syndrome; vertical transmission; Zika virus
ID SEXUAL TRANSMISSION; ANTIBODIES; BRAZIL; RISK; ENHANCEMENT; PROTECTION;
   PREGNANCY; PLACENTA; PROTEASE; STATES
AB Zika virus infection (ZVI) is a great concern for human health because it frequently causes fetal anomalies. Little is known about pathophysiology of ZVI because it has been regarded as a mild, no life-threatening infection. However, the latest endemic in South and Central America took attention of perinatologists, microbiologists, and pathologists. Both in vivo and in vitro studies suggest neurotropic nature of Zika virus but do not clarify viral kinetics during vertical transmissions. In this review, we focus on the clinical and microbiological natures ZVI for pregnant women especially how placental barriers are broken down.
C1 [Fuwa, Kazumasa] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo, Tokyo, Japan.
   [Hayakawa, Satoshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan.
RP Hayakawa, S (corresponding author), Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan.
EM hayakawa.satoshi@nihon-u.ac.jp
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, GUID US LAB TEST ZIK
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liotta G, 2015, INT J ENV RES PUB HE, V12, P13224, DOI 10.3390/ijerph121013224
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pacheco O, 2016, N ENGL J MED
   Pessoa R, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Saude Md, EPIDEMIOLOGICAL REPO
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, 2016, MICR GUILL BARR SYND
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
NR 52
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12605
DI 10.1111/aji.12605
PG 7
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200002
PM 27966238
OA Bronze
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus, HSV-2 and placenta
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Letter
ID INFECTION
C1 [Joob, Beuy] Sanitat Med Acad Ctr 1, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat Med Acad Ctr 1, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Joob B, 2016, ASIAN PAC J REPROD, V5, P356, DOI DOI 10.1016/j.apjr.2016.06.006
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
NR 3
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12603
DI 10.1111/aji.12603
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200001
PM 27868270
OA Bronze
DA 2020-07-08
ER

PT J
AU Kwak-Kim, J
   Song, J
   Kim, MWI
   Gilman-Sachs, A
AF Kwak-Kim, Joanne
   Song, Jeehey
   Kim, Michael Woo-il
   Gilman-Sachs, Alice
TI Zika virus infection and biological treatment for reproductive medicine
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE guidelines; immunotherapy; infertility; IVIG; pregnancy; Zika
ID MALE SEXUAL TRANSMISSION; WEST-NILE-VIRUS; PLASMA DERIVATIVES;
   FRENCH-POLYNESIA; SEMEN; SAFETY; PERSISTENCE; ROBUSTNESS; RNA
AB The recent Zika virus (ZIKV) epidemic is particularly challenging in the field of reproductive medicine as various biological tissues and byproducts, such as intravenous immunoglobulin G or cells are utilized during reproductive cycles, and an infected mother has an increased risk of having babies with fetal microcephaly and other congenital brain anomalies. In this review, current guidelines for prevention of sexual transmission of ZIKV, ZIKV testing, and tissue and blood product usages are summarized for physicians caring for those planning pregnancy or going through infertility
C1 [Kwak-Kim, Joanne; Song, Jeehey; Kim, Michael Woo-il] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Obstet & Gynecol, Reproduct Med, Vernon Hills, IL USA.
   [Kwak-Kim, Joanne; Gilman-Sachs, Alice] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, N Chicago, IL USA.
RP Kwak-Kim, J (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Obstet & Gynecol, Dept Microbiol & Immunol, Vernon Hills, IL USA.
EM joanne.kwakkim@rosalindfranklin.edu
RI Kwak-Kim, Joanne/G-2750-2019
OI Kwak-Kim, Joanne/0000-0002-8409-1645
CR American Society for Reproductive Medicine, GUID PROV CAR WOM ME
   [Anonymous], 2016, NATURE, V530, P5, DOI 10.1038/530005a
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Caballero S, 2014, BIOLOGICALS, V42, P79, DOI 10.1016/j.biologicals.2013.10.003
   Center for Disease Control and Prevention, ZIKA BLOOD TRANSF
   Centers for Disease Control and Prevention, ZIK VIR SYMPT TEST T
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, CLIN GUID HEALTHC PR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dichtelmueller HO, 2011, TRANSFUSION, V51, P1412, DOI 10.1111/j.1537-2995.2010.03003.x
   Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   Flechas J., 5 POOL ZIKA POSITIVE
   Food and Drug Administration, REV REC RED RISK ZIK
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honner P., LEARNING NETWORK TOU
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Joseph A., ZIKA CASE FLORIDA CO
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Petersen EE, UPDATE TERIM GUIDANC
   Plasma Protein Therapeutics Association, ZIK VIR PLASM PROT T
   Remington KM, 2004, VOX SANG, V87, P10, DOI 10.1111/j.1423-0410.2004.00530.x
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Stucki M, 2008, BIOLOGICALS, V36, P239, DOI 10.1016/j.biologicals.2008.01.004
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO, PREV SEX TRANSM ZIK
NR 42
TC 1
Z9 1
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12606
DI 10.1111/aji.12606
PG 5
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200003
PM 27868318
DA 2020-07-08
ER

PT J
AU Novak, CM
   Sheffield, JS
   Burd, I
AF Novak, Christopher M.
   Sheffield, Jeanne S.
   Burd, Irina
TI Zika virus: Future reproductive concerns
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
DE congenital infection; viral persistence; Zika virus
ID HEPATITIS-C VIRUS; MALE SEXUAL TRANSMISSION; PERINATAL TRANSMISSION;
   VERTICAL TRANSMISSION; PREGNANT-WOMEN; UNITED-STATES; INFECTION; FETAL;
   BRAZIL; RESPONSES
AB The pandemic spread of Zika virus (ZIKV), a member of the flavivirus genus of the Flaviviridae family, has become a major public health concern. Reproductive specialists are particularly concerned over the spread of ZIKV as it is now known to have both sexual and transplacental routes of transmission resulting in fetal congenital abnormalities. Other members of the Flaviviridae family, hepatitis C virus (HCV) and bovine viral diarrhea virus (BVDV) (which primarily affects cattle), are well known to reproductive specialists as both sexually transmitted illnesses that are capable of vertical transmission. Congenital infection with BVDV also has a predilection for neuro- - teratogenicity as has been seen with ZIKV. HCV and BVDV are also known to be capable of persistent infection in offspring. Could this be the case with ZIKV? Examining what we know about HCV and BVDV, in addition to what we have already learned about ZIKV, may answer some of the questions that remain about ZIKV. Herein, we review the current literature as it pertains to ZIKV vertical transmission and neuro-teratogenicity and compare it to what is known about HCV and BVDV.
C1 [Novak, Christopher M.; Sheffield, Jeanne S.; Burd, Irina] Johns Hopkins Univ Sch Med, Div Maternal Fetal Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Baltimore, MD USA.
   [Burd, Irina] Johns Hopkins Univ Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Baltimore, MD USA.
RP Burd, I (corresponding author), Johns Hopkins Univ Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Baltimore, MD USA.
EM iburd@jhmi.edu
CR Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Azzari C, 2008, J MED VIROL, V80, P65, DOI 10.1002/jmv.21023
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Bielefeldt-Ohmann H, 2008, J COMP PATHOL, V138, P72, DOI 10.1016/j.jcpa.2007.10.006
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Ceci O, 2001, J PEDIATR GASTR NUTR, V33, P570, DOI 10.1097/00005176-200111000-00011
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, EM PREP RESP REC MAN
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Giugliano S, 2015, J IMMUNOL, V195, P3737, DOI 10.4049/jimmunol.1500409
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
   Hansen TR, 2015, ANIM HEALTH RES REV, V16, P15, DOI 10.1017/S1466252315000122
   Hansen TR, 2010, AM J REPROD IMMUNOL, V64, P295, DOI 10.1111/j.1600-0897.2010.00904.x
   Hurtado CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012232
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kelling CL, 2013, BIOLOGICALS, V41, P20, DOI 10.1016/j.biologicals.2012.09.006
   Le Campion A, 2012, VIRUSES-BASEL, V4, P3531, DOI 10.3390/v4123531
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Resti M, 2002, CLIN INFECT DIS, V35, P236, DOI 10.1086/341302
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Shin T, 2001, J Vet Sci, V2, P81
   Slowik May K, 2005, Semin Pediatr Infect Dis, V16, P296, DOI 10.1053/j.spid.2005.06.009
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tosone G, 2014, WORLD J HEPATOL, V6, P538, DOI 10.4254/wjh.v6.i8.538
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   ZANETTI AR, 1995, LANCET, V345, P289, DOI 10.1016/S0140-6736(95)90277-5
NR 47
TC 3
Z9 3
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12615
DI 10.1111/aji.12615
PG 5
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200008
PM 27976454
OA Bronze
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
AF Rodriguez-Morales, Alfonso J.
TI Zika virus, coinfections and placenta
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Letter
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Joob B, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12603
   Lago EG, 2007, PAEDIATR PERINAT EP, V21, P525, DOI 10.1111/j.1365-3016.2007.00869.x
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
NR 5
TC 0
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12624
DI 10.1111/aji.12624
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200010
PM 28028879
DA 2020-07-08
ER

PT J
AU Zambrano, H
   Waggoner, J
   Leon, K
   Pinsky, B
   Vera, K
   Schettino, M
   Rivera, L
   Landivar, J
   Granda, M
   Lee, A
   Mor, G
AF Zambrano, Hector
   Waggoner, Jesse
   Leon, Karina
   Pinsky, Benjamin
   Vera, Ketty
   Schettino, Marissa
   Rivera, Lisette
   Landivar, Jose
   Granda, Maria
   Lee, Angela
   Mor, Gil
TI High incidence of Zika virus infection detected in plasma and cervical
   cytology specimens from pregnant women in Guayaquil, Ecuador
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE cervical cytology; incidence; pregnancy; preterm labor; Zika virus
ID CHIKUNGUNYA
AB Zika virus (ZIKV) infection during pregnancy has been linked to severe birth defects, and the epidemiologic situation of the ZIKV epidemic in Ecuador is poorly understood. Guayaquil, Ecuador, has a tropical climate and experiences frequent outbreaks of dengue and chikungunya virus, and in December 2015, ZIKV was identified. Given the well-documented effects of ZIKV in pregnancy, including microcephaly, we tested for the presence of ZIKV in both plasma and cervical cytology of pregnant women. We report the identification of a population of pregnant women with a high incidence of ZIKV infection detected in the plasma and lower reproductive tract. A case-control study was performed to determine the incidence of ZIKV infection among low-income, pregnant women at risk for preterm delivery compared to matched controls. Plasma and cervical cytology specimens were tested for ZIKV by rRT-PCR. Fifty-nine pregnant women were enrolled. The incidence of ZIKV was 54% (32/59) overall: 18/31 (58.1%) in cases and 14/28 (50.0%) in controls. ZIKV detection in plasma and cervical cytology specimens demonstrated good agreement. Overall, outcomes for neonates born to ZIKV-positive and ZIKV-negative mothers were similar. However, two neonates were born with microcephaly to case mothers who were ZIKV positive. We report a high incidence of ZIKV infection (54%) in a distinctive population in Guayaquil, Ecuador. We identify ZIKV in cervical samples that correlates with ZIKV in the plasma. These data raise concerns regarding the breadth of the ZIKV epidemic in Ecuador and demonstrate the utility of cervical cytology specimens for ZIKV testing.
C1 [Zambrano, Hector; Vera, Ketty; Schettino, Marissa; Rivera, Lisette; Landivar, Jose] Hosp Luis Vernaza, Lab Biol Mol, Guayaquil, Ecuador.
   [Waggoner, Jesse] Emory Univ Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Leon, Karina] Hosp Enrique C Sotomayor, Serv Gineco Obstetricia, Guayaquil, Ecuador.
   [Pinsky, Benjamin] Stanford Univ Sch Med, Dept Pathol, Stanford, CA USA.
   [Pinsky, Benjamin] Stanford Univ Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA USA.
   [Granda, Maria] ESPAE Grad Sch Management, Escuela Super Politecn Litoral, ESPOL, Guayaquil, Ecuador.
   [Lee, Angela] Dartmouth Coll, Geisel Sch Med, Hanover, NH USA.
   [Mor, Gil] Yale Univ Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, New Haven, CT USA.
RP Zambrano, H (corresponding author), Hosp Luis Vernaza, Lab Biol Mol, Guayaquil, Ecuador.; Mor, G (corresponding author), Yale Univ Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, New Haven, CT USA.
EM hzambrano@jbgye.org.ec; gil.mor@yale.edu
RI amsalu, ribka/G-8780-2019
OI Pinsky, Benjamin/0000-0001-8751-4810
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R56 AI124356]
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Madan Ashima, 2002, J Perinatol, V22, P230, DOI 10.1038/sj.jp.7210703
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 12
TC 14
Z9 14
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12630
DI 10.1111/aji.12630
PG 5
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200011
PM 28177195
OA Bronze
DA 2020-07-08
ER

PT J
AU Harapan, H
   Aletta, A
   Anwar, S
   Setiawan, AM
   Maulana, R
   Wahyuniati, N
   Ramadana, MR
   Haryanto, S
   Rodriguez-Morales, AJ
   Jamil, KF
AF Harapan, Harapan
   Aletta, Alma
   Anwar, Samsul
   Setiawan, Abdul M.
   Maulana, Reza
   Wahyuniati, Nur
   Ramadana, Muhammad R.
   Haryanto, Sotianingsih
   Rodriguez-Morales, Alfonso J.
   Jamil, Kurnia F.
TI Healthcare workers' knowledge towards Zika virus infection in Indonesia:
   A survey in Aceh
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Zika fever; Knowledge; Attitude; Health care worker;
   Indonesia
ID CHIKUNGUNYA VIRUS; DENGUE; COLOMBIA; FEVER; COINFECTION; OUTBREAK;
   STUDENTS; PATIENT; CITIES
AB Objective: To assess the knowledge on Zika virus (ZIKV) infection among healthcare providers (doctors) in Aceh province, Indonesia. Methods: A self-administered Internet based survey was conducted from 3 May to 3 June 2016 among the members of doctor organizations in Aceh province. A set of validated. pre-tested questionnaire was used to measure knowledge regarding ZIKV infection and to collect a range of explanatory variables. A two-steps logistic regression analysis was employed to assess the association of participants' demographic, workplace characteristics and other explanatory variables with the knowledge. Results: A total of 442 participants included in the final analysis and 35.9% of them (159) had a good knowledge on ZIKV infection. Multivariate model revealed that type of occupation, type of workplace, availability of access to medical journals and experience made Zika disease as differential diagnose were associated with knowledge on ZIKV infection. In addition, three significant source of information regarding ZIKV were online media (60%), medical article or medical news (16.2%) and television (13.2%). Conclusion: The knowledge of the doctors in Aceh regarding ZIKV infection is relatively low. Doctors who have a good knowledge on ZIKV infection are more confident to established ZIKV disease as differential diagnosis in their clinical setting. Therefore, such program to increase healthcare providers' knowledge regarding ZIKV infection is needed to screen potential carriers of ZIKV infection.
C1 [Harapan, Harapan; Aletta, Alma; Maulana, Reza; Wahyuniati, Nur; Ramadana, Muhammad R.; Jamil, Kurnia F.] Syiah Kuala Univ, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Banda Aceh 23111, Indonesia.
   [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia.
   [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.
   [Aletta, Alma] Syiah Kuala Univ, Sch Med, Dept Family Med, Banda Aceh, Indonesia.
   [Anwar, Samsul] Syiah Kuala Univ, Dept Stat, Fac Math & Nat Sci, Banda Aceh, Indonesia.
   [Setiawan, Abdul M.] State Islamic Univ Maulana Malik Ibrahim, Fac Med & Hlth Sci, Dept Microbiol, Malang, Indonesia.
   [Haryanto, Sotianingsih] Jambi Univ, Fac Med & Hlth Sci, Dept Clin Pathol, Jambi, Indonesia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Risaralda, Colombia.
   [Jamil, Kurnia F.] Syiah Kuala Univ, Dept Internal Med, Sch Med, Banda Aceh, Indonesia.
RP Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Banda Aceh 23111, Indonesia.
EM harapan@unsyiah.ac.id
RI Harapan, Harapan/I-8741-2016; AJ, Rodriguez-Morales/R-9765-2016
OI Harapan, Harapan/0000-0001-7630-8413; AJ,
   Rodriguez-Morales/0000-0001-9773-2192; Setiawan, abdul
   Malik/0000-0002-6913-2007
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CDC, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159139
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412
   Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Maha MS, 2015, EMERG INFECT DIS, V21, P379, DOI 10.3201/eid2102.141121
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 30
TC 18
Z9 18
U1 0
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD FEB
PY 2017
VL 10
IS 2
BP 182
EP 186
DI 10.1016/j.apjtm.2017.01.018
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EL6LI
UT WOS:000394733700016
PM 28237488
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Immunological reactive rate to Zika virus in canine sera: A report from
   a tropical area and concern on pet, zoonosis and reservoir host
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika; IhG; Pet; Zoonosis; Reservoir host
AB This letter to editor discusses and describes Zika virus IgG seropositivity rate in canine sera from endemic area. This is the first world report and it raises an urgent concern on pet. zoonosis and reservoir host regarding Zika virus.
C1 [Joob, Beuy] Saniat I Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Saniat I Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Joob B, 2016, J VECTOR DIS, V53, P192
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 11
TC 5
Z9 6
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD FEB
PY 2017
VL 10
IS 2
BP 199
EP 200
DI 10.1016/j.apjtm.2017.01.011
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EL6LI
UT WOS:000394733700020
PM 28237492
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vesnaver, TV
   Tul, N
   Mehrabi, S
   Parissone, F
   Strafela, P
   Mlakar, J
   Pizem, J
   Korva, M
   Zupanc, TA
   Popovic, M
AF Vesnaver, T. Vipotnik
   Tul, N.
   Mehrabi, S.
   Parissone, F.
   Strafela, P.
   Mlakar, J.
   Pizem, J.
   Korva, M.
   Zupanc, T. Avsic
   Popovic, M.
TI Zika virus associated microcephaly/micrencephaly-fetal brain imaging in
   comparison with neuropathology
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
ID POLYMICROGYRIA; INFECTION; BRAZIL
C1 [Vesnaver, T. Vipotnik] Univ Med Ctr Ljubljana, Inst Radiol, Ljubljana, Slovenia.
   [Tul, N.] Univ Med Ctr Ljubljana, Div Obstet & Gynecol, Dept Perinatol, Ljubljana, Slovenia.
   [Mehrabi, S.] Univ Verona, Inst Radiol, Policlin GB Rossi, Verona, Italy.
   [Parissone, F.] Univ Verona, Dept Surg Sci Dent Gynaecol & Paediat, Obstet & Gynaecol Sect, Verona, Italy.
   [Mlakar, J.] Univ Maribor, Inst Pathol, Fac Med, Maribor, Slovenia.
   [Mlakar, J.; Pizem, J.; Popovic, M.] Univ Ljubljana, Fac Med, Inst Pathol, Korytkova 2, Ljubljana 1000, Slovenia.
   [Korva, M.] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.
RP Popovic, M (corresponding author), Univ Ljubljana, Fac Med, Inst Pathol, Korytkova 2, Ljubljana 1000, Slovenia.
EM mara.popovic@mf.uni-lj.si
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Barkovich AJ, 2010, NEURORADIOLOGY, V52, P479, DOI 10.1007/s00234-009-0644-2
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Courtier J, 2012, ULTRASOUND OBST GYN, V40, P604, DOI 10.1002/uog.11121
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Judkins AR, 2011, J NEUROPATH EXP NEUR, V70, P438, DOI 10.1097/NEN.0b013e31821ccf1c
   Leventer RJ, 2010, BRAIN, V133, P1415, DOI 10.1093/brain/awq078
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Popa RT, IMAGING PATTERN FETA, DOI [10.1594/ecr2012/C-2491, DOI 10.1594/ECR2012/C-2491]
   Salmaso R, 2007, J MATERN-FETAL NEO M, V20, P559, DOI 10.1080/14767050701412081
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Singer ME, 1991, TXB FETAL PERINATAL, P3
   Squier W, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0080-3
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 18
TC 10
Z9 10
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD FEB
PY 2017
VL 124
IS 3
BP 521
EP 525
DI 10.1111/1471-0528.14423
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EO9KL
UT WOS:000397007500032
PM 27885789
DA 2020-07-08
ER

PT J
AU Mammas, IN
   Theodoridou, M
   Kramvis, A
   Thiagarajan, P
   Gardner, S
   Papaioannou, G
   Melidou, A
   Koutsaki, M
   Kostagianni, G
   Achtsidis, V
   Koutsaftiki, C
   Calachanis, M
   Zaravinos, A
   Greenough, A
   Spandidos, DA
AF Mammas, Ioannis N.
   Theodoridou, Maria
   Kramvis, Anna
   Thiagarajan, Prakash
   Gardner, Sharryn
   Papaioannou, Georgia
   Melidou, Angeliki
   Koutsaki, Maria
   Kostagianni, Georgia
   Achtsidis, Vassilis
   Koutsaftiki, Chryssie
   Calachanis, Marcos
   Zaravinos, Apostolos
   Greenough, Anne
   Spandidos, Demetrios A.
TI Paediatric Virology: A rapidly increasing educational challenge
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Proceedings Paper
CT 2nd Workshop on Paediatric Virology
CY OCT 08, 2016
CL Athens, GREECE
DE Paediatric Virology; viral infections; HIV-1; AIDS; hepatitis B;
   hepatitis C; Zika virus; influenza; Coxsackie viruses; HPV; MRI; ENT;
   conjunctivitis
ID CHRONIC HEPATITIS-C; INFLUENZA-A H1N1; ACUTE DISSEMINATED
   ENCEPHALOMYELITIS; ACUTE INFECTIVE CONJUNCTIVITIS; ALPHA-2B PLUS
   RIBAVIRIN; IN-SITU HYBRIDIZATION; FOOT-MOUTH DISEASE; NAIL MATRIX
   ARREST; VIRAL-INFECTIONS; NEUROLOGIC MANIFESTATIONS
AB The '2nd Workshop on Paediatric Virology', which took place on Saturday the 8th of October 2016 in Athens, Greece, provided an overview on recent views and advances on Paediatric Virology. Emphasis was given to HIV-1 management in Greece, a country under continuous financial crisis, hepatitis B vaccination in Africa, treatment options for hepatitis C virus in childhood, Zika virus in pregnancy and infancy, the burden of influenza on childhood, hand-foot-mouth disease and myocarditis associated with Coxsackie viruses. Other general topics covered included a critical evaluation of Paediatric Accident and Emergency viral infections, multimodality imaging of viral infections in children, surgical approaches of otolaryngologists to complex viral infections, new advances in the diagnosis and treatment of viral conjunctivitis and novel molecular diagnostic methods for HPV in childhood. A brief historical overview of the anti-vaccination movement was also provided, as well as presentations on the educational challenge of Paediatric Virology as a new subspecialty of Paediatrics. This review highlights selected lectures and discussions of the workshop.
C1 [Mammas, Ioannis N.; Spandidos, Demetrios A.] Univ Crete, Sch Med, Dept Clin Virol, Iraklion 71003, Greece.
   [Theodoridou, Maria] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens 11527, Greece.
   [Kramvis, Anna] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hepatitis Virus Div Res Unit, ZA-2193 Johannesburg, South Africa.
   [Thiagarajan, Prakash] Nobles Isle Man Hosp, Div Womens & Childrens Hlth, Neonatal Unit, Douglas IM4 4RJ, Isle Man, England.
   [Gardner, Sharryn] Southport & Ormskirk Hosp NHS Trust, Dept Childrens Accid & Emergency, Ormskirk L39 2AZ, England.
   [Papaioannou, Georgia] Mitera Childrens Hosp, Dept Paediat Radiol, Athens 15123, Greece.
   [Melidou, Angeliki] Aristotle Univ Thessaloniki, Sch Med, Microbiol Lab 2, Thessaloniki 54124, Greece.
   [Koutsaki, Maria] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Paediat 3,Paediat Neurol Div, Athens 12462, Greece.
   [Kostagianni, Georgia] Triassio Gen Hosp, Head & Neck Surg, Dept Otorhinolaryngol, Elefsina 19200, Greece.
   [Achtsidis, Vassilis] Royal Cornwall Hosp, Dept Ophthalmol, Truro TR1 3LQ, England.
   [Koutsaftiki, Chryssie] PICU, Topeka, KS USA.
   [Calachanis, Marcos] Penteli Childrens Hosp, Dept Paediat Cardiol, Penteli 15236, Greece.
   [Zaravinos, Apostolos] European Univ Cyprus, Sch Sci, Dept Life Sci, CY-1516 Nicosia, Cyprus.
   [Greenough, Anne] Kings Coll London, Allergy & Lung Biol, Div Asthma, London SE5 9RS, England.
RP Spandidos, DA (corresponding author), Univ Crete, Sch Med, Dept Clin Virol, Iraklion 71003, Greece.
EM spandidos@spandidos.gr
RI Zaravinos, Apostolos/B-2528-2019
OI Zaravinos, Apostolos/0000-0003-4625-5562; Spandidos,
   Demetrios/0000-0002-1146-931X; Kramvis, Anna/0000-0001-6006-3765;
   Greenough, Anne/0000-0002-8672-5349
FU Medical Research CouncilMedical Research Council UK (MRC) [G1000758]
CR Abd-Elgawad MM, 2013, ALEX J MED, V49, P363, DOI 10.1016/j.ajme.2013.03.008
   Achtsidis V, 2016, INT J MOL MED, V38, pS66
   Adams D, 2013, PEDIATRICS, V131, P225, DOI 10.1542/peds.2012-1220
   Algeciras-Schimnich A, 2007, CANCER CYTOPATHOL, V111, P330, DOI 10.1002/cncr.22946
   American Academy of Ophthalmology, 2016, 2016 2017 BAS CLIN S
   Amin R, 2008, PEDIATR INFECT DIS J, V27, P390, DOI 10.1097/INF.0b013e31816507b2
   [Anonymous], 2016, 21 WORLD C ADV ONC 1
   Arens M, 2001, J CLIN VIROL, V22, P11, DOI 10.1016/S1386-6532(01)00156-1
   Askalan R, 2001, STROKE, V32, P1257, DOI 10.1161/01.STR.32.6.1257
   Azari AA, 2013, JAMA-J AM MED ASSOC, V310, P1721, DOI 10.1001/jama.2013.280318
   Bakken I, 2015, BMC INFECT DIS, V15, P506
   BALAJI S, 1994, BRIT HEART J, V72, P354
   Baltagi SA, 2010, PEDIATR CRIT CARE ME, V11, P179, DOI 10.1097/PCC.0b013e3181cf4652
   BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bass D, 2004, J PEDIATR GASTR NUTR, V39, P270, DOI 10.1097/00005176-200409000-00009
   Baxby D, 2002, VACCINE, V20, P2140, DOI 10.1016/S0264-410X(02)00028-2
   Bennet R, 2016, VACCINE, V34, P3298, DOI 10.1016/j.vaccine.2016.04.082
   Bernier V, 2001, EUR J PEDIATR, V160, P649, DOI 10.1007/s004310100815
   Bryant K, ITS NOT JUST A VIRUS
   Buznach N, 2005, PEDIATR INFECT DIS J, V24, P823, DOI 10.1097/01.inf.0000178066.24569.98
   Calachanis M, 2016, INT J MOL MED, V38, pS66
   Campaign SS, 2016, GUID SOC CRIT CAR ME
   Centers for Disease Control and Prevention, 2016, ACIP VOT US LAIV 201
   Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2016, ZIK INF
   Centers for Disease Control and Prevention, ZIK VIR COMPL QUEST
   Chad Hayes S, 2015, WASHINGTON POST
   Chauhan N, 2007, INT J PEDIATR OTORHI, V71, P341, DOI 10.1016/j.ijporl.2006.10.012
   CHERRY JD, 1967, AM HEART J, V73, P681, DOI 10.1016/0002-8703(67)90178-0
   Christoforidi M, 2016, INT J MOL MED, V38, pS68
   Clementz GC, 2000, PEDIATR DERMATOL, V17, P7, DOI 10.1046/j.1525-1470.2000.01702.x
   Cleveland Clinic, 2016, REC FEV ITS VIR ITS
   Condliffe J, 2015, GIZMODO         0708
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   Cottrell EB, 2013, ANN INTERN MED, V158, P109, DOI 10.7326/0003-4819-158-2-201301150-00575
   Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594
   de Araujo MR, 2009, J CLIN VIROL, V45, P90, DOI 10.1016/j.jcv.2009.03.020
   DERY P, 1974, AM J DIS CHILD, V128, P464, DOI 10.1001/archpedi.1974.02110290034006
   Druyts E, 2013, CLIN INFECT DIS, V56, P961, DOI 10.1093/cid/cis1031
   Ekstrand JJ, 2012, SEMIN PEDIATR NEUROL, V19, P96, DOI 10.1016/j.spen.2012.02.004
   Ekstrand JJ, 2010, ANN NEUROL, V68, P762, DOI 10.1002/ana.22184
   Esposito S, 2015, AUTOIMMUN REV, V14, P923, DOI 10.1016/j.autrev.2015.06.002
   Everitt HA, 2006, BMJ-BRIT MED J, V333, P321, DOI 10.1136/bmj.38891.551088.7C
   Ferro A, 2014, Ann Ig, V26, P54
   Francois G., 2008, Southern African Journal of Epidemiology & Infection, V23, P24
   Fretzayas Andrew, 2014, Prague Med Rep, V115, P67
   FRIEDMAN RA, 1994, J AM COLL CARDIOL, V24, P780, DOI 10.1016/0735-1097(94)90029-9
   FRIEDMAN RA, 1998, SCI PRACTICE PEDIAT, P1777
   Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147
   Gao LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100003
   Gardner S, 2016, INT J MOL MED, V38, pS65
   GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250
   Greenough A, 2015, INT J MOL MED, V36, pS89
   Guerin N, 1997, Euro Surveill, V2, P2
   Guo M, 2008, J CLIN MICROBIOL, V46, P274, DOI 10.1128/JCM.01299-07
   Guo W, 2012, BRIT J RADIOL, V85, P1385, DOI 10.1259/bjr/20276974
   Gupta K, 2016, J PEDIATR NEUROSCI, V11, P46, DOI 10.4103/1817-1745.181244
   HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703
   Hammer LD, 2010, PEDIATRICS, V125, P1295, DOI 10.1542/peds.2010-0743
   Hayes Chad, 2016, JUST VIRUS WHAT YOUR
   Hellenic Center for Disease Control and Prevention, ANN REP EP SURV INFL
   Hellenic Center for Disease Control and Prevention (HCDCP), 2014, REC DAT HIV INF GREE
   Hesselink AT, 2004, CANCER CYTOPATHOL, V102, P11, DOI 10.1002/cncr.11904
   HOSIER DM, 1958, AMA J DIS CHILD, V96, P251, DOI 10.1001/archpedi.1958.02060060253001
   Huang M, 1998, PEDIATR CARDIOL, V19, P498, DOI 10.1007/s002469900369
   Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209
   Hurt AC, 2016, ANTIVIR RES, V132, P178, DOI 10.1016/j.antiviral.2016.06.001
   Ingrid Rabe, 2016, ZIK VIR WHAT CLIN NE
   Ismail HIM, 2015, BRAIN DEV-JPN, V37, P120, DOI 10.1016/j.braindev.2014.03.008
   Jamieson D, 2016, 10 QUESTIONS ZIKA CD
   Jelliffe S., 1918, N Y MED J, V108, P807
   Jiang M, 2012, NEW ENGL J MED, V367, P91, DOI 10.1056/NEJMc1110981
   JONES P, 1991, ARCH DIS CHILD, V66, P364, DOI 10.1136/adc.66.3.364
   Kaminska K, 2013, CASE REP DERMATOL, V5, P203, DOI 10.1159/000354533
   Kanski JJ, 2007, CLIN OPHTHALMOLOGY S
   Kissling E, 2016, EUROSURVEILLANCE, V21, P18, DOI 10.2807/1560-7917.ES.2016.21.6.30134
   Koelman DLH, 2016, NEUROLOGY, V86, P2085, DOI 10.1212/WNL.0000000000002723
   Kostagianni G, 2016, INT J MOL MED, V38, pS65
   KOUTSAFTIKI C, 2016, INT J MOL MED S1, V38, pS67
   Koutsaki M, 2016, INT J MOL MED, V38, pS66
   Kramvis A, 2016, INT J MOL MED, V38, pS66
   Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x
   Kramvis A, 2016, INT J MOL MED, V38, pS64
   Kwong KL, 2006, PEDIATR NEUROL, V35, P395, DOI 10.1016/j.pediatrneurol.2006.07.005
   Lafond KE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001977
   Lee ACC, 2000, ARCH PEDIAT ADOL MED, V154, P75
   LEWIS AB, 1993, PEDIATR CARDIOL, V14, P9
   Lipke MM, 2006, CLIN MED RES, V4, P273, DOI 10.3121/cmr.4.4.273
   Lo CP, 2008, NEUROIMAG CLIN N AM, V18, P119, DOI 10.1016/j.nic.2007.12.002
   Lo CP, 2008, NEUROIMAG CLIN N AM, V18, pviii
   Long G, 1998, J ULTRAS MED, V17, P29
   Luzuriaga K, 2016, NEW ENGL J MED, V374, P761, DOI 10.1056/NEJMra1505256
   Mammas IN, 2016, INT J MOL MED, V38, pS67
   Mammas IN, 2016, INT J MOL MED, V38, pS65
   Mammas IN, 2016, EXP THER MED, V12, P541, DOI 10.3892/etm.2016.3420
   Mammas IN, 2016, EXP THER MED, V12, P539, DOI 10.3892/etm.2016.3421
   Mammas IN, 2016, EXP THER MED, V11, P6, DOI 10.3892/etm.2015.2890
   Mammas IN, 2016, EXP THER MED, V11, P3, DOI 10.3892/etm.2015.2889
   Mammas IN, 2014, INFECT GENET EVOL, V21, P220, DOI 10.1016/j.meegid.2013.11.002
   Mammas IN, 2011, PEDIATR INFECT DIS J, V30, P384, DOI 10.1097/INF.0b013e3182039a4b
   Mammas IN, 2009, EUR J PEDIATR, V168, P267, DOI 10.1007/s00431-008-0882-z
   Matsumori A, 1999, JPN CIRC J, V63, P934, DOI 10.1253/jcj.63.934
   Meier JD, 2014, AM FAM PHYSICIAN, V89, P353
   Melidou A, 2016, INT J MOL MED, V38, pS66
   MILLER GD, 1968, J AMER MED ASSOC, V203, P827, DOI 10.1001/jama.203.10.827
   Misir Ahmet Ferhat, 2013, J Indian Soc Pedod Prev Dent, V31, P279, DOI 10.4103/0970-4388.121833
   Newland JG, 2007, J PEDIATR-US, V150, P306, DOI 10.1016/j.jpeds.2006.11.054
   Nohynek Hand THLInfluenza Research Team, 2016, SEAS CHILDH INFL VAC
   Ohmer S, 2016, CURR OPIN PEDIATR, V28, P93, DOI 10.1097/MOP.0000000000000313
   Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438
   Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O
   Ozkan M, 2011, PEDIATR NEUROL, V45, P72, DOI 10.1016/j.pediatrneurol.2011.02.010
   Papagrigoriou-Theodoridou M, 1997, PEDIATRIKI, V60, P173
   Papaioannou G, 2016, INT J MOL MED, V38, pS65
   Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X
   Pawlowska M, 2015, WORLD J GASTROENTERO, V21, P10783, DOI 10.3748/wjg.v21.i38.10783
   Pawlowska M, 2010, MED SCI MONITOR, V16, pCR616
   Pebody R, 2016, EUROSURVEILLANCE, V21, P31, DOI 10.2807/1560-7917.ES.2016.21.13.30179
   PELTOLA H, 1994, NEW ENGL J MED, V331, P1397, DOI 10.1056/NEJM199411243312101
   Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049
   POLITIS C, 1986, PLASMA THER TRANSFUS, V7, P41
   Quora, 2016, WHY DO DOCT PRESCR A
   Rose PW, 2005, LANCET, V366, P37, DOI 10.1016/S0140-6736(05)66709-8
   Rush J, 2016, CURR OPIN PEDIATR, V28, P250, DOI 10.1097/MOP.0000000000000334
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6
   SCHIEKEN RM, 1975, J PEDIATR-US, V87, P831, DOI 10.1016/S0022-3476(75)80321-0
   Schmidt K, 2003, VACCINE, V21, P1044, DOI 10.1016/S0264-410X(02)00628-X
   SHAW DWW, 1993, AM J ROENTGENOL, V160, P125, DOI 10.2214/ajr.160.1.8416608
   Siberry GK, 2014, PEDIATR REV, V35, P268, DOI 10.1542/pir.35-7-268
   Sinclair C, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.12.20745
   Sohn AH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18555
   Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8
   Spoulou V, 2011, HORM-INT J ENDOCRINO, V10, P149, DOI 10.14310/horm.2002.1305
   Stenner Markus, 2014, GMS Curr Top Otorhinolaryngol Head Neck Surg, V13, pDoc10, DOI 10.3205/cto000113
   Stiehm ER, 2016, APPROACH CHILD RECUR
   Straussberg R, 2001, PEDIATR NEUROL, V24, P49, DOI 10.1016/S0887-8994(00)00234-4
   Takacs T, 2008, J VIROL METHODS, V149, P153, DOI 10.1016/j.jviromet.2007.12.009
   Theodoridou M, 2016, INT J MOL MED, V38, pS64
   Thiagarajan P, 2016, INT J MOL MED, V38, pS64
   Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438
   Visscher KL, 2009, CAN FAM PHYSICIAN, V55, P1071
   Weber TP, 2010, EMERG INFECT DIS, V16, P664, DOI 10.3201/eid1604.090434
   WHO, 2016, RISK ASS SEAS INFL H
   WHO, GUID SCREEN CAR TREA
   WHO, 2015, HIV HEP COINF
   WHO, 2015, GLASG DECL HEP
   WHO UNICEF, WHO UNICEF EST NAT I
   Wirth S, 2010, J HEPATOL, V52, P501, DOI 10.1016/j.jhep.2010.01.016
   Woods CR, 2016, J PEDIAT INF DIS SOC, V5, P259, DOI 10.1093/jpids/piv010
   Zaravinos A, 2016, INT J MOL MED, V38, pS68
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 153
TC 17
Z9 17
U1 0
U2 10
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD FEB
PY 2017
VL 13
IS 2
BP 364
EP 377
DI 10.3892/etm.2016.3997
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EL9GH
UT WOS:000394927900002
PM 28352303
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Rivino, L
   Lim, MQ
AF Rivino, Laura
   Lim, Mei Qiu
TI CD4(+) and CD8(+) T-cell immunity to Dengue - lessons for the study of
   Zika virus
SO IMMUNOLOGY
LA English
DT Review
DE T cells; memory; virus; human; cell trafficking
ID ORIGINAL ANTIGENIC SIN; COMPREHENSIVE ANALYSIS; PROTECTIVE ROLE;
   RESPONSES; INFECTION; FEVER; IMMUNIZATION; PATHOGENESIS; EFFECTOR;
   VACCINE
AB Dengue virus (DENV) and Zika virus (ZIKV) are rapidly emerging mosquito-borne flaviviruses that represent a public health concern. Understanding host protective immunity to these viruses is critical for the design of optimal vaccines. Over a decade of research has highlighted a significant contribution of the T-cell response to both protection and/or disease enhancement during DENV infection, the latter being mainly associated with sub-optimal cross-reactive T-cell responses during secondary infections. Phase IIb/III clinical trials of the first licensed tetravalent dengue vaccine highlight increased vaccine efficacy in dengue-immune as opposed to dengue-naive vaccinees, suggesting a possible immunoprotective role of pre-existing DENV-specific T cells that are boosted upon vaccination. No vaccine is available for ZIKV and little is known about the T-cell response to this virus. ZIKV and DENV are closely related viruses with a sequence identity ranging from 44% and 56% for the structural proteins capsid and envelope to 68% for the more conserved non-structural proteins NS3/NS5, which represent the main targets of the CD4(+) and CD8(+) T-cell response to DENV, respectively. In this review we discuss our current knowledge of T-cell immunity to DENV and what it can teach us for the study of ZIKV. The extent of T-cell cross-reactivity towards ZIKV of pre-existing DENV-specific memory T cells and its potential impact on protective immunity and/or immunopathology will also be discussed.
C1 [Rivino, Laura; Lim, Mei Qiu] Duke NUS Med Sch, Emerging Infect Dis Programme, 8 Coll Rd, Singapore 169857, Singapore.
RP Rivino, L (corresponding author), Duke NUS Med Sch, Emerging Infect Dis Programme, 8 Coll Rd, Singapore 169857, Singapore.
EM laura.rivino@duke-nus.edu.sg
OI Rivino, Laura/0000-0001-6213-9794
FU Singapore National Medical Research CouncilNational Medical Research
   Council, Singapore [CBRG-NIG R-913-301-289-213]
FX Mei Qiu Lim is supported by a Cooperative Basic Research Grant-New
   Investigator Grant (CBRG-NIG R-913-301-289-213) of the Singapore
   National Medical Research Council to Laura Rivino.
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chang CXL, 2013, EUR J IMMUNOL, V43, P1109, DOI 10.1002/eji.201243088
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Friberg H, 2010, IMMUNOL CELL BIOL, P8
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851
   KANGWANPONG D, 1995, CLIN DIAGN VIROL, V3, P165, DOI 10.1016/0928-0197(94)00032-P
   Klenerman P, 1998, NATURE, V394, P482
   Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078
   MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526
   Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Sandoval F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004888
   Selin LK, 2004, SEMIN IMMUNOL, V16, P335, DOI 10.1016/j.smim.2004.08.014
   Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Staumont-Salle D, 2014, J EXP MED, V211, P1185, DOI 10.1084/jem.20121350
   Stettler K, 2016, SCIENCE, P1
   Townsley E, 2014, IMMUNOLOGY, V141, P27, DOI 10.1111/imm.12161
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zivny J, 1999, J IMMUNOL, V163, P2754
NR 64
TC 25
Z9 26
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD FEB
PY 2017
VL 150
IS 2
BP 146
EP 154
DI 10.1111/imm.12681
PG 9
WC Immunology
SC Immunology
GA EL7GZ
UT WOS:000394790400003
PM 27763656
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Benelli, G
   Pavela, R
   Iannarelli, R
   Petrelli, R
   Cappellacci, L
   Cianfaglione, K
   Afshar, FH
   Nicoletti, M
   Canale, A
   Maggi, F
AF Benelli, Giovanni
   Pavela, Roman
   Iannarelli, Romilde
   Petrelli, Riccardo
   Cappellacci, Loredana
   Cianfaglione, Kevin
   Afshar, Fariba Heshmati
   Nicoletti, Marcello
   Canale, Angelo
   Maggi, Filippo
TI Synergized mixtures of Apiaceae essential oils and related plant-borne
   compounds: Larvicidal effectiveness on the filariasis vector Culex
   quinquefasciatus Say
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Biopesticides; Essential oils; Helosciadium nodiflorum; Pimpinella
   anisum; Smymium olusatrum; Trachyspermum ammi
ID SMYRNIUM-OLUSATRUM L.; ECO-FRIENDLY LARVICIDES; ANOPHELES-SUBPICTUS;
   PIMPINELLA-ANISUM; AEDES-ALBOPICTUS; VETERINARY IMPORTANCE; INSECTICIDAL
   ACTIVITY; AROMATIC-COMPOUNDS; MOSQUITO VECTORS; ACUTE TOXICITY
AB The recent outbreaks of mosquito-borne diseases, such as chikungunya and Zika virus, highlighted the pivotal importance of effective mosquito control programs. Nowadays, Culicidae management is being challenging, due to the rapid development of resistance to synthetic pesticides and the spread of highly invasive mosquito vectors worldwide. This research explored the chemical composition of four Apiaceae essential oils (EOs) from Trachysperrnum ammi, Smyrnium olusatrum, Pimpinelld anisum and"Helosciadium nodiflortlm and their potential as sources of synergistic binary mixtures with high effectiveness against larvae of the filariasis vector Culex quinquefasciatus. The essential oils were all highly toxic to the larvae, showing LC50 of 17.6, 17.5, 25.9 and 20.6 mu l L-1, respectively. GC-MS analysis put in evidence thymol, (E)-anethole, myristicin and (Z)-beta-ocimene, and isofuranodiene and germacrone as the main essential oil components, respectively. Three effective EOs were selected to prepare binary mixtures. T. ammi + P. anisum (ratio 1:2) and S. olusatrum + P. anisum (ratio 1:1) were the most toxic larvicidal blends, showing LC50 of 15.2 and 16.9, mu l L-1, respectively. LT50 values were 45 and 30 min, respectively. Notably, short time exposure to both binary mixtures strongly reduced emergence rates, fertility and natality of C. quinquefasciatus that survived after the treatment at the larval stage. Larvicidal assays assessing the acute toxicity of EC) main constituents, i.e. germacrone, isofuranodiene and (E)-anethole, were carried out. LC50 were 18.6 mg L-1, 33.7 mg L-1 and 24.8 mu l L-1. Overall, our results pointed out the promising potential of these EOs to develop cheap and effective mosquito larvicides, as well as the importance to consider the synergistic effects among the tested botanicals during the design of novel mosquito larvicides. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Iannarelli, Romilde; Petrelli, Riccardo; Cappellacci, Loredana; Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Cianfaglione, Kevin] Univ Bretagne Occidentale, UFR Sci & Tech, EA Geoarchitecture 2219, Brest, France.
   [Cianfaglione, Kevin] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy.
   [Afshar, Fariba Heshmati] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
   [Afshar, Fariba Heshmati] Tabriz Univ Med Sci, Dept Pharmacognosy, Tabriz, Iran.
   [Nicoletti, Marcello] Sapienza Univ, Dept Environm Biol, Rome, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Cianfaglione, Kevin/AAL-8874-2020; Pavela, Roman/Q-8647-2016; Benelli,
   Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; Pavela, Roman/0000-0001-7866-4278
FU University of Camerino [FAR 2014/15]; University of Camerino (Fondo di
   Ateneo per la Ricerca) [FPI 000044]; PROAPI (PRAF); University of Pisa,
   Department of Agriculture, Food and Environment [COFIN2015_22]; Ministry
   of Agriculture of the Czech RepublicMinistry of Agriculture, Czech
   Republic [QJ1510160]
FX The Authors would like to thank the University of Camerino (FAR 2014/15,
   Fondo di Ateneo per la Ricerca, FPI 000044) for financial support, and
   BIM Tronto (Bacino Imbrifero Montano), Ascoli Piceno, Italy, for
   allowing us collection of aniseeds of 'Castignano' ecotype. G. Benelli
   is supported by PROAPI (PRAF 2015) and University of Pisa, Department of
   Agriculture, Food and Environment (Grant ID: COFIN2015_22). R. Pavela
   would also like to thank the Ministry of Agriculture of the Czech
   Republic for its financial support concerning botanical pesticide
   research (Project NAZV No. QJ1510160). Funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   [Anonymous], 2008, NIST 08
   [Anonymous], 2012, FLAV FRAGR NAT SYNTH
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Bellomaria B., 1982, NATURA MONTAGNA, V4, P87
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BERENBAUM M, 1985, J CHEM ECOL, V11, P1349, DOI 10.1007/BF01012136
   Cascone P, 2015, J PLANT PHYSIOL, V173, P28, DOI 10.1016/j.jplph.2014.08.011
   Cecchini C, 2010, FLAVOUR FRAG J, V25, P493, DOI 10.1002/ffj.2010
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   Chang CL, 2009, J ECON ENTOMOL, V102, P203, DOI 10.1603/029.102.0129
   Chaubey MK, 2008, J OLEO SCI, V57, P171, DOI 10.5650/jos.57.171
   DOSS RP, 1980, PHYTOCHEMISTRY, V19, P2379, DOI 10.1016/S0031-9422(00)91031-8
   Evergetis E, 2013, IND CROP PROD, V41, P365, DOI 10.1016/j.indcrop.2012.04.058
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Hebeish A, 2008, CARBOHYD POLYM, V74, P268, DOI 10.1016/j.carbpol.2008.02.013
   Ibrahim MA, 2001, AGR FOOD SCI FINLAND, V10, P243, DOI 10.23986/afsci.5697
   Kamaraj C, 2011, ASIAN PAC J TROP MED, V4, P698, DOI 10.1016/S1995-7645(11)60177-6
   Kimbaris AC, 2012, PARASITOL RES, V111, P2403, DOI 10.1007/s00436-012-3097-1
   Koul O, 2013, IND CROP PROD, V49, P428, DOI 10.1016/j.indcrop.2013.05.032
   LEUNG AY, 1996, ENCY COMMON NATURAL
   LICHTENSTEIN EP, 1963, J AGR FOOD CHEM, V11, P410, DOI 10.1021/jf60129a017
   Maggi F, 2015, FLAVOUR FRAG J, V30, P139, DOI 10.1002/ffj.3221
   Maggi F, 2012, FOOD CHEM, V135, P2852, DOI 10.1016/j.foodchem.2012.07.027
   Mehlhorn H., 2015, ENCY PARASITOLOGY, P893
   Mollo E, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00092
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nicoletti M., 2016, EMERGING INSECT BORN, V11, P216
   Pandey SK, 2009, PARASITOL RES, V105, P507, DOI 10.1007/s00436-009-1429-6
   Park IK, 2006, PEST MANAG SCI, V62, P723, DOI 10.1002/ps.1228
   Pavela R., 2016, TRENDS PLANT SCI
   Pavela R, 2007, J ESSENT OIL BEAR PL, V10, P346, DOI 10.1080/0972060X.2007.10643566
   Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2016, EXP PARASITOL, V165, P51, DOI 10.1016/j.exppara.2016.03.016
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pavela R, 2014, IND CROP PROD, V60, P247, DOI 10.1016/j.indcrop.2014.06.030
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Pignatti S, 1982, FLORA DITALIA, V2, P187
   Quassinti L, 2014, FITOTERAPIA, V97, P133, DOI 10.1016/j.fitote.2014.06.004
   Quassinti L, 2013, FOOD CHEM, V138, P808, DOI 10.1016/j.foodchem.2012.11.075
   Rajeshwari C. U., 2011, NUTS SEEDS HLTH DIS, V175, P182
   REICHARDT PB, 1990, J CHEM ECOL, V16, P1961, DOI 10.1007/BF01020508
   RYAN MF, 1988, J CHEM ECOL, V14, P1965, DOI 10.1007/BF01013489
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586
   Seo SM, 2009, J AGR FOOD CHEM, V57, P6596, DOI 10.1021/jf9015416
   Somjit C, 2015, Commun Agric Appl Biol Sci, V80, P187
   Soni R, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/1428194
   Srivastava S, 2001, PHARM BIOL, V39, P226, DOI 10.1076/phbi.39.3.226.5933
   Viegi L, 2001, VETERINARIA, VLIV, P405
   Vitali LA, 2016, ARAB J CHEM, V9, P775, DOI 10.1016/j.arabjc.2015.06.002
   WHO, 1996, CTDWHOPESIC961
   Wink M, 2008, CURR DRUG METAB, V9, P996, DOI 10.2174/138920008786927794
   Yeom HJ, 2012, J AGR FOOD CHEM, V60, P7194, DOI 10.1021/jf302009w
   Zarshenas Mohammad M., 2014, Journal of Natural Remedies, V14, P98, DOI 10.18311/jnr/2014/96
NR 68
TC 72
Z9 73
U1 5
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD FEB
PY 2017
VL 96
BP 186
EP 195
DI 10.1016/j.indcrop.2016.11.059
PG 10
WC Agricultural Engineering; Agronomy
SC Agriculture
GA EL3YP
UT WOS:000394556900023
DA 2020-07-08
ER

PT J
AU Anaya, JM
   Rodriguez, Y
   Monsalve, DM
   Vega, D
   Ojeda, E
   Gonzalez-Bravo, D
   Rodriguez-Jimenez, M
   Pinto-Diaz, CA
   Chaparro, P
   Gunturiz, ML
   Ansari, AA
   Gershwin, ME
   Molano-Gonzalez, N
   Ramirez-Santana, C
   Acosta-Ampudia, Y
AF Anaya, Juan-Manuel
   Rodriguez, Yhojan
   Monsalve, Diana M.
   Vega, Daniel
   Ojeda, Ernesto
   Gonzalez-Bravo, Diana
   Rodriguez-Jimenez, Monica
   Pinto-Diaz, Carlos A.
   Chaparro, Pablo
   Gunturiz, Maria L.
   Ansari, Aftab A.
   Gershwin, M. Eric
   Molano-Gonzalez, Nicolas
   Ramirez-Santana, Carolina
   Acosta-Ampudia, Yeny
TI A comprehensive analysis and immunobiology of autoimmune neurological
   syndromes during the Zika virus outbreak in Cucuta, Colombia
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Article
DE Zika virus; Mycoplasma pneumoniae; Guillain-Barre syndrome; Transverse
   myelitis; Epidemiology; Public health; Colombia
ID GUILLAIN-BARRE-SYNDROME; MOSQUITO-BORNE; INFECTION; DISEASE; DIAGNOSIS;
   PATIENT; CELLS; EPIDEMIOLOGY; TRANSMISSION; MANAGEMENT
AB We have focused on the epidemiology and immunobiology of Zika virus (ZIKV) infection and factors associated with the development of Guillain-Barre syndrome (GBS) and other neurological syndromes in Cucuta, the capital of North Santander department, Colombia. Data of patients with ZIKV disease reported to the national population-based surveillance system were used to calculate the basic reproduction number (R-0) and the attack rates (ARs) as well as to develop epidemiological maps. Patients with neurological syndromes were contacted and their diagnoses were confirmed. A case-control study in which 29 patients with GBS associated with ZIKV compared with 74-matched control patients with ZIKV infection alone was undertaken. Antibodies against arboviruses and other infections that may trigger GBS were evaluated. The estimated value of R-0 ranged between 2.68 (95% CI 2.54-2.67) to 4.57 (95% CI 4.18-5.01). The sex-specific ARs were 1306 per 100,000 females, and 552 per 100,000 males. A non-linear interaction between age and gender on the ARs was observed. The incidence of GBS in Cucuta increased 4.41 times secondary to ZIKV infection. The lag time between ZIKV infection and neurological symptoms was 7 days (interquartile range 2-14.5). Patients with GBS appeared to represent a lower socioeconomic status and were living near to environmentally contaminated areas. All GBS patients were positive for IgG antibodies against both ZIKV and Dengue virus, and 69% were positive for Chikungunya virus. Noteworthy, GBS was associated with a previous infection with M. pneumoniae (OR: 3.95; 95% CI 1.44-13.01; p = 0.006). No differences in antibody levels against C jejuni, Epstein-Barr virus and cytomegalovirus were observed. High rates of cranial nerves involvement and dysautonomia were present in 82% and 75.9%, respectively. Intensive care unit (ICU) admission was necessary in 69% of the GBS patients. Most of the patients disclosed a high disability condition (Hughes grade 4). Dysautonomia was the main risk factor of poor GBS prognosis (i.e., ICU admission and disability). Thirteen patients were diagnosed with other neurological syndromes different to GBS (6 with transverse myelitis, 3 with encephalitis, 3 with peripheral facial palsy and one with thoraco-lumbosacral myelopathy). Our data confirm an increased transmission of ZIKV in Cucuta, and provide support to the view that severe neurological syndromes are related to ZIKV disease. The complex ways by which previous infections and socioeconomic status interact to increase the risk of GBS in people infected by ZIKV should be further investigated. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Anaya, Juan-Manuel; Rodriguez, Yhojan; Monsalve, Diana M.; Gonzalez-Bravo, Diana; Rodriguez-Jimenez, Monica; Pinto-Diaz, Carlos A.; Molano-Gonzalez, Nicolas; Ramirez-Santana, Carolina; Acosta-Ampudia, Yeny] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Cra 26-63-B-51, Bogota, Colombia.
   [Vega, Daniel] Mederi Hosp Univ Mayor, Intens Care Unit, Bogota, Colombia.
   [Ojeda, Ernesto] Mederi Hosp Univ Mayor, Dept Neurol, Bogota, Colombia.
   [Chaparro, Pablo; Gunturiz, Maria L.] Inst Nacl Salud, Bogota, Colombia.
   [Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
RP Anaya, JM (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Cra 26-63-B-51, Bogota, Colombia.; Gershwin, ME (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
EM juan.anaya@urosario.edu.co; megershwin@ucdavis.edu
RI Ramirez-Santana, Carolina/J-2363-2016; Anaya, Juan-Manuel/J-1960-2016;
   Rodriguez-Jimenez, Monica/J-1899-2016; Molano-Gonzalez,
   Nicolas/I-6806-2016; Monsalve, Diana M./J-2374-2016; Acosta-Ampudia,
   Yeny/J-2401-2016
OI Ramirez-Santana, Carolina/0000-0003-2137-4899; Anaya,
   Juan-Manuel/0000-0002-6444-1249; Rodriguez-Jimenez,
   Monica/0000-0002-8536-1491; Molano-Gonzalez,
   Nicolas/0000-0001-7002-8795; Monsalve, Diana M./0000-0002-1145-1312;
   Rodriguez, Yhojan/0000-0002-0956-1491; GUNTURIZ, MARIA
   LUZ/0000-0001-9803-7909; Acosta-Ampudia, Yeny/0000-0001-8491-9134
FU Universidad del Rosario [ABN011]; Colciencias , Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX The authors would like to thank the patients who participated in this
   study and all numerous people for their assistance and hard work,
   without whom this study would have been impossible, including Hermelinda
   Rueda, Freddy Calderon, Ruben D. Mantilla, Javier Viccini, Juan Camilo
   Castellanos, Daniel Hincapie, Diana Pulido, Sandra Saade, Enrique
   Rodriguez, Nelson Barba, Diana Diaz, Elizabeth Zapata, Deyanira Paipilla
   Monroy, Leidy Y. Torres Espinosa, Juliana Saavedra, Alejandra Torres,
   and Benjamin Reyes. We also thank the Major of the city of Cucuta, Cesar
   Rojas, and the Secretary of Health, Judith M. Ortega, for their trust.
   Supported by Universidad del Rosario (ABN011), and Colciencias
   (747-2016), Bogota, Colombia.
CR Acosta-Ampudia Y., 2016, MED BOGOTA, V38, P187
   Alhomoud IA, 2009, SAUDI MED J, V30, P1067
   Amer Assoc Neuromuscular & Electrodiagnost Studies, 2006, MUSCLE NERVE, V33, P436, DOI 10.1002/mus.20493
   American Association of Electrodiagnostic Medicine, 1999, Muscle Nerve Suppl, V8, pS91
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, LANG ENV STAT COMP
   [Anonymous], 2014, SURVEILLANCE DENGUE
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ASBURY AK, 1990, ANN NEUROL, V27, pS2, DOI 10.1002/ana.410270703
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhat A, 2010, AUTOIMMUN REV, V9, pA395, DOI 10.1016/j.autrev.2009.12.007
   Borchers AT, 2012, AUTOIMMUN REV, V11, P231, DOI 10.1016/j.autrev.2011.05.018
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chalela JA, 2001, SEMIN NEUROL, V21, P399, DOI 10.1055/s-2001-19411
   Chan KH, 2006, EUR J NEUROL, V13, P862, DOI 10.1111/j.1468-1331.2006.01376.x
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Choe MC, 2015, SEMIN NEUROL, V35, P29, DOI 10.1055/s-0035-1544243
   Chowell G., 2016, PLOS CURR, V8
   De la O-Pena Daniel, 2015, Rev Med Inst Mex Seguro Soc, V53, P678
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dieli-Crimi R, 2015, J AUTOIMMUN, V64, P26, DOI 10.1016/j.jaut.2015.07.003
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Fairfax KA, 2015, J AUTOIMMUN, V62, P1, DOI 10.1016/j.jaut.2015.06.001
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Frohman EM, 2010, NEW ENGL J MED, V363, P564, DOI 10.1056/NEJMcp1001112
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gonzalez P, 2016, NEUROLOGIA, V31, P389, DOI 10.1016/j.nrl.2014.09.004
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Hummers LK, 2004, NEUROLOGY, V62, P147, DOI 10.1212/01.WNL.0000101715.32569.1A
   Husson F, 2011, EXPLORATORY MULTIVAR
   Jacob A, 2008, SEMIN NEUROL, V28, P105, DOI 10.1055/s-2007-1019132
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jasti AK, 2016, EXPERT REV CLIN IMMU, V12, P1175, DOI 10.1080/1744666X.2016.1193006
   Joly AL, 2015, J AUTOIMMUN, V63, P23, DOI 10.1016/j.jaut.2015.06.009
   Kopytko D., 2014, POL ANN MED, V21, P158
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu J, 2015, J AUTOIMMUN, V63, P1, DOI 10.1016/j.jaut.2015.07.011
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Mahecha M. P., 2016, IMMUNOL RES
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Ministerio de Salud y Proteccion Social, 2015, CIRC EXT 0043
   Mok CC, 1998, J RHEUMATOL, V25, P467
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Noble JA, 2015, J AUTOIMMUN, V64, P101, DOI 10.1016/j.jaut.2015.07.014
   Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147
   Pacheco O., 2016, N ENGL MED
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Profice P, 2013, SPINAL CORD, V51, P511, DOI 10.1038/sc.2013.30
   Red Nacional de Vigilancia Epidemiologica, 2016, PROT VIG SAL PUBL EN
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rojas DP, 2016, EURO SURVEILL, V21
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sauteur PMM, 2016, ANN NEUROL, V80, P566, DOI 10.1002/ana.24755
   Secretaria de Salud de Cucuta, 2015, AN SIT SAL ASIS
   Seldin MF, 2015, J AUTOIMMUN, V64, P1, DOI 10.1016/j.jaut.2015.08.015
   Seneviratne U, 2000, POSTGRAD MED J, V76, P774, DOI 10.1136/pmj.76.902.774
   Shah S, 2008, PEDIATR ANESTH, V18, P681, DOI 10.1111/j.1460-9592.2008.02521.x
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solomon I. H., 2016, J NEUROINFECT DIS, V7
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Wang YH, 2015, J AUTOIMMUN, V59, P26, DOI 10.1016/j.jaut.2015.01.011
   Wasay M, 2015, NEUROLOGY, V84, P421, DOI 10.1212/WNL.0000000000001177
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Webb GJ, 2016, J AUTOIMMUN, V66, P25, DOI 10.1016/j.jaut.2015.08.016
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wood S. N., 2006, GEN ADDITIVE MODELS
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization (WHO), 2014, HLTH ENV LINK IN
   World Health Organization (WHO), 2016, WHO SPEC EV PUBL HLT
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang HL, 2010, NEUROLOGY, V75, P194, DOI 10.1212/WNL.0b013e3181e7920c
NR 90
TC 35
Z9 36
U1 0
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
EI 1095-9157
J9 J AUTOIMMUN
JI J. Autoimmun.
PD FEB
PY 2017
VL 77
BP 123
EP 138
DI 10.1016/j.jaut.2016.12.007
PG 16
WC Immunology
SC Immunology
GA EL5AO
UT WOS:000394634000012
PM 28062188
OA Other Gold
DA 2020-07-08
ER

PT J
AU Kutsuna, S
   Kato, Y
   Nakayama, E
   Taniguchi, S
   Takasaki, T
   Yamamoto, K
   Takeshita, N
   Hayakawa, K
   Kanagawa, S
   Ohmagari, N
AF Kutsuna, Satoshi
   Kato, Yasuyuki
   Nakayama, Eri
   Taniguchi, Satoshi
   Takasaki, Tomohiko
   Yamamoto, Kei
   Takeshita, Nozomi
   Hayakawa, Kayoko
   Kanagawa, Shuzo
   Ohmagari, Norio
TI A case of consecutive infection with Zika virus and Chikungunya virus in
   Bora Bora, French Polynesia
SO JOURNAL OF INFECTION AND CHEMOTHERAPY
LA English
DT Article
DE Chikungunya fever; Mosquito-borne diseases; Zika virus infection;
   Neutralizing antibody
AB Chikungunya fever (CHIK) and Zika virus (ZIKV) infection have similar endemic areas and clinical manifestations. We report a case of CHIK at 1 year after a ZIKV infection in Bora Bora (French Polynesia), which we diagnosed based on IgM to the CHIK virus and neutralizing antibodies to ZIKV. (C) 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Kutsuna, Satoshi; Kato, Yasuyuki; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.
   [Nakayama, Eri; Taniguchi, Satoshi; Takasaki, Tomohiko] Natl Inst Infect Dis, Dept Virol, Shinjuku Ku, Tokyo, Japan.
RP Kutsuna, S (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.
EM sonare.since1192@gmail.com
OI Kutsuna, Satoshi/0000-0002-6929-8955
FU National Center for Global Health and MedicineNational Center for Global
   Health & Medicine - Japan [27-6001]; Japan Agency for Medical Research
   and Development, AMEDJapan Agency for Medical Research and Development
   (AMED) [15fk0108046h0003]
FX This work was supported by grants from the National Center for Global
   Health and Medicine (27-6001), and Japan Agency for Medical Research and
   Development, AMED (15fk0108046h0003).
CR Cauchemez S, 2016, LANCET
   Cerbino-Neto J, 2016, EMERG INFECT DIS
   Korhonen EM, 2015, EURO SURVEILL
   Kutsuna S, 2014, EURO SURVEILL
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EURO SURVEILL
   Sardi S, 2016, J CLIN MICROBIOL
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, WHO DIR GEN SUMM OUT
   Zambrano H, 2016, AM J TROP MED HYG
NR 16
TC 2
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1341-321X
EI 1437-7780
J9 J INFECT CHEMOTHER
JI J. Infect. Chemother.
PD FEB
PY 2017
VL 23
IS 2
BP 114
EP 116
DI 10.1016/j.jiac.2016.08.003
PG 3
WC Infectious Diseases; Pharmacology & Pharmacy
SC Infectious Diseases; Pharmacology & Pharmacy
GA EO1FS
UT WOS:000396444400010
PM 27600176
DA 2020-07-08
ER

PT J
AU Saldana, MA
   Hegde, S
   Hughes, GL
AF Saldana, Miguel A.
   Hegde, Shivanand
   Hughes, Grant L.
TI Microbial control of arthropod-borne disease
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Review
DE microbiome; paratransgenesis; mosquito; arbovirus; vector control;
   malaria
ID WEST NILE VIRUS; INSECT-SPECIFIC FLAVIVIRUS; AEDES-AEGYPTI MOSQUITOS;
   IXODES-SCAPULARIS TICKS; JAK-STAT PATHWAY; LA-CROSSE VIRUS;
   TRYPANOSOMA-CRUZI; ANOPHELES-GAMBIAE; GUT MICROBIOTA; DENGUE VIRUS
AB Arthropods harbor a diverse array of microbes that profoundly influence many aspects of host biology, including vector competence. Additionally, symbionts can be engineered to produce molecules that inhibit pathogens. Due to their intimate association with the host, microbes have developed strategies that facilitate their transmission, either horizontally or vertically, to conspecifics. These attributes make microbes attractive agents for applied strategies to control arthropod-borne disease. Here we discuss the recent advances in microbial control approaches to reduce the burden of pathogens such as Zika, Dengue and Chikungunya viruses, and Trypanosome and Plasmodium parasites. We also highlight where further investigation is warranted.
C1 [Saldana, Miguel A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Hegde, Shivanand; Hughes, Grant L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Hughes, Grant L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Hughes, Grant L.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Hughes, Grant L.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
RP Hughes, GL (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Hughes, GL (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Hughes, GL (corresponding author), Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.; Hughes, GL (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
EM glhughes@utmb.edu
RI Hegde, Shivanand/L-4999-2019
OI Hughes, Grant/0000-0002-7567-7185; Saldana, Miguel/0000-0003-0470-1667;
   hegde, shivanand/0000-0001-7249-6795
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI124452, 2T32AI007526]; University
   of Texas Rising Star award
FX GLH was supported by a NIH grant (R21AI124452) and a University of Texas
   Rising Star award. MAS was supported by a NIH grant (2T32AI007526).
CR Afanasiev BN, 1999, VIROLOGY, V257, P62, DOI 10.1006/viro.1999.9621
   Ai-Salem WS, 2016, EMERG INFECT DIS, V22, P931, DOI 10.3201/eid2205.160042
   Akhoundi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050259
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Aliota MT, SCI REP, V6, P28792
   Anglero-Rodriguez YI, 2016, SCI REP-UK, V6, DOI 10.1038/srep34084
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762
   Arora AK, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0175-3
   Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007
   Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381
   Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985
   Ballard JWO, 2007, INSECT MOL BIOL, V16, P799, DOI 10.1111/j.1365-2583.2007.00760.x
   Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561
   Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144
   Bestetti RB, 2015, NEW ENGL J MED, V373, P1881, DOI [10.1056/NEJMc1510996, 10.1056/NEJMra1410150]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bisi DC, 2011, APPL ENVIRON MICROB, V77, P4669, DOI 10.1128/AEM.00514-11
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bongio NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143541
   Boucias DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061150
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95
   Broderick NA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0295
   Buarque DS, 2016, BIOCHIMIE, V123, P138, DOI 10.1016/j.biochi.2016.02.009
   Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074
   Buck M., 2016, SCI REP, P1, DOI DOI 10.1038/S41598-016-0001-8
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136
   Castro DP, 2007, EXP PARASITOL, V117, P201, DOI 10.1016/j.exppara.2007.04.014
   Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591
   Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185
   Chavshin AR, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0635-6
   Chen SC, 2015, APPL ENVIRON MICROB, V81, P2233, DOI 10.1128/AEM.03733-14
   Chen XL, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0270-z
   Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Clayton KA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1245-z
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631
   Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238
   De Vooght L, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0156-6
   De Vooght L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-23
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8
   Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27
   Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274
   Durvasula RV, 1999, ANN ENTOMOL SOC AM, V92, P937, DOI 10.1093/aesa/92.6.937
   Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653
   Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025
   Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004
   Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052
   Frank T, 2013, LANCET, V381, P1876, DOI 10.1016/S0140-6736(13)60318-9
   Fryxell RTT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146651
   Gall CA, 2016, ISME J, V10, P1846, DOI 10.1038/ismej.2015.266
   Garay JAR, 2016, GENOME ANNOUNC, V4
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Genes C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-66
   Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gu JB, 2010, AM J TROP MED HYG, V83, P614, DOI 10.4269/ajtmh.2010.10-0074
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066
   Hughes GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004182
   Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hughes GL, 2011, CURR MICROBIOL, V63, P392, DOI 10.1007/s00284-011-9990-5
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Ignatova E. A., 1996, Mikrobiolohichnyi Zhurnal, V58, P12
   Isoe J, 2011, P NATL ACAD SCI USA, V108, pE211, DOI 10.1073/pnas.1102637108
   Jasinskas A, 2007, APPL ENVIRON MICROB, V73, P334, DOI 10.1128/AEM.02009-06
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Jeffries CL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003576
   Joshi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-336
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kukutla P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097715
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Ledermann JP, 2004, J ECON ENTOMOL, V97, P1828, DOI 10.1603/0022-0493-97.6.1828
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Leonard JN, 2005, J VIROL, V79, P1645, DOI 10.1128/JVI.79.3.1645-1654.2005
   Lewis Z, 2015, CURR OPIN INSECT SCI, V9, P86, DOI 10.1016/j.cois.2015.03.003
   Liu PW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20979
   Maltz MA, 2012, APPL ENVIRON MICROB, V78, P7760, DOI 10.1128/AEM.01858-12
   Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3
   Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121
   Marti GA, 2006, MYCOPATHOLOGIA, V162, P369, DOI 10.1007/s11046-006-0072-3
   Martin E, 2016, MED VET ENTOMOL, V30, P101, DOI 10.1111/mve.12149
   McNaughton D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002794
   McNaughton D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001785
   Medlock J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002374
   Menchaca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067129
   Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x
   Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   MOURYA DT, 1985, INDIAN J MED RES, V81, P247
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Murphy KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22587
   Murray JV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00043
   Muturi EJ, 2016, MOL ECOL, V25, P4075, DOI 10.1111/mec.13741
   Muturi EJ, 2016, ACTA TROP, V164, P54, DOI 10.1016/j.actatropica.2016.08.018
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001
   Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579
   Noden BH, 2011, PARASITOL INT, V60, P440, DOI 10.1016/j.parint.2011.07.007
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pang XJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.23, 10.1038/nmicrobiol.2016.23]
   Pei D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1049-1
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Ren XX, 2014, PEERJ, V2, DOI 10.7717/peerj.584
   Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135
   Ricci I., 2010, ANTON LEEUW INT J G, V99, P43
   Ricci I, 2011, ENVIRON MICROBIOL, V13, P911, DOI 10.1111/j.1462-2920.2010.02395.x
   Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002
   Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689
   Rossi P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0888-0
   Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095
   Sakamoto JM, 2016, PEERJ, V4, DOI 10.7717/peerj.2324
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   SCHLEIN Y, 1985, PARASITOLOGY, V90, P57, DOI 10.1017/S0031182000049015
   Schlein Y, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0845-y
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207
   Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Soares TS, 2015, BIOCHIMIE, V112, P41, DOI 10.1016/j.biochi.2015.02.014
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897
   Steyn A, 2016, MICROB ECOL, V71, P747, DOI 10.1007/s00248-015-0709-1
   Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222
   Suzuki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05127
   Taracena ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003358
   Tchioffo MT, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01500
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Teo J, 2014, GENOME BIOL EVOL, V6, P1158, DOI 10.1093/gbe/evu094
   Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2
   Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108
   Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Valzano M, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1059-7
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   van Tol S, 2016, ADV INSECT PHYSIOL, V51, P243, DOI 10.1016/bs.aiip.2016.04.006
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Vieira CS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0736-2
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang JW, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00069
   Wang JW, 2013, J INVERTEBR PATHOL, V112, pS32, DOI 10.1016/j.jip.2012.03.028
   Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106
   Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001
   Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weiss BL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003318
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Whitten MMA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0042
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xia H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121609
   Xie PW, 2013, NUCLEIC ACID THER, V23, P244, DOI 10.1089/nat.2012.0405
   Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837
   Zele F, 2012, J EVOLUTION BIOL, V25, P1243, DOI 10.1111/j.1420-9101.2012.02519.x
   Zhang GM, 2014, INSECT BIOCHEM MOLEC, V53, P81, DOI 10.1016/j.ibmb.2014.08.003
   Zink SD, 2015, VIRUSES-BASEL, V7, P5619, DOI 10.3390/v7102886
   Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
NR 210
TC 22
Z9 22
U1 0
U2 32
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2017
VL 112
IS 2
BP 81
EP 93
DI 10.1590/0074-02760160373
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EK8ED
UT WOS:000394155800001
PM 28177042
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saulino, D
   Gaston, E
   Younke, B
   Conyers, JA
   Covinsky, M
   Tatevian, N
   Bhattacharjee, M
AF Saulino, David
   Gaston, Elizabeth
   Younke, Brianne
   Conyers, Jeffrey A.
   Covinsky, Micheal
   Tatevian, Nina
   Bhattacharjee, Meenakshi
TI The First Zika-Related Infant Mortality in the United States: An Autopsy
   Case Report
SO MODERN PATHOLOGY
LA English
DT Meeting Abstract
CT 106th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology (USCAP)
CY MAR 04-10, 2017
CL San Antonio, TX
SP US & Canadian Acad Pathol
C1 [Saulino, David; Gaston, Elizabeth; Younke, Brianne; Conyers, Jeffrey A.; Covinsky, Micheal; Tatevian, Nina; Bhattacharjee, Meenakshi] Univ Texas, Houston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
EI 1530-0285
J9 MODERN PATHOL
JI Mod. Pathol.
PD FEB
PY 2017
VL 30
SU 2
MA 27
BP 10A
EP 10A
PG 1
WC Pathology
SC Pathology
GA EL2RO
UT WOS:000394467300028
DA 2020-07-08
ER

PT J
AU Vouga, M
   Baud, D
   Schaub, B
AF Vouga, Manon
   Baud, David
   Schaub, Bruno
TI Comment on "Associated ultrasonographic findings in fetuses with
   microcephaly because of suspected Zika virus (ZIKV) infection during
   pregnancy"
SO PRENATAL DIAGNOSIS
LA English
DT Editorial Material
C1 [Vouga, Manon; Baud, David] Univ Lausanne Hosp, Matern Unit, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Univ Hosp, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Schaub, Bruno] Univ Hosp Martinique, Multidisciplinary Ctr Prenatal Diag, Maison Femme Mere Enfant, Fort De France, Martinique, France.
RP Baud, D (corresponding author), Univ Lausanne Hosp, Matern Unit, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Univ Hosp, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
EM david.baud@chuv.ch
OI Baud, David/0000-0001-9914-6496
CR Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Schaub B, 2017, ULTRASOUND OBST GYN, V49, P658, DOI 10.1002/uog.17210
   Vouga M, 2017, PRENATAL DIAG, V37, P206, DOI 10.1002/pd.4964
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
NR 6
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD FEB
PY 2017
VL 37
IS 2
BP 206
EP 206
DI 10.1002/pd.4964
PG 1
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA EL4PX
UT WOS:000394604400015
PM 28205300
OA Bronze
DA 2020-07-08
ER

PT J
AU Carvalho, FHC
AF Costa Carvalho, Francisco Herlanio
TI Response to "Associated ultrasonographic findings in fetuses with
   microcephaly because of suspected Zika virus (ZIKV) infection during
   pregnancy"
SO PRENATAL DIAGNOSIS
LA English
DT Editorial Material
C1 [Costa Carvalho, Francisco Herlanio] Fed Univ Ceara UFC, Dept Maternal & Child Hlth, Sch Med, Fortaleza, Ceara, Brazil.
RP Carvalho, FHC (corresponding author), Fed Univ Ceara UFC, Dept Maternal & Child Hlth, Sch Med, Fortaleza, Ceara, Brazil.
EM herlaniocosta@uol.com.br
CR Carvalho FHC, 2017, PRENATAL DIAG, V37, P207, DOI 10.1002/pd.4985
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
NR 9
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD FEB
PY 2017
VL 37
IS 2
BP 207
EP +
DI 10.1002/pd.4985
PG 2
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA EL4PX
UT WOS:000394604400016
PM 28205302
OA Bronze
DA 2020-07-08
ER

PT J
AU Kelly, TR
   Karesh, WB
   Johnson, CK
   Gilardi, KVK
   Anthony, SJ
   Goldstein, T
   Olson, SH
   Machalaba, C
   Mazet, JAK
AF Kelly, Terra R.
   Karesh, William B.
   Johnson, Christine Kreuder
   Gilardi, Kirsten V. K.
   Anthony, Simon J.
   Goldstein, Tracey
   Olson, Sarah H.
   Machalaba, Catherine
   Mazet, Jonna A. K.
CA PREDICT Consortium
TI One Health proof of concept: Bringing a transdisciplinary approach to
   surveillance for zoonotic viruses at the human-wild animal interface
SO PREVENTIVE VETERINARY MEDICINE
LA English
DT Article; Proceedings Paper
CT 14th Symposium of the
   International-Society-for-Veterinary-Epidemiology-and-Economics (ISVEE)
CY NOV 03-07, 2015
CL Merida, MEXICO
SP Univ Autonoma Yucatan, State Govt Yucatan, Univ Florida, ISVEE 13 Maastricht 2012, US Dept Agr, UC Davis MPVM Program, One Hlth Inst, Int Vet Epidemiol & Econ Fdn, Soc Vet Epidemiol & Prevent Med, Assoc Vet Epidemiol & Prevent Med, Int Soc Vet Epidemiol & Econ
DE Emerging infectious disease; Human-wildlife interface; One Health;
   Surveillance; Wildlife; zoonotic
ID MOUNTAIN GORILLAS; DISEASE; TUBERCULOSIS; TRANSMISSION; CORONAVIRUS;
   PREDICTION; INFECTION; ECOLOGY; TRADE; BATS
AB As the world continues to react and respond inefficiently to emerging infectious diseases, such as Middle Eastern Respiratory Syndrome and the Ebola and Zika viruses, a growing transdisciplinary community has called for a more proactive and holistic approach to prevention and preparedness - One Health. Such an approach presents important opportunities to reduce the impact of disease emergence events and also to mitigate future emergence through improved cross-sectoral coordination. In an attempt to provide proof of concept of the utility of the One Health approach, the US Agency for International Development's PREDICT project consortium designed and implemented a targeted, risk-based surveillance strategy based not on humans as sentinels of disease but on detecting viruses early, at their source, where intervention strategies can be implemented before there is opportunity for spillover and spread in people or food animals. Here, we share One Health approaches used by consortium members to illustrate the potential for successful One Health outcomes that can be achieved through collaborative, transdisciplinary partnerships. PREDICT's collaboration with partners around the world on strengthening local capacity to detect hundreds of viruses in wild animals, coupled with a series of cutting-edge virological and analytical activities, have significantly improved our baseline knowledge on the zoonotic pool of viruses and the risk of exposure to people. Further testament to the success of the project's One Health approach and the work of its team of dedicated One Health professionals are the resulting 90 peer reviewed, scientific publications in under 5 years that improve our understanding of zoonoses and the factors influencing their emergence. The findings are assisting in global health improvements, including surveillance science, diagnostic technologies, understanding of viral evolution, and ecological driver identification. Through its One Health leadership and multi disciplinary partnerships, PREDICT has forged new networks of professionals from the human, animal, and environmental health sectors to promote global health, improving our understanding of viral disease spillover from wildlife and implementing strategies for preventing and controlling emerging disease threats. (C) 2016 The Author(s). Published by Elsevier B.V.
C1 [Kelly, Terra R.; Johnson, Christine Kreuder; Gilardi, Kirsten V. K.; Goldstein, Tracey; Mazet, Jonna A. K.] Univ Calif Davis, Sch Vet Med, One Hlth Inst, 1089 Vet Med Dr, Davis, CA 95616 USA.
   [Kelly, Terra R.; Johnson, Christine Kreuder; Gilardi, Kirsten V. K.; Goldstein, Tracey; Mazet, Jonna A. K.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, 1089 Vet Med Dr, Davis, CA 95616 USA.
   [Karesh, William B.; Anthony, Simon J.; Machalaba, Catherine] EcoHealth Alliance, 460 West 34th St,17th Floor, New York, NY 10001 USA.
   [Anthony, Simon J.] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, 722 West 168th St, New York, NY 10032 USA.
   [Olson, Sarah H.] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA.
RP Mazet, JAK (corresponding author), Univ Calif Davis, Sch Vet Med, One Hlth Inst, 1089 Vet Med Dr, Davis, CA 95616 USA.; Mazet, JAK (corresponding author), Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, 1089 Vet Med Dr, Davis, CA 95616 USA.
EM trkelly@ucdavis.edu; karesh@ecohealthalliance.org;
   ckjohnson@ucdavis.edu; kvgilardi@ucdavis.edu; sja2127@cumc.columbia.edu;
   tgoldstein@ucdavis.edu; solson@wcs.org; Machalaba@ecohealthalliance.org;
   jkmazet@ucdavis.edu
RI Campos, Angelica Cristine Almeida/Z-6089-2019
OI Campos, Angelica Cristine Almeida/0000-0003-0425-7498; Thomas,
   Kate/0000-0001-6314-8326; Karesh, William/0000-0001-6042-2860; Horwood,
   Paul/0000-0001-9622-0742; Olival, Kevin/0000-0003-3211-1875; Rico,
   Oscar/0000-0002-9833-1101; Suzan, Gerardo/0000-0003-2508-6376;
   Abu-Basha, Ehab/0000-0003-2848-9461
FU American people through the United States Agency for International
   Development (USAID)United States Agency for International Development
   (USAID)
FX This work was made possible by the generous support of the American
   people through the United States Agency for International Development
   (USAID). The contents are the responsibility of the PREDICT Consortium
   and do not necessarily reflect the views of USAID or the United States
   Government. Special thanks to the PREDICT partners in and the
   governments of Bangladesh, Bolivia, Brazil, Cambodia, Cameroon, China,
   Gabon, Democratic Republic of Congo, Indonesia, Laos, Malaysia, Mexico,
   Nepal, Peru, Tanzania, Uganda, Republic of Congo, Rwanda, Thailand, and
   Vietnam. The success realized by the PREDICT project, documented herein,
   would not have been possible without the valuable contributions of
   Dennis Carroll, Andrew Clements, Alisa Pereira, and August Pabst.
CR Ahuka-Mundeke S, 2012, AIDS RES HUM RETROV, V28, P628, DOI [10.1089/aid.2011.0211, 10.1089/AID.2011.0211]
   Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0
   Anthony SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9147
   Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Cook R., 2004, ONE WORLD ONE HLTH B
   Evans TS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003813
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gibbs S. E. J., 2013, ONE HLTH HUMAN ANIMA
   Gilardi KVK, 2014, EMERG INFECT DIS, V20, P1883, DOI 10.3201/eid2011.140075
   Goldstein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062259
   Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924
   Heymann DL, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.OH-0011-2012
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Karesh WB, 2005, EMERG INFECT DIS, V11, P1000
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Karesh WB, 2009, MT SINAI J MED, V76, P429, DOI 10.1002/msj.20139
   Levinson J, 2013, EMERG INFECT DIS, V19, P743, DOI 10.3201/eid1905.121042
   Loh EH, 2015, VECTOR-BORNE ZOONOT, V15, P432, DOI 10.1089/vbz.2013.1563
   Mazet JAK, 2014, REV SCI TECH OIE, V33, P443, DOI 10.20506/rst.33.2.2295
   Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172
   Mikota SK, 2011, TUBERCULOSIS, V91, P208, DOI 10.1016/j.tube.2011.02.007
   Montali RJ, 2001, REV SCI TECH OIE, V20, P291, DOI 10.20506/rst.20.1.1268
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006
   Olson SH, 2015, EMERG INFECT DIS, V21, P1285, DOI 10.3201/eid2108.141156
   Olson SH, 2013, EMERG INFECT DIS, V19, P2031, DOI 10.3201/eid1912.130649
   Olson Sarah H, 2012, Emerg Health Threats J, V5, DOI 10.3402/ehtj.v5i0.9134
   Olson SH, 2012, J WILDLIFE DIS, V48, P888, DOI 10.7589/2011-11-341
   Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883
   Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522
   Reed PE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003143
   Rejmanek D, 2015, J VIROL, V89, P10993, DOI 10.1128/JVI.01573-15
   Rubin C, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.OH-0016-2012
   Schwind JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110236
   Schwind JS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-684
   Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10
   Smith KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051219
   Spelman LH, 2013, J ZOO WILDLIFE MED, V44, P1027, DOI 10.1638/2013-0014R.1
   Switzer W. M., 2012, NOVEL SIMIAN FOAMY V, P1
   Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789
   World Bank, 2012, PEOPL PATH OUR PLAN
NR 42
TC 24
Z9 24
U1 4
U2 48
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5877
EI 1873-1716
J9 PREV VET MED
JI Prev. Vet. Med.
PD FEB 1
PY 2017
VL 137
SI SI
BP 112
EP 118
DI 10.1016/j.prevetmed.2016.11.023
PN B
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA EK8SC
UT WOS:000394193500002
PM 28034593
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Manrique-Hernandez, EF
   Fernandez-Nino, JA
   Idrovo, AJ
AF Manrique-Hernandez, E. F.
   Fernandez-Nino, J. A.
   Idrovo, A. J.
TI Global performance of epidemiologic surveillance of Zika virus: rapid
   assessment of an ongoing epidemic
SO PUBLIC HEALTH
LA English
DT Article
C1 [Manrique-Hernandez, E. F.; Fernandez-Nino, J. A.; Idrovo, A. J.] Univ Ind Santander, Sch Med, Dept Publ Hlth, Bucaramanga, Colombia.
RP Idrovo, AJ (corresponding author), Univ Ind Santander, Sch Med, Dept Publ Hlth, Bucaramanga, Colombia.
EM idrovoaj@yahoo.com.mx
OI Idrovo, Alvaro J/0000-0001-9579-1463; Fernandez-Nino, Julian
   Alfredo/0000-0002-8948-8481
FU Public Health Department, School of Medicine, Universidad Industrial de
   Santander.
FX These analyses were supported by the Public Health Department, School of
   Medicine, Universidad Industrial de Santander.
CR Benford F., 1938, P AM PHILOS SOC, V81, P551, DOI DOI 10.2307/984802
   German R R, 2001, MMWR Recomm Rep, V50, P1
   Gomez-Camponovo M, 2016, BIOMEDICA IN PRESS
   Hill TP, 1998, AM SCI, V86, P358, DOI 10.1511/1998.4.358
   Idrovo AJ, 2011, EPIDEMIOL INFECT, V139, P1827, DOI 10.1017/S095026881100015X
   KUIPER NH, 1962, P KON NED AK WET A, V63, P38
   Pacheco O, 2016, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
NR 10
TC 4
Z9 4
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD FEB
PY 2017
VL 143
BP 14
EP 16
DI 10.1016/j.puhe.2016.10.023
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EM5MB
UT WOS:000395354500004
PM 28159022
DA 2020-07-08
ER

PT J
AU Dutra, HL
   Caragata, EP
   Moreira, LA
AF Carneiro Dutra, Heverton Leandro
   Caragata, Eric Pearce
   Moreira, Luciano Andrade
TI The re-emerging arboviral threat: Hidden enemies The emergence of
   obscure arboviral diseases, and the potential use of Wolbachia in their
   control
SO BIOESSAYS
LA English
DT Review
DE chikungunya; dengue; Mayaro; O'Nyong-Nyong; Oropouche; Wolbachia; Zika
ID MAYARO VIRUS-INFECTION; CULICOIDES BITING MIDGES; AEDES-AEGYPTI
   MOSQUITOS; ONYONG-NYONG FEVER; ZIKA VIRUS; CHIKUNGUNYA VIRUS;
   YELLOW-FEVER; OROPOUCHE VIRUS; JAPANESE ENCEPHALITIS; VERTICAL
   TRANSMISSION
AB Mayaro, Oropouche, andO'Nyong-Nyong sharemany traits with more prominent arboviruses, like dengue and yellow fever, chikungunya, and Zika. These include severe clinical symptoms, multiple animal hosts, and widespread vector species living in close proximity to human habitats, all of which constitute significant risk factors for more frequent outbreaks in the future, greatly increasing the potential of these hidden enemies to follow Zika and become the next wave of global arboviral threats. Critically, the current dearth of knowledge on these arboviruses might impede the success of future control efforts, including the potential application of Wolbachia pipientis. This bacterium inherently possesses broad anti-pathogen properties and a means of genetic drive that allows it to eliminate or replace target vector populations. We conclude that control of obscure arboviruses with Wolbachia might be possible, but successful implementation will be critically dependent on the ability to transinfect key vector species.
C1 [Carneiro Dutra, Heverton Leandro; Caragata, Eric Pearce; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vectores Endossimbiontes & Interacao Pa, Belo Horizonte, MG, Brazil.
RP Moreira, LA (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vectores Endossimbiontes & Interacao Pa, Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
RI Dutra, Heverton Leandro Carneiro/V-7517-2019
OI Dutra, Heverton Leandro Carneiro/0000-0002-0917-4512
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   BLACKBURN NK, 1995, RES VIROLOGY, V146, P69, DOI 10.1016/0923-2516(96)80591-7
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Burke DS, 1998, ARBOVIRUSES EPIDEMIO, P63
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carpenter S, 2013, ANTIVIR RES, V100, P102, DOI 10.1016/j.antiviral.2013.07.020
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI [10.1089/vbz.2006.0648, 10.1089/vbz.2007.7272]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauquet C.M., 2005, VIRUS TAXONOMY
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Friedrich-Janicke B, 2014, EMERG INFECT DIS, V20, P1255, DOI 10.3201/eid2007.140043
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Hoch A.L., 1987, Bulletin of the Pan American Health Organization, V21, P55
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Howe GM, 1979, MED HIST, V23, P242
   Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Mackenzie JS, 2007, PERSP MED V, V16, P201, DOI 10.1016/S0168-7069(06)16010-3
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MARSHALL TFD, 1982, ANN TROP MED PARASIT, V76, P153
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307
   MEZENCIO JMS, 1989, ARCH VIROL, V104, P299, DOI 10.1007/BF01315551
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nunes M.R.T., 2007, CADERNOS SAUDE COLET, V15, P303
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Patino-Barbosa AM, 2016, J INFECT PUBLIC HEAL, V9, P532, DOI 10.1016/j.jiph.2015.10.001
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pinheiro FM, 1962, REV SERV ESP SAUDE P, V12, P15
   Posey DL, 2005, AM J TROP MED HYG, V73, P32, DOI 10.4269/ajtmh.2005.73.1.0730032
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rios-Gonzalez CM, 2017, J INFECT PUBLIC HEAL, V10, P137, DOI 10.1016/j.jiph.2016.05.006
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Shepard DS, 2016, LANCET INFECT DIS, V3099, P1
   SHORE H., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P361, DOI 10.1016/0035-9203(61)90106-7
   Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89
   Smietanka K, 2016, EMERG INFECT DIS, V22, P1201, DOI 10.3201/eid2207.151708
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   TAKASHIMA I, 1989, J MED ENTOMOL, V26, P454, DOI 10.1093/jmedent/26.5.454
   Tappe D, 2014, EMERG INFECT DIS, V20, P1766, DOI 10.3201/eid2010.140823
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148
   Weaver SC, 2005, ARCH VIROL, P33
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
   WILLIAMS M. C, 1961, TRANS ROY SOC TROP MED AND HYG, V55, P135, DOI 10.1016/0035-9203(61)90017-7
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 128
TC 10
Z9 11
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD FEB
PY 2017
VL 39
IS 2
AR 1600175
DI 10.1002/bies.201600175
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA EP2IK
UT WOS:000397206400010
PM 28026036
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Brazil and Colombia to Scale Up Bacterial Fight Against Zika and Dengue
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD FEB 1
PY 2017
VL 64
IS 3
BP ii
EP ii
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3RQ
UT WOS:000397299800004
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Congenital Zika virus infection: The tropical Asian perspective
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2017, SEIZURE-EUR J EPILEP, V45, P1, DOI 10.1016/j.seizure.2016.11.004
NR 3
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1388-2457
EI 1872-8952
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD FEB
PY 2017
VL 128
IS 2
BP 289
EP 289
DI 10.1016/j.clinph.2016.12.009
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EP2KC
UT WOS:000397210900001
PM 28042993
DA 2020-07-08
ER

PT J
AU Doughty, CT
   Yawetz, S
   Lyons, J
AF Doughty, Christopher T.
   Yawetz, Sigal
   Lyons, Jennifer
TI Emerging Causes of Arbovirus Encephalitis in North America: Powassan,
   Chikungunya, and Zika Viruses
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Arboviruses; Encephalitis; Zika virus; Chikungunya virus; Powassan virus
ID DEER TICK VIRUS; MALE SEXUAL TRANSMISSION; NEW-ENGLAND DEER; NEW-YORK;
   UNITED-STATES; AEDES-AEGYPTI; RISK-FACTORS; PUERTO-RICO; CASE SERIES;
   INFECTION
AB Arboviruses are arthropod-borne viruses transmitted by the bite of mosquitoes, ticks, or other arthropods. Arboviruses are a common and an increasing cause of human illness in North America. Powassan virus, Chikungunya virus, and Zika virus are arboviruses that have all recently emerged as increasing causes of neurologic illness. Powassan virus almost exclusively causes encephalitis, but cases are rare, sporadic, and restricted to portions of North America and Russia. Chikungunya virus has spread widely across the world, causing millions of infections. Encephalitis is a rare manifestation of illness but is more common and severe in neonates and older adults. Zika virus has recently spread through much of the Americas and has been associated mostly with microcephaly and other congenital neurologic complications. Encephalitis occurring in infected adults has also been recently reported. This review will discuss the neuropathogenesis of these viruses, their transmission and geographic distribution, the spectrum of their neurologic manifestations, and the appropriate method of diagnosis.
C1 [Doughty, Christopher T.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.
   [Doughty, Christopher T.; Lyons, Jennifer] Brigham & Womens Hosp, Dept Neurol, Div Neurol Infect & Inflammatory Dis, 45 Francis St, Boston, MA 02115 USA.
   [Doughty, Christopher T.; Yawetz, Sigal; Lyons, Jennifer] Harvard Med Sch, Boston, MA USA.
   [Yawetz, Sigal] Brigham & Womens Hosp, Dept Internal Med, Div Infect Dis, Boston, MA 02115 USA.
RP Lyons, J (corresponding author), Brigham & Womens Hosp, Dept Neurol, Div Neurol Infect & Inflammatory Dis, 45 Francis St, Boston, MA 02115 USA.; Lyons, J (corresponding author), Harvard Med Sch, Boston, MA USA.
EM jlyons5@partners.org
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Aliota MT, 2014, VECTOR-BORNE ZOONOT, V14, P245, DOI 10.1089/vbz.2013.1475
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606
   Bank AM, 2016, J NEUROVIROL, V22, P125, DOI 10.1007/s13365-015-0372-9
   Beasley DWC, 2001, VIRUS RES, V79, P81, DOI 10.1016/S0168-1702(01)00330-6
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, ARBONET MAP VIEW
   CDC, ZIK VIR CAS COUNTS U
   CDC, POW VIR DIS CAS DEAT
   CDC, CHIK VIR US
   CDC, 2015, ARB DIS NEUR NONN 20
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P761
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chernokhaeva LL, 2016, VACCINE, V34, P2354, DOI 10.1016/j.vaccine.2016.03.041
   Chiam CW, 2015, J GEN VIROL, V96, P3243, DOI 10.1099/jgv.0.000263
   Choi EEJ, 2012, CLIN NEUROL NEUROSUR, V114, P172, DOI 10.1016/j.clineuro.2011.10.001
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268
   Ebel GD, 2000, AM J TROP MED HYG, V63, P36, DOI 10.4269/ajtmh.2000.63.36
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   El Khoury MY, 2013, EMERG INFECT DIS, V19, P1926, DOI 10.3201/eid1912.130903
   El Khoury MY, 2013, CLIN INFECT DIS, V56, pE40, DOI 10.1093/cid/cis938
   Feldstein LR, 2016, AM J TROP MED HYG
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freour T, 2016, EUROSURVEILLANCE S23, V21
   Frolova M P, 1985, Neurosci Behav Physiol, V15, P62, DOI 10.1007/BF01186452
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gauri L A, 2012, J Assoc Physicians India, V60, P68
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gholam BIA, 1999, CAN MED ASSOC J, V161, P1419
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hermance ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155889
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   Hughes BW, 2016, EBIOMEDICINE, DOI [10.1016/j.ebiom.2016.06.026, DOI 10.1016/J.EBIOM.2016.06.026.]
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2001, AM J TROP MED HYG, V65, P671, DOI 10.4269/ajtmh.2001.65.671
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Leonova GN, 2009, ARCH VIROL, V154, P811, DOI 10.1007/s00705-009-0376-y
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   MANDL CW, 1993, VIROLOGY, V194, P173, DOI 10.1006/viro.1993.1247
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McLEAN D M, 1959, Can Med Assoc J, V80, P708
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997
   Nofchissey RA, 2013, AM J TROP MED HYG, V88, P1159, DOI 10.4269/ajtmh.12-0586
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oehler E, 2015, EUROSURVEILLANCE S48, V20
   PAHO, 2016, NUMB REP CAS CHIK FE
   Perti T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004630
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raval Mihir, 2012, BMC Res Notes, V5, P594, DOI 10.1186/1756-0500-5-594
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Rodrigues Faria N., 2016, PLOS CURR
   Roze B, 2016, EUROSURVEILLANCE, V21, P1
   Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5
   Santos RI, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080220
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   SMITH R, 1974, AM J DIS CHILD, V127, P691, DOI 10.1001/archpedi.1974.02110240077010
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Sung S, 2013, EMERG INFECT DIS, V19, P1504, DOI 10.3201/eid1909.121846
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tavakoli NP, 2009, NEW ENGL J MED, V360, P2099, DOI 10.1056/NEJMoa0806326
   Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   THOMAS LA, 1960, P SOC EXP BIOL MED, V104, P355, DOI 10.3181/00379727-104-25836
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004625
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Weaver SC, 2012, ANTIVIR RES, V94, P242, DOI 10.1016/j.antiviral.2012.04.002
   Weger-Lucarelli J, 2016, J VIROL, V90, P2418, DOI 10.1128/JVI.02792-15
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 120
TC 12
Z9 13
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1528-4042
EI 1534-6293
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD FEB
PY 2017
VL 17
IS 2
AR 12
DI 10.1007/s11910-017-0724-3
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EO9TS
UT WOS:000397031600008
PM 28229397
DA 2020-07-08
ER

PT J
AU Moos, WH
   Pinkert, CA
   Irwin, MH
   Faller, DV
   Kodukula, K
   Glavas, IP
   Steliou, K
AF Moos, Walter H.
   Pinkert, Carl A.
   Irwin, Michael H.
   Faller, Douglas V.
   Kodukula, Krishna
   Glavas, Ioannis P.
   Steliou, Kosta
TI Epigenetic Treatment of Persistent Viral Infections
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Review
DE carnitinoid; CRISPR/Cas9; druggable target; gene editing; herpesvirus;
   infection; innate immune system; microbiome; mitochondria;
   neurodegenerative disease; neuropsychiatric disease; pathogenic species;
   pathophysiology; synthetic biology; therapeutic intervention; virome
ID HERPES-SIMPLEX-VIRUS; HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; GUT
   MICROBIOME; ZIKA VIRUS; PARKINSONS-DISEASE; ARGININE BUTYRATE; ADAPTER
   PROTEIN; GENE-EXPRESSION; RECENT PROGRESS
AB Approximately 2,500 years ago, Hippocrates used the word herpes as a medical term to describe lesions that appeared to creep or crawl on the skin, advocating heat as a possible treatment. During the last 50 years, pharmaceutical research has made great strides, and therapeutic options have expanded to include small molecule antiviral agents, protease inhibitors, preventive vaccines for a handful of the papillomaviruses, and even cures for hepatitis C virus infections. However, effective treatments for persistent and recurrent viral infections, particularly the highly prevalent herpesviruses, continue to represent a significant unmet medical need, affecting the majority of the world's population. Exploring the population diversity of the human microbiome and the effects its compositional variances have on the immune system, health, and disease are the subjects of intense investigational research and study. Among the collection of viruses, bacteria, fungi, and single-cell eukaryotes that comprise the human microbiome, the virome has been grossly understudied relative to the influence it exerts on human pathophysiology, much as mitochondria have until recently failed to receive the attention they deserve, given their critical biomedical importance. Fortunately, cellular epigenetic machinery offers a wealth of druggable targets for therapeutic intervention in numerous disease indications, including those outlined above. With advances in synthetic biology, engineering our body's commensal microorganisms to seek out and destroy pathogenic species is clearly on the horizon. This is especially the case given recent breakthroughs in genetic manipulation with tools such as the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated) gene-editing platforms. Tying these concepts together with our previous work on the microbiome and neurodegenerative and neuropsychiatric diseases, we suggest that, because mammalian cells respond to a viral infection by triggering a cascade of antiviral innate immune responses governed substantially by the cell's mitochondria, small molecule carnitinoids represent a new class of therapeutics with potential widespread utility against many infectious insults. (C) 2016 Wiley Periodicals, Inc.
C1 [Moos, Walter H.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, UCSF Box 2280,600 16th St, San Francisco, CA 94143 USA.
   [Pinkert, Carl A.] Univ Alabama, Coll Arts & Sci, Dept Biol Sci, Tuscaloosa, AL USA.
   [Irwin, Michael H.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL USA.
   [Faller, Douglas V.] Boston Univ, Sch Med, Dept Med, Boston, MA USA.
   [Faller, Douglas V.] Boston Univ, Canc Res Ctr, Sch Med, Boston, MA USA.
   [Kodukula, Krishna] Bridgewater Coll, Bridgewater, MA USA.
   [Glavas, Ioannis P.] New York Univ, Sch Med, Dept Ophthalmol, New York, NY USA.
   [Steliou, Kosta] PhenoMatriX Inc, 9 Hawthorne Pl Suite 4R, Boston, MA 02114 USA.
RP Moos, WH (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, UCSF Box 2280,600 16th St, San Francisco, CA 94143 USA.; Steliou, K (corresponding author), PhenoMatriX Inc, 9 Hawthorne Pl Suite 4R, Boston, MA 02114 USA.
EM walter.moos@ucsf.edu; steliou@bu.edu
OI Pinkert, Carl/0000-0001-7460-3881; Moos, Walter/0000-0001-7244-811X
FU Foundation for a Cure for Mitochondrial Disease (MitoCure)
FX Preparation of this manuscript was supported by The Foundation for a
   Cure for Mitochondrial Disease (MitoCure). We thank Drs. David N. Harpp
   and Robert J. Zamboni (McGill University) and Dr. Whitney R. Powers
   (Boston University) for their helpful discussions and insight.
CR Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Ahuja M, 2016, J NEUROSCI, V36, P6332, DOI 10.1523/JNEUROSCI.0426-16.2016
   Andreini C, 2016, J PROTEOME RES, V15, P1308, DOI 10.1021/acs.jproteome.6b00045
   Annas GJ, 2016, CELL, V165, P507
   Bailon E, 2010, IMMUNOBIOLOGY, V215, P863, DOI 10.1016/j.imbio.2010.01.001
   BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115
   Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338
   Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BESWICK T S, 1962, Med Hist, V6, P214
   Birkmann A, 2016, CURR OPIN VIROL, V18, P9, DOI 10.1016/j.coviro.2016.01.013
   Boeke JD, 2016, SCIENCE, V353, P126, DOI 10.1126/science.aaf6850
   Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227
   Bourgeois S, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0255-y
   Braff D, ADV DRUG DE IN PRESS
   Breslow R, 2016, CHEM ENG NEWS, V94, P28
   Broecker F, 2016, ANN NY ACAD SCI, V1372, P29, DOI 10.1111/nyas.13100
   Caggiu E, 2016, J NEUROIMMUNOL, V291, P110, DOI 10.1016/j.jneuroim.2016.01.007
   Canani RB, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-4
   Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12.1519, 10.3748/wjg.v17.i12. 1519]
   Cao ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22002
   Cherry C, 2016, TRENDS MOL MED, V22, P391, DOI 10.1016/j.molmed.2016.03.009
   Chubukov V, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.9
   Claesen J, 2015, ACS SYNTH BIOL, V4, P358, DOI 10.1021/sb500258b
   Clement C, 2011, INVEST OPHTH VIS SCI, V52, P1770, DOI 10.1167/iovs.09-5019
   Conrad RJ, 2016, ACS CHEM BIOL, V11, P669, DOI 10.1021/acschembio.5b00999
   Das B, 2015, VIROLOGY, V474, P65, DOI 10.1016/j.virol.2014.10.033
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Dreyfus DH, 2013, J ALLERGY CLIN IMMUN, V132, P1278, DOI 10.1016/j.jaci.2013.02.039
   DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793, DOI 10.1128/MMBR.40.4.793-802.1976
   Dunn DA, 2014, TRANSGENIC ANIMAL TE, P239
   El-Araby AM, 2016, ARCH PHARM, V349, P73, DOI 10.1002/ardp.201500375
   Ellis SE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.87
   EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   Farrell P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.38, 10.1038/nmicrobiol.2016.38]
   Fliervoet LAL, ADV DRUG DE IN PRESS
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Ghosh SK, 2012, ADV VIROL, V2012, DOI 10.1155/2012/509296
   Ghosh SK, 2012, BLOOD, V119, P1008, DOI 10.1182/blood-2011-06-362434
   Gilbert KM, 2006, LIFE SCI, V78, P2159, DOI 10.1016/j.lfs.2005.09.047
   Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982
   Giudice A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6021934
   Gjyshi O, 2015, J VIROL, V89, P7874, DOI 10.1128/JVI.00895-15
   Godke RA, 2014, TRANSGENIC ANIMAL TE, P581
   Golkar Z., 2016, J MOL BIOMARK DIAG, V7, P10, DOI [10.4172/2155-9929.1000280, DOI 10.4172/2155-9929.1000280]
   Gorres KL, 2016, MBIO, V7, DOI 10.1128/mBio.00113-16
   Goswami R, 2016, WORLD J IMMUNOL, V6, P39, DOI DOI 10.5411/WJI.V6.I1.39
   Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149
   Greely HT, 2016, END SEX FUTURE HUMAN, P400
   Gross A, 2016, BBA-BIOENERGETICS, V1857, P1243, DOI 10.1016/j.bbabio.2016.01.017
   Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002
   Handley SA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0287-y
   Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853
   Hippocrates, 400 BCE APHORISMS
   Holmes D, 2014, NAT MED, V20, P571, DOI 10.1038/nm0614-571
   Hughes SH, 2016, CELL HOST MICROBE, V19, P588, DOI 10.1016/j.chom.2016.04.010
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Hwang KY, 2016, J VIROL, V90, P506, DOI 10.1128/JVI.01903-15
   Irwin MH, 2016, DRUG DEVELOP RES, V77, P109, DOI 10.1002/ddr.21294
   Jha HC, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010018
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076
   Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044
   Katzenell S, 2016, J VIROL, V90, P4706, DOI 10.1128/JVI.02908-15
   Knipe DM, 2015, P NATL ACAD SCI USA, V112, P11993, DOI 10.1073/pnas.1516224112
   Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946
   Koppel N, 2016, CELL CHEM BIOL, V23, P18, DOI 10.1016/j.chembiol.2015.12.008
   Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059
   Ledford H, 2016, NATURE, V531, P156, DOI 10.1038/531156a
   Li SS, 2014, REV MED VIROL, V24, P223, DOI 10.1002/rmv.1783
   Lieberman PM, 2016, CELL HOST MICROBE, V19, P619, DOI 10.1016/j.chom.2016.04.008
   Lieberman PM, 2014, SCIENCE, V343, P1323, DOI 10.1126/science.1252786
   Limongi D, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6547248
   Liu B, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9340
   Liu HM, 2016, EBIOMEDICINE, V9, P195, DOI 10.1016/j.ebiom.2016.06.015
   Liu S, 2016, INT J CANCER, V139, P736, DOI 10.1002/ijc.30074
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851
   Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569
   Manal M, 2016, BIOORG CHEM, V67, P18, DOI 10.1016/j.bioorg.2016.05.005
   Matcovitch-Natan O, SCIENCE IN PRESS, DOI [10.1126/science.aad8670, DOI 10.1126/SCIENCE.AAD8670]
   Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039
   McAllister TE, 2016, J MED CHEM, V59, P1308, DOI 10.1021/acs.jmedchem.5b01758
   McFadden K, 2016, P NATL ACAD SCI USA, V113, pE782, DOI 10.1073/pnas.1517141113
   Mentzer SJ, 1998, BLOOD CELL MOL DIS, V24, P114, DOI 10.1006/bcmd.1998.0178
   Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Miller JK, 2013, PROBIOTICS ANTIMICRO, V5, P69, DOI 10.1007/s12602-013-9133-3
   Mimee M, ADV DRUG DE IN PRESS
   Moos WH, 2016, BIORESEARCH OPEN ACC, V5, P137, DOI 10.1089/biores.2016.0010
   Moos WH, 2016, DRUG DEVELOP RES, V77, P53, DOI 10.1002/ddr.21295
   More SS, 2016, INVEST OPHTH VIS SCI, V57, P3231, DOI 10.1167/iovs.15-17406
   Morris G, 2016, MOL NEUROBIOL, V53, P2550, DOI 10.1007/s12035-015-9262-7
   Nascimento JM, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2014.3
   Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054
   Nicoll MP, 2012, FEMS MICROBIOL REV, V36, P684, DOI 10.1111/j.1574-6976.2011.00320.x
   Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019
   Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006
   Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006
   Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937
   Pande V, 2016, J MED CHEM, V59, P1299, DOI 10.1021/acs.jmedchem.5b01507
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Pearce BD, 2001, MOL PSYCHIATR, V6, P634, DOI 10.1038/sj.mp.4000956
   Perrine SR, 2007, BLOOD, V109, P2571, DOI 10.1182/blood-2006-01-024703
   Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872
   Pierce EN, 2016, CHEM RES TOXICOL, V29, P1151, DOI 10.1021/acs.chemrestox.6b00115
   Pinkert CA, 2014, TRANSGENIC ANIMAL TE, P639
   Prasad K. N., 2015, BALKAN MIL MED REV, V18, P116
   Prasad KN, 2016, J AM COLL NUTR, V35, P175, DOI 10.1080/07315724.2014.1003419
   Rochette L, 2015, CAN J PHYSIOL PHARM, V93, P1021, DOI 10.1139/cjpp-2014-0353
   Roizman B, 2001, Herpes, V8, P23
   Roizman B, 2015, VIROLOGY, V479, P562, DOI 10.1016/j.virol.2015.02.036
   Ruderfer Daniel, 2015, Pediatr Rev, V36, P86, DOI 10.1542/pir.36-2-86
   Saraya Abhinbhen W, 2016, BMC Res Notes, V9, P95, DOI 10.1186/s13104-016-1922-9
   Sarkar S, 2011, ANTICANCER RES, V31, P2723
   Sawaya GF, 2015, ANN INTERN MED, V162, P851, DOI 10.7326/M14-2426
   Schretlen DJ, 2010, SCHIZOPHR RES, V118, P224, DOI 10.1016/j.schres.2010.01.008
   Schuchat A, 2015, NEW ENGL J MED, V372, P775, DOI 10.1056/NEJMe1415742
   Scumpia PO, 2014, NEUROCHEM INT, V64, P55, DOI 10.1016/j.neuint.2013.11.006
   Severance EG, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.18
   Shu MF, 2015, P NATL ACAD SCI USA, V112, pE5420, DOI 10.1073/pnas.1515369112
   Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227
   Smith LM, 2015, PEDIATRICS, V135, pE1131, DOI 10.1542/peds.2014-2961
   Smith-Sonneborn J., 2016, VIROL MYCOL, V5, P150, DOI [10.4172/2161-0517.1000150, DOI 10.4172/2161-0517.1000150]
   Song J, 2016, INT J OPHTHALMOL-CHI, V9, P780, DOI 10.18240/ijo.2016.05.25
   Stamatiou DP, 2016, ONCOL LETT, V11, P1635, DOI 10.3892/ol.2016.4144
   Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223
   Steliou K, 2009, DRUG DEVELOP RES, V70, P499, DOI 10.1002/ddr.20342
   Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011
   Stone D, 2016, HUM GENET, V135, P1071, DOI 10.1007/s00439-016-1686-2
   Su CH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0495-5
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Sullivan CS, 2015, SCIENTIST, V29, P33
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142
   Thomas S, 2016, CELL DEATH BIOL DIS, P187, DOI 10.1007/978-1-4939-3612-0_10
   Vahid F, 2015, GENE, V562, P8, DOI 10.1016/j.gene.2015.02.045
   van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032
   Vladan Bajic, 2012, Med Hypothesis Discov Innov Ophthalmol, V1, P24
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607
   Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035
   Xing F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151173
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Yedery RD, 2015, ANTIBIOTICS-BASEL, V4, P44, DOI 10.3390/antibiotics4010044
   Yin MJ, 1998, NATURE, V396, P77
   Ying ZK, 2011, INFLAMM RES, V60, P219, DOI 10.1007/s00011-010-0256-7
   Yolken R, 2004, HERPES, V11, P83
   Zhang QP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27572
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
   Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016
   Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5
   Zwergel C, 2016, J CLIN EPIGENETICS, V2, P1, DOI [DOI 10.21767/2472-1158.100015, 10.21767/2472-1158.100015]
NR 168
TC 10
Z9 10
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4391
EI 1098-2299
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD FEB
PY 2017
VL 78
IS 1
BP 24
EP 36
DI 10.1002/ddr.21366
PG 13
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EO9FQ
UT WOS:000396995000002
PM 27761936
DA 2020-07-08
ER

PT J
AU Vazquez-Prokopec, GM
   Montgomery, BL
   Horne, P
   Clennon, JA
   Ritchie, SA
AF Vazquez-Prokopec, Gonzalo M.
   Montgomery, Brian L.
   Horne, Peter
   Clennon, Julie A.
   Ritchie, Scott A.
TI Combining contact tracing with targeted indoor residual spraying
   significantly reduces dengue transmission
SO SCIENCE ADVANCES
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; NORTH QUEENSLAND; SURVEILLANCE; EPIDEMIC;
   PATTERNS; HETEROGENEITIES; CULICIDAE; COUNTRIES; EFFICACY; BEHAVIOR
AB The widespread transmission of dengue viruses (DENV), coupled with the alarming increase of birth defects and neurological disorders associated with Zika virus, has put the world in dire need of more efficacious tools for Aedes aegypti-borne disease mitigation. We quantitatively investigated the epidemiological value of location-based contact tracing (identifying potential out-of-home exposure locations by phone interviews) to infer transmission foci where high-quality insecticide applications can be targeted. Space-time statistical modeling of data from a large epidemic affecting Cairns, Australia, in 2008-2009 revealed a complex pattern of transmission driven primarily by human mobility (Cairns accounted for similar to 60% of virus transmission to and from residents of satellite towns, and 57% of all potential exposure locations were nonresidential). Targeted indoor residual spraying with insecticides in potential exposure locations reduced the probability of future DENV transmission by 86 to 96%, compared to unsprayed premises. Our findings provide strong evidence for the effectiveness of combining contact tracing with residual spraying within a developed urban center, and should be directly applicable to areas with similar characteristics (for example, southern USA, Europe, or Caribbean countries) that need to control localized Aedes-borne virus transmission or to protect pregnant women's homes in areas with active Zika transmission. Future theoretical and empirical research should focus on evaluation of the applicability and scalability of this approach to endemic areas with variable population size and force of DENV infection.
C1 [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA.
   [Montgomery, Brian L.; Horne, Peter] Queensland Hlth, Trop Publ Hlth Unit Network, Cairns, Qld 4870, Australia.
   [Montgomery, Brian L.] Metro South Hlth, Metro South Publ Hlth Unit, Brisbane, Qld 4113, Australia.
   [Clennon, Julie A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
   [Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Qld 4878, Australia.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld 4878, Australia.
RP Vazquez-Prokopec, GM (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.; Vazquez-Prokopec, GM (corresponding author), Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA.
EM gmvazqu@emory.edu
RI amsalu, ribka/G-8780-2019
FU Emory Global Health Institute; Marcus Foundation [00052002]; NSFNational
   Science Foundation (NSF) [NSF/DEB/EEID:1640698]; National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [1044698]
FX G.M.V.-P. received support from the Emory Global Health Institute and
   Marcus Foundation (project #00052002) and the NSF (NSF/DEB/EEID:1640698)
   to perform this research. S.A.R. is funded by National Health and
   Medical Research Council Senior Research Fellowship 1044698.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Anders KL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003528
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Castle T, 1999, Rev Panam Salud Publica, V5, P100
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Csardi G., 2014, INT J COMPLEX SYST, DOI [10.3724/SP.J.1087.2009.02191., DOI 10.3724/SP.J.1087.2009.02191]
   Dixon MG, 2015, EMERG INFECT DIS, V21, P2022, DOI 10.3201//eid2111.150684
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554
   Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   GARNETT GP, 1993, SEX TRANSM DIS, V20, P181, DOI 10.1097/00007435-199307000-00001
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   GIGLIOLI G, 1948, AM J TROP MED, V28, P43
   Greiner AL, 2015, INT J INFECT DIS, V41, P53, DOI 10.1016/j.ijid.2015.10.025
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Halloran ME, 2010, DESIGN ANAL VACCINE
   Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P32
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25
   Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nathan M B, 1982, Bull Pan Am Health Organ, V16, P28
   Osse R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-163
   Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37
   PANT C P, 1973, Southeast Asian Journal of Tropical Medicine and Public Health, V4, P231
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Reiter P, 1997, DENGUE DENGUE HEMORR
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Ross JV, 2015, MATH MED BIOL, V32, P331, DOI 10.1093/imammb/dqu014
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Taylor C, 2005, CLIN DIAGN LAB IMMUN, V12, P371, DOI 10.1128/CDLI.12.3.371-374.2005
   Therneau T. M., 2015, COXME MIXED EFFECTS
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053
   Vazquez-Prokopec GM, 2016, TRENDS PARASITOL, V32, P356, DOI 10.1016/j.pt.2016.01.001
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
NR 58
TC 38
Z9 38
U1 1
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD FEB
PY 2017
VL 3
IS 2
AR e1602024
DI 10.1126/sciadv.1602024
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO9WT
UT WOS:000397039500041
PM 28232955
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Roberts, SL
   Elbe, S
AF Roberts, Stephen L.
   Elbe, Stefan
TI Catching the flu: Syndromic surveillance, algorithmic governmentality
   and global health security
SO SECURITY DIALOGUE
LA English
DT Article
DE Algorithms; global health security; governmentality; pandemic; syndromic
   surveillance
ID INFECTIOUS-DISEASE DETECTION; INTERNET
AB How do algorithms shape the imaginary and practice of security? Does their proliferation point to a shift in the political rationality of security? If so, what is the nature and extent of that shift? This article argues that efforts to strengthen global health security are major drivers in the development and proliferation of new algorithmic security technologies. In response to a seeming epidemic of potentially lethal infectious disease outbreaks - including HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), pandemic flu, Middle East Respiratory Syndrome (MERS), Ebola and Zika -governments and international organizations are now using several next-generation syndromic surveillance systems to rapidly detect new outbreaks globally. This article analyses the origins, design and function of three such internet-based surveillance systems: (1) the Program for Monitoring Emerging Diseases, (2) the Global Public Health Intelligence Network and (3) HealthMap. The article shows how each newly introduced system became progressively more reliant upon algorithms to mine an ever-growing volume of indirect data sources for the earliest signs of a possible new outbreak - gradually propelling algorithms into the heart of global outbreak detection. That turn to the algorithm marks a significant shift in the underlying problem, nature and role of knowledge in contemporary security policy.
C1 [Roberts, Stephen L.] Univ Sussex, Ctr Global Hlth Policy, Brighton, E Sussex, England.
   [Elbe, Stefan] Univ Sussex, Int Relat, Brighton, E Sussex, England.
   [Elbe, Stefan] Univ Sussex, Interdisciplinary Ctr Global Hlth Policy, Brighton, E Sussex, England.
RP Roberts, SL (corresponding author), Univ Sussex, Dept Int Relat, Ctr Global Hlth Policy, Arts C, Brighton BN1 9SJ, E Sussex, England.
EM sr311@sussex.ac.uk
OI Elbe, Stefan/0000-0002-5567-5262
FU University of Sussex, UK
FX The research leading to this article has received funding through the
   Chancellor's International Research Scholarship (2013-2016) from the
   University of Sussex, UK.
CR Amoore L, 2009, ANTIPODE, V41, P49, DOI 10.1111/j.1467-8330.2008.00655.x
   Blench M, 2008, 8 AMTA C HAW 21 25 O
   Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a
   Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107
   Collier SJ, 2015, THEOR CULT SOC, V32, P19, DOI 10.1177/0263276413510050
   Cowan P, 2006, J AM VET ASS, V229, P1090
   Daugman J, 2004, IEEE T CIRC SYST VID, V14, P21, DOI 10.1109/TCSVT.2003.818350
   Dutt Ashok K., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P755
   Elbe S, 2006, INT STUD QUART, V50, P119, DOI 10.1111/j.1468-2478.2006.00395.x
   Elbe S, 2008, REV INT POLIT ECON, V15, P116, DOI 10.1080/09692290701751324
   Elbe S, 2014, REV INT STUD, V40, P919, DOI 10.1017/S0260210514000151
   Elbe S, 2014, SECUR DIALOGUE, V45, P440, DOI 10.1177/0967010614530072
   Elbe S, 2010, HEALTH POLICY PLANN, V25, P476, DOI 10.1093/heapol/czq050
   Elbe Stefan, 2009, VIRUS ALERT SECURITY
   Fearnley L, 2008, ENVIRON PLANN A, V40, P1615, DOI 10.1068/a4060
   Fidler DP, 2004, SARS, GOVERNANCE AND THE GLOBALIZATION OF DISEASE, P1, DOI 10.1057/9780230006263
   Foucault M., 2007, SECURITY TERRITORY P
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Gillespie T, 2014, INSIDE TECHNOL, P167
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Henning Kelly J, 2004, MMWR Suppl, V53, P5
   Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7
   Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038
   Introna L., 2004, SURVEILLANCE SOC, V2, P177, DOI [DOI 10.1057/9780230594180, DOI 10.24908/ss.v2i2/3.3373]
   Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114
   Lakoff A, 2008, CULT ANTHROPOL, V23, P399, DOI 10.1111/j.1548-1360.2008.00013.x
   Lakoff A, 2015, ECON SOC, V44, P40, DOI 10.1080/03085147.2014.983833
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Mawudeku A, 2006, GLOBAL PUBLIC HLTH I
   Mayer-Schonberger Viktor, 2013, BIG DATA REVOLUTION
   Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088
   Mykhalovskiy Eric, 2010, GLOBAL PUBLIC HLTH V
   Nelson R, 2008, LANCET INFECT DIS, V8, P596, DOI 10.1016/S1473-3099(08)70219-6
   Pallipparambil G, 2014, INSECTS DIS HIST
   Public Health England, 2014, SYNDR SURV SYST AN
   Rouvroy A., 2011, LAW HUMAN AGENCY AUT, P119
   Rouvroy A, 2013, PRIVACY DUE PROCESS, P143
   Rouvroy A, 2015, PAN ALL WATCH OV ALG
   Samimian-Darash L, 2011, SOCIOL HEALTH ILL, V33, P930, DOI 10.1111/j.1467-9566.2011.01340.x
   WHO, 2005, INT HLTH REG 2005
   Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]
   Woodall J, 1997, SIM Q            JUN
   Zhang YL, 2009, DECIS SUPPORT SYST, V47, P508, DOI 10.1016/j.dss.2009.04.016
NR 44
TC 11
Z9 11
U1 2
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0967-0106
EI 1460-3640
J9 SECUR DIALOGUE
JI Secur. Dialogue
PD FEB
PY 2017
VL 48
IS 1
SI SI
BP 46
EP 62
DI 10.1177/0967010616666443
PG 17
WC International Relations
SC International Relations
GA EP2KS
UT WOS:000397212500004
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Claus, C
   Bergs, S
   Emmrich, NC
   Hubschen, JM
   Mankertz, A
   Liebert, UG
AF Claus, C.
   Bergs, S.
   Emmrich, N. C.
   Hubschen, J. M.
   Mankertz, A.
   Liebert, U. G.
TI A sensitive one-step TaqMan amplification approach for detection of
   rubella virus clade I and II genotypes in clinical samples
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; TIME PCR ASSAYS; RT-PCR; QUANTIFICATION;
   VALIDATION; RNA; MEASLES
AB Although teratogenic rubella virus (RV) causes a vaccine-preventable disease, it is still endemic in several countries worldwide. Thus, there is a constant risk of RV importation into non-endemic areas. RV monitoring, especially during measles and Zika virus outbreaks, requires reliable diagnostic tools. For this study, a TaqMan-based one-step reverse transcription-quantitative PCR (RT-qPCR) assay, with the p90 gene as a novel and so far unexplored target for detection of clade I and II genotypes, was developed and evaluated. Automated nucleic acid extraction was carried out. Performance characteristics of the TaqMan RT-qPCR assay were determined for a RV plasmid standard and RNA extracted from virus-infected cell culture supernatants representing clade I and II genotypes. Diagnostic specificity and sensitivity were validated against other RNA and DNA viruses, relevant for RV diagnostic approaches and for RV-positive clinical samples, respectively. The assay is specific and highly sensitive with a limit of detection as low as five to one copies per reaction or 200 infectious virus particles per ml. The coefficients of variation (CV) were specified as intra- (within one run) and inter- (between different runs) assay variation, and calculated based on the standard deviations for the obtained Ct values of the respective samples. Intra- and inter-assay CV values were low, with a maximum of 3.4% and 2.4%, respectively. The assay was shown to be suitable and specific for the analysis of clinical samples. With p90 as a novel target, the highly sensitive and specific TaqMan assay outlined in this study is suitable for RV diagnosis worldwide.
C1 [Claus, C.; Bergs, S.; Emmrich, N. C.; Liebert, U. G.] Univ Leipzig, Inst Virol, Leipzig, Germany.
   [Hubschen, J. M.] Luxembourg Inst Hlth, Dept Infect & Immun, WHO European Reg Reference Lab Measles & Rubella, Esch Sur Alzette, Luxembourg.
   [Mankertz, A.] Robert Koch Inst, WHO European Reg Reference Lab Measles & Rubella, Berlin, Germany.
RP Claus, C (corresponding author), Univ Leipzig, Inst Virol, Leipzig, Germany.
EM claudia.claus@medizin.uni-leipzig.de
RI Hubschen, Judith/AAF-5113-2020
CR Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099
   Abo H, 2014, J VIROL METHODS, V207, P73, DOI 10.1016/j.jviromet.2014.06.013
   Ammour Y, 2013, J VIROL METHODS, V187, P57, DOI 10.1016/j.jviromet.2012.09.011
   Claus C, 2006, J GEN VIROL, V87, P3029, DOI 10.1099/vir.0.82035-0
   Cloete LJ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-166
   Dabbagh AJ, 2013, MMWR-MORBID MORTAL W, V62, P983
   Dmitriev GV, 2012, MOL GENET MICROBIOL+, V27, P120, DOI 10.3103/S0891416812030032
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fellahi Siham, 2016, BMC Res Notes, V9, P231, DOI 10.1186/s13104-016-2037-z
   Fernandes-Monteiro AG, 2015, HUM VACC IMMUNOTHER, V11, P1865, DOI 10.4161/21645515.2014.990854
   FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0
   Hubschen JM, 2008, J VIROL METHODS, V149, P246, DOI 10.1016/j.jviromet.2008.01.032
   Knepp JH, 2003, J CLIN MICROBIOL, V41, P3532, DOI 10.1128/JCM.41.8.3532-3536.2003
   Kuhar U, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-172
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Linnet K, 2004, CLIN CHEM, V50, P732, DOI 10.1373/clinchem.2003.029983
   Lopez-Vazquez C, 2015, DIS AQUAT ORGAN, V114, P99, DOI 10.3354/dao02840
   Macey JF, 2011, J INFECT DIS, V204, pS585, DOI 10.1093/infdis/jir406
   Okamoto K, 2010, J VIROL METHODS, V168, P267, DOI 10.1016/j.jviromet.2010.05.016
   OKERBLOM C, 1984, J VIROL, V51, P354, DOI 10.1128/JVI.51.2.354-358.1984
   Omar SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024789
   Otsuki N, 2011, VACCINE, V29, P1863, DOI 10.1016/j.vaccine.2011.01.016
   Padhi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110082
   Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342
   Raymaekers M, 2009, J CLIN LAB ANAL, V23, P145, DOI 10.1002/jcla.20307
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tzeng WP, 2003, J VIROL, V77, P9502, DOI 10.1128/JVI.77.17.9502-9510.2003
   WHOb, 2013, WKLY EPIDEMIOL REC, V88, P337
   Yermalovich MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111541
   Zhao LH, 2006, ACTA BIOCH BIOPH SIN, V38, P731, DOI 10.1111/j.1745-7270.2006.00213.x
   Zhao LH, 2015, J VIROL METHODS, V219, P84, DOI 10.1016/j.jviromet.2015.03.023
   Zhu Z, 2014, J MED VIROL, V86, P2114, DOI 10.1002/jmv.23936
NR 32
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2017
VL 162
IS 2
BP 477
EP 486
DI 10.1007/s00705-016-3131-1
PG 10
WC Virology
SC Virology
GA EL0MD
UT WOS:000394315600016
PM 27807657
OA Bronze
DA 2020-07-08
ER

PT J
AU Saulino, D
   Gaston, E
   Younke, B
   Conyers, J
   Covinsky, M
   Tatevian, N
   Bhattacharjee, M
AF Saulino, David
   Gaston, Elizabeth
   Younke, Brianne
   Conyers, Jeffrey
   Covinsky, Micheal
   Tatevian, Nina
   Bhattacharjee, Meenakshi
TI The First Zika-Related Infant Mortality in the United States: An Autopsy
   Case Report
SO LABORATORY INVESTIGATION
LA English
DT Meeting Abstract
CT 106th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology (USCAP)
CY MAR 04-10, 2017
CL San Antonio, TX
SP US & Canadian Acad Pathol
C1 [Saulino, David; Gaston, Elizabeth; Younke, Brianne; Conyers, Jeffrey; Covinsky, Micheal; Tatevian, Nina; Bhattacharjee, Meenakshi] Univ Texas Houston, Houston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD FEB
PY 2017
VL 97
SU 1
MA 27
BP 10A
EP 10A
PG 1
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA EK1YT
UT WOS:000393724400028
DA 2020-07-08
ER

PT J
AU Goo, L
   VanBlargan, LA
   Dowd, KA
   Diamond, MS
   Pierson, TC
AF Goo, Leslie
   VanBlargan, Laura A.
   Dowd, Kimberly A.
   Diamond, Michael S.
   Pierson, Theodore C.
TI A single mutation in the envelope protein modulates flavivirus
   antigenicity, stability, and pathogenesis
SO PLOS PATHOGENS
LA English
DT Article
ID WEST-NILE-VIRUS; ANTIBODY-MEDIATED NEUTRALIZATION; CROSS-REACTIVE
   ANTIBODIES; DENGUE VIRUS; MONOCLONAL-ANTIBODY; STRUCTURAL BASIS;
   ENVIRONMENTAL-TEMPERATURE; COXSACKIEVIRUS B3; VECTOR COMPETENCE; HIGHLY
   POTENT
AB The structural flexibility or 'breathing' of the envelope (E) protein of flaviviruses allows virions to sample an ensemble of conformations at equilibrium. The molecular basis and functional consequences of virus conformational dynamics are poorly understood. Here, we identified a single mutation at residue 198 (T198F) of the West Nile virus (WNV) E protein domain I-II hinge that regulates virus breathing. The T198F mutation resulted in a similar to 70-fold increase in sensitivity to neutralization by a monoclonal antibody targeting a cryptic epitope in the fusion loop. Increased exposure of this otherwise poorly accessible fusion loop epitope was accompanied by reduced virus stability in solution at physiological temperatures. Introduction of a mutation at the analogous residue of dengue virus (DENV), but not Zika virus (ZIKV), E protein also increased accessibility of the cryptic fusion loop epitope and decreased virus stability in solution, suggesting that this residue modulates the structural ensembles sampled by distinct flaviviruses at equilibrium in a context dependent manner. Although the T198F mutation did not substantially impair WNV growth kinetics in vitro, studies in mice revealed attenuation of WNV T198F infection. Overall, our study provides insight into the molecular basis and the in vitro and in vivo consequences of flavivirus breathing.
C1 [Goo, Leslie; Dowd, Kimberly A.; Pierson, Theodore C.] Natl Inst Hlth, Viral Pathogenesis Sect, Bethesda, MD USA.
   [VanBlargan, Laura A.; Diamond, Michael S.] Washington Univ Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Med, St Louis, MO USA.
   [VanBlargan, Laura A.; Diamond, Michael S.] Washington Univ Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Mol Microbiol, St Louis, MO USA.
   [VanBlargan, Laura A.; Diamond, Michael S.] Washington Univ Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Pathol & Immunol, St Louis, MO USA.
RP Pierson, TC (corresponding author), Natl Inst Hlth, Viral Pathogenesis Sect, Bethesda, MD USA.
EM piersontc@mail.nih.gov
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU Burroughs Wellcome FundBurroughs Wellcome Fund; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 A1073755]; National Institute of
   Allergy and Infectious Diseases Division of Intramural ResearchUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID)
FX This work was supported by grants from the Burroughs Wellcome Fund (MSD)
   and the National Institutes of Health (R01 A1073755) (MSD), and by the
   National Institute of Allergy and Infectious Diseases Division of
   Intramural Research (TCP). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G, 2016, NATURE
   Baronti C, 2014, GENOME ANNOUNC, V2
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brien J.D., 2013, CURR PROTOC MICROBIO, V31, p15D 3 1
   Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Carson SD, 2014, J VIROL, V88, P11568, DOI 10.1128/JVI.01790-14
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0
   CORNEL AJ, 1993, J MED ENTOMOL, V30, P449, DOI 10.1093/jmedent/30.2.449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221
   Dowd KA DC, 2016, CELL REPORTS IN PRES, V16
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144
   HEINZ BA, 1989, J VIROL, V63, P2476, DOI 10.1128/JVI.63.6.2476-2485.1989
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074
   Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1
   Leaman DP, 2015, J VIROL, V89, P6725, DOI 10.1128/JVI.03738-14
   Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774
   Lin TY, 2012, J VIROL, V86, P3501, DOI 10.1128/JVI.06435-11
   Lindsey NP, 2014, MMWR-MORBID MORTAL W, V63, P521
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Markoff L, 2000, VACCINE, V18, P26, DOI 10.1016/S0264-410X(00)00038-4
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Organtini LJ, 2014, J VIROL, V88, P5755, DOI 10.1128/JVI.00299-14
   Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808
   PEVEAR DC, 1989, J VIROL, V63, P2002, DOI 10.1128/JVI.63.5.2002-2007.1989
   PHELPS DK, 1995, J MOL BIOL, V254, P544, DOI 10.1006/jmbi.1995.0637
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08
   Reisdorph N, 2003, VIROLOGY, V314, P34, DOI 10.1016/S0042-6822(03)00452-5
   Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223
   SCOTT DW, 1970, CLIN EXP IMMUNOL, V6, P313
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Tsang SK, 2000, J MOL BIOL, V296, P335, DOI 10.1006/jmbi.1999.3483
   VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761
   Velumani S, 2016, HUM VACC IMMUNOTHER, V12, P1265, DOI 10.1080/21645515.2015.1126012
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Wahala WMPB, 2012, J VIROL, V86, P4019, DOI 10.1128/JVI.06871-11
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wilder-Smith A, 2016, EXPERT REV VACCINES, V15, P437, DOI 10.1586/14760584.2016.1143366
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Yun SI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004290
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 126
TC 28
Z9 29
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2017
VL 13
IS 2
AR e1006178
DI 10.1371/journal.ppat.1006178
PG 32
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EN1BH
UT WOS:000395744700015
PM 28207910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lysaght, T
   Lederman, Z
   Tambyah, PA
AF Lysaght, Tamra
   Lederman, Zohar
   Tambyah, Paul Anantharajah
TI COMMENT ON: ZIKA IN SINGAPORE: INSIGHTS FROM ONE HEALTH AND SOCIAL
   MEDICINE REPLY
SO SINGAPORE MEDICAL JOURNAL
LA English
DT Letter
C1 [Lysaght, Tamra; Lederman, Zohar] Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
RP Lysaght, T (corresponding author), Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore.
EM tlysaght@nus.edu.sg
CR American Veterinary Medical Association, ON HLTH NEW PROF IMP
   Lange JH, 2017, SINGAP MED J, V58, DOI 10.11622/smedj.2017010
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   Parham PE, 2015, PHILOS T R SOC LON B, V370
   Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671
NR 5
TC 0
Z9 0
U1 0
U2 2
PU SINGAPORE MEDICAL ASSOC
PI SINGAPORE
PA LEVEL 2 ALUMNI MEDICAL CENTRE, 2 COLLEGE RD, SINGAPORE 169850, SINGAPORE
SN 0037-5675
J9 SINGAP MED J
JI Singap. Med. J.
PD FEB
PY 2017
VL 58
IS 2
BP 114
EP 114
DI 10.11622/smedj.2017011
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EO1RR
UT WOS:000396476100012
PM 28210743
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lange, JH
   Cegolon, L
AF Lange, John H.
   Cegolon, Luca
TI COMMENT ON: ZIKA IN SINGAPORE: INSIGHTS FROM ONE HEALTH AND SOCIAL
   MEDICINE
SO SINGAPORE MEDICAL JOURNAL
LA English
DT Letter
C1 [Lange, John H.] Envirosafe Training & Consultants, Pittsburgh, PA USA.
   [Cegolon, Luca] Univ Padua, Dept Med, Padua, Italy.
RP Lange, JH (corresponding author), Envirosafe Training & Consultants, Pittsburgh, PA USA.
EM jhlange1@hotmail.com
OI Cegolon, Luca/0000-0002-6285-7355
CR Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   Kuranel, 2010, OSONG PUBLIC HLTH RE, V1, P4
   Lange JH, 2002, INDOOR BUILT ENVIRON, V11, P119
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   McIver L, 2016, ENVIRON HEALTH PERSP, V124, P1707, DOI 10.1289/ehp.1509756
NR 5
TC 1
Z9 1
U1 0
U2 4
PU SINGAPORE MEDICAL ASSOC
PI SINGAPORE
PA LEVEL 2 ALUMNI MEDICAL CENTRE, 2 COLLEGE RD, SINGAPORE 169850, SINGAPORE
SN 0037-5675
J9 SINGAP MED J
JI Singap. Med. J.
PD FEB
PY 2017
VL 58
IS 2
AR UNSP 113
DI 10.11622/smedj.2017010
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EO1RR
UT WOS:000396476100011
PM 28210744
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Panning, M
AF Panning, Marcus
TI Zika Virus Serology: More Diagnostic Targets, more Reliable Answers?
SO EBIOMEDICINE
LA English
DT Editorial Material
ID CROSS-REACTIVITY; INFECTION
C1 [Panning, Marcus] Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany.
RP Panning, M (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany.
EM marcus.panning@uniklinik-freiburg.de
RI Panning, Marcus/I-7889-2016
CR Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Huzly D, 2016, EURO SURVEILL, V21
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Steinhagen K, 2016, EURO SURVEILL, V21
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong S. J., 2017, EBIOMEDICINE
NR 9
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD FEB
PY 2017
VL 16
BP 12
EP 13
DI 10.1016/j.ebiom.2017.01.045
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EM4DB
UT WOS:000395262400006
PM 28174133
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wong, SJ
   Furuya, A
   Zou, J
   Xie, XP
   Dupuis, AP
   Kramer, LD
   Shi, PY
AF Wong, Susan J.
   Furuya, Andrea
   Zou, Jing
   Xie, Xuping
   Dupuis, Alan P., II
   Kramer, Laura D.
   Shi, Pei-Yong
TI A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; Diagnosis; Serologic assay; Multiplex microsphere
   immunoassay
ID INFECTION; DENGUE; NS1
AB Rapid and accurate diagnosis of infectious agents is essential for patient care, disease control, and countermeasure development. The present serologic diagnosis of Zika virus (ZIKV) infection relies mainly on IgM-capture ELISA which is confounded with the flaw of cross-reactivity among different flaviviruses. In this communication, we report a multiplex microsphere immunoassay (MIA) that captures the diagnostic power of viral envelope protein (that elicits robust, yet cross-reactive antibodies to other flaviviruses) and the differential power of viral nonstructural proteins NS1 and NS5 (that induce more virus-type specific antibodies). Using 153 patient specimens with known ZIKV and/or dengue virus (DENV; a closely related flavivirus) infections, we showed that (i) ZIKV envelope-based MIA is equivalent or more sensitive than IgM-capture ELISA in diagnosing ZIKV infection, (ii) antibody responses to NS1 and NS5 proteins are more ZIKV-specific than antibody response to envelope protein, (iii) inclusion of NS1 and NS5 in the MIA improves the diagnostic accuracy when compared with the MIA that uses envelope protein alone. The multiplex MIA achieves a rapid diagnosis (turnaround timeb 4 h) and requires small specimen volume (10 mu l) in a single reaction. This serologic assay could be developed for use in clinical diagnosis of ZIKV infection and for monitoring immune responses in vaccine trials. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Wong, Susan J.; Furuya, Andrea; Dupuis, Alan P., II; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.
   [Zou, Jing; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
RP Wong, SJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM susan.wong@health.ny.gov; peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019
FU University of Texas Medical Branch (UTMB); UTMB Innovation and
   Commercialization award; University of Texas STARs Award; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01AI087856]; Pan American Health Organization
   [SCON2016-01353]; UTMB CTSAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR-001439]
FX P.Y.S. was supported by University of Texas Medical Branch (UTMB)
   startup award, UTMB Innovation and Commercialization award, University
   of Texas STARs Award, NIH grant R01AI087856, Pan American Health
   Organization grant SCON2016-01353, and UTMB CTSA UL1TR-001439.
CR Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Garcia G, 1997, AM J TROP MED HYG, V56, P466, DOI 10.4269/ajtmh.1997.56.466
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LINDENBACH B, 2013, FIELDS VIROLOGY, V1, P712
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shu PY, 2002, J CLIN MICROBIOL, V40, P1840, DOI 10.1128/JCM.40.5.1840-1844.2002
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
NR 15
TC 44
Z9 47
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD FEB
PY 2017
VL 16
BP 136
EP 140
DI 10.1016/j.ebiom.2017.01.008
PG 5
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EM4DB
UT WOS:000395262400026
PM 28094237
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
AF Rodriguez-Morales, Alfonso J.
TI Neuroimaging findings of Zika virus infection: beyond the brain CT scans
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Letter
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Poretti A, 2016, AM J NEURORADIOL, V37, P1764, DOI 10.3174/ajnr.A4924
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
NR 4
TC 2
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD FEB
PY 2017
VL 35
IS 2
BP 86
EP 86
DI 10.1007/s11604-016-0603-x
PG 1
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EK9VB
UT WOS:000394270900006
PM 27896560
OA Bronze
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
AF Mehrjardi, Mohammad Zare
TI Neuroimaging findings of Zika virus infection Emphasis of the emerging
   global threat
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Letter
C1 [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
EM zare@sbmu.ac.ir
RI Mehrjardi, Mohammad Zare/G-8980-2017
OI Mehrjardi, Mohammad Zare/0000-0001-5793-5323
CR Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Rodriguez-Morales AJ, 2017, JPN J RADIOL, V35, P86, DOI 10.1007/s11604-016-0603-x
NR 3
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD FEB
PY 2017
VL 35
IS 2
BP 87
EP 88
DI 10.1007/s11604-016-0605-8
PG 2
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EK9VB
UT WOS:000394270900007
PM 28074378
DA 2020-07-08
ER

PT J
AU St George, K
   Sohl, IS
   Dufort, EM
   Dean, AB
   White, JL
   Limberger, R
   Sommer, JN
   Ostrowski, S
   Wong, SJ
   Backenson, PB
   Kuhles, D
   Blog, D
   Taylor, J
   Hutton, B
   Zucker, HA
AF St George, Kirsten
   Sohl, Inderbir S.
   Dufort, Elizabeth M.
   Dean, Amy B.
   White, Jennifer L.
   Limberger, Ronald
   Sommer, Jamie N.
   Ostrowski, Stephanie
   Wong, Susan J.
   Backenson, P. Bryon
   Kuhles, Daniel
   Blog, Debra
   Taylor, Jill
   Hutton, Brad
   Zucker, Howard A.
TI Zika Virus Testing Considerations: Lessons Learned from the First 80
   Real-Time Reverse Transcription-PCR-Positive Cases Diagnosed in New York
   State
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE diagnostics; emerging pathogens; molecular methods; specimen selection;
   viral diagnosis
ID PREGNANT-WOMEN; UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDELINES;
   SPECIMENS; EXPOSURE; AMERICA; RNA
AB The performance and interpretation of laboratory tests for Zika virus (ZKV) continue to be evaluated. Serology is cross-reactive, laborious, and frequently difficult to interpret, and serum was initially solely recommended for molecular diagnosis. ZKV testing was initiated in January 2016 in New York State for symptomatic patients, pregnant women, their infants, and patients with Guillain-Barre syndrome who had traveled to areas with ZKV transmission. Subsequently, eligibility was expanded to pregnant women with sexual partners with similar travel histories. Serum and urine collected within 4 weeks of symptom onset or within 6 weeks of travel were tested with real-time reverse transcription-PCR (RT-PCR) assays targeting the ZKV envelope and NS2B genes. In this review of lessons learned from the first 80 positive cases in NYS, ZKV RNA was detected in urine only in 50 patients, in serum only in 19 patients, and in both samples concurrently in 11 patients, with average viral loads in urine a log higher than those in serum. Among 93 positive samples from the 80 patients, 41 were positive on both gene assays, 52 were positive on the envelope only, and none were positive on the NS2B only. Of the 80 infected patients, test results for 74 (93%) would have defined their infection status as not detected or equivocal if the requirement for positive results from two assay targets (two-target-positive requirement) in the initial federal guidance to public health laboratories was enforced, if urine was not tested, or if the extended eligibility time for molecular testing was not implemented. These changes facilitated more extensive molecular diagnosis of ZKV, reducing reliance on time-consuming and potentially inconclusive serology.
C1 [St George, Kirsten; Dean, Amy B.; Limberger, Ronald; Wong, Susan J.; Taylor, Jill] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.
   [Sohl, Inderbir S.; Dufort, Elizabeth M.; White, Jennifer L.; Sommer, Jamie N.; Ostrowski, Stephanie; Backenson, P. Bryon; Kuhles, Daniel; Blog, Debra] New York State Dept Hlth, Div Epidemiol, Albany, NY 12237 USA.
   [Hutton, Brad] New York State Dept Hlth, Off Publ Hlth, Albany, NY USA.
   [Zucker, Howard A.] New York State Dept Hlth, Off Commissioner, Albany, NY USA.
RP St George, K (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.
EM Kirsten.St.George@health.ny.gov
FU ThermoFisher; Akonni Biosystems; Royalty Paying Collaborative Agreement;
   Zeptometrix; Centers for Disease Control and Prevention (CDC)
   cooperative agreementUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
   [1U38OT000143-03]; CDC cooperative agreementUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50CK000423]
FX Kirsten St. George receives research funding support from ThermoFisher
   and Akonni Biosystems and has a Royalty Paying Collaborative Agreement
   with Zeptometrix. This report was supported in part by an appointment
   (ISS) to the Applied Epidemiology Fellowship Program administered by the
   Council of State and Territorial Epidemiologists, funded by Centers for
   Disease Control and Prevention (CDC) cooperative agreement number
   1U38OT000143-03. The work was also supported in part by CDC cooperative
   agreement number U50CK000423 (awarded to Debra Blog).
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Tavakoli NP, 2007, J CLIN MICROBIOL, V45, P3972, DOI 10.1128/JCM.01692-07
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 28
TC 20
Z9 20
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD FEB
PY 2017
VL 55
IS 2
BP 535
EP 544
DI 10.1128/JCM.01232-16
PG 10
WC Microbiology
SC Microbiology
GA EK0LF
UT WOS:000393617300024
PM 27927917
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Weisblum, Y
   Oiknine-Djian, E
   Vorontsov, OM
   Haimov-Kochman, R
   Zakay-Rones, Z
   Meir, K
   Shveiky, D
   Elgavish, S
   Nevo, Y
   Roseman, M
   Bronstein, M
   Stockheim, D
   From, I
   Eisenberg, I
   Lewkowicz, AA
   Yagel, S
   Panet, A
   Wolf, DG
AF Weisblum, Yiska
   Oiknine-Djian, Esther
   Vorontsov, Olesya M.
   Haimov-Kochman, Ronit
   Zakay-Rones, Zichria
   Meir, Karen
   Shveiky, David
   Elgavish, Sharona
   Nevo, Yuval
   Roseman, Moshe
   Bronstein, Michal
   Stockheim, David
   From, Ido
   Eisenberg, Iris
   Lewkowicz, Aya A.
   Yagel, Simcha
   Panet, Amos
   Wolf, Dana G.
TI Zika Virus Infects Early- and Midgestation Human Maternal Decidual
   Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal
   Interface
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE congenital HCMV; congenital Zika virus; decidua; decidual innate immune
   response; intrauterine transmission; organ culture; placenta
ID HUMAN CYTOMEGALOVIRUS; TRANSMISSION; CELLS; PREGNANCY; BRAZIL;
   RESTRICTION; GROWTH; BRAIN; MODEL
AB Zika virus (ZIKV) has emerged as a cause of congenital brain anomalies and a range of placenta-related abnormalities, highlighting the need to unveil the modes of maternal-fetal transmission. The most likely route of vertical ZIKV transmission is via the placenta. The earliest events of ZIKV transmission in the maternal decidua, representing the maternal uterine aspect of the chimeric placenta, have remained unexplored. Here, we show that ZIKV replicates in first-trimester human maternal-decidual tissues grown ex vivo as three-dimensional (3D) organ cultures. An efficient viral spread in the decidual tissues was demonstrated by the rapid upsurge and continued increase of tissue-associated ZIKV load and titers of infectious cell-free virus progeny, released from the infected tissues. Notably, maternal decidual tissues obtained at midgestation remained similarly susceptible to ZIKV, whereas fetus-derived chorionic villi demonstrated reduced ZIKV replication with increasing gestational age. A genome-wide transcriptome analysis revealed that ZIKV substantially upregulated the decidual tissue innate immune responses. Further comparison of the innate tissue response patterns following parallel infections with ZIKV and human cytomegalovirus (HCMV) revealed that unlike HCMV, ZIKV did not induce immune cell activation or trafficking responses in the maternal-fetal interface but rather upregulated placental apoptosis and cell death molecular functions. The data identify the maternal uterine aspect of the human placenta as a likely site of ZIKV transmission to the fetus and further reveal distinct patterns of innate tissue responses to ZIKV. Our unique experimental model and findings could further serve to study the initial stages of congenital ZIKV transmission and pathogenesis and evaluate the effect of new therapeutic interventions.
   IMPORTANCE In view of the rapid spread of the current ZIKV epidemic and the severe manifestations of congenital ZIKV infection, it is crucial to learn the fundamental mechanisms of viral transmission from the mother to the fetus. Our studies of ZIKV infection in the authentic tissues of the human maternal-fetal interface unveil a route of transmission whereby virus originating from the mother could reach the fetal compartment via efficient replication within the maternal decidual aspect of the placenta, coinhabited by maternal and fetal cells. The identified distinct placental tissue innate immune responses and damage pathways could provide a mechanistic basis for some of the placental developmental abnormalities associated with ZIKV infection. The findings in the unique model of the human decidua should pave the way to future studies examining the interaction of ZIKV with decidual immune cells and to evaluation of therapeutic interventions aimed at the earliest stages of transmission.
C1 [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya M.; From, Ido; Wolf, Dana G.] Hadassah Hebrew Univ Med Ctr, Clin Virol Unit, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya M.; Zakay-Rones, Zichria; From, Ido; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Biochem, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya M.; Zakay-Rones, Zichria; From, Ido; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, IMRIC, Chanock Ctr Virol, Jerusalem, Israel.
   [Haimov-Kochman, Ronit; Shveiky, David; Eisenberg, Iris; Lewkowicz, Aya A.; Yagel, Simcha] Hadassah Hebrew Univ Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel.
   [Meir, Karen] Hadassah Hebrew Univ Med Ctr, Dept Pathol, Jerusalem, Israel.
   [Elgavish, Sharona; Nevo, Yuval; Roseman, Moshe] Hebrew Univ Jerusalem, I CORE Computat Ctr, Bioinformat Unit, Jerusalem, Israel.
   [Elgavish, Sharona; Nevo, Yuval; Roseman, Moshe] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel.
   [Bronstein, Michal] Hebrew Univ Jerusalem, Ctr Genom Technol, Alexander Silberman Inst Life Sci, Jerusalem, Israel.
   [Stockheim, David] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel.
RP Wolf, DG (corresponding author), Hadassah Hebrew Univ Med Ctr, Clin Virol Unit, Jerusalem, Israel.
EM dana.wolf@ekmd.huji.ac.il
FU Israel Science FoundationIsrael Science Foundation; European
   UnionEuropean Union (EU) [316655]; Israeli Ministry of Health
FX This work was supported by the Israel Science Foundation, the European
   Union Seventh Framework Programme 562 FP7/2012-2016 (grant agreement
   number 316655), and the Israeli Ministry of Health.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Bouteiller P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00404
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Red-Horse Kristy, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007720
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Weisblum Y, 2015, VIROLOGY, V485, P289, DOI 10.1016/j.virol.2015.06.023
   Weisblum Y, 2014, SEMIN IMMUNOPATHOL, V36, P615, DOI 10.1007/s00281-014-0449-1
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
NR 50
TC 7
Z9 7
U1 0
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2017
VL 91
IS 4
AR UNSP e01905
DI 10.1128/JVI.01905-16
PG 13
WC Virology
SC Virology
GA EK4FU
UT WOS:000393883300017
PM 27974560
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Boylan, BT
   Moreira, FR
   Carlson, TW
   Bernard, KA
AF Boylan, Brendan T.
   Moreira, Fernando R.
   Carlson, Tim W.
   Bernard, Kristen A.
TI Mosquito cell-derived West Nile virus replicon particles mimic arbovirus
   inoculum and have reduced spread in mice
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ENCEPHALITIS-VIRUS; DC-SIGN; STRUCTURAL PROTEINS; DENDRITIC CELLS; I
   INTERFERON; INFECTION; ATTACHMENT; PROTECTION; INDUCTION; TROPISM
AB Half of the human population is at risk of infection by an arthropod-borne virus. Many of these arboviruses, such as West Nile, dengue, and Zika viruses, infect humans by way of a bite from an infected mosquito. This infectious inoculum is insect cell-derived giving the virus particles distinct qualities not present in secondary infectious virus particles produced by infected vertebrate host cells. The insect cell-derived particles differ in the glycosylation of virus structural proteins and the lipid content of the envelope, as well as their induction of cytokines. Thus, in order to accurately mimic the inoculum delivered by arthropods, arboviruses should be derived from arthropod cells. Previous studies have packaged replicon genome in mammalian cells to produce replicon particles, which undergo only one round of infection, but no studies exist packaging replicon particles in mosquito cells. Here we optimized the packaging of West Nile virus replicon genome in mosquito cells and produced replicon particles at high concentration, allowing us to mimic mosquito cell-derived viral inoculum. These particles were mature with similar genome equivalents-to-infectious units as full-length West Nile virus. We then compared the mosquito cell-derived particles to mammalian cell-derived particles in mice. Both replicon particles infected skin at the inoculation site and the draining lymph node by 3 hours post-inoculation. The mammalian cell-derived replicon particles spread from the site of inoculation to the spleen and contralateral lymph nodes significantly more than the particles derived from mosquito cells. This in vivo difference in spread of West Nile replicons in the inoculum demonstrates the importance of using arthropod cell-derived particles to model early events in arboviral infection and highlights the value of these novel arthropod cell-derived replicon particles for studying the earliest virushost interactions for arboviruses.
C1 [Boylan, Brendan T.; Moreira, Fernando R.; Carlson, Tim W.; Bernard, Kristen A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Bernard, KA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM kristen.bernard@wisc.edu
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01-AI099231-01, T32AI007414];
   Office of The Director of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [T35OD011078]
FX This work was supported by National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health under Award Number
   R01-AI099231-01 (KAB) and training grants supported by National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health under Award Number T32AI007414 (FRM) and Office of The
   Director of the National Institutes of Health under Award Number
   T35OD011078 (TWC). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609
   Anraku I, 2002, J VIROL, V76, P3791, DOI 10.1128/JVI.76.8.3791-3799.2002
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Bourne N, 2007, J VIROL, V81, P9100, DOI 10.1128/JVI.00316-07
   BRANDT WE, 1970, J VIROL, V6, P500, DOI 10.1128/JVI.6.4.500-506.1970
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   CDC, W NIL VIR STAT MAPS
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   DAVIS NL, 1995, VIROLOGY, V212, P102, DOI 10.1006/viro.1995.1458
   de Wispelaere M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004081
   Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Harvey TJ, 2003, J VIROL, V77, P7796, DOI 10.1128/JVI.77.14.7796-7803.2003
   He LL, 2010, J VIROL, V84, P5270, DOI 10.1128/JVI.00044-10
   Hernandez R, 2003, J VIROL, V77, P12710, DOI 10.1128/JVI.77.23.12710-12719.2003
   Hoff MJBvd, 1992, NUCL ACIDS RES, V20
   HSIEH P, 1984, J BIOL CHEM, V259, P2375
   Hussmann KL, 2014, J GEN VIROL, V95, P1991, DOI 10.1099/vir.0.065474-0
   Ishikawa T, 2006, MICROBIOL IMMUNOL, V50, P211, DOI 10.1111/j.1348-0421.2006.tb03788.x
   Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998
   Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003
   Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Lim PY, 2010, VIROLOGY, V400, P93, DOI 10.1016/j.virol.2010.01.029
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Pyankov OV, 2015, J INFECT DIS, V212, pS368, DOI 10.1093/infdis/jiv019
   Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004
   Shabman RS, 2007, J VIROL, V81, P237, DOI 10.1128/JVI.01590-06
   Shi PY, 2001, J CLIN MICROBIOL, V39, P1264, DOI 10.1128/JCM.39.4.1264-1271.2001
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07
   SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Taylor TJ, 2016, VIROLOGY, V496, P186, DOI 10.1016/j.virol.2016.06.006
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   Winkelmann ER, 2014, VIROLOGY, V450, P278, DOI 10.1016/j.virol.2013.12.021
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
NR 52
TC 2
Z9 2
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005394
DI 10.1371/journal.pntd.0005394
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EO0RW
UT WOS:000396406600025
PM 28187142
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Muzari, MO
   Devine, G
   Davis, J
   Crunkhorn, B
   van den Hurk, A
   Whelan, P
   Russell, R
   Walker, J
   Horne, P
   Ehlers, G
   Ritchie, S
AF Muzari, Mutizwa Odwell
   Devine, Gregor
   Davis, Joseph
   Crunkhorn, Bruce
   van den Hurk, Andrew
   Whelan, Peter
   Russell, Richard
   Walker, James
   Horne, Peter
   Ehlers, Gerhard
   Ritchie, Scott
TI Holding back the tiger: Successful control program protects Australia
   from Aedes albopictus expansion
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DIPTERA-CULICIDAE; STEGOMYIA ALBOPICTUS; SOURCE REDUCTION; MOSQUITO;
   DENGUE; AEGYPTI; VECTOR; SPREAD; INFESTATION; DISCOVERY
AB Background
   The Asian tiger mosquito, Aedes albopictus, is an important vector of dengue, chikungunya and Zika viruses and is a highly invasive and aggressive biter. Established populations of this species were first recognised in Australia in 2005 when they were discovered on islands in the Torres Strait, between mainland Australia and Papua New Guinea. A control program was implemented with the original goal of eliminating Ae. albopictus from the Torres Strait. We describe the evolution of management strategies that provide a template for Ae. albopictus control that can be adopted elsewhere.
   Methodology / Principal findings
   The control strategy implemented between 2005 and 2008 targeted larval habitats using source reduction, insect-growth regulator and pyrethroid insecticide to control larvae and adults in the containers. However, the infrequency of insecticide reapplication, the continual accumulation and replacement of containers, and imminent re-introduction of mosquitoes through people's movement from elsewhere compromised the program. Consequently, in 2009 the objective of the program changed from elimination to quarantine, with the goal of preventing Ae albopictus from infesting Thursday and Horn islands, which are the transport hubs connecting the Torres Strait to mainland Australia. However, larval control strategies did not prevent the species establishing on these islands in 2010. Thereafter, an additional strategy adopted by the quarantine program in early 2011 was harborage spraying, whereby the vegetated, well shaded resting sites of adult Ae. albopictus were treated with a residual pyrethroid insecticide. Inclusion of this additional measure led to a 97% decline in Ae. albopictus numbers within two years. In addition, the frequency of container treatment was increased to five weeks between treatments, compared to an average of 8 weeks that occurred in the earlier iterations of the program. By 2015 and 2016, Ae. albopictus populations on the two islands were undetectable in 70-90% of surveys conducted. Importantly, a comprehensive surveillance network in selected strategic areas has not identified established populations of this species on the Australian mainland.
   Conclusions / Significance The program has successfully reduced Ae. albopictus populations on Thursday Island and Horn Island to levels where it is undetectable in up to 90% of surveys, and has largely removed the risk of mainland establishment via that route. The vector management strategies adopted in the later years of the program have been demonstrably successful and provide a practical management framework for dengue, chikungunya or Zika virus outbreaks vectored by Ae. albopictus. As of June 2016, Ae. albopictus had not established on the Australian mainland and this program has likely contributed significantly to this outcome.
C1 [Muzari, Mutizwa Odwell; Davis, Joseph; Crunkhorn, Bruce; Ehlers, Gerhard] Cairns & Hinterland Hosp & Hlth Serv, Trop Publ Hlth Serv Cairns, Med Entomol, Cairns, Qld, Australia.
   [Devine, Gregor] Royal Brisbane Hosp, Mosquito Control Lab, QIMR Berghofer Med Res Inst, Herston, Qld, Australia.
   [van den Hurk, Andrew] Queensland Govt, Publ Hlth Virol Forens & Sci Serv, Dept Hlth, Archerfield, Qld, Australia.
   [Whelan, Peter] Biting Insect Tech Extens Serv, Nightcliff, NT, Australia.
   [Russell, Richard] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   [Walker, James] Dept Agr & Water Resources, Northern Australia Quarantine Strategy, Cairns, Qld, Australia.
   [Horne, Peter] Cairns & Hinterland Hosp & Hlth Serv, Trop Publ Hlth Serv Cairns, Hlth Surveillance, Cairns, Qld, Australia.
   [Ritchie, Scott] James Cook Univ, Australian Inst Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia.
RP Muzari, MO (corresponding author), Cairns & Hinterland Hosp & Hlth Serv, Trop Publ Hlth Serv Cairns, Med Entomol, Cairns, Qld, Australia.
EM Odwell.Muzari@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019; Devine, Gregor J/H-1141-2014
OI van den Hurk, Andrew/0000-0001-6262-831X; Devine, Gregor
   J/0000-0001-6312-0390
FU Australian Government Department of HealthAustralian
   GovernmentDepartment of Health & Ageing; Queensland Health
FX The program was funded by the Australian Government Department of Health
   through their National Partnership Agreement with Queensland Health. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ALARCON-ELBAL P.M., 2013, MEMORIAS I O CRUZ, V109, P782
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   COOPER RD, 1994, J AUST ENTOMOL SOC, V33, P115
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   Farajollahi A, 2012, J AM MOSQUITO CONTR, V28, P237, DOI 10.2987/12-6229R.1
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hanna JN, 1998, MED J AUSTRALIA, V168, P221, DOI 10.5694/j.1326-5377.1998.tb140134.x
   Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866
   Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105
   Horwood P, 2013, W PAC SURVEILL RESPO, V4, P1
   Hubbard JL, 2005, PEST CONTROL TECHNOL, V44, P56
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   KAY BH, 1990, MED J AUSTRALIA, V153, P31, DOI 10.5694/j.1326-5377.1990.tb125460.x
   Kuno G, 2012, J MED ENTOMOL, V49, P1163, DOI 10.1603/ME12022
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Li CX, 2010, J AM MOSQUITO CONTR, V26, P346, DOI 10.2987/10-6007.1
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Mitchell C. J., 1995, Parassitologia (Rome), V37, P109
   Montgomery B.L, 2009, MOSQUITO BITES ASIA, V4, P4
   MONTGOMERY BL, 2005, ARBOVIRUS RES AUST, V9, P268
   Muzari O, 2016, CHHHS RES QUAL S 4 A
   Muzari OM, 2014, J MED ENTOMOL, V51, P444, DOI 10.1603/ME13141
   Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546
   NGUYEN HT, 2007, NO TERRITORY DIS CON, V14, P39
   Nguyen HT, 2009, J AM MOSQUITO CONTR, V25, P74, DOI 10.2987/08-5752.1
   Nicholson J, 2014, J MED ENTOMOL, V51, P948, DOI 10.1603/ME14079
   Pettit WJ, 2010, J AM MOSQUITO CONTR, V26, P387, DOI 10.2987/09-5962.1
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Ritchie Scott, 2001, Arbovirus Research in Australia, V8, P288
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Rueda LM, 2004, ZOOTAXA, V589, P60
   Russell RC, 2005, COMMUN DIS INTELL, V29, P296
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1
   Trout RT, 2006, PEST CONTROL TECHNOL, V34, P110
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1
   Whelan P, 2001, Commun Dis Intell Q Rep, V25, P283
   Whelan P, 2009, ARBOVIRUS RES AUST, V10, P188
   Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1
NR 52
TC 17
Z9 17
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005286
DI 10.1371/journal.pntd.0005286
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EN1AD
UT WOS:000395741700015
PM 28192520
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Charette, M
   Berrang-Ford, L
   Llanos-Cuentas, EA
   Carcarno, C
   Kulkarni, M
AF Charette, Margot
   Berrang-Ford, Lea
   Llanos-Cuentas, Elmer Alejandro
   Carcarno, Cesar
   Kulkarni, Manisha
TI What caused the 2012 dengue outbreak in Pucallpa, Peru? A
   socio-ecological autopsy
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Dengue; Infectious disease outbreak; Environmental health; Peru
ID EPIDEMIOLOGY; CLIMATE; VIRUS; PREVENTION; DYNAMICS; AMERICA; FEVER;
   URBAN; VARIABILITY; PATTERNS
AB Dengue is highly endemic in Peru, with increases in transmission particularly since vector re-infestation of the country in the 1980s. Pucallpa, the second largest city in the Peruvian Amazon, experienced a large outbreak in 2012 that caused more than 10,000 cases and 13 deaths. To date, there has been limited research on dengue in the Peruvian Amazon outside of Iquitos, and no published review or critical analysis of the 2012 Pucallpa dengue outbreak. This study describes the incidence, surveillance, and control of dengue in Ucayali to understand the factors that contributed to the 2012 Pucallpa outbreak. We employed a socio-ecological autopsy approach to consider distal and proximal contributing factors, drawing on existing literature and interviews with key personnel involved in dengue control, surveillance and treatment in Ucayali. Spatio-temporal analysis showed that relative risk of dengue was higher in the northern districts of Calleria (RR = 2.18), Manantay (RR = 1.49) and Yarinacocha (RR = 1.25) compared to all other districts between 2004 and 2014. The seasonal occurrence of the 2012 outbreak is consistent with typical seasonal patterns for dengue incidence in the region. Our assessment suggests that the outbreak was proximally triggered by the introduction of a new virus serotype (DENV-2 Asian/America) to the region. Increased travel, rapid urbanization, and inadequate water management facilitated the potential for virus spread and transmission, both within Pucallpa and regionally. These triggers occurred within the context of failures in surveillance and control programming, including underfunded and ad hoc vector control. These findings have implications for future prevention and control of dengue in Ucayali as new diseases such as chikungunya and Zika threaten the region. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Charette, Margot; Berrang-Ford, Lea] McGill Univ, Dept Geog, Burnside Hall Bldg,Room 705, Montreal, PQ H3A OB9, Canada.
   [Llanos-Cuentas, Elmer Alejandro; Carcarno, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, 31 Av Honorio Delgado 430, Lima, Peru.
   [Kulkarni, Manisha] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, 600 Peter Morand Cres,301D, Ottawa, ON K1G 5Z3, Canada.
RP Charette, M (corresponding author), McGill Univ, Dept Geog, Burnside Hall Bldg,Room 705, Montreal, PQ H3A OB9, Canada.
EM margotcharette@mail.mcgill.ca
OI Llanos-Cuentas, Alejandro/0000-0002-7567-5534
FU Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du
   Quebec [32183]; Canadian Institutes of Health Research Open Operating
   Grant
FX We would like to express our gratitude to all key informants in Pucallpa
   who have participated in the interviews. In addition, we would like to
   thank the Direccion Regional de Salud (DIRESA) Ucayali and the Servicio
   Nacional de Meteorologia e Hidrologia del Peru (SENAMHI), who provided
   data for the quantitative analysis. We would like to thank our research
   assistant, Rosa Mercedes Silvera, for her indispensable help at every
   stage of the fieldwork, Mya Sherman, for her guidance throughout the
   research project, Oliver Coomes, for his detailed and constructive
   comments, Christian Abizaid for his unique insight on the study area and
   Adrian Fernandez Jauregui for every map in this paper. This work was
   funded by the Fonds de Recherche du Quebec - Sante (#32183), and a
   Canadian Institutes of Health Research Open Operating Grant. This
   research was approved by the McGill University Research Ethics Board in
   Montreal, Canada.
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Ali SH, 2004, SOC SCI MED, V58, P2601, DOI 10.1016/j.socscimed.2003.09.013
   Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x
   Barham B. L., 1999, UNASYLVAFAO3442, P34
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Cruz CD, 2013, INFECT GENET EVOL, V18, P220, DOI 10.1016/j.meegid.2013.04.029
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   DGE, 2012, B EP SEM EP, V03
   DGE, 2015, CAS DENG DEP PER
   Diaz C, 2009, CAD SAUDE PUBLICA, V25, pS59, DOI 10.1590/S0102-311X2009001300006
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303
   Espinoza JC, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024008
   Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Goy Jennifer, 2005, EcoHealth, V2, P47, DOI 10.1007/s10393-004-0069-7
   Guagliardo S. A., 2015, RIVER BOATS CONTRIBU
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hayes CG, 1996, AM J TROP MED HYG, V55, P459, DOI 10.4269/ajtmh.1996.55.459
   Hecht S. B., 2014, THE SOCIAL LIVES OF
   Horstick O., 2015, REVIEWING DENGUE STI, V9
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   INEI, 2009, COMP EST DEP UC 2008
   INEI, 2009, PER EST PROYECC POBL, P400
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Koopman JS, 1996, AM J PUBLIC HEALTH, V86, P630, DOI 10.2105/AJPH.86.5.630
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Lopez-Gatell H, 2015, NEGLECT TROP DIS, P203, DOI 10.1007/978-3-7091-1422-3_11
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mamani Enrique, 2011, Rev. perú. med. exp. salud publica, V28, P72
   Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420
   Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9
   McLaren L, 2005, J EPIDEMIOL COMMUN H, V59, P6, DOI 10.1136/jech.2003.018044
   McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887
   MINSA, 2011, GUIA TECN GUIA PRACT, P44
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Mostorino E Rosa, 2002, Rev. perú. med. exp. salud publica, V19, P171
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Padoch C, 2008, ECOL SOC, V13
   Phillips I, 1992, Bull Pan Am Health Organ, V26, P201
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32
   San Martin JL, 2006, DELIVERY ISSUES RELA
   Santos-Granero F., 2000, TAMED FRONTIERS SOC
   Schneider J., 2012, TIME LINE DENGUE AM
   SECHREST L, 1995, EVAL PROGRAM PLANN, V18, P77, DOI 10.1016/0149-7189(94)00051-X
   Sherman M, 2015, NAT HAZARDS, V77, P2049, DOI 10.1007/s11069-015-1690-1
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668
   Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P10, DOI 10.1179/2046904712Z.00000000047
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   WHO, 2013, RESP BROT DENG CIUD, P64
   Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600
   World Health Organization, 2012, GLOB STRAT DENG PREV, P43
NR 68
TC 2
Z9 2
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD FEB
PY 2017
VL 174
BP 122
EP 132
DI 10.1016/j.socscimed.2016.12.010
PG 11
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA EK4XM
UT WOS:000393931200016
PM 28024241
OA Green Published
DA 2020-07-08
ER

PT J
AU van de Beek, D
   Brouwer, MC
AF van de Beek, Diederik
   Brouwer, Matthijs C.
TI 2016, the year of Zika virus
SO NATURE REVIEWS NEUROLOGY
LA English
DT Editorial Material
ID BACTERIAL-MENINGITIS
AB In 2016, the literature on neurological infections was, understandably, dominated by Zika virus. However, we should not overlook important publications on the treatment of cryptococcal and bacterial meningitis.
C1 [van de Beek, Diederik; Brouwer, Matthijs C.] Univ Amsterdam, Acad Med Ctr, Amsterdam Neurosci, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.
RP van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Neurosci, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.
EM d.vandebeek@amc.uva.nl
RI van de Beek, Diederik/Y-2713-2019
OI van de Beek, Diederik/0000-0002-4571-044X
CR Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024
   Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rhein J, 2016, LANCET INFECT DIS, V16, P809, DOI 10.1016/S1473-3099(16)00074-8
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007
NR 10
TC 4
Z9 4
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD FEB
PY 2017
VL 13
IS 2
BP 69
EP 70
DI 10.1038/nrneurol.2016.202
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EK2CT
UT WOS:000393735700001
PM 28084324
DA 2020-07-08
ER

PT J
AU Kumar, VS
   Webster, M
AF Kumar, Vikram Sheel
   Webster, Molly
TI Synthetic Biology Takes on Zika
SO CLINICAL CHEMISTRY
LA English
DT Editorial Material
C1 [Kumar, Vikram Sheel] Dimagi Inc, Boston, MA USA.
RP Kumar, VS (corresponding author), 390 Commonwealth Ave,Apt 605, Boston, MA 02215 USA.
EM vkumar@dimagi.com
CR Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Yong E., 2016, ATLANTIC
NR 3
TC 0
Z9 0
U1 0
U2 5
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD FEB
PY 2017
VL 63
IS 2
BP 622
EP 623
DI 10.1373/clinchem.2016.269464
PG 2
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA EJ6WG
UT WOS:000393360000034
PM 28130487
OA Bronze
DA 2020-07-08
ER

PT J
AU Lammert, S
   Walker, AT
   Erskine, S
   Rao, SR
   Esposito, DH
   Ryan, ET
   Robbins, GK
   LaRocque, RC
AF Lammert, Sara
   Walker, Allison Taylor
   Erskine, Stefanie
   Rao, Sowmya R.
   Esposito, Douglas H.
   Ryan, Edward T.
   Robbins, Gregory K.
   LaRocque, Regina C.
TI Characteristics of US Travelers to Zika Virus-Affected Countries in the
   Americas, March 2015 October 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UNITED-STATES; HEALTH-CARE; TRANSMISSION
AB Zika virus has recently been introduced to the Americas and is spreading rapidly. We evaluated the characteristics of US travelers to Zika virus affected countries who were seen at Global TravEpiNet sites during March 2015 October 2016. Nearly three quarters of travelers were men or women of reproductive age.
C1 [Lammert, Sara; Ryan, Edward T.; Robbins, Gregory K.; LaRocque, Regina C.] Massachusetts Gen Hosp, Travelers Advice & Immunizat Ctr, Boston, MA 02114 USA.
   [Walker, Allison Taylor; Erskine, Stefanie; Esposito, Douglas H.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Rao, Sowmya R.] Boston Univ, Med Ctr, Dept Surg, Boston, MA USA.
   [Rao, Sowmya R.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA.
   [Ryan, Edward T.; Robbins, Gregory K.; LaRocque, Regina C.] Harvard Med Sch, Boston, MA USA.
RP LaRocque, RC (corresponding author), Massachusetts Gen Hosp, Gray Jackson 504,55 Fruit St, Boston, MA 02114 USA.
EM rclarocque@mgh.harvard.edu
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U19CI000514, U01CK000175]
FX This work was supported by Centers for Disease Control and Prevention
   Grants U19CI000514 and U01CK000175.
CR Centers for Disease Control and Prevention, 2016, CDC HLTH INF INT TRA
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   International Trade Administration. Office of Travel and Tourism Industries US Department of Commerce, PROF US RES TRAV VIS
   LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460
   LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839
   LaRocque RC, 2010, J TRAVEL MED, V17, P387, DOI 10.1111/j.1708-8305.2010.00457.x
   Millman AJ, 2016, AM J TROP MED HYG, V94, P1336, DOI 10.4269/ajtmh.15-0815
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 14
TC 6
Z9 6
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2017
VL 23
IS 2
BP 324
EP 327
DI 10.3201/eid2302.161292
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EJ3CI
UT WOS:000393088600025
PM 27926355
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Best, SM
AF Best, Sonja M.
TI The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I
   Interferon Signaling
SO JOURNAL OF VIROLOGY
LA English
DT Review
DE JAK-STAT; NS5; antagonism; dengue virus; flavivirus; interferons;
   tick-borne encephalitis virus; West Nile virus; yellow fever virus; Zika
   virus
ID WEST-NILE-VIRUS; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE-RESPONSES;
   TICK-BORNE FLAVIVIRUS; DENGUE VIRUS; ZIKA VIRUS; ANTIVIRAL RESPONSE;
   ALPHA-INTERFERON; RNA-POLYMERASE; RIG-I
AB The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus examined thus far that causes disease in humans, from dengue virus to ZIKV, antagonizes the host type I interferon (IFN-I) response by preventing JAK-STAT signaling, suggesting that suppression of this pathway is an important determinant of infection. The most direct and potent viral inhibitor of this pathway is the nonstructural protein NS5. However, the mechanisms utilized by NS5 from different flaviviruses are often quite different, sometimes despite close evolutionary relationships between viruses. The varied mechanisms of NS5 as an IFN-I antagonist are also surprising given that the evolution of NS5 is restrained by the requirement to maintain function of two enzymatic activities critical for virus replication, the methyltransferase and RNA-dependent RNA polymerase. This review discusses the different strategies used by flavivirus NS5 to evade the antiviral effects of IFN-I and how this information can be used to better model disease and develop antiviral countermeasures.
C1 [Best, Sonja M.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
RP Best, SM (corresponding author), NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
EM sbest@niaid.nih.gov
RI Best, Sonja M/G-7301-2017
OI Best, Sonja M/0000-0003-0206-297X
FU Intramural Research Program of the National Institutes of Health,
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
FX This work was supported by the Intramural Research Program of the
   National Institutes of Health, National Institute of Allergy and
   Infectious Diseases.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Chatterjee S, 2016, J MOL BIOL, V428, P3467, DOI 10.1016/j.jmb.2016.07.017
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07
   Evans JD, 2011, VIRAL IMMUNOL, V24, P253, DOI 10.1089/vim.2010.0126
   Fletcher AJ, 2013, CURR TOP MICROBIOL, V371, P29, DOI 10.1007/978-3-642-37765-5_2
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117
   Cordero JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090704
   Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001
   Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Hirai-Yuki A, 2016, SCIENCE, V353, P1541, DOI 10.1126/science.aaf8325
   Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Khromykh AA, 1999, J VIROL, V73, P9247, DOI 10.1128/JVI.73.11.9247-9255.1999
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kumar A., 2016, EMBO REP
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang JJ, 2009, VACCINE, V27, P2746, DOI 10.1016/j.vaccine.2009.03.007
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lin RJ, 2004, J VIROL, V78, P9285, DOI 10.1128/JVI.78.17.9285-9294.2004
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu BM, 2014, J VIROL, V88, P13821, DOI 10.1128/JVI.02505-14
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003
   Lupi A, 2008, AMINO ACIDS, V35, P739, DOI 10.1007/s00726-008-0055-4
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Maringer K, 2014, CYTOKINE GROWTH F R, V25, P669, DOI 10.1016/j.cytogfr.2014.08.004
   Mashimo T, 2008, CURR TOP MICROBIOL, V321, P85
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Misra A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00176
   Morrison Juliet, 2014, JAKSTAT, V3, pe27715, DOI 10.4161/jkst.27715
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Overby AK, 2011, VIRULENCE, V2, P238, DOI 10.4161/viru.2.3.16162
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200
   Smith AA, 2016, CELL HOST MICROBE, V20, P91, DOI 10.1016/j.chom.2016.06.001
   Smith AA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00116
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865
   Taylor RT, 2011, METHODS, V55, P166, DOI 10.1016/j.ymeth.2011.08.003
   Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004
   Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   Yang TC, 2013, PROTEOMICS, V13, P3442, DOI 10.1002/pmic.201300001
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoshii K, 2014, J VIROL, V88, P5406, DOI 10.1128/JVI.00421-14
   Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 110
TC 52
Z9 53
U1 1
U2 24
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2017
VL 91
IS 3
AR UNSP e01970
DI 10.1128/JVI.01970-16
PG 14
WC Virology
SC Virology
GA EJ4NR
UT WOS:000393194600022
PM 27881649
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Mohammadi, D
AF Mohammadi, Dara
TI The Zika seven
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2017
VL 17
IS 2
BP 149
EP 149
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EJ0NJ
UT WOS:000392906000033
DA 2020-07-08
ER

PT J
AU Osuna, CE
   Lim, SY
   Deleage, C
   Griffin, BD
   Stein, D
   Schroeder, LT
   Omage, R
   Best, K
   Luo, M
   Hraber, PT
   Andersen-Elyard, H
   Ojeda, EFC
   Huang, S
   Vanlandingham, DL
   Higgs, S
   Perelson, AS
   Estes, JD
   Safronetz, D
   Lewis, MG
   Whitney, JB
AF Osuna, Christa E.
   Lim, So-Yon
   Deleage, Claire
   Griffin, Bryan D.
   Stein, Derek
   Schroeder, Lukas T.
   Omage, Robert
   Best, Katharine
   Luo, Ma
   Hraber, Peter T.
   Andersen-Elyard, Hanne
   Ojeda, Erwing Fabian Cardozo
   Huang, Scott
   Vanlandingham, Dana L.
   Higgs, Stephen
   Perelson, Alan S.
   Estes, Jacob D.
   Safronetz, David
   Lewis, Mark G.
   Whitney, James B.
TI Zika viral dynamics and shedding in rhesus and cynomolgus macaques (vol
   22, pg 1448, 2016)
SO NATURE MEDICINE
LA English
DT Correction
RI ; Omange, Were/F-1454-2016
OI Cardozo Ojeda, Erwing/0000-0001-8690-9896; Omange,
   Were/0000-0002-0421-110X
CR Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
NR 1
TC 3
Z9 3
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD FEB
PY 2017
VL 23
IS 2
BP 264
EP 264
DI 10.1038/nm0217-264b
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA EK2AH
UT WOS:000393729000020
PM 28170376
OA Bronze
DA 2020-07-08
ER

PT J
AU Mayer, SV
   Tesh, RB
   Vasilakis, N
AF Mayer, Sandra V.
   Tesh, Robert B.
   Vasilakis, Nikos
TI The emergence of arthropod-borne viral diseases: A global prospective on
   dengue, chikungunya and zika fevers
SO ACTA TROPICA
LA English
DT Review
DE Arboviruses; Dengue; Zika; Chikungunya; Human transmission; Emergence
ID WEST-NILE-VIRUS; CONGO HEMORRHAGIC-FEVER; AEDES-AEGYPTI; JAPANESE
   ENCEPHALITIS; INFECTIOUS-DISEASE; VECTOR COMPETENCE; CHANDIPURA VIRUS;
   ECONOMIC-IMPACT; ROCIO-VIRUS; ANTIGENIC RELATIONSHIPS
AB Arthropod-borne viruses (arboviruses) present a substantial threat to human and animal health worldwide. Arboviruses can cause a variety of clinical presentations that range from mild to life threatening symptoms. Many arboviruses are present in nature through two distinct cycles, the urban and sylvatic cycle that are maintained in complex biological cycles. In this review we briefly discuss the factors driving the emergence of arboviruses, such as the anthropogenic aspects of unrestrained human population growth, economic expansion and globalization. Also the important aspects of viruses and vectors in the occurrence of arboviruses epidemics. The focus of this review will be on dengue, zika and chikungunya viruses, particularly because these viruses are currently causing a negative impact on public health and economic damage around the world. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mayer, Sandra V.; Tesh, Robert B.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Vasilakis, Nikos] UTMB, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA.
   [Tesh, Robert B.; Vasilakis, Nikos] UTMB, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Vasilakis, Nikos] UTMB, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Vasilakis, N (corresponding author), 2-138D Keiller Bldg,301 Univ Blvd, Galveston, TX 77555 USA.
EM nivasila@utmb.edu
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1U01AI115577]
FX This work was supported by grant 1U01AI115577 from the U.S. National
   Institutes of Health. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The authors have no conflicting financial interests.
CR ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P323
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   Aubry M., 2015, ASTMH 64 ANN M PHIL
   Barber LM, 2010, EMERG INFECT DIS, V16, P480, DOI 10.3201/eid1603.090667
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Busch M, 2015, JAAPA-J AM ACAD PHYS, V28, P54, DOI 10.1097/01.JAA.0000470441.99693.e1
   BYLON D, 1780, VERHANDELUNGEN BATAV, P17
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CALISHER CH, 1988, ARBOVIRUSES EPIDEMIO, V1, P19
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005
   CDC, 2010, SAINT LOUIS ENC
   CDC, 2013, OMSK HEM FEV OHF
   CDC, 2015, E EQ ENC
   CDC, 2013, MURR VALL ENC
   CDC, 2014, KYAS FOR DIS KFD
   CDC, 2015, CROSS ENC
   CDC, 2015, W NIL VIR
   CDC, 2016, ZIK VIR
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1202
   Centers for Disease Control and Prevention (CDC), 2016, DENGUE
   CFSPH (Center for Food Security and Public Health), 2015, E W VEN EQ ENC
   Chinikar S, 2008, TRANSBOUND EMERG DIS, V55, P200, DOI 10.1111/j.1865-1682.2008.01028.x
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Christie James, 1881, Glasgow Med J, V16, P161
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2015, SINDB FEV
   ECDC (European Centre for Disease Prevention and Control), 2015, ZIK VIR INF OUTBR BR
   Ehlkes L, 2012, WEST PAC SURVEILL RE, V3, DOI [10.5365/WPSAR.2012.3.1.004, 10.5365/wpsar.2012.3.1.004]
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   European Centre for Disease Prevention and Control, 2014, MON CURR THREATS ECD
   Fischer M., 2015, TICKBORNE ENCEPHALIT
   FONTENILLE D, 1994, AM J TROP MED HYG, V50, P570, DOI 10.4269/ajtmh.1994.50.570
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gershman M.D., 2015, YELLOW FEVER
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Gubler DJ, 1997, TROP MED INT HEALTH, V2, pA1
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ., 2016, ARBOVIRUSES QU UNPUB
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Guler S, 2012, INT J INFECT DIS, V16, pE244, DOI 10.1016/j.ijid.2011.12.001
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607
   Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Han N, 2014, J VIROL, V88, P11469, DOI 10.1128/JVI.02050-14
   Harris MC, 2015, AM J TROP MED HYG, V93, P461, DOI 10.4269/ajtmh.14-0128
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgs S., 2005, NATURAL CYCLES VECTO, P167
   HIRSCH A, 1883, HDB GEOGRAPHICAL HIS, V1, P55
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005
   HOWE GM, 1977, WORLD GEOGRAPHY HUMA
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P709, DOI 10.1089/vbz.2015.1821
   I.L.R. Institute, 2012, 4 ILR I DEP INT DEV
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Jupp PG, 1988, ARBOVIRUSES EPIDEMIO, VII, P137
   Karabatsos N., 1985, INT CATALOGUE ARBOVI
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   King AMQ, 2011, VIRUS TAXONOMY
   Klapsing P, 2005, EMERG INFECT DIS, V11, P613, DOI 10.3201/eid1104.041070
   Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13
   Kurkela S, 2008, EMERG INFECT DIS, V14, P41, DOI 10.3201/eid1401.070510
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Leichtenstern O., 1896, INFLUENZA DENGUE SPE, VIV, P133
   Leisnham PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091655
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LEVINS R, 1993, LANCET, V342, P1292, DOI 10.1016/0140-6736(93)92376-5
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maiti D, 2014, J RES MED DENT SCI, V2, P1, DOI 10.5455/jrmds.2014231
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866
   MCSHERRY JA, 1982, SCOT MED J, V27, P183, DOI 10.1177/003693308202700215
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507
   Menghani S, 2012, ACTA TROP, V124, P1, DOI 10.1016/j.actatropica.2012.06.001
   MITCHELL CJ, 1986, REV SAUDE PUBL, V20, P171, DOI 10.1590/S0034-89101986000300001
   MORSE SS, 1994, ANN NY ACAD SCI, V740, P199, DOI 10.1111/j.1749-6632.1994.tb19870.x
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Murray KA, 2012, ENVIRON INT, V48, P56, DOI 10.1016/j.envint.2012.06.015
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688
   Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024
   Newcomb J, 2011, EC IMPACT SELECTED I
   NEWCOMB J, 2003, BIOL BORDERS SARS NE
   Nguyen T.T., 2013, MOLECULES, V18
   Nobuchi H, 1979, KANPO RINSHO, V26, P422
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   OIE, 2013, BLUETONGUE
   Olive MM, 2012, J WILDLIFE DIS, V48, P241, DOI 10.7589/0090-3558-48.2.241
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, 2015, EP UPD ZIK VIR INF 1
   PAHO/WHO, 2016, ZIK EP UPD
   Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877
   PEPPER P, 1941, ANN MED HIST, V3, P363
   PHAC, 2011, ONYONG NYONG VIR
   PHAC, 2014, ROSS RIV VIR
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   ProMEDmail, 2014, ZIK VIR PAC
   ProMEDmail, 2015, UMD ILLN BRAZ
   Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ruzek D, 2010, LANCET, V376, P2104, DOI 10.1016/S0140-6736(10)61120-8
   Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211
   SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   Shayan S, 2015, LABMEDICINE, V46, P180, DOI 10.1309/LMN1P2FRZ7BKZSCO
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014
   Stanton A.T., 1919, B ENTOMOL RES, V10, P333
   Staples J.E., 2015, CHIKUNGUNYA CDC HLTH
   Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603
   Tantely LM, 2015, AM J TROP MED HYG, V92, P722, DOI 10.4269/ajtmh.14-0421
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   TESH RB, 1983, AM J TROP MED HYG, V32, P621, DOI 10.4269/ajtmh.1983.32.621
   TESH RB, 1988, ANNU REV ENTOMOL, V33, P169, DOI 10.1146/annurev.en.33.010188.001125
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tufan Z.K., 2013, VIROL MYCOL, V2, P109, DOI DOI 10.4172/2161-0517.1000109
   Tuncer P, 2014, ANKARA UNIV VET FAK, V61, P49, DOI 10.1501/Vetfak_0000002604
   van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141
   Vanlandingham DL, 2006, AM J TROP MED HYG, V74, P663, DOI 10.4269/ajtmh.2006.74.663
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Vasilakis N, 2008, AM J TROP MED HYG, V79, P128, DOI 10.4269/ajtmh.2008.79.128
   Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P183
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001
   Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009
   World Economic Forum (WEF), 2015, GLOB RISKS 2015
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Yun SM, 2014, EMERG INFECT DIS, V20, P1358, DOI 10.3201/eid2008.131857
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zohrabian A, 2004, EMERG INFECT DIS, V10, P1736, DOI 10.3201/eid1010.030925
   Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782
NR 184
TC 108
Z9 113
U1 10
U2 94
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2017
VL 166
BP 155
EP 163
DI 10.1016/j.actatropica.2016.11.020
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EI8PN
UT WOS:000392769900021
PM 27876643
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Walther, D
   Scheuch, DE
   Kampen, H
AF Walther, D.
   Scheuch, D. E.
   Kampen, H.
TI The invasive Asian tiger mosquito Aedes albopictus (Diptera: Culicidae)
   in Germany: Local reproduction and overwintering
SO ACTA TROPICA
LA English
DT Article
DE Aedes albopictus; Establishment; Germany; Mueckenatlas; Overwintering;
   Passive surveillance
ID JAPONICUS-JAPONICUS DIPTERA; STEGOMYIA ALBOPICTUS; SKUSE DIPTERA; 1ST
   RECORD; SPREAD; POPULATION
AB Within the framework of a German mosquito monitoring programme, the 'Mueckenatlas' (mosquito atlas) has been established as an instrument of citizen participation in mosquito mapping. In 2015, a strikingly large number of Aedes albopictus, which had not been considered established in Germany, was submitted. Three of six collection sites showed local reproduction, with demonstration of developmental stages over three months at two sites. The third populated site was checked only once in October. Developmental stages of Ae. albopictus were found again at these three sites in spring 2016, including one site in southeastern Germany where reproduction had already been documented in 2014. Although population genetic analyses performed on specimens collected at the latter locality in 2014 and 2015 did not provide proof for hibernation, the finding of developmental stages at this and two other very same sites as in the year before and at very early times in the season strongly suggest accomplished overwintering of Ae. albopictus in Germany.
   Obviously, the second extremely mild winter in Germany in a row and ongoing adaptation of Ae. albopictus to the temperate European climate allow the species to push northwards from endemic regions in the south. Due to the vector competence of Ae. albopictus for numerous pathogens, including dengue, chikungunya and Zika viruses, action should be taken immediately after the detection of local reproduction to eliminate the populations. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Walther, D.] Leibniz Ctr Agr Landscape Res, Eberswalder Str 84, D-15374 Muencheberg, Germany.
   [Scheuch, D. E.; Kampen, H.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, D-17493 Greifswald, Insel Riems, Germany.
RP Walther, D (corresponding author), Leibniz Ctr Agr Landscape Res, Eberswalder Str 84, D-15374 Muencheberg, Germany.
EM doreen.walther@zalf.de; dorothee.scheuch@fli.de; helge.kampen@fli.de
FU German Federal Ministry of Food and Agriculture (BMEL) through the
   Federal Office for Agriculture and Food (BLE) [2819104615, 2819104115]
FX This work was financially supported by the German Federal Ministry of
   Food and Agriculture (BMEL) through the Federal Office for Agriculture
   and Food (BLE), grant numbers 2819104615 and 2819104115. The contents of
   this publication are the sole responsibility of the authors and do not
   necessarily reflect the views of the funders. The funders had no role in
   study design, data collection and analysis, the decision to publish or
   the preparation of the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Cancrini G., 1995, Parassitologia (Rome), V37, P141
   DWD (German Weather Service), 2015, DEUTSCHL
   DWD (German Weather Service), 2016, DEUTSCHL
   ECDC, 2012, GUID SURV INV MOSQ S
   ECDC (European Centre for Disease Prevention and Control), 2015, ZIK VIR INF OUTBR BR
   Egizi A, 2015, BIOL INVASIONS, V17, P123, DOI 10.1007/s10530-014-0710-5
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599
   Hofhuis A, 2009, VECTOR-BORNE ZOONOT, V9, P217, DOI 10.1089/vbz.2008.0071
   ISSG (Invasive Species Specialist Group), 2009, GLOBAL INVASIVE SPEC
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y
   Kampen H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-284
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Schaffner F, 2004, J AM MOSQUITO CONTR, V20, P201
   Schaffner F, 2001, MOSQUITOES EUROPE ID
   Schaffner Francis, 2001, European Mosquito Bulletin, V9, P1
   Scholte E. J., 2012, European Mosquito Bulletin, P1
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Werner D, 2012, EUROSURVEILLANCE, V17, P14
   Werner D, 2016, PARASITOL RES, V115, P1331, DOI 10.1007/s00436-015-4848-6
   Werner D, 2015, PARASITOL RES, V114, P831, DOI 10.1007/s00436-014-4244-7
   Werner D, 2013, PARASITOL RES, V112, P3665, DOI 10.1007/s00436-013-3564-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zielke DE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1447-z
   Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093
NR 40
TC 19
Z9 19
U1 1
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2017
VL 166
BP 186
EP 192
DI 10.1016/j.actatropica.2016.11.024
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EI8PN
UT WOS:000392769900024
PM 27876647
DA 2020-07-08
ER

PT J
AU Schneider, AD
   Malone, RW
   Guo, JT
   Homan, J
   Linchangco, G
   Witter, ZL
   Vinesett, D
   Damodaran, L
   Janies, DA
AF Schneider, Adriano de Bernardi
   Malone, Robert W.
   Guo, Jun-Tao
   Homan, Jane
   Linchangco, Gregorio
   Witter, Zachary L.
   Vinesett, Dylan
   Damodaran, Lambodhar
   Janies, Daniel A.
TI Molecular evolution of Zika virus as it crossed the Pacific to the
   Americas
SO CLADISTICS
LA English
DT Article
ID PHYLOGENETIC ANALYSES; TRANSMISSION; INFECTION; GENOMES; MUSASHI;
   SPECIFICITY; EPIDEMIC; OUTBREAK; MODELS; BRAZIL
AB Zika virus was previously considered to cause only a benign infection in humans. Studies of recent outbreaks of Zika virus in the Pacific, South America, Mexico and the Caribbean have associated the virus with severe neuropathology. Viral evolution may be one factor contributing to an apparent change in Zika disease as it spread from Southeast Asia across the Pacific to the Americas. To address this possibility, we have employed computational tools to compare the phylogeny, geography, immunology and RNA structure of Zika virus isolates from Africa, Asia, the Pacific and the Americas. In doing so, we compare and contrast methods and results for tree search and rooting of Zika virus phylogenies. In some phylogenetic analyses we find support for the hypothesis that there is a deep common ancestor between African and Asian clades (the "Asia/Africa" hypothesis). In other phylogenetic analyses, we find that Asian lineages are descendent from African lineages (the "out of Africa" hypothesis). In addition, we identify and evaluate key mutations in viral envelope protein coding and untranslated terminal RNA regions. We find stepwise mutations that have altered both immunological motif sets and regulatory sequence elements. Both of these sets of changes distinguish viruses found in Africa from those in the emergent Asia-Pacific-Americas lineage. These findings support the working hypothesis that mutations acquired by Zika virus in the Pacific and Americas contribute to changes in pathology. These results can inform experiments required to elucidate the role of viral genetic evolution in changes in neuropathology, including microcephaly and other neurological and skeletomuscular issues in infants, and Guillain-Barre syndrome in adults. (C) The Willi Hennig Society 2016.
C1 [Schneider, Adriano de Bernardi; Guo, Jun-Tao; Linchangco, Gregorio; Witter, Zachary L.; Vinesett, Dylan; Damodaran, Lambodhar; Janies, Daniel A.] Univ North Carolina Charlotte, Dept Bioinformat & Genom, 9201 Univ City Blvd, Charlotte, NC 28223 USA.
   [Malone, Robert W.] Ather Pharmaceut, 2981 Zion Rd, Troy, VA 22974 USA.
   [Malone, Robert W.] Harvard Med Sch, Global Clin Scholars Res Training Program, Boston, MA USA.
   [Homan, Jane] IoGenetics LLC, 3591 Anderson St,Suite 218, Madison, WI 53704 USA.
RP Janies, DA (corresponding author), Univ North Carolina Charlotte, Dept Bioinformat & Genom, 9201 Univ City Blvd, Charlotte, NC 28223 USA.
EM djanies@uncc.edu
RI de Bernardi Schneider, Adriano/E-6252-2017
OI de Bernardi Schneider, Adriano/0000-0001-7487-266X; Malone, Robert
   W./0000-0003-0340-7490; Damodaran, Lambodhar/0000-0001-7180-6173
FU UNC Research Opportunities Initiative grant; NC State University;
   UNC-Chapel Hill; Defense Advanced Research Projects Agency (DARPA)United
   States Department of DefenseDefense Advanced Research Projects Agency
   (DARPA); Space and Naval Warfare Systems Center, Pacific (SSC Pacific)
   [N66001-15-C-4039]
FX Research reported in this publication was supported by a UNC Research
   Opportunities Initiative grant to UNC Charlotte, NC State University,
   and UNC-Chapel Hill. This material is based upon work supported by the
   Defense Advanced Research Projects Agency (DARPA) and Space and Naval
   Warfare Systems Center, Pacific (SSC Pacific) under Contract No.
   N66001-15-C-4039. The sequence data reported in the paper is publicly
   available in NCBIs Genbank. We gratefully acknowledge all the
   researchers and institutions that submitted prepublication data to the
   public domain in this public health emergency (Table S1). We thank
   Matthew James Pettit for help with artwork.
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, ZIK VIR SE AS
   CDC, 2016, ZIK VIR SING
   Colitti M, 2009, J MOL HISTOL, V40, P139, DOI 10.1007/s10735-009-9224-3
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elvang A, 2011, VECTOR-BORNE ZOONOT, V11, P649, DOI 10.1089/vbz.2010.0105
   European Centre for Disease Control and Prevention (ECDC), 2016, RAP RISK ASS ZIK VIR, P1
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Homan J., 2016, BIORXIV, DOI [10.1101/044834, DOI 10.1101/044834]
   Janies D, 2008, CLADISTICS, V24, P111, DOI 10.1111/j.1096-0031.2008.00199.x
   Janies D, 2011, NATURE, V470, P329
   Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388
   Maddison W., 2015, MESQ VER 3 04
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke Alyssa T, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.849adc0ad16beec4536695281707f785
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Sun EL, 2015, MOL BIOL CELL, V26, P1947, DOI 10.1091/mbc.E14-11-1497
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zearfoss NR, 2014, J BIOL CHEM, V289, P35530, DOI 10.1074/jbc.M114.597112
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 65
TC 4
Z9 4
U1 1
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0748-3007
EI 1096-0031
J9 CLADISTICS
JI Cladistics
PD FEB
PY 2017
VL 33
IS 1
BP 1
EP 20
DI 10.1111/cla.12178
PG 20
WC Evolutionary Biology
SC Evolutionary Biology
GA EK5BY
UT WOS:000393943100001
OA Bronze
DA 2020-07-08
ER

PT J
AU Lin, HH
   Huang, LM
   Wu, SC
AF Lin, Hsiao-Han
   Huang, Li-Min
   Wu, Suh-Chin
TI Zika Virus Molecular Biology and Perspectives for Vaccine Development: A
   Review
SO JOURNAL OF NURSING RESEARCH
LA English
DT Review
ID INFECTION; ASSOCIATION
C1 [Lin, Hsiao-Han] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.
   [Huang, Li-Min] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan.
   [Huang, Li-Min] Natl Taiwan Univ, Childrens Hosp, Dept Pediat, Taipei, Taiwan.
   [Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Med Sci, Inst Biotechnol, Hsinchu, Taiwan.
RP Huang, LM (corresponding author), 8 Zhongshan S Rd, Taipei 100, Taiwan.; Wu, SC (corresponding author), 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.
EM lmhuang@ntu.edu.tw; scwu@mx.nthu.edu.tw
OI HUANG, LI-MIN/0000-0002-9291-260X
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo J. S. S., 2016, B WHO, V4
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   WHO, 2016, HIST ZIK VIR
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, 2016, WHO VACC PIP TRACK
   World Health Organization, 2016, ZIK VIR SIT REP
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 17
TC 3
Z9 3
U1 0
U2 31
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1682-3141
J9 J NURS RES
JI J. Nurs. Res.
PD FEB
PY 2017
VL 25
IS 1
BP 3
EP 6
DI 10.1097/jnr.0000000000000205
PG 4
WC Nursing
SC Nursing
GA EI9PH
UT WOS:000392840100001
PM 28072676
DA 2020-07-08
ER

PT J
AU Murugan, K
   Wei, J
   Alsalhi, MS
   Nicoletti, M
   Paulpandi, M
   Samidoss, CM
   Dinesh, D
   Chandramohan, B
   Paneerselvam, C
   Subramaniam, J
   Vadivalagan, C
   Wei, H
   Amuthavalli, P
   Jaganathan, A
   Devanesan, S
   Higuchi, A
   Kumar, S
   Aziz, A
   Nataraj, D
   Vaseeharan, B
   Canale, A
   Benelli, G
AF Murugan, Kadarkarai
   Wei, Jiang
   Alsalhi, Mohamad Saleh
   Nicoletti, Marcello
   Paulpandi, Manickam
   Samidoss, Christina Mary
   Dinesh, Devakumar
   Chandramohan, Balamurugan
   Paneerselvam, Chellasamy
   Subramaniam, Jayapal
   Vadivalagan, Chithravel
   Wei, Hui
   Amuthavalli, Pandiyan
   Jaganathan, Anitha
   Devanesan, Sandhanasamy
   Higuchi, Akon
   Kumar, Suresh
   Aziz, Al Thabiani
   Nataraj, Devaraj
   Vaseeharan, Baskaralingam
   Canale, Angelo
   Benelli, Giovanni
TI Magnetic nanoparticles are highly toxic to chloroquine-resistant
   Plasmodium falciparum, dengue virus (DEN-2), and their mosquito vectors
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Antiviral activity; Malaria; Magnetospirillum gryphiswaldense;
   Magnetotactic bacteria; Yellow fever; Zika virus
ID SYNTHESIZED SILVER NANOPARTICLES; AMB-1 MAGNETOTACTIC BACTERIA; AEGYPTI
   DIPTERA-CULICIDAE; IN-VITRO; MAGNETOSPIRILLUM-GRYPHISWALDENSE; MEDIATED
   SYNTHESIS; BORNE DISEASES; ANTIPLASMODIAL ACTIVITY; VETERINARY
   IMPORTANCE; ANOPHELES-STEPHENSI
AB A main challenge in parasitology is the development of reliable tools to prevent or treat mosquito-borne diseases. We investigated the toxicity of magnetic nanoparticles (MNP) produced by Magnetospirillum gryphiswaldense (strain MSR-1) on chloroquine-resistant (CQ-r) and sensitive (CQ-s) Plasmodium falciparum, dengue virus (DEN-2), and two of their main vectors, Anopheles stephensi and Aedes aegypti, respectively. MNP were studied by Fourier-transform infrared spectroscopy and transmission electron microscopy. They were toxic to larvae and pupae of An. stephensi, LC50 ranged from 2.563 ppm (1st instar larva) to 6.430 ppm (pupa), and Ae. aegypti, LC50 ranged from 3.231 ppm (1st instar larva) to 7.545 ppm (pupa). MNP IC50 on P. falciparum were 83.32 mu g ml(-1) (CQ-s) and 87.47 mu g ml(-1) (CQ-r). However, the in vivo efficacy of MNP on Plasmodium berghei was low if compared to CQ-based treatments. Moderate cytotoxicity was detected on Vero cells post-treatment with MNP doses lower than 4 mu g ml(-1). MNP evaluated at 2-8 mu g ml(-1) inhibited DEN-2 replication inhibiting the expression of the envelope (E) protein. In conclusion, our findings represent the first report about the use of MNP in medical and veterinary entomology, proposing them as suitable materials to develop reliable tools to combat mosquito-borne diseases.
C1 [Murugan, Kadarkarai; Paulpandi, Manickam; Samidoss, Christina Mary; Dinesh, Devakumar; Chandramohan, Balamurugan; Subramaniam, Jayapal; Vadivalagan, Chithravel; Amuthavalli, Pandiyan; Jaganathan, Anitha] Bharathiar Univ, Dept Zool, Sch Life Sci, Coimbatore 641046, Tamil Nadu, India.
   [Wei, Jiang] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China.
   [Alsalhi, Mohamad Saleh; Devanesan, Sandhanasamy] King Saud Univ, Res Chair Laser Diag Canc, Dept Phys & Astron, Riyadh, Saudi Arabia.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Paneerselvam, Chellasamy; Aziz, Al Thabiani] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Wei, Hui] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou 350013, Fujian, Peoples R China.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongli, Taoyuan 32001, Taiwan.
   [Kumar, Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Serdang, Malaysia.
   [Nataraj, Devaraj] Bharathiar Univ, Dept Phys, Coimbatore 641046, Tamil Nadu, India.
   [Vaseeharan, Baskaralingam] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI alsalhi, mohamad/M-5013-2019; Nataraj, Devaraj/T-1700-2017; AlSalhi,
   Mohamad S/F-2217-2019; Benelli, Giovanni/A-9100-2013; Devanesan,
   S./AAH-9593-2020; Higuchi, Akon/AAA-9711-2019; Murugan,
   Kadarkarai/AAP-3937-2020; Kumar S, Suresh/J-2423-2017; baskaralingam,
   vaseeharan/Z-1025-2018
OI Nataraj, Devaraj/0000-0002-4711-8263; AlSalhi, Mohamad
   S/0000-0002-4557-8821; Benelli, Giovanni/0000-0001-8971-6010; Devanesan,
   S./0000-0002-5897-9237; VADIVALAGAN, Chithravel/0000-0002-1751-4361;
   Kumar S, Suresh/0000-0002-0505-7554; baskaralingam,
   vaseeharan/0000-0001-7889-0363
FU Deanship of Scientific Research, King Saud University, Saudi Arabia
   [RGP-1435-057]; PROAPI (PRAF); University of Pisa, Department of
   Agriculture, Food and Environment [COFIN2015_22]
FX The authors would like to thank Prof. H. Mehlhorn and the anonymous
   reviewers for their helpful suggestions on an earlier version of this
   study. Furthermore, the authors are grateful to the Deanship of
   Scientific Research, King Saud University, Saudi Arabia, for the
   financial support (project no. RGP-1435-057). G. Benelli is sponsored by
   PROAPI (PRAF 2015) "Valutazione della qualita organolettica del polline
   d'api fresco sottoposto a differenti trattamenti di condizionamento" and
   University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID: COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR Akbarzadeh A, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-144
   Alphandery E, 2011, J PHYS CHEM C, V115, P18, DOI 10.1021/jp104580t
   Alphandery E, 2013, INT J HYPERTHER, V29, P801, DOI 10.3109/02656736.2013.821527
   Alphandery E, 2012, INT J PHARMACEUT, V434, P444, DOI 10.1016/j.ijpharm.2012.06.015
   Alphandery E, 2011, ACS NANO, V5, P6279, DOI 10.1021/nn201290k
   Argotte-Ramos R, 2006, J NAT PROD, V69, P1442, DOI 10.1021/np060233p
   Bagavan A, 2011, PARASITOL RES, V108, P15, DOI 10.1007/s00436-010-2034-4
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Ene A. C., 2008, Trends in Medical Research, V3, P16, DOI 10.3923/tmr.2008.16.23
   Faraji M, 2010, J IRAN CHEM SOC, V7, P1, DOI 10.1007/BF03245856
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Grancharov SG, 2005, J PHYS CHEM B, V109, P13030, DOI 10.1021/jp051098c
   Guo FF, 2011, APPL MICROBIOL BIOT, V90, P1277, DOI 10.1007/s00253-011-3189-3
   Ishih A, 2003, PHYTOTHER RES, V17, P1234, DOI 10.1002/ptr.1365
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Li X, 2007, LETT APPL MICROBIOL, V45, P508, DOI 10.1111/j.1472-765X.2007.02221.x
   Liu Y, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-99
   Mehlhorn H., 2015, ENCY PARASITOLOGY, P893
   Mukunthan K. S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P270, DOI 10.1016/S2221-1691(11)60041-5
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997
   Rajakumar G, 2015, PARASITOL RES, V114, P1397, DOI 10.1007/s00436-015-4318-1
   Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382
   Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Sun J, 2011, J NANO MAT, V2011
   Sun JB, 2008, BIOTECHNOL BIOENG, V101, P1313, DOI 10.1002/bit.22011
   Sun JB, 2007, CANCER LETT, V258, P109, DOI 10.1016/j.canlet.2007.08.018
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   WHO, 2015, WHO UPD ART RES
   Xiang L, 2007, LETT APPL MICROBIOL, V45, P75, DOI 10.1111/j.1472-765X.2007.02143.x
   Yoshino Tomoko, 2010, Recent Pat Biotechnol, V4, P214, DOI 10.2174/187220810793611455
NR 52
TC 15
Z9 16
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD FEB
PY 2017
VL 116
IS 2
BP 495
EP 502
DI 10.1007/s00436-016-5310-0
PG 8
WC Parasitology
SC Parasitology
GA EI6WL
UT WOS:000392637900006
PM 27815736
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Most, B
   de Santi, VP
   Pages, F
   Mura, M
   Uedelhoven, WM
   Faulde, MK
AF Most, Bruno
   de Santi, Vincent Pommier
   Pages, Frederic
   Mura, Marie
   Uedelhoven, Waltraud M.
   Faulde, Michael K.
TI Long-lasting permethrin-impregnated clothing: protective efficacy
   against malaria in hyperendemic foci, and laundering, wearing, and
   weathering effects on residual bioactivity after worst-case use in the
   rain forests of French Guiana.
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Permethrin-impregnated clothing; Malaria prevention; Long-lasting
   activity; Personal protection; Laundering resistance; Weathering effects
ID VECTOR-BORNE DISEASES; ILLEGAL GOLD MINERS; IXODES-RICINUS;
   AEDES-AEGYPTI; PERSONAL PROTECTION; CONTACT TOXICITY; UNIFORMS;
   TRANSMISSION; PYRETHROIDS; PREVENTION
AB Personal protective measures against hematophagous vectors constitute the first line of defense against arthropod-borne diseases. However, guidelines for the standardized testing and licensing of insecticide-treated clothing are still lacking. The aim of this study was to analyze the preventive effect of long-lasting polymer-coated permethrin-impregnated clothing (PTBDU) against malaria after exposure to high-level disease transmission sites as well as the corresponding loss of permethrin and bioactivity during worst-case field use. Between August 2011 and June 2012, 25 personnel wearing PTBDUs and exposed for 9.5 person-months in hyperendemic malaria foci in the rain forest of French Guiana contracted no cases of malaria, whereas 125 persons wearing untreated uniforms only, exposed for 30.5 person-months, contracted 11 cases of malaria, indicating that PTBDU use significantly (p = 0.0139) protected against malaria infection. In the field, PTBDUs were laundered between 1 and 218 times (mean 25.2 +/- 44.8). After field use, the mean remaining permethrin concentration in PTBDU fabric was 732.1 +/- 321.1 min varying between 130 and 1270 mg/m(2) (mean 743.9 +/- 304.2 mg/m(2)) in blouses, and between 95 and 1290 mg/m(2) (mean 720.2 +/- 336.9 mg/m(2)) in trousers. Corresponding bioactivity, measured according to internal licensing conditions as KD99 times against Aedes aegypti mosquitoes, varied between 27.5 and 142.5 min (mean 47.7 +/- 22.1 min) for blouses, and between 25.0 and 360 min (mean 60.2 +/- 66.1 min) for trousers. We strongly recommend the use of long-lasting permethrin-impregnated clothing for the prevention of mosquito-borne diseases, including chikungunya, dengue, and zika fevers, which are currently resurging globally.
C1 [Most, Bruno] Bundeswehr Med Off, Director Dept A, Koblenz, Germany.
   [de Santi, Vincent Pommier; Pages, Frederic] French Armed Forces Ctr Epidemiol & Publ Hlth CES, Camp Mil St Marthe, Marseille, France.
   [Pages, Frederic] French Inst Publ Hlth Surveillance, Reg Off, Cire OI, Inst Veille Sanit, St Denis, Reunion, France.
   [Mura, Marie] Inst Rech Biomed Armees, Bretigny Sur Orge, France.
   [Uedelhoven, Waltraud M.] Bundeswehr Res Inst Mat Fuels & Lubricants, Erding, Germany.
   [Faulde, Michael K.] Cent Inst Bundeswehr Med Serv, Dept Med Entomol Zool, POB 7340, D-56065 Koblenz, Germany.
   [Faulde, Michael K.] Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany.
RP Faulde, MK (corresponding author), Cent Inst Bundeswehr Med Serv, Dept Med Entomol Zool, POB 7340, D-56065 Koblenz, Germany.; Faulde, MK (corresponding author), Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany.
EM MichaelFaulde@bundeswehr.org
RI de Santi, Vincent Pommier/S-6203-2018
OI de Santi, Vincent Pommier/0000-0001-9971-1133
CR [Anonymous], 2001, Wkly Epidemiol Rec, V76, P189
   Appel KE, 2008, INT J HYG ENVIR HEAL, V211, P88, DOI 10.1016/j.ijheh.2007.10.005
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Buczek A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0977-0
   BURGESS N R H, 1988, International Pest Control, V30, P144
   Darriet F, 1984, WHOVBC8489919
   de Santi VP, 2016, EMERG INFECT DIS, V22, P903, DOI 10.3201/eid2205.151957
   de Santi VP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1088-x
   Douine M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1367-6
   Dusfour I, 2012, MEM I OSWALDO CRUZ, V107, P429, DOI 10.1590/S0074-02762012000300021
   Faulde M, 2006, MED CORPS INT, V26, P4
   Faulde M, 2008, INT J MED MICROBIOL, V298, P321, DOI 10.1016/j.ijmm.2007.11.007
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   Faulde M, 2012, PARASITOL RES, V110, P2341, DOI 10.1007/s00436-011-2769-6
   Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472
   Faulde M, 2016, PARASITOL RES, V115, P1573, DOI 10.1007/s00436-015-4892-2
   Faulde MK, 2003, J MED ENTOMOL, V40, P935, DOI 10.1603/0022-2585-40.6.935
   Fryauff DJ, 1996, J AM MOSQUITO CONTR, V12, P84
   International Organization for Standardization (ISO), 2012, 63302012 EN ISO
   Karacic S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166399
   Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130
   Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x
   Pages F, 2010, CLIN MICROBIOL INFEC, V16, P209, DOI 10.1111/j.1469-0691.2009.03132.x
   Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81
   Pimenta PFP, 2015, MEM I OSWALDO CRUZ, V110, P23, DOI 10.1590/0074-02760140266
   ProMED, 2016, MAL VEN INCR COUNTR, V50
   SCHRECK CE, 1982, J ECON ENTOMOL, V75, P1059, DOI 10.1093/jee/75.6.1059
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   SOTO J, 1995, CLIN INFECT DIS, V21, P599, DOI 10.1093/clinids/21.3.599
   US Armed Forces Pest Management Board, 2009, 36 US ARM FORC PEST
   Vaughn MF, 2014, AM J PREV MED, V46, P473, DOI 10.1016/j.amepre.2014.01.008
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297
   *WHO, 2001, WER, V26, P201
   WIWeB, 2016, BED ZUL VEKT GEM TL
NR 34
TC 7
Z9 7
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD FEB
PY 2017
VL 116
IS 2
BP 677
EP 684
DI 10.1007/s00436-016-5333-6
PG 8
WC Parasitology
SC Parasitology
GA EI6WL
UT WOS:000392637900025
PM 27942961
DA 2020-07-08
ER

PT J
AU Carroll, VS
AF Carroll, V. Susan
TI Executive Summary: The Zika Virus
SO JOURNAL OF NEUROSCIENCE NURSING
LA English
DT Editorial Material
C1 [Carroll, V. Susan] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA.
RP Carroll, VS (corresponding author), Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA.
EM Susan.carroll25@gmail.com
CR [Anonymous], 2016, ZIK VIR POT COMPL
   Brasil P., 2016, NEW ENGL J MED, V374, P7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, 2016, WHO ZIK VIR DIS, VAuthor
NR 9
TC 0
Z9 0
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0888-0395
EI 1945-2810
J9 J NEUROSCI NURS
JI J. Neurosci. Nurs.
PD FEB
PY 2017
VL 49
IS 1
BP 2
EP 4
DI 10.1097/JNN.0000000000000263
PG 3
WC Clinical Neurology; Nursing
SC Neurosciences & Neurology; Nursing
GA EI3RY
UT WOS:000392410200002
PM 28060216
DA 2020-07-08
ER

PT J
AU Kulkarni, SA
   Strobelt, E
   Sargsyan, Z
AF Kulkarni, Shradha A.
   Strobelt, Evan
   Sargsyan, Zaven
TI Capillary Fragility in Zika Virus Infection
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Kulkarni, Shradha A.; Strobelt, Evan; Sargsyan, Zaven] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
EM shradha.kulkarni@bcm.edu
CR Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Wang K, 2014, NEW ENGL J MED, V370, pE1, DOI 10.1056/NEJMicm1305270
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 4
TC 5
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD FEB
PY 2017
VL 130
IS 2
DI 10.1016/j.amjmed.2016.10.008
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EI6RH
UT WOS:000392623200006
PM 28117038
OA Bronze
DA 2020-07-08
ER

PT J
AU Hajra, A
   Bandyopadhyay, D
   Heise, LR
   Bhadra, R
   Ball, S
   Hajra, SK
AF Hajra, Adrija
   Bandyopadhyay, Dhrubajyoti
   Heise, Lyndsey R.
   Bhadra, Rajarshi
   Ball, Somedeb
   Hajra, Shyamal Kumar
TI Zika and pregnancy: A comprehensive review
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
DE fetal anomaly; microcephaly; pregnancy; Zika virus infection
ID VIRUS-INFECTION; GLOBAL THREAT
AB Zika virus (ZIKV) infection is a well-nurtured topic for healthcare personnel nowadays. Central nervous system involvement including microcephaly and ocular involvements has already been reported in neonates of affected pregnant ladies. In this article, we have discussed these effects on the newborns of ZIKV-infected mothers. The proposed pathogenesis, modes of transmission of this infection from mothers to the fetuses, diagnosis of the cases and precaution for the pregnant ladies have also been discussed. We have gathered the recently available data on the risk of ZIKV for expectant mothers from PubMed, https://www.gov.uk/guidance/zika-virus as well as from centers for disease control and prevention websites.
C1 [Hajra, Adrija] IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
   [Bandyopadhyay, Dhrubajyoti] St Vincent Char, Dept Internal Med, Cleveland, OH, St Vincent.
   [Heise, Lyndsey R.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA.
   [Bhadra, Rajarshi] Teaching affiliate Case Western Reserve Univ, St Vincent Char Med Ctr, Dept Internal Med, Cleveland, OH USA.
   [Ball, Somedeb] Apollo Gleneagles Hosp, Dept Cardiol, Kolkata, India.
   [Hajra, Shyamal Kumar] NMB Ctr, Dept Internal Med, Serampore, W Bengal, India.
RP Hajra, A (corresponding author), IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
EM adrija847@gmail.com
RI Bandyopadhyay, Dhrubajyoti/AAQ-5622-2020; Hajra, Adrija/AAM-5736-2020;
   Ball, Somedeb/Q-7364-2019
OI Bandyopadhyay, Dhrubajyoti/0000-0002-0709-4324; Ball,
   Somedeb/0000-0002-1754-1204
CR Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Edwards MS, 2016, UPTODATE
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guibaud L, 2016, ULTRASOUND OBST GYN, V48, P16, DOI 10.1002/uog.15926
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Guo J, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0096-4
   Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   LaBeaud AD, 2016, UPTODATE
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   McCabe ER, 2016, UPTODATE
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nielsen KK, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30254-9
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Silverstein PS, RECENT DEV VERTICAL
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Vasquez AM, 2016, AM J TRANSPLANT, V16, P2487, DOI 10.1111/ajt.13941
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 35
TC 6
Z9 6
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12607
DI 10.1111/aji.12607
PG 7
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200004
PM 27885741
OA Bronze
DA 2020-07-08
ER

PT J
AU Lucchese, G
   Kanduc, D
AF Lucchese, Guglielmo
   Kanduc, Darja
TI Minimal immune determinants connect Zika virus, human Cytomegalovirus,
   and Toxoplasma gondii to microcephaly-related human proteins
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE human Cytomegalovirus; microcephaly-related proteins; minimal immune
   determinants; multiple cross-reactivity; pentapeptide sharing;
   Toxoplasma gondii; Zika virus
ID EPITOPE
AB Aiming at the molecular definition of the relationship(s) between prenatal infections and fetal microcephaly and using pentapeptides as minimal immune determinants, we analyzed the peptide matching between proteins from infectious agents involved in microcephalic syndromes (namely Zika virus, human Cytomegalovirus, and Toxoplasma gondii) and human proteins that, when altered, have been specifically associated with microcephaly. We report that an unexpected high number of epitopic pentapeptides (ie,34) are common to the three fetopathogenic agents and repeatedly occur throughout an important number of microcephaly-related human proteins. The data introduce the issue of multiple cross-reactivity into the etiology on ZIKV-associated pathologies. Indeed, the commonality of immune determinants might lead to a sequence of boostered immune responses if the host undergoes different fetopathogenic infections, thus temporally scanning a potential clinical progression toward brain malformations. At this juncture, the past history of maternal infections/vaccinations might dictate the fetal pathologic outcome.
C1 [Lucchese, Guglielmo] Free Univ Berlin, Brain Language Lab, Berlin, Germany.
   [Kanduc, Darja] Univ Bari, Dept Biosci, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
RP Kanduc, D (corresponding author), Univ Bari, Dept Biosci, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
EM darja.kanduc@uniba.it
RI Lucchese, Guglielmo/AAL-9860-2020
OI Lucchese, Guglielmo/0000-0002-1809-6376
FU Deutscher Akademischer Austauschdienst (DAAD)Deutscher Akademischer
   Austausch Dienst (DAAD); Deutsche Forschungsgemeinschaft (DFG)German
   Research Foundation (DFG); Freie UniversitAt Berlin; University of Bari
FX Deutscher Akademischer Austauschdienst (DAAD); Deutsche
   Forschungsgemeinschaft (DFG); Freie UniversitAt Berlin; University of
   Bari
CR Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DONLEY DK, 1993, SEMIN NEUROL, V13, P106, DOI 10.1055/s-2008-1041114
   Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Frank A., 2002, IMMUNOLOGY AND EVOLU
   Kanduc D, 2008, PEPTIDES, V29, P1755, DOI 10.1016/j.peptides.2008.05.022
   Kanduc Darja, 2016, Curr Drug Discov Technol, V13, P225
   Kanduc D, 2015, J IMMUNOL RES, DOI 10.1155/2015/541282
   Kanduc D, 2015, ANTI-CANCER AGENT ME, V15, P1264, DOI 10.2174/1871520615666150716105543
   Kanduc D, 2013, CURR PROTEIN PEPT SC, V14, P111, DOI 10.2174/1389203711314020003
   Kanduc Darja, 2012, Front Biosci (Schol Ed), V4, P1393
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lucchese G, 2011, SELF NONSELF, V2, P49
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009
   McCulloch V, 2000, EMBO J, V19, P4134, DOI 10.1093/emboj/19.15.4134
   Plosa EJ, 2012, PEDIATR REV, V33, P156, DOI 10.1542/pir.33-4-156
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Remington JS, 2011, INFECT DIS FOETUS NE
   Roitt I., 1994, ESSENTIAL IMMUNOLOGY, P32
   SEVER JL, 1988, PEDIATRICS, V82, P181
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   Volpe JJ, 2008, NEUROLOGY NEWBORN
   Zeng WG, 2007, MOL IMMUNOL, V44, P3724, DOI 10.1016/j.molimm.2007.04.004
NR 30
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12608
DI 10.1111/aji.12608
PG 9
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200005
PM 27878897
OA Bronze
DA 2020-07-08
ER

PT J
AU Simoni, MK
   Jurado, KA
   Abrahams, VM
   Fikrig, E
   Guller, S
AF Simoni, Michael K.
   Jurado, Kellie Ann
   Abrahams, Vikki M.
   Fikrig, Erol
   Guller, Seth
TI Zika virus infection of Hofbauer cells
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE congenital Zika syndrome; Hofbauer cells; placenta; Zika virus
ID DENGUE VIRUS; MACROPHAGE PLASTICITY; UNKNOWN ETIOLOGY; HUMAN PLACENTA;
   PREGNANCY; POLARIZATION; TROPHOBLAST; SYNCYTIOTROPHOBLAST; TRANSMISSION;
   MECHANISM
AB Recent studies have linked antenatal infection with Zika virus (ZIKV) with major adverse fetal and neonatal outcomes, including microcephaly. There is a growing consensus for the existence of a congenital Zika syndrome (CZS). Previous studies have indicated that non-placental macrophages play a key role in the replication of dengue virus (DENV), a closely related flavivirus. As the placenta provides the conduit for vertical transmission of certain viruses, and placental Hofbauer cells (HBCs) are fetal-placental macrophages located adjacent to fetal capillaries, it is not surprising that several recent studies have examined infection of HBCs by ZIKV. In this review, we describe congenital abnormalities associated with ZIKV infection, the role of HBCs in the placental response to infection, and evidence for the susceptibility of HBCs to ZIKV infection. We conclude that HBCs may contribute to the spread of ZIKV in placenta and promote vertical transmission of ZIKV, ultimately compromising fetal and neonatal development and function. Current evidence strongly suggests that further studies are warranted to dissect the specific molecular mechanism through which ZIKV infects HBCs and its potential impact on the development of CZS.
C1 [Simoni, Michael K.; Abrahams, Vikki M.; Guller, Seth] Yale Sch Med, Dept Obstet, Gynecol & Reprod Sci, New Haven, CT USA.
   [Jurado, Kellie Ann; Fikrig, Erol] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Guller, S (corresponding author), Yale Sch Med, Dept Obstet, Gynecol & Reprod Sci, New Haven, CT USA.
EM seth.guller@yale.edu
OI Simoni, Michael/0000-0002-4514-4804
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [5T32 AI007019-40, R01AI121183]; Albert
   McKern Scholar Award
FX The sources of funding are as follows: 5T32 AI007019-40 (K.A.J.),
   R01AI121183 from NIAID (V.M.A.) and an Albert McKern Scholar Award
   (S.G.). E.F. is an investigator with the Howard Hughes Medical
   Institute.
CR Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Boily-Larouche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040706
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brownbill P, 2000, AM J PHYSIOL-REG I, V278, pR677
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CASTELLUCCI M, 1980, CELL TISSUE RES, V210, P235
   Castellucci M., 2000, PATHOLOGY HUMAN PLAC
   Chen KH, 2011, ULTRASOUND OBST GYN, V37, P328, DOI 10.1002/uog.7733
   Chen KH, 2012, ULTRASOUND MED BIOL, V38, P1011, DOI 10.1016/j.ultrasmedbio.2012.02.004
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Genen L, 2004, J PEDIATR-US, V144, P316, DOI 10.1016/j.jpeds.2003.12.015
   Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003
   Joerink M, 2011, PLACENTA, V32, P380, DOI 10.1016/j.placenta.2011.02.003
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khan S, 2000, BIOL REPROD, V62, P1075, DOI 10.1095/biolreprod62.4.1075
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834
   King CC, 2013, CURR HIV RES, V11, P10
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NELSON DM, 1990, AM J PATHOL, V136, P855
   Nelson DM, 1996, PLACENTA, V17, P387, DOI 10.1016/S0143-4004(96)90019-3
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005
   Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009
   Romero R, 2003, J NUTR, V133, p1668S, DOI 10.1093/jn/133.5.1668S
   Rosenberg AZ, 2016, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2016-0401-OA, DOI 10.5858/ARPA.2016-0401-OA.]
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Seval Y, 2007, PLACENTA, V28, P841, DOI 10.1016/j.placenta.2007.01.010
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112
   Tang ZH, 2011, AM J REPROD IMMUNOL, V66, P336, DOI 10.1111/j.1600-0897.2011.01006.x
   Toti P, 2011, AM J REPROD IMMUNOL, V65, P470, DOI 10.1111/j.1600-0897.2010.00927.x
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
NR 48
TC 30
Z9 31
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR UNSP e12613
DI 10.1111/aji.12613
PG 4
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200006
PM 27966815
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Adcock, RS
   Chu, YK
   Golden, JE
   Chung, DH
AF Adcock, Robert S.
   Chu, Yong-Kyu
   Golden, Jennifer E.
   Chung, Dong-Hoon
TI Evaluation of anti-Zika virus activities of broad-spectrum antivirals
   and NIH clinical collection compounds using a cell-based,
   high-throughput screen assay
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID IN-VITRO; 6-AZAURIDINE; ENTRY; INHIBITOR; RIBAVIRIN; MODEL
AB Recent studies have clearly underscored the association between Zika virus (ZIKV) and severe neurological diseases such as microcephaly and Guillain-Barre syndrome. Given the historical complacency surrounding this virus, however, no significant antiviral screenings have been performed to specifically target ZIKV. As a result, there is an urgent need for a validated screening method and strategy that is focused on highlighting potential anti-ZIKV inhibitors that can be further advanced via rigorous validation and optimization. To address this critical gap, we sought to test whether a cell-based assay that measures protection from the ZIKV-induced cytopathic effect could serve as a high-throughput screen assay for discovering novel anti-ZIKV inhibitors. Employing this approach, we tested the anti-ZIKV activity of previously known broad-spectrum antiviral compounds and discovered several compounds (e.g., NITD008, SaliPhe, and CID 91632869) with anti-ZIKV activity. Interestingly, while GTP synthesis inhibitors (e.g., ribavirin or mycophenolic acid) were too toxic or showed no anti-ZIKV activity (EC50 > 50 mu M), ZIKV was highly susceptible to pyrimidine synthesis inhibitors (e.g., brequinar) in the assay.
   We amended the assay into a high-throughput screen (HTS)-compatible 384-well format and then screened the NIH Clinical Compound Collection library, which includes a total of 727 compounds organized, using an 8-point dose response format with two Zika virus strains (MR766 and PRVABC59, a recent human isolate). The screen discovered 6-azauridine and finasteride as potential anti-ZIKV inhibitors with EC50 levels of 3.18 and 9.85 M for MR766, respectively. We further characterized the anti-ZIKV activity of 6-azauridine and several pyrimidine synthesis inhibitors such as brequinar in various secondary assays including an antiviral spectrum test within flaviviruses and alphaviruses, Western blot (protein), real-time PCR (RNA), and plaque reduction assays (progeny virus). From these assays, we discovered that brequinar has potent anti-ZIKV activity. Our results show that a broad anti-ZIKV screen of compound libraries with our CPE-based HTS assay will reveal multiple chemotypes that could be pursued as lead compounds for therapies to treat ZIKV-associated diseases or as molecular probes to study the biology of the ZIKV replication mechanism. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Adcock, Robert S.; Chu, Yong-Kyu; Chung, Dong-Hoon] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA.
   [Golden, Jennifer E.] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.
   [Chung, Dong-Hoon] Univ Louisville, Sch Med, Dept Microbiol & Immunol, 505 Hancock St South,CTRB Off 617, Louisville, KY 40202 USA.
RP Chung, DH (corresponding author), Univ Louisville, Sch Med, Dept Microbiol & Immunol, 505 Hancock St South,CTRB Off 617, Louisville, KY 40202 USA.
EM dhchun01@louisville.edu
OI Golden, Jennifer/0000-0002-6813-3710
FU Center for Predictive Medicine for Biodefense and Emerging Infectious
   Diseases, University of Louisville
FX This study was supported by the Center for Predictive Medicine for
   Biodefense and Emerging Infectious Diseases, University of Louisville.
   The funder had no role in study design, data analysis, and preparation
   of the manuscript. SaliPhe was a kind gift from Dr. Don Stewart (Omm
   Scientific Inc.). The NIH Clinical Collection library was obtained from
   the NIH Small Molecule Repository (http://nihsmr.evotec.com/evotec/). We
   thank Dr. Barbara Johnson (CDC, USA) for providing Zika viruses, MR766
   and PRVABC59. Dr. Robert Tesh, University of Texas Medical Branch,
   kindly provided WNV strains of NY-99 and B956. The following reagents
   were obtained through the NIH Biodefense and Emerging Infections
   Research Resources Repository, NIAID, NIH: Japanese Encephalitis
   Viruses, SA14 (NR-2335) and Nakayama (NR-90), and Chikungunya Virus,
   S-27 (NR-13220).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005
   Amet T, 2008, MICROBES INFECT, V10, P471, DOI 10.1016/j.micinf.2008.01.009
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108
   BONO VH, 1964, J CLIN INVEST, V43, P1486, DOI 10.1172/JCI105025
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Chung DH, 2010, MOLECULES, V15, P1690, DOI 10.3390/molecules15031690
   Chung DH, 2016, ANTIMICROB AGENTS CH, V60, P4552, DOI 10.1128/AAC.00282-16
   Chung DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004213
   CLINE JC, 1969, APPL MICROBIOL, V18, P14, DOI 10.1128/AEM.18.1.14-20.1969
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598
   Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002
   del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061
   Deng CL, 2014, J VIROL, V88, P11915, DOI 10.1128/JVI.01207-14
   DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004
   Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARMON MW, 1976, J INFECT DIS, V133, P7, DOI 10.1093/infdis/133.1.7
   Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kolokoltsov AA, 2006, VIROLOGY, V347, P333, DOI 10.1016/j.virol.2005.11.051
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu SM, 2006, BIOCHEM BIOPH RES CO, V347, P51, DOI 10.1016/j.bbrc.2006.06.107
   Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000
   Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216
   Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Potena L, 2004, CIRCULATION, V109, P532, DOI 10.1161/01.CIR.0000109485.79183.81
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rubin E. J., 2016, N ENGL J MED
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smee Donald F., 2012, Antiviral Chemistry & Chemotherapy, V22, P263, DOI 10.3851/IMP2105
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317
   Tacklind J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006015.pub3
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200
   Xu M., 2016, QHTS ASSAY MEASUREME
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 61
TC 69
Z9 70
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2017
VL 138
BP 47
EP 56
DI 10.1016/j.antiviral.2016.11.018
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EJ1ZE
UT WOS:000393008400006
PM 27919709
DA 2020-07-08
ER

PT J
AU Puccioni-Sohler, M
   Roveroni, N
   Rosadas, C
   Ferry, F
   Peralta, JM
   Tanuri, A
AF Puccioni-Sohler, Marzia
   Roveroni, Natalia
   Rosadas, Carolina
   Ferry, Fernando
   Peralta, Jose Mauro
   Tanuri, Amilcar
TI Dengue infection in the nervous system: lessons learned for Zika and
   Chikungunya
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE Zika virus infection; Dengue; Chikungunya fever; Neurology
ID NEUROLOGICAL MANIFESTATIONS; CEREBROSPINAL-FLUID; VIRUS-INFECTION;
   BRAZIL; TRANSMISSION; INVOLVEMENT; BRAIN
AB Dengue, Zika and Chikungunya are emerging arboviruses and important causes of acute febrile disease in tropical areas. Although dengue does not represent a new condition, a geographic expansion over time has occurred with the appearance of severe neurological complications. Neglect has allowed the propagation of the vector (Aedes spp), which is also responsible for the transmission of other infections such as Zika and Chikungunya throughout the world. The increased number of infected individuals has contributed to the rise of neurological manifestations including encephalitis, myelitis, meningitis, Guillain-Barre syndrome and congenital malformations such as microcephaly. In this narrative review, we characterize the impact of the geographic expansion of the vector on the appearance of neurological complications, and highlight the lack of highly accurate laboratory tests for nervous system infections. This represents a challenge for public health in the world, considering the high number of travelers and people living in endemic areas.
C1 [Puccioni-Sohler, Marzia; Roveroni, Natalia; Ferry, Fernando] Univ Fed Estado Rio de Janeiro UNIRIO, Hosp Univ Gaffree & Guinle, Escola Med & Cirurg, Rua Mariz e Barros 775, BR-20270004 Rio De Janeiro, RJ, Brazil.
   [Puccioni-Sohler, Marzia; Rosadas, Carolina] Univ Fed Rio de Janeiro, Fac Med, Posgrad Doencas Infecciosas & Parasitarias, Rio De Janeiro, RJ, Brazil.
   [Peralta, Jose Mauro] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.
RP Puccioni-Sohler, M (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Hosp Univ Gaffree & Guinle, Escola Med & Cirurg, Rua Mariz e Barros 775, BR-20270004 Rio De Janeiro, RJ, Brazil.
EM m_puccioni@yahoo.com.br
FU Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.330/2016]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), BrazilCAPES
FX Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ) (E-26/201.330/2016), edital Arbovirus, and PhD scholarship from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Brazil for C.R.
CR Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   de Albuquerque IGC, 2012, REV SOC BRAS MED TRO, V45, P128, DOI 10.1590/S0037-86822012000100026
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Sousa Adriano Miranda, 2006, Journal of Infection and Chemotherapy, V12, P396, DOI 10.1007/s10156-006-0475-6
   de Sousa Adriano Miranda, 2014, Trop Med Health, V42, P115, DOI 10.2149/tmh.2014-06
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Kashyap Rajpal S, 2010, Cerebrospinal Fluid Res, V7, P12, DOI 10.1186/1743-8454-7-12
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Misra UK, 2015, J CLIN VIROL, V72, P146, DOI 10.1016/j.jcv.2015.08.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Puccioni-Sohler M, 2015, ARQ NEURO-PSIQUIAT, V73, P698, DOI 10.1590/0004-282X20150074
   Puccioni-Sohlera M, 2016, INT J INFECT DIS, V53, P21, DOI 10.1016/j.ijid.2016.10.019
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Roze B, 2016, EUROSURVEILLANCE, V21, P2
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yamamoto Yuuji, 2002, Journal of Infection and Chemotherapy, V8, P175, DOI 10.1007/s101560200030
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 41
TC 8
Z9 8
U1 0
U2 10
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD FEB
PY 2017
VL 75
IS 2
BP 123
EP 126
DI 10.1590/0004-282X20160189
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EL3IY
UT WOS:000394514000010
PM 28226083
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kamtchum-Tatuene, J
   Makepeace, BL
   Benjamin, L
   Baylis, M
   Solomon, T
AF Kamtchum-Tatuene, Joseph
   Makepeace, Benjamin L.
   Benjamin, Laura
   Baylis, Matthew
   Solomon, Tom
TI The potential role of Wolbachia in controlling the transmission of
   emerging human arboviral infections
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE arboviruses; chikungunya virus; dengue virus; Japanese encephalitis
   virus; prevention; transinfection; transmission; West Nile virus;
   Wolbachia; yellow fever virus; Zika virus
ID AEDES-AEGYPTI; DENGUE VIRUS; IMMUNE-RESPONSES; VIRULENT WOLBACHIA;
   GENE-EXPRESSION; BLOCKS DENGUE; MOSQUITO; CHOLESTEROL; PATHWAY;
   POPULATIONS
AB Purpose of review
   Wolbachia is a genus of Gram-negative intracellular bacteria that is naturally found in more than half of all arthropod species. These bacteria cannot only reduce the fitness and the reproductive capacities of arthropod vectors, but also increase their resistance to arthropod-borne viruses (arboviruses). This article reviews the evidence supporting a Wolbachia-based strategy for controlling the transmission of dengue and other arboviral infections.
   Recent findings
   Studies conducted 1 year after the field release of Wolbachia-infected mosquitoes in Australia have demonstrated the suppression of dengue virus (DENV) replication in and dissemination by mosquitoes. Recent mathematical models show that this strategy could reduce the transmission of DENV by 70%. Consequently, the WHO is encouraging countries to boost the development and implementation of Wolbachia-based prevention strategies against other arboviral infections. However, the evidence regarding the efficacy of Wolbachia to prevent the transmission of other arboviral infections is still limited to an experimental framework with conflicting results in some cases. There is a need to demonstrate the efficacy of such strategies in the field under various climatic conditions, to select the Wolbachia strain that has the best pathogen interference/spread trade-off, and to continue to build community acceptance.
   Summary
   Wolbachia represents a promising tool for controlling the transmission of arboviral infections that needs to be developed further. Long-term environmental monitoring will be necessary for timely detection of potential changes in Wolbachia/vector/virus interactions.
C1 [Kamtchum-Tatuene, Joseph; Benjamin, Laura; Solomon, Tom] Univ Liverpool, Liverpool Brain Infect Grp, Liverpool, Merseyside, England.
   [Makepeace, Benjamin L.] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Liverpool, Merseyside, England.
   [Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England.
   [Baylis, Matthew; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.
RP Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England.
EM tsolomon@liverpool.ac.uk
RI TATUENE, Joseph KAMTCHUM/Q-3990-2019; TATUENE, Joseph
   KAMTCHUM/W-3028-2017
OI TATUENE, Joseph KAMTCHUM/0000-0002-1041-4202; TATUENE, Joseph
   KAMTCHUM/0000-0002-1041-4202; Solomon, Tom/0000-0001-7266-6547; Baylis,
   Matthew/0000-0003-0335-187X; Benjamin, Laura/0000-0002-9685-1664
FU Wellcome TrustWellcome Trust; National Institute of Health
   ResearchNational Institute for Health Research (NIHR); Health Protection
   Research Unit in Emerging and Zoonotic Infections; European
   UnionEuropean Union (EU) [734584]; Biotechnology and Biological Sciences
   Research CouncilBiotechnology and Biological Sciences Research Council
   (BBSRC) [BB/K018507/1]; Medical Research CouncilMedical Research Council
   UK (MRC) [MC_PC_15090]; National Institute for Health ResearchNational
   Institute for Health Research (NIHR) [NF-SI-0514-10177,
   RP-PG-0108-10048]
FX The authors acknowledge the institutions supporting their research: the
   Wellcome Trust (J.K.T., L.B.), the National Institute of Health Research
   (T.S.), the Health Protection Research Unit in Emerging and Zoonotic
   Infections (M.B., T.S.) and the European Union's Horizon 2020 research
   and innovation programme grant agreement No. 734584 (T.S.).
CR Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545
   Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Ahmed MZ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004672
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288
   Banzhoff Angelika, 2008, Travel Med Infect Dis, V6, P331, DOI 10.1016/j.tmaid.2008.06.011
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chatterjee PK, 2000, J VIROL, V74, P1623, DOI 10.1128/JVI.74.4.1623-1631.2000
   Chen HL, 2015, J CHIN MED ASSOC, V78, P271, DOI 10.1016/j.jcma.2014.12.009
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Freedman DO, 2016, NEW ENGL J MED, V375, P247, DOI 10.1056/NEJMra1508815
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hertig M, 1924, J MED RES, V44, P329
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Jeffries CL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003576
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003
   Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309
   Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Popovici J, 2010, MEM I OSWALDO CRUZ, V105, P957, DOI 10.1590/S0074-02762010000800002
   Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0
   Resnik DB, 2014, DEV WORLD BIOETH, V14, P37, DOI 10.1111/dewb.12011
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Rust RS, 2012, SEMIN PEDIATR NEUROL, V19, P130, DOI 10.1016/j.spen.2012.03.002
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12
   Shayan S, 2015, LABMEDICINE, V46, P180, DOI 10.1309/LMN1P2FRZ7BKZSCO
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Smartt CT, 2009, AM J TROP MED HYG, V81, P258, DOI 10.4269/ajtmh.2009.81.258
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Thomas P, 2011, DEV COMP IMMUNOL, V35, P360, DOI 10.1016/j.dci.2010.11.007
   Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wasay M, 2015, NEUROLOGY, V84, P421, DOI 10.1212/WNL.0000000000001177
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 101
TC 15
Z9 15
U1 1
U2 73
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD FEB
PY 2017
VL 30
IS 1
BP 108
EP 116
DI 10.1097/QCO.0000000000000342
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EI0NN
UT WOS:000392171300014
PM 27849636
OA Green Published
DA 2020-07-08
ER

PT J
AU Bryson, Y
AF Bryson, Yvonne
TI Zika virus congenital syndrome, the new Z in TORCHZ? Prospects for
   diagnosis prevention and treatment
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Editorial Material
C1 [Bryson, Yvonne] UCLA, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA.
   [Bryson, Yvonne] UCLA, Mattel Childrens Hosp, Los Angeles, CA USA.
RP Bryson, Y (corresponding author), UCLA, David Geffen Sch Med, Mattel Childrens Hosp, Pediat & Infect Dis,Dept Pediat, 10833 Le Conte Ave MDCC 22-442, Los Angeles, CA 90095 USA.
EM ybryson@mednet.ucla.edu
NR 0
TC 2
Z9 2
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2017
VL 29
IS 1
BP 94
EP 96
DI 10.1097/MOP.0000000000000453
PG 3
WC Pediatrics
SC Pediatrics
GA EL4OV
UT WOS:000394601400014
PM 28027061
DA 2020-07-08
ER

PT J
AU Deseda, CC
AF Deseda, Carmen C.
TI Epidemiology of Zika
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE arbovirus; microcephaly; mosquitoes
ID SEXUAL TRANSMISSION; VIRUS OUTBREAK; STATES
AB Purpose of reviewZika virus (ZIKV) is the latest 'emerging virus' that has affected the Americas. First identified in the mid-20th century in Uganda, it was described as a vector arthropod-borne virus (arbovirus) and subsequently found capable of producing illness in humans. The illness was not different from other flavivirus infections and caused a relatively mild disease characterized by low-grade fever, nonspecific exanthem, nonpurulent conjunctivitis, and mild to moderate arthralgia. It was capable of producing infections described as sporadic isolated cases; in 2007, it was confirmed as the pathogen causing the first known ZIKV epidemic subsequently associated with congenital neonatal microcephaly in many countries in the Americas.Recent findingsIt rapidly spread to other countries in the Americas and, as of September 2016, it has been detected in 46 countries and territories. Different from other flavivirus infections, ZIKV has proven to be related to more serious complications. These include Guillain-Barre syndrome and neonatal congenital malformations, which includes microcephaly and neurologic damage to the developing fetus, particularly if the maternal infection occurs early in pregnancy. These two complications are a cause of great concern.SummaryIt is pivotal to conduct epidemiological laboratory-based surveillance and studies on the virus' inherent characteristics to understand the pathophysiology of this infection and develop adequate strategies to mitigate this new threat.
C1 [Deseda, Carmen C.] Caribbean Travel Med Clin, San Juan, PR 00918 USA.
RP Deseda, CC (corresponding author), Caribbean Travel Med Clin, San Juan, PR 00918 USA.
EM desedamd@hotmail.com
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, ZIK VIR
   Center for Disease Control, 2016, MAPS ZIK US
   Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Organizacion Panamericana de la Salud/ Organizacion Mundial de la Salud, 2016, ACT EP
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 17
TC 12
Z9 12
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2017
VL 29
IS 1
BP 97
EP 101
DI 10.1097/MOP.0000000000000442
PG 5
WC Pediatrics
SC Pediatrics
GA EL4OV
UT WOS:000394601400015
PM 27845968
DA 2020-07-08
ER

PT J
AU Grossi-Soyster, EN
   LaBeaud, AD
AF Grossi-Soyster, Elysse N.
   LaBeaud, A. Desiree
TI Clinical aspects of Zika virus
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE arbovirus; arthropod-borne virus; mosquito-borne virus; Zika
ID INTERIM GUIDANCE; PREGNANT-WOMEN; UNITED-STATES; INFECTION;
   EPIDEMIOLOGY; MANIFESTATIONS; OUTBREAK; BRAZIL; TRANSMISSION; TRAVEL
AB Purpose of reviewZika virus (ZIKV) is a mosquito-borne flavivirus that has caused a sudden and explosive outbreak in South America and the Caribbean in the last year, and has been declared a public health emergency by the WHO. As ZIKV afflicts previously naive populations, more severe clinical presentations and sequelae have been observed. A specific emphasis has been placed on the neurological effects in infants resulting from viral exposure in utero.Recent findingsAcute onset of ZIKV disease is seen in approximately 20% of cases, whereas most individuals (80%) exposed are asymptomatic. Presentation of illness is typically mild, with disease spectrum ranging from arthralgia and rash to encephalitis, myelitis, and Guillain-Barre syndrome. Infants have been uniquely impacted by the current outbreak with significant congenital exposure resulting in permanent neurological defects and developmental complications.SummaryThe current ZIKV outbreak has illustrated the emergent capabilities of mosquito-borne viruses and the teratogenic nature of ZIKV. Causality and risk factors associated with severe manifestations, as well as chronic sequelae, have yet to be determined. Extensive research is required to understand the molecular mechanisms of infection, develop improved assays for differential diagnosis, and improve overall knowledge of the spectrum of ZIKV disease in order to develop modes of prevention and treatment.
C1 [Grossi-Soyster, Elysse N.; LaBeaud, A. Desiree] Stanford Univ, Sch Med, Pediat Infect Dis Div, 300 Pasteur Dr,M-C 5208, Stanford, CA 94305 USA.
RP LaBeaud, AD (corresponding author), Stanford Univ, Sch Med, Pediat Infect Dis Div, 300 Pasteur Dr,M-C 5208, Stanford, CA 94305 USA.
EM dlabeaud@stanford.edu
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   [California Department of Public Health Health CfF], 2016, EV FOLL UP PROC SUSP
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Laval F, 2016, MED SANTE TROP, V26, P145, DOI 10.1684/mst.2016.0575
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Flores MS, 2016, CLEV CLIN J MED, V83, P1, DOI 10.3949/ccjm.83a.16027
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ganczak M, 2016, GINEKOL POL, V87, P538, DOI 10.5603/GP.2016.0040
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Killion MM, 2016, MCN-AM J MATERN-CHIL, V41, P252, DOI 10.1097/NMC.0000000000000246
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kularatne SAM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/639178
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGovern LM, 2007, J TRAVEL MED, V14, P117, DOI 10.1111/j.1708-8305.2006.00093.x
   Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005
   Nicastri E, 2016, EUROSURVEILLANCE, V21
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vasconcelos-Santos DV, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1313
   Ze-Ze L, 2016, IDCases, V4, P46, DOI 10.1016/j.idcr.2016.03.004
NR 43
TC 9
Z9 9
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2017
VL 29
IS 1
BP 102
EP 106
DI 10.1097/MOP.0000000000000449
PG 5
WC Pediatrics
SC Pediatrics
GA EL4OV
UT WOS:000394601400016
PM 27870688
DA 2020-07-08
ER

PT J
AU Gabaglia, CR
AF Gabaglia, Claudia Raja
TI Zika virus and diagnostics
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE diagnostic; PCR; serology; Zika; ZIKV
ID MALE SEXUAL TRANSMISSION; WEST NILE; INFECTION; CELLS; INACTIVATION;
   GENOME; RNA
AB Purpose of reviewThe purpose of this review is to present what is known about the Zika virus (ZIKV) at the time of writing this review. The viral structure and its phylogeny, as well as the limitations of current available techniques used for diagnosis, are discussed.Recent findingsCrystallography and cryo-electron microscopy of the whole ZIKV, or a few of its proteins, are confirming its overall antigenic relatedness to other flaviviruses. Sequencing has revealed its dynamic genetic variation and has placed the Western cluster of Zika isolates within the Asian phylogenic tree. Genetic codon mutations, although highly prevalent, do not usually translate into modifications at amino acid or proteomic levels, revealing conserved enzymatic functions that could potentially be addressed therapeutically. Clinical characterization of ZIKV infection is complicated because of symptoms similar to dengue and chikungunya. Diagnosis requires specialized laboratories with costly reagents and highly trained personnel. Although commercial labs are now offering ZIKV diagnostic tests, most of them are not fully tested in comparison with standard molecular techniques standardized at CDC and local health departments. We are still in desperate need of simpler diagnostic tests that better discriminate ZIKV from coendemic arboviruses.SummaryThe area of better Zika diagnostic assays is a rapidly developing field with the public attention directed to this epidemic. Academic interest in this topic is driving fast disclosure of information in peer-reviewed journals and grey papers via web-based forums. We expect in the near future that new promising strategies for improved Zika diagnostics will translate into preventive and therapeutic tools.
C1 [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, 4263 Oceanside Blvd Ste 106-159, Oceanside, CA 92056 USA.
RP Gabaglia, CR (corresponding author), Biomed Res Inst Southern Calif, 4263 Oceanside Blvd Ste 106-159, Oceanside, CA 92056 USA.
EM cgabaglia@bri-sc.org
CR Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2016, BRAZ CONF BLOOD TRAN
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Besnard M, 2014, EURO SURVEILL, V19
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, N ENGL J
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   KERR JA, 1952, J IMMUNOL, V68, P461
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rodrigues LC, 2016, LANCET INFECT DIS
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 58
TC 4
Z9 4
U1 1
U2 19
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2017
VL 29
IS 1
BP 107
EP 113
DI 10.1097/MOP.0000000000000446
PG 7
WC Pediatrics
SC Pediatrics
GA EL4OV
UT WOS:000394601400017
PM 27870689
DA 2020-07-08
ER

PT J
AU Quanquin, N
   Wang, LL
   Cheng, GH
AF Quanquin, Natalie
   Wang, Lulan
   Cheng, Genhong
TI Potential for treatment and a Zika virus vaccine
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE treatment; vaccine; Zika virus
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; DENGUE VIRUS; CROSS-REACTIVITY;
   RECOMBINANT LIVE; INFECTION; EMERGENCE; BIOLOGY
AB Purpose of reviewZika virus (ZIKV) has only recently been exposed as a significant public health threat, and much of our limited knowledge of its pathogenesis and triggered immune responses were discovered in only the last few years. There are currently no ZIKV-specific therapeutics or vaccines available. This review seeks to bring the reader up-to-date with the latest developments in finding a way to combat this emerging infectious disease.Recent findingsCurrent strategies used for developing ZIKV vaccines or treatments follow proven methods used against other flaviviruses. Unfortunately, ZIKV carries many unique challenges, such as the need to target drugs and vaccines towards immunocompromised populations (pregnant mothers and fetuses), the risk of stimulating harmful immune responses (either autoimmune or antibody-dependent enhancement of infection in those with previous flavivirus exposure), frequently silent infection that may delay treatment and increase risk of transmission to others, and multiple routes of transmission (arthropod vector, sexual, bloodborne, and potentially other body fluids).SummaryCurrent medical recommendations are directed towards resolving symptoms and not the actual infection; however, ZIKV treatments and vaccines are in development. Vector control and travel restrictions to endemic areas may remain our only available interventions for some time.
C1 [Quanquin, Natalie; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Wang, Lulan] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA USA.
   [Wang, Lulan; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.
   [Wang, Lulan; Cheng, Genhong] Peking Union Med Coll, Beijing, Peoples R China.
   [Wang, Lulan; Cheng, Genhong] Suzhou Inst Syst, Suzhou, Jiangsu, Peoples R China.
RP Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
EM gcheng@mednet.ucla.edu
RI amsalu, ribka/G-8780-2019
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI069120, AI056154, AI078389, T32
   AI089398-07]; Ministry of Science and Technology of ChinaMinistry of
   Science and Technology, China [2015ZX09102023, 2015CB910501]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81590765, 31470273]; Institutional Research Fund for Thousand
   Talents Program at the Chinese Academy of Medical Sciences; National Key
   Plan for Scientific Research and Development of China [2016YFD0500300]
FX This work was supported by the NIH R01 grants AI069120, AI056154 and
   AI078389, and T32 AI089398-07 grant; The Ministry of Science and
   Technology of China (2015ZX09102023, 2015CB910501); The National Natural
   Science Foundation of China (81590765, 31470273); Institutional Research
   Fund for Thousand Talents Program at the Chinese Academy of Medical
   Sciences; and the National Key Plan for Scientific Research and
   Development of China (2016YFD0500300).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin Anna P, 2016, J Infect Dis, V214, P832, DOI 10.1093/infdis/jiw067
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fellner Chris, 2016, P T, V41, P242
   Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gostin LO, 2016, JAMA-J AM MED ASSOC, V315, P2395, DOI 10.1001/jama.2016.4919
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoyt K, 2016, NAT BIOTECHNOL, V34, P384, DOI 10.1038/nbt.3532
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leibovitch EC, 2016, NEUROTHERAPEUTICS, V13, P562, DOI 10.1007/s13311-016-0453-3
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Monath TP, 2002, VACCINE, V20, P1004, DOI 10.1016/S0264-410X(01)00457-1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, ZIK SIT REP NEUR SYN
   Wilder-Smith A, 2016, EXPERT REV VACCINES, V15, P433, DOI 10.1586/14760584.2016.1154459
   World Health Organization, 2016, CURR ZIK PROD PIP
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 44
TC 4
Z9 5
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2017
VL 29
IS 1
BP 114
EP 121
DI 10.1097/MOP.0000000000000441
PG 8
WC Pediatrics
SC Pediatrics
GA EL4OV
UT WOS:000394601400018
PM 27906864
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Vasilakis, N
   Weaver, SC
AF Vasilakis, Nikos
   Weaver, Scott C.
TI Flavivirus transmission focusing on Zika
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID YELLOW-FEVER; POTENTIAL VECTOR; CULEX-PIPIENS; DENGUE VIRUS; HOST-RANGE;
   MOSQUITOS; SUSCEPTIBILITY; QUINQUEFASCIATUS; DISCOVERY; EMERGENCE
AB Flaviviruses are among the most diverse viruses with over 85 species recognized. Taxonomically, this genus is one of the 4 recognized genera within the family Flaviviridae. Most flaviviruses of human public health significance, for example, dengue, yellow fever and Zika viruses, are arthropod-borne (arboviruses) and have two evolutionarily and ecologically distinct transmission cycles: a sylvatic transmission cycle, where the virus circulates between zoonotic vertebrate reservoir and amplification hosts and arboreal mosquitoes; and an urban transmission cycle, where the virus circulates between humans and peridomestic Aedes spp. mosquitoes. Zika virus (ZIKV), a flavivirus closely related to West Nile, dengue, Spondweni, Japanese encephalitis and yellow fever viruses, remained in obscurity since its discovery in 1947, but has recently emerged to cause a series of epidemics in the South Pacific, and most recently reaching nearly pandemic levels with its introduction in the Americas. Available epidemiologic and experimental evidence points to Aedes aegypti as the principal urban vector, possibly supplemented by Aedes albopictus in some locations. Unfortunately, the former is one of the most difficult mosquitoes to control owing to its highly anthropophilic behavior.
C1 [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun,Dept Pathol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun,Dept Pathol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM nivasila@utmb.edu; sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942, 1U01AI115577]; Brown
   Foundation of Houston; Institute of Human Infection and Immunity (IHII)
FX This work was supported in part by NIH grants R24AI120942, 1U01AI115577
   and grants by the Brown Foundation of Houston and Institute of Human
   Infection and Immunity (IHII). We would also like to thank Shannan Rossi
   and Sasha Azar for expert graphic design. The funding agencies had no
   involvement in the writing of the report or in the decision to submit
   this article for publication.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EUROSURVEILLANCE, P21
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Azmi SA, 2015, J VECTOR DIS, V52, P252
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Boccolini D, 2016, EUROSURVEILLANCE, P21
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Cornet M., 1979, ORSTOM ENTOMOL MED P, V17, P149
   de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dick GW, 2017, CURRENT OPINION VIRO, V22, P30
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M., 2016, J INFECT DIS
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Guo XX, 2014, J AM MOSQUITO CONTR, V30, P309, DOI 10.2987/14-6439R.1
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hanley KA, 2013, INFECT GENET EVOL
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Olson KE, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P315
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Ritchie S, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P281
   Roundy CM, 2016, EMERG INFECT DIS
   Simmonds P., 2012, VIRUS TAXONOMY, P1003
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Walker T, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P291
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2016, ANTIVIRAL RES
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 40
Z9 43
U1 3
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2017
VL 22
BP 30
EP 35
DI 10.1016/j.coviro.2016.11.007
PG 6
WC Virology
SC Virology
GA EP4UB
UT WOS:000397374300007
PM 27936448
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Li, YK
   He, LL
   He, RL
   Yau, SST
AF Li, Yongkun
   He, Lily
   He, Rong Lucy
   Yau, Stephen S. -T.
TI Zika and Flaviviruses Phylogeny Based on the Alignment-Free Natural
   Vector Method
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE Zika virus; Flavivirus; evolution; natural vector
ID VIRUS GENOME; TRANSMISSION; MICRONESIA; EVOLUTION; EPIDEMIC; LINEAGES;
   AMERICA; SPACE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus. It was first isolated from Uganda in 1947 and has become an emergent event since 2007. However, because of the inconsistency of alignment methods, the evolution of ZIKV remains poorly understood. In this study, we first use the complete protein and an alignment-free method to build a phylogenetic tree of 87 Zika strains in which Asian, East African, and West African lineages are characterized. We also use the NS5 protein to construct the genetic relationship among 44 Zika strains. For the first time, these strains are divided into two clades: African 1 and African 2. This result suggests that ZIKV originates from Africa, then spread to Asia, Pacific islands, and throughout the Americas. We also perform the phylogeny analysis for 53 viruses in genus Flavivirus to which ZIKV belongs using complete proteins. Our conclusion is consistent with the classification by the hosts and transmission vectors.
C1 [Li, Yongkun; He, Lily; Yau, Stephen S. -T.] Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China.
   [He, Rong Lucy] Chicago State Univ, Dept Biol Sci, Chicago, IL USA.
RP Yau, SST (corresponding author), Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China.
EM yau@uic.edu
FU National Natural Sciences Foundation of ChinaNational Natural Science
   Foundation of China [31271408]; Tsinghua University; Tsinghua University
   Independent Research Project Grant
FX This study is supported by the National Natural Sciences Foundation of
   China (31271408 to S.S.-T.Y.), Tsinghua University startup fund (to
   S.S.-T.Y.), and Tsinghua University Independent Research Project Grant
   (to S.S.-T.Y.). The funders did not take part in study design, in
   collection and analysis of data, in the writing of the article, or in
   the decision to publish this article.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dai Q, 2008, BIOINFORMATICS, V24, P2296, DOI 10.1093/bioinformatics/btn436
   Deng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017293
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Huang HH, 2014, MOL PHYLOGENET EVOL, V81, P29, DOI 10.1016/j.ympev.2014.08.003
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li YK, 2016, MOL PHYLOGENET EVOL, V99, P53, DOI 10.1016/j.ympev.2016.03.009
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Wu GA, 2009, P NATL ACAD SCI USA, V106, P12826, DOI 10.1073/pnas.0905115106
   Yu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064328
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 24
TC 8
Z9 8
U1 0
U2 26
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD FEB
PY 2017
VL 36
IS 2
BP 109
EP 116
DI 10.1089/dna.2016.3532
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA EI9IC
UT WOS:000392820200004
PM 27977308
DA 2020-07-08
ER

PT J
AU Duong, V
   Ong, S
   Leang, R
   Huy, R
   Ly, S
   Mounier, U
   Ou, T
   In, S
   Peng, BN
   Ken, S
   Buchy, P
   Tarantola, A
   Horwood, PF
   Dussart, P
AF Duong, Veasna
   Ong, Sivuth
   Leang, Rithea
   Huy, Rekol
   Ly, Sowath
   Mounier, Ugo
   Ou, Teyputita
   In, Saraden
   Peng, Bonin
   Ken, Sreymom
   Buchy, Philippe
   Tarantola, Arnaud
   Horwood, Paul F.
   Dussart, Philippe
TI Low Circulation of Zika Virus, Cambodia, 2007-2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK
AB We describe a retrospective study on circulation of Zika virus in Cambodia during 2007-2016 among patients with dengue-like symptoms and Aedes aegypti mosquitoes. Our findings suggest that Zika virus in Cambodia belongs to the Asia genotype, is endemic, has low prevalence, and has had low-level impact on public health.
C1 [Duong, Veasna; Ong, Sivuth; Ly, Sowath; Mounier, Ugo; Ou, Teyputita; In, Saraden; Peng, Bonin; Ken, Sreymom; Tarantola, Arnaud; Horwood, Paul F.; Dussart, Philippe] Inst Pasteur, Phnom Penh, Cambodia.
   [Leang, Rithea; Huy, Rekol] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Buchy, Philippe] GlaxoSmithKline Vaccines Res & Dev, Singapore, Singapore.
RP Dussart, P (corresponding author), Inst Pasteur Cambodge, Virol Unit, 5 Monivong Blvd,POB 983, Phnom Penh, Cambodia.
EM pdussart@pasteur-kh.org
RI Veasna, Duong/I-9684-2014; Dussart, Philippe/P-4152-2014; Tarantola,
   Arnaud/D-2149-2015
OI Veasna, Duong/0000-0003-0353-1678; Dussart,
   Philippe/0000-0002-1931-3037; Tarantola, Arnaud/0000-0002-6946-7958;
   BUCHY, Philippe/0000-0003-1372-3008; Horwood, Paul/0000-0001-9622-0742
FU Institut Pasteur International Network, Actions Concertees
   Inter-Pasteuriennes [2014/A15]; European UnionEuropean Union (EU) [282
   378]
FX Our study was funded by Institut Pasteur International Network, Actions
   Concertees Inter-Pasteuriennes (2014/A15) and the European Union Seventh
   Framework Programme (FP7/2007/2011) under Grant Agreement 282 378.
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, MMWR-MORBID MORTAL W, V65, P474
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   ProMED, AM EUR AS
   ProMED, SING AL TRAV ADV
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
NR 15
TC 20
Z9 22
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2017
VL 23
IS 2
BP 296
EP 299
DI 10.3201/eid2302.161432
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EJ3CI
UT WOS:000393088600018
PM 27875110
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Fernandes, NCCA
   Nogueira, JS
   Ressio, RA
   Cirqueira, CS
   Kimura, LM
   Fernandes, KR
   Cunha, MS
   Souza, RP
   Guerra, JM
AF Fernandes, Natalia C. C. A.
   Nogueira, Juliana S.
   Ressio, Rodrigo A.
   Cirqueira, Cinthya S.
   Kimura, Lidia M.
   Fernandes, Karolina R.
   Cunha, Mariana S.
   Souza, Renato P.
   Guerra, Juliana M.
TI Experimental Zika virus infection induces spinal cord injury and
   encephalitis in newborn Swiss mice
SO EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE Flavivirus; Mouse; Brain; Pathology; Encephalopathy; Myelitis
ID CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; PATHOGENESIS; BRAIN
AB A widespread epidemic of Zika virus (ZIKV) infection was reported in 2015 in South and Central America, with neurological symptons including meningoencephalitis and Guillain-Barre syndrome in adults, besides an apparent increased incidence of microcephaly in infants born to infected mothers. It is becoming a necessity to have a trustworthy animal model to better understand ZIKV infection. In this study we used newborn white Swiss mice as a model to investigate the ZIKV strain recently isolated in Brazil. ZIKV was inoculated via intracerebral and subcutaneous routes and analysed through gross histopathology and immunohistochemistry. Here we demonstrated first that the intracerebral group (ICG) displayed severe cerebral lesions, with neuronal death, presence of apoptotic bodies, white matter degeneration and neutrophil perivascular cuffing. In the subcutaneous group (SCG), we observed moderate cerebral lesions, morphologically similar to that found in ICG and additional myelopathy, with architectural loss, marked by neuronal death and apoptotic bodies. Interestingly, we found an intense astrogliosis in brain of both groups, with increased immunoexpression of GFAP (glial fibrillary acidic protein) and presence of hypertrophic astrocytes. The spinal cord of subcutaneous group (SCG) exhibited reduction of astrocytes, but those positive for GFAP were hypertrophic and presented prolonged cellular processes. Finally significant lesions in the central nervous system (CNS) were present in newborn mice inoculated by both routes, but SCG method led to an important neurological manifestations (including myelopathy), during a longer period of time and appears for us to be a better model for ZIKV infection. (C) 2016 Elsevier GmbH. All rights reserved.
C1 [Fernandes, Natalia C. C. A.; Ressio, Rodrigo A.; Cirqueira, Cinthya S.; Kimura, Lidia M.; Fernandes, Karolina R.; Guerra, Juliana M.] IAL, Ctr Patol, Av Dr Arnaldo 351-7,Sala 706, BR-01246000 Sao Paulo, SP, Brazil.
   [Nogueira, Juliana S.; Cunha, Mariana S.; Souza, Renato P.] IAL, Ctr Virol, Av Dr Arnaldo 355, BR-01246000 Sao Paulo, SP, Brazil.
RP Fernandes, NCCA (corresponding author), IAL, Ctr Patol, Av Dr Arnaldo 351-7,Sala 706, BR-01246000 Sao Paulo, SP, Brazil.
EM nccafernandes@yahoo.com.br
RI Souza, Thiago Moreno L./G-2900-2012; Guerra, Juliana
   Mariotti/H-5310-2012; Fernandes, Natalia/H-4537-2012
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Guerra, Juliana
   Mariotti/0000-0002-0326-7187; Fernandes, Natalia/0000-0003-4754-4200;
   Pereira de Souza, Renato/0000-0003-1315-7085
FU Instituto Adolfo Lutz
FX This study was financially supported by Instituto Adolfo Lutz.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chowell G, PLOS CURRENTS OUTBRE
   Cugola F. R., 2016, NATURE
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Edgar MA, 2008, ARCH PATHOL LAB MED, V132, P500, DOI 10.1043/1543-2165(2008)132[500:TDDOCN]2.0.CO;2
   European Centre for Disease Prevention Control. December, 2015, RAP RISK ASS ZIK VIR
   Hou JX, 2016, CNS NEUROSCI THER, V22, P244, DOI 10.1111/cns.12509
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643
   Velandia ML, 2012, VIRAL GENOMES - MOLECULAR STRUCTURE, DIVERSITY, GENE EXPRESSION MECHANISMS AND HOST-VIRUS INTERACTIONS, P219
   Martines RB, 2015, MMWR, V65
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nagata N, 2015, J NEUROPATH EXP NEUR, V74, P250, DOI 10.1097/NEN.0000000000000166
   Nathanson N., 2007, VIRAL PATHOGENESIS I, P130
   Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   STINCHCOMBE S, 1995, CARCINOGENESIS, V16, P1271, DOI 10.1093/carcin/16.6.1271
   Verkhratsky A, 2015, NEUROCHEM RES, V40, P389, DOI 10.1007/s11064-014-1403-2
   Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x
NR 29
TC 30
Z9 32
U1 0
U2 35
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-2993
EI 1618-1433
J9 EXP TOXICOL PATHOL
JI Exp. Toxicol. Pathol.
PD FEB
PY 2017
VL 69
IS 2
BP 63
EP 71
DI 10.1016/j.etp.2016.11.004
PG 9
WC Pathology; Toxicology
SC Pathology; Toxicology
GA EJ0LT
UT WOS:000392901100001
PM 27899230
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Galindo-Marquez, ML
   Garcia-Loaiza, CJ
   Sabogal-Roman, JA
   Marin-Loaiza, S
   Ayala, AF
   Lagos-Grisales, GJ
   Lozada-Riascos, CO
   Parra-Valencia, E
   Rojas-Palacios, JH
   Lopez, E
   Lopez, P
   Grobusch, MP
AF Rodriguez-Morales, Alfonso J.
   Leonor Galindo-Marquez, Maria
   Julian Garcia-Loaiza, Carlos
   Alejandro Sabogal-Roman, Juan
   Marin-Loaiza, Santiago
   Ayala, Andres F.
   Lagos-Grisales, Guillermo J.
   Lozada-Riascos, Carlos O.
   Parra-Valencia, Esteban
   Rojas-Palacios, Jorge H.
   Lopez, Eduardo
   Lopez, Pio
   Grobusch, Martin P.
TI Mapping Zika virus disease incidence in Valle del Cauca
SO INFECTION
LA English
DT Article
DE Zika; Epidemiology; Public health; Travelers; Colombia; Latin America
ID INFORMATION-SYSTEM GIS; OUTBREAK IMPLICATIONS; TRAVEL ADVICE;
   CHIKUNGUNYA FEVER; PUBLIC-HEALTH; LATIN-AMERICA; ONE COASTAL; COLOMBIA;
   DENGUE; INFECTION
AB Geographical information systems (GIS) use for development of epidemiological maps in tropical diseases is increasingly frequently utilized. Here, we apply this technique to map the current Zika virus (ZIKV) outbreak in Colombia.
   Surveillance cases data of the ongoing epidemic of ZIKV in Valle del Cauca department and its capital, Cali (2015-2016), were used to estimate cumulated incidence rates (cases/100,000 population) to develop the first maps in the department and it municipalities. The GIS software used was Kosmo Desktop 3.0RC1(A (R)). Three thematic incidence rate maps were developed.
   Up to April 2, 2016, 9,825 cases of ZIKV were reported (15.15 % of the country cases). The burden of ZIKV infection has been concentrated in the North of the department. Valle del Cauca borders with other departments with incidence of ZIKV infection, such as Quindio (173 cases) and Risaralda (687 cases). Eleven municipalities of Valle del Cauca had cases in the range between 250 and 499 cases/100,000, all in the North and East of the department. Cali, the capital concentrates more than a third of the reported cases of ZIKV in Valle del Cauca.
   Use of GIS-based epidemiological maps allows to guide decision-making for prevention and control of diseases that constitute significant public health problems in the region and the country, such as exemplified by the emergence of ZIKV infection, particularly in departments such as Valle del Cauca with a high disease incidence.
C1 [Rodriguez-Morales, Alfonso J.; Leonor Galindo-Marquez, Maria; Julian Garcia-Loaiza, Carlos; Alejandro Sabogal-Roman, Juan; Marin-Loaiza, Santiago; Ayala, Andres F.; Lagos-Grisales, Guillermo J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Riohacha, La Guajira, Colombia.
   [Rodriguez-Morales, Alfonso J.; Parra-Valencia, Esteban; Lopez, Eduardo; Lopez, Pio; Grobusch, Martin P.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Lozada-Riascos, Carlos O.] Univ Tecnol Pereira, Reg Informat Syst, Pereira, Risaralda, Colombia.
   [Parra-Valencia, Esteban] Univ Catolica Santisima Concepcion, Fac Med, Concepcion, Chile.
   [Rojas-Palacios, Jorge H.] Secretary Hlth Cali, Cali, Valle Del Cauca, Colombia.
   [Lopez, Eduardo; Lopez, Pio] Ctr Estudios Infectol Pediat, Cali, Valle Del Cauca, Colombia.
   [Lopez, Eduardo; Lopez, Pio] Univ Valle, Dept Pediat, Cali, Valle Del Cauca, Colombia.
   [Grobusch, Martin P.] Univ Amsterdam, Ctr Trop Med & Travel Med, Dept Infect Dis, Div Internal Med, Amsterdam, Netherlands.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), OLFIS, Riohacha, La Guajira, Colombia.; Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Parra-Valencia,
   Esteban/0000-0002-7071-9374; Galindo Marquez, Maria
   Leonor/0000-0003-2498-0878
FU Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia
FX Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia. This
   study is part of the project "Desarrollo de Mapas Epidemiologicos a
   traves de Sistemas de Informacion Geografica para la Caracterizacion
   Geografica de Enfermedades Infecciosas y Tropicales en el Eje Cafetero
   de Colombia" (Code 5-15-5 [2015-2017]), Universidad Tecnologica de
   Pereira, Pereira, Risaralda, Colombia.
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Instituto Nacional de Salud de Bogota, 2016, ZIK SEM EP 13 2016
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Mattar S, 2013, INT J INFECT DIS, V17, pE358, DOI 10.1016/j.ijid.2012.11.021
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Quintero-Herrera LL, 2015, J INFECT PUBLIC HEAL, V8, P291, DOI 10.1016/j.jiph.2014.11.005
   Rodriguez-Morales AJ, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.176529, DOI 10.2471/BLT.16.176529]
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Shih YCT, 2009, PHARMACOECONOMICS, V27, P947, DOI 10.2165/11314110-000000000-00000
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   von Eije Karin J, 2015, Ned Tijdschr Geneeskd, V160, pD153
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   Zea Diego, 2011, Rev. salud pública, V13, P785, DOI 10.1590/s0124-00642011000500007
NR 27
TC 10
Z9 10
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
PD FEB
PY 2017
VL 45
IS 1
BP 93
EP 102
DI 10.1007/s15010-016-0948-1
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA EL0FJ
UT WOS:000394298000011
PM 27743307
DA 2020-07-08
ER

PT J
AU Kantor, AM
   Dong, S
   Held, NL
   Ishimwe, E
   Passarelli, AL
   Clem, RJ
   Franz, AWE
AF Kantor, A. M.
   Dong, S.
   Held, N. L.
   Ishimwe, E.
   Passarelli, A. L.
   Clem, R. J.
   Franz, A. W. E.
TI Identification and initial characterization of matrix metalloproteinases
   in the yellow fever mosquito, Aedes aegypti
SO INSECT MOLECULAR BIOLOGY
LA English
DT Article
DE Aedes aegypti; midgut; bloodmeal; matrix metalloproteinase; basal
   lamina; virus dissemination; catalytic domain; phylogeny
ID BASEMENT-MEMBRANE; TISSUE INHIBITORS; BASAL LAMINA; DROSOPHILA; FAMILY;
   INFECTION; EVOLUTION; DOMAINS; TRANSMISSION; SPECIFICITY
AB Aedes aegypti is a major vector for arboviruses such as dengue, chikungunya and Zika viruses. During acquisition of a viremic bloodmeal, an arbovirus infects mosquito midgut cells before disseminating to secondary tissues, including the salivary glands. Once virus is released into the salivary ducts it can be transmitted to another vertebrate host. The midgut is surrounded by a basal lamina (BL) in the extracellular matrix, consisting of a proteinaceous mesh composed of collagen IV and laminin. BL pore size exclusion limit prevents virions from passing through. Thus, the BL probably requires remodelling via enzymatic activity to enable efficient virus dissemination. Matrix metalloproteinases (MMPs) are extracellular endopeptidases that are involved in remodelling of the extracellular matrix. Here, we describe and characterize the nine Ae. aegypti encoded MMPs, AeMMPs 129, which share common features with other invertebrate and vertebrate MMPs. Expression profiling in Ae. aegypti revealed that Aemmp4 and Aemmp6 were upregulated during metamorphosis, whereas expression of Aemmp1 and Aemmp2 increased during bloodmeal digestion. Aemmp1 expression was also upregulated in the presence of a bloodmeal containing chikungunya virus. Using polyclonal antibodies, AeMMP1 and AeMMP2 were specifically detected in tissues associated with the mosquito midgut.
C1 [Kantor, A. M.; Dong, S.; Held, N. L.; Franz, A. W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA.
   [Ishimwe, E.; Passarelli, A. L.; Clem, R. J.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.
RP Franz, AWE (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, 303 Connaway Hall, Columbia, MO 65211 USA.
EM franza@missouri.edu
OI Dong, Shengzhang/0000-0002-8218-4688
FU National Institutes of Health-National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI091972]
FX The authors thank Dr Gavin Conant from the Animal Reproductive Group of
   the Animal Science Research Center of the University of Missouri for his
   help with the phylogenetic analyses. We also thank Dr Alexander
   Jurkevich of the University of Missouri Molecular Cytology Core for his
   assistance with confocal imaging. The chikungunya virus experiments were
   conducted in the Laboratory for Infectious Disease Research (LIDR) of
   the University of Missouri. This study was supported by National
   Institutes of Health-National Institute of Allergy and Infectious
   Diseases grant R01AI091972 (A.L.P., R.J.C., A.W.E.F.).
CR BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I
   Bond ND, 2011, DEV BIOL, V360, P286, DOI 10.1016/j.ydbio.2011.09.015
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
   Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763
   BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004
   Cawston TE, 2010, CELL TISSUE RES, V339, P221, DOI 10.1007/s00441-009-0887-6
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Fasciglione GF, 2012, J BIOL INORG CHEM, V17, P663, DOI 10.1007/s00775-012-0886-z
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Glasheen BM, 2009, P NATL ACAD SCI USA, V106, P2659, DOI 10.1073/pnas.0804171106
   Gomez DE, 1997, EUR J CELL BIOL, V74, P111
   Goulielmaki E, 2014, INFECT IMMUN, V82, P4865, DOI 10.1128/IAI.02080-14
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   HOUK EJ, 1981, ACTA TROP, V38, P163
   Jackson Brian C., 2010, Human Genomics, V4, P194
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751
   Li DY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0536-z
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200
   Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200
   Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200
   Lopez-Pelegrin M, 2015, J BIOL CHEM, V290, P4728, DOI 10.1074/jbc.M114.605956
   Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196
   Massova I, 1998, FASEB J, V12, P1075
   Means JC, 2010, P NATL ACAD SCI USA, V107, P9825, DOI 10.1073/pnas.0913582107
   Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072
   Mitten EK, 2012, INSECT BIOCHEM MOLEC, V42, P854, DOI 10.1016/j.ibmb.2012.08.001
   Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051
   Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8
   Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Passarelli AL, 2011, VIROLOGY, V411, P383, DOI 10.1016/j.virol.2011.01.009
   Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001
   Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007
   SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0
   Schmidt Rebecca L, 2011, Self Nonself, V2, P125
   Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703
   Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745
   Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27
   Uria JA, 2000, CANCER RES, V60, P4745
   Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570
   Vishnuvardhan S, 2013, J EXP ZOOL PART B, V320B, P105, DOI 10.1002/jez.b.22487
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   Wada K, 1998, GENE, V211, P57, DOI 10.1016/S0378-1119(98)00076-6
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wendell MD, 2000, INSECT MOL BIOL, V9, P119, DOI 10.1046/j.1365-2583.2000.00166.x
   YURCHENCO PD, 1994, METHOD ENZYMOL, V245, P489
   YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0
NR 57
TC 12
Z9 12
U1 0
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1075
EI 1365-2583
J9 INSECT MOL BIOL
JI Insect Mol. Biol.
PD FEB
PY 2017
VL 26
IS 1
BP 113
EP 126
DI 10.1111/imb.12275
PG 14
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA EH7GO
UT WOS:000391941200010
PM 28054419
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Reznik, SE
   Ashby, CR
AF Reznik, Sandra E.
   Ashby, Charles R., Jr.
TI Sofosbuvir: an antiviral drug with potential efficacy against Zika
   infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS
C1 [Reznik, Sandra E.; Ashby, Charles R., Jr.] St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA.
   [Reznik, Sandra E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA.
   [Reznik, Sandra E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA.
RP Reznik, SE; Ashby, CR (corresponding author), St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA.; Reznik, SE (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA.; Reznik, SE (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA.
EM rezniks@stjohns.edu; cnsratdoc@optonline.net
CR [Anonymous], 2015, PROD INF
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7
   Kirby BJ, 2015, CLIN PHARMACOKINET, V54, P677, DOI 10.1007/s40262-015-0261-7
   Lu G., 2016, ANTIMICROB AGENTS CH
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Retallack H, 2016, P NATL ACAD SCI
   Sacramento CQ, 2016, BIORXIV
   Sofia MJ, 2013, ADV PHARMACOL, V67, P39, DOI 10.1016/B978-0-12-405880-4.00002-0
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 16
TC 18
Z9 19
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2017
VL 55
BP 29
EP 30
DI 10.1016/j.ijid.2016.12.011
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EP2KN
UT WOS:000397212000008
PM 27988410
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Arias, A
   Torres-Tobar, L
   Hernandez, G
   Paipilla, D
   Palacios, E
   Torres, Y
   Duran, J
   Ugarte, US
   Ardila-Sierra, A
   Castellanos, G
AF Arias, Arturo
   Torres-Tobar, Lilian
   Hernandez, Gualberto
   Paipilla, Deyanira
   Palacios, Eduardo
   Torres, Yahaira
   Duran, Julian
   Sebastian Ugarte, U.
   Ardila-Sierra, Adriana
   Castellanos, Gabriel
TI Guillain-Barree syndrome in patients with a recent history of Zika in
   Cucuta, Colombia: A descriptive case series of 19 patients from December
   2015 to March 2016
SO JOURNAL OF CRITICAL CARE
LA English
DT Article
DE Guillain-Barre syndrome; Polyradiculoneuropathy; Zika virus infection;
   Disease outbreaks; Case reports
ID VIRUS; OUTBREAK
AB Purpose: Zika virus (ZIKV) infection is an emerging global threat and a public health problem in the Americas. Guillain-Barree syndrome (GBS) has been recently associated to ZIKV. This report presents a case series of GBS possibly associated to ZIKV. Methods: Clinical and demographic data from patients with GBS treated in 5 intensive care units and with recent history of ZIKV in Cucuta, Colombia were collected from December 1 2015 to April 30 2016. Electrophysiological examination, lumbar puncture, and reverse transcriptase-polymerase chain reaction for ZIKV were performed in 14, 10, and 1 patients, respectively.
   Results: Nineteen patients with GBS and a recent history of acute viral syndrome compatible with ZIKV infection were studied (mean age, 44 years; range, 17-78). Neurologic symptoms developed at a median of 10 days after the onset of the viral symptoms. Albuminocytological dissociation was found in 8 cases. Electrophysiological criteria for acute motor axonal neuropathy were found in all patients tested. Five patients met level 1, 8 patients level 2, and 6 patients level 3 of diagnostic certainty for GBS in the Brighton classification. Fifteen patients required respiratory assistance, 16 received intravenous immunoglobulins, and 3 had plasmapheresis. Seventynine percent of patients were in Hughes GBS disability scale 4 to 5 at discharge and no patients died during the observation period. Acute ZIKV infection, confirmed by reverse transcriptase-polymerase chain reaction, was observed for 1 patient.
   Conclusions: All cases of this GBS outbreak had a recent history ZIKV infection, reinforcing existing evidence for the association between GBS and ZIKV. Future genetic and immunologic studies are warranted to further investigate the cause of the outbreak in detail. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Arias, Arturo] Fund Univ Ciencias Salud, Intens Care Unit, Clin Norte, Cucuta Norte Santander, Bogota, Colombia.
   [Torres-Tobar, Lilian; Hernandez, Gualberto] Fund Univ Ciencias Salud, Grup Ciencias Basicas Salud, Bogota, Colombia.
   [Paipilla, Deyanira; Torres, Yahaira] SOMEFYR, Bogota, Colombia.
   [Palacios, Eduardo] Fund Univ Ciencias Salud, Hosp Sanjose, Dept Neurol, Bogota, Colombia.
   [Duran, Julian] Intens Care Unit, Clin Norte, Bogota, Colombia.
   [Sebastian Ugarte, U.] Clin Indisa Univ Andrs Bello, Jefe Centro Pacientes Crticos, Vinadelmar, Chile.
   [Ardila-Sierra, Adriana; Castellanos, Gabriel] Fund Univ Ciencias Salud, Div Res, Bogota, Colombia.
RP Castellanos, G (corresponding author), Fund Univ Ciencias Salud, Div Res, Bogota, Colombia.
EM gcastellanos@fucsalud.edu.co
RI castellanos, gabriel/G-3358-2016
OI castellanos, gabriel/0000-0001-8121-1552; Torres-Tobar,
   Lilian/0000-0002-1251-2682; Ardila-Sierra, Adriana/0000-0002-4070-0365
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, N ENGL J MED
   Chen JK, 2002, AM J NEPHROL, V22, P560, DOI 10.1159/000065268
   DANE, 2016, B TECN
   Egea-Jimenez C, 2013, REV CIENC SOC, V19, P92
   Gast Galvis A, 1982, HIST FIEBRE AMARILLA
   Gonzalez P, 2014, NEUROLOGIA BARC SPAI
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   INS, 2015, B EP SEM BES, P56
   INS, 2016, B EP SEM BES, P100
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucchese G, 2016, AUTOIMMUN REV
   McGarvey PB, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0061-0
   Mecharles S, 2016, LANCET
   Misirli H, 2008, Electromyogr Clin Neurophysiol, V48, P103
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Ortiz-Corredor F, 2007, DISABIL REHABIL, V29, P883, DOI 10.1080/09638280701240326
   Pacheco O, 2016, N ENGL J MED
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Reyna-Villasmil E, 2016, MED CLIN
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Smith AG, 1997, MUSCLE NERVE, V20, P1445
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Uncini A, 2015, J NEUROL NEUROSUR PS, V86, P5, DOI 10.1136/jnnp-2014-308220
   WHO PAHO, 2016, EP UPD ZIK VIR INF
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2016, ID MAN GUILL BARR SY
NR 36
TC 37
Z9 40
U1 0
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD FEB
PY 2017
VL 37
BP 19
EP 23
DI 10.1016/j.jcrc.2016.08.016
PG 5
WC Critical Care Medicine
SC General & Internal Medicine
GA EO9UW
UT WOS:000397034600005
PM 27610587
DA 2020-07-08
ER

PT J
AU Suwanmanee, S
   Luplertlop, N
AF Suwanmanee, San
   Luplertlop, Natthanej
TI Dengue and Zika viruses: lessons learned from the similarities between
   these Aedes mosquito-vectored arboviruses
SO JOURNAL OF MICROBIOLOGY
LA English
DT Review
DE Dengue virus; Zika virus; Aedes mosquito; arboviruses; flavivirus;
   microcephaly
ID ANTIBODY-DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; PLASMA LEAKAGE;
   CLINICAL-MANIFESTATIONS; INFECTION; DISEASE; BRAZIL; EPIDEMIOLOGY;
   EMERGENCE; OUTBREAK
AB The currently spreading arbovirus epidemic is having a severe impact on human health worldwide. The two most common flaviviruses, dengue virus (DENY) and Zika virus (ZIKV), are transmitted through the same viral vector, Aedes spp. mosquitoes. Since the discovery of DENY in 1943, this virus has been reported to cause around 390 million human infections per year, approximately 500,000 of which require hospitalization and over 20,000 of which are lethal. The present DENY epidemic is primarily concentrated in Southeast Asia. ZIKV, which was discovered in 1952, is another important arthropod-borne flavivirus. The neurotropic role of ZIKV has been reported in infected newborns with microcephaly and in adults with Guillain-Barre syndrome. Despite DENY and ZIKV sharing the same viral vector, their complex pathogenic natures are poorly understood, and the infections they cause do not have specific treatments or effective vaccines. Therefore, this review will describe what is currently known about the clinical characteristics, pathogenesis mechanisms, and transmission of these two viruses. Better understanding of the interrelationships between DENY and ZIKV will provide a useful perspective for developing an effective strategy for controlling both viruses in the future.
C1 [Suwanmanee, San; Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10400, Thailand.
RP Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10400, Thailand.
EM natthanej.lup@mahidol.ac.th
FU Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D.
   ProgramThailand Research Fund (TRF) [PHD/0001/2557]; Mahidol University
FX A scholarship from the Thailand Research Fund (TRF) through the Royal
   Golden Jubilee Ph.D. Program (Grant No. PHD/0001/2557) to S.S. and a
   research grant from Mahidol University to N.L. are gratefully
   acknowledged.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   [Anonymous], 2015, HUM VACC IMMUNOTHER, V10, P3427
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Bajpai Smrati, 2016, J Assoc Physicians India, V64, P42
   Balasubramanian S, 2006, INDIAN PEDIATR, V43, P334
   Balasubramanian S, 2004, J TROP PEDIATRICS, V50, P123, DOI 10.1093/tropej/50.2.123
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Christian EA, 2013, P NATL ACAD SCI USA, V110, P18662, DOI 10.1073/pnas.1310962110
   Constenla D, 2016, EXPERT REV VACCINES, V15, P547, DOI 10.1586/14760584.2016.1134329
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DIETZ VJ, 1992, B WORLD HEALTH ORGAN, V70, P745
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Flingai S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12616
   Gan Victor C, 2014, Curr Treat Options Infect Dis, V6, P208
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Hadinegoro RS, 2012, PAEDIATR INT CHILD H, V32, P33, DOI 10.1179/2046904712Z.00000000052
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Howard CR, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.37
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Massey TH, 2016, J NEUROL, V263, P1255, DOI 10.1007/s00415-016-8165-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Organization W. H., 2011, COMPR GUILDL PREV CO
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pillet S, 2009, VIROLOGIE, V13, P183
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puttikhunt C, 2003, J VIROL METHODS, V109, P55, DOI 10.1016/S0166-0934(03)00045-4
   Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Roze B., 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.E5.2016.21.9.30154, DOI 10.2807/1560-7917.E5.2016.21.9.30154]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmidt CW, 2016, ENVIRON HEALTH PERSP, V124, pA157, DOI 10.1289/ehp.124-A157
   Schwartz D.A., 2016, ARCH PATHOL LAB MED
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sim S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0907-2
   Singhi S, 2007, J PEDIAT-BRAZIL, V83, pS22, DOI 10.1590/S0021-75572007000300004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073
   Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10
   Srikiatkhachorn A, 2009, THROMB HAEMOSTASIS, V102, P1042, DOI 10.1160/TH09-03-0208
   Tantawichien Terapong, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P79
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   Toan NT, 2015, TROP MED INT HEALTH, V20, P840, DOI 10.1111/tmi.12498
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110620
NR 104
TC 18
Z9 18
U1 0
U2 36
PU MICROBIOLOGICAL  SOCIETY KOREA
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER 803, 635-4 YEOGSAM-DONG, KANGNAM-KU,
   SEOUL 135-703, SOUTH KOREA
SN 1225-8873
EI 1976-3794
J9 J MICROBIOL
JI J. Microbiol.
PD FEB
PY 2017
VL 55
IS 2
BP 81
EP 89
DI 10.1007/s12275-017-6494-4
PG 9
WC Microbiology
SC Microbiology
GA EJ0JJ
UT WOS:000392894200001
PM 28120186
DA 2020-07-08
ER

PT J
AU Gelber, SE
   Grunebaum, A
   Chervenak, FA
AF Gelber, Shari E.
   Grunebaum, Amos
   Chervenak, Frank A.
TI Prenatal screening for microcephaly: an update after three decades
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE Microcephaly; prenatal diagnosis; ultrasound; Zika virus
ID ZIKA VIRUS; CIRCUMFERENCE
AB Background: Due to the recent outbreak of Zika virus, there has been a newfound interest in fetal and neonatal microcephaly. In 1984, Chervenak et al. proposed criteria for the prenatal ultrasound diagnosis of microcephaly as <= 3 standard deviations (SD) from the mean. Despite improvements in medicine these criteria have not been reevaluated in 30 years.
   Objective: To examine how the original 1984-Chervenak et al. criteria for the diagnosis of fetal microcephaly apply to a current population utilizing modern ultrasound equipment and techniques.
   Study design: Retrospective database review of 27,697 ultrasound exams between 18 and 40 weeks' gestation. Mean and SDs were calculated for each week of gestation from 18 to 40 completed weeks and these were compared to the 1984 data.
   Results: There is no statistically significant difference in gestational age-specific mean head circumference (HC) between the two studied populations. Because the current dataset is larger the SD differ.
   Conclusions: The 1984 ultrasound criteria for microcephaly remain valid. Physicians today have two alternatives: either use the 3SD cutoff as recommended by Chervenak et al. and endorsed by the Society for Maternal-Fetal Medicine (SMFM) or develop a new dataset for one's population with statistical validation.
C1 [Gelber, Shari E.; Grunebaum, Amos; Chervenak, Frank A.] Cornell Univ, Weill Med Coll, Dept Obstet & Gynecol, 525 East 68th St,Box 122, New York, NY 10065 USA.
RP Gelber, SE (corresponding author), Cornell Univ, Weill Med Coll, Dept Obstet & Gynecol, 525 East 68th St,Box 122, New York, NY 10065 USA.
EM shg7001@med.cornell.edu
RI Sampiev, Abdulmutalip/N-4757-2019; Chervenak, Frank/P-3555-2017
OI Sampiev, Abdulmutalip/0000-0002-5100-2239; Chervenak,
   Frank/0000-0002-4600-0853
CR CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512, DOI 10.1016/0002-9378(84)90027-9
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Dean A. G., OPENEPI OPEN SOURCE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Jeanty P, 1984, Am J Perinatol, V1, P118, DOI 10.1055/s-2007-999987
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smulian JC, 1999, OBSTET GYNECOL, V93, P692, DOI 10.1016/S0029-7844(98)00517-1
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
NR 16
TC 9
Z9 9
U1 0
U2 6
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD FEB
PY 2017
VL 45
IS 2
BP 167
EP 170
DI 10.1515/jpm-2016-0220
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA EJ6LS
UT WOS:000393331500003
PM 27662643
DA 2020-07-08
ER

PT J
AU Campos, RK
   Wong, B
   Xie, XP
   Lu, YF
   Shi, PY
   Pompon, J
   Garcia-Blanco, MA
   Bradrick, SS
AF Campos, Rafael K.
   Wong, Benjamin
   Xie, Xuping
   Lu, Yi-Fan
   Shi, Pei-Yong
   Pompon, Julien
   Garcia-Blanco, Mariano A.
   Bradrick, Shelton S.
TI RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early
   Viral Protein Accumulation
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE flavivirus; ribosomal proteins; translation
ID RNA SECONDARY STRUCTURE; CAP-INDEPENDENT TRANSLATION; HEPATITIS-C VIRUS;
   DENGUE VIRUS; MESSENGER-RNA; RIBOSOMAL STALK; YELLOW-FEVER; DEPENDENT
   TRANSLATION; UNTRANSLATED REGION; ZIKA VIRUS
AB The Flavivirus genus contains several arthropod-borne viruses that pose global health threats, including dengue viruses (DENV), yellow fever virus (YFV), and Zika virus (ZIKV). In order to understand how these viruses replicate in human cells, we previously conducted genome-scale RNA interference screens to identify candidate host factors. In these screens, we identified ribosomal proteins RPLP1 and RPLP2 (RPLP1/2) to be among the most crucial putative host factors required for DENV and YFV infection. RPLP1/2 are phosphoproteins that bind the ribosome through interaction with another ribosomal protein, RPLP0, to form a structure termed the ribosomal stalk. RPLP1/2 were validated as essential host factors for DENV, YFV, and ZIKV infection in two human cell lines: A549 lung adenocarcinoma and HuH-7 hepatoma cells, and for productive DENV infection of Aedes aegypti mosquitoes. Depletion of RPLP1/2 caused moderate cell-line-specific effects on global protein synthesis, as determined by metabolic labeling. In A549 cells, global translation was increased, while in HuH-7 cells it was reduced, albeit both of these effects were modest. In contrast, RPLP1/2 knockdown strongly reduced early DENV protein accumulation, suggesting a requirement for RPLP1/2 in viral translation. Furthermore, knockdown of RPLP1/2 reduced levels of DENV structural proteins expressed from an exogenous transgene. We postulate that these ribosomal proteins are required for efficient translation elongation through the viral open reading frame. In summary, this work identifies RPLP1/2 as critical flaviviral host factors required for translation.
   IMPORTANCE Flaviviruses cause important diseases in humans. Examples of mosquito-transmitted flaviviruses include dengue, yellow fever and Zika viruses. Viruses require a plethora of cellular factors to infect cells, and the ribosome plays an essential role in all viral infections. The ribosome is a complex macromolecular machine composed of RNA and proteins and it is responsible for protein synthesis. We identified two specific ribosomal proteins that are strictly required for flavivirus infection of human cells and mosquitoes: RPLP1 and RPLP2 (RPLP1/2). These proteins are part of a structure known as the ribosomal stalk and help orchestrate the elongation phase of translation. We show that flaviviruses are particularly dependent on the function of RPLP1/2. Our findings suggest that ribosome composition is an important factor for virus translation and may represent a regulatory layer for translation of specific cellular mRNAs.
C1 [Campos, Rafael K.; Lu, Yi-Fan; Garcia-Blanco, Mariano A.; Bradrick, Shelton S.] Duke Univ, Ctr RNA Biol, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.
   [Campos, Rafael K.; Xie, Xuping; Shi, Pei-Yong; Garcia-Blanco, Mariano A.; Bradrick, Shelton S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Wong, Benjamin; Shi, Pei-Yong; Pompon, Julien; Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Pompon, Julien] MIVEGEC, IRD, Montpellier, France.
   [Lu, Yi-Fan] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY USA.
RP Garcia-Blanco, MA; Bradrick, SS (corresponding author), Duke Univ, Ctr RNA Biol, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Garcia-Blanco, MA; Bradrick, SS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Garcia-Blanco, MA (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
EM maragarc@utmb.edu; ssbradri@utmb.edu
RI Xie, Xuping/AAD-7406-2019; Campos, Rafael Kroon/AAB-5135-2020
OI Campos, Rafael Kroon/0000-0002-4852-0449
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI101431]
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Artero-Castro A, 2009, EXP CELL RES, V315, P1372, DOI 10.1016/j.yexcr.2009.02.007
   Artero-Castro A, 2015, AUTOPHAGY, V11, P1499, DOI 10.1080/15548627.2015.1063764
   Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152
   Burki T, 2016, LANCET INFECT DIS, V16, P896, DOI 10.1016/S1473-3099(16)30224-9
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gorochowski TE, 2015, NUCLEIC ACIDS RES, V43, P3022, DOI 10.1093/nar/gkv199
   Green A, 2016, LANCET, V387, P2493, DOI 10.1016/S0140-6736(16)30835-2
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hertz MI, 2013, MOL CELL BIOL, V33, P1016, DOI 10.1128/MCB.00879-12
   Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868
   Huang JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002766
   Ishii K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-37
   Ito K, 2014, NUCLEIC ACIDS RES, V42, P14042, DOI 10.1093/nar/gku1248
   Jiang N, 2015, ARCH BIOCHEM BIOPHYS, V583, P130, DOI 10.1016/j.abb.2015.08.006
   Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808
   Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427
   Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krokowski D, 2007, BIOCHEM BIOPH RES CO, V355, P575, DOI 10.1016/j.bbrc.2007.02.024
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mao YH, 2014, NUCLEIC ACIDS RES, V42, P4813, DOI 10.1093/nar/gku159
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   MARKOFF L, 1989, J VIROL, V63, P3345, DOI 10.1128/JVI.63.8.3345-3352.1989
   Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039
   Martinez-Azorin F, 2008, BIOCHEM J, V413, P527, DOI 10.1042/BJ20080049
   Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499
   McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156
   Nguyen-Lefebvre AT, 2014, ONCOGENE, V33, P1581, DOI 10.1038/onc.2013.93
   Olivares E, 2014, J VIROL, V88, P5936, DOI 10.1128/JVI.00279-14
   Perucho L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099956
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041
   Rodnina MV, 2016, J MOL BIOL, V428, P2165, DOI 10.1016/j.jmb.2016.03.022
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346
   TRACY S, 1992, ARCH VIROL, V122, P399, DOI 10.1007/BF01317202
   Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012
   Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x
   Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014
   Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 69
TC 27
Z9 27
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2017
VL 91
IS 4
AR UNSP e01706
DI 10.1128/JVI.01706-16
PG 17
WC Virology
SC Virology
GA EK4FU
UT WOS:000393883300010
PM 27974556
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Salinas, S
   Erkilic, N
   Damodar, K
   Moles, JP
   Fournier-Wirth, C
   Van de Perre, P
   Kalatzis, V
   Simonin, Y
AF Salinas, Sara
   Erkilic, Nejla
   Damodar, Krishna
   Moles, Jean-Pierre
   Fournier-Wirth, Chantal
   Van de Perre, Philippe
   Kalatzis, Vasiliki
   Simonin, Yannick
TI Zika Virus Efficiently Replicates in Human Retinal Epithelium and
   Disturbs Its Permeability
SO JOURNAL OF VIROLOGY
LA English
DT Letter
DE Retina; Zika virus; polarized epithelia
ID GENE-THERAPY
C1 [Salinas, Sara; Moles, Jean-Pierre; Fournier-Wirth, Chantal; Van de Perre, Philippe; Simonin, Yannick] Univ Montpellier, Etab Francais Sang, INSERM, Pathogenesis & Control Chron Infect,UMR 1058, Montpellier, France.
   [Erkilic, Nejla; Damodar, Krishna; Kalatzis, Vasiliki] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France.
   [Erkilic, Nejla; Damodar, Krishna; Kalatzis, Vasiliki; Simonin, Yannick] Univ Montpellier, Montpellier, France.
   [Fournier-Wirth, Chantal] Etab Francais Sang, Montpellier, France.
   [Van de Perre, Philippe] CHU Montpellier, Montpellier, France.
RP Salinas, S (corresponding author), Univ Montpellier, Etab Francais Sang, INSERM, Pathogenesis & Control Chron Infect,UMR 1058, Montpellier, France.; Kalatzis, V (corresponding author), Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France.; Kalatzis, V (corresponding author), Univ Montpellier, Montpellier, France.
EM sara.salinas@inserm.fr; vasiliki.kalatzis@inserm.fr
RI Moles, Jean-Pierre/M-2286-2017; Van de Perre, Philippe/B-9692-2008;
   Salinas, Sara/O-1856-2013; Salinas, Sara/O-1150-2019; Kalatzis,
   Vasiliki/F-6170-2019
OI Moles, Jean-Pierre/0000-0002-6863-6350; Van de Perre,
   Philippe/0000-0002-3912-0427; Salinas, Sara/0000-0003-4492-2093;
   Salinas, Sara/0000-0003-4492-2093; Kalatzis,
   Vasiliki/0000-0002-9626-8807; simonin, yannick/0000-0002-3475-1369
FU Retina France, France Choroideremia; Asociacion de Afectados
   Coroideremia; REACTing
FX This work was funded by Retina France, France Choroideremia (N.E.), the
   Asociacion de Afectados Coroideremia (K.D.), and REACTing.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Li Y, 2014, MOL THER, V22, P1688, DOI 10.1038/mt.2014.100
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, N ENGL J MED
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 16
TC 14
Z9 14
U1 0
U2 40
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2017
VL 91
IS 3
AR UNSP e02144
DI 10.1128/JVI.02144-16
PG 4
WC Virology
SC Virology
GA EJ4NR
UT WOS:000393194600032
PM 27852856
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Marquez, S
   Carrera, J
   Pullan, ST
   Lewandowski, K
   Paz, V
   Loman, N
   Quick, J
   Bonsall, D
   Powell, R
   Theze, J
   Pybus, OG
   Klenerman, P
   Eisenberg, J
   Coloma, J
   Carroll, MW
   Trueba, G
   Logue, CH
AF Marquez, S.
   Carrera, J.
   Pullan, S. T.
   Lewandowski, K.
   Paz, V.
   Loman, N.
   Quick, J.
   Bonsall, D.
   Powell, R.
   Theze, J.
   Pybus, O. G.
   Klenerman, P.
   Eisenberg, J.
   Coloma, J.
   Carroll, M. W.
   Trueba, G.
   Logue, C. H.
TI First Complete Genome Sequences of Zika Virus Isolated from Febrile
   Patient Sera in Ecuador
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Here, we present the complete genome sequences of two Zika virus (ZIKV) strains, EcEs062_16 and EcEs089_16, isolated from the sera of febrile patients in Esmeraldas City, in the northern coastal province of Esmeraldas, Ecuador, in April 2016. These are the first complete ZIKV genomes to be reported from Ecuador.
C1 [Marquez, S.; Carrera, J.; Trueba, G.; Logue, C. H.] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Quito, Ecuador.
   [Pullan, S. T.; Lewandowski, K.; Carroll, M. W.; Logue, C. H.] Publ Hlth England, Porton Down, England.
   [Paz, V.] Hosp Delfina Torres Concha, Clin Lab, Esmeraldas, Ecuador.
   [Loman, N.; Quick, J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Bonsall, D.; Klenerman, P.] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England.
   [Powell, R.] Primer Design Ltd, Southampton, Hants, England.
   [Theze, J.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Eisenberg, J.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
   [Coloma, J.] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RP Logue, CH (corresponding author), Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Quito, Ecuador.; Logue, CH (corresponding author), Publ Hlth England, Porton Down, England.
EM clogue@usfq.edu.ec
RI Loman, Nicholas/Z-1573-2019; Pybus, Oliver g/B-2640-2012; Trueba,
   Gabriel/F-9707-2015
OI Pybus, Oliver g/0000-0002-8797-2667; Trueba,
   Gabriel/0000-0003-2617-9021; Loman, Nicholas/0000-0002-9843-8988;
   bonsall, david/0000-0003-2187-0550
FU Public Health England (PHE); USFQ; University of California,
   BerkeleyUniversity of California System
FX This project was partially funded by Public Health England (PHE), USFQ,
   and the University of California, Berkeley. All real-time PCR reagents
   were provided freely by Primer Design, Ltd. PHE European Collection of
   Authenticated Cell Cultures (ECACC) generously provided C6/36 cell
   lines. No external funding was provided for this work.
CR Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   Ministry of Public Health of Ecuador, 2016, CAS CONF AUT IMP ZIK, P47
   Pan American Health Organization/World Health Organization, 2016, ZIK SUSP CONF CAS RE
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
NR 6
TC 2
Z9 2
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD FEB
PY 2017
VL 5
IS 8
AR e01673-16
DI 10.1128/genomeA.01673-16
PG 2
WC Microbiology
SC Microbiology
GA VI1EB
UT WOS:000460682000019
PM 28232448
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prasad, VM
   Miller, AS
   Klose, T
   Sirohi, D
   Buda, G
   Jiang, W
   Kuhn, RJ
   Rossmann, MG
AF Prasad, Vidya Mangala
   Miller, Andrew S.
   Klose, Thomas
   Sirohi, Devika
   Buda, Geeta
   Jiang, Wen
   Kuhn, Richard J.
   Rossmann, Michael G.
TI Structure of the immature Zika virus at 9 angstrom resolution
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID WEST-NILE VIRUS; ANTIBODY-MEDIATED NEUTRALIZATION; DENGUE VIRUS;
   DEPENDENT ENHANCEMENT; MATURATION; PROTEIN; INFECTION; MICROSCOPY;
   DISEASE
AB The current Zika virus (ZIKV) epidemic is characterized by severe pathogenicity in both children and adults. Sequence changes in ZIKV since its first isolation are apparent when pre-epidemic strains are compared with those causing the current epidemic. However, the residues that are responsible for ZIKV pathogenicity are largely unknown. Here we report the cryo-electron microscopy (cryo-EM) structure of the immature ZIKV at 9-angstrom resolution. The cryo-EM map was fitted with the crystal structures of the precursor membrane and envelope glycoproteins and was shown to be similar to the structures of other known immature flaviviruses. However, the immature ZIKV contains a partially ordered capsid protein shell that is less prominent in other immature flaviviruses. Furthermore, six amino acids near the interface between pr domains at the top of the spikes were found to be different between the pre-epidemic and epidemic ZIKV, possibly influencing the composition and structure of the resulting viruses.
C1 [Prasad, Vidya Mangala; Miller, Andrew S.; Klose, Thomas; Sirohi, Devika; Buda, Geeta; Jiang, Wen; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
RP Kuhn, RJ; Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
EM kuhnr@purdue.edu; mr@purdue.edu
RI Sirohi, Devika/I-7136-2019
OI Sirohi, Devika/0000-0001-8601-6211; Jiang, Wen/0000-0002-1292-2411
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RO1 AI076331, RO1
   AI073755]
FX We thank M. Sevvana for discussions about the manuscript. We thank S.
   Kelly for helping us prepare the manuscript. We also thank the Purdue
   Cryo-EM Facility for equipment access and support. This work was
   supported by the National Institutes of Health (RO1 AI076331 to M.G.R.
   and R.J.K., and a subaward for RO1 AI073755 (principal investigator: M.
   S. Diamond, Washington University) to both M.G.R. and R.J.K.).
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0
   Davenport TM, 2013, J VIROL, V87, P10855, DOI 10.1128/JVI.01535-13
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lindenbach BD, 2013, FIELDS VIROLOGY, P712
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 32
TC 57
Z9 59
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD FEB
PY 2017
VL 24
IS 2
BP 184
EP +
DI 10.1038/nsmb.3352
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EL0JW
UT WOS:000394309700013
PM 28067914
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Antony, KM
   Ehrenthal, D
   Evensen, A
   Iruretagoyena, JI
AF Antony, Kathleen M.
   Ehrenthal, Deborah
   Evensen, Ann
   Iruretagoyena, J. Igor
TI Travel During Pregnancy: Considerations for the Obstetric Provider
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Review
ID YELLOW-FEVER VACCINATION; WATER-PURIFICATION TABLETS; ACUTE RESPIRATORY
   SYNDROME; FLIGHT RADIATION-EXPOSURE; PLANNING AIR-TRAVEL; HIGH-ALTITUDE;
   ZIKA VIRUS; UNITED-STATES; VENOUS THROMBOSIS; TYPHOID-FEVER
AB Importance: Travel among US citizens is becoming increasingly common, and travel during pregnancy is also speculated to be increasingly common. During pregnancy, the obstetric provider may be the first or only clinician approached with questions regarding travel.
   Objective: In this review, we discuss the reasons women travel during pregnancy, medical considerations for long-haul air travel, destination-specific medical complications, and precautions for pregnant women to take both before travel and while abroad. To improve the quality of pretravel counseling for patients before or during pregnancy, we have created 2 tools: a guide for assessing the pregnant patient's risk during travel and a pretravel checklist for the obstetric provider. Evidence Acquisition: A PubMed search for English-language publications about travel during pregnancy was performed using the search terms "travel" and "pregnancy" andwas limited to those published since the year 2000. Studies on subtopics were not limited by year of publication.
   Results: Eight review articles were identified. Three additional studies that analyzed data from travel clinics were found, and 2 studies reported on the frequency of international travel during pregnancy. Additional publications addressed air travel during pregnancy (10 reviews, 16 studies), high-altitude travel during pregnancy (5 reviews, 5 studies), and destination-specific illnesses in pregnant travelers.
   Conclusions and Relevance: Travel during pregnancy including international travel is common. Pregnant travelers have unique travel-related and destination-specific risks. We review those risks and provide tools for obstetric providers to use in counseling pregnant travelers.
   Target Audience: Obstetricians and gynecologists, family physicians, and midwives.
   Learning Objectives: After completing this activity, the learner should be better able to ask appropriate questions of women who are planning travel during pregnancy; understand the increased risks borne by pregnant women who travel, especially to locations with limited medical resources and/or high rates of foodborne, waterborne, or mosquito-borne illnesses; counsel women about precautions regarding air travel including reducing risk of venous thromboembolism; and counsel women about destination-specific risks or feel empowered to refer women to travel clinics for patients with comorbidities, planning travel to high-risk destinations, orwho require immunizations not used for routine vaccination of US patients.
C1 [Antony, Kathleen M.; Iruretagoyena, J. Igor] Univ Wisconsin, Div Maternal Fetal Med, Dept Obstet & Gynecol, 202 South Pk St, Madison, WI 53706 USA.
   [Ehrenthal, Deborah] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.
   [Evensen, Ann] Univ Wisconsin, Dept Family Med & Community Hlth, Madison, WI 53706 USA.
RP Antony, KM (corresponding author), Univ Wisconsin, Div Maternal Fetal Med, Dept Obstet & Gynecol, 202 South Pk St, Madison, WI 53706 USA.
EM kantony@wisc.edu
RI amsalu, ribka/G-8780-2019
OI Antony, Kathleen M/0000-0003-3537-8030
CR ACOG Practice Bulletin No, 2013, OBSTET GYNECOL, V122, P706, DOI DOI 10.1097/01.AOG.0000433981.36184.4E
   American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V114, P954
   American College of Obstetrics and Gynecologists, 2015, OBSTET GYNECOL, V125, P1510, DOI [10.1097/J.235426, DOI 10.1097/01.AOG.0000466430.19823.53]
   Cardona-Ospina JA, 2015, TRAVEL MED INFECT DI, V13, P335, DOI 10.1016/j.tmaid.2015.06.014
   [Anonymous], 2013, Obstet Gynecol, V121, P1411, DOI 10.1097/01.AOG.0000431054.33593.e3
   [Anonymous], 1996, MMWR-MORBID MORTAL W, V45, P538
   [Anonymous], 2015, MAT MORT
   Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3
   Antony KM, 2015, AM J PERINAT, V32, P545, DOI 10.1055/s-0034-1396700
   ARTAL R, 1995, AM J OBSTET GYNECOL, V172, P1170, DOI 10.1016/0002-9378(95)91475-7
   Arya R, 2002, BRIT J HAEMATOL, V116, P653, DOI 10.1046/j.0007-1048.2001.03330.x
   Aspholm R, 1999, J OCCUP ENVIRON MED, V41, P486, DOI 10.1097/00043764-199906000-00015
   Aubel Noemie, 2009, Rev Prat, V59, P23
   Aw B, 2014, CAN FAM PHYSICIAN, V60, P1091
   Barish RJ, 2004, OBSTET GYNECOL, V103, P1326, DOI 10.1097/01.AOG.0000126947.90065.90
   Barish RJ, 2006, HEALTH PHYS, V91, pS10, DOI 10.1097/01.HP.0000214138.14949.9b
   BARRY M, 1989, JAMA-J AM MED ASSOC, V261, P728, DOI 10.1001/jama.261.5.728
   Becker NG, 2006, AUST NZ J PUBL HEAL, V30, P5, DOI 10.1111/j.1467-842X.2006.tb00077.x
   Ben-Chetrit E, 2015, J TRAVEL MED, V22, P94, DOI 10.1111/jtm.12165
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Bi YH, 2015, J GEN VIROL, V96, P1055, DOI 10.1099/vir.0.000054
   BLOLAND PB, 1995, AIDS, V9, P721, DOI 10.1097/00002030-199507000-00009
   Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109
   Brabin B, 1997, ANN HUM BIOL, V24, P547, DOI 10.1080/03014469700005312
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brigham SA, 1999, HUM REPROD, V14, P2868, DOI 10.1093/humrep/14.11.2868
   Cannegieter SC, 2006, PLOS MED, V3, P1258, DOI 10.1371/journal.pmed.0030307
   Cannegieter SC, 2013, THROMB RES, V131, pS55, DOI 10.1016/S0049-3848(13)70023-9
   Cannegieter SC, 2012, BEST PRACT RES CL HA, V25, P345, DOI 10.1016/j.beha.2012.07.008
   Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758
   Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144
   Carroll I Dale, 2008, Travel Med Infect Dis, V6, P259, DOI 10.1016/j.tmaid.2008.04.005
   Carroll I Dale, 2007, Travel Med Infect Dis, V5, P183, DOI 10.1016/j.tmaid.2006.11.002
   Cavalcanti DP, 2007, TROP MED INT HEALTH, V12, P833, DOI 10.1111/j.1365-3156.2007.01851.x
   Centers for Disease Control and Prevention, 2016, AR WITH ZIK
   Centers for Disease Control and Prevention, 2016, ZIK VIR AR ZIK
   Centers for Disease Control and Prevention, 2016, INF AD PAT 2016 REC
   Centers for Disease Control and Prevention, 2013, IMM PREGN
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chaudhry SA, 2015, CAN FAM PHYSICIAN, V61, P607
   Chen J, 2008, HEALTH PHYS, V95, P407, DOI 10.1097/01.HP.0000318888.79738.23
   Chibber R, 2006, AUST NZ J OBSTET GYN, V46, P24, DOI 10.1111/j.1479-828X.2006.00508.x
   Clark HC, 1914, J EXP MED, V22, P427, DOI 10.1084/jem.22.4.427
   [Clinical Evaluation & Disease Centers for Disease Control and Prevention], 2016, ZIK VIR HOM HEALTHC
   Cobelens FGJ, 1998, TROP MED INT HEALTH, V3, P687, DOI 10.1046/j.1365-3156.1998.00294.x
   Committee on Obstetric Practice American College of Obstetricians and Gynecologists, 2014, Obstet Gynecol, V124, P1241, DOI 10.1097/01.AOG.0000457501.73326.6c
   Cone JE, 1998, J OCCUP ENVIRON MED, V40, P210, DOI 10.1097/00043764-199803000-00002
   Cooper Marvin C, 2006, Travel Med Infect Dis, V4, P196, DOI 10.1016/j.tmaid.2005.06.003
   D'Acremont V, 2008, J TRAVEL MED, V15, P77, DOI 10.1111/j.1708-8305.2007.00175.x
   Dahl E, 2007, INT MARIT HEALTH, V58, P195
   DANIELL WE, 1990, AVIAT SPACE ENVIR MD, V61, P840
   de Miranda 2nd HA, 2016, OPHTHALMOLOGY, P1
   Denny M., 2016, PADI BLOG
   DILDY GA, 1990, J REPROD MED, V35, P273
   Ducarme G, 2010, AM J PERINAT, V27, P171, DOI 10.1055/s-0029-1234035
   Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x
   Elinav E, 2006, GASTROENTEROLOGY, V130, P1129, DOI 10.1053/j.gastro.2006.01.007
   Entin PL, 2004, HIGH ALT MED BIOL, V5, P321, DOI 10.1089/1527029042002826
   Espinosa FM, 2000, LANCET, V356, P685, DOI 10.1016/S0140-6736(05)73838-1
   Espinoza E, 2005, J MATERN-FETAL NEO M, V18, P101, DOI 10.1080/147670500231989
   Evans MR, 2001, J INFECTION, V43, P140, DOI 10.1053/jinf.2001.0876
   Everett CB, 1996, BRIT J GEN PRACT, V46, P7
   Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440
   Figueroa Damian R, 1994, Ginecol Obstet Mex, V62, P362
   Fletcher H M, 2003, J Obstet Gynaecol, V23, P73
   Freedman DO, 2016, NEW ENGL J MED, V375, P247, DOI 10.1056/NEJMra1508815
   Freeland AL, 2016, MMWR-MORBID MORTAL W, V65, DOI 10.15585/mmwr.mm6501a1
   Freeman Mala, 2004, Archives of Gynecology and Obstetrics, V269, P274
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502
   Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003
   Gallus AS, 2005, SEMIN THROMB HEMOST, V31, P90, DOI 10.1055/s-2005-863810
   GEORGITIS WJ, 1993, MIL MED, V158, P794
   Gerba CP, 1997, WILD ENVIRON MED, V8, P96, DOI 10.1580/1080-6032(1997)008[0096:EOIWPT]2.3.CO;2
   Giddings SL, 2016, MED CLIN N AM, V100, P317, DOI 10.1016/j.mcna.2015.08.017
   Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75
   Goodyer L, 2000, J TRAVEL MED, V7, P38
   Granja AC, 1998, ANN TROP MED PARASIT, V92, P257, DOI 10.1080/00034989859816
   [Guidelines for Vaccinating Pregnant Women Centers for Disease Control and Prevention], 2014, ACIP GUID VACC REC P
   Haber P, 2015, VACCINE, V33, P1987, DOI 10.1016/j.vaccine.2015.01.080
   Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206
   Hagmann S, 2007, PEDIATR EMERG CARE, V23, P326, DOI 10.1097/01.pec.0000270164.78238.7d
   Hamer DH, 2004, J TRAVEL MED, V11, P23, DOI 10.2310/7060.2004.13577
   Harinasuta T, 1990, B SOC FR PARASITOL, V429
   Hasbun Jorge Jr, 2006, Infect Dis Obstet Gynecol, V2006, P64828
   HEALY TP, 1995, MED VET ENTOMOL, V9, P331, DOI 10.1111/j.1365-2915.1995.tb00143.x
   Held BHE, 2007, ALERT DIVER, P48
   Herwaldt BL, 2000, ANN INTERN MED, V132, P982, DOI 10.7326/0003-4819-132-12-200006200-00009
   Hezelgrave NL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2506
   Hill DR, 2006, CLIN INFECT DIS, V43, P1499, DOI 10.1086/508782
   Hinderaker SG, 2003, BJOG-INT J OBSTET GY, V110, P616, DOI 10.1016/S1470-0328(03)02953-7
   Hochberg NS, 2013, MAYO CLIN PROC, V88, P1231, DOI 10.1016/j.mayocp.2013.07.018
   HUCH R, 1986, AM J OBSTET GYNECOL, V154, P996, DOI 10.1016/0002-9378(86)90736-2
   Iams JD, 1998, AM J OBSTET GYNECOL, V178, P1035, DOI 10.1016/S0002-9378(98)70544-7
   International Commission on Radiological Protection, 1991, 1990 REC ICRP
   International SOS, 2016, TRAV RISK MAP
   Irgens A, 2003, SCAND J WORK ENV HEA, V29, P94, DOI 10.5271/sjweh.710
   Izadi Morteza, 2015, Adv Biomed Res, V4, P60, DOI 10.4103/2277-9175.151879
   Jaeger VK, 2015, TRAVEL MED INFECT DI, V13, P475, DOI 10.1016/j.tmaid.2015.10.001
   Jean D, 2005, HIGH ALT MED BIOL, V6, P22, DOI 10.1089/ham.2005.6.22
   Jean D, 2012, HIGH ALT MED BIOL, V13, P73, DOI 10.1089/ham.2012.1021
   Jones CA, 2014, J OBSTET GYNAECOL CA, V36, P1101, DOI 10.1016/S1701-2163(15)30389-3
   Josephs LK, 2013, PRIM CARE RESP J, V22, P234, DOI 10.4104/pcrj.2013.00046
   Jothivijayarani A., 2002, Primary Care Update for Ob/Gyns, V9, P36, DOI 10.1016/S1068-607X(01)00100-7
   Julian CG, 2011, AM J HUM BIOL, V23, P509, DOI 10.1002/ajhb.21167
   Julian CG, 2011, CLIN CHEST MED, V32, P21, DOI 10.1016/j.ccm.2010.10.008
   Kadir MM, 2010, ACTA OBSTET GYN SCAN, V89, P540, DOI 10.3109/00016340903473566
   Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296
   Kametas NA, 2004, ACTA OBSTET GYN SCAN, V83, P627, DOI 10.1111/j.0001-6349.2004.00434.x
   Khaskheli MN, 2015, JCPSP-J COLL PHYSICI, V25, P734, DOI 10.2015/JCPSP.734737
   Kingman CE, 2003, J TRAVEL MED, V10, P330, DOI 10.2310/7060.2003.9353
   Koren G, 2008, CAN FAM PHYSICIAN, V54, P1241
   Kreuz FR, 1999, CLIN DYSMORPHOL, V8, P295
   Kuipers S, 2007, J INTERN MED, V262, P615, DOI 10.1111/j.1365-2796.2007.01867.x
   Kuipers S, 2007, PLOS MED, V4, P1508, DOI 10.1371/journal.pmed.0040290
   Kuipers S, 2014, BRIT J HAEMATOL, V165, P412, DOI 10.1111/bjh.12724
   Landau D, 2015, CHEMOSPHERE, V139, P340, DOI 10.1016/j.chemosphere.2015.06.091
   Lauria L, 2006, AVIAT SPACE ENVIR MD, V77, P533
   Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   LEMAR HJ, 1995, J CLIN ENDOCR METAB, V80, P220, DOI 10.1210/jc.80.1.220
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Loutan L, 2003, INT J ANTIMICROB AG, V21, P158, DOI 10.1016/S0924-8579(02)00367-9
   Luks AM, 2008, CHEST, V133, P744, DOI 10.1378/chest.07-1417
   Magann EF, 2010, OBSTET GYNECOL SURV, V65, P396, DOI 10.1097/OGX.0b013e3181e572ae
   Marsden AG, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05483.x
   Marshall CA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2991-3
   Martinelli I, 2003, ARCH INTERN MED, V163, P2771, DOI 10.1001/archinte.163.22.2771
   MCFARLAND JW, 1993, LANCET, V342, P112, DOI 10.1016/0140-6736(93)91311-9
   McGovern LM, 2007, J TRAVEL MED, V14, P117, DOI 10.1111/j.1708-8305.2006.00093.x
   McGready R, 2004, Travel Med Infect Dis, V2, P127, DOI 10.1016/j.tmaid.2004.03.008
   MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517
   McMullan R, 2007, Travel Med Infect Dis, V5, P276, DOI 10.1016/j.tmaid.2007.06.002
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Meinhold CB, 1993, LIMITATION EXPOSURE
   Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140
   Mieske K, 2010, J TRAVEL MED, V17, P48, DOI 10.1111/j.1708-8305.2009.00369.x
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moro PL, 2013, OBSTET GYNECOL, V122, P1271, DOI 10.1097/AOG.0000000000000010
   Morof D.F., 2015, CDC HLTH INFORM INT
   Morrell S, 1997, AUST NZ J PUBL HEAL, V21, P221, DOI 10.1111/j.1467-842X.1997.tb01690.x
   MOSER MR, 1979, AM J EPIDEMIOL, V110, P1
   Murano T, 2013, J EMERG MED, V45, pE161, DOI 10.1016/j.jemermed.2013.05.009
   Murphy JL, 2014, ENVIRON SCI TECHNOL, V48, P5849, DOI 10.1021/es500644d
   MURRAY CJL, 1990, T ROY SOC TROP MED H, V84, P1, DOI 10.1016/0035-9203(90)90364-K
   NASIDI A, 1993, T ROY SOC TROP MED H, V87, P337, DOI 10.1016/0035-9203(93)90156-K
   Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878
   Niermeyer S, 1999, ADV EXP MED BIOL, V474, P65
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   NOSTEN F, 1994, J INFECT DIS, V169, P595, DOI 10.1093/infdis/169.3.595
   O'Driscoll T, 2011, CAN J RURAL MED, V16, P128
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Papaiordanou P, 2001, 41 INT C ANT AG CHEM
   Pasternak B, 2011, ARCH INTERN MED, V171, P259, DOI 10.1001/archinternmed.2010.521
   Perret C, 2005, J INFECTION, V51, P287, DOI 10.1016/j.jinf.2004.10.003
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Phillips-Howard PA, 1998, J TRAVEL MED, V5, P121, DOI 10.1111/j.1708-8305.1998.tb00484.x
   Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ravelli ACJ, 2011, BJOG-INT J OBSTET GY, V118, P457, DOI 10.1111/j.1471-0528.2010.02816.x
   Razeghinejad MR, 2010, CLIN EXP OPTOM, V93, P458, DOI 10.1111/j.1444-0938.2010.00526.x
   Robert E, 1999, VACCINE, V17, P283, DOI 10.1016/S0264-410X(98)00051-6
   Roberts DJ, 2016, HEMATOL ONCOL CLIN N, V30, P477, DOI 10.1016/j.hoc.2015.11.011
   Rodger MA, 2003, BEST PRACT RES CL HA, V16, P279, DOI 10.1016/S1521-6926(02)00093-2
   Royal College of Obstetricians & Gynaecologists, 2010, DIAGN TREATM MAL PRE
   Royal College of Obstetricians & Gynaecologists (Institution/Organization), 1 ROYAL COLL OBST GY
   Sammour RN, 2012, J TRAVEL MED, V19, P289, DOI 10.1111/j.1708-8305.2012.00637.x
   Schlagenhauf P, 2003, J TRAVEL MED, V10, P106, DOI 10.2310/7060.2003.31764
   Sehgal M, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25326
   SEOUD M, 1988, OBSTET GYNECOL, V71, P711
   SHOLAPURKAR SL, 1988, T ROY SOC TROP MED H, V82, P376, DOI 10.1016/0035-9203(88)90124-1
   Shrikrishna D, 2011, THORAX, V66, P831, DOI 10.1136/thoraxjnl-2011-200694
   Silva ID, 2009, J OCCUP ENVIRON MED, V51, P1298, DOI 10.1097/JOM.0b013e3181b9ae2f
   Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9
   Singal Kiran Kumar, 2014, J Indian Med Assoc, V112, P113
   Singh Neeru, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P10
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Smereck J, 2011, J EMERG MED, V40, P393, DOI 10.1016/j.jemermed.2010.04.029
   Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120
   Smoak BL, 1997, J INFECT DIS, V176, P831, DOI 10.1086/517315
   Sotiriadis A, 2004, BMJ-BRIT MED J, V329, P152, DOI 10.1136/bmj.329.7458.152
   St Leger Dowse M, 2006, J Obstet Gynaecol, V26, P509
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Steffen R, 2016, JAMA-J AM MED ASSOC, V313, P71
   STIRLING Y, 1984, THROMB HAEMOSTASIS, V52, P176
   Sukumaran D, 2016, PARASITOL RES, V115, P1453, DOI 10.1007/s00436-015-4879-z
   Sulaiman K, 2007, INT J INFECT DIS, V11, P337, DOI 10.1016/j.ijid.2006.09.007
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   TAUXE RV, 1987, AM J EPIDEMIOL, V125, P150, DOI 10.1093/oxfordjournals.aje.a114498
   Tchirikov M, 2012, INT J GYNECOL OBSTET, V117, P260, DOI 10.1016/j.ijgo.2012.01.016
   The American College of Obstetricians and Gynecologists, 2014, OBSTET GYNECOL, V124, P348
   Thompson LM, 2011, ENVIRON HEALTH PERSP, V119, P1489, DOI 10.1289/ehp.1002928
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Uchikova EH, 2005, EUR J OBSTET GYN R B, V119, P185, DOI 10.1016/j.ejogrb.2004.06.038
   Van Herck K, 2004, J TRAVEL MED, V11, P3, DOI 10.2310/7060.2004.13609
   van Loon JJA, 2015, J CHEM ECOL, V41, P567, DOI 10.1007/s10886-015-0587-5
   Vandelaer J, 2003, VACCINE, V21, P3442, DOI 10.1016/S0264-410X(03)00347-5
   Vanhauwere B, 1998, AM J TROP MED HYG, V58, P17, DOI 10.4269/ajtmh.1998.58.17
   VAUGHAN TL, 1984, J OCCUP ENVIRON MED, V26, P676
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viglianil MB, 2013, CASE REP MED, DOI 10.1155/2013/973297
   Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]
   Voss M, 2004, J Obstet Gynaecol, V24, P859
   Westhoff CL, 2015, J WOMENS HLTH LARCHM, V25, P63
   White NJ, 2002, T R SOC TROP MED HYG, V96, P180
   Whitty CJM, 2005, BJOG-INT J OBSTET GY, V112, P1189, DOI 10.1111/j.1471-0528.2005.00714.x
   Widdowson MA, 2005, JAMA-J AM MED ASSOC, V293, P1859, DOI 10.1001/jama.293.15.1859
   Wilder-Smith A, 2004, J TRAVEL MED, V11, P130
   Willen SM, 2014, J TRAVEL MED, V21, P332, DOI 10.1111/jtm.12142
   World Health Organization, 2012, INT TRAV HLTH
   World Health Organization, 2016, TRAV PREEX MED COND
   WORSHAM GF, 1978, JAMA-J AM MED ASSOC, V240, P251, DOI 10.1001/jama.1978.03290030069029
   Yanow SK, 2016, TRENDS PARASITOL, V32, P416, DOI 10.1016/j.pt.2016.01.008
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
   Zamudio S, 2003, HIGH ALT MED BIOL, V4, P171, DOI 10.1089/152702903322022785
   ZAMUDIO S, 1995, J APPL PHYSIOL, V79, P7
   Zamudio S, 2007, FRONT BIOSCI-LANDMRK, V12, P2967, DOI 10.2741/2286
   1995, MMWR MORB MORTAL WKL, V44, P137
NR 225
TC 5
Z9 5
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD FEB
PY 2017
VL 72
IS 2
BP 97
EP 115
DI 10.1097/OGX.0000000000000398
PG 19
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EL2IC
UT WOS:000394442300018
PM 28218771
DA 2020-07-08
ER

PT J
AU Ali, S
   Gugliemini, O
   Harber, S
   Harrison, A
   Houle, L
   Ivory, J
   Kersten, S
   Khan, R
   Kim, J
   LeBoa, C
   Nez-Whitfield, E
   O'Marr, J
   Rothenberg, E
   Segnitz, RM
   Sila, S
   Verwillow, A
   Vogt, M
   Yang, A
   Mordecai, EA
AF Ali, Sofia
   Gugliemini, Olivia
   Harber, Serena
   Harrison, Alexandra
   Houle, Lauren
   Ivory, Javarcia
   Kersten, Sierra
   Khan, Rebia
   Kim, Jenny
   LeBoa, Chris
   Nez-Whitfield, Emery
   O'Marr, Jamieson
   Rothenberg, Emma
   Segnitz, R. Max
   Sila, Stephanie
   Verwillow, Anna
   Vogt, Miranda
   Yang, Adrienne
   Mordecai, Erin A.
TI Environmental and Social Change Drive the Explosive Emergence of Zika
   Virus in the Americas
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID AEDES STEGOMYIA AEGYPTI; DENGUE EPIDEMICS; BRAZIL; VECTOR; TRANSMISSION;
   ARBOVIRUSES; CHIKUNGUNYA; ALBOPICTUS; MOSQUITOS; SINGAPORE
AB Since Zika virus (ZIKV) was detected in Brazil in 2015, it has spread explosively across the Americas and has been linked to increased incidence of microcephaly and Guillain-Barre A syndrome (GBS). In one year, it has infected over 500,000 people (suspected and confirmed cases) in 40 countries and territories in the Americas. Along with recent epidemics of dengue (DENV) and chikungunya virus (CHIKV), which are also transmitted by Aedes aegypti and Ae. albopictus mosquitoes, the emergence of ZIKV suggests an ongoing intensification of environmental and social factors that have given rise to a new regime of arbovirus transmission. Here, we review hypotheses and preliminary evidence for the environmental and social changes that have fueled the ZIKV epidemic. Potential drivers include climate variation, land use change, poverty, and human movement. Beyond the direct impact of microcephaly and GBS, the ZIKV epidemic will likely have social ramifications for women's health and economic consequences for tourism and beyond.
C1 [Ali, Sofia; Gugliemini, Olivia; Harber, Serena; Harrison, Alexandra; Houle, Lauren; Ivory, Javarcia; Kersten, Sierra; Khan, Rebia; Kim, Jenny; LeBoa, Chris; Nez-Whitfield, Emery; O'Marr, Jamieson; Rothenberg, Emma; Segnitz, R. Max; Sila, Stephanie; Verwillow, Anna; Vogt, Miranda; Yang, Adrienne; Mordecai, Erin A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
RP Mordecai, EA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
EM emordeca@stanford.edu
OI Mordecai, Erin/0000-0002-4402-5547; Houle, Lauren/0000-0002-9094-486X;
   Yang, Adrienne/0000-0002-9019-2944
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1518681, DEB-1640780]; Stanford Center for Innovation in Global
   Health; Stanford Woods Institute for the Environment; Stanford
   University Introductory Seminars program
FX EAM was supported by the National Science Foundation (nsf.gov;
   DEB-1518681 and DEB-1640780), the Stanford Center for Innovation in
   Global Health (http://globalhealth.stanford.edu/), and the Stanford
   Woods Institute for the Environment (https://woods.stanford.edu/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; This paper is
   the product of a Stanford University Introductory Seminar: BIO 2N
   Ecology and Evolution of Infectious Disease in a Changing World. We
   thank the Stanford University Introductory Seminars program for support.
   Felix Hol, Haripriya Mukundarajan, and members of the Mordecai, Fukami,
   and Peay labs provided thoughtful comments on earlier versions of this
   manuscript.
CR Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Althouse B, 2016, BIORXIV, P47175
   [Anonymous], 2016, CUM ZIK SUSP CONF CA
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Archibald Cynthia, 2011, J Cult Divers, V18, P114
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biller D., 2016, BRAZILS UNEMPLOYMENT
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Cabezas J., 2016, REUTERS         0121
   Carvalho DO, 2015, PLOS NEGL TROP DIS, V9
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, BIORXIV, P49395
   Foote RH, 1960, SCIENCE, V133, P1473
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grills A, 2016, MMWR MORB MORTAL WKL, V65
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Hales DS, 2002, LANCET, V360
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Harger N., 2014, CULTURAL APPROACHES
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heller L, 2015, INSTATUTION CIV ENG, P1
   Insituto Brasileiro de Geografia e Estatistica, 2011, 2010 CENS 11 4 MILL
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Jones C., 2015, US TODAY
   Katz JM, 2016, STAT
   Kindhauser MK, 2016, B WHO
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Macdonald DW., 1985, PRIMATES
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8
   Manjarres-Suarez Alejandra, 2013, Rev. costarric. salud pública, V22, P68
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mohney G., 2016, ABC NEWS
   Mordecai E, 2016, BIORXIV, P63735
   Morse S. S., 2001, PLAGUES AND POLITICS, P8, DOI [DOI 10.1057/9780230524248_2, 10.1057/9780230524248_2]
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   O Globo, 2014, GLOBO
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD
   Paul L., 2016, BIORXIV
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pinto Naiara, 2009, P413, DOI 10.1007/978-0-387-78705-3_16
   Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124
   Portal da Saude-Ministerio da Saude (Internet), 2015, CONF ZIK VIR BRAS
   Prisant N., 2016, LANCET INFECT DIS
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   San Martin, 2016, CRUX TAKEING CATHOLI
   Sandy M., 2016, TIME
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Severo OP, 1955, ERADICATION AEDES AE
   Stewart Ibarra AM, 2013, IMPLICATIONS TARGETE, V8, DOI [10.1371/journal.pone.0078263, DOI 10.1371/JOURNAL.PONE.0078263]
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tabatabaei SM, 2015, INT J INFECT, V2
   Tavernise S, 2016, NY TIMES
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   WESSELHOEFT C, 1947, NEW ENGL J MED, V236, P978, DOI 10.1056/NEJM194706262362605
   WHO, 2016, ZIK VIR OUTBR GLOB R
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2009, INT TRAV HLTH
   World Health Organization & Pan American Health Organization, 2012, UND ADDR VIOL WOM SE
   Zika Mis M., 2016, REUTERS
NR 78
TC 42
Z9 42
U1 4
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005135
DI 10.1371/journal.pntd.0005135
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EN1AD
UT WOS:000395741700003
PM 28182667
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chua, A
   Prat, I
   Nuebling, CM
   Wood, D
   Moussy, F
AF Chua, Arlene
   Prat, Irena
   Nuebling, Claudius Micha
   Wood, David
   Moussy, Francis
TI Update on Zika Diagnostic Tests and WHO's Related Activities
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; ANTIBODY
C1 [Chua, Arlene; Prat, Irena; Nuebling, Claudius Micha; Wood, David; Moussy, Francis] WHO, Geneva, Switzerland.
   [Chua, Arlene] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Moussy, Francis] Univ Geneva, Inst Global Hlth, Geneva, Switzerland.
RP Chua, A (corresponding author), WHO, Geneva, Switzerland.; Chua, A (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
EM chuaa@who.int
FU World Health OrganizationWorld Health Organization [001]
CR Adibi JJ, 2016, LANCET, V6736, P1
   [Anonymous], 2016, TARG PROD PROF BETT
   Baden LR, 2016, NEW ENGL J MED
   Baylis SA, 2016, COLLABORATIVE STUDY
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS, V3099, P1
   Cao-Lormeau V, 2016, LANCET IN PRESS, V6736
   CDC, 2016, ZIK VIR WHAT CLIN NE
   Chen Z, 2016, J AIDS CLIN RES, V7, P1
   Chua AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003734
   Corman VM, 2016, B WHO
   Driggers RW, 2016, NEW ENGL J MED
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, ZIK VIR DIS EP POT A, P1
   Fornara C, 2015, J CLIN VIROL, V64, P45, DOI 10.1016/j.jcv.2015.01.004
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, ENGL J MED
   Musso D, 2016, GENOME SEQUENCE CAND, V4, P4
   Porras AI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003697
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ramdasi AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103257
   Rasmussen SA, 2016, ZIKA VIRUS BIRTH DEF, P1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tappe D, 2014, EUROSURVEILLANCE, V19, P1
   UNICEF, 2015, INN HIV POINT OF CAR, V2015
   World Health Organization, 2014, M REP HIGH PRIOR TAR
   World Health Organization (WHO), ZIK DIAGN TESTS PIP
   World Health Organization(WHO), 2016, WHO SIT REP ZIK VIS
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 37
TC 17
Z9 17
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005269
DI 10.1371/journal.pntd.0005269
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EN1AD
UT WOS:000395741700013
PM 28151953
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xavier-Neto, J
   Carvalho, M
   Pascoalino, BD
   Cardoso, AC
   Costa, AMS
   Pereira, AHM
   Santos, LN
   Saito, A
   Marques, RE
   Smetana, JHC
   Consonni, SR
   Bandeira, C
   Costa, VV
   Bajgelman, MC
   de Oliveira, PSL
   Cordeiro, MT
   Gil, LHVG
   Pauletti, BA
   Granato, DC
   Leme, AFP
   Freitas, L
   de Freitas, CBMH
   Teixeira, MM
   Bevilacqua, E
   Franchini, K
AF Xavier-Neto, Jose
   Carvalho, Murilo
   Pascoalino, Bruno dos Santos
   Cardoso, Alisson Campos
   Sousa Costa, Angela Maria
   Macedo Pereira, Ana Helena
   Santos, Luana Nunes
   Saito, Angela
   Marques, Rafael Elias
   Costa Smetana, Juliana Helena
   Consonni, Silvio Roberto
   Bandeira, Carla
   Costa, Vivian Vasconcelos
   Bajgelman, Marcio Chaim
   Lopes de Oliveira, Paulo Sergio
   Cordeiro, Marli Tenorio
   Vega Gonzales Gil, Laura Helena
   Pauletti, Bianca Alves
   Granato, Daniela Campos
   Paes Leme, Adriana Franco
   Freitas-Junior, Lucio
   Moraes Holanda de Freitas, Carolina Borsoi
   Teixeira, Mauro Martins
   Bevilacqua, Estela
   Franchini, Kleber
TI Hydrocephalus and arthrogryposis in an immunocompetent mouse model of
   ZIKA teratogeny: A developmental study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM;
   VIRUS-INFECTION; MICE; EXPRESSION; INTERFACE; PREGNANCY; PLACENTA;
   BRAZIL; DAMAGE
AB The teratogenic mechanisms triggered by ZIKV are still obscure due to the lack of a suitable animal model. Here we present a mouse model of developmental disruption induced by ZIKV hematogenic infection. The model utilizes immunocompetent animals from wild-type FVB/NJ and C57BL/6J strains, providing a better analogy to the human condition than approaches involving immunodeficient, genetically modified animals, or direct ZIKV injection into the brain. When injected via the jugular vein into the blood of pregnant females harboring conceptuses from early gastrulation to organogenesis stages, akin to the human second and fifth week of pregnancy, ZIKV infects maternal tissues, placentas and embryos/fetuses. Early exposure to ZIKV at developmental day 5 (second week in humans) produced complex manifestations of anterior and posterior dysraphia and hydrocephalus, as well as severe malformations and delayed development in 10.5 days post-coitum (dpc) embryos. Exposure to the virus at 7.5-9.5 dpc induces intra-amniotic hemorrhage, widespread edema, and vascular rarefaction, often prominent in the cephalic region. At these stages, most affected embryos/fetuses displayed gross malformations and/or intrauterine growth restriction (IUGR), rather than isolated microcephaly. Disrupted conceptuses failed to achieve normal developmental landmarks and died in utero. Importantly, this is the only model so far to display dysraphia and hydrocephalus, the harbinger of microcephaly in humans, as well as arthrogryposis, a set of abnormal joint postures observed in the human setting. Late exposure to ZIKV at 12.5 dpc failed to produce noticeable malformations. We have thus characterized a developmental window of opportunity for ZIKV-induced teratogenesis encompassing early gastrulation, neurulation and early organogenesis stages. This should not, however, be interpreted as evidence for any safe developmental windows for ZIKV exposure. Late developmental abnormalities correlated with damage to the placenta, particularly to the labyrinthine layer, suggesting that circulatory changes are integral to the altered phenotypes.
C1 [Xavier-Neto, Jose; Carvalho, Murilo; Pascoalino, Bruno dos Santos; Cardoso, Alisson Campos; Sousa Costa, Angela Maria; Macedo Pereira, Ana Helena; Santos, Luana Nunes; Saito, Angela; Marques, Rafael Elias; Costa Smetana, Juliana Helena; Consonni, Silvio Roberto; Bajgelman, Marcio Chaim; Lopes de Oliveira, Paulo Sergio; Pauletti, Bianca Alves; Granato, Daniela Campos; Paes Leme, Adriana Franco; Freitas-Junior, Lucio; Moraes Holanda de Freitas, Carolina Borsoi; Franchini, Kleber] Brazilian Biosci Natl Lab, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, Campinas, SP, Brazil.
   [Santos, Luana Nunes; Bandeira, Carla; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, SP, Brazil.
   [Costa, Vivian Vasconcelos; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Lab Imunofarmacol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Cordeiro, Marli Tenorio; Vega Gonzales Gil, Laura Helena] Univ Fed Pernambuco, FIOCRUZ, CPqAM, Ave Prof Moraes Rego S-N,Cidade Univ, Recife, PE, Brazil.
RP Xavier-Neto, J; Franchini, K (corresponding author), Brazilian Biosci Natl Lab, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, Campinas, SP, Brazil.
EM xavier.neto@lnbio.cnpem.br; kleber.franchini@lnbio.cnpem.br
RI Smetana, Juliana/J-5354-2013; Freitas-Junior, Lucio H/C-8677-2011;
   Bandeira, Carla Leticia/U-8685-2017; Carvalho, Murilo/B-7950-2012;
   Consonni, Silvio Roberto/R-9281-2019; Saito, Angela/G-6107-2019;
   Teixeira, Mauro M/A-4587-2008; Costa, Vivian VVC/I-2499-2018; Marques,
   Rafael Elias/R-4890-2016; Moraes, Carolina Borsoi/I-4408-2014; Oliveira,
   Paulo/K-5588-2013; Bajgelman, Marcio/A-8146-2019; Bevilacqua,
   Estela/H-3354-2011
OI Smetana, Juliana/0000-0001-9827-7013; Freitas-Junior, Lucio
   H/0000-0002-8904-7897; Bandeira, Carla Leticia/0000-0002-0796-3462;
   Carvalho, Murilo/0000-0001-6881-5271; Teixeira, Mauro
   M/0000-0002-6944-3008; Costa, Vivian VVC/0000-0002-0175-642X; Marques,
   Rafael Elias/0000-0002-6949-0947; Moraes, Carolina
   Borsoi/0000-0002-0689-2770; Bajgelman, Marcio/0000-0003-3371-1143;
   Bevilacqua, Estela/0000-0003-4178-4625; Consonni, Silvio
   Roberto/0000-0003-3149-021X
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   440379/2016-4]; Fundacao de Amparo a Pesquisa do Estado de Sao
   PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [FAPESP 2013/22695-0]; individual CNPq fellowship for Productivity in
   Science [CNPq 305537/2014-8]; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/07632-0]
FX This study was partially funded by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq 440379/2016-4), Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/22695-0) and an
   individual CNPq fellowship for Productivity in Science to JXN (CNPq
   305537/2014-8). The results in the manuscript constitute preliminary
   evidence in an application to a FAPESP grant (Project 2016/07632-0). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bevilacqua E, 2014, PLACENTA, V35, pS51, DOI 10.1016/j.placenta.2013.10.015
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Creasy RK, 2009, CREASY RESNIKS MATER, pxvii
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davis GH, 2003, CLIN PERINATOL, V30, P531, DOI 10.1016/S0095-5108(03)00053-8
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Paula Freitas B, 2016, JAMA OPHTHALMOLOGY
   Doce N, 2016, BRAZIL SCI SEEK UNRA
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   DOWNS KM, 1993, DEVELOPMENT, V118, P1255
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hannon T, 2012, OBSTET GYNECOL, V120, P1345, DOI [10.1097/AOG.0b013e3182732b53, http://10.1097/AOG.0b013e3182732b53]
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Kauffman MH., 1994, ATLAS MOUSE DEV
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432
   Medina F, 2012, CURRENT PROTOCOLS MI
   Menkes JH, 2006, CHILD NEUROLOGY, pxiii
   Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1016/j.ctim.2007.01.003, 10.1002/0471142735.im1501s77]
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mouillet JF, 2014, INT J DEV BIOL, V58, P281, DOI 10.1387/ijdb.130349ys
   Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rajan AJ, 2000, J IMMUNOL, V164, P2120, DOI 10.4049/jimmunol.164.4.2120
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sav A, 2008, SPINA BIFIDA MANAGEM, P43
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Seaman WT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-194
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Steel CD, 2008, LAB ANIMAL, V37, P26, DOI 10.1038/laban0108-26
   Stevens DB, 1999, J IMMUNOL, V162, P7501
   Theiler K., 1989, HOUSE MOUSE ATLAS EM
   Tonra James R, 2002, Cerebellum, V1, P57, DOI 10.1080/147342202753203096
   Ueno M, 2013, DEV CELL, V27, P373, DOI 10.1016/j.devcel.2013.10.019
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   XavierNeto J, 1996, AM J PHYSIOL-HEART C, V271, pH1407
   Yadav RK, 2014, J SCI INNOVATIVE RES, V3, P258
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110620
NR 53
TC 22
Z9 22
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005363
DI 10.1371/journal.pntd.0005363
PG 29
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EN1AD
UT WOS:000395741700032
PM 28231241
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bowen, JR
   Quicke, KM
   Maddur, MS
   O'Neal, JT
   McDonald, CE
   Fedorova, NB
   Puri, V
   Shabman, RS
   Pulendran, B
   Suthar, MS
AF Bowen, James R.
   Quicke, Kendra M.
   Maddur, Mohan S.
   O'Neal, Justin T.
   McDonald, Circe E.
   Fedorova, Nadia B.
   Puri, Vinita
   Shabman, Reed S.
   Pulendran, Bali
   Suthar, Mehul S.
TI Zika Virus Antagonizes Type I Interferon Responses during Infection of
   Human Dendritic Cells
SO PLOS PATHOGENS
LA English
DT Article
ID HEPATITIS-C VIRUS; RIG-I; SEXUAL TRANSMISSION; BETA-INTERFERON; NS5
   PROTEIN; PUERTO-RICO; NOVEMBER 1; DENGUE; INHIBITION; INDUCTION
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that is causally linked to severe neonatal birth defects, including microcephaly, and is associated with Guillain-Barre syndrome in adults. Dendritic cells (DCs) are an important cell type during infection by multiple mosquito-borne flaviviruses, including dengue virus, West Nile virus, Japanese encephalitis virus, and yellow fever virus. Despite this, the interplay between ZIKV and DCs remains poorly defined. Here, we found human DCs supported productive infection by a contemporary Puerto Rican isolate with considerable variability in viral replication, but not viral binding, between DCs from different donors. Historic isolates from Africa and Asia also infected DCs with distinct viral replication kinetics between strains. African lineage viruses displayed more rapid replication kinetics and infection magnitude as compared to Asian lineage viruses, and uniquely induced cell death. Infection of DCs with both contemporary and historic ZIKV isolates led to minimal up-regulation of T cell co-stimulatory and MHC molecules, along with limited secretion of inflammatory cytokines. Inhibition of type I interferon (IFN) protein translation was observed during ZIKV infection, despite strong induction at the RNA transcript level and up-regulation of other host antiviral proteins. Treatment of human DCs with RIG-I agonist potently restricted ZIKV replication, while type I IFN had only modest effects. Mechanistically, we found all strains of ZIKV antagonized type I IFN-mediated phosphorylation of STAT1 and STAT2. Combined, our findings show that ZIKV subverts DC immunogenicity during infection, in part through evasion of type I IFN responses, but that the RLR signaling pathway is still capable of inducing an antiviral state, and therefore may serve as an antiviral therapeutic target.
C1 [Bowen, James R.; Quicke, Kendra M.; O'Neal, Justin T.; McDonald, Circe E.; Suthar, Mehul S.] Emory Univ Sch Med, Div Infect Dis, Dept Pediat, Atlanta, GA USA.
   [Bowen, James R.; Quicke, Kendra M.; Maddur, Mohan S.; O'Neal, Justin T.; McDonald, Circe E.; Pulendran, Bali; Suthar, Mehul S.] Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA USA.
   [Maddur, Mohan S.; Pulendran, Bali] Emory Univ Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA.
   [Fedorova, Nadia B.; Puri, Vinita; Shabman, Reed S.] J Craig Venter Inst, Rockville, MD USA.
RP Suthar, MS (corresponding author), Emory Univ Sch Med, Div Infect Dis, Dept Pediat, Atlanta, GA USA.; Suthar, MS (corresponding author), Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA USA.
EM msuthar@emory.edu
FU National Institutes of Health Children's Healthcare of Atlanta
   [U19A1083019, R56A1110516, R21A1113485, 2U19A1090023, 5R37DK057665,
   5R37A1048638, 2U19A1057266, U19A1110819]; Emory Vaccine Center; Georgia
   Research Alliance
FX This work was funded in part by National Institutes of Health grants
   U19A1083019 (MSS), R56A1110516 (MSS) and R21A1113485 (MSS), 2U19A1090023
   (BP), 5R37DK057665 (BP), 5R37A1048638 (BP), 2U19A1057266 (BP),
   U19A1110819 (RSS) Children's Healthcare of Atlanta, Emory Vaccine
   Center, and The Georgia Research Alliance (MSS). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Aleyas AG, 2010, J IMMUNOL, V185, P1429, DOI 10.4049/jimmunol.0902536
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beljanski V, 2015, J VIROL, V89, P10612, DOI 10.1128/JVI.01526-15
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027
   Brasil P, 2016, N ENGL J MED
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   Cugola F. R., 2016, NATURE
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J., 2016, CELL STEM CELL
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, N ENGL J MED
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Faria NR, 2016, SCIENCE
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298
   Govero J, 2016, NATURE
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Grant A., 2016, CELL HOST MICROBE
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11
   Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Kulkarni RR, 2014, J VIROL, V88, P13990, DOI 10.1128/JVI.02273-14
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11
   Lazear HM, 2016, CELL HOST MICROBE
   Li C, 2016, CELL STEM CELL
   Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Motta IJ, 2016, N ENGL J MED
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Pattabhi S, 2016, J VIROL, V90, P2372, DOI 10.1128/JVI.02202-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08
   Pulendran B, 2015, ANNU REV IMMUNOL, V33, P563, DOI 10.1146/annurev-immunol-020711-075049
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Quicke KM, 2016, CELL HOST MICROBE
   Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110
   Rossi SL, 2016, AM J TROP MED HYG
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007
   Shan C, 2016, CELL HOST MICROBE
   Sharp TM, 2016, CLIN INFECT DIS
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Travanty E, 2015, J VIROL, V89, P11935, DOI 10.1128/JVI.01792-15
   Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 80
TC 127
Z9 128
U1 2
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2017
VL 13
IS 2
AR e1006164
DI 10.1371/journal.ppat.1006164
PG 30
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EN1BH
UT WOS:000395744700012
PM 28152048
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pardy, RD
   Rajah, MM
   Condotta, SA
   Taylor, NG
   Sagan, SM
   Richer, MJ
AF Pardy, Ryan D.
   Rajah, Maaran M.
   Condotta, Stephanie A.
   Taylor, Nathan G.
   Sagan, Selena M.
   Richer, Martin J.
TI Analysis of the T Cell Response to Zika Virus and Identification of a
   Novel CD8(+) T Cell Epitope in Immunocompetent Mice
SO PLOS PATHOGENS
LA English
DT Article
ID VIRAL-INFECTION; NEURAL-NETWORKS; DENGUE VIRUS; SPECIFICITY;
   VACCINATION; PREGNANCY; EXPANSION; IMMUNITY; MODELS
AB Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family. Although ZIKV infection is typically mild and self-limiting in healthy adults, infection has been associated with neurological symptoms such as Guillain-Barre A syndrome, and a causal link has been established between fetal microcephaly and ZIKV infection during pregnancy. These risks, and the magnitude of the ongoing ZIKV pandemic, have created an urgent need for the development of animal models to study the immune response to ZIKV infection. Previous animal models have primarily focused on pathogenesis in immunocompromised mice. In this study, we provide a model of ZIKV infection in wild-type immunocompetent C57BL/6 mice, and have provided an analysis of the immune response to infection. We evaluated the activation of several innate immune cell types, and studied the kinetics, phenotype, and functionality of T cell responses to ZIKV infection. Our results demonstrate that ZIKV infection is mild in wildtype immunocompetent C57BL/6 mice, resulting in minimal morbidity. Our data establish that at the peak of the adaptive response, antigen-experienced CD4(+) T cells polarize to a Th1 phenotype, and antigen-experienced CD8(+) T cells exhibit an activated effector phenotype, producing both effector cytokines and cytolytic molecules. Furthermore, we have identified a novel ZIKV CD8(+) T cell epitope in the envelope protein that is recognized by the majority of responding cells. Our model provides an important reference point that will help dissect the impact of polymorphisms in the circulating ZIKV strains on the immune response and ZIKV pathogenesis. In addition, the identification of a ZIKV epitope will allow for the design of tetramers to study epitope-specific T cell responses, and will have important implications for the design and development of ZIKV vaccine strategies.
C1 [Pardy, Ryan D.; Rajah, Maaran M.; Condotta, Stephanie A.; Taylor, Nathan G.; Sagan, Selena M.; Richer, Martin J.] McGill Univ, Microbiome & Dis Tolerance Ctr, Dept Microbiol & Immunol, Montreal, PQ, Canada.
RP Sagan, SM; Richer, MJ (corresponding author), McGill Univ, Microbiome & Dis Tolerance Ctr, Dept Microbiol & Immunol, Montreal, PQ, Canada.
EM selena.sagan@mcgill.ca; martin.j.richer@mcgill.ca
OI Sagan, Selena/0000-0002-8484-3632; Pardy, Ryan/0000-0002-0024-8888
FU McGill University; Fonds de Recherche du Quebec Nature et Technologies
   [189120]; Fonds de Recherche du Quebec Sante-Chercheurs-Boursiers Junior
   1 [32807]; Natural Sciences and Engineering Research Council of Canada
   (NSERC) Canada Graduate Scholarship Masters (CGS-M)
FX This work was supported by start-up funds from McGill University (SMS
   and MJR) as well as operating funds from the Fonds de Recherche du
   Quebec Nature et Technologies (SMS) (#189120,
   http://www.frqnt.gouv.qc.ca/en/accueil). SMS is a Tier II Canada
   Research Chair in RNA Biology and Viral Infections. MJR received salary
   support from the Fonds de Recherche du Quebec Sante-Chercheurs-Boursiers
   Junior 1 (#32807, http://www.frqs.gouv.qc.ca/en/). MMR would like to
   thank the McGill University Faculty of Medicine Max E. Binz Fellowship
   for graduate training. RDP would like to thank the Natural Sciences and
   Engineering Research Council of Canada (NSERC) Canada Graduate
   Scholarship Masters (CGS-M) for graduate support
   (http.//www.nserc-crsng.qcca/index_eng.asp). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639
   Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180
   Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829
   Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010
   Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438
   Kimura D, 2016, IMMUNITY, V44, P672, DOI 10.1016/j.immuni.2016.02.011
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Kristensen NN, 2004, J GEN VIROL, V85, P1703, DOI 10.1099/vir.0.79903-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135
   Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202
   McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   PIRCHER H, 1987, EUR J IMMUNOL, V17, P159, DOI 10.1002/eji.1830170202
   Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333
   Varga SM, 2000, J VIROL, V74, P4429, DOI 10.1128/JVI.74.9.4429-4432.2000
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 47
TC 48
Z9 50
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2017
VL 13
IS 2
AR e1006184
DI 10.1371/journal.ppat.1006184
PG 26
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EN1BH
UT WOS:000395744700017
PM 28231312
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Van Mieghem, T
   Bianchi, DW
   Levy, B
   Deprest, J
   Chitty, LS
   Ghidini, A
AF Van Mieghem, Tim
   Bianchi, Diana W.
   Levy, Brynn
   Deprest, Jan
   Chitty, Lyn S.
   Ghidini, Alessandro
TI In case you missed it: the Prenatal Diagnosis editors bring you the most
   significant advances of 2016
SO PRENATAL DIAGNOSIS
LA English
DT Editorial Material
ID TWIN TRANSFUSION SYNDROME; ZIKA VIRUS-INFECTION; LASER-SURGERY; FETUSES;
   ANEUPLOIDY; MOSAICISM; DEFECTS; REVEALS; INFANTS; EMBRYOS
C1 [Van Mieghem, Tim] Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada.
   [Van Mieghem, Tim] Univ Toronto, Toronto, ON, Canada.
   [Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA.
   [Levy, Brynn] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA.
   [Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium.
   [Chitty, Lyn S.] Great Ormond St NHS Fdn Trust, North Thames NHS Genom Med Ctr, London, England.
   [Chitty, Lyn S.] UCL Great Ormond St Inst Child Hlth, Genet & Genom Med, London, England.
   [Ghidini, Alessandro] Inova Alexandria Hosp, Alexandria, VA USA.
RP Van Mieghem, T (corresponding author), Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada.; Van Mieghem, T (corresponding author), Univ Toronto, Toronto, ON, Canada.
EM tim.vanmieghem@sinaihealthsystem.ca
OI Deprest, Jan/0000-0002-4920-945X; Van Mieghem, Tim/0000-0002-3034-6905
CR Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379
   Alamillo CL, 2015, PRENATAL DIAG, V35, P1073, DOI 10.1002/pd.4648
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   [Anonymous], 2016, Nature, V537, P7, DOI 10.1038/537007a
   Botelho RD, 2017, FETAL DIAGN THER, V42, P28, DOI 10.1159/000449382
   Callaway E, 2016, NATURE, V532, P289, DOI 10.1038/532289a
   Chitty L. S., 2016, ULTRASOUND OBSTET S1, V48, P356, DOI [10.1002/uog.17084, DOI 10.1002/U0G.17084]
   Chmait RH, 2016, PRENATAL DIAG, V36, P63, DOI 10.1002/pd.4713
   Committee on Genetics and the Society for Maternal-Fetal Medicine, 2016, Obstet Gynecol, V128, pe262
   Committee SP., 2016, AM J OBSTET GYNECOL, V214, pB2
   Deprest J, 2016, PRENATAL DIAG, V36, P3, DOI 10.1002/pd.4758
   Donofrio MT, 2003, PEDIATR CARDIOL, V24, P436, DOI 10.1007/s00246-002-0404-0
   Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Drury S, 2015, PRENATAL DIAG, V35, P1010, DOI 10.1002/pd.4675
   Emery SP, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.024
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gaur L, 2016, PRENATAL DIAG, V36, P752, DOI 10.1002/pd.4856
   Graf K, 2016, ULTRASOUND OBST GYN, V47, P158, DOI 10.1002/uog.14937
   Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421
   Guerra B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.052
   Hinch E, 2016, PRENATAL DIAG, V36, P507, DOI 10.1002/pd.4814
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Horst M, 2017, NEUROUROL URODYNAM, V36, P1651, DOI 10.1002/nau.23174
   Hui LS, 2015, PRENATAL DIAG, V35, P1, DOI 10.1002/pd.4497
   Ishii T, 2017, REPROD BIOMED ONLINE, V34, P27, DOI 10.1016/j.rbmo.2016.09.009
   Jansen FAR, 2016, PRENATAL DIAG, V36, P601, DOI 10.1002/pd.4842
   Kalynchuk EJ, 2015, PRENATAL DIAG, V35, P1030, DOI 10.1002/pd.4635
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8
   Le Page M., 2017, NEW SCI
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, P342
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.003
   Leyder M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.003
   Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5
   Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568
   Lopriore E, 2009, OBSTET GYNECOL, V113, P361, DOI 10.1097/AOG.0b013e318195873e
   Matthijs G, 2016, EUR J HUM GENET, V24, P2, DOI 10.1038/ejhg.2015.226
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   Maxwell SM, 2016, FERTIL STERIL, V106, P1414, DOI 10.1016/j.fertnstert.2016.08.017
   Munne S, 2016, FERTIL STERIL, V105, P1146, DOI 10.1016/j.fertnstert.2016.01.016
   Murgia M., NEWSWEEK
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pangalos C, 2016, PEERJ, V4, DOI 10.7717/peerj.1955
   Pedreira DA, 2016, AM J OBSTET GYNECOL, V214, pe1
   Petropoulos S, 2016, CELL, V165, P1012, DOI 10.1016/j.cell.2016.03.023
   Peyvandi S, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2015.4450
   Quinlan-Jones E, 2016, PRENATAL DIAG, V36, P935, DOI 10.1002/pd.4916
   Reardon S, 2015, NATURE, V528, P173, DOI 10.1038/528173a
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Sachdev NM, 2017, FERTIL STERIL, V107, P6, DOI 10.1016/j.fertnstert.2016.10.006
   Scott RT, 2016, FERTIL STERIL, V105, P1150, DOI 10.1016/j.fertnstert.2016.01.007
   Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597
   Slaghekke F, 2014, LANCET, V383, P2144, DOI 10.1016/S0140-6736(13)62419-8
   Smith EC, 2016, HUM MOL GENET, V25, pR99, DOI 10.1093/hmg/ddw170
   Treff NR, 2017, FERTIL STERIL, V107, P27, DOI 10.1016/j.fertnstert.2016.09.039
   Vassena R, 2016, HUM REPROD UPDATE, V22, P411, DOI 10.1093/humupd/dmw005
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
NR 58
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD FEB
PY 2017
VL 37
IS 2
BP 117
EP 122
DI 10.1002/pd.5007
PG 6
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA EL4PX
UT WOS:000394604400001
PM 28205301
DA 2020-07-08
ER

PT J
AU Baranitharan, M
   Dhanasekaran, S
   Kovendan, K
   Murugan, K
   Gokulakrishnan, J
   Benelli, G
AF Baranitharan, Mathalaimuthu
   Dhanasekaran, Shanmugam
   Kovendan, Kalimuthu
   Murugan, Kadarkarai
   Gokulakrishnan, Jayapal
   Benelli, Giovanni
TI Coleus aromaticus leaf extract fractions: A source of novel ovicides,
   larvicides and repellents against Anopheles, Aedes and Culex mosquito
   vectors?
SO PROCESS SAFETY AND ENVIRONMENTAL PROTECTION
LA English
DT Article
DE Acute toxicity; Aedes aegypti; Anopheles stephensi; Culex
   quinquefasciatus; GC-MS; Thin layer chromatography
ID QUINQUEFASCIATUS DIPTERA; STEPHENSI LISTON.; ESSENTIAL OILS; ZIKA VIRUS;
   AEGYPTI; PLANT; MALARIA; DENGUE; L.; NANOPARTICLES
AB Eco-friendly tools to manage mosquito young instar populations in an IPM framework are urgently required. Here, we analyzed six ethyl acetate and methanol fractions of Coleus aromaticus leaf extract using thin layer chromatography and GC-MS, in order to shed light on the main chemical constituents with toxicity on mosquitoes. The fractions were tested as ovicides, larvicides and repellents against the mosquito vectors Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. In GC-MS analysis, a total of nine compounds were identified in the methanolic extract composition, the main component was 11-octadecenoic acid, methyl ester. The highest larvicidal activity was observed for the methanol fraction 4 against Ae. aegypti, An. stephensi and Cx. quinquefasciatus with LC50 values of 23.90, 22.32 and 20.51 ppm. In the ovicidal experiments, 100% mortality was exterted by methanol fraction 4 tested at 40 ppm against Ae. aegypti, An. stephensi and Cx. quinquefasciatus. Furthermore, high repellence of methanol fraction 4 tested at 2.5 mg/cm(2) was observed in "arm in cage" tests for at least 320 min. We hypothesized that 11-octadecenoic acid, methyl ester was the main constituent responsible for the mosquitocidal and repellent activity of C. aromaticus fractions. (C) 2016 Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Baranitharan, Mathalaimuthu; Dhanasekaran, Shanmugam] Annamalai Univ, Dept Zool, Div Phytochem & Entomotox, Annamalainagar 608002, Tamil Nadu, India.
   [Dhanasekaran, Shanmugam] Thiru Kolanjiappar Govt Arts Coll, Dept Zool, PG & Res, Viruddhachalam 606001, Tamil Nadu, India.
   [Kovendan, Kalimuthu; Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Dept Zool, Div Entomol, Coimbatore 641046, Tamil Nadu, India.
   [Gokulakrishnan, Jayapal] Poompuhar Coll, Dept Zool, Melaiyur 609107, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Kovendan, K (corresponding author), Bharathiar Univ, Sch Life Sci, Dept Zool, Div Entomol, Coimbatore 641046, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM gokulloyo@yahoo.co.in; benelli.giovanni@gmail.com
RI Murugan, Kadarkarai/AAP-3937-2020; Benelli, Giovanni/A-9100-2013;
   Kalimuthu, Kovendan/V-6519-2017
OI Benelli, Giovanni/0000-0001-8971-6010; Kalimuthu,
   Kovendan/0000-0003-1239-525X
FU University Grants Commission, New DelhiUniversity Grants Commission,
   India [F 42-597/2013SR]
FX The authors are grateful to the Professor and Head, Department of
   Zoology, Annamalai University, Annamalainagar for the laboratory
   facilities provided and University Grants Commission, New Delhi, for
   their financial assistance (Ref. No. F 42-597/2013SR).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Balasubramanian J, 2015, PARASITOL RES, V114, P4219, DOI 10.1007/s00436-015-4658-x
   Balu S., 2015, INT J RECENT SCI RES, V6, P2690
   Benelli G., 2017, J CLUST SCI
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bilal H, 2012, AFR ENTOMOL, V20, P8, DOI 10.4001/003.020.0102
   Buznego M. T., 1999, REV NEUROL, V29, P229
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Daravath Samba Shiva, 2015, ADV ENTOMOL, V3, P118
   DEEPA M, 2014, INT J MOSQ RES A, V1, P30
   Gurgel APAD, 2009, J ETHNOPHARMACOL, V125, P361, DOI 10.1016/j.jep.2009.07.006
   Finney DJ, 1971, PROBIT ANAL, P633
   Geng YJ, 2009, PARASITOL RES, V105, P843, DOI 10.1007/s00436-009-1470-5
   Ghosh S, 2013, J TROP PARASITOL, V3, P67, DOI DOI 10.4103/2229-5070.113917
   Govindarajan M, 2014, PARASITOL RES, V113, P1435, DOI 10.1007/s00436-014-3784-1
   Govindarajan M, 2014, PARASITOL RES, V113, P777, DOI 10.1007/s00436-013-3709-4
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Japheth O. O., 2014, African Journal of Biotechnology, V13, P2175
   Jayanthi P, 2012, PARASITOL RES, V111, P2129, DOI 10.1007/s00436-012-3061-0
   Kamakshi KT, 2015, INT J MOSQ RES A, V2, P13
   Khanna VG, 2011, PARASITOL RES, V109, P1373, DOI 10.1007/s00436-011-2384-6
   Kokate C. K., 1994, PRACTICAL PHARMACOGN, P4
   Kovendan K., 2014, ASIAN PAC J TROP DIS, V4, P930
   Kovendan K, 2013, PARASITOL RES, V112, P1205, DOI 10.1007/s00436-012-3252-8
   Kovendan K, 2012, PARASITOL RES, V110, P195, DOI 10.1007/s00436-011-2469-2
   KUMAR MS, 2013, ASIAN J PLANT SCI RE, V3, P43
   Kumaravel S., 2010, INT J APPL CHEM, V6, P363
   Lame Y, 2015, J ARTHROPOD-BORNE DI, V9, P226
   Mehlhom H., 2016, PARASITOLOGY RES MON, V8
   Murthy PS, 2009, FOOD CHEM, V114, P1014, DOI 10.1016/j.foodchem.2008.10.064
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   NAVBDP, 2014, DENG DENG HAEM FEV
   Ndung'u MW, 2004, J AGR FOOD CHEM, V52, P5027, DOI 10.1021/jf049474y
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6
   Park IK, 2005, J AGR FOOD CHEM, V53, P969, DOI 10.1021/jf048208h
   Patil CD, 2011, PARASITOL RES, V108, P1253, DOI 10.1007/s00436-010-2174-6
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2014, PLANT PROTECT SCI, V50, P36, DOI 10.17221/48/2013-PPS
   Ramkumar G, 2015, PARASITOL RES, V114, P1139, DOI 10.1007/s00436-014-4288-8
   Rashmi Sahay K., 2011, INT J PHARM BIO SCI, V2, pB488
   Rout O. P., 2012, INT J APPL BIOL PHAR, V3, P348
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Shaalan E. A., 2012, Journal of Entomology, V9, P183, DOI 10.3923/je.2012.183.186
   Sharma P, 2009, PARASITOL RES, V106, P171, DOI 10.1007/s00436-009-1644-1
   Shivaji Bole, 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P974
   Siddiqui BS, 2004, CHEM PHARM BULL, V52, P1349, DOI 10.1248/cpb.52.1349
   Siddiqui BS, 2003, CHEM PHARM BULL, V51, P415, DOI 10.1248/cpb.51.415
   Soni H., 2012, ASIAN J PHARM CLIN R, V5, P12
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Vatandoost H, 2004, East Mediterr Health J, V10, P573
   WHO, 2015, MALARIA
   WHO, 2014, MALARIA
   WHO, 2014, LYMPH FIL FACT SHEET
   WHO, 2014, GUE SEV DENG
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Wong W., 2007, W WONG GREEN CULTURE
   World Health Organization,, 2008, DENGUE DENGUE HAEMOR
   World Health Organization, 2010, ENTOMOL EXP APPL, V35, P11
   World Health Organization, 2009, WHOCDSNTDWHOPES20094, P4
NR 64
TC 9
Z9 9
U1 1
U2 7
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0957-5820
EI 1744-3598
J9 PROCESS SAF ENVIRON
JI Process Saf. Environ. Protect.
PD FEB
PY 2017
VL 106
BP 23
EP 33
DI 10.1016/j.psep.2016.12.003
PG 11
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA EN4HO
UT WOS:000395968800003
DA 2020-07-08
ER

PT J
AU Uraki, R
   Hwang, J
   Jurado, KA
   Householder, S
   Yockey, LJ
   Hastings, AK
   Homer, RJ
   Iwasaki, A
   Fikrig, E
AF Uraki, Ryuta
   Hwang, Jesse
   Jurado, Kellie Ann
   Householder, Sarah
   Yockey, Laura J.
   Hastings, Andrew K.
   Homer, Robert J.
   Iwasaki, Akiko
   Fikrig, Erol
TI Zika virus causes testicular atrophy
SO SCIENCE ADVANCES
LA English
DT Article
ID HUMAN LEYDIG-CELLS; SEXUAL TRANSMISSION; NEURAL PROGENITORS; MICE;
   INFECTION; BRAIN; ORGANOIDS; EXPOSURE; LEADS; PERSISTENCE
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has recently been found to cause fetal infection and neonatal abnormalities, including microcephaly and neurological dysfunction. ZIKV persists in the semen months after the acute viremic phase in humans. To further understand the consequences of ZIKV persistence in males, we infected Ifnar1(-/-) mice via subcutaneous injection of a pathogenic but nonlethal ZIKV strain. ZIKV replication persists within the testes even after clearance from the blood, with interstitial, testosterone-producing Leydig cells supporting virus replication. We found high levels of viral RNA and antigen within the epididymal lumen, where sperm is stored, and within surrounding epithelial cells. Unexpectedly, at 21 days post-infection, the testes of the ZIKV-infected mice were significantly smaller compared to those of mock-infected mice, indicating progressive testicular atrophy. ZIKV infection caused a reduction in serum testosterone, suggesting that male fertility can be affected. Our findings have important implications for nonvector-borne vertical transmission, as well as long-term potential reproductive deficiencies, in ZIKV-infected males.
C1 [Uraki, Ryuta; Hwang, Jesse; Householder, Sarah; Hastings, Andrew K.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, 333 Cedar St, New Haven, CT 06520 USA.
   [Jurado, Kellie Ann; Yockey, Laura J.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.
   [Homer, Robert J.] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.
   [Homer, Robert J.] US Dept Vet Affairs, Affairs Connecticut Healthcare Syst Pathol & Lab, West Haven, CT 06516 USA.
   [Iwasaki, Akiko; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, 333 Cedar St, New Haven, CT 06520 USA.; Fikrig, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM erol.fikrig@yale.edu
RI Iwasaki, Akiko/Z-1591-2019; homer, robert/P-3884-2019
OI Iwasaki, Akiko/0000-0002-7824-9856; homer, robert/0000-0002-2055-5885
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32 AI007019-40, 4T32HL007974-15, T32
   GM007205]
FX This work was supported by NIH grants 5T32 AI007019-40 (to K.A.J.),
   4T32HL007974-15 (to J.H.), and T32 GM007205 (to L.J.Y.).
CR Abney TO, 1999, STEROIDS, V64, P610, DOI 10.1016/S0039-128X(99)00041-0
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jones RC, 1999, INT J ANDROL, V22, P57
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Goffic R, 2003, J VIROL, V77, P3297, DOI 10.1128/JVI.77.5.3297-3300.2003
   Le Tortorec A, 2008, HUM REPROD, V23, P2095, DOI 10.1093/humrep/den207
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhu WW, 2013, MOL ENDOCRINOL, V27, P1455, DOI 10.1210/me.2013-1075
NR 43
TC 59
Z9 60
U1 1
U2 6
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD FEB
PY 2017
VL 3
IS 2
AR e1602899
DI 10.1126/sciadv.1602899
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EO9WT
UT WOS:000397039500038
PM 28261663
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Parmet, WE
   Sinha, MS
AF Parmet, Wendy E.
   Sinha, Michael S.
TI A panic foretold: Ebola in the United States
SO CRITICAL PUBLIC HEALTH
LA English
DT Editorial Material
DE Law; politics; public policy; Ebola; germ panics
ID MEDIA REASSURANCE; PUBLIC-HEALTH; DISEASES; FEAR
AB This paper reconsiders the Ebola response in the US as a panic that was both predictable and problematic. Public health professionals and policy-makers have historically drawn attention to and prepared for emerging infectious diseases by raising the specter of catastrophe, generating fears that the media and politicians are often willing to amplify. Although this approach can increase awareness of and funding for global health threats, it also sows the seeds of panic, stigmatizing people associated with the disease, and compromising an effective, evidence-based response. We offer lessons for public health leaders as they review the US Ebola response in order to prepare more responsibly for future disease scares such as that posed by the Zika virus.
C1 [Parmet, Wendy E.] Northeastern Univ, Law, Boston, MA 02115 USA.
   [Parmet, Wendy E.] Northeastern Univ, Publ Policy & Urban Affairs, Boston, MA 02115 USA.
   [Sinha, Michael S.] Boston Med Ctr, Dept Internal Med, Boston, MA USA.
   [Sinha, Michael S.] Boston Univ, Sch Med, Boston, MA 02118 USA.
RP Parmet, WE (corresponding author), Northeastern Univ, Law, Boston, MA 02115 USA.; Parmet, WE (corresponding author), Northeastern Univ, Publ Policy & Urban Affairs, Boston, MA 02115 USA.
EM w.parmet@neu.edu
CR [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   Apuzzo Matt, 2014, NY TIMES
   Brinker L., 2014, TEA PARTY CONGRESSMA
   Bukaty R., 2014, JUDGE REJECTS ATTEMP
   Centers for Disease Control and Prevention, 2012, 1 GLOB EST 2009 H1NI
   Centers for Disease Control and Prevention, 2014, STAT EBOL PROT
   Centers for Disease Control and Prevention, 2014, INT US GUID MON MOV
   Cohen HW, 1999, AM J PUBLIC HEALTH, V89, P1629, DOI 10.2105/AJPH.89.11.1629
   Cohen S., 1972, FOLK DEVILS MORAL PA
   Corderoy Amy, 2014, SYDNEY MORNING HERAL
   Craighill P. M., 2014, WASHINGTON POST
   *CTR LAW PUBL HLTH, 2001, MOD STAT EM HLTH POW
   Financial Tracking Service, 2015, EBOL VIR OUTBR W AFR
   Frieden T., 2014, COMMUNICATION
   Garrett Laurie, 1994, COMING PLAGUE NEWLY
   Jacobson L., 2014, TAMPA BAY TIMES
   Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604
   Joffe H, 2011, PSYCHOL HEALTH, V26, P667, DOI 10.1080/08870441003763238
   Joffe Helene, 1999, RISK AND THE OTHER, DOI [10.1017/CBO9780511489846, DOI 10.1017/CBO9780511489846]
   Kilianski A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005097
   Lederberg Joshua, 1992, EMERGING INFECTIONS
   Lupkin S., 2014, EBOLA AM TIMELINE DE
   Mack A., 2010, INFECT DIS MOVEMENT
   McAuliff M., 2014, NOW THAT EL C SEEMS
   Medecins sans Frontieres, 2014, EB W AFR EP REQ MASS
   Merino JG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6712
   Morrison J. S., 2014, T FRIEDEN US EBOLA R
   Orden E., 2014, WALL STREET J
   Pandey A., 2014, INT BUSINESS TIMES
   Parmet Wendy E, 2008, Hastings Cent Rep, V38, P57
   Parmet WE, 2009, J LEGAL MED, V30, P83, DOI 10.1080/01947640802694593
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Piotrowski D., 2014, ARE WE RISK EBOLAINF
   Preston R., 1995, THE HOT ZONE
   Ray J., 2014, POLL HUGE SUPPORT QU
   Robey TE, 2015, AM J BIOETHICS, V15, P59, DOI 10.1080/15265161.2015.1009569
   Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135
   Saad L., 2014, EBOLA RANKS AM TOP 3
   SATCHER D, 1995, EMERG INFECT DIS, V1, P1, DOI 10.3201/eid0101.950101
   Sinha MS, 2007, J LEGAL MED, V28, P397, DOI 10.1080/01947640701554500
   The Vigilant Citizen, 2012, CONT DIS MOV ED MASS
   The White House Office of Science and Technology Policy, 1996, FACT SHEET ADDR THRE
   Tomes N, 2000, AM J PUBLIC HEALTH, V90, P191, DOI 10.2105/AJPH.90.2.191
   Tuttle I., 2014, NATL REV
   Ungar S, 2001, BRIT J SOCIOL, V52, P271, DOI 10.1080/00071310120044980
   Ungar S, 1998, BRIT J SOCIOL, V49, P36, DOI 10.2307/591262
   Ungar S, 2008, SCI COMMUN, V29, P472, DOI 10.1177/1075547008316219
   Upshur R., 2014, ETHICS INFECT DIS
   Wald P, 2008, CONTAGIOUS CULTURES
   Washer P., 2010, EMERG INFECT DIS, DOI [10.1057/9780230277182, DOI 10.1057/9780230277182]
   Wayne A., 2014, C NEARL GRANTS OB EB
   Yuhas Alan, 2014, GUARDIAN
NR 52
TC 4
Z9 4
U1 1
U2 107
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0958-1596
EI 1469-3682
J9 CRIT PUBLIC HEALTH
JI Crit. Public Heath
PD FEB
PY 2017
VL 27
IS 1
BP 148
EP 155
DI 10.1080/09581596.2016.1159285
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA EF2AO
UT WOS:000390126800014
DA 2020-07-08
ER

PT J
AU Doss, CGP
   Siva, R
   Christopher, BP
   Chakraborty, C
   Zhu, HL
AF Doss, C. George Priya
   Siva, R.
   Christopher, B. Prabhu
   Chakraborty, Chiranjib
   Zhu, Hailong
TI Zika: How safe is India?
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Article
DE Zika virus; Preventive measures; India
ID VIRUS; DENGUE; TRANSMISSION; COUNTRIES
AB Zika virus, which originated from a forest in Uganda, has affected countries in Africa, Latin America and Asia. Most people infected with Zika are asymptomatic and present with clinical manifestations ranging from mild fever to severe neurological disorders. Recent outbreaks in Southeast Asian countries, Centers for Disease Control and Prevention has warned pregnant woman to avoid nonessential traveling to 11 Asian countries. Reports about the sexual transmission route of Zika have pushed the World Health Organization to declare it a 'public health emergency'. Having this current warning status, it has become mandatory to consider where second highly populated country India stands in terms of spreading awareness and taking precautionary measures against the Zika virus infection. Therefore, this paper aims to highlight the importance of Zika in Indian population by considering several indicators such as the population size and ratio, rates of mortality, closely related diseases, government initiatives, and other micro-level factors which are prone to Zika effects.
C1 [Doss, C. George Priya; Siva, R.] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.
   [Christopher, B. Prabhu] VIT Univ, VIT BS, Vellore 632014, Tamil Nadu, India.
   [Chakraborty, Chiranjib] Galgotias Univ, Sch Comp & Informat Sci, Dept Bioinformat, Greater Noida 201310, Uttar Pradesh, India.
   [Zhu, Hailong] Hong Kong Baptist Univ, Sch Chinese Med, Integrated Bioinformed & Translat Sci, 7 Baptist Univ Rd, Hong Kong, Hong Kong, Peoples R China.
RP Zhu, HL (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Integrated Bioinformed & Translat Sci, 7 Baptist Univ Rd, Hong Kong, Hong Kong, Peoples R China.
EM hlzhu@hkbu.edu.hk
RI amsalu, ribka/G-8780-2019
OI C, George Priya Doss/0000-0002-5971-8290; Ramamoorthy,
   Siva/0000-0001-7509-8602; Chkraborty, Chiranjib/0000-0002-3958-239X
FU Research Grants Council of Hong KongHong Kong Research Grants Council
   [212111, 212613]; Faculty Research Grant of Hong Kong Baptist University
   [FRG/14-15/063, FRG2/13-14/056]
FX This work was supported by the Research Grants Council of Hong Kong
   (Nos: 212111 and 212613) and the Faculty Research Grant of Hong Kong
   Baptist University (Nos: FRG/14-15/063 and FRG2/13-14/056).
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Johansson MA, 2016, NEW ENGL J MED, V375
   Lupton K., 2016, BR J NURS, V25, P200
   Maurice J, 2016, LANCET, V387, P1147, DOI 10.1016/S0140-6736(16)30012-5
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Tambo E, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0148-3
   Thappa D. M., 2007, Indian Journal of Sexually Transmitted Diseases, V28, P69
   WHO, 2015, TRENDS MAT MORT 1990
NR 16
TC 5
Z9 5
U1 0
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD JAN 31
PY 2017
VL 6
AR 37
DI 10.1186/s40249-016-0234-6
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EL0HX
UT WOS:000394304600001
PM 28173851
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Coffey, LL
   Pesavento, PA
   Keesler, RI
   Singapuri, A
   Watanabe, J
   Watanabe, R
   Yee, J
   Bliss-Moreau, E
   Cruzen, C
   Christe, KL
   Reader, JR
   von Morgenland, W
   Gibbons, AM
   Allen, AM
   Linnen, J
   Gao, K
   Delwart, E
   Simmons, G
   Stone, M
   Lanteri, M
   Bakkour, S
   Busch, M
   Morrison, J
   Van Rompay, KKA
AF Coffey, Lark L.
   Pesavento, Patricia A.
   Keesler, Rebekah I.
   Singapuri, Anil
   Watanabe, Jennifer
   Watanabe, Rie
   Yee, JoAnn
   Bliss-Moreau, Eliza
   Cruzen, Christina
   Christe, Kari L.
   Reader, J. Rachel
   von Morgenland, Wilhelm
   Gibbons, Anne M.
   Allen, A. Mark
   Linnen, Jeff
   Gao, Kui
   Delwart, Eric
   Simmons, Graham
   Stone, Mars
   Lanteri, Marion
   Bakkour, Sonia
   Busch, Michael
   Morrison, John
   Van Rompay, Koen K. A.
TI Zika Virus Tissue and Blood Compartmentalization in Acute Infection of
   Rhesus Macaques
SO PLOS ONE
LA English
DT Article
ID SIMIAN IMMUNODEFICIENCY VIRUS; TRANSMISSION; PATHOGENESIS; TRANSFUSION;
   VACCINE; BRAZIL; CELLS; MODEL
AB Animal models of Zika virus (ZIKV) are needed to better understand tropism and pathogenesis and to test candidate vaccines and therapies to curtail the pandemic. Humans and rhesus macaques possess similar fetal development and placental biology that is not shared between humans and rodents. We inoculated 2 non-pregnant rhesus macaques with a 2015 Brazilian ZIKV strain. Consistent with most human infections, the animals experienced no clinical disease but developed short-lived plasma viremias that cleared as neutralizing antibody developed. In 1 animal, viral RNA (vRNA) could be detected longer in whole blood than in plasma. Despite no major histopathologic changes, many adult tissues contained vRNA 14 days post-infection with highest levels in hemolymphatic tissues. These observations warrant further studies to investigate ZIKV persistence and its potential clinical implications for transmission via blood products or tissue and organ transplants.
C1 [Coffey, Lark L.; Pesavento, Patricia A.; Singapuri, Anil; Watanabe, Rie] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.
   [Keesler, Rebekah I.; Watanabe, Jennifer; Yee, JoAnn; Bliss-Moreau, Eliza; Cruzen, Christina; Christe, Kari L.; Reader, J. Rachel; von Morgenland, Wilhelm; Gibbons, Anne M.; Allen, A. Mark; Morrison, John; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.
   [Linnen, Jeff; Gao, Kui] Hologic, San Diego, CA USA.
   [Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP Coffey, LL (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.; Van Rompay, KKA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
EM lcoffey@ucdavis.edu; kkvanrompay@ucdavis.edu
RI Simmons, Graham/G-3523-2012
OI Simmons, Graham/0000-0002-9615-7023
FU CNPRC; Office of Research Infrastructure Programs/OD [P510D011107];
   Pathology, Microbiology and Immunology Department
FX This study was supported by a CNPRC pilot research grant to LC and KVR,
   the Office of Research Infrastructure Programs/OD (P510D011107), and
   start up funds from the Pathology, Microbiology and Immunology
   Department to LC. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. Although JL and KG are employees of Hologic, their role in
   the study was to test samples from macaques. Hologic did not provide any
   funding or salary support for other manuscript co-authors.; We
   acknowledge the research and support staff at CNPRC for their assistance
   with all aspects of the study, as well as the UC Davis IACUC and
   Environmental Health and Safety Offices for expedited approval for work
   on this project. Sarah Mills, Abigail Spinner and the staff of the
   Pathogen Detection Laboratory and Clinical Laboratories at CNPRC were
   especially helpful with necropsies and biospecimen processing, and
   analysis. Kathy West provided illustrations. The Zika research team at
   the Wisconsin National Primate Research Center provided ongoing advice
   and data-sharing. The Unite des Virus Emergents, Marseille, France,
   provided the inactivated French Polynesia 2013 standard. This study was
   supported by a CNPRC pilot research grant to LC and KVR, the Office of
   Research Infrastructure Programs/OD (P510D011107), and start up funds
   from the Pathology, Microbiology and Immunology Department to LC. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Although JL and
   KG are employees of Hologic, their role in the study was to test samples
   from macaques. Hologic did not provide any funding or salary support for
   other manuscript co-authors.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, 2016, ZIKA VIRUS
   CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hologic, 2016, APT ZIK VIR ASS
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, BULLETIN OF THE WORL
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lustig Y, 2016, EURO SURVEILL, V21
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pan-American Health Organization, 2016, COUNTR TERR AUT TRAN
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scharko AM, 1996, P NATL ACAD SCI USA, V93, P6425, DOI 10.1073/pnas.93.13.6425
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841
   Stone M, 2017, TRANSFUSION IN PRESS
   Van Rompay KKA, 2004, J VIROL, V78, P5324, DOI 10.1128/JVI.78.10.5324-5337.2004
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 44
TC 52
Z9 53
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 31
PY 2017
VL 12
IS 1
AR e0171148
DI 10.1371/journal.pone.0171148
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN6QW
UT WOS:000396129500044
PM 28141843
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dhillon, RS
   Srikrishna, D
   Jha, AK
AF Dhillon, Ranu S.
   Srikrishna, Devabhaktuni
   Jha, Ashish K.
TI Containing Zika while we wait for a vaccine
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
ID VIRUS
C1 [Dhillon, Ranu S.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.
   [Dhillon, Ranu S.] Harvard Med Sch, Boston, MA 02115 USA.
   [Srikrishna, Devabhaktuni] Patient KnowHow San Mateo, San Mateo, CA USA.
   [Jha, Ashish K.] Harvard Inst Global Hlth, Boston, MA USA.
RP Dhillon, RS (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Dhillon, RS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM dhillon.ranu.s@gmail.com
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Alvarez Lizette, 2016, NY TIMES
   American Academy of Dermatology, 2016, AN END TO THE HIV AI
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V356
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Belluck P., 2016, NY TIMES
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Chang D., 2016, MIAMI HERALD
   Dhillon RS, 2016, LANCET INFECT DIS, V16, P1109, DOI 10.1016/S1473-3099(16)30338-3
   Dhillon RS, 2015, LANCET INFECT DIS, V15, P147, DOI 10.1016/S1473-3099(14)71035-7
   Funk S, 2014, NATURE, V515, P493, DOI 10.1038/515492b
   Goldschmidt D., 2016, CABLE NEWS NETWORK
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   McNeil Jr Donald G., 2016, NY TIMES
   Miller HI., 2016, WALL STREET J
   Onishi Norimitsu, 2015, NY TIMES
   Osterholm MT, 2016, SCIENCE, V353, P1073, DOI 10.1126/science.aai9078
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Serdobova I, 2006, AM J PUBLIC HEALTH, V96, P1554, DOI 10.2105/AJPH.2005.074583
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thomas Katie, 2016, NY TIMES
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
NR 25
TC 1
Z9 1
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 30
PY 2017
VL 356
AR j379
DI 10.1136/bmj.j379
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EJ8BO
UT WOS:000393449600001
PM 28137716
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Aagaard, KM
   Lahon, A
   Suter, MA
   Arya, RP
   Seferovic, MD
   Vogt, MB
   Hu, M
   Stossi, F
   Mancini, MA
   Harris, RA
   Kahr, M
   Eppes, C
   Rac, M
   Belfort, MA
   Park, CS
   Lacorazza, D
   Rico-Hesse, R
AF Aagaard, Kjersti M.
   Lahon, Anismrita
   Suter, Melissa A.
   Arya, Ravi P.
   Seferovic, Maxim D.
   Vogt, Megan B.
   Hu, Min
   Stossi, Fabio
   Mancini, Michael A.
   Harris, R. Alan
   Kahr, Maike
   Eppes, Catherine
   Rac, Martha
   Belfort, Michael A.
   Park, Chun Shik
   Lacorazza, Daniel
   Rico-Hesse, Rebecca
TI Primary Human Placental Trophoblasts are Permissive for Zika Virus
   (ZIKV) Replication
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; VILLOUS TROPHOBLAST; RT-PCR; CYTOTROPHOBLASTS;
   CELLS; RNA
AB Zika virus (ZIKV) is an emerging mosquito-borne (Aedes genus) arbovirus of the Flaviviridae family. Although ZIKV has been predominately associated with a mild or asymptomatic dengue-like disease, its appearance in the Americas has been accompanied by a multi-fold increase in reported incidence of fetal microcephaly and brain malformations. The source and mode of vertical transmission from mother to fetus is presumptively transplacental, although a causal link explaining the interval delay between maternal symptoms and observed fetal malformations following infection has been missing. In this study, we show that primary human placental trophoblasts from non-exposed donors (n = 20) can be infected by primary passage ZIKV-FLR isolate, and uniquely allowed for ZIKV viral RNA replication when compared to dengue virus (DENV). Consistent with their being permissive for ZIKV infection, primary trophoblasts expressed multiple putative ZIKV cell entry receptors, and cellular function and differentiation were preserved. These findings suggest that ZIKV-FLR strain can replicate in human placental trophoblasts without host cell destruction, thereby serving as a likely permissive reservoir and portal of fetal transmission with risk of latent microcephaly and malformations.
C1 [Aagaard, Kjersti M.; Suter, Melissa A.; Seferovic, Maxim D.; Hu, Min; Harris, R. Alan; Kahr, Maike; Eppes, Catherine; Rac, Martha; Belfort, Michael A.] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.; Suter, Melissa A.; Seferovic, Maxim D.; Hu, Min; Harris, R. Alan; Kahr, Maike; Eppes, Catherine; Rac, Martha; Belfort, Michael A.] Baylor Coll Med, Div Maternal Fetal Med, Dept Gynecol, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.; Suter, Melissa A.; Seferovic, Maxim D.; Hu, Min; Harris, R. Alan; Kahr, Maike; Eppes, Catherine; Rac, Martha; Belfort, Michael A.; Park, Chun Shik; Lacorazza, Daniel] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.; Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.; Stossi, Fabio; Mancini, Michael A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Lahon, Anismrita; Arya, Ravi P.; Vogt, Megan B.; Rico-Hesse, Rebecca] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Vogt, Megan B.] Baylor Coll Med, Integrat Mol & Biol Sci Program, Houston, TX 77030 USA.
   [Park, Chun Shik; Lacorazza, Daniel] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
RP Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Gynecol, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
EM aagaardt@bcm.edu
RI ARYA, RAVI/AAF-4108-2020; Harris, R. Alan/AAI-2784-2020
OI ARYA, RAVI/0000-0001-9255-610X; Harris, R. Alan/0000-0002-7333-4752
FU Integrated Microscopy Core at Baylor College of Medicine; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [HD007495, DK56338, CA125123]; Dan L. Duncan Cancer
   Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics
FX The authors also thank the staff directly involved in clinical
   recruitment and specimen processing (Jia Chen and Michelle Moeller), and
   Maureen Mancini and Radhika D. Dandekar for crucial execution of single
   molecule RNA FISH experimentation. The authors are grateful to Drs.
   Janet Butel, Mary Estes, James Versalovic, Rodion Gorchakov, Antonio
   Frias and Margaret Petroff for critical review of the manuscript. We
   thank Dr. Hans Johansson at LGC Biosearch Technologies for final design
   and synthesis of the probe set, and for reagents for Stellaris (TM) RNA
   FISH. Microscopy for this project was supported by the Integrated
   Microscopy Core at Baylor College of Medicine with funding from the NIH
   (HD007495, DK56338, and CA125123), the Dan L. Duncan Cancer Center, and
   the John S. Dunn Gulf Coast Consortium for Chemical Genomics.
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   Chen YL, 2013, J MATER CHEM A, V1, P13301, DOI 10.1039/c3ta12911j
   Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Cugola F. R., 2016, NATURE
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Driggers R. W., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824, DOI 10.1056/NEJMOA1601824]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Giugliano S, 2015, J IMMUNOL, V195, P3737, DOI 10.4049/jimmunol.1500409
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Bellego Frederique, 2009, Methods Mol Biol, V550, P73, DOI 10.1007/978-1-60327-009-0_4
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   Maldonado-Estrada J, 2004, J IMMUNOL METHODS, V286, P21, DOI 10.1016/j.jim.2003.03.001
   Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620
   Martines R. B., 2016, MMWR MORB MORTAL WKL
   Mayhew TM, 2014, PLACENTA, V35, P229, DOI 10.1016/j.placenta.2014.01.011
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mouillet JF, 2015, AM J OBSTET GYNECOL, V213, pS163, DOI 10.1016/j.ajog.2015.05.057
   Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ryan MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-313
   SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993
   STROMBERG K, 1978, IN VITRO CELL DEV B, V14, P631
   Swofford DL, 2002, PAUP PHYLOGENETIC AN
   Tang H, 2016, CELL STEM CELL
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vasilopoulou E, 2010, J CLIN ENDOCR METAB, V95, P4762, DOI 10.1210/jc.2010-0354
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yelamanchili SV, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005032
   Zhang WY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-128
NR 51
TC 50
Z9 50
U1 0
U2 26
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 27
PY 2017
VL 7
AR 41389
DI 10.1038/srep41389
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EJ4BC
UT WOS:000393159900001
PM 28128342
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, GY
   Larsen, CN
   Baumgarth, N
   Klem, EB
   Scheuermann, RH
AF Sun, Guangyu
   Larsen, Christopher N.
   Baumgarth, Nicole
   Klem, Edward B.
   Scheuermann, Richard H.
TI Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus
SO PLOS ONE
LA English
DT Article
ID HEPATITIS-C VIRUS; CLEAVAGE; CLASSIFICATION; INHIBITORS; PROTEASE
AB The rapid spread of Zika virus (ZIKV) has caused much concern in the global health community, due in part to a link to fetal microcephaly and other neurological illnesses. While an increasing amount of ZIKV genomic sequence data is being generated, an understanding of the virus molecular biology is still greatly lacking. A significant step towards establishing ZIKV proteomics would be the compilation of all proteins produced by the virus, and the resultant virus genotypes. Here we report for the first time such data, using new computational methods for the annotation of mature peptide proteins, genotypes, and recombination events for all ZIKV genomes.
C1 [Sun, Guangyu; Larsen, Christopher N.] Vecna Technol Inc, Greenbelt, MD 20770 USA.
   [Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.
   [Baumgarth, Nicole] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Klem, Edward B.] Northrop Grumman Hlth Solut, Rockville, MD USA.
   [Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA.
   [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.
   [Scheuermann, Richard H.] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
RP Larsen, CN (corresponding author), Vecna Technol Inc, Greenbelt, MD 20770 USA.
EM clarsen@vecna.com
RI Baumgarth, Nicole/AAI-6949-2020
OI Larsen, Christopher N/0000-0002-1051-5767
FU National Institute of Allergy and Infectious Diseases (NIAID) as part of
   the National Institutes of Health (NIH); USA Department of Health and
   Human Services (DHHS) [HHSN272201400028C]
FX This project is funded by the National Institute of Allergy and
   Infectious Diseases (NIAID) as part of the National Institutes of Health
   (NIH), USA Department of Health and Human Services (DHHS), under
   Contract No. HHSN272201400028C and is a collaboration between Northrop
   Grumman Health IT (Prime), J. Craig Venter Institute (RHS - PI), and
   Vecna Technologies, Inc. (GS, CNL). NB is a Co-PI. Vecna is an
   independent privately held woman owned small business, subcontracting
   along with the J. Craig Venter Institute to the Northrop Grumman
   corporation under this contracted funding vehicle. The funder provided
   support in the form of salary support for all authors, but did not have
   any additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The specific
   roles of these authors are articulated in the 'author contributions'
   section.
CR Addis SNK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0375-4
   [Anonymous], 2016, CDC DIV VECT BORN DI
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hraber P, 2008, J GEN VIROL, V89, P2098, DOI 10.1099/vir.0.83657-0
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4
   Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374
   Shrinet J, 2016, B WHO
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236
NR 19
TC 13
Z9 14
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 26
PY 2017
VL 12
IS 1
AR e0170462
DI 10.1371/journal.pone.0170462
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7IT
UT WOS:000396176100106
PM 28125631
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ma, WQ
   Li, SH
   Ma, SQ
   Jia, LN
   Zhang, FC
   Zhang, Y
   Zhang, JY
   Wong, G
   Zhang, SS
   Lu, XC
   Liu, M
   Yan, JH
   Li, W
   Qin, C
   Han, DS
   Qin, CF
   Wang, N
   Li, XD
   Gao, GF
AF Ma, Wenqiang
   Li, Shihua
   Ma, Shuoqian
   Jia, Lina
   Zhang, Fuchun
   Zhang, Yong
   Zhang, Jingyuan
   Wong, Gary
   Zhang, Shanshan
   Lu, Xuancheng
   Liu, Mei
   Yan, Jinghua
   Li, Wei
   Qin, Chuan
   Han, Daishu
   Qin, Chengfeng
   Wang, Na
   Li, Xiangdong
   Gao, George Fu
TI Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice
   (vol 167, pg 1511, 2016)
SO CELL
LA English
DT Correction
EM xiangdongli@cau.edu.cn; gaof@im.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
CR Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
NR 1
TC 34
Z9 35
U1 3
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JAN 26
PY 2017
VL 168
IS 3
BP 542
EP 542
DI 10.1016/j.cell.2017.01.009
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EN8KP
UT WOS:000396249600020
PM 28129543
OA Bronze
DA 2020-07-08
ER

PT J
AU Chen, L
   Hafeez, F
   Curry, CL
   Elgart, G
AF Chen, Lucy
   Hafeez, Farhaan
   Curry, Christine L.
   Elgart, George
TI Cutaneous Eruption in a US Woman with Locally Acquired Zika Virus
   Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Chen, Lucy; Hafeez, Farhaan; Curry, Christine L.; Elgart, George] Univ Miami, Miami, FL 33136 USA.
RP Chen, L (corresponding author), Univ Miami, Miami, FL 33136 USA.
EM lucy.chen@jhsmiami.org
CR Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, ADV PEOPL LIV TRAV S
NR 2
TC 8
Z9 8
U1 0
U2 5
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 26
PY 2017
VL 376
IS 4
BP 400
EP 401
DI 10.1056/NEJMc1610614
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EJ3KR
UT WOS:000393111600029
PM 28075694
DA 2020-07-08
ER

PT J
AU Ogden, NH
   Fazil, A
   Safronetz, D
   Drebot, MA
   Wallace, J
   Rees, EE
   Decock, K
   Ng, V
AF Ogden, Nicholas H.
   Fazil, Aamir
   Safronetz, David
   Drebot, Michael A.
   Wallace, Justine
   Rees, Erin E.
   Decock, Kristina
   Ng, Victoria
TI Risk of travel-related cases of Zika virus infection is predicted by
   transmission intensity in outbreak-affected countries
SO PARASITES & VECTORS
LA English
DT Article
DE Zika virus; Travellers; Risk; Basic reproduction number
ID MALE SEXUAL TRANSMISSION; UNITED-STATES; DISEASE; SPREAD; AREAS
AB Background: Zika virus (ZIKV) infection is emerging globally, currently causing outbreaks in the Caribbean, and Central and South America, and putting travellers to affected countries at risk. Model-based estimates for the basic reproduction number (R-0) of ZIKV in affected Caribbean and Central and South American countries, obtained from 2015 to 2016 human case surveillance data, were compared by logistic regression and Receiver-Operating Characteristic (ROC), with the prevalence of ZIKV-positive test results in Canadians who travelled to them.
   Results: Estimates of R-0 for each country were a good predictor of the ZIKV test result (ROC area under the curve = 0.83) and the odds of testing positive was 11-fold greater for travellers visiting countries with estimated R-0 >= 2.76, compared to those visiting countries with R-0 < 2.76.
   Conclusions: Risk to travellers varies widely amongst countries affected by ZIKV outbreaks. Estimates of R-0 from surveillance data can assist in assessing levels of risk for travellers and may help improve travel advice. They may also allow better prediction of spread of ZIKV from affected countries by travellers.
C1 [Ogden, Nicholas H.; Rees, Erin E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Rue Sicotte, St Hyacinthe, PQ, Canada.
   [Fazil, Aamir; Wallace, Justine; Ng, Victoria] Publ Hlth Agcy Canada, Natl Microbiol Lab, Res Lane, Guelph, ON, Canada.
   [Safronetz, David; Drebot, Michael A.; Decock, Kristina] Publ Hlth Agcy Canada, Natl Microbiol Lab, Arlington Rd, Winnipeg, MB, Canada.
RP Ogden, NH (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Rue Sicotte, St Hyacinthe, PQ, Canada.
EM nicholas.ogden@phac-aspc.gc.ca
FU Public Health Agency of Canada
FX This study was funded by the Public Health Agency of Canada. This
   article was reviewed and approved for submission by the funding source.
CR Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3
   Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x
   ANDERSON R M, 1991
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Dohoo I, 2003, VET EPIDEMIOLOGIC RE, P349
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fisman DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083622
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Guerbois M, 2016, J INFECT DI IN PRESS
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huff A, 2016, PLOS CURR, V10, P8
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Majumder MS, 2017, B WHO
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Ng V, 2016, ENV HLTH PE IN PRESS
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Royston P, 1991, STATA TECH B, V3, P7
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
   Zhang Q, 2016, PROJ SPREAD ZIK VIR
   Zika Working Group, 2016, Can Commun Dis Rep, V42, P101
NR 37
TC 8
Z9 8
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 25
PY 2017
VL 10
AR 41
DI 10.1186/s13071-017-1977-z
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EN9ND
UT WOS:000396326000001
PM 28122631
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nicolini, AM
   McCracken, KE
   Yoon, JY
AF Nicolini, Ariana M.
   McCracken, Katherine E.
   Yoon, Jeong-Yeol
TI Future developments in biosensors for field-ready Zika virus diagnostics
SO JOURNAL OF BIOLOGICAL ENGINEERING
LA English
DT Review
DE Zika; Flaviviruses; Biosensors; RT-PCR; LAMP; Immunoassays
ID MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE-CHAIN-REACTION; HAND-HELD
   DEVICE; VISUAL DETECTION; STRUCTURAL BASIS; GENE-SEQUENCES; PCR DEVICE;
   TIME; QUANTIFICATION; FLAVIVIRUSES
AB Since early reports of the recent Zika virus outbreak in May 2015, much has been learned and discussed regarding Zika virus infection and transmission. However, many opportunities still remain for translating these findings into field-ready sensors and diagnostics. In this brief review, we discuss current diagnostic methods, consider the prospects of translating other flavivirus biosensors directly to Zika virus sensing, and look toward the future developments needed for high-sensitivity and high-specificity biosensors to come.
C1 [Nicolini, Ariana M.; Yoon, Jeong-Yeol] Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.
   [McCracken, Katherine E.; Yoon, Jeong-Yeol] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
   Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.
RP Yoon, JY (corresponding author), Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.; Yoon, JY (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
EM jyyoon@email.arizona.edu
OI Klug, Katherine/0000-0002-1728-4623
FU BIO5 Institute; University of Arizona; SMART scholarship from U.S.
   Department of Defense; U.S. National Science Foundation Graduate
   Research FellowshipNational Science Foundation (NSF) [DGE-1143953]
FX Funding for this research was provided by BIO5 Institute, The University
   of Arizona. AMN acknowledges the support of the SMART scholarship from
   U.S. Department of Defense. KEM acknowledges support from the U.S.
   National Science Foundation Graduate Research Fellowship under grant
   number DGE-1143953. Any opinion, findings, and conclusions or
   recommendations expressed in this material are those of the author(s)
   and do not necessarily reflect the views of the National Science
   Foundation.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Ahrberg CD, 2016, ANAL CHEM, V88, P4803, DOI 10.1021/acs.analchem.6b00278
   Ahrberg CD, 2016, LAB CHIP, V16, P586, DOI 10.1039/c5lc01415h
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Badawi MM, 2016, AM J BIOMED RES, V4, P46
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalcanti IT, 2012, BIOCHEM ENG J, V67, P225, DOI 10.1016/j.bej.2012.06.016
   CDC, 2016, ZIK MAC ELISA
   CDC (U.S. Centers for Disease Control and Prevention), 2016, TYP ZIK VIR TESTS
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Centers for Disease Control and Prevention, 2016, TRIOPL REAL TIM RT P
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Craw P, 2015, SENSORS-BASEL, V15, P23418, DOI 10.3390/s150923418
   Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Fakruddin M, 2013, J PHARM BIOALLIED SC, V5, P245, DOI 10.4103/0975-7406.120066
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FDA (U.S. Food and Drug Administration), 2016, EM US AUTH ZIK VIR E
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Harshman DK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400061
   Hologic, 2016, APT ZIK VIR ASS PACK
   Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059
   Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003
   Jahanshahi P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03851
   Jenkins DM, 2011, BIOSENS BIOELECTRON, V30, P255, DOI 10.1016/j.bios.2011.09.020
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li TJ, 2016, NPG ASIA MATER, V8, DOI 10.1038/am.2016.70
   Lim S, 2014, J CHROMATOGR B, V963, P134, DOI 10.1016/j.jchromb.2014.06.004
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b
   Lu WJ, 2016, BIOSENS BIOELECTRON, V75, P28, DOI 10.1016/j.bios.2015.08.016
   Luminex, 2016, XMAP MULTIFLEX ZIKA
   Ma XJ, 2010, J VIROL METHODS, V167, P214, DOI 10.1016/j.jviromet.2010.03.027
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Myers FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070266
   Nagatani N, 2011, ANALYST, V136, P5143, DOI 10.1039/c1an15638a
   Pan American Health Organization (PAHO) / World Health Organization (WHO), 2016, ZIK EP UPD 15 DEC 20
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Manzano J, 2016, ACS NANO, V10, P3102, DOI 10.1021/acsnano.5b07338
   Sayad AA, 2016, SENSOR ACTUAT B-CHEM, V227, P600, DOI 10.1016/j.snb.2015.10.116
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Semenza JC, 2013, EUROSURVEILLANCE, V54, P2
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stedtfeld RD, 2014, ENVIRON SCI TECHNOL, V48, P13855, DOI 10.1021/es503472h
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 68
TC 22
Z9 22
U1 0
U2 27
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-1611
J9 J BIOL ENG
JI J. Biol. Eng.
PD JAN 23
PY 2017
VL 11
AR 7
DI 10.1186/s13036-016-0046-z
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA EN3RK
UT WOS:000395925400002
PM 28127399
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcez, PP
   Nascimento, JM
   de Vasconcelos, JM
   da Costa, RM
   Delvecchio, R
   Trindade, P
   Loiola, EC
   Higa, LM
   Cassoli, JS
   Vitoria, G
   Sequeira, PC
   Sochacki, J
   Aguiar, RS
   Fuzii, HT
   de Filippis, AMB
   Vianez, JLDG
   Tanuri, A
   Martins-de-Souza, D
   Rehen, SK
AF Garcez, Patricia P.
   Nascimento, Juliana Minardi
   de Vasconcelos, Janaina Mota
   da Costa, Rodrigo Madeiro
   Delvecchio, Rodrigo
   Trindade, Pablo
   Loiola, Erick Correia
   Higa, Luiza M.
   Cassoli, Juliana S.
   Vitoria, Gabriela
   Sequeira, Patricia C.
   Sochacki, Jaroslaw
   Aguiar, Renato S.
   Fuzii, Hellen Thais
   Bispo de Filippis, Ana M.
   Goncalves Vianez Junior, Joao Lidio da Silva
   Tanuri, Amilcar
   Martins-de-Souza, Daniel
   Rehen, Stevens K.
TI Zika virus disrupts molecular fingerprinting of human neurospheres
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; CELL-SURVIVAL; STEM-CELLS; PROTEINS; GENE;
   HEPATITIS; REPLICATION; EFFICIENT; ALIGNMENT; RCK/P54
AB Zika virus (ZIKV) has been associated with microcephaly and other brain abnormalities; however, the molecular consequences of ZIKV to human brain development are still not fully understood. Here we describe alterations in human neurospheres derived from induced pluripotent stem (iPS) cells infected with the strain of Zika virus that is circulating in Brazil. Combining proteomics and mRNA transcriptional profiling, over 500 proteins and genes associated with the Brazilian ZIKV infection were found to be differentially expressed. These genes and proteins provide an interactome map, which indicates that ZIKV controls the expression of RNA processing bodies, miRNA biogenesis and splicing factors required for self-replication. It also suggests that impairments in the molecular pathways underpinning cell cycle and neuronal differentiation are caused by ZIKV. These results point to biological mechanisms implicated in brain malformations, which are important to further the understanding of ZIKV infection and can be exploited as therapeutic potential targets to mitigate it.
C1 [Garcez, Patricia P.; Nascimento, Juliana Minardi; da Costa, Rodrigo Madeiro; Loiola, Erick Correia; Vitoria, Gabriela; Sochacki, Jaroslaw; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Nascimento, Juliana Minardi; Cassoli, Juliana S.; Martins-de-Souza, Daniel] Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [de Vasconcelos, Janaina Mota; Goncalves Vianez Junior, Joao Lidio da Silva] Evandro Chagas Inst, Ctr Technol Innovat, Belem, Para, Brazil.
   [Delvecchio, Rodrigo; Higa, Luiza M.; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Sequeira, Patricia C.; Bispo de Filippis, Ana M.] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Fuzii, Hellen Thais] Fed Univ Para, Belem, Para, Brazil.
RP Garcez, PP; Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.; Garcez, PP; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Martins-de-Souza, D (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
EM ppgarcez@icb.ufrj.br; dmsouza@unicamp.br; srehen@lance.ufrj.org
RI Madeiro, Rodrigo/M-6433-2017; Martins-de-Souza, Daniel/E-7021-2010;
   Nascimento, Juliana/B-8764-2009; Higa, Luiza/W-2698-2019; Trindade,
   Pablo/D-8913-2016; Rehen, Stevens K/J-5874-2012; Garcez,
   Patricia/F-8026-2012; Aguiar, Renato S/G-3542-2015; Silva Cassoli,
   Juliana/L-3783-2013; Vianez Junior, Joao Lidio/I-9547-2016; Loiola,
   Erick/I-4106-2016
OI Madeiro, Rodrigo/0000-0001-5646-8858; Martins-de-Souza,
   Daniel/0000-0003-3595-5846; Nascimento, Juliana/0000-0003-3126-4984;
   Trindade, Pablo/0000-0001-5953-7054; Rehen, Stevens
   K/0000-0003-4216-9501; Garcez, Patricia/0000-0002-9107-1335; Aguiar,
   Renato S/0000-0001-5180-3717; Silva Cassoli,
   Juliana/0000-0002-2174-6309; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Loiola, Erick/0000-0002-7926-795X
FU Brazilian Development Bank (BNDES); Funding Authority for Studies and
   Projects (FINEP); National Council of Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Foundation for Research Support in the State of Rio
   de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ); Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [14/21035-0, 14/14881-1, 13/08711-3, 14/10068-4]; Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES
FX The authors thank the technical support of Ismael Gomes, Dr. Renata
   Maciel for providing neural stem cells, Dr. Sandro Patroca da Silva for
   the phylogenetic and bioinformatic helpful advises and Nisha Pulimood
   Foti for English editing. Authors also thank Fabricio Pamplona and Mind
   the Graph. Funds were provided by the Brazilian Development Bank
   (BNDES); Funding Authority for Studies and Projects (FINEP); National
   Council of Scientific and Technological Development (CNPq); Foundation
   for Research Support in the State of Rio de Janeiro (FAPERJ); the Sao
   Paulo Research Foundation (FAPESP, grants 14/21035-0, 14/14881-1,
   13/08711-3 and 14/10068-4); ISD return home award and fellowships from
   the Coordination for the Improvement of Higher Education Personnel
   (CAPES).
CR Ahmed S, 2013, J IMMUNOL, V190, P2217, DOI 10.4049/jimmunol.1201630
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003
   Calvet G., 2016, LANCET INFECT DIS, P1
   Cosker KE, 2016, NAT NEUROSCI, V19, P690, DOI 10.1038/nn.4280
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J., 2016, STEM CELLS, P1, DOI [10.1016/j.stem.2016.04.014, DOI 10.1016/J.STEM.2016.04.014]
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Distler U., NAT METHODS
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004319
   Hao N, 2013, NUCLEIC ACIDS RES, V41, P5626, DOI 10.1093/nar/gkt206
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huys A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067437
   Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Keightley MC, 2013, FEBS LETT, V587, P2150, DOI 10.1016/j.febslet.2013.05.030
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004199
   Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132
   Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miyaji K, 2003, J VIRAL HEPATITIS, V10, P241, DOI 10.1046/j.1365-2893.2003.00447.x
   Mlakar J, 2016, NEW ENGL J MED, V374, P1
   Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H., 2016, ZIKA VIRUS HUMAN PLA, DOI [10.1101/058883, DOI 10.1101/058883]
   Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455
   Tiwari KK, 2015, TOXICOL IN VITRO, V29, P1369, DOI 10.1016/j.tiv.2015.05.008
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 59
TC 38
Z9 38
U1 0
U2 35
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 23
PY 2017
VL 7
AR 40780
DI 10.1038/srep40780
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3SK
UT WOS:000392411400001
PM 28112162
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika Virus - 10 Public Health Achievements in 2016 and Future Priorities
   (vol 65, pg 1482, 2016 )
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Correction
CR 2016, MMWR MORBIDITY MORTA, V65, P1482
NR 1
TC 0
Z9 0
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 20
PY 2017
VL 66
IS 2
BP 64
EP 64
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EJ0LR
UT WOS:000392900800009
DA 2020-07-08
ER

PT J
AU Phelps, C
   Madhavan, G
   Rappuoli, R
   Colwell, R
   Fineberg, H
AF Phelps, Charles
   Madhavan, Guruprasad
   Rappuoli, Rino
   Colwell, Rita
   Fineberg, Harvey
TI Beyond cost-effectiveness: Using systems analysis for infectious disease
   preparedness
SO VACCINE
LA English
DT Article
DE Cost-effectiveness; Systems analysis; Ebola; infectious diseases; Global
   health; Preparedness; Zika
ID EBOLA
AB Until the recent outbreaks, Ebola vaccines ranked low in decision makers' priority lists based on cost-effectiveness analysis and (or) corporate profitability. Despite a relatively small number of Ebolarelated cases and deaths (compared to other causes), Ebola vaccines suddenly leapt to highest priority among international health agencies and vaccine developers. Clearly, earlier cost-effectiveness analyses badly missed some factors affecting real world decisions. Multi-criteria systems analysis can improve evaluation and prioritization of vaccine development and also of many other health policy and investment decisions. Neither cost-effectiveness nor cost-benefit analysis can capture important aspects of problems such as Ebola or the emerging threat of Zika, especially issues of inequality and disparity issues that dominate the planning of many global health and economic organizations. Cost-benefit analysis requires assumptions about the specific value of life an idea objectionable to many analysts and policy makers. Additionally, standard cost-effectiveness calculations cannot generally capture effects on people uninfected with Ebola for example, but nevertheless affected through such factors as contagion, herd immunity, and fear of dread disease, reduction of travel and commerce, and even the hope of disease eradication. Using SMART Vaccines, we demonstrate how systems analysis can visibly include important "other factors" and more usefully guide decision making and beneficially alter priority setting processes. (C) 2016 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Phelps, Charles] Univ Rochester, Rochester, NY 14627 USA.
   [Madhavan, Guruprasad] Natl Acad Sci Engn & Med, Washington, DC USA.
   [Rappuoli, Rino] GlaxoSmithKline Vaccines, Siena, SI, Italy.
   [Colwell, Rita] Univ Maryland, College Pk, MD 20742 USA.
   [Colwell, Rita] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Fineberg, Harvey] Gordon & Betty Moore Fdn, Palo Alto, CA USA.
RP Madhavan, G (corresponding author), 500 Fifth St NW, Washington, DC 20001 USA.
EM gmadhavan@nas.edu
FU Department of Health and Human Services' National Vaccine Program
   Office; National Institute of Health Fogarty International CenterUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC)
FX We thank the Department of Health and Human Services' National Vaccine
   Program Office and the National Institute of Health Fogarty
   International Center for supporting this research in part through a
   contract with the National Academy of Sciences. We appreciate the
   contributions of Lonnie King, Scott Levin, Kinpritma Sangha, Rose Marie
   Martinez, Patrick Kelley, and the advisory members who served on the
   SMART Vaccines project committees of the National Academies. CP, GM, RC,
   and HF declare no conflicts of interests. RR is a full-time employee of
   GlaxoSmithKline Vaccines.
CR BATOR FM, 1957, AM ECON REV, V47, P22
   Bloom D, 2005, WORLD ECON, V6, P15, DOI DOI 10.1007/978-1-4419-7185-2_1
   Centers for Disease Control and Prevention,, OUTBR CHRON EB VIR D
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859
   Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gold M. R., 1996, COST EFFECTIVENESS H
   Grady D., 2014, NY TIMES
   Keeney RL, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P232, DOI 10.1017/CBO9780511611308.014
   Madhavan G, 2015, RANKING VACCINES APP
   Neumann PJ, 2010, NEW ENGL J MED, V363, P1495, DOI 10.1056/NEJMp1007168
   Tan-Torres Edejer T., 2003, MAKING CHOICES HLTH
   TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2
NR 13
TC 7
Z9 7
U1 2
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JAN 20
PY 2017
VL 35
SU 1
BP A46
EP A49
DI 10.1016/j.vaccine.2016.08.090
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EJ5KU
UT WOS:000393257700011
PM 28017432
DA 2020-07-08
ER

PT J
AU Penot, P
   Brichler, S
   Guilleminot, J
   Lascoux-Combe, C
   Taulera, O
   Gordien, E
   Leparc-Goffart, I
   Molina, J
AF Penot, P.
   Brichler, S.
   Guilleminot, J.
   Lascoux-Combe, C.
   Taulera, O.
   Gordien, E.
   Leparc-Goffart, I.
   Molina, J.
TI Infectious Zika virus in vaginal secretions from an HIV-infected woman,
   France, August 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION; SEMEN; PERSISTENCE
AB A woman with controlled HIV infection developed in late August 2016 a pruritic rash with fever and conjunctival hyperaemia after a trip to the French Caribbean islands. On day 3 after symptom onset, Zika virus RNA was detected in plasma, urine and vaginal samples with respective viral loads of 3.8, 6.1 and 5.3 log copies/mL. Notably, we demonstrated the presence of infectious Zika virus particles in the vaginal samples by isolation in cell culture.
C1 [Penot, P.] Andre Gregoire Hosp, Internal Med & Infect Dis Dept, Montreuil, France.
   [Penot, P.; Lascoux-Combe, C.; Molina, J.] St Louis Hosp, Infect & Trop Dis Dept, Paris, France.
   [Brichler, S.; Gordien, E.] Avicenne Hosp, Dept Clin Microbiol, Bobigny, France.
   [Guilleminot, J.] St Louis Hosp, Family Planning Clin, Paris, France.
   [Taulera, O.] St Louis Hosp, Dept Internal Med, Paris, France.
   [Leparc-Goffart, I.] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Leparc-Goffart, I.] EPV Aix Marseille Univ, INSERM French Natl Inst Hlth & Med Res, IRD French Inst Res Dev, EHESP French Sch Publ Hlth,UMR Emergence Pathol V, Marseille, France.
RP Penot, P (corresponding author), Andre Gregoire Hosp, Internal Med & Infect Dis Dept, Montreuil, France.; Penot, P (corresponding author), St Louis Hosp, Infect & Trop Dis Dept, Paris, France.
EM penotpauline@gmail.com
RI BRICHLER, Segolene/R-7039-2018; GORDIEN, Emmanuel/T-7791-2018
OI BRICHLER, Segolene/0000-0002-7336-7730; 
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Penot P, REV MED INT IN PRESS
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 20
TC 16
Z9 16
U1 0
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 19
PY 2017
VL 22
IS 3
BP 8
EP 10
AR 30444
DI 10.2807/1560-7917.ES.2017.22.3.30444
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EJ5AD
UT WOS:000393228000002
PM 28128730
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maringer, K
   Yousuf, A
   Heesom, KJ
   Fan, J
   Lee, D
   Fernandez-Sesma, A
   Bessant, C
   Matthews, DA
   Davidson, AD
AF Maringer, Kevin
   Yousuf, Amjad
   Heesom, Kate J.
   Fan, Jun
   Lee, David
   Fernandez-Sesma, Ana
   Bessant, Conrad
   Matthews, David A.
   Davidson, Andrew D.
TI Proteomics informed by transcriptomics for characterising active
   transposable elements and genome annotation in Aedes aegypti
SO BMC GENOMICS
LA English
DT Article
DE Aedes aegypti; Genome annotation; Non-model organism; PIT; Proteomics
   informed by transcriptomics; Transposon
ID SALIVARY-GLAND TRANSCRIPTS; NON-LTR RETROTRANSPOSONS; ADULT FEMALE
   MOSQUITO; RNA-SEQ DATA; PROTEIN IDENTIFICATION; EUKARYOTIC GENOMES;
   ANOPHELES-GAMBIAE; MALARIA MOSQUITO; DNA TRANSPOSONS; EVOLUTION
AB Background: Aedes aegypti is a vector for the (re-) emerging human pathogens dengue, chikungunya, yellow fever and Zika viruses. Almost half of the Ae. aegypti genome is comprised of transposable elements (TEs). Transposons have been linked to diverse cellular processes, including the establishment of viral persistence in insects, an essential step in the transmission of vector-borne viruses. However, up until now it has not been possible to study the overall proteome derived from an organism's mobile genetic elements, partly due to the highly divergent nature of TEs. Furthermore, as for many non-model organisms, incomplete genome annotation has hampered proteomic studies on Ae. aegypti.
   Results: We analysed the Ae. aegypti proteome using our new proteomics informed by transcriptomics (PIT) technique, which bypasses the need for genome annotation by identifying proteins through matched transcriptomic (rather than genomic) data. Our data vastly increase the number of experimentally confirmed Ae. aegypti proteins. The PIT analysis also identified hotspots of incomplete genome annotation, and showed that poor sequence and assembly quality do not explain all annotation gaps. Finally, in a proof-of-principle study, we developed criteria for the characterisation of proteomically active TEs. Protein expression did not correlate with a TE's genomic abundance at different levels of classification. Most notably, long terminal repeat (LTR) retrotransposons were markedly enriched compared to other elements. PIT was superior to 'conventional' proteomic approaches in both our transposon and genome annotation analyses.
   Conclusions: We present the first proteomic characterisation of an organism's repertoire of mobile genetic elements, which will open new avenues of research into the function of transposon proteins in health and disease. Furthermore, our study provides a proof-of-concept that PIT can be used to evaluate a genome's annotation to guide annotation efforts which has the potential to improve the efficiency of annotation projects in non-model organisms. PIT therefore represents a valuable new tool to study the biology of the important vector species Ae. aegypti, including its role in transmitting emerging viruses of global public health concern.
C1 [Maringer, Kevin; Yousuf, Amjad; Lee, David; Matthews, David A.; Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
   [Maringer, Kevin; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Yousuf, Amjad] Taibah Univ, Coll Appl Med Sci, Medina, Saudi Arabia.
   [Heesom, Kate J.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England.
   [Fan, Jun; Bessant, Conrad] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.
   [Maringer, Kevin] Univ Surrey, Dept Microbial Sci, Guildford GU2 7XH, Surrey, England.
RP Maringer, K; Davidson, AD (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
EM K.Maringer@surrey.ac.uk; Andrew.Davidson@bristol.ac.uk
RI Bessant, Conrad/E-7620-2010
OI Maringer, Kevin/0000-0003-0977-8807; Yousuf, Amjad/0000-0003-2573-8645;
   Matthews, David/0000-0003-4611-8795; Fan, Jun/0000-0003-3899-2191;
   Bessant, Conrad/0000-0002-7983-1020
FU Medical Research Council, UKMedical Research Council UK (MRC)
   [G0801973]; BBSRCBiotechnology and Biological Sciences Research Council
   (BBSRC) [BB/M020118/1, BB/L018438/1, BB/K016075/1, BB/M02542X/1];
   NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI073450]; Sir Henry Wellcome fellowship
   [096062]; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/K016075/1]; Medical Research CouncilMedical Research Council UK
   (MRC) [G0801973]
FX This work was funded by Medical Research Council, UK Grant G0801973 to
   AD, BBSRC grants BB/M020118/1, BB/L018438/1 and BB/K016075/1 to DAM and
   CB. BBSRC funding BB/M02542X/1 to ADD and DAM, NIH/NIAID R01AI073450
   grant to AF-S and a Sir Henry Wellcome fellowship to KM (grant number
   096062).
CR Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110
   Anderson DC, 2006, J PROTEOME RES, V5, P3096, DOI 10.1021/pr060272m
   Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849
   Armengaud J, 2014, J PROTEOMICS, V105, P5, DOI 10.1016/j.jprot.2014.01.007
   Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9
   Biedler J, 2003, MOL BIOL EVOL, V20, P1811, DOI 10.1093/molbev/msg189
   Boulesteix M, 2005, CYTOGENET GENOME RES, V110, P500, DOI 10.1159/000084983
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Castellano L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1257-2
   Chen X-G, 2015, P NATL ACAD SCI
   COLLINS M, 1984, NATURE, V308, P323, DOI 10.1038/308323a0
   Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dhivya S, 2016, CRIT REV ONCOL HEMAT, V98, P81, DOI 10.1016/j.critrevonc.2015.10.012
   Ding CQ, 2012, MOL BIOL REP, V39, P1617, DOI 10.1007/s11033-011-0901-4
   Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/NMETH.2227, 10.1038/nmeth.2227]
   Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6
   Fan J, 2015, MOL CELL PROTEOMICS, V14, P3087, DOI 10.1074/mcp.O115.048777
   Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337
   Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Goodchild A, 2004, J PROTEOME RES, V3, P1164, DOI 10.1021/pr0498988
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guo BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065867
   Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794
   Han JS, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-15
   Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225
   Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616
   Hutchins AP, 2015, SCI BULL, V60, P1722, DOI 10.1007/s11434-015-0905-x
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Kelkar DS, 2014, MOL CELL PROTEOMICS, V13, P3184, DOI 10.1074/mcp.M114.038299
   Kleiner M, 2013, MBIO, V4, DOI 10.1128/mBio.00223-13
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Li WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050290
   Lutz SM, 2003, AM J HUM GENET, V73, P1431, DOI 10.1086/379744
   Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052
   Marondedze C, 2012, APPL BIOCHEM BIOTECH, V168, P306, DOI 10.1007/s12010-012-9774-9
   Mudenda L, 2014, INT J PARASITOL, V44, P1029, DOI 10.1016/j.ijpara.2014.07.003
   Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pearson WR, 2013, CURR PROTOC BIOINFOR
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Piegu B, 2015, MOL PHYLOGENET EVOL, V86, P90, DOI 10.1016/j.ympev.2015.03.009
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   Sheynkman GM, 2013, MOL CELL PROTEOMICS, V12, P2341, DOI 10.1074/mcp.O113.028142
   Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27
   Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052
   Tirloni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094831
   Torres Adalgisa R, 2013, Proteomics Insights, V6, P7, DOI 10.4137/PRI.S13288
   Tu Z, 2004, INSECT BIOCHEM MOLEC, V34, P631, DOI 10.1016/j.ibmb.2004.03.016
   van Rij RP, 2009, TRENDS MICROBIOL, V17, P163, DOI 10.1016/j.tim.2009.01.003
   Villar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089564
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165
   Woo S, 2014, J PROTEOME RES, V13, P21, DOI 10.1021/pr400294c
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
   Wynne JW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0532-x
   Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174
   Zhang YY, 2015, J PROTEOMICS, V129, P25, DOI 10.1016/j.jprot.2015.07.006
NR 67
TC 18
Z9 18
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD JAN 19
PY 2017
VL 18
AR 101
DI 10.1186/s12864-016-3432-5
PG 18
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA EL1KY
UT WOS:000394380500002
PM 28103802
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Sacramento, CQ
   de Melo, GR
   de Freitas, CS
   Rocha, N
   Hoelz, LVB
   Miranda, M
   Fintelman-Rodrigues, N
   Marttorelli, A
   Ferreira, AC
   Barbosa-Lima, G
   Abrantes, JL
   Vieira, YR
   Bastos, MM
   Volotao, ED
   Nunes, EP
   Tschoeke, DA
   Leomil, L
   Loiola, EC
   Trindade, P
   Rehen, SK
   Bozza, FA
   Bozza, PT
   Boechat, N
   Thompson, FL
   de Filippis, AMB
   Bruning, K
   Souza, TML
AF Sacramento, Carolina Q.
   de Melo, Gabrielle R.
   de Freitas, Caroline S.
   Rocha, Natasha
   Boas Hoelz, Lucas Villas
   Miranda, Milene
   Fintelman-Rodrigues, Natalia
   Marttorelli, Andressa
   Ferreira, Andre C.
   Barbosa-Lima, Giselle
   Abrantes, Juliana L.
   Vieira, Yasmine Rangel
   Bastos, Monica M.
   Volotao, Eduardo de Mello
   Nunes, Estevao Portela
   Tschoeke, Diogo A.
   Leomil, Luciana
   Loiola, Erick Correia
   Trindade, Pablo
   Rehen, Stevens K.
   Bozza, Fernando A.
   Bozza, Patricia T.
   Boechat, Nubia
   Thompson, Fabiano L.
   de Filippis, Ana M. B.
   Bruning, Karin
   Souza, Thiago Moreno L.
TI The clinically approved antiviral drug sofosbuvir inhibits Zika virus
   replication
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DEPENDENT-RNA-POLYMERASE; INFECTION; DENGUE; CELLS
AB Zika virus (ZIKV) is a member of the Flaviviridae family, along with other agents of clinical significance such as dengue (DENV) and hepatitis C (HCV) viruses. Since ZIKV causes neurological disorders during fetal development and in adulthood, antiviral drugs are necessary. Sofosbuvir is clinically approved for use against HCV and targets the protein that is most conserved among the members of the Flaviviridae family, the viral RNA polymerase. Indeed, we found that sofosbuvir inhibits ZIKV RNA polymerase, targeting conserved amino acid residues. Sofosbuvir inhibited ZIKV replication in different cellular systems, such as hepatoma (Huh-7) cells, neuroblastoma (SH-Sy5y) cells, neural stem cells (NSC) and brain organoids. In addition to the direct inhibition of the viral RNA polymerase, we observed that sofosbuvir also induced an increase in A-to-G mutations in the viral genome. Together, our data highlight a potential secondary use of sofosbuvir, an anti-HCV drug, against ZIKV.
C1 [Sacramento, Carolina Q.; de Melo, Gabrielle R.; de Freitas, Caroline S.; Rocha, Natasha; Fintelman-Rodrigues, Natalia; Marttorelli, Andressa; Ferreira, Andre C.; Barbosa-Lima, Giselle; Abrantes, Juliana L.; Vieira, Yasmine Rangel; Bozza, Fernando A.; Bozza, Patricia T.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Sacramento, Carolina Q.; de Melo, Gabrielle R.; de Freitas, Caroline S.; Rocha, Natasha; Fintelman-Rodrigues, Natalia; Marttorelli, Andressa; Ferreira, Andre C.; Barbosa-Lima, Giselle; Abrantes, Juliana L.; Vieira, Yasmine Rangel; Nunes, Estevao Portela; Bozza, Fernando A.; Souza, Thiago Moreno L.] Fiocruz MS, INI, Rio De Janeiro, RJ, Brazil.
   [Sacramento, Carolina Q.; de Melo, Gabrielle R.; de Freitas, Caroline S.; Rocha, Natasha; Fintelman-Rodrigues, Natalia; Marttorelli, Andressa; Ferreira, Andre C.; Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Souza, Thiago Moreno L.] Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
   [Boas Hoelz, Lucas Villas; Bastos, Monica M.; Boechat, Nubia] Fiocruz MS, Inst Tecnol Farmacos Farmanguinhos, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene] Fiocruz MS, IOC, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene; Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Abrantes, Juliana L.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil.
   [Volotao, Eduardo de Mello] Fiocruz MS, IOC, Lab Virol Comparada & Ambiental, Rio De Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.] Univ Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Rio De Janeiro, Brazil.
   [Loiola, Erick Correia; Trindade, Pablo; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [de Filippis, Ana M. B.] Fiocruz MS, IOC, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Bruning, Karin] BMK Consortium, Rio De Janeiro, RJ, Brazil.
   [Bruning, Karin] Blanver Farmoquim Ltd, Taboao Da Serra, Brazil.
   [Bruning, Karin] Microbiol Quim & Farmaceut Ltd, Taboao Da Serra, Brazil.
   [Bruning, Karin] Karin Bruning & Cia Ltd, Taboao Da Serra, Brazil.
RP Souza, TML (corresponding author), Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, INI, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
EM tmoreno@cdts.fiocruz.br
RI Hoelz, Lucas/C-6584-2017; Boechat, Nubia/K-2520-2019; Boechat,
   Nubia/N-1406-2014; Trindade, Pablo/D-8913-2016; Rehen, Stevens
   K/J-5874-2012; Tschoeke, Diogo A/F-9913-2019; Souza, Thiago Moreno
   L./G-2900-2012; Bozza, Fernando A/A-2618-2013; Leomil,
   Luciana/O-4860-2019; Loiola, Erick/I-4106-2016
OI Hoelz, Lucas/0000-0002-9163-1574; Boechat, Nubia/0000-0003-0146-2218;
   Boechat, Nubia/0000-0003-0146-2218; Trindade, Pablo/0000-0001-5953-7054;
   Rehen, Stevens K/0000-0003-4216-9501; Tschoeke, Diogo
   A/0000-0001-8134-4259; Souza, Thiago Moreno L./0000-0003-2212-3899;
   Bozza, Fernando A/0000-0003-4878-0256; Loiola,
   Erick/0000-0002-7926-795X; Bozza, Patricia/0000-0001-8349-9529
FU Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Thanks are due to Drs Carlos M. Morel, Marcio L. Rodrigues, Renata Curi
   and Fabricia Pimenta for their strong advisement and support regarding
   the technological development underlying this project. This work was
   supported by Conselho Nacional de Desenvolvimento e Pesquisa (CNPq),
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bhatia HK, 2014, J PHARMACOL PHARMACO, V5, P278, DOI 10.4103/0976-500X.142464
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chutaputti A, 2000, J GASTROEN HEPATOL, V15, pE156, DOI 10.1046/j.1440-1746.2000.02114.x
   Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002
   De Clercq E, 2013, MED RES REV, V33, P1249, DOI 10.1002/med.21281
   Delvecchio R, 2016, BIORXIV, DOI [10.1101/051268, DOI 10.1101/051268]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferron F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-255
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gilead, 2015, PROD MON PR SOVALDI
   Guo DH, 2014, DNA CELL BIOL, V33, P20, DOI 10.1089/dna.2013.2193
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114910
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Piperno A, 2014, CURR MED CHEM, V21, P1843, DOI 10.2174/0929867321666131228205935
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sacramento C. Q., 2016, BIORXIV, V2016, DOI [10.1101/061671, DOI 10.1101/061671]
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Souza TML, 2008, ANTIVIR RES, V77, P20, DOI 10.1016/j.antiviral.2007.08.011
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhong LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22635
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 50
TC 87
Z9 90
U1 0
U2 61
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 18
PY 2017
VL 7
AR 40920
DI 10.1038/srep40920
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI0GT
UT WOS:000392151800001
PM 28098253
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fikrig, K
   Johnson, BJ
   Fish, D
   Ritchie, SA
AF Fikrig, Kara
   Johnson, Brian J.
   Fish, Durland
   Ritchie, Scott A.
TI Assessment of synthetic floral-based attractants and sugar baits to
   capture male and female Aedes aegypti (Diptera: Culicidae)
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Entomological surveillance; Mosquito trap; Floral lures;
   Sugar lures; Zika; Dengue
ID AUTOCIDAL GRAVID OVITRAP; ALBOPICTUS DIPTERA; ANOPHELES-SERGENTII;
   MOSQUITOS; DENGUE; SURVEILLANCE; VECTOR; TRAP; ATSB; TRANSMISSION
AB Background: The viruses transmitted by Aedes aegypti, including dengue and Zika viruses, are rapidly expanding in geographic range and as a threat to public health. In response, control programs are increasingly turning to the use of sterile insect techniques resulting in a need to trap male Ae. aegypti to monitor the efficacy of the intervention. However, there is a lack of effective and cheap methods for trapping males. Thus, we attempted to exploit the physiological need to obtain energy from sugar feeding in order to passively capture male and female Ae. aegypti (nulliparous and gravid) in free-flight attraction assays. Candidate lures included previously identified floral-based (phenylacetaldehyde, linalool oxide, phenylethyl alcohol, and acetophenone) attractants and an attractive toxic sugar bait-based (ATSB) solution of guava and mango nectars. A free-flight attraction assay assessed the number of mosquitoes attracted to each candidate lure displayed individually. Then, a choice test was performed between the best-performing lure and a water control displayed in Gravid Aedes Traps (GAT).
   Results: Results from the attraction assays indicated that the ATSB solution of guava and mango nectars was the most promising lure candidate for males; unlike the floral-based attractants tested, it performed significantly better than the water control. Nulliparous and gravid females demonstrated no preference among the lures and water controls indicating a lack of attraction to floral-based attractants and sugar baits in a larger setting. Although the guava-mango ATSB lure was moderately attractive to males when presented directly (i.e. no need to enter a trap or other confinement), it failed to attract significantly more male, nulliparous female, or gravid female Ae. aegypti than water controls when presented inside a Gravid Aedes Trap.
   Conclusions: Our findings suggest that the use of volatile floral-based attractants and sugar mixtures that have been identified in the literature is not an effective lure by which to kill Ae. aegypti at ATSB stations nor capture them in the GAT. Future trapping efforts would likely be more successful if focused on more promising methods for capturing male and female Ae. aegypti.
C1 [Fikrig, Kara; Fish, Durland] Yale Univ, Yale Sch Publ Hlth, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Johnson, Brian J.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, POB 6811, Cairns, Qld 4870, Australia.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, POB 6811, Cairns, Qld 4870, Australia.
RP Fikrig, K (corresponding author), Yale Univ, Yale Sch Publ Hlth, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
EM kmfikrig@gmail.com
FU Downs Fellowship of the Yale School of Public Health; Australian
   National Health and Medical Research Council Senior Research
   FellowshipNational Health and Medical Research Council of Australia
   [1044698]
FX This research was funded by the Downs Fellowship of the Yale School of
   Public Health and the Australian National Health and Medical Research
   Council Senior Research Fellowship 1044698.
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Cairns Queensland Daily Weather Observations, CAIRNS QUEENSL DAIL
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Jhumur US, 2007, ARTHROPOD-PLANT INTE, V1, P245, DOI 10.1007/s11829-007-9022-3
   Johnson BJ, 2016, J MED ENTOMOL, DOI [10.1093/tjw166, DOI 10.1093/TJW166]
   Johnson BJ, 2016, J MED ENTOMOL, V53, P245, DOI 10.1093/jme/tjv165
   Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Muller GC, 2008, J AM MOSQUITO CONTR, V24, P147, DOI 10.2987/8756-971X(2008)24[147:DOASAA]2.0.CO;2
   Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210
   Muller GC, 2008, T ROY SOC TROP MED H, V102, P480, DOI 10.1016/j.trstmh.2008.01.008
   Naranjo DP, 2013, PARASITOL RES, V112, P1583, DOI 10.1007/s00436-013-3312-8
   Patz JA, 2001, TRENDS IMMUNOL, V22, P171, DOI 10.1016/S1471-4906(01)01867-1
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Revay EE, 2015, ACTA TROP, V150, P29, DOI 10.1016/j.actatropica.2015.06.018
   Revay EE, 2014, PARASITOL RES, V113, P73, DOI 10.1007/s00436-013-3628-4
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ritchie SA, 2013, J MED ENTOMOL, V50, P185, DOI 10.1603/ME12112
   Rodriguez SD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-211
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Spencer CY, 2005, J AM MOSQUITO CONTR, V21, P177, DOI 10.2987/8756-971X(2005)21[177:FVITDV]2.0.CO;2
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   von Oppen S, 2015, ENTOMOL EXP APPL, V155, P184, DOI 10.1111/eea.12297
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   World Health Organization, 2016, SAUDI MED J, V37, P334
   Xue RD, 2008, J AM MOSQUITO CONTR, V24, P415, DOI 10.2987/5683.1
   Xue RD, 2006, J AM MOSQUITO CONTR, V22, P497, DOI 10.2987/8756-971X(2006)22[497:AOBABT]2.0.CO;2
NR 43
TC 6
Z9 6
U1 1
U2 17
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 17
PY 2017
VL 10
AR 32
DI 10.1186/s13071-016-1946-y
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EN9MU
UT WOS:000396325100001
PM 28095875
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Hickman, HD
   Pierson, TC
AF Hickman, Heather D.
   Pierson, Theodore C.
TI T Cells Take on Zika Virus
SO IMMUNITY
LA English
DT Editorial Material
ID DENGUE VIRUS; PEPTIDES
AB Although CD8(+) T cells provide protection against many viral infections, their role in Zika virus (ZIKV) immunity has not been extensively examined. In a recent issue of Cell Host & Microbe, Elong Ngono et al. (2017) define antigenic epitopes determining CD8(+) T cell immunity in murine models of ZIKV infection.
C1 [Hickman, Heather D.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
EM piersontc@niaid.nih.gov
OI Hickman, Heather/0000-0003-4168-4894
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Starck SR, 2016, IMMUNOL REV, V272, P8, DOI 10.1111/imr.12434
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 10
TC 2
Z9 2
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JAN 17
PY 2017
VL 46
IS 1
BP 13
EP 14
DI 10.1016/j.immuni.2016.12.020
PG 3
WC Immunology
SC Immunology
GA EJ0RP
UT WOS:000392918300006
PM 28099861
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, SF
   Shi, YX
   Zheng, K
   Dai, J
   Li, XB
   Yuan, S
   Chen, L
   Huang, JC
AF Li, Shufen
   Shi, Yongxia
   Zheng, Kui
   Dai, Jun
   Li, Xiaobo
   Yuan, Shuai
   Chen, Ling
   Huang, Jicheng
TI Morphologic and Molecular Characterization of a Strain of Zika Virus
   Imported into Guangdong, China
SO PLOS ONE
LA English
DT Article
ID MOSQUITO CELLS; SOUTH-PACIFIC; DENGUE; REPLICATION; INFECTION; EPIDEMIC;
   SITES; MICE
AB The recent outbreaks of Zika virus (ZIKV) disease have caused worldwide concerns. Guangdong province is one of the commercial centers in China and communicates frequently with the epidemic areas. To date, 65.2% of the ZIKV infection cases in China were imported via port of entry in Guangdong. The continuous surveillance of imported cases is crucial for the prevention and control of potential ZIKV infection outbreak in China. In this study, a strain of ZIKV was isolated from the serum of a 6-year-old child returning from Venezuela. The morphology of the ZIKV was analyzed in vivo and in vitro by electron microscopy, and clusters of virus particles were found in the loose cytoplasmic membrane structures. The genomic sequence of the isolated ZIKV was determined, and the alignment and phylogenetic analysis identified one unique amino acid substitution occurring in the non-structural protein 4B (NS4B), and the isolated virus belonged to the Asian lineage.
C1 [Li, Shufen; Shi, Yongxia; Zheng, Kui; Dai, Jun; Li, Xiaobo; Yuan, Shuai; Huang, Jicheng] Guangdong Entry Exit Inspect & Quarantine Bur, Inspect & Quarantine Technol Ctr, Guangzhou, Guangdong, Peoples R China.
   [Li, Shufen; Chen, Ling] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.
RP Huang, JC (corresponding author), Guangdong Entry Exit Inspect & Quarantine Bur, Inspect & Quarantine Technol Ctr, Guangzhou, Guangdong, Peoples R China.
EM jichenghuang@126.com
FU China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2016M592458]
FX This study was funded by China Postdoctoral Science Foundation (Grant
   No. 2016M592458).
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   HASE T, 1987, ARCH VIROL, V96, P135, DOI 10.1007/BF01320956
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SRIURAIRATNA S, 1973, INFECT IMMUN, V8, P1017, DOI 10.1128/IAI.8.6.1017-1028.1973
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
NR 30
TC 4
Z9 5
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 17
PY 2017
VL 12
IS 1
AR e0169256
DI 10.1371/journal.pone.0169256
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3EK
UT WOS:000392372300018
PM 28095443
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hamer, DH
   Barbre, KA
   Chen, LH
   Grobusch, MP
   Schlagenhauf, P
   Goorhuis, A
   van Genderen, PJJ
   Molina, I
   Asgeirsson, H
   Kozarsky, PE
   Caumes, E
   Hagmann, SH
   Mockenhaupt, FP
   Eperon, G
   Barnett, ED
   Bottieau, E
   Boggild, AK
   Gautret, P
   Hynes, NA
   Kuhn, S
   Lash, R
   Leder, K
   Libman, M
   Malvy, DJM
   Perret, C
   Rothe, C
   Schwartz, E
   Wilder-Smith, A
   Cetron, MS
   Esposito, DH
AF Hamer, Davidson H.
   Barbre, Kira A.
   Chen, Lin H.
   Grobusch, Martin P.
   Schlagenhauf, Patricia
   Goorhuis, Abraham
   van Genderen, Perry J. J.
   Molina, Israel
   Asgeirsson, Hilmir
   Kozarsky, Phyllis E.
   Caumes, Eric
   Hagmann, Stefan H.
   Mockenhaupt, Frank P.
   Eperon, Gilles
   Barnett, Elizabeth D.
   Bottieau, Emmanuel
   Boggild, Andrea K.
   Gautret, Philippe
   Hynes, Noreen A.
   Kuhn, Susan
   Lash, Ryan
   Leder, Karin
   Libman, Michael
   Malvy, Denis J. M.
   Perret, Cecilia
   Rothe, Camilla
   Schwartz, Eli
   Wilder-Smith, Annelies
   Cetron, Martin S.
   Esposito, Douglas H.
CA GeoSentinel Surveillance Network
TI Travel-Associated Zika Virus Disease Acquired in the Americas Through
   February 2016 A GeoSentinel Analysis
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; MALE SEXUAL TRANSMISSION; UPDATE INTERIM
   GUIDANCE; UNITED-STATES; SURVEILLANCE; REPELLENTS; INFECTION; EXPOSURE;
   WOMEN; RISK
AB Background: Zika virus has spread rapidly in the Americas and has been imported into many nonendemic countries by travelers.
   Objective: To describe clinical manifestations and epidemiology of Zika virus disease in travelers exposed in the Americas.
   Design: Descriptive, using GeoSentinel records.
   Setting: 63 travel and tropical medicine clinics in 30 countries.
   Patients: Ill returned travelers with a confirmed, probable, or clinically suspected diagnosis of Zika virus disease seen between January 2013 and 29 February 2016.
   Measurements: Frequencies of demographic, trip, and clinical characteristics and complications.
   Results: Starting in May 2015, 93 cases of Zika virus disease were reported. Common symptoms included exanthema (88%), fever (76%), and arthralgia (72%). Fifty-nine percent of patients were exposed in South America; 71% were diagnosed in Europe. Case status was established most commonly by polymerase chain reaction (PCR) testing of blood and less often by PCR testing of other body fluids or serology and plaque-reduction neutralization testing. Two patients developed Guillain-Barre syndrome, and 3 of 4 pregnancies had adverse outcomes (microcephaly, major fetal neurologic abnormalities, and intrauterine fetal death).
   Limitation: Surveillance data collected by specialized clinics may not be representative of all ill returned travelers, and denominator data are unavailable.
   Conclusion: These surveillance data help characterize the clinical manifestations and adverse outcomes of Zika virus disease among travelers infected in the Americas and show a need for global standardization of diagnostic testing. The serious fetal complications observed in this study highlight the importance of travel advisories and prevention measures for pregnant women and their partners. Travelers are sentinels for global Zika virus circulation and may facilitate further transmission.
C1 Boston Univ, Sch Med, Sch Publ Hlth, Boston Med Ctr, Boston, MA 02118 USA.
   Harvard Med Sch, Boston, MA USA.
   Ctr Dis Control & Prevent, Atlanta, GA USA.
   Emory Univ, Atlanta, GA 30322 USA.
   Mt Auburn Hosp, Cambridge, MA USA.
   Univ Amsterdam, Amsterdam, Netherlands.
   [Schlagenhauf, Patricia] Univ Zurich, Ctr Travel Med, WHO Collaborating Ctr Travellers Hlth Epidemiol, Biostat & Prevent Inst, Hirschengraben 84, CH-8001 Zurich, Switzerland.
   Harbor Hosp, Rotterdam, Netherlands.
   Univ Autonoma Barcelona, Vall dHebron Univ Hosp, PROSICS Barcelona, Barcelona, Spain.
   Karolinska Univ Hosp, Stockholm, Sweden.
   UPMC Univ, Grp Hosp Pitie Salpetriere, Paris, France.
   Bronx Lebanon Hosp Ctr, Bronx, NY 10456 USA.
   Icahn Sch Med Mt Sinai, Bronx, NY USA.
   Charite, Berlin, Germany.
   Univ Hosp Geneva, Geneva, Switzerland.
   Inst Trop Med, Antwerp, Belgium.
   Univ Toronto, Toronto Gen Hosp, Toronto, ON, Canada.
   Publ Hlth Ontario Labs, Toronto, ON, Canada.
   Aix Marseille Univ, Marseille, France.
   Johns Hopkins Sch Med, Baltimore, MD USA.
   Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada.
   Monash Univ, Melbourne, Vic, Australia.
   McGill Univ, Montreal, PQ, Canada.
   Ctr Hosp Univ Bordeaux, Bordeaux, France.
   Pontificia Univ Catolica Chile, Santiago, Chile.
   Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   Tel Hashomer, Sheba Med Ctr, Tel Aviv, Israel.
   Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   Heidelberg Univ, Heidelberg, Germany.
   Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   Umea Univ, Umea, Sweden.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Crosstown 3rd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.
   [Barbre, Kira A.] Task Force Global Hlth, 325 Swanton Way, Decatur, GA 30030 USA.
   [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, 330 Mt Auburn St, Cambridge, MA 02138 USA.
   [Grobusch, Martin P.; Goorhuis, Abraham] Univ Amsterdam, Ctr Trop & Travel Med, Meibergdreef 9,POB 226600, NL-1100 DD Amsterdam, Netherlands.
   [van Genderen, Perry J. J.] Havenziekenhuis Travel Clin Haringvliet, NL-3011 TG Rotterdam, Netherlands.
   [Molina, Israel] Hosp Gen Valle Hebron, Anexos 6a Planta,PO Vall Hebron 119, Barcelona 08035, Spain.
   [Asgeirsson, Hilmir] Karolinska Univ Hosp, Dept Infect Dis, SE-14186 Stockholm, Sweden.
   [Kozarsky, Phyllis E.] Emory Univ, Dept Med, Div Infect Dis, 550 Peachtree St,Med Off Tower, Atlanta, GA 30308 USA.
   [Caumes, Eric] Hosp Pitie Salpetriere, Serv Malad Infectieuses & Trop, 47-83 Bld lhop, F-75651 Paris 13, France.
   [Hagmann, Stefan H.] Bronx Lebanon Hosp Ctr, Div Pediat Infect Dis, 1650 Selwyn Ave 2C, Bronx, NY 10457 USA.
   [Mockenhaupt, Frank P.] Charite, Inst Trop Med & Int Hlth, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Eperon, Gilles] Univ Hosp Geneva, Div Trop & Humanitarian Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.
   [Barnett, Elizabeth D.] Boston Med Ctr, Maxwell Finland Lab Infect Dis, 670 Albany St,6th Floor, Boston, MA 02118 USA.
   [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, 155 Nationalestr, B-2000 Antwerp, Belgium.
   [Boggild, Andrea K.] Toronto Gen Hosp, Trop Dis Unit, 200 Elizabeth St,13EN 1350, Toronto, ON M5G 2C4, Canada.
   [Gautret, Philippe] Aix Marseille Univ, Fac Med, CNRS,INSERM 1095, URMITE,UMR63, 27 bd Jean Moulin, F-13005 Marseille, France.
   [Hynes, Noreen A.] Johns Hopkins Univ, Sch Med, Geograph Med Ctr, Div Infect Dis, 1503 Jefferson St,Suite 114,JHU SOM DOM, Baltimore, MD 21205 USA.
   [Kuhn, Susan] Alberta Childrens Prov Gen Hosp, 2888 Shaganappi Trail NW, Calgary T3B A68, AB, Canada.
   [Lash, Ryan; Cetron, Martin S.; Esposito, Douglas H.] Centers Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.
   [Leder, Karin] Royal Melbourne Hosp, Victorian Infect Dis Serv, Grattan St, Parkville, Vic 3050, Australia.
   [Libman, Michael] Royal Victoria Hosp, MacLean Ctr Trop Dis, 1001 Boul Carie Room E05-1830, Montreal H4A 3J1, PQ, Canada.
   [Malvy, Denis J. M.] CHU, Serv Malad Infect & Trop, Pl Amelie Raba Leon, F-33075 Bordeaux, France.
   [Perret, Cecilia] Pontificia Univ Catolica Chile Marcoleta, Ctr Enfermedades Trop & Salud Viajero, 391 3ER PISO, Santiago, Chile.
   [Rothe, Camilla] Univ Med Ctr Hamburg Eppendorf, Dept Med, Div Infect Dis & Trop Med, Bernhard Nocht Klin, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Schwartz, Eli] Sheba Med Ctr, Ctr Geog Med, Dept Internal Med C, Tel HaShomer Ramat Gan, Israel.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Novena Campus,11 Mandalay Rd, Singapore 308232, Singapore.
RP Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Crosstown 3rd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.
EM dhamer@bu.edu; kirabarbre@gmail.com
RI Leder, Karin/AAD-2388-2019; Hynes, Noreen/AAA-2550-2020; Mockenhaupt,
   Frank P/U-9824-2017; MALVY, Denis/T-7930-2019; Hamer,
   Davidson/J-2020-2019; Wilder-Smith, Annelies/F-8751-2015
OI Leder, Karin/0000-0003-1368-1039; Mockenhaupt, Frank
   P/0000-0002-8117-5421; Hamer, Davidson/0000-0002-4700-1495; Chen,
   Lin/0000-0002-5684-8436; Molina Romero, Israel/0000-0001-6642-7515;
   Asgeirsson, Hilmir/0000-0003-3869-8021; Schlagenhauf,
   Patricia/0000-0002-1075-7010
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [U50CK00189]; ISTM [U50CK00189]; ISTM; Public Health
   Agency of Canada
FX This project was supported by a cooperative agreement (U50CK00189)
   between the CDC and the ISTM and by funding from the ISTM and the Public
   Health Agency of Canada.
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Council of State and Territorial Epidemiologists, 2016, COUNC STAT TERR EP I
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dugas J, 2010, OCCUP ENVIRON MED, V67, P196, DOI 10.1136/oem.2009.047373
   Duijster JW, 2016, INFECTION
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Grobusch MP, 2016, LANCET, V387, P1813, DOI 10.1016/S0140-6736(16)30178-7
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO, 2016, PREV SEX TRANSM ZIK
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 42
Z9 43
U1 1
U2 56
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD JAN 17
PY 2017
VL 166
IS 2
BP 99
EP +
DI 10.7326/M16-1842
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA EH5WB
UT WOS:000391842600014
PM 27893080
DA 2020-07-08
ER

PT J
AU Rausch, K
   Hackett, BA
   Weinbren, NL
   Reeder, SM
   Sadovsky, Y
   Hunter, CA
   Schultz, DC
   Coyne, CB
   Cherry, S
AF Rausch, Keiko
   Hackett, Brent A.
   Weinbren, Nathan L.
   Reeder, Sophia M.
   Sadovsky, Yoel
   Hunter, Christopher A.
   Schultz, David C.
   Coyne, Carolyn B.
   Cherry, Sara
TI Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral
   Active against Zika Virus
SO CELL REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; KINASE INHIBITORS; INFECTION; IDENTIFICATION;
   FLAVIVIRUSES; REPLICATION; RNA
AB Zika virus is an emerging arthropod-borne flavivirus for which there are no vaccines or specific therapeutics. We screened a library of 2,000 bioactive compounds for their ability to block Zika virus infection in three distinct cell types with two different strains of Zika virus. Using a microscopy-based assay, we validated 38 drugs that inhibited Zika virus infection, including FDA-approved nucleoside analogs. Cells expressing high levels of the attachment factor AXL can be protected from infection with receptor tyrosine kinase inhibitors, while placental-derived cells that lack AXL expression are insensitive to this inhibition. Importantly, we identified nanchangmycin as a potent inhibitor of Zika virus entry across all cell types tested, including physiologically relevant primary cells. Nanchangmycin also was active against other medically relevant viruses, including West Nile, dengue, and chikungunya viruses that use a similar route of entry. This study provides a resource of small molecules to study Zika virus pathogenesis.
C1 [Rausch, Keiko; Hackett, Brent A.; Weinbren, Nathan L.; Reeder, Sophia M.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.
   [Schultz, David C.] Univ Penn, High Throughput Screening Core, Philadelphia, PA 19104 USA.
   [Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 19104 USA.
   [Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 19104 USA.
   [Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 19104 USA.
RP Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
EM cherrys@mail.med.upenn.edu
RI Syed, Khajamohiddin/L-8774-2013; Reeder, Sophia/N-9237-2016
OI Syed, Khajamohiddin/0000-0002-1497-3570; Reeder,
   Sophia/0000-0003-4027-4252
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI074951, R01AI122749,
   R01AI095500]; Linda Montague Investigator Award; ITMAT Pilot; Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease
   AwardBurroughs Wellcome Fund
FX We thank Drs. R. Tesh, S. Hensley, S. Weiss, M. Heise, and M. Diamond
   for viruses. We thank A. Bass for initial real time-qPCR studies, Y. Liu
   for Chinese translations, S. Goldstein for technical advice, and Q. Fang
   for generating neuronal cultures. In addition, we thank members of the
   S.C. and C.B.C. labs and the High-Throughput Screening Core for
   technical support and advice. This work was supported by NIH grants
   R01AI074951, R01AI122749, and R01AI095500 to S.C. Support was provided
   by the Linda Montague Investigator Award, ITMAT Pilot, and the Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease Award
   to S.C.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Gao H., 2012, J NEUROSCI, V2, pe148
   Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMILL RL, 1969, J ANTIBIOT, V22, P161, DOI 10.7164/antibiotics.22.161
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Ouyang L., 1993, J JIANGXI AGR U, V15, P148
   Panda D, 2013, CELL REP, V5, P1737, DOI 10.1016/j.celrep.2013.11.028
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sun YH, 2002, MICROBIOL-SGM, V148, P361, DOI 10.1099/00221287-148-2-361
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang ZJ, 2012, MOL BIOSYST, V8, P2523, DOI 10.1039/c2mb25099c
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 44
TC 71
Z9 72
U1 2
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JAN 17
PY 2017
VL 18
IS 3
BP 804
EP 815
DI 10.1016/j.celrep.2016.12.068
PG 12
WC Cell Biology
SC Cell Biology
GA EO1PO
UT WOS:000396470600019
PM 28099856
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Li, G
   Poulsen, M
   Fenyvuesvolgyi, C
   Yashiroda, Y
   Yoshida, M
   Simard, JM
   Gallo, RC
   Zhao, RY
AF Li, Ge
   Poulsen, Melissa
   Fenyvuesvolgyi, Csaba
   Yashiroda, Yoko
   Yoshida, Minoru
   Simard, J. Marc
   Gallo, Robert C.
   Zhao, Richard Y.
TI Characterization of cytopathic factors through genome-wide analysis of
   the Zika viral proteins in fission yeast
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika genome; Zika proteins; fission yeast; Schizosaccharomyces pombe;
   cytopathic factors
ID BORNE ENCEPHALITIS-VIRUS; CELL-DEATH; SCHIZOSACCHAROMYCES-POMBE; DENGUE
   VIRUS; OXIDATIVE STRESS; NS3 PROTEASE; R VPR; ACTIVATION; EXPRESSION;
   GENE
AB The Zika virus (ZIKV) causes microcephaly and the Guillain-Barre syndrome. Little is known about how ZIKV causes these conditions or which ZIKV viral protein(s) is responsible for the associated ZIKV-induced cytopathic effects, including cell hypertrophy, growth restriction, cell-cycle dysregulation, and cell death. We used fission yeast for the rapid, global functional analysis of the ZIKV genome. All 14 proteins or small peptides were produced under an inducible promoter, and we measured the intracellular localization and the specific effects on ZIKV-associated cytopathic activities of each protein. The subcellular localization of each ZIKV protein was in overall agreement with its predicted protein structure. Five structural and two nonstructural ZIKV proteins showed various levels of cytopathic effects. The expression of these ZIKV proteins restricted cell proliferation, induced hypertrophy, or triggered cellular oxidative stress leading to cell death. The expression of premembrane protein (prM) resulted in cell-cycle G1 accumulation, whereas membrane-anchored capsid (anaC), membrane protein (M), envelope protein (E), and nonstructural protein 4A (NS4A) caused cell-cycle G2/M accumulation. A mechanistic study revealed that NS4A-induced cellular hypertrophy and growth restriction were mediated specifically through the target of rapamycin (TOR) cellular stress pathway involving Tor1 and type 2A phosphatase activator Tip41. These findings should provide a reference for future research on the prevention and treatment of ZIKV diseases.
C1 [Li, Ge; Poulsen, Melissa; Fenyvuesvolgyi, Csaba; Simard, J. Marc; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   [Yashiroda, Yoko; Yoshida, Minoru] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan.
   [Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.
   [Gallo, Robert C.; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Gallo, Robert C.; Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
   [Gallo, Robert C.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
RP Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Gallo, RC; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.; Gallo, RC; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Gallo, RC (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
EM rgallo@ihv.umaryland.edu; RZhao@som.umaryland.edu
RI Yoshida, Minoru/C-8049-2014; Yashiroda, Yoko/C-8769-2014
OI Yoshida, Minoru/0000-0002-4376-5674; Zhao, Richard
   Y./0000-0003-3424-2852
FU University of Maryland Medical Center
FX We thank Dr. Hongli Tang, Florida State University, for providing the
   ZIKV MR766 viral extract and Dr. Volodymyr Gerzanich, University of
   Maryland, for assistance with fluorescence microscopy. This work was
   supported in part by funding from the University of Maryland Medical
   Center (R.Y.Z.).
CR ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Andreola ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/549020
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Benko Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151286
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fenyvuesvolgyi C, 2005, BBA-MOL CELL RES, V1746, P155, DOI 10.1016/j.bbamcr.2005.09.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hartwell LH, 2004, BIOSCIENCE REP, V24, P523, DOI 10.1007/s10540-005-2743-6
   Huard S, 2008, CELL RES, V18, P961, DOI 10.1038/cr.2008.272
   Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Le Sage V, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060152
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li L, 2005, CELL RES, V15, P923, DOI 10.1038/sj.cr.7290370
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin JC, 2014, J IMMUNOL, V193, P1258, DOI 10.4049/jimmunol.1302675
   Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lista MJ, 2015, BIOTECHNOL J, V10, P1670, DOI 10.1002/biot.201500161
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222
   MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D
   MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857
   Melino S, 2006, FEBS J, V273, P3650, DOI 10.1111/j.1742-4658.2006.05369.x
   Mikawa T, 2010, GENES CELLS, V15, P229, DOI 10.1111/j.1365-2443.2009.01376.x
   Miller N, 2010, CURR OPIN MOL THER, V12, P31
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Moran M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   MORENO S, 1991, METHOD ENZYMOL, V194, P795
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nasmyth K, 2001, CELL, V107, P689, DOI 10.1016/S0092-8674(01)00604-3
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Nkeze J, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0037-7
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0
   Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramanathan MP, 2006, VIROLOGY, V345, P56, DOI 10.1016/j.virol.2005.08.043
   Ray K, 2014, J BIOSCIENCES, V39, P3, DOI 10.1007/s12038-014-9416-1
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170
   Yang TC, 2010, MICROBES INFECT, V12, P643, DOI 10.1016/j.micinf.2010.04.007
   Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1
   Yiang GT, 2013, MOL MED REP, V7, P826, DOI 10.3892/mmr.2013.1261
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279
   ZHAO YQ, 1995, DNA CELL BIOL, V14, P359, DOI 10.1089/dna.1995.14.359
   Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996
   Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208
   Zhao YQ, 2000, FRONT BIOSCI-LANDMRK, V5, pD905, DOI 10.2741/zhao
   Zhao YQ, 1998, BIOTECHNIQUES, V25, P438, DOI 10.2144/98253st06
   Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003
NR 85
TC 27
Z9 28
U1 1
U2 25
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 17
PY 2017
VL 114
IS 3
BP E376
EP E385
DI 10.1073/pnas.1619735114
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH9MQ
UT WOS:000392095800014
PM 28049830
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Da Costa, A
   Garza, E
   Graham, JB
   Swarts, JL
   Soerens, AG
   Gale, M
   Lund, JM
AF Da Costa, Andreia
   Garza, Esteban
   Graham, Jessica B.
   Swarts, Jessica L.
   Soerens, Andrew G.
   Gale, Michael
   Lund, Jennifer M.
TI Extrinsic MAVS signaling is critical for Treg maintenance of Foxp3
   expression following acute flavivirus infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID REGULATORY T-CELLS; WEST-NILE-VIRUS; TOLL-LIKE; RIG-I; CUTTING EDGE; RNA
   VIRUSES; TGF-BETA; RECEPTOR; IMMUNITY; SUPPRESSION
AB Given the rapid spread of flaviviruses such as West Nile virus (WNV) and Zika virus, it is critical that we develop a complete understanding of the key mediators of an effective anti-viral response. We previously demonstrated that WNV infection of mice deficient in mitochondrial antiviral-signaling protein (MAVS), the signaling adaptor for RNA helicases such as RIG-I, resulted in increased death and dysregulated immunity, which correlated with a failure of Treg expansion following infection. Thus, we sought to determine if intrinsic MAVS signaling is required for participation of Tregs in anti-WNV immunity. Despite evidence of increased Treg cell division, Foxp3 expression was not stably maintained after WNV infection in MAVS-deficient mice. However, intrinsic MAVS signaling was dispensable for Treg proliferation and suppressive capacity. Further, we observed generation of an effective anti-WNV immune response when Tregs lacked MAVS, thereby demonstrating that Treg detection of the presence of WNV through the MAVS signaling pathway is not required for generation of effective immunity. Together, these data suggest that while MAVS signaling has a considerable impact on Treg identity, this effect is not mediated by intrinsic MAVS signaling but rather is likely an effect of the overproduction of pro-inflammatory cytokines generated in MAVS-deficient mice after WNV infection.
C1 [Da Costa, Andreia; Garza, Esteban; Graham, Jessica B.; Swarts, Jessica L.; Soerens, Andrew G.; Lund, Jennifer M.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Da Costa, Andreia; Soerens, Andrew G.; Gale, Michael; Lund, Jennifer M.] Univ Washington, Grad Program Pathobiol, Dept Global Hlth, Seattle, WA 98195 USA.
   [Gale, Michael] Univ Washington, Sch Med, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA USA.
RP Lund, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Lund, JM (corresponding author), Univ Washington, Grad Program Pathobiol, Dept Global Hlth, Seattle, WA 98195 USA.
EM jlund@fredhutch.org
OI Lund, Jennifer/0000-0003-3284-979X
FU National Institute of Allergy and Infectious Diseases of the US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI087657, U19AI083019];
   Diseases of Public Health Importance Training Grant [T32AI007509]
FX We thank Greg Mize for expertise in real-time PCR techniques, members of
   the Lund lab and the Center for the Study of Immune Mechanisms of
   Flavivirus Control (University of Washington) for helpful discussions,
   Tisha Graham and Aimee Sekine for mouse colony maintenance and technical
   assistance. Funding for the present study was provided by the National
   Institute of Allergy and Infectious Diseases of the US National
   Institutes of Health (R01 AI087657, to JML and U19AI083019 (Project 1),
   to MG) and the Diseases of Public Health Importance Training Grant
   (T32AI007509, to ADC).
CR Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245
   Bendigs S, 1999, EUR J IMMUNOL, V29, P1209, DOI 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J
   Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916
   Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633
   Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551
   Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148
   Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768
   Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2
   Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065
   Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023
   Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721
   Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153
   Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009
   Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428
   Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Lee SE, 2012, GASTROENTEROLOGY, V143, P145, DOI 10.1053/j.gastro.2012.03.042
   Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108
   Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209
   Michallet MC, 2013, CURR OPIN MICROBIOL, V16, P296, DOI 10.1016/j.mib.2013.04.003
   Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949
   Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401
   Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003
   Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Soerens AG, 2016, MUCOSAL IMMUNOL, V9, P1395, DOI 10.1038/mi.2016.19
   Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556
   Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085
   Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343
   Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479
   Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725
   Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007
   Yuan XM, 2014, IMMUNOL REV, V259, P103, DOI 10.1111/imr.12163
   Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112
NR 45
TC 3
Z9 3
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 17
PY 2017
VL 7
AR 40720
DI 10.1038/srep40720
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH7DK
UT WOS:000391932900001
PM 28094802
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Florida Declares New Area of Zika Transmission in Miami
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 15
PY 2017
VL 64
IS 2
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1GB
UT WOS:000397132300001
DA 2020-07-08
ER

PT J
AU Leyser, M
   Fernandes, A
   Passos, P
   Pupe, C
   Matta, APC
   Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   Fernandes, Alexandre
   Passos, Pamela
   Pupe, Camila
   Matta, Andre P. C.
   Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI Microcephaly and arthrogryposis multiplex congenita: The full-blown CNS
   spectrum in newborns with ZIKV infection
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
ID VIRUS
AB The recent alarming statements concerning the newborn ZIKV-induced microcephaly epidemics in the Northeast of Brazil, released by the Brazilian Ministry of Health, as well as important international health agencies, such as the World Health Organization and the Pan American Health Organization, raised many "why and how" questions so far, that will hopefully be scientifically answered, as more researches in that regard come up in the long term.
   In this paper, we describe another potentially ZIKV-induced central nervous system and musculoskeletal disorder that has accompanied microcephaly in these children: atrhogryposis multiplex congenita.
   The goal is to bring up some hypotheses for possible underlying molecular mechanisms based on published data taken from animal models, such as ovine and cattle, which once infected by other types of arboviroses and viruses that also belong to the Flaviviridae family, presented, too, with the full-blown CNS spectrum of malformations at birth. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Leyser, Marcio; Fernandes, Alexandre; Passos, Pamela; Pupe, Camila; Matta, Andre P. C.; Vasconcelos, Marcio Moacyr; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, BR-24033900 Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Univ Fed Fluminense, Antonio Pedro Univ Hosp, BR-24033900 Niteroi, RJ, Brazil.
EM marcioley@icloud.com
RI Fernandes, Alexandre R/K-3341-2016; Leyser, Marcio/Z-4422-2019
OI Fernandes, Alexandre/0000-0001-6253-265X; Leyser,
   Marcio/0000-0002-2929-8416
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G., 2016, LANCET INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kul O, 2008, VET PATHOL, V45, P191, DOI 10.1354/vp.45-2-191
   Mlakar J., 2016, NEW ENGL J MED
   Moller-Madsen B, 2015, J CHILD ORTHOP, V9, P425, DOI 10.1007/s11832-015-0688-2
   Peperkamp NH, 2015, VET PATHOL, V52, P1057, DOI 10.1177/0300985814560231
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro J.A., 2016, MICROBES INFECT, P1
NR 13
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2017
VL 372
BP 73
EP 74
DI 10.1016/j.jns.2016.11.030
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EJ1WZ
UT WOS:000393002500016
PM 28017252
DA 2020-07-08
ER

PT J
AU Pastula, DM
   Khan, AS
   Sharp, TM
   Biaukula, VL
   Naivalu, TK
   Rafai, E
   Belay, E
   Staples, JE
   Fischer, M
   Kosoy, OI
   Laven, JJ
   Bennett, EJ
   Jenney, AWJ
   Naidu, RN
   Lanciotti, RS
   Galloway, RL
   Nilles, EJ
   Sejvar, JJ
   Kama, M
AF Pastula, Daniel M.
   Khan, Aalisha Sahu
   Sharp, Tyler M.
   Biaukula, Viema L.
   Naivalu, Taina K.
   Rafai, Eric
   Belay, Ermias
   Staples, J. Erin
   Fischer, Marc
   Kosoy, Olga I.
   Laven, Janeen J.
   Bennett, Elizabeth J.
   Jenney, Adam W. J.
   Naidu, Ravi Narayan
   Lanciotti, Robert S.
   Galloway, Renee L.
   Nilles, Eric J.
   Sejvar, James J.
   Kama, Mike
TI Investigation of a Guillain-Barre syndrome cluster in the Republic of
   Fiji
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Guillain-Barre syndrome; Epidemiology; Case-control study; Fiji; Dengue
   virus; Zika virus
ID ZIKA VIRUS; INFECTION; DIAGNOSIS
AB Background: In 2014, we investigated a cluster of Guillain-Barre syndrome (GBS) in Fiji that occurred during a dengue epidemic. We designed a case-control study to determine the etiology.
   Methods: Cases were patients meeting Brighton Collaboration criteria for GBS with onset from February 2014 to May 2014. Controls were persons without symptoms of GBS who were matched by age group and location. We collected information on demographics and potential exposures. Serum samples were tested for evidence of recent arboviral or Leptospira spp. infections.
   Results: Nine cases of GBS were identified for an incidence of five cases per 100,000 population/year. Median age of cases was 27 years (range: 0.8-52); five (56%) were male. Six (67%) reported an acute illness prior to GBS onset. Among the 9 cases and 28 controls enrolled, odds ratios for reported exposures or antibodies against various arboviruses or Leptospira spp. were not statistically significant.
   Conclusions: No clear etiologies were identified for this unusual GBS cluster. There was a temporal association between the GBS cluster and a dengue epidemic, but we were unable to substantiate an epidemiologic or laboratory association. Further study is needed to explore potential associations between arboviral infections and GBS. (C) 2016 Published by Elsevier B.V.
C1 [Pastula, Daniel M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Pastula, Daniel M.; Sharp, Tyler M.; Staples, J. Erin; Fischer, Marc; Kosoy, Olga I.; Laven, Janeen J.; Lanciotti, Robert S.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Pastula, Daniel M.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA.
   [Khan, Aalisha Sahu; Naivalu, Taina K.; Rafai, Eric; Kama, Mike] Fiji Minist Hlth & Med Serv, Suva, Fiji.
   [Biaukula, Viema L.; Nilles, Eric J.] World Hlth Org, Western Pacific Reg, Suva, Fiji.
   [Belay, Ermias; Galloway, Renee L.; Sejvar, James J.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, 1600 Clifton Rd,Mailstop A39, Atlanta, GA 30333 USA.
   [Bennett, Elizabeth J.; Jenney, Adam W. J.; Naidu, Ravi Narayan] Colonial War Mem Hosp, Suva, Fiji.
RP Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, 1600 Clifton Rd,Mailstop A39, Atlanta, GA 30333 USA.
EM zea3@cdc.gov
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Nilles,
   Eric/0000-0001-7044-5257; Belay, Ermias/0000-0002-9837-0960
FU Fiji Ministry of Health and Medical Services; World Health
   OrganizationWorld Health Organization; U.S. Centers for Disease Control
   and PreventionUnited States Department of Health & Human ServicesCenters
   for Disease Control & Prevention - USA
FX This work was supported by the Fiji Ministry of Health and Medical
   Services, World Health Organization, and the U.S. Centers for Disease
   Control and Prevention.
CR CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Fujimura H, 2013, HAND CLINIC, V115, P383, DOI 10.1016/B978-0-444-52902-2.00021-7
   Goris M. G., 2014, CURR PROTOC MICROBIO, V32
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005
   HART IK, 1988, Q J MED, V67, P425
   Hojberg L, 2005, SCAND J INFECT DIS, V37, P522, DOI 10.1080/00365540510038514
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kitazawa K, 1998, J NEUROL SCI, V156, P99, DOI 10.1016/S0022-510X(98)00020-3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sharma Chandra Mohan, 2011, J Indian Med Assoc, V109, P682
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
NR 30
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2017
VL 372
BP 350
EP 355
DI 10.1016/j.jns.2016.08.064
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EJ1WZ
UT WOS:000393002500068
PM 27842986
DA 2020-07-08
ER

PT J
AU Offerdahl, DK
   Dorward, DW
   Hansen, BT
   Bloom, ME
AF Offerdahl, Danielle K.
   Dorward, David W.
   Hansen, Bryan T.
   Bloom, Marshall E.
TI Cytoarchitecture of Zika virus infection in human neuroblastoma and
   Aedes albopictus cell lines
SO VIROLOGY
LA English
DT Article
DE Flavivirus; Zika virus; Human neuroblastoma; SK-N-SH; Aedes albopictus;
   C6/36; Electron microscopy; Electron tomography
ID 3-DIMENSIONAL ARCHITECTURE; ENDOPLASMIC-RETICULUM; SEXUAL TRANSMISSION;
   REPLICATION SITES; MOSQUITO CELLS; DENGUE; ELECTRON; MATURATION
AB The Zika virus (ZIKV) pandemic is a global concern due to its role in the development of congenital anomalies of the central nervous system. This mosquito-borne flavivirus alternates between mammalian and mosquito hosts, but information about the biogenesis of ZIKV is limited. Using a human neuroblastoma cell line (SK-N-SH) and an Aedes albopictus mosquito cell line (C6/36), we characterized ZIKV infection by immunofluorescence, transmission electron microscopy (TEM), and electron tomography (ET) to better understand infection in these disparate host cells. ZIKV replicated well in both cell lines, but infected SK-N-SH cells suffered a lytic crisis. Flaviviruses scavenge host cell membranes to serve as replication platforms and ZIKV showed the hallmarks of this process. Via TEM, we identified virus particles and 60-100 nm spherular vesicles. ET revealed these vesicular replication compartments contain smaller 20-30 nm spherular structures. Our studies indicate that SK-N-SH and C6/36 cells are relevant models for viral cytoarchitecture study.
C1 [Offerdahl, Danielle K.; Bloom, Marshall E.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
   [Dorward, David W.; Hansen, Bryan T.] NIAID, Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA.
RP Bloom, ME (corresponding author), NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
EM mbloom@nih.gov
OI Offerdahl, Danielle K/0000-0002-0736-1664
FU Intramural Research Program of NIH/NIAID, United States
FX These studies were supported by the Intramural Research Program of
   NIH/NIAID, United States.
CR Anderson K.B., 2016, ANN INTERN MED
   Barreto-Vieira D. Ferreira, 2016, ULTRASTRUCTURE ZIKA
   Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155
   Barth O., 1992, REPLICATION DENGUE V, P565
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Brasil P, 2016, N ENGL J MED
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2016, 1 FEM MAL SEX TRANSM
   Chen TH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001613
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484
   Hughes BW, 2016, EBIOMEDICINE
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mlera L, 2016, MBIO, V7, DOI 10.1128/mBio.00314-16
   Mlera L, 2015, MBIO, V6, DOI 10.1128/mBio.00614-15
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Qian X., 2016, CELL, V165, P1
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Romero-Brey I, 2015, VIRUSES-BASEL, V7, P6316, DOI 10.3390/v7122940
   SINGH KRP, 1968, CURR SCI INDIA, V37, P65
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Takasaki T, 2001, INTERVIROLOGY, V44, P48, DOI 10.1159/000050030
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whiteman MC, 2015, J VIROL, V89, P1474, DOI 10.1128/JVI.02215-14
   Wikan N, 2009, J VIROL METHODS, V157, P227, DOI 10.1016/j.jviromet.2008.12.019
   World Health Organization, 2016, ZIK SIT REP
NR 46
TC 26
Z9 26
U1 1
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 15
PY 2017
VL 501
BP 54
EP 62
DI 10.1016/j.virol.2016.11.002
PG 9
WC Virology
SC Virology
GA EI1UG
UT WOS:000392263000006
PM 27863275
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Cecchetto, J
   Fernandes, FCB
   Lopes, R
   Bueno, PR
AF Cecchetto, Juliana
   Fernandes, Flavio C. B.
   Lopes, Rute
   Bueno, Paulo R.
TI The capacitive sensing of NS1 Flavivirus biomarker
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Electrochemical capacitance spectroscopy; Electrochemical impedance
   spectroscopy; Flavivirus; Dengue; NS1
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FREE IMPEDIMETRIC IMMUNOSENSOR;
   LABEL-FREE DETECTION; ULTRASENSITIVE DETECTION; PROTEIN BIOMARKERS;
   PRINTED ELECTRODE; VIRUS-INFECTION; DENGUE; BIOSENSOR; BLOOD
AB NS1 is a biomarker for different Flavivirus diseases such as dengue (DENV), zika (ZIKV) and chikungunya (CHIKV) and was herein selectively quantified by electrochemical capacitive sensing (an impedance-derived capacitance methodology wherein the redox probe is contained in the receptive layer) mainly aiming dengue diagnosis in phosphate buffer saline and blood serum environments (up to the neat level). The capacitive sensing was compared to traditional concurrent impedimetric approach (in which the redox probe is added in the biological solution) and other transient methods stated in the literature regarding figures of merit such as limit of detection, linear range, relative standard deviation and affinity constant. Capacitive and impedimetric assays showed equivalent results for linear range, repeatability, sensitivity and constant of affinity. Nonetheless capacitive assays presented better reproducibility with a relative standard deviation (RSD) of 3 +/- 1 and 7 +/- 4 (all in percentage) in PBS and serum, respectively, meanwhile for impedimetric assays the RSD values were 9 +/- 5 in PBS and 12 +/- 6 in serum. Thus, by using capacitive assays, an improvement on the analytical performance was observed with the limit of detection about sixty-fold lower in neat serum (similar to 0.5 ng mL(-1) for capacitive over ng mL(-1) for impedimetric assays) compared to traditional electrochemistry methods in general hence demonstrating the superior detection sensitivity for NS1 protein. Accordingly, redox tagged capacitive assays are suitable for the development of multiplex point-of-care neglected diseases sensing applications.
C1 [Cecchetto, Juliana; Fernandes, Flavio C. B.; Lopes, Rute; Bueno, Paulo R.] Sao Paulo State Univ, Univ Estadual Paulista UNESP, Nanobion Grp, Inst Chem, CP 355, BR-14800900 Sao Paulo, Brazil.
RP Bueno, PR (corresponding author), Sao Paulo State Univ, Univ Estadual Paulista UNESP, Nanobion Grp, Inst Chem, CP 355, BR-14800900 Sao Paulo, Brazil.
EM prbueno@iq.unesp.br
RI Lopes, Rute/D-1880-2017; Bedatty Fernandes, Flavio/M-4542-2017
OI Lopes, Rute/0000-0002-7634-741X; Bedatty Fernandes,
   Flavio/0000-0001-9920-0317
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Bart M, 2005, BIOSENS BIOELECTRON, V21, P49, DOI 10.1016/j.bios.2004.10.009
   Fernandes FCB, 2015, ANAL CHEM, V87, P12137, DOI 10.1021/acs.analchem.5b02976
   Fernandes FCB, 2013, BIOSENS BIOELECTRON, V50, P437, DOI 10.1016/j.bios.2013.06.043
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhaysar K., 2009, BIOSENS BIOELECTRON, V25, P506
   Bryan T, 2013, BIOSENS BIOELECTRON, V39, P94, DOI 10.1016/j.bios.2012.06.051
   Bueno P.R., 2015, PHYS CHEM CHEM PHYS
   Bueno PR, 2014, ANAL CHEM, V86, P1337, DOI 10.1021/ac403135b
   Bueno PR, 2012, J PHYS CHEM B, V116, P8822, DOI 10.1021/jp303700f
   Cavalcanti IT, 2012, BIOCHEM ENG J, V67, P225, DOI 10.1016/j.bej.2012.06.016
   Cecchetto J, 2015, SENSOR ACTUAT B-CHEM, V213, P150, DOI 10.1016/j.snb.2015.02.068
   Centers for Disease Control and Prevention, 2016, DIAGN TEST MOL TEST
   Chikkaveeraiah BV, 2012, ACS NANO, V6, P6546, DOI 10.1021/nn3023969
   Chikkaveeraiah BV, 2011, BIOSENS BIOELECTRON, V26, P4477, DOI 10.1016/j.bios.2011.05.005
   Chuang YH, 2011, BIOSENS BIOELECTRON, V28, P368, DOI 10.1016/j.bios.2011.07.049
   Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855
   Darwish NT, 2016, J ELECTROCHEM SOC, V163, pB19, DOI 10.1149/2.0471603jes
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Elshafey R, 2013, BIOSENS BIOELECTRON, V39, P220, DOI 10.1016/j.bios.2012.07.049
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fernandes FCB, 2014, BIOSENS BIOELECTRON, V57, P96, DOI 10.1016/j.bios.2014.01.044
   Figueiredo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07865
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Ionescu RE, 2010, ELECTROCHIM ACTA, V55, P6228, DOI 10.1016/j.electacta.2009.11.029
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lehr J, 2014, ANAL CHEM, V86, P2559, DOI 10.1021/ac403727h
   Li LD, 2011, BIOSENS BIOELECTRON, V30, P261, DOI 10.1016/j.bios.2011.09.022
   Lin JH, 2013, BIOSENS BIOELECTRON, V41, P342, DOI 10.1016/j.bios.2012.08.051
   Lin KC, 2010, BIOSENS BIOELECTRON, V25, P2336, DOI 10.1016/j.bios.2010.03.032
   Liu-Helmersson J., 2016, EBIOMEDICINE
   LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001
   LONG GL, 1983, ANAL CHEM, V55, pA722
   LONG GL, 1983, ANAL CHEM, V55, pA720
   LONG GL, 1983, ANAL CHEM, V55, pA724
   Luo XL, 2013, CHEM SOC REV, V42, P5944, DOI 10.1039/c3cs60077g
   Marques SM, 2015, ELECTROCHIM ACTA, V182, P946, DOI 10.1016/j.electacta.2015.09.169
   Mason R. L., 2003, STAT DESIGN ANAL EXP
   McCORMICK H.L., 1994, VITAMINS ASCORBIC AC
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Ohno R, 2013, BIOSENS BIOELECTRON, V40, P422, DOI 10.1016/j.bios.2012.07.052
   Pan American Health Organization, 2015, DESCR CURR EP TRENDS
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Patil A. V., 2014, ANAL CHEM
   Peeling R.W., 2010, NAT REV MICROBIOL, V8
   Pournaghi-Azar MH, 2009, ELECTROANAL, V21, P1822, DOI 10.1002/elan.200804570
   Qureshi A, 2010, PHYS CHEM CHEM PHYS, V12, P9176, DOI 10.1039/c004133e
   Ramon-Azcon J, 2008, BIOSENS BIOELECTRON, V23, P1367, DOI 10.1016/j.bios.2007.12.010
   Sadana A, 2015, FRACTAL ANAL BIOMARK, P559
   Sahab ZJ, 2007, BIOMARK INSIGHTS, V2, P21
   Sahoo P, 2013, BIOSENS BIOELECTRON, V44, P164, DOI 10.1016/j.bios.2013.01.023
   Santos A, 2015, J ANAL BIOANAL TECH, pS07
   Santos A, 2016, BIOSENS BIOELECTRON, V83, P368, DOI 10.1016/j.bios.2016.04.043
   Santos A, 2015, BIOSENS BIOELECTRON, V68, P281, DOI 10.1016/j.bios.2014.12.059
   Santos A, 2014, BIOSENS BIOELECTRON, V62, P102, DOI 10.1016/j.bios.2014.06.034
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Silva MMS, 2014, TALANTA, V128, P505, DOI 10.1016/j.talanta.2014.06.009
   Sinawang PD, 2016, BIOSENS BIOELECTRON, V77, P400, DOI 10.1016/j.bios.2015.09.048
   Su CC, 2003, ANAL CHIM ACTA, V479, P117, DOI 10.1016/S0003-2670(02)01529-5
   Subedi D, 2014, OPEN J CLIN DIAGNOST, V4, P8
   Telsnig D, 2012, INT J ELECTROCHEM SC, V7, P10476
   Valentin MA, 2011, J PHARMACEUT BIOMED, V55, P869, DOI 10.1016/j.jpba.2011.03.033
   Vazquez S, 2010, DIAGN MICR INFEC DIS, V68, P46, DOI 10.1016/j.diagmicrobio.2010.04.006
   Venkatanarayanan A, 2013, ANAL CHEM, V85, P2216, DOI 10.1021/ac302943q
   World Health Organization, 2016, GLOB STRAT DENG PREV
   Yan SC, 2010, J ELECTROANAL CHEM, V641, P136, DOI 10.1016/j.jelechem.2009.12.019
   Yang LJ, 2004, ANAL CHEM, V76, P1107, DOI 10.1021/ac0352575
NR 70
TC 33
Z9 33
U1 7
U2 70
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JAN 15
PY 2017
VL 87
BP 949
EP 956
DI 10.1016/j.bios.2016.08.097
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA EF7HB
UT WOS:000390499600129
PM 27665517
OA Green Published
DA 2020-07-08
ER

PT J
AU Russell, K
   Hills, SL
   Oster, AM
   Porse, CC
   Danyluk, G
   Cone, M
   Brooks, R
   Scotland, S
   Schiffman, E
   Fredette, C
   White, JL
   Ellingson, K
   Hubbard, A
   Cohn, A
   Fischer, M
   Mead, P
   Powers, AM
   Brooks, JT
AF Russell, Kate
   Hills, Susan L.
   Oster, Alexandra M.
   Porse, Charsey Cole
   Danyluk, Gregory
   Cone, Marshall
   Brooks, Richard
   Scotland, Sarah
   Schiffman, Elizabeth
   Fredette, Carolyn
   White, Jennifer L.
   Ellingson, Katherine
   Hubbard, Allison
   Cohn, Amanda
   Fischer, Marc
   Mead, Paul
   Powers, Ann M.
   Brooks, John T.
TI Male-to-Female Sexual Transmission of Zika Virus-United States,
   January-April 2016
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Zika virus; sexual transmission; semen
AB We report on 9 cases of male-to-female sexual transmission of Zika virus in the United States occurring January-April 2016. This report summarizes new information about both timing of exposure and symptoms of sexually transmitted Zika virus disease, and results of semen testing for Zika virus from 2 male travelers.
C1 [Russell, Kate; Brooks, Richard] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Russell, Kate] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Hills, Susan L.; Fischer, Marc; Mead, Paul; Powers, Ann M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA USA.
   [Oster, Alexandra M.; Brooks, John T.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.
   [Porse, Charsey Cole] Calif Dept Publ Hlth, Sacramento, CA USA.
   [Danyluk, Gregory] Florida Dept Hlth, Winter Haven, FL USA.
   [Cone, Marshall] Florida Dept Hlth, Tallahassee, FL USA.
   [Brooks, Richard] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA.
   [Scotland, Sarah] Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA.
   [Schiffman, Elizabeth] Minnesota Dept Hlth, St Paul, MN USA.
   [Fredette, Carolyn] New Hampshire Dept Hlth & Human Serv, Concord, NH USA.
   [White, Jennifer L.] New York State Dept Hlth, Albany, NY USA.
   [Ellingson, Katherine] Oregon Publ Hlth Div, Portland, OR USA.
   [Hubbard, Allison] Virginia Dept Hlth, Richmond, VA USA.
   [Cohn, Amanda] Ctr Dis Control & Prevent, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
RP Russell, K (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A 32, Atlanta, GA 30329 USA.
EM vnt0@cdc.gov
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T., 2016, EURO SURVEILL, V21
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   World Health Organization, 2016, WHOZIKVMOC161REV2
NR 16
TC 64
Z9 64
U1 1
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 15
PY 2017
VL 64
IS 2
BP 211
EP 213
DI 10.1093/cid/ciw692
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1GB
UT WOS:000397132300024
PM 27986688
OA Bronze
DA 2020-07-08
ER

PT J
AU Pfaender, S
   Vielle, NJ
   Ebert, N
   Steinmann, E
   Alves, MP
   Thiel, V
AF Pfaender, Stephanie
   Vielle, Nathalie J.
   Ebert, Nadine
   Steinmann, Eike
   Alves, Marco P.
   Thiel, Volker
TI Inactivation of Zika virus in human breast milk by prolonged storage or
   pasteurization
SO VIRUS RESEARCH
LA English
DT Article
DE Zika virus; Breast milk; Stability; Antiviral; Pasteurization
ID INFECTION
AB Zika virus infection during pregnancy poses a serious risk for pregnant women as it can cause severe birth defects. Even though the virus is mainly transmitted via mosquitos, human-to-human transmission has been described. Infectious viral particles have been detected in breast milk of infected women which raised concerns regarding the safety of breastfeeding in areas of Zika virus transmission or in case of a suspected or confirmed Zika virus infection. In this study, we show that Zika virus is effectively inactivated in human breast milk after prolonged storage or upon pasteurization of milk. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Pfaender, Stephanie; Vielle, Nathalie J.; Ebert, Nadine; Alves, Marco P.; Thiel, Volker] Univ Bern, Dept Infect Dis & Pat hobiol, Bern, Switzerland.
   [Pfaender, Stephanie; Vielle, Nathalie J.; Ebert, Nadine; Alves, Marco P.; Thiel, Volker] Inst Immunol & Virol, Fed Dept Home Affairs, Langgassstr 122, CH-3012 Bern, Switzerland.
   [Pfaender, Stephanie; Vielle, Nathalie J.; Ebert, Nadine; Alves, Marco P.; Thiel, Volker] Inst Immunol & Virol, Fed Dept Home Affairs, Langgassstr 122, CH-3012 Mittelhausern, Switzerland.
   [Steinmann, Eike] TWINCORE Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany.
   [Vielle, Nathalie J.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
RP Thiel, V (corresponding author), Inst Immunol & Virol, Fed Dept Home Affairs, Langgassstr 122, CH-3012 Bern, Switzerland.; Thiel, V (corresponding author), Inst Immunol & Virol, Fed Dept Home Affairs, Langgassstr 122, CH-3012 Mittelhausern, Switzerland.
EM volker.thiel@vetsuisse.unibe.ch
RI Thiel, Volker/AAI-2391-2019
OI Pfaender, Stephanie/0000-0002-3957-5448; Thiel,
   Volker/0000-0002-5783-0887; Steinmann, Eike/0000-0002-3654-9965
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [165076, 160780]; European UnionEuropean Union (EU)
   [278433-PREDEMICS]
FX VT was supported by a grant from the Swiss National Science Foundation
   (SNF #165076 and #160780). This project was supported by European
   Union's Seventh Framework Program for research, technological
   development and demonstration under grant agreement No.
   278433-PREDEMICS.
CR [Anonymous], 2016, WHO GUID APPR GUID R
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   HAMOSH M, 1985, PEDIATRICS, V75, P146
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lucey J. A., 2015, Nutrition Today, V50, P189, DOI 10.1097/NT.0000000000000108
   Pfaender S, 2013, J INFECT DIS, V208, P1943, DOI 10.1093/infdis/jit519
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212
   WHO, 2016, ZIK SIT REP 25 AUG 2
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 15
TC 15
Z9 15
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 15
PY 2017
VL 228
BP 58
EP 60
DI 10.1016/j.virusres.2016.11.025
PG 3
WC Virology
SC Virology
GA EJ2CR
UT WOS:000393018000008
PM 27889615
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Gerardin, P
   Cao-Lormeau, VM
   Musso, D
   Despres, P
   Besnard, M
AF Gerardin, Patrick
   Cao-Lormeau, Van-Mai
   Musso, Didier
   Despres, Philippe
   Besnard, Marianne
TI Zika rash and increased risk of congenital brain abnormalities
SO LANCET
LA English
DT Letter
ID VIRUS
C1 [Gerardin, Patrick] Ctr Hosp Univ Reun, INSERM, CIC 1410, F-97448 St Pierre, Reunion, France.
   [Gerardin, Patrick; Despres, Philippe] Univ La Reunion, UMR Proc Infect Milieu Insulaire Trop 134, CNRS 9192, INSERM 1187,IRD 249,Plateforme Technol CYROI, St Clotilde, Reunion, France.
   [Cao-Lormeau, Van-Mai; Musso, Didier] Inst Louis Malarde, Papeete, Tahiti, France.
   [Besnard, Marianne] Ctr Hosp French Polynesia, Serv Reanimat Neonatale, Pirae, France.
RP Gerardin, P (corresponding author), Ctr Hosp Univ Reun, INSERM, CIC 1410, F-97448 St Pierre, Reunion, France.; Gerardin, P (corresponding author), Univ La Reunion, UMR Proc Infect Milieu Insulaire Trop 134, CNRS 9192, INSERM 1187,IRD 249,Plateforme Technol CYROI, St Clotilde, Reunion, France.
EM patrick.gerardin@chu-reunion.fr
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020; Cao-Lormeau,
   Van-Mai/H-4879-2018
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Cao-Lormeau, Van-Mai/0000-0001-5606-7480
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
NR 5
TC 5
Z9 5
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 14
PY 2017
VL 389
IS 10065
BP 151
EP 152
DI 10.1016/S0140-6736(17)30014-4
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EH9UT
UT WOS:000392117600018
PM 28102133
OA Bronze
DA 2020-07-08
ER

PT J
AU Vouga, M
   Musso, D
   Schaub, B
   Panchaud, A
   Baud, D
AF Vouga, Manon
   Musso, Didier
   Schaub, Bruno
   Panchaud, Alice
   Baud, David
TI Zika virus: are we going too far?
SO LANCET
LA English
DT Letter
ID CYTOMEGALOVIRUS; SEMEN
C1 [Vouga, Manon; Baud, David] Univ Hosp, Materno Fetal & Obstet Res Unit, Dept Femme Mere Enfant, CH-1011 Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Hosp, Lausanne, Switzerland.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Schaub, Bruno] Univ Hosp Martinique, Multidisciplinary Ctr Prenatal Diag, Obstet & Gynecol, Dept Femme Mere Enfant, Fort De France, France.
   [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
RP Baud, D (corresponding author), Univ Hosp, Materno Fetal & Obstet Res Unit, Dept Femme Mere Enfant, CH-1011 Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Hosp, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016; Panchaud,
   Alice/S-6535-2019
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Panchaud, Alice/0000-0001-6086-2401; Baud, David/0000-0001-9914-6496
CR DUTKO FJ, 1979, P NATL ACAD SCI USA, V76, P2988, DOI 10.1073/pnas.76.6.2988
   LANG DJ, 1974, NEW ENGL J MED, V291, P121, DOI 10.1056/NEJM197407182910303
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
NR 5
TC 5
Z9 5
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 14
PY 2017
VL 389
IS 10065
BP 151
EP 151
DI 10.1016/S0140-6736(17)30013-2
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EH9UT
UT WOS:000392117600017
PM 28102134
OA Bronze
DA 2020-07-08
ER

PT J
AU Victora, CG
   Castro, MC
   Franca, GVA
   Schuler-Faccini, L
   Barros, FC
AF Victora, Cesar G.
   Castro, Marcia C.
   Franca, Giovanny V. A.
   Schuler-Faccini, Lavinia
   Barros, Fernando C.
TI Zika rash and increased risk of congenital brain abnormalities Reply
SO LANCET
LA English
DT Letter
ID BRAZIL
C1 [Victora, Cesar G.; Barros, Fernando C.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil.
   [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Franca, Giovanny V. A.] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Barros, Fernando C.] Univ Catolica Pelotas, Pelotas, RS, Brazil.
RP Victora, CG (corresponding author), Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil.
EM cvictora@equidade.org
RI de Franca, Giovanny Vinicius Araujo/L-7385-2018; Castro,
   Marcia/S-2681-2019; Victora, Cesar Gomes/Y-2455-2019; SCHULER-FACCINI,
   LAVINIA/C-8309-2013
OI de Franca, Giovanny Vinicius Araujo/0000-0002-7530-2017; Castro,
   Marcia/0000-0003-4606-2795; Victora, Cesar Gomes/0000-0002-2465-2180;
   SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
NR 5
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 14
PY 2017
VL 389
IS 10065
BP 152
EP 152
DI 10.1016/S0140-6736(17)30015-6
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EH9UT
UT WOS:000392117600019
PM 28102136
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, X
   Liu, T
   Lin, LF
   Song, T
   Du, XL
   Lin, HL
   Xiao, JP
   He, JF
   Liu, LP
   Zhu, GH
   Zeng, WL
   Guo, LC
   Cao, Z
   Ma, WJ
   Zhang, YH
AF Li, Xing
   Liu, Tao
   Lin, Lifeng
   Song, Tie
   Du, Xiaolong
   Lin, Hualiang
   Xiao, Jianpeng
   He, Jianfeng
   Liu, Liping
   Zhu, Guanghu
   Zeng, Weilin
   Guo, Lingchuan
   Cao, Zheng
   Ma, Wenjun
   Zhang, Yonghui
TI Application of the analytic hierarchy approach to the risk assessment of
   Zika virus disease transmission in Guangdong Province, China
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Risk assessment; Transmission; China
ID INFECTIOUS-DISEASES; DENGUE; EPIDEMIOLOGY; ASIA
AB Background: An international spread of Zika virus (ZIKV) infection has attracted global attention in 2015. The infection also affected Guangdong province, which is located in southern China. Multiple factors, including frequent communication with South America and Southeast Asia, suitable climate (sub-tropical) for the habitat of Aedes species, may increase the risk of ZIKV disease transmission in this region.
   Methods: An analytic hierarchy process (AHP) method was used to develop a semi-quantitative ZIKV risk assessment model. After selecting indicators, we invited experts in related professions to identify the index weight and based on that a hierarchical structure was generated. Then a series of pairwise comparisons were used to determine the relative importance of the criteria. Finally, the optimal model was established to estimate the spatial and seasonal transmission risk of ZIKV.
   Results: A total of 15 factors that potentially influenced the risk of ZIKV transmission were identified. The factor that received the largest weight was epidemic of ZIKV in Guangdong province (combined weight [CW] =0.37), followed by the mosquito density (CW=0.18) and the epidemic of DENV in Guangdong province (CW=0.14). The distribution of 123 districts/counties' RIs of ZIKV in Guangdong through different seasons were presented, respectively.
   Conclusions: Higher risk was observed within Pearl River Delta including Guangzhou, Shenzhen and Jiangmen, and the risk is greater in summer and autumn compared to spring and winter.
C1 [Li, Xing; Liu, Tao; Du, Xiaolong; Lin, Hualiang; Xiao, Jianpeng; Zhu, Guanghu; Zeng, Weilin; Guo, Lingchuan] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, 160 Qunxian Rd, Guangzhou 511430, Guangdong, Peoples R China.
   [Lin, Lifeng; Song, Tie; He, Jianfeng; Liu, Liping; Zhang, Yonghui] Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou 511430, Guangdong, Peoples R China.
   [Cao, Zheng; Ma, Wenjun] Chinese Acad Sci, Guangzhou Inst Geochem, 511 Kehua St, Guangzhou 510640, Guangdong, Peoples R China.
RP Zhang, YH (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou 511430, Guangdong, Peoples R China.; Ma, WJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Geochem, 511 Kehua St, Guangzhou 510640, Guangdong, Peoples R China.
EM mawj@gdiph.org.cn; zyh@cdcp.org.cn
FU Guangdong Provincial Science and Technology Project Funding
   [2016A020251001]
FX This study was supported by Guangdong Provincial Science and Technology
   Project Funding (project number: 2016A020251001).
CR Barboza P, 2008, MED MALADIES INFECT, V38, P513, DOI 10.1016/j.medmal.2008.06.011
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOLAN JG, 1989, MED DECIS MAKING, V9, P40, DOI 10.1177/0272989X8900900108
   GDHIC, 2012, HLTH STAT YB GUANGD
   Gupta JK, 2012, INDOOR AIR, V22, P388, DOI 10.1111/j.1600-0668.2012.00773.x
   He Fan, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P645
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kayal T, 2011, TECHNOL ECON DEV ECO, V17, P313, DOI 10.3846/20294913.2011.583727
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Liu CX, 2014, ASIA-PAC J PUBLIC HE, V26, P58, DOI 10.1177/1010539512472356
   Lu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119562
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   National Bureau of Statistics, 2012, TAB 2010 POP CENS PE
   Ooi EE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0345-0
   SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P1
   Statistics GPBo, 2012, GUANGD STAT YB 2012
   Tu CY, 2014, JPN J INFECT DIS, V67, P417
   Wiwanitkit V., 2016, EPIDEMIOL HLTH
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
   Yang XJ, 2013, INFORM SCIENCES, V222, P384, DOI 10.1016/j.ins.2012.08.019
   Zhu Q, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25051
NR 27
TC 9
Z9 10
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 13
PY 2017
VL 17
AR 65
DI 10.1186/s12879-016-2170-2
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EP4JD
UT WOS:000397345900001
PM 28086897
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Benjamin, RJ
AF Benjamin, Richard J.
TI Zika virus in the blood supply
SO BLOOD
LA English
DT Editorial Material
ID CHIKUNGUNYA VIRUS; PUERTO-RICO; DONATIONS; TRANSFUSION; EPIDEMIC
C1 [Benjamin, Richard J.] Georgetown Univ, Washington, DC 20057 USA.
RP Benjamin, RJ (corresponding author), Georgetown Univ, Washington, DC 20057 USA.
CR Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Snyder EL, 2015, NEW ENGL J MED, V373, P882, DOI 10.1056/NEJMc1507761
NR 10
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD JAN 12
PY 2017
VL 129
IS 2
BP 144
EP 145
DI 10.1182/blood-2016-12-751925
PG 4
WC Hematology
SC Hematology
GA EO2LO
UT WOS:000396528200009
PM 28082294
OA Bronze
DA 2020-07-08
ER

PT J
AU Gallian, P
   Cabie, A
   Richard, P
   Paturel, L
   Charrel, RN
   Pastorino, B
   Leparc-Goffart, I
   Tiberghien, P
   de Lamballerie, X
AF Gallian, Pierre
   Cabie, Andre
   Richard, Pascale
   Paturel, Laure
   Charrel, Remi N.
   Pastorino, Boris
   Leparc-Goffart, Isabelle
   Tiberghien, Pierre
   de Lamballerie, Xavier
TI Zika virus in asymptomatic blood donors in Martinique
SO BLOOD
LA English
DT Letter
ID SEXUAL TRANSMISSION; INFECTION; BRAZIL
C1 [Gallian, Pierre; Charrel, Remi N.; Pastorino, Boris; Leparc-Goffart, Isabelle; de Lamballerie, Xavier] Aix Marseille Univ, French Inst Res Dev, INSERM,Unite Mixte Rech Emergence Pathol Virales, Inst Hosp Univ Mediterranee Infect, Marseille, France.
   [Gallian, Pierre; Tiberghien, Pierre] Etab Francais Sang, La Plaine St Denis, France.
   [Cabie, Andre] CHU Ft De France, Serv Malad Infect & Trop, Fort De France, Martinique, France.
   [Cabie, Andre] Univ Antilles, INSERM, Ctr Invest Clin 1424, Equipe Accueil 4537, Fort De France, Martinique, France.
   [Richard, Pascale; Paturel, Laure] Etab Francais Sang, Fort De France, Martinique, France.
   [Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Tiberghien, Pierre] Univ Franche Comte, INSERM, Etab Francais Sang UMR 1098, Besancon, France.
RP Gallian, P (corresponding author), Etab Francais Sang Alpes Mediterranee, 149 Bd Baille, F-13005 Marseille, France.
EM pierre.gallian@efs.sante.fr
RI Tiberghien, Pierre/AAH-5878-2019
OI Cabie, Andre/0000-0003-0117-3061; pastorino, boris/0000-0001-5233-5193;
   Charrel, Remi/0000-0002-7675-8251
FU Etablissement Francais du Sang; INSERMInstitut National de la Sante et
   de la Recherche Medicale (Inserm); Aix- Marseille University; European
   CommissionEuropean Commission Joint Research Centre
FX This work was supported by the Etablissement Francais du Sang, INSERM,
   and Aix-Marseille University. P.G., A.C., R.N.C., B.P., I. L.-G., and
   X.d.L. are members of the ZIKAlliance project, funded by the European
   Commission.
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lustig Y, 2016, EURO SURVEILL, V21
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Sante publique France, 2016, EP B CIRE ANT GUYAN, V22
   Sante publique France, 2015, EP B CIRE ANT GUYAN, V1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 19
TC 63
Z9 63
U1 2
U2 6
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD JAN 12
PY 2017
VL 129
IS 2
BP 263
EP 266
DI 10.1182/blood-2016-09-737981
PG 6
WC Hematology
SC Hematology
GA EO2LO
UT WOS:000396528200023
PM 27827826
OA Bronze
DA 2020-07-08
ER

PT J
AU Heitmann, A
   Jansen, S
   Luhken, R
   Leggewie, M
   Badusche, M
   Pluskota, B
   Becker, N
   Vapalahti, O
   Schmidt-Chanasit, J
   Tannich, E
AF Heitmann, A.
   Jansen, S.
   Luehken, R.
   Leggewie, M.
   Badusche, M.
   Pluskota, B.
   Becker, N.
   Vapalahti, O.
   Schmidt-Chanasit, J.
   Tannich, E.
TI Experimental transmission of Zika virus by mosquitoes from central
   Europe
SO EUROSURVEILLANCE
LA English
DT Article
ID AEDES-ALBOPICTUS; CULEX-PIPIENS; WEST NILE; VECTOR
AB Mosquitoes collected in Germany in 2016, including Culex pipiens pipiens biotype pipiens, Culex torrentium and Aedes albopictus, as well as Culex pipiens pipiens biotype molestus (in colony since 2011) were experimentally infected with Zika virus (ZIKV) at 18 degrees C or 27 degrees C. None of the Culex taxa showed vector competence for ZIKV. In contrast, Aedes albopictus were susceptible for ZIKV but only at 27 degrees C, with transmission rates similar to an Aedes aegypti laboratory colony tested in parallel.
C1 [Heitmann, A.; Jansen, S.; Luehken, R.; Leggewie, M.; Badusche, M.; Schmidt-Chanasit, J.; Tannich, E.] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Jansen, S.; Leggewie, M.; Schmidt-Chanasit, J.; Tannich, E.] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Pluskota, B.; Becker, N.] Inst Dipterol IfD, Speyer, Germany.
   [Becker, N.] Heidelberg Univ, Heidelberg, Germany.
   [Vapalahti, O.] Univ Helsinki, Helsinki, Finland.
   [Vapalahti, O.] Helsinki Univ Hosp, Helsinki, Finland.
RP Luhken, R (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.
EM renkeluhken@gmail.com
RI Heitmann, Anna/K-4523-2019
OI Heitmann, Anna/0000-0002-9584-0947; Luhken, Renke/0000-0002-1984-839X;
   Vapalahti, Olli/0000-0003-2270-6824
FU Leibniz Association [SAW-2014-SGN-3]; German Federal Ministry of Food
   and Agriculture (BMEL) through the Federal Office for Agriculture and
   Food (BLE) [28-1-91.048-15]
FX We thank Ella Weinert and Michelle Helms for excellent technical
   assistance and Jessica Borstler for analyses of Culex mosquitoes. ML was
   supported by the Leibniz Association, grant number SAW-2014-SGN-3. This
   work was financially supported by the German Federal Ministry of Food
   and Agriculture (BMEL) through the Federal Office for Agriculture and
   Food (BLE) with the grant number 28-1-91.048-15.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Huber K, 2014, PARASITOL RES, V113, P3201, DOI 10.1007/s00436-014-4000-z
   Jost H, 2011, J CLIN VIROL, V52, P278, DOI 10.1016/j.jcv.2011.08.002
   Leggewie M, 2016, ONE HEALTH, V2, P88, DOI 10.1016/j.onehlt.2016.04.001
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   [Regional Office for Europpe (Europe) World Health Organization (WHO)], 2016, ZIK VIR TECHN REP IN
   Vogels CBF, 2015, VECTOR-BORNE ZOONOT, V15, P619, DOI 10.1089/vbz.2015.1820
NR 19
TC 42
Z9 42
U1 1
U2 12
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 12
PY 2017
VL 22
IS 2
BP 4
EP 6
AR 30437
DI 10.2807/1560-7917.ES.2017.22.2.30437
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EJ4ZZ
UT WOS:000393227600002
PM 28106528
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nitsche, C
   Zhang, LL
   Weigel, LF
   Schilz, J
   Graf, D
   Bartenschlager, R
   Hilgenfeld, R
   Klein, CD
AF Nitsche, Christoph
   Zhang, Linlin
   Weigel, Lena F.
   Schilz, Jonas
   Graf, Dominik
   Bartenschlager, Ralf
   Hilgenfeld, Rolf
   Klein, Christian D.
TI Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal
   Chemistry and Structural Biology
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID VIRUS NS2B-NS3 PROTEASE; ANTIVIRAL ACTIVITY; DENGUE PROTEASE; NS3
   PROTEASE; DISCOVERY; HYBRIDS; ESTERS; POTENT; SELECTIVITY; BINDING
AB A thousand-fold affinity gain is achieved by introduction of a C-terminal boronic acid moiety into dipeptidic inhibitors of the Zika, West Nile, and dengue virus proteases. The resulting compounds have K-i values in the two-digit nanomolar range, are not cytotoxic, and inhibit virus replication. Structure activity relationships and a high resolution X-ray cocrystal structure with West Nile virus protease provide a basis for the design of optimized covalent-reversible inhibitors aimed at emerging flaviviral pathogens.
C1 [Nitsche, Christoph; Weigel, Lena F.; Graf, Dominik; Klein, Christian D.] Heidelberg Univ, Med Chem, IPMB, INF 364, D-69120 Heidelberg, Germany.
   [Zhang, Linlin; Schilz, Jonas; Hilgenfeld, Rolf] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Ratzeburger Allee 160, D-23562 Lubeck, Germany.
   [Zhang, Linlin; Bartenschlager, Ralf; Hilgenfeld, Rolf] German Ctr Infect Res DZIF, Sites Hamburg Lubeck Borstel Riems & Heidelberg, Braunschweig, Germany.
   [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, INF 345, D-69120 Heidelberg, Germany.
   [Nitsche, Christoph] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
RP Klein, CD (corresponding author), Heidelberg Univ, Med Chem, IPMB, INF 364, D-69120 Heidelberg, Germany.
EM c.klein@uni-heidelberg.de
RI Bartenschlager, Ralf/L-2582-2015
OI Bartenschlager, Ralf/0000-0001-5601-9307; Klein,
   Christian/0000-0003-3522-9182
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [KL-1356/3-1]; German Center for Infection Research (DZIF) [8029801911]
FX We thank Dr. Tom Sundermann, Heiko Rudy, Tobias Timmermann, Natascha
   Stefan, and Yasmin Gul for support. Dr. Mascha Jakel kindly provided
   (+)-pinanediol. Dr. Mira A. M. Behnam and Dr. Daizong Lin were valuable
   partners for discussions. The project was supported by the Deutsche
   Forschungsgemeinschaft, Grant KL-1356/3-1, and by the German Center for
   Infection Research (DZIF), Grant 8029801911.
CR Adams J, 1999, CANCER RES, V59, P2615
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Dubiella C, 2015, ANGEW CHEM INT EDIT, V54, P15888, DOI 10.1002/anie.201506631
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hecker SJ, 2015, J MED CHEM, V58, P3682, DOI 10.1021/acs.jmedchem.5b00127
   Jost C, 2014, J MED CHEM, V57, P7590, DOI 10.1021/jm5006918
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Matteson DS, 2013, J ORG CHEM, V78, P10009, DOI 10.1021/jo4013942
   MATTESON DS, 1983, J AM CHEM SOC, V105, P2077, DOI 10.1021/ja00345a074
   MATTESON DS, 1980, J AM CHEM SOC, V102, P7590, DOI 10.1021/ja00545a046
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Turker L, 2006, INDIAN J CHEM A, V45, P1339
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Weisner J, 2015, ANGEW CHEM INT EDIT, V54, P10313, DOI 10.1002/anie.201502142
   WITYAK J, 1995, J ORG CHEM, V60, P3717, DOI 10.1021/jo00117a024
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
NR 25
TC 45
Z9 46
U1 8
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD JAN 12
PY 2017
VL 60
IS 1
BP 511
EP 516
DI 10.1021/acs.jmedchem.6b01021
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EH8PP
UT WOS:000392035100036
PM 27966962
DA 2020-07-08
ER

PT J
AU Korver, AMH
   Smith, RJH
   Van Camp, G
   Schleiss, MR
   Bitner-Glindzicz, MAK
   Lustig, LR
   Usami, S
   Boudewyns, AN
AF Korver, Anna M. H.
   Smith, Richard J. H.
   Van Camp, Guy
   Schleiss, Mark R.
   Bitner-Glindzicz, Maria A. K.
   Lustig, Lawrence R.
   Usami, Shin-ichi
   Boudewyns, An N.
TI Congenital hearing loss
SO NATURE REVIEWS DISEASE PRIMERS
LA English
DT Article
ID AUTOSOMAL RECESSIVE DEAFNESS; CYTOMEGALOVIRUS CMV INFECTION; HAIR-CELL
   STEREOCILIA; ZIKA VIRUS-INFECTION; COCHLEAR IMPLANTATION; AUDITORY
   NEUROPATHY; INTRAUTERINE TRANSMISSION; AMPLITUDE COMPRESSION; ETIOLOGIC
   DIAGNOSIS; CLINICAL-EVALUATION
AB Congenital hearing loss (hearing loss that is present at birth) is one of the most prevalent chronic conditions in children. In the majority of developed countries, neonatal hearing screening programmes enable early detection; early intervention will prevent delays in speech and language development and has long-lasting beneficial effects on social and emotional development and quality of life. A diagnosis of hearing loss is usually followed by a search for an underlying aetiology. Congenital hearing loss might be attributed to environmental and prenatal factors, which prevail in low-income settings; congenital infections, particularly cytomegalovirus infection, are also a common risk factor for hearing loss. Genetic causes probably account for the majority of cases in developed countries; mutations can affect any component of the hearing pathway, in particular, inner ear homeostasis (endolymph production and maintenance) and mechano-electrical transduction (the conversion of a mechanical stimulus into electrochemical activity). Once the underlying cause of hearing loss is established, it might direct therapeutic decision making and guide prevention and (genetic) counselling. Management options include specific antimicrobial therapies, surgical treatment of craniofacial abnormalities and implantable or non-implantable hearing devices. An improved understanding of the pathophysiology and molecular mechanisms that underlie hearing loss and increased awareness of recent advances in genetic testing will promote the development of new treatment and screening strategies.
C1 [Korver, Anna M. H.] St Antonius Hosp, Dept Pediat, POB 2500, NL-3430 EM Nieuwegein, Netherlands.
   [Smith, Richard J. H.] Univ Iowa, Mol Otolaryngol & Renal Res Labs, Iowa City, IA USA.
   [Smith, Richard J. H.] Univ Iowa, Genet PhD Program, Iowa City, IA USA.
   [Van Camp, Guy] Univ Antwerp, Univ Antwerp Hosp, Dept Med Genet, Antwerp, Belgium.
   [Schleiss, Mark R.] Univ Minnesota, Sch Med, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA.
   [Bitner-Glindzicz, Maria A. K.] UCL, Great Ormond St Inst Child Hlth, Genet & Genom Med Programme, London, England.
   [Lustig, Lawrence R.] Columbia Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, New York, NY USA.
   [Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano, Japan.
   [Boudewyns, An N.] Univ Antwerp, Univ Antwerp Hosp, Dept Otorhinolaryngol Head & Neck Surg, Antwerp, Belgium.
RP Korver, AMH (corresponding author), St Antonius Hosp, Dept Pediat, POB 2500, NL-3430 EM Nieuwegein, Netherlands.
EM a.korver@antoniusziekenhuis.nl
RI Van Camp, Guy/F-3386-2013
OI Van Camp, Guy/0000-0001-5105-9000; Smith, Richard/0000-0003-1201-6731
FU US National Institute on Deafness and Other Communication
   DisordersUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Deafness &
   Other Communication Disorders (NIDCD) [RO1s DC003544, DC002842,
   DC012049]; US National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01s HD044864,
   HD079918]; Great Ormond Street Hospital Children's Charity; National
   Institute for Health Research Biomedical Research Centre at Great Ormond
   Street Hospital for Children NHS Foundation Trust and University College
   London
FX This work was supported by US National Institute on Deafness and Other
   Communication Disorders grants RO1s DC003544, DC002842 and DC012049 to
   R.J.H.S. and US National Institute of Child Health and Human Development
   grants R01s HD044864 and HD079918 to M. R. S. M.A.K.B.-G. is supported
   by Great Ormond Street Hospital Children's Charity and the National
   Institute for Health Research Biomedical Research Centre at Great Ormond
   Street Hospital for Children NHS Foundation Trust and University College
   London. All authors thank their colleague A. Snik for his input to
   earlier versions of this manuscript.
CR Alford RL, 2014, GENET MED, V16, P347, DOI 10.1038/gim.2014.2
   Austeng ME, 2010, INT J AUDIOL, V49, P65, DOI 10.3109/14992020903214053
   Bamiou DE, 2000, CLIN OTOLARYNGOL, V25, P98, DOI 10.1046/j.1365-2273.2000.00346.x
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219
   Benson K. B., 1988, AUDIO ENG HDB
   Birman CS, 2012, OTOL NEUROTOL, V33, P1347, DOI 10.1097/MAO.0b013e31826939cc
   BOOTHROYD A, 1988, J SPEECH HEAR RES, V31, P362, DOI 10.1044/jshr.3103.362
   Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Boudewyns A, 2011, OTOL NEUROTOL, V32, P799, DOI 10.1097/MAO.0b013e31821b0d07
   Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467
   Bradford RD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004774
   Buchman CA, 2004, LARYNGOSCOPE, V114, P309, DOI 10.1097/00005537-200402000-00025
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Cannon M. J., BMC INFECT DIS, V14, P569
   Alvarado JC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00086
   Centers for Disease Control and Prevention, 2013, SEX TRANSM DIS SURV
   Chau J, 2009, INT J PEDIATR OTORHI, V73, P787, DOI 10.1016/j.ijporl.2009.02.021
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Chen G, 2010, CURR DRUG METAB, V11, P886, DOI 10.2174/138920010794479673
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Colgan S, 2012, ACAD PEDIATR, V12, P171, DOI 10.1016/j.acap.2012.02.002
   Cone-Wesson B, 2000, EAR HEARING, V21, P488, DOI 10.1097/00003446-200010000-00012
   CONEWESSON B, 2000, CURR OPIN OTOLARYNGO, V8, P421
   Cremers C W, 1988, Adv Otorhinolaryngol, V40, P9
   Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176
   De Leenheer EMR, 2011, INT J PEDIATR OTORHI, V75, P27, DOI 10.1016/j.ijporl.2010.05.040
   Declau F, 2008, PEDIATRICS, V121, P1119, DOI 10.1542/peds.2007-1479
   Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036
   Donaudy F, 2006, J MED GENET, V43, P157, DOI 10.1136/jmg.2005.032086
   Doshi J, 2015, EXPERT REV MED DEVIC, V12, P73, DOI 10.1586/17434440.2015.975117
   Driscoll C, 2015, INT J PEDIATR OTORHI, V79, P654, DOI 10.1016/j.ijporl.2015.02.007
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Eppsteiner RW, 2012, HEARING RES, V292, P51, DOI 10.1016/j.heares.2012.08.007
   Esterberg Robert, 2013, Drug Discov Today Dis Models, V10, DOI 10.1016/j.ddmod.2012.02.001
   Fettiplace R, 2014, PHYSIOL REV, V94, P951, DOI 10.1152/physrev.00038.2013
   Fitzpatrick EM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1974
   Fitzpatrick EM, 2015, EAR HEARING, V36, P688, DOI 10.1097/AUD.0000000000000184
   Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037
   Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536
   Francois M, 2015, EUR ANN OTORHINOLARY, V132, P251, DOI 10.1016/j.anorl.2015.08.026
   FREIJ BJ, 1988, CLIN PERINATOL, V15, P247
   Gantt S, 2016, JAMA PEDIATR, V170, P1173, DOI 10.1001/jamapediatrics.2016.2016
   Gaylor JM, 2013, JAMA OTOLARYNGOL, V139, P265, DOI 10.1001/jamaoto.2013.1744
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Golub JS, 2012, OTOL NEUROTOL, V33, P147, DOI 10.1097/MAO.0b013e318241b6d3
   Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108
   Grimmer JF, 2007, INT J PEDIATR OTORHI, V71, P275, DOI 10.1016/j.ijporl.2006.10.010
   Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004
   Harlor Allen D Buz Jr, 2009, Pediatrics, V124, P1252, DOI 10.1542/peds.2009-1997
   Hart CK, 2013, LARYNGOSCOPE, V123, P809, DOI 10.1002/lary.23425
   Holden-Pitt L, 1998, AM ANN DEAF, V143, P72
   Jagger DJ, 2015, CELL TISSUE RES, V360, P633, DOI 10.1007/s00441-014-2029-z
   James SH, 2015, CLIN PERINATOL, V42, P47, DOI 10.1016/j.clp.2014.10.005
   Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198
   Kasic JF, 2001, OTOLARYNG CLIN N AM, V34, P501, DOI 10.1016/S0030-6665(05)70345-5
   Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091
   Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kim BG, 2016, LARYNGOSCOPE, V126, pE286, DOI 10.1002/lary.25786
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kiringoda R, 2013, OTOL NEUROTOL, V34, P790, DOI 10.1097/MAO.0b013e318291c651
   Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049
   Kochhar A, 2007, GENET MED, V9, P393, DOI 10.1097/GIM.0b013e3180980bd0
   Koenighofer M, 2015, WIEN KLIN WOCHENSCHR, V127, P440, DOI 10.1007/s00508-014-0653-y
   Korver AMH, 2011, LARYNGOSCOPE, V121, P409, DOI 10.1002/lary.21377
   Korver AMH, 2010, JAMA-J AM MED ASSOC, V304, P1701, DOI 10.1001/jama.2010.1501
   Lammens F, 2013, INT J PEDIATR OTORHI, V77, P1385, DOI 10.1016/j.ijporl.2013.06.002
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Liesbeth R, 2011, INT J PEDIATR OTORHI, V75, P376, DOI 10.1016/j.ijporl.2010.12.008
   Lin HC, 2007, OTOL NEUROTOL, V28, P788, DOI 10.1097/MAO.0b013e3180cab754
   Luers JC, 2013, OTOL NEUROTOL, V34, P1005, DOI 10.1097/MAO.0b013e3182990d2b
   LUSTIG LR, 1994, HEARING RES, V74, P29, DOI 10.1016/0378-5955(94)90173-2
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046
   MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504
   Mathers C, 2000, GLOBAL BURDEN HEARIN
   McCall AA, 2010, EAR HEARING, V31, P156, DOI 10.1097/AUD.0b013e3181c351f2
   McCormack A, 2013, INT J AUDIOL, V52, P360, DOI 10.3109/14992027.2013.769066
   McCreery RW, 2012, AM J AUDIOL, V21, P269, DOI 10.1044/1059-0889(2012/12-0013)
   McLeod R, 2006, CLIN INFECT DIS, V42, P1383, DOI 10.1086/501360
   MILLER E, 1982, LANCET, V2, P781
   Miyagawa M, 2016, OTOL NEUROTOL, V37, pE126, DOI 10.1097/MAO.0000000000000936
   MOORE BCJ, 1991, EAR HEARING, V12, pS154, DOI 10.1097/00003446-199112001-00009
   Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700
   Mueller H., 1998, AUDIOLOGISTS DESK RE
   Mukherjea D, 2015, EXPERT OPIN INV DRUG, V24, P201, DOI 10.1517/13543784.2015.960076
   Nagasawa K, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3333
   Nakagawa T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00206
   National Institute on Deafness and Other Communication Disorders, CHARTS TABL HEAR STA
   Naz S, 2004, J MED GENET, V41, P591, DOI 10.1136/jmg.2004.018523
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nicolas S, 2013, OTOL NEUROTOL, V34, P111, DOI 10.1097/MAO.0b013e31827a2020
   Nikolopoulos TP, 2014, INT J PEDIATR OTORHI, V78, P171, DOI 10.1016/j.ijporl.2013.12.021
   Nikolopoulos TP, 2006, OTOL NEUROTOL, V27, pS1, DOI 10.1097/01.mao.0000185150.69704.18
   Niparko JK, 2003, OTOL NEUROTOL, V24, P73, DOI 10.1097/00129492-200301000-00015
   Nittrouer S, 2016, OTOL NEUROTOL, V37, pE43, DOI 10.1097/MAO.0000000000000906
   Norton SJ, 2000, EAR HEARING, V21, P508, DOI 10.1097/00003446-200010000-00013
   Oz HS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00385
   Park AH, 2014, LARYNGOSCOPE, V124, P2624, DOI 10.1002/lary.24752
   Pessoa L., 2011, BMJ CASE REP, V2011
   Phillips JS, 2014, OTOL NEUROTOL, V35, P1011, DOI 10.1097/MAO.0000000000000361
   Pimperton H, 2016, ARCH DIS CHILD, V101, P9, DOI 10.1136/archdischild-2014-307516
   Rance G, 2002, ANN OTO RHINOL LARYN, V111, P22
   Rapin I, 2006, J AM ACAD AUDIOL, V17, P147, DOI 10.3766/jaaa.17.2.7
   Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022
   Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426
   Rohlfs AK, 2010, EUR J PEDIATR, V169, P1353, DOI 10.1007/s00431-010-1228-1
   Roland JT, 2016, LARYNGOSCOPE, V126, P175, DOI 10.1002/lary.25451
   Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903
   Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Salviz M, 2013, OTOL NEUROTOL, V34, P1165, DOI 10.1097/MAO.0b013e31828297b6
   Schachtele S. J., J NEUROVIROL, V17
   Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801
   Schleiss MR, 2013, FUTURE VIROL, V8, P1161, DOI 10.2217/fvl.13.106
   SCHLEISS MR, 2006, DRUG DISCOV TODAY DI, V3, P105
   Schraders M, 2012, AM J HUM GENET, V91, P883, DOI 10.1016/j.ajhg.2012.09.012
   Schraff SA, 2007, OTOLARYNG HEAD NECK, V137, P612, DOI 10.1016/j.otohns.2007.03.044
   Schwager K., 2007, GMS CURR TOP OTORHIN, V6
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Shearer AE, 2014, GENOME MED, V6, DOI 10.1186/gm554
   Shibata SB, 2010, J COMMUN DISORD, V43, P295, DOI 10.1016/j.jcomdis.2010.04.001
   Sidell D, 2016, INT J PEDIATR OTORHI, V84, P132, DOI 10.1016/j.ijporl.2016.03.002
   Sloan-Heggen CM, 2016, HUM GENET, V135, P441, DOI 10.1007/s00439-016-1648-8
   Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3
   Snik AFM, 2005, ANN OTO RHINOL LARYN, V114, P2
   Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996
   Soderberg-Naucler C, 2014, EXPERT REV ANTI-INFE, V12, P211, DOI 10.1586/14787210.2014.870472
   Spivak L, 2009, AM J AUDIOL, V18, P24, DOI 10.1044/1059-0889(2008/08-0015)
   Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741
   STEPHENS D, 2001, DEFINITIONS PROTOCOL, P9
   Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919
   Swanepoel D, 2009, EUR ARCH OTO-RHINO-L, V266, P213, DOI 10.1007/s00405-008-0738-1
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Taylor KR, 2013, HUM MUTAT, V34, P539, DOI 10.1002/humu.22268
   Thiebaut R, 2007, LANCET, V369, P115
   Tjellstrom A, 2001, OTOLARYNG CLIN N AM, V34, P337, DOI 10.1016/S0030-6665(05)70335-2
   Usami S, 2012, ACTA OTO-LARYNGOL, V132, P377, DOI 10.3109/00016489.2011.649493
   van Dommelen P, 2010, ACTA PAEDIATR, V99, P344, DOI 10.1111/j.1651-2227.2009.01614.x
   van Dommelen Paula, 2015, J Pediatr, V166, P840, DOI 10.1016/j.jpeds.2014.12.041
   Van Kerschaver E, 2013, EUR J PUBLIC HEALTH, V23, P55, DOI 10.1093/eurpub/cks010
   Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003
   Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI 10.1097/QCO.0000000000000066
   Wan GQ, 2013, SEMIN CELL DEV BIOL, V24, P448, DOI 10.1016/j.semcdb.2013.03.009
   Watkin P, 2012, INT J AUDIOL, V51, P519, DOI 10.3109/14992027.2012.673237
   Webster WS, 1998, TERATOLOGY, V58, P13
   Werner M, 2015, HEARING RES, V321, P1, DOI 10.1016/j.heares.2014.12.011
   Westerberg BD, 2008, INT J PEDIATR OTORHI, V72, P931, DOI 10.1016/j.ijporl.2008.03.001
   Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8
   Wright R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e9
   Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751
   Xu Jingjing, 2014, Korean J Audiol, V18, P97, DOI 10.7874/kja.2014.18.3.97
   Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640
   Yariz KO, 2012, AM J HUM GENET, V91, P872, DOI 10.1016/j.ajhg.2012.09.011
   Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161
   Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009
   Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605
   Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108
   Zong L, 2015, J MED GENET, V52, P523, DOI 10.1136/jmedgenet-2014-102961
NR 165
TC 50
Z9 51
U1 1
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2056-676X
J9 NAT REV DIS PRIMERS
JI Nat. Rev. Dis. Primers
PD JAN 12
PY 2017
VL 3
AR 16094
DI 10.1038/nrdp.2016.94
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA EQ2IB
UT WOS:000397891100001
PM 28079113
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Gokhale, NS
   Horner, SM
AF Gokhale, Nandan S.
   Horner, Stacy M.
TI Knotty Zika Virus Blocks Exonuclease to Produce Subgenomic Flaviviral
   RNAs
SO CELL HOST & MICROBE
LA English
DT Editorial Material
AB In a recent issue of Science, Akiyama et al. (2016) prove the existence of a pseudoknot that stabilizes a nuclease-resistant RNA structure in the 3' untranslated region of Zika virus. This reinforced structure blocks the 5'-> 3' exonuclease Xrn1 for the production of pathogenic subgenomic flaviviral RNAs.
C1 [Gokhale, Nandan S.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
RP Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
EM stacy.horner@duke.edu
OI Gokhale, Nandan/0000-0002-4459-4053
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI125416]
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Da Silva Filipe A., 2016, PLOS NEGLECT TROP D, V10
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
NR 11
TC 3
Z9 3
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JAN 11
PY 2017
VL 21
IS 1
BP 1
EP 2
DI 10.1016/j.chom.2016.12.013
PG 2
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EI9QN
UT WOS:000392843900001
PM 28081439
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Tschoeke, DA
   de Oliveira, LS
   Leomil, L
   Tanuri, A
   Thompson, FL
AF Tschoeke, Diogo Antonio
   de Oliveira, Louisi Souza
   Leomil, Luciana
   Tanuri, Amilcar
   Thompson, Fabiano Lopes
TI Pregnant women carrying microcephaly foetuses and Zika virus contain
   potentially pathogenic microbes and parasites in their amniotic fluid
SO BMC MEDICAL GENOMICS
LA English
DT Article
DE Zika Virus; Metatranscriptomics; Microbiome; Microchepaly
ID PRETERM INFANTS; SPARGANOSIS; DIVERSITY; DISEASE
AB Background: Microcephaly has become a major public health problem in Brazil. The total number of newborns with microcephaly was reported to be >4000 in June 2016. Studies suggest that Zika Virus is a major cause of new microcephaly cases in Brazil. Inside the uterus, the foetus is surrounded by the Amniotic Fluid, a proximal fluid that contains foetal and maternal cells as well as microorganisms and where Zika Virus was already found.
   Case presentation: A previous study reported the presence of the Zika Virus in the amniotic fluid (collected in the 28th gestational week) of two pregnant women carrying microcephaly foetuses in Brazil. The virus was detected by means of real-time PCR and metatranscriptomic analysis. We compared the microbiome of these two cases with metatranscriptomic sequences from 16 pregnant women collected at various times in their pregnancies
   Conclusion: Several strains of bacteria (e.g., Streptococcus and Propionibacterium) found in Amniotic Fluid may be involved in neurological diseases. When the foetus is infected by the Zika Virus, due to neurological damage, they do not move inside the uterus, thus changing the Amniotic Fluid environment, potentially leading to secondary problems. Zika infection could also lead to an immunodeficient state, making bacterial colonization of the foetuses easier. An altered microbial composition during pregnancy may also result in harmful secondary metabolite production from certain microbes that further impair foetal brain development. However, these observations of potentially harmful microbial species are correlations and thus cannot be assumed to be causative agents of (microcephaly) disease. In our study, microbial and parasitic diversity of the Amniotic Fluid was lower in patients infected by ZIKV, compared to that of Prenatal and Preterm controls. The present study was a first attempt to shed light on the microbial and parasitic diversity associated with ZIKV-infected pregnant women bearing microcephaly foetuses, and the presence of diverse microbial and parasite communities in the Amniotic Fluid suggests a poor health status of both the pregnant women and the foetuses they carry.
C1 [Tschoeke, Diogo Antonio; de Oliveira, Louisi Souza; Leomil, Luciana; Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, Inst Biol, CCS, Lab Microbiol,Ilha Fundao, Anexo Ao Bloco A, BR-21941902 Rio De Janeiro, Brazil.
   [Tschoeke, Diogo Antonio; Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestao Tecnol CT2, Rio de Janeiro, RJ, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, CCS, Lab Virol Mol,Ilha Fundao, Bloco A, Rio De Janeiro, RJ, Brazil.
   [Tschoeke, Diogo Antonio] Univ Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Macae, RJ, Brazil.
RP Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, CCS, Lab Microbiol,Ilha Fundao, Anexo Ao Bloco A, BR-21941902 Rio De Janeiro, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestao Tecnol CT2, Rio de Janeiro, RJ, Brazil.
EM fabianothompson1@gmail.com
RI Tschoeke, Diogo A/F-9913-2019; Leomil, Luciana/O-4860-2019
OI Tschoeke, Diogo A/0000-0001-8134-4259; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX These work was done using fundings from CNPq, CAPES, and FAPERJ.
CR Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217
   Bennett HM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0510-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001
   DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056
   Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116
   Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111
   Kamath-Rayne BD, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0138-5
   Liu Q, 2015, LANCET INFECT DIS, V15, P1226, DOI 10.1016/S1473-3099(15)00133-4
   Oksanen, 2005, VEGAN R FUNCTIONS VE
   Payne MS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00595
   Romano-Keeler J, 2015, PEDIATR RES, V77, P189, DOI 10.1038/pr.2014.163
   Saxena D, 2012, CURR HIV-AIDS REP, V9, P44, DOI 10.1007/s11904-011-0103-7
   Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
   Zhou Xia, 2010, Infect Dis Obstet Gynecol, V2010, P737425, DOI 10.1155/2010/737425
NR 22
TC 3
Z9 3
U1 0
U2 31
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1755-8794
J9 BMC MED GENOMICS
JI BMC Med. Genomics
PD JAN 11
PY 2017
VL 10
AR 5
DI 10.1186/s12920-016-0242-1
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA EI4EU
UT WOS:000392446700001
PM 28077143
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ngono, AE
   Vizcarra, EA
   Tang, WW
   Sheets, N
   Joo, Y
   Kim, K
   Gorman, MJ
   Diamond, MS
   Shresta, S
AF Ngono, Annie Elong
   Vizcarra, Edward A.
   Tang, William W.
   Sheets, Nicholas
   Joo, Yunichel
   Kim, Kenneth
   Gorman, Matthew J.
   Diamond, Michael S.
   Shresta, Sujan
TI Mapping and Role of the CD8(+) T Cell Response During Primary Zika Virus
   Infection in Mice
SO CELL HOST & MICROBE
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; SEXUAL TRANSMISSION; PROTECTIVE ROLE;
   WESTERN-HEMISPHERE; MOUSE MODELS; DISEASE; PATHOGENESIS; REPLICATION;
   INTERFERON; ANTIBODIES
AB CD8(+) T cells may play a dual role in protection against and pathogenesis of flaviviruses, including Zika virus (ZIKV). We evaluated the CD8(+) T cell response in ZIKV-infected LysMCre(+)IFNAR(fl/fl) C57BL/6 (H-2(b)) mice lacking the type I interferon receptor in a subset ofmyeloid cells. In total, 26 and 15CD8(+) T cell-reactive peptides for ZIKV African (MR766) and Asian (FSS13025) lineage strains, respectively, were identified and validated. CD8(+) T cells from infected mice were polyfunctional and mediated cytotoxicity. Adoptive transfer of ZIKV-immune CD8(+) T cells reduced viral burdens, whereas their depletion led to higher tissue burdens, and CD8(-/-) mice displayed highermortality with ZIKV infection. Collectively, these results demonstrate that CD8(+) T cells protect against ZIKV infection. Further, this study provides a T cell competent mouse model for investigating ZIKV-specific T cell responses.
C1 [Ngono, Annie Elong; Vizcarra, Edward A.; Tang, William W.; Sheets, Nicholas; Joo, Yunichel; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Med Mol Microbiol Pathol & Immunol, St Louis, MO 63110 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM sujan@lji.org
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIAID/NIH grants [R01 AI116813, R01 AI073755, R01 AI104972]; La Jolla
   Institute for Allergy and Immunology
FX We thank Jason Greenbaum and Sumetha Kannan for bioinformatics analyses,
   and Matthew Young and Anila Mamidi for technical assistance with FFAs
   and breeding/maintaining mice. This research was funded by NIAID/NIH
   grants (R01 AI116813 to S.S., and R01 AI073755 and R01 AI104972 to
   M.S.D.) and the La Jolla Institute for Allergy and Immunology
   institutional support. M.S.D. is a consultant for Inbios and Visterra,
   and is on the Scientific Advisory Boards of Moderna and OraGene.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lopez CB, 2006, J VIROL, V80, P4538, DOI 10.1128/JVI.80.9.4538-4545.2006
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Oehler E., 2013, EURO SURVEILL, V19
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08
   Tang W. W., 2016, CELL REP, V166, P1247
   Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
NR 64
TC 111
Z9 113
U1 2
U2 31
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JAN 11
PY 2017
VL 21
IS 1
BP 35
EP 46
DI 10.1016/j.chom.2016.12.010
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EI9QN
UT WOS:000392843900007
PM 28081442
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Froeschl, G
   Huber, K
   von Sonnenburg, F
   Nothdurft, HD
   Bretzel, G
   Hoelscher, M
   Zoeller, L
   Trottmann, M
   Pan-Montojo, F
   Dobler, G
   Woelfel, S
AF Froeschl, Guenter
   Huber, Kristina
   von Sonnenburg, Frank
   Nothdurft, Hans-Dieter
   Bretzel, Gisela
   Hoelscher, Michael
   Zoeller, Lothar
   Trottmann, Matthias
   Pan-Montojo, Francisco
   Dobler, Gerhard
   Woelfel, Silke
TI Long-term kinetics of Zika virus RNA and antibodies in body fluids of a
   vasectomized traveller returning from Martinique: a case report
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Whole blood; Ejaculate; Vasectomy; Cell culture; Phylogeny;
   Case report
ID WHOLE-BLOOD; TRANSMISSION
AB Background: The magnitude of the current Zika virus (ZIKV) epidemic has led to a declaration of a Public Health Emergency of International Concern by the WHO. Findings of viable viral particles in semen for several weeks are corroborating reports of sexual transmission of ZIKV. Serious consequences of a positive diagnostic result particularly in the pregnant patient are calling for precise diagnostic tools also at later time points after infection. Currently, recommendations suggest a diagnostic period of direct viral detection of 5 to 7 days after onset of symptoms in serum or plasma, and up to 3 weeks in urine samples.
   Case presentation: A vasectomized 41-year-old German returning from Martinique presented at the outpatient clinic of the Department for Infectious Diseases and Tropical Medicine, Munich, with subfebrile temperature, rash, malaise, severe retro-orbital pain and occipital lymphadenopathy. The main complaints resolved after ten days without specific treatment. We are reporting on clinical course and results of direct and indirect detection methods of ZIKV in different sample types including whole blood, ejaculate, urine, serum, plasma and saliva samples up to 119 days post symptom onset. Ejaculate samples remained PCR positive for ZIKV until day 77, whole blood samples until day 101.
   Conclusions: The case presentation adds to the still limited knowledge of kinetics of detection of ZIKV by direct as well as indirect methods. Here, a complete data set including results from PCR, serology and cell culture is provided allowing an improved evaluation of optimum diagnostic periods for testing a variety of sample types. Moreover, a high viral load of ZIKV RNA was detected in ejaculate of the vasectomized patient. This finding sheds new light on the possible localizations of ZIKV replication in the human male reproductive tract.
C1 [Froeschl, Guenter; Huber, Kristina; von Sonnenburg, Frank; Nothdurft, Hans-Dieter; Bretzel, Gisela; Hoelscher, Michael] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Leopoldstr 5, D-80802 Munich, Germany.
   [Froeschl, Guenter; Hoelscher, Michael; Zoeller, Lothar; Dobler, Gerhard; Woelfel, Silke] German Ctr Infect Res DZIF, Partner Site Munich, D-80802 Munich, Germany.
   [Zoeller, Lothar; Dobler, Gerhard; Woelfel, Silke] Bundeswehr Inst Microbiol BwIM, Neuherbergstr 11, D-80937 Munich, Germany.
   [Trottmann, Matthias] Univ Munich LMU, Med Ctr, Dept Urol, Marchioninistr 15, D-81377 Munich, Germany.
   [Pan-Montojo, Francisco] Univ Munich LMU, Med Ctr, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.
RP Froeschl, G (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Leopoldstr 5, D-80802 Munich, Germany.; Froeschl, G (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, D-80802 Munich, Germany.
EM froeschl@lrz.uni-muenchen.de
RI Hoelscher, Michael/D-3436-2012; Pan-Montojo, Francisco/Q-2928-2017
OI Pan-Montojo, Francisco/0000-0002-1647-5196
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kasper DL, 2010, HARRISONS INFECT DIS
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   World Health Organisation WHO, 2010, LAB MAN EX PROC HUM
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, LAB TEST ZIK VIR INF
NR 21
TC 42
Z9 43
U1 1
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 10
PY 2017
VL 17
AR 55
DI 10.1186/s12879-016-2123-9
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EP4IV
UT WOS:000397345100006
PM 28068904
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Meertens, L
   Labeau, A
   Dejarnac, O
   Cipriani, S
   Sinigaglia, L
   Bonnet-Madin, L
   Le Charpentier, T
   Hafirassou, ML
   Zamborlini, A
   Cao-Lormeau, VM
   Coulpier, M
   Misse, D
   Jouvenet, N
   Tabibiazar, R
   Gressens, P
   Schwartz, O
   Amara, A
AF Meertens, Laurent
   Labeau, Athena
   Dejarnac, Ophelie
   Cipriani, Sara
   Sinigaglia, Laura
   Bonnet-Madin, Lucie
   Le Charpentier, Tifenn
   Hafirassou, Mohamed Lamine
   Zamborlini, Alessia
   Cao-Lormeau, Van-Mai
   Coulpier, Muriel
   Misse, Dorothee
   Jouvenet, Nolwenn
   Tabibiazar, Ray
   Gressens, Pierre
   Schwartz, Olivier
   Amara, Ali
TI Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate
   Immune Responses
SO CELL REPORTS
LA English
DT Article
ID TAM RECEPTORS; INFECTION; BRAIN; MICE; NEUROGENESIS; ACTIVATION;
   INHIBITORS; CORTEX; DAMAGE
AB ZIKA virus (ZIKV) is an emerging pathogen responsible for neurological disorders and congenital microcephaly. However, the molecular basis for ZIKV neurotropism remains poorly understood. Here, we show that Axl is expressed in human microglia and astrocytes in the developing brain and that itmediates ZIKV infection of glial cells. Axl-mediated ZIKV entry requires the Axl ligand Gas6, which bridges ZIKV particles to glial cells. Following binding, ZIKV is internalized through clathrin-mediated endocytosis and traffics to Rab5+ endosomes to establish productive infection. During entry, the ZIKV/Gas6 complex activates Axl kinase activity, which downmodulates interferon signaling and facilitates infection. ZIKV infection of human glial cells is inhibited by MYD1, an engineered Axl decoy receptor, and by the Axl kinase inhibitor R428. Our results highlight the dual role of Axl during ZIKV infection of glial cells: promoting viral entry and modulating innate immune responses. Therefore, inhibiting Axl function may represent a potential target for future antiviral therapies.
C1 [Meertens, Laurent; Labeau, Athena; Dejarnac, Ophelie; Bonnet-Madin, Lucie; Hafirassou, Mohamed Lamine; Zamborlini, Alessia; Amara, Ali] Hop St Louis, CNRS 7212, Lab Pathol & Virol Mol, INSERM U944, 1 Ave Claude Vellefaux, F-75010 Paris, France.
   [Meertens, Laurent; Labeau, Athena; Dejarnac, Ophelie; Bonnet-Madin, Lucie; Hafirassou, Mohamed Lamine; Zamborlini, Alessia; Amara, Ali] Hop St Louis, Inst Univ Hematol, 1 Ave Claude Vellefaux, F-75010 Paris, France.
   [Meertens, Laurent; Labeau, Athena; Dejarnac, Ophelie; Bonnet-Madin, Lucie; Hafirassou, Mohamed Lamine; Zamborlini, Alessia; Amara, Ali] Univ Paris Diderot, Hop St Louis, Sorbonne Paris Cite, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.
   [Cipriani, Sara; Le Charpentier, Tifenn; Gressens, Pierre] Univ Paris Diderot, INSERM, Sorbonne Paris Cite, PROTECT, F-75019 Paris, France.
   [Sinigaglia, Laura; Jouvenet, Nolwenn] Inst Pasteur, Viral Genom & Vaccinat Unit, UMR CNRS 3569, F-75724 Paris, France.
   [Zamborlini, Alessia] Conservatoire Arts & Metiers, Lab PVM, 292 Rue St Martin, F-75003 Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Coulpier, Muriel] Univ Paris Est, ANSES, Ecole Natl Vet Alfort, UMR Virol, F-94700 Maisons Alfort, France.
   [Misse, Dorothee] CNRS, UMR IRD 224, Lab MIVEGEC, F-34394 Montpellier, France.
   [Tabibiazar, Ray] Ruga Corp, Houston Ctr 2, 909 Fannin St,2000, Houston, TX 77010 USA.
   [Schwartz, Olivier] Inst Pasteur, Unite Virus & Immunite, 28 Rue Dr Roux, F-75724 Paris, France.
RP Meertens, L; Amara, A (corresponding author), Hop St Louis, CNRS 7212, Lab Pathol & Virol Mol, INSERM U944, 1 Ave Claude Vellefaux, F-75010 Paris, France.; Meertens, L; Amara, A (corresponding author), Hop St Louis, Inst Univ Hematol, 1 Ave Claude Vellefaux, F-75010 Paris, France.; Meertens, L; Amara, A (corresponding author), Univ Paris Diderot, Hop St Louis, Sorbonne Paris Cite, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.
EM laurent.meertens@inserm.fr; ali.amara@inserm.fr
RI jouvenet, nolwenn/K-2067-2019; gressens, pierre/M-7557-2017; Meertens,
   Laurent/E-8043-2017; Cao-Lormeau, Van-Mai/H-4879-2018; Amara,
   Ali/E-8803-2017
OI jouvenet, nolwenn/0000-0001-6103-6048; gressens,
   pierre/0000-0002-0909-4221; Meertens, Laurent/0000-0003-2811-3675;
   Cao-Lormeau, Van-Mai/0000-0001-5606-7480; zamborlini,
   alessia/0000-0002-8902-1996; SCHWARTZ, OLIVIER/0000-0002-0729-1475;
   AMARA, Ali/0000-0002-0283-1815
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI101400]; European Union Horizon
   Research and Innovation Programme under ZIKAlliance Grant [734548];
   Labex Integrative Biology of Emerging Infectious Diseases; French
   National Research Agency "Investissements d'Avenir'' ProgramFrench
   National Research Agency (ANR) [ANR-10-IHUB-0002, CE14-0029]
FX This works was supported by NIH Grant R01 AI101400), the European Union
   Horizon 2020 Research and Innovation Programme under ZIKAlliance Grant
   Agreement 734548, Labex Integrative Biology of Emerging Infectious
   Diseases, and the French National Research Agency "Investissements
   d'Avenir'' Program ANR-10-IHUB-0002 and CE14-0029 Grant TIMTAMDEN]. The
   authors thank Greg Lemke and Erin Lew (Salk Institute) for providing the
   purified recombinant Gas6. We are most grateful to Dr. C. Montero-Menei
   for providing hNPCs. We thank Stephane Dallongeville (Institut Pasteur)
   for the help with ICY image analysis.
CR Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266
   Fernandez-Fernandez L, 2008, THROMB HAEMOSTASIS, V100, P604, DOI 10.1160/TH08-04-0253
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Ji R, 2015, METAB BRAIN DIS, V30, P633, DOI 10.1007/s11011-014-9636-y
   Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229
   Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Osso LA, 2015, CELL, V163, P1574, DOI 10.1016/j.cell.2015.12.001
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Retallack H., 2016, BIORXIV, DOI [10.1101/058883, DOI 10.1101/058883]
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schmid ET, 2016, ELIFE, V5, DOI 10.7554/eLife.12414
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 44
TC 156
Z9 157
U1 3
U2 36
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JAN 10
PY 2017
VL 18
IS 2
BP 324
EP 333
DI 10.1016/j.celrep.2016.12.045
PG 10
WC Cell Biology
SC Cell Biology
GA EO1OQ
UT WOS:000396468200004
PM 28076778
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, HJ
   Liu, SQ
   Zhang, B
   Wei, WQ
AF Wang, Hongju
   Liu, Siqing
   Zhang, Bo
   Wei, Wenqiang
TI Analysis of Synonymous Codon Usage Bias of Zika Virus and Its Adaption
   to the Hosts (vol 11, e0166260, 2016)
SO PLOS ONE
LA English
DT Correction
CR Wang HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166260
NR 1
TC 1
Z9 3
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 9
PY 2017
VL 12
IS 1
AR e0170128
DI 10.1371/journal.pone.0170128
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH5WO
UT WOS:000391843900086
PM 28068395
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, ZW
   Li, ZL
   Yuan, S
AF Zhang, Zhong-Wei
   Li, Zi-Lin
   Yuan, Shu
TI The Role of Secretory Autophagy in Zika Virus Transfer through the
   Placental Barrier
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE Zika virus; microcephaly; secretory autophagy; exosome; placental
   barrier
ID MYCOBACTERIUM-TUBERCULOSIS; CELLS; INFECTION; IDENTIFICATION;
   MACROPHAGES; VACUOLES; EXOSOMES; REVEALS; MICE
AB Recent studies indicated that the Zika virus genome could be detected in the amniotic fluid and the fetal brain, which confirms that the virus can cross the placental barrier. Secretory autophagy or exosome pathways may participate in this virus transfer. Autophagy modulators regulate autophagosome formation or membrane fusion with lysosomal vesicles and therefore inhibit viral nucleocapsid releasing or virus transfer to the fetus hypothetically. However, some autophagy modulators may enhance virus replication. Autophagy inhibitors may arrest placental development; while exaggeration of autophagy in human placenta may be associated with the fetal growth restriction. Therefore, autophagy modulators should be used carefully due to their complex clinical effects. Alternatively, exosome-specific inhibitors might be also considered, although their safety of both maternal and fetal conditions must be carefully assessed before any advancement to human clinical trials.
C1 [Zhang, Zhong-Wei; Yuan, Shu] Sichuan Agr Univ, Coll Resources, Chengdu, Peoples R China.
   [Li, Zi-Lin] Gen Hosp Lanzhou Mil Reg, Lanzhou, Peoples R China.
RP Yuan, S (corresponding author), Sichuan Agr Univ, Coll Resources, Chengdu, Peoples R China.
EM roundtree318@hotmail.com
FU Preeminent Youth Fund of Sichuan Province [2015JQO045]
FX This work was funded by the Preeminent Youth Fund of Sichuan Province
   (2015JQO045).
CR Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Brojeni PY, 2012, REPROD TOXICOL, V33, P265, DOI 10.1016/j.reprotox.2011.11.003
   Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   Chifenti Barbara, 2013, Clin Exp Reprod Med, V40, P33, DOI 10.5653/cerm.2013.40.1.33
   Curtis S, 2013, J MATERN-FETAL NEO M, V26, P339, DOI 10.3109/14767058.2012.733764
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   [董悦生 Dong Yuesheng], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1514
   Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fedson DS, 2013, ANTIVIR RES, V99, P417, DOI 10.1016/j.antiviral.2013.06.018
   Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x
   Gong Jin-Sung, 2014, Clin Exp Reprod Med, V41, P97, DOI 10.5653/cerm.2014.41.3.97
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550
   Paula LADE, 2008, MOL REPROD DEV, V75, P1063, DOI 10.1002/mrd.20841
   Pirooz S, 2014, AUTOPHAGY, V10, P1355, DOI 10.4161/auto.29075
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/revreprod/4.2.81
   Schiebler M, 2015, EMBO MOL MED, V7, P127, DOI 10.15252/emmm.201404137
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5
NR 42
TC 34
Z9 35
U1 0
U2 43
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JAN 9
PY 2017
VL 6
AR 206
DI 10.3389/fcimb.2016.00206
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EG9RP
UT WOS:000391397500002
PM 28119857
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kodati, S
   Palmore, TN
   Spellman, FA
   Cunningham, D
   Weistrop, B
   Sen, HN
AF Kodati, Shilpa
   Palmore, Tara N.
   Spellman, Frank A.
   Cunningham, Denise
   Weistrop, Benjamin
   Sen, H. Nida
TI Bilateral posterior uveitis associated with Zika virus infection
SO LANCET
LA English
DT Editorial Material
C1 [Kodati, Shilpa; Cunningham, Denise; Sen, H. Nida] NEI, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA.
   [Palmore, Tara N.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Spellman, Frank A.] NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Spellman, Frank A.] Retina Grp Washington, Washington, DC USA.
   [Weistrop, Benjamin] New York Med Coll, Valhalla, NY 10595 USA.
RP Sen, HN (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.
EM senh@nei.nih.gov
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
NR 5
TC 32
Z9 33
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 7
PY 2017
VL 389
IS 10064
BP 125
EP 126
DI 10.1016/S0140-6736(16)32518-1
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG7VH
UT WOS:000391264000044
PM 27939402
OA Bronze
DA 2020-07-08
ER

PT J
AU Oussayef, NL
   Pillai, SK
   Honein, MA
   Ben Beard, C
   Bell, B
   Boyle, CA
   Eisen, LM
   Kohl, K
   Kuehnert, MJ
   Lathrop, E
   Martin, SW
   Martin, R
   McAllister, JC
   McClune, EP
   Mead, P
   Meaney-Delman, D
   Petersen, B
   Petersen, LR
   Polen, KND
   Powers, AM
   Redd, SC
   Sejvar, JJ
   Sharp, T
   Villanueva, J
   Jamieson, DJ
AF Oussayef, Nadia L.
   Pillai, Satish K.
   Honein, Margaret A.
   Ben Beard, C.
   Bell, Beth
   Boyle, Coleen A.
   Eisen, Lars M.
   Kohl, Katrin
   Kuehnert, Matthew J.
   Lathrop, Eva
   Martin, Stacey W.
   Martin, Rebecca
   McAllister, Janet C.
   McClune, Elizabeth Pantino
   Mead, Paul
   Meaney-Delman, Dana
   Petersen, Brett
   Petersen, Lyle R.
   Polen, Kara N. D.
   Powers, Ann M.
   Redd, Stephen C.
   Sejvar, James J.
   Sharp, Tyler
   Villanueva, Julie
   Jamieson, Denise J.
TI Zika Virus-10 Public Health Achievements in 2016 and Future Priorities
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; MALE SEXUAL TRANSMISSION;
   GUILLAIN-BARRE-SYNDROME; UNITED-STATES; PUERTO-RICO; PREGNANT-WOMEN;
   REPRODUCTIVE AGE; INFECTION; PREVENTION; GUIDELINES
C1 [Oussayef, Nadia L.; Pillai, Satish K.; Honein, Margaret A.; Ben Beard, C.; Bell, Beth; Boyle, Coleen A.; Eisen, Lars M.; Kohl, Katrin; Kuehnert, Matthew J.; Lathrop, Eva; Martin, Stacey W.; Martin, Rebecca; McAllister, Janet C.; McClune, Elizabeth Pantino; Mead, Paul; Meaney-Delman, Dana; Petersen, Brett; Petersen, Lyle R.; Polen, Kara N. D.; Powers, Ann M.; Redd, Stephen C.; Sejvar, James J.; Sharp, Tyler; Villanueva, Julie; Jamieson, Denise J.] CDC, Atlanta, GA 30333 USA.
RP Pillai, SK (corresponding author), CDC, Atlanta, GA 30333 USA.
EM eocevent236@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR [Anonymous], 2016, REV REC RED RISK ZIK
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, CDC UPD GUID TRAV TE
   CDC, 2016, GUID US LAB TEST ZIK
   CDC, 2016, ZIK VIR CAS COUNTS U
   CDC, 2016, CDC UPD GUID PREGN W
   CDC, 2016, CDC GUID TRAV TEST P
   CDC, 2016, CDC EXP GUID TRAV TE
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Food and Drug Administration, 2016, FDA ALL US INV TEST
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2016, JAMA PEDIAT
   Honein MA, 2016, NEW ENGL J MED, V375, P2393, DOI 10.1056/NEJMe1613368
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 40
TC 14
Z9 15
U1 0
U2 9
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 6
PY 2017
VL 65
IS 52
BP 1482
EP 1488
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EH6UF
UT WOS:000391908700006
PM 28056005
OA Bronze
DA 2020-07-08
ER

PT J
AU Oviedo-Pastrana, M
   Mendez, N
   Mattar, S
   Arrieta, G
   Gomezcaceres, L
AF Oviedo-Pastrana, Misael
   Mendez, Nelson
   Mattar, Salim
   Arrieta, German
   Gomezcaceres, Luty
TI Epidemic outbreak of Chikungunya in two neighboring towns in the
   Colombian Caribbean: a survival analysis
SO ARCHIVES OF PUBLIC HEALTH
LA English
DT Article
DE Kaplan meier estimate; Environment and public health; Comparative study;
   Infectious disease vector; Health economics; Culicidae; Risk management;
   Demography
ID VIRUS; ARTHRALGIA
AB Background: The first autochthonous Chikungunya virus transmission in Colombia was reported in September 2014. Three months later, every town in the Caribbean region was affected, including the bordering towns of Ovejas and Corozal, in the department of Sucre. The objective of the study was to analyze and compare the temporal dynamics of the outbreak of Chikungunya in two towns of the department of Sucre.
   Methods: Households with suspicious cases with clinical symptomatology for Chikungunya were enrolled. In each house an epidemiological questionnaire was applied to collect economic and social information and methods for vector control.
   Results: The study analyzed data collected between 09/01/2014 and 01/31/2015; 458 families in Corozal and 516 families in Ovejas were identified with Chikungunya cases. Estimated attack rates were 10,621 cases and 1640 cases per 100,000 inhabitants, in Ovejas and Corozal, respectively. The 75-day survival curve was 27.2% lower (0.632, CI = 0.614-0.651) in Ovejas than in Corozal (0.904, CI = 0.891-0.917). After 120 days, both curves showed a stable horizontal slope, close to a survival probability of 0.54, indicating the end of the epidemic period. The log-rank test (X-2 = 94.6, 1fd, p-value = 0.000) showed the improved survival of Chikungunya in the town of Corozal. The relative risk between the two towns was 0.863 (CI = 0.809-0.921; p-value < 0.001).
   Conclusions: The dynamics of the temporal distribution of CHIKV could be influenced by socioeconomic and preventable risk factors. Poor socioeconomic conditions such as the lack and poor efficiency of water supply and waste collection services could be determining factors in the proliferation of CHIKV. The survival analysis proved to be a suitable method for studying the presentation of CHIKV and can be applied to other prevalent vector-borne diseases such as the ZIKA and Dengue.
C1 [Oviedo-Pastrana, Misael; Mendez, Nelson; Mattar, Salim; Arrieta, German] Univ Cordoba, Inst Invest Biol Trop, Carrera 6 76-103, Monteria, Cordoba, Colombia.
   [Arrieta, German; Gomezcaceres, Luty] Corp Univ Caribe CECAR, Grp Salud Publ, Km 1,Via Corozal, Sincelejo, Colombia.
   [Mattar, Salim; Arrieta, German] Clin Salud Social SAS, Carrera 16 27A-74, Sincelejo, Colombia.
RP Mattar, S (corresponding author), Univ Cordoba, Inst Invest Biol Trop, Carrera 6 76-103, Monteria, Cordoba, Colombia.; Mattar, S (corresponding author), Clin Salud Social SAS, Carrera 16 27A-74, Sincelejo, Colombia.
EM mattarsalim@hotmail.com
OI Mendez Alvarez, Nelson David/0000-0003-3530-5413; Gomezcaceres,
   Luty/0000-0001-9409-4009
FU Corporacion Universitaria del Caribe - CECAR [AM50501010303009]
FX Corporacion Universitaria del Caribe - CECAR, small funding grant:
   "Epidemic surveillance and perception of the illness of the Chikungunya
   virus in the social context of the inhabitants of the municipalities of
   Corozal and Ovejas, Sucre". Code: AM50501010303009. University of
   Cordoba, sustainability agenda of research groups code: FMV-01-16.
CR [Anonymous], 2014, LANCET, V383, P488, DOI 10.1016/S0140-6736(14)60167-7
   Campo A, 2014, INFORME QUINCENAL EP, V20, P1
   Castillo J, 2015, INFORME QUINCENAL EP, V20, P205
   DANE, CENS GEN 2005 INF CO
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Gay N, 2013, AM J TROP MED HYG, V2016, P393, DOI DOI 10.4269/AJTMH.15-0308
   Instituto Nacional de Salud (Colombia), B EP SEM SEM EP
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Larrieu S, 2010, J CLIN VIROL, V47, P85, DOI 10.1016/j.jcv.2009.11.014
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Martinez M, 2014, INF QUINC EPIDEMIOL, V19, P260
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Mendez N, 2015, BIOMEDICA, V35, P110
   Ministerio de Salud y Proteccion Social (Colombia), PLAN NAC RESP FRENT
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   OPS/OMS, 2016, CHIK DAT EST
   Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Sasaki Y, 2015, J GEN FAM MED, V16, P204, DOI 10.14442/jgfm.16.3_204
   Seyler T, 2010, T ROY SOC TROP MED H, V104, P133, DOI 10.1016/j.trstmh.2009.07.014
   Stel VS, 2011, NEPHRON CLIN PRACT, V119, pC255, DOI 10.1159/000328916
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 24
TC 9
Z9 9
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0778-7367
EI 2049-3258
J9 ARCH PUBLIC HEALTH
JI Arch. PUblic Health
PD JAN 6
PY 2017
VL 75
AR 1
DI 10.1186/s13690-016-0169-1
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EG8XD
UT WOS:000391339500001
PM 28074128
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Teng, Y
   Bi, DH
   Xie, GG
   Jin, Y
   Huang, Y
   Lin, BH
   An, XP
   Feng, D
   Tong, YG
AF Teng, Yue
   Bi, Dehua
   Xie, Guigang
   Jin, Yuan
   Huang, Yong
   Lin, Baihan
   An, Xiaoping
   Feng, Dan
   Tong, Yigang
TI Dynamic Forecasting of Zika Epidemics Using Google Trends
SO PLOS ONE
LA English
DT Article
ID VIRUS; STATES
AB We developed a dynamic forecasting model for Zika virus (ZIKV), based on real-time online search data from Google Trends (GTs). It was designed to provide Zika virus disease (ZVD) surveillance and detection for Health Departments, and predictive numbers of infection cases, which would allow them sufficient time to implement interventions. In this study, we found a strong correlation between Zika-related GTs and the cumulative numbers of reported cases (confirmed, suspected and total cases; p<0.001). Then, we used the correlation data from Zika-related online search in GTs and ZIKV epidemics between 12 February and 20 October 2016 to construct an autoregressive integrated moving average (ARIMA) model (0, 1, 3) for the dynamic estimation of ZIKV outbreaks. The forecasting results indicated that the predicted data by ARIMA model, which used the online search data as the external regressor to enhance the forecasting model and assist the historical epidemic data in improving the quality of the predictions, are quite similar to the actual data during ZIKV epidemic early November 2016. Integer-valued autoregression provides a useful base predictive model for ZVD cases. This is enhanced by the incorporation of GTs data, confirming the prognostic utility of search query based surveillance. This accessible and flexible dynamic forecast model could be used in the monitoring of ZVD to provide advanced warning of future ZIKV outbreaks.
C1 [Teng, Yue; Huang, Yong; An, Xiaoping; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.
   [Teng, Yue; Bi, Dehua; Xie, Guigang; Jin, Yuan; Huang, Yong; An, Xiaoping; Tong, Yigang] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Bi, Dehua] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON, Canada.
   [Jin, Yuan] Beijing Inst Biotechnol, Beijing, Peoples R China.
   [Lin, Baihan] Univ Washington, Dept Psychol Phys & Comp Sci & Engn, Inst Prot Design, Computat Neurosci Program, Seattle, WA 98195 USA.
   [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Standard Operat Management, Beijing, Peoples R China.
RP Teng, Y; Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.; Teng, Y; Tong, YG (corresponding author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Feng, D (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Standard Operat Management, Beijing, Peoples R China.
EM tong.yigang@gmail.com; danfeng@sklpb.org; yueteng@sklpb.org
OI Tong, Yigang/0000-0002-8503-8045; Lin, Baihan/0000-0002-7979-5509
FU State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1408,
   SKLPBS1451]
FX This work was supported by grants from the State Key Laboratory of
   Pathogen and Biosecurity Program (No. SKLPBS1408 and No. SKLPBS1451).;
   We thank Drs. Wuchun Cao in State Key Laboratory of Pathogen and
   Biosecurity for discussions and our colleagues in the Beijing Institute
   of Microbiology and Epidemiology for help in technical assistance. This
   work was supported by grants from the State Key Laboratory of Pathogen
   and Biosecurity Program (No. SKLPBS1408 and No. SKLPBS1451).
CR Akhtar S, 2009, WORLD J GASTROENTERO, V15, P1607, DOI 10.3748/wjg.15.1607
   Bakker KM, 2016, P NATL ACAD SCI USA, V113, P6689, DOI 10.1073/pnas.1523941113
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayden EC, 2016, NATURE, V531, P19, DOI 10.1038/531019a
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mlakar J., 2009, NEW ENGL J MED, V374, P951
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Stock JH, 2011, INTRO ECONOMETRICS
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112
NR 26
TC 41
Z9 42
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 6
PY 2017
VL 12
IS 1
AR e0165085
DI 10.1371/journal.pone.0165085
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH3AX
UT WOS:000391641500007
PM 28060809
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, H
   Kang, NN
   An, K
   Kim, D
   Koo, J
   Kim, MS
AF Kim, Hyerin
   Kang, NaNa
   An, KyuHyeon
   Kim, Doyun
   Koo, JaeHyung
   Kim, Min-Soo
TI MRPrimerV: a database of PCR primers for RNA virus detection
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID REAL-TIME PCR; PROBE DATABASE; RTPRIMERDB; UPDATE; RESOURCE; DESIGN; DNA
AB Many infectious diseases are caused by viral infections, and in particular by RNA viruses such as MERS, Ebola and Zika. To understand viral disease, detection and identification of these viruses are essential. Although PCR is widely used for rapid virus identification due to its low cost and high sensitivity and specificity, very few online database resources have compiled PCR primers for RNA viruses. To effectively detect viruses, the MRPrimerV database (http://MRPrimerV.com) contains 152 380 247 PCR primer pairs for detection of 1818 viruses, covering 7144 coding sequences (CDSs), representing 100% of the RNA viruses in the most up-to-date NCBI RefSeq database. Due to rigorous similarity testing against all human and viral sequences, every primer in MRPrimerV is highly target-specific. Because MRPrimerV ranks CDSs by the penalty scores of their best primer, users need only use the first primer pair for a single-phase PCR or the first two primer pairs for two-phase PCR. Moreover, MRPrimerV provides the list of genome neighbors that can be detected using each primer pair, covering 22 192 variants of 532 RefSeq RNA viruses. We believe that the public availability of MRPrimerV will facilitate viral metagenomics studies aimed at evaluating the variability of viruses, as well as other scientific tasks.
C1 [Kim, Hyerin; An, KyuHyeon; Kim, Min-Soo] DGIST, Dept Informat & Commun Engn, 333 Techno Jungang Daero, Daegu 42988, South Korea.
   [Kang, NaNa; Kim, Doyun; Koo, JaeHyung] DGIST, Dept Brain & Cognit Sci, Daegu 42988, South Korea.
RP Kim, MS (corresponding author), DGIST, Dept Informat & Commun Engn, 333 Techno Jungang Daero, Daegu 42988, South Korea.; Koo, J (corresponding author), DGIST, Dept Brain & Cognit Sci, Daegu 42988, South Korea.
EM jkoo001@dgist.ac.kr; mskim@dgist.ac.kr
RI Koo, JaeHyung/R-3036-2019
OI Koo, JaeHyung/0000-0002-5538-8001
FU National Research Foundation of Korea (NRF)National Research Foundation
   of Korea [2016R1A2B2009063]; DGIST R&D Program of the Ministry of
   Science, ICT & Technology of Korea [16-BD-06, 16-BD-0404]; DGIST R&D
   Program of the Ministry of Science, ICT and Future Planning
   [15-01-HRLA-02]; Basic Science Research Program through the NRF -
   Ministry of Science, ICT & Future Planning [2014R1A1A1008227]; Korea
   government (MSIP) [R0190-16-2012]
FX National Research Foundation of Korea (NRF) [2016R1A2B2009063]; DGIST
   R&D Program of the Ministry of Science, ICT & Technology of Korea
   [16-BD-06, 16-BD-0404]; The DGIST R&D Program of the Ministry of
   Science, ICT and Future Planning [15-01-HRLA-02]; Basic Science Research
   Program through the NRF funded by the Ministry of Science, ICT & Future
   Planning [2014R1A1A1008227]; Korea government (MSIP) [Institute for
   Information & communications Technology Promotion (IITP) R0190-16-2012,
   High Performance Big Data Analytics Platform Performance Acceleration
   Technologies Development]. Funding for open access charge: DGIST R&D
   Program of the Ministry of Science, ICT and Future Planning
   [16-BD-0404]; Korea government (MSIP) (Institute for Information &
   communications Technology Promotion (IITP) R0190-16-2012, High
   Performance Big Data Analytics Platform Performance Acceleration
   Technologies Development].
CR Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300
   Bao YM, 2004, J VIROL, V78, P7291, DOI 10.1128/JVI.78.14.7291-7298.2004
   Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207
   Corman VM, 2012, EUROSURVEILLANCE, V17, P2
   Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767
   Kim H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv632
   Lee Sang-il, 2015, J Prev Med Public Health, V48, P274, DOI 10.3961/jpmph.15.064
   Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777
   Onodera K, 2002, NUCLEIC ACIDS RES, V30, P203, DOI 10.1093/nar/30.1.203
   Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011
   Pattyn F, 2006, NUCLEIC ACIDS RES, V34, pD684, DOI 10.1093/nar/gkj155
   Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800
   Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 18
TC 5
Z9 5
U1 1
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 4
PY 2017
VL 45
IS D1
BP D475
EP D481
DI 10.1093/nar/gkw1095
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EO3DQ
UT WOS:000396575500068
PM 27899620
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tukasan, C
   Furlan, NB
   Estofolete, CF
   Nogueira, ML
   da Silva, NS
AF Tukasan, Caroline
   Furlan, Nathalia Barbosa
   Estofolete, Cassia Fernanda
   Nogueira, Mauricio Lacerda
   da Silva, Natal Santos
TI Evaluation of the importance of fever with respect to dengue prognosis
   according to the 2009 WHO classification: a retrospective study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue fever; Severe dengue; Dengue epidemiology; WHO 2009
   classification
ID DISEASE SEVERITY; VIRUS-INFECTION; ZIKA; CHIKUNGUNYA; ADULTS; BRAZIL
AB Background: The 2009 revised World Health Organization (WHO) guidelines for dengue describe fever as the core symptom. Accordingly, the diagnosis of non-febrile patients is complicated. The aim of this study was to evaluate the importance of fever in patients with dengue according to the 2009 revised WHO classification.
   Methods: In this study, we assessed 30,670 dengue cases using enzyme-linked immunosorbent assay, detection of the non-structural protein 1, or polymerase chain reaction for diagnostic confirmation. Fisher's exact test was used to evaluate associations between fever and related clinical manifestations. The Mann-Whitney U test was used to assess the association of dengue classification with fever and time to treatment. The effects of fever and time to treatment on the risk of progression were analyzed using an ordinal logistic regression to stereotype the model.
   Results: Disease classification was found to associate significantly with both fever and time to treatment (both P < 0.001). Non-febrile patients were nearly four-fold more likely to exhibit "dengue without warning signs" than "severe dengue" (odds ratio [OR] = 3.74; 95% confidence interval [CI]: 3.20-4.36). Patients who received treatment within 7 days were twice as likely to have " dengue without warning signs" as opposed to " severe dengue" when compared to those who waited >7 days (OR = 2.23; 95% CI: 1.78-2.80). However, this difference was negligible in the multivariate analysis (OR = 1.02; 95% CI: 0.98-1.07).
   Conclusions: Fever is a risk factor for disease progression in patients with dengue. However, non-febrile patients should not be neglected because this may delay treatment and could lead to more severe disease.
C1 [Tukasan, Caroline; Furlan, Nathalia Barbosa; da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Sao Paulo, Brazil.
   [Estofolete, Cassia Fernanda; Nogueira, Mauricio Lacerda; da Silva, Natal Santos] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Sao Paulo, Brazil.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Sao Paulo, Brazil.; Nogueira, ML; da Silva, NS (corresponding author), Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil.; da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Sao Paulo, Brazil.
EM mnogueira@famerp.br; natalss@gmail.com
RI Estofolete, Cassia/N-6673-2019; Nogueira, Mauricio L/B-7599-2012; da
   Silva, Natal Santos/E-9579-2015
OI Estofolete, Cassia/0000-0001-7324-1591; Nogueira, Mauricio
   L/0000-0003-1102-2419; da Silva, Natal Santos/0000-0002-0856-1748
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3] to MLN.
CR Amancio FF, 2015, BRAZIL PLOS ONE, V10
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Cavalcanti LPD, 2014, MEM I OSWALDO CRUZ, V109, P93, DOI 10.1590/0074-0276140384
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Heilman James M, 2014, Open Med, V8, pe105
   Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Hoffmeister B, 2015, INFECTION, V43, P21, DOI 10.1007/s15010-014-0688-z
   Huang SY, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0343
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Tuan NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003638
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Singhi S, 2007, J PEDIAT-BRAZIL, V83, pS22, DOI 10.1590/S0021-75572007000300004
   Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451
   Suleman M, 2016, ASIAN PAC J TROP MED, V9, P371, DOI 10.1016/j.apjtm.2016.03.010
   Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291
   Thanachartwet V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1150-2
   Unnikrishnan Rahul, 2015, J Family Med Prim Care, V4, P369, DOI 10.4103/2249-4863.161323
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 24
TC 4
Z9 4
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 4
PY 2017
VL 17
AR 6
DI 10.1186/s12879-016-2128-4
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA EG5GZ
UT WOS:000391073200001
PM 28052760
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hatcher, EL
   Zhdanov, SA
   Bao, YM
   Blinkova, O
   Nawrocki, EP
   Ostapchuck, Y
   Schaffer, AA
   Brister, JR
AF Hatcher, Eneida L.
   Zhdanov, Sergey A.
   Bao, Yiming
   Blinkova, Olga
   Nawrocki, Eric P.
   Ostapchuck, Yuri
   Schaffer, Alejandro A.
   Brister, J. Rodney
TI Virus Variation Resource - improved response to emergent viral outbreaks
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID GROUP-A ROTAVIRUSES; WEST NILE VIRUS; GENOME ANNOTATION; BIOTECHNOLOGY
   INFORMATION; NATIONAL CENTER; SEQUENCE; DATABASE; WEB; CLASSIFICATION
AB The Virus Variation Resource is a value-added viral sequence data resource hosted by the National Center for Biotechnology Information. The resource is located at http://www.ncbi.nlm.nih.gov/genome/viruses/variation/ and includes modules for seven viral groups: influenza virus, Dengue virus, West Nile virus, Ebolavirus, MERS coronavirus, Rotavirus A and Zika virus. Each module is supported by pipelines that scan newly released GenBank records, annotate genes and proteins and parse sample descriptors and then map them to controlled vocabulary. These processes in turn support a purpose-built search interface where users can select sequences based on standardized gene, protein and metadata terms. Once sequences are selected, a suite of tools for downloading data, multi-sequence alignment and tree building supports a variety of user directed activities. This manuscript describes a series of features and functionalities recently added to the Virus Variation Resource.
C1 [Hatcher, Eneida L.; Zhdanov, Sergey A.; Bao, Yiming; Blinkova, Olga; Nawrocki, Eric P.; Ostapchuck, Yuri; Schaffer, Alejandro A.; Brister, J. Rodney] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.
RP Brister, JR (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.
EM jamesbr@ncbi.nlm.nih.gov
RI Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019
FU Intramural Research Program of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; National Library of MedicineUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM)
FX Intramural Research Program of the National Institutes of Health;
   National Library of Medicine. Funding for open access charge: Intramural
   Research Program of the National Institutes of Health; National Library
   of Medicine.
CR Agbemabiese CA, 2016, INFECT GENET EVOL, V45, P122, DOI 10.1016/j.meegid.2016.08.024
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07
   Bao Y, 2007, NUCLEIC ACIDS RES, V35, pW280, DOI 10.1093/nar/gkm354
   Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Bell A, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.20.21131
   Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216
   Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207
   Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268
   Brister JR, 2012, VIROLOGY, V434, P175, DOI 10.1016/j.virol.2012.09.027
   Brister JR, 2010, VIRUSES-BASEL, V2, P2258, DOI 10.3390/v2102258
   Cochrane G, 2016, NUCLEIC ACIDS RES, V44, pD48, DOI 10.1093/nar/gkv1323
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faggioni G, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-283
   Foley B., 2013, 1326007 LAUR AL NAT
   Greene JM, 2007, INFECT IMMUN, V75, P3212, DOI 10.1128/IAI.00105-07
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854
   Kuhn JH, 2014, VIRUSES-BASEL, V6, P3663, DOI 10.3390/v6093663
   Lingala S, 2015, GASTROENTEROL CLIN N, V44, P717, DOI 10.1016/j.gtc.2015.07.003
   Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238
   Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   McVey DS, 2015, REV SCI TECH OIE, V34, P431, DOI 10.20506/rst.34.2.2369
   Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509
   O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Resch W, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-65
   Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984
   Zaslavsky L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-237
NR 32
TC 33
Z9 33
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 4
PY 2017
VL 45
IS D1
BP D482
EP D490
DI 10.1093/nar/gkw1065
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EO3DQ
UT WOS:000396575500069
PM 27899678
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dzieciolowska, S
   Larroque, AL
   Kranjec, EA
   Drapeau, P
   Samarut, E
AF Dzieciolowska, Stefania
   Larroque, Anne-Laure
   Kranjec, Elizabeth-Ann
   Drapeau, Pierre
   Samarut, Eric
TI The larvicide pyriproxyfen blamed during the Zika virus outbreak does
   not cause microcephaly in zebrafish embryos
SO SCIENTIFIC REPORTS
LA English
DT Article
ID JUVENILE-HORMONE ACTION; NEURAL STEM-CELLS; MATERNAL PHENYLKETONURIA;
   TRANSGENIC ZEBRAFISH; GFAP; NEUROTOXICITY; METAMORPHOSIS; PERSPECTIVE;
   PROGENITORS; DISRUPTION
AB Although the zika virus (ZIKV) has now been strongly correlated with emerging cases of microcephaly in the Americas, suspicions have been raised regarding the use of pyriproxyfen, a larvicide that prevents mosquito development, in drinking water. The effects of this compound on neurodevelopment have not yet been addressed specifically in vertebrates. As a result, we aimed at addressing the effects, if any, of pyriproxyfen on neurodevelopment in the zebrafish embryo as a vertebrate model. Using zebrafish transgenic lines expressing GFP in different cell populations (elavl3 in newborn neurons, gfap and nestin in neural stem cells), we focused on the analysis of whole embryonic brain volume after confocal 3D-reconstruction and the quantification of purified neural stem cells during early neurodevelopment by FACS-cell sorting from whole in vivo embryos. Interestingly, though lethal at very high doses, pyriproxyfen did not cause brain malformation nor any significant changes in the number of observed stem cells in the developing central nervous system. Our data indicate that pyriproxyfen does not affect central nervous system development in zebrafish, suggesting that this larvicide on its own, may not be correlated with the increase in microcephaly cases reported recently.
C1 [Dzieciolowska, Stefania; Drapeau, Pierre; Samarut, Eric] Univ Montreal, Dept Neurosci, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada.
   [Larroque, Anne-Laure; Kranjec, Elizabeth-Ann] McGill Univ, Ctr Hlth, Res Inst, Drug Discovery Platform, Montreal, PQ, Canada.
   [Drapeau, Pierre; Samarut, Eric] DanioDesign Inc, Montreal, PQ, Canada.
RP Samarut, E (corresponding author), Univ Montreal, Dept Neurosci, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada.
EM eric.samarut@umontreal.ca
OI SAMARUT, ERIC/0000-0001-7818-2009
FU FRQS-affiliated GRSNC (Groupe de Recherche sur le Systeme Nerveux
   Central); Quebec MEESR (Ministere de l'Education, de l'Enseignement
   Superieur et de Recherche); CRCHUM; McGill Integrated Program in
   Neurosciences; CIHR of CanadaCanadian Institutes of Health Research
   (CIHR)
FX We are very grateful to Dominique Gauchat from the CRCHUM cytometry
   platform for her technical help regarding cell purification and to
   Sanjoy Kumar from the Drug discovery platform of the Research Institute
   of the McGill University Health Center. Also, we thank Guy Laliberte and
   Marina Drits of the CRCHUM zebrafish platform. We also thank JK, HD and
   LsS for passive support. ES is funded by the FRQS-affiliated GRSNC
   (Groupe de Recherche sur le Systeme Nerveux Central), the Quebec MEESR
   (Ministere de l'Education, de l'Enseignement Superieur et de Recherche)
   and the CRCHUM. SD is funded by the McGill Integrated Program in
   Neurosciences. PD is funded by the CIHR of Canada.
CR ABRASCO, NOT TECN MICR DOENC
   Almendrala A., VIRAL STORY LINKS ZI
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   AVERY GB, 1972, AM J DIS CHILD, V123, P214, DOI 10.1001/archpedi.1972.02110090084008
   Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006
   Braunbeck T, 2015, ENVIRON SCI POLLUT R, V22, P16247, DOI 10.1007/s11356-014-3814-7
   Capo-Chichi JM, 2015, J MED GENET, V52, P303, DOI 10.1136/jmedgenet-2014-102952
   Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   COWIE VA, 1987, J MENT DEFIC RES, V31, P229
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dwilson S. D., 2016, PYRIPROXYFEN 5 FAST
   ECDC, ZIK VIR EP AM POT AS
   FOX News Latino (FOX), 2016, BRAZ STAT SUSP LARV
   Freeman M., 2016, ZIKA OR INSECTICIDE
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Johnson K, 2016, GLIA, V64, P1170, DOI 10.1002/glia.22990
   Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   KOYAMA Y, 1989, Journal of Toxicological Sciences, V14, P43
   Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude (Brazil), 2015, MIN DIV B EP MICR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nishimura Y, 2015, CONGENIT ANOM, V55, P1, DOI 10.1111/cga.12079
   OUELLETTE EM, 1977, NEW ENGL J MED, V297, P528, DOI 10.1056/NEJM197709082971003
   Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898
   (REDUAS) Red Universitaria de Ambiente Y Salud, 2016, REPORT PHYS CROP SPR
   RIDDIFORD LM, 1970, SCIENCE, V167, P287, DOI 10.1126/science.167.3916.287
   Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014
   Rouse B, 2000, J PEDIATR-US, V136, P57, DOI 10.1016/S0022-3476(00)90050-7
   Russo S., 2016, LARVICIDE AFFAIR RIP
   SAMSON HH, 1984, ALCOHOL CLIN EXP RES, V8, P201, DOI 10.1111/j.1530-0277.1984.tb05839.x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SupertiFurga A, 1996, EUR J PEDIATR, V155, P992, DOI 10.1007/BF02282896
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Truong L, 2016, ENVIRON POLLUT, V218, P1089, DOI 10.1016/j.envpol.2016.08.061
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Van den Eeden S K, 1990, Paediatr Perinat Epidemiol, V4, P147
   Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644
   Westerfield M., 1995, ZEBRAFISH BOOK GUIDE
   Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337
   (WHOPES) World Health Organization Pesticide Evaluation Scheme, 2012, WHOPES REC COMP FORM
   Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004
   World Health Organization (WHO), PYR DRINK WAT US VEC
   Yabut O, 2014, NEURON, V82, P501, DOI 10.1016/j.neuron.2014.04.025
   Yuan XC, 2015, INT J BIOL MARKER, V30, pE434, DOI 10.5301/jbm.5000156
NR 54
TC 12
Z9 12
U1 0
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 4
PY 2017
VL 7
AR 40067
DI 10.1038/srep40067
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH0IG
UT WOS:000391446700001
PM 28051181
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI New Tool to Study Zika Virus
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 10
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JAN 3
PY 2017
VL 317
IS 1
BP 18
EP 18
DI 10.1001/jama.2016.19026
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG4JE
UT WOS:000391009100006
PM 28030682
DA 2020-07-08
ER

PT J
AU Muller, WJ
   Miller, ES
AF Muller, William J.
   Miller, Emily S.
TI Preliminary Results From the US Zika Pregnancy Registry Untangling Risks
   for Congenital Anomalies
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID VIRUS-INFECTION; STATES; BRAZIL
C1 [Muller, William J.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, 320 E Super St,Morton 4-685, Chicago, IL 60611 USA.
   [Miller, Emily S.] Northwestern Univ, Feinberg Sch Med, Dept Obstet Gynecol, Chicago, IL 60611 USA.
RP Muller, WJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, 320 E Super St,Morton 4-685, Chicago, IL 60611 USA.
EM wjmuller@northwestern.edu
OI Muller, William J/0000-0001-7690-0695
CR Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8
NR 14
TC 3
Z9 3
U1 0
U2 15
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JAN 3
PY 2017
VL 317
IS 1
BP 35
EP 36
DI 10.1001/jama.2016.18632
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG4JE
UT WOS:000391009100017
PM 27960198
DA 2020-07-08
ER

PT J
AU Honein, MA
   Dawson, AL
   Petersen, EE
   Jones, AM
   Lee, EH
   Yazdy, MM
   Ahmad, N
   Macdonald, J
   Evert, N
   Bingham, A
   Ellington, SR
   Shapiro-Mendoza, CK
   Oduyebo, T
   Fine, AD
   Brown, CM
   Sommer, JN
   Gupta, J
   Cavicchia, P
   Slavinski, S
   White, JL
   Owen, SM
   Petersen, LR
   Boyle, C
   Meaney-Delman, D
   Jamieson, DJ
AF Honein, Margaret A.
   Dawson, April L.
   Petersen, Emily E.
   Jones, Abbey M.
   Lee, Ellen H.
   Yazdy, Mahsa M.
   Ahmad, Nina
   Macdonald, Jennifer
   Evert, Nicole
   Bingham, Andrea
   Ellington, Sascha R.
   Shapiro-Mendoza, Carrie K.
   Oduyebo, Titilope
   Fine, Anne D.
   Brown, Catherine M.
   Sommer, Jamie N.
   Gupta, Jyoti
   Cavicchia, Philip
   Slavinski, Sally
   White, Jennifer L.
   Owen, S. Michele
   Petersen, Lyle R.
   Boyle, Coleen
   Meaney-Delman, Dana
   Jamieson, Denise J.
CA US Zika Pregnancy Registry
TI Birth Defects Among Fetuses and Infants of US Women With Evidence of
   Possible Zika Virus Infection During Pregnancy
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; BRAZIL; TRANSMISSION; EXPOSURE;
   RISK
AB IMPORTANCE Understanding the risk of birth defects associated with Zika virus infection during pregnancy may help guide communication, prevention, and planning efforts. In the absence of Zika virus, microcephaly occurs in approximately 7 per 10 000 live births.
   OBJECTIVE To estimate the preliminary proportion of fetuses or infants with birth defects after maternal Zika virus infection by trimester of infection and maternal symptoms.
   DESIGN, SETTING, AND PARTICIPANTS Completed pregnancies with maternal, fetal, or infant laboratory evidence of possible recent Zika virus infection and outcomes reported in the continental United States and Hawaii from January 15 to September 22, 2016, in the US Zika Pregnancy Registry, a collaboration between the CDC and state and local health departments.
   EXPOSURES Laboratory evidence of possible recent Zika virus infection in a maternal, placental, fetal, or infant sample.
   MAIN OUTCOMES AND MEASURES Birth defects potentially Zika associated: brain abnormalities with or without microcephaly, neural tube defects and other early brain malformations, eye abnormalities, and other central nervous system consequences.
   RESULTS Among 442 completed pregnancies in women (median age, 28 years; range, 15-50 years) with laboratory evidence of possible recent Zika virus infection, birth defects potentially related to Zika virus were identified in 26 (6%; 95% CI, 4%-8%) fetuses or infants. There were 21 infants with birth defects among 395 live births and 5 fetuses with birth defects among 47 pregnancy losses. Birth defects were reported for 16 of 271 (6%; 95% CI, 4%-9%) pregnant asymptomatic women and 10 of 167 (6%; 95% CI, 3%-11%) symptomatic pregnant women. Of the 26 affected fetuses or infants, 4 had microcephaly and no reported neuroimaging, 14 had microcephaly and brain abnormalities, and 4 had brain abnormalities without microcephaly; reported brain abnormalities included intracranial calcifications, corpus callosum abnormalities, abnormal cortical formation, cerebral atrophy, ventriculomegaly, hydrocephaly, and cerebellar abnormalities. Infants with microcephaly (18/442) represent 4% of completed pregnancies. Birth defects were reported in 9 of 85 (11%; 95% CI, 6%-19%) completed pregnancies with maternal symptoms or exposure exclusively in the first trimester (or first trimester and periconceptional period), with no reports of birth defects among fetuses or infants with prenatal exposure to Zika virus infection only in the second or third trimesters.
   CONCLUSIONS AND RELEVANCE Among pregnant women in the United States with completed pregnancies and laboratory evidence of possible recent Zika infection, 6% of fetuses or infants had evidence of Zika-associated birth defects, primarily brain abnormalities and microcephaly, whereas among women with first-trimester Zika infection, 11% of fetuses or infants had evidence of Zika-associated birth defects. These findings support the importance of screening pregnant women for Zika virus exposure.
C1 [Honein, Margaret A.; Dawson, April L.; Petersen, Emily E.; Jones, Abbey M.; Ellington, Sascha R.; Shapiro-Mendoza, Carrie K.; Oduyebo, Titilope; Meaney-Delman, Dana; Jamieson, Denise J.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.
   [Lee, Ellen H.; Fine, Anne D.; Slavinski, Sally] New York City Dept Hlth & Mental Hyg, Queens, NY USA.
   [Yazdy, Mahsa M.; Brown, Catherine M.] Massachusetts Dept Publ Hlth, Boston, MA USA.
   [Ahmad, Nina; Sommer, Jamie N.; White, Jennifer L.] New York State Dept Hlth, Albany, NY USA.
   [Macdonald, Jennifer; Gupta, Jyoti] Virginia Dept Hlth, Richmond, VA USA.
   [Evert, Nicole] Texas Dept State Hlth Serv, Austin, TX USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.
EM mrh7@cdc.gov
RI amsalu, ribka/G-8780-2019; Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Jamieson,
   Denise/0000-0003-2597-1201; Yazdy, Mahsa/0000-0002-7415-5350
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA US EM
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Leal MC, BRAZ J OTORHINOLARYN
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Webster WS, 1998, TERATOLOGY, V58, P13
NR 39
TC 218
Z9 220
U1 2
U2 399
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JAN 3
PY 2017
VL 317
IS 1
BP 59
EP 68
DI 10.1001/jama.2016.19006
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG4JE
UT WOS:000391009100020
PM 27960197
OA Bronze
DA 2020-07-08
ER

PT J
AU Caminade, C
   Turner, J
   Metelmann, S
   Hesson, JC
   Blagrove, MSC
   Solomon, T
   Morse, AP
   Baylis, M
AF Caminade, Cyril
   Turner, Joanne
   Metelmann, Soeren
   Hesson, Jenny C.
   Blagrove, Marcus S. C.
   Solomon, Tom
   Morse, Andrew P.
   Baylis, Matthew
TI Global risk model for vector-borne transmission of Zika virus reveals
   the role of El Nino 2015
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; R-0 model; El Nino; Ae. aegypti; Ae. albopictus
ID AEDES-ALBOPICTUS DIPTERA; BLOOD-FEEDING PATTERNS; POTENTIAL VECTOR;
   AEGYPTI MOSQUITOS; CLIMATE-CHANGE; CULICIDAE; DENGUE; AMERICA; EPIDEMIC;
   BEHAVIOR
AB Zika, a mosquito-borne viral disease that emerged in South America in 2015, was declared a Public Health Emergency of International Concern by the WHO in February of 2016. We developed a climate-driven R-0 mathematical model for the transmission risk of Zika virus (ZIKV) that explicitly includes two keymosquito vector species: Aedes aegypti and Aedes albopictus. The model was parameterized and calibrated using the most up to date information from the available literature. It was then driven by observed gridded temperature and rainfall datasets for the period 1950-2015. We find that the transmission risk in South America in 2015 was the highest since 1950. This maximum is related to favoring temperature conditions that caused the simulated biting rates to be largest and mosquito mortality rates and extrinsic incubation periods to be smallest in 2015. This event followed the suspected introduction of ZIKV in Brazil in 2013. The ZIKV outbreak in Latin America has very likely been fueled by the 2015-2016 El Nino climate phenomenon affecting the region. The highest transmission risk globally is in South America and tropical countries where Ae. aegypti is abundant. Transmission risk is strongly seasonal in temperate regions where Ae. albopictus is present, with significant risk of ZIKV transmission in the southeastern states of the United States, in southern China, and to a lesser extent, over southern Europe during the boreal summer season.
C1 [Caminade, Cyril; Turner, Joanne; Hesson, Jenny C.; Blagrove, Marcus S. C.; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool CH64 7TE, Merseyside, England.
   [Caminade, Cyril; Metelmann, Soeren; Blagrove, Marcus S. C.; Solomon, Tom; Morse, Andrew P.; Baylis, Matthew] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3GL, Merseyside, England.
   [Metelmann, Soeren; Morse, Andrew P.] Univ Liverpool, Sch Environm Sci, Dept Geog & Planning, Liverpool L69 7ZT, Merseyside, England.
   [Hesson, Jenny C.] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 7BE, Merseyside, England.
RP Caminade, C (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool CH64 7TE, Merseyside, England.; Caminade, C (corresponding author), Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3GL, Merseyside, England.
EM Cyril.Caminade@liverpool.ac.uk
OI Morse, Andrew/0000-0002-0413-2065; Solomon, Tom/0000-0001-7266-6547;
   Caminade, Cyril/0000-0002-3846-7082
FU National Institute for Health Research (NIHR) Health Protection Research
   Unit in Emerging and Zoonotic Infections at the University of Liverpool;
   Public Health England (PHE); Liverpool School of Tropical Medicine; Farr
   Institute for Health Informatics Research through Medical Research
   Council [MR/M0501633/1]; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/K018507/1]; Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15090]; National Institute for Health ResearchNational
   Institute for Health Research (NIHR) [RP-PG-0108-10048,
   NF-SI-0514-10177]
FX The research was funded by the National Institute for Health Research
   (NIHR) Health Protection Research Unit in Emerging and Zoonotic
   Infections at the University of Liverpool in partnership with Public
   Health England (PHE) and Liverpool School of Tropical Medicine. C.C.
   acknowledges support from The Farr Institute for Health Informatics
   Research through Medical Research Council Grant MR/M0501633/1. The views
   expressed are those of the authors and are not necessarily those of the
   National Health Service, the NIHR, the Department of Health, or PHE.
CR Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Aron J.L., 1982, P139
   Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lord CC, 1996, J MED ENTOMOL, V33, P328, DOI 10.1093/jmedent/33.3.328
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   NVBDCP, 2016, DENG CAS DEATHS IND
   Oliver SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067380
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6
   ROGERS DJ, 1988, PARASITOLOGY, V97, P193, DOI 10.1017/S0031182000066853
   Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Scott TW, 2003, WAG UR FRON, V2, P187
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Tawatsin A, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P113, DOI 10.1007/978-90-481-2458-9_8
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 69
TC 65
Z9 66
U1 3
U2 129
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 3
PY 2017
VL 114
IS 1
BP 119
EP 124
DI 10.1073/pnas.1614303114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG5OM
UT WOS:000391093700037
PM 27994145
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, ERA
   Mohana-Borges, R
   de Alencastro, RB
   Horta, BAC
AF Oliveira, Edson R. A.
   Mohana-Borges, Ronaldo
   de Alencastro, Ricardo B.
   Horta, Bruno A. C.
TI The flavivirus capsid protein: Structure, function and perspectives
   towards drug design
SO VIRUS RESEARCH
LA English
DT Article
DE Flavivirus; Capsid protein; Drug design; Antiviral; Review
ID VIRUS CORE PROTEIN; YELLOW-FEVER VIRUS; JAPANESE ENCEPHALITIS-VIRUS;
   PUBLIC-HEALTH PREPAREDNESS; STRUCTURE-BASED DISCOVERY; N-TERMINAL
   REGION; DENGUE-VIRUS; ZIKA VIRUS; IN-VITRO; NONSTRUCTURAL PROTEINS
AB Flaviviruses, such as dengue and zika viruses, are etiologic agents transmitted to humans mainly by arthropods and are of great epidemiological interest. The flavivirus capsid protein is a structural element required for the viral nucleocapsid assembly that presents the classical function of sheltering the viral genome. After decades of research, many reports have shown its different functionalities and influence over cell normal functioning. The subcellular distribution of this protein, which involves accumulation around lipid droplets and nuclear localization, also corroborates with its multi-functional characteristic. As flavivirus diseases are still in need of global control and in view of the possible key functionalities that the capsid protein promotes over flavivirus biology, novel considerations arise towards anti-flavivirus drug research. This review covers the main aspects concerning structural and functional features of the flavivirus C protein, ultimately, highlighting prospects in drug discovery based on this viral target. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Oliveira, Edson R. A.; de Alencastro, Ricardo B.; Horta, Bruno A. C.] Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, RJ, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
RP Oliveira, ERA (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Ctr Tecnol, Ave Athos da Silveira Ramos 149,Bloco A,Sala 609, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM edsonrao@gmail.com
RI Borges, Ronaldo S Mohana/C-5575-2013; Horta, Bruno AC/L-5079-2013
OI Horta, Bruno AC/0000-0002-3952-1474; Oliveira, Edson
   RA/0000-0002-8606-7454
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the Brazilian foundations CAPES, CNPq and
   FAPERJ. ERAO also acknowledges CAPES for his postdoctoral fellowship.
CR Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008
   Alen MMF, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/628475
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beesetti H., 2016, EXPERT OPIN INV DRUG, V24, P1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108
   BIEDRZYCKA A, 1987, J GEN VIROL, V68, P1317, DOI 10.1099/0022-1317-68-5-1317
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Castro JEZ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/370872
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chang CJ, 2001, DNA CELL BIOL, V20, P569, DOI 10.1089/104454901317094981
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Cregar-Hernandez Lynne, 2011, Antiviral Chemistry & Chemotherapy, V21, P209, DOI 10.3851/IMP1767
   Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Durbin AP, 2016, CELL, V166, P1, DOI 10.1016/j.cell.2016.06.036
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Fajardo E., 2016, J BIOMOL STRUCT DYN, V35, P1
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fassati A, 2012, VIRUS RES, V170, P15, DOI 10.1016/j.virusres.2012.09.012
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Freire JM, 2015, FEBS J, V282, P2267, DOI 10.1111/febs.13274
   Freire JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081450
   Freire JM, 2013, BIOPOLYMERS, V100, P325, DOI 10.1002/bip.22266
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hayakawa M, 2015, BIOCHEM BIOPH RES CO, V463, P1165, DOI 10.1016/j.bbrc.2015.06.077
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Ho JY, 2016, J ANTIMICROB CHEMOTH, V71, P1922, DOI 10.1093/jac/dkw101
   Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kaiser R, 2016, NERVENARZT, V87, P667, DOI 10.1007/s00115-016-0134-9
   Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P229, DOI 10.1007/s10354-012-0119-7
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kiermayr S, 2004, J VIROL, V78, P8078, DOI 10.1128/JVI.78.15.8078-8084.2004
   Klumpp K, 2014, CURR OPIN VIROL, V5, P63, DOI 10.1016/j.coviro.2014.02.002
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kunze Ursula, 2008, Travel Med Infect Dis, V6, P380, DOI 10.1016/j.tmaid.2008.06.004
   Kunze U, 2016, TICKS TICK-BORNE DIS, V7, P399, DOI 10.1016/j.ttbdis.2015.12.018
   Larocca R. A., 2016, NATURE IN PRESS
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li JL, 2012, BIOCHEM BIOPH RES CO, V418, P622, DOI 10.1016/j.bbrc.2012.01.050
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Lowe R, 2015, T ROY SOC TROP MED H, V109, P607, DOI 10.1093/trstmh/trv068
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Makarov VA, 2015, CHEMMEDCHEM, V10, P1629, DOI 10.1002/cmdc.201500304
   MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mandl CW, 2004, VIRAL IMMUNOL, V17, P461, DOI 10.1089/vim.2004.17.461
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   MARKOFF L, 1994, VIROLOGY, V204, P526, DOI 10.1006/viro.1994.1566
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Nemesio H, 2013, MOL MEMBR BIOL, V30, P273, DOI 10.3109/09687688.2013.805835
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Ni P, 2013, VIROLOGY, V446, P123, DOI 10.1016/j.virol.2013.07.023
   Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Noda M, 2012, BIOL-TARGETS THER, V6, P409, DOI 10.2147/BTT.S37792
   NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1
   Oh WK, 2006, BIOCHEM BIOPH RES CO, V347, P994, DOI 10.1016/j.bbrc.2006.06.190
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Perilla JR, 2016, J PHYS CHEM LETT, V7, P1836, DOI 10.1021/acs.jpclett.6b00517
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piccini LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140824
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Potisopon S, 2016, NUCLEIC ACIDS RES, V44, P2974, DOI 10.1093/nar/gkv1294
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Roby JA, 2014, J GEN VIROL, V95, P2176, DOI 10.1099/vir.0.064121-0
   RUIZLINARES A, 1989, J VIROL, V63, P4199, DOI 10.1128/JVI.63.10.4199-4209.1989
   Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x
   Salgado D, 2012, PEDIATR INFECT DIS J, V31, P771, DOI 10.1097/INF.0b013e3182575e6a
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schlick P, 2010, VACCINE, V28, P5903, DOI 10.1016/j.vaccine.2010.06.045
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   SPEIGHT G, 1988, J GEN VIROL, V69, P23, DOI 10.1099/0022-1317-69-1-23
   Steffen R, 2016, J TRAVEL MED, V23, P1, DOI 10.1093/jtm/taw018
   Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17
   Tadano M., 1989, J GEN VIROL, V70
   Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444
   Thenin-Houssier S, 2016, ANTIMICROB AGENTS CH, V60, P2195, DOI 10.1128/AAC.02574-15
   Thomas SJ, 2015, VACCINE, V33, pD24, DOI 10.1016/j.vaccine.2015.05.095
   Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327
   Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003
   Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006
   Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verma R, 2014, HUM VACC IMMUNOTHER, V10, P126, DOI 10.4161/hv.26549
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203
   WRIGHT PJ, 1989, VIROLOGY, V171, P61, DOI 10.1016/0042-6822(89)90510-2
   Xiao XD, 2011, BIOCHEM BIOPH RES CO, V411, P253, DOI 10.1016/j.bbrc.2011.06.109
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
   YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yang JS, 2003, EMERG INFECT DIS, V9, P406
   Yang L, 2016, ANTIVIR RES, V125, P25, DOI 10.1016/j.antiviral.2015.11.004
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
NR 169
TC 31
Z9 32
U1 2
U2 85
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 2
PY 2017
VL 227
BP 115
EP 123
DI 10.1016/j.virusres.2016.10.005
PG 9
WC Virology
SC Virology
GA EE6NO
UT WOS:000389729700015
PM 27751882
DA 2020-07-08
ER

PT S
AU Kim, CW
   Ahn, SH
   Yoon, T
AF Kim, Chan Woo
   Ahn, Se Hwan
   Yoon, Taeseon
GP IEEE
TI Comparison of Flavivirus Using Datamining-Apriori, K-means, and Decision
   Tree Algorithm
SO 2017 19TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATIONS TECHNOLOGY
   (ICACT) - OPENING NEW ERA OF SMART SOCIETY
SE International Conference on Advanced Communication Technology
LA English
DT Proceedings Paper
CT 19th International Conference on Advanced Communication Technology
   (ICACT)
CY FEB 19-22, 2017
CL Pyeongchang, SOUTH KOREA
SP Global IT Res Inst, IEEE Commun Soc, Natl Informat Soc Agcy, Elect & Telecommunicat Res Inst, Gangwon Convent & Visitors Bur, Korean Inst Commun Sci, IEEK Commun Soc, Korean Inst Informat Scientists & Engineers, Open Stand & Internet Assoc, Korea Inst Informat Secur & Crytol
DE zika virus and flavivirus; genetic treatment; apriori; k-means; decision
   tree algorithm
ID VIRUS; ENCEPHALITIS; EXPRESSION
AB Nowadays, zika virus infection-occurred in brazil-is becoming serious global problem. Temporary treatments-using drug-can alleviate symptoms for a while but cannot be a basic solution for infections. We researched amino acids of Zika virus and other four kinds of flaviviruses-Dengue fever, Yellow fever, Saint Louis, Japanese Encephalitis-with bioinformatic experiment; Apriori, K-means and Decision Tree algorithm. Results show differences and common things among them-Japanese Encephalitis has most representative amino acid.
C1 [Kim, Chan Woo; Ahn, Se Hwan] Hankuk Acad Foreign Studies, Nat Sci, Yongin, South Korea.
   [Yoon, Taeseon] Korea Univ, Comp Sci & Engn, Seoul, South Korea.
RP Yoon, T (corresponding author), Korea Univ, Comp Sci & Engn, Seoul, South Korea.
EM kimcwbest1@gmail.com; brandon07@naver.com; tsyoon@hafs.hs.kr
CR [Anonymous], NEUR DIS ASS 17D 204
   [Anonymous], RAP DET QUAN RNA EB
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kuhn Richard J., 2014, SELECTED PAPERS MG R, P317
   Lustig Yaniv, 2016, EURO SURVEILL EUROSU, V21.26
   Olaru C, 2003, FUZZY SET SYST, V138, P221, DOI 10.1016/S0165-0114(03)00089-7
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   ROEHRIG JT, 1983, VIROLOGY, V128, P118, DOI 10.1016/0042-6822(83)90323-9
   SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458
   Weissenb Ack Herbert, 2002, EMERG INFECT DIS, V8. 7, P652
   Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X
   Ye Yanbin, 2006, 4 INT C SOFTW ENG RE
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1738-9445
BN 978-8-9968-6509-4
J9 INT CONF ADV COMMUN
PY 2017
BP 454
EP 457
PG 4
WC Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BH8BP
UT WOS:000403150000086
DA 2020-07-08
ER

PT S
AU Jang, J
   Bae, SE
AF Jang, Jinhwa
   Bae, Se-Eun
GP IEEE
TI Comparative Coevolutionary Analysis between Zika Virus and Dengue Virus
SO 2017 INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATION
   TECHNOLOGY CONVERGENCE (ICTC)
SE International Conference on Information and Communication Technology
   Convergence
LA English
DT Proceedings Paper
CT International Conference on Information and Communication Technology
   Convergence (ICTC)
CY OCT 18-20, 2017
CL SOUTH KOREA
SP Korean Inst Commun & Informat Sci, IEEE Commun Soc, IEICE Commun Soc, Minist Sci & ICT, Elect & Telecommunicat Res Inst, Inst Informat & Commun Technol Promot, Samsung Elect, LG Elect, ERICSSON, LG, LGU+, KT, Contela Inc, GSI, Natl Instruments, InterDigital, Korea IETF Forum, Jeju Convernt & Visitors Bur
DE Coevolution; ZIKV; DENV; Flaviviridae; Phylogenetic inferences
AB Zika virus (ZIKV) is member of the family flaviviridae including Dengue virus (DENY), West Nile virus and Yellow fever virus. Likewise ZIKV and DENY are ecologically associated with each other. In this study, we conducted comparative coevolutionary analysis between ZIKV and DENY including heuristic search and patristic distance correlation test by species of mosquitoes. We determined ZIKV and DENY show a difference in coevolutionary pattern according to mosquito species. Coevolutionary analysis of the COl sequence from Aedes species produce a tree similar to the taxonomic relationships of ZIKV. The significance mapping ZIKV into host value indicated p=0.159 (+/-10.011). On the other hand, DENY show the significance mapping host value indicated p=0.954 (+/-0.006). Phylogenetic inferences indicate differ between ZIKV and DENY. These results indicate that ZIKV might have coevolution with mosquitoes differ from DENY. So, development and preparation of the viral vaccine required according to coevolutionary patterns.
C1 [Jang, Jinhwa] Korea Inst Sci & Technol Informat, Biomed Predict Technol Lab, Daejeon, South Korea.
   [Jang, Jinhwa] Seoul Natl Univ, Grad Sch Publ Hlth, Lab Computat Biol & Bioinformat, Seoul, South Korea.
   [Bae, Se-Eun] Samsung Genome Inst, Bioinformat Lab, Seoul, South Korea.
RP Jang, J (corresponding author), Korea Inst Sci & Technol Informat, Biomed Predict Technol Lab, Daejeon, South Korea.; Jang, J (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Lab Computat Biol & Bioinformat, Seoul, South Korea.
EM jhjang@kisti.re.kr; mdbse4@snu.ac.kr
FU Bio & Medical Technology Development Program of the NRF - Korean
   government, MSIP [2016 M3A9B6915714]
FX This research was supported by the Bio & Medical Technology Development
   Program of the NRF funded by the Korean government, MSIP (2016
   M3A9B6915714).
CR Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Charleston M, PAGE RDM TREEMAP
   Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004
   Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Obbard DJ, 2014, CURR OPIN VIROL, V8, P73, DOI 10.1016/j.coviro.2014.07.002
   Patil JA, 2011, INFECT GENET EVOL, V11, P1443, DOI 10.1016/j.meegid.2011.05.011
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
NR 16
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2162-1233
BN 978-1-5090-4032-2
J9 I C INF COMM TECH CO
PY 2017
BP 49
EP 53
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BJ6YF
UT WOS:000426978700012
DA 2020-07-08
ER

PT J
AU Marban-Castro, E
   Gonce, A
   Martinez, MJ
   Fumado, V
   Lopez, M
   Garcia, L
   Salazar, L
   Salvia, D
   Oliveira, I
   Rodriguez-Valero, N
   Pinazo, MJ
   Requena-Mendez, A
   Llenas-Garcia, J
   Saco, A
   Castillo, P
   Fuente-Moreno, M
   Casellas, A
   Gonzalez, R
   Munoz, J
   Gascon, J
   Ordi, J
   Menendez, C
   Bardaji, A
AF Marban-Castro, Elena
   Gonce, Anna
   Martinez, Miguel J.
   Fumado, Victoria
   Lopez, Marta
   Garcia, Laura
   Salazar, Laura
   Salvia, Dolors
   Oliveira, Ines
   Rodriguez-Valero, Natalia
   Jesus Pinazo, Maria
   Requena-Mendez, Ana
   Llenas-Garcia, Jara
   Saco, Adela
   Castillo, Paola
   Fuente-Moreno, Marina
   Casellas, Aina
   Gonzalez, Raquel
   Munoz, Jose
   Gascon, Joaquim
   Ordi, Jaume
   Menendez, Clara
   Bardaji, Azucena
TI HOW IS ZIKA AFFECTING PREGNANT TRAVELERS? ZIKA VIRUS SURVEILLANCE IN A
   NON-ENDEMIC AREA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Marban-Castro, Elena; Martinez, Miguel J.; Fumado, Victoria; Oliveira, Ines; Rodriguez-Valero, Natalia; Jesus Pinazo, Maria; Requena-Mendez, Ana; Llenas-Garcia, Jara; Fuente-Moreno, Marina; Casellas, Aina; Gonzalez, Raquel; Munoz, Jose; Gascon, Joaquim; Ordi, Jaume; Menendez, Clara; Bardaji, Azucena] Univ Barcelona, Barcelona Inst Global Hlth, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain.
   [Gonce, Anna; Lopez, Marta; Garcia, Laura; Salazar, Laura; Salvia, Dolors] Univ Barcelona, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Dept Maternal Fetal Med, Barcelona, Spain.
   [Gonce, Anna; Lopez, Marta; Garcia, Laura; Salazar, Laura; Salvia, Dolors] Univ Barcelona, Hosp St Joan de Deu, Barcelona, Spain.
   [Saco, Adela; Castillo, Paola] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain.
RI Gonzalez, Raquel/J-3604-2017; Casellas, Aina/Q-1247-2016; Pinazo, Maria
   Jesus M/X-6093-2018; Rodriguez-Valero, Natalia/AAD-7083-2020; Bardaji,
   Azucena/AAE-9145-2019; Gascon, Joaquim/M-3598-2015
OI Gonzalez, Raquel/0000-0001-5487-801X; Casellas,
   Aina/0000-0003-4939-8411; Pinazo, Maria Jesus M/0000-0002-4237-1075;
   Bardaji, Azucena/0000-0002-5135-0540; Gascon,
   Joaquim/0000-0002-5045-1585
NR 0
TC 0
Z9 0
U1 0
U2 11
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 137
BP 44
EP 44
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202137
DA 2020-07-08
ER

PT J
AU Berenson, AB
   Trinh, HN
   Hirth, JM
   Guo, FJ
   Fuchs, EL
   Weaver, SC
AF Berenson, Abbey B.
   Trinh, Ha N.
   Hirth, Jacqueline M.
   Guo, Fangjian
   Fuchs, Erika L.
   Weaver, Scott C.
TI Knowledge and Prevention Practices among US Pregnant Immigrants from
   Zika Virus Outbreak Areas
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID UNITED-STATES; TRANSMISSION
AB Weadministered an anonymous survey to assess knowledge, attitudes, and prevention practices related to the Zika virus among pregnant women residing in Texas. Multivariate logistic regression models controlling for age, race/ethnicity, education, and number of years in the United States assessed differences between women born in outbreak areas (N= 390) versus those born in the United States (N= 249). Results demonstrated that most women wanted more information on the Zika virus and desired to obtain it from their physician. The majority did not know that the Zika virus could be spread through sex with an asymptomatic partner or how often those infected were symptomatic. Few womentook precautions to avoid mosquito bites. Only 40% reported frequently using repellent; 21% stated that cost was problematic and almost half were concerned about use during pregnancy. Three-fourths stated they would agree to vaccination, if available. Compared with U. S.-born women, those born in outbreak areas were more likely to have already discussed the Zika virus with their doctor (adjusted odds ratio [aOR] = 1.86, 95% confidence interval [CI] = 1.27, 2.71) and identify microcephaly as the most common birth defect (aOR = 2.59, 95% CI = 1.78, 3.76). Moreover, women born in outbreak areas were less likely to desire to keep it a secret if they became infected (aOR = 0.47, 95% CI = 0.31, 0.71). This study found that, regardless of birthplace, pregnant womenneed more education on the Zika virus disease and assurance regarding the safety of using repellent during pregnancy. They also need financial assistance for repellent, especially if living in states where transmission by mosquitos has been reported.
C1 [Berenson, Abbey B.; Trinh, Ha N.; Hirth, Jacqueline M.; Guo, Fangjian; Fuchs, Erika L.] Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, Galveston, TX 77555 USA.
   [Berenson, Abbey B.; Trinh, Ha N.; Hirth, Jacqueline M.; Guo, Fangjian; Fuchs, Erika L.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immunol, Dept Pathol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Berenson, AB (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Ctr Interdisciplinary Res Womens Hlth, 301 Univ Blvd, Galveston, TX 77555 USA.
EM abberens@utmb.edu; hntrinh@utmb.edu; jmhirth@utmb.edu; faguo@utmb.edu;
   elfuchs@utmb.edu; sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU Office of Research on Women's Health (ORWH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Office of Research on Women's Health (ORWH) [K12HD052023]; Eunice
   Kennedy Shriver National Institute of Child Health and Human Development
   (NICHD) at the National Institutes of Health (NIH); NIH/NICHDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD055163]
FX Fuchs and Guo are supported by an institutional research career
   development award (K12HD052023: Building Interdisciplinary Research
   Careers in Women's Health Program-BIRCWH; Berenson, PI) from the Office
   of Research on Women's Health (ORWH) and the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development (NICHD) at the
   National Institutes of Health (NIH). Dr. Fuchs also worked on the
   project as a postdoctoral fellow supported by an institutional training
   grant (National Research Service Award T32HD055163, Berenson, PI) from
   NIH/NICHD. Trinh is a current postdoctoral fellow supported by
   T32HD055163.The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the NIH.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   American College of Obstetricians and Gynecologists, 2016, PRACT ADV ZIK VIR
   Baker D, 2004, GENET MED, V6, P211, DOI 10.1097/01.GIM.0000132684.94642.A0
   Bedrosian SR, 2016, MMWR-MORBID MORTAL W, V65, P68, DOI 10.15585/mmwr.su6503a10
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Centers for Disease Control and Prevention, 2016, ZIK VIR PREGN
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   First Nations Centre National Aboriginal Health Organization, 2016, 1 NAT KNOWL PROT W N
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Harvard TH, 2016, MANY FAMILIES PREGNA
   Ipsos Public Affairs, 2016, IPS REUT POLL DAT IP
   National Center for Health Statistics, 2013, SURV DESCR
   NORC at the University of Chicago, 2016, NEW SURV AM ATT ZIK
   Texas Health and Human Services, 2016, TEX MED BRINGS BACK
   United States Environmental Protection Agency (USEPA), 2007, RER EL DEC RED PERM
   University of Florida, 2016, ZIK DOESNT DET AM TR
   US EPA, 2016, DEET
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2016, 1 M INT HLTH REG 200
NR 22
TC 17
Z9 18
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 155
EP 162
DI 10.4269/ajtmh.17-0062
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900027
PM 28719291
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Azar, SR
   Roundy, CM
   Rossi, SL
   Huang, JH
   Leal, G
   Yun, R
   Fernandez-Salas, I
   Vitek, CJ
   Paploski, IAD
   Stark, PM
   Vela, J
   Debboun, M
   Reyna, M
   Kitron, U
   Ribeiro, GS
   Hanley, KA
   Vasilakis, N
   Weaver, SC
AF Azar, Sasha R.
   Roundy, Christopher M.
   Rossi, Shannan L.
   Huang, Jing H.
   Leal, Grace
   Yun, Ruimei
   Fernandez-Salas, Ildefonso
   Vitek, Christopher J.
   Paploski, Igor A. D.
   Stark, Pamela M.
   Vela, Jeremy
   Debboun, Mustapha
   Reyna, Martin
   Kitron, Uriel
   Ribeiro, Guilherme S.
   Hanley, Kathryn A.
   Vasilakis, Nikos
   Weaver, Scott C.
TI Differential Vector Competency of Aedes albopictus Populations from the
   Americas for Zika Virus
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID EQUINE ENCEPHALITIS-VIRUS; CHIKUNGUNYA VIRUS; BLOOD MEALS; WEST-NILE;
   AEGYPTI; TRANSMISSION; MOSQUITOS; DENGUE; INFECTION; BRAZIL
AB To evaluate the potential role of Aedes albopictus (Skuse) as a vector of Zika virus (ZIKV), colonized mosquitoes of low generation number (<= F5) from Brazil, Houston, and the Rio Grande Valley of Texas engorged on viremic mice infected with ZIKV strains originating from Senegal, Cambodia, Mexico, Brazil, or Puerto Rico. Vector competence was established by monitoring infection, dissemination, and transmission potential after 3, 7, and 14 days of extrinsic incubation. Positive saliva samples were assayed for infectious titer. Although all three mosquito populations were susceptible to all ZIKV strains, rates of infection, dissemination, and transmission differed among mosquito and virus strains. Aedes albopictus from Salvador, Brazil, were the least efficient vectors, demonstrating susceptibility to infection to two American strains of ZIKV but failing to shed virus in saliva. Mosquitoes from the Rio Grande Valley were the most efficient vectors and were capable of shedding all three tested ZIKV strains into saliva after 14 days of extrinsic incubation. In particular, ZIKV strain DakAR 41525 (Senegal 1954) was significantly more efficient at dissemination and saliva deposition than the others tested in Rio Grande mosquitoes. Overall, our data indicate that, while Ae. albopictus is capable of transmitting ZIKV, its competence is potentially dependent on geographic origin of both the mosquito population and the viral strain.
C1 [Azar, Sasha R.; Roundy, Christopher M.; Rossi, Shannan L.; Huang, Jing H.; Leal, Grace; Yun, Ruimei; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Pathol, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Roundy, Christopher M.; Rossi, Shannan L.; Huang, Jing H.; Leal, Grace; Yun, Ruimei; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Roundy, Christopher M.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso] Inst Nacl Salud Publ, Ctr Reg Salud Publ, Tapachula, Chiapas, Mexico.
   [Vitek, Christopher J.] Univ Texas Rio Grande Valley, Edinburg, TX USA.
   [Paploski, Igor A. D.; Ribeiro, Guilherme S.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Paploski, Igor A. D.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Stark, Pamela M.; Vela, Jeremy; Debboun, Mustapha; Reyna, Martin] Harris Cty Publ Hlth, Mosquito & Vector Control Div, Houston, TX USA.
   [Kitron, Uriel] Emory Univ, Populat Biol Ecol & Evolut Grad Program, Grad Div Biol & Biomed Sci, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
RP Vasilakis, N; Weaver, SC (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.
EM srazar@utmb.edu; cmroundy@utmb.edu; slrossi@utmb.edu; jhhuang@utmb.edu;
   grleal@utmb.edu; ruyun@utmb.edu; ildefonso.fernandez@insp.mxhiapas;
   christopher.vitek@utrgv.edu; igorufprmv@gmail.com; pstark@hcphes.org;
   jvela@hcphes.org; mdebboun@hcphes.org; mreyna@hcphes.org;
   ukitron@emory.edu; gsribeiro@gmail.com; khanley@nmsu.edu;
   nivasila@utmb.edu; sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011; Paploski, Igor AD/D-7015-2014; Ribeiro,
   Guilherme/B-6624-2008
OI Weaver, Scott C/0000-0001-8016-8556; Paploski, Igor
   AD/0000-0002-3689-2042; Ribeiro, Guilherme/0000-0002-6798-2059
FU Institute for Human Infections and Immunity; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R24AI120942, R01AI121452, 1U01AI115577, 1R15AI113628-01]; Brazilian
   National Council of Technological and Scientific Development
   [440891/2016-7, 400830/2013-2]; Coordination for the Improvement of
   Higher Education [440891/2016-7]
FX This work was supported by a pilot grant by the Institute for Human
   Infections and Immunity. NIH grants R24AI120942 and R01AI121452 (SCW),
   1U01AI115577 (NV) and 1R15AI113628-01 (KAH), and grants from Brazilian
   National Council of Technological and Scientific Development
   (440891/2016-7 and 400830/2013-2) and the Coordination for the
   Improvement of Higher Education (440891/2016-7) (GSR). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. The authors have no
   conflicting financial interests.
CR Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Centers for Disease Control and Prevention, 2016, COUNTR TERR ACT LOC
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hanley KA, 2005, VECTOR-BORNE ZOONOT, V5, P1, DOI 10.1089/vbz.2005.5.1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841
   Smith DR, 2005, AM J TROP MED HYG, V73, P33, DOI 10.4269/ajtmh.2005.73.33
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Texas Department of State Health Services, 2016, TEX ANN LOC ZIK VIR
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 59
TC 35
Z9 37
U1 4
U2 8
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 2
BP 330
EP 339
DI 10.4269/ajtmh.16-0969
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5MI
UT WOS:000423197200007
PM 28829735
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Olschlager, S
   Enfissi, A
   Zaruba, M
   Kazanji, M
   Rousset, D
AF Oelschlaeger, Stephan
   Enfissi, Antoine
   Zaruba, Mareen
   Kazanji, Mirdad
   Rousset, Dominique
TI Diagnostic Validation of the RealStar (R) Zika Virus Reverse
   Transcription Polymerase Chain Reaction Kit for Detection of Zika Virus
   RNA in Urine and Serum Specimens
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB With the Zika virus outbreak in South America starting in 2015 and its potential to cause malformation of the fetus in infected women, the need for diagnostic methods became obvious. Until now, only limited data are available on the diagnostic performance of commercial kits. Here, we present data comparing the RealStar (R) Zika Virus RT-PCR Kit 1.0 for detection of Zika virus from 208 serum and urine samples collected in French Guiana with a reference method. Of these, 114 samples tested positive with the RealStar (R) Kit and 111 with the reference method.
C1 [Oelschlaeger, Stephan; Zaruba, Mareen] Altona Diagnost GmbH, Res & Dev, Hamburg, Germany.
   [Enfissi, Antoine; Kazanji, Mirdad; Rousset, Dominique] Inst Pasteur, Lab Virol, CNR Arbovirus, Cayenne, French Guiana.
   [Enfissi, Antoine; Kazanji, Mirdad; Rousset, Dominique] Inst Pasteur, Lab Virol, Cayenne, French Guiana.
RP Olschlager, S (corresponding author), Altona Diagnost GmbH, Morkenstr 12, D-22767 Hamburg, Germany.
EM stephan.oelschlaeger@gmail.com; aenfissi@pasteuer-cayenne.fr;
   mareen.zaruba@altona-diagnostics.com; mkazanji@pasteur-cayenne.fr;
   drousset@pasteur-cayenne.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147
FU altona Diagnostics GmbH
FX S. Olschlager and M. Zaruba are employees of altona Diagnostics GmbH.
   They receive salary but do not own shares of the company. They also work
   for Ultone Diagnostics GMBH.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, 2014, ZIK VIR DIAGN TESTS
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Pessoa R, 2016, EURO SURVEILL, V21
   WHO. Sec 2, 2016, WHOZIKVLAB161, P4
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 9
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 4
BP 1070
EP 1071
DI 10.4269/ajtmh.17-0268
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5QM
UT WOS:000423208300014
PM 28722641
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ferreira, MLB
   de Brito, CAA
   Moreira, AJP
   Machado, MID
   Henriques-Souza, A
   Cordeiro, MT
   Marques, ETD
   Pena, LJ
AF Brito Ferreira, Maria Lucia
   Antunes de Brito, Carlos Alexandre
   Porto Moreira, Alvaro Jose
   de Morais Machado, Maria Iris
   Henriques-Souza, Adelia
   Cordeiro, Marli Tenorio
   de Azevedo Marques, Ernesto Torres, Jr.
   Pena, Lindomar Jose
TI Guillain-Barre Syndrome, Acute Disseminated Encephalomyelitis and
   Encephalitis Associated with Zika Virus Infection in Brazil: Detection
   of Viral RNA and Isolation of Virus during Late Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; TRANSMISSION
AB Zika virus (ZIKV) emerged in Brazil in 2015, which was followed by an increase of Guillain-Barre Syndrome (GBS) cases. We report the epidemiological, clinical, and laboratory findings of the first six neurological cases associated with ZIKV in Brazil seen in a reference neurology hospital in Pernambuco, Brazil. In all cases, ZIKV was detected in serum and/or cerebrospinal fluid (CSF) samples. In this case series, four cases were defined as GBS, one as acute disseminated encephalomyelitis (ADEM) and the other as encephalitis. ZIKV was detected in all cases by RT-PCR and virus isolation was successful in two patients. The time between ZIKV acute symptoms and the development of neurological manifestations varied from 3 to 13 days and ZIKV was detected between 15 and 34 days after the initial symptoms. Our results highlight the need to include ZIKV as a differential diagnosis for neurological syndromes in countries with circulation of this arbovirus. Because the viremia in these patients appears to persist longer, direct diagnostic techniques such as RT-PCR and viral isolation should be considered even if it is after the acute phase of viral infection.
C1 [Brito Ferreira, Maria Lucia; Porto Moreira, Alvaro Jose; de Morais Machado, Maria Iris] Hosp Restorat, Dept Neurol, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Fed Univ Pernambuco UFPE, Dept Med, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Henriques-Souza, Adelia] Hosp Restauracao, Dept Pediat, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; de Azevedo Marques, Ernesto Torres, Jr.; Pena, Lindomar Jose] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, FIOCRUZ, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Fed Univ Pernambuco UFPE, Dept Med, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM lucabrito@uol.com.br; cbritoc@gmail.com; alvarojpm@yahoo.com.br;
   irismorais@terra.com.br; adelianeuro@gmail.com; marli.tenorio@gmail.com;
   marques@pitt.edu; lindomar.pena@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX LJP is supported by grants from FACEPE and CNPq.
CR [Anonymous], 2016, ZIK EP UPD, P1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brazilian Ministry of Health, 2015, PROT AT SAUD RESP OC
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Control ECfDPa, 2014, RAP RISK ASS ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marli T, 2016, J INFECT DIS, V214, P1897
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, 1 DEC 2015 NEUR SYND
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 24
TC 20
Z9 21
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
BP 1405
EP 1409
DI 10.4269/ajtmh.17-0106
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5VW
UT WOS:000423222300020
PM 29140242
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lindholm, DA
   Myers, T
   Widjaja, S
   Grant, EM
   Telu, K
   Lalani, T
   Fraser, J
   Fairchok, M
   Ganesan, A
   Johnson, MD
   Kunz, A
   Tribble, DR
   Yun, HC
AF Lindholm, David A.
   Myers, Todd
   Widjaja, Susana
   Grant, Edward M.
   Telu, Kalyani
   Lalani, Tahaniyat
   Fraser, Jamie
   Fairchok, Mary
   Ganesan, Anuradha
   Johnson, Mark D.
   Kunz, Anjali
   Tribble, David R.
   Yun, Heather C.
CA Infect Dis Clinical Res Program
TI Mosquito Exposure and Chikungunya and Dengue Infection among Travelers
   during the Chikungunya Outbreak in the Americas
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID REDUCTION NEUTRALIZATION TEST; GEOSENTINEL SURVEILLANCE;
   VIRUS-INFECTION; ILLNESS; HEALTH; FEVER; ASSAY; ZIKA; PREVALENCE;
   VALIDATION
AB Travelers are at risk for arbovirus infection. We prospectively enrolled 267 Department of Defense beneficiaries traveling to chikungunya-outbreak regions in the Americas between December 2013 and May 2015 and assessed travel characteristics and serologic exposure to chikungunya virus (CHIKV) and dengue virus (DENV). Ten ill-returning travelers were also assessed retrospectively. Self-reported mosquito exposure was common (64% of 198 evaluable travelers saw mosquitoes; 53% of 201 reported >= 1 bite). Increased exposure was associated with active-duty travelers (odds ratio [OR] = 2.6 [1.3-5.4] for seeing mosquitoes) or travelers visiting friends and relatives (VFR) (OR = 3.5 [1.0-10.0] for high-intensity bite exposure). Arbovirus infection was defined as seroconversion on plaque reduction neutralization testing (PRNT) of pre- and posttravel sera. For ill subjects enrolled posttravel, infection was defined by a positive convalescent PRNT and/or a positive reverse transcription polymerase chain reaction for CHIKV or DENV. We identified seven cases of arbovirus infection: four with CHIKV, five with DENV, and two with both. The composite attack rate for CHIKV and DENV infection was 3.7% of 108 evaluable, immunologically naive, prospectively assessed travelers; there was serologic and/or polymerase chain reaction evidence of arbovirus infection in three of four evaluable (three of 10 total) ill-returning travelers. We identified both symptomatic and asymptomatic cases. Military purpose of travel and VFR travel accounted for five of seven cases. Pretravel counseling is important and should target higher risk groups. Given a shared vector between CHIKV, DENV, and Zika virus (ZIKV), this study can also help guide counseling for travelers to ZIKV-outbreak regions.
C1 [Lindholm, David A.; Yun, Heather C.] San Antonio Mil Med Ctr, San Antonio, TX USA.
   [Myers, Todd; Widjaja, Susana] Naval Infect Dis Diagnost Lab, Silver Spring, MD USA.
   [Grant, Edward M.; Telu, Kalyani; Lalani, Tahaniyat; Fraser, Jamie; Fairchok, Mary; Ganesan, Anuradha; Johnson, Mark D.; Kunz, Anjali; Tribble, David R.; Yun, Heather C.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.
   [Lalani, Tahaniyat; Fraser, Jamie; Fairchok, Mary; Ganesan, Anuradha] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA.
   [Lalani, Tahaniyat] Naval Med Ctr, Portsmouth, VA USA.
   [Fairchok, Mary; Kunz, Anjali] Madigan Army Med Ctr, Tacoma, WA 98431 USA.
   [Ganesan, Anuradha] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA.
   [Johnson, Mark D.] Naval Hlth Res Ctr, San Diego, CA USA.
RP Lindholm, DA (corresponding author), Wright Patterson Med Ctr, Infect Dis Serv, 4881 Sugar Maple Dr, Wright Patterson AFB, OH 45433 USA.
EM david.lindholm@us.af.mil; todd.e.myers.mil@mail.mil;
   susana.widjaja.ctr@mail.mil; edward.m.grant@gmail.com; ktelu@idcrp.org;
   tlalani@idcrp.org; jamie.fraser.ctr@usuhs.edu;
   mary.p.fairchok.ctr@mail.mil; anuradha.ganesan.ctr@mail.mil;
   mark.d.johnson292.mil@mail.mil; anjali.n.kunz.mil@mail.mil;
   dtribble@idcrp.org; heather.c.yun.mil@mail.mil
OI Lindholm, David/0000-0001-5428-7404
FU Infectious Disease Clinical Research Program (IDCRP); Department of
   Defense (DoD) through the Uniformed Services University of the Health
   SciencesUnited States Department of Defense; National Institute of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID); National Institutes
   of Health (NIH) under the Inter-Agency [Y1-AI-5072]
FX The study was supported by the Infectious Disease Clinical Research
   Program (IDCRP), a Department of Defense (DoD) program executed through
   the Uniformed Services University of the Health Sciences, the National
   Institute of Allergy and Infectious Diseases, and National Institutes of
   Health (NIH), under the Inter-Agency Agreement Y1-AI-5072.
CR ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408
   Baaten GGG, 2011, EMERG INFECT DIS, V17, P821, DOI 10.3201/eid1705.101125
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Chen LH, 2012, CURR OPIN INFECT DIS, V25, P523, DOI 10.1097/QCO.0b013e328356ffd5
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004073
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   de Laval F, 2013, J TRAVEL MED, V20, P259, DOI 10.1111/j.1708-8305.2012.00674.x
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Doucoure S, 2015, INSECTS, V6, P961, DOI 10.3390/insects6040961
   Doucoure S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001487
   Evans MR, 2001, J INFECTION, V43, P140, DOI 10.1053/jinf.2001.0876
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075
   Horvath LL, 2005, J TRAVEL MED, V12, P332, DOI 10.2310/7060.2005.12606
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Khan K, 2014, PLOS CURR, V6
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460
   LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization, 2015, NUMB REP CAS CHIK FE
   Pan American Health Organization, 2015, NUMB REP CAS DENG SE
   Pan American Health Organization, 2016, NUMB REP CAS DENG SE
   Pan American Health Organization, 2016, ZIK EP UPD 23 JUN 20
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, CUM ZIK SUSP CONF CA
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, NUMB REP CAS CHIK FE
   Potasman I, 1999, EMERG INFECT DIS, V5, P824, DOI 10.3201/eid0506.990615
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233
   RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952
   Sanchez-Vegas C, 2013, J TRAVEL MED, V20, P352, DOI 10.1111/jtm.12057
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 55
TC 7
Z9 7
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 96
IS 4
BP 903
EP 912
DI 10.4269/ajtmh.16-0635
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EV4WA
UT WOS:000401763000026
PM 28115671
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Hall-Mendelin, S
   Hewitson, GR
   Genge, D
   Burtonclay, PJ
   De Jong, AJ
   Pyke, AT
   van den Hurk, AF
AF Hall-Mendelin, Sonja
   Hewitson, Glen R.
   Genge, Doris
   Burtonclay, Peter J.
   De Jong, Amanda J.
   Pyke, Alyssa T.
   van den Hurk, Andrew F.
TI FTA Cards Facilitate Storage, Shipment, and Detection of Arboviruses in
   Infected Aedes aegypti Collected in Adult Mosquito Traps
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; VIRAL-RNA; DIPTERA; CULICIDAE; SURVEILLANCE;
   VIRUS
AB The utility of applying infected Aedes aegypti to Flinders Technology Associates (FTA (R)) cards for storage, transport, and detection of dengue, Zika, and Barmah Forest viruses was assessed in laboratory-based experiments. The mosquitoes had been removed from Gravid Aedes Traps maintained under conditions of high temperature and humidity. RNA of all viruses could be detected in infected mosquitoes on FTA cards either individually or in pools with uninfected mosquitoes, and stored for up to 28 days. Importantly, there was only a minimal decrease in RNA levels in mosquitoes between days 0 and 28, indicating that viral RNA was relatively stable on the cards. FTA cards thus provide a mechanism for storing potentially infected mosquitoes collected in the field and transporting them to a central diagnostic facility for virus detection.
C1 [Hall-Mendelin, Sonja; Hewitson, Glen R.; Genge, Doris; Burtonclay, Peter J.; De Jong, Amanda J.; Pyke, Alyssa T.; van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol, Forens Serv, Coopers Plains, Australia.
   [Hall-Mendelin, Sonja; Hewitson, Glen R.; Genge, Doris; Burtonclay, Peter J.; De Jong, Amanda J.; Pyke, Alyssa T.; van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol, Sci Serv, Coopers Plains, Australia.
RP van den Hurk, AF (corresponding author), Queensland Govt, Dept Hlth, Forens Serv, Publ Hlth Virol, POB 594, Archerfield, Qld 4108, Australia.; van den Hurk, AF (corresponding author), Queensland Govt, Dept Hlth, Sci Serv, Publ Hlth Virol, POB 594, Archerfield, Qld 4108, Australia.
EM Sonja.Hall-Mendelin@health.qld.gov.au; Glen.Hewitson@health.qld.gov.au;
   Doris.Genge@health.qld.gov.au; Peter.Burtonclay@health.qld.gov.au;
   Amanda.DeJong@health.qld.gov.au; Alyssa.Pyke@health.qld.gov.au;
   andrew.vandenhurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019
OI van den Hurk, Andrew/0000-0001-6262-831X; Pyke,
   Alyssa/0000-0003-3512-4321
CR Abdelwhab EM, 2011, J VIROL METHODS, V174, P120, DOI 10.1016/j.jviromet.2011.03.017
   Bangs MJ, 2001, J MED ENTOMOL, V38, P720, DOI 10.1603/0022-2585-38.5.720
   Barth H, 2016, J VIROL METHODS, V229, P60, DOI 10.1016/j.jviromet.2015.12.010
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866
   Johansen CA, 2002, AM J TROP MED HYG, V67, P656, DOI 10.4269/ajtmh.2002.67.656
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Turell MJ, 2002, J MED ENTOMOL, V39, P1, DOI 10.1603/0022-2585-39.1.1
   van den Hurk AF, 2014, VECTOR-BORNE ZOONOT, V14, P66, DOI 10.1089/vbz.2013.1373
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 19
TC 7
Z9 7
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 96
IS 5
BP 1241
EP 1243
DI 10.4269/ajtmh.16-0981
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EV4WO
UT WOS:000401764600039
PM 28500814
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gendernalik, A
   Weger-Lucarelli, J
   Luna, SMG
   Fauver, JR
   Ruckert, C
   Murrieta, RA
   Bergren, N
   Samaras, D
   Nguyen, C
   Kading, RC
   Ebel, GD
AF Gendernalik, Alex
   Weger-Lucarelli, James
   Luna, Selene M. Garcia
   Fauver, Joseph R.
   Ruckert, Claudia
   Murrieta, Reyes A.
   Bergren, Nicholas
   Samaras, Demitrios
   Nguyen, Chilinh
   Kading, Rebekah C.
   Ebel, Gregory D.
TI American Aedes vexans Mosquitoes are Competent Vectors of Zika Virus
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VALLEY FEVER VIRUS; DIPTERA-CULICIDAE; INFECTION; EPIDEMIC; VIREMIA;
   WEST
AB Starting in 2013-2014, the Americas have experienced a massive outbreak of Zika virus (ZIKV) which has now reached at least 49 countries. Although most cases have occurred in South America and the Caribbean, imported and autochthonous cases have occurred in the United States. Aedes aegypti and Aedes albopictus mosquitoes are known vectors of ZIKV. Little is known about the potential for temperate Aedes mosquitoes to transmit ZIKV. Aedes vexans has a worldwide distribution, is highly abundant in particular localities, aggressively bites humans, and is a competent vector of several arboviruses. However, it is not clear whether Ae. vexans mosquitoes are competent to transmit ZIKV. To determine the vector competence of Ae. vexans for ZIKV, wild-caught mosquitoes were exposed to an infectious bloodmeal containing a ZIKV strain isolated during the current outbreak. Approximately 80% of 148 mosquitoes tested became infected by ZIKV, and approximately 5% transmitted infectious virus after 14 days of extrinsic incubation. These results establish that Ae. vexans are competent ZIKV vectors. Their relative importance as vectors (i.e., their vectorial capacity) depends on feeding behavior, longevity, and other factors that are likely to vary in ecologically distinct environments.
C1 [Gendernalik, Alex; Weger-Lucarelli, James; Luna, Selene M. Garcia; Fauver, Joseph R.; Ruckert, Claudia; Murrieta, Reyes A.; Bergren, Nicholas; Samaras, Demitrios; Nguyen, Chilinh; Kading, Rebekah C.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, 1690 Campus Delivery, Ft Collins, CO 80523 USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, 1690 Campus Delivery, Ft Collins, CO 80523 USA.
EM gregory.ebel@colostate.edu
OI Ruckert, Claudia/0000-0003-3732-6752; Garcia-Luna, Selene
   M./0000-0001-8420-5078; Weger-Lucarelli, James/0000-0002-9483-1694
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI067380, AI125996]; Fogarty
   International CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [2D43TW001130-0681]; National Science
   FoundationNational Science Foundation (NSF) [DGE-1450032]
FX This work was funded by grants from the National Institute of Allergy
   and Infectious Diseases, National Institutes of Health under grant
   numbers AI067380 and AI125996. S. G. L. was supported by a grant from
   the Fogarty International Center under grant number 2D43TW001130-0681
   and R. A. M. was supported by a grant from the National Science
   Foundation under grant number DGE-1450032.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Becker N., 2003, MOSQUITOES THEIR CON
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Mitchell CJ, 1983, TOPICS VECTOR RES, P63
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ndiaye E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1383-y
   PATRICAN LA, 1985, AM J TROP MED HYG, V34, P992, DOI 10.4269/ajtmh.1985.34.992
   THOMPSON PATRICK H., 1965, ANN ENTOMOL SOC AMER, V58, P927, DOI 10.1093/aesa/58.6.927
   Turell MJ, 2013, J MED ENTOMOL, V50, P1111, DOI 10.1603/ME13049
   Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 21
TC 20
Z9 21
U1 1
U2 10
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 96
IS 6
BP 1338
EP 1340
DI 10.4269/ajtmh.16-0963
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FA7WW
UT WOS:000405659100012
PM 28719283
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Julander, JG
   Siddharthan, V
   Evans, J
   Taylor, R
   Tolbert, K
   Apuli, C
   Stewart, J
   Collins, P
   Gebre, M
   Neilson, S
   Van Wettere, A
   Lee, YM
   Sheridan, WP
   Morrey, JD
   Babu, YS
AF Julander, Justin G.
   Siddharthan, Venkatraman
   Evans, Joe
   Taylor, Ray
   Tolbert, Kelsey
   Apuli, Chad
   Stewart, Jason
   Collins, Preston
   Gebre, Makda
   Neilson, Skot
   Van Wettere, Arnaud
   Lee, Young-Min
   Sheridan, William P.
   Morrey, John D.
   Babu, Y. S.
TI Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika
   virus in cell culture and in a mouse model
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; ZIKV; AG129 mice; Antiviral; BCX4430; Ribavirin; Flavivirus
ID GUILLAIN-BARRE-SYNDROME; YELLOW-FEVER; VERTICAL TRANSMISSION; NUCLEOSIDE
   ANALOG; INFECTION; PREGNANCY; MICE
AB Zika virus (ZIKV) is currently undergoing pandemic emergence. While disease is typically subclinical, severe neurologic manifestations in fetuses and newborns after congenital infection underscore an urgent need for antiviral interventions. The adenosine analog BCX4430 has broad-spectrum activity against a wide range of RNA viruses, including potent in vivo activity against yellow fever, Marburg and Ebola viruses. We tested this compound against African and Asian lineage ZIKV in cytopathic effect inhibition and virus yield reduction assays in various cell lines. To further evaluate the efficacy in a relevant animal model, we developed a mouse model of severe ZIKV infection, which recapitulates various human disease manifestations including peripheral virus replication, conjunctivitis, encephalitis and myelitis. Time-course quantification of viral RNA accumulation demonstrated robust viral replication in several relevant tissues, including high and persistent viral loads observed in the brain and testis. The presence of viral RNA in various tissues was confirmed by an infectious culture assay as well as immunohistochemical staining of tissue sections. Treatment of ZIKV-infected mice with BCX4430 significantly improved outcome even when treatment was initiated during the peak of viremia. The demonstration of potent activity of BCX4430 against ZIKV in a lethal mouse model warrant its continued clinical development. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Julander, Justin G.; Siddharthan, Venkatraman; Evans, Joe; Tolbert, Kelsey; Stewart, Jason; Collins, Preston; Gebre, Makda; Neilson, Skot; Morrey, John D.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.
   [Taylor, Ray; Sheridan, William P.; Babu, Y. S.] BioCryst Pharmaceut Inc, Durham, NC USA.
   [Apuli, Chad] Codiagnost Inc, Bountiful, UT USA.
   [Van Wettere, Arnaud; Lee, Young-Min] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.
RP Julander, JG (corresponding author), Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.
EM justin.julander@usu.edu
OI Ditton, Thomas/0000-0003-4622-2613; Gebre, Makda/0000-0001-8520-2178;
   Van Wettere, Arnaud/0000-0002-9611-1316
FU Virology Branch, NIAID, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201000039I,
   HHSN272201100019I/HHSN27200016]
FX We thank Heidi Julander for maintaining the AG129 colonies and Thomas
   Ditton, Neil Motter, Jared Bennett, Jason Fairborne, Rachelle Stanton,
   Devin Pfister, John McClatchy, Jean Maxwell, Mitch Stevensen and Sabrina
   Anderson for their technical assistance in performing animal studies and
   data analysis. We also thank Jana Kent and Joseph Featherstone of
   Co-Diagnostics Inc. for generous provision of reagents and assistance
   with their quantitative qRT-PCR assay for detecting ZIKV RNA. This work
   was supported by the Virology Branch, NIAID, NIH [HHSN272201000039I,
   Task Order A90 and HHSN272201100019I/HHSN27200016, Task Order B23].
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   BROCKLEHURST P, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003510
   Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costa F., 2016, ANN INTERN MED
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gatherer D, 2015, J GEN VIROL
   Gowen BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012760
   Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102
   Huntington S, 2015, AIDS, V29, P801, DOI 10.1097/QAD.0000000000000620
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Lazear H. M., 2016, J VIROL
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrey JD, 2002, ANTIVIR RES, V55, P107, DOI 10.1016/S0166-3542(02)00013-X
   Morrey JD, 2010, J NEUROVIROL, V16, P318, DOI 10.3109/13550284.2010.501847
   O'Shea S, 1998, J MED VIROL, V54, P113, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;113::AID-JMV8&gt;3.0.CO;2-9
   Papp E, 2015, J INFECT DIS, V211, P10, DOI 10.1093/infdis/jiu393
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG
   Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 38
TC 72
Z9 76
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2017
VL 137
BP 14
EP 22
DI 10.1016/j.antiviral.2016.11.003
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EJ1YA
UT WOS:000393005300003
PM 27838352
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hercik, K
   Kozak, J
   Sala, M
   Dejmek, M
   Hrebabecky, H
   Zbornikova, E
   Smola, M
   Ruzek, D
   Nencka, R
   Boura, E
AF Hercik, Kamil
   Kozak, Jaroslav
   Sala, Michal
   Dejmek, Milan
   Hrebabecky, Hubert
   Zbornikova, Eva
   Smola, Miroslav
   Ruzek, Daniel
   Nencka, Radim
   Boura, Evzen
TI Adenosine triphosphate analogs can efficiently inhibit the Zika virus
   RNA-dependent RNA polymerase
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID CRYSTAL-STRUCTURE; NUCLEOSIDE INHIBITORS; NUCLEOTIDE
AB We describe the expression and purification of an active recombinant Zika virus RNA-dependent RNA polymerase (RdRp). Next, we present the development and optimization of an in vitro assay to measure its activity. We then applied the assay to selected triphosphate analogs and discovered that 2'-C-methylated nucleosides exhibit strong inhibitory activity. Surprisingly, also carbocyclic derivatives with the carbohydrate locked in a North-like conformation as well as a ribonucleotide with a South conformation exhibited strong activity. Our results suggest that the traditional 2'-C-methylated nucleosides pursued in the race for anti-HCV treatment can be superseded by brand new scaffolds in the case of the Zika virus. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Hercik, Kamil; Kozak, Jaroslav; Sala, Michal; Dejmek, Milan; Hrebabecky, Hubert; Zbornikova, Eva; Smola, Miroslav; Nencka, Radim; Boura, Evzen] AS CR, Vvi, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic.
   [Ruzek, Daniel] Vet Res Inst, Hudcova 70, CZ-62100 Brno, Czech Republic.
   [Ruzek, Daniel] Czech Acad Sci, Ctr Biol, Inst Parasitol, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
RP Nencka, R; Boura, E (corresponding author), AS CR, Vvi, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic.
EM nencka@uochb.cas.cz; boura@uochb.cas.cz
RI Nencka, Radim/G-5296-2014; Ruzek, Daniel/G-9275-2014; Boura,
   Evzen/G-5275-2014; Sala, Michal/H-2839-2014; Zbornikova, Eva/I-5786-2014
OI Ruzek, Daniel/0000-0003-4655-2380; Zbornikova, Eva/0000-0002-7510-220X;
   Boura, Evzen/0000-0002-9652-4065; Hrebabecky, Hubert/0000-0001-7211-390X
FU Czech Science FoundationGrant Agency of the Czech Republic [15-09310S];
   Academy of Sciences of the Czech RepublicCzech Academy of Sciences [RVO:
   61388963]
FX The project was supported by Czech Science Foundation (Registration No.
   15-09310S). The project was also supported by the Academy of Sciences of
   the Czech Republic (RVO: 61388963).
CR Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chapron C, 2014, BIOORG MED CHEM LETT, V24, P2699, DOI 10.1016/j.bmcl.2014.04.050
   Clarkson R, 2015, J ORG CHEM, V80, P2198, DOI 10.1021/jo502712g
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Dejmek M, 2015, BIOORGAN MED CHEM, V23, P184, DOI 10.1016/j.bmc.2014.11.011
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hrebabecky H, 2015, ORG BIOMOL CHEM, V13, P9300, DOI 10.1039/c5ob00987a
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Rezabkova L, 2010, J STRUCT BIOL, V170, P451, DOI 10.1016/j.jsb.2010.03.009
   Sala M, 2015, ORG BIOMOL CHEM, V13, P2703, DOI 10.1039/c4ob02193b
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   Xie X., 2016, EBIOMEDICINE
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 30
TC 37
Z9 39
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2017
VL 137
BP 131
EP 133
DI 10.1016/j.antiviral.2016.11.020
PG 3
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EJ1YA
UT WOS:000393005300016
PM 27902932
DA 2020-07-08
ER

PT J
AU Bullard-Feibelman, KM
   Govero, J
   Zhu, Z
   Salazar, V
   Veselinovic, M
   Diamond, MS
   Geiss, BJ
AF Bullard-Feibelman, Kristen M.
   Govero, Jennifer
   Zhu, Zhe
   Salazar, Vanessa
   Veselinovic, Milena
   Diamond, Michael S.
   Geiss, Brian J.
TI The FDA-approved drug sofosbuvir inhibits Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; GUILLAIN-BARRE-SYNDROME; METHYLTRANSFERASE
   DOMAIN; NS5 PROTEIN; GENOTYPE 1; RESISTANCE; EMERGENCE; OUTBREAK;
   PSI-7977; CAP
AB The rapidly expanding Zika virus (ZIKV) epidemic has affected thousands of individuals with severe cases causing Guillain-Barre syndrome, congenital malformations, and microcephaly. Currently, there is no available vaccine or therapy to prevent or treat ZIKV infection. We evaluated whether sofosbuvir, an FDA-approved nucleotide polymerase inhibitor for the distantly related hepatitis C virus, could have antiviral activity against ZIKV infection. Cell culture studies established that sofosbuvir efficiently inhibits replication and infection of several ZIKV strains in multiple human tumor cell lines and isolated human fetal derived neuronal stem cells. Moreover, oral treatment with sofosbuvir protected against ZIKV-induced death in mice. These results suggest that sofosbuvir may be a candidate for further evaluation as a therapy against ZIKV infection in humans. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bullard-Feibelman, Kristen M.; Veselinovic, Milena; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Govero, Jennifer; Salazar, Vanessa; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Ctr Human Immunol & Immunotherapy Programs, Sch Med, St Louis, MO USA.
   [Zhu, Zhe] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.
RP Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM brian.geiss@colostate.edu
RI Diamond, Michael/AAH-1733-2019; Zhu, Zhe/H-6009-2019; Geiss,
   Brian/J-3021-2017
OI Diamond, Michael/0000-0002-8791-3165; Zhu, Zhe/0000-0002-5385-948X;
   Geiss, Brian/0000-0001-8180-5772; Salazar, Vanessa/0000-0002-1947-6039
FU Colorado State University College Research Council; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI073755, R01 AI114675]
FX This work was in part supported by grants from the Colorado State
   University College Research Council, NIH R01 AI073755 to M.S.D., and NIH
   R01 AI114675 to B.J.G. We thank Dr. Jeremy Rich for support of Dr. Zhe
   Zhu.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Berden FAC, 2014, NETH J MED, V72, P388
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cada Dennis J, 2014, Hosp Pharm, V49, P466, DOI 10.1310/hpj4905-466
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101
   Cholongitas E, 2014, ANN GASTROENTEROL, V27, P331
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dutartre H, 2006, ANTIMICROB AGENTS CH, V50, P4161, DOI 10.1128/AAC.00433-06
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   Govero J, 2016, NATURE
   GRUN JB, 1986, J VIROL, V60, P1113, DOI 10.1128/JVI.60.3.1113-1124.1986
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7
   KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440
   Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ramirez S., 2016, GASTROENTEROLOGY
   Ramirez S, 2014, HEPATOLOGY, V59, P395, DOI 10.1002/hep.26660
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regan CP, 2016, HEPATOLOGY, V64, P1430, DOI 10.1002/hep.28752
   Rodriguez-Torres M, 2013, J HEPATOL, V58, P663, DOI 10.1016/j.jhep.2012.11.018
   Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544
   Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Xu M., 2016, NAT MED
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 58
TC 105
Z9 108
U1 0
U2 61
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2017
VL 137
BP 134
EP 140
DI 10.1016/j.antiviral.2016.11.023
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EJ1YA
UT WOS:000393005300017
PM 27902933
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Balasubramanian, A
   Teramoto, T
   Kulkarni, AA
   Bhattacharjee, AK
   Padmanabhan, R
AF Balasubramanian, Anuradha
   Teramoto, Tadahisa
   Kulkarni, Amol A.
   Bhattacharjee, Apurba K.
   Padmanabhan, Radhakrishnan
TI Antiviral activities of selected antimalarials against dengue virus type
   2 and Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE In silico modeling; Stereo-electronic profiles; Molecular electrostatic
   potentials (MEPs); Renilla luciferase reporter replicon; Autophagy;
   Cathepsin B
ID RNA-SYNTHESIS; MYCOPHENOLIC-ACID; REPLICATION; AMODIAQUINE; TRANSLATION;
   INFECTION; AUTOPHAGY; MEMBRANE; VACCINE; PROTEIN
AB In a previous study, twelve antimalarial compounds, amodiaquine (AQ) and derivatives, were shown to have potent anti-dengue viral (DENV) activity by using the stable DENV2 Renilla luciferase reporter replicon expressing BHK-21 cells, infectivity (plaque), and the qRT-PCR assays. In this study, we performed molecular modeling on these compounds to determine their stereo-electronic properties required for optimal antiviral activity. Based on the similarity of calculated stereo-electronic profiles, specifically the electrostatic potential profiles of the compounds, and in silico screening of related compounds from literature, we identified three additional compounds, Quinacrine (QC), Mefloquine (MQ), and GSK369796. Analysis of their antiviral activities indicated that all three compounds have high anti-DENV activity in the DENV2 replicon expressing cells with EC50 values of 5.30 +/- 1.31 mu M (QC), 3.22 +/- 0.37 mu M (MQ), and 5.06 +/- 0.86 mu M (GSK369796). The infectivity assays revealed the EC50 values of 7.09 +/- 1.67 mu M (QC), 4.36 +/- 0.31 mu M (MQ) and 3.03 +/- 0.35 mu M (GSK369796). The mode of action of these compounds is through inhibition of autophagy, thereby affecting DENV2 replication. Moreover, these compounds also showed antiviral activity against the rapidly emerging Zika virus (ZIKV) with EC50 values of 2.27 +/- 0.14 mu M (QC), 3.95 +/- 0.21 mu M (MQ), and 2.57 +/- 0.09 mu M (GSK369796). (C) 2016 Elsevier B.V. All rights reserved.
C1 [Balasubramanian, Anuradha; Teramoto, Tadahisa; Bhattacharjee, Apurba K.; Padmanabhan, Radhakrishnan] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA.
   [Kulkarni, Amol A.] Howard Univ, Coll Pharm, Dept Pharmaceut Sci, Washington, DC 20059 USA.
RP Padmanabhan, R (corresponding author), Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA.
EM ab3094@georgetown.edu; rp55@georgetown.edu
FU National Center for Advancing Translational SciencesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR000101, UL1RR031975]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI109185]
FX This project has been funded in part with Federal funds (UL1TR000101
   previously UL1RR031975) from the National Center for Advancing
   Translational Sciences, National Institutes of Health, through the
   Georgetown-Howard Universities Clinical and Translational Science Awards
   Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative,
   "Re-Engineering the Clinical Research Enterprise and an R21 grant from
   National Institutes of Health (AI109185 to R.P.). We thank Dr. Barbara
   Johnson, Center for Disease Control (Atlanta, GA) for the gift of Zika
   virus (MR766) strain. A provisional patent application has been filed by
   Georgetown University listing R.P. as one of the inventors.
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2006, HUM VACCINES, V2, P167, DOI 10.4161/hv.2.4.2944
   Fink K, 2014, EXPERT REV VACCINES, V13, P185, DOI 10.1586/14760584.2014.870888
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Lam SK, 2013, EXPERT REV VACCINES, V12, P995, DOI 10.1586/14760584.2013.824712
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   MACKENZIE AH, 1983, AM J MED, V75, P5, DOI 10.1016/0002-9343(83)91264-0
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Miorin L, 2016, METHODS, V98, P82, DOI 10.1016/j.ymeth.2015.11.002
   Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P1882, DOI 10.1001/jama.2013.4903
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   O'Neill P. M., 2012, TREATMENT PREVENTION
   O'Neill PM, 2009, J MED CHEM, V52, P1408, DOI 10.1021/jm8012618
   O'Neill PM, 2003, J MED CHEM, V46, P4933, DOI 10.1021/jm030796n
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Padmanabhan R, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P13
   Padmanabhan R, 2015, METHODS, V91, P20, DOI 10.1016/j.ymeth.2015.08.002
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x
   Qiao SX, 2013, AUTOPHAGY, V9, P2087, DOI 10.4161/auto.26506
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1
   Subramani S, 2007, CELL, V130, P18, DOI 10.1016/j.cell.2007.06.041
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Teramoto T., 2013, VIROLOGY
   Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Zilbermintz L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13476
NR 55
TC 41
Z9 41
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2017
VL 137
BP 141
EP 150
DI 10.1016/j.antiviral.2016.11.015
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EJ1YA
UT WOS:000393005300018
PM 27889529
DA 2020-07-08
ER

PT J
AU Baz, M
   Goyette, N
   Griffin, BD
   Kobinger, GP
   Boivin, G
AF Baz, Mariana
   Goyette, Nathalie
   Griffin, Bryan D.
   Kobinger, Gary P.
   Boivin, Guy
TI In vitro susceptibility of geographically and temporally distinct Zika
   viruses to favipiravir and ribavirin
SO ANTIVIRAL THERAPY
LA English
DT Article
ID WEST NILE VIRUS; ANTIVIRAL ACTIVITY; DENGUE VIRUS; MOUSE MODEL; T-705;
   INFECTION; INHIBITION; EFFICACY; ANALOGS
AB Background: Zika virus, a previously neglected mosquitoborne virus, is prompting worldwide concern because of its connection with congenital defects, Guillain-Barre syndrome, meningoencephalitis and myelitis in infected individuals. However, no specific antiviral therapy is available at present. In this study, we investigated the in vitro susceptibility of geographically and temporally distinct Zika viruses against the RNA polymerase inhibitors, favipiravir (T-705) and ribavirin.
   Methods: The in vitro activity of each drug and a 1: 1 mixture combination was assessed against five geographically and temporally distinct Zika strains by plaque reduction assay (PRA), the gold standard phenotypic method.
   Results: We showed that both drugs exhibit in vitro inhibitory activity against five different Zika strains isolated in different years and continents, with mean 50% inhibitory concentration (IC50) values of 35 +/- 14 and 35 +/- 20 mu M, respectively, by PRA. We did not observe a synergistic effect when both drugs were combined at the equimolar concentration (IC50 = 33 +/- 11 mu M).
   Conclusions: These results indicate that T-705 has the potential to be used in patients with complicated diseases and/or those individuals presenting with significant comorbidities.
C1 [Baz, Mariana; Goyette, Nathalie; Kobinger, Gary P.; Boivin, Guy] CHU Quebec, Res Ctr Infect Dis, Quebec City, PQ, Canada.
   [Baz, Mariana; Goyette, Nathalie; Kobinger, Gary P.; Boivin, Guy] Laval Univ, Quebec City, PQ, Canada.
   [Griffin, Bryan D.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.
   [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Baz, M; Boivin, G (corresponding author), CHU Quebec, Res Ctr Infect Dis, Quebec City, PQ, Canada.; Baz, M; Boivin, G (corresponding author), Laval Univ, Quebec City, PQ, Canada.
EM mariana.baz@crchudequebec.ulaval.ca; guy.boivin@crchudequebec.ulaval.ca
CR ClinicalTrials.gov, 2013, PHAS 3 EFF SAF STUD
   Cooper Allison C, 2003, Pediatr Nurs, V29, P452
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07
   HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865
   Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jochmans D, 2016, ANTIMICROB AGENTS CH, V60, P4620, DOI 10.1128/AAC.00709-16
   Julander JG, 2009, ANTIVIR RES, V82, P169, DOI 10.1016/j.antiviral.2009.02.201
   KOCHHAR DM, 1980, TOXICOL APPL PHARM, V52, P99, DOI 10.1016/0041-008X(80)90252-5
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000
   MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104
   Mentre F, 2015, LANCET INFECT DIS, V15, P150, DOI 10.1016/S1473-3099(14)71047-3
   Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009
   Perreault M, 2016, STEROIDS, V115, P105, DOI 10.1016/j.steroids.2016.08.015
   Piret J, 2016, J CLIN MICROBIOL, V54, P2120, DOI 10.1128/JCM.03274-15
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005
   Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V424, P777, DOI 10.1016/j.bbrc.2012.07.034
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012
   Vernekar SKV, 2015, J MED CHEM, V58, P4016, DOI 10.1021/acs.jmedchem.5b00327
   WHO, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 30
TC 9
Z9 10
U1 0
U2 2
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2017
VL 22
IS 7
BP 613
EP 618
DI 10.3851/IMP3180
PG 6
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA FW4AZ
UT WOS:000425256100007
PM 28694390
DA 2020-07-08
ER

PT J
AU Alvarado, MG
   Schwartz, DA
AF Alvarado, Maria Gabriela
   Schwartz, David A.
TI Zika Virus Infection in Pregnancy, Microcephaly, and Maternal and Fetal
   Health
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID CEREBRAL ORGANOIDS; BRAIN; MODEL; INFANTS; BRAZIL; BIRTH; RISK
AB Context.-The global epidemic of Zika virus (ZIKV) infection has emerged as an important public health problem affecting pregnant women and their infants.
   Objectives.-To review the causal association between ZIKV infection during pregnancy and intrauterine fetal infection, microcephaly, brain damage, congenital malformation syndrome, and experimental laboratory models of fetal infection. Many questions remain regarding the risk factors, pathophysiology, epidemiology, and timing of maternal-fetal transmission and disease. These include mechanisms of fetal brain damage and microcephaly; the role of covariables, such as viral burden, duration of viremia, and host genetics, on vertical transmission; and the clinical and pathologic spectrum of congenital Zika syndrome. Additional questions include defining the potential long-term physical and neurobehavioral outcomes for infected infants, whether maternal or fetal host genetics influence the clinical outcome, and whether ZIKV infection can cause maternal morbidity. Finally, are experimental laboratory and animal models of ZIKV infection helpful in addressing maternal-fetal viral transmission and the development of congenital microcephaly? This communication provides current information and attempts to address some of these important questions.
   Data Sources.-Comprehensive review of published scientific literature.
   Conclusions.-Recent advances in epidemiology, clinical medicine, pathology, and experimental studies have provided a great amount of new information regarding vertical ZIKV transmission and the mechanisms of congenital microcephaly, brain damage, and congenital Zika syndrome in a relatively short time. However, much work still needs to be performed to more completely understand the maternal and fetal aspects of this new and emerging viral disease.
C1 [Alvarado, Maria Gabriela] Georgia State Univ, Dept Anthropol, Atlanta, GA 30303 USA.
   [Schwartz, David A.] Augusta Univ, Dept Pathol, Med Coll Georgia, Augusta, GA USA.
RP Schwartz, DA (corresponding author), 1950 Grace Arbor Ct, Atlanta, GA 30329 USA.
EM davidalanschwartz@gmail.com
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Branswell H., 2016, STAT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2016, AM J TROP MED HYG, V94, P1187, DOI 10.4269/ajtmh.16-0277
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca CV, LANCET, DOI [10.1016/S0140-6736(16)30902-3, DOI 10.1016/S0140-6736(16)30902-3]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schwartz DA, 2016, PATHOLOGY HELPS UNDE
   Schwartz DA, FETAL BRAIN DAMAGE Z
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   WHO, WHO DIR GEN SUMM OUT
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 55
TC 43
Z9 43
U1 0
U2 25
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 26
EP 32
DI 10.5858/arpa.2016-0382-RA
PG 7
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800005
PM 27636525
OA Bronze
DA 2020-07-08
ER

PT J
AU Rosenberg, AZ
   Yu, WY
   Hill, A
   Reyes, CA
   Schwartz, DA
AF Rosenberg, Avi Z.
   Yu, Weiying
   Hill, Ashley
   Reyes, Christine A.
   Schwartz, David A.
TI Placental Pathology of Zika Virus Viral Infection of the Placenta
   Induces Villous Stromal Macrophage (Hofbauer Cell) Proliferation and
   Hyperplasia
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID EMERGING INFECTIONS; VILLITIS; TISSUES; BRAZIL; BRAIN
AB Context.-The placenta is an important component in understanding the fetal response to intrauterine Zika virus infection, but the pathologic changes in this organ remain largely unknown. Hofbauer cells are fetal-derived macrophages normally present in the chorionic villous stroma. They have been implicated in a variety of physiological and pathologic processes, in particular involving infectious agents.
   Objectives.-To characterize the fetal and maternal responses and viral localization in the placenta following Zika virus transmission to an 11 weeks' gestation fetus. The clinical course was notable for prolonged viremia in the mother and extensive neuronal necrosis in the fetus. The fetus was delivered at 21 weeks' gestation after pregnancy termination.
   Design.-The placenta was evaluated by using immunohistochemistry for inflammatory cells (macrophages/monocytes [Hofbauer cells], B and T lymphocytes) and proliferating cells, and an RNA probe to Zika virus. The fetal brain and the placenta were previously found to be positive for Zika virus RNA by reverse transcriptionpolymerase chain reaction.
   Results.-The placenta demonstrated prominently enlarged, hydropic chorionic villi with hyperplasia and focal proliferation of Hofbauer cells. The degree of Hofbauer cell hyperplasia gave an exaggerated immature appearance to the villi. No acute or chronic villitis, villous necrosis, remote necroinflammatory abnormalities, chorioamnionitis, funisitis, or hemorrhages were present. An RNA probe to Zika virus was positive in villous stromal cells, presumably Hofbauer cells.
   Conclusions.-Zika virus placental infection induces proliferation and prominent hyperplasia of Hofbauer cells in the chorionic villi but does not elicit villous necrosis or a maternal or fetal lymphoplasmacellular or acute inflammatory cell reaction.
C1 [Rosenberg, Avi Z.; Yu, Weiying; Hill, Ashley; Reyes, Christine A.] Childrens Natl Med Ctr, Dept Pathol, Washington, DC 20010 USA.
   [Schwartz, David A.] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA.
RP Schwartz, DA (corresponding author), 1950 Grace Arbor Court, Atlanta, GA 30329 USA.
EM davidalanschwartz@gmail.com
OI Rosenberg, Avi/0000-0003-2356-950X
CR [Anonymous], 2016, SCI DAILY
   Backe E, 1994, TROPHOBLAST RES, V8, P271
   Backe Eva, 1993, Placenta, V14, pA3, DOI 10.1016/S0143-4004(05)80471-0
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CASTELLUCCI M, 1987, PLACENTA, V8, P65, DOI 10.1016/0143-4004(87)90040-3
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GENEST DR, 1992, OBSTET GYNECOL, V80, P585
   Grigoriadis C, 2013, REV BRAS GINECOL OBS, V35, P407, DOI 10.1590/S0100-72032013000900005
   Hung TH, 2006, PLACENTA, V27, P996, DOI 10.1016/j.placenta.2005.11.002
   Joerink M, 2011, PLACENTA, V32, P380, DOI 10.1016/j.placenta.2011.02.003
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Lora J, 1993, P AM SOC TROP MED HY, V271
   Martines RB, LANCET, DOI 0.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NAHMIAS AJ, 1994, TROPHOBLAST RES, V8, P193, DOI DOI 10.1016/S0143-4004(05)80344-3
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REDLINE RW, 1993, AM J PATHOL, V143, P473
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 1996, CLIN INFECT DIS, V23, P248, DOI 10.1093/clinids/23.2.248
   SCHWARTZ DA, 1995, AM J PATHOL, V147, P1525
   SCHWARTZ DA, 1992, ARCH PATHOL LAB MED, V116, P21
   Schwartz DA, 1996, ARCH PATHOL LAB MED, V120, P117
   Schwartz DA, 2016, PATHOLOGY HELPS UNDE
   SCHWARTZ DA, 1994, TROPHOBLAST RES, V8, P223
   Schwartz DA, 2016, FETAL BRAIN DAMAGE Z
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 44
TC 59
Z9 59
U1 0
U2 17
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 43
EP 48
DI 10.5858/arpa.2016-0401-OA
PG 6
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800007
PM 27681334
OA Bronze
DA 2020-07-08
ER

PT J
AU Schwartz, DA
AF Schwartz, David A.
TI Autopsy and Postmortem Studies Are Concordant Pathology of Zika Virus
   Infection Is Neurotropic in Fetuses and Infants With Microcephaly
   Following Transplacental Transmission
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID EMERGING INFECTIONS; BRAIN
AB Context.-Pathology studies have been important in concluding that Zika virus infection occurring in pregnant women can result in vertical transmission of the agent from mother to fetus. Fetal and infant autopsies have provided crucial direct evidence that Zika virus can infect an unborn child, resulting in microcephaly, other malformations, and, in some cases, death.
   Objective.-To better understand the etiologic role and mechanism(s) of Zika virus in causing birth defects such as microcephaly, this communication analyzes the spectrum of clinical and autopsy studies reported from fetuses and infants who developed intrauterine Zika virus infection, and compares these findings with experimental data related to Zika virus infection.
   Design.-Retrospective analysis of reported clinical, autopsy, pathology, and related postmortem studies from 9 fetuses and infants with intrauterine Zika virus infection and microcephaly. Results.-All fetuses and infants examined demonstrated an overlapping spectrum of gross and microscopic neuropathologic abnormalities. Direct cytopathic effects of infection by the Zika virus were confined to the brain; in cases where other organs were evaluated, no direct viral effects were identified.
   Conclusions.-There is concordance of the spectrum of brain damage, reinforcing previous data indicating that the Zika virus has a strong predilection for cells of the fetal central nervous system following vertical transmission. The occurrence of additional congenital abnormalities suggests that intrauterine brain damage from Zika virus interferes with normal fetal development, resulting in fetal akinesia. Experimental in vitro and in vivo studies of Zika virus infection corroborate the human autopsy findings of neural specificity.
C1 [Schwartz, David A.] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA.
RP Schwartz, DA (corresponding author), 1950 Grace Arbor Ct, Atlanta, GA 30329 USA.
EM davidalanschwartz@gmail.com
CR Centers for Disease Control and Prevention, 2016, INT CDC ZIK IN PRESS
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918
   Konstantinidou A, 2007, J MED VIROL, V79, P754, DOI 10.1002/jmv.20887
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization/World Health Organization, 2016, ZIK EP
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schwartz DA, 1997, ARCH PATHOL LAB MED, V121, P776
   Schwartz DA, 1996, CLIN INFECT DIS, V23, P248, DOI 10.1093/clinids/23.2.248
   SCHWARTZ DA, 1995, AM J PATHOL, V147, P1525
   Schwartz DA, 1996, ARCH PATHOL LAB MED, V120, P117
   Schwartz DA, 2016, PATHOLOGY HELPS UNDE
   Schwartz DA, 2016, FETAL BRAIN DAMAGE Z
   Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Strong A, 2016, HEALTH CARE WOMEN IN, V37, P922, DOI 10.1080/07399332.2016.1167896
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Witters I, 2002, AM J MED GENET, V113, P23, DOI 10.1002/ajmg.10698
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 34
TC 29
Z9 29
U1 0
U2 7
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 68
EP 72
DI 10.5858/arpa.2016-0343-OA
PG 5
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800010
PM 27557413
OA Bronze
DA 2020-07-08
ER

PT J
AU Esposito, S
   Longo, MR
AF Esposito, Susanna
   Longo, Maria Roberta
TI Guillain-Barre syndrome
SO AUTOIMMUNITY REVIEWS
LA English
DT Review
DE Acute inflammatory demyelinating polyneuropathy; Acute motor axonal
   neuropathy; Acute paralytic neuropathy; Guillain-Barre syndrome
ID CLINICAL-FEATURES; ZIKA VIRUS; INFLUENZA; DIAGNOSIS; INFECTION;
   VACCINES; IMMUNOTHERAPY; VACCINATIONS; EPIDEMIOLOGY; AUTOIMMUNITY
AB The term Guillain-Barre syndrome (GBS), the most frequent cause of acute paralytic neuropathy, covers a number of recognisably distinct variants. The exact cause of GBS is unknown, but 50-70% of cases appear 1-2 weeks after a respiratory or gastrointestinal infection, or another immune stimulus that induces an aberrant autoimmune response targeting peripheral nerves and their spinal roots. The interplay between the microbial and host factors that dictate whether and how the immune response shifts towards autoreactivity is still unclear, and nothing is known about the genetic and environmental factors that affect an individual's susceptibility to the disease. All patients with GBS need meticulous monitoring, and can benefit from supportive care and the early start of specific treatment. This review summarises the clinical features and diagnostic criteria of GBS and proposes an algorithm for its management An analysis of the literature showed that, about one century after it was first described, new information concerning its etiopathogenesis has allowed the development of new treatment strategies that should be started immediately after diagnosis; however, the available therapies are not sufficient in many patients, especially in the presence of the acute inflammatory demyelinating polyneuropathy. New post-infectious forms, such as those caused by Zika virus and enterovirus D68, need to be carefully analysed and, in order to improve patient outcomes, research should continue to aim at identifying new biomarkers of disease severity and better means of avoiding axonal injury. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Esposito, Susanna; Longo, Maria Roberta] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Via Commenda 9, I-20122 Milan, Italy.
RP Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Via Commenda 9, I-20122 Milan, Italy.
EM susanna.esposito@unimi.it
RI Esposito, Susanna/K-3475-2016
OI Esposito, Susanna/0000-0003-4103-2837
FU Italian Ministry of Health (Fondazione IRCCS Ca' Granda Ospedale
   Maggiore Policlinico Ricerca Corrente) [2016 850/01]
FX This review was supported by a grant from the Italian Ministry of Health
   (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Ricerca
   Corrente 2016 850/01). The authors declare that they have no potential
   conflict of interest.
CR Agrawal S, 2007, ARCH DIS CHILDHOOD-E, V92, P161, DOI 10.1136/adc.2004.065706
   ALDIN ASN, 1985, BMJ-BRIT MED J, V291, P535, DOI 10.1136/bmj.291.6494.535
   ALTER M, 1990, ANN NEUROL, V27, pS7, DOI 10.1002/ana.410270704
   Bardenheier BH, 2016, VACCINE, V34, P4406, DOI 10.1016/j.vaccine.2016.07.019
   Bogliun G, 2004, ACTA NEUROL SCAND, V110, P100, DOI 10.1111/j.1600-0404.2004.00272.x
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051
   DiCapua Daniel B, 2015, J Clin Neuromuscul Dis, V17, P47, DOI 10.1097/CND.0000000000000091
   Eldar AH, 2014, AUTOIMMUN REV, V13, P525, DOI 10.1016/j.autrev.2014.01.033
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gadre G, 2010, J NEUROL NEUROSUR PS, V81, P812, DOI 10.1136/jnnp.2009.185504
   Ghaderi S, 2016, EUR J EPIDEMIOL, V31, P67, DOI 10.1007/s10654-015-0047-0
   Griffin JW, 1996, ANN NEUROL, V39, P17, DOI 10.1002/ana.410390105
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005
   Hahn AF, 1998, LANCET, V352, P635, DOI 10.1016/S0140-6736(97)12308-X
   HALLAS J, 1988, ACTA NEUROL SCAND, V78, P118, DOI 10.1111/j.1600-0404.1988.tb03632.x
   Hawken S, 2015, EMERG INFECT DIS, V21, P224, DOI 10.3201/eid2102.131879
   Ho T, 1999, CURR OPIN NEUROL, V12, P389, DOI 10.1097/00019052-199908000-00004
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5
   Jasti AK, 2016, EXPERT REV CLIN IMMU, P1
   Korinthenberg R, 2005, PEDIATRICS, V116, P8, DOI 10.1542/peds.2004-1324
   Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003
   Liu J, 2015, COCHRANE DB SYST REV, V4
   Loshaj-Shala A, 2015, J NEUROIMMUNOL, V289, P168, DOI 10.1016/j.jneuroim.2015.11.005
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Lucchese G, 2016, AUTOIMMUN REV, V15, P854, DOI 10.1016/j.autrev.2016.04.003
   Arias LHM, 2015, VACCINE, V33, P3773, DOI 10.1016/j.vaccine.2015.05.013
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   Moise L, 2016, EXPERT REV VACCINES, V15, P607, DOI 10.1586/14760584.2016.1123098
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   Ostronoff F, 2008, BONE MARROW TRANSPL, V42, P71, DOI 10.1038/bmt.2008.81
   Pithadia AB, 2010, PHARMACOL REP, V62, P220, DOI 10.1016/S1734-1140(10)70261-9
   Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62
   Roodbol J, 2014, J PERIPHER NERV SYST, V19, P121, DOI 10.1111/jns5.12068
   ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706
   Rosen BA, 2012, PEDIATR REV, V33, P164, DOI 10.1542/pir.33-4-164
   Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345
   Ryan MM, 2013, CURR OPIN PEDIATR, V25, P689, DOI 10.1097/MOP.0b013e328365ad3f
   Sauteur PM Meyer, 2016, ANN NEUROL
   Schaller B, 2001, EUR NEUROL, V46, P167, DOI 10.1159/000050798
   Schessl J, 2006, EUR J PEDIATR, V165, P605, DOI 10.1007/s00431-006-0140-1
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Soliven B, 2014, ILAR J, V54, P282, DOI 10.1093/ilar/ilt054
   Sudo M, 2016, INT IMMUNOPHARMACOL, V40, P11, DOI 10.1016/j.intimp.2016.08.019
   Tselis AC, 2014, HAND CLINIC, V123, P285, DOI 10.1016/B978-0-444-53488-0.00013-4
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van den Berg B, 2014, NEUROLOGY, V82, P1984, DOI 10.1212/WNL.0000000000000481
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Van Koningsveld R, 2000, NEUROLOGY, V54, P620, DOI 10.1212/WNL.54.3.620
   Vitaliti G, 2015, HUM VACC IMMUNOTHER, V11, P2749, DOI 10.1080/21645515.2015.1061161
   Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Williams CJ, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.4.30119
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Willison HJ, 2013, TRENDS IMMUNOL, V34, P453, DOI 10.1016/j.it.2013.05.001
   WINNER SJ, 1990, Q J MED, V77, P1297, DOI 10.1093/qjmed/77.3.1297
   Wong AHY, 2015, J PERIPHER NERV SYST, V20, P47, DOI 10.1111/jns.12104
   Yikilmaz A, 2010, CHILD NERV SYST, V26, P1103, DOI 10.1007/s00381-010-1197-8
   Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4
   Zivkovic S, 2015, ACTA NEUROL SCAND
   Zuccoli G, 2011, AM J NEURORADIOL, V32, P639, DOI 10.3174/ajnr.A2358
NR 67
TC 41
Z9 44
U1 2
U2 57
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD JAN
PY 2017
VL 16
IS 1
BP 96
EP 101
DI 10.1016/j.autrev.2016.09.022
PG 6
WC Immunology
SC Immunology
GA EI7LN
UT WOS:000392679500012
PM 27666816
DA 2020-07-08
ER

PT J
AU de Puig, H
   Bosch, I
   Carre-Camps, M
   Hamad-Schifferli, K
AF de Puig, Helena
   Bosch, Irene
   Carre-Camps, Marc
   Hamad-Schifferli, Kimberly
TI Effect of the Protein Corona on Antibody-Antigen Binding in Nanoparticle
   Sandwich Immunoassays
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; SILVER NANOPARTICLES; GOLD NANOPARTICLES;
   CANCER; DIAGNOSTICS; CONFORMATION; RELEASE; YIELD
AB We investigated the effect of the protein corona on the function of nanoparticle (NP) antibody (Ab) conjugates in dipstick sandwich immunoassays. Ab specific for Zika virus nonstructural protein 1 (NS1) were conjugated to gold NPs, and another anti-NS1 Ab was immobilized onto the nitrocellulose membrane. Sandwich immunoassay formation was influenced by whether the strip was run in corona forming conditions, i.e., in human serum. Strips run in buffer or pure solutions of bovine serum albumin exhibited false positives, but those run in human serum did not. Serum pretreatment of the nitrocellulose also eliminated false positives. Corona formation around the NP-Ab in serum was faster than the immunoassay time scale. Langmuir binding analysis determined how the immobilized Ab affinity for the NP-Ab/NS1 was impacted by corona formation conditions, quantified as an effective dissociation constant, K-D(eff). Results show that corona formation mediates the specificity and sensitivity of the antibody antigen interaction of Zika biomarkers in immunoassays, and plays a critical but beneficial role.
C1 [de Puig, Helena; Hamad-Schifferli, Kimberly] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   [Bosch, Irene] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Carre-Camps, Marc] Univ Ramon Llull, Inst Quim Sarria, Dept Chem Engn, Via Augusta 390, Barcelona 08017, Spain.
   [Hamad-Schifferli, Kimberly] Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.
EM kim.hamad@umb.edu
OI /0000-0002-5368-6996
FU NIH NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI100190]; MIT/SUTD International Design
   Centre; Rafael del Pino Fellowship; Tata Fellowship; Food Drug
   Administration ORISE Fellowship; AEDES project, Colombia
FX This work was funded by NIH NIAID (AI100190). H.d.P. was supported by
   the MIT/SUTD International Design Centre, a Rafael del Pino Fellowship
   and a Tata Fellowship. Irene Bosch was supported by the Food Drug
   Administration ORISE Fellowship and by AEDES project, Colombia. We thank
   Lee Gehrke for support and advice. We thank Justina Tam for experimental
   support. We thank CMSE at MIT for use of their facilities.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Badu-Tawiah AK, 2015, LAB CHIP, V15, P655, DOI 10.1039/c4lc01239a
   Bergese P, 2007, J COLLOID INTERF SCI, V316, P1017, DOI 10.1016/j.jcis.2007.08.048
   Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Choi DH, 2010, BIOSENS BIOELECTRON, V25, P1999, DOI 10.1016/j.bios.2010.01.019
   Cifuentes-Rius A, 2013, ACS NANO, V7, P10066, DOI 10.1021/nn404166q
   Dam DHM, 2012, ACS NANO, V6, P3318, DOI 10.1021/nn300296p
   de Puig H, 2015, J PHYS CHEM C, V119, P17408, DOI 10.1021/acs.jpcc.5b03624
   de Puig H, 2011, SMALL, V7, P2477, DOI 10.1002/smll.201100530
   Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949
   El-Sayed IH, 2005, NANO LETT, V5, P829, DOI 10.1021/nl050074e
   Fleischer CC, 2012, J PHYS CHEM B, V116, P8901, DOI 10.1021/jp304630q
   Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g
   Fu EL, 2011, MICROFLUID NANOFLUID, V10, P29, DOI 10.1007/s10404-010-0643-y
   Hamad-Schifferli K, 2015, NANOMEDICINE-UK, V10, P1663, DOI [10.2217/nnm.15.6, 10.2217/NNM.15.6]
   Jiang X, 2010, J R SOC INTERFACE, V7, pS5, DOI 10.1098/rsif.2009.0272.focus
   Johnston H, 2012, J CONTROL RELEASE, V164, P307, DOI 10.1016/j.jconrel.2012.08.018
   Kah JCY, 2012, ACS NANO, V6, P6730, DOI 10.1021/nn301389c
   Barran-Berdon AL, 2013, LANGMUIR, V29, P6485, DOI 10.1021/la401192x
   Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g
   Mandl A, 2017, BIOCONJUGATE CHEM, V28, P38, DOI 10.1021/acs.bioconjchem.6b00459
   Mirshafiee V, 2013, CHEM COMMUN, V49, P2557, DOI 10.1039/c3cc37307j
   Park S, 2004, NANO LETT, V4, P1925, DOI 10.1021/nl048920t
   Park S, 2010, CURR OPIN CHEM BIOL, V14, P616, DOI 10.1016/j.cbpa.2010.06.186
   Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a
   Patra A, 2016, SMALL, V12, P1174, DOI 10.1002/smll.201501603
   Pitek AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040685
   Polo E, 2013, CHEM COMMUN, V49, P3676, DOI 10.1039/c3cc39112d
   Quesada-Gonzalez D, 2015, BIOSENS BIOELECTRON, V73, P47, DOI 10.1016/j.bios.2015.05.050
   Sacchetti C, 2013, ACS NANO, V7, P1974, DOI 10.1021/nn400409h
   Saha K, 2016, ACS NANO, V10, P4421, DOI 10.1021/acsnano.6b00053
   Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]
   Sokolov K, 2003, TECHNOL CANCER RES T, V2, P491, DOI 10.1177/153303460300200602
   Tan YH, 2008, ACS NANO, V2, P2374, DOI 10.1021/nn800508f
   Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939
   Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q
   Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338
   Welsher K, 2015, J AM CHEM SOC, V137, P580, DOI 10.1021/ja511297d
   Wong RC, 2009, LATERAL FLOW IMMUNOASSAY, P1, DOI 10.1007/978-1-59745-240-3
   Xie JP, 2007, CHEM MATER, V19, P2823, DOI 10.1021/cm0700100
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   You CC, 2007, NANO TODAY, V2, P34, DOI 10.1016/S1748-0132(07)70085-3
   Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712
NR 44
TC 20
Z9 20
U1 6
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JAN
PY 2017
VL 28
IS 1
BP 230
EP 238
DI 10.1021/acs.bioconjchem.6b00523
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA EI4JG
UT WOS:000392459200026
PM 28095684
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Sankar, S
   Ramamurthy, M
   Nandagopal, B
   Sridharan, G
AF Sankar, Sathish
   Ramamurthy, Mageshbabu
   Nandagopal, Balaji
   Sridharan, Gopalan
TI In Silico Validation of D7 Salivary Protein-derived B- and T-cell
   Epitopes of Aedes aegypti as Potential Vaccine to Prevent Transmission
   of Flaviviruses and Togaviruses to Humans
SO BIOINFORMATION
LA English
DT Article
DE mosquito salivary protein; D7; Epitope; MHC; Flaviviruses; Togaviruses
ID TAP-BINDING PEPTIDES; DENGUE VIRUS; YELLOW-FEVER; PREDICTION; INFECTION
AB Mosquito (Aedes aegyptii) salivary proteins play a crucial role in facilitating viral transmission from vector-to-host due to their role in facilitating the "blood meal" of the vector. Three main proteins, D7, aegyptin and Sialokinin play a role in this process. Using in-silico programs, we identified B-and T-cell epitopes in the mosquito salivary proteins D7 long and short form. T-cell epitopes with high affinity to the most prevalent HLA MHC class-I supertypes among different population groups was chosen. It is our postulate that these epitopes could be successful in eliciting B and T cell responses, which would decrease the vector blood meal efficiency and hence protect against host infection by certain viruses. These include causative agents like Dengue viruses, Chikungunya virus, Zika and Yellow fever viruses. These viruses are of major public health importance in several countries in the Americas, Asia and Africa. Experimental evidence exists in previously published literature showing the protective effect of antibodies to certain salivary proteins in susceptible hosts. A novel approach of immunizing humans against the vector proteins to reduce transmission of viruses is now under investigation in several laboratories. We have identified the following two B cell epitopes LAALHVTAAPLWDAKDPEQF one from D7L and the other TSEYPDRQNQIEELNKLCKN from D7S. Likewise, two T cell epitopes MTSKNELDV one from D7L and the other YILCKASAF from D7S with affinity to the predominant MHC class-I supertypes were identified towards evaluation as potential vaccine.
C1 [Sankar, Sathish; Ramamurthy, Mageshbabu; Nandagopal, Balaji; Sridharan, Gopalan] Sri Narayani Hosp & Res Ctr, Sri Sakthi Amma Inst Biomed Res, Vellore 632055, Tamil Nadu, India.
RP Sankar, S (corresponding author), Sri Narayani Hosp & Res Ctr, Sri Sakthi Amma Inst Biomed Res, Vellore 632055, Tamil Nadu, India.
EM sathish3107@gmail.com
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042
   Amat-ur-Rasool H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119854
   ANDERSON JM, 2006, BMC GENOMICS, V7
   Anugraha G, 2015, SCAND J IMMUNOL, V82, P380, DOI 10.1111/sji.12340
   Atkinson SC, 2015, NAT STRUCT MOL BIOL, V22, P532, DOI 10.1038/nsmb.3048
   Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104
   Bhasin Manoj, 2007, V409, P381, DOI 10.1007/978-1-60327-118-9_28
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200
   CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Dhawan R, 2017, OMICS, V21, P45, DOI 10.1089/omi.2016.0160
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Dimitrov I, 2016, METHODS MOL BIOL, V1404, P761, DOI 10.1007/978-1-4939-3389-1_50
   Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06
   Doucoure S, 2015, INSECTS, V6, P961, DOI 10.3390/insects6040961
   Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Janahi EM, 2017, EXCLI J, V16, P63, DOI 10.17179/excli2016-719
   Juhn J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-1
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Khetarpal N, 2016, J IMMUNOL RES, DOI 10.1155/2016/6803098
   Li XL, 2010, PROTEIN PEPTIDE LETT, V17, P1129, DOI 10.2174/092986610791760469
   Londono-Renteria B, 2015, BIOMEDICA, V35, P572, DOI 10.7705/biomedica.v35i4.2530
   Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200
   McCracken M, 2014, VIROLOGY, V133
   Moseman EA, 2013, IMMUNOL REV, V255, P110, DOI 10.1111/imr.12093
   Oktarianti R, 2015, J INFECT PUBLIC HEAL, V8, P575, DOI 10.1016/j.jiph.2015.04.022
   Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400
   Roeffen W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0972-0
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sankar S, 2017, BIOINFORMATION, V13, P94, DOI 10.6026/97320630013094
   Sasaki T, 2017, JPN J INFECT DIS, V70, P38, DOI 10.7883/yoken.JJID.2015.671
   Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1
   Singh H, 2013, PLOS ONE, V8
   Singh SP, 2016, HUM IMMUNOL, V77, P295, DOI 10.1016/j.humimm.2015.11.012
   Stevanovic S, 2002, TRANSPL IMMUNOL, V10, P133, DOI 10.1016/S0966-3274(02)00059-X
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 50
TC 1
Z9 1
U1 0
U2 1
PU BIOMEDICAL INFORMATICS
PI TAMIL NADU
PA NO 42, 2ND MAIN RD, CHENNAI, TAMIL NADU, 600 020, INDIA
SN 0973-8894
EI 0973-2063
J9 BIOINFORMATION
JI Bioinformation
PY 2017
VL 13
IS 11
BP 366
EP 375
DI 10.6026/97320630013366
PG 10
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GZ7HY
UT WOS:000449650400003
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Drew, VJ
   Barro, L
   Seghatchian, J
   Burnouf, T
AF Drew, Victor J.
   Barro, Lassina
   Seghatchian, Jerard
   Burnouf, Thierry
TI Towards pathogen inactivation of red blood cells and whole blood
   targeting viral DNA/RNA: design, technologies, and future prospects for
   developing countries
SO BLOOD TRANSFUSION
LA English
DT Review
DE blood; red blood cell; virus; pathogen; inactivation
ID HEPATITIS-C VIRUS; FRESH-FROZEN PLASMA; PLATELET TRANSFUSION; GENOTYPE
   6; INFECTION; EPIDEMIOLOGY; REDUCTION; MALARIA; SYSTEM; TRANSMISSION
AB Over 110 million units of blood are collected yearly. The need for blood products is greater in developing countries, but so is the risk of contracting a transfusion-transmitted infection. Without efficient donor screening/viral testing and validated pathogen inactivation technology, the risk of transfusion-transmitted infections correlates with the infection rate of the donor population. The World Health Organization has published guidelines on good manufacturing practices in an effort to ensure a strong global standard of transfusion and blood product safety. Sub-Saharan Africa is a high-risk region for malaria, human immunodeficiency virus (HIV), hepatitis B virus and syphilis. Southeast Asia experiences high rates of hepatitis C virus. Areas with a tropical climate have an increased risk of Zika virus, Dengue virus, West Nile virus and Chikungunya, and impoverished countries face economical limitations which hinder efforts to acquire the most modern pathogen inactivation technology. These systems include Mirasol (R) Pathogen Reduction Technology, INTERCEPT (R), and THERAFLEX (R). Their procedures use a chemical and ultraviolet or visible light for pathogen inactivation and significantly decrease the threat of pathogen transmission in plasma and platelets. They are licensed for use in Europe and are used in several other countries. The current interest in the blood industry is the development of pathogen inactivation technologies that can treat whole blood (WB) and red blood cell (RBC). The Mirasol system has recently undergone phase III clinical trials for treating WB in Ghana and has demonstrated some efficacy toward malaria inactivation and low risk of adverse effects. A 2nd-generation of the INTERCEPT (R) S-303 system for WB is currently undergoing a phase III clinical trial. Both methodologies are applicable for WB and components derived from virally reduced WB or RBC.
C1 [Drew, Victor J.; Barro, Lassina; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan.
   [Barro, Lassina] Natl Ctr Blood Transfus, Ouagadougou, Burkina Faso.
   [Seghatchian, Jerard] Int Consultancy Blood Components Qual Improvement, London, England.
   [Burnouf, Thierry] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, 250 Wuxing St, Taipei, Taiwan.
RP Burnouf, T (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, 250 Wuxing St, Taipei, Taiwan.
EM thburnouf@gmail.com
RI Burnouf, Thierry/H-4784-2019
CR Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X
   Amer A, 2016, J VIROL ANTIVIR RES, V5, P3
   Angchaisuksiri P, 2014, THROMB RES, V133, P5, DOI 10.1016/j.thromres.2013.09.030
   [Anonymous], 2014, NURSING STANDARD, V50, P17
   AuBuchon JP, 2002, TRANSFUSION, V42, P146, DOI 10.1046/j.1537-2995.2002.00021.x
   Australian Red Cross Blood Service, 2015, 2105 SURV REP TRANSF
   Benjamin RJ, 2005, TRANSFUSION, V45, P1739, DOI 10.1111/j.1537-2995.2005.00583.x
   Bisseye C, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.69.2767
   Bowen V, 2015, MMWR-MORBID MORTAL W, V64, P1241, DOI 10.15585/mmwr.mm6444a3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRUISTEN S, 1993, AIDS RES HUM RETROV, V9, P259, DOI 10.1089/aid.1993.9.259
   Burnouf T, 2013, VOX SANG, V104, P1, DOI 10.1111/j.1423-0410.2012.01621.x
   Burnouf T, 2007, TRANSFUS MED REV, V21, P101, DOI 10.1016/j.tmrv.2006.11.001
   Castiglia S, 2014, CYTOTHERAPY, V16, P750, DOI 10.1016/j.jcyt.2013.12.008
   Centers for Dis ease Control and Prevention, 2013, DIS ORG BLOOD SAF
   Centers for Disease Control and Prevention, 2016, ZIK BLOOD TRANSF
   Centers for Disease Control and Prevention, 2016, HEP C FAQS PUBL
   Chao DT, 2011, ALIMENT PHARM THER, V34, P286, DOI 10.1111/j.1365-2036.2011.04714.x
   Chatterjee Kabita, 2016, Asian J Transfus Sci, V10, P127, DOI 10.4103/0973-6247.187946
   Chen L, 2016, J ANTIVIR ANTIRETROV, V8
   Chou ML, 2012, VOX SANG, V102, P277, DOI 10.1111/j.1423-0410.2011.01560.x
   Chou ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117800
   Cohen SE, 2013, INFECT DIS CLIN N AM, V27, P705, DOI 10.1016/j.idc.2013.08.005
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   De Santis Marco, 2012, Infect Dis Obstet Gynecol, V2012, P430585, DOI 10.1155/2012/430585
   de Sousa G, 2015, TRANSFUS APHER SCI, V52, P228, DOI 10.1016/j.transci.2015.02.010
   Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108
   Dhingra N., 2006, MAKING SAFE BLOOD AV
   Di Minno G, 2016, BLOOD REV, V30, P35, DOI 10.1016/j.blre.2015.07.004
   Dodd RY, 2012, BRIT J HAEMATOL, V159, P135, DOI 10.1111/bjh.12031
   El-Ekiaby M, 2010, TRANSFUSION MED, V20, P48, DOI 10.1111/j.1365-3148.2009.00963.x
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Food and Drug Administration (FDA), 2015, SEL COMM GRAS SUBST
   Food & Drug Administration, 2016, FDA ADV TEST ZIK VIR
   Freimanis G, 2013, TRANSFUSION, V53, P1429, DOI 10.1111/j.1537-2995.2012.03943.x
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Garraud O, 2016, BLOOD TRANSFUS-ITALY, V14, P109, DOI 10.2450/2015.0042-15
   Goodrich RP, 2009, TRANSFUSION, V49, P1205, DOI 10.1111/j.1537-2995.2009.02126.x
   Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
   Harrington T, 2003, TRANSFUSION, V43, P1018, DOI 10.1046/j.1537-2995.2003.00481.x
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   HOROWITZ B, 1992, BLOOD, V79, P826
   Kaiser-Guignard J, 2014, BLOOD REV, V28, P235, DOI 10.1016/j.blre.2014.07.005
   Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557
   Kitchen AD, 2006, VOX SANG, V90, P77, DOI 10.1111/j.1423-0410.2006.00733.x
   Kleinman S, 2015, TRANSFUSION, V55, P2983, DOI 10.1111/trf.13259
   Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882
   Kucirka LM, 2011, AM J TRANSPLANT, V11, P1188, DOI 10.1111/j.1600-6143.2011.03460.x
   Kwon SY, 2016, ISBT SCI SERIES, V11, P117
   Lee TH, 1998, TRANSFUSION, V38, P580, DOI 10.1046/j.1537-2995.1998.38698326338.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   del Prado GRL, 2014, J INFECT DEV COUNTR, V8, P1, DOI 10.3855/jidc.4610
   Lozano M, 2016, PRESSE MED, V45, pE289, DOI 10.1016/j.lpm.2016.06.020
   Marks DC, 2014, ISBT SCI SER, V9, P44, DOI 10.1111/voxs.12085
   Milner D, 2012, PATHOGENESIS MALARIA
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Mittal A, 2007, OPHTHALMOLOGY, V114, P1798, DOI 10.1016/j.ophtha.2007.03.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreno M, 2006, J VIRAL HEPATITIS, V13, P28, DOI 10.1111/j.1365-2893.2005.00650.x
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mundt JM, 2014, PHOTOCHEM PHOTOBIOL, V90, P957, DOI 10.1111/php.12311
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Neisser-Svae A, 2015, TRANSFUS APHER SCI, V52, P237, DOI 10.1016/j.transci.2015.02.012
   Nkohkwo A, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.363
   Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
   Owusu-Ofori AK, 2011, EMERG INFECT DIS, V17, P2080, DOI 10.3201/eid1711.110985
   Padovani JL, 2013, REV SOC BRAS MED TRO, V46, P154, DOI 10.1590/0037-8682-1627-2013
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Picker SM., 2013, J BLOOD DISORD TRANS, V3, P133
   Pinto JT, 2016, ADV NUTR, V7, P973, DOI 10.3945/an.116.012716
   Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Salunkhe V, 2015, TRANSFUS APHER SCI, V52, P19, DOI 10.1016/j.transci.2014.12.016
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   Schmidt PJ, 2001, TRANSFUSION, V41, P1069, DOI 10.1046/j.1537-2995.2001.41081069.x
   Schmidt WN, 1997, J INFECT DIS, V176, P20, DOI 10.1086/514024
   Seed CR, 2015, VOX SANG, V108, P113, DOI 10.1111/vox.12198
   Seghatchian J, 2015, TRANSFUS APHER SCI, V52, P233, DOI 10.1016/j.transci.2015.02.011
   Seghatchian J, 2013, TRANSFUS APHER SCI, V49, P357, DOI 10.1016/j.transci.2013.07.023
   Seo DH, 2015, WORLD J HEPATOL, V7, P600, DOI 10.4254/wjh.v7.i3.600
   Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0
   Sobral Patricia Marial, 2012, Rev. Bras. Hematol. Hemoter., V34, P231, DOI 10.5581/1516-8484.20120056
   Solheim BG, 2008, TRANSFUS APHER SCI, V39, P75, DOI 10.1016/j.transci.2008.05.003
   Tormey CA, 2016, TRANSFUSION, V56, P863, DOI 10.1111/trf.13432
   Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X
   Urwin PJM, 2016, VOX SANG, V110, P310, DOI 10.1111/vox.12371
   Thong VD, 2014, WORLD J GASTROENTERO, V20, P2927, DOI 10.3748/wjg.v20.i11.2927
   Walsh GM, 2016, TRANSFUS MED REV, V30, P53, DOI 10.1016/j.tmrv.2016.02.003
   WANG SG, 1995, VIROLOGY, V213, P254, DOI 10.1006/viro.1995.1567
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   WHO, 2011, ANN 4 WHO GUID GOOD
   Wiltshire M, 2016, TRANSFUSION MED, V26, P208, DOI 10.1111/tme.12298
   World Health Organization, 2016, 10 FACTS BLOOD TRANS
   World Health Organization, 2016, FACT SHEET ZIK
   World Health Organization, 2005, ANN 4 WHO REC PROD C
NR 96
TC 26
Z9 26
U1 0
U2 6
PU SIMTI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PY 2017
VL 15
IS 6
BP 512
EP 521
DI 10.2450/2017.0344-16
PG 10
WC Hematology
SC Hematology
GA FK9AJ
UT WOS:000413802600006
PM 28488960
DA 2020-07-08
ER

PT J
AU El Ghouzzi, V
   Bianchi, FT
   Molineris, I
   Mounce, BC
   Berto, GE
   Rak, M
   Lebon, S
   Aubry, L
   Tocco, C
   Gai, M
   Chiotto, AMA
   Sgro, F
   Pallavicini, G
   Simon-Loriere, E
   Passemard, S
   Vignuzzi, M
   Gressens, P
   Di Cunto, F
AF El Ghouzzi, Vincent
   Bianchi, Federico T.
   Molineris, Ivan
   Mounce, Bryan C.
   Berto, Gaia E.
   Rak, Malgorzata
   Lebon, Sophie
   Aubry, Laetitia
   Tocco, Chiara
   Gai, Marta
   Chiotto, Alessandra M. A.
   Sgro, Francesco
   Pallavicini, Gianmarco
   Simon-Loriere, Etienne
   Passemard, Sandrine
   Vignuzzi, Marco
   Gressens, Pierre
   Di Cunto, Ferdinando
TI ZIKA virus elicits P53 activation and genotoxic stress in human neural
   progenitors similar tomutations involved in severe forms of genetic
   microcephaly and p53 (vol 7, e2440, 2017)
SO CELL DEATH & DISEASE
LA English
DT Correction
RI gressens, pierre/M-7557-2017; Pallavicini, Gianmarco/AAQ-3254-2020
OI gressens, pierre/0000-0002-0909-4221; Pallavicini,
   Gianmarco/0000-0002-7735-3010
CR El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
NR 1
TC 0
Z9 0
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN
PY 2017
VL 8
AR e2567
DI 10.1038/cddis.2016.446
PG 1
WC Cell Biology
SC Cell Biology
GA EK1IM
UT WOS:000393679000019
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Iovine, NM
   Lednicky, J
   Cherabuddi, K
   Crooke, H
   White, SK
   Loeb, JC
   Cella, E
   Ciccozzi, M
   Salemi, M
   Morris, JG
AF Iovine, Nicole M.
   Lednicky, John
   Cherabuddi, Kartikeya
   Crooke, Hannah
   White, Sarah K.
   Loeb, Julia C.
   Cella, Eleonora
   Ciccozzi, Massimo
   Salemi, Marco
   Morris, J. Glenn, Jr.
TI Coinfection With Zika and Dengue-2 Viruses in a Traveler Returning From
   Haiti, 2016: Clinical Presentation and Genetic Analysis
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika virus; dengue virus; Haiti
ID INFECTION
AB Zika virus and dengue virus serotype 2 were isolated from a patient with travel to Haiti who developed fever, rash, arthralgias, and conjunctivitis. The infecting Zika virus was related to Venezuelan and Brazilian strains but evolved along a lineage originating from strains isolated in 2014 in the same region of Haiti.
C1 [Iovine, Nicole M.; Cherabuddi, Kartikeya; Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Div Infect Dis, Gainesville, FL USA.
   [Iovine, Nicole M.; Lednicky, John; White, Sarah K.; Cella, Eleonora; Ciccozzi, Massimo; Salemi, Marco; Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lednicky, John; White, Sarah K.; Loeb, Julia C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.
   [Crooke, Hannah] Univ Florida, Dept Epidemiol, Coll Med, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Cella, Eleonora; Ciccozzi, Massimo; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Sci, Gainesville, FL USA.
   [Cella, Eleonora; Ciccozzi, Massimo] Ist Super Sanita, Mol Epidemiol & Microbial Evolut Epidemiol Unit, Reference Ctr Phylogeny, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
RP Iovine, NM (corresponding author), Univ Florida Hlth, Shands Hosp, Div Infect Dis & Global Med, Rm D2-14D,1600 SW Archer Rd, Gainesville, FL 32610 USA.
EM nicole.iovine@medicine.ufl.edu
RI Lednicky, John A/C-5678-2012; Cella, Eleonora/J-9961-2016; Cherabuddi,
   Kartikeya/AAD-5897-2019; ciccozzi, massimo/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cherabuddi,
   Kartikeya/0000-0001-7390-9053; ciccozzi, massimo/0000-0003-3866-9239;
   Kwiatkowski, Hannah/0000-0003-0139-7567
FU Emerging Pathogens Institute at the University of Florida
FX This work was supported by institutional funding made available by the
   Emerging Pathogens Institute at the University of Florida.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Goeijenbier M, 2016, NETH J MED, V74, P104
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Paul LM, DENGUE VIRUS ANTIBOD
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   VENTURA AK, 1976, J INFECT DIS, V134, P436, DOI 10.1093/infdis/134.5.436
NR 12
TC 23
Z9 23
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP 72
EP 75
DI 10.1093/cid/ciw667
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100020
PM 27694479
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Prisant, N
   Breurec, S
   Moriniere, C
   Bujan, L
   Joguet, G
AF Prisant, Nadia
   Breurec, Sebastien
   Moriniere, Catherine
   Bujan, Louis
   Joguet, Guillaume
TI Zika Virus Genital Tract Shedding in Infected Women of Childbearing age
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
C1 [Prisant, Nadia; Moriniere, Catherine; Joguet, Guillaume] Ctr Etud & Conservat CEufs & Sperme Humain CECOS, Pole Parents Enfants, CCMR, Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Inst Pasteur Guadeloupe, Unite Environm & Sante, Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Univ Antilles, Fac Med Hyacinthe Bastaraud, Pointe a Pitre, Guadeloupe, France.
   [Bujan, Louis] CHU, CECOS, Grp Act Med Reprod, Toulouse, France.
   [Bujan, Louis] Univ Toulouse III, Grp Rech Fertilite Humaine, EA3694, Toulouse, France.
RP Prisant, N (corresponding author), CHU Pointe A Pitre, CCMR, CECOS Caraibes, F-97159 Pointe a Pitre, Guadeloupe, France.
EM nadia.prisant@chu-guadeloupe.fr
OI Bujan, Louis/0000-0003-1540-0536
FU French Agence de la Biomedecine
FX This work was supported by the French Agence de la Biomedecine.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 6
TC 23
Z9 23
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP 107
EP 109
DI 10.1093/cid/ciw669
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100032
PM 27682065
OA Bronze
DA 2020-07-08
ER

PT J
AU Carvalho, MDCG
   Miranda, DD
   van der Linden, V
   Sobral, PF
   Ramos, RCF
   Rocha, MAW
   Cordeiro, MT
   de Alencar, SP
   Nunes, ML
AF Costa Gomes Carvalho, Maria Durce
   Miranda-Filho, Democrito de Barros
   van der Linden, Vanessa
   Sobral, Paula Fabiana
   Ferreira Ramos, Regina Coeli
   Wanderley Rocha, Maria Angela
   Cordeiro, Marli Tenorio
   de Alencar, Sarah Pinheiro
   Nunes, Magda Lahorgue
TI Sleep EEG patterns in infants with congenital Zika virus syndrome
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Article
DE EEG; Zika virus; Microcephaly; Newborns
ID PROGNOSTIC VALUE; FULL-TERM; ELECTROENCEPHALOGRAM; OUTBREAK; PRETERM;
   STATES
AB Objectives: To describe sleep EEG patterns of neonates, and infants with microcephaly due to congenital Zika virus (ZikV) syndrome.
   Methods: A descriptive case series of EEGs performed in a cohort of neonates with microcephaly monitored from October 2015 to February 2016 at a University Hospital in Northeast Brazil. Infants were investigated following an established protocol that includes EEG, neuroimaging studies, PCR and specific antibodies for ZikV detection.
   Results: EEGs (n = 37) from 37 infants were reviewed. Age at investigation varied from 1 to 5 months (mean = 2.6). Diffuse low voltage (n = 7), background asymmetry (n = 6) and modified hypsarrhythmia with or without burst-suppression (n = 11), were the main background abnormalities identified. Interictal EEG abnormalities were identified in 23 recordings (62%) and localized as focal frontal (n = 8) or occipital (n = 2) spikes/sharp, multifocal spikes/sharp waves (n = 13). Electrographic seizures without clinical manifestation were identified in 4 recordings and characterized as focal pseudo rhythmic pattern. Further findings were focal high amplitude slow waves that were registered in the frontal (n = 3) or occipital (n = 1) regions.
   Conclusions: Different types of EEG abnormalities were encountered with a predominance of interictal epileptogenic activity and hypsarrhythmia.
   Significance: Sleep EEGs in congenital Zika virus syndrome are consistently abnormal even in infants who have not yet developed epilepsy. (C) 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Costa Gomes Carvalho, Maria Durce; Miranda-Filho, Democrito de Barros; Sobral, Paula Fabiana; Ferreira Ramos, Regina Coeli; Wanderley Rocha, Maria Angela; de Alencar, Sarah Pinheiro] UPE Univ Pernambuco, Recife, PE, Brazil.
   [van der Linden, Vanessa] AACD, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Aggeu Magalhaes Res Ctr, Dept Virol, Recife, PE, Brazil.
   [Nunes, Magda Lahorgue] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue] Brain Inst Rio Grande do Sul Brains, Av Ipiranga 6690,Bldg 63,103, BR-90610000 Porto Alegre, RS, Brazil.
RP Nunes, ML (corresponding author), Brain Inst Rio Grande do Sul Brains, Av Ipiranga 6690,Bldg 63,103, BR-90610000 Porto Alegre, RS, Brazil.
EM nunes@pucrs.br
OI Silva, Paula/0000-0001-9475-4732
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308590/2013-9]
FX MLN is researcher level 1D from the National Advisory Board (Conselho
   Nacional de Ciencia e Tecnologia - CNPq) - Brazil. DBMF received partial
   support from CNPq (process 308590/2013-9).
CR Besnard M, 2014, EURO SURVEILL
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   De Weerd AW, 1999, RECOMMENDATIONS PRAC, P149
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FOIS A, 1957, NEUROLOGY, V7, P703, DOI 10.1212/WNL.7.10.703
   HOLMES GL, 1993, J CLIN NEUROPHYSIOL, V10, P323, DOI 10.1097/00004691-199307000-00008
   HRACHOVY RA, 1984, EPILEPSIA, V25, P317, DOI 10.1111/j.1528-1157.1984.tb04195.x
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Khan RL, 2008, J CHILD NEUROL, V23, P144, DOI 10.1177/0883073807308711
   LOMBROSO CT, 1985, PEDIATRICS, V76, P52
   Lombroso CT, 1987, ELECTROENCEPHALOGRAP, P725
   Menache CC, 2002, PEDIATR NEUROL, V27, P93, DOI 10.1016/S0887-8994(02)00396-X
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2015, PROT AT SAUD RESP OC
   Mizrahi Eli M., 2001, Epilepsia, V42, P102
   Mlakar J, 2016, NEJM
   MONOD N, 1972, ELECTROEN CLIN NEURO, V32, P529, DOI 10.1016/0013-4694(72)90063-6
   Nunes ML, 2014, CLIN NEUROPHYSIOL, V125, P1121, DOI 10.1016/j.clinph.2013.10.049
   Nunes ML, 2005, ARQ NEURO-PSIQUIAT, V63, P14, DOI 10.1590/S0004-282X2005000100003
   Nunes ML, 1997, ELECTROEN CLIN NEURO, V102, P186, DOI 10.1016/S0013-4694(96)95191-7
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON, P1
   Scher MS, 1988, J CHILD NEUROL, V3, P175
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stockard-Pope JE, 1992, ATLAS NEONATAL ELECT, P329
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Weisman O, 2011, PEDIATRICS, V128, P706, DOI 10.1542/peds.2011-0047
NR 28
TC 24
Z9 24
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1388-2457
EI 1872-8952
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD JAN
PY 2017
VL 128
IS 1
BP 204
EP 214
DI 10.1016/j.clinph.2016.11.004
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EO0GW
UT WOS:000396377300022
PM 27923187
DA 2020-07-08
ER

PT J
AU Dina, NE
   Colnita, A
   Szoke-Nagy, T
   Porav, AS
AF Dina, Nicoleta Elena
   Colnita, Alia
   Szoke-Nagy, Tiberiu
   Porav, Alin Sebastian
TI A Critical Review on Ultrasensitive, Spectroscopic-based Methods for
   High-throughput Monitoring of Bacteria during Infection Treatment
SO CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE Antimicrobial resistance; high-throughput monitoring; mycobacteria;
   ultrasensitive spectroscopy
ID ENHANCED RAMAN-SPECTROSCOPY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY;
   PRINCIPAL COMPONENT ANALYSIS; SINGLE-CELL ANALYSIS; LABEL-FREE
   DETECTION; SERS DETECTION; RAPID IDENTIFICATION; SCATTERING SERS;
   SURFACE; MYCOBACTERIA
AB The world is in the midst of a pre-emptive public health emergency, one that is just as dramatic as the global aggressive viruses-related crises (Ebola, Zika, or SARS), but not as visible. The superbugs and their antimicrobial resistance do not cause much public alarm or awareness, but provoke financial losses of $100trillion annually (WHO, http://www.who.int/mediacentre/commentaries/superbugs-action-now/en/).This status quo review offers an overview of ultrasensitive methods for high-throughput monitoring of bacteria during infection treatment, the effects of antibiotics on bacteria at single-cell level and the challenges we will face in their detection due to the extraordinary capability of these superbugs to gain and constantly improve multiresistance to antibiotics. A special emphasis is put on the ultrasensitive spectroscopic-based analysis techniques, using nanotechnology or not necessarily, that are more and more promising alternatives to conventional culture-based ones. The particular case of Mycobacteria detection is discussed based on recent reported work.
C1 [Dina, Nicoleta Elena; Colnita, Alia; Szoke-Nagy, Tiberiu; Porav, Alin Sebastian] Natl Inst R&D Isotop & Mol Technol, Dept Mol & Biomol Phys, Donat 67-103, Cluj Napoca 400293, Romania.
   [Szoke-Nagy, Tiberiu; Porav, Alin Sebastian] Babes Bolyai Univ, Fac Biol & Geol, Cluj Napoca, Romania.
RP Dina, NE (corresponding author), Natl Inst R&D Isotop & Mol Technol, Dept Mol & Biomol Phys, Donat 67-103, Cluj Napoca 400293, Romania.
EM nicoleta.dina@itim-cj.ro
RI Porav, Alin Sebastian/AAH-4420-2019; Szoke-Nagy, Tiberiu/C-2823-2012;
   Dina, Nicoleta Elena/E-3434-2016; Colnita, Alia/Q-3566-2019; Colnita,
   Alia/A-1756-2017
OI Porav, Alin Sebastian/0000-0003-4238-0083; Dina, Nicoleta
   Elena/0000-0002-0435-2105; Colnita, Alia/0000-0002-5795-8928; Colnita,
   Alia/0000-0002-5795-8928; Szoke-Nagy, Tiberiu/0000-0003-1773-3991
FU grant of the Romanian National Authority for Scientific Research and
   Innovation, CNCS - UEFISCDI [PN-II-RU-TE-2014-4-0862]
FX This work was supported by a grant of the Romanian National Authority
   for Scientific Research and Innovation, CNCS - UEFISCDI, project number
   PN-II-RU-TE-2014-4-0862.
CR Abadian PN, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4867739
   Aldosky HYY, 2012, J PHYS CONF SER, V407, DOI 10.1088/1742-6596/407/1/012020
   Alula MT, 2017, MICROCHIM ACTA, V184, P219, DOI 10.1007/s00604-016-2013-2
   Assmann C, 2015, ANAL BIOANAL CHEM, V407, P8343, DOI 10.1007/s00216-015-8912-y
   Athamneh AIM, 2012, APPL ENVIRON MICROB, V78, P7805, DOI 10.1128/AEM.02000-12
   Baccar H, 2010, TALANTA, V82, P810, DOI 10.1016/j.talanta.2010.05.060
   Bayoudh S, 2008, COLLOID SURFACE A, V318, P291, DOI 10.1016/j.colsurfa.2008.01.005
   Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902
   Boardman AK, 2016, ANAL CHEM, V88, P8026, DOI 10.1021/acs.analchem.6b01273
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   Brogioni B, 2014, MEDCHEMCOMM, V5, P1058, DOI 10.1039/c4md00088a
   Buijtels PCAM, 2008, J CLIN MICROBIOL, V46, P961, DOI 10.1128/JCM.01763-07
   Chan JW, 2005, ANAL CHEM, V77, P5870, DOI 10.1021/ac050692f
   Chauvet R, 2017, APPL SPECTROSC REV, V52, P123, DOI 10.1080/05704928.2016.1209760
   Chen J, 2017, CHEM SOC REV, V46, P1272, DOI 10.1039/c6cs00313c
   De Gelder J, 2007, ANAL CHIM ACTA, V585, P234, DOI 10.1016/j.aca.2006.12.050
   Delogu G, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.070
   Dina NE, 2017, ANALYST, V142, P1782, DOI [10.1039/c7an00106a, 10.1039/C7AN00106A]
   Dochow S, 2016, J BIOPHOTONICS, V9, P958, DOI 10.1002/jbio.201500341
   Dudak Fahriye Ceyda, 2009, Biotechnology Journal, V4, P1003, DOI 10.1002/biot.200800316
   Eberhardt K, 2015, EXPERT REV MOL DIAGN, V15, P773, DOI 10.1586/14737159.2015.1036744
   Efrima S, 1998, J PHYS CHEM B, V102, P5947, DOI 10.1021/jp9813903
   Esko JD, 2009, ESSENTIALS GLYCOBIOL
   Freitag I, 2016, ANALYST, V141, P5986, DOI 10.1039/c6an01739h
   Fu P, 2016, NANOSCALE, V8, P15008, DOI 10.1039/c6nr04086a
   Fujita Y, 2005, MICROBIOL-SGM, V151, P3403, DOI 10.1099/mic.0.28158-0
   Galler K, 2016, ANAL BIOANAL CHEM, V408, P8053, DOI 10.1007/s00216-016-9905-1
   Galler K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24155
   Garcia-Aljaro C, 2008, APPL ENVIRON MICROB, V74, P4054, DOI 10.1128/AEM.02806-07
   Gong TX, 2015, BIOSENS BIOELECTRON, V64, P227, DOI 10.1016/j.bios.2014.08.077
   Guo SX, 2016, ANALYST, V141, P2396, DOI 10.1039/c6an00041j
   Haisch C, 2016, ANAL BIOANAL CHEM, V408, P4535, DOI 10.1007/s00216-016-9444-9
   Hidi IJ, 2016, ANAL BIOANAL CHEM, V408, P8393, DOI 10.1007/s00216-016-9957-2
   Hidi IJ, 2016, J PHYS CHEM C, V120, P20613, DOI 10.1021/acs.jpcc.6b01005
   Hidi IJ, 2016, ANAL CHEM, V88, P9173, DOI 10.1021/acs.analchem.6b02316
   Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x
   Jahn IJ, 2017, ANALYST, V142, P1022, DOI 10.1039/c7an00118e
   Jahn M, 2016, ANALYST, V141, P756, DOI 10.1039/c5an02057c
   Jiang XX, 2013, ANAL CHEM, V85, P2809, DOI 10.1021/ac303337b
   Kim S, 2012, ELECTROCHIM ACTA, V82, P126, DOI 10.1016/j.electacta.2012.05.131
   Kneipp J, 2008, CHEM SOC REV, V37, P1052, DOI 10.1039/b708459p
   Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r
   Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667
   Kneipp K, 2006, TOP APPL PHYS, V103, P261
   Kogermann K, 2016, EUR J PHARM SCI, V95, P2, DOI 10.1016/j.ejps.2016.08.042
   Kotanen Christian N., 2016, Sensing and Bio-Sensing Research, V8, P20, DOI 10.1016/j.sbsr.2016.03.002
   Krafft C, 2016, PROC SPIE, V9704, DOI 10.1117/12.2217781
   Kusic D, 2016, ANAL CHEM, V88, P2533, DOI 10.1021/acs.analchem.5b04699
   Li MQ, 2012, CURR OPIN BIOTECH, V23, P56, DOI 10.1016/j.copbio.2011.11.019
   Lin HY, 2014, SMALL, V10, P4700, DOI 10.1002/smll.201401526
   Liu TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005470
   Liu YJ, 2017, ANAL CHIM ACTA, V952, P9, DOI 10.1016/j.aca.2016.11.064
   Liu Y, 2017, BIOSENS BIOELECTRON, V94, P131, DOI 10.1016/j.bios.2017.02.032
   Lorenz B, 2017, TRENDS MICROBIOL, V25, P413, DOI 10.1016/j.tim.2017.01.002
   Maalouf R, 2007, ANAL CHEM, V79, P4879, DOI 10.1021/ac070085n
   Maglica Z, 2015, MBIO, V6, DOI 10.1128/mBio.02236-14
   Manina G, 2015, CELL HOST MICROBE, V17, P32, DOI 10.1016/j.chom.2014.11.016
   Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6
   Mircescu NE, 2014, ANAL BIOANAL CHEM, V406, P3051, DOI 10.1007/s00216-014-7761-4
   Moritz TJ, 2010, J CLIN MICROBIOL, V48, P4287, DOI 10.1128/JCM.01565-10
   Moritz TJ, 2010, ANAL CHEM, V82, P2703, DOI 10.1021/ac902351a
   Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157
   Nedeljkovic A, 2016, FOOD ANAL METHOD, V9, P1315, DOI 10.1007/s12161-015-0317-1
   Neugebauer U., 2013, OPT PHOTON, V8, P36, DOI DOI 10.1002/OPPH.201300031
   Neugebauer U, 2015, INT J ANTIMICROB AG, V46, pS35, DOI 10.1016/j.ijantimicag.2015.10.014
   Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247
   Pahlow S, 2016, ANAL CHEM, V88, P1570, DOI 10.1021/acs.analchem.5b02829
   Pahlow S, 2015, ADV DRUG DELIVER REV, V89, P105, DOI 10.1016/j.addr.2015.04.006
   Patel IS, 2008, J RAMAN SPECTROSC, V39, P1660, DOI 10.1002/jrs.2064
   Patze S, 2017, ANAL CHIM ACTA, V949, P1, DOI 10.1016/j.aca.2016.10.009
   Pop HF, 2015, STUD U BABES-BOL CHE, V60, P101
   Pop HF, 2009, CHEMOMETR INTELL LAB, V97, P25, DOI 10.1016/j.chemolab.2008.06.006
   Pourjabbar A, 2014, COMPUT GEOSCI-UK, V72, P122, DOI 10.1016/j.cageo.2014.07.004
   Premasiri WR, 2017, ANAL BIOANAL CHEM, V409, P3043, DOI 10.1007/s00216-017-0244-7
   Premasiri WR, 2013, SPECTROSCOPY-US, V28, P52
   Premasiri WR, 2016, ANAL BIOANAL CHEM, V408, P4631, DOI 10.1007/s00216-016-9540-x
   Premasiri WR, 2011, APPL SPECTROSC, V65, P493, DOI 10.1366/10-06173
   Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n
   Radu AI, 2016, ANALYST, V141, P4447, DOI [10.1039/C6AN00390G, 10.1039/c6an00390g]
   Rebuffo-Scheer CA, 2007, J MICROBIOL METH, V68, P282, DOI 10.1016/j.mimet.2006.08.011
   Rivera-Betancourt OE, 2013, ANALYST, V138, P6774, DOI 10.1039/c3an01157g
   ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0
   Ryabchykov O, 2016, CHEMOMETR INTELL LAB, V155, P1, DOI 10.1016/j.chemolab.2016.03.024
   Sarbu C, 2005, TALANTA, V65, P1215, DOI 10.1016/j.talanta.2004.08.047
   Sarbu C, 2008, ANAL BIOANAL CHEM, V390, P1293, DOI 10.1007/s00216-007-1711-3
   Sarbu C, 2011, TALANTA, V85, P1112, DOI 10.1016/j.talanta.2011.05.030
   Schie IW, 2016, ANALYST, V141, P6387, DOI 10.1039/c6an01018k
   Schie IW, 2016, J BIOPHOTONICS, V9, P994, DOI 10.1002/jbio.201600095
   Schroder UC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08217
   Schroder UC, 2013, ANAL CHEM, V85, P10717, DOI 10.1021/ac4021616
   Schuster KC, 2000, J MICROBIOL METH, V42, P29, DOI 10.1016/S0167-7012(00)00169-X
   Sharma VK, 2016, CHEMOSPHERE, V150, P702, DOI 10.1016/j.chemosphere.2015.12.084
   Silge A, 2014, SYST APPL MICROBIOL, V37, P360, DOI 10.1016/j.syapm.2014.05.007
   Smith R, 2016, ANALYST, V141, P3590, DOI 10.1039/c6an00152a
   Szymanska-Chargot M, 2016, PLANTA, V243, P935, DOI 10.1007/s00425-015-2456-4
   Tang MJ, 2013, ANAL BIOANAL CHEM, V405, P1577, DOI 10.1007/s00216-012-6556-8
   Taylor Allen D., 2008, P83, DOI 10.1007/978-0-387-75113-9_5
   Tolstik E, 2016, NANOMED-NANOTECHNOL, V12, P1931, DOI 10.1016/j.nano.2016.04.004
   Torkabadi HH, 2014, BIOCHEMISTRY-US, V53, P4113, DOI 10.1021/bi500529c
   Uenishi Y, 2008, J MICROBIOL METH, V72, P149, DOI 10.1016/j.mimet.2007.11.016
   Vogler N, 2016, J BIOPHOTONICS, V9, P533, DOI 10.1002/jbio.201500237
   Wagner M, 2009, ANNU REV MICROBIOL, V63, P411, DOI 10.1146/annurev.micro.091208.073233
   Wang PX, 2016, ANALYST, V141, P1356, DOI 10.1039/c5an02175h
   Wang PX, 2016, ANAL BIOANAL CHEM, V408, P933, DOI 10.1007/s00216-015-9184-2
   Wang WQ, 2017, SENSOR ACTUAT B-CHEM, V239, P515, DOI 10.1016/j.snb.2016.08.040
   Wang WB, 2016, ACS APPL MATER INTER, V8, P15591, DOI 10.1021/acsami.6b02905
   Wang WB, 2015, FOOD AGR IMMUNOL, V26, P738, DOI 10.1080/09540105.2015.1023266
   Wang Y, 2012, ANAL CHEM, V84, P8345, DOI 10.1021/ac301904x
   Wenning M, 2006, ENVIRON MICROBIOL, V8, P848, DOI 10.1111/j.1462-2920.2005.00971.x
   Xu LG, 2016, MATER TODAY, V19, P595, DOI 10.1016/j.mattod.2016.05.015
   Xu LG, 2016, ADV FUNCT MATER, V26, P1602, DOI 10.1002/adfm.201504587
   Yan D, 2017, ACS PHOTONICS, V4, P138, DOI 10.1021/acsphotonics.6b00688
   Yan D, 2016, ANALYST, V141, P6104, DOI 10.1039/c6an01670g
   Yang DC, 2015, INT J ANTENN PROPAG, DOI 10.1155/2015/109818
   Yang LJ, 2004, ANAL CHEM, V76, P1107, DOI 10.1021/ac0352575
   Yuan YF, 2017, COORDIN CHEM REV, V337, P1, DOI 10.1016/j.ccr.2017.02.006
   Zhou HB, 2015, MICROCHIM ACTA, V182, P2259, DOI 10.1007/s00604-015-1570-0
   Zhou HB, 2015, ANAL CHEM, V87, P6553, DOI 10.1021/acs.analchem.5b01271
   Zhou HB, 2014, ANAL CHEM, V86, P1525, DOI 10.1021/ac402935p
NR 119
TC 4
Z9 4
U1 8
U2 43
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8347
EI 1547-6510
J9 CRIT REV ANAL CHEM
JI Crit. Rev. Anal. Chem.
PY 2017
VL 47
IS 6
BP 499
EP 512
DI 10.1080/10408347.2017.1332974
PG 14
WC Chemistry, Analytical
SC Chemistry
GA FN4JU
UT WOS:000415972500004
PM 28541711
DA 2020-07-08
ER

PT J
AU Zinszer, K
   Morrison, K
   Brownstein, JS
   Marinho, F
   Santos, AF
   Nsoesie, EO
AF Zinszer, Kate
   Morrison, Kathryn
   Brownstein, John S.
   Marinho, Fatima
   Santos, Alexandre F.
   Nsoesie, Elaine O.
TI Reconstruction of Zika Virus Introduction in Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SPREAD
AB We estimated the speed of Zika virus introduction in Brazil by using confirmed cases at the municipal level. Our models indicate a southward pattern of introduction starting from the northeastern coast and a pattern of movement toward the western border with an average speed of spread of 42 km/day or 15,367 km/year.
C1 [Zinszer, Kate; Brownstein, John S.] Bostons Childrens Hosp, Boston, MA USA.
   [Morrison, Kathryn] McGill Univ, Montreal, PQ, Canada.
   [Brownstein, John S.] Harvard Med Sch, Boston, MA USA.
   [Marinho, Fatima; Santos, Alexandre F.] Minist Hlth, Brasilia, DF, Brazil.
   [Nsoesie, Elaine O.] Univ Washington, Seattle, WA 98195 USA.
   [Zinszer, Kate] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA.
RP Zinszer, K (corresponding author), Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA.; Zinszer, K (corresponding author), Boston Childrens Hosp, Computat Epidemiol Grp, 300 Longwood Ave,3409, Boston, MA 02215 USA.
EM kate.zinszer@mail.mcgill.ca
OI Fonseca Santos, Alexandre/0000-0001-6525-2856
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR); National Library of Medicine, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM010812]; National Institute of Environmental Health Sciences,
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [K01ES025438]
FX K.Z. was supported by Canadian Institutes of Health Research; J.B. was
   supported by the National Library of Medicine, National Institutes of
   Health (grant R01LM010812); and E.N. was supported by the National
   Institute of Environmental Health Sciences, National Institutes of
   Health (grant K01ES025438).
CR Adjemian JZ, 2007, AM J TROP MED HYG, V76, P365, DOI 10.4269/ajtmh.2007.76.365
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   World Health Organisation, ZIK VIR COMPL
   World Health Organization, ZIK VIR INF PAR
   Zinszer K, 2015, LANCET INFECT DIS, V15, P1005, DOI 10.1016/S1473-3099(15)00234-0
NR 13
TC 16
Z9 17
U1 0
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 92
EP 94
DI 10.3201/eid2301.161274
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400013
PM 27618573
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Murray, KO
   Gorchakov, R
   Carlson, AR
   Berry, R
   Lai, LL
   Natrajan, M
   Garcia, MN
   Correa, A
   Patel, SM
   Aagaard, K
   Mulligan, MJ
AF Murray, Kristy O.
   Gorchakov, Rodion
   Carlson, Anna R.
   Berry, Rebecca
   Lai, Lilin
   Natrajan, Muktha
   Garcia, Melissa N.
   Correa, Armando
   Patel, Shital M.
   Aagaard, Kjersti
   Mulligan, Mark J.
TI Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFECTION
AB Infection with Zika virus is an emerging public health crisis. We observed prolonged detection of virus RNA in vaginal mucosal swab specimens and whole blood for a US traveler with acute Zika virus infection who had visited Honduras. These findings advance understanding of Zika virus infection and provide data for additional testing strategies.
C1 [Murray, Kristy O.; Gorchakov, Rodion; Berry, Rebecca; Garcia, Melissa N.; Correa, Armando; Patel, Shital M.; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
   [Murray, Kristy O.; Gorchakov, Rodion; Berry, Rebecca; Garcia, Melissa N.; Correa, Armando; Patel, Shital M.; Aagaard, Kjersti] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Carlson, Anna R.] Baylor St Lukes Gen Hosp, Houston, TX USA.
   [Lai, Lilin; Natrajan, Muktha; Mulligan, Mark J.] Emory Univ, Sch Med, Atlanta, GA USA.
   [Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Pediat Trop Med, Houston, TX 77030 USA.
   [Murray, Kristy O.] Natl Sch Trop Med, Houston, TX 77030 USA.
RP Murray, KO (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Murray, KO (corresponding author), Baylor Coll Med, Dept Pediat, Pediat Trop Med, Houston, TX 77030 USA.; Murray, KO (corresponding author), Natl Sch Trop Med, Houston, TX 77030 USA.; Murray, KO (corresponding author), Baylor Coll Med, Natl Sch Trop Med, 1102 Bates St,Ste 550, Houston, TX 77030 USA.
EM kmurray@bcm.edu
RI Mulligan, Mark/V-9275-2019
OI Lai, Lilin/0000-0002-9528-6990; Natrajan, Muktha/0000-0003-1854-0382
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01A1091816-01];
   Emory University School of Medicine discretionary funds; Georgia
   Research Alliance
FX This study was supported in part by a grant from the National Institutes
   of Health (R01A1091816-01) to K.O.M, Emory University School of Medicine
   discretionary funds to M.J.M., and the Georgia Research Alliance.
CR Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, UPD ZIK VIR AM
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 15
TC 117
Z9 117
U1 1
U2 33
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 99
EP 101
DI 10.3201/eid2301.161394
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400015
PM 27748649
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Benelli, G
   Romano, D
AF Benelli, Giovanni
   Romano, Donato
TI Mosquito vectors of Zika virus
SO ENTOMOLOGIA GENERALIS
LA English
DT Article
DE dengue; Flavivirus; mosquito-borne diseases; Integrated Vector
   Management
ID STERILE INSECT TECHNIQUE; VETERINARY IMPORTANCE; INFECTION; DENGUE;
   NANOPARTICLES; RESISTANCE; PREDATION; AMERICA; MALARIA; FIGHT
AB The recent Zika virus outbreaks have been recognized as "Public Health Emergency of International Concern" by WHO. In this review, we summarized current knowledge about Zika virus vector competence in mosquitoes. Aedes africanus was the first species where Zika virus was isolated. Currently, Aedes aegypti and Aedes albopictus are reported as the main species with Zika virus vector competence by many researches. Recently, laboratory experiments showed the vector competence for Zika virus of two new mosquitoes species: Aedes hensilli (23% of infected mosquitoes transmitted Zika virus), and Aedes vexans (5% of infected mosquitoes transmitted Zika virus). Furthermore, Zika virus has been isolated in several species of the genus Aedes, as well as in Mansonia uniformis, Culex perfuscus and Anopheles coustani, but the vector competence of these species was not evaluated in laboratory experiments. Culex quinquefasciatus was found both competent and non-competent vector in studies from different research groups. Overall, the findings summarized in this review showed that Zika virus can be transmitted mainly by Aedes mosquito species, highlighting the pivotal role of effective and eco-friendly control strategies against mosquito vectors, which should always rely to the criteria of Integrated Vector Management, avoiding conventional single-intervention approaches.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni; Romano, Donato] BioRobot Inst, St Anna Sch Adv Studies, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), BioRobot Inst, St Anna Sch Adv Studies, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; Romano,
   Donato/0000-0003-4975-3495
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Becker Norbert, 2012, P31
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Coelho F. C., 2017, BIORXIV
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Melaun C, 2015, PARASITOL RES, V114, P1051, DOI 10.1007/s00436-014-4274-1
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, GLOB BRIEF VECT BORN
NR 48
TC 80
Z9 80
U1 3
U2 22
PU E SCHWEIZERBARTSCHE VERLAGSBUCHHANDLUNG
PI STUTTGART
PA NAEGELE U OBERMILLER, SCIENCE PUBLISHERS, JOHANNESSTRASSE 3A, D 70176
   STUTTGART, GERMANY
SN 0171-8177
EI 2363-7102
J9 ENTOMOL GEN
JI Entomol. Gen.
PY 2017
VL 36
IS 4
BP 309
EP 318
DI 10.1127/entomologia/2017/0496
PG 10
WC Entomology
SC Entomology
GA FN5SR
UT WOS:000416068700003
DA 2020-07-08
ER

PT J
AU Niemeyer, B
   Niemeyer, R
   Borges, R
   Marchiori, E
AF Niemeyer, Bruno
   Niemeyer, Renato
   Borges, Rafael
   Marchiori, Edson
TI Acute Disseminated Encephalomyelitis Following Zika Virus Infection
SO EUROPEAN NEUROLOGY
LA English
DT Editorial Material
C1 [Niemeyer, Bruno] Inst Estadual Cerebro Paulo Niemeyer, Rua Rezende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Niemeyer, Renato] Hosp Clin Jacarepagua, Rio De Janeiro, Brazil.
   [Borges, Rafael] 3D Diagnost Imagem, Rio De Janeiro, Brazil.
   [Marchiori, Edson] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Niemeyer, B (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, Rua Rezende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM bruno.niemeyer@hotmail.com
OI Marchiori, Edson/0000-0001-8797-7380
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
NR 2
TC 18
Z9 21
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-3022
EI 1421-9913
J9 EUR NEUROL
JI Eur. Neurol.
PY 2017
VL 77
IS 1-2
BP 45
EP 46
DI 10.1159/000453396
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EI5UI
UT WOS:000392559900007
PM 27894121
DA 2020-07-08
ER

PT J
AU Barzon, L
   Palu, G
AF Barzon, Luisa
   Palu, Giorgio
TI Current views on Zika virus vaccine development
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Editorial Material
DE Adenovirus vector-based vaccine; chimeric vaccine; clinical trial; DNA
   plasmid vaccine; flavivirus; live attenuated vaccine;
   nucleoside-modified mRNA vaccine; purified inactivated virus vaccine;
   vaccine; Zika virus
ID PROTECTIVE EFFICACY; INFECTION; IMMUNITY
C1 [Barzon, Luisa; Palu, Giorgio] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016
OI Barzon, Luisa/0000-0003-0720-8456
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   European Centre for Disease Prevention and Control, 2017, RAP RISK ASS
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   PAHO/WHO, 2017, ZIK CUM CAS
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
NR 21
TC 17
Z9 17
U1 2
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PY 2017
VL 17
IS 10
BP 1185
EP 1192
DI 10.1080/14712598.2017.1346081
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA FF7OM
UT WOS:000409205800001
PM 28644745
OA Bronze
DA 2020-07-08
ER

PT J
AU Savino, W
   Messias, CV
   Mendes-da-Cruz, DA
   Passos, P
   Ferreira, ACAF
   Nascimento, OJ
AF Savino, Wilson
   Messias, Carolina V.
   Mendes-da-Cruz, Daniella A.
   Passos, Pamela
   Ferreira, Ana Carolina A. F.
   Nascimento, Osvaldo J.
TI Zika Virus Infection in the Elderly: Possible Relationship with
   Guillain-Barre Syndrome
SO GERONTOLOGY
LA English
DT Article
DE Zika virus; Aging; Guillain-Barre syndrome; Autoimmunity; Vaccine; T
   cells
ID REGULATORY T-CELLS; FRENCH-POLYNESIA; DENGUE VIRUS; TRANSMISSION;
   OUTBREAK; REPERTOIRE; COMPLEMENT; ANTIGEN; BRAZIL; BLOOD
AB The Zika virus (ZIKV) outbreak in French Polynesia, in 2013, and in Brazil, in 2015, was correlated with neurological complications, which comprised, among others, congenital microcephaly and Guillain-Barre syndrome (GBS), which includes a group of acute autoimmune neuropathies generally reported after respiratory or gastrointestinal infectious diseases. Despite being relatively rare, the incidence rate of GBS rises with age, which makes GBS more frequent in the elderly, in whom it is also a more severe disease with slower recovery than in younger patients. Different forms of GBS have been described having diagnostic confirmation of a previous infection with the ZIKV virus. Although we do not have enough evidence that elderly people are a particularly susceptible population to developing GBS following ZIKV infection, this is plausible. We should consider this possibility, particularly taking into account that aging subjects are more susceptible to infections. In this context, a deeper understanding of how the immune system in the elderly functions in relation to ZIKV infection is necessary, as well as an under-standing of what kind of alterations of the nervous system such an infection triggers in the elderly, beyond GBS. This will be relevant for better therapeutic interventions and for designing vaccine candidates that can be applied in an aging population, particularly those prone to develop ZIKV-induced autoimmunity. (C) 2016 S. Karger AG, Basel
C1 [Savino, Wilson; Messias, Carolina V.; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Leonidas Deane Bldg,Room 510,Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Savino, Wilson; Messias, Carolina V.; Mendes-da-Cruz, Daniella A.] Fluminense Fed Univ, Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Niteroi, RJ, Brazil.
   [Passos, Pamela; Ferreira, Ana Carolina A. F.; Nascimento, Osvaldo J.] Fluminense Fed Univ, Dept Neurol, Niteroi, RJ, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Leonidas Deane Bldg,Room 510,Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506
FU Fiocruz Brazil; Faperj BrazilCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CNPq BrazilNational
   Council for Scientific and Technological Development (CNPq); Capes
   BrazilCAPES; FOCEM (Mercosur)
FX This work was done in the framework of funding by Fiocruz, Faperj, CNPq,
   and Capes, Brazil, as well as FOCEM (Mercosur).
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brazilian Ministry of Health, 2015, MIN SAUD INV AUM CAS
   Brazilian Ministry of Health, 2016, MICR 1 749 CAS CONF
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cencioni MT, 2009, INT J IMMUNOPATH PH, V22, P1043, DOI 10.1177/039463200902200420
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Dunn-Walters DK, 2016, CLIN EXP IMMUNOL, V183, P50, DOI 10.1111/cei.12700
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   Han RK, 2014, J CLIN IMMUNOL, V34, P94, DOI 10.1007/s10875-013-9965-3
   Harness J, 2008, J CLIN NEUROSCI, V15, P1031, DOI 10.1016/j.jocn.2007.09.016
   Jagger A, 2014, GERONTOLOGY, V60, P130, DOI 10.1159/000355303
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller L, 2015, AGEING RES REV, V23, P116, DOI 10.1016/j.arr.2015.01.005
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nyati KK, 2011, ARCH NEUROL-CHICAGO, V68, P445, DOI 10.1001/archneurol.2011.51
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peric S, 2016, J PERIPHER NERV SYST, V21, P105, DOI 10.1111/jns.12163
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schmidt B, 1996, MUSCLE NERVE, V19, P474, DOI 10.1002/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   Tabibian-Keissar H, 2016, EUR J IMMUNOL, V46, P480, DOI 10.1002/eji.201545586
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Koningsveld R, 2001, NEUROLOGY, V56, P1467, DOI 10.1212/WNL.56.11.1467
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, GUILLAIN BARRE SYNDR
   Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 50
TC 5
Z9 6
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PY 2017
VL 63
IS 3
BP 210
EP 215
DI 10.1159/000453579
PG 6
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA ES9SQ
UT WOS:000399901300002
PM 28002820
DA 2020-07-08
ER

PT J
AU Redd, SC
   Frieden, TR
AF Redd, Stephen C.
   Frieden, Thomas R.
TI CDC'S EVOLVING APPROACH TO EMERGENCY RESPONSE
SO HEALTH SECURITY
LA English
DT Editorial Material
ID ZIKA VIRUS; HEALTH SECURITY; DISEASE OUTBREAK; UNITED-STATES; EBOLA;
   PREPAREDNESS; INFECTION; PROGRAM
AB The Centers for Disease Control and Prevention (CDC) transformed its approach to preparing for and responding to public health emergencies following the anthrax attacks of 2001. The Office of Public Health Preparedness and Response, an organizational home for emergency response at CDC, was established, and 4 programs were created or greatly expanded after the anthrax attacks: (1) an emergency management program, including an Emergency Operations Center; (2) increased support of state and local health department efforts to prepare for emergencies; (3) a greatly enlarged Strategic National Stockpile of medicines, vaccines, and medical equipment; and (4) a regulatory program to assure that work done on the most dangerous pathogens and toxins is done as safely and securely as possible. Following these changes, CDC led responses to 3 major public health emergencies: the 2009-10 H1N1 influenza pandemic, the 2014-16 Ebola epidemic in West Africa, and the ongoing Zika epidemic. This article reviews the programs of CDC's Office of Public Health Preparedness, the major responses, and how these responses have resulted in changes in CDC's approach to responding to public health emergencies.
C1 [Redd, Stephen C.] Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
   [Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Redd, SC (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A48, Atlanta, GA 30329 USA.
EM scr1@cdc.gov
OI Frieden, Thomas/0000-0002-4759-2256
CR Atkins CY, 2011, EMERG INFECT DIS, V17, P1591, DOI 10.3201/eid1709.110295
   Borse RH, 2013, EMERG INFECT DIS, V19, P439, DOI 10.3201/eid1903.120394
   Brown CM, 2014, MMWR-MORBID MORTAL W, V63, P1163
   Centers for Disease Control and Prevention, 2016, PUBL HLTH RESP SUPP
   Centers for Disease Control and Prevention, 2009, NOV H1N1 FLU SIT UPD
   Centers for Disease Control and Prevention, 2016, EM OP CTR CDC EM OP
   Centers for Disease Control and Prevention, UPD CDCS POL ER EFF
   Centers for Disease Control and Prevention (CDC), 2009, FIN EST 2009 10 SEAS
   Centers for Disease Control Prevention, 2009, PUBL HLTH PREP STREN
   Cliff A, 2004, BRIT MED BULL, V69, P87, DOI 10.1093/bmb/ldh011
   Corse T, 2015, WORLD MED HEALTH POL, V7, P402, DOI 10.1002/wmh3.164
   CRONBERG S, 1965, J Hist Med Allied Sci, V20, P33
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   DHHS [U. S. Department of Health and Human Services], 2010, PUBL HLTH EM MED COU
   Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Etheridge Elizabeth W., 1992, SENTINEL HLTH HIST C
   Fraser CM, 2001, NAT GENET, V29, P253, DOI 10.1038/ng763
   Global Polio Eradication Initiative, 2016, POL THIS WEEK 2 NOV
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Inglesby T, 2014, BIOSECUR BIOTERROR, V12, P63, DOI 10.1089/bsp.2014.3314
   Khan AS, 2014, LANCET, V384, P93, DOI 10.1016/S0140-6736(14)60260-9
   Khan AS, 2011, LANCET, V378, P953, DOI 10.1016/S0140-6736(11)61263-4
   Leidel L, 2013, MMWR-MORBID MORTAL W, V62, P709
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Pastel RH, 2006, CLIN LAB MED, V26, P299, DOI 10.1016/j.cll.2006.03.004
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds B, 2007, CRISIS EMERGENCY RIS
   Saker L., 2004, GLOBALIZATION INFECT
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867
   Singleton CM, 2014, J PUBLIC HEALTH MAN, V20, P197, DOI 10.1097/PHH.0b013e31829ddd21
   SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102
   The Centers for Disease Control and Prevention, 2014 EB OUTBR W AFR
   United Nations, 2014, WORLD URB PROSP 2014
   Vanderford ML, 2003, J HEALTH COMMUN, V8, P11, DOI 10.1080/10810730390224820
   WHO, 2011, CUM NUMB CONF HUM CA
NR 39
TC 11
Z9 12
U1 11
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JAN-FEB
PY 2017
VL 15
IS 1
BP 41
EP 52
DI 10.1089/hs.2017.0006
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EL0ZA
UT WOS:000394349100015
PM 28146366
DA 2020-07-08
ER

PT J
AU Ioannou, P
   Soundoulounaki, S
   Spernovasilis, N
   Papadopoulou, E
   Papa, A
   Gikas, A
AF Ioannou, Petros
   Soundoulounaki, Stella
   Spernovasilis, Nikolaos
   Papadopoulou, Elpida
   Papa, Anna
   Gikas, Achilleas
TI Zika virus infection in a newly married Greek couple
SO IDCASES
LA English
DT Article
DE Zika virus infection; Family planning; Returning traveler
AB Zika virus (ZIKV) is a member of the Flaviviridae family causing asymptomatic or mildly symptomatic infections with fever, rash, arthralgia and headache. It is transmitted by the Aedes species mosquitoes and also sexually and transplacentally, and has been recently associated with congenital neurologic birth defects in South and Central America. We report the case of a newly married couple from Greece who travelled to Cuba for their honeymoon and developed mild symptoms consistent with arboviral infection. After returning to Greece, they were found to have been infected by Zika virus during their honeymoon. These are the first two cases of Zika virus infection in Greece, the southeastern border of Europe, denoting that Zika virus infection poses a threat for public health worldwide, since returning travelers could be asymptomatic carriers of the virus, not only leading to risk of neurologic birth defects for their offspring but also the real risk of transmission of the virus in their country by local Aedes mosquitoes.
C1 [Ioannou, Petros; Soundoulounaki, Stella; Spernovasilis, Nikolaos; Gikas, Achilleas] Univ Hosp Heraklion, Dept Internal Med & Infect Dis, Iraklion, Crete, Greece.
   [Papadopoulou, Elpida; Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, Thessaloniki, Greece.
RP Ioannou, P (corresponding author), Univ Hosp Heraklion, Dept Internal Med, Iraklion 71500, Crete, Greece.
EM petros_io@hotmail.com; ocean_soul_16@yahoo.gr; nikspe@hotmail.com;
   papelpis@yahoo.gr; annap@med.auth.gr; gikas.achilles@uoc.gr
OI Ioannou, Petros/0000-0003-1082-5674
FU Hellenic Center for Disease Control and Prevention, Ministry of Health
FX The National Reference Centre for Arboviruses & Hemorrhagic Fever
   viruses is supported by the Hellenic Center for Disease Control and
   Prevention, Ministry of Health. We thank Elpida Gavana at Aristotle
   University of Thessaloniki for excellent technical assistance in
   serology.
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Maria AT, 2016, EURO SURVEILL, V21
   McCarthy M., 2016, BMJ-BRIT MED J, V30, pi1813
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization Epidemiological alert, 2015, NEUR SYNDR CONG MALF
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 12
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-2509
J9 IDCases
JI IDCases
PY 2017
VL 8
BP 92
EP +
DI 10.1016/j.idcr.2017.04.019
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA FH2QQ
UT WOS:000410986700032
PM 28516037
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duong, V
   Dussart, P
   Buchy, P
AF Duong, Veasna
   Dussart, Philippe
   Buchy, Philippe
TI Zika virus in Asia
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; Asia
ID NATIONAL DENGUE SURVEILLANCE; INFECTION; CAMBODIA; INDONESIA;
   ARBOVIRUSES; ANTIBODIES; THAILAND; NEUTRALIZATION; TRANSMISSION;
   POPULATIONS
AB Zika virus (ZIKV) is an emerging mosquito-borne virus that was first isolated from a sentinel rhesus monkey in the Zika Forest in Uganda in 1947. In Asia, the virus was isolated in Malaysia from Aedes aegypti mosquitoes in 1966, and the first human infections were reported in 1977 in Central Java, Indonesia. In this review, all reported cases of ZIKV infection in Asia as of September 1, 2016 are summarized and some of the hypotheses that could currently explain the apparently low incidence of Zika cases in Asia are explored. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Duong, Veasna; Dussart, Philippe] Inst Pasteur Cambodge, Phnom Penh, Cambodia.
   [Buchy, Philippe] R&D Asia Pacific, GlaxoSmithKline Vaccines, 150 Beach Rd, Singapore 189720, Singapore.
RP Buchy, P (corresponding author), R&D Asia Pacific, GlaxoSmithKline Vaccines, 150 Beach Rd, Singapore 189720, Singapore.
EM philippe.x.buchy@gsk.com
RI Veasna, Duong/I-9684-2014; Dussart, Philippe/P-4152-2014
OI Veasna, Duong/0000-0003-0353-1678; Dussart,
   Philippe/0000-0002-1931-3037; BUCHY, Philippe/0000-0003-1372-3008
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2016, YONHAPNEWS
   [Anonymous], 2016, TAIWAN CONFIRMS 6 IM
   [Anonymous], 2016, ZIK VIR CHIN HONG KO
   [Anonymous], 2016, CHANNEL NEWSASIA
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Duong V, 2012, EMERG INFECT DIS, V18, P2066, DOI 10.3201/eid1812.120471
   Duong V, 2011, ACTA TROP, V120, P146, DOI 10.1016/j.actatropica.2011.07.008
   Ellison DW, 2016, GENOME ANNOUNC, V4
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   FUKUNAGA T, 1974, BIKEN J, V17, P169
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Higgs S, 2016, T ROY SOC TROP MED H, V110, P207, DOI 10.1093/trstmh/trw020
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Liao Y, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P593, DOI 10.3760/cma.j.issn.0254-6450.2016.05.001
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Ministry of Health, 2016, 1 CAS LOC TRANSM ZIK
   Ministry of Health, 2016, 1 CAS ZIK VIR INF SI
   Ministry of Health, 2016, LOC COMM SPREAD ZIK
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   ProMED, 2016, ZIK VIR 26 AM AS EUR
   ProMED, 2016, PRO MBDS ZIK VIR THA
   ProMED, 2016, ZIK VIR 43 AM EUR TA
   ProMED, 2016, ZIK VIR SING AL TRAV
   ProMED, 2016, ZIK VIR 33 AM AS EUR
   ProMED, 2016, ZIK VIR 34 AM AS AFR
   ProMED, 2016, PRO MBDS ZIK VIR VIE
   ProMED, 2016, PRO EDR ZIK VIR 13 A
   ProMED, 2016, ZIK VIR 16 AM AS PAC
   ProMED, 2016, PRO EDR ZIK VIR 41 A
   ProMED, 2016, ZIK VIR 11 AM EUR AS
   ProMED, 2016, ZIK VIR 27 AM AS EUR
   ProMED, 2016, ZIK VIR 13 AM AS EUR
   ProMED, 2016, ZIK VR 35 AM AS EUR
   ProMED, 2016, ZIK VIR 46 AM AS PAC
   ProMED, 2016, ZIK VIR 30 AM AS ATL
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   SEKEYOVA M, 1969, J HYG EPID MICROB IM, V13, P288
   Shinohara K., 2014, ZIKA VIRUS JAPAN EX
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Strafela P, 2016, ARCH PATHOL LAB MED
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Torres JR, 2016, INT J INFECT DIS, V51, P123, DOI 10.1016/j.ijid.2016.09.001
   Touch S, 2009, TROP MED INT HEALTH, V14, P1365, DOI 10.1111/j.1365-3156.2009.02380.x
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2016, ZIK VIR INF MALD
   Zhang J., 2016, J TRAVEL MED, V23
   Zheng C G, 2016, Zhonghua Er Ke Za Zhi, V54, P375, DOI 10.3760/cma.j.issn.0578-1310.2016.05.013
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 98
TC 25
Z9 28
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JAN
PY 2017
VL 54
BP 121
EP 128
DI 10.1016/j.ijid.2016.11.420
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EO0YY
UT WOS:000396425800025
PM 27939768
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dhama, K
   Munjal, A
   Iqbal, HMN
AF Dhama, Kuldeep
   Munjal, Ashok
   Iqbal, Hafiz M. N.
TI Recent Advances and Novel Strategies for the Development of Biomedical
   Therapeutics: State-of-the-art and Future Perspectives
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Editorial Material
DE Biomedicine; therapeutics; drugs; medicines; herbs; drug delivery;
   immunomodulation; vaccine; nanotechnology; disease; health
AB This special issue is published in International Journal of Pharmacology (Vol. 13, Issue 7) with twenty peer-reviewed articles on recent advances and novel strategies for the development of biomedical therapeutics, immunomodulatory agents, delivery of drugs, and vaccines for safeguarding various health issues. The topics/themes covered include: Advances and progress in developing vaccines to counter the threats of Zika virus; Quinazolinone derivatives as a potential class of compounds in Malaria drug discovery; Innovations in the treatment options towards drug-resistant tuberculosis; The role of antioxidants in designing effective drugs for life threatening ailments; Promising anti-diabetic drugs, medicines and herbs; Medicinal values and beneficial applications of Psyllium husk (Plantago ovata), Green tea (Camellia sinensis); Medicinal applications of Stevia rebaudiana, a potential zero calorie sweetener, steviol glycosides; Anticancer and nutraceutical potentialities of phytase/phytate; Cell penetrating peptides as therapeutic vehicles and their use as anticancer peptide; Biomedical applications of pentatricopeptide repeat directed RNA editing with regards to diseases, cancers, and drugs; Next-generation sequencing for drug designing and cancer treatment; Progress towards various approaches from drug discovery to drug targeting;Advantages of selective drug distribution in cancer treatment with special reference to Brentuximab vedotin;G-protein coupled receptors in revolutionizing drug discovery and pharma based research; Bio-inspired synthesis of silver nanoparticles to combat antimicrobial resistanceand other pharmacological potentialities; Usage of biomaterials-based hydrogels in biomedical sectors and drug delivery potentialities; Biomedical applications and utilization of diverse nanomaterials; Role of nanotechnology in animal and poultry nutrition; Applications of chromium in poultry nutrition and health, and the toxic effects. The articles published would be useful for medical and veterinary professionals, clinicians, researchers, students/scholars, animal producers, the pharmaceutical industry and biomedicine experts.
C1 [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Bareilly 243122, Uttar Pradesh, India.
   [Munjal, Ashok] Barkatullah Univ, Dept Biochem & Genet, Bhopal 462026, Madhya Pradesh, India.
   [Iqbal, Hafiz M. N.] Tecnol Monterrey, Sch Engn & Sci, Campus Monterrey,Ave Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.
RP Dhama, K (corresponding author), ICAR Indian Vet Res Inst, Bareilly 243122, Uttar Pradesh, India.
EM kdhama@rediffmail.com; ashokmunjal70@yahoo.co.in; hafiz.iqbal@itesm.mx
RI Dhama, Kuldeep/B-7852-2015; Iqbal, Hafiz M.N./J-5423-2014
OI Dhama, Kuldeep/0000-0001-7469-4752; Iqbal, Hafiz
   M.N./0000-0003-4855-2720
NR 0
TC 3
Z9 3
U1 1
U2 29
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2017
VL 13
IS 7
BP 929
EP 933
DI 10.3923/ijp.2017.929.933
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FB9YO
UT WOS:000406495500021
OA Bronze
DA 2020-07-08
ER

PT J
AU Murray, JS
AF Murray, John S.
TI Understanding Zika virus
SO JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING
LA English
DT Article
ID CLINICAL-MANIFESTATIONS; EPIDEMIOLOGY; THREAT
AB Purpose. This article describes what pediatric healthcare professionals should know about Zika virus (ZIKV).
   Literature Review. ZIKV is classified as an arthropod-borne, single-stranded RNA virus of the Flaviviridae family and genus Flavivirus. ZIKV is not new. The virus was first discovered almost 70 years ago in Uganda. The first isolate of the virus was found in rhesus monkeys in the Zika Forrest, hence the nomenclature. The primary route of ZIKV transmission to humans is through the bite of an infected Aedes species mosquito-primarily Aedes aegypti. When the mosquito bites individuals infected with the virus, mosquitos then become the vector of transmitting the infection to others. Women can also pass ZIKV to their fetus during pregnancy and at the time of delivery. ZIKV can also be transmitted through sexual activity from an individual who is infected with the virus to his or her partners. It is estimated that approximately 18% of individuals infected with ZIKV will go on to develop symptoms. When symptoms develop, it is usually within 3-12 days, although this may vary. Most often, symptoms are mild and self-limited. The most common symptoms are fever, arthralgia, maculopapular rash, and conjunctivitis lasting up to seven days. Less frequent symptoms include headache, vertigo, myalgia, vomiting, and diarrhea. At present, there is no vaccine available to prevent ZIKV and no specific antiviral treatment. Supportive care consisting of rest, hydration, analgesics, antihistamines, and antipyretics is recommended as needed. Given that there is no vaccine or treatment for ZIKV, considerable efforts must be focused on prevention. One of the most effective ways of preventing ZIKV infection is through avoiding mosquito bites, especially when traveling to or residing in areas where transmission is present. Precautions should include wearing appropriate attire with the objective of having as little skin exposed as possible, use of screens for windows and doors, and use of insect repellent.
   Practice Implications. What is known about ZIKV changes continually. An infectious threat that was relatively obscure just a few months ago has now become a topic of heightened interest worldwide. Pediatric healthcare professionals must remain cognizant of evolving developments and emerging new evidence.
EM JMurray325@aol.com
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks J. T., 2016, UPDATE INTERIM GUIDA
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, INT GUID PREV SEX TR
   Centers for Disease Control and Prevention, 2016, ZIK MOSQ STAND WAT
   Centers for Disease Control and Prevention, 2015, PROT MOSQ TICKS OTH
   Centers for Disease Control and Prevention, 2016, BAS ZIK VIR SEX
   Centers for Disease Control and Prevention, 2016, ZIK VIR CLIN GUID HE
   Centers for Disease Control and Prevention, 2016, UPD INT GUID HLTH CA
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2016, ZIK COMM TOOLK
   Centers for Disease Control and Prevention, 2016, ZIK VIR PRINT RES
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Engel J, 2016, J PUBLIC HEALTH MAN, V22, P323, DOI 10.1097/PHH.0000000000000431
   Environmental Protection Agency, 2016, SAF REV DEET
   Environmental Protection Agency, 2016, BTI MOSQ CONTR
   Environmental Protection Agency, 2016, INS REP RED INS BIT
   European Centre for Disease Prevention and Control, 2016, AED AEG
   European Centre for Disease Prevention and Control, 2016, AED ALB
   Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x
   Hilton L., 2016, ZIK VIR TOP MOSQ REP
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karwowski M. P., 2016, CDC UPDATE PEDIAT HL
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   National Institutes of Health, 2016, GUILL BARR SYNDR FAC
   O'Malley PA, 2016, CLIN NURSE SPEC, V30, P194, DOI 10.1097/NUR.0000000000000218
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rabe I. B., 2016, INTERIM GUIDANCE INT
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stanczyk NM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h99
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   WHO, 2016, HIST ZIK VIR
NR 39
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1539-0136
EI 1744-6155
J9 J SPEC PEDIATR NURS
JI J. Spec. Pediatr. Nurs.
PD JAN
PY 2017
VL 22
IS 1
AR e12164
DI 10.1111/jspn.12164
PG 9
WC Nursing; Pediatrics
SC Nursing; Pediatrics
GA EO3XC
UT WOS:000396627000008
PM 27862959
DA 2020-07-08
ER

PT J
AU Benelli, G
   Govindarajan, M
AF Benelli, Giovanni
   Govindarajan, Marimuthu
TI Green-Synthesized Mosquito Oviposition Attractants and Ovicides: Towards
   a Nanoparticle-Based "Lure and Kill" Approach?
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Aganosma cymosa; Dengue; Malaria; Filariasis; Nanotechnology
ID CULEX-QUINQUEFASCIATUS DIPTERA; NONTARGET AQUATIC ORGANISMS; SILVER
   NANOPARTICLES; ANOPHELES-STEPHENSI; AEDES-AEGYPTI; ANTIBACTERIAL
   ACTIVITY; LEAF EXTRACT; ACUTE TOXICITY; CULICIDAE; MALARIA
AB Mosquitoes are key vectors of malaria, dengue, yellow fever, chikungunya, West Nile, Japanese encephalitis, lymphatic filariasis, Zika virus and St. Louis encephalitis virus. Eco-friendly control tools of Culicidae vectors are a priority. Green nanotechnologies may help to boost the effectiveness of mosquito vector control. We proposed a facile fabrication of poly-disperse and stable silver nanoparticles (AgNPs) using the Aganosma cymosa leaf extract. Nanoparticles were characterized by UV-visible spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction analysis, atomic force microscopy, scanning electron microscopy and transmission electron microscopy. Nanoparticles showed high toxicity on eggs and larvae of Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. LC50 values were 12.45, 13.58 and 14.79 mu g/mL, respectively. No egg hatchability was noted post-treatment with 40, 50 and 60 mu g/mL, respectively. Nanoparticles were found safer to non-target mosquito predators Anisops bouvieri, Diplonychus indicus and Gambusia affinis, LC50 values ranged from 673.36 to 2247.43 A mu g/mL. Notably, AgNPs showed high oviposition attractiveness towards the three mosquito species. Overall, the oviposition attractiveness of the A. cymosa extract coupled with the ovicidal action of AgNPs can help to develop "lure and kill" tools to be used at mosquito breeding sites.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com; drgovind1979@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX Prof. C. Lukehart and two anonymous reviewers improved an earlier
   version of this study. The authors would like to thank Professor and
   Head, Department of Zoology, Annamalai University for the laboratory
   facilities provided. The authors would also like to acknowledge the
   cooperation of staff members of the VCRC (ICMR), Pondicherry. Giovanni
   Benelli is supported by PROAPI (PRAF 2015) and University of Pisa,
   Department of Agriculture, Food and Environment (Grant ID:
   COFIN2015_22). Funders had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Augustus GDPS, 2011, BIOMASS BIOENERG, V35, P3012, DOI 10.1016/j.biombioe.2011.03.043
   Benelli G., 2016, ENZYM, DOI [10.1016/j.enzmictec.2016.08.022, DOI 10.1016/J.ENZMICTEC.2016.08.022]
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Deo PG, 1998, INT PEST CONTROL, V30, P118
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Jeong SH, 2005, J MATER SCI, V40, P5407, DOI 10.1007/s10853-005-4339-8
   KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Li S., 2007, GREEN CHEM, P9852
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017
   Pullaiah T., 2006, ENCY WORLD MED PLANT
   Savithramma N., 2011, International Journal of ChemTech Research, V3, P1394
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Shanmugam N, 2014, APPL NANOSCI, V4, P881, DOI 10.1007/s13204-013-0271-4
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   Woodrow G. M., 1888, HINTS GARDENING INDI
   World Health Organization, 2005, WHOCDSWHOPESGCDPP3
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
   Yugandhar P, 2016, APPL NANOSCI, V6, P223, DOI 10.1007/s13204-015-0428-4
   Zhang MJ, 2008, NANO LETT, V8, P1277, DOI 10.1021/nl0725704
NR 41
TC 127
Z9 129
U1 1
U2 17
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2017
VL 28
IS 1
SI SI
BP 287
EP 308
DI 10.1007/s10876-016-1088-6
PG 22
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA EL0QB
UT WOS:000394325800020
DA 2020-07-08
ER

PT J
AU Tauro, LB
   Bandeira, AC
   Ribeiro, GS
   Reis, MG
   Pizarro, CPRM
   Araujo, KA
   Castro, AP
   Queiroz, JM
   Simon, SS
   Menezes, G
   Campos, GS
   Sardi, S
AF Tauro, L. B.
   Bandeira, A. C.
   Ribeiro, G. S.
   Reis, M. G.
   Pizarro, C. P. R. M.
   Araujo, K. A.
   Castro, A. P.
   Queiroz, J. M.
   Simon, S. S.
   Menezes, G.
   Campos, G. S.
   Sardi, S.
TI Potential use of saliva samples to diagnose Zika virus infection
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Letter
C1 [Tauro, L. B.; Ribeiro, G. S.; Reis, M. G.] Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Bandeira, A. C.; Pizarro, C. P. R. M.; Araujo, K. A.; Castro, A. P.; Queiroz, J. M.; Simon, S. S.] Hosp Alianca, Salvador, BA, Brazil.
   [Bandeira, A. C.] Bahiana Sch Med, Salvador, BA, Brazil.
   [Bandeira, A. C.] Fac Sci & Technol, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Reis, M. G.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Reis, M. G.] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   [Menezes, G.; Campos, G. S.; Sardi, S.] Univ Fed Bahia, Inst Hlth Sci, Virol Lab, Salvador, BA, Brazil.
RP Tauro, LB (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM lauratauro@gmail.com
RI Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; sardi,
   silvia ines/P-9349-2016
OI Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060; sardi, silvia ines/0000-0002-2002-8436
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
NR 10
TC 13
Z9 13
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2017
VL 89
IS 1
BP 1
EP 2
DI 10.1002/jmv.24696
PG 2
WC Virology
SC Virology
GA EB2CR
UT WOS:000387165200001
PM 27671098
DA 2020-07-08
ER

PT J
AU Kahan, DM
   Jamieson, KH
   Landrum, A
   Winneg, K
AF Kahan, Dan M.
   Jamieson, Kathleen Hall
   Landrum, Asheley
   Winneg, Kenneth
TI Culturally antagonistic memes and the Zika virus: an experimental test
SO JOURNAL OF RISK RESEARCH
LA English
DT Article
DE risk perception; affect heuristic; cultural cognition; Zika virus
ID RISK PERCEPTIONS; COGNITIVE-ABILITY; SELF-AFFIRMATION; MYSIDE BIAS;
   WORLDVIEWS; POLICY; MODEL; PARTY; POLARIZATION; DISPOSITIONS
AB This paper examines a remedy for a defect in existing accounts of public risk perceptions. The accounts in question feature two dynamics: the affect heuristic, which emphasizes the impact of visceral feelings on information processing; and the cultural cognition thesis, which describes the tendency of individuals to form beliefs that reflect and reinforce their group commitments. The defect is the failure of these two dynamics, when combined, to explain the peculiar selectivity of public risk controversies: despite their intensity and disruptiveness, such controversies occur less frequently than the affect heuristic and the cultural cognition thesis seem to predict. To account for this aspect of public risk perceptions, the paper describes a model that adds the phenomenon of culturally antagonistic memes - argumentative tropes that fuse positions on risk with contested visions of the best life. Arising adventitiously, antagonistic memes transform affect and cultural cognition from consensus-generating, truth-convergent influences on information processing into conflictual, identity-protective ones. The paper supports this model with experimental results involving perceptions of the risk of the Zika virus: a general sample of US subjects, whose cultural orientations were measured with the Cultural Cognition Worldview Scales, formed polarized affective reactions when exposed to information that was pervaded with antagonistic memes linking Zika to global warming; when exposed to comparable information linking Zika to unlawful immigration, the opposing affective stances of the subjects flipped in direction. Normative and prescriptive implications of these results are discussed.
C1 [Kahan, Dan M.] Yale Univ, Yale Law Sch, New Haven, CT 06520 USA.
   [Jamieson, Kathleen Hall] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA.
   [Landrum, Asheley; Winneg, Kenneth] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.
RP Kahan, DM (corresponding author), Yale Univ, Yale Law Sch, New Haven, CT 06520 USA.
EM dan.kahan@yale.edu
RI Landrum, Asheley/J-2360-2015
OI Landrum, Asheley/0000-0002-3074-804X
FU 'Science of Science Communication' initiative of the Annenberg Public
   Policy Center at the University of Pennsylvania
FX This work was supported by the 'Science of Science Communication'
   initiative of the Annenberg Public Policy Center at the University of
   Pennsylvania.
CR Abruzzo S., 2016, BROOKLYN DAILY  0205
   Annenberg Public Policy Center, 2016, ANN SCI KNOWL SURV
   Annenberg Public Policy Center, 2016, MOR 4 10 MIST THINK
   [Anonymous], 2011, DEC MAK IND DIFF INV
   Ansolabehere S, 2013, ANNU REV POLIT SCI, V16, P307, DOI 10.1146/annurev-polisci-022811-160625
   BALK IN J.M., 1998, CULTURAL SOFTWARE
   Blackmore S., 2000, MEME MACHINE
   Bolsen T., 2013, I POLICY RES NW U WO
   Bolsen T, 2015, J COMMUN, V65, P745, DOI 10.1111/jcom.12171
   Bolsen T, 2015, ANN AM ACAD POLIT SS, V658, P271, DOI 10.1177/0002716214558393
   Bolsen T, 2014, POLIT BEHAV, V36, P235, DOI 10.1007/s11109-013-9238-0
   Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808
   Corsi J., 2016, WND             0201
   Damasio Antonio R., 2010, SELF COMES MIND CONS
   Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x
   Douglas M., 1966, PURITY DANGER ANAL C
   Douglas M., 1999, IMPLICIT MEANINGS SE, P218
   DOUGLAS M, 1982, RISK CULTURE ESSAY S
   Douglas Mary, 1970, NATURAL SYMBOLS EXPL
   Druckman JN, 2012, CRIT REV, V24, P199, DOI 10.1080/08913811.2012.711022
   Druckman JN, 2012, AM POLIT SCI REV, V106, P430, DOI 10.1017/S0003055412000123
   Elster J., 1989, CEMENT SOC STUDY SOC
   Erickson Erick, 2011, REDSATE         0817
   Evans AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142879
   Ferrari Matteo, 2009, RISK PERCEPTION CULT
   Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S
   Fowler EF, 2015, ANN AM ACAD POLIT SS, V658, P155, DOI 10.1177/0002716214555505
   Ganzach Y, 2008, JUDGM DECIS MAK, V3, P317
   Gaskell G, 1999, SCIENCE, V285, P384, DOI 10.1126/science.285.5426.384
   Gillis J, 2016, NY TIMES, pA6
   Gollust S. E., 2015, HUMAN VACCINES IMMUN, V23, pe143
   Gollust SE, 2010, HEALTH AFFAIR, V29, P2041, DOI 10.1377/hlthaff.2010.0174
   Goodman Ellen, 2015, BOSTON GLOBE
   Greene J. D., 2013, MORAL TRIBES EMOTION
   Gusfield Joseph, 1993, SMOKING POLICY LAW P
   GUSFIELD JR, 1968, CALIF LAW REV, V56, P54, DOI 10.2307/3479496
   Hallman W. K., 2013, PUBLIC PERCEPTIONS L, DOI 10.7282/T33N255N
   Hamilton LC, 2012, POLAR GEOGR, V35, P155, DOI 10.1080/1088937X.2012.684155
   Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8
   HASTORF AH, 1954, J ABNORM SOC PSYCH, V49, P129, DOI 10.1037/h0057880
   Jamieson KH, 2014, P NATL ACAD SCI USA, V111, P13598, DOI 10.1073/pnas.1320868111
   Johnson B., 2016, PJ MEDIA        0426
   Jost John T, 2013, OXFORD HDB SOCIAL CO, P851
   Kahan D. M., OXFORD HDB SCI SCI C
   Kahan D. M., 2006, HARVARD LAW REV, V119, P166
   Kahan D. M., 2015, J SCI COMMUNICATION, V14, P1, DOI [DOI 10.22323/2.14030404, DOI 10.2139/SSRN.2562025,]
   Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a
   Kahan DM, 2017, J RISK RES, V20, P995, DOI 10.1080/13669877.2016.1148067
   Kahan DM, 2015, POLIT PSYCHOL, V36, P1, DOI 10.1111/pops.12244
   Kahan DM, 2016, U PENN LAW REV, V164, P349
   Kahan DM, 2013, SCIENCE, V342, P53, DOI 10.1126/science.1245724
   Kahan DM, 2013, JUDGM DECIS MAK, V8, P407
   Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547
   Kahan DM, 2012, STANFORD LAW REV, V64, P851
   Kahan DM, 2011, HARVARD LAW REV, V125, P1
   Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246
   Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0
   Kahan DM, 2010, LAW HUMAN BEHAV, V34, P118, DOI 10.1007/s10979-008-9174-4
   Kahan DM, 2006, HARVARD LAW REV, V119, P1071
   Kahan DM, EMERGING TRENDS SOCI
   Kahan DM, BEHAV PUBLIC POLICY
   Kam CD, 2005, POLIT BEHAV, V27, P163, DOI 10.1007/s11109-005-1764-y
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Keil FC, 2003, TRENDS COGN SCI, V7, P368, DOI 10.1016/S1364-6613(03)00158-X
   Keil FC, 2012, CURR DIR PSYCHOL SCI, V21, P329, DOI 10.1177/0963721412453721
   Keil FC, 2010, COGNITIVE SCI, V34, P826, DOI 10.1111/j.1551-6709.2010.01108.x
   King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316
   KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480
   Lau RR, 2001, AM J POLIT SCI, V45, P951, DOI 10.2307/2669334
   LESSIG L, 1995, U CHICAGO LAW REV, V62, P943, DOI 10.2307/1600054
   Lodge M., 2013, RATIONALIZING VOTER
   LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098
   Macpherson R, 2007, LEARN INDIVID DIFFER, V17, P115, DOI 10.1016/j.lindif.2007.05.003
   Malkin Michelle, 2016, NATL REV
   MARGOLIS H, 1987, PATTERNS THINKING CO
   Margolis Howard, 1996, DEALING RISK WHY PUB
   McFadden BR, 2016, FASEB J, V30, P3091, DOI 10.1096/fj.201600598
   McKibben  B., 2016, GUARDIAN
   Mercer Greg, 2016, ATLANTIC
   Milman O, 2016, GUARDIAN
   Mondak Jeffery, 1993, POLITICAL BEHAV, V15, P167, DOI DOI 10.1007/BF00993852
   Nathanson CA, 1999, J HEALTH POLIT POLIC, V24, P421, DOI 10.1215/03616878-24-3-421
   Page Christina, 2006, NERVE           0628
   Peters E, 1996, J APPL SOC PSYCHOL, V26, P1427, DOI 10.1111/j.1559-1816.1996.tb00079.x
   Peters E, 2006, J COMMUN, V56, pS140, DOI 10.1111/j.1460-2466.2006.00287.x
   Peters EM, 2004, RISK ANAL, V24, P1349, DOI 10.1111/j.0272-4332.2004.00531.x
   Poortinga W, 2005, RISK ANAL, V25, P199, DOI 10.1111/j.0272-4332.2005.00579.x
   Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063
   RAYNER S, 1992, SOCIAL THEORIES OF RISK, P83
   RENN O, 2000, CROSS CULTURAL RISK
   Romer D, 2007, PREV SCI, V8, P89, DOI 10.1007/s11121-007-0064-7
   Sato Kyoko, 2007, MEANINGS GENETICALLY
   Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5
   Sherman DK, 2002, CURR DIR PSYCHOL SCI, V11, P119, DOI 10.1111/1467-8721.00182
   Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x
   Slovic P, 2010, FEELING RISK NEW PER
   Slovic P., 1998, RISK DECISION POLICY, V3, P165, DOI DOI 10.1080/135753098348275
   SLOVIC P, 2000, CROSS CULTURAL RISK, P55
   Slovic P, 2000, PERCEPTION RISK
   Stanovich K., 2009, 2 MINDS DUAL PROCESS, P55, DOI DOI 10.1093/ACPROF:OSO/9780199230167.003.0003
   Stanovich K., 2011, RATIONALITY REFLECTI
   Stanovich KE, 2008, THINK REASONING, V14, P129, DOI 10.1080/13546780701679764
   Stanovich KE, 2007, THINK REASONING, V13, P225, DOI 10.1080/13546780600780796
   Sunstein CR, 2006, HARVARD LAW REV, V119, P1110
   Taormino Tristan, 2006, VILLAGE VOICE
   Toplak ME, 2003, APPL COGNITIVE PSYCH, V17, P851, DOI 10.1002/acp.915
   Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105
   Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414
   Westfall J, 2015, PERSPECT PSYCHOL SCI, V10, P145, DOI 10.1177/1745691615569849
   Xue W, 2014, J ENVIRON PSYCHOL, V40, P249, DOI 10.1016/j.jenvp.2014.07.002
   Zaller J.R., 1992, NATURE ORIGINS MASS
NR 111
TC 18
Z9 19
U1 2
U2 18
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1366-9877
EI 1466-4461
J9 J RISK RES
JI J. Risk Res.
PY 2017
VL 20
IS 1
BP 1
EP 40
DI 10.1080/13669877.2016.1260631
PG 40
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA EI9TU
UT WOS:000392852900001
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Sokal, A
   D'Ortenzio, E
   Houhou-Fidouh, N
   Brichler, S
   Dorchies, J
   Cabras, O
   Leparc-Goffart, I
   Yazdanpanah, Y
   Matheron, S
AF Sokal, Aurelien
   D'Ortenzio, Eric
   Houhou-Fidouh, Nadira
   Brichler, Segolene
   Dorchies, Justine
   Cabras, Ornella
   Leparc-Goffart, Isabelle
   Yazdanpanah, Yazdan
   Matheron, Sophie
TI Zika virus infection: report of the first imported cases in a Paris
   travel centre
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika virus; importation cases; arbovirus
AB We describe characteristics of 17 patients with a Zika virus (ZIKV) infection seen in a Travel Center in Paris during the 4 months following the WHO alert on ZIKV. Sixteen were imported cases, including 13 from the Caribbean. One was a women living in Paris infected through sexual transmission. One case was a pregnant woman. All cases were symptomatic with fever, fatigue and cutaneous rash in 15/17, 13/17, and 16/17, respectively. Leucopenia was observed in 6/17, thrombopenia in 2/17. Diagnosis was confirmed by ZIKV RT-PCR (plasma: 12/17; urine 15/17) or detection of ZIKV IgM (2/17). Two patients were hospitalized but all evolved well.
C1 [Sokal, Aurelien; D'Ortenzio, Eric; Dorchies, Justine; Cabras, Ornella; Yazdanpanah, Yazdan; Matheron, Sophie] Hop Bichat Claude Bernard, Hop Paris Nord Val de Seine, AP HP, Serv Malad Infect & Trop, Paris, France.
   [D'Ortenzio, Eric; Yazdanpanah, Yazdan; Matheron, Sophie] INSERM, IAME, UMR 1137, Paris, France.
   [Houhou-Fidouh, Nadira] Hop Bichat Claude Bernard, Hop Paris Nord Val de Seine, AP HP, Serv Virol, Paris, France.
   [Brichler, Segolene] Hop Univ Paris Seine St Denis, Hop Avicenne, AP HP, Serv Virol, Bobigny, France.
   [Leparc-Goffart, Isabelle] Ctr Natl Reference Arbovirus, Inst Rech Biomed Armees, Marseille, France.
   [Yazdanpanah, Yazdan; Matheron, Sophie] Univ Paris Diderot, Sorbonne Paris Cite, France 7, Denis Diderot, Paris, France.
RP D'Ortenzio, E (corresponding author), Hop Bichat Claude Bernard, Hop Paris Nord Val de Seine, AP HP, Serv Malad Infect & Trop, Paris, France.; D'Ortenzio, E (corresponding author), INSERM, IAME, UMR 1137, Paris, France.
EM eric.dortenzio@inserm.fr
RI BRICHLER, Segolene/R-7039-2018
OI BRICHLER, Segolene/0000-0002-7336-7730; D'Ortenzio,
   Eric/0000-0002-4527-6209
CR [Anonymous], 2016, N Engl J Med, V375, P498, DOI 10.1056/NEJMx160025
   [Anonymous], 2016, ZIKA VIRUS DONNEES E
   [Anonymous], EP UPD OUTBR ZIK VIR
   [Anonymous], 2016, SIT EP VIR ZIK ANT G, P1
   [Anonymous], 2016, PREV TRANSM SEX VIR, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   World Health Organization, 2016, EM COMM ZIK VIR OBS
   World Health Organization, 2016, PREV SEX TRANSM ZIK, P1
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 15
TC 7
Z9 7
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JAN
PY 2017
VL 24
IS 1
AR taw066
DI 10.1093/jtm/taw066
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA EW9FV
UT WOS:000402823100001
OA Bronze
DA 2020-07-08
ER

PT J
AU Weger-Lucarelli, J
   Duggal, NK
   Bullard-Feibelman, K
   Veselinovic, M
   Romo, H
   Nguyen, C
   Ruckert, C
   Brault, AC
   Bowen, RA
   Stenglein, M
   Geiss, BJ
   Ebel, GD
AF Weger-Lucarelli, James
   Duggal, Nisha K.
   Bullard-Feibelman, Kristen
   Veselinovic, Milena
   Romo, Hannah
   Chilinh Nguyen
   Ruckert, Claudia
   Brault, Aaron C.
   Bowen, Richard A.
   Stenglein, Mark
   Geiss, Brian J.
   Ebel, Gregory D.
TI Development and Characterization of Recombinant Virus Generated from a
   New World Zika Virus Infectious Clone
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Flavivirus; Zika virus; infectious clones
ID UNITED-STATES; TRANSMISSION; PREGNANCY; WOMEN; MICE
AB Zika virus (ZIKV; family Flaviviridae, genus Flavivirus) is a rapidly expanding global pathogen that has been associated with severe clinical manifestations, including devastating neurological disease in infants. There are currently no molecular clones of a New World ZIKV available that lack significant attenuation, hindering progress toward understanding determinants of transmission and pathogenesis. Here we report the development and characterization of a novel ZIKV reverse genetics system based on a 2015 isolate from Puerto Rico (PRVABC59). We generated a two-plasmid infectious clone system from which infectious virus was rescued that replicates in human and mosquito cells with growth kinetics representative of wildtype ZIKV. Infectious clone-derived virus initiated infection and transmission rates in Aedes aegypti mosquitoes comparable to those of the primary isolate and displayed similar pathogenesis in AG129 mice. This infectious clone system provides a valuable resource to the research community to explore ZIKV molecular biology, vaccine development, antiviral development, diagnostics, vector competence, and disease pathogenesis.
   IMPORTANCE ZIKV is a rapidly spreading mosquito-borne pathogen that has been linked to Guillain-Barre syndrome in adults and congenital microcephaly in developing fetuses and infants. ZIKV can also be sexually transmitted. The viral molecular determinants of any of these phenotypes are not well understood. There is no reverse genetics system available for the current epidemic virus that will allow researchers to study ZIKV immunity, develop novel vaccines, or develop antiviral drugs. Here we provide a novel infectious clone system generated from a recent ZIKV isolated from a patient infected in Puerto Rico. This infectious clone produces virus with in vitro and in vivo characteristics similar to those of the primary isolate, providing a critical tool to study ZIKV infection and disease.
C1 [Weger-Lucarelli, James; Bullard-Feibelman, Kristen; Veselinovic, Milena; Romo, Hannah; Chilinh Nguyen; Ruckert, Claudia; Bowen, Richard A.; Stenglein, Mark; Geiss, Brian J.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Duggal, Nisha K.; Romo, Hannah; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Geiss, BJ; Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Geiss, BJ (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
EM brian.geiss@colostate.edu; gregory.ebel@colostate.edu
RI Geiss, Brian/J-3021-2017; Stenglein, Mark/E-3541-2017
OI Geiss, Brian/0000-0001-8180-5772; Stenglein, Mark/0000-0002-0993-813X;
   Weger-Lucarelli, James/0000-0002-9483-1694; Ruckert,
   Claudia/0000-0003-3732-6752
FU National Institute of Allergy and Infectious Diseases, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI114675, AI067380]
FX This work was supported in part by the National Institute of Allergy and
   Infectious Diseases, NIH, under grants AI114675 (B.J.G.) and
   AI067380(G.D.E.).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Guerbois M., 2016, J INFECT DIS
   Kindhauser MK, 2016, B WHO
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee W, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/259181
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
NR 24
TC 47
Z9 47
U1 1
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2017
VL 91
IS 1
AR UNSP e01765-16
DI 10.1128/JVI.01765-16
PG 10
WC Virology
SC Virology
GA EJ4LR
UT WOS:000393189200028
PM 27795432
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wikan, N
   Smith, DR
AF Wikan, Nitwara
   Smith, Duncan R.
TI First published report of Zika virus infection in people: Simpson, not
   MacNamara
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID ISOLATIONS; NIGERIA
C1 [Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus, Salaya, Nakhon Pathom, Thailand.
   [Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya Campus, Salaya, Nakhon Pathom, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus, Salaya, Nakhon Pathom, Thailand.; Smith, DR (corresponding author), Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya Campus, Salaya, Nakhon Pathom, Thailand.
EM duncan.smi@mahidol.ac.th
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   WHO, 2016, COUNTR TERR REP MOSQ
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 12
TC 17
Z9 17
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2017
VL 17
IS 1
BP 15
EP 17
DI 10.1016/S1473-3099(16)30525-4
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EE8GW
UT WOS:000389864700011
PM 27998553
OA Bronze
DA 2020-07-08
ER

PT J
AU Weaver, SC
AF Weaver, Scott C.
TI Emergence of Epidemic Zika Virus Transmission and Congenital Zika
   Syndrome: Are Recently Evolved Traits to Blame?
SO MBIO
LA English
DT Article
ID MODEL
AB The mechanisms responsible for the dramatic emergence of Zika virus (ZIKV), accompanied by congenital Zika syndrome and Guillain-Barre syndrome (GBS), remain unclear. However, two hypotheses are prominent: (i) evolution for enhanced urban transmission via adaptation to mosquito vectors, or for enhanced human infection to increase amplification, or (ii) the stochastic introduction of ZIKV into large, naive human populations in regions with abundant Aedes aegypti populations, leading to enough rare, severe infection outcomes for their first recognition. Advances in animal models for human infection combined with improvements in serodiagnostics, better surveillance, and reverse genetic approaches should provide more conclusive evidence of whether mosquito transmission or human pathogenesis changed coincidentally with emergence in the South Pacific and the Americas. Ultimately, understanding the mechanisms of epidemic ZIKV emergence, and its associated syndromes, is critical to predict future risks as well as to target surveillance and control measures in key locations.
C1 [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organization, 2016, ZIK SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 24
Z9 24
U1 1
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2017
VL 8
IS 1
AR e02063-16
DI 10.1128/mBio.02063-16
PG 5
WC Microbiology
SC Microbiology
GA EN2JE
UT WOS:000395835000081
PM 28074023
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xie, XP
   Yang, YJ
   Muruato, AE
   Zou, J
   Shan, C
   Nunes, BTD
   Medeiros, DBA
   Vasconcelos, PFC
   Weaver, SC
   Rossi, SL
   Shi, PY
AF Xie, Xuping
   Yang, Yujiao
   Muruato, Antonio E.
   Zou, Jing
   Shan, Chao
   Nunes, Bruno T. D.
   Medeiros, Daniele B. A.
   Vasconcelos, Pedro F. C.
   Weaver, Scott C.
   Rossi, Shannan L.
   Shi, Pei-Yong
TI Understanding Zika Virus Stability and Developing a Chimeric Vaccine
   through Functional Analysis
SO MBIO
LA English
DT Article
ID DENGUE VIRUS; RNA SYNTHESIS; TRANSMISSION; ENHANCEMENT; INFECTION;
   BIOLOGY; PROTEIN; LETHAL; MICE
AB Compared with other flaviviruses, Zika virus (ZIKV) is uniquely associated with congenital diseases in pregnant women. One recent study reported that (i) ZIKV has higher thermostability than dengue virus (DENV [a flavivirus closely related to ZIKV]), which might contribute to the disease outcome; (ii) the higher thermostability of ZIKV could arise from an extended loop structure in domain III of the viral envelope (E) protein and an extra hydrogen-bond interaction between E molecules (V. A. Kostyuchenko, E. X. Y. Lim, S. Zhang, G. Fibriansah, T.-S. Ng, J. S. G. Ooi, J. Shi, and S.-M. Lok, Nature 533: 425-428, 2016,https://doi.org/10.1038/nature17994). Here we report the functional analysis of the structural information in the context of complete ZIKV and DENV-2 virions. Swapping the prM-E genes between ZIKV and DENV-2 switched the thermostability of the chimeric viruses, identifying the prM-E proteins as the major determinants for virion thermostability. Shortening the extended loop of the E protein by 1 amino acid was lethal for ZIKV assembly/release. Mutations (Q350I and T351V) that abolished the extra hydrogen-bond interaction between the E proteins did not reduce ZIKV thermostability, indicating that the extra interaction does not increase the thermostability. Interestingly, mutant T351V was attenuated in A129 mice defective in type I interferon receptors, even though the virus retained the wild-type thermostability. Furthermore, we found that a chimeric ZIKV with the DENV-2 prM-E and a chimeric DENV-2 with the ZIKV prM-E were highly attenuated in A129 mice; these chimeric viruses were highly immunogenic and protective against DENV-2 and ZIKV challenge, respectively. These results indicate the potential of these chimeric viruses for vaccine development.
   IMPORTANCE Analysis of a recently observed high-resolution structure of ZIKV led to a hypothesis that its unusual stability may contribute to the associated, unique disease outcomes. Here we performed a functional analysis to demonstrate that viral prM-E genes are the main determinants for the high stability of ZIKV. The extra hydrogen-bond interaction (observed in the high-resolution structure) between ZIKV E proteins did not enhance virion stability, whereas the extended loop of E protein (CD loop in domain III) was essential for ZIKV assembly. More importantly, we found that a chimeric ZIKV with DENV-2 prM-E genes and a chimeric DENV-2 with ZIKV prM-E genes were highly attenuated in A129 mice. Mice immunized with these chi-meric viruses generated robust neutralizing antibody responses and were fully protected from DENV-2 and ZIKV challenge, respectively, indicating that these chimeric viruses could be further developed as vaccine candidates.
C1 [Xie, Xuping; Yang, Yujiao; Zou, Jing; Shan, Chao; Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Yang, Yujiao] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.
   [Muruato, Antonio E.; Weaver, Scott C.; Rossi, Shannan L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA.
   [Muruato, Antonio E.; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Inst Evandro Chagas Minist Saude, Secao Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA.
   [Weaver, Scott C.; Rossi, Shannan L.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX USA.
   [Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI amsalu, ribka/G-8780-2019; Weaver, Scott C/D-6490-2011; Xie,
   Xuping/AAD-7406-2019; Vasconcelos, Pedro/AAH-3142-2019
OI Weaver, Scott C/0000-0001-8016-8556; Shan, Chao/0000-0002-3953-3782
FU Novartis Institutes for Biomedical Research; University of Texas Medical
   Branch; University of Texas STARs Award; NIH grantUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI087856]; Pan American Health Organization/Brazil Ministry of
   Health [SCON2016-01353]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI120942]
FX X.X. was awarded with a postdoctoral fellowship from Novartis Institutes
   for Biomedical Research. P.-Y.S. was supported by a University of Texas
   Medical Branch startup award and an innovation/commercialization award,
   a University of Texas STARs Award, NIH grant R01AI087856, and a grant
   from the Pan American Health Organization (SCON2016-01353)/Brazil
   Ministry of Health. This research was also supported by NIH grant
   AI120942 to S.C.W.
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 29
TC 44
Z9 47
U1 1
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2017
VL 8
IS 1
AR e02134-16
DI 10.1128/mBio.02134-16
PG 14
WC Microbiology
SC Microbiology
GA EN2JE
UT WOS:000395835000086
PM 28174309
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giacoppo, JDS
   Carregal, JB
   Junior, MC
   da Cunha, EFF
   Ramalho, TC
AF Giacoppo, Juliana de O. S.
   Carregal, Juliano B.
   Junior, Moacyr C.
   da Cunha, Elaine F. F.
   Ramalho, Teodorico C.
TI Towards the understanding of tetrahydroquinolines action in Aedes
   aegypti: larvicide or adulticide?
SO MOLECULAR SIMULATION
LA English
DT Article
DE Aedes Aegypti; ecdysone receptor; potassium channel activated by calcium
   (BK channel); docking; molecular dynamics
ID HIGH-CONDUCTANCE; CHANNELS; DOCKING; SEARCH; EXPRESSION; DYNAMICS;
   MOLECULE; EFFICACY; RECEPTOR; MEMBER
AB Aedes aegypti is an important vector of arboviruses such as dengue, yellow fever, chikungunya and Zika. Among the various types of insecticides used to combat this vector, the insect growth regulators have been developed and recommended for control of their larvae. In this work compounds with proven regulatory action, tetrahydroquinolines will be studied. These regulators act on the hormones responsible for the insect development. Ecdysone, one of the main hormones involved in this process has a specific receptor (EcR), where tetrahydroquinolines derivatives can bind, disrupting the normal action of this hormone, because they have structure similar to hormone 20-hydroxyecdysone (20E). In addition, studies show that this class of compounds interacts strongly in the potassium channel activated by calcium (BK channel). Thus, the goal is to study the action of compounds (tetrahydroquinolines) as insecticides and evaluate their larvicidal action (action on the ecdysone receptor) or adulticide (action on the BK channel) through homology modelling techniques, molecular docking and molecular dynamics simulations and aiming to propose a compound that presents both actions (larvicide / adulticide).
C1 [Giacoppo, Juliana de O. S.; da Cunha, Elaine F. F.; Ramalho, Teodorico C.] Univ Fed Lavras, Dept Chem, Lavras, Brazil.
   [Carregal, Juliano B.; Junior, Moacyr C.] Fed Univ Sao Joao Rey, Dept Chem, Divinopolis, Brazil.
   [Ramalho, Teodorico C.] Univ Hradec Kralove, Ctr Basic & Appl Res, Hradec Kralove, Czech Republic.
RP Ramalho, TC (corresponding author), Univ Fed Lavras, Dept Chem, Lavras, Brazil.
EM teo@dqi.ufla.br
RI da Cunha, Elaine F. F./U-7334-2019; Ramalho, Teodorico C./H-3204-2012
OI Ramalho, Teodorico C./0000-0002-7324-1353
FU Fundacao de Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais
   State Research Foundation (FAPEMIG) [PPM-00831-15]
FX This work was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais [grant number PPM-00831-15].
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   AQVIST J, 1990, J PHYS CHEM-US, V94, P8021
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bosire CM, 2014, J ASIA-PAC ENTOMOL, V17, P531, DOI 10.1016/j.aspen.2014.05.003
   Case D.A., 2010, AMBER 11
   CHO WL, 1995, INSECT BIOCHEM MOLEC, V25, P19, DOI 10.1016/0965-1748(94)00045-J
   Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242
   Franca TCC, 2013, CURR COMPUT-AID DRUG, V9, P507, DOI 10.2174/15734099113099990033
   Cox DH, 2014, BIOPHYS J, V107, P2797, DOI 10.1016/j.bpj.2014.10.069
   da Cunha EFF, 2008, J BIOMOL STRUCT DYN, V25, P377, DOI 10.1080/07391102.2008.10507186
   de Assis TM, 2016, CHEM BIOL DRUG DES, V87, P455, DOI 10.1111/cbdd.12683
   de Castro AA, 2016, COMB CHEM HIGH T SCR, V19, P334, DOI 10.2174/1386207319666160325113844
   de Lima WEA, 2016, LETT DRUG DES DISCOV, V13, P360, DOI 10.2174/1570180812666150918191550
   Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349
   Giacoppo JOS, 2015, J BIOMOL STRUCT DYN, V33, P2048, DOI 10.1080/07391102.2014.989408
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hehre W.J., 1999, PC SPARTAN PRO
   Hoffmann KH, 1998, PHYTOPARASITICA, V26, P323, DOI 10.1007/BF02981447
   Kitamura S, 2014, BIOORG MED CHEM LETT, V24, P1715, DOI 10.1016/j.bmcl.2014.02.043
   KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G
   Kontoyianni M, 2004, J MED CHEM, V47, P558, DOI 10.1021/jm0302997
   Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662
   Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m
   Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968
   Martins TLC, 2003, MAGN RESON CHEM, V41, P983, DOI 10.1002/mrc.1299
   Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066
   Mulla MS, 2004, J AM MOSQUITO CONTR, V20, P64
   Palli SR, 2005, VITAM HORM, V73, P59, DOI 10.1016/S0083-6729(05)73003-X
   Perry MD, 2009, AM J PHYSIOL-GASTR L, V297, pG159, DOI 10.1152/ajpgi.00132.2009
   Ponte CG, 2012, MOL PHARMACOL, V81, P567, DOI 10.1124/mol.111.075853
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   Riddiford LM, 1985, BIOCHEM PHARMACOL, V8, P37
   Santos OA, 2003, QUIM NOVA, V26, P253, DOI 10.1590/S0100-40422003000200019
   Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7
   Shamim A, 2015, J MOL GRAPH MODEL, V60, P180, DOI 10.1016/j.jmgm.2015.05.013
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Smagghe G, 2012, ADV INSECT PHYSIOL, V43, P163, DOI 10.1016/B978-0-12-391500-9.00002-4
   Smith HC, 2003, BIOORG MED CHEM LETT, V13, P1943, DOI 10.1016/S0960-894X(03)00317-2
   Sridharan V, 2011, CHEM REV, V111, P7157, DOI 10.1021/cr100307m
   Thavara U, 2004, J AM MOSQUITO CONTR, V20, P176
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
   Vatandoost H., 2001, PESTOLOGY, V25, P69
   Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922
   Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n
   Yu M, 2016, ACTA PHARMACOL SIN, V37, P56, DOI 10.1038/aps.2015.139
NR 46
TC 9
Z9 9
U1 1
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0892-7022
EI 1029-0435
J9 MOL SIMULAT
JI Mol. Simul.
PY 2017
VL 43
IS 2
BP 121
EP 133
DI 10.1080/08927022.2016.1239823
PG 13
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EE2SS
UT WOS:000389435200006
DA 2020-07-08
ER

PT J
AU Holmes, D
AF Holmes, David
TI DISEASE WATCH Zika virus - concerns for male fertility
SO NATURE REVIEWS ENDOCRINOLOGY
LA English
DT Editorial Material
OI Holmes, David/0000-0002-4560-3572
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5029
EI 1759-5037
J9 NAT REV ENDOCRINOL
JI Nat. Rev. Endocrinol.
PD JAN
PY 2017
VL 13
IS 1
BP 3
EP 3
DI 10.1038/nrendo.2016.191
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FD2HI
UT WOS:000407355600003
PM 27857129
DA 2020-07-08
ER

PT J
AU Krauer, F
   Riesen, M
   Reveiz, L
   Oladapo, OT
   Martinez-Vega, R
   Porgo, TV
   Haefliger, A
   Broutet, NJ
   Low, N
AF Krauer, Fabienne
   Riesen, Maurane
   Reveiz, Ludovic
   Oladapo, Olufemi T.
   Martinez-Vega, Ruth
   Porgo, Teegwende V.
   Haefliger, Anina
   Broutet, Nathalie J.
   Low, Nicola
CA WHO Zika Causality Working Grp
TI Zika Virus Infection as a Cause of Congenital Brain Abnormalities and
   Guillain-Barre Syndrome: Systematic Review
SO PLOS MEDICINE
LA English
DT Review
ID WEST-NILE-VIRUS; CAMPYLOBACTER-JEJUNI INFECTION; JAPANESE ENCEPHALITIS;
   PREGNANT-WOMEN; DENGUE VIRUS; YELLOW-FEVER; DISEASE; ASSOCIATION;
   OUTBREAK; AMERICA
AB Background
   The World Health Organization (WHO) stated in March 2016 that there was scientific consensus that the mosquito-borne Zika virus was a cause of the neurological disorder Guillain-Barre syndrome (GBS) and of microcephaly and other congenital brain abnormalities based on rapid evidence assessments. Decisions about causality require systematic assessment to guide public health actions. The objectives of this study were to update and reassess the evidence for causality through a rapid and systematic review about links between Zika virus infection and (a) congenital brain abnormalities, including microcephaly, in the foetuses and offspring of pregnant women and (b) GBS in any population, and to describe the process and outcomes of an expert assessment of the evidence about causality.
   Methods and Findings
   The study had three linked components. First, in February 2016, we developed a causality framework that defined questions about the relationship between Zika virus infection and each of the two clinical outcomes in ten dimensions: temporality, biological plausibility, strength of association, alternative explanations, cessation, dose-response relationship, animal experiments, analogy, specificity, and consistency. Second, we did a systematic review (protocol number CRD42016036693). We searched multiple online sources up to May 30, 2016 to find studies that directly addressed either outcome and any causality dimension, used methods to expedite study selection, data extraction, and quality assessment, and summarised evidence descriptively. Third, WHO convened a multidisciplinary panel of experts who assessed the review findings and reached consensus statements to update the WHO position on causality. We found 1,091 unique items up to May 30, 2016. For congenital brain abnormalities, including microcephaly, we included 72 items; for eight of ten causality dimensions (all except dose-response relationship and specificity), we found that more than half the relevant studies supported a causal association with Zika virus infection. For GBS, we included 36 items, of which more than half the relevant studies supported a causal association in seven of ten dimensions (all except dose-response relationship, specificity, and animal experimental evidence). Articles identified nonsystematically from May 30 to July 29, 2016 strengthened the review findings. The expert panel concluded that (a) the most likely explanation of available evidence from outbreaks of Zika virus infection and clusters of microcephaly is that Zika virus infection during pregnancy is a cause of congenital brain abnormalities including microcephaly, and (b) the most likely explanation of available evidence from outbreaks of Zika virus infection and GBS is that Zika virus infection is a trigger of GBS. The expert panel recognised that Zika virus alone may not be sufficient to cause either congenital brain abnormalities or GBS but agreed that the evidence was sufficient to recommend increased public health measures. Weaknesses are the limited assessment of the role of dengue virus and other possible cofactors, the small number of comparative epidemiological studies, and the difficulty in keeping the review up to date with the pace of publication of new research.
   Conclusions
   Rapid and systematic reviews with frequent updating and open dissemination are now needed both for appraisal of the evidence about Zika virus infection and for the next public health threats that will emerge. This systematic review found sufficient evidence to say that Zika virus is a cause of congenital abnormalities and is a trigger of GBS.
C1 [Krauer, Fabienne; Riesen, Maurane; Haefliger, Anina; Low, Nicola] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.
   [Reveiz, Ludovic] Pan Amer Hlth Org, Washington, DC USA.
   [Oladapo, Olufemi T.; Porgo, Teegwende V.; Broutet, Nathalie J.] World Hlth Org, UNDP UNFPA UNICEF WHO World Bank, Special Programme Res Dev & Res Training Human Re, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Martinez-Vega, Ruth] Univ Ind Santander, Escuela Microbiol, Santander, Colombia.
   [Porgo, Teegwende V.] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada.
RP Low, N (corresponding author), Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.
EM nicola.low@ispm.unibe.ch
RI Low, Nicola/H-4718-2019; amsalu, ribka/G-8780-2019; Martinez-Vega,
   Ruth/AAD-3601-2019
OI Low, Nicola/0000-0003-4817-8986; Martinez-Vega,
   Ruth/0000-0002-6477-334X; Porgo, Teegwende Valerie/0000-0003-0298-0711;
   Krauer, Fabienne/0000-0001-8341-4011
FU World Health OrganizationWorld Health Organization [2016/611294-0,
   2016/630126-0]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [320030_170069]
FX The review was funded by the World Health Organization (www.who.int,
   contract numbers 2016/611294-0 and 2016/630126-0 awarded to NL) and the
   Swiss National Science Foundation (www.snf.ch, SNSF special action fund
   and project grant 320030_170069 awarded to NL). The following World
   Health Organization staff are coauthors of the study: LR, OTO, and NJB.
   They were involved in the study design, data interpretation, decision to
   publish, and preparation of the manuscript. The WHO Zika Causality
   Working Group was involved in interpretation of the data and the
   decision to publish.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   ARGALL KG, 1991, J NEUROIMMUNOL, V35, P273, DOI 10.1016/0165-5728(91)90181-6
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EURO SURVEILL, V21
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campanati L, 2016, IMPACT AFRICAN BRAZI
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Chung CC, 2007, INFECTION, V35, P30, DOI 10.1007/s15010-007-6038-7
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dos Santos T, 2016, N ENGL J MED
   Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, BIORXIV
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION
   Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860
   Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603
   European Centre for Disease Prevention and Control, 2016, RAD RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Ganguly B, 2016, DISRUPTION HUMAN AST
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2016, COMBINED PROTEOME TR
   Gordis L, 2009, ASS CAUSATION DERIVI, P227
   Gregg NM, 1941, EPIDEMIOL INFECT, V107, P35
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanaoka MM, 2016, ZIKA VIRUS ASS MICRO
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Homan J, 2016, ANTIBODY MEDIATED EP
   Institut de veille sanitaire, 2014, VIR ZIK POL 2013 201
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jackson BR, 2014, EPIDEMIOL INFECT, V142, P1089, DOI 10.1017/S0950268813001908
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Loshaj-Shala A, 2015, J NEUROIMMUNOL, V289, P168, DOI 10.1016/j.jneuroim.2015.11.005
   Low N, 2016, CAUSALITY FRAMEWORK
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610
   McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   MISHU B, 1993, CLIN INFECT DIS, V17, P104, DOI 10.1093/clinids/17.1.104
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   National Institute for Health and Clinical Excellence, 2015, DEV NICE GUID MAN AP
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan American Health Organization, 2016, EP AL ZIK VIR INF 3
   Pan American Health Organization, 2016, EP AL ZIK VIR INF 31
   Pan American Health Organization, 2016, EP AL ZIK VIR INF
   Pan American Health Organization, 2016, EP UPD ZIK VIR INF 2
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Pylro V, 2016, EXPLORING MIRNAS KEY
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   REAGAN RL, 1954, TEX REP BIOL MED, V12, P524
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Rodrigues LC, 2016, LANCET INFECT DIS
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335
   Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sauteur PMM, 2016, ANN NEUROL, V80, P566, DOI 10.1002/ana.24755
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2016, INT J INFECT DIS, V45, P24, DOI 10.1016/j.ijid.2016.02.086
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thayer KA, 2016, ENVIRON INT, V92-93, P585, DOI 10.1016/j.envint.2016.03.027
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tracz Vitek, 2016, F1000Res, V5, P130, DOI 10.12688/f1000research.7968.1
   Tseng YF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-20
   van den Berg B, 2016, Ned Tijdschr Geneeskd, V160, pD155
   Vandenbroucke JP, 1999, J ROY SOC MED, V92, P159, DOI 10.1177/014107689909200401
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   WHO, 2016, ZIK SIT REP NEUR SYN
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   World Health O, 2016, ZIK VIR RES AG
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, ZIK CAUS STAT ZIK VI
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Yung CF, 2016, CLIN INFECT DIS, V63, P708, DOI 10.1093/cid/ciw355
   Zika Experimental Science Team, 2016, ZIKV 003 ZIKV 005 IN
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 148
TC 168
Z9 173
U1 2
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2017
VL 14
IS 1
AR e1002203
DI 10.1371/journal.pmed.1002203
PG 27
WC Medicine, General & Internal
SC General & Internal Medicine
GA EN0SM
UT WOS:000395719900005
PM 28045901
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cardoso, CW
   Kikuti, M
   Prates, APPB
   Paploski, IAD
   Tauro, LB
   Silva, MMO
   Santana, P
   Rego, MFS
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Cardoso, Cristiane W.
   Kikuti, Mariana
   Prates, Ana Paula P. B.
   Paploski, Igor A. D.
   Tauro, Laura B.
   Silva, Monaise M. O.
   Santana, Perla
   Rego, Marta F. S.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI Unrecognized Emergence of Chikungunya Virus during a Zika Virus Outbreak
   in Salvador, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DISEASE; DENGUE
AB Background
   Chikungunya virus (CHIKV) entered Brazil in 2014, causing a large outbreak in Feira de Santana, state of Bahia. Although cases have been recorded in Salvador, the capital of Bahia, located similar to 100 km of Feira de Santana, CHIKV transmission has not been perceived to occur epidemically, largely contrasting with the Zika virus (ZIKV) outbreak and ensuing complications reaching the city in 2015.
   Methodology/Principal Findings
   This study aimed to determine the intensity of CHIKV transmission in Salvador between November 2014 and April 2016. Results of all the CHIKV laboratory tests performed in the public sector were obtained and the frequency of positivity was analyzed by epidemiological week. Of the 2,736 tests analyzed, 456 (16.7%) were positive. An increasing in the positivity rate was observed, starting in January/2015, and peaking at 68% in August, shortly after the exanthematous illness outbreak attributed to ZIKV.
   Conclusions/Significance
   Public health authorities and health professionals did not immediately detect the increase in CHIKV cases, likely because all the attention was directed to the ZIKV outbreak and ensuing complications. It is important that regions in the world that harbor arbovirus vectors and did not experience intense ZIKV and CHIKV transmission be prepared for the potential co-emergence of these two viruses.
C1 [Cardoso, Cristiane W.; Prates, Ana Paula P. B.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Kikuti, Mariana; Paploski, Igor A. D.; Tauro, Laura B.; Silva, Monaise M. O.; Santana, Perla; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Kikuti, Mariana; Paploski, Igor A. D.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Rego, Marta F. S.] Secretaria Saude Estado Bahia, Lab Cent Saude Publ, Salvador, BA, Brazil.
   [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Kikuti, Mariana/G-2313-2017; Reis, Mitermayer/AAO-9742-2020; Paploski,
   Igor AD/D-7015-2014; Ribeiro, Guilherme/B-6624-2008
OI Kikuti, Mariana/0000-0001-8119-7236; Reis,
   Mitermayer/0000-0002-3051-9060; Paploski, Igor AD/0000-0002-3689-2042;
   Ribeiro, Guilherme/0000-0002-6798-2059; Cardoso,
   Cristiane/0000-0001-5432-1174
FU National Council for Scientific and Technological
   Development-CNPqNational Council for Scientific and Technological
   Development (CNPq) [400830/2013-2]; Bahia Foundation for Research
   Support FAPESB; Coordination for the Improvement of Higher Education
   Personnel CAPES, Brazilian Ministry of EducationCAPES
FX Financial support was provided by the National Council for Scientific
   and Technological Development-CNPq (grant: 400830/2013-2 to GSR; and
   scholarships to: IADP, UK, MGR, GSR); the Bahia Foundation for Research
   Support FAPESB (scholarship to: MMOS); and the Coordination for the
   Improvement of Higher Education Personnel CAPES, Brazilian Ministry of
   Education (scholarship to: MK). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Ballera JE, 2015, J WPSAR, V6, P3, DOI DOI 10.5365/WPSAR.2015.6.1.006
   Brasil P, 2016, N ENGL J MED
   BRAZIL, 2015, B EP MON CAS DENG FE, V52, P43
   BRAZIL, 2015, FEBR CHIK MAN CLIN
   BRAZIL, 2016, B EP MON CAS DENG FE, V37, P47
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Campos GS, 2015, EMERG INFECT DIS J, V21
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Coimbra TLM, 2007, REV INST MED TROP SP, P221
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002
   da SP Vieira CJ, 2015, ACTA TROP, V147, P12
   Feldstein LR, 2016, AM J TROP MED HYG, P16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   PAHO, 2014, CHIKV SURV AM DET LA
   Paploski IAD, 2016, EMERG INFECT DIS J, V22
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues Faria N, 2016, PLOS CURR OUTBREAKS, V1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Salvador, 2015, AL EP 01 2015 FEBR C
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004625
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 14
Z9 14
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005334
DI 10.1371/journal.pntd.0005334
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000082
PM 28114414
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jupatanakul, N
   Sim, S
   Anglero-Rodriguez, YI
   Souza-Neto, J
   Das, S
   Poti, KE
   Rossi, SL
   Bergren, N
   Vasilakis, N
   Dimopoulos, G
AF Jupatanakul, Natapong
   Sim, Shuzhen
   Anglero-Rodriguez, Yesseinia I.
   Souza-Neto, Jayme
   Das, Suchismita
   Poti, Kristin E.
   Rossi, Shannan L.
   Bergren, Nicholas
   Vasilakis, Nikos
   Dimopoulos, George
TI Engineered Aedes aegypti JAK/STAT Pathway-Mediated Immunity to Dengue
   Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID JAK-STAT PATHWAY; ANOPHELES-GAMBIAE; RNA HELICASE; GENE DRIVE; MOSQUITO;
   DROSOPHILA; INFECTION; VECTOR; REPLICATION; ACTIVATION
AB We have developed genetically modified Ae. aegypti mosquitoes that activate the conserved antiviral JAK/STAT pathway in the fat body tissue, by overexpressing either the receptor Dome or the Janus kinase Hop by the blood feeding-induced vitellogenin (Vg) promoter. Transgene expression inhibits infection with several dengue virus (DENV) serotypes in the midgut as well as systemically and in the salivary glands. The impact of the transgenes Dome and Hop on mosquito longevity was minimal, but it resulted in a compromised fecundity when compared to wild-type mosquitoes. Overexpression of Dome and Hop resulted in profound transcriptome regulation in the fat body tissue as well as the midgut tissue, pinpointing several expression signatures that reflect mechanisms of DENV restriction. Our transcriptome studies and reverse genetic analyses suggested that enrichment of DENV restriction factor and depletion of DENV host factor transcripts likely accounts for the DENV inhibition, and they allowed us to identify novel factors that modulate infection. Interestingly, the fat body-specific activation of the JAK/STAT pathway did not result in any enhanced resistance to Zika virus (ZIKV) or chikungunya virus (CHIKV) infection, thereby indicating a possible specialization of the pathway's antiviral role.
C1 [Jupatanakul, Natapong; Sim, Shuzhen; Anglero-Rodriguez, Yesseinia I.; Souza-Neto, Jayme; Das, Suchismita; Poti, Kristin E.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Rossi, Shannan L.; Bergren, Nicholas; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Bergren, Nicholas; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Jupatanakul, Natapong] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Thailand Sci Pk, Pathum Thani 12120, Thailand.
   [Sim, Shuzhen] Genome Inst Singapore, 60 Biopolis St,02-01 Genome, Singapore 138672, Singapore.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
EM gdimopo1@jhu.edu
RI Souza-Neto, Jayme A/E-7841-2010
OI Souza-Neto, Jayme A/0000-0001-9281-894X
FU Agency for Science, Technology and Research, SingaporeAgency for Science
   Technology & Research (ASTAR); Royal Thai Government; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [NIAID: AI101431, R21AI090188, 1R24AI120942]
FX SS was supported by a fellowship from the Agency for Science, Technology
   and Research, Singapore. NJ was supported by a fellowship from the Royal
   Thai Government. The work was supported by grants from the NIH, NIAID:
   AI101431 (to GD), R21AI090188 (to GD), 1R24AI120942 (to NV). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411
   Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07
   Ariumi Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00423
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Chakrabarti S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006089
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005
   Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567
   Fu Q, 2015, J MED ENTOMOL
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669
   Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   KLOWDEN MJ, 1994, J MED ENTOMOL, V31, P618, DOI 10.1093/jmedent/31.4.618
   Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5
   Li CuiXia, 2013, Asian Agricultural Research, V5, P3
   Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x
   Luo H, 1999, DEV BIOL, V213, P432, DOI 10.1006/dbio.1999.9390
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Middha S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-260
   Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631
   Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337
   Morin-Poulard I, 2014, JAK STAT, V2
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Nawa M, 2001, J VIROL METHODS, V92, P65, DOI 10.1016/S0166-0934(00)00274-3
   NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v
   Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5
   Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030
   Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633
   ROMANS P, 1995, INSECT BIOCHEM MOLEC, V25, P939, DOI 10.1016/0965-1748(95)00037-V
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1
   Xu D, 2014, JAK STAT, V2
   Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8
   Yang IV, 2002, GENOME BIOL, V3
   Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192
   Yu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002303
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 63
TC 44
Z9 46
U1 2
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005187
DI 10.1371/journal.pntd.0005187
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000014
PM 28081143
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McGough, SF
   Brownstein, JS
   Hawkins, JB
   Santillana, M
AF McGough, Sarah F.
   Brownstein, John S.
   Hawkins, Jared B.
   Santillana, Mauricio
TI Forecasting Zika Incidence in the 2016 Latin America Outbreak Combining
   Traditional Disease Surveillance with Search, Social Media, and News
   Report Data
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID QUERY DATA; VIRUS; ILLNESS; TIME; FLU
AB Background
   Over 400,000 people across the Americas are thought to have been infected with Zika virus as a consequence of the 2015-2016 Latin American outbreak. Official government-led case count data in Latin America are typically delayed by several weeks, making it difficult to track the disease in a timely manner. Thus, timely disease tracking systems are needed to design and assess interventions to mitigate disease transmission.
   Methodology/Principal Findings
   We combined information from Zika-related Google searches, Twitter microblogs, and the HealthMap digital surveillance system with historical Zika suspected case counts to track and predict estimates of suspected weekly Zika cases during the 2015-2016 Latin American outbreak, up to three weeks ahead of the publication of official case data. We evaluated the predictive power of these data and used a dynamic multivariable approach to retrospectively produce predictions of weekly suspected cases for five countries: Colombia, El Salvador, Honduras, Venezuela, and Martinique. Models that combined Google (and Twitter data where available) with autoregressive information showed the best out-of-sample predictive accuracy for 1-week ahead predictions, whereas models that used only Google and Twitter typically performed best for 2-and 3-week ahead predictions.
   Significance
   Given the significant delay in the release of official government-reported Zika case counts, we show that these Internet-based data streams can be used as timely and complementary ways to assess the dynamics of the outbreak.
C1 [McGough, Sarah F.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [McGough, Sarah F.; Brownstein, John S.; Hawkins, Jared B.; Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02215 USA.
   [McGough, Sarah F.; Brownstein, John S.; Hawkins, Jared B.; Santillana, Mauricio] Boston Childrens Hosp, Div Emergency Med, Computat Epidemiol Grp, Boston, MA 02215 USA.
   [Brownstein, John S.; Hawkins, Jared B.; Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA USA.
RP McGough, SF (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; McGough, SF (corresponding author), Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02215 USA.; McGough, SF (corresponding author), Boston Childrens Hosp, Div Emergency Med, Computat Epidemiol Grp, Boston, MA 02215 USA.
EM sfm341@g.harvard.edu; msantill@g.harvard.edu
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Agence Regionale de Sante, 2016, POINTS EP ZIK
   Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258
   Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   CDC, 2016, ZIK TRANSM RISKS
   CDC, 2016, ZIK SYMPT
   Cook S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023610
   Dalton C, 2009, COMMUN DIS INTELL, V33, P316
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Hills SL, 2016, MMWR MORB MORTAL WKL, V65
   Instituto Nacional de Salud, 2016, REP AN ZIK
   Johansson MA, SCI REP IN PRESS
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Majumder Maimuna S, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.e6659013c1d7f11bdab6a20705d1e865
   Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416
   Nsoesie EO, 2015, SCI REP-UK, V5, DOI 10.1038/srep09112
   Olkowski S, 2016, SENTINEL VERSUS PASS
   Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256
   PAHO, 2016, REG ZIK EP UPD
   PAHO, 2016, CUM ZIK SUSP CONF CA, P2015
   PAHO, 2016, ZIKA VIRUS CASE DEFI
   Pan American Health Organization/ World Health Organization, 2016, CUM ZIK SUSP CONF CA
   Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098
   R Core Team. R, 2016, LANG ENV STAT COMP
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Santillana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25732
   Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513
   Santillana M, 2014, CLIN INFECT DIS, V59, P1446, DOI 10.1093/cid/ciu647
   Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020
   Scott TW, 2009, CURR TOP MICROBIOL, P115
   Shang MJ, 2013, J FIX POINT THEORY A, V8, DOI DOI 10.1371/J0URNAL.P0NE.0064323
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Smolinski MS, 2015, AM J PUBLIC HEALTH, V105, P2124, DOI 10.2105/AJPH.2015.302696
   Soules A, 2013, GRAIN, V20
   Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x
   Vogel G, 2016, SCIENCE, V352, P3450, DOI [10.1126/science.aaf5036, DOI 10.1126/SCIENCE.AAF5036]
   WHO, 2016, ZIKA VIR SIT REP
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Wu J, 2016, CHINESE MED J-PEKING, V129, P2347, DOI 10.4103/0366-6999.190672
   Yang S, 2016, ARXIV161202812
   Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112
NR 51
TC 49
Z9 49
U1 4
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005295
DI 10.1371/journal.pntd.0005295
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000062
PM 28085877
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Silva, JVJ
   Lopes, TRR
   de Oliveira, EF
   Oliveira, RAD
   Gil, LHVG
AF Joaquim Silva Junior, Jose Valter
   Rocha Lopes, Thaisa Regina
   de Oliveira-Filho, Edmilson Ferreira
   dos Santos Oliveira, Renato Antonio
   Vega Gonzales Gil, Laura Helena
TI Perspectives on the Zika outbreak: herd immunity, antibodydependent
   enhancement and vaccine
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Letter
ID CROSS-REACTIVITY; VIRUS; INFECTION
C1 [Joaquim Silva Junior, Jose Valter; de Oliveira-Filho, Edmilson Ferreira; dos Santos Oliveira, Renato Antonio; Vega Gonzales Gil, Laura Helena] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
   [Rocha Lopes, Thaisa Regina] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Setor Virol, Recife, PE, Brazil.
RP Silva, JVJ (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
EM josevalterjsilvajr@gmail.com
RI Oliveira, Renato/AAN-9879-2020; Oliveira, Renato/A-2863-2013;
   Oliveira-Filho, Edmilson F/A-6305-2012; Oliveira, Renato/AAN-9394-2020
OI Oliveira, Renato/0000-0002-4044-0794; Oliveira,
   Renato/0000-0002-4044-0794; Oliveira-Filho, Edmilson
   F/0000-0002-3771-1565; 
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   World Health Organization, 2016, DENG VACC RES
NR 11
TC 6
Z9 6
U1 0
U2 4
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2017
VL 59
AR UNSP e21
DI 10.1590/S1678-9946201759021
PG 2
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ3KO
UT WOS:000404610000010
PM 28423096
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramharack, P
   Oguntade, S
   Soliman, MES
AF Ramharack, Pritika
   Oguntade, Sofiat
   Soliman, Mahmoud E. S.
TI Delving into Zika virus structural dynamics - a closer look at NS3
   helicase loop flexibility and its role in drug discovery
SO RSC ADVANCES
LA English
DT Article
ID CRYSTAL-STRUCTURE; DESIGN; INHIBITOR; INFECTION
AB The Zika virus has emerged as a pathogen of major health concern. The rapid spread of the virus has led to uproar in the medical domain as scientists frantically race to develop effective vaccines and small molecules to inhibit the virus. In the past year, there has been a flood of Zika knowledge published including its characteristics, transmission routes and its role in disease conditions such as microcephaly and Gullian-Barre syndrome. Targeted therapy against specific viral maturation proteins is necessary in halting the replication of the virus in the human host, thus decreasing host-host transmission. This prompted us to investigate the structural properties of the Zika NS3 helicase when bound to ATP-competitive inhibitor, NITD008. In this study, comparative molecular dynamic simulations were employed for APO and bound protein to demonstrate the molecular mechanism of the helicase. Results clearly revealed that NITD008-binding caused significant residue fluctuations at the P-loop compared to the rigid nature of the APO conformation. The NITD008-helicase complex also revealed residues 339-348 to transition from a (3)10-helix to a stable alpha-helix. These protein fluctuations were verified by investigation of dynamic cross correlation and principal component analysis. The fundamental dynamic analysis presented in this report is crucial in understanding Zika NS3 helicase function, thereby giving insights toward an inhibition mechanism. The information reported on the binding mode at the ATPase active site may also assist in designing effective inhibitors against this detrimental viral target.
C1 [Ramharack, Pritika; Oguntade, Sofiat; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Modeling & Drug Design Res Grp, Westville Campus, ZA-4001 Durban, South Africa.
   [Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Pharmaceut Sci, Westville Campus, ZA-4001 Durban, South Africa.
   [Soliman, Mahmoud E. S.] Zagazig Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Zagazig, Egypt.
   [Soliman, Mahmoud E. S.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
RP Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Modeling & Drug Design Res Grp, Westville Campus, ZA-4001 Durban, South Africa.; Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Pharmaceut Sci, Westville Campus, ZA-4001 Durban, South Africa.; Soliman, MES (corresponding author), Zagazig Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Zagazig, Egypt.; Soliman, MES (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
EM soliman@ukzn.ac.za
OI Ramharack, Pritika/0000-0001-5850-6782
FU National Research Foundation [102103]
FX The authors acknowledge the National Research Foundation for their
   financial support (UID: 102103) and the Center for High Performance
   Computing (http://www.chpc.ac.za) for their computational resources.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Broxmeyer L, 2016, MOD RES INFLAMM, V5, P20
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Centers for Disease Control Centers Dis. Control Prev., 2016, ZIK VIR HOM, P1
   Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dick G. W. A., 1969, T R SOC TROP MED HYG, V63, P708
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Ferreira L. G., 2015, MOL DOCKING STRUCTUR, V20
   Godschalk F, 2013, PHYS CHEM CHEM PHYS, V15, P7731, DOI 10.1039/c3cp00116d
   Gosu V, 2014, SCI REP-UK, V4, DOI 10.1038/srep05748
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Hayes J. M., 2011, ZIKA VIRUS OUTSIDE A, P171
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a
   Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356
   Jain R., 2016, NAT STRUCT MOL BIOL, V2, P1
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kusumaningrum S., 2014, J APP SCI, V4, P47, DOI [10.7324/JAPS.2014.4119, DOI 10.7324/JAPS.2014.4119]
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mahfuz M., 2014, INDIAN J PHARM BIOL, V2, P44
   Malone R. W., 2016, PLOS NEGLECTED TROP, V10, P1
   Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974
   Palomo AM, 2016, J PUBLIC HEALTH POL, V37, P133, DOI 10.1057/jphp.2016.11
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Nair Pramod C., 2014, In Silico Pharmacology, V2, P4, DOI 10.1186/s40203-014-0004-8
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde A. R., 2016, EMERG INFECT DIS, V22, P1
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Ramirez D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040525
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sanner M. F., 2008, SCRIPPS RES I, V26, P1
   Seifert E, 2014, J CHEM INF MODEL, V54, P1552, DOI 10.1021/ci500161d
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Turmel M. J., 2016, LANCET, V6736, P2501
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
   Ylilauri M, 2013, J CHEM INF MODEL, V53, P2626, DOI 10.1021/ci4002475
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 57
TC 13
Z9 13
U1 0
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2017
VL 7
IS 36
BP 22133
EP 22144
DI 10.1039/c7ra01376k
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA ET3DO
UT WOS:000400157700016
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lequime, S
   Lambrechts, L
AF Lequime, Sebastian
   Lambrechts, Louis
TI Discovery of flavivirus-derived endogenous viral elements in Anopheles
   mosquito genomes supports the existence of Anopheles-associated
   insect-specific flaviviruses
SO VIRUS EVOLUTION
LA English
DT Article
DE Flavivirus; host range; Anopheles sinensis; Anopheles minimus; ISF; EVE
ID WEST NILE VIRUS; YUNNAN PROVINCE; NEW-YORK; EVOLUTION; CHINA; INFECTION;
   ALIGNMENT; SEQUENCE; GAMBIAE; BIRDS
AB The Flavivirus genus encompasses several arboviruses of public health significance such as dengue, yellow fever, and Zika viruses. It also includes insect-specific flaviviruses (ISFs) that are only capable of infecting insect hosts. The vast majority of mosquito-infecting flaviviruses have been associated with mosquito species of the Aedes and Culex genera in the Culicinae subfamily, which also includes most arbovirus vectors. Mosquitoes of the Anophelinae subfamily are not considered significant arbovirus vectors; however, flaviviruses have occasionally been detected in field-caught Anopheles specimens. Whether such observations reflect occasional spillover or laboratory contamination or whether Anopheles mosquitoes are natural hosts of flaviviruses is unknown. Here, we provide in silico and in vivo evidence of transcriptionally active, flavivirus-derived endogenous viral elements (EVEs) in the genome of Anopheles minimus and Anopheles sinensis. Such non-retroviral endogenization of RNA viruses is consistent with a shared evolutionary history between flaviviruses and Anophelesmosquitoes. Phylogenetic analyses of the two newly described EVEs support the existence of a distinct clade of Anopheles-associated ISFs.
C1 [Lequime, Sebastian; Lambrechts, Louis] Inst Pasteur, Insect Virus Interact Grp, Dept Genomes & Genet, Paris, France.
   [Lequime, Sebastian; Lambrechts, Louis] CNRS, Unite Rech Associee 3012, Paris, France.
   [Lequime, Sebastian] Univ Paris 06, Cellule Pasteur UPMC, Paris, France.
RP Lequime, S (corresponding author), Inst Pasteur, Insect Virus Interact Grp, Dept Genomes & Genet, Paris, France.; Lequime, S (corresponding author), CNRS, Unite Rech Associee 3012, Paris, France.; Lequime, S (corresponding author), Univ Paris 06, Cellule Pasteur UPMC, Paris, France.
EM sebastian.lequime@gmail.com
RI Lequime, Sebastian/E-9380-2011; Lambrechts, Louis/A-2057-2010
OI Lequime, Sebastian/0000-0002-3140-0651; Lambrechts,
   Louis/0000-0001-5958-2138
FU French Government's Investissement d'Avenir program Laboratoire
   d'Excellence Integrative Biology of Emerging Infectious DiseasesFrench
   National Research Agency (ANR) [ANR-10-LABX-62-IBEID]; City of Paris
   Emergence(s) program in Biomedical ResearchRegion Ile-de-France;
   University Pierre and Marie Curie
FX This work was supported by the French Government's Investissement
   d'Avenir program Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases grant ANR-10-LABX-62-IBEID, and the City of
   Paris Emergence(s) program in Biomedical Research. S.L. was supported by
   a doctoral fellowship from University Pierre and Marie Curie. The
   funders had no role in study design, data collection and interpretation,
   or the decision to submit the work for publication.
CR Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011
   Aranda C, 2009, VECTOR-BORNE ZOONOT, V9, P171, DOI 10.1089/vbz.2008.0073
   Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007
   Bell-Sakyi L, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00025
   Bernard KA, 2001, EMERG INFECT DIS, V7, P679
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x
   Calzolari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063978
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Clements A, 2012, BIOLOGY OF MOSQUITOES, VOL 3: TRANSMISSION OF VIRUSES AND INTERACTIONS WITH BACTERIA, P90, DOI 10.1079/9781845932428.0090
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Feng Y, 2012, JPN J INFECT DIS, V65, P215, DOI 10.7883/yoken.65.215
   Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199
   FILIPE AR, 1972, ACTA VIROL, V16, P361
   Flegel TW, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-32
   Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111
   Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kemenesi G, 2014, EUROSURVEILLANCE, V19, P16, DOI 10.2807/1560-7917.ES2014.19.16.20779
   Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Liang WK, 2015, ARCH VIROL, V160, P2259, DOI 10.1007/s00705-015-2492-1
   Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016
   Logue K, 2015, MOL ECOL, V24, P1263, DOI 10.1111/mec.13107
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408
   Zhou D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-42
   Zuo SQ, 2014, VIRUS RES, V180, P31, DOI 10.1016/j.virusres.2013.12.005
NR 41
TC 18
Z9 18
U1 1
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD JAN
PY 2017
VL 3
IS 1
AR UNSP vew035
DI 10.1093/ve/vew035
PG 8
WC Virology
SC Virology
GA FH0QJ
UT WOS:000410845300002
PM 28078104
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sahadeo, NSD
   Allicock, OM
   De Salazar, PM
   Auguste, AJ
   Widen, S
   Olowokure, B
   Gutierrez, C
   Valadere, AM
   Polson-Edwards, K
   Weaver, SC
   Carrington, CVF
AF Sahadeo, N. S. D.
   Allicock, O. M.
   De Salazar, P. M.
   Auguste, A. J.
   Widen, S.
   Olowokure, B.
   Gutierrez, C.
   Valadere, A. M.
   Polson-Edwards, K.
   Weaver, S. C.
   Carrington, C. V. F.
TI Understanding the evolution and spread of chikungunya virus in the
   Americas using complete genome sequences
SO VIRUS EVOLUTION
LA English
DT Article
DE Caribbean; chikungunya virus; complete genome; evolution; Americas;
   selection analysis
ID ONYONG-NYONG VIRUS; ZIKA VIRUS; INFECTION; EPIDEMIC; OUTBREAK;
   DATAMONKEY; MUTATION; RNA
AB Local transmission of chikungunya virus (CHIKV) was first detected in the Americas in December 2013, after which it spread rapidly throughout the Caribbean islands and American mainland, causing a major chikungunya fever epidemic. Previous phylogenetic analysis of CHIKV from a limited number of countries in the Americas suggests that an Asian genotype strain was responsible, except in Brazil where both Asian and East/Central/South African (ECSA) lineage strains were detected. In this study, we sequenced thirty-three complete CHIKV genomes from viruses isolated in 2014 from fourteen Caribbean islands, the Bahamas and two mainland countries in the Americas. Phylogenetic analyses confirmed that they all belonged to the Asian genotype and clustered together with other Caribbean and mainland sequences isolated during the American outbreak, forming an 'Asian/American' lineage defined by two amino acid substitutions, E2 V368A and 6K L20M, and divided into two well-supported clades. This lineage is estimated to be evolving at a mean rate of 5 x 10(-4) substitutions per site per year (95% higher probability density, 2.9-7.9 x 10(-4)) and to have arisen from an ancestor introduced to the Caribbean (most likely from Oceania) in about March 2013, 9 months prior to the first report of CHIKV in the Americas. Estimation of evolutionary rates for individual gene regions and selection analyses indicate that (in contrast to the Indian Ocean Lineage that emerged from the ECSA genotype followed by adaptive evolution and with a significantly higher substitution rate) the evolutionary dynamics of the Asian/American lineage are very similar to the rest of the Asian genotype and natural selection does not appear to have played a major role in its emergence. However, several codon sites with evidence of positive selection were identified within the non-structural regions of Asian genotype sequences outside of the Asian/American lineage.
C1 [Sahadeo, N. S. D.; Allicock, O. M.; Carrington, C. V. F.] Univ West Indies, Fac Med Sci, Dept Preclin Sci, St Augustine Campus, St Augustine, Trinidad Tobago.
   [De Salazar, P. M.; Olowokure, B.; Gutierrez, C.; Valadere, A. M.; Polson-Edwards, K.] Caribbean Publ Hlth Agcy, Port Of Spain, Trinidad Tobago.
   [De Salazar, P. M.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Auguste, A. J.; Widen, S.; Weaver, S. C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Auguste, A. J.; Widen, S.; Weaver, S. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Carrington, CVF (corresponding author), Univ West Indies, Fac Med Sci, Dept Preclin Sci, St Augustine Campus, St Augustine, Trinidad Tobago.
EM christine.carrington@sta.uwi.edu
OI Auguste, Albert/0000-0001-9048-0041
FU UWI-Trinidad and Tobago Research and Development Impact Fund; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI120942, AI121452];
   James W. McLaughlin endowment fund
FX This study was supported by the UWI-Trinidad and Tobago Research and
   Development Impact Fund [to C.V.F.C], National Institutes of Health
   [AI120942 and AI121452 to S.C.W.]. A.J.A. was supported by the James W.
   McLaughlin endowment fund.
CR Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Auguste AJ, 2015, J VIROL, V89, P676, DOI 10.1128/JVI.02264-14
   BRIGHTON SW, 1983, S AFR MED J, V63, P313
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429
   Diaz Y, 2015, AM J TROP MED HYG, V92, P482, DOI 10.4269/ajtmh.14-0404
   Diaz-Quinonez J. A., 2015, GENOME ANNOUNCEMENTS, V3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gerardin P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-5
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LEVINSON RS, 1990, VIROLOGY, V175, P110, DOI 10.1016/0042-6822(90)90191-S
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Myles KM, 2006, J VIROL, V80, P4992, DOI 10.1128/JVI.80.10.4992-4997.2006
   Pan American Health Organization, 2014, NUMB REP CAS CHIK FE
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Roth A., 2014, EMERGING INFECT DIS, V20
   Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
NR 47
TC 25
Z9 26
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD JAN
PY 2017
VL 3
IS 1
AR UNSP vex010
DI 10.1093/ve/vex010
PG 10
WC Virology
SC Virology
GA FH0QJ
UT WOS:000410845300011
PM 28480053
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Epitope finding in Zika virus molecule: The first world report
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Article
AB Zika virus infection is a new problematic virus infection that becomes the present public health problem. Now this mosquito borne infectious disease can be seen worldwide and can cause dengue-like infection. In addition, it can also induce transplacental infection and result in congenital neurological defect. To prevent this infection, there is still no specific vaccine. To find a new vaccine, finding epitope is the first step. Here, the authors report the study to find epitope within Zika virus molecule. According to this study, the appropriate epitopes can be seen. This is the first world report on epitope finding for Zika virus. The data can be useful for further vaccine development.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2006, CHINESE MED J-PEKING, V119, P1760
   Wiwanitkit Viroj, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P330, DOI 10.1016/S2221-1691(13)60073-8
   Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152
NR 7
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD JAN
PY 2017
VL 7
IS 1
BP 1
EP 3
DI 10.1016/j.apjtb.2016.04.015
PG 3
WC Tropical Medicine
SC Tropical Medicine
GA EF1XC
UT WOS:000390117400001
OA DOAJ Gold
DA 2020-07-08
ER

PT S
AU Bordi, L
   Avsic-Zupanc, T
   Lalle, E
   Vairo, F
   Capobianchi, MR
   Vasconcelos, PFD
AF Bordi, Licia
   Avsic-Zupanc, Tatjana
   Lalle, Eleonora
   Vairo, Francesco
   Capobianchi, Maria Rosaria
   da Costa Vasconcelos, Pedro Fernando
BE Rezza, G
   Ippolito, G
TI Emerging Zika Virus Infection: A Rapidly Evolving Situation
SO EMERGING AND RE-EMERGING VIRAL INFECTIONS: ADVANCES IN MICROBIOLOGY,
   INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 6
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Zika Virus; Spread; Diagnosis; Pathogenetic Effects; Phylogenesis;
   Transmission; Clinical Manifestation
ID CONTINENTAL UNITED-STATES; MALE SEXUAL TRANSMISSION; YELLOW-FEVER;
   ENVELOPE PROTEIN; AEDES-ALBOPICTUS; A226V MUTATION; DENGUE; CHIKUNGUNYA;
   DIAGNOSIS; OUTBREAK
AB Zika virus is a mosquito-borne flavivirus, firstly identified in Uganda and responsible for sporadic human cases in Africa and Asia until recently, when large outbreak occurred in Pacific Ocean and the Americas. Since the main vectors during its spread outside of Africa have been Ae. albopictus and Ae. aegypti mosquitoes, which are widely distributed all over the world, there is urgent need for a coordinated response for prevention and spread of ZIKV epidemics.
   Despite clinical manifestation of Zika virus infection are usually mild and self limiting, there are reports suggesting, during the recent epidemic, an association of ZIKV infection with severe consequences, including fetal/newborn microcephaly, due to vertical in utero transmission, autoimmune-neurological presentations including cranial nerve dysfunction, and Guillain-Barre Syndrome in adults. The primary mode of transmission of Zika virus between humans is through the bite of an infected female mosquito of the Aedes genus, but also sexual and blood transfusion transmission may occur. Moreover, a case of non-sexual spread from one person to another has been described, indicating that we still have more to learn about Zika transmission.
   Biological basis for pathogenetic effects are under investigation. Laboratory diagnosis is challenging since, so far, there are no "gold standard" diagnostic tools, and the low and short viremia in the acute phase, and together with the high cross-reactivity among the members of flavivirus genus are the most challenging aspects to be overcome.
C1 [Bordi, Licia; Lalle, Eleonora; Capobianchi, Maria Rosaria] IRCCS, Virol Lab, Natl Inst Infect Dis Lazzaro Spallanzani, Via Portuense 292, I-00149 Rome, Italy.
   [Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.
   [Vairo, Francesco] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Emerging & Reemerging Infect Dis Unit, Rome, Italy.
   [da Costa Vasconcelos, Pedro Fernando] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
RP Capobianchi, MR (corresponding author), IRCCS, Virol Lab, Natl Inst Infect Dis Lazzaro Spallanzani, Via Portuense 292, I-00149 Rome, Italy.
EM licia.bordi@inmi.it; tatjana.avsic@mf.uni-lj.si; eleonora.lalle@inmi.it;
   francesco.vairo@inmi.it; maria.capobianchi@inmi.it;
   pedrovasconcelos@iec.pa.gov.br
RI Vasconcelos, Pedro/AAH-3142-2019; Bordi, Licia/B-6827-2017
OI AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Bordi,
   Licia/0000-0003-3962-3646; lalle, eleonora/0000-0002-7063-9905
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   Bordi L, 2011, NEW MICROBIOL, V34, P87
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CaoLormeau VM, 2016, GUILLAIN BARRE SYNDR, DOI [10.1016/S01406736(16)005626, DOI 10.1016/S0140-6736(16)00562-6]
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Deng YQ, 2016, SCI CHINA LIFE SCI
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   European Centre forDisease Prevention and Control, 2016, ZIK VIR INF OUTB BRA
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner LM, 2016, LANCET, DOI [10.1016/S14733099(16)001766, DOI 10.1016/S1473-3099(16)00176-6]
   Ghiulai RM, 2014, GLYCOCONJUGATE J, V31, P231, DOI 10.1007/s10719-014-9517-y
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Higgs S, 2016, ZIKA VIRUS EMERG EME, V16, P75
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hindiyeh M, 2001, EMERG INFECT DIS, V7, P748
   Iamarino A, 2015, SPREAD PANDEMIC ZIKA, DOI [10.1101/032839, DOI 10.1101/032839]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li H, 2016, CELL STEM CELL
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liuzzi G, 2016, EUR J INTERN MED, V33, pE20, DOI 10.1016/j.ejim.2016.04.022
   Liuzzi G, 2016, NEW MICROBIOL, V39, P83
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Ministerio da Saude (Brazil), 2016, MICR MIN SAU DIV B E
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, LANCET INFECT DIS, V16, P771, DOI 10.1016/S1473-3099(16)30074-3
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powers AM, 2010, CLIN LAB MED, V30, P209, DOI 10.1016/j.cll.2009.10.003
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robin Y, 1978, B SOC PATHOL EXOT, V68, P249
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Scherret JH, 2001, ANN NY ACAD SCI, V951, P361, DOI 10.1111/j.1749-6632.2001.tb02719.x
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shakir R, 2016, J NEUROL SCI, V363, P164, DOI 10.1016/j.jns.2016.02.045
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Solomon T, 2016, LANCET, V16
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Takasaki T, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, MED MICROBIOL IMMUN, DOI [10.1007/s0043015-04457, DOI 10.1007/S0043-015-0445-7]
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   THIEL HJ, 2005, VIRUS TAXONOMY, P981
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Wang LG, 2016, AQUACULT REP, V4, P10, DOI 10.1016/j.aqrep.2016.05.002
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WESTAWAY EG, 1987, ARCH VIROL, V94, P215, DOI 10.1007/BF01310715
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   WHO, 2016, SIT REP
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2016, ZIK VIR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 162
TC 5
Z9 5
U1 0
U2 1
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-3-319-52485-6; 978-3-319-52484-9
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2017
VL 972
BP 61
EP 86
DI 10.1007/5584_2016_187
D2 10.1007/978-3-319-52485-6
PG 26
WC Biology; Public, Environmental & Occupational Health; Infectious
   Diseases; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Public, Environmental &
   Occupational Health; Infectious Diseases; Research & Experimental
   Medicine
GA BL0JX
UT WOS:000446018300006
PM 28032327
DA 2020-07-08
ER

PT S
AU Al-Surimi, K
   Khalifa, M
   Bahkali, S
   EL-Metwally, A
   Househ, M
AF Al-Surimi, Khaled
   Khalifa, Mohammed
   Bahkali, Salwa
   EL-Metwally, Ashraf
   Househ, Mowafa
BE Rezza, G
   Ippolito, G
TI The Potential of Social Media and Internet-Based Data in Preventing and
   Fighting Infectious Diseases: From Internet to Twitter
SO EMERGING AND RE-EMERGING VIRAL INFECTIONS: ADVANCES IN MICROBIOLOGY,
   INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 6
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Social media; Internet; Infectious diseases; Public health surveillance
ID PUBLIC-HEALTH SURVEILLANCE; WEB; VISUALIZATION; SYSTEMS
AB Health threats due to infectious diseases used to be a major public health concerns around the globe till mid of twentieth century when effective public health interventions helped in eradicating a number of infectious diseases around the world. Over the past 15 years, there has been a rise in the number of emerging and reemerging infectious diseases being reported such as the Acute Respiratory Syndrome (SARS) in 2002, HINI in 2009, Middle East Respiratory Syndrome (MERS) in 2012, Ebola in 2014, and Zika in 2016. These emerging viral infectious diseases have led to serious public health concerns leading to death and causing fear and anxiety among the public. More importantly, at the moment, the prevention and control of viral infectious diseases is difficult due to a lack of effective vaccines. Thus having real-time reporting tools are paramount to alert relevant public health surveillance systems and authorities about taking the right and necessary actions to control and minimize the potential harmful effects of viral infectious diseases. Social media and Internet-based data can play a major role in real-time reporting to empower active public health surveillance systems for controlling and fighting infectious diseases.
C1 [Al-Surimi, Khaled; EL-Metwally, Ashraf; Househ, Mowafa] King Saud Bin Abdulaziz Univ Hlth Sci, Minist Natl Guard Hlth Affairs, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia.
   [Al-Surimi, Khaled] Imperial Coll London, Dept Primary Care & Publ Hlth, Sch Publ Hlth, Fac Med, London, England.
   [Khalifa, Mohammed] King Faisal Specialist Hosp & Res Ctr, Med Informat, Jeddah, Saudi Arabia.
   [Bahkali, Salwa] Princess Norah Bent Abdurrahman Univ, King Abdullah Bin Abdul Aziz Univ Hosp, Women Hlth Family & Community Med Org, Riyadh, Saudi Arabia.
RP Al-Surimi, K (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Minist Natl Guard Hlth Affairs, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia.; Al-Surimi, K (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, Sch Publ Hlth, Fac Med, London, England.
EM kalsurimi@gmail.com
OI Al-Surimi, Khaled/0000-0002-7845-258X; Khalifa,
   Mohamed/0000-0002-5919-8352; Househ, Mowafa/0000-0002-3648-6271
CR Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258
   Anema A, 2014, LANCET INFECT DIS, V14, P1035, DOI 10.1016/S1473-3099(14)70953-3
   Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740
   Bhatti R, 2015, J HOSP LIBRARIANSHIP, V15, P53
   Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672
   Brownstein J.S., 2007, EUROSURVEILLANCE, V12
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   Brownstein JS, 2009, NEW ENGL J MED, V360
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107
   Cheng CKY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-339
   Choffnes E, 2007, GLOBAL INFECT DIS SU
   Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597
   Corley CD, 2010, INT J ENV RES PUB HE, V7, P596, DOI 10.3390/ijerph7020596
   Culotta A, 2010, ARXIV10074748
   Dredze M., 2013, AAAI WORKSH EXP BOUN
   Eke PI, 2011, J DENT RES, V90, P1045, DOI 10.1177/0022034511415277
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Friendly M., 2001, MILESTONES HIST THEM
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Hartley DM, 2014, MILBANK Q, V92, P34, DOI 10.1111/1468-0009.12039
   Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003
   Kass-Hout TA, 2013, BRIT MED BULL, V108, P5, DOI 10.1093/bmb/ldt028
   Kautz H, 2013, 23 INT JOINT C ART I
   Keller M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-385
   Krieck M., 2011, P HLTH WEB SCI WORKS
   Lavrac N, 2007, J BIOMED INFORM, V40, P438, DOI 10.1016/j.jbi.2006.10.003
   M'ikanatha NM, 2006, BIOSECUR BIOTERROR, V4, P293, DOI 10.1089/bsp.2006.4.293
   M'ikanatha NM, 2004, JAMA-J AM MED ASSOC, V291, P1069, DOI 10.1001/jama.291.9.1069
   MEDICINENET, 2015, DEF DIS SURV
   Milinovich GJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0690-1
   Milinovich GJ, 2015, LANCET GLOB HEALTH, V3, pE20, DOI 10.1016/S2214-109X(14)70356-0
   Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Olson SH, 2015, EMERG INFECT DIS, V21, P1285, DOI 10.3201/eid2108.141156
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Sadilek A., 2012, P 5 ACM INT C WEB SE
   Sturtevant JL, 2007, DISASTER MED PUBLIC, V1, P117, DOI 10.1097/DMP.0b013e318159cbae
   Thompson LA, 2011, J MED INTERNET RES, V13, P3, DOI 10.2196/jmir.1590
   Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038
   Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549
   Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]
   World Health Organization, 2015, INF DIS
   Yang YT, 2013, J PUBLIC HEALTH RES, V2, P17, DOI 10.4081/jphr.2013.e4
NR 45
TC 10
Z9 10
U1 9
U2 12
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-3-319-52485-6; 978-3-319-52484-9
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2017
VL 972
BP 131
EP 139
DI 10.1007/5584_2016_132
D2 10.1007/978-3-319-52485-6
PG 9
WC Biology; Public, Environmental & Occupational Health; Infectious
   Diseases; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Public, Environmental &
   Occupational Health; Infectious Diseases; Research & Experimental
   Medicine
GA BL0JX
UT WOS:000446018300010
PM 28004307
OA Green Published
DA 2020-07-08
ER

PT S
AU Bordi, L
   Avsic-Zupanc, T
   Lalle, E
   Vairo, F
   Capobianchi, MR
   Vasconcelos, PFD
AF Bordi, Licia
   Avsic-Zupanc, Tatjana
   Lalle, Eleonora
   Vairo, Francesco
   Capobianchi, Maria Rosaria
   da Costa Vasconcelos, Pedro Fernando
BE Rezza, G
   Ippolito, G
TI Emerging Zika Virus Infection: A Rapidly Evolving Situation (vol 972, pg
   61, 2017)
SO EMERGING AND RE-EMERGING VIRAL INFECTIONS: ADVANCES IN MICROBIOLOGY,
   INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 6
SE Advances in Experimental Medicine and Biology
LA English
DT Correction; Book Chapter
RI Vasconcelos, Pedro/AAH-3142-2019
OI lalle, eleonora/0000-0002-7063-9905; AVSIC ZUPANC,
   TATJANA/0000-0001-6243-0688
CR BORDI L, 2017, EMERGING ZIKA VIRUS, V972, P61, DOI DOI 10.1007/5584_2016_187
NR 1
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-3-319-52485-6; 978-3-319-52484-9
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2017
VL 972
BP 141
EP 141
DI 10.1007/5584_2017_16
D2 10.1007/978-3-319-52485-6
PG 1
WC Biology; Public, Environmental & Occupational Health; Infectious
   Diseases; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Public, Environmental &
   Occupational Health; Infectious Diseases; Research & Experimental
   Medicine
GA BL0JX
UT WOS:000446018300011
PM 28255910
OA Bronze
DA 2020-07-08
ER

PT J
AU Gonzalez-Escobar, G
   Valadere, AM
   Adams, R
   Polson-Edwards, K
   Hinds, AQJ
   Misir, A
   Hospedales, CJ
AF Gonzalez-Escobar, Gabriel
   Marie Valadere, Anne
   Adams, Rosmond
   Polson-Edwards, Karen
   Hinds, Avery Q. J.
   Misir, Akenath
   James Hospedales, C.
TI Prolonged Zika virus viremia in a patient with Guillain-Barre syndrome
   in Trinidad and Tobago
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Guillain-Barre syndrome; polymerase chain reaction; Zika virus; Trinidad
   and Tobago
ID DENGUE VIRUS; CROSS-REACTIVITY; INFECTION
AB An emerging mosquito-borne flavivirus, Zika virus (ZIKV) is a significant public health concern because of the syndromes associated with the infection. In addition, ZIKV is considered a major problem due to large-scale spread of the disease and the possible clinical complications for the central nervous system, especially Guillain-Barre syndrome (GBS) and microcephaly. Since the introduction of ZIKV in the Caribbean, molecular detection of the viral RNA has been utilized as a more specific and sensitive approach to demonstrating acute infection. However, it is generally accepted that the virus has a short viremic period, generally less than 5 days. Serologic testing has the inconvenience of strong cross-reactivity among flaviviruses, such as dengue and yellow fever. As part of the laboratory surveillance activities for Zika and other arboviruses at the Caribbean Public Health Agency, in 2016 a sample from a male who was clinically diagnosed with GBS tested positive for Zika virus by real-time polymerase chain reaction (rRT-PCR). The serum sample had been taken on day 21 after the onset of symptoms. The case had initially been characterized as a typical ZIKV infection (mild fever with a generalized maculopapular rash). Later, weakness of limbs and other peripheral neurological symptoms appeared. Enzyme-linked immunoassay (ELISA) showed that the sample was negative for IgM antibodies against Zika, Chikungunya, and dengue viruses. The plaque reduction neutralization test was positive for ZIKV. This indicated parallel development of viremia and immune response against ZIKV. Recent reports have demonstrated a longer duration of the viremia in ZIKV infections. However, our report is the first one that links the infection with extended viremia and the development in parallel of a GBS case.
C1 [Gonzalez-Escobar, Gabriel; Marie Valadere, Anne; Adams, Rosmond; Polson-Edwards, Karen; Hinds, Avery Q. J.; James Hospedales, C.] Caribbean Publ Hlth Agcy CARPHA, Port Of Spain, Trinidad Tobago.
   [Misir, Akenath] Minist Hlth, Port Of Spain, Trinidad Tobago.
RP Gonzalez-Escobar, G (corresponding author), Caribbean Publ Hlth Agcy CARPHA, Port Of Spain, Trinidad Tobago.
EM escobaga@carpha.org
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044682
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pan American Health Organization, 2016, GUID ZIK VIR DIS ITS
   Paul LM, DENGUE VIRUS ANTIBOD
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
NR 20
TC 2
Z9 2
U1 0
U2 2
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR UNSP e136
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8CX
UT WOS:000441138600019
PM 29466521
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Larrandaburu, M
   Vianna, FSL
   da Silva, AA
   Nacul, L
   Sanseverino, MTV
   Schuler-Faccini, L
AF Larrandaburu, Mariela
   Luiz Vianna, Fernanda Sales
   da Silva, Andre Anjos
   Nacul, Luis
   Vieira Sanseverino, Maria Teresa
   Schuler-Faccini, Lavinia
TI Zika virus infection and congenital anomalies in the Americas:
   opportunities for regional action
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Zika virus; microcephaly; epidemiological surveillance; Americas
ID BRAZIL; TRANSMISSION
AB The Zika virus (ZIKV) was identified in 1947 in the Zika forest in Uganda, but recently it has emerged as a public health threat. The first evidence of human infection occurred in 1952, but only in April 2007 was the first outbreak in humans recognized. In the Americas, a ZIKV outbreak began in Brazil in 2015, and from the second half of 2015 onward, a substantial number of newborns with severe microcephaly began to be reported to health authorities. In February 2016, the World Health Organization (WHO) declared that the clusters of microcephaly cases in areas affected by ZIKV constituted a Public Health Emergency of International Concern. Seldom has there been such a resultingly vast production of scientific literature in record time. In this report we discuss the impact of ZIKV infection during pregnancy, the diagnosis and surveillance of microcephaly, the recognition of a clinical phenotype of ZIKV congenital infection, and opportunities for public health action. We consider this to be a unique opportunity for countries in the Region of the Americas to develop, strengthen, and improve surveillance systems for congenital anomalies and teratogen information services. Creating health needs assessment tools for low- and middle-income countries may help them to develop effective policies to ensure primary, secondary, and tertiary prevention measures for congenital anomalies. Such initiatives will be useful for ZIKV congenital syndrome control and also for having a much wider impact on a significant proportion of preventable and manageable congenital conditions.
C1 [Larrandaburu, Mariela; Luiz Vianna, Fernanda Sales; da Silva, Andre Anjos; Vieira Sanseverino, Maria Teresa; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.
   [Nacul, Luis] London Sch Hyg & Trop Med Sch, London, England.
RP Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.
EM lschuler@hcpa.edu.br
RI Vianna, Fernanda Sales Luiz/O-4337-2019; SCHULER-FACCINI,
   LAVINIA/C-8309-2013
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
FU CAPES (Brazilian Ministry of Education)CAPES
FX Dr. Larrandaburu holds a Ph.D. scholarship from CAPES (Brazilian
   Ministry of Education).
CR Brasil Ministerio da Saude., 2015, MIN SAUD MICR B EP
   Brasil Ministerio da Saude Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias., 2016, INF EP 53 SEM EP 46
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Estudio Colaborativo Latino Americano de Malformaciones Congenitas, V3 ECLAMC
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Pan American Health Organization/ World Health Organization, 2016, ZIK EP UPD 17 NOV 20
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   United Nations, 2016, CONV RIGHTS PERS DIS
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, WHA6317 WHO
   World Health Organization, 1 M INT HLTH REG 200
   World Health Organization, 2016, ZIK SIT REP 24 NOV 2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 21
TC 0
Z9 0
U1 0
U2 1
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR UNSP e174
DI 10.26633/RPSP.2017.174
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8CX
UT WOS:000441138600057
PM 31384281
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Medlen, KP
   Poretti, A
   Huisman, TAGM
   Di Muro, J
   Butler, P
   Woletz, P
   Jimenez, P
AF Medlen, Kayiba Peggy
   Poretti, Andrea
   Huisman, Thierry A. G. M.
   Di Muro, Jonel
   Butler, Priscilla
   Woletz, Paula
   Jimenez, Pablo
TI Radiological findings of abnormalities associated with congenital Zika
   virus infection: conclusions from World Radiology Day 2016
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Zika virus; Zika virus infection; diagnostic imaging; microcephaly;
   neuroimaging; tomography; x-ray computed; magnetic resonance imaging;
   radiography; ultrasonography; Latin America; Caribbean Region; Americas
AB In July 2015, Brazil reported an association between Zika virus infection and Guillain-Barre syndrome, and then in October 2015, between Zika and microcephaly. Most countries and territories in the Region of the Americas were later affected by the virus, creating a public health emergency.
   Each year, the Pan American Health Organization (PAHO), Regional Office of the World Health Organization commemorates World Radiology Day (WRD), which highlights the role of radiology in public health. In 2016, PAHO devoted its WRD efforts to the Zika infection. Experts and partners presented and discussed the various radiological findings of Zika infection, the crucial role of obstetric ultrasound in the screening and monitoring of abnormalities associated with confirmed Zika virus infection, and the appropriateness of utilizing other neuroimaging technologies to study brain abnormalities in neonates and infants with prenatal Zika virus infection. The conclusions of WRD 2016 recommend that upon confirmation, prenatal ultrasound be used as the main tool to investigate and monitor suspected cases, with subsequent multidisciplinary postnatal assessments that include neuropediatric clinical studies and relevant neuroimaging. Additionally, radiology technicians should be adequately trained and a quality assurance program should be implemented to ensure timely, safe, and accurate diagnosis.
C1 [Medlen, Kayiba Peggy; Jimenez, Pablo] Pan Amer Hlth Org, Dept Hlth Syst & Serv, Unit Med & Hlth Technol, Radiol Hlth Program, Washington, DC 20037 USA.
   [Poretti, Andrea; Huisman, Thierry A. G. M.] Johns Hopkins Univ, Radiol & Radiol Sci, Baltimore, MD USA.
   [Di Muro, Jonel] Hosp Luis Razzetti, Barcelona, Anzoategui, Venezuela.
   [Butler, Priscilla] Amer Coll Radiol, Reston, VA USA.
   [Woletz, Paula] Howard Community Coll, Diagnost Med Sonog, Columbia, MD USA.
RP Medlen, KP (corresponding author), Pan Amer Hlth Org, Dept Hlth Syst & Serv, Unit Med & Hlth Technol, Radiol Hlth Program, Washington, DC 20037 USA.
EM medlenk@paho.org
CR American College of Radiology, RAD DOS AD COMM IM E
   [Anonymous], APPR CRIT
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation National Research Council, 2006, HLTH RISKS EXP LOW L
   European Commission; Food and Agriculture Organization of the United Nations; International Atomic Energy Agency; International Labour Organization; OECD Nuclear Energy Agency; Pan American Health Organization; United Nations Environment Programme; World Health Organization, 2014, RAD PROT SAF RAD SOU
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huisman TAGM, 2008, PEDIATR RADIOL, V38, pS415, DOI 10.1007/s00247-008-0895-9
   International Commission of Radio-logical Protection, 2013, ANN ICRP, V33
   International Commission on Radiological Protection, 2000, ANN ICRP, V30
   Mohan S, 2013, CLIN RADIOL, V68, P1155, DOI 10.1016/j.crad.2013.06.011
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Orman G, 2015, J NEUROIMAGING, V25, P31, DOI 10.1111/jon.12108
   Pan American Health Organization, 2016, PROV CONS CAR PREGN
   Pan American Health Organization, REG ZIK EP UPD
   Pan American Health Organization World Health Organization, 2016, VEN ZIK EP REP
   PAN Americna Health Organization, ZIK EP UPD
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   United States Centers for Disease Control and Prevention, PREN DIAGN MICR
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 21
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR UNSP e133
DI 10.26633/RPSP.2017.133
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8CX
UT WOS:000441138600017
PM 31384263
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Orellano, P
   Vezzani, D
   Quaranta, N
   Cionco, R
   Reynoso, J
   Salomon, O
AF Orellano, Pablo
   Vezzani, Dario
   Quaranta, Nancy
   Cionco, Rodolfo
   Reynoso, Julieta
   Salomon, Oscar
TI Potential occurrence of Zika from subtropical to temperate Argentina
   considering the basic reproduction number (R-0)
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Zika virus infection; Aedes; disease vectors; epidemiologic models;
   Argentina
ID AEDES-AEGYPTI; MOSQUITO-BORNE; VIRUS; DENGUE; TRANSMISSION; SPREAD;
   INFECTION; EPIDEMIC; OUTBREAK; VECTOR
AB Objective. To assess the potential occurrence of Zika transmission throughout Argentina by the mosquito Aedes aegypti considering the basic reproduction number (R-0).
   Methods. A model originally developed for dengue was adapted for Zika. R-0 was estimated as a function of seven parameters, three of them were considered temperature-dependent. Seasonal Zika occurrence was evaluated in 9 locations representing different climatic suitability for the vector. Data of diary temperatures were extracted and included in the model. A threshold of R-0 =1 was fixed for Zika occurrence. Sensitivity analyses were performed to evaluate the uncertainty around the results.
   Results. Zika transmission has the potential to occur in all studied locations at least in some moment of the year. In the northern region, transmission might be possible throughout the whole year or with an interruption in winter. The maximum R-0 was estimated in 6.9, which means an average of 7 secondary cases from a primary case. The probabilistic sensitivity analysis showed that during winter the transmission can only be excluded in the southern fringe of geographic distribution of the vector and in part of central Argentina.
   Conclusion. Zika virus has the potential to be transmitted in Argentina throughout the current geographic range of the mosquito vector. Although the transmission would be mainly seasonal, the possibility of winter transmission cannot be excluded in northern and central Argentina, meaning that there is a potential endemic maintenance of the disease.
C1 [Orellano, Pablo] Univ Tecnol Nacl, CONICET, Buenos Aires, DF, Argentina.
   [Vezzani, Dario] Univ Nacl Ctr Prov Buenos Aires, CONICET, Buenos Aires, DF, Argentina.
   [Quaranta, Nancy; Cionco, Rodolfo] Univ Tecnol Nacl, CIC, Buenos Aires, DF, Argentina.
   [Reynoso, Julieta] Hosp Interzonal Gen Agudos San Felipe, San Nicolas De Los Arroy, Argentina.
   [Salomon, Oscar] Inst Nacl Med Trop, CONICET, Puerto Iguazu, Argentina.
RP Orellano, P (corresponding author), Univ Tecnol Nacl, CONICET, Buenos Aires, DF, Argentina.
EM porellaneo@frsn.utn.edu.ar
OI Cionco, Rodolfo/0000-0002-9032-5815
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalgaard P, 2008, LATTICE MULTIVARIATE
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Instituto Nacional de Tecnologia Agopecuaria Argentina, SIST INF GEST AGR
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Ministerio de Salud de la Nacion Argentina, B INT VIG
   Mirams GR, 2016, J PHYSIOL-LONDON, V594, P6833, DOI 10.1113/JP271671
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pouillot R, PACKAGE MC2D
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sarkar D, PACKAGE LATTICE
   Thangamani S, 2016, AM J TROP MED HYG, V29
   Torres JR, 2016, INT J INFECT DIS, V51, P123, DOI 10.1016/j.ijid.2016.09.001
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 44
TC 2
Z9 2
U1 1
U2 2
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR UNSP e120
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8CX
UT WOS:000441138600004
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yadav, PD
   Kumar, V
   Kumar, S
   Mote, CS
   Majumdar, TD
   Gokhale, M
   Kore, P
   Mourya, DT
AF Yadav, Pragya D.
   Kumar, Vimal
   Kumar, Sandeep
   Mote, Chandrashekhar S.
   Majumdar, Triparna D.
   Gokhale, Mangesh
   Kore, Pravin
   Mourya, Devendra T.
TI Zika virus Pathogenesis in Infant Mice after Natural Transmission by the
   Bite of Infected Mosquitoes
SO INTERVIROLOGY
LA English
DT Article
DE Zika virus; Pathogenesis; CD1 mice; Immunohistochemistry; Histopathology
ID AEDES-AEGYPTI MOSQUITOS; CHIKUNGUNYA; AMERICA; STATE
AB Objectives: The objective of this study was to understand natural disease progression in infant CD1 mice after the bite of Aedes aegypti mosquitoes infected by the Zika virus (ZIKV, MR-766 strain). Methods: A. aegypti mosquitoes were experimentally infected with ZIKV MR-766 strain via the oral feeding route. Infected mosquitoes were allowed to feed on infant CD1 mice. Sick mice were euthanized, and their organs were collected and subjected to real-time RT-PCR, histopathology, and immunohistochemistry. Results: Clinical symptoms appeared in mice after 4-5 days of being bitten by mosquitoes, following which they were euthanized. Real-time RT-PCR analysis showed the presence of viral RNA in various organs such as the brain, liver, kidney, spleen, lungs, and intestines of the mice. The brain tissue specimens showed higher viral loads as determined by threshold values (Ct value) in the real-time RT-PCR assay. Histopathological and immunohistochemistry studies also revealed the presence of the virus and associated lesions in the brain, indicating that ZIKV shows tropism for neuronal tissue. Conclusions: This study demonstrates ZIKV pathogenesis in infant CD1 mice and that these mice are highly susceptible to natural infection with this ZIKV strain. (c) 2018 S. Karger AG, Basel.
C1 [Yadav, Pragya D.; Kumar, Sandeep; Majumdar, Triparna D.; Gokhale, Mangesh; Kore, Pravin; Mourya, Devendra T.] Natl Inst Virol, Microbial Containment Complex,20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
   [Kumar, Vimal] Natl Jalma Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India.
   [Mote, Chandrashekhar S.] Krantisinh Nana Patil Coll Vet Sci, Satara, India.
RP Mourya, DT (corresponding author), Natl Inst Virol, Microbial Containment Complex,20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
EM directorniv@gmail.com
FU Indian Council of Medical Research, New Delhi, IndiaIndian Council of
   Medical Research (ICMR)
FX We received a grant from the Indian Council of Medical Research, New
   Delhi, India. The funders had no role in study design, data collection
   and interpretation, or the decision to submit the work for publication.
CR Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   Awadh Asma, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.2fced6e886074f6db162a00d4940133b
   BANERJEE K, 1988, INDIAN J MED RES, V87, P134
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Harada Masakazu, 1996, Medical Entomology and Zoology, V47, P103
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V6736, P30883
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mourya DT, 2000, T ROY SOC TROP MED H, V94, P460, DOI 10.1016/S0035-9203(00)90141-X
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   WANG J, 2016, INT J ENV RES PUBLIC, V13
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 0
Z9 0
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2017
VL 60
IS 6
BP 227
EP 234
DI 10.1159/000486841
PG 8
WC Virology
SC Virology
GA GN7QG
UT WOS:000439339400002
PM 29597193
OA Bronze
DA 2020-07-08
ER

PT J
AU Daniels, J
AF Daniels, John
TI INFECTIOUS DISEASE TESTING IN TRANSFUSION MEDICINE - FROM ANTI-HBV TO
   ZIKA VIRUS: A BRIEF HISTORY
SO JOURNAL OF LEGAL MEDICINE
LA English
DT Meeting Abstract
C1 [Daniels, John] Univ Texas Hlth Sci Ctr San Antonio, Transfus Med Dept Pathol, San Antonio, TX 78229 USA.
EM danielsj@uthscsa.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0194-7648
EI 1521-057X
J9 J LEGAL MED
JI J. Legal Med.
PY 2017
VL 37
SU 1
DI 10.1080/01947648.2017.1479104
PG 2
WC Law; Social Sciences, Biomedical
SC Government & Law; Biomedical Social Sciences
GA GH9JH
UT WOS:000433985200010
PM 29847276
DA 2020-07-08
ER

PT J
AU Lawicki, J
   Pham, A
   Le, M
   Miao, K
   Lee, S
   Kim, S
   Afghani, B
AF Lawicki, J.
   Pham, A.
   Le, M.
   Miao, K.
   Lee, S.
   Kim, S.
   Afghani, B.
TI BEYOND MICROCEPHALY: OTHER MANIFESTATIONS OF NEONATAL AND INFANTILE
   CONGENITAL ZIKA VIRUS
SO JOURNAL OF INVESTIGATIVE MEDICINE
LA English
DT Meeting Abstract
CT Western Medical Research Conference
CY JAN 26-28, 2017
CL Carmel, CA
C1 [Lawicki, J.] Tufts Univ, Medford, MA 02155 USA.
   [Lawicki, J.; Pham, A.; Le, M.; Miao, K.; Lee, S.; Kim, S.; Afghani, B.] UC Irvine, Irvine, CA USA.
   [Afghani, B.] CHOC Childrens Hosp, Orange, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1081-5589
EI 1708-8267
J9 J INVEST MED
JI J. Invest. Med.
PD JAN
PY 2017
VL 65
IS 1
MA 46
BP 117
EP 118
DI 10.1136/jim-2016-000365.46
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA GG9XT
UT WOS:000433055100047
DA 2020-07-08
ER

PT J
AU James-Powell, T
   Brown, Y
   Christie, CDC
   Melbourne-Chambers, R
   Moore, JT
   Morgan, O
   Butler, B
   Swaby, K
   Garbutt, A
   Anzinger, J
   Pierre, RB
   Onyonyor, A
   Bryan, L
   Palmer, PM
   Mitchell, P
   Johnson, P
   Bishop, K
   Jaggon, JR
   De La Haye, W
AF James-Powell, T.
   Brown, Y.
   Christie, C. D. C.
   Melbourne-Chambers, R.
   Moore, J. T.
   Morgan, O.
   Butler, B.
   Swaby, K.
   Garbutt, A.
   Anzinger, J.
   Pierre, R. B.
   Onyonyor, A.
   Bryan, L.
   Palmer, P. M.
   Mitchell, P.
   Johnson, P.
   Bishop, K.
   Jaggon, J. R.
   De La Haye, W.
TI Trends of Microcephaly and Severe Arthrogryposis in Three Urban
   Hospitals following the Zika, Chikungunya and Dengue Fever Epidemics of
   2016 in Jamaica
SO WEST INDIAN MEDICAL JOURNAL
LA English
DT Article
DE Aedes aegypti mosquito; chikungunya fever; congenital syndrome
   associated with Zika virus; dengue fever; Jamaica; microcephaly;
   newborn; Zika virus
ID VIRUS-INFECTION; CHILDREN; PREGNANCY; BRAZIL
AB Introduction: Jamaica experienced its maiden Zika virus (ZIKV) epidemic in 2016, while dengue (serotypes 3 and 4) and chikungunya were also circulating.
   Aim: We describe initial trends in microcephaly and arthrogryposis observed by the clinicians from three urban birthing facilities during late 2016 to early 2017.
   Methods: Reporting of infant microcephaly was required from all birthing facilities in,Jamaica. Staff were to he trained in measuring the occipito-frontal head circumference (OFC) using World Health Organization's (WHO) standards. Affected newborns were to be referred for comprehensive paediatric evaluation.
   Results: Hospital A reported 15 full-term newborns with microcephaly, 10 were delivered between Nrovember 10, 2016 and,January 6, 2017. All were fill-term newborns with OFC ranging from 28.5 to 31.5 cm, severe microcephaly with OFC's < -3 Z scores was seen in ten. Most (12, 80%) had the characteristic craniofacial phenotype of congenital syndrome associated with Zika (CSAZ). Ten had neonatal ultrasounds which revealed intracerebral calcifications (4), dilated and/or asymmetric lateral ventricles (4), grossly overlapping sutures anchor closed or small fontanelles (3), cerebral atrophy (one) and absent frontal lobe sulcation with increased periventricular white matter (one). Computerized tomography (CT) scans revealed calcifications and dilated ventricles with thinning of cortical mantle (two others). Four mothers reported rash. The rate of microcephaly was estimated as 0.8% (10/1212) live births. In hospital B, among 414/629 (65%) of primarily term vaginal live births reviewed during eight weeks of December to January 2017, 17 had OFCs < 32 cm; eight patients had OFC < -2 Z score, six patients had OFC < - 3 Z score and three patients had OFC at -2 Z score; 14 patients (3%) were therefore microcephalic. Seventeen had relative microcephaly. Among the 14 microcephaly cases, five term babies had low birthweight three had seizures within 24 hours, 6/14 were adolescents aged 15-19 years and among 11/14 with uterine ultrasonography one was' abnormal with head-body discrepancy. Two had a cranial ultrasonogram showing intracerebral calcifications, dilated lateral ventricle and cerebral atrophy. One mother reported rash in pregnancy.,Microcephaly rate was 1.63% (14/857 live births). Hospital C identified 2% (1/43) microcephaly rate (OFC < 31.4 cm < - 2 Z scores) amongst symptomatic mothers during May 1, 2016 through March 31, 2017. Four others had low OFCs (< 33 cm), but not in the range for microcephaly. Therefore, 84% (36/43) of babies born to symptomatic mothers had normal OFC. Microcephaly rate for all live births fir the period was 2.2% (26/1180). The monthly rate varied from 0% to 5% (6/118) peaking in March. Of two babies referred with severe arthrogryposis and microcephaly one had characteristic evidence on nuclear magnetic resonance imaging of corpus callosum dysgenesis, occipital lobe cyst, cerebellar hypoplasia and intracranial calcifications. In the other, CT scan of the brain revealed microcephaly with cortical atrophy, severe ventriculomegaly of the lateral and third ventricles,,fine calcifications in the thalami and basal ganglia bilaterally and in the right frontal lobe, with a huge posterior fossa cyst communicating with the 4th ventricle. He died and autopsy confirmed these findings. Cross-reactivity of serological tests for dengue and Zika virus challenged laboratory diagnosis in mothers and newborns.
   Conclusion: Newborns with "characteristic CSAZ features" are being born in urban settings primarily to asymptomatic mothers in Jamaica. Diagnosis is challenged by serological cross reactivity between the circulating,flaviviruses. Team management is multidisciplinary and will he a costly intervention for developing countries to implement to maximize the neuro-developmental potential of this new and vulnerable population of children.
C1 [James-Powell, T.; Butler, B.] Spanish Town Hosp, Dept Pediat, St Catherine, Jamaica.
   [Brown, Y.; Morgan, O.; Mitchell, P.] Victoria Jubilee Matern Hosp, Kingston, Jamaica.
   [Christie, C. D. C.; Melbourne-Chambers, R.; Moore, J. T.; Swaby, K.; Garbutt, A.; Pierre, R. B.; Palmer, P. M.] Univ Hosp West Indies, Dept Child & Adolescent Hlth, Infect Dis Neurol Child Dev & Behav, Kingston, Jamaica.
   [Anzinger, J.] Univ West Indies, Dept Microbiol, Kingston, Jamaica.
   [Onyonyor, A.; Mitchell, P.] Spanish Town Hosp, Dept Obstet, St Catherine, Jamaica.
   [Bryan, L.] Univ Hosp West Indies, Dept Obstet, Kingston, Jamaica.
   [Johnson, P.] Univ West Indies, Dept Radiol Neuroradiol, Kingston, Jamaica.
   [Bishop, K.; Jaggon, J. R.] Univ West Indies, Dept Pathol, Perinatal Neuro, Kingston, Jamaica.
   [De La Haye, W.] Minist Hlth, Kingston, Jamaica.
RP Christie, CDC (corresponding author), Univ West Indies, Dept Child Paediat & Adolescent Hlth, Kingston 7, Jamaica.
EM Celia.ChristieSamuels@uwimona.edu.jm
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   [Anonymous], 2017, ZIKA VIRUS MICROCEPH
   Brazilian Ministry of Health, 2017, INT GUID SURV HLTH C
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CDC, 2016, MORB MORT WKLY REP M
   Chan M., 2016, WHO DIRECTOR GEN SUM
   Christie CDC, 2016, W INDIAN MED J, V65, P431, DOI 10.7727/wimj.2016.529
   Christie CDC, 2016, W INDIAN MED J, V65, P239, DOI 10.7727/wimj.2016.454
   Christie CDC, 2012, W INDIAN MED J, V61, P396, DOI 10.7727/wimj.2012.211
   Christie CD, 2017, ANN PUBLIC HLTH RES, V4, P1061
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Davidson TD, 2016, W INDIAN MED J, V65, P442, DOI 10.7727/wimj.2016.525
   De Araujo TV, 2016, LANCET INFECT DIS, DOI [10.1016/S1473-3099(16)30318-9, DOI 10.1016/S1473-3099(16)30318-9]
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   De Paule Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001//jamaophthalmology, DOI 10.1001//JAMAOPHTHALMOLOGY]
   del Campo M, 2017, AM J MED GENET, V9999, P1
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4850
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Melbourne-Chambers R, 2016, W INDIAN MED J, V65, P425, DOI 10.7727/wimj.2016.526
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministry of Health, 2015, ZIK PREP RESP PLAN O, V5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, JAMA PEDIAT REV, DOI [10.1001/jamapeds.2016.3982, DOI 10.1001/JAMAPEDS.2016.3982]
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nascimento LB, 2017, LANCET INFECT DIS, V17, P949, DOI 10.1016/S1473-3099(17)30169-X
   PAHO/WHO, 2016, GUID SURV ZIK VIR IT
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen S, 2016, N ENGL J MED    0413, DOI [10.1056/NEJMsr1604336, DOI 10.1056/NEJMSR1604336]
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Samms-Vaughan M, 2006, W INDIAN MED J, DOI [10.1590/S0043-31442006000600002, DOI 10.1590/S0043-314420060]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Webster-Kerr KR, 2016, W INDIAN MED J, V65, P243, DOI 10.7727/wimj.2016.488
   World Health Organization (WHO), EP AL NEUR SYNDR CON
NR 44
TC 0
Z9 0
U1 0
U2 3
PU UNIV WEST INDIES FACULTY MEDICAL SCIENCES
PI KINGSTON
PA MONA CAMPUS, KINGSTON 7, JAMAICA
SN 2309-5830
J9 W INDIAN MED J
JI West Ind. Med. J.
PY 2017
VL 66
IS 1
BP 10
EP 19
DI 10.7727/wimj.2017.124
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA GG6OK
UT WOS:000432816200003
OA Bronze
DA 2020-07-08
ER

PT S
AU Tripathy, BK
   Thakur, S
   Chowdhury, R
AF Tripathy, B. K.
   Thakur, Saurabh
   Chowdhury, Rahul
BE Behera, HS
   Mohapatra, DP
TI A Classification Model to Analyze the Spread and Emerging Trends of the
   Zika Virus in Twitter
SO COMPUTATIONAL INTELLIGENCE IN DATA MINING, CIDM 2016
SE Advances in Intelligent Systems and Computing
LA English
DT Proceedings Paper
CT 3rd International Conference on Computational Intelligence in Data
   Mining (ICCIDM)
CY DEC 10-11, 2016
CL Bhubaneswar, INDIA
SP Kalinga Inst Ind Technol
DE Zika; Twitter analysis; Twitter classification; Support vector machines;
   Naive Bayes algorithm
AB The Zika disease is a 2015-16 virus epidemic and continues to be a global health issue. The recent trend in sharing critical information on social networks such as Twitter has been a motivation for us to propose a classification model that classifies tweets related to Zika and thus enables us to extract helpful insights into the community. In this paper, we try to explain the process of data collection from Twitter, the preprocessing of the data, building a model to fit the data, comparing the accuracy of support vector machines and Naive Bayes algorithm for text classification and state the reason for the superiority of support vector machine over Naive Bayes algorithm. Useful analytical tools such as word clouds are also presented in this research work to provide a more sophisticated method to retrieve community support from social networks such as Twitter.
C1 [Tripathy, B. K.; Thakur, Saurabh; Chowdhury, Rahul] VIT Univ, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India.
RP Tripathy, BK (corresponding author), VIT Univ, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India.
EM tripathybk@vit.ac.in; saurabh.chandrakantthakur2013@vit.ac.in;
   rahul.chowdhury2013@vit.ac.in
RI Tripathy, B. K./O-1604-2018
OI Tripathy, B. K./0000-0003-3455-4549
CR Bensaid A., 2004, P WORKSH COMP APPR A
   Cristianini N., 2000, INTRO SUPPORT VECTOR
   Hassan Sundus, 2011, MULT C INMIC 2011 IE
   JOACHIMS T, 1998, EUR C MACH LEARN
   Khan AZ, 2015, INT J ELECT COMMUNIC, V4, P89
   Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431
   McCallum Andrew, 1998, AAAI 98 WORKSH LEARN, V752
   Pak A., 2010, LREC, V10
   Sakaki T., 2010, P 19 INT C WORLD WID
   Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283
   Shmilovici A, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P257, DOI 10.1007/0-387-25465-X_12
   Tong S., 2002, J MACHINE LEARNING R, V2, P999, DOI DOI 10.1162/153244302760185243
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2194-5357
EI 2194-5365
BN 978-981-10-3874-7; 978-981-10-3873-0
J9 ADV INTELL SYST
PY 2017
VL 556
BP 643
EP 650
DI 10.1007/978-981-10-3874-7_61
PG 8
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Operations Research & Management Science
SC Computer Science; Operations Research & Management Science
GA BK1SD
UT WOS:000432203900061
DA 2020-07-08
ER

PT J
AU Neves, ID
   Rezende, SRD
   Kirk, JM
   Pontes, EG
   De Carvalho, MG
AF Neves, Ilzenayde de A.
   Rezende, Sabrina R. da F.
   Kirk, Juliana M.
   Pontes, Emerson G.
   De Carvalho, Mario G.
TI Composition and Larvicidal Activity of Essential Oil of Eugenia
   candolleana DC. (MYRTACEAE) against Aedes aegypti
SO REVISTA VIRTUAL DE QUIMICA
LA English
DT Article
DE Larvicidal; GC-MS; Sesquiterpenes; LC50; Aedes aegypti
ID L. DIPTERA-CULICIDAE; CHEMICAL-COMPOSITION; INSECTICIDAL ACTIVITY;
   ANOPHELES-STEPHENSI; LARVAE; PLANTS; BIOACTIVITY; COMPONENTS;
   EUCALYPTUS; TOXICITY
AB The mosquito Aedes aegypti is the vector of the dengue, Chikungunya and Zika virus. The increasing resistance of mosquitoes to commercial insecticides impairs regular control programs; therefore, chemical prospecting of plant species with larvicidal properties has been an alternative for the control of this vector. The essential oil of Eugenia candollena DC was obtained through the hydrodistillation method, using a modified Clevenger-type apparatus, being its constituents identified using gas chromatography-mass spectrometry and its constituents were quantified by gas chromatography. The oil proved rich in sesquiterpenes, containing beta-elemene (35.87 +/- 0.13%) as major component. Aedes aegypti larvae mortality rate of 100% was obtained after 24 h of treatment with the oil at concentrations of 0.50 mu g. mu L-1 and the LC50 at this time was estimated to be 0.30 mu g. mu L-1
C1 [Neves, Ilzenayde de A.; Rezende, Sabrina R. da F.; Kirk, Juliana M.; Pontes, Emerson G.; De Carvalho, Mario G.] Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, BR 465,Km 7, BR-23890000 Seropedica, RJ, Brazil.
RP De Carvalho, MG (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, BR 465,Km 7, BR-23890000 Seropedica, RJ, Brazil.
EM mgeraldo@ufrrj.br
RI Pontes, Emerson/P-9347-2016; de Carvalho, Mario Geraldo/D-8850-2015
OI de Carvalho, Mario Geraldo/0000-0001-5805-734X
FU Fundacao Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular
   (INCT-EM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX The authors are grateful to Fundacao Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ) Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), and Instituto Nacional de Ciencia e
   Tecnologia-Entomologia Molecular (INCT-EM) for scholarships and
   financial support.
CR Aciole SDG, 2011, REV COLOMB ENTOMOL, V37, P262
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Aguilera Lucita, 2003, Rev Cubana Med Trop, V55, P100
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Apel MA, 2002, J ESSENT OIL RES, V14, P290, DOI 10.1080/10412905.2002.9699858
   Brun GR, 2010, PERSPECTIVA, V34, P135
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Chantraine JM, 1998, PHYTOTHER RES, V12, P350, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;350::AID-PTR311&gt;3.0.CO;2-7
   Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   Costa J.G.M., 2005, Rev. bras. farmacogn., V15, P304, DOI 10.1590/S0102-695X2005000400008
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Douglas MH, 2004, PHYTOCHEMISTRY, V65, P1255, DOI 10.1016/j.phytochem.2004.03.019
   Guimaraes AG, 2009, REV BRAS FARMACOGN, V19, P883, DOI 10.1590/S0102-695X2009000600016
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412
   Krishnappa K, 2012, J VECTOR DIS, V49, P86
   Lima MAA, 2011, AFR J BIOTECHNOL, V10, P11716
   Lucia A, 2008, ENTOMOL EXP APPL, V129, P107, DOI 10.1111/j.1570-7458.2008.00757.x
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Lucia A, 2012, PARASITOL RES, V110, P1675, DOI 10.1007/s00436-011-2685-9
   Magalhaes LAM, 2010, MOLECULES, V15, P5734, DOI 10.3390/molecules15085734
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Massebo F, 2009, AFR J BIOTECHNOL, V8, P4183
   Mora FD, 2010, NAT PROD COMMUN, V5, P965
   Nakamura MJ, 2010, BIOCHEM SYST ECOL, V38, P1170, DOI 10.1016/j.bse.2010.11.003
   Park HM, 2011, J MED ENTOMOL, V48, P405, DOI 10.1603/ME10108
   Prophiro JS, 2012, PARASITOL RES, V110, P713, DOI 10.1007/s00436-011-2547-5
   Ramos MFD, 2010, J ESSENT OIL RES, V22, P109
   Regnault-Roger C., 1997, INTEGR PEST MANAG RE, V2, P25, DOI DOI 10.1023/A:1018472227889
   SAS Institute, 2002, SAS VERS 9 0
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   Stefanello MEA, 2009, LAT AM J PHARM, V28, P449
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Tennyson S., 2013, Middle East Journal of Scientific Research, V13, P64
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, P1
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   WHO, 2009, TEM DRINK WAT US VEC
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 44
TC 4
Z9 4
U1 1
U2 1
PU BRAZILIAN CHEMICAL SOC
PI NITEROI
PA SECRETERIA REGIONAL RIO DO JANEIRO, UNIV FED FLUMINENSE, NITEROI, RJ
   24020-141, BRAZIL
SN 1984-6835
J9 REV VIRTUAL QUIM
JI Rev. Virtual Quim.
PY 2017
VL 9
IS 6
BP 2305
EP 2315
DI 10.21577/1984-6835.20170138
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA GF6BH
UT WOS:000432051300012
OA Bronze
DA 2020-07-08
ER

PT S
AU Kuhlman, CJ
   Ren, YH
   Lewis, B
   Schlitt, J
AF Kuhlman, Chris J.
   Ren, Yihui
   Lewis, Bryan
   Schlitt, James
BE Chan, V
   DAmbrogio, A
   Zacharewicz, G
   Mustafee, N
TI HYBRID AGENT-BASED MODELING OF ZIKA IN THE UNITED STATES
SO 2017 WINTER SIMULATION CONFERENCE (WSC)
SE Winter Simulation Conference Proceedings
LA English
DT Proceedings Paper
CT Winter Simulation Conference (WSC)
CY DEC 03-06, 2017
CL Las Vegas, NV
SP AnyLogic Co, OLD DOMIN UNIV, IDEA FUS, Modelling Simulat & Visualizat Engn, Simio, FlexSim, sas, Operat Res Soc, Journal of Simulat, Springer, Assoc Comp Machinery - Special Interest Grp Simulat, Amer Statist Assoc, Arbeitsgemeinschaft Simulat, Inst Elect & Elect Engn, Syst Man & Cybernet Soc, Inst Ind & Syst Engineers, Inst Operat Res & Management Sci - Simulat Soc, Natl Inst Standards & Technol, Soc Modeling & Simulat Int
AB Vector-borne infectious diseases present computational modelers with a unique challenge: finding the right balance between model fidelity and simulation costs. In this work, we introduce a hybrid agent-based model that achieves a balance that readily scales to problem sizes of millions of human agents and mosquitoes. Macroscopically, our model results agree with those from a low-cost compartmental model; microscopically, like agent-based models, it provides details at the individual level. We apply this model to a synthetic human population of 1.2 million individuals from Miami, Florida in the United States to model the Zika outbreak in the Fall of 2016. We identify two high-risk locations within this region, a detail which cannot be revealed by traditional compartmental models. The principles-based mathematical derivation of the hybrid agent-based model can be adapted to other scenarios facing similar tradeoffs.
C1 [Kuhlman, Chris J.; Ren, Yihui; Lewis, Bryan; Schlitt, James] Virginia Tech, Biocomplex Inst, 1015 Life Sci Circle, Blacksburg, VA 24061 USA.
RP Kuhlman, CJ (corresponding author), Virginia Tech, Biocomplex Inst, 1015 Life Sci Circle, Blacksburg, VA 24061 USA.
EM ckuhlman@vt.edu; yren2@bi.vt.edu; bryanlewis@bi.vt.edu;
   jschlitt@bi.vt.edu
RI Ren, Yihui/Z-4013-2019
OI Ren, Yihui/0000-0002-5750-6964
FU NIH's National Institute of General Medical Sciences [5U01GM070694-13,
   1R01GM109718]; Defense Threat Reduction Agency Comprehensive National
   Incident Management SystemUnited States Department of DefenseDefense
   Threat Reduction Agency [HDTRA1-11-D-0016-0001]
FX We thank the anonymous WSC reviewers for their helpful comments and
   recommendations. We thank our external collaborators and members of the
   Network Dynamics and Simulation Science Laboratory (NDSSL) for their
   suggestions and comments. We thank Bill Marmagas and the Compute Staff
   of the Biocomplexity Institute of Virginia Tech. This work has been
   partially supported by the NIH's National Institute of General Medical
   Sciences grants 5U01GM070694-13 and 1R01GM109718 as well as Defense
   Threat Reduction Agency Comprehensive National Incident Management
   System Contract HDTRA1-11-D-0016-0001.
CR Barrett Christopher L, 2009, Proceedings of the 2009 Winter Simulation Conference (WSC 2009), P1003, DOI 10.1109/WSC.2009.5429425
   Bisset K., 2016, INT C BIOM HLTH INF
   Brailsford SC, 2010, WINT SIMUL C PROC, P2293, DOI 10.1109/WSC.2010.5678927
   Chahal K, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P1469, DOI 10.1109/WSC.2008.4736226
   Figueredo GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095150
   Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006
   Jindal A., 2017, 16 INT C AUT AG MULT
   Manore CA, 2015, J BIOL DYNAM, V9, P52, DOI 10.1080/17513758.2015.1005698
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Mielczarek B, 2016, WINT SIMUL C PROC, P1535, DOI 10.1109/WSC.2016.7822204
   Perkins T. A., 2016, NATURE MICROBIOLOGY, V1, P1
   Schwarz P., 2016, 34 INT SYST DYN C
   Schweitzer F, 2010, EUR PHYS J B, V77, P533, DOI 10.1140/epjb/e2010-00292-1
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Viana J, 2014, WINT SIMUL C PROC, P1585, DOI 10.1109/WSC.2014.7020010
   Zhang Q., 2017, P NATL ACAD SCI PNAS
NR 16
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0891-7736
BN 978-1-5386-3428-8
J9 WINT SIMUL C PROC
PY 2017
BP 1085
EP 1096
PG 12
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BJ7WX
UT WOS:000427768601023
DA 2020-07-08
ER

PT S
AU Scheidegger, APG
   Banerjee, A
AF Scheidegger, Anna Paula Galvao
   Banerjee, Amarnath
BE Chan, V
   DAmbrogio, A
   Zacharewicz, G
   Mustafee, N
TI AN AGENT-BASED MODEL TO INVESTIGATE BEHAVIOR IMPACTS ON VECTOR-BORNE
   DISEASE SPREAD
SO 2017 WINTER SIMULATION CONFERENCE (WSC)
SE Winter Simulation Conference Proceedings
LA English
DT Proceedings Paper
CT Winter Simulation Conference (WSC)
CY DEC 03-06, 2017
CL Las Vegas, NV
SP AnyLogic Co, OLD DOMIN UNIV, IDEA FUS, Modelling Simulat & Visualizat Engn, Simio, FlexSim, sas, Operat Res Soc, Journal of Simulat, Springer, Assoc Comp Machinery - Special Interest Grp Simulat, Amer Statist Assoc, Arbeitsgemeinschaft Simulat, Inst Elect & Elect Engn, Syst Man & Cybernet Soc, Inst Ind & Syst Engineers, Inst Operat Res & Management Sci - Simulat Soc, Natl Inst Standards & Technol, Soc Modeling & Simulat Int
ID DYNAMICS; OUTBREAK; ZIKA
AB This study aims to use agent-based simulation as a tool to illustrate the importance of human behavior in the dynamics of vector-borne disease spread. For this, a baseline compartmental model was developed and, based on it, four different scenarios considering human behavior were proposed: two assuming the whole population adopts the same behavior and two assuming each individual has his/her own behavior. Paired t-test was used to compare the proposed scenarios with the baseline, based on two output responses from the simulation experiments: total number of infected people and duration of the epidemic. Results from the data analysis indicate that behavior is an important factor and, as such, it must be further investigated and included in infectious-disease spread models to obtain more accurate results. As a final remark, we presented possible explanations to why human behavior has been neglected in many epidemiological models up to now.
C1 [Scheidegger, Anna Paula Galvao; Banerjee, Amarnath] Texas A&M Univ, Ind & Syst Engn Dept, 3131 TAMU, College Stn, TX 77843 USA.
RP Scheidegger, APG (corresponding author), Texas A&M Univ, Ind & Syst Engn Dept, 3131 TAMU, College Stn, TX 77843 USA.
EM apscheidegger@tamu.edu; banerjee@tamu.edu
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES
FX The authors would like to thank CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) for the financial support to this work trough
   the Science without Borders program.
CR Aleman DM, 2009, WINT SIMUL C PROC, P1928
   Bisset K, 2011, P 2011 WINT SIM C, P2938
   Bisset KR, 2009, WINT SIMUL C PROC, P1971
   Bobashev Georgiy V, 2007, 2007 Winter Simulation Conference, P1532, DOI 10.1109/WSC.2007.4419767
   BRANDEAU ML, 2008, P 2008 WINT SIM C, P1578
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Diaz D. A, 2016, P 2016 WINT SIM C, P1994
   Dietz K, 2002, MATH BIOSCI, V180, P1, DOI 10.1016/S0025-5564(02)00122-0
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Funk S, 2015, EPIDEMICS-NETH, V10, P21, DOI 10.1016/j.epidem.2014.09.005
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   KREUGER K, 2015, P 2015 WINT SIM C, P737
   Li Y., 2016, PREVENTING CHRONIC D, V2016, P13
   Lima T, 2014, WINT SIMUL C PROC, P1481, DOI 10.1109/WSC.2014.7020001
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384
   Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008
   Paleshi A, 2011, WINT SIMUL C PROC, P1340, DOI 10.1109/WSC.2011.6147855
   Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0
   ROSS R, 1908, REPORT PREVENTION MA
   SANCHEZ PJ, 2015, P 2015 WINT SIM C, P151
   Scheidegger A. P. G, 2017, P 2017 APPL HUM FACT
   Scheidegger A. P. G, 2017, P 2017 IND SYST ENG
   Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820
   Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6
   Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006
   Wenham C, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0307
   WHO World Health Organization, 2016, TOP 10 CAUS DEATH
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization (WHO), 2015, HLTH 2015 MDGS MILL
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zarei M, 2011, P 2011 IIE ANN C, P1
   Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153
NR 36
TC 1
Z9 1
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0891-7736
BN 978-1-5386-3428-8
J9 WINT SIMUL C PROC
PY 2017
BP 2833
EP 2844
PG 12
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BJ7WX
UT WOS:000427768603004
DA 2020-07-08
ER

PT J
AU Nava, A
   Shimabukuro, JS
   Chmura, AA
   Luz, SLB
AF Nava, Alessandra
   Shimabukuro, Juliana Suieko
   Chmura, Aleksei A.
   Bessa Luz, Sergio Luiz
TI The Impact of Global Environmental Changes on Infectious Disease
   Emergence with a Focus on Risks for Brazil
SO ILAR JOURNAL
LA English
DT Review
DE climate change; disease emergence; EIDs; environmental drivers;
   landscape change; vector-borne diseases; weather; zoonoses
ID LAND-USE CHANGE; HABITAT FRAGMENTATION; ANTHROPOGENIC DRIVERS;
   SPECIES-DIVERSITY; HOST DIVERSITY; CLIMATE-CHANGE; ZIKA VIRUS; WILDLIFE;
   MALARIA; TRANSMISSION
AB Environmental changes have a huge impact on the emergence and reemergence of certain infectious diseases, mostly in countries with high biodiversity and serious unresolved environmental, social, and economic issues. This article summarizes the most important findings with special attention to Brazil and diseases of present public health importance in the country such as Chikungunya, dengue fever, yellow fever, Zika, hantavirus pulmonary syndrome, leptospirosis, leishmaniasis, and Chagas disease. An extensive literature review revealed a relationship between infectious diseases outbreaks and climate change events (El Nino, La Nina, heatwaves, droughts, floods, increased temperature, higher rainfall, and others) or environmental changes (habitat fragmentation, deforestation, urbanization, bushmeat consumption, and others). To avoid or control outbreaks, integrated surveillance systems and effective outreach programs are essential. Due to strong global and local influence on emergence of infectious diseases, a more holistic approach is necessary to mitigate or control them in low-income nations.
C1 [Nava, Alessandra] FIOCRUZ ILMD, Manaus, Amazonas, Brazil.
   [Shimabukuro, Juliana Suieko] Univ Sao Paulo, Sao Paulo, Brazil.
   [Chmura, Aleksei A.] EcoHlth Alliance, New York, NY USA.
   [Chmura, Aleksei A.] Kingston Univ, London, England.
   [Bessa Luz, Sergio Luiz] Inst Leonidas & Maria Deane FIOCRUZ Amazonia, Manaus, Amazonas, Brazil.
RP Nava, A (corresponding author), Rua Terezina 476, BR-69057070 Manaus, Amazonas, Brazil.
EM navaveterinaria@gmail.com
RI Nava, Alessandra/AAH-2900-2019; Chmura, Aleksei/K-9971-2018
OI Chmura, Aleksei/0000-0001-5544-0431; Luz, Sergio Luiz
   Bessa/0000-0001-5887-7372
CR Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052
   Alexander KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003652
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Batista PM, 2012, REV SOC BRAS MED TRO, V45, P168, DOI 10.1590/S0037-86822012000200006
   Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056
   Bouma MJ, 2003, T ROY SOC TROP MED H, V97, P133, DOI 10.1016/S0035-9203(03)90099-X
   Central Intelligence Agency (CIA), 2017, WORLD FACTBOOK
   Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   CONFALONIERI U., 2000, GLOB CHANG HUM HLTH, V1, P174
   Costa D, 2016, ECONOMICA, V47, P312
   Crutzen P.J., 2000, GLOBAL CHANGE NEWSLE, V41, P17, DOI DOI 10.1007/3-540-26590-2_3
   da Costa AP, 2016, ACTA TROP, V164, P185, DOI 10.1016/j.actatropica.2016.08.033
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   DYER O, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J707
   Dzingirai V, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0169
   Eduardo V, 2017, BRAZIL CLIMATE CHANG, P193
   FAHR J, 2006, RAP B BIOL ASSESSMEN, V40, P168
   Fearnside PM, 1999, ENVIRON MANAGE, V24, P483, DOI 10.1007/s002679900248
   Gay Noellie, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P161, DOI 10.1016/j.ijppaw.2014.06.003
   Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2
   Gibbs KE, 2009, DIVERS DISTRIB, V15, P242, DOI 10.1111/j.1472-4642.2008.00543.x
   Gomez A, 2008, ANN NY ACAD SCI, V1149, P16, DOI 10.1196/annals.1428.046
   Goncalves AQ, 2012, PLOS NEGLECT TROP D, V6, P1349
   Gracie R, 2014, INT J ENV RES PUB HE, V11, P10366, DOI 10.3390/ijerph111010366
   Harvell CD, 2002, ENVIRON INT, V86, P14
   Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788
   Huang ZYX, 2016, PARASITOLOGY, P3
   Imai Chisato, 2016, Trop Med Health, V44, P23, DOI 10.1186/s41182-016-0021-x
   Jaffry KT, 2009, INT J AGRIC BIOL, V11, P217
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kamiya T, 2014, ECOGRAPHY, V37, P689, DOI 10.1111/j.1600-0587.2013.00571.x
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x
   Kerbiriou C., 2009, DIVERS DISTRIB, V15, P641, DOI DOI 10.1111/J.1472-4642.2009.00569.X
   Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108
   Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3
   Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9
   Loh E, 2016, TROPICAL CONSERVATIO, V13, P79
   Machalaba C, 2015, UN GLOBAL SUSTAINABL
   Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006
   Marengo JA, 2015, INT J CLIMATOL, V36
   MEA, 2003, EC HUM WELL BEING FR
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006
   N'Goran EK, 1997, B WORLD HEALTH ORGAN, V75, P541
   Nelson GC, 2006, ECOL SOC, V11
   Oliveira BL, 2014, HYGEIA, V10
   Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022
   Otshudiema JO, 2017, MMWR MORB MORTAL WKL, V66
   Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Paull SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2078
   Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561
   PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347
   Pinto VL, 2014, J INFECT DEV COUNTR, V8, P137, DOI 10.3855/jidc.3254
   Prist PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163459
   Prodes Project, 2016, PROD PROJ
   Randell H, 2016, POPUL ENVIRON, V37, P265, DOI 10.1007/s11111-015-0245-4
   Redding DW, 2016, METHODS ECOL EVOL, V7, P646, DOI 10.1111/2041-210X.12549
   Matias CAR, 2016, BRAZ J MICROBIOL, V47, P882, DOI 10.1016/j.bjm.2016.07.012
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498
   Rosa EA, 2004, AMBIO, V33, P509, DOI 10.1639/0044-7447(2004)033[0509:TTADOE]2.0.CO;2
   Rossetto EV, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759017, 10.1590/S1678-9946201759017]
   Rubio AV, 2014, ECOHEALTH, V11, P526, DOI 10.1007/s10393-014-0944-9
   Salomon OD, 2012, J TROP MED, V2012, P1
   Sangenis Luiz Henrique Conde, 2016, Rev. bras. epidemiol., V19, P803, DOI 10.1590/1980-5497201600040010
   Santos JP, 2016, HYGIEA, V12, P1
   Suzan G, 2008, ANN NY ACAD SCI, V1149, P80, DOI 10.1196/annals.1428.063
   Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325
   Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211
   TURNER BL, 1990, GLOBAL ENVIRON CHANG, V1, P14, DOI 10.1016/0959-3780(90)90004-S
   Tyukavina A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601047
   van Vliet N, 2015, ETHNOBIOL CONSERV, V4, DOI 10.15451/ec2014-11-3.7-1-11
   VASCONCELOS PFD, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Vaz VC, 2007, PARASITOLOGY, V134, P1785, DOI 10.1017/S003118200700323X
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
   Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494
   Wallace RG, 2014, ENVIRON PLANN A, V46, P2533, DOI 10.1068/a4712com
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701
   World Health Organization, 2017, GLOBAL ENV CHANGE
   Wu XX, 2016, ENVIRON INT, V86, P14, DOI 10.1016/j.envint.2015.09.007
   Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 96
TC 8
Z9 8
U1 5
U2 22
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1084-2020
EI 1930-6180
J9 ILAR J
JI ILAR J.
PY 2017
VL 58
IS 3
BP 393
EP 400
DI 10.1093/ilar/ilx034
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA GC0UD
UT WOS:000429492500008
PM 29253158
OA Bronze
DA 2020-07-08
ER

PT J
AU Vanlerberghe, V
   Gomez-Dantes, H
   Vazquez-Prokopec, G
   Alexander, N
   Manrique-Saide, P
   Coelho, G
   Toledo, ME
   Ocampo, CB
   Van der Stuyft, P
AF Vanlerberghe, Veerle
   Gomez-Dantes, Hector
   Vazquez-Prokopec, Gonzalo
   Alexander, Neal
   Manrique-Saide, Pablo
   Coelho, Giovanini
   Eugenia Toledo, Maria
   Ocampo, Clara B.
   Van der Stuyft, Patrick
CA DENTARGET Network
TI Changing paradigms in Aedes control: considering the spatial
   heterogeneity of dengue transmission
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Dengue; epidemiology; Aedes; vector control; Belgium; Brazil; Colombia;
   Cuba; Mexico; Peru; Caribbean region; Latin America
ID VIRUS; AEGYPTI; AMERICA; EPIDEMIOLOGY; POPULATIONS; CHIKUNGUNYA;
   PREVENTION; IMPACT; CIRCULATION; CHALLENGES
AB Current dengue vector control strategies, focusing on reactive implementation of insecticide-based interventions in response to clinically apparent disease manifestations, tend to be inefficient, short-lived, and unsustainable within the worldwide epidemiological scenario of virus epidemic recrudescence. As a result of a series of expert meetings and deliberations, a paradigm shift is occurring and a new strategy, using risk stratification at the city level in order to concentrate proactive, sustained efforts in areas at high risk for transmission, has emerged. In this article, the authors 1) outline this targeted, proactive intervention strategy, within the context of dengue epidemiology, the dynamics of its transmission, and current Aedes control strategies, and 2) provide support from published literature for the need to empirically test its impact on dengue transmission as well as on the size of disease outbreaks. As chikungunya and Zika viruses continue to expand their range, the need for a science-based, proactive approach for control of urban Aedes spp. mosquitoes will become a central focus of integrated disease management planning.
C1 [Vanlerberghe, Veerle] Inst Trop Med, Gen Epidemiol & Dis Control Unit, Antwerp, Belgium.
   [Gomez-Dantes, Hector] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.
   [Vazquez-Prokopec, Gonzalo] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Alexander, Neal] London Sch Hyg & Trop Med, London, England.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Entomol Bioassays Unit, Merida, Yucatan, Venezuela.
   [Coelho, Giovanini] Brazilian Minist Hlth, Natl Dengue Control Program, Brasilia, DF, Brazil.
   [Eugenia Toledo, Maria] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba.
   [Ocampo, Clara B.] Int Training & Med Res Ctr, Cali, Colombia.
   [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, Ghent, Belgium.
RP Vanlerberghe, V (corresponding author), Inst Trop Med, Gen Epidemiol & Dis Control Unit, Antwerp, Belgium.
EM vvanlerberghe@itg.be
FU Institute of Tropical Medicine (Antwerp); Belgian Directorate-General
   for Development Co-operation
FX The DENTARGET network received funding from the framework agreement
   between the Institute of Tropical Medicine (Antwerp) and the Belgian
   Directorate-General for Development Co-operation. The funders had no
   role in content discussions or in preparation of manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Baly A, 2009, AM J TROP MED HYG, V81, P88, DOI 10.4269/ajtmh.2009.81.88
   Barbazan P, 2002, MICROBES INFECT, V4, P699, DOI 10.1016/S1286-4579(02)01589-7
   Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Cattand P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P451
   Degener CM, 2015, MEM I OSWALDO CRUZ, V110, P517, DOI 10.1590/0074-02760140374
   Dom NC, 2013, T ROY SOC TROP MED H, V107, P715, DOI 10.1093/trstmh/trt073
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gomez-Dantes H, 2011, SALUD PUBLICA MEXICO, V53, pS349
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler DJ, 2011, TROP MED HLTH S, V39, P3, DOI DOI 10.2149/TMH.2011S05
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Cuong HQ, 2013, EMERG INFECT DIS, V19, P945, DOI 10.3201/eid1906.121323
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Ranson H., 2010, TROPIKA, V1
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Sanchez L, 2010, TROP MED INT HEALTH, V15, P173, DOI 10.1111/j.1365-3156.2009.02437.x
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Toledo ME, 2011, TROP MED INT HEALTH, V16, P744, DOI 10.1111/j.1365-3156.2011.02762.x
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases; Scientific Working Group on Dengue, 2007, SCI WORK GROUP M DEN
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x
   Vazquez-Prokopec GM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001788
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 7
Z9 7
U1 2
U2 7
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR UNSP e16
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC2MR
UT WOS:000429617600001
PM 31391815
OA DOAJ Gold
DA 2020-07-08
ER

PT B
AU Riad, MH
   Scoglio, CM
   Mcvey, DS
   Cohnstaedt, LW
AF Riad, Mahbubul H.
   Scoglio, Caterina M.
   Mcvey, D. Scott
   Cohnstaedt, Lee W.
GP IEEE
TI Estimation of Parameters and Basic Reproductive Ratio for Japanese
   Encephalitis Transmission in the Philippines using a Sequential Monte
   Carlo Filter
SO 2017 IEEE CONFERENCE ON CONTROL TECHNOLOGY AND APPLICATIONS (CCTA 2017)
LA English
DT Proceedings Paper
CT 1st Annual IEEE Conference on Control Technology and Applications
CY AUG 27-30, 2017
CL HI
SP IEEE, CSS, IEEE Robot & Automat Soc, SICE
ID WEST-NILE; EPIDEMIC; TRACKING; SPREAD; MODEL
AB We developed a sequential Monte Carlo filter to estimate the states and the parameters in a stochastic model of Japanese Encephalitis (JE) spread in the Philippines. This method is particularly important for its adaptability to the availability of new incidence data. This method can also capture the variability in the incidence through time which is dependent upon various factors relating to the host species and the weather. Parameters estimated from the particle filter simulations show seasonal as well as yearly variations. The basic reproductive ratio fluctuations are in compliance with the endemicity of JE in the Philippines. The estimated basic reproductive ratio is comparable with other similar mosquito transmitted disease like Zika, dengue, and West Nile viruses.
C1 [Riad, Mahbubul H.; Scoglio, Caterina M.] Kansas State Univ, Dept Elect Engn, 1701D Platt St, Manhattan, KS 66506 USA.
   [Mcvey, D. Scott; Cohnstaedt, Lee W.] USDA, 1515 Coll Ave, Manhattan, KS 66502 USA.
RP Riad, MH (corresponding author), Kansas State Univ, Dept Elect Engn, 1701D Platt St, Manhattan, KS 66506 USA.
EM mahbubriad@ksu.edu
FU United States Department of Agriculture (USDA)United States Department
   of Agriculture (USDA) [427647]; National Science FoundationNational
   Science Foundation (NSF) [CIF-1423411]
FX This work was supported by United States Department of Agriculture
   (USDA) under Project No. 427647, and by the National Science Foundation
   under Grant No. CIF-1423411.
CR Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374
   Calistri P, 2016, TRANSBOUND EMERG DIS, V63, P485, DOI 10.1111/tbed.12290
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   He D., 2009, J ROYAL SOC INTERFAC
   Khan A, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-12
   Lopez AL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003630
   Liu J, 2001, STAT ENG IN, P197
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mukhopadhyay B.B., 1994, INT J MATH MATH SCI, V17, P347
   Naresh R, 2009, APPL APPL MATH, V4, P155
   Plagemann C, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2185
   Riad Mahbubul H., 2016, STOCH ENV RES RISK A, P1
   Shahtori NM, 2016, P AMER CONTR CONF, P1277, DOI 10.1109/ACC.2016.7525093
   Sheinson DM, 2014, MATH BIOSCI, V255, P21, DOI 10.1016/j.mbs.2014.06.018
   Skvortsov A, 2012, MATH BIOSCI, V240, P12, DOI 10.1016/j.mbs.2012.05.010
   TAPASWI PK, 1995, ECOL MODEL, V83, P295, DOI 10.1016/0304-3800(94)00102-X
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-2182-6
PY 2017
BP 668
EP 673
PG 6
WC Automation & Control Systems; Engineering, Electrical & Electronic
SC Automation & Control Systems; Engineering
GA BJ6YT
UT WOS:000426981500109
DA 2020-07-08
ER

PT S
AU Muppalla, R
   Miller, M
   Banerjee, T
   Romine, W
AF Muppalla, Roopteja
   Miller, Michele
   Banerjee, Tanvi
   Romine, William
GP IEEE
TI Discovering Explanatory Models to Identify Relevant Tweets on Zika
SO 2017 39TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 39th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY JUL 11-15, 2017
CL SOUTH KOREA
SP IEEE Engn Med & Biol Soc, PubMed, MEDLINE, Korean Soc Med & Biol Engn
AB Zika virus has caught the worlds attention, and has led people to share their opinions and concerns on social media like Twitter. Using text-based features, extracted with the help of Parts of Speech (POS) taggers and N-gram, a classifier was built to detect Zika related tweets from Twitter. With a simple logistic classifier, the system was successful in detecting Zika related tweets from Twitter with a 92% accuracy. Moreover, key features were identified that provide deeper insights on the content of tweets relevant to Zika. This system can be leveraged by domain experts to perform sentiment analysis, and understand the temporal and spatial spread of Zika.
C1 [Muppalla, Roopteja; Banerjee, Tanvi] Wright State Univ, Dept Comp Sci & Engn, Dayton, OH 45435 USA.
   [Miller, Michele; Romine, William] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.
RP Banerjee, T (corresponding author), Wright State Univ, Dept Comp Sci & Engn, Dayton, OH 45435 USA.
EM tanvi@knoesis.org; william.romine@wright.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1K01LM012439-01]; Department of
   Education I3 project [U411C140081]; Institute of Educational Sciences
   (IES) [R305A150364]
FX Banerjee and Muppalla would like to acknowledge funding from NIH project
   1K01LM012439-01. Romine and Miller were partially supported by
   Department of Education I3 project U411C140081 and Institute of
   Educational Sciences (IES) award R305A150364.
CR Agarwal A., 2011, P WORKSH LANG SOC ME, P30
   Alvaro N, 2015, J BIOMED INFORM, V58, P280, DOI 10.1016/j.jbi.2015.11.004
   Anderson D, 2004, MODEL SELECTION MULT
   Aramaki E., 2011, P C EMP METH NAT LAN, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199
   Barbosa L., 2010, INT C COMP LING, V2010, P36
   Bhattacharya S., 2012, AAAI FALL S INF RETR
   CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10
   Gimpel K., 2011, P 49 ANN M ASS COMP, V2, P42
   Ji X, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), P335, DOI 10.1109/ICHI.2013.47
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031
   Miller M., 2017, J MED INTER IN PRESS
   Paul M.J., 2011, ICWSM, V2011, P265
   Purohit H., 2015, ARXIV150302086
   Robertson A., 2013, 2013 NAT C HLTH COMM
   Schmidt C., 2012, ENVIRON HEALTH PERSP, V120, pa31
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Solomonolf R.J., 1957, IRE National Convention Record, V5, P56
   Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 20
TC 3
Z9 3
U1 1
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-5090-2809-2
J9 P ANN INT IEEE EMBS
PY 2017
BP 1194
EP 1197
PG 4
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA BJ7CZ
UT WOS:000427085301161
PM 29060089
DA 2020-07-08
ER

PT B
AU Livingston, J
   Steele, R
AF Livingston, Jacob
   Steele, Robert
BE Chakrabarti, S
   Saha, HN
TI A Crowdsensing Algorithm for Imputing Zika Outbreak Location Data
SO 2017 IEEE 8TH ANNUAL UBIQUITOUS COMPUTING, ELECTRONICS AND MOBILE
   COMMUNICATION CONFERENCE (UEMCON)
LA English
DT Proceedings Paper
CT 8th IEEE Annual Ubiquitous Computing, Electronics and Mobile
   Communication Conference (UEMCON)
CY OCT 19-21, 2017
CL Columbia Univ, New York, NY
SP IEEE, IEEE New York Sect, IEEE USA, IEEE Reg 1, Univ Engn & Management
HO Columbia Univ
DE Zika; Crowdsensing; Smartphone; Communicable disease
ID INFORMATION
AB The Internet of Things is becoming an integral part of today's solutions to critical issues. In this paper, we consider applications to the field of Zika outbreaks. Current solutions are limited to preventative measures such as spraying pesticides, destruction of mosquito breeding grounds, and avoiding the outdoors in the evening. However, these current methods have significant limitations because the geographic areas of Zika-carrying mosquito infestation are not known in fine-grained detail and testing for these locations is difficult. However, through crowdsensing techniques there are ways to better identify and narrow location determination. Devices such as smartphones are very common among the majority of citizens, and these devices can collect a plethora of information. This paper will focus on the use of crowdsensing techniques coupled with medical professional's diagnosis of Zika virus to impute possible vector data to provide more fine-grained and sophisticated location determination for Zika outbreaks.
C1 [Livingston, Jacob; Steele, Robert] Florida Polytech Univ, Dept Data Analyt, Lakeland, FL 33805 USA.
RP Livingston, J (corresponding author), Florida Polytech Univ, Dept Data Analyt, Lakeland, FL 33805 USA.
EM jacoblivingston0427@floridapoly.edu; rsteele@floridapoly.edu
CR Camargo J. T. F. D., 2017, PROCEDIA COMPUTER SC, V104, P294
   CDC, 2017, ZIK VIR
   Cheng C, 2017, CHEMELECTROCHEM, V4, P485, DOI 10.1002/celc.201600831
   Clarke A., 2014, MOB INF SYST, V10, P229
   Clarke A, 2015, J ASSOC INF SCI TECH, V66, P2596, DOI 10.1002/asi.23356
   Dutta Joy, 2017, P 18 INT C DISTR COM, P42
   Fotouhi H., 2016, 3 EAI INT C IOT TECH
   Pagliari C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004795
   Pryss R, 2015, IEEE INT CONF MO, P352, DOI [10.1109/MS.2015.55, 10.1109/MobServ.2015.55]
   Steele R, 2015, CRIT REV FOOD SCI, V55, P1929, DOI 10.1080/10408398.2013.765828
   Steele R, 2013, PERS UBIQUIT COMPUT, V17, P533, DOI 10.1007/s00779-012-0506-5
   Steele R, 2009, INT J MED INFORM, V78, P788, DOI 10.1016/j.ijmedinf.2009.08.001
   Vasilateanu A., 2015, P IEEE E HLTH BIOENG, P1
NR 13
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-1104-3
PY 2017
BP 334
EP 340
PG 7
WC Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BJ7XR
UT WOS:000427814500056
DA 2020-07-08
ER

PT B
AU Gui, XN
   Kou, YB
   Pine, KH
   Chen, YA
AF Gui, Xinning
   Kou, Yubo
   Pine, Kathleen H.
   Chen, Yunan
GP ACM
TI Managing Uncertainty: Using Social Media for Risk Assessment during a
   Public Health Crisis
SO PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN
   COMPUTING SYSTEMS (CHI'17)
LA English
DT Proceedings Paper
CT ACM SIGCHI Conference on Human Factors in Computing Systems (CHI)
CY MAY 06-11, 2017
CL Denver, CO
SP Assoc Comp Machinery, ACM SIGCHI
DE Crisis Informatics; decision-making; information seeking; online forums;
   risk assessment; social media; uncertainty reduction; public health;
   Zika virus
ID SHARED DECISION-MAKING; COMMUNICATION; INFORMATION; ZIKA
AB Recently, diseases like H1N1 influenza, Ebola, and Zika virus have created severe crises, requiring public resources and personal behavior adaptation. Crisis Informatics literature examines interconnections of people, organizations, and IT during crisis events. However, how people use technology to cope with disease crises (outbreaks, epidemics, and pandemics) remains understudied. We investigate how individuals used social media in response to the outbreak of Zika, focusing on travel-related decisions. We found that extreme uncertainty and ambiguity characterized the Zika virus crisis. To cope, people turned to social media for information gathering and social learning geared towards personal risk assessment and modifying decisions when dealing with partial and conflicting information about Zika. In particular, individuals sought local information and used socially informed logical reasoning to deduce the risk at a specific locale. We conclude with implications for designing information systems to support individual risk assessment and decision-making when faced with uncertainty and ambiguity during public health crises.
C1 [Gui, Xinning; Chen, Yunan] Univ Calif Irvine, Irvine, CA 92697 USA.
   [Kou, Yubo] Purdue Univ, W Lafayette, IN 47907 USA.
   [Chen, Yunan] Arizona State Univ, Phoenix, AZ USA.
RP Gui, XN (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.
EM guix@uci.edu; kou2@purdue.edu; khpine@asu.edu; yunanc@uci.edu
OI Kou, Yubo/0000-0002-4255-3725
FU National Science FoundationNational Science Foundation (NSF)
   [HCC-1219197]; UC Irvine Academic Senate Council on Research, Computing
   and Libraries (CORCL) award
FX Many thanks to Kai Zheng, Tera Leigh Reynolds, and Clara Caldeira for
   their cogent comments, and to our anonymous reviewers for their
   insightful feedback. This work was partially supported by the National
   Science Foundation under grant HCC-1219197 and 2015-2016 UC Irvine
   Academic Senate Council on Research, Computing and Libraries (CORCL)
   award.
CR Anker AE, 2011, PATIENT EDUC COUNS, V82, P346, DOI 10.1016/j.pec.2010.12.008
   Brashers DE, 2001, J COMMUN, V51, P477, DOI 10.1111/j.1460-2466.2001.tb02892.x
   Centers for Disease Control & Prevention (CDC), 2016, CDC ADDS BAH INT TRA
   Centers for Disease Control & Prevention (CDC), 2016, ZIK VIR PREGN WOM
   Centers for Disease Control & Prevention (CDC), 2016, ZIK VIR TEST ZIK
   Centers for Disease Control & Prevention (CDC), ZIK VIR SYMPT TEST T
   Centers for Disease Control & Prevention (CDC), 2016, ZIK VIR TRANSM
   Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249
   Cobb Camille, 2014, P 17 ACM C COMP SUPP, DOI DOI 10.1145/2531602.2531712
   Cohen E, 2016, CNN
   Corbin J, 2015, BASICS QUALITATIVE R
   Culotta A., 2014, P SIGCHI C HUM FACT, P1335, DOI DOI 10.1145/2556288.2557139
   Cutilli Carolyn Crane, ORTHOPEDIC NURSING, V29, P214
   Davies-Cole John O., 2016, PACIFIC J MED SCI, V16, P3
   De Choudhury M., 2014, P SIGCHI C HUM FACT, P3563, DOI DOI 10.1145/2556288.2557197
   Ding H., 2010, CHINA MEDIA RESEARCH, V6, P80
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fraustino J. D., 2012, SOCIAL MEDIA USE DIS
   Freimuth VS, 2006, HEALTH COMMUN, V20, P141, DOI 10.1207/s15327027hc2002_5
   Garimella VRK, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P5543, DOI 10.1145/2858036.2858234
   Goggins Sean P, 2012, P ACM 2012 C COMP SU, P57, DOI [10.1145/2145204.2145218, DOI 10.1145/2145204.2145218]
   Gundel S., 2005, J CONTING CRISIS MAN, V13, P106, DOI [10.1111/jccm.2005.13. issue-3, DOI 10.1111/JCCM.2005.13.ISSUE-3]
   Hagar C, 2010, AUST J EMERG MANAG, V25, P38
   Hassad Rossi A., 2016, MEDPAGE TODAY
   Hellmann Daniel E., 2016, P OF CSCW 2016, P1282
   Heverin T, 2012, J AM SOC INF SCI TEC, V63, P34, DOI 10.1002/asi.21685
   Huang YLL, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P969, DOI 10.1145/2675133.2675202
   Hughes A.L., 2014, CRITICAL ISSUES DISA, P349
   Hughes A.L., 2014, P 32 ANN ACM C HUM F, P1505, DOI [10.1145/2556288.2557227, DOI 10.1145/2556288.2557227]
   Hughes AL, 2012, J HOMEL SECUR EMERG, V9
   Huh Jina, 2013, AMIA Annu Symp Proc, V2013, P627
   Imran M, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2771588
   Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073
   Kanthawala S, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5369
   Kate S, 2010, P 7 INT ISCRAM C SEA, P1, DOI DOI 10.1111/J.1556-4029.2009.01231.X
   Kogan M, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P981, DOI 10.1145/2675133.2675218
   Macias W, 2009, J COMPUT-MEDIAT COMM, V15, P1, DOI 10.1111/j.1083-6101.2009.01490.x
   Mamykina L, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3217, DOI 10.1145/2702123.2702566
   Mark G, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P689
   Mark Gloria, 2012, P ACM 2012 C COMP SU, P37, DOI DOI 10.1145/2145204.2145215
   Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Munro Robert, 2012, P SPRING S ASS ADV A, P52
   Palen L., 2007, P 3 INT C E SOC SCI
   Palen L, 2016, SCIENCE, V353, P224, DOI 10.1126/science.aag2579
   Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007
   Paul M.J., 2011, ICWSM, V2011, P265
   Procopio CH, 2007, J APPL COMMUN RES, V35, P67, DOI 10.1080/00909880601065722
   Qu Y, 2011, CSCW 2011 MARCH 19 2, P25, DOI DOI 10.1145/1958824.1958830
   Qu Y., 2009, P 42 HAW INT C SYST, DOI [10.1109/HICSS.2009.330, DOI 10.1109/HICSS.2009.330]
   Rubin AM, 2009, COMMUN SER, P165
   Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006
   Sarcevic Aleksandra, 2012, P ACM 2012 C COMP SU, P47, DOI DOI 10.1145/2145204.2145217
   Sarter NB, 1991, INT J AVIAT PSYCHOL, V1, P45, DOI DOI 10.1207/S15327108IJAP0101_4
   Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003
   Semaan B, 2012, P ACM 2012 C COMP SU, P27, DOI DOI 10.1145/2145204.2145214
   Shklovski I., 2008, P 2008 ACM C COMP SU, P127, DOI DOI 10.1145/1460563.1460584
   Stacey D., 2014, COCHRANE DATABASE SY, V1
   Starbird K, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P360, DOI 10.1145/2858036.2858551
   Starbird K, 2012, CHANDOS INF PROF SER, P43
   Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241
   Tang PC, 1998, J AM MED INFORM ASSN, V5, P563, DOI 10.1136/jamia.1998.0050563
   Unruh KT, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P183, DOI 10.1145/1753326.1753354
   Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486
   Vieweg Sarah, 2008, P ISCRAM 2009
   Villa R, 2016, CLIN TER, V167, P7, DOI 10.7417/CT.2016.1907
   World Health Organization, 2016, ZIK VIR COMPL
NR 69
TC 5
Z9 5
U1 2
U2 4
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-4655-9
PY 2017
BP 4520
EP 4533
DI 10.1145/3025453.3025891
PG 14
WC Computer Science, Cybernetics; Computer Science, Interdisciplinary
   Applications
SC Computer Science
GA BJ6WU
UT WOS:000426970504037
OA Bronze
DA 2020-07-08
ER

PT S
AU Li, K
   Principe, JC
AF Li, Kan
   Principe, Jose C.
GP IEEE
TI Flight Dynamics Modeling and Recognition using Finite State Machine for
   Automatic Insect Recognition
SO 2017 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN)
SE IEEE International Joint Conference on Neural Networks (IJCNN)
LA English
DT Proceedings Paper
CT International Joint Conference on Neural Networks (IJCNN)
CY MAY 14-19, 2017
CL Anchorage, AK
SP Int Neurol Network Soc, IEEE Computat Intelligence Soc, Intel, BMI, Budapest Semester Cognit Sci
DE Audio processing; computational entomology; dynamic modeling; finite
   state machine; kernel adaptive filtering
AB In this paper, we propose a novel state-based approach to insect flight dynamics modeling and automatic insect recognition (AIR). An emerging technology uses noninvasive laser sensors to capture flight information of flying insects in situ. However current computational entomolo*- methods treat these optical signals as static patterns, rather than time series. We propose to evaluate each insect passage as a nonstationary process involving a sequence of pseudo-acoustic frames and model the short-term flight dynamics using a kernel adaptive autoregressive-moving-average (KAARMA) network. Since flight behavior is both nonlinear and nonstationary in nature, dynamic modeling provides a general framework that fully exploits the transitional and contextual information. Using the kernel adaptive ARMA algorithm and spatial clustering, each flight passage is defined to be an ordered sequence of states in a discretized spatiotemporal space. The state transition trajectories are used to construct a finite state machine (FSM) recognizer. The computational efficiency of the automaton classifier eliminates the need to perform numeric computations and enables realtime performance with far-reaching implications in entomology, agriculture, and disease control and prevention. Results show multiclass KAARMA classifier outperforms the state-of-theart AIR methods, using support vector machine (SVM), deep learning autoencoder, and batch learning, in identifying Zika vector mosquito Aedes aegypti among five species of flying insects, while using significantly more efficient data representation. The extracted FSM from trained KAARMA network retained competitive performance compared to the current computationally expensive implementations.
C1 [Li, Kan; Principe, Jose C.] Univ Florida, Computat NeuroEngn Lab CNEL, Gainesville, FL 32611 USA.
RP Li, K (corresponding author), Univ Florida, Computat NeuroEngn Lab CNEL, Gainesville, FL 32611 USA.
FU DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [N66001-10-C-2008, N66001-15-1-4054]
FX YY This work was supported by DARPA Contracts N66001-10-C-2008 and
   N66001-15-1-4054.
CR ANGLUIN D, 1983, COMPUT SURV, V15, P237, DOI 10.1145/356914.356918
   ATAL BS, 1971, J ACOUST SOC AM, V50, P637, DOI 10.1121/1.1912679
   Barcellos C., 2016, EMERG INFECT DIS, V22
   Batista G., 2011, P 17 ACM SIGKDD INT, P761
   CHOMSKY N, 1956, IRE T INFORM THEOR, V2, P113
   DAVIS SB, 1980, IEEE T ACOUST SPEECH, V28, P357, DOI 10.1109/TASSP.1980.1163420
   DESOUZA VMA, 2013, P BRAZ C INT SYST, P76, DOI DOI 10.1109/BRACIS.2013.21
   Gill R. J., 2015, J INTELLIGENT ROB S1, V80, pS313
   Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585
   GOLD EM, 1978, INFORM CONTROL, V37, P302, DOI 10.1016/S0019-9958(78)90562-4
   Grube A., 2011, PESTICIDES IND SALES
   HARRISON MA, 1978, INTRO FORMAL LANGUAG
   Huang XD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16806
   Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4
   Li K., 2017, P INT C AC SPEECH SI
   Li K, 2016, IEEE T NEUR NET LEAR, V27, P334, DOI 10.1109/TNNLS.2015.2418323
   Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065
   McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259
   Minsky ML, 1967, COMPUTATION FINITE I
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4
   Potts SG, 2016, ASSESSMENT REPORT PO
   QI YQ, 2015, P IJCNN, V337, P1, DOI DOI 10.1007/978-3-662-46463-2_1
   Reed SC, 1942, GENETICS, V27, P0349
   Sathantriphop S, 2006, TROP BIOMED, V23, P97
   SIEGELMANN HT, 1995, J COMPUT SYST SCI, V50, P132, DOI 10.1006/jcss.1995.1013
   Silva DF, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P99, DOI 10.1109/ICMLA.2013.24
   Vincent P., 2008, P 25 INT C MACH LEAR, P1096, DOI [10.1145/1390156.1390294, DOI 10.1145/1390156.1390294]
   World Health Organization, 2014, WHODCOWHD20141
NR 29
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2161-4393
BN 978-1-5090-6182-2
J9 IEEE IJCNN
PY 2017
BP 3733
EP 3740
PG 8
WC Computer Science, Artificial Intelligence; Computer Science, Hardware &
   Architecture; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BJ6WL
UT WOS:000426968703132
DA 2020-07-08
ER

PT J
AU Vieira, MADES
   Cruz, ACR
   Barros, ANM
   Costa, DL
   da Silva, EVP
   Batista, FMD
   Azevedo, RDD
   Rodrigues, SG
   Araujo, RC
   Vasconcelos, PFD
AF da Cunha e Silva Vieira, Marcelo Adriano
   Ribeiro Cruz, Ana Cecilia
   Mesquita Barros, Ananda Naya
   Costa, Dorcas Lamounier
   Pinto da Silva, Eliana Vieira
   de Araujo Batista, Francisca Miriane
   da Silva Azevedo, Raimunda do Socorro
   Rodrigues, Sueli Guerreiro
   Araujo-Junior, Rui Cipriano
   da Costa Vasconcelos, Pedro Fernando
TI Guillain-Barre syndrome and dengue-like disease in 2015: temporal
   relationship in Piaui state and implications on Zika virus surveillance
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Letter
ID FLACCID PARALYSIS; BRAZIL; INFECTIONS
C1 [da Cunha e Silva Vieira, Marcelo Adriano] Secretaria Estado Saude Piaui, Inst Doencas Tropicais Natan Portella, Teresina, Piaui, Brazil.
   [da Cunha e Silva Vieira, Marcelo Adriano; Araujo-Junior, Rui Cipriano] Fundacao Municipal Saude Teresina, Diretoria Vigilencia Saude, Teresina, Piaui, Brazil.
   [Ribeiro Cruz, Ana Cecilia; Pinto da Silva, Eliana Vieira; da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Secao Arbovirol &a Febres Hemorrag, Ananindeua, Para, Brazil.
   [Mesquita Barros, Ananda Naya; de Araujo Batista, Francisca Miriane] Secretaria Estado Saude Piaui, Gerencia Vigilancia Saude, Teresina, Piaui, Brazil.
   [Costa, Dorcas Lamounier] Univ Fed Piaui, Dept Med Especializada, Teresina, Piaui, Brazil.
RP Vieira, MADES (corresponding author), Inst Doencas Tropicais Natan Portella, Dept Neurol, Rua Governador Artur de Vasconcelos 151, BR-64001450 Teresina, Piaui, Brazil.
EM macsvieira@superig.com.br
RI Vasconcelos, Pedro/AAH-3142-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Piaui. Secretaria de Estado da Saude, 2016, B EPIDEMIOL SEMANAL
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643
   Solomon T, 2003, CURR OPIN INFECT DIS, V16, P375, DOI 10.1097/00001432-200310000-00002
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Wessa P., 2012, CROSS CORRELATION FU
   WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P613, DOI 10.1136/jnnp.51.5.613
   World Health Organization, 2016, ZIK SIT REP
NR 20
TC 4
Z9 4
U1 0
U2 1
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2017
VL 59
AR UNSP e22
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ3KO
UT WOS:000404610000011
PM 28423097
OA DOAJ Gold
DA 2020-07-08
ER

PT B
AU Quadri, SM
   Prashanth, TK
   Pongpaichet, S
   Esmin, AAA
   Jain, R
AF Quadri, Syed Munawwar
   Prashanth, T. K.
   Pongpaichet, Siripen
   Esmin, Ahmed A. A.
   Jain, Ramesh
GP IEEE
TI TargetZIKA: Epidemic Situation Detection and Risk Preparedness for ZIKA
   Virus
SO 2017 10TH INTERNATIONAL CONFERENCE ON UBI-MEDIA COMPUTING AND WORKSHOPS
   (UBI-MEDIA)
LA English
DT Proceedings Paper
CT 10th International Conference on Ubi-media Computing and Workshops
   (Ubi-Media)
CY AUG 01-04, 2017
CL Kasetsart Univ Sriracha Campus, Fac Engn, Pattaya, THAILAND
SP IEEE Thailand Sect, Natl Cent Univ, IEEE Thailand Sect, Geo Informat & Space Technol Dev Agcy
HO Kasetsart Univ Sriracha Campus, Fac Engn
AB We propose a framework for disaster situation modeling in smart city using micro-reporting from the most efficient and reliable sources of multimedia, people with mobile phones. By using micro-reports generated from a crowdsourced mobile phone application and EventShop to analyze all kinds of Zika related data, TargetZIKA aims to combat the spread of the Zika virus in Brazil. EventShop is an open-source platform which provides a generic infrastructure for ingesting and aggregating heterogeneous spatio-temporal data streams derived from various sources like in situ sensors and social media. By using the foremost technologies for disaster situation mapping, we develop not only a method to rate the dangerous states and locations in Brazil but also a tool for simple visualization of the smart-citizen's environment.
C1 [Quadri, Syed Munawwar; Prashanth, T. K.] PES Inst Technol, Bangalore, Karnataka, India.
   [Pongpaichet, Siripen] Mahidol Univ, Fac Informat & Commun Technol, Salaya, Nakhon Pathom, Thailand.
   [Esmin, Ahmed A. A.] Univ Fed Lavras, Lavras, MG, Brazil.
   [Jain, Ramesh] Univ Calif Irvine, Irvine, CA USA.
RP Quadri, SM (corresponding author), PES Inst Technol, Bangalore, Karnataka, India.
EM syedmunawwar990@gmail.com; prashanth9c007@gmail.com;
   siripen.pon@mahidol.ac.th; ahmed@dcc.ufla.br; jain@ics.uci.edu
FU Faculty of Information and Communication Technology, Mahidol University
FX This project would not have been possible without help and support of
   many individuals and organizations from Brazil. We would like to extend
   our sincere gratitude to all of them. We also thank Asquith Bailey and
   Pinaki Sinha from Krumbs Inc. for assistance with Krumbs SDK[12]. This
   research project was partially supported by Faculty of Information and
   Communication Technology, Mahidol University.
CR [Anonymous], 2015, WHO UNICEF WAT SUPPL
   [Anonymous], WORLD ZIK VIR OUTBR
   [Anonymous], 2015, CUMULATIVE ZIKA SUSP
   [Anonymous], 2016, ZIK VIR STAT BRAZ
   [Anonymous], 2016, SUSPECTED CONFIRMED
   [Anonymous], 2016, MICROCEPHALY ZIKA ST
   [Anonymous], POP NUMB DENS HEALTH
   [Anonymous], 2016, MOSQUITO CONTROL CAN
   Brasil P, 2016, NEW ENGL J MED, DOI 10.1056/NEJMoa1602412.
   Derczynski L., 2013, P INT C REC ADV NAT, P198
   KELVIN A., 2016, J INFECT DEV COUNTRI, V10
   Pongpaichet S, 2016, ICMR'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA RETRIEVAL, P87, DOI 10.1145/2911996.2912020
   Reilly Michael, 2016, MIT TECHNOLOGY  0129
   Singh V. K., 2016, SITUATION RECOGNITIO
NR 14
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-2761-7
PY 2017
BP 229
EP 234
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Engineering, Electrical & Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BJ7GJ
UT WOS:000427256900036
DA 2020-07-08
ER

PT S
AU Liu, K
   Du, Q
   Ren, GD
   Yu, B
   Zhang, C
AF Liu, Kan
   Du, Qian
   Ren, Guodong
   Yu, Bin
   Zhang, Chi
GP IEEE
TI Identification of Differential Alternative Splicing Events with an
   Adjusted Beta-Distribution Model
SO 2017 IEEE INTERNATIONAL CONFERENCE ON ELECTRO INFORMATION TECHNOLOGY
   (EIT)
SE International Conference on Electro Information Technology
LA English
DT Proceedings Paper
CT IEEE International Conference on Electro Information Technology (EIT)
CY MAY 14-17, 2017
CL Lincoln, NE
SP IEEE
DE alternative splicing (AS); next generation sequencing; RNA-seq
ID RNA-SEQ DATA; CELL-DIFFERENTIATION; POLLEN GERMINATION; TUBE GROWTH;
   ARABIDOPSIS; TRANSCRIPTION; GENE
AB High-throughput next generation sequencing of cDNA, i.e. RNA-Seq, presents an unprecedented resource for characterizing the alternative splicing (AS) in complex eukaryotic transcriptomes. Accumulating evidences indicate that AS is developmentally regulated, but the precise responses of AS event to development is not well understood. Here, we describe a new method, based on an adjusted beta-distribution model, for detection of differential AS patterns from RNA-Seq data comparisons. Applying our method to two datasets of RNA-Seq for zika infection in human cells and pollen tissue in Arabidopsis thaliana, we identified 1,871 differentially AS events for 1,394 protein-coding genes in human and 496 differentially AS events for 358 protein-coding genes in Arabidopsis, respectively. The results included known AS events reported before as well as novel events, which demonstrate that the biological replicates are important in the effective identification using beta-distribution. With a high accurate rate, our new method in differential AS identification will facilitate future investigation on transcriptomic annotation.
C1 [Liu, Kan; Du, Qian; Yu, Bin; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.
   [Ren, Guodong] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai, Peoples R China.
RP Liu, K (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.
RI Ren, Guodong/F-9823-2011; Zhang, Chi/C-4996-2009
OI Ren, Guodong/0000-0002-1895-7578; Zhang, Chi/0000-0002-1827-8137
FU NE Soybean Board funds
FX We thank Dr. Shangang Jia and Weilong Yang for technical assistance and
   method discussion. This study is supported by NE Soybean Board funds.
CR Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111
   Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Borg M, 2011, PLANT CELL, V23, P534, DOI 10.1105/tpc.110.081059
   Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327
   Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   English AC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-102
   Estrada AD, 2015, PEERJ, V3, DOI 10.7717/peerj.919
   Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026
   Li HM, 2012, FEBS LETT, V586, P1027, DOI 10.1016/j.febslet.2012.02.046
   Loraine AE, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P118, DOI 10.1109/CSB.2002.1039335
   Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Wang W., GENE, V518, P164
   Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375
NR 20
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2154-0357
BN 978-1-5090-4767-3
J9 INT CONF ELECTRO INF
PY 2017
BP 276
EP 279
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BJ7DK
UT WOS:000427099000056
DA 2020-07-08
ER

PT B
AU Ghenai, A
   Mejova, Y
AF Ghenai, Amira
   Mejova, Yelena
BE GiraudCarrier, C
   Facelli, J
   Nakajima, H
   Cummins, M
   Meixner, G
TI Catching Zika Fever: Application of Crowdsourcing and Machine Learning
   for Tracking Health Misinformation on Twitter
SO 2017 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI)
LA English
DT Proceedings Paper
CT 5th IEEE International Conference on Healthcare Informatics (ICHI)
CY AUG 23-26, 2017
CL Park City, UT
SP IEEE, IEEE Comp Soc, NSF, SyncTimes, Journal Hlth Care Informat Res, Univ Utah Hlth
AB In February 2016, World Health Organization declared the Zika outbreak a Public Health Emergency of International Concern. With developing evidence it can cause birth defects, and the Summer Olympics coming up in the worst affected country, Brazil, the virus caught fire on social media. In this work, we use Zika as a case study in building a tool for tracking the misinformation around health concerns on Twitter. We collect more than 13 million tweets regarding the Zika outbreak and track rumors outlined by the World Health Organization and Snopes fact checking website. The tool pipeline, which incorporates health professionals, crowdsourcing, and machine learning, allows us to capture health-related rumors around the world, as well as clarification campaigns by reputable health organizations. We discover an extremely bursty behavior of rumor-related topics, and show that, once the questionable topic is detected, it is possible to identify rumor-bearing tweets using automated techniques.
C1 [Ghenai, Amira] Univ Waterloo, Waterloo, ON, Canada.
   [Mejova, Yelena] HBKU, Qatar Comp Res Inst, Doha, Qatar.
RP Ghenai, A (corresponding author), Univ Waterloo, Waterloo, ON, Canada.
EM aghenai@uwaterloo.ca; ymejova@hbku.edu.qa
CR Chatila Wissam M., 2008, WORLD J GASTROENTERO, V5
   Costello Anna B., 2005, PARE
   Felker Bradford, 2010, PRIM CARE COMPANION
   Healthcare Cost and Utilization Project, 2000, CLIN CLASS SOFTW CCS, pXXX
   Kubinger KD, 2003, PSYCHOL SCI, V45, P106
   Padhy N., 2012, INT J COMPUTER SCI E, V2
   Prichard SS, 2000, KIDNEY INT, V57, pS100, DOI 10.1046/j.1523-1755.2000.07417.x
   Rache Gilles, 2006, INT M PSYCH SOC
   Rassekh SR, 2010, J CANCER EPIDEMIOL, V2010, DOI 10.1155/2010/569517
   Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697
   Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941
   StatWiki, CONF FACT AN MOD IND
   *WHO, INT CLASS DIS ICD
NR 13
TC 4
Z9 4
U1 3
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-4881-6
PY 2017
BP 518
EP 523
DI 10.1109/ICHI.2017.58
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Medical Informatics
SC Computer Science; Medical Informatics
GA BJ7DE
UT WOS:000427093300084
DA 2020-07-08
ER

PT B
AU Rojas, MNR
   Porcasi, X
   Ferreyra, MFG
   Lopez, L
   Lanfri, M
   Lighezzolo, A
   Guzman, C
   Aguirre, E
   Albornoz, C
   Scavuzzo, CM
AF Rojas, Maria Nazarena R.
   Porcasi, Ximena
   Garcia Ferreyra, Maria Fernanda
   Lopez, Laura
   Lanfri, Mario
   Lighezzolo, Andres
   Guzman, Claudio
   Aguirre, Exequiel
   Albornoz, Carlos
   Marcelo Scavuzzo, Carlos
GP IEEE
TI Use of geospatial tools for decision-making in the arboviruses
   prevention and control, in the Cordoba city, Argentina
SO 2017 XVII WORKSHOP ON INFORMATION PROCESSING AND CONTROL (RPIC)
LA English
DT Proceedings Paper
CT 17th Workshop on Information Processing and Control (RPIC)
CY OCT 20-22, 2017
CL Mar del Plata, ARGENTINA
SP IEEE
DE Arbovirus; Ae. aegypti; Remote Sensing; Maximum Entropy (MaxEnt)
ID AEDES-AEGYPTI; DENGUE; DYNAMICS; OUTBREAK
AB In Argentina, the Dengue virus (within the group of arbovirosis) has been a major public health problem since 1997. The most important outbreak in the history was carried out in 2016, and with the main transmitting vector Ae. Aegypti the transmission of the Chikungunya and Zika viruses was potentiated. The goal of this study is provide useful tools, such as the Aedes distribution prediction models, for decision makers in order to control vector. We apply maximun entropy method using Aedes breeding sites and macro environmental variables derived from Spot 6 images. Five maps of probability of vector presence was produced. Un increment in the areas with a high probability of presence from 4.8% in October to 8.8% in January was observed. The spatio-temporal distribution patterns of Ae. Aegypti accomplished in this work intends to contribute in taking actions in vector control in Cordoba city.
C1 [Rojas, Maria Nazarena R.; Porcasi, Ximena; Garcia Ferreyra, Maria Fernanda; Lanfri, Mario; Lighezzolo, Andres; Aguirre, Exequiel; Albornoz, Carlos; Marcelo Scavuzzo, Carlos] Comis Nacl Actividades Espaciales, Buenos Aires, DF, Argentina.
   [Lopez, Laura; Guzman, Claudio] Min Salud Prov Cordoba, Area Epidemiol, Cordoba, Argentina.
RP Rojas, MNR (corresponding author), Comis Nacl Actividades Espaciales, Buenos Aires, DF, Argentina.
EM nrojas@conae.gov.ar; ximena.porcasi@conae.gov.ar;
   fgarciaferreyra@conae.gov.ar; laulop@hotmail.com; lamfri@conae.gov.ar;
   alighezzolo@conae.gov.ar; Cguzman77@hotmail.com; eaguirre@conae.gov.ar;
   calbornoz@conae.gov.ar; scavuzzo@conae.gov.ar
CR Arboleda S, 2009, INT J ENV RES PUB HE, V6, P3040, DOI 10.3390/ijerph6123040
   Beron CM, 2016, INVESTIGACIONES MOSQ
   CAPITANELLI RG, 1979, GEOGRAFIA FISICA PRO, P45
   Dominguez M., 2000, SOC ENTOMOL ARGENT, V59, P41
   Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621
   Espinosa MO, 2016, GEOSPATIAL HEALTH, V11, P307, DOI 10.4081/gh.2016.471
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   GLASS GE, 1992, GEO INFO SYSTEMS, V2, P65
   Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085
   Jarsun B., 2003, CARACTERIZACION GEN, P23
   Estallo EL, 2016, IEEE J-STARS, V9, P5461, DOI 10.1109/JSTARS.2016.2604577
   Nelson M. J., 1986, AEDES AEGYPTI BIOL E, P50
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Porcasi X, 2012, GEOSPATIAL HEALTH, V6, pS31
   Rotela C. H., 2012, DESARROLLO MODELOS I
   Rotela C. H., 2010, SELPER, V30, P85
   Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003
   Sbarato R. D., 2000, ESTUDIO IMPACTO AMBI
   Stein M, 2005, REV SAUDE PUBL, V39, P559, DOI [10.1590/S0034-89102005000400007, 10.1590/s0034-89102005000400007]
   Valerio Lluis, 2016, MED CLIN BARC, V146
   WOOD BL, 1992, INT J REMOTE SENS, V13, P2813, DOI 10.1080/01431169208904083
NR 22
TC 0
Z9 0
U1 1
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-987-544-754-7
PY 2017
PG 5
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BJ7ES
UT WOS:000427184900100
DA 2020-07-08
ER

EF